Gene,Gene_ID,disease_name,disease_id,score,Calculated_Risk_Score,Num_SNPs,Total_Risk_Score,Weighted_Gene_Score,Feature_Type,Gene_Length_bp
FBN1,ENSG00000166147,Marfan syndrome,MONDO_0007947,0.8966798238959253,8.966804904181789,1,0.4,0.4,transcript,60013.0
SOS1,ENSG00000115904,Noonan syndrome,MONDO_0018997,0.8705764800548861,8.705788408422087,2,0.8,1.6,transcript,67774.0
SLC22A5,ENSG00000197375,Systemic primary carnitine deficiency,Orphanet_158,0.8672687749972517,8.67269331890899,1,0.4,0.4,transcript,71827.0
SPAST,ENSG00000021574,Autosomal dominant spastic paraplegia type 4,Orphanet_100985,0.8672580226066255,8.672585402384598,1,0.4,0.4,transcript,77275.0
GALC,ENSG00000054983,Krabbe disease,MONDO_0009499,0.8592547080021959,8.592619972960454,2,0.8,1.6,transcript,21950.0
RET,ENSG00000165731,multiple endocrine neoplasia type 2A,MONDO_0008234,0.8583241632332175,8.5832516445972,1,0.4,0.4,transcript,39951.0
RET,ENSG00000165731,medullary thyroid gland carcinoma,MONDO_0015277,0.8559795494557313,8.559805506822338,1,0.4,0.4,transcript,39951.0
BRCA2,ENSG00000139618,breast cancer,MONDO_0007254,0.8548846942723206,8.548849934710663,1,0.5,0.5,transcript,167113.0
BRCA2,ENSG00000139618,breast neoplasm,EFO_0003869,0.8546627679684532,8.54663067167199,1,0.5,0.5,transcript,167113.0
DYNC2H1,ENSG00000187240,asphyxiating thoracic dystrophy 3,MONDO_0013127,0.8531996080725445,8.532006237134139,1,0.5,0.5,transcript,49230.0
EGFR,ENSG00000146648,non-small cell lung carcinoma,EFO_0003060,0.8495102762038971,8.495140080693634,2,0.8,1.6,transcript,42874.0
PPARG,ENSG00000132170,type 2 diabetes mellitus,MONDO_0005148,0.8486377702559134,8.511908696753357,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,type 2 diabetes mellitus,MONDO_0005148,0.8486377702559134,8.511908696753357,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,type 2 diabetes mellitus,MONDO_0005148,0.8486377702559134,8.511908696753357,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,type 2 diabetes mellitus,MONDO_0005148,0.8486377702559134,8.511908696753357,59,24.0,1416.0,gene_variant,55462.0
GLB1,ENSG00000170266,mucopolysaccharidosis type 4B,MONDO_0009660,0.8473485669415689,8.473516577495062,1,0.5,0.5,transcript,16177.0
TYR,ENSG00000077498,oculocutaneous albinism type 1A,MONDO_0008745,0.8468634243534792,8.46875806720988,1,0.5,0.5,transcript,4038.0
AGA,ENSG00000038002,aspartylglucosaminuria,MONDO_0008830,0.8449861552155568,8.449959533735031,1,0.5,0.5,transcript,5103.0
SKI,ENSG00000157933,Shprintzen-Goldberg syndrome,MONDO_0008426,0.8449776577590219,8.449829098598622,1,0.4,0.4,transcript,7616.0
GLB1,ENSG00000170266,GM1 gangliosidosis type 1,MONDO_0009260,0.8448513509507921,8.448544417587293,1,0.5,0.5,transcript,16177.0
SUMF1,ENSG00000144455,Multiple sulfatase deficiency,Orphanet_585,0.8428600609929631,8.428632959302863,1,0.4,0.4,transcript,12365.0
AR,ENSG00000169083,androgen insensitivity syndrome,MONDO_0019154,0.8424737152055584,8.424778481841445,2,0.8,1.6,transcript,38713.0
GBE1,ENSG00000114480,glycogen storage disease due to glycogen branching enzyme deficiency,MONDO_0009292,0.8415526961562311,8.41558784065643,1,0.5,0.5,transcript,8213.0
ANO5,ENSG00000171714,autosomal recessive limb-girdle muscular dystrophy type 2L,MONDO_0012652,0.8369989968761427,8.369995015124891,1,0.4,0.4,transcript,79265.0
GLB1,ENSG00000170266,GM1 gangliosidosis type 3,MONDO_0009262,0.8368940112883008,8.36897102096238,1,0.5,0.5,transcript,16177.0
BRCA2,ENSG00000139618,Hereditary breast and ovarian cancer syndrome,Orphanet_145,0.8367333122861857,8.367336114849316,1,0.5,0.5,transcript,167113.0
GLB1,ENSG00000170266,GM1 gangliosidosis type 2,MONDO_0009261,0.8365398139490504,8.365429047569876,1,0.5,0.5,transcript,16177.0
KCNQ1,ENSG00000053918,long QT syndrome 1,MONDO_0100316,0.8362779383336674,8.362973056674312,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
VPS13A,ENSG00000197969,Choreoacanthocytosis,Orphanet_2388,0.8355132495222666,8.35513924047148,1,0.4,0.4,transcript,59301.0
LRRK2,ENSG00000188906,Hereditary late-onset Parkinson disease,Orphanet_411602,0.8349741052756088,8.349759810571843,2,0.9,1.8,transcript,95960.0
ALDOB,ENSG00000136872,hereditary fructose intolerance,MONDO_0009249,0.8345801895400516,8.345843307554983,1,0.4,0.4,transcript,9659.0
BRCA2,ENSG00000139618,Fanconi anemia complementation group D1,MONDO_0011584,0.8341638595090799,8.341641587078257,1,0.5,0.5,transcript,167113.0
MMADHC,ENSG00000168288,"Methylmalonic acidemia with homocystinuria, type cblD",Orphanet_79283,0.8296786492639707,8.296868058708224,1,0.4,0.4,transcript,4904.0
BRCA2,ENSG00000139618,breast carcinoma,EFO_0000305,0.8292560766020882,8.29256375800834,1,0.5,0.5,transcript,167113.0
WRN,ENSG00000165392,Werner syndrome,MONDO_0010196,0.8278599076163855,8.27862647792853,1,0.5,0.5,transcript,18247.0
SPRED1,ENSG00000166068,Legius syndrome,MONDO_0012669,0.827230168779278,8.27234626100428,1,0.4,0.4,transcript,8974.0
TBX5,ENSG00000089225,Holt-Oram syndrome,MONDO_0007732,0.8271561196033219,8.271686489690227,2,0.8,1.6,transcript,12770.0
SHH,ENSG00000164690,holoprosencephaly 3,MONDO_0007733,0.8258269473151775,8.258322622234953,1,0.4,0.4,transcript,7526.0
DPYD,ENSG00000188641,dihydropyrimidine dehydrogenase deficiency,MONDO_0010130,0.8238869286253052,8.238927507026224,1,0.5,0.5,transcript,8588.0
KLHL3,ENSG00000146021,pseudohypoaldosteronism type 2D,MONDO_0013781,0.8236002175398649,8.236049486081994,2,0.8,1.6,transcript,33819.0
AR,ENSG00000169083,partial androgen insensitivity syndrome,MONDO_0010720,0.8229769855485846,8.229811185271705,2,0.8,1.6,transcript,38713.0
GHR,ENSG00000112964,Laron syndrome,MONDO_0009877,0.8210809175033865,8.210818036550515,1,0.4,0.4,transcript,45139.0
ANO5,ENSG00000171714,gnathodiaphyseal dysplasia,MONDO_0008151,0.8201943478966875,8.201948525330339,1,0.4,0.4,transcript,79265.0
RET,ENSG00000165731,multiple endocrine neoplasia type 2B,MONDO_0008082,0.8196079332979929,8.196089345244953,1,0.4,0.4,transcript,39951.0
GFPT1,ENSG00000198380,Congenital myasthenic syndromes,Orphanet_590,0.818469410941056,8.18470921343956,1,0.4,0.4,transcript,26483.0
MMADHC,ENSG00000168288,methylmalonic aciduria and homocystinuria type cblD,MONDO_0010185,0.8174910019084023,8.17499158515254,1,0.4,0.4,transcript,4904.0
TYR,ENSG00000077498,oculocutaneous albinism type 1B,MONDO_0011749,0.8173474087209687,8.173597910884775,1,0.5,0.5,transcript,4038.0
PEX7,ENSG00000112357,Refsum disease,Orphanet_773,0.8171684084454838,8.171726628594383,1,0.4,0.4,transcript,9402.0
GCH1,ENSG00000131979,dystonia 5,MONDO_0007495,0.816759845914235,8.167632222964416,1,0.4,0.4,transcript,11847.0
NBAS,ENSG00000151779,infantile liver failure syndrome 2,MONDO_0014659,0.8167212921295202,8.167246467085205,2,1.0,2.0,transcript,59620.0
MTR,ENSG00000116984,methylcobalamin deficiency type cblG,MONDO_0009609,0.8158511666850812,8.158516079280627,1,0.4,0.4,transcript,90653.0
CCBE1,ENSG00000183287,Hennekam syndrome,MONDO_0016256,0.8152874305690586,8.15288809594088,1,0.4,0.4,transcript,29006.0
ANOS1,ENSG00000011201,hypogonadotropic hypogonadism 1 with or without anosmia,MONDO_0010635,0.8150971636789248,8.151023143356335,1,0.4,0.4,transcript,7766.0
GJB2,ENSG00000165474,palmoplantar keratoderma-deafness syndrome,MONDO_0007852,0.8149972042562548,8.150058848118103,1,0.4,0.4,transcript,4608.0
NDUFS4,ENSG00000164258,mitochondrial complex I deficiency,MONDO_0100133,0.8149288533808948,8.149395115210494,1,0.4,0.4,transcript,3753.0
SI,ENSG00000090402,congenital sucrase-isomaltase deficiency,MONDO_0009114,0.8149182964478249,8.149255010587758,1,0.5,0.5,transcript,6940.0
RP2,ENSG00000102218,retinitis pigmentosa,MONDO_0019200,0.8145559468294035,8.145667576402143,1,0.4,0.4,transcript,3700.0
BMPR2,ENSG00000204217,"pulmonary hypertension, primary, 1",MONDO_0024533,0.8135895522922568,8.135913294381606,1,0.4,0.4,transcript,22508.0
SGCB,ENSG00000163069,autosomal recessive limb-girdle muscular dystrophy type 2E,MONDO_0011423,0.813273161416255,8.132804209443856,1,0.4,0.4,transcript,5510.0
PEX2,ENSG00000164751,peroxisome biogenesis disorder 5A (Zellweger),MONDO_0013932,0.8130148955026041,8.130192781036778,1,0.4,0.4,transcript,9127.0
LRBA,ENSG00000198589,combined immunodeficiency due to LRBA deficiency,MONDO_0013863,0.8113005110428253,8.113009051936274,1,0.4,0.4,transcript,101484.0
FREM2,ENSG00000150893,Fraser syndrome,MONDO_0009046,0.8104446008284127,8.105337115038717,6,2.5,15.0,transcript,16833.0
CP,ENSG00000047457,aceruloplasminemia,MONDO_0011426,0.8103961568267681,8.103982626219164,1,0.5,0.5,transcript,23744.0
PHIP,ENSG00000146247,PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome,MONDO_0035133,0.8101285327732248,8.101293304885681,1,0.5,0.5,transcript,62679.0
PEX7,ENSG00000112357,rhizomelic chondrodysplasia punctata type 1,MONDO_0008972,0.8096144944417485,8.09618748855703,1,0.4,0.4,transcript,9402.0
FBN1,ENSG00000166147,"ectopia lentis 1, isolated, autosomal dominant",MONDO_0007514,0.809441312201,8.094419787232535,1,0.4,0.4,transcript,60013.0
BRCA2,ENSG00000139618,cancer,MONDO_0004992,0.809106095890186,8.091063950889318,1,0.5,0.5,transcript,167113.0
FRAS1,ENSG00000138759,Fraser syndrome,MONDO_0009046,0.8078344647959333,8.078376784503941,2,0.9,1.8,transcript,56011.0
GJA3,ENSG00000121743,Posterior polar cataract,Orphanet_98993,0.807490100326388,8.074977719796292,1,0.4,0.4,transcript,5214.0
TGFBR1,ENSG00000106799,Loeys-Dietz syndrome 1,MONDO_0012212,0.806734473424144,8.067348981833586,1,0.4,0.4,transcript,94171.0
ALPK3,ENSG00000136383,hypertrophic cardiomyopathy,EFO_0000538,0.8063180289620713,8.063217585658009,1,0.4,0.4,transcript,10725.0
PKP2,ENSG00000057294,Arrhythmogenic right ventricular dysplasia,Orphanet_247,0.8061916162615861,8.062072263984186,4,1.6,6.4,transcript,40999.0
GCH1,ENSG00000131979,GTP cyclohydrolase I deficiency with hyperphenylalaninemia,MONDO_0100186,0.8059713221371119,8.059746985193184,1,0.4,0.4,transcript,11847.0
SLC6A5,ENSG00000165970,hereditary hyperekplexia,MONDO_0021022,0.8059396927332323,8.059435563476436,1,0.4,0.4,transcript,10353.0
SLC25A46,ENSG00000164209,"neuropathy, hereditary motor and sensory, type vib",EFO_0009075,0.8055387766917383,8.055407720027576,1,0.4,0.4,transcript,20047.0
THAP1,ENSG00000131931,"Primary dystonia, DYT6 type",Orphanet_98806,0.8054768596326468,8.054847961405834,1,0.4,0.4,transcript,5040.0
FBN1,ENSG00000166147,Acromicric dysplasia,MONDO_0007055,0.8041599621113951,8.041606286336487,1,0.4,0.4,transcript,60013.0
GBE1,ENSG00000114480,adult polyglucosan body disease,MONDO_0009897,0.8041533197213482,8.041594076307602,1,0.5,0.5,transcript,8213.0
GALNT3,ENSG00000115339,familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome,Orphanet_306661,0.8036047961381312,8.036076869381601,1,0.4,0.4,transcript,13837.0
SH3TC2,ENSG00000169247,Charcot-Marie-Tooth disease type 4C,MONDO_0011113,0.8030391752850824,8.030396176259503,1,0.4,0.4,transcript,90428.0
AR,ENSG00000169083,prostate cancer,MONDO_0008315,0.8029552448422713,8.029593778208573,2,0.8,1.6,transcript,38713.0
CLDN16,ENSG00000113946,renal hypomagnesemia 3,MONDO_0009550,0.8028883840277404,8.028984216688947,1,0.4,0.4,transcript,3985.0
TRPC6,ENSG00000137672,focal segmental glomerulosclerosis,EFO_0004236,0.8025000022433534,8.025028909557099,1,0.4,0.4,transcript,13847.0
FBN1,ENSG00000166147,geleophysic dysplasia 2,MONDO_0013612,0.801886295466196,8.018869619884496,1,0.4,0.4,transcript,60013.0
PPA2,ENSG00000138777,sudden cardiac arrest,EFO_0004278,0.8016594295071408,8.016621701341961,1,0.5,0.5,transcript,18244.0
AP1S2,ENSG00000182287,syndromic X-linked intellectual disability 5,MONDO_0010574,0.8016218818285646,8.016239627774773,1,0.4,0.4,transcript,19222.0
TRIT1,ENSG00000043514,combined oxidative phosphorylation deficiency 35,MONDO_0054742,0.8003209708079176,8.003224910846079,1,0.4,0.4,transcript,26311.0
MC2R,ENSG00000185231,familial glucocorticoid deficiency,MONDO_0008733,0.8001255410462645,8.001350017842022,1,0.4,0.4,transcript,4228.0
FBN1,ENSG00000166147,stiff skin syndrome,MONDO_0008492,0.7999448018122904,7.999454683345439,1,0.4,0.4,transcript,60013.0
UNC80,ENSG00000144406,"hypotonia, infantile, with psychomotor retardation and characteristic facies",MONDO_0014176,0.7990871175780205,7.990875837784867,1,0.4,0.4,transcript,85800.0
GJB2,ENSG00000165474,keratoderma hereditarium mutilans,MONDO_0007422,0.7986522754814325,7.98660956036988,1,0.4,0.4,transcript,4608.0
MMADHC,ENSG00000168288,Methylmalonic acidemia with homocystinuria,Orphanet_26,0.797452997910108,7.974611545169596,1,0.4,0.4,transcript,4904.0
PEX2,ENSG00000164751,Peroxisome biogenesis disorder-Zellweger syndrome spectrum,Orphanet_79189,0.7972997657363634,7.973041483374371,1,0.4,0.4,transcript,9127.0
HFE,ENSG00000010704,hereditary hemochromatosis type 1,EFO_0006513,0.7971643903481864,7.971652188657613,1,0.4,0.4,transcript,48279.0
PDHX,ENSG00000110435,pyruvate dehydrogenase E3-binding protein deficiency,MONDO_0009503,0.7956299776985056,7.956344544752264,1,0.4,0.4,transcript,8935.0
SLC39A8,ENSG00000138821,SLC39A8-CDG,MONDO_0014746,0.7954746743325342,7.954754048727687,1,0.4,0.4,transcript,54754.0
PIGN,ENSG00000197563,multiple congenital anomalies-hypotonia-seizures syndrome 1,MONDO_0013563,0.7954154898755184,7.954157438582856,1,0.4,0.4,transcript,157491.0
KCNQ3,ENSG00000184156,Benign familial neonatal seizures,Orphanet_1949,0.7952619906838837,7.952676284569634,2,0.8,1.6,transcript,28380.0
LRP2,ENSG00000081479,Donnai-Barrow syndrome,MONDO_0009104,0.7947539667521669,7.947556256221446,1,0.5,0.5,transcript,30141.0
FGA,ENSG00000171560,familial dysfibrinogenemia,MONDO_0014452,0.7944420750199267,7.944488974657736,1,0.4,0.4,transcript,5863.0
GJB2,ENSG00000165474,Bart-Pumphrey syndrome,MONDO_0007866,0.7939639612349843,7.939726417905398,1,0.4,0.4,transcript,4608.0
LDLRAP1,ENSG00000157978,homozygous familial hypercholesterolemia,MONDO_0018328,0.7937386828083639,7.937412741532719,1,0.4,0.4,transcript,15436.0
BRCA2,ENSG00000139618,ovarian neoplasm,EFO_0003893,0.7935715728588665,7.935718720576123,1,0.5,0.5,transcript,167113.0
DAG1,ENSG00000173402,autosomal recessive limb-girdle muscular dystrophy type 2P,MONDO_0013440,0.7935287648287157,7.935293836405969,1,0.4,0.4,transcript,64640.0
NBAS,ENSG00000151779,Short stature-optic atrophy-Pelger-HuÃ«t anomaly syndrome,Orphanet_391677,0.7929760254922763,7.929793800712766,2,1.0,2.0,transcript,59620.0
SPART,ENSG00000133104,Troyer syndrome,MONDO_0010156,0.792905129916495,7.929065564500186,1,0.4,0.4,transcript,28040.0
DSC2,ENSG00000134755,Arrhythmogenic right ventricular dysplasia,Orphanet_247,0.7927758948208196,7.927771390274823,2,0.8,1.6,transcript,128596.0
AR,ENSG00000169083,prostate carcinoma,EFO_0001663,0.792393488087032,7.92397621065618,2,0.8,1.6,transcript,38713.0
NEK1,ENSG00000137601,short-rib thoracic dysplasia 6 with or without polydactyly,MONDO_0009894,0.7920365491643633,7.920379751511907,2,0.8,1.6,transcript,112203.0
LAMA1,ENSG00000101680,ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome,MONDO_0014419,0.7905870321149505,7.9058862163682235,1,0.5,0.5,transcript,31456.0
ASPM,ENSG00000066279,autosomal recessive primary microcephaly,MONDO_0016660,0.790462407784663,7.904659076193931,2,0.9,1.8,transcript,51431.0
CYP24A1,ENSG00000019186,Autosomal recessive infantile hypercalcemia,Orphanet_300547,0.789325711012754,7.893447314597345,2,0.8,1.6,transcript,8412.0
OTULIN,ENSG00000154124,infantile-onset periodic fever-panniculitis-dermatosis syndrome,MONDO_0014912,0.7892656809787059,7.892676044255225,1,0.4,0.4,transcript,20796.0
FANCF,ENSG00000183161,Fanconi anemia complementation group F,EFO_0009045,0.7891691610846184,7.891813154449952,1,0.4,0.4,transcript,3291.0
KIAA0586,ENSG00000100578,Joubert syndrome 23,MONDO_0014664,0.7878677208972017,7.878682860030461,1,0.5,0.5,transcript,88479.0
GJB2,ENSG00000165474,autosomal dominant keratitis-ichthyosis-hearing loss syndrome,MONDO_0007850,0.787641767651443,7.876504482069985,1,0.4,0.4,transcript,4608.0
FBN1,ENSG00000166147,progeroid and marfanoid aspect-lipodystrophy syndrome,MONDO_0014831,0.7858026363205153,7.858033028427688,1,0.4,0.4,transcript,60013.0
ACADSB,ENSG00000196177,2-methylbutyryl-CoA dehydrogenase deficiency,MONDO_0012392,0.7854063688301445,7.854110510260943,1,0.4,0.4,transcript,8543.0
ACTN2,ENSG00000077522,dilated cardiomyopathy 1AA,MONDO_0012808,0.7852677871362224,7.852694556974011,2,0.8,1.6,transcript,95891.0
GCH1,ENSG00000131979,Hyperphenylalaninemia,Orphanet_238583,0.7847735581948767,7.847769345770831,1,0.4,0.4,transcript,11847.0
MACF1,ENSG00000127603,lissencephaly 9 with complex brainstem malformation,MONDO_0032677,0.7841021139131631,7.841026465983961,2,0.8,1.6,gene_variant,300365.0
SEC63,ENSG00000025796,Isolated polycystic liver disease,Orphanet_2924,0.7820189055245947,7.820464579507389,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
GHR,ENSG00000112964,short stature due to partial GHR deficiency,MONDO_0011420,0.7819455455321481,7.81946431683813,1,0.4,0.4,transcript,45139.0
PEX13,ENSG00000162928,peroxisome biogenesis disorder 11A (Zellweger),MONDO_0013949,0.7818465528523064,7.818511358037271,1,0.4,0.4,transcript,8728.0
TRPC6,ENSG00000137672,familial idiopathic steroid-resistant nephrotic syndrome,MONDO_0019006,0.781734618029957,7.817375067423135,1,0.4,0.4,transcript,13847.0
EGFR,ENSG00000146648,lung adenocarcinoma,EFO_0000571,0.7814118051378716,7.814155370033378,2,0.8,1.6,transcript,42874.0
SMC3,ENSG00000108055,Cornelia de Lange syndrome,MONDO_0016033,0.7806286867452507,7.806295479975114,1,0.4,0.4,transcript,46444.0
CERKL,ENSG00000188452,retinitis pigmentosa,MONDO_0019200,0.7802660993523568,7.802681067395416,1,0.5,0.5,transcript,24908.0
PEX13,ENSG00000162928,peroxisome biogenesis disorder 11B,MONDO_0013950,0.7799391815011938,7.799437644526145,1,0.4,0.4,transcript,8728.0
ITGA8,ENSG00000077943,renal hypodysplasia/aplasia 1,MONDO_0024519,0.7799155536685458,7.799620292688556,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
PROK2,ENSG00000163421,hypogonadotropic hypogonadism,MONDO_0018555,0.7785371101544712,7.7858865654622385,2,0.8,1.6,transcript,3104.0
CNTNAP2,ENSG00000174469,cortical dysplasia-focal epilepsy syndrome,MONDO_0012400,0.7785226889001581,7.785234570673112,1,0.4,0.4,transcript,52072.0
RET,ENSG00000165731,pheochromocytoma,MONDO_0008233,0.7780190252433801,7.780200264698826,1,0.4,0.4,transcript,39951.0
IQCB1,ENSG00000173226,Senior-Loken syndrome,MONDO_0017842,0.7776933059211246,7.7769746781895,1,0.4,0.4,transcript,9611.0
SGCD,ENSG00000170624,autosomal recessive limb-girdle muscular dystrophy type 2F,MONDO_0011028,0.7773858156928333,7.773876945974319,1,0.4,0.4,transcript,21289.0
SLC25A46,ENSG00000164209,"neuropathy, hereditary motor and sensory, type 6B",MONDO_0014671,0.7772515022541181,7.7725349756513715,1,0.4,0.4,transcript,20047.0
ANO5,ENSG00000171714,Miyoshi muscular dystrophy 3,MONDO_0013222,0.7766709537696496,7.76671458405996,1,0.4,0.4,transcript,79265.0
DDR2,ENSG00000162733,spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome,MONDO_0010077,0.7764076430659042,7.764090471165904,1,0.4,0.4,transcript,28489.0
SLC5A7,ENSG00000115665,Congenital myasthenic syndromes,Orphanet_590,0.7762388494106944,7.762444057379621,1,0.4,0.4,transcript,7199.0
SC5D,ENSG00000109929,lathosterolosis,MONDO_0011816,0.7760565126136428,7.760587968920963,1,0.4,0.4,transcript,17511.0
SLC22A5,ENSG00000197375,systemic primary carnitine deficiency disease,MONDO_0008919,0.775495528785921,7.754960856795682,1,0.4,0.4,transcript,71827.0
KCNQ1,ENSG00000053918,Jervell and Lange-Nielsen syndrome 1,MONDO_0024540,0.7751408263903989,7.751601937241627,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
PRDM5,ENSG00000138738,brittle cornea syndrome,MONDO_0009242,0.774838472906194,7.748465337656832,2,0.8,1.6,transcript,19849.0
INF2,ENSG00000203485,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E,Orphanet_93114,0.7742145534693237,7.742148597574182,1,0.4,0.4,transcript,130596.0
SPAST,ENSG00000021574,hereditary spastic paraplegia 4,MONDO_0008438,0.773842126088392,7.738426437202263,1,0.4,0.4,transcript,77275.0
HECW2,ENSG00000138411,"neurodevelopmental disorder with hypotonia, seizures, and absent language",MONDO_0014995,0.7709919274019409,7.709925090170862,1,0.4,0.4,transcript,68774.0
PLEC,ENSG00000178209,autosomal recessive limb-girdle muscular dystrophy type 2Q,MONDO_0013390,0.7709468115340367,7.709477179606011,2,0.9,1.8,transcript,198582.0
PPARG,ENSG00000132170,PPARG-related familial partial lipodystrophy,MONDO_0011448,0.7706687346939736,7.732218341133959,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,PPARG-related familial partial lipodystrophy,MONDO_0011448,0.7706687346939736,7.732218341133959,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,PPARG-related familial partial lipodystrophy,MONDO_0011448,0.7706687346939736,7.732218341133959,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,PPARG-related familial partial lipodystrophy,MONDO_0011448,0.7706687346939736,7.732218341133959,59,24.0,1416.0,gene_variant,55462.0
ANKH,ENSG00000154122,chondrocalcinosis 2,MONDO_0007319,0.7705435393618592,7.706203836241542,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,chondrocalcinosis 2,MONDO_0007319,0.7705435393618592,7.706203836241542,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,chondrocalcinosis 2,MONDO_0007319,0.7705435393618592,7.706203836241542,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,chondrocalcinosis 2,MONDO_0007319,0.7705435393618592,7.706203836241542,5,2.4,12.0,transcript,15616.0
SLC11A2,ENSG00000110911,microcytic anemia with liver iron overload,MONDO_0008787,0.7705069496135211,7.705097457408847,2,0.8,1.6,transcript,57222.0
FBN1,ENSG00000166147,"Weill-Marchesani syndrome 2, dominant",MONDO_0012013,0.7700287088354987,7.7002937535775215,1,0.4,0.4,transcript,60013.0
NDUFS4,ENSG00000164258,Leigh syndrome,MONDO_0009723,0.7700106731287291,7.7002133126888355,1,0.4,0.4,transcript,3753.0
FANCF,ENSG00000183161,Fanconi anemia,MONDO_0019391,0.7698758753400599,7.698880297004367,1,0.4,0.4,transcript,3291.0
FARSB,ENSG00000116120,Rajab interstitial lung disease with brain calcifications 1,MONDO_0100215,0.7696746231841538,7.696797252249701,1,0.4,0.4,transcript,7840.0
DCDC2,ENSG00000146038,sclerosing cholangitis,EFO_0004268,0.7683741978102933,7.6837877551686224,1,0.4,0.4,transcript,8738.0
INF2,ENSG00000203485,focal segmental glomerulosclerosis 5,MONDO_0013191,0.767935210086729,7.6793551637482365,1,0.4,0.4,transcript,130596.0
CEP85L,ENSG00000111860,lissencephaly 10,MONDO_0030031,0.7678505820084267,7.6785212230647435,1,0.4,0.4,transcript,25969.0
BPTF,ENSG00000171634,neurodevelopmental disorder with dysmorphic facies and distal limb anomalies,MONDO_0060596,0.767773883187154,7.677758456068175,2,0.8,1.6,transcript,81532.0
PKP2,ENSG00000057294,arrhythmogenic right ventricular cardiomyopathy,MONDO_0016587,0.767771739494477,7.6778734963130955,4,1.6,6.4,transcript,40999.0
DDR2,ENSG00000162733,Spondyloepimetaphyseal dysplasia - short limb - abnormal calcification,Orphanet_93358,0.7674128316500246,7.674142357007108,1,0.4,0.4,transcript,28489.0
PLEC,ENSG00000178209,"epidermolysis bullosa simplex 5B, with muscular dystrophy",MONDO_0009181,0.7673462714902615,7.673471779168258,2,0.9,1.8,transcript,198582.0
CA8,ENSG00000178538,Dysequilibrium syndrome,Orphanet_1766,0.7670582414805475,7.670623369039118,1,0.4,0.4,transcript,9767.0
FGA,ENSG00000171560,congenital afibrinogenemia,MONDO_0008737,0.766588439122888,7.665952615687348,1,0.4,0.4,transcript,5863.0
BCKDHB,ENSG00000083123,maple syrup urine disease type 1B,MONDO_0023692,0.7658095457921958,7.663822834783356,10,4.0,40.0,transcript,6984.0
CLDN1,ENSG00000163347,neonatal ichthyosis-sclerosing cholangitis syndrome,MONDO_0011874,0.7655498315409753,7.657148650634095,4,1.6,6.4,transcript,3878.0
PDP1,ENSG00000164951,pyruvate dehydrogenase phosphatase deficiency,MONDO_0012120,0.7654258756534824,7.654282123750621,1,0.4,0.4,transcript,17118.0
SAMD9L,ENSG00000177409,ataxia-pancytopenia syndrome,MONDO_0008038,0.7642544454259472,7.642552907166215,1,0.4,0.4,transcript,47321.0
AR,ENSG00000169083,Kennedy disease,MONDO_0010735,0.7641388908320407,7.641430238106267,2,0.8,1.6,transcript,38713.0
FAT4,ENSG00000196159,Hennekam lymphangiectasia-lymphedema syndrome 2,MONDO_0014454,0.763903477835451,7.639043488397189,1,0.4,0.4,transcript,45924.0
LRRK2,ENSG00000188906,Parkinson disease,MONDO_0005180,0.763360802714582,7.633626784961576,2,0.9,1.8,transcript,95960.0
PDE3A,ENSG00000172572,Brachydactyly - arterial hypertension,Orphanet_1276,0.7630537956406954,7.6305627395544136,1,0.4,0.4,gene_variant,16140.0
NRCAM,ENSG00000091129,neurodevelopmental disorder with neuromuscular and skeletal abnormalities,MONDO_0859236,0.7625671337113873,7.6256829904277845,1,0.4,0.4,transcript,34325.0
ADK,ENSG00000156110,adenosine kinase deficiency,MONDO_0100255,0.7616480768185092,7.616499751622043,1,0.4,0.4,transcript,21071.0
KIAA0586,ENSG00000100578,short-rib thoracic dysplasia 14 with polydactyly,MONDO_0014688,0.7616043099926995,7.6160487509854375,1,0.5,0.5,transcript,88479.0
ANKRD17,ENSG00000132466,Chopra-Amiel-Gordon syndrome,MONDO_0859186,0.7614296495963643,7.614305685873123,1,0.4,0.4,transcript,43526.0
UMPS,ENSG00000114491,orotic aciduria,MONDO_0009797,0.7613928349161536,7.613947205523202,1,0.4,0.4,transcript,21213.0
AR,ENSG00000169083,prostate adenocarcinoma,EFO_0000673,0.7612092818503222,7.6121341482890825,2,0.8,1.6,transcript,38713.0
GRIA4,ENSG00000152578,neurodevelopmental disorder with or without seizures and gait abnormalities,MONDO_0060641,0.7585375303176131,7.585384594697617,1,0.4,0.4,transcript,43050.0
GABRA1,ENSG00000022355,"developmental and epileptic encephalopathy, 19",MONDO_0014328,0.7582971996279547,7.582980679850231,1,0.4,0.4,transcript,46064.0
BRCA2,ENSG00000139618,prostate carcinoma,EFO_0001663,0.757835040852872,7.578353400516178,1,0.5,0.5,transcript,167113.0
GJB2,ENSG00000165474,autosomal dominant nonsyndromic hearing loss 3A,MONDO_0011103,0.7576731286834063,7.576818092389618,1,0.4,0.4,transcript,4608.0
IMPG2,ENSG00000081148,retinitis pigmentosa,MONDO_0019200,0.757432103795124,7.57453655519262,2,0.9,1.8,transcript,8352.0
TGFBR1,ENSG00000106799,multiple self-healing squamous epithelioma,MONDO_0007566,0.7573200757379235,7.573205004971381,1,0.4,0.4,transcript,94171.0
CACNA1D,ENSG00000157388,aldosterone-producing adenoma with seizures and neurological abnormalities,MONDO_0014200,0.7565553077694578,7.565557042958862,1,0.4,0.4,transcript,100876.0
KCNN3,ENSG00000143603,Zimmermann-Laband syndrome,MONDO_0000200,0.755958159535445,7.5597006311643895,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
FGA,ENSG00000171560,Familial renal amyloidosis,Orphanet_85450,0.7553838931103495,7.553907155561963,1,0.4,0.4,transcript,5863.0
BRCA2,ENSG00000139618,Hereditary breast cancer,Orphanet_227535,0.7552250765986069,7.552253757973527,1,0.5,0.5,transcript,167113.0
DNAJC21,ENSG00000168724,autosomal dominant aplasia and myelodysplasia,MONDO_0013851,0.7551896249573243,7.551905272604531,1,0.4,0.4,transcript,44331.0
GABRA1,ENSG00000022355,juvenile myoclonic epilepsy,MONDO_0009696,0.7550962890074545,7.550971573645229,1,0.4,0.4,transcript,46064.0
BRCA2,ENSG00000139618,hereditary breast carcinoma,MONDO_0016419,0.754929307564653,7.549296067633988,1,0.5,0.5,transcript,167113.0
ATF6,ENSG00000118217,achromatopsia,MONDO_0018852,0.7546181820439675,7.546188172872656,1,0.4,0.4,transcript,62968.0
ALAD,ENSG00000148218,porphyria due to ALA dehydratase deficiency,MONDO_0013000,0.7543837889236474,7.543875199188904,1,0.4,0.4,transcript,10721.0
CR2,ENSG00000117322,"immunodeficiency, common variable, 7",MONDO_0013862,0.7542670902281569,7.5426892282081734,1,0.4,0.4,transcript,21827.0
ANKH,ENSG00000154122,craniometaphyseal dysplasia,MONDO_0015465,0.7538348998490615,7.539117441113565,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,craniometaphyseal dysplasia,MONDO_0015465,0.7538348998490615,7.539117441113565,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,craniometaphyseal dysplasia,MONDO_0015465,0.7538348998490615,7.539117441113565,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,craniometaphyseal dysplasia,MONDO_0015465,0.7538348998490615,7.539117441113565,5,2.4,12.0,transcript,15616.0
FBXO28,ENSG00000143756,developmental and epileptic encephalopathy 100,MONDO_0030695,0.7534337084370389,7.535386072097233,5,2.0,10.0,transcript,9533.0
SLC25A46,ENSG00000164209,"pontocerebellar hypoplasia, type 1E",MONDO_0030260,0.7526613722696358,7.526633675806549,1,0.4,0.4,transcript,20047.0
MAP3K7,ENSG00000135341,frontometaphyseal dysplasia 2,MONDO_0014935,0.7521194735074194,7.521284121797472,4,1.6,6.4,transcript,71599.0
SH3TC2,ENSG00000169247,carpal tunnel syndrome,EFO_0004143,0.7512388845161172,7.51239326856985,1,0.4,0.4,transcript,90428.0
FAS,ENSG00000026103,autoimmune lymphoproliferative syndrome,MONDO_0017979,0.7507380698809338,7.507382907033871,1,0.4,0.4,transcript,181141.0
GJB2,ENSG00000165474,deafness,EFO_0001063,0.749915876961027,7.499245575165825,1,0.4,0.4,transcript,4608.0
FYCO1,ENSG00000163820,Partial congenital cataract,Orphanet_98992,0.749911062218082,7.499135233021896,1,0.4,0.4,transcript,16253.0
BCKDHB,ENSG00000083123,maple syrup urine disease,MONDO_0009563,0.7498220011338147,7.503947388199545,10,4.0,40.0,transcript,6984.0
KYNU,ENSG00000115919,"vertebral, cardiac, renal, and limb defects syndrome 2",MONDO_0060555,0.7494406826890597,7.494565075604827,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
CACNA1D,ENSG00000157388,hypertension,EFO_0000537,0.7483891411390226,7.483895376654511,1,0.4,0.4,transcript,100876.0
PDE10A,ENSG00000112541,infantile-onset generalized dyskinesia with orofacial involvement,MONDO_0044637,0.7476771611074459,7.476791323168376,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
ACER3,ENSG00000078124,alkaline ceramidase 3 deficiency,MONDO_0044718,0.7473166072078707,7.473566072078707,1,0.4,0.4,transcript,1000.0
RET,ENSG00000165731,Hirschsprung disease,MONDO_0018309,0.747229396738554,7.472303979650565,1,0.4,0.4,transcript,39951.0
KCNQ1,ENSG00000053918,"atrial fibrillation, familial, 3",MONDO_0011857,0.7458922817967348,7.459116491304986,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
MAP3K7,ENSG00000135341,cardiospondylocarpofacial syndrome,MONDO_0008005,0.745881532570315,7.458904712426428,4,1.6,6.4,transcript,71599.0
DSC2,ENSG00000134755,familial isolated arrhythmogenic right ventricular dysplasia,MONDO_0016342,0.7454287316692338,7.4542997587589666,2,0.8,1.6,transcript,128596.0
PPARG,ENSG00000132170,diabetes mellitus,EFO_0000400,0.7442306723313122,7.467837717507345,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,diabetes mellitus,EFO_0000400,0.7442306723313122,7.467837717507345,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,diabetes mellitus,EFO_0000400,0.7442306723313122,7.467837717507345,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,diabetes mellitus,EFO_0000400,0.7442306723313122,7.467837717507345,59,24.0,1416.0,gene_variant,55462.0
TGFBR1,ENSG00000106799,Loeys-Dietz syndrome,MONDO_0018954,0.7441794711462577,7.441798959054724,1,0.4,0.4,transcript,94171.0
EGFR,ENSG00000146648,cancer,MONDO_0004992,0.7440054264873728,7.440091583528391,2,0.8,1.6,transcript,42874.0
DAG1,ENSG00000173402,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A9",MONDO_0014683,0.743979286547664,7.439799053595452,1,0.4,0.4,transcript,64640.0
FBN1,ENSG00000166147,MASS syndrome,MONDO_0011431,0.7426614151232641,7.426620816455176,1,0.4,0.4,transcript,60013.0
CASQ2,ENSG00000118729,catecholaminergic polymorphic ventricular tachycardia,MONDO_0017990,0.7423462794860478,7.423475445882048,1,0.4,0.4,transcript,31618.0
FAT4,ENSG00000196159,van Maldergem syndrome 2,MONDO_0014242,0.7422492343268395,7.422501053311074,1,0.4,0.4,transcript,45924.0
CDH23,ENSG00000107736,Pituitary Gland Adenoma,EFO_1000478,0.742188022391097,7.421887774613941,1,0.5,0.5,transcript,66219.0
GAN,ENSG00000261609,giant axonal neuropathy,MONDO_0000128,0.7417821531566963,7.417832195674244,1,0.4,0.4,transcript,37509.0
BRCA2,ENSG00000139618,medulloblastoma,EFO_0002939,0.7415012006687813,7.415014998675272,1,0.5,0.5,transcript,167113.0
CACNA1D,ENSG00000157388,sinoatrial node dysfunction and deafness,MONDO_0013960,0.7404277512690786,7.40428147795507,1,0.4,0.4,transcript,100876.0
NDUFAF2,ENSG00000164182,mitochondrial complex I deficiency,MONDO_0100133,0.7395926688418005,7.395966893463739,1,0.4,0.4,transcript,9949.0
TENM4,ENSG00000149256,essential tremor,EFO_0003108,0.7387618850739816,7.387636301224066,1,0.4,0.4,transcript,22922.0
CDH23,ENSG00000107736,deafness,EFO_0001063,0.7378649218958535,7.3786567696615055,1,0.5,0.5,transcript,66219.0
GABRA1,ENSG00000022355,epilepsy,EFO_0000474,0.7377769073945867,7.377777757516551,1,0.4,0.4,transcript,46064.0
BRCA2,ENSG00000139618,prostate cancer,MONDO_0008315,0.7377432233875659,7.377435225863117,1,0.5,0.5,transcript,167113.0
LRP2,ENSG00000081479,serum creatinine amount,OBA_2050096,0.7369670730484424,7.369687319184202,1,0.5,0.5,transcript,30141.0
BRCA2,ENSG00000139618,ovarian cancer,MONDO_0008170,0.7367519297510259,7.367522289497717,1,0.5,0.5,transcript,167113.0
IQGAP2,ENSG00000145703,platelet volume,OBA_0003277,0.7359530080960647,7.359544751891664,1,0.5,0.5,transcript,34081.0
SLC22A2,ENSG00000112499,serum creatinine amount,OBA_2050096,0.7353306204924499,7.353345926870874,1,0.4,0.4,transcript,10070.0
BRCA2,ENSG00000139618,pancreatic carcinoma,EFO_0002618,0.7349592762366896,7.349595754354353,1,0.5,0.5,transcript,167113.0
KCNQ1,ENSG00000053918,Jervell and Lange-Nielsen syndrome,MONDO_0002441,0.7348275981021773,7.348469654359411,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
UMPS,ENSG00000114491,Hereditary orotic aciduria,Orphanet_30,0.7340473876924805,7.340492733286469,1,0.4,0.4,transcript,21213.0
SGCD,ENSG00000170624,dilated cardiomyopathy 1L,MONDO_0011702,0.7333088563897472,7.3331073529434585,1,0.4,0.4,transcript,21289.0
KCNQ1,ENSG00000053918,Prolonged QT interval,HP_0001657,0.7332848949148144,7.333042622485782,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
PEX13,ENSG00000162928,Zellweger syndrome,Orphanet_912,0.7330970691934343,7.33101652144855,1,0.4,0.4,transcript,8728.0
DPY19L2,ENSG00000177990,male infertility due to globozoospermia,MONDO_0015746,0.7327171303677714,7.327312049631268,2,0.8,1.6,transcript,11368.0
IQGAP2,ENSG00000145703,platelet count,EFO_0004309,0.7325459634486648,7.325474305417666,1,0.5,0.5,transcript,34081.0
BRCA2,ENSG00000139618,glioma susceptibility 3,MONDO_0013093,0.7320513924058937,7.320516916046395,1,0.5,0.5,transcript,167113.0
DYNC2H1,ENSG00000187240,"Short rib-polydactyly syndrome, Verma-Naumoff type",Orphanet_93271,0.7318868055790821,7.318878212199515,1,0.5,0.5,transcript,49230.0
C6,ENSG00000039537,Immunodeficiency due to a late component of complements deficiency,Orphanet_169150,0.7307594101233046,7.307623664291048,1,0.5,0.5,transcript,16913.0
ANOS1,ENSG00000011201,Kallmann syndrome,MONDO_0018800,0.7295872811165558,7.295924317732645,1,0.4,0.4,transcript,7766.0
LINS1,ENSG00000140471,"intellectual disability, autosomal recessive 27",MONDO_0013702,0.7289567949704474,7.289595237812317,1,0.5,0.5,transcript,18323.0
NDUFAF2,ENSG00000164182,Leigh syndrome,MONDO_0009723,0.7282461885717977,7.28250209076371,1,0.4,0.4,transcript,9949.0
INF2,ENSG00000203485,Charcot-Marie-Tooth disease dominant intermediate E,MONDO_0013758,0.7264475435925115,7.264478498806062,1,0.4,0.4,transcript,130596.0
SLC30A9,ENSG00000014824,psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome,MONDO_0044726,0.7261555764874728,7.261907528201146,3,1.3,3.9000000000000004,transcript,11087.0
BMPR2,ENSG00000204217,pulmonary arterial hypertension,EFO_0001361,0.7260002339228915,7.260020110687952,1,0.4,0.4,transcript,22508.0
TNFRSF11A,ENSG00000141655,Osteopetrosis - hypogammaglobulinemia,Orphanet_178389,0.7256341132986508,7.256465724171681,2,0.8,1.6,transcript,12842.0
LAMA1,ENSG00000101680,Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome,Orphanet_370022,0.7255042274053918,7.255058169272636,1,0.5,0.5,transcript,31456.0
CDH23,ENSG00000107736,Usher syndrome type 1,MONDO_0010168,0.7254259601761893,7.254267152464863,1,0.5,0.5,transcript,66219.0
FBN1,ENSG00000166147,aortic aneurysm,EFO_0001666,0.7246171157617308,7.246177822839843,1,0.4,0.4,transcript,60013.0
COLEC10,ENSG00000184374,3MC syndrome,MONDO_0017398,0.7245953424500494,7.246058604621451,1,0.4,0.4,transcript,3803.0
PLEC,ENSG00000178209,"Epidermolysis bullosa simplex, Ogna type",Orphanet_79401,0.7241837371224095,7.241846435489738,2,0.9,1.8,transcript,198582.0
PLEC,ENSG00000178209,Epidermolysis bullosa simplex with muscular dystrophy,Orphanet_257,0.7238558900121573,7.238567964387217,2,0.9,1.8,transcript,198582.0
PLEC,ENSG00000178209,Epidermolysis bullosa simplex with pyloric atresia,Orphanet_158684,0.7237581214663826,7.237590278929471,2,0.9,1.8,transcript,198582.0
PLEC,ENSG00000178209,"epidermolysis bullosa simplex 5C, with pyloric atresia",MONDO_0012807,0.7235733315390404,7.235742379656047,2,0.9,1.8,transcript,198582.0
LRP2,ENSG00000081479,cystatin C measurement,EFO_0004617,0.7232601388989178,7.232617977688956,1,0.5,0.5,transcript,30141.0
ANO6,ENSG00000177119,Scott syndrome,MONDO_0009885,0.7213197079170998,7.213204500321276,1,0.4,0.4,transcript,53900.0
FREM2,ENSG00000150893,isolated cryptophthalmia,MONDO_0007410,0.7199784959860919,7.200676066615508,6,2.5,15.0,transcript,16833.0
ANO5,ENSG00000171714,aspartate aminotransferase measurement,EFO_0004736,0.7191736505843468,7.191741552206932,1,0.4,0.4,transcript,79265.0
RFX7,ENSG00000181827,"intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities",MONDO_0957228,0.7190961646328108,7.190971238654247,1,0.4,0.4,transcript,41700.0
KIAA0586,ENSG00000100578,Joubert syndrome,MONDO_0018772,0.7188468086669628,7.188473737728072,1,0.5,0.5,transcript,88479.0
SLC30A8,ENSG00000164756,HbA1c measurement,EFO_0004541,0.71808724182965,7.181182585980904,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,HbA1c measurement,EFO_0004541,0.71808724182965,7.181182585980904,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,HbA1c measurement,EFO_0004541,0.71808724182965,7.181182585980904,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,HbA1c measurement,EFO_0004541,0.71808724182965,7.181182585980904,4,1.6,6.4,gene_variant,20634.0
SHH,ENSG00000164690,"microphthalmia, isolated, with coloboma 5",MONDO_0012709,0.7178145245871312,7.1781983949544905,1,0.4,0.4,transcript,7526.0
GJB2,ENSG00000165474,autosomal dominant nonsyndromic hearing loss,MONDO_0019587,0.717162480243423,7.171711607989785,1,0.4,0.4,transcript,4608.0
CAVIN2,ENSG00000168497,platelet volume,OBA_0003277,0.7167676294685832,7.167807270455314,1,0.4,0.4,transcript,3054.0
IQGAP2,ENSG00000145703,reticulocyte count,EFO_0007986,0.7165553488408182,7.165568159339199,1,0.5,0.5,transcript,34081.0
FBN1,ENSG00000166147,familial thoracic aortic aneurysm and aortic dissection,MONDO_0019625,0.7153628976175709,7.153635641398243,1,0.4,0.4,transcript,60013.0
TMTC3,ENSG00000139324,lissencephaly spectrum disorders,MONDO_0018838,0.7153306803335553,7.153345812502708,1,0.4,0.4,transcript,10254.0
TMTC3,ENSG00000139324,Lissencephaly,HP_0001339,0.7153306803335553,7.153345812502708,1,0.4,0.4,transcript,10254.0
KERA,ENSG00000139330,cornea plana 2,MONDO_0009014,0.715196726756756,7.152693549909821,2,0.8,1.6,transcript,2203.0
TRDN,ENSG00000186439,catecholaminergic polymorphic ventricular tachycardia,MONDO_0017990,0.7145923203565268,7.145942407006524,1,0.5,0.5,transcript,26037.0
IQGAP2,ENSG00000145703,serum albumin amount,OBA_2050068,0.7140068321896667,7.1400829928276845,1,0.5,0.5,transcript,34081.0
DCDC2,ENSG00000146038,Senior-Boichis syndrome,MONDO_0019394,0.71313489982306,7.13139477529629,1,0.4,0.4,transcript,8738.0
KCNQ1,ENSG00000053918,Romano-Ward syndrome,Orphanet_101016,0.7128716549249934,7.128910222587571,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
CDH23,ENSG00000107736,"hearing loss, autosomal recessive",MONDO_0019588,0.7125890031098747,7.125897581801717,1,0.5,0.5,transcript,66219.0
TYR,ENSG00000077498,strand of hair color,OBA_0002313,0.7123718246130324,7.12384206980541,1,0.5,0.5,transcript,4038.0
DYNC2H1,ENSG00000187240,Jeune syndrome,MONDO_0018770,0.7123549376425482,7.123559532834175,1,0.5,0.5,transcript,49230.0
SLC39A8,ENSG00000138821,congenital disorder of glycosylation type II,EFO_0005546,0.7120692770199939,7.120700075602285,1,0.4,0.4,transcript,54754.0
BCAS3,ENSG00000141376,Hengel-Maroofian-Schols syndrome,MONDO_0859208,0.711864202502847,7.1186524241466245,1,0.5,0.5,transcript,48081.0
PDE3B,ENSG00000152270,high density lipoprotein cholesterol measurement,EFO_0004612,0.71184115215682,7.118486350863869,2,0.8,1.6,transcript,21382.0
TNPO3,ENSG00000064419,autosomal dominant limb-girdle muscular dystrophy type 1F,MONDO_0012034,0.7115225801082974,7.115252473439743,1,0.5,0.5,transcript,18746.0
ADAMTS3,ENSG00000156140,Hennekam syndrome,MONDO_0016256,0.7109335419063034,7.109384734807086,1,0.4,0.4,transcript,8111.0
LINS1,ENSG00000140471,autosomal recessive non-syndromic intellectual disability,MONDO_0019502,0.7107841428713176,7.107868716821019,1,0.5,0.5,transcript,18323.0
KCNQ1,ENSG00000053918,familial long QT syndrome,MONDO_0019171,0.7107769758214332,7.107963431551969,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
SPAST,ENSG00000021574,hereditary spastic paraplegia,MONDO_0019064,0.7106170140720908,7.106175317039251,1,0.4,0.4,transcript,77275.0
TGFBR1,ENSG00000106799,familial thoracic aortic aneurysm and aortic dissection,MONDO_0019625,0.7105096082334268,7.105100329926414,1,0.4,0.4,transcript,94171.0
MSX2,ENSG00000120149,parietal foramina 1,MONDO_0008197,0.7097864323788002,7.097982562038076,1,0.4,0.4,transcript,3383.0
SLC30A8,ENSG00000164756,type 2 diabetes mellitus,MONDO_0005148,0.7096690329478889,7.097000497163292,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,type 2 diabetes mellitus,MONDO_0005148,0.7096690329478889,7.097000497163292,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,type 2 diabetes mellitus,MONDO_0005148,0.7096690329478889,7.097000497163292,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,type 2 diabetes mellitus,MONDO_0005148,0.7096690329478889,7.097000497163292,4,1.6,6.4,transcript,20634.0
ANO5,ENSG00000171714,autosomal recessive limb-girdle muscular dystrophy,MONDO_0015152,0.7090408169109551,7.090413215473015,1,0.4,0.4,transcript,79265.0
CA8,ENSG00000178538,Rare hereditary ataxia,Orphanet_183518,0.7086387017611039,7.0864279718446825,1,0.4,0.4,transcript,9767.0
NDUFAF4,ENSG00000123545,mitochondrial complex I deficiency,MONDO_0100133,0.7072782661133776,7.072894206030598,1,0.4,0.4,transcript,3586.0
TEX15,ENSG00000133863,spermatogenic failure 25,MONDO_0054729,0.707247865387359,7.072493577464802,1,0.5,0.5,transcript,33504.0
FYB1,ENSG00000082074,thrombocytopenia 3,MONDO_0010120,0.7067701415491194,7.067721065717173,1,0.5,0.5,transcript,25445.0
GPD2,ENSG00000115159,type 2 diabetes mellitus,MONDO_0005148,0.7067573129355317,7.067590795639214,1,0.4,0.4,transcript,22642.0
PEX2,ENSG00000164751,Zellweger syndrome,Orphanet_912,0.7058442284170894,7.058486110181631,1,0.4,0.4,transcript,9127.0
LRP2,ENSG00000081479,urate measurement,EFO_0004531,0.7057795970078505,7.0578125587782825,1,0.5,0.5,transcript,30141.0
CDH23,ENSG00000107736,Usher syndrome,MONDO_0019501,0.7057139603161288,7.057147153864258,1,0.5,0.5,transcript,66219.0
ADGRV1,ENSG00000164199,Usher syndrome type 2,MONDO_0016484,0.7050429285255144,7.050433710425513,1,0.5,0.5,transcript,112990.0
TBX5,ENSG00000089225,heart rate,OBA_1001087,0.7049566580404361,7.049691874061369,2,0.8,1.6,transcript,12770.0
MSX2,ENSG00000120149,parietal foramina with cleidocranial dysplasia,MONDO_0008198,0.7049325083827706,7.049443322077779,1,0.4,0.4,transcript,3383.0
NEMF,ENSG00000165525,intellectual developmental disorder with speech delay and axonal peripheral neuropathy,MONDO_0030849,0.7045195778589779,7.045215961853817,1,0.5,0.5,transcript,24773.0
FBN1,ENSG00000166147,Weill-Marchesani syndrome,MONDO_0018096,0.7038524707681754,7.038531372904289,1,0.4,0.4,transcript,60013.0
BCKDHB,ENSG00000083123,maple syrup urine disease type 1A,MONDO_0023691,0.7035690766774039,7.041418143635436,10,4.0,40.0,transcript,6984.0
FGA,ENSG00000171560,familial visceral amyloidosis,MONDO_0007099,0.7022233214903603,7.022301439362071,1,0.4,0.4,transcript,5863.0
NDUFS4,ENSG00000164258,diabetes mellitus,EFO_0000400,0.7018914308380201,7.019020889781746,1,0.4,0.4,transcript,3753.0
PTPRJ,ENSG00000149177,platelet volume,OBA_0003277,0.7018493203838295,7.01856839180822,2,0.8,1.6,transcript,21280.0
BMPR2,ENSG00000204217,pulmonary venoocclusive disease,MONDO_0009937,0.7015741633467802,7.01575940492684,1,0.4,0.4,transcript,22508.0
ADAMTS3,ENSG00000156140,Abnormality of the skeletal system,HP_0000924,0.7012381042819156,7.012430358563207,1,0.4,0.4,transcript,8111.0
GCH1,ENSG00000131979,GTP cyclohydrolase I deficiency,MONDO_0100184,0.7001181806602759,7.001215570424823,1,0.4,0.4,transcript,11847.0
TAF2,ENSG00000064313,microcephaly-thin corpus callosum-intellectual disability syndrome,MONDO_0014273,0.6998430179231774,6.998432972215798,1,0.5,0.5,transcript,179020.0
GJB2,ENSG00000165474,hearing loss,EFO_0004238,0.6993595967815552,6.993682773371107,1,0.4,0.4,transcript,4608.0
DYNC1I2,ENSG00000077380,neurodevelopmental disorder with microcephaly and structural brain anomalies,MONDO_0032779,0.6974302992231575,6.974314179165236,1,0.4,0.4,transcript,35756.0
IQGAP2,ENSG00000145703,reticulocyte measurement,EFO_0010700,0.6958657160599754,6.958671831530771,1,0.5,0.5,transcript,34081.0
SOS1,ENSG00000115904,hereditary gingival fibromatosis,MONDO_0016070,0.6949394927891364,6.94941853576459,2,0.8,1.6,transcript,67774.0
SGCB,ENSG00000163069,autosomal recessive limb-girdle muscular dystrophy,MONDO_0015152,0.6947051167827365,6.947123763108671,1,0.4,0.4,transcript,5510.0
TNFRSF11A,ENSG00000141655,osteitis deformans,EFO_0004261,0.6946166590351801,6.946291181536974,2,0.8,1.6,transcript,12842.0
FITM2,ENSG00000197296,Siddiqi syndrome,EFO_0010633,0.6946018086385813,6.9461045168093225,1,0.4,0.4,transcript,4628.0
TCF7L2,ENSG00000148737,type 2 diabetes mellitus,MONDO_0005148,0.6944143017845422,6.94421556777388,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,type 2 diabetes mellitus,MONDO_0005148,0.6944143017845422,6.94421556777388,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,type 2 diabetes mellitus,MONDO_0005148,0.6944143017845422,6.94421556777388,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,type 2 diabetes mellitus,MONDO_0005148,0.6944143017845422,6.94421556777388,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
CD2AP,ENSG00000198087,focal segmental glomerulosclerosis,EFO_0004236,0.6939203279735806,6.939255349509303,1,0.4,0.4,transcript,7682.0
RET,ENSG00000165731,non-small cell lung carcinoma,EFO_0003060,0.6938649766329212,6.938659778594237,1,0.4,0.4,transcript,39951.0
SHH,ENSG00000164690,holoprosencephaly,MONDO_0016296,0.6937027981035951,6.93708113011913,1,0.4,0.4,transcript,7526.0
COL25A1,ENSG00000188517,Congenital ptosis,Orphanet_91411,0.6927405661194166,6.9274206228549104,1,0.4,0.4,transcript,26735.0
GABRA1,ENSG00000022355,major depressive disorder,MONDO_0002009,0.6924478573041973,6.924487256612657,1,0.4,0.4,transcript,46064.0
PLEC,ENSG00000178209,epidermolysis bullosa simplex with nail dystrophy,MONDO_0014661,0.6922887998137045,6.922897062402689,2,0.9,1.8,transcript,198582.0
MYO5A,ENSG00000197535,Griscelli syndrome type 1,MONDO_0008962,0.6918934461925682,6.918936501586894,1,0.4,0.4,transcript,196111.0
TYR,ENSG00000077498,Abnormality of skin pigmentation,HP_0001000,0.691496186536699,6.915085689042076,1,0.5,0.5,transcript,4038.0
NRK,ENSG00000123572,body height,OBA_VT0001253,0.690539075761775,6.905415975118696,1,0.4,0.4,transcript,15862.0
MSX2,ENSG00000120149,craniosynostosis 2,MONDO_0011481,0.6900429212443663,6.900547450693736,1,0.4,0.4,transcript,3383.0
LDLRAP1,ENSG00000157978,familial hypercholesterolemia,EFO_0004911,0.6899724892291268,6.899750805740347,1,0.4,0.4,transcript,15436.0
CACNA1D,ENSG00000157388,cardiovascular disease,EFO_0000319,0.6893844633188231,6.893848598452515,1,0.4,0.4,transcript,100876.0
BRCA2,ENSG00000139618,secondary malignant neoplasm,EFO_0009812,0.6891491949349835,6.891494941337292,1,0.5,0.5,transcript,167113.0
PDE3B,ENSG00000152270,triglyceride measurement,EFO_0004530,0.6885241465626103,6.885316294921772,2,0.8,1.6,transcript,21382.0
PDE3A,ENSG00000172572,coronary artery disease,EFO_0001645,0.6882216582070394,6.882241365217854,1,0.4,0.4,gene_variant,16140.0
SAMD9L,ENSG00000177409,monosomy 7 myelodysplasia and leukemia syndrome 1,MONDO_0009646,0.6877589144549184,6.877597597455928,1,0.4,0.4,transcript,47321.0
ZNF148,ENSG00000163848,"global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies",MONDO_0014994,0.6873922918185392,6.873934786565061,1,0.4,0.4,transcript,33703.0
KCNQ1,ENSG00000053918,Familial short QT syndrome,Orphanet_51083,0.6865334733563688,6.865528406901326,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
CNTNAP2,ENSG00000174469,autism,EFO_0003758,0.6854808483645966,6.854816165317497,1,0.4,0.4,transcript,52072.0
IL4R,ENSG00000077238,asthma,MONDO_0004979,0.6849084430582401,6.849102994651644,1,0.4,0.4,transcript,21547.0
AR,ENSG00000169083,hypospadias,EFO_0004209,0.6848844022734482,6.848885352520342,2,0.8,1.6,transcript,38713.0
TECRL,ENSG00000205678,catecholaminergic polymorphic ventricular tachycardia,MONDO_0017990,0.6843722579291895,6.844125353961845,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
CERKL,ENSG00000188452,Retinal dystrophy,HP_0000556,0.682712700742726,6.827147081299109,1,0.5,0.5,transcript,24908.0
OTULIN,ENSG00000154124,"immunodeficiency 107, susceptibility to invasive staphylococcus aureus infection",MONDO_0031030,0.6815925794213457,6.815945028681623,1,0.4,0.4,transcript,20796.0
TNRC6B,ENSG00000100354,global developmental delay with speech and behavioral abnormalities,MONDO_0030995,0.6814900446347246,6.814906898168273,1,0.4,0.4,transcript,61998.0
AR,ENSG00000169083,neoplasm,EFO_0000616,0.6814574150634831,6.8146154804206915,2,0.8,1.6,transcript,38713.0
KRT74,ENSG00000170484,hypotrichosis 3,MONDO_0013514,0.6799756020844784,6.79982004133134,1,0.4,0.4,transcript,6248.0
EGFR,ENSG00000146648,head and neck squamous cell carcinoma,EFO_0000181,0.6793244241482138,6.7932815601368,2,0.8,1.6,transcript,42874.0
ATP9A,ENSG00000054793,neurodevelopmental disorder with poor growth and behavioral abnormalities,MONDO_0859377,0.679209608859414,6.792121454819011,1,0.4,0.4,transcript,15769.0
ANO5,ENSG00000171714,serum alanine aminotransferase measurement,EFO_0004735,0.6786395783464433,6.786400829827897,1,0.4,0.4,transcript,79265.0
BRCA2,ENSG00000139618,BRCA2-related cancer predisposition,MONDO_0700269,0.6786060984330688,6.786063976318147,1,0.5,0.5,transcript,167113.0
CCDC88C,ENSG00000015133,Spinocerebellar ataxia type 40,EFO_0009057,0.6785107079468915,6.785126402206947,1,0.4,0.4,transcript,20701.0
SORL1,ENSG00000137642,Alzheimer disease,MONDO_0004975,0.677613052232708,6.776177531990177,2,0.9,1.8,transcript,38290.0
SLC22A2,ENSG00000112499,lipoprotein A measurement,EFO_0006925,0.67657854567909,6.765825178737276,1,0.4,0.4,transcript,10070.0
EGFR,ENSG00000146648,glioblastoma multiforme,EFO_0000519,0.6765151372093904,6.765188690748566,2,0.8,1.6,transcript,42874.0
SMAD2,ENSG00000175387,Loeys-Dietz syndrome 6,MONDO_0030500,0.6764608063120993,6.765101860176499,9,3.6,32.4,transcript,65614.0
KITLG,ENSG00000049130,"hyperpigmentation with or without hypopigmentation, familial progressive",MONDO_0007771,0.6756727302967072,6.756896658943926,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
EGFR,ENSG00000146648,colorectal adenocarcinoma,EFO_0000365,0.6756552307355947,6.75658962601061,2,0.8,1.6,transcript,42874.0
GJB2,ENSG00000165474,nonsyndromic genetic hearing loss,MONDO_0019497,0.6755496919728314,6.755583725283869,1,0.4,0.4,transcript,4608.0
CD2AP,ENSG00000198087,familial idiopathic steroid-resistant nephrotic syndrome,MONDO_0019006,0.6755472003511245,6.755524073284741,1,0.4,0.4,transcript,7682.0
NDUFS4,ENSG00000164258,type 2 diabetes mellitus,MONDO_0005148,0.675037593988311,6.750482521284655,1,0.4,0.4,transcript,3753.0
ARL3,ENSG00000138175,Joubert syndrome,MONDO_0018772,0.6744280188880771,6.7443845185625655,1,0.4,0.4,transcript,3834.0
GJB2,ENSG00000165474,KID syndrome,MONDO_0018781,0.6735066162783544,6.735152968339099,1,0.4,0.4,transcript,4608.0
RET,ENSG00000165731,familial medullary thyroid carcinoma,MONDO_0007958,0.6731834562440834,6.731844574705859,1,0.4,0.4,transcript,39951.0
GLB1,ENSG00000170266,GM1 gangliosidosis,MONDO_0018149,0.6730107559958429,6.730138468037802,1,0.5,0.5,transcript,16177.0
TNFRSF11A,ENSG00000141655,familial expansile osteolysis,MONDO_0008275,0.6730061197952492,6.730185789137665,2,0.8,1.6,transcript,12842.0
SLC5A7,ENSG00000115665,Presynaptic congenital myasthenic syndromes,Orphanet_98914,0.6727885765072338,6.727941328345015,1,0.4,0.4,transcript,7199.0
BRCA2,ENSG00000139618,familial pancreatic carcinoma,MONDO_0015278,0.6723753695375733,6.72375668736319,1,0.5,0.5,transcript,167113.0
HFM1,ENSG00000162669,primary ovarian insufficiency,EFO_0004266,0.6722849646253897,6.722979482660025,2,1.0,2.0,transcript,15404.0
BRCA2,ENSG00000139618,hereditary breast ovarian cancer syndrome,MONDO_0003582,0.6721039236408886,6.721042228396343,1,0.5,0.5,transcript,167113.0
GRIN2B,ENSG00000273079,West syndrome,MONDO_0018097,0.671925978368418,6.7192640533111225,1,0.4,0.4,transcript,93685.0
MYO3A,ENSG00000095777,deafness,EFO_0001063,0.6715607952329358,6.715631668119331,1,0.5,0.5,transcript,21083.0
TYR,ENSG00000077498,Ocular albinism with congenital sensorineural deafness,Orphanet_352740,0.671452644581841,6.714650269493496,1,0.5,0.5,transcript,4038.0
ANO5,ENSG00000171714,limb-girdle muscular dystrophy,MONDO_0016971,0.6703502637662846,6.7035076840263095,1,0.4,0.4,transcript,79265.0
RET,ENSG00000165731,multiple endocrine neoplasia,MONDO_0017169,0.6701732479957306,6.701742492222332,1,0.4,0.4,transcript,39951.0
PDE3A,ENSG00000172572,cardiovascular disease,EFO_0000319,0.6700170293517351,6.70019507666481,1,0.4,0.4,gene_variant,16140.0
GJB2,ENSG00000165474,"hearing loss, autosomal recessive",MONDO_0019588,0.6697748132930327,6.697834938485882,1,0.4,0.4,transcript,4608.0
ANKH,ENSG00000154122,HbA1c measurement,EFO_0004541,0.6696142784164666,6.696911226787616,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,HbA1c measurement,EFO_0004541,0.6696142784164666,6.696911226787616,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,HbA1c measurement,EFO_0004541,0.6696142784164666,6.696911226787616,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,HbA1c measurement,EFO_0004541,0.6696142784164666,6.696911226787616,5,2.4,12.0,gene_variant,15616.0
ADGRV1,ENSG00000164199,Febrile seizure (within the age range of 3 months to 6 years),HP_0002373,0.6693243973926793,6.693248399097162,1,0.5,0.5,transcript,112990.0
SGCB,ENSG00000163069,limb-girdle muscular dystrophy,MONDO_0016971,0.6690604947667206,6.690677542948512,1,0.4,0.4,transcript,5510.0
GJA3,ENSG00000121743,early-onset non-syndromic cataract,MONDO_0011060,0.6689149547523852,6.6892262640562645,1,0.4,0.4,transcript,5214.0
KCNQ1,ENSG00000053918,cardiac arrhythmia,EFO_0004269,0.668242652435505,6.682620197692687,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
DAG1,ENSG00000173402,"muscular dystrophy-dystroglycanopathy, type A",MONDO_0000171,0.6682013212804331,6.682019400923143,1,0.4,0.4,transcript,64640.0
TYR,ENSG00000077498,oculocutaneous albinism,MONDO_0018910,0.6677727027838539,6.677850851513626,1,0.5,0.5,transcript,4038.0
FZD6,ENSG00000164930,nonsyndromic congenital nail disorder 1,MONDO_0008060,0.6677390656746928,6.677470548892531,2,0.8,1.6,transcript,20027.0
DYNC2H1,ENSG00000187240,"short rib-polydactyly syndrome, Majewski type",MONDO_0019662,0.6675884057812824,6.675894214221518,1,0.5,0.5,transcript,49230.0
PPARG,ENSG00000132170,high density lipoprotein cholesterol measurement,EFO_0004612,0.6669681391511686,6.695212385705909,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,high density lipoprotein cholesterol measurement,EFO_0004612,0.6669681391511686,6.695212385705909,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,high density lipoprotein cholesterol measurement,EFO_0004612,0.6669681391511686,6.695212385705909,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,high density lipoprotein cholesterol measurement,EFO_0004612,0.6669681391511686,6.695212385705909,59,24.0,1416.0,transcript,55462.0
F13B,ENSG00000143278,congenital factor XIII deficiency,MONDO_0018029,0.6666806908286381,6.666914806430533,1,0.5,0.5,transcript,4634.0
ADGRV1,ENSG00000164199,Usher syndrome,MONDO_0019501,0.6656012700776658,6.656017125947026,1,0.5,0.5,transcript,112990.0
GJB2,ENSG00000165474,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome,Orphanet_2698,0.6653199192914219,6.653285998469774,1,0.4,0.4,transcript,4608.0
SOS1,ENSG00000115904,rasopathy,EFO_1001502,0.6649165126857574,6.649188734730799,2,0.8,1.6,transcript,67774.0
SHH,ENSG00000164690,solitary median maxillary central incisor syndrome,MONDO_0007819,0.6642695619674142,6.642748768757319,1,0.4,0.4,transcript,7526.0
ACVR1C,ENSG00000123612,BMI-adjusted waist-hip ratio,EFO_0007788,0.6635747662827043,6.635866976771861,2,0.8,1.6,transcript,13410.0
IQCB1,ENSG00000173226,Leber congenital amaurosis,MONDO_0018998,0.6631222745702082,6.631264364680336,1,0.4,0.4,transcript,9611.0
CENPE,ENSG00000138778,Seckel syndrome,MONDO_0019342,0.6629768073854642,6.6297937675853715,1,0.5,0.5,transcript,19460.0
TMEM106B,ENSG00000106460,tremor-ataxia-central hypomyelination syndrome,MONDO_0018656,0.6621874961377561,6.6219078378647085,2,0.8,1.6,transcript,48667.0
EGFR,ENSG00000146648,lung cancer,MONDO_0008903,0.6617065773571437,6.617103092226099,2,0.8,1.6,transcript,42874.0
SGCD,ENSG00000170624,limb-girdle muscular dystrophy,MONDO_0016971,0.6613606965981625,6.613625755027612,1,0.4,0.4,transcript,21289.0
FRRS1L,ENSG00000260230,developmental and epileptic encephalopathy,MONDO_0100062,0.6597907426541596,6.597993332581864,2,0.8,1.6,transcript,18625.0
THAP1,ENSG00000131931,torsion dystonia 6,MONDO_0011264,0.6596917654475027,6.596997019554393,1,0.4,0.4,transcript,5040.0
OTOGL,ENSG00000165899,"hearing loss, autosomal recessive",MONDO_0019588,0.6592652088050415,6.592666946008337,1,0.5,0.5,transcript,33652.0
NBAS,ENSG00000151779,short stature-optic atrophy-Pelger-HuC+t anomaly syndrome,MONDO_0013889,0.657924561012134,6.579279155911344,2,1.0,2.0,transcript,59620.0
PDE3A,ENSG00000172572,stroke,EFO_0000712,0.6571641972148659,6.571666755296118,1,0.4,0.4,gene_variant,16140.0
ENPEP,ENSG00000138792,hypertension,EFO_0000537,0.6568678914859629,6.56872131469003,1,0.4,0.4,transcript,9434.0
EDEM1,ENSG00000134109,alkaline phosphatase measurement,EFO_0004533,0.6566887630585558,6.567020609308963,2,0.8,1.6,transcript,12032.0
CACNA1D,ENSG00000157388,heart failure,EFO_0003144,0.6557756302273523,6.557760267537808,1,0.4,0.4,transcript,100876.0
FAT1,ENSG00000083857,head and neck squamous cell carcinoma,EFO_0000181,0.6556937213155829,6.556958408577618,1,0.5,0.5,transcript,23590.0
PEX2,ENSG00000164751,peroxisome biogenesis disorder,MONDO_0019234,0.6555504763143466,6.555548589154203,1,0.4,0.4,transcript,9127.0
DAG1,ENSG00000173402,limb-girdle muscular dystrophy,MONDO_0016971,0.655470330260347,6.554709490722281,1,0.4,0.4,transcript,64640.0
BMPR2,ENSG00000204217,pulmonary venoocclusive disease 1,MONDO_0020713,0.6552004494321539,6.552022265780576,1,0.4,0.4,transcript,22508.0
FGA,ENSG00000171560,familial hypodysfibrinogenemia,MONDO_0016638,0.6545338693695872,6.545406918154341,1,0.4,0.4,transcript,5863.0
BRCA2,ENSG00000139618,neoplasm,EFO_0000616,0.6528267690739992,6.52827068272745,1,0.5,0.5,transcript,167113.0
GRIN2B,ENSG00000273079,Intellectual disability,HP_0001249,0.6527604404617569,6.52760867424451,1,0.4,0.4,transcript,93685.0
PDE3B,ENSG00000152270,body height,OBA_VT0001253,0.649962447291833,6.499699302213998,2,0.8,1.6,transcript,21382.0
KRT74,ENSG00000170484,autosomal dominant wooly hair,MONDO_0020717,0.6497195594500036,6.497259614986592,1,0.4,0.4,transcript,6248.0
EGFR,ENSG00000146648,neoplasm,EFO_0000616,0.6496514857217759,6.496552175872422,2,0.8,1.6,transcript,42874.0
IQGAP2,ENSG00000145703,total blood protein measurement,EFO_0004536,0.6483798274591273,6.48381294552229,1,0.5,0.5,transcript,34081.0
ATP5F1A,ENSG00000152234,Isolated ATP synthase deficiency,Orphanet_254913,0.6477238282347062,6.477252083064699,1,0.4,0.4,transcript,28984.0
LRPAP1,ENSG00000163956,Rare isolated myopia,Orphanet_98619,0.6458079445188778,6.458310081360217,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
SYNJ2,ENSG00000078269,serum gamma-glutamyl transferase measurement,EFO_0004532,0.6457931379143284,6.457982526768116,2,0.8,1.6,transcript,31282.0
SYNE2,ENSG00000054654,Emery-Dreifuss muscular dystrophy,MONDO_0016830,0.6450349009163544,6.450361644679452,2,1.0,2.0,transcript,158284.0
RET,ENSG00000165731,gastrointestinal stromal tumor,MONDO_0011719,0.6443221278595378,6.443231290860403,1,0.4,0.4,transcript,39951.0
EXO1,ENSG00000174371,cancer,MONDO_0004992,0.6438653882064115,6.4387833151472105,2,1.0,2.0,transcript,15452.0
PDE10A,ENSG00000112541,"striatal degeneration, autosomal dominant 2",MONDO_0014835,0.6431220114017753,6.43123982611167,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
MSX2,ENSG00000120149,parietal foramina,MONDO_0018953,0.6423671047928834,6.423789286178907,1,0.4,0.4,transcript,3383.0
FYCO1,ENSG00000163820,early-onset nuclear cataract,MONDO_0020376,0.6421169379350439,6.421193990191514,1,0.4,0.4,transcript,16253.0
PARP1,ENSG00000143799,ovarian cancer,MONDO_0008170,0.6416764937444319,6.416770807022297,1,0.5,0.5,transcript,85185.0
SHH,ENSG00000164690,Solitary median maxillary central incisor,HP_0006315,0.6416316921609407,6.416370070692586,1,0.4,0.4,transcript,7526.0
SHH,ENSG00000164690,schizencephaly,MONDO_0010011,0.6408627992098576,6.408681141181754,1,0.4,0.4,transcript,7526.0
MYO3A,ENSG00000095777,"hearing loss, autosomal recessive",MONDO_0019588,0.6407905943666864,6.407929659456837,1,0.5,0.5,transcript,21083.0
GCH1,ENSG00000131979,Dystonia,HP_0001332,0.64054359748064,6.405469738628465,1,0.4,0.4,transcript,11847.0
CRYGD,ENSG00000118231,cataract,MONDO_0005129,0.640502961701487,6.405652669974372,1,0.4,0.4,transcript,642.0
CNTN1,ENSG00000018236,Compton-North congenital myopathy,MONDO_0012929,0.6404353558653968,6.404370085530801,1,0.4,0.4,transcript,24203.0
BRCA2,ENSG00000139618,Fanconi anemia,MONDO_0019391,0.6401493917023398,6.401496909010856,1,0.5,0.5,transcript,167113.0
RBM28,ENSG00000106344,ANE syndrome,MONDO_0012794,0.6395704795244738,6.395777030007718,2,0.8,1.6,transcript,22150.0
CRYGD,ENSG00000118231,Cataract-microcornea syndrome,Orphanet_1377,0.6393860077304447,6.394483130263949,1,0.4,0.4,transcript,642.0
RET,ENSG00000165731,renal cell carcinoma,EFO_0000681,0.6393462596065956,6.393472608330981,1,0.4,0.4,transcript,39951.0
DCDC2,ENSG00000146038,"hearing loss, autosomal recessive",MONDO_0019588,0.6390392768851093,6.390438545916783,1,0.4,0.4,transcript,8738.0
SNIP1,ENSG00000163877,Christianson syndrome,MONDO_0010278,0.6386321273323744,6.386366769229112,1,0.4,0.4,transcript,8792.0
EGFR,ENSG00000146648,"inflammatory skin and bowel disease, neonatal, 2",MONDO_0014481,0.6386055037749255,6.386092356403918,2,0.8,1.6,transcript,42874.0
SLC44A1,ENSG00000070214,"neurodegeneration, childhood-onset, with ataxia, tremor, optic atrophy, and cognitive decline",MONDO_0030028,0.6374739187957377,6.374748796874452,1,0.4,0.4,transcript,41628.0
CCDC88C,ENSG00000015133,congenital hydrocephalus,MONDO_0016349,0.6366851869452386,6.366871192190418,1,0.4,0.4,transcript,20701.0
PLEC,ENSG00000178209,"pidermolysis bullosa simplex 5A, Ogna type",MONDO_0007555,0.6364986386236531,6.364995450502175,2,0.9,1.8,transcript,198582.0
INF2,ENSG00000203485,focal segmental glomerulosclerosis,EFO_0004236,0.6364454532967484,6.36445759584843,1,0.4,0.4,transcript,130596.0
IMPG2,ENSG00000081148,adult-onset foveomacular vitelliform dystrophy,MONDO_0011979,0.6363737207171247,6.363952724412627,2,0.9,1.8,transcript,8352.0
ATP5F1A,ENSG00000152234,"mitochondrial complex V (ATP synthase) deficiency, nuclear type 4A",MONDO_0957254,0.6363539074651406,6.363552875369043,1,0.4,0.4,transcript,28984.0
IL17A,ENSG00000112115,psoriasis,EFO_0000676,0.6360571587506795,6.360785376924218,1,0.4,0.4,transcript,1871.0
ARL3,ENSG00000138175,retinitis pigmentosa,MONDO_0019200,0.6360058976675044,6.360163306356838,1,0.4,0.4,transcript,3834.0
FGA,ENSG00000171560,Familial afibrinogenemia,Orphanet_98880,0.6348109761714852,6.3481779861733205,1,0.4,0.4,transcript,5863.0
ALAD,ENSG00000148218,Acute hepatic porphyria,Orphanet_95157,0.6345198578918143,6.345235888870573,1,0.4,0.4,transcript,10721.0
ADAMTS3,ENSG00000156140,body fat percentage,EFO_0007800,0.6343468653477808,6.3435179692218595,1,0.4,0.4,transcript,8111.0
ADAMTS3,ENSG00000156140,appendicular lean mass,EFO_0004980,0.6324739650937794,6.324788966681845,1,0.4,0.4,transcript,8111.0
TYR,ENSG00000077498,oculocutaneous albinism type 1,MONDO_0018135,0.6319651102975178,6.319774926650265,1,0.5,0.5,transcript,4038.0
KCNQ3,ENSG00000184156,Seizure,HP_0001250,0.6318101759634085,6.318158137364882,2,0.8,1.6,transcript,28380.0
SGCD,ENSG00000170624,autosomal recessive limb-girdle muscular dystrophy,MONDO_0015152,0.6314262198476543,6.31428098752253,1,0.4,0.4,transcript,21289.0
PPARG,ENSG00000132170,ulcerative colitis,EFO_0000729,0.6313702210401684,6.339233204595907,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,ulcerative colitis,EFO_0000729,0.6313702210401684,6.339233204595907,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,ulcerative colitis,EFO_0000729,0.6313702210401684,6.339233204595907,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,ulcerative colitis,EFO_0000729,0.6313702210401684,6.339233204595907,59,24.0,1416.0,transcript,55462.0
FIGLA,ENSG00000183733,primary ovarian insufficiency,EFO_0004266,0.6305403649010008,6.306096169785632,1,0.5,0.5,transcript,722.0
PEX13,ENSG00000162928,peroxisome biogenesis disorder,MONDO_0019234,0.6298639935573112,6.298685765087319,1,0.4,0.4,transcript,8728.0
PDE3B,ENSG00000152270,hip circumference,OBA_1000032,0.6297041551121938,6.297116380417607,2,0.8,1.6,transcript,21382.0
HFE,ENSG00000010704,Familial porphyria cutanea tarda,EFO_0009043,0.6296052646851157,6.296060932026906,1,0.4,0.4,transcript,48279.0
TNFRSF11A,ENSG00000141655,autosomal recessive osteopetrosis 7,MONDO_0012859,0.6294471303625003,6.294595894810176,2,0.8,1.6,transcript,12842.0
DSC2,ENSG00000134755,arrhythmogenic right ventricular cardiomyopathy,MONDO_0016587,0.6282569207625751,6.2825816496923785,2,0.8,1.6,transcript,128596.0
ALDOB,ENSG00000136872,serum creatinine amount,OBA_2050096,0.6275775161239717,6.275816573394184,1,0.4,0.4,transcript,9659.0
SLC30A8,ENSG00000164756,glucose measurement,EFO_0004468,0.6273749644082018,6.274059811766422,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,glucose measurement,EFO_0004468,0.6273749644082018,6.274059811766422,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,glucose measurement,EFO_0004468,0.6273749644082018,6.274059811766422,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,glucose measurement,EFO_0004468,0.6273749644082018,6.274059811766422,4,1.6,6.4,transcript,20634.0
PDE11A,ENSG00000128655,primary pigmented nodular adrenocortical disease,MONDO_0015999,0.6270419596530823,6.270483379668156,2,0.8,1.6,transcript,25085.0
C2CD4A,ENSG00000198535,IGF-1 measurement,EFO_0004627,0.6262936365341595,6.263052475646385,1,0.4,0.4,transcript,3445.0
CEP85L,ENSG00000111860,hypertrophic cardiomyopathy,EFO_0000538,0.6255056792234356,6.255072195214833,1,0.4,0.4,transcript,25969.0
GRIN2B,ENSG00000273079,Parkinson disease,MONDO_0005180,0.6251931050061291,6.251935319688233,1,0.4,0.4,transcript,93685.0
RASA2,ENSG00000155903,lymphocyte percentage of leukocytes,EFO_0007993,0.62501799628134,6.250227576192759,1,0.4,0.4,transcript,8401.0
GABRA1,ENSG00000022355,Seizure,HP_0001250,0.6248501262620691,6.248509946191375,1,0.4,0.4,transcript,46064.0
BRCA2,ENSG00000139618,bile duct adenocarcinoma,MONDO_0003193,0.624409035894513,6.244093350932588,1,0.5,0.5,transcript,167113.0
GRIN2B,ENSG00000273079,complex neurodevelopmental disorder,MONDO_0100038,0.6237956292491911,6.237960562118852,1,0.4,0.4,transcript,93685.0
ENPEP,ENSG00000138792,systolic blood pressure,EFO_0006335,0.6236706928671856,6.236749328502256,1,0.4,0.4,transcript,9434.0
IKZF3,ENSG00000161405,immunodeficiency 84,MONDO_0030333,0.6226642768118893,6.226650508955678,1,0.4,0.4,transcript,51674.0
IQGAP2,ENSG00000145703,platelet component distribution width,EFO_0007984,0.6212568602352644,6.212583273283661,1,0.5,0.5,transcript,34081.0
SMC5,ENSG00000198887,Atelis syndrome 2,MONDO_0859576,0.6208428253349262,6.208492603413612,1,0.5,0.5,transcript,7770.0
RET,ENSG00000165731,neoplasm,EFO_0000616,0.6200409059320122,6.200419071585148,1,0.4,0.4,transcript,39951.0
MSX2,ENSG00000120149,"Craniosynostosis, Boston type",Orphanet_1541,0.6195066215834889,6.195184454084963,1,0.4,0.4,transcript,3383.0
SUMF1,ENSG00000144455,mucosulfatidosis,MONDO_0010088,0.61869720895634,6.18700443893663,1,0.4,0.4,transcript,12365.0
ANKH,ENSG00000154122,citrate measurement,EFO_0010114,0.6176244133506176,6.177012576129126,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,citrate measurement,EFO_0010114,0.6176244133506176,6.177012576129126,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,citrate measurement,EFO_0010114,0.6176244133506176,6.177012576129126,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,citrate measurement,EFO_0010114,0.6176244133506176,6.177012576129126,5,2.4,12.0,gene_variant,15616.0
FBN1,ENSG00000166147,isolated ectopia lentis,MONDO_0015998,0.6168233659350506,6.16824032457304,1,0.4,0.4,transcript,60013.0
MYO5A,ENSG00000197535,Griscelli disease type 1,Orphanet_79476,0.6167156325451402,6.167158365112614,1,0.4,0.4,transcript,196111.0
ENPEP,ENSG00000138792,diastolic blood pressure,EFO_0006336,0.616579202749971,6.165834427330111,1,0.4,0.4,transcript,9434.0
PIGN,ENSG00000197563,multiple congenital anomalies-hypotonia-seizures syndrome,MONDO_0100247,0.6162230771513673,6.162233311341345,1,0.4,0.4,transcript,157491.0
PEX7,ENSG00000112357,rhizomelic chondrodysplasia punctata,MONDO_0015776,0.6151558873907151,6.151601418046696,1,0.4,0.4,transcript,9402.0
SELENOI,ENSG00000138018,"spastic paraplegia 81, autosomal recessive",MONDO_0032905,0.614999357188078,6.150035160568656,1,0.4,0.4,transcript,9618.0
IL17A,ENSG00000112115,psoriatic arthritis,EFO_0003778,0.61486894572912,6.148903246708623,1,0.4,0.4,transcript,1871.0
SLC5A7,ENSG00000115665,distal hereditary motor neuropathy type 7,MONDO_0015355,0.6147987480044611,6.148043043317288,1,0.4,0.4,transcript,7199.0
PDE11A,ENSG00000128655,IGF-1 measurement,EFO_0004627,0.6143308012643276,6.143371795780609,2,0.8,1.6,transcript,25085.0
CACNA1D,ENSG00000157388,essential hypertension,MONDO_0001134,0.6138189995673136,6.1381939609374205,1,0.4,0.4,transcript,100876.0
ACVR1C,ENSG00000123612,birth weight,EFO_0004344,0.6135479916295855,6.135599230240673,2,0.8,1.6,transcript,13410.0
HTR2C,ENSG00000147246,schizophrenia,MONDO_0005090,0.6133844677652311,6.133884100501795,1,0.5,0.5,transcript,12683.0
HTR2C,ENSG00000147246,bipolar disorder,MONDO_0004985,0.6114336553786669,6.114375976636152,1,0.5,0.5,transcript,12683.0
PDE3A,ENSG00000172572,brachydactyly-arterial hypertension syndrome,MONDO_0007211,0.6113067126308083,6.113091909455543,1,0.4,0.4,gene_variant,16140.0
KYNU,ENSG00000115919,congenital vertebral-cardiac-renal anomalies syndrome,MONDO_0020831,0.6110402004039519,6.110560252753749,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
FARSB,ENSG00000116120,Rajab interstitial lung disease with brain calcifications,MONDO_0100214,0.6109588688583925,6.109639708992088,1,0.4,0.4,transcript,7840.0
SORT1,ENSG00000134243,coronary artery disease,EFO_0001645,0.6109359344868125,6.109381174163039,1,0.4,0.4,transcript,18324.0
TCF7L2,ENSG00000148737,colorectal adenocarcinoma,EFO_0000365,0.6101502649359923,6.101575199288381,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,colorectal adenocarcinoma,EFO_0000365,0.6101502649359923,6.101575199288381,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,colorectal adenocarcinoma,EFO_0000365,0.6101502649359923,6.101575199288381,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,colorectal adenocarcinoma,EFO_0000365,0.6101502649359923,6.101575199288381,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
PTPRO,ENSG00000151490,familial idiopathic steroid-resistant nephrotic syndrome,MONDO_0019006,0.6099658903112014,6.099663351708482,1,0.4,0.4,transcript,89916.0
GRIN2B,ENSG00000273079,Alzheimer disease,MONDO_0004975,0.6097102341817399,6.097106611444341,1,0.4,0.4,transcript,93685.0
MAGI2,ENSG00000187391,nephrotic syndrome,EFO_0004255,0.6096802083281847,6.09680664667884,1,0.4,0.4,transcript,87654.0
GABRA4,ENSG00000109158,epilepsy,EFO_0000474,0.6096174134516213,6.096199285421647,1,0.4,0.4,transcript,15904.0
ADAMTS3,ENSG00000156140,body height,OBA_VT0001253,0.6090979343596328,6.091028659340378,1,0.4,0.4,transcript,8111.0
GPD2,ENSG00000115159,diabetes mellitus,EFO_0000400,0.6090408765586528,6.090426431870425,1,0.4,0.4,transcript,22642.0
GABRA1,ENSG00000022355,insomnia,EFO_0004698,0.6087258257663026,6.08726694123371,1,0.4,0.4,transcript,46064.0
IQGAP1,ENSG00000140575,cancer,MONDO_0004992,0.608479671928524,6.0848508172024705,2,0.8,1.6,transcript,29576.0
HTR2C,ENSG00000147246,major depressive disorder,MONDO_0002009,0.6084308169309369,6.084347592158853,1,0.5,0.5,transcript,12683.0
FRS2,ENSG00000166225,cancer,MONDO_0004992,0.6079112271026668,6.079128379922806,1,0.4,0.4,transcript,24831.0
AR,ENSG00000169083,hypogonadism,MONDO_0002146,0.6078857971898043,6.0788993016839035,2,0.8,1.6,transcript,38713.0
NDUFAF2,ENSG00000164182,type 2 diabetes mellitus,MONDO_0005148,0.60779559313974,6.077996136443133,1,0.4,0.4,transcript,9949.0
HTR2C,ENSG00000147246,autism,EFO_0003758,0.6071789599214166,6.071829022063649,1,0.5,0.5,transcript,12683.0
NDUFAF4,ENSG00000123545,type 2 diabetes mellitus,MONDO_0005148,0.6069640384666994,6.069751929563816,1,0.4,0.4,transcript,3586.0
FBN1,ENSG00000166147,aneurysm,EFO_0009659,0.6066325752163765,6.0663324173863,1,0.4,0.4,transcript,60013.0
CYSLTR1,ENSG00000173198,asthma,MONDO_0004979,0.6063927346277082,6.064117482937807,2,0.8,1.6,transcript,8415.0
GABRG1,ENSG00000163285,epilepsy,EFO_0000474,0.6061655656089797,6.063786464021138,6,2.4000000000000004,14.400000000000002,transcript,6758.0
GRIA4,ENSG00000152578,epilepsy,EFO_0000474,0.6059892947137318,6.059902238658804,1,0.4,0.4,transcript,43050.0
CD86,ENSG00000114013,rheumatoid arthritis,EFO_0000685,0.6059639481158079,6.059671315618883,1,0.4,0.4,transcript,12565.0
AR,ENSG00000169083,Familial prostate cancer,Orphanet_1331,0.6057212701740611,6.057254031526471,2,0.8,1.6,transcript,38713.0
PHC1,ENSG00000111752,autosomal recessive primary microcephaly,MONDO_0016660,0.6056267378127715,6.056286528612223,1,0.5,0.5,transcript,26109.0
CACNA1D,ENSG00000157388,coronary artery disease,EFO_0001645,0.6054873507505669,6.054877472769954,1,0.4,0.4,transcript,100876.0
GABRG1,ENSG00000163285,insomnia,EFO_0004698,0.6047591771269956,6.049722579201296,6,2.4000000000000004,14.400000000000002,transcript,6758.0
GABRG1,ENSG00000163285,major depressive disorder,MONDO_0002009,0.6046174199890159,6.048305007821499,6,2.4000000000000004,14.400000000000002,transcript,6758.0
CACNA1D,ENSG00000157388,Prinzmetal's angina,EFO_1000013,0.6043288648711579,6.043292613975864,1,0.4,0.4,transcript,100876.0
GABRA1,ENSG00000022355,panic disorder,EFO_0004262,0.6041973167696558,6.041981851267242,1,0.4,0.4,transcript,46064.0
FBN1,ENSG00000166147,Aortic dissection,HP_0002647,0.604093663286855,6.040943298091085,1,0.4,0.4,transcript,60013.0
PDE10A,ENSG00000112541,IGF-1 measurement,EFO_0004627,0.6039802885260628,6.0398225973545445,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
HTR2C,ENSG00000147246,schizoaffective disorder,EFO_0005411,0.6036407079552342,6.036446502401826,1,0.5,0.5,transcript,12683.0
CYSLTR1,ENSG00000173198,allergic rhinitis,EFO_0005854,0.6035726309732461,6.035916446393186,2,0.8,1.6,transcript,8415.0
SOS1,ENSG00000115904,cancer,MONDO_0004992,0.6033442102835964,6.033465710709191,2,0.8,1.6,transcript,67774.0
PDE3B,ENSG00000152270,sitting height measurement,EFO_0011011,0.6032045613568512,6.032120442864181,2,0.8,1.6,transcript,21382.0
PKP2,ENSG00000057294,cardiomyopathy,EFO_0000318,0.6031011997051328,6.031168098419654,4,1.6,6.4,transcript,40999.0
GABRG1,ENSG00000163285,panic disorder,EFO_0004262,0.6030885772056018,6.033016579987359,6,2.4000000000000004,14.400000000000002,transcript,6758.0
BRCA2,ENSG00000139618,urinary bladder carcinoma,MONDO_0004986,0.6029183073751412,6.02918606573887,1,0.5,0.5,transcript,167113.0
FGF5,ENSG00000138675,cancer,MONDO_0004992,0.6027534042552695,6.027643354570185,2,0.8,1.6,transcript,14637.0
GABRG1,ENSG00000163285,Agitation,HP_0000713,0.6027471988105273,6.029602796036613,6,2.4000000000000004,14.400000000000002,transcript,6758.0
GABRA1,ENSG00000022355,Agitation,HP_0000713,0.6027471988105273,6.027480671675956,1,0.4,0.4,transcript,46064.0
PDE3B,ENSG00000152270,asthma,MONDO_0004979,0.6024261967394212,6.024336796689881,2,0.8,1.6,transcript,21382.0
PDE3A,ENSG00000172572,asthma,MONDO_0004979,0.6021111752859732,6.021136536007192,1,0.4,0.4,gene_variant,16140.0
EGFR,ENSG00000146648,head and neck malignant neoplasia,EFO_0006859,0.6018830791871557,6.018868110526219,2,0.8,1.6,transcript,42874.0
FBN1,ENSG00000166147,neonatal Marfan syndrome,MONDO_0017309,0.6018430648030211,6.018437313252746,1,0.4,0.4,transcript,60013.0
NDUFAF4,ENSG00000123545,diabetes mellitus,EFO_0000400,0.6017093979393019,6.017205524289841,1,0.4,0.4,transcript,3586.0
NDUFAF2,ENSG00000164182,diabetes mellitus,EFO_0000400,0.6017093979393019,6.017134184438753,1,0.4,0.4,transcript,9949.0
GABRA1,ENSG00000022355,anxiety disorder,EFO_0006788,0.6015071796440594,6.015080480011278,1,0.4,0.4,transcript,46064.0
GABRG1,ENSG00000163285,anxiety disorder,EFO_0006788,0.6012755770461485,6.014886578392826,6,2.4000000000000004,14.400000000000002,transcript,6758.0
ARHGAP29,ENSG00000137962,cleft lip,EFO_0003959,0.6011793687668548,6.011813913387573,1,0.5,0.5,transcript,24721.0
TCF7L2,ENSG00000148737,prostate carcinoma,EFO_0001663,0.6006950048681996,6.007022598610454,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,prostate carcinoma,EFO_0001663,0.6006950048681996,6.007022598610454,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,prostate carcinoma,EFO_0001663,0.6006950048681996,6.007022598610454,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,prostate carcinoma,EFO_0001663,0.6006950048681996,6.007022598610454,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
ATXN3,ENSG00000066427,Machado-Joseph disease,MONDO_0007182,0.6006288278331804,6.006294001529354,1,0.4,0.4,transcript,69891.0
HFE,ENSG00000010704,variegate porphyria,MONDO_0008297,0.6002664315594601,6.00267260077035,1,0.4,0.4,transcript,48279.0
IL4R,ENSG00000077238,atopic eczema,EFO_0000274,0.5999107097216225,5.999125661285468,1,0.4,0.4,transcript,21547.0
HTR1F,ENSG00000179097,migraine disorder,MONDO_0005277,0.5997502459386524,5.997620592877369,1,0.4,0.4,transcript,3386.0
CACNA1D,ENSG00000157388,angina pectoris,EFO_0003913,0.5994769586077691,5.994773551341976,1,0.4,0.4,transcript,100876.0
HTR2C,ENSG00000147246,aggressive behavior,EFO_0003015,0.5988095284018684,5.988134706868167,1,0.5,0.5,transcript,12683.0
GHR,ENSG00000112964,Turner syndrome,MONDO_0019499,0.5985150101291019,5.985158962807668,1,0.4,0.4,transcript,45139.0
GABRA4,ENSG00000109158,migraine disorder,MONDO_0005277,0.5985038203721792,5.985063354627225,1,0.4,0.4,transcript,15904.0
GHR,ENSG00000112964,pituitary dwarfism,EFO_1001109,0.598384722099197,5.983856082508619,1,0.4,0.4,transcript,45139.0
GRIN2B,ENSG00000273079,infection,EFO_0000544,0.5981436773421626,5.981441043048568,1,0.4,0.4,transcript,93685.0
SAMD9L,ENSG00000177409,spinocerebellar ataxia 49,MONDO_0030805,0.5980300118622643,5.980308571529387,1,0.4,0.4,transcript,47321.0
EPRS1,ENSG00000136628,"leukodystrophy, hypomyelinating, 15",MONDO_0054782,0.5976108224515806,5.976152939235892,1,0.5,0.5,transcript,11182.0
GRIA4,ENSG00000152578,migraine disorder,MONDO_0005277,0.5972692269464271,5.972701560985758,1,0.4,0.4,transcript,43050.0
FSIP2,ENSG00000188738,azoospermia,EFO_0000279,0.5968923462050881,5.969202402078776,4,2.0,8.0,transcript,28680.0
IL17A,ENSG00000112115,ankylosing spondylitis,EFO_0003898,0.5968836356998366,5.96905014641579,1,0.4,0.4,transcript,1871.0
HTR2C,ENSG00000147246,Agitation,HP_0000713,0.5966972301764404,5.967011724613887,1,0.5,0.5,transcript,12683.0
GRIN2B,ENSG00000273079,influenza,EFO_0007328,0.596693717880564,5.966941448432582,1,0.4,0.4,transcript,93685.0
GRIN2B,ENSG00000273079,alcohol dependence,MONDO_0007079,0.5966112138781412,5.966116408408354,1,0.4,0.4,transcript,93685.0
HTR2C,ENSG00000147246,bipolar I disorder,EFO_0009963,0.596503655260101,5.965075975450493,1,0.5,0.5,transcript,12683.0
GABRA1,ENSG00000022355,anxiety,EFO_0005230,0.5964963956314874,5.964972639885557,1,0.4,0.4,transcript,46064.0
GABRA1,ENSG00000022355,alcohol dependence,MONDO_0007079,0.5960689553523694,5.960698237094378,1,0.4,0.4,transcript,46064.0
BRCA2,ENSG00000139618,prophylactic surgery,EFO_0009580,0.5960309933932111,5.960312925919569,1,0.5,0.5,transcript,167113.0
SHH,ENSG00000164690,triphalangeal thumb-polysyndactyly syndrome,MONDO_0017454,0.5959308332550854,5.959361481634033,1,0.4,0.4,transcript,7526.0
FGF5,ENSG00000138675,bone development disease,EFO_0005541,0.5958182061931233,5.9582913739487235,2,0.8,1.6,transcript,14637.0
BRCA2,ENSG00000139618,squamous cell lung carcinoma,EFO_0000708,0.5955757862166036,5.955760854153493,1,0.5,0.5,transcript,167113.0
TYR,ENSG00000077498,cutaneous melanoma,EFO_0000389,0.595405421627838,5.954178039953467,1,0.5,0.5,transcript,4038.0
GABRG1,ENSG00000163285,alcohol dependence,MONDO_0007079,0.5953920082518719,5.95605089045006,6,2.4000000000000004,14.400000000000002,transcript,6758.0
GABRG1,ENSG00000163285,migraine disorder,MONDO_0005277,0.5951950676466844,5.954081484398184,6,2.4000000000000004,14.400000000000002,transcript,6758.0
GABRA1,ENSG00000022355,migraine disorder,MONDO_0005277,0.5951950676466844,5.951959360037527,1,0.4,0.4,transcript,46064.0
AR,ENSG00000169083,Hypogonadotropic hypogonadism,HP_0000044,0.5944967061749511,5.945008391535371,2,0.8,1.6,transcript,38713.0
GABRG1,ENSG00000163285,anxiety,EFO_0005230,0.5943085518537753,5.945216326469094,6,2.4000000000000004,14.400000000000002,transcript,6758.0
RET,ENSG00000165731,thyroid neoplasm,EFO_0003841,0.5941977108604868,5.941987120869893,1,0.4,0.4,transcript,39951.0
SORT1,ENSG00000134243,low density lipoprotein cholesterol measurement,EFO_0004611,0.5941344742056687,5.941366571351601,1,0.4,0.4,transcript,18324.0
CACNA1D,ENSG00000157388,myocardial infarction,EFO_0000612,0.5940047835421076,5.940051800685361,1,0.4,0.4,transcript,100876.0
EGFR,ENSG00000146648,urinary bladder carcinoma,MONDO_0004986,0.5933250512587956,5.933287831242619,2,0.8,1.6,transcript,42874.0
PPARG,ENSG00000132170,body fat percentage,EFO_0007800,0.5933066272204969,5.958597266399192,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,body fat percentage,EFO_0007800,0.5933066272204969,5.958597266399192,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,body fat percentage,EFO_0007800,0.5933066272204969,5.958597266399192,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,body fat percentage,EFO_0007800,0.5933066272204969,5.958597266399192,59,24.0,1416.0,gene_variant,55462.0
FGF5,ENSG00000138675,systolic blood pressure,EFO_0006335,0.5930873779402845,5.930983091420336,2,0.8,1.6,transcript,14637.0
CYSLTR1,ENSG00000173198,seasonal allergic rhinitis,EFO_0003956,0.5930618215992944,5.93080835265367,2,0.8,1.6,transcript,8415.0
FRS2,ENSG00000166225,bone development disease,EFO_0005541,0.5928516943954913,5.928533052851051,1,0.4,0.4,transcript,24831.0
SORT1,ENSG00000134243,total cholesterol measurement,EFO_0004574,0.5927749729877443,5.927771559172356,1,0.4,0.4,transcript,18324.0
FGA,ENSG00000171560,cancer,MONDO_0004992,0.5926173952264036,5.9262421767225035,1,0.4,0.4,transcript,5863.0
HTR2C,ENSG00000147246,depressive disorder,MONDO_0002050,0.5925652295322709,5.925691718172192,1,0.5,0.5,transcript,12683.0
STT3B,ENSG00000163527,STT3B-congenital disorder of glycosylation,MONDO_0014271,0.5925632093405241,5.92565181629859,1,0.4,0.4,transcript,20281.0
TBX5,ENSG00000089225,atrial fibrillation,EFO_0000275,0.5923770807833266,5.923896101490275,2,0.8,1.6,transcript,12770.0
SLC25A37,ENSG00000147454,mean corpuscular hemoglobin,EFO_0004527,0.5921147348728887,5.921166518670419,1,0.4,0.4,transcript,20866.0
GABRA4,ENSG00000109158,alcohol dependence,MONDO_0007079,0.5918984165346614,5.919009316252047,1,0.4,0.4,transcript,15904.0
TTC39B,ENSG00000155158,triglyceride measurement,EFO_0004530,0.5917801139934856,5.917954795660666,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
CASQ2,ENSG00000118729,catecholaminergic polymorphic ventricular tachycardia 1,MONDO_0011484,0.5915515267555228,5.915527918576798,1,0.4,0.4,transcript,31618.0
SORT1,ENSG00000134243,high density lipoprotein cholesterol measurement,EFO_0004612,0.5915472414800877,5.915494244095791,1,0.4,0.4,transcript,18324.0
BANK1,ENSG00000153064,systemic lupus erythematosus,MONDO_0007915,0.5915363978834907,5.915576466575999,3,1.3,3.9000000000000004,transcript,18354.0
CDH23,ENSG00000107736,nonsyndromic genetic hearing loss,MONDO_0019497,0.5914799404177068,5.914806954880039,1,0.5,0.5,transcript,66219.0
FGF5,ENSG00000138675,diastolic blood pressure,EFO_0006336,0.5914511836311138,5.914621148328629,2,0.8,1.6,transcript,14637.0
ANKH,ENSG00000154122,glucose measurement,EFO_0004468,0.591233851296493,5.91310695558788,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,glucose measurement,EFO_0004468,0.591233851296493,5.91310695558788,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,glucose measurement,EFO_0004468,0.591233851296493,5.91310695558788,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,glucose measurement,EFO_0004468,0.591233851296493,5.91310695558788,5,2.4,12.0,transcript,15616.0
GBE1,ENSG00000114480,"glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form",MONDO_0017698,0.590877106346188,5.908831942555998,1,0.5,0.5,transcript,8213.0
SLC39A8,ENSG00000138821,high density lipoprotein cholesterol measurement,EFO_0004612,0.5905205163273988,5.905212468676333,1,0.4,0.4,transcript,54754.0
SLC39A8,ENSG00000138821,neuroimaging measurement,EFO_0004346,0.5903698945391417,5.903706250793762,1,0.4,0.4,transcript,54754.0
SORT1,ENSG00000134243,lipid measurement,EFO_0004529,0.5897058089576745,5.897079918871659,1,0.4,0.4,transcript,18324.0
ING1,ENSG00000153487,head and neck squamous cell carcinoma,EFO_0000181,0.5896873334239182,5.89689981729003,1,0.4,0.4,transcript,15104.0
PIGB,ENSG00000069943,developmental and epileptic encephalopathy,MONDO_0100062,0.5893837813206187,5.893877964173826,1,0.5,0.5,transcript,12453.0
EGFR,ENSG00000146648,breast cancer,MONDO_0007254,0.5893541089256344,5.893578407911007,2,0.8,1.6,transcript,42874.0
GABRG1,ENSG00000163285,Seizure,HP_0001250,0.5893008788199434,5.895139596130775,6,2.4000000000000004,14.400000000000002,transcript,6758.0
HFE,ENSG00000010704,diabetic retinopathy,EFO_0003770,0.5889514806697985,5.889523091873734,1,0.4,0.4,transcript,48279.0
HTR2C,ENSG00000147246,psychosis,EFO_0005407,0.5889480383464324,5.889519806313808,1,0.5,0.5,transcript,12683.0
SLC39A8,ENSG00000138821,cortical thickness,EFO_0004840,0.5887975007413601,5.887982312815946,1,0.4,0.4,transcript,54754.0
SLC39A8,ENSG00000138821,amygdala volume,OBA_2050034,0.5884246230473492,5.884253535875837,1,0.4,0.4,transcript,54754.0
FGA,ENSG00000171560,Hypofibrinogenemia,HP_0011900,0.5883497093954599,5.883565318413067,1,0.4,0.4,transcript,5863.0
FGF5,ENSG00000138675,glomerular filtration rate,OBA_0003747,0.5879937970116023,5.880047282133513,2,0.8,1.6,transcript,14637.0
TET1,ENSG00000138336,body height,OBA_VT0001253,0.5875271230899645,5.8753128455480015,1,0.4,0.4,transcript,9612.0
GRIN2B,ENSG00000273079,Dementia,HP_0000726,0.5874409660962088,5.8744139305890295,1,0.4,0.4,transcript,93685.0
GHR,ENSG00000112964,acromegaly,EFO_1001485,0.5874409336154313,5.874418197670961,1,0.4,0.4,transcript,45139.0
PLCL2,ENSG00000154822,erythrocyte volume,OBA_0003460,0.5874355155955251,5.87449370808549,2,0.8,1.6,transcript,11548.0
TYR,ENSG00000077498,oculocutaneous albinism type 6,MONDO_0018264,0.5873619294271963,5.87374311794705,1,0.5,0.5,transcript,4038.0
TCF7L2,ENSG00000148737,diabetes mellitus,EFO_0000400,0.5872199355849153,5.872271905777611,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,diabetes mellitus,EFO_0000400,0.5872199355849153,5.872271905777611,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,diabetes mellitus,EFO_0000400,0.5872199355849153,5.872271905777611,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,diabetes mellitus,EFO_0000400,0.5872199355849153,5.872271905777611,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
KCNQ1,ENSG00000053918,multiple sclerosis,MONDO_0005301,0.5871127300111096,5.871320973448734,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
KCNQ3,ENSG00000184156,multiple sclerosis,MONDO_0005301,0.5871127300111096,5.871183677841893,2,0.8,1.6,transcript,28380.0
FGF5,ENSG00000138675,hypertension,EFO_0000537,0.5870841678833981,5.870950990851472,2,0.8,1.6,transcript,14637.0
SORT1,ENSG00000134243,cholesteryl ester measurement,EFO_0010351,0.5869748401271637,5.869770230566552,1,0.4,0.4,transcript,18324.0
GRIN2B,ENSG00000273079,major depressive disorder,MONDO_0002009,0.586883764765061,5.8688419172775514,1,0.4,0.4,transcript,93685.0
PLXND1,ENSG00000004399,BMI-adjusted waist-hip ratio,EFO_0007788,0.5868760179482551,5.868783860452523,1,0.5,0.5,transcript,21114.0
COL24A1,ENSG00000171502,Dupuytren Contracture,EFO_0004229,0.5866771872242704,5.866796268436898,1,0.4,0.4,transcript,16396.0
FGF5,ENSG00000138675,trichomegaly,MONDO_0008593,0.586596863037614,5.8660779423936305,2,0.8,1.6,transcript,14637.0
SLC22A2,ENSG00000112499,glomerular filtration rate,OBA_0003747,0.5863961153612003,5.864000875558379,1,0.4,0.4,transcript,10070.0
SLC39A8,ENSG00000138821,brain volume,OBA_2050009,0.5863494001131744,5.863501306534089,1,0.4,0.4,transcript,54754.0
PDE3B,ENSG00000152270,lipoprotein measurement,EFO_0004732,0.5859169937222889,5.859244766518558,2,0.8,1.6,transcript,21382.0
SORT1,ENSG00000134243,intermediate density lipoprotein measurement,EFO_0008595,0.5855503957504231,5.855525786799145,1,0.4,0.4,transcript,18324.0
SLC39A8,ENSG00000138821,body mass index,EFO_0004340,0.5854684250009107,5.854691555411452,1,0.4,0.4,transcript,54754.0
LRP2,ENSG00000081479,glomerular filtration rate,OBA_0003747,0.5854048950916418,5.854065539616196,1,0.5,0.5,transcript,30141.0
RET,ENSG00000165731,thyroid carcinoma,EFO_0002892,0.5851586887455623,5.851596899720648,1,0.4,0.4,transcript,39951.0
SORT1,ENSG00000134243,phospholipids:total lipids ratio,EFO_0020946,0.5850445632376459,5.850467461671372,1,0.4,0.4,transcript,18324.0
TTC39B,ENSG00000155158,high density lipoprotein cholesterol measurement,EFO_0004612,0.5848542912026492,5.8486965677523015,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
VPS13A,ENSG00000197969,chorea-acanthocytosis,MONDO_0008695,0.5846402667609107,5.8464094128579225,1,0.4,0.4,transcript,59301.0
PDE3B,ENSG00000152270,reticulocyte count,EFO_0007986,0.5845958290233481,5.8460331195291495,2,0.8,1.6,transcript,21382.0
SORT1,ENSG00000134243,free cholesterol measurement,EFO_0008591,0.5844883574279045,5.844905403573959,1,0.4,0.4,transcript,18324.0
FBN1,ENSG00000166147,musculoskeletal system disease,EFO_0009676,0.5843177721236621,5.843184386459156,1,0.4,0.4,transcript,60013.0
FGF5,ENSG00000138675,serum creatinine amount,OBA_2050096,0.5840696034410269,5.840805346427759,2,0.8,1.6,transcript,14637.0
GALNT3,ENSG00000115339,bone tissue density,OBA_1000110,0.5839562210888235,5.8395911188885234,1,0.4,0.4,transcript,13837.0
SORT1,ENSG00000134243,phospholipid measurement,EFO_0004639,0.583756342318643,5.837585252481344,1,0.4,0.4,transcript,18324.0
SORT1,ENSG00000134243,esterified cholesterol measurement,EFO_0008589,0.5828147876622839,5.828169705917753,1,0.4,0.4,transcript,18324.0
SORT1,ENSG00000134243,cholesterol:total lipids ratio,EFO_0020943,0.5821932677628374,5.821954506923288,1,0.4,0.4,transcript,18324.0
PDE1C,ENSG00000154678,"hearing loss, autosomal dominant 74",MONDO_0029137,0.5820844230562412,5.82089858946708,2,0.8,1.6,transcript,29434.0
AR,ENSG00000169083,hypogonadotropic hypogonadism,MONDO_0018555,0.5818975194230929,5.819016524016789,2,0.8,1.6,transcript,38713.0
IYD,ENSG00000009765,familial thyroid dyshormonogenesis,MONDO_0010132,0.5815331827708282,5.815349231119351,1,0.4,0.4,transcript,22984.0
SLC39A8,ENSG00000138821,total cholesterol measurement,EFO_0004574,0.5814453793904164,5.814461099306509,1,0.4,0.4,transcript,54754.0
SLC39A8,ENSG00000138821,osteoarthritis,MONDO_0005178,0.5814323982595412,5.814331287997757,1,0.4,0.4,transcript,54754.0
PLCL2,ENSG00000154822,mean corpuscular hemoglobin concentration,EFO_0004528,0.5814244005846073,5.814382557976312,2,0.8,1.6,transcript,11548.0
SLC39A8,ENSG00000138821,diastolic blood pressure,EFO_0006336,0.5813427325968442,5.813434631370788,1,0.4,0.4,transcript,54754.0
GRIN2B,ENSG00000273079,depressive disorder,MONDO_0002050,0.581317209939613,5.813176369023072,1,0.4,0.4,transcript,93685.0
TCF7L2,ENSG00000148737,monocyte count,EFO_0005091,0.5809775098421125,5.8098476483495824,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,monocyte count,EFO_0005091,0.5809775098421125,5.8098476483495824,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,monocyte count,EFO_0005091,0.5809775098421125,5.8098476483495824,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,monocyte count,EFO_0005091,0.5809775098421125,5.8098476483495824,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
ETV5,ENSG00000244405,body mass index,EFO_0004340,0.5807623244962857,5.807655417407159,1,0.4,0.4,transcript,12433.0
BTC,ENSG00000174808,cancer,MONDO_0004992,0.5807172419981024,5.807294482843398,1,0.4,0.4,transcript,3277.0
PLCL2,ENSG00000154822,erythrocyte count,EFO_0004305,0.5806458873340457,5.806597425470696,2,0.8,1.6,transcript,11548.0
SORT1,ENSG00000134243,glomerular filtration rate,OBA_0003747,0.5805995705422543,5.806017534717457,1,0.4,0.4,transcript,18324.0
AR,ENSG00000169083,orchitis,EFO_1001078,0.5805707016580218,5.805748346366078,2,0.8,1.6,transcript,38713.0
TSPAN9,ENSG00000011105,glomerular filtration rate,OBA_0003747,0.5803756136578142,5.803791620220183,1,0.5,0.5,transcript,14091.0
RET,ENSG00000165731,multiple endocrine neoplasia type 2,MONDO_0019003,0.5803004973207092,5.803014985472117,1,0.4,0.4,transcript,39951.0
GREM1,ENSG00000166923,colorectal cancer,MONDO_0005575,0.5799789560836007,5.799807784900885,1,0.4,0.4,transcript,21949.0
PARP1,ENSG00000143799,neoplasm,EFO_0000616,0.5798137645638904,5.798143515216882,1,0.5,0.5,transcript,85185.0
SORT1,ENSG00000134243,Hypercholesterolemia,HP_0003124,0.5797463558663427,5.797485387958341,1,0.4,0.4,transcript,18324.0
SLC39A8,ENSG00000138821,systolic blood pressure,EFO_0006335,0.5796850645708986,5.796857951111331,1,0.4,0.4,transcript,54754.0
IL4R,ENSG00000077238,eosinophil count,EFO_0004842,0.5796841770404074,5.796860334473318,1,0.4,0.4,transcript,21547.0
TYR,ENSG00000077498,skin pigmentation,OBA_VT0002095,0.5796691387114906,5.796815210789993,1,0.5,0.5,transcript,4038.0
SYNJ2,ENSG00000078269,alkaline phosphatase measurement,EFO_0004533,0.5795186124340673,5.795237271965505,2,0.8,1.6,transcript,31282.0
HFE,ENSG00000010704,Alzheimer disease type 1,MONDO_0007088,0.5795066621611895,5.795074906787644,1,0.4,0.4,transcript,48279.0
CYP24A1,ENSG00000019186,serum creatinine amount,OBA_2050096,0.579197642010793,5.792166624577736,2,0.8,1.6,transcript,8412.0
SNX13,ENSG00000071189,high density lipoprotein cholesterol measurement,EFO_0004612,0.5791509632912019,5.7915219580491355,1,0.4,0.4,transcript,32454.0
SORT1,ENSG00000134243,free cholesterol:total lipids ratio,EFO_0020945,0.5788909616401217,5.7889314456961305,1,0.4,0.4,transcript,18324.0
TAF2,ENSG00000064313,HIV infection,EFO_0000764,0.5787534184672349,5.787536977656374,1,0.5,0.5,transcript,179020.0
EGFR,ENSG00000146648,breast carcinoma,EFO_0000305,0.5785790811512823,5.785828130167486,2,0.8,1.6,transcript,42874.0
PDE11A,ENSG00000128655,eye measurement,EFO_0004731,0.5784627250139524,5.784691033276856,2,0.8,1.6,transcript,25085.0
SORT1,ENSG00000134243,cholesteryl esters:total lipids ratio,EFO_0020944,0.5780160346570065,5.7801821758649785,1,0.4,0.4,transcript,18324.0
SLC39A8,ENSG00000138821,schizophrenia,MONDO_0005090,0.5780089337741577,5.7800966431439225,1,0.4,0.4,transcript,54754.0
GABRA1,ENSG00000022355,pain,EFO_0003843,0.5779874672066261,5.779883355636945,1,0.4,0.4,transcript,46064.0
GABRG1,ENSG00000163285,pain,EFO_0003843,0.5779874672066261,5.7820054799976015,6,2.4000000000000004,14.400000000000002,transcript,6758.0
ETV5,ENSG00000244405,high density lipoprotein cholesterol measurement,EFO_0004612,0.5777343994488019,5.777376166932321,1,0.4,0.4,transcript,12433.0
SLC30A8,ENSG00000164756,diabetes mellitus,EFO_0000400,0.5776829244651223,5.777139412335627,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,diabetes mellitus,EFO_0000400,0.5776829244651223,5.777139412335627,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,diabetes mellitus,EFO_0000400,0.5776829244651223,5.777139412335627,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,diabetes mellitus,EFO_0000400,0.5776829244651223,5.777139412335627,4,1.6,6.4,gene_variant,20634.0
PLA2R1,ENSG00000153246,membranous glomerulonephritis,EFO_0004254,0.577669592245553,5.776775114694692,2,0.8,1.6,transcript,20204.0
ETV5,ENSG00000244405,glomerular filtration rate,OBA_0003747,0.5775909784837661,5.775941957281962,1,0.4,0.4,transcript,12433.0
DDR2,ENSG00000162733,Warburg-Cinotti syndrome,EFO_0010166,0.5775230749015455,5.775244789522318,1,0.4,0.4,transcript,28489.0
TTC39B,ENSG00000155158,total cholesterol measurement,EFO_0004574,0.5775081783318928,5.775235439044738,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
FGF5,ENSG00000138675,pulse pressure measurement,EFO_0005763,0.5774858940405473,5.774968252422963,2,0.8,1.6,transcript,14637.0
SORT1,ENSG00000134243,triglycerides:total lipids ratio,EFO_0020947,0.5773735214584359,5.773757043879273,1,0.4,0.4,transcript,18324.0
PDCD5,ENSG00000105185,Red cell distribution width,EFO_0009188,0.5772556193323093,5.772634303067283,1,0.4,0.4,transcript,5121.0
GJB2,ENSG00000165474,Hearing impairment,HP_0000365,0.577193744336634,5.772024248921895,1,0.4,0.4,transcript,4608.0
GABRA4,ENSG00000109158,Seizure,HP_0001250,0.5771639060816741,5.771664211722174,1,0.4,0.4,transcript,15904.0
FBN1,ENSG00000166147,Rare disease with thoracic aortic aneurysm and aortic dissection,Orphanet_285014,0.5770964117909927,5.770970783132461,1,0.4,0.4,transcript,60013.0
FGF5,ENSG00000138675,mean arterial pressure,EFO_0006340,0.577074727090346,5.77085658292095,2,0.8,1.6,transcript,14637.0
MDM4,ENSG00000198625,prostate carcinoma,EFO_0001663,0.5769654093123273,5.769659963993483,1,0.4,0.4,transcript,68133.0
GABRA1,ENSG00000022355,generalised epilepsy,EFO_0005917,0.5769453215660789,5.769461899231473,1,0.4,0.4,transcript,46064.0
GRB14,ENSG00000115290,type 2 diabetes mellitus,MONDO_0005148,0.5767981013396937,5.768021380739756,1,0.4,0.4,transcript,9909.0
KYNU,ENSG00000115919,encephalopathy due to hydroxykynureninuria,MONDO_0009372,0.5767383974097027,5.767542222811256,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
SLC39A8,ENSG00000138821,alcohol consumption quality,OBA_1000840,0.5765529969047267,5.7655372744496125,1,0.4,0.4,transcript,54754.0
LRBA,ENSG00000198589,common variable immunodeficiency,MONDO_0015517,0.5760751855919638,5.7607557974276595,1,0.4,0.4,transcript,101484.0
PDE3A,ENSG00000172572,Airway obstruction,HP_0006536,0.5758173118439065,5.758197901586525,1,0.4,0.4,gene_variant,16140.0
CYP24A1,ENSG00000019186,glomerular filtration rate,OBA_0003747,0.5756220891561511,5.756411096031316,2,0.8,1.6,transcript,8412.0
LDLRAP1,ENSG00000157978,platelet volume,OBA_0003277,0.5755544519823678,5.755570433272758,1,0.4,0.4,transcript,15436.0
CP,ENSG00000047457,cerebellar ataxia,MONDO_0000437,0.5754494704399157,5.754515762350639,1,0.5,0.5,transcript,23744.0
SPATA22,ENSG00000141255,Canavan disease,MONDO_0010079,0.5752883246129891,5.752916918431056,1,0.5,0.5,transcript,14849.0
SORT1,ENSG00000134243,myocardial infarction,EFO_0000612,0.5749828125235222,5.749849954530136,1,0.4,0.4,transcript,18324.0
RET,ENSG00000165731,hereditary neoplastic syndrome,MONDO_0015356,0.5748347347501612,5.748357359766637,1,0.4,0.4,transcript,39951.0
CACNA1D,ENSG00000157388,systolic blood pressure,EFO_0006335,0.5747788114644917,5.747792079909202,1,0.4,0.4,transcript,100876.0
SORT1,ENSG00000134243,triglyceride measurement,EFO_0004530,0.5746483857810408,5.746505687105322,1,0.4,0.4,transcript,18324.0
GRIN2B,ENSG00000273079,"intellectual disability, autosomal dominant",MONDO_0100172,0.5746102973720852,5.746107243347794,1,0.4,0.4,transcript,93685.0
TCF7L2,ENSG00000148737,glucose measurement,EFO_0004468,0.5744746174282851,5.744818724211308,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,glucose measurement,EFO_0004468,0.5744746174282851,5.744818724211308,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,glucose measurement,EFO_0004468,0.5744746174282851,5.744818724211308,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,glucose measurement,EFO_0004468,0.5744746174282851,5.744818724211308,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
SLAMF7,ENSG00000026751,multiple myeloma,EFO_0001378,0.5744735851310097,5.744752047609242,1,0.4,0.4,transcript,24697.0
CDH23,ENSG00000107736,hearing loss,EFO_0004238,0.5742654716663079,5.7426622673660495,1,0.5,0.5,transcript,66219.0
FGF5,ENSG00000138675,atrial fibrillation,EFO_0000275,0.5741594699897445,5.741704011914936,2,0.8,1.6,transcript,14637.0
SPAST,ENSG00000021574,Spastic paraplegia,HP_0001258,0.5741113502628181,5.741118678946525,1,0.4,0.4,transcript,77275.0
KCNQ1,ENSG00000053918,Abnormality of the cardiovascular system,HP_0001626,0.5740150316151491,5.740343989489128,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
CNTNAP2,ENSG00000174469,Pitt-Hopkins-like syndrome,MONDO_0016377,0.5739504632733587,5.739512314405119,1,0.4,0.4,transcript,52072.0
ACVR1C,ENSG00000123612,total cholesterol measurement,EFO_0004574,0.573918285345848,5.739302167403298,2,0.8,1.6,transcript,13410.0
SLC39A8,ENSG00000138821,triglyceride measurement,EFO_0004530,0.573854978565592,5.738557091058265,1,0.4,0.4,transcript,54754.0
FGFR1OP2,ENSG00000111790,cancer,MONDO_0004992,0.573779277479953,5.7378289084942,1,0.4,0.4,transcript,11070.0
SORT1,ENSG00000134243,serum creatinine amount,OBA_2050096,0.5737459774688314,5.737481603983228,1,0.4,0.4,transcript,18324.0
ANO5,ENSG00000171714,isolated asymptomatic elevation of creatine phosphokinase,MONDO_0016103,0.5736926487628178,5.736931533991642,1,0.4,0.4,transcript,79265.0
FGF5,ENSG00000138675,erythrocyte count,EFO_0004305,0.5735372275104395,5.7354815871218845,2,0.8,1.6,transcript,14637.0
NEK1,ENSG00000137601,Orofaciodigital syndrome type 2,Orphanet_2751,0.5734625035934449,5.734639295802723,2,0.8,1.6,transcript,112203.0
EGFR,ENSG00000146648,neuroimaging measurement,EFO_0004346,0.5734109246982547,5.73414656563721,2,0.8,1.6,transcript,42874.0
ATP10D,ENSG00000145246,ceramide measurement,EFO_0010222,0.5732963893162186,5.732995715972776,1,0.5,0.5,transcript,15712.0
FGF5,ENSG00000138675,coronary artery disease,EFO_0001645,0.5732912427029361,5.733021739046851,2,0.8,1.6,transcript,14637.0
PPARG,ENSG00000132170,obesity,EFO_0001073,0.5731746760538654,5.757277754732876,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,obesity,EFO_0001073,0.5731746760538654,5.757277754732876,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,obesity,EFO_0001073,0.5731746760538654,5.757277754732876,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,obesity,EFO_0001073,0.5731746760538654,5.757277754732876,59,24.0,1416.0,transcript,55462.0
LRBA,ENSG00000198589,cholelithiasis,EFO_0004799,0.5731653639517499,5.73165758102552,1,0.4,0.4,transcript,101484.0
CACNA1D,ENSG00000157388,stroke,EFO_0000712,0.572778374462112,5.727787709885405,1,0.4,0.4,transcript,100876.0
TCF7L2,ENSG00000148737,HbA1c measurement,EFO_0004541,0.5726958562822975,5.727031112751432,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,HbA1c measurement,EFO_0004541,0.5726958562822975,5.727031112751432,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,HbA1c measurement,EFO_0004541,0.5726958562822975,5.727031112751432,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,HbA1c measurement,EFO_0004541,0.5726958562822975,5.727031112751432,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
RET,ENSG00000165731,Inherited cancer-predisposing syndrome,Orphanet_140162,0.5726177874578396,5.726187886843421,1,0.4,0.4,transcript,39951.0
TGFBR1,ENSG00000106799,Rare disease with thoracic aortic aneurysm and aortic dissection,Orphanet_285014,0.5725520566391874,5.725524813984021,1,0.4,0.4,transcript,94171.0
SLC39A8,ENSG00000138821,low density lipoprotein cholesterol measurement,EFO_0004611,0.5723017560667965,5.723024866070309,1,0.4,0.4,transcript,54754.0
PDE3A,ENSG00000172572,essential thrombocythemia,EFO_0000479,0.5722957769174114,5.722982552321573,1,0.4,0.4,gene_variant,16140.0
GABRA4,ENSG00000109158,pain,EFO_0003843,0.5721548864453547,5.72157401535898,1,0.4,0.4,transcript,15904.0
SLC39A8,ENSG00000138821,body fat percentage,EFO_0007800,0.5721050645007112,5.721057950409457,1,0.4,0.4,transcript,54754.0
SLC39A8,ENSG00000138821,calcium measurement,EFO_0004838,0.5720839487890171,5.720846793292517,1,0.4,0.4,transcript,54754.0
AFF1,ENSG00000172493,triglyceride measurement,EFO_0004530,0.5719112765035205,5.719122987632256,1,0.4,0.4,transcript,39129.0
FGF5,ENSG00000138675,hemoglobin measurement,EFO_0004509,0.5716335708161613,5.716445020179103,2,0.8,1.6,transcript,14637.0
FGF5,ENSG00000138675,preeclampsia,EFO_0000668,0.5716032894891666,5.716142206909156,2,0.8,1.6,transcript,14637.0
PDCD5,ENSG00000105185,erythrocyte volume,OBA_0003460,0.5715663454636418,5.715741564380609,1,0.4,0.4,transcript,5121.0
TCF7L2,ENSG00000148737,hematocrit,EFO_0004348,0.5714501292539576,5.714573842468033,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,hematocrit,EFO_0004348,0.5714501292539576,5.714573842468033,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,hematocrit,EFO_0004348,0.5714501292539576,5.714573842468033,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,hematocrit,EFO_0004348,0.5714501292539576,5.714573842468033,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
PDCD5,ENSG00000105185,mean corpuscular hemoglobin concentration,EFO_0004528,0.5713246340894093,5.713324450638283,1,0.4,0.4,transcript,5121.0
HFE,ENSG00000010704,hemochromatosis,EFO_1000642,0.5712008699914665,5.712016985090414,1,0.4,0.4,transcript,48279.0
GRIN2B,ENSG00000273079,epilepsy,EFO_0000474,0.5711325614077725,5.711329883704666,1,0.4,0.4,transcript,93685.0
ETV5,ENSG00000244405,serum creatinine amount,OBA_2050096,0.5710224816404731,5.710256988849032,1,0.4,0.4,transcript,12433.0
SNX13,ENSG00000071189,triglyceride measurement,EFO_0004530,0.5709305909897714,5.709318235034831,1,0.4,0.4,transcript,32454.0
PDE3B,ENSG00000152270,essential thrombocythemia,EFO_0000479,0.5708687880340455,5.708762709636124,2,0.8,1.6,transcript,21382.0
CACNA1D,ENSG00000157388,heart rate,OBA_1001087,0.570859820377959,5.708602169043875,1,0.4,0.4,transcript,100876.0
GABRA1,ENSG00000022355,childhood absence epilepsy,MONDO_0010826,0.5705873025939264,5.705881709509948,1,0.4,0.4,transcript,46064.0
IMPG2,ENSG00000081148,Retinal dystrophy,HP_0000556,0.5705020869559863,5.705236386801242,2,0.9,1.8,transcript,8352.0
BANK1,ENSG00000153064,platelet volume,OBA_0003277,0.5704626417755295,5.704838905496388,3,1.3,3.9000000000000004,transcript,18354.0
PDCD5,ENSG00000105185,HbA1c measurement,EFO_0004541,0.5699479657851023,5.6995577675952145,1,0.4,0.4,transcript,5121.0
ACVR1C,ENSG00000123612,low density lipoprotein cholesterol measurement,EFO_0004611,0.5699312490027444,5.699431803972261,2,0.8,1.6,transcript,13410.0
TYR,ENSG00000077498,melanoma,EFO_0000756,0.569819160900773,5.698315432682817,1,0.5,0.5,transcript,4038.0
NAF1,ENSG00000145414,"pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 7",MONDO_0957261,0.5697689426389152,5.697751376581198,1,0.5,0.5,transcript,8071.0
TNFRSF11A,ENSG00000141655,bone tissue density,OBA_1000110,0.5697651641974648,5.697776233159821,2,0.8,1.6,transcript,12842.0
SLC39A8,ENSG00000138821,hemoglobin measurement,EFO_0004509,0.5695844300631164,5.69585160603351,1,0.4,0.4,transcript,54754.0
TTC39B,ENSG00000155158,lipid measurement,EFO_0004529,0.5695598146645554,5.695751802371364,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
SLC39A8,ENSG00000138821,serum albumin amount,OBA_2050068,0.5694670736536573,5.694678041938919,1,0.4,0.4,transcript,54754.0
TMEM106B,ENSG00000106460,major depressive disorder,MONDO_0002009,0.5693823407247652,5.6938562837348,2,0.8,1.6,transcript,48667.0
HFE,ENSG00000010704,hereditary hemochromatosis,MONDO_0006507,0.569256607487778,5.692574360053529,1,0.4,0.4,transcript,48279.0
PLEC,ENSG00000178209,epidermolysis bullosa simplex,MONDO_0017610,0.5692074254361944,5.692083318627588,2,0.9,1.8,transcript,198582.0
SV2C,ENSG00000122012,botulism,EFO_0005542,0.569067134332723,5.690699372196966,1,0.4,0.4,transcript,14271.0
PDE3B,ENSG00000152270,Airway obstruction,HP_0006536,0.569067134332723,5.6907461726229,2,0.8,1.6,transcript,21382.0
IQGAP2,ENSG00000145703,erythrocyte count,EFO_0004305,0.5690491029034436,5.6905056999654535,1,0.5,0.5,transcript,34081.0
PDE3A,ENSG00000172572,high density lipoprotein cholesterol measurement,EFO_0004612,0.5689768542882805,5.689793326030264,1,0.4,0.4,gene_variant,16140.0
PPARG,ENSG00000132170,triglyceride measurement,EFO_0004530,0.568925828621756,5.714789280411783,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,triglyceride measurement,EFO_0004530,0.568925828621756,5.714789280411783,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,triglyceride measurement,EFO_0004530,0.568925828621756,5.714789280411783,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,triglyceride measurement,EFO_0004530,0.568925828621756,5.714789280411783,59,24.0,1416.0,transcript,55462.0
CACNA1D,ENSG00000157388,diabetes mellitus,EFO_0000400,0.5688896986394316,5.688900951658601,1,0.4,0.4,transcript,100876.0
NAF1,ENSG00000145414,"chromosome, telomeric region length",OBA_0003784,0.5688252848615516,5.6883147988075615,1,0.5,0.5,transcript,8071.0
UGT2B15,ENSG00000196620,metabolite measurement,EFO_0004725,0.5687785360981423,5.688722568104198,2,1.0,2.0,transcript,2134.0
MYO1B,ENSG00000128641,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5687238312098218,5.687251720518706,1,0.4,0.4,transcript,29832.0
FLRT2,ENSG00000185070,heart rate,OBA_1001087,0.5685153473060749,5.685488991830971,7,2.8000000000000003,19.6,transcript,58417.0
RP2,ENSG00000102218,Retinal dystrophy,HP_0000556,0.5684378488954822,5.68448659706293,1,0.4,0.4,transcript,3700.0
SORT1,ENSG00000134243,apolipoprotein B measurement,EFO_0004615,0.5684360764979028,5.684382594273942,1,0.4,0.4,transcript,18324.0
KCNQ1,ENSG00000053918,Myasthenia gravis,EFO_0004991,0.5684283049409148,5.684476722746785,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
KCNQ3,ENSG00000184156,Myasthenia gravis,EFO_0004991,0.5684283049409148,5.684339427139944,2,0.8,1.6,transcript,28380.0
OTULINL,ENSG00000145569,eosinophil count,EFO_0004842,0.5682368095838218,5.682418070850712,1,0.4,0.4,transcript,8004.0
ADAMTS3,ENSG00000156140,BMI-adjusted waist circumference,EFO_0007789,0.5681335274900576,5.681384590644627,1,0.4,0.4,transcript,8111.0
MACF1,ENSG00000127603,Lissencephaly,HP_0001339,0.5680830197215573,5.680835524067903,2,0.8,1.6,gene_variant,300365.0
TTC39B,ENSG00000155158,cholesteryl ester measurement,EFO_0010351,0.5680198689421657,5.680352345147467,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
OTULINL,ENSG00000145569,asthma,MONDO_0004979,0.5679840858156725,5.679890833169218,1,0.4,0.4,transcript,8004.0
CASQ2,ENSG00000118729,atrial fibrillation,EFO_0000275,0.5679371705868783,5.6793843568903535,1,0.4,0.4,transcript,31618.0
AR,ENSG00000169083,androgenetic alopecia,EFO_0004191,0.567877535124526,5.678816681031121,2,0.8,1.6,transcript,38713.0
TTC39B,ENSG00000155158,phospholipids:total lipids ratio,EFO_0020946,0.5676819160527508,5.6769728162533175,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
TCF7L2,ENSG00000148737,body mass index,EFO_0004340,0.5676462837108202,5.676535387036659,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,body mass index,EFO_0004340,0.5676462837108202,5.676535387036659,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,body mass index,EFO_0004340,0.5676462837108202,5.676535387036659,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,body mass index,EFO_0004340,0.5676462837108202,5.676535387036659,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TRDN,ENSG00000186439,catecholaminergic polymorphic ventricular tachycardia 1,MONDO_0011484,0.5672646021035738,5.672665224476995,1,0.5,0.5,transcript,26037.0
EGFR,ENSG00000146648,EGFR-related lung cancer,EFO_0022194,0.5672494365208632,5.672531683863295,2,0.8,1.6,transcript,42874.0
SLC25A37,ENSG00000147454,mean corpuscular hemoglobin concentration,EFO_0004528,0.5672133019314136,5.6721521892556686,1,0.4,0.4,transcript,20866.0
ANO5,ENSG00000171714,creatine kinase measurement,EFO_0004534,0.5668257942295067,5.668262988658531,1,0.4,0.4,transcript,79265.0
ANKH,ENSG00000154122,type 2 diabetes mellitus,MONDO_0005148,0.5667036065056869,5.667804507679819,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,type 2 diabetes mellitus,MONDO_0005148,0.5667036065056869,5.667804507679819,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,type 2 diabetes mellitus,MONDO_0005148,0.5667036065056869,5.667804507679819,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,type 2 diabetes mellitus,MONDO_0005148,0.5667036065056869,5.667804507679819,5,2.4,12.0,transcript,15616.0
KCNQ1,ENSG00000053918,QT interval,EFO_0004682,0.5666943321451064,5.667136994788702,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
EGFR,ENSG00000146648,squamous cell carcinoma,EFO_0000707,0.5665695800607119,5.665733119261781,2,0.8,1.6,transcript,42874.0
SLC39A8,ENSG00000138821,hematocrit,EFO_0004348,0.5665440374522626,5.665447679924971,1,0.4,0.4,transcript,54754.0
ADAMTS3,ENSG00000156140,low density lipoprotein cholesterol measurement,EFO_0004611,0.5665107270065377,5.665156585809428,1,0.4,0.4,transcript,8111.0
RET,ENSG00000165731,renal agenesis,MONDO_0018470,0.5664201667136957,5.664211679401982,1,0.4,0.4,transcript,39951.0
SORT1,ENSG00000134243,angina pectoris,EFO_0003913,0.5660997833736945,5.661019663031858,1,0.4,0.4,transcript,18324.0
LRP2,ENSG00000081479,uric acid measurement,EFO_0004761,0.5660624423018098,5.660641011717876,1,0.5,0.5,transcript,30141.0
GRIA4,ENSG00000152578,Seizure,HP_0001250,0.566051324093584,5.6605225324573265,1,0.4,0.4,transcript,43050.0
TCF7L2,ENSG00000148737,type 1 diabetes mellitus,MONDO_0005147,0.5659185822936443,5.659258372864901,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,type 1 diabetes mellitus,MONDO_0005147,0.5659185822936443,5.659258372864901,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,type 1 diabetes mellitus,MONDO_0005147,0.5659185822936443,5.659258372864901,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,type 1 diabetes mellitus,MONDO_0005147,0.5659185822936443,5.659258372864901,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
SORT1,ENSG00000134243,fatty acid measurement,EFO_0005110,0.5656980584777375,5.657002414072289,1,0.4,0.4,transcript,18324.0
AKAP6,ENSG00000151320,body mass index,EFO_0004340,0.5656794142720372,5.657368922779023,7,2.8000000000000003,19.6,transcript,34100.0
GABRA1,ENSG00000022355,depressive disorder,MONDO_0002050,0.5656279700975653,5.656288384546336,1,0.4,0.4,transcript,46064.0
GABRA1,ENSG00000022355,Lennox-Gastaut syndrome,MONDO_0016532,0.5655309469798582,5.655318153369265,1,0.4,0.4,transcript,46064.0
PARP1,ENSG00000143799,platelet count,EFO_0004309,0.5655028681404983,5.655034550982961,1,0.5,0.5,transcript,85185.0
ARAP1,ENSG00000186635,type 2 diabetes mellitus,MONDO_0005148,0.5653768277295164,5.6537772869129315,1,0.4,0.4,transcript,44397.0
FNDC3B,ENSG00000075420,neuroimaging measurement,EFO_0004346,0.5653613666535713,5.653667284041829,2,0.8,1.6,transcript,29841.0
SLC39A8,ENSG00000138821,alcohol use disorder measurement,EFO_0009458,0.5653299726241637,5.653307031643982,1,0.4,0.4,transcript,54754.0
CACNA1D,ENSG00000157388,hyperlipidemia,MONDO_0021187,0.5649606915028931,5.649610880293216,1,0.4,0.4,transcript,100876.0
SOS1,ENSG00000115904,Noonan syndrome and Noonan-related syndrome,MONDO_0020297,0.5643845133288361,5.643868741161587,2,0.8,1.6,transcript,67774.0
FGF5,ENSG00000138675,urate measurement,EFO_0004531,0.5643307100972565,5.643416412990056,2,0.8,1.6,transcript,14637.0
SLC39A8,ENSG00000138821,apolipoprotein A 1 measurement,EFO_0004614,0.5642927798348517,5.642935103750863,1,0.4,0.4,transcript,54754.0
CDH23,ENSG00000107736,Rare genetic deafness,Orphanet_96210,0.5642001988305813,5.642009539008783,1,0.5,0.5,transcript,66219.0
PDCD5,ENSG00000105185,platelet volume,OBA_0003277,0.564098400887226,5.641062118616451,1,0.4,0.4,transcript,5121.0
FGF5,ENSG00000138675,hematocrit,EFO_0004348,0.5640286785394464,5.640396097411954,2,0.8,1.6,transcript,14637.0
LDLRAP1,ENSG00000157978,platelet count,EFO_0004309,0.5639968300373832,5.639994213822912,1,0.4,0.4,transcript,15436.0
SNX13,ENSG00000071189,serum albumin amount,OBA_2050068,0.5639667593269919,5.639679918407037,1,0.4,0.4,transcript,32454.0
PDE3A,ENSG00000172572,Ischemic stroke,HP_0002140,0.5639319687434907,5.639344470582367,1,0.4,0.4,gene_variant,16140.0
RASGRP3,ENSG00000152689,neuroimaging measurement,EFO_0004346,0.5637528332354381,5.6375395352671385,1,0.4,0.4,transcript,35705.0
GABRG1,ENSG00000163285,depressive disorder,MONDO_0002050,0.563633324983676,5.6384640577681004,6,2.4000000000000004,14.400000000000002,transcript,6758.0
CP,ENSG00000047457,Hermansky-Pudlak syndrome 3,MONDO_0013555,0.5636297326098275,5.6363183840497575,1,0.5,0.5,transcript,23744.0
LY75-CD302,ENSG00000248672,platelet crit,EFO_0007985,0.5635213059642142,5.635257975200892,1,0.5,0.5,transcript,11132.0
FYCO1,ENSG00000163820,early-onset non-syndromic cataract,MONDO_0011060,0.5635128831652402,5.635153442493477,1,0.4,0.4,transcript,16253.0
SLC39A8,ENSG00000138821,brain attribute,OBA_2045210,0.5633782964209122,5.633790269611467,1,0.4,0.4,transcript,54754.0
TYR,ENSG00000077498,basal cell carcinoma,EFO_0004193,0.5632334143527551,5.632457967202638,1,0.5,0.5,transcript,4038.0
AR,ENSG00000169083,Klinefelter's syndrome,EFO_1001006,0.5630326354309434,5.630367684095294,2,0.8,1.6,transcript,38713.0
SORT1,ENSG00000134243,vitamin D measurement,EFO_0004631,0.5628591829440681,5.6286136587355955,1,0.4,0.4,transcript,18324.0
PDE3B,ENSG00000152270,coronary artery disease,EFO_0001645,0.562776949689247,5.627844326188138,2,0.8,1.6,transcript,21382.0
CACNA1D,ENSG00000157388,atrial fibrillation,EFO_0000275,0.5623763787809739,5.623767753074024,1,0.4,0.4,transcript,100876.0
SLC39A8,ENSG00000138821,diet measurement,EFO_0008111,0.5621105064124272,5.621112369526617,1,0.4,0.4,transcript,54754.0
TSPAN9,ENSG00000011105,serum creatinine amount,OBA_2050096,0.5619890268687716,5.619925752329757,1,0.5,0.5,transcript,14091.0
VPS13A,ENSG00000197969,erythrocyte volume,OBA_0003460,0.5616597052226505,5.616603797475321,1,0.4,0.4,transcript,59301.0
NBEAL1,ENSG00000144426,coronary artery disease,EFO_0001645,0.5614898851534188,5.614902705135861,1,0.4,0.4,transcript,103799.0
PDE1A,ENSG00000115252,coronary artery disease,EFO_0001645,0.5614717282425712,5.6148438335558835,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
PDE3A,ENSG00000172572,triglyceride measurement,EFO_0004530,0.5614692093966404,5.614716877113863,1,0.4,0.4,gene_variant,16140.0
FGF5,ENSG00000138675,blood urea nitrogen measurement,EFO_0004741,0.5614286141801792,5.614395453819282,2,0.8,1.6,transcript,14637.0
GHR,ENSG00000112964,Prader-Willi syndrome,MONDO_0008300,0.5613887881074451,5.613896742591099,1,0.4,0.4,transcript,45139.0
SLC22A2,ENSG00000112499,chronic kidney disease,EFO_0003884,0.5613774627510986,5.613814349457361,1,0.4,0.4,transcript,10070.0
FAM114A1,ENSG00000197712,response to stimulus,GO_0050896,0.5612973239668078,5.613021919234829,1,0.4,0.4,transcript,8217.0
QKI,ENSG00000112531,cancer,MONDO_0004992,0.5612205681120301,5.612241253276196,2,0.8,1.6,transcript,44979.0
SORT1,ENSG00000134243,apolipoprotein A 1 measurement,EFO_0004614,0.5610828775334853,5.610850604629767,1,0.4,0.4,transcript,18324.0
TCF7L2,ENSG00000148737,hemoglobin measurement,EFO_0004509,0.561061012126065,5.610682671189108,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,hemoglobin measurement,EFO_0004509,0.561061012126065,5.610682671189108,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,hemoglobin measurement,EFO_0004509,0.561061012126065,5.610682671189108,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,hemoglobin measurement,EFO_0004509,0.561061012126065,5.610682671189108,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
BMPR2,ENSG00000204217,heritable pulmonary arterial hypertension,MONDO_0017148,0.5610302156000715,5.610319927459752,1,0.4,0.4,transcript,22508.0
PLXND1,ENSG00000004399,Truncus arteriosus,HP_0001660,0.5609981668350444,5.610005349320417,1,0.5,0.5,transcript,21114.0
AR,ENSG00000169083,acne,EFO_0003894,0.5607320815246575,5.607362145032435,2,0.8,1.6,transcript,38713.0
CACNA1D,ENSG00000157388,diastolic blood pressure,EFO_0006336,0.5607259732700031,5.607263697964315,1,0.4,0.4,transcript,100876.0
CAVIN2,ENSG00000168497,platelet count,EFO_0004309,0.5605135754187162,5.605266729956644,1,0.4,0.4,transcript,3054.0
TCF7L2,ENSG00000148737,body weight,EFO_0004338,0.5604372380027589,5.604444929956047,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,body weight,EFO_0004338,0.5604372380027589,5.604444929956047,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,body weight,EFO_0004338,0.5604372380027589,5.604444929956047,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,body weight,EFO_0004338,0.5604372380027589,5.604444929956047,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
SH3TC2,ENSG00000169247,Charcot-Marie-Tooth disease type 4,MONDO_0018995,0.5603009471332845,5.603013894741523,1,0.4,0.4,transcript,90428.0
BMPR2,ENSG00000204217,primary pulmonary hypertension,MONDO_0001999,0.5601316839468559,5.601334610927595,1,0.4,0.4,transcript,22508.0
TTC39B,ENSG00000155158,apolipoprotein A 1 measurement,EFO_0004614,0.5601259178524164,5.601412834249974,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
PARP1,ENSG00000143799,ovarian carcinoma,EFO_0001075,0.5600696613893855,5.600702483471832,1,0.5,0.5,transcript,85185.0
ADGRV1,ENSG00000164199,Rare genetic deafness,Orphanet_96210,0.5598642942878965,5.598647368049334,1,0.5,0.5,transcript,112990.0
LSM6,ENSG00000164167,neurodegenerative disease,EFO_0005772,0.5598564589587102,5.598729998457152,2,0.8,1.6,transcript,9673.0
GBE1,ENSG00000114480,disorder of glycogen metabolism,MONDO_0002412,0.5598107707443455,5.598168586537573,1,0.5,0.5,transcript,8213.0
CEP85L,ENSG00000111860,familial isolated dilated cardiomyopathy,EFO_0700036,0.559327763974421,5.593293042724687,1,0.4,0.4,transcript,25969.0
AKAP11,ENSG00000023516,neutrophil count,EFO_0004833,0.5592768365739627,5.5931683657396265,1,0.4,0.4,transcript,1000.0
SCAMP1,ENSG00000085365,platelet count,EFO_0004309,0.5592738437927762,5.592764784917619,1,0.4,0.4,transcript,15182.0
GPAT3,ENSG00000138678,blood sodium bicarbonate amount,OBA_2050094,0.5592252691689648,5.59239981812643,2,0.8,1.6,transcript,10875.0
TCF7L2,ENSG00000148737,breast carcinoma,EFO_0000305,0.5589161021651478,5.5892335715799355,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,breast carcinoma,EFO_0000305,0.5589161021651478,5.5892335715799355,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,breast carcinoma,EFO_0000305,0.5589161021651478,5.5892335715799355,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,breast carcinoma,EFO_0000305,0.5589161021651478,5.5892335715799355,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
MC2R,ENSG00000185231,multiple sclerosis,MONDO_0005301,0.5589040607953636,5.589135215333012,1,0.4,0.4,transcript,4228.0
EXO1,ENSG00000174371,erythrocyte volume,OBA_0003460,0.5589028062143507,5.589157495226603,2,1.0,2.0,transcript,15452.0
DTHD1,ENSG00000197057,neutrophil count,EFO_0004833,0.5588031700558381,5.588058101107513,1,0.5,0.5,transcript,18939.0
PLCL2,ENSG00000154822,Red cell distribution width,EFO_0009188,0.5587340504343796,5.587479056474035,2,0.8,1.6,transcript,11548.0
GRB14,ENSG00000115290,HbA1c measurement,EFO_0004541,0.5587306556181567,5.587346923524387,1,0.4,0.4,transcript,9909.0
PKN2,ENSG00000065243,neurodegenerative disease,EFO_0005772,0.5587297348479079,5.587328160372469,1,0.4,0.4,transcript,12982.0
GRIN2B,ENSG00000273079,postencephalitic Parkinson disease,EFO_1001402,0.5587297348479079,5.587301618106021,1,0.4,0.4,transcript,93685.0
GRIN2B,ENSG00000273079,cerebral atherosclerosis,EFO_1000860,0.5587297348479079,5.587301618106021,1,0.4,0.4,transcript,93685.0
GRIN2B,ENSG00000273079,secondary Parkinson disease,EFO_1001175,0.5587297348479079,5.587301618106021,1,0.4,0.4,transcript,93685.0
GFPT1,ENSG00000198380,neurodegenerative disease,EFO_0005772,0.5587297348479079,5.587312452508079,1,0.4,0.4,transcript,26483.0
RCL1,ENSG00000120158,platelet count,EFO_0004309,0.5586312457405963,5.586351130904948,1,0.4,0.4,transcript,10343.0
GHR,ENSG00000112964,Growth delay,HP_0001510,0.5585463311928105,5.585472173444754,1,0.4,0.4,transcript,45139.0
PDE3B,ENSG00000152270,body weight,EFO_0004338,0.5584035230941848,5.584110060237518,2,0.8,1.6,transcript,21382.0
RASA2,ENSG00000155903,lymphocyte count,EFO_0004587,0.558327845655761,5.583326069936969,1,0.4,0.4,transcript,8401.0
DDR2,ENSG00000162733,body height,OBA_VT0001253,0.5582322799680488,5.5823368401873505,1,0.4,0.4,transcript,28489.0
SMARCC1,ENSG00000173473,congenital hydrocephalus,MONDO_0016349,0.5580450597665362,5.580564744772446,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,congenital hydrocephalus,MONDO_0016349,0.5580450597665362,5.580564744772446,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,congenital hydrocephalus,MONDO_0016349,0.5580450597665362,5.580564744772446,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,congenital hydrocephalus,MONDO_0016349,0.5580450597665362,5.580564744772446,2,0.8,1.6,gene_variant,14017.0
RTKN2,ENSG00000182010,rheumatoid arthritis,EFO_0000685,0.5579975376583105,5.580010634405935,1,0.4,0.4,transcript,11345.0
CMYA5,ENSG00000164309,heart rate,OBA_1001087,0.5579923384128129,5.579951000808604,1,0.5,0.5,transcript,18105.0
GPR180,ENSG00000152749,triglyceride measurement,EFO_0004530,0.5579379342857648,5.579424367621267,1,0.4,0.4,transcript,8884.0
RFX7,ENSG00000181827,neurodegenerative disease,EFO_0005772,0.5577325469338642,5.5773350616647805,1,0.4,0.4,transcript,41700.0
TCF7L2,ENSG00000148737,systolic blood pressure,EFO_0006335,0.5577017243443512,5.57708979337197,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,systolic blood pressure,EFO_0006335,0.5577017243443512,5.57708979337197,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,systolic blood pressure,EFO_0006335,0.5577017243443512,5.57708979337197,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,systolic blood pressure,EFO_0006335,0.5577017243443512,5.57708979337197,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
PPARG,ENSG00000132170,"familial partial lipodystrophy, Dunnigan type",MONDO_0007906,0.5574945428822212,5.600476423016435,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,"familial partial lipodystrophy, Dunnigan type",MONDO_0007906,0.5574945428822212,5.600476423016435,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,"familial partial lipodystrophy, Dunnigan type",MONDO_0007906,0.5574945428822212,5.600476423016435,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,"familial partial lipodystrophy, Dunnigan type",MONDO_0007906,0.5574945428822212,5.600476423016435,59,24.0,1416.0,gene_variant,55462.0
HFM1,ENSG00000162669,monocyte count,EFO_0005091,0.5570796087601455,5.570925924007583,2,1.0,2.0,transcript,15404.0
FBN1,ENSG00000166147,thoracic aortic aneurysm,EFO_0004282,0.5569142751523707,5.569149416746241,1,0.4,0.4,transcript,60013.0
TCF7L2,ENSG00000148737,Myopia,HP_0000545,0.5566994254169729,5.567066804098187,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,Myopia,HP_0000545,0.5566994254169729,5.567066804098187,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,Myopia,HP_0000545,0.5566994254169729,5.567066804098187,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,Myopia,HP_0000545,0.5566994254169729,5.567066804098187,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
FBN1,ENSG00000166147,marfan syndrome/loeys-dietz syndrome/familial thoracic aortic aneurysms and dissections,EFO_0009299,0.5566746961652553,5.566753626875088,1,0.4,0.4,transcript,60013.0
CYP24A1,ENSG00000019186,calcium measurement,EFO_0004838,0.5566583767629993,5.566773972099798,2,0.8,1.6,transcript,8412.0
FNDC3B,ENSG00000075420,mean corpuscular hemoglobin concentration,EFO_0004528,0.5565690491405985,5.5657441089121,2,0.8,1.6,transcript,29841.0
FGF5,ENSG00000138675,androgenetic alopecia,EFO_0004191,0.5565307817673697,5.565417129691187,2,0.8,1.6,transcript,14637.0
KCNQ1,ENSG00000053918,Beckwith-Wiedemann syndrome,MONDO_0007534,0.5565175408011186,5.565369081348823,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
LPP,ENSG00000145012,eosinophil count,EFO_0004842,0.5565055185684742,5.565124085865604,4,1.6,6.4,transcript,92888.0
PCDH18,ENSG00000189184,systolic blood pressure,EFO_0006335,0.5564727272603598,5.564804444262307,2,0.8,1.6,transcript,20733.0
KLF10,ENSG00000155090,serum alanine aminotransferase measurement,EFO_0004735,0.5564461687563445,5.564522533319453,1,0.4,0.4,transcript,6574.0
PKP2,ENSG00000057294,Abnormality of the cardiovascular system,HP_0001626,0.5561745016987643,5.561901118355968,4,1.6,6.4,transcript,40999.0
CCBE1,ENSG00000183287,brain attribute,OBA_2045210,0.5560936562739032,5.560950352989325,1,0.4,0.4,transcript,29006.0
ID4,ENSG00000172201,body weight,EFO_0004338,0.5559167767339712,5.559580883786911,2,0.8,1.6,transcript,3873.0
DCDC2,ENSG00000146038,glomerular filtration rate,OBA_0003747,0.555911730258086,5.5591630796465505,1,0.4,0.4,transcript,8738.0
PLCL2,ENSG00000154822,red blood cell density,OBA_2045260,0.5558556611789672,5.558695163919912,2,0.8,1.6,transcript,11548.0
IL4R,ENSG00000077238,C-reactive protein measurement,EFO_0004458,0.555698533916687,5.557003903236113,1,0.4,0.4,transcript,21547.0
GJB2,ENSG00000165474,X-linked mixed hearing loss with perilymphatic gusher,MONDO_0010576,0.5556655224536464,5.556742030092019,1,0.4,0.4,transcript,4608.0
SNX13,ENSG00000071189,total cholesterol measurement,EFO_0004574,0.5555744220919113,5.55575654605623,1,0.4,0.4,transcript,32454.0
CYTL1,ENSG00000170891,peak expiratory flow,EFO_0009718,0.5555556846630945,5.555775784780916,1,0.4,0.4,transcript,1827.0
GABRG1,ENSG00000163285,generalized anxiety disorder,EFO_1001892,0.5555024176430615,5.557154984361956,6,2.4000000000000004,14.400000000000002,transcript,6758.0
GABRA1,ENSG00000022355,generalized anxiety disorder,EFO_1001892,0.5555024176430615,5.555032860001299,1,0.4,0.4,transcript,46064.0
PDE3A,ENSG00000172572,lipid measurement,EFO_0004529,0.5554843141338801,5.554867924486261,1,0.4,0.4,gene_variant,16140.0
PKN2,ENSG00000065243,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5554808052289463,5.554838864182853,1,0.4,0.4,transcript,12982.0
FAT3,ENSG00000165323,neuroimaging measurement,EFO_0004346,0.5554574732593577,5.554583061588891,1,0.4,0.4,transcript,48025.0
GABRA4,ENSG00000109158,postpartum depression,EFO_0007453,0.5554546488183064,5.554571639088497,1,0.4,0.4,transcript,15904.0
GABRG1,ENSG00000163285,postpartum depression,EFO_0007453,0.5554546488183064,5.556677296114405,6,2.4000000000000004,14.400000000000002,transcript,6758.0
GABRA1,ENSG00000022355,postpartum depression,EFO_0007453,0.5554546488183064,5.554555171753748,1,0.4,0.4,transcript,46064.0
BICC1,ENSG00000122870,gout,EFO_0004274,0.5554006583406865,5.554054677671624,1,0.4,0.4,transcript,8317.0
GJB2,ENSG00000165474,X-linked mixed deafness with perilymphatic gusher,Orphanet_383,0.5552959425989618,5.5530462315451725,1,0.4,0.4,transcript,4608.0
CEP68,ENSG00000011523,triglyceride measurement,EFO_0004530,0.5552541160577678,5.552577927686638,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,triglyceride measurement,EFO_0004530,0.5552541160577678,5.552577927686638,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,triglyceride measurement,EFO_0004530,0.5552541160577678,5.552577927686638,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,triglyceride measurement,EFO_0004530,0.5552541160577678,5.552577927686638,3,1.5,4.5,gene_variant,122392.0
TBX5,ENSG00000089225,familial bicuspid aortic valve,MONDO_0007194,0.5552299725168399,5.552425018825408,2,0.8,1.6,transcript,12770.0
ALPK3,ENSG00000136383,Abnormality of the cardiovascular system,HP_0001626,0.5552076338217684,5.55211363425498,1,0.4,0.4,transcript,10725.0
KCNQ1,ENSG00000053918,short QT syndrome type 2,MONDO_0012313,0.5551550192256868,5.5517438655945055,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
FAM114A1,ENSG00000197712,neutrophil measurement,EFO_0803548,0.5551104930209912,5.551153609776664,1,0.4,0.4,transcript,8217.0
CLDN16,ENSG00000113946,Autosomal dominant primary hypomagnesemia with hypocalciuria,Orphanet_34528,0.5550947231781238,5.551047608192782,1,0.4,0.4,transcript,3985.0
PDE1A,ENSG00000115252,glomerular filtration rate,OBA_0003747,0.5550563604602425,5.550690155732597,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
ANKRD17,ENSG00000132466,neurodegenerative disease,EFO_0005772,0.554892744391159,5.54893663382107,1,0.4,0.4,transcript,43526.0
PDE10A,ENSG00000112541,coronary artery disease,EFO_0001645,0.5545421059672331,5.5454407717662475,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
PDE1C,ENSG00000154678,coronary artery disease,EFO_0001645,0.5545421059672331,5.5454754185769985,2,0.8,1.6,transcript,29434.0
ETV5,ENSG00000244405,body weight,EFO_0004338,0.5544002411598105,5.544034584042406,1,0.4,0.4,transcript,12433.0
PDE1A,ENSG00000115252,diastolic blood pressure,EFO_0006336,0.5543091677693435,5.543218228823606,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
KCNQ3,ENSG00000184156,benign neonatal seizures,MONDO_0016027,0.5542641444672103,5.5426978224029,2,0.8,1.6,transcript,28380.0
TYR,ENSG00000077498,skin neoplasm,EFO_0004198,0.5540400563623152,5.540524387298239,1,0.5,0.5,transcript,4038.0
WRN,ENSG00000165392,cancer,MONDO_0004992,0.5540049716289154,5.540077118053827,1,0.5,0.5,transcript,18247.0
SKIL,ENSG00000136603,prostate carcinoma,EFO_0001663,0.5539840731253224,5.5398571910748,1,0.5,0.5,transcript,30377.0
UGT2B15,ENSG00000196620,total cholesterol measurement,EFO_0004574,0.5539689452633636,5.540626659756411,2,1.0,2.0,transcript,2134.0
KLHL3,ENSG00000146021,pseudohypoaldosteronism type 2A,MONDO_0007772,0.5538643489339783,5.538690800023127,2,0.8,1.6,transcript,33819.0
PDE10A,ENSG00000112541,hypothyroidism,EFO_0004705,0.5538396157059378,5.538415869153295,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
ASTN2,ENSG00000148219,Bardet-Biedl syndrome,MONDO_0015229,0.5537488849286871,5.537547603693453,2,0.8,1.6,transcript,27232.0
PTPRJ,ENSG00000149177,neurodegenerative disease,EFO_0005772,0.5535998885047527,5.536074073017452,2,0.8,1.6,transcript,21280.0
IQCB1,ENSG00000173226,nephronophthisis,MONDO_0019005,0.5535070377937327,5.535111996915581,1,0.4,0.4,transcript,9611.0
UGT2B15,ENSG00000196620,erythrocyte volume,OBA_0003460,0.5534957623821974,5.535894830944748,2,1.0,2.0,transcript,2134.0
PDE10A,ENSG00000112541,thyroid stimulating hormone amount,OBA_1000983,0.5534698780810657,5.534718492904575,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
GJB2,ENSG00000165474,Rare genetic deafness,Orphanet_96210,0.5534407424135003,5.534494229690558,1,0.4,0.4,transcript,4608.0
GABRG1,ENSG00000163285,Lennox-Gastaut syndrome,MONDO_0016532,0.5533871689213433,5.536002497144774,6,2.4000000000000004,14.400000000000002,transcript,6758.0
PDE3A,ENSG00000172572,total cholesterol measurement,EFO_0004574,0.5533187108118415,5.533211891265874,1,0.4,0.4,gene_variant,16140.0
EXO1,ENSG00000174371,eosinophil count,EFO_0004842,0.5532502900345714,5.5326323334288094,2,1.0,2.0,transcript,15452.0
LMO4,ENSG00000143013,basophil measurement,EFO_0803539,0.5532020186026795,5.532071666078275,1,0.4,0.4,transcript,7770.0
HTR2C,ENSG00000147246,obesity,EFO_0001073,0.553198567457547,5.532025097424953,1,0.5,0.5,transcript,12683.0
KITLG,ENSG00000049130,neutrophil count,EFO_0004833,0.553185246691717,5.532021822894024,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
LPP,ENSG00000145012,HbA1c measurement,EFO_0004541,0.553144180382975,5.531510704010612,4,1.6,6.4,transcript,92888.0
ARFIP1,ENSG00000164144,Red cell distribution width,EFO_0009188,0.5531182287640952,5.531209340258293,1,0.4,0.4,transcript,14786.0
SMAD2,ENSG00000175387,colorectal adenocarcinoma,EFO_0000365,0.5527041033169985,5.527534830225491,9,3.6,32.4,transcript,65614.0
EGFR,ENSG00000146648,response to tyrosine kinase inhibitor,EFO_0009170,0.5526604215349816,5.5266415340044786,2,0.8,1.6,transcript,42874.0
CP,ENSG00000047457,histidine measurement,EFO_0009769,0.5525265162767687,5.5252862207191695,1,0.5,0.5,transcript,23744.0
CCDC88C,ENSG00000015133,brain connectivity attribute,OBA_2045295,0.5522543503632654,5.522562826370686,1,0.4,0.4,transcript,20701.0
PARP1,ENSG00000143799,ovarian neoplasm,EFO_0003893,0.5521997319005505,5.522003188583483,1,0.5,0.5,transcript,85185.0
FIGN,ENSG00000182263,systolic blood pressure,EFO_0006335,0.5521954196508169,5.521990951079519,1,0.4,0.4,transcript,10883.0
TCF7L2,ENSG00000148737,gestational diabetes,EFO_0004593,0.5521509975473137,5.521582525401595,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,gestational diabetes,EFO_0004593,0.5521509975473137,5.521582525401595,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,gestational diabetes,EFO_0004593,0.5521509975473137,5.521582525401595,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,gestational diabetes,EFO_0004593,0.5521509975473137,5.521582525401595,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
PLCL2,ENSG00000154822,mean corpuscular hemoglobin,EFO_0004527,0.5521384069616384,5.521522621746623,2,0.8,1.6,transcript,11548.0
TTC39B,ENSG00000155158,cholelithiasis,EFO_0004799,0.5518664078722024,5.5188177344478335,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
KITLG,ENSG00000049130,"Waardenburg syndrome, IIa 2F",MONDO_0030983,0.5517671583886058,5.5178409398629125,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
NEK7,ENSG00000151414,neutrophil count,EFO_0004833,0.5517534468879803,5.517579733109746,1,0.4,0.4,transcript,8837.0
AR,ENSG00000169083,male infertility,EFO_0004248,0.5516434779052637,5.516476108838497,2,0.8,1.6,transcript,38713.0
CEP68,ENSG00000011523,systolic blood pressure,EFO_0006335,0.5515073224207797,5.515109991316758,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,systolic blood pressure,EFO_0006335,0.5515073224207797,5.515109991316758,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,systolic blood pressure,EFO_0006335,0.5515073224207797,5.515109991316758,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,systolic blood pressure,EFO_0006335,0.5515073224207797,5.515109991316758,3,1.5,4.5,transcript,122392.0
METTL14,ENSG00000145388,neurodegenerative disease,EFO_0005772,0.5513749809399627,5.513775396299135,1,0.4,0.4,transcript,15633.0
CEP68,ENSG00000011523,atrial fibrillation,EFO_0000275,0.5513689077440458,5.513725844549419,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,atrial fibrillation,EFO_0000275,0.5513689077440458,5.513725844549419,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,atrial fibrillation,EFO_0000275,0.5513689077440458,5.513725844549419,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,atrial fibrillation,EFO_0000275,0.5513689077440458,5.513725844549419,3,1.5,4.5,transcript,122392.0
ANO5,ENSG00000171714,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.5512333119246168,5.5123381656096315,1,0.4,0.4,transcript,79265.0
BICC1,ENSG00000122870,urate measurement,EFO_0004531,0.5512325895526766,5.512373989791525,1,0.4,0.4,transcript,8317.0
IKBIP,ENSG00000166130,neurodegenerative disease,EFO_0005772,0.5511872888339344,5.512143387071381,2,0.8,1.6,transcript,5915.0
CACNA1D,ENSG00000157388,Coronary Vasospasm,EFO_0004225,0.5511872888339344,5.511876853603629,1,0.4,0.4,transcript,100876.0
SLC25A37,ENSG00000147454,Red cell distribution width,EFO_0009188,0.5511688706849155,5.511707876790687,1,0.4,0.4,transcript,20866.0
AR,ENSG00000169083,sexual dysfunction,EFO_0004714,0.55114532033788,5.51149453316466,2,0.8,1.6,transcript,38713.0
KITLG,ENSG00000049130,erythrocyte volume,OBA_0003460,0.5510316052724329,5.510485408701184,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
FBXO42,ENSG00000037637,neurodegenerative disease,EFO_0005772,0.5509669541972336,5.509705113337387,1,0.4,0.4,transcript,11245.0
CEP68,ENSG00000011523,high density lipoprotein cholesterol measurement,EFO_0004612,0.5509615252941124,5.509652020050084,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,high density lipoprotein cholesterol measurement,EFO_0004612,0.5509615252941124,5.509652020050084,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,high density lipoprotein cholesterol measurement,EFO_0004612,0.5509615252941124,5.509652020050084,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,high density lipoprotein cholesterol measurement,EFO_0004612,0.5509615252941124,5.509652020050084,3,1.5,4.5,transcript,122392.0
CACNA1D,ENSG00000157388,mean arterial pressure,EFO_0006340,0.550954452670617,5.509548491970455,1,0.4,0.4,transcript,100876.0
LPP,ENSG00000145012,asthma,MONDO_0004979,0.5509476357781397,5.50954525796226,4,1.6,6.4,transcript,92888.0
PTK2,ENSG00000169398,neurodegenerative disease,EFO_0005772,0.5508060468287282,5.508065310491938,1,0.4,0.4,transcript,82607.0
SH3TC2,ENSG00000169247,Charcot-Marie-Tooth disease,MONDO_0015626,0.5507752811279427,5.507757234688106,1,0.4,0.4,transcript,90428.0
ADGRV1,ENSG00000164199,Retinal dystrophy,HP_0000556,0.5507547875680373,5.507552300850742,1,0.5,0.5,transcript,112990.0
CYTL1,ENSG00000170891,BMI-adjusted waist-hip ratio,EFO_0007788,0.5507461528731743,5.507680466881715,1,0.4,0.4,transcript,1827.0
RASGRP3,ENSG00000152689,brain volume,OBA_2050009,0.5507395199230254,5.507406402143012,1,0.4,0.4,transcript,35705.0
EGFR,ENSG00000146648,white matter integrity,EFO_0004641,0.5506751302714306,5.506788621368968,2,0.8,1.6,transcript,42874.0
AP1S2,ENSG00000182287,X-linked intellectual disability - Dandy-Walker malformation - basal ganglia disease - Seizures,Orphanet_1568,0.5506652350803053,5.506673160292181,1,0.4,0.4,transcript,19222.0
PRKCB,ENSG00000166501,acute myeloid leukemia,EFO_0000222,0.5506576472487108,5.506600438934083,1,0.4,0.4,transcript,16690.0
C2CD2,ENSG00000157617,platelet count,EFO_0004309,0.5504961028445621,5.504975009571101,1,0.4,0.4,transcript,28610.0
UGT2B15,ENSG00000196620,alkaline phosphatase measurement,EFO_0004533,0.5504675573556831,5.505612780679606,2,1.0,2.0,transcript,2134.0
GHR,ENSG00000112964,lean body mass,EFO_0004995,0.5504081057209241,5.50408991872589,1,0.4,0.4,transcript,45139.0
SKP2,ENSG00000145604,neurodegenerative disease,EFO_0005772,0.5502263432909833,5.5022684557638195,1,0.4,0.4,transcript,79636.0
EGFR,ENSG00000146648,platelet count,EFO_0004309,0.5499455356874909,5.499492675529572,2,0.8,1.6,transcript,42874.0
TCF7L2,ENSG00000148737,pulse pressure measurement,EFO_0005763,0.5498707061607429,5.498779611535886,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,pulse pressure measurement,EFO_0005763,0.5498707061607429,5.498779611535886,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,pulse pressure measurement,EFO_0005763,0.5498707061607429,5.498779611535886,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,pulse pressure measurement,EFO_0005763,0.5498707061607429,5.498779611535886,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
BANK1,ENSG00000153064,body mass index,EFO_0004340,0.5498432933824814,5.498645421565906,3,1.3,3.9000000000000004,transcript,18354.0
C2orf73,ENSG00000177994,serum creatinine amount,OBA_2050096,0.5497854119367489,5.497902428546232,1,0.4,0.4,transcript,8280.0
FYCO1,ENSG00000163820,early-onset zonular cataract,MONDO_0020379,0.5497219742638685,5.49724435347976,1,0.4,0.4,transcript,16253.0
TGFBR1,ENSG00000106799,cancer,MONDO_0004992,0.5496981374222518,5.496985621814664,1,0.4,0.4,transcript,94171.0
SLC35A5,ENSG00000138459,neurodegenerative disease,EFO_0005772,0.5496501987923134,5.49653928396043,1,0.4,0.4,transcript,10725.0
ULK4,ENSG00000168038,hematocrit,EFO_0004348,0.5496265523972856,5.4963064840777145,1,0.5,0.5,transcript,12207.0
PDE3B,ENSG00000152270,stroke,EFO_0000712,0.5496159459143566,5.4962342884392354,2,0.8,1.6,transcript,21382.0
IL17A,ENSG00000112115,psoriasis vulgaris,EFO_1001494,0.5496017657079282,5.496231446496705,1,0.4,0.4,transcript,1871.0
QSER1,ENSG00000060749,platelet count,EFO_0004309,0.5495866570265285,5.495893245468016,1,0.5,0.5,transcript,18744.0
PLCL2,ENSG00000154822,mean reticulocyte volume,EFO_0010701,0.5495562375173517,5.495700927303756,2,0.8,1.6,transcript,11548.0
SEC63,ENSG00000025796,autosomal dominant polycystic liver disease,MONDO_0000447,0.5494048223190653,5.4943237474520945,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
ASTN2,ENSG00000148219,autosomal recessive limb-girdle muscular dystrophy type 2H,MONDO_0009683,0.5493055677170672,5.493114431577252,2,0.8,1.6,transcript,27232.0
PLCL2,ENSG00000154822,basophil count,EFO_0005090,0.5492799297966885,5.492937850097124,2,0.8,1.6,transcript,11548.0
NEBL,ENSG00000078114,atrial fibrillation,EFO_0000275,0.5492603609134447,5.492611430953411,1,0.4,0.4,transcript,51139.0
ADAMTS3,ENSG00000156140,total cholesterol measurement,EFO_0004574,0.5492066828808005,5.492116144552057,1,0.4,0.4,transcript,8111.0
RET,ENSG00000165731,thyroid cancer,MONDO_0002108,0.5491715886993225,5.49172589925825,1,0.4,0.4,transcript,39951.0
FNDC3B,ENSG00000075420,BMI-adjusted waist circumference,EFO_0007789,0.5491135660685474,5.49118927819159,2,0.8,1.6,transcript,29841.0
SLC22A2,ENSG00000112499,X-12798 measurement,EFO_0021335,0.5490728767427335,5.4907684893737105,1,0.4,0.4,transcript,10070.0
TYR,ENSG00000077498,skin cancer,MONDO_0002898,0.5490340896729761,5.490464720404847,1,0.5,0.5,transcript,4038.0
SLC25A37,ENSG00000147454,erythrocyte count,EFO_0004305,0.5488239355456354,5.488258525397885,1,0.4,0.4,transcript,20866.0
PDE3B,ENSG00000152270,vitamin D measurement,EFO_0004631,0.5487546090620827,5.4876209199164965,2,0.8,1.6,transcript,21382.0
GABRA1,ENSG00000022355,status epilepticus,EFO_0008526,0.5487532932373814,5.487541615944498,1,0.4,0.4,transcript,46064.0
DCDC2,ENSG00000146038,deafness,EFO_0001063,0.5486835382118812,5.486881159184502,1,0.4,0.4,transcript,8738.0
GPM6A,ENSG00000150625,schizophrenia,MONDO_0005090,0.5485055447086614,5.485073618167339,1,0.4,0.4,transcript,22013.0
CYTL1,ENSG00000170891,BMI-adjusted waist circumference,EFO_0007789,0.5485020668293641,5.4852396064436135,1,0.4,0.4,transcript,1827.0
UGT2B15,ENSG00000196620,high density lipoprotein cholesterol measurement,EFO_0004612,0.5484449896303462,5.485387103426236,2,1.0,2.0,transcript,2134.0
FAM8A1,ENSG00000137414,basophil measurement,EFO_0803539,0.5484326649488684,5.484345891358994,1,0.4,0.4,transcript,20788.0
OXSR1,ENSG00000172939,mean corpuscular hemoglobin concentration,EFO_0004528,0.5484306332734014,5.4843469089157955,1,0.4,0.4,transcript,9858.0
ROCK2,ENSG00000134318,neurodegenerative disease,EFO_0005772,0.5483677065033368,5.483688058635091,1,0.5,0.5,transcript,45481.0
FGF5,ENSG00000138675,uric acid measurement,EFO_0004761,0.5483370460586094,5.483479772603585,2,0.8,1.6,transcript,14637.0
FGF5,ENSG00000138675,balding measurement,EFO_0007825,0.5483137112723645,5.483246424741135,2,0.8,1.6,transcript,14637.0
FNDC3B,ENSG00000075420,Red cell distribution width,EFO_0009188,0.5483125898691861,5.483179516197977,2,0.8,1.6,transcript,29841.0
UGT2B15,ENSG00000196620,triglyceride measurement,EFO_0004530,0.5483080831418742,5.4840180385415165,2,1.0,2.0,transcript,2134.0
AKAP6,ENSG00000151320,atrial fibrillation,EFO_0000275,0.548292255562438,5.4834973356830305,7,2.8000000000000003,19.6,transcript,34100.0
CYP24A1,ENSG00000019186,vitamin D measurement,EFO_0004631,0.5482821766724854,5.483011971194659,2,0.8,1.6,transcript,8412.0
ASPM,ENSG00000066279,genetic disorder,EFO_0000508,0.5482615611829741,5.482650610177041,2,0.9,1.8,transcript,51431.0
PDE3A,ENSG00000172572,sex hormone-binding globulin measurement,EFO_0004696,0.5482209886863776,5.482234670011236,1,0.4,0.4,gene_variant,16140.0
USP15,ENSG00000135655,neurodegenerative disease,EFO_0005772,0.5482137032613118,5.482220150455748,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
FIGN,ENSG00000182263,diastolic blood pressure,EFO_0006336,0.548161755144142,5.4816543060127705,1,0.4,0.4,transcript,10883.0
PDE10A,ENSG00000112541,stroke,EFO_0000712,0.5481074567115619,5.481094279209536,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
PDE1C,ENSG00000154678,stroke,EFO_0000712,0.5481074567115619,5.481128926020287,2,0.8,1.6,transcript,29434.0
PDE1A,ENSG00000115252,stroke,EFO_0000712,0.5481074567115619,5.4812011182457905,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
PLCL2,ENSG00000154822,eosinophil count,EFO_0004842,0.5480997312071543,5.481135864201781,2,0.8,1.6,transcript,11548.0
FGA,ENSG00000171560,Ischemic stroke,HP_0002140,0.5480481542713076,5.480549767171544,1,0.4,0.4,transcript,5863.0
SP4,ENSG00000105866,total cholesterol measurement,EFO_0004574,0.5480132207941864,5.480156200264321,1,0.4,0.4,transcript,16672.0
UGT2B15,ENSG00000196620,testosterone measurement,EFO_0004908,0.5479382172985517,5.480319380108292,2,1.0,2.0,transcript,2134.0
FGF5,ENSG00000138675,potassium measurement,EFO_0009283,0.5479335772651475,5.479445084668964,2,0.8,1.6,transcript,14637.0
PPARG,ENSG00000132170,body mass index,EFO_0004340,0.5478515636794569,5.504046630988792,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,body mass index,EFO_0004340,0.5478515636794569,5.504046630988792,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,body mass index,EFO_0004340,0.5478515636794569,5.504046630988792,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,body mass index,EFO_0004340,0.5478515636794569,5.504046630988792,59,24.0,1416.0,transcript,55462.0
PLXND1,ENSG00000004399,BMI-adjusted hip circumference,EFO_0008039,0.5478020027843885,5.478043708813858,1,0.5,0.5,transcript,21114.0
PDCD5,ENSG00000105185,mean corpuscular hemoglobin,EFO_0004527,0.5477947120644077,5.478025230388267,1,0.4,0.4,transcript,5121.0
IL1A,ENSG00000115008,neutrophil count,EFO_0004833,0.5477811137046598,5.478009451374807,1,0.4,0.4,transcript,2017.0
CCDC88C,ENSG00000015133,neuroimaging measurement,EFO_0004346,0.5477547799636097,5.477567122374128,1,0.4,0.4,transcript,20701.0
TCF7L2,ENSG00000148737,bone tissue density,OBA_1000110,0.5475929144442052,5.47600169437051,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,bone tissue density,OBA_1000110,0.5475929144442052,5.47600169437051,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,bone tissue density,OBA_1000110,0.5475929144442052,5.47600169437051,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,bone tissue density,OBA_1000110,0.5475929144442052,5.47600169437051,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
GABRG1,ENSG00000163285,status epilepticus,EFO_0008526,0.5475797232071513,5.477928040002854,6,2.4000000000000004,14.400000000000002,transcript,6758.0
NBAS,ENSG00000151779,infantile liver failure,MONDO_0000023,0.5474481445016615,5.474514990806618,2,1.0,2.0,transcript,59620.0
PDE3A,ENSG00000172572,systolic blood pressure,EFO_0006335,0.547439208352646,5.47441686667392,1,0.4,0.4,gene_variant,16140.0
UGT2B15,ENSG00000196620,sex hormone-binding globulin measurement,EFO_0004696,0.5473054071218258,5.473991278341033,2,1.0,2.0,transcript,2134.0
FIGN,ENSG00000182263,body mass index,EFO_0004340,0.5472701333151372,5.472738087722722,1,0.4,0.4,transcript,10883.0
DPYD,ENSG00000188641,body mass index,EFO_0004340,0.5472224806332106,5.472283027105278,1,0.5,0.5,transcript,8588.0
CDH23,ENSG00000107736,Retinal dystrophy,HP_0000556,0.5471889418068907,5.471896968771877,1,0.5,0.5,transcript,66219.0
IQCB1,ENSG00000173226,Retinal dystrophy,HP_0000556,0.5470483259318067,5.470524878296321,1,0.4,0.4,transcript,9611.0
FBN1,ENSG00000166147,Abnormality of the cardiovascular system,HP_0001626,0.5470265471799092,5.4702721370216265,1,0.4,0.4,transcript,60013.0
ACVR1C,ENSG00000123612,BMI-adjusted waist circumference,EFO_0007789,0.5468558670726382,5.4686779846712,2,0.8,1.6,transcript,13410.0
LRP2,ENSG00000081479,gout,EFO_0004274,0.5465933505394963,5.46595009409474,1,0.5,0.5,transcript,30141.0
ABCB1,ENSG00000085563,response to tramadol,EFO_0022041,0.5465880568661412,5.46590461637207,1,0.5,0.5,transcript,20792.0
DSC2,ENSG00000134755,Abnormality of the cardiovascular system,HP_0001626,0.5465552731317103,5.46556517338373,2,0.8,1.6,transcript,128596.0
GLB1,ENSG00000170266,asthma,MONDO_0004979,0.546525267374759,5.465283581826963,1,0.5,0.5,transcript,16177.0
RCL1,ENSG00000120158,erythrocyte volume,OBA_0003460,0.5463629283127941,5.463667956626925,1,0.4,0.4,transcript,10343.0
GHR,ENSG00000112964,IGF-1 measurement,EFO_0004627,0.546357179343638,5.463580654953029,1,0.4,0.4,transcript,45139.0
TMEM170B,ENSG00000205269,platelet volume,OBA_0003277,0.546312632829612,5.463171317611158,1,0.4,0.4,transcript,8891.0
THAP1,ENSG00000131931,Dystonia,HP_0001332,0.5462189797949513,5.462269163028878,1,0.4,0.4,transcript,5040.0
SV2C,ENSG00000122012,Red cell distribution width,EFO_0009188,0.5460821018403341,5.460849047273077,1,0.4,0.4,transcript,14271.0
KCNQ3,ENSG00000184156,epilepsy,EFO_0000474,0.545865118502095,5.458707562751746,2,0.8,1.6,transcript,28380.0
TTC39B,ENSG00000155158,free cholesterol measurement,EFO_0008591,0.5457887555449538,5.458041211175347,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
CACNA1D,ENSG00000157388,potassium measurement,EFO_0009283,0.5456786480410207,5.456790445674492,1,0.4,0.4,transcript,100876.0
ETV5,ENSG00000244405,total cholesterol measurement,EFO_0004574,0.5456604287453864,5.456636459898166,1,0.4,0.4,transcript,12433.0
TTC39B,ENSG00000155158,lipoprotein measurement,EFO_0004732,0.5456047389369306,5.456201045095116,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
TCF7L2,ENSG00000148737,Drugs used in diabetes use measurement,EFO_0009924,0.5455449686010352,5.45552223593881,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,Drugs used in diabetes use measurement,EFO_0009924,0.5455449686010352,5.45552223593881,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,Drugs used in diabetes use measurement,EFO_0009924,0.5455449686010352,5.45552223593881,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,Drugs used in diabetes use measurement,EFO_0009924,0.5455449686010352,5.45552223593881,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
BICC1,ENSG00000122870,open-angle glaucoma,EFO_0004190,0.5455112510443954,5.455160604708713,1,0.4,0.4,transcript,8317.0
PKP2,ENSG00000057294,familial isolated arrhythmogenic right ventricular dysplasia,MONDO_0016342,0.5454249466334484,5.4544055677028105,4,1.6,6.4,transcript,40999.0
TBXT,ENSG00000164458,sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome,MONDO_0014314,0.5453610020438862,5.45407049626388,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
FNDC3B,ENSG00000075420,open-angle glaucoma,EFO_0004190,0.5453292644961257,5.453346262467373,2,0.8,1.6,transcript,29841.0
ONECUT1,ENSG00000169856,C-reactive protein measurement,EFO_0004458,0.5453203242030704,5.4532560891703525,1,0.4,0.4,transcript,7569.0
PDE1A,ENSG00000115252,serum creatinine amount,OBA_2050096,0.5452749445752431,5.452875996882602,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
LRBA,ENSG00000198589,neutrophil count,EFO_0004833,0.545259588371675,5.452599825224771,1,0.4,0.4,transcript,101484.0
DCDC2,ENSG00000146038,serum creatinine amount,OBA_2050096,0.5451965721267847,5.452011498333538,1,0.4,0.4,transcript,8738.0
MMADHC,ENSG00000168288,"vitamin B12-responsive methylmalonic acidemia, type cblDv2",MONDO_0017685,0.5451302856599352,5.451384422667867,1,0.4,0.4,transcript,4904.0
NDUFAF4,ENSG00000123545,neurodegenerative disease,EFO_0005772,0.5450910989427591,5.451022534324412,1,0.4,0.4,transcript,3586.0
SLC25A37,ENSG00000147454,erythrocyte volume,OBA_0003460,0.5450632191195534,5.450651361137066,1,0.4,0.4,transcript,20866.0
UBE2G2,ENSG00000184787,neurodegenerative disease,EFO_0005772,0.5450271037694656,5.450297092931759,1,0.4,0.4,transcript,15352.0
ID4,ENSG00000172201,lean body mass,EFO_0004995,0.5449778030116721,5.4501911465639195,2,0.8,1.6,transcript,3873.0
C2orf73,ENSG00000177994,glomerular filtration rate,OBA_0003747,0.5449530810729099,5.449579119907842,1,0.4,0.4,transcript,8280.0
FAM8A1,ENSG00000137414,eosinophil count,EFO_0004842,0.544849170823306,5.448510950103369,1,0.4,0.4,transcript,20788.0
FNDC3B,ENSG00000075420,HbA1c measurement,EFO_0004541,0.5447764380594226,5.447817998100342,2,0.8,1.6,transcript,29841.0
DMRTA1,ENSG00000176399,neuroimaging measurement,EFO_0004346,0.5445770125835018,5.445841733425422,1,0.4,0.4,transcript,5586.0
PDE3B,ENSG00000152270,triglycerides:total lipids ratio,EFO_0020947,0.5444991992800394,5.445066822096064,2,0.8,1.6,transcript,21382.0
DNAJC21,ENSG00000168724,Shwachman-Diamond syndrome,MONDO_0009833,0.544383648686184,5.443845509893128,1,0.4,0.4,transcript,44331.0
GALR1,ENSG00000166573,IGF-1 measurement,EFO_0004627,0.5443689801030174,5.443834414189971,2,0.8,1.6,transcript,11064.0
KCNQ1,ENSG00000053918,epilepsy,EFO_0000474,0.5442215473321955,5.4424091466595925,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
SYNE2,ENSG00000054654,atrial fibrillation,EFO_0000275,0.5442110620843111,5.44212325635902,2,1.0,2.0,transcript,158284.0
SLC30A8,ENSG00000164756,triglyceride measurement,EFO_0004530,0.543996531253488,5.4402754802192845,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,triglyceride measurement,EFO_0004530,0.543996531253488,5.4402754802192845,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,triglyceride measurement,EFO_0004530,0.543996531253488,5.4402754802192845,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,triglyceride measurement,EFO_0004530,0.543996531253488,5.4402754802192845,4,1.6,6.4,gene_variant,20634.0
BICC1,ENSG00000122870,blood urea nitrogen measurement,EFO_0004741,0.5438510357337291,5.4385584516020495,1,0.4,0.4,transcript,8317.0
ACVR1C,ENSG00000123612,waist-hip ratio,EFO_0004343,0.54383782579532,5.438497571898018,2,0.8,1.6,transcript,13410.0
HEPHL1,ENSG00000181333,pili torti-developmental delay-neurological abnormalities syndrome,MONDO_0009871,0.5437760206220112,5.437829064887697,1,0.4,0.4,transcript,5809.0
PDE10A,ENSG00000112541,hemoglobin measurement,EFO_0004509,0.5437508249313208,5.437527961407125,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
KITLG,ENSG00000049130,strand of hair color,OBA_0002313,0.5437310900819191,5.437480256796046,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
TECRL,ENSG00000205678,Abnormality of the cardiovascular system,HP_0001626,0.5437165476442971,5.4375682511129195,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
TTC39B,ENSG00000155158,phospholipid measurement,EFO_0004639,0.5436957169198102,5.437110824923912,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
SLC22A5,ENSG00000197375,platelet volume,OBA_0003277,0.5436664994821699,5.436670563758171,1,0.4,0.4,transcript,71827.0
TCF7L2,ENSG00000148737,total cholesterol measurement,EFO_0004574,0.543528264629716,5.435355196225618,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,total cholesterol measurement,EFO_0004574,0.543528264629716,5.435355196225618,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,total cholesterol measurement,EFO_0004574,0.543528264629716,5.435355196225618,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,total cholesterol measurement,EFO_0004574,0.543528264629716,5.435355196225618,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
BANK1,ENSG00000153064,high density lipoprotein cholesterol measurement,EFO_0004612,0.5435144480305399,5.4353569680464915,3,1.3,3.9000000000000004,transcript,18354.0
ACTN2,ENSG00000077522,autosomal dominant dilated cardiomyopathy,EFO_0009142,0.5433978800911006,5.433995486522794,2,0.8,1.6,transcript,95891.0
PTPRJ,ENSG00000149177,lymphocyte count,EFO_0004587,0.5433265737806532,5.433340925776457,2,0.8,1.6,transcript,21280.0
NUP153,ENSG00000124789,HIV infection,EFO_0000764,0.543169818522439,5.431726169776916,1,0.5,0.5,transcript,17867.0
LARP4B,ENSG00000107929,glomerular filtration rate,OBA_0003747,0.5431574153466703,5.431585165469786,1,0.5,0.5,transcript,45405.0
UGT2B15,ENSG00000196620,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5431351657679917,5.4322888648026915,2,1.0,2.0,transcript,2134.0
CASQ2,ENSG00000118729,Abnormality of the cardiovascular system,HP_0001626,0.5430666822456831,5.430679473478401,1,0.4,0.4,transcript,31618.0
TTC39B,ENSG00000155158,ubiquinone measurement,EFO_0021486,0.5430286648067945,5.4304403037937545,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
ACVR1C,ENSG00000123612,reticulocyte count,EFO_0007986,0.5430161945301778,5.430281259246596,2,0.8,1.6,transcript,13410.0
ADAMTS3,ENSG00000156140,lipid measurement,EFO_0004529,0.542886122219509,5.428910537939141,1,0.4,0.4,transcript,8111.0
PDE11A,ENSG00000128655,forced expiratory volume,EFO_0004314,0.542883527101641,5.428899054153743,2,0.8,1.6,transcript,25085.0
PHC1,ENSG00000111752,low density lipoprotein cholesterol measurement,EFO_0004611,0.542845332319363,5.428472473678138,1,0.5,0.5,transcript,26109.0
ZNF573,ENSG00000189144,C-reactive protein measurement,EFO_0004458,0.5428331105876827,5.428358722557302,1,0.5,0.5,transcript,18105.0
SNX13,ENSG00000071189,aspartate aminotransferase measurement,EFO_0004736,0.5427997301107499,5.4280096262446165,1,0.4,0.4,transcript,32454.0
TCF7L2,ENSG00000148737,coronary artery disease,EFO_0001645,0.5427725815806393,5.427798365734851,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,coronary artery disease,EFO_0001645,0.5427725815806393,5.427798365734851,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,coronary artery disease,EFO_0001645,0.5427725815806393,5.427798365734851,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,coronary artery disease,EFO_0001645,0.5427725815806393,5.427798365734851,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
ANKH,ENSG00000154122,diabetes mellitus,EFO_0000400,0.542465446148516,5.42542290410811,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,diabetes mellitus,EFO_0000400,0.542465446148516,5.42542290410811,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,diabetes mellitus,EFO_0000400,0.542465446148516,5.42542290410811,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,diabetes mellitus,EFO_0000400,0.542465446148516,5.42542290410811,5,2.4,12.0,gene_variant,15616.0
CD2AP,ENSG00000198087,Alzheimer disease,MONDO_0004975,0.5424167698388206,5.424219768161702,1,0.4,0.4,transcript,7682.0
FAS,ENSG00000026103,tumor necrosis factor receptor superfamily member 6 measurement,EFO_0010610,0.5423298449065586,5.423300657290118,1,0.4,0.4,transcript,181141.0
TTC39B,ENSG00000155158,low density lipoprotein cholesterol measurement,EFO_0004611,0.5420830025073489,5.420983680799298,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
BICC1,ENSG00000122870,uric acid measurement,EFO_0004761,0.5420149402047525,5.420197496312284,1,0.4,0.4,transcript,8317.0
TLK1,ENSG00000198586,platelet volume,OBA_0003277,0.5419708378180884,5.419722273341894,1,0.4,0.4,transcript,28787.0
ONECUT2,ENSG00000119547,C-reactive protein measurement,EFO_0004458,0.5419514630326738,5.420676456052879,7,2.8000000000000003,19.6,transcript,16870.0
PEX2,ENSG00000164751,testosterone measurement,EFO_0004908,0.5417801145645381,5.417844971656118,1,0.4,0.4,transcript,9127.0
SNX13,ENSG00000071189,apolipoprotein A 1 measurement,EFO_0004614,0.5417620669655356,5.4176329947924735,1,0.4,0.4,transcript,32454.0
EGFR,ENSG00000146648,viral disease,EFO_0000763,0.5417118951964172,5.417156270618834,2,0.8,1.6,transcript,42874.0
TCF7L2,ENSG00000148737,erythrocyte count,EFO_0004305,0.541620877670593,5.416281326634388,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,erythrocyte count,EFO_0004305,0.541620877670593,5.416281326634388,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,erythrocyte count,EFO_0004305,0.541620877670593,5.416281326634388,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,erythrocyte count,EFO_0004305,0.541620877670593,5.416281326634388,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
SOS1,ENSG00000115904,Abnormality of the cardiovascular system,HP_0001626,0.5415657020586976,5.415680628460202,2,0.8,1.6,transcript,67774.0
ENPEP,ENSG00000138792,fibrinopeptide A measurement,EFO_0800672,0.5414435964389557,5.414478364219957,1,0.4,0.4,transcript,9434.0
TNFRSF11A,ENSG00000141655,alkaline phosphatase measurement,EFO_0004533,0.5414007970158069,5.4141325613432425,2,0.8,1.6,transcript,12842.0
STX7,ENSG00000079950,reticulocyte count,EFO_0007986,0.5413472578837166,5.413561093995387,2,0.8,1.6,transcript,18076.0
NUP153,ENSG00000124789,influenza,EFO_0007328,0.541290761614044,5.4129356006929665,1,0.5,0.5,transcript,17867.0
FGF5,ENSG00000138675,blood sodium bicarbonate amount,OBA_2050094,0.5410890475797546,5.410999787815037,2,0.8,1.6,transcript,14637.0
ULK4,ENSG00000168038,diastolic blood pressure,EFO_0006336,0.541061080399965,5.410651764104508,1,0.5,0.5,transcript,12207.0
SLC7A2,ENSG00000003989,glutamine measurement,EFO_0009768,0.5409962276739511,5.410083272360621,3,1.4,4.199999999999999,transcript,34712.0
FLRT2,ENSG00000185070,glomerular filtration rate,OBA_0003747,0.5409558243687104,5.409893762457325,7,2.8000000000000003,19.6,transcript,58417.0
PPARG,ENSG00000132170,eosinophil count,EFO_0004842,0.5409371516697953,5.434902510892176,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,eosinophil count,EFO_0004842,0.5409371516697953,5.434902510892176,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,eosinophil count,EFO_0004842,0.5409371516697953,5.434902510892176,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,eosinophil count,EFO_0004842,0.5409371516697953,5.434902510892176,59,24.0,1416.0,transcript,55462.0
NUP43,ENSG00000120253,influenza,EFO_0007328,0.5409211817593593,5.409414016506775,2,0.8,1.6,transcript,7913.0
NUP43,ENSG00000120253,HIV infection,EFO_0000764,0.5409211817593593,5.409414016506775,2,0.8,1.6,transcript,7913.0
NBAS,ENSG00000151779,acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins,MONDO_0013111,0.5408714793162589,5.408748338952592,2,1.0,2.0,transcript,59620.0
PDE3B,ENSG00000152270,total lipids in large VLDL,EFO_0022175,0.5408246493849517,5.408321323145186,2,0.8,1.6,transcript,21382.0
PDE3A,ENSG00000172572,cholesteryl ester measurement,EFO_0010351,0.5407688323766875,5.4077131069143345,1,0.4,0.4,gene_variant,16140.0
TRDN,ENSG00000186439,Abnormality of the cardiovascular system,HP_0001626,0.5406940092302229,5.406959295743486,1,0.5,0.5,transcript,26037.0
REEP3,ENSG00000165476,platelet volume,OBA_0003277,0.540678408031847,5.406853863989091,1,0.4,0.4,transcript,5732.0
GALNT3,ENSG00000115339,alkaline phosphatase measurement,EFO_0004533,0.5406725576313692,5.406754484313981,1,0.4,0.4,transcript,13837.0
CMTR2,ENSG00000180917,neurodegenerative disease,EFO_0005772,0.5405984952413364,5.406088371713992,2,0.8,1.6,transcript,15471.0
PDE10A,ENSG00000112541,erythrocyte count,EFO_0004305,0.5405797431648074,5.405817143741991,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
PARP8,ENSG00000151883,basophil measurement,EFO_0803539,0.5405632118792824,5.405679195616314,2,0.8,1.6,transcript,33987.0
QSER1,ENSG00000060749,cystatin C measurement,EFO_0004617,0.5404860884684314,5.404887559887045,1,0.5,0.5,transcript,18744.0
ZNF143,ENSG00000166478,body weight,EFO_0004338,0.5404555800504212,5.404582080331816,1,0.5,0.5,transcript,19026.0
TCF7L2,ENSG00000148737,sodium measurement,EFO_0009282,0.5404447673250568,5.404520223179025,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,sodium measurement,EFO_0009282,0.5404447673250568,5.404520223179025,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,sodium measurement,EFO_0009282,0.5404447673250568,5.404520223179025,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,sodium measurement,EFO_0009282,0.5404447673250568,5.404520223179025,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
RCL1,ENSG00000120158,erythrocyte count,EFO_0004305,0.5404119230453455,5.40415790395244,1,0.4,0.4,transcript,10343.0
SLC25A37,ENSG00000147454,body mass index,EFO_0004340,0.5403794323929731,5.403813493871263,1,0.4,0.4,transcript,20866.0
FGF5,ENSG00000138675,chloride measurement,EFO_0009284,0.5403730304356217,5.403839616373707,2,0.8,1.6,transcript,14637.0
GRIN2B,ENSG00000273079,genetic disorder,EFO_0000508,0.5402978785374194,5.402983055001136,1,0.4,0.4,transcript,93685.0
VPS13A,ENSG00000197969,neurodegenerative disease,EFO_0005772,0.540278722249824,5.402793967747056,1,0.4,0.4,transcript,59301.0
CERKL,ENSG00000188452,neurodegenerative disease,EFO_0005772,0.5402725965097733,5.402746038969582,1,0.5,0.5,transcript,24908.0
TBX5,ENSG00000089225,pulse pressure measurement,EFO_0005763,0.5400465401344638,5.400590695001647,2,0.8,1.6,transcript,12770.0
CD2AP,ENSG00000198087,platelet volume,OBA_0003277,0.5399944427424791,5.399996497198288,1,0.4,0.4,transcript,7682.0
PICALM,ENSG00000073921,Alzheimer disease,MONDO_0004975,0.5399003687304336,5.399016955622908,1,0.4,0.4,transcript,30147.0
LPP,ENSG00000145012,open-angle glaucoma,EFO_0004190,0.5398689117081615,5.3987580172624785,4,1.6,6.4,transcript,92888.0
PRTG,ENSG00000166450,neuroimaging measurement,EFO_0004346,0.5398193774784198,5.398411850868521,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
PDE3A,ENSG00000172572,pulse pressure measurement,EFO_0005763,0.5398176743368439,5.398201526515899,1,0.4,0.4,gene_variant,16140.0
ULK4,ENSG00000168038,erythrocyte count,EFO_0004305,0.5397691269429933,5.397732229534791,1,0.5,0.5,transcript,12207.0
GHR,ENSG00000112964,chronic kidney disease,EFO_0003884,0.5396865317217685,5.3968741787343335,1,0.4,0.4,transcript,45139.0
REEP3,ENSG00000165476,platelet count,EFO_0004309,0.5396225108936027,5.396294892606647,1,0.4,0.4,transcript,5732.0
PPARG,ENSG00000132170,calcium measurement,EFO_0004838,0.5395957768758022,5.421488762952245,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,calcium measurement,EFO_0004838,0.5395957768758022,5.421488762952245,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,calcium measurement,EFO_0004838,0.5395957768758022,5.421488762952245,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,calcium measurement,EFO_0004838,0.5395957768758022,5.421488762952245,59,24.0,1416.0,transcript,55462.0
PARP8,ENSG00000151883,type 2 diabetes mellitus,MONDO_0005148,0.5395882249304116,5.3959293261276065,2,0.8,1.6,transcript,33987.0
RNMT,ENSG00000101654,neurodegenerative disease,EFO_0005772,0.5395780111193772,5.3957965329032715,1,0.4,0.4,transcript,24358.0
EGFR,ENSG00000146648,lung carcinoma,EFO_0001071,0.5395100817686654,5.395138136341317,2,0.8,1.6,transcript,42874.0
QSER1,ENSG00000060749,glomerular filtration rate,OBA_0003747,0.5394985517958489,5.395012193161221,1,0.5,0.5,transcript,18744.0
SKP2,ENSG00000145604,erythrocyte volume,OBA_0003460,0.5394982569778429,5.394987592632416,1,0.4,0.4,transcript,79636.0
IL4R,ENSG00000077238,respiratory system disease,EFO_0000684,0.5394705746925286,5.39472431099453,1,0.4,0.4,transcript,21547.0
TYR,ENSG00000077498,Vitiligo,EFO_0004208,0.5394674368462351,5.394798192137437,1,0.5,0.5,transcript,4038.0
SAMD9L,ENSG00000177409,Ataxia - pancytopenia,Orphanet_2585,0.539363755225025,5.393646005156993,1,0.4,0.4,transcript,47321.0
AGA,ENSG00000038002,N-acetylglucosaminylasparagine measurement,EFO_0800151,0.5392825839574067,5.392923821153531,1,0.5,0.5,transcript,5103.0
DTHD1,ENSG00000197057,monocyte count,EFO_0005091,0.539273173195301,5.392758132502141,1,0.5,0.5,transcript,18939.0
STX7,ENSG00000079950,Red cell distribution width,EFO_0009188,0.5392250540531144,5.392339055689365,2,0.8,1.6,transcript,18076.0
FGF5,ENSG00000138675,Agents acting on the renin-angiotensin system use measurement,EFO_0009931,0.5391790189627625,5.391899501645116,2,0.8,1.6,transcript,14637.0
PHC1,ENSG00000111752,total cholesterol measurement,EFO_0004574,0.5391660819079988,5.391679969564495,1,0.5,0.5,transcript,26109.0
RFX7,ENSG00000181827,Red cell distribution width,EFO_0009188,0.5391289151553973,5.391298743880112,1,0.4,0.4,transcript,41700.0
CA8,ENSG00000178538,neutrophil count,EFO_0004833,0.5390495122536858,5.390536076770502,1,0.4,0.4,transcript,9767.0
TTC39B,ENSG00000155158,free cholesterol:total lipids ratio,EFO_0020945,0.5390175880885523,5.390329536611333,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
RFX3,ENSG00000080298,neurodegenerative disease,EFO_0005772,0.5388504111448327,5.388560612613664,2,0.8,1.6,transcript,28318.0
GABRA1,ENSG00000022355,Epileptic encephalopathy,HP_0200134,0.5386299459436906,5.38630814300759,1,0.4,0.4,transcript,46064.0
PLCL2,ENSG00000154822,protein measurement,EFO_0004747,0.538614534205294,5.38628389418318,2,0.8,1.6,transcript,11548.0
LARP4B,ENSG00000107929,serum creatinine amount,OBA_2050096,0.5385540416378494,5.385551428381577,1,0.5,0.5,transcript,45405.0
ADAMTS3,ENSG00000156140,esterified cholesterol measurement,EFO_0008589,0.5385223861815956,5.385273177560007,1,0.4,0.4,transcript,8111.0
ITGB8,ENSG00000105855,asthma,MONDO_0004979,0.5385053275794086,5.385223803007388,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
TCF7L2,ENSG00000148737,chronic kidney disease,EFO_0003884,0.538489154284681,5.384964092775268,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,chronic kidney disease,EFO_0003884,0.538489154284681,5.384964092775268,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,chronic kidney disease,EFO_0003884,0.538489154284681,5.384964092775268,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,chronic kidney disease,EFO_0003884,0.538489154284681,5.384964092775268,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
UGT2B15,ENSG00000196620,low density lipoprotein cholesterol measurement,EFO_0004611,0.5384211624726727,5.385148831849501,2,1.0,2.0,transcript,2134.0
LRP2,ENSG00000081479,Intellectual disability,HP_0001249,0.5383757575441467,5.383774164141244,1,0.5,0.5,transcript,30141.0
MACF1,ENSG00000127603,high density lipoprotein cholesterol measurement,EFO_0004612,0.5383067418557108,5.383072745409438,2,0.8,1.6,gene_variant,300365.0
RCN2,ENSG00000117906,glomerular filtration rate,OBA_0003747,0.5382776392785644,5.382803707726917,1,0.4,0.4,transcript,14644.0
UMPS,ENSG00000114491,coronary artery disease,EFO_0001645,0.5382699896453627,5.3827187528152916,1,0.4,0.4,transcript,21213.0
TCF7L2,ENSG00000148737,low density lipoprotein cholesterol measurement,EFO_0004611,0.5382634691250267,5.382707241178724,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
TCF7L2,ENSG00000148737,low density lipoprotein cholesterol measurement,EFO_0004611,0.5382634691250267,5.382707241178724,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,low density lipoprotein cholesterol measurement,EFO_0004611,0.5382634691250267,5.382707241178724,3,1.2000000000000002,3.6000000000000005,transcript,49621.0
TCF7L2,ENSG00000148737,low density lipoprotein cholesterol measurement,EFO_0004611,0.5382634691250267,5.382707241178724,3,1.2000000000000002,3.6000000000000005,gene_variant,49621.0
PEAK1,ENSG00000173517,type 2 diabetes mellitus,MONDO_0005148,0.5381936919297096,5.381943841748336,1,0.4,0.4,transcript,57783.0
PPARG,ENSG00000132170,total cholesterol measurement,EFO_0004574,0.5380963492920049,5.406494487114272,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,total cholesterol measurement,EFO_0004574,0.5380963492920049,5.406494487114272,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,total cholesterol measurement,EFO_0004574,0.5380963492920049,5.406494487114272,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,total cholesterol measurement,EFO_0004574,0.5380963492920049,5.406494487114272,59,24.0,1416.0,transcript,55462.0
SMAD2,ENSG00000175387,Loeys-Dietz syndrome,MONDO_0018954,0.5380550129904763,5.3810439269602695,9,3.6,32.4,transcript,65614.0
NID2,ENSG00000087303,triglyceride measurement,EFO_0004530,0.5380542088144822,5.380587222645634,1,0.5,0.5,transcript,11078.0
SPRED1,ENSG00000166068,Abnormality of the cardiovascular system,HP_0001626,0.5380059693489107,5.380104266700606,1,0.4,0.4,transcript,8974.0
SNX13,ENSG00000071189,circulating fibrinogen levels,OBA_0000061,0.53796772663055,5.3796895914426175,1,0.4,0.4,transcript,32454.0
LPP,ENSG00000145012,basal cell carcinoma,EFO_0004193,0.5378520798847651,5.378589699028514,4,1.6,6.4,transcript,92888.0
GHR,ENSG00000112964,endocrine system disease,EFO_0001379,0.5378464826905242,5.37847368842189,1,0.4,0.4,transcript,45139.0
SYNE2,ENSG00000054654,neurodegenerative disease,EFO_0005772,0.5378409519139999,5.378422154655908,2,1.0,2.0,transcript,158284.0
LHFPL2,ENSG00000145685,retinal vasculature measurement,EFO_0010554,0.5378380831041011,5.378407723605217,1,0.4,0.4,transcript,14874.0
METTL8,ENSG00000123600,Woodhouse-Sakati syndrome,MONDO_0009419,0.537446324356912,5.374475264605935,1,0.4,0.4,transcript,33275.0
DENND1B,ENSG00000213047,neuroticism measurement,EFO_0007660,0.5372920041441493,5.373356798953723,5,2.0,10.0,transcript,22896.0
CFAP299,ENSG00000197826,strand of hair color,OBA_0002313,0.537280187011585,5.3728670082086065,1,0.5,0.5,transcript,7676.0
TRPC6,ENSG00000137672,trait in response to prednisolone,OBA_2040133,0.5372127700859061,5.372156587982625,1,0.4,0.4,transcript,13847.0
GRB14,ENSG00000115290,high density lipoprotein cholesterol measurement,EFO_0004612,0.5370588965013081,5.3706293323559,1,0.4,0.4,transcript,9909.0
GJB2,ENSG00000165474,autosomal recessive nonsyndromic hearing loss 1B,MONDO_0012977,0.5370424636435852,5.3705114419914075,1,0.4,0.4,transcript,4608.0
RET,ENSG00000165731,Aganglionic megacolon,HP_0002251,0.5369730443325316,5.369740455590341,1,0.4,0.4,transcript,39951.0
VPS13A,ENSG00000197969,mean corpuscular hemoglobin concentration,EFO_0004528,0.5369485957889777,5.369492703138593,1,0.4,0.4,transcript,59301.0
GMCL2,ENSG00000244234,platelet count,EFO_0004309,0.5368019492284773,5.368159010945394,1,0.4,0.4,transcript,2867.0
PTPN4,ENSG00000088179,neurodegenerative disease,EFO_0005772,0.5366583695289555,5.367047302150937,5,2.0,10.0,transcript,21570.0
ALDOB,ENSG00000136872,glomerular filtration rate,OBA_0003747,0.5365149264971896,5.365190677126363,1,0.4,0.4,transcript,9659.0
ETV5,ENSG00000244405,HbA1c measurement,EFO_0004541,0.5365083679831515,5.365115852275816,1,0.4,0.4,transcript,12433.0
IL4R,ENSG00000077238,childhood onset asthma,MONDO_0005405,0.5365012960233771,5.365031524303015,1,0.4,0.4,transcript,21547.0
PARP1,ENSG00000143799,erythrocyte volume,OBA_0003460,0.5363386604280487,5.363392473858465,1,0.5,0.5,transcript,85185.0
GRB14,ENSG00000115290,glucose measurement,EFO_0004468,0.5363120383905896,5.363160751248715,1,0.4,0.4,transcript,9909.0
ADAMTS3,ENSG00000156140,intermediate density lipoprotein measurement,EFO_0008595,0.5362579492566774,5.3626288083108244,1,0.4,0.4,transcript,8111.0
RCL1,ENSG00000120158,mean corpuscular hemoglobin concentration,EFO_0004528,0.5362179060568638,5.362217734067623,1,0.4,0.4,transcript,10343.0
ITPRID2,ENSG00000138434,monocyte count,EFO_0005091,0.5361297597921196,5.361306385460466,1,0.4,0.4,transcript,45519.0
SNX13,ENSG00000071189,platelet volume,OBA_0003277,0.5360349778432456,5.360362103569573,1,0.4,0.4,transcript,32454.0
BPTF,ENSG00000171634,neurodegenerative disease,EFO_0005772,0.5357538137283457,5.357557761480092,2,0.8,1.6,transcript,81532.0
SRSF7,ENSG00000115875,neurodegenerative disease,EFO_0005772,0.5357048841244776,5.357070804785298,1,0.4,0.4,transcript,18212.0
PLCL2,ENSG00000154822,fetal genotype effect measurement,EFO_0007959,0.5356585374780114,5.356723926910353,2,0.8,1.6,transcript,11548.0
SPATA22,ENSG00000141255,genetic disorder,EFO_0000508,0.5356461706042263,5.3564953783434275,1,0.5,0.5,transcript,14849.0
RASA2,ENSG00000155903,neutrophil count,EFO_0004833,0.535602159022675,5.3560692036061095,1,0.4,0.4,transcript,8401.0
MAP2K6,ENSG00000108984,"osteoarthritis, hip",EFO_1000786,0.535572788821655,5.355745190751373,1,0.4,0.4,transcript,23118.0
ONECUT1,ENSG00000169856,testosterone measurement,EFO_0004908,0.535486225266932,5.354915099808968,1,0.4,0.4,transcript,7569.0
ONECUT1,ENSG00000169856,sex hormone-binding globulin measurement,EFO_0004696,0.5353816346550935,5.353869193690583,1,0.4,0.4,transcript,7569.0
SEMA3A,ENSG00000075213,neuroimaging measurement,EFO_0004346,0.5353243127773124,5.353273332409536,1,0.4,0.4,transcript,13243.0
LPP,ENSG00000145012,blood urea nitrogen measurement,EFO_0004741,0.535298608763167,5.353054987812533,4,1.6,6.4,transcript,92888.0
TC2N,ENSG00000165929,calcium measurement,EFO_0004838,0.5352125719122375,5.352148483905256,1,0.4,0.4,transcript,17571.0
LMO4,ENSG00000143013,basophil count,EFO_0005090,0.5351755174139288,5.351806654190768,1,0.4,0.4,transcript,7770.0
GFPT1,ENSG00000198380,glomerular filtration rate,OBA_0003747,0.5351099074318119,5.351114178347118,1,0.4,0.4,transcript,26483.0
PDE3A,ENSG00000172572,diastolic blood pressure,EFO_0006336,0.5350511194830244,5.350535977977704,1,0.4,0.4,gene_variant,16140.0
SLC22A2,ENSG00000112499,chylomicron amount,OBA_2050296,0.5350429392993198,5.350469114939574,1,0.4,0.4,transcript,10070.0
PPA2,ENSG00000138777,neurodegenerative disease,EFO_0005772,0.5349184668695981,5.349212074966536,1,0.5,0.5,transcript,18244.0
LRRK2,ENSG00000188906,platelet volume,OBA_0003277,0.5348465416139554,5.348484173955311,2,0.9,1.8,transcript,95960.0
GHR,ENSG00000112964,body weights and measures,EFO_0004324,0.5348360593809252,5.3483694553259005,1,0.4,0.4,transcript,45139.0
PDE3B,ENSG00000152270,cholesteryl ester measurement,EFO_0010351,0.5348296492398054,5.3483713216937225,2,0.8,1.6,transcript,21382.0
SH3TC2,ENSG00000169247,diastolic blood pressure,EFO_0006336,0.53472252185982,5.347229642006879,1,0.4,0.4,transcript,90428.0
FBN1,ENSG00000166147,pregnancy disorder,EFO_0009682,0.5345667079605062,5.345673744827597,1,0.4,0.4,transcript,60013.0
EGFR,ENSG00000146648,colorectal neoplasm,EFO_0004142,0.5342424067824192,5.342461386478854,2,0.8,1.6,transcript,42874.0
PDE11A,ENSG00000128655,lean body mass,EFO_0004995,0.5341607373888138,5.341671157025471,2,0.8,1.6,transcript,25085.0
TRDMT1,ENSG00000107614,platelet count,EFO_0004309,0.5340806948306989,5.340820739983712,1,0.4,0.4,transcript,29003.0
NID2,ENSG00000087303,high density lipoprotein cholesterol measurement,EFO_0004612,0.5339389438555201,5.339434573056013,1,0.5,0.5,transcript,11078.0
TEX15,ENSG00000133863,male infertility with azoospermia or oligozoospermia due to single gene mutation,EFO_0700088,0.533853172360656,5.338546647197773,1,0.5,0.5,transcript,33504.0
CD86,ENSG00000114013,psoriatic arthritis,EFO_0003778,0.5338012227161728,5.338044061622532,1,0.4,0.4,transcript,12565.0
SEMA6D,ENSG00000137872,diet measurement,EFO_0008111,0.5337994352980427,5.33800377982809,1,0.5,0.5,transcript,53040.0
GREM1,ENSG00000166923,hereditary mixed polyposis syndrome,MONDO_0011023,0.5337746660828303,5.337764884893181,1,0.4,0.4,transcript,21949.0
ACVR1C,ENSG00000123612,reticulocyte measurement,EFO_0010700,0.5336552099194442,5.336671413139259,2,0.8,1.6,transcript,13410.0
ARAP1,ENSG00000186635,platelet volume,OBA_0003277,0.5335732394941765,5.335741404559532,1,0.4,0.4,transcript,44397.0
TNRC6B,ENSG00000100354,genetic disorder,EFO_0000508,0.5335049129765393,5.3350555815864205,1,0.4,0.4,transcript,61998.0
KRT74,ENSG00000170484,Woolly hair,HP_0002224,0.5334351364805792,5.334415385292347,1,0.4,0.4,transcript,6248.0
YWHAG,ENSG00000170027,developmental and epileptic encephalopathy,MONDO_0100062,0.5333605007948066,5.333712970161291,1,0.4,0.4,transcript,3705.0
PRDM5,ENSG00000138738,cortical thickness,EFO_0004840,0.5333470444729977,5.333551053324869,2,0.8,1.6,transcript,19849.0
FNDC3B,ENSG00000075420,heart rate,OBA_1001087,0.5333317967505021,5.333371585011137,2,0.8,1.6,transcript,29841.0
BICC1,ENSG00000122870,hemoglobin measurement,EFO_0004509,0.533181520698031,5.33186330124507,1,0.4,0.4,transcript,8317.0
EGFR,ENSG00000146648,medullary thyroid gland carcinoma,MONDO_0015277,0.5331698920711583,5.331736239366245,2,0.8,1.6,transcript,42874.0
TC2N,ENSG00000165929,platelet volume,OBA_0003277,0.5331575062603346,5.3315978273862275,1,0.4,0.4,transcript,17571.0
ETV5,ENSG00000244405,apolipoprotein A 1 measurement,EFO_0004614,0.533128680359918,5.331318976043482,1,0.4,0.4,transcript,12433.0
ANKH,ENSG00000154122,phosphate measurement,EFO_0010968,0.5330012309917741,5.330780752540692,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,phosphate measurement,EFO_0010968,0.5330012309917741,5.330780752540692,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,phosphate measurement,EFO_0010968,0.5330012309917741,5.330780752540692,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,phosphate measurement,EFO_0010968,0.5330012309917741,5.330780752540692,5,2.4,12.0,gene_variant,15616.0
CD86,ENSG00000114013,juvenile idiopathic arthritis,EFO_0002609,0.5329544417302413,5.329576251763217,1,0.4,0.4,transcript,12565.0
PPARG,ENSG00000132170,low density lipoprotein cholesterol measurement,EFO_0004611,0.5329485978420506,5.355016972614729,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,low density lipoprotein cholesterol measurement,EFO_0004611,0.5329485978420506,5.355016972614729,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,low density lipoprotein cholesterol measurement,EFO_0004611,0.5329485978420506,5.355016972614729,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,low density lipoprotein cholesterol measurement,EFO_0004611,0.5329485978420506,5.355016972614729,59,24.0,1416.0,gene_variant,55462.0
FIGN,ENSG00000182263,pulse pressure measurement,EFO_0005763,0.5328150911035608,5.328187665606959,1,0.4,0.4,transcript,10883.0
LY75-CD302,ENSG00000248672,platelet count,EFO_0004309,0.5327497717640217,5.327542633198966,1,0.5,0.5,transcript,11132.0
MAP2K6,ENSG00000108984,"osteoarthritis, knee",EFO_0004616,0.5327486145158743,5.327503447693565,1,0.4,0.4,transcript,23118.0
RPS20,ENSG00000008988,Diamond-Blackfan anemia,MONDO_0015253,0.5326842962227162,5.326860171709587,1,0.4,0.4,transcript,23243.0
SHH,ENSG00000164690,glomerular filtration rate,OBA_0003747,0.5326835162481878,5.326888311565056,1,0.4,0.4,transcript,7526.0
ST8SIA4,ENSG00000113532,lymphocyte count,EFO_0004587,0.5326763136800529,5.326806013850588,1,0.4,0.4,transcript,9329.0
IQGAP2,ENSG00000145703,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5325395913201075,5.325410584132093,1,0.5,0.5,transcript,34081.0
CCDC50,ENSG00000152492,autosomal dominant nonsyndromic hearing loss,MONDO_0019587,0.5325394815667017,5.325431262136266,1,0.4,0.4,transcript,10975.0
MDM4,ENSG00000198625,bone marrow failure syndrome 6,MONDO_0030015,0.5324598563084946,5.324604433955155,1,0.4,0.4,transcript,68133.0
KPNA4,ENSG00000186432,neurodegenerative disease,EFO_0005772,0.5323131185204879,5.323140178415005,1,0.4,0.4,transcript,44478.0
OTOGL,ENSG00000165899,Rare genetic deafness,Orphanet_96210,0.5322540340251145,5.322555198209067,1,0.5,0.5,transcript,33652.0
SNX13,ENSG00000071189,triglycerides:total lipids ratio,EFO_0020947,0.5321303680965461,5.321316006102578,1,0.4,0.4,transcript,32454.0
IQGAP2,ENSG00000145703,high density lipoprotein cholesterol measurement,EFO_0004612,0.5320755889178563,5.320770560109581,1,0.5,0.5,transcript,34081.0
PCDH18,ENSG00000189184,hypertension,EFO_0000537,0.5320030013976292,5.320107185635001,2,0.8,1.6,transcript,20733.0
PPARG,ENSG00000132170,serum albumin amount,OBA_2050068,0.5316805679098175,5.342336673292398,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,serum albumin amount,OBA_2050068,0.5316805679098175,5.342336673292398,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,serum albumin amount,OBA_2050068,0.5316805679098175,5.342336673292398,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,serum albumin amount,OBA_2050068,0.5316805679098175,5.342336673292398,59,24.0,1416.0,gene_variant,55462.0
STX7,ENSG00000079950,mean corpuscular hemoglobin concentration,EFO_0004528,0.5316671680489032,5.316760195647253,2,0.8,1.6,transcript,18076.0
GPR180,ENSG00000152749,low density lipoprotein cholesterol measurement,EFO_0004611,0.5316177394323002,5.316222419086621,1,0.4,0.4,transcript,8884.0
PPARG,ENSG00000132170,proctitis,EFO_0005628,0.5316098226427198,5.341629220621421,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,proctitis,EFO_0005628,0.5316098226427198,5.341629220621421,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,proctitis,EFO_0005628,0.5316098226427198,5.341629220621421,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,proctitis,EFO_0005628,0.5316098226427198,5.341629220621421,59,24.0,1416.0,transcript,55462.0
DENND1B,ENSG00000213047,neuroimaging measurement,EFO_0004346,0.5315719174030535,5.316155931542765,5,2.0,10.0,transcript,22896.0
PHIP,ENSG00000146247,Intellectual disability,HP_0001249,0.5315281770780416,5.315289747933849,1,0.5,0.5,transcript,62679.0
ADAMTS3,ENSG00000156140,high density lipoprotein cholesterol measurement,EFO_0004612,0.5314916245386274,5.314965561130325,1,0.4,0.4,transcript,8111.0
PSD3,ENSG00000156011,platelet volume,OBA_0003277,0.5314551028284659,5.314560471378217,1,0.4,0.4,transcript,42359.0
PDE10A,ENSG00000112541,hematocrit,EFO_0004348,0.5314243248440761,5.314262960534678,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
UGT2B15,ENSG00000196620,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.5313596790194054,5.314533997316828,2,1.0,2.0,transcript,2134.0
SHH,ENSG00000164690,serum creatinine amount,OBA_2050096,0.5313517768168939,5.313570917252117,1,0.4,0.4,transcript,7526.0
GALNT3,ENSG00000115339,femoral neck bone mineral density,EFO_0007785,0.5312751833021443,5.312780741021731,1,0.4,0.4,transcript,13837.0
PPARG,ENSG00000132170,sex hormone-binding globulin measurement,EFO_0004696,0.5312549337431142,5.338080331625364,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,sex hormone-binding globulin measurement,EFO_0004696,0.5312549337431142,5.338080331625364,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,sex hormone-binding globulin measurement,EFO_0004696,0.5312549337431142,5.338080331625364,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,sex hormone-binding globulin measurement,EFO_0004696,0.5312549337431142,5.338080331625364,59,24.0,1416.0,transcript,55462.0
ETV5,ENSG00000244405,fat pad mass,OBA_0004528,0.531242727705881,5.312459449503112,1,0.4,0.4,transcript,12433.0
ARAP1,ENSG00000186635,body mass index,EFO_0004340,0.5310201764160573,5.31021077377834,1,0.4,0.4,transcript,44397.0
TMEM17,ENSG00000186889,prostate carcinoma,EFO_0001663,0.5309836035408304,5.309900035408305,1,0.4,0.4,transcript,6250.0
ZNF573,ENSG00000189144,sex hormone-binding globulin measurement,EFO_0004696,0.5309473423230201,5.309501039910676,1,0.5,0.5,transcript,18105.0
CCDC50,ENSG00000152492,deafness,EFO_0001063,0.5308825445304115,5.308861891773363,1,0.4,0.4,transcript,10975.0
KITLG,ENSG00000049130,mean corpuscular hemoglobin concentration,EFO_0004528,0.5308543748479182,5.308713104456037,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
ITGB8,ENSG00000105855,eosinophil count,EFO_0004842,0.5307347757993582,5.307518285206884,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
AR,ENSG00000169083,breast cancer,MONDO_0007254,0.5306066761859661,5.306108091645521,2,0.8,1.6,transcript,38713.0
GLB1,ENSG00000170266,genetic disorder,EFO_0000508,0.5305879778364435,5.3059106864438075,1,0.5,0.5,transcript,16177.0
SPRED1,ENSG00000166068,Noonan syndrome and Noonan-related syndrome,MONDO_0020297,0.5305860647306598,5.305905220518098,1,0.4,0.4,transcript,8974.0
FYCO1,ENSG00000163820,COVID-19,MONDO_0100096,0.5305824219588532,5.305848830429607,1,0.4,0.4,transcript,16253.0
ARPC5,ENSG00000162704,neurodegenerative disease,EFO_0005772,0.5305805353993648,5.305832083028061,1,0.4,0.4,transcript,14965.0
COQ3,ENSG00000132423,neurodegenerative disease,EFO_0005772,0.5305776583290346,5.3059271290186105,1,0.4,0.4,transcript,2657.0
GRIN2B,ENSG00000273079,"GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder",MONDO_0035122,0.5305524136140386,5.305528405767328,1,0.4,0.4,transcript,93685.0
UGT2B15,ENSG00000196620,vanillylmandelate (VMA) measurement,EFO_0800119,0.5305304688643759,5.306241895766534,2,1.0,2.0,transcript,2134.0
PDE3A,ENSG00000172572,HbA1c measurement,EFO_0004541,0.5304492823275754,5.304517606423214,1,0.4,0.4,gene_variant,16140.0
GFRAL,ENSG00000187871,body mass index,EFO_0004340,0.5304432142927323,5.304641457422353,1,0.4,0.4,transcript,1911.0
TTC39B,ENSG00000155158,omega-6 polyunsaturated fatty acid measurement,EFO_0005680,0.5303979558749664,5.304133214475474,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
PPARG,ENSG00000132170,liver disease,EFO_0001421,0.5303784757151395,5.329315751345618,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,liver disease,EFO_0001421,0.5303784757151395,5.329315751345618,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,liver disease,EFO_0001421,0.5303784757151395,5.329315751345618,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,liver disease,EFO_0001421,0.5303784757151395,5.329315751345618,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,serum alanine aminotransferase measurement,EFO_0004735,0.5303256514580964,5.328787508775187,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,serum alanine aminotransferase measurement,EFO_0004735,0.5303256514580964,5.328787508775187,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,serum alanine aminotransferase measurement,EFO_0004735,0.5303256514580964,5.328787508775187,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,serum alanine aminotransferase measurement,EFO_0004735,0.5303256514580964,5.328787508775187,59,24.0,1416.0,gene_variant,55462.0
ONECUT2,ENSG00000119547,aspartate aminotransferase measurement,EFO_0004736,0.530311287636519,5.304274702091332,7,2.8000000000000003,19.6,transcript,16870.0
MSX2,ENSG00000120149,strand of hair color,OBA_0002313,0.5302869978580735,5.302988216830809,1,0.4,0.4,transcript,3383.0
SLC25A37,ENSG00000147454,platelet volume,OBA_0003277,0.5302446124454295,5.3024652943958275,1,0.4,0.4,transcript,20866.0
PARP11,ENSG00000111224,erythrocyte count,EFO_0004305,0.530173882148021,5.3017567699680495,1,0.4,0.4,transcript,22286.0
PLCL2,ENSG00000154822,psoriasis,EFO_0000676,0.5300875165288339,5.301013717418578,2,0.8,1.6,transcript,11548.0
ZNF682,ENSG00000197124,triglyceride measurement,EFO_0004530,0.5300801496587119,5.3008274706130925,1,0.5,0.5,transcript,19250.0
SLC25A37,ENSG00000147454,hematocrit,EFO_0004348,0.5299234030683088,5.299253200624619,1,0.4,0.4,transcript,20866.0
GPR180,ENSG00000152749,alkaline phosphatase measurement,EFO_0004533,0.5297824281017108,5.297869305780728,1,0.4,0.4,transcript,8884.0
AKAP6,ENSG00000151320,body fat percentage,EFO_0007800,0.5297699009282959,5.29827378934161,7,2.8000000000000003,19.6,transcript,34100.0
KCNIP4,ENSG00000185774,testosterone measurement,EFO_0004908,0.5296746826251618,5.296879474237027,2,0.8,1.6,transcript,12062.0
GJB2,ENSG00000165474,genetic disorder,EFO_0000508,0.5296562685150776,5.296649490706332,1,0.4,0.4,transcript,4608.0
FBN1,ENSG00000166147,connective tissue disease,EFO_1001986,0.5296207471148886,5.296214136371421,1,0.4,0.4,transcript,60013.0
MTMR6,ENSG00000139505,neurodegenerative disease,EFO_0005772,0.5295204021131639,5.295257646185264,1,0.5,0.5,transcript,9324.0
CNTNAP2,ENSG00000174469,genetic disorder,EFO_0000508,0.5295185898025792,5.295193579697323,1,0.4,0.4,transcript,52072.0
EXO1,ENSG00000174371,basal cell carcinoma,EFO_0004193,0.529492604163978,5.295055474722876,2,1.0,2.0,transcript,15452.0
FUT2,ENSG00000176920,alkaline phosphatase measurement,EFO_0004533,0.5293345076826965,5.293468103277652,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
AGA,ENSG00000038002,aspartate measurement,EFO_0010462,0.5293294591989404,5.293392573568867,1,0.5,0.5,transcript,5103.0
BANK1,ENSG00000153064,diastolic blood pressure,EFO_0006336,0.5292802393997499,5.293014881738591,3,1.3,3.9000000000000004,transcript,18354.0
ARAP1,ENSG00000186635,glucose measurement,EFO_0004468,0.5292217437678762,5.29222644729653,1,0.4,0.4,transcript,44397.0
BPTF,ENSG00000171634,genetic disorder,EFO_0000508,0.5290804870943612,5.290824495140247,2,0.8,1.6,transcript,81532.0
PHC1,ENSG00000111752,BMI-adjusted waist-hip ratio,EFO_0007788,0.5290226887016517,5.290246037501024,1,0.5,0.5,transcript,26109.0
ARHGAP29,ENSG00000137962,aspartate aminotransferase measurement,EFO_0004736,0.5289346679478797,5.289366905197821,1,0.5,0.5,transcript,24721.0
LPP,ENSG00000145012,serum urea amount,OBA_2050065,0.5288244924283695,5.2883138244645576,4,1.6,6.4,transcript,92888.0
KCNQ1,ENSG00000053918,heart conduction disease,MONDO_0000992,0.5286606286659796,5.286799959997434,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
RASA2,ENSG00000155903,body mass index,EFO_0004340,0.5286345635989054,5.286393249368413,1,0.4,0.4,transcript,8401.0
COG3,ENSG00000136152,"congenital disorder of glycosylation, type IIbb",MONDO_0957820,0.5286146859037125,5.2862006977363825,1,0.5,0.5,transcript,9287.0
EVI5,ENSG00000067208,total cholesterol measurement,EFO_0004574,0.528609840197209,5.286104057920734,1,0.4,0.4,transcript,70722.0
ULK4,ENSG00000168038,pulse pressure measurement,EFO_0005763,0.5285878833018093,5.285919793122951,1,0.5,0.5,transcript,12207.0
AFF1,ENSG00000172493,high density lipoprotein cholesterol measurement,EFO_0004612,0.5285379351928425,5.2853895745254755,1,0.4,0.4,transcript,39129.0
GBE1,ENSG00000114480,fetal akinesia deformation sequence,MONDO_0008824,0.5284991921991236,5.285052801085354,1,0.5,0.5,transcript,8213.0
DLC1,ENSG00000164741,pulse pressure measurement,EFO_0005763,0.5284455767206838,5.284467446379953,1,0.4,0.4,transcript,34249.0
TXK,ENSG00000074966,platelet volume,OBA_0003277,0.5284157102176457,5.284186494490366,1,0.4,0.4,transcript,13609.0
CAV2,ENSG00000105971,atrial fibrillation,EFO_0000275,0.5283849718141438,5.2838738917076435,1,0.4,0.4,transcript,16547.0
MANSC4,ENSG00000205693,glucose measurement,EFO_0004468,0.5283793513986801,5.284093453998798,1,0.5,0.5,transcript,1667.0
DPYD,ENSG00000188641,diet measurement,EFO_0008111,0.5283661421193222,5.283719641966394,1,0.5,0.5,transcript,8588.0
ACVR1C,ENSG00000123612,glucose measurement,EFO_0004468,0.528347005724275,5.283589371187567,2,0.8,1.6,transcript,13410.0
SEMA3A,ENSG00000075213,Kallmann syndrome,MONDO_0018800,0.528327381677542,5.283304021411832,1,0.4,0.4,transcript,13243.0
CBLB,ENSG00000114423,glomerular filtration rate,OBA_0003747,0.5283200740181196,5.283209231848748,1,0.4,0.4,transcript,47105.0
CCBE1,ENSG00000183287,erythrocyte volume,OBA_0003460,0.5282825150146014,5.282838940396307,1,0.4,0.4,transcript,29006.0
GALR1,ENSG00000166573,lean body mass,EFO_0004995,0.5282814951230324,5.28295956439012,2,0.8,1.6,transcript,11064.0
UGT2B15,ENSG00000196620,IGF-1 measurement,EFO_0004627,0.5282792354076548,5.283729561199322,2,1.0,2.0,transcript,2134.0
RASA2,ENSG00000155903,monocyte count,EFO_0005091,0.5282414169190599,5.282461782569958,1,0.4,0.4,transcript,8401.0
AR,ENSG00000169083,endometriosis,EFO_0001065,0.5282265120625722,5.282306450411582,2,0.8,1.6,transcript,38713.0
TTC39B,ENSG00000155158,free cholesterol in large HDL measurement,EFO_0022157,0.5281406821907786,5.281560477633596,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
FBXO22,ENSG00000167196,serum creatinine amount,OBA_2050096,0.528055665982946,5.280577858621128,1,0.4,0.4,transcript,18869.0
PDE1A,ENSG00000115252,lean body mass,EFO_0004995,0.5280482550630827,5.280609101760999,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
NUP153,ENSG00000124789,viral disease,EFO_0000763,0.527999386776198,5.280021852314507,1,0.5,0.5,transcript,17867.0
RET,ENSG00000165731,"central hypoventilation syndrome, congenital",MONDO_0800031,0.5279858868453948,5.279868880718973,1,0.4,0.4,transcript,39951.0
SLC22A5,ENSG00000197375,metabolite measurement,EFO_0004725,0.5279184002211146,5.279189571147618,1,0.4,0.4,transcript,71827.0
CACNA1D,ENSG00000157388,pulse pressure measurement,EFO_0005763,0.527866742426742,5.278671389531705,1,0.4,0.4,transcript,100876.0
EXO1,ENSG00000174371,mean corpuscular hemoglobin concentration,EFO_0004528,0.5278521393342502,5.278650826425598,2,1.0,2.0,transcript,15452.0
STARD13,ENSG00000133121,platelet count,EFO_0004309,0.5278435547063195,5.278450363524283,1,0.4,0.4,transcript,26997.0
ARAP1,ENSG00000186635,HbA1c measurement,EFO_0004541,0.5276717352895561,5.276726362513329,1,0.4,0.4,transcript,44397.0
LPP,ENSG00000145012,lymphocyte count,EFO_0004587,0.5275909285398742,5.275978185579605,4,1.6,6.4,transcript,92888.0
CYP24A1,ENSG00000019186,atopic eczema,EFO_0000274,0.5274914008081322,5.275104212551127,2,0.8,1.6,transcript,8412.0
NUP43,ENSG00000120253,viral disease,EFO_0000763,0.5274417831704423,5.274620030617604,2,0.8,1.6,transcript,7913.0
NCKAP1,ENSG00000061676,neurodegenerative disease,EFO_0005772,0.5274362440617252,5.2743722698346005,1,0.4,0.4,transcript,40695.0
EVI5,ENSG00000067208,low density lipoprotein cholesterol measurement,EFO_0004611,0.527379450260966,5.273800158558304,1,0.4,0.4,transcript,70722.0
DBR1,ENSG00000138231,neurodegenerative disease,EFO_0005772,0.5273115576022014,5.273134007502984,1,0.4,0.4,transcript,21702.0
FAT3,ENSG00000165323,brain volume,OBA_2050009,0.5272838578377338,5.272846907372653,1,0.4,0.4,transcript,48025.0
AR,ENSG00000169083,metastatic prostate cancer,EFO_0000196,0.527243919461786,5.27248052440372,2,0.8,1.6,transcript,38713.0
TMEM106B,ENSG00000106460,high density lipoprotein cholesterol measurement,EFO_0004612,0.5271611515879501,5.271644392366649,2,0.8,1.6,transcript,48667.0
CNTLN,ENSG00000044459,major depressive disorder,MONDO_0002009,0.5271292689225923,5.271414149789196,2,0.8,1.6,transcript,13173.0
SLC22A5,ENSG00000197375,monocyte count,EFO_0005091,0.5270874186502577,5.270879755439048,1,0.4,0.4,transcript,71827.0
QSER1,ENSG00000060749,sex hormone-binding globulin measurement,EFO_0004696,0.5269698017056132,5.269724692258864,1,0.5,0.5,transcript,18744.0
LSM6,ENSG00000164167,Alzheimer disease,MONDO_0004975,0.5268771472813407,5.268936881683458,2,0.8,1.6,transcript,9673.0
CYP24A1,ENSG00000019186,serum urea amount,OBA_2050065,0.5268608696891794,5.2687989013616,2,0.8,1.6,transcript,8412.0
SLC22A5,ENSG00000197375,eosinophil count,EFO_0004842,0.5268544702120161,5.268550271056633,1,0.4,0.4,transcript,71827.0
PDE11A,ENSG00000128655,cystatin C measurement,EFO_0004617,0.5268445124440465,5.2685089075777976,2,0.8,1.6,transcript,25085.0
MACF1,ENSG00000127603,neuroimaging measurement,EFO_0004346,0.526759602876771,5.26760135562004,2,0.8,1.6,gene_variant,300365.0
FAS,ENSG00000026103,chronic lymphocytic leukemia,EFO_0000095,0.5267577148791047,5.267579357015579,1,0.4,0.4,transcript,181141.0
ID4,ENSG00000172201,forced expiratory volume,EFO_0004314,0.5266947579847483,5.2673606962946815,2,0.8,1.6,transcript,3873.0
THAP1,ENSG00000131931,neurodegenerative disease,EFO_0005772,0.5266923573539983,5.267002938619349,1,0.4,0.4,transcript,5040.0
PHIP,ENSG00000146247,genetic disorder,EFO_0000508,0.5266555979024179,5.266563956177612,1,0.5,0.5,transcript,62679.0
HS6ST3,ENSG00000185352,body mass index,EFO_0004340,0.5266306977373276,5.266353837729414,1,0.4,0.4,transcript,8536.0
PPARG,ENSG00000132170,colon carcinoma,EFO_1001950,0.5265815560919386,5.291346555113608,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,colon carcinoma,EFO_1001950,0.5265815560919386,5.291346555113608,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,colon carcinoma,EFO_1001950,0.5265815560919386,5.291346555113608,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,colon carcinoma,EFO_1001950,0.5265815560919386,5.291346555113608,59,24.0,1416.0,transcript,55462.0
PDE3B,ENSG00000152270,cholesterol to total lipids in medium HDL percentage ,EFO_0022237,0.5265519413181758,5.265594242477428,2,0.8,1.6,transcript,21382.0
PPP1R2,ENSG00000184203,neurodegenerative disease,EFO_0005772,0.526507567426656,5.265122158868536,1,0.4,0.4,transcript,8605.0
ONECUT1,ENSG00000169856,neurodegenerative disease,EFO_0005772,0.526507567426656,5.265128521406209,1,0.4,0.4,transcript,7569.0
GPAT3,ENSG00000138678,chloride measurement,EFO_0009284,0.5265012489526103,5.265159615962885,2,0.8,1.6,transcript,10875.0
TMEM236,ENSG00000148483,aspartate aminotransferase measurement,EFO_0004736,0.5264904038646646,5.265194156507027,2,0.8,1.6,transcript,5515.0
PDE10A,ENSG00000112541,cardiovascular disease,EFO_0000319,0.5264730470820786,5.264750182914704,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
CFHR4,ENSG00000134365,macular degeneration,EFO_0009606,0.5264149984141653,5.264190492932061,1,0.5,0.5,transcript,12343.0
RCL1,ENSG00000120158,mean corpuscular hemoglobin,EFO_0004527,0.5263394906586246,5.2634335800852305,1,0.4,0.4,transcript,10343.0
LPP,ENSG00000145012,hypothyroidism,EFO_0004705,0.5263161973671426,5.263230873852289,4,1.6,6.4,transcript,92888.0
ACVR1C,ENSG00000123612,apolipoprotein B measurement,EFO_0004615,0.5262581004299055,5.262700318243873,2,0.8,1.6,transcript,13410.0
BACE2,ENSG00000182240,neuroimaging measurement,EFO_0004346,0.526240014184625,5.262533697772794,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
ATG16L1,ENSG00000085978,Crohn's disease,EFO_0000384,0.526236046125379,5.262372452739835,1,0.4,0.4,transcript,33357.0
SKIL,ENSG00000136603,prostate cancer,MONDO_0008315,0.5262193405212151,5.262209865033727,1,0.5,0.5,transcript,30377.0
PDE1A,ENSG00000115252,cardiovascular disease,EFO_0000319,0.5261845666911847,5.261972218042019,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
CEP68,ENSG00000011523,pulse pressure measurement,EFO_0005763,0.5261824999390916,5.261861766499877,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,pulse pressure measurement,EFO_0005763,0.5261824999390916,5.261861766499877,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,pulse pressure measurement,EFO_0005763,0.5261824999390916,5.261861766499877,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,pulse pressure measurement,EFO_0005763,0.5261824999390916,5.261861766499877,3,1.5,4.5,gene_variant,122392.0
PALM2AKAP2,ENSG00000157654,heart rate,OBA_1001087,0.5261525527947136,5.261533515167584,1,0.4,0.4,transcript,50080.0
SI,ENSG00000090402,intestinal disaccharide deficiency and disaccharide malabsorption,EFO_1000060,0.5261379875719714,5.261451921829224,1,0.5,0.5,transcript,6940.0
SMARCC1,ENSG00000173473,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.261494022826798,2,0.8,1.6,transcript,14017.0
EPHA5,ENSG00000145242,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.261390600442882,1,0.4,0.4,transcript,37297.0
SMARCC1,ENSG00000173473,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.261494022826798,2,0.8,1.6,gene_variant,14017.0
GABRG1,ENSG00000163285,Stiff-Person syndrome,EFO_0007498,0.5261379875719714,5.263510683651054,6,2.4000000000000004,14.400000000000002,transcript,6758.0
LSM6,ENSG00000164167,lysosomal storage disease,MONDO_0002561,0.5261379875719714,5.261545284589764,2,0.8,1.6,transcript,9673.0
GHR,ENSG00000112964,gonadal dysgenesis,MONDO_0001967,0.5261379875719714,5.261388737236362,1,0.4,0.4,transcript,45139.0
SOS1,ENSG00000115904,bone development disease,EFO_0005541,0.5261379875719714,5.2614034835929395,2,0.8,1.6,transcript,67774.0
SMARCC1,ENSG00000173473,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.261494022826798,2,0.8,1.6,gene_variant,14017.0
ONECUT2,ENSG00000119547,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.262541701445855,7,2.8000000000000003,19.6,transcript,16870.0
FAM210A,ENSG00000177150,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.261402021661469,1,0.4,0.4,transcript,18062.0
ZNF483,ENSG00000173258,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.261463356884276,2,0.8,1.6,transcript,19166.0
TRAPPC8,ENSG00000153339,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.261400284715999,1,0.5,0.5,transcript,24499.0
FGA,ENSG00000171560,Noonan syndrome,MONDO_0018997,0.5261379875719714,5.261448100178182,1,0.4,0.4,transcript,5863.0
IQGAP1,ENSG00000140575,Noonan syndrome,MONDO_0018997,0.5261379875719714,5.261433973636944,2,0.8,1.6,transcript,29576.0
SEC63,ENSG00000025796,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.261655399981155,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
SMARCC1,ENSG00000173473,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.261494022826798,2,0.8,1.6,transcript,14017.0
GABRA1,ENSG00000022355,Stiff-Person syndrome,EFO_0007498,0.5261379875719714,5.261388559290397,1,0.4,0.4,transcript,46064.0
COG3,ENSG00000136152,neurodegenerative disease,EFO_0005772,0.5261379875719714,5.2614337144189705,1,0.5,0.5,transcript,9287.0
LSM6,ENSG00000164167,Parkinson disease,MONDO_0005180,0.5261379875719714,5.261545284589764,2,0.8,1.6,transcript,9673.0
LSM6,ENSG00000164167,multiple sclerosis,MONDO_0005301,0.5261379875719714,5.261545284589764,2,0.8,1.6,transcript,9673.0
PEAK1,ENSG00000173517,HbA1c measurement,EFO_0004541,0.5260728513048532,5.260735435499772,1,0.4,0.4,transcript,57783.0
TYR,ENSG00000077498,genetic disorder,EFO_0000508,0.5260652841008682,5.260776664683768,1,0.5,0.5,transcript,4038.0
AKAP6,ENSG00000151320,intelligence,EFO_0004337,0.5260576724459781,5.261151504518432,7,2.8000000000000003,19.6,transcript,34100.0
SLC22A5,ENSG00000197375,Decreased circulating carnitine concentration,HP_0003234,0.5259990873519517,5.259996442455988,1,0.4,0.4,transcript,71827.0
SOCS4,ENSG00000180008,neurodegenerative disease,EFO_0005772,0.5259976806591007,5.25999618080393,1,0.4,0.4,transcript,20646.0
NDUFS4,ENSG00000164258,serum creatinine amount,OBA_2050096,0.525906414814985,5.259170729551395,1,0.4,0.4,transcript,3753.0
LSM11,ENSG00000155858,neurodegenerative disease,EFO_0005772,0.525869870756793,5.258759618181605,1,0.4,0.4,transcript,6567.0
RTF1,ENSG00000137815,neurodegenerative disease,EFO_0005772,0.525855725267968,5.258608972359018,1,0.4,0.4,transcript,7734.0
PDE3A,ENSG00000172572,serum alanine aminotransferase measurement,EFO_0004735,0.5257534304778849,5.2575590879263085,1,0.4,0.4,gene_variant,16140.0
FRMD4B,ENSG00000114541,heart rate,OBA_1001087,0.5257200017094924,5.257276113356695,2,0.8,1.6,transcript,21026.0
PHC1,ENSG00000111752,high density lipoprotein cholesterol measurement,EFO_0004612,0.5257030739507552,5.25704988999206,1,0.5,0.5,transcript,26109.0
BIRC6,ENSG00000115760,cancer,MONDO_0004992,0.5256413480774345,5.256420663031298,1,0.5,0.5,transcript,69616.0
FAT1,ENSG00000083857,squamous cell lung carcinoma,EFO_0000708,0.5256029213545127,5.256050408966916,1,0.5,0.5,transcript,23590.0
KCNJ15,ENSG00000157551,body weight,EFO_0004338,0.5255718010021692,5.255727844072092,1,0.4,0.4,transcript,40675.0
NRK,ENSG00000123572,neurodegenerative disease,EFO_0005772,0.5255614688083634,5.25563990558458,1,0.4,0.4,transcript,15862.0
BICC1,ENSG00000122870,hematocrit,EFO_0004348,0.5255176766747103,5.255224861011862,1,0.4,0.4,transcript,8317.0
GABRA4,ENSG00000109158,anxiety,EFO_0005230,0.5254809567191984,5.254834718097417,1,0.4,0.4,transcript,15904.0
CACNA1D,ENSG00000157388,Increased blood pressure,HP_0032263,0.5254530340869653,5.254534306133938,1,0.4,0.4,transcript,100876.0
GRIN2B,ENSG00000273079,pain,EFO_0003843,0.5254195778388435,5.254200048015377,1,0.4,0.4,transcript,93685.0
BTBD8,ENSG00000189195,monocyte count,EFO_0005091,0.5253733241546998,5.253749723614509,1,0.5,0.5,transcript,30336.0
SLC35B4,ENSG00000205060,platelet volume,OBA_0003277,0.5253183652408573,5.253225572341502,1,0.4,0.4,transcript,9542.0
MAGI2,ENSG00000187391,body mass index,EFO_0004340,0.5252837715534598,5.252842278931591,1,0.4,0.4,transcript,87654.0
TAF1B,ENSG00000115750,neurodegenerative disease,EFO_0005772,0.5252587691854598,5.252642092899098,1,0.5,0.5,transcript,9191.0
SLC25A37,ENSG00000147454,hemoglobin measurement,EFO_0004509,0.5251872597712244,5.251891767653776,1,0.4,0.4,transcript,20866.0
PAG1,ENSG00000076641,serum albumin amount,OBA_2050068,0.5251595204128993,5.251725296006382,2,0.8,1.6,transcript,12299.0
TLR10,ENSG00000174123,neutrophil measurement,EFO_0803548,0.5251522290312634,5.251683732529774,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
TLR10,ENSG00000174123,response to stimulus,GO_0050896,0.5251225554823724,5.251386997040864,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
STARD13,ENSG00000133121,hemoglobin measurement,EFO_0004509,0.5250633962513326,5.250648778974414,1,0.4,0.4,transcript,26997.0
PDE11A,ENSG00000128655,vital capacity,EFO_0004312,0.5250340622388733,5.250404405526066,2,0.8,1.6,transcript,25085.0
TBX5,ENSG00000089225,Abnormality of the cardiovascular system,HP_0001626,0.5249173752413159,5.249299046070167,2,0.8,1.6,transcript,12770.0
AFF1,ENSG00000172493,mean corpuscular hemoglobin concentration,EFO_0004528,0.5248064878076656,5.248075100673707,1,0.4,0.4,transcript,39129.0
LMO4,ENSG00000143013,neutrophil count,EFO_0004833,0.524739991473593,5.24745139478741,1,0.4,0.4,transcript,7770.0
GUF1,ENSG00000151806,West syndrome,MONDO_0018097,0.5247097171432099,5.247139093122382,1,0.5,0.5,transcript,11927.0
SV2C,ENSG00000122012,erythrocyte volume,OBA_0003460,0.5246693599635698,5.246721628505433,1,0.4,0.4,transcript,14271.0
ULK4,ENSG00000168038,systolic blood pressure,EFO_0006335,0.5246517075700823,5.2465580358056805,1,0.5,0.5,transcript,12207.0
BICC1,ENSG00000122870,multicystic dysplastic kidney,MONDO_0015988,0.5246369873636596,5.246417967901355,1,0.4,0.4,transcript,8317.0
EVI5,ENSG00000067208,neurodegenerative disease,EFO_0005772,0.5244808916065299,5.244814572013943,1,0.4,0.4,transcript,70722.0
TTC39B,ENSG00000155158,linoleic acid measurement,EFO_0006807,0.5244518741646774,5.244672397372584,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
SLC25A37,ENSG00000147454,body weight,EFO_0004338,0.5244281834558853,5.244301004500385,1,0.4,0.4,transcript,20866.0
ATP10D,ENSG00000145246,metabolite measurement,EFO_0004725,0.5244028465725111,5.244060288535701,1,0.5,0.5,transcript,15712.0
PARP11,ENSG00000111224,erythrocyte volume,OBA_0003460,0.5243086303317891,5.243104251805731,1,0.4,0.4,transcript,22286.0
PALM2AKAP2,ENSG00000157654,monocyte count,EFO_0005091,0.5242313885847002,5.24232187306745,1,0.4,0.4,transcript,50080.0
TYR,ENSG00000077498,albinism,MONDO_0043209,0.5241034808431214,5.241158632106301,1,0.5,0.5,transcript,4038.0
CEP68,ENSG00000011523,type 2 diabetes mellitus,MONDO_0005148,0.5240096169809124,5.240132936918085,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,type 2 diabetes mellitus,MONDO_0005148,0.5240096169809124,5.240132936918085,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,type 2 diabetes mellitus,MONDO_0005148,0.5240096169809124,5.240132936918085,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,type 2 diabetes mellitus,MONDO_0005148,0.5240096169809124,5.240132936918085,3,1.5,4.5,transcript,122392.0
SP4,ENSG00000105866,low density lipoprotein cholesterol measurement,EFO_0004611,0.5238766393574347,5.238790385896803,1,0.4,0.4,transcript,16672.0
AKAP6,ENSG00000151320,fat pad mass,OBA_0004528,0.5238557422090335,5.239132202148986,7,2.8000000000000003,19.6,transcript,34100.0
SLAIN2,ENSG00000109171,platelet volume,OBA_0003277,0.5238298685306915,5.23843442807437,2,0.8,1.6,transcript,11787.0
TYR,ENSG00000077498,cancer,MONDO_0004992,0.5238162574625453,5.2382863983005405,1,0.5,0.5,transcript,4038.0
PTPRJ,ENSG00000149177,total cholesterol measurement,EFO_0004574,0.5237966492295523,5.2380416802654475,2,0.8,1.6,transcript,21280.0
STARD13,ENSG00000133121,hematocrit,EFO_0004348,0.5237817248106987,5.237832064568075,1,0.4,0.4,transcript,26997.0
FBXO22,ENSG00000167196,neurodegenerative disease,EFO_0005772,0.52377262114809,5.2377474102725685,1,0.4,0.4,transcript,18869.0
MIOS,ENSG00000164654,neurodegenerative disease,EFO_0005772,0.5237027211791474,5.237388589544157,4,1.6,6.4,transcript,17710.0
LTBP1,ENSG00000049323,BMI-adjusted waist circumference,EFO_0007789,0.5236222953647658,5.236235613077351,1,0.4,0.4,transcript,31597.0
ONECUT2,ENSG00000119547,sex hormone-binding globulin measurement,EFO_0004696,0.5235259615100297,5.2364214408264385,7,2.8000000000000003,19.6,transcript,16870.0
RET,ENSG00000165731,hepatocellular carcinoma,EFO_0000182,0.523521441070091,5.235224422965936,1,0.4,0.4,transcript,39951.0
FBXO22,ENSG00000167196,glomerular filtration rate,OBA_0003747,0.5234367837800461,5.2343890365921295,1,0.4,0.4,transcript,18869.0
LHX9,ENSG00000143355,neurodegenerative disease,EFO_0005772,0.5233724062576574,5.233798329193729,2,0.8,1.6,transcript,21544.0
CDH23,ENSG00000107736,Joubert syndrome and related disorders,MONDO_0015369,0.5233404900213122,5.233412450916092,1,0.5,0.5,transcript,66219.0
TYR,ENSG00000077498,squamous cell carcinoma,EFO_0000707,0.52321624865927,5.232286310267786,1,0.5,0.5,transcript,4038.0
SH3TC2,ENSG00000169247,systolic blood pressure,EFO_0006335,0.5232154923209826,5.232159346618505,1,0.4,0.4,transcript,90428.0
PDE3A,ENSG00000172572,appendicular lean mass,EFO_0004980,0.5231680119195387,5.231704902342846,1,0.4,0.4,gene_variant,16140.0
EVI5,ENSG00000067208,monocyte count,EFO_0005091,0.5231438998643964,5.231444654592607,1,0.4,0.4,transcript,70722.0
ZNF148,ENSG00000163848,neurodegenerative disease,EFO_0005772,0.52305649287883,5.23057679716797,1,0.4,0.4,transcript,33703.0
SLC30A8,ENSG00000164756,Drugs used in diabetes use measurement,EFO_0009924,0.5229986345734396,5.2302965134188,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,Drugs used in diabetes use measurement,EFO_0009924,0.5229986345734396,5.2302965134188,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,Drugs used in diabetes use measurement,EFO_0009924,0.5229986345734396,5.2302965134188,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,Drugs used in diabetes use measurement,EFO_0009924,0.5229986345734396,5.2302965134188,4,1.6,6.4,transcript,20634.0
PDE3B,ENSG00000152270,reticulocyte measurement,EFO_0010700,0.5229566064113534,5.229640893409203,2,0.8,1.6,transcript,21382.0
FAM171B,ENSG00000144369,neuroimaging measurement,EFO_0004346,0.5229468856307895,5.229538652155042,1,0.4,0.4,transcript,5731.0
SLC25A37,ENSG00000147454,fat pad mass,OBA_0004528,0.5229465059960865,5.229484229902397,1,0.4,0.4,transcript,20866.0
CADPS,ENSG00000163618,body mass index,EFO_0004340,0.522917132862413,5.229180646334769,1,0.4,0.4,transcript,42929.0
ACVR1C,ENSG00000123612,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.5229158211314576,5.229277525259394,2,0.8,1.6,transcript,13410.0
FNDC3B,ENSG00000075420,hypertrophic cardiomyopathy,EFO_0000538,0.5228777697460543,5.2288313149666585,2,0.8,1.6,transcript,29841.0
C12orf42,ENSG00000179088,body mass index,EFO_0004340,0.5225535785238976,5.225570924742806,1,0.5,0.5,transcript,14229.0
LRBA,ENSG00000198589,colobomatous microphthalmia-rhizomelic dysplasia syndrome,MONDO_0014380,0.5225285108229623,5.225289049737643,1,0.4,0.4,transcript,101484.0
LRBA,ENSG00000198589,syndromic microphthalmia,MONDO_0016073,0.5225285108229623,5.225289049737643,1,0.4,0.4,transcript,101484.0
CD86,ENSG00000114013,eosinophil count,EFO_0004842,0.5224967949429935,5.2249997838907385,1,0.4,0.4,transcript,12565.0
EGFR,ENSG00000146648,monocyte count,EFO_0005091,0.5224696184692319,5.2247335033469815,2,0.8,1.6,transcript,42874.0
TYR,ENSG00000077498,amino acid metabolism disease,MONDO_0037871,0.5223590098378608,5.223713922053695,1,0.5,0.5,transcript,4038.0
LRRC7,ENSG00000033122,neutrophil count,EFO_0004833,0.5222573229911361,5.222637333616912,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
MEOX2,ENSG00000106511,triglyceride measurement,EFO_0004530,0.5222064246709551,5.222232951897236,1,0.4,0.4,transcript,2371.0
OXSR1,ENSG00000172939,erythrocyte volume,OBA_0003460,0.5221755148125575,5.221795724307357,1,0.4,0.4,transcript,9858.0
CBLB,ENSG00000114423,hypothyroidism,EFO_0004705,0.522167104714272,5.221679538810271,1,0.4,0.4,transcript,47105.0
AHNAK2,ENSG00000185567,rheumatoid arthritis,EFO_0000685,0.5220949676222758,5.220997505948933,2,1.0,2.0,transcript,41815.0
SLC25A36,ENSG00000114120,neurodegenerative disease,EFO_0005772,0.5220525843496443,5.220539510299777,1,0.4,0.4,transcript,29268.0
PDE3A,ENSG00000172572,apolipoprotein A 1 measurement,EFO_0004614,0.5220462627170784,5.220487410318244,1,0.4,0.4,gene_variant,16140.0
AFF1,ENSG00000172493,basophil measurement,EFO_0803539,0.5220380124832743,5.2203903474297935,1,0.4,0.4,transcript,39129.0
CCDC34,ENSG00000109881,bone tissue density,OBA_1000110,0.5219490438165764,5.219583961663543,1,0.4,0.4,transcript,4277.0
PPARG,ENSG00000132170,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5219254989721247,5.244785983915469,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5219254989721247,5.244785983915469,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5219254989721247,5.244785983915469,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5219254989721247,5.244785983915469,59,24.0,1416.0,gene_variant,55462.0
CYP24A1,ENSG00000019186,cystatin C measurement,EFO_0004617,0.5219093879961139,5.219284084430944,2,0.8,1.6,transcript,8412.0
ASTN2,ENSG00000148219,Bardet-Biedl syndrome 11,MONDO_0014439,0.5219015079660447,5.219073834067029,2,0.8,1.6,transcript,27232.0
PDE3A,ENSG00000172572,heart rate,OBA_1001087,0.5218394534441169,5.218419317588628,1,0.4,0.4,gene_variant,16140.0
FNDC3B,ENSG00000075420,BMI-adjusted waist-hip ratio,EFO_0007788,0.5218359009440571,5.218412626946686,2,0.8,1.6,transcript,29841.0
SNX13,ENSG00000071189,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.5218103196210132,5.218115521347249,1,0.4,0.4,transcript,32454.0
TTC39B,ENSG00000155158,total lipids in HDL measurement ,EFO_0022307,0.5218096572961717,5.218250228687526,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
UGT2B15,ENSG00000196620,mean corpuscular hemoglobin concentration,EFO_0004528,0.521781275031352,5.2187499574362946,2,1.0,2.0,transcript,2134.0
SPAST,ENSG00000021574,genetic disorder,EFO_0000508,0.5217669626852539,5.217674803170882,1,0.4,0.4,transcript,77275.0
AKAP6,ENSG00000151320,body weight,EFO_0004338,0.5217430253815829,5.21800503387448,7,2.8000000000000003,19.6,transcript,34100.0
PTPRJ,ENSG00000149177,high density lipoprotein cholesterol measurement,EFO_0004612,0.5217156521778131,5.217231709748056,2,0.8,1.6,transcript,21280.0
CTBP2,ENSG00000175029,hearing loss,EFO_0004238,0.5217039637396258,5.217053700610406,1,0.4,0.4,transcript,28443.0
UMPS,ENSG00000114491,platelet volume,OBA_0003277,0.5216364051300142,5.2163829076618065,1,0.4,0.4,transcript,21213.0
REEP3,ENSG00000165476,erythrocyte volume,OBA_0003460,0.5215960954021188,5.216030737691809,1,0.4,0.4,transcript,5732.0
GBE1,ENSG00000114480,diet measurement,EFO_0008111,0.5215785779584099,5.215846658678218,1,0.5,0.5,transcript,8213.0
REEP3,ENSG00000165476,sex hormone-binding globulin measurement,EFO_0004696,0.521535313342812,5.215422917098741,1,0.4,0.4,transcript,5732.0
DLC1,ENSG00000164741,heart rate,OBA_1001087,0.5214385793524955,5.21439747269807,1,0.4,0.4,transcript,34249.0
SNIP1,ENSG00000163877,neurodegenerative disease,EFO_0005772,0.5214073823800653,5.214119319706022,1,0.4,0.4,transcript,8792.0
PDE10A,ENSG00000112541,hyperthyroidism,EFO_0009189,0.5213369854603882,5.213389566697799,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
CYP24A1,ENSG00000019186,urate measurement,EFO_0004531,0.5212523130941564,5.21271333541137,2,0.8,1.6,transcript,8412.0
TNPO3,ENSG00000064419,neurodegenerative disease,EFO_0005772,0.5212384427976249,5.212411100333018,1,0.5,0.5,transcript,18746.0
AKAP11,ENSG00000023516,neurodegenerative disease,EFO_0005772,0.5211752138897099,5.212152138897099,1,0.4,0.4,transcript,1000.0
GIPC2,ENSG00000137960,glomerular filtration rate,OBA_0003747,0.5211501637520032,5.211892835564042,2,0.8,1.6,transcript,4090.0
BCKDHB,ENSG00000083123,lean body mass,EFO_0004995,0.5210648458520046,5.216375835381443,10,4.0,40.0,transcript,6984.0
LRBA,ENSG00000198589,alkaline phosphatase measurement,EFO_0004533,0.5209668500687337,5.209672442195358,1,0.4,0.4,transcript,101484.0
FIGN,ENSG00000182263,coronary artery disease,EFO_0001645,0.5208963869672883,5.209000624244234,1,0.4,0.4,transcript,10883.0
PDE1A,ENSG00000115252,hypertension,EFO_0000537,0.5207441743018228,5.2075682941484,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
LRBA,ENSG00000198589,gallstones,EFO_0004210,0.5207396930528085,5.207400872036107,1,0.4,0.4,transcript,101484.0
SMARCC1,ENSG00000173473,body mass index,EFO_0004340,0.5207082903867013,5.207197050974098,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,body mass index,EFO_0004340,0.5207082903867013,5.207197050974098,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,body mass index,EFO_0004340,0.5207082903867013,5.207197050974098,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,body mass index,EFO_0004340,0.5207082903867013,5.207197050974098,2,0.8,1.6,transcript,14017.0
KCNJ15,ENSG00000157551,lean body mass,EFO_0004995,0.5207010020060083,5.2070198541104835,1,0.4,0.4,transcript,40675.0
PCDH18,ENSG00000189184,diastolic blood pressure,EFO_0006336,0.5206621899969379,5.206699071628088,2,0.8,1.6,transcript,20733.0
BANK1,ENSG00000153064,lean body mass,EFO_0004995,0.5205440512664208,5.2056530004053,3,1.3,3.9000000000000004,transcript,18354.0
TTC39B,ENSG00000155158,choline measurement,EFO_0010116,0.5205018624430187,5.205172280155996,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
PPARG,ENSG00000132170,body weight,EFO_0004338,0.5204510788036318,5.230041782230541,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,body weight,EFO_0004338,0.5204510788036318,5.230041782230541,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,body weight,EFO_0004338,0.5204510788036318,5.230041782230541,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,body weight,EFO_0004338,0.5204510788036318,5.230041782230541,59,24.0,1416.0,transcript,55462.0
PLA2R1,ENSG00000153246,platelet count,EFO_0004309,0.5204082036249286,5.204161228488447,2,0.8,1.6,transcript,20204.0
TSPAN9,ENSG00000011105,lean body mass,EFO_0004995,0.5203934276004076,5.203969759646117,1,0.5,0.5,transcript,14091.0
BICC1,ENSG00000122870,glomerular filtration rate,OBA_0003747,0.520376349695788,5.20381159122264,1,0.4,0.4,transcript,8317.0
LPP,ENSG00000145012,monocyte count,EFO_0005091,0.5203433694456907,5.2035025946377695,4,1.6,6.4,transcript,92888.0
APOBEC3H,ENSG00000100298,lymphocyte count,EFO_0004587,0.5202425436458231,5.202502020796734,1,0.4,0.4,transcript,5223.0
ALG10B,ENSG00000175548,vitamin D measurement,EFO_0004631,0.5201846751645494,5.202552567568701,5,2.0,10.0,transcript,14168.0
FZD6,ENSG00000164930,nail disorder,MONDO_0002884,0.5201733793616432,5.201813685762035,2,0.8,1.6,transcript,20027.0
TTC39B,ENSG00000155158,apolipoprotein B measurement,EFO_0004615,0.5200776581143105,5.200930236868914,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
RASA2,ENSG00000155903,erythrocyte count,EFO_0004305,0.52006661371763,5.200713750555659,1,0.4,0.4,transcript,8401.0
PDE3A,ENSG00000172572,hypertension,EFO_0000537,0.5200506269125007,5.200531052272467,1,0.4,0.4,gene_variant,16140.0
RET,ENSG00000165731,neuroendocrine neoplasm,EFO_1001901,0.520019333913663,5.200203351401655,1,0.4,0.4,transcript,39951.0
PFAS,ENSG00000178921,dyskeratosis congenita,MONDO_0015780,0.5199677146803817,5.19970047313925,1,0.4,0.4,transcript,17148.0
TYR,ENSG00000077498,benign neoplasm of eye,MONDO_0021454,0.5199109021433648,5.199232845108734,1,0.5,0.5,transcript,4038.0
PARP1,ENSG00000143799,cancer,MONDO_0004992,0.5198691548345802,5.198697417923779,1,0.5,0.5,transcript,85185.0
PTPRJ,ENSG00000149177,triglyceride measurement,EFO_0004530,0.5198418449038896,5.198493637008821,2,0.8,1.6,transcript,21280.0
PDE3B,ENSG00000152270,phospholipids:total lipids ratio,EFO_0020946,0.519798082007139,5.198055649367059,2,0.8,1.6,transcript,21382.0
SH3TC2,ENSG00000169247,genetic disorder,EFO_0000508,0.5196962549452836,5.196966972861515,1,0.4,0.4,transcript,90428.0
GBE1,ENSG00000114480,body mass index,EFO_0004340,0.5196678576655003,5.196739455749122,1,0.5,0.5,transcript,8213.0
QKI,ENSG00000112531,body mass index,EFO_0004340,0.5196366393015295,5.196401965171189,2,0.8,1.6,transcript,44979.0
RIF1,ENSG00000080345,erythrocyte volume,OBA_0003460,0.5196267885270747,5.196329428587773,3,1.3,3.9000000000000004,transcript,63370.0
PDE3A,ENSG00000172572,heart failure,EFO_0003144,0.5196208438573835,5.196233221721295,1,0.4,0.4,gene_variant,16140.0
MEOX2,ENSG00000106511,heel bone mineral density,EFO_0009270,0.5196186338489476,5.19635504367716,1,0.4,0.4,transcript,2371.0
GLB1,ENSG00000170266,eosinophil count,EFO_0004842,0.5195339870607488,5.19537077868686,1,0.5,0.5,transcript,16177.0
PIGN,ENSG00000197563,genetic disorder,EFO_0000508,0.5194780301018574,5.194782840846247,1,0.4,0.4,transcript,157491.0
PDE3B,ENSG00000152270,total cholesterol measurement,EFO_0004574,0.5194297168991121,5.19437199828679,2,0.8,1.6,transcript,21382.0
BICC1,ENSG00000122870,systolic blood pressure,EFO_0006335,0.5193710929914873,5.1937590241796325,1,0.4,0.4,transcript,8317.0
ZNF682,ENSG00000197124,chylomicron amount,OBA_2050296,0.5193596249779763,5.193622223805736,1,0.5,0.5,transcript,19250.0
FRMD4B,ENSG00000114541,atrial fibrillation,EFO_0000275,0.5193086152198341,5.193162248460111,2,0.8,1.6,transcript,21026.0
SHH,ENSG00000164690,FEV/FVC ratio,EFO_0004713,0.5193037687092336,5.1930908361755135,1,0.4,0.4,transcript,7526.0
CDH23,ENSG00000107736,monocyte count,EFO_0005091,0.519276912861496,5.192776679317931,1,0.5,0.5,transcript,66219.0
RASA2,ENSG00000155903,erythrocyte volume,OBA_0003460,0.5191429000708532,5.1914766140878905,1,0.4,0.4,transcript,8401.0
LDLRAP1,ENSG00000157978,Abnormality of the cardiovascular system,HP_0001626,0.5190997382579157,5.191023296028237,1,0.4,0.4,transcript,15436.0
TTC39B,ENSG00000155158,free cholesterol to total lipids in medium HDL percentage ,EFO_0022282,0.519093976839649,5.1910934241222995,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
PDE11A,ENSG00000128655,Myopia,HP_0000545,0.5189670800926496,5.189734584063829,2,0.8,1.6,transcript,25085.0
LAMA1,ENSG00000101680,type 2 diabetes mellitus,MONDO_0005148,0.5188331837730756,5.188347732949475,1,0.5,0.5,transcript,31456.0
AFF1,ENSG00000172493,erythrocyte volume,OBA_0003460,0.5186762433464527,5.186772656061577,1,0.4,0.4,transcript,39129.0
MRPL35,ENSG00000132313,neurodegenerative disease,EFO_0005772,0.5186596093123226,5.186659909332543,1,0.4,0.4,transcript,6268.0
AHCTF1,ENSG00000153207,neurodegenerative disease,EFO_0005772,0.5186584828652006,5.186598095122329,1,0.5,0.5,transcript,37689.0
PRDM5,ENSG00000138738,neuroimaging measurement,EFO_0004346,0.5186535713291162,5.186616321886053,2,0.8,1.6,transcript,19849.0
LPP,ENSG00000145012,celiac disease,EFO_0001060,0.518642664862607,5.186495548806933,4,1.6,6.4,transcript,92888.0
PDE3B,ENSG00000152270,triglycerides to total lipids in medium HDL percentage ,EFO_0022333,0.5186276315282918,5.1863511445785875,2,0.8,1.6,transcript,21382.0
PAG1,ENSG00000076641,total blood protein measurement,EFO_0004536,0.5185878747974924,5.186008839852312,2,0.8,1.6,transcript,12299.0
PLCL2,ENSG00000154822,intelligence,EFO_0004337,0.5185387055150221,5.18552560728046,2,0.8,1.6,transcript,11548.0
TSPAN9,ENSG00000011105,neutrophil count,EFO_0004833,0.5184854261353771,5.184889744995811,1,0.5,0.5,transcript,14091.0
DPYD,ENSG00000188641,schizophrenia,MONDO_0005090,0.5184383867945326,5.184442088718498,1,0.5,0.5,transcript,8588.0
FIGN,ENSG00000182263,glomerular filtration rate,OBA_0003747,0.5184227888779895,5.184264643351246,1,0.4,0.4,transcript,10883.0
PLXNA4,ENSG00000221866,neurodegenerative disease,EFO_0005772,0.5183710016547839,5.183722263945267,1,0.4,0.4,transcript,32660.0
C4orf33,ENSG00000151470,metabolite measurement,EFO_0004725,0.5183308913317894,5.183759966950991,4,1.6,6.4,transcript,14189.0
NAF1,ENSG00000145414,neurodegenerative disease,EFO_0005772,0.5182619984007901,5.182681934199947,1,0.5,0.5,transcript,8071.0
FYCO1,ENSG00000163820,aspartate aminotransferase measurement,EFO_0004736,0.5182162839864775,5.18218745070585,1,0.4,0.4,transcript,16253.0
FMN1,ENSG00000248905,cutaneous melanoma,EFO_0000389,0.5181643455562716,5.181679153115202,2,0.8,1.6,transcript,44821.0
ONECUT1,ENSG00000169856,body mass index,EFO_0004340,0.5181407717551502,5.18146056469115,1,0.4,0.4,transcript,7569.0
PRTG,ENSG00000166450,erythrocyte volume,OBA_0003460,0.5180635518170419,5.180853594254742,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
FBN1,ENSG00000166147,systolic blood pressure,EFO_0006335,0.518049701888929,5.180503684111824,1,0.4,0.4,transcript,60013.0
SLC35D3,ENSG00000182747,calcium measurement,EFO_0004838,0.5180278663106985,5.180449384404468,1,0.4,0.4,transcript,2343.0
RFX7,ENSG00000181827,erythrocyte volume,OBA_0003460,0.5179865241312488,5.179874833638626,1,0.4,0.4,transcript,41700.0
SP8,ENSG00000164651,prostate specific antigen amount,OBA_2050200,0.5179619923650288,5.17969483001733,1,0.4,0.4,transcript,5340.0
TBX5,ENSG00000089225,systolic blood pressure,EFO_0006335,0.517957651932388,5.1797018129808885,2,0.8,1.6,transcript,12770.0
NEBL,ENSG00000078114,pulse pressure measurement,EFO_0005763,0.5179555907632448,5.179563729451412,1,0.4,0.4,transcript,51139.0
EGFR,ENSG00000146648,squamous cell lung carcinoma,EFO_0000708,0.5179481262525537,5.1795185811802,2,0.8,1.6,transcript,42874.0
ZNF436,ENSG00000125945,serum creatinine amount,OBA_2050096,0.5178688095942425,5.178721737658153,1,0.4,0.4,transcript,11890.0
GJB2,ENSG00000165474,sensorineural hearing loss,EFO_1001176,0.5178133510740781,5.178220316296336,1,0.4,0.4,transcript,4608.0
SLC25A37,ENSG00000147454,blood sodium bicarbonate amount,OBA_2050094,0.517752581517754,5.177544985119073,1,0.4,0.4,transcript,20866.0
DPYD,ENSG00000188641,triglyceride measurement,EFO_0004530,0.517725811273572,5.177316333508892,1,0.5,0.5,transcript,8588.0
ANKH,ENSG00000154122,open-angle glaucoma,EFO_0004190,0.5176969751407613,5.177738194030564,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,open-angle glaucoma,EFO_0004190,0.5176969751407613,5.177738194030564,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,open-angle glaucoma,EFO_0004190,0.5176969751407613,5.177738194030564,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,open-angle glaucoma,EFO_0004190,0.5176969751407613,5.177738194030564,5,2.4,12.0,transcript,15616.0
TFEC,ENSG00000105967,platelet count,EFO_0004309,0.5176631213272876,5.176646910627872,1,0.4,0.4,transcript,25482.0
CEP85L,ENSG00000111860,Rare familial disorder with hypertrophic cardiomyopathy,Orphanet_99739,0.5176012227560559,5.176027630541036,1,0.4,0.4,transcript,25969.0
CD69,ENSG00000110848,lymphocyte count,EFO_0004587,0.5175323029660134,5.176167505381456,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
OTOGL,ENSG00000165899,vestibular disease,EFO_0009691,0.5175243844188049,5.175258702145972,1,0.5,0.5,transcript,33652.0
STXBP4,ENSG00000166263,neurodegenerative disease,EFO_0005772,0.5175084267734184,5.1754759791212335,5,2.0,10.0,transcript,25529.0
LRBA,ENSG00000198589,cystatin C measurement,EFO_0004617,0.5174469221958603,5.174473163466624,1,0.4,0.4,transcript,101484.0
PICALM,ENSG00000073921,platelet count,EFO_0004309,0.5173905806785377,5.17391907510395,1,0.4,0.4,transcript,30147.0
UBXN2A,ENSG00000173960,hemoglobin measurement,EFO_0004509,0.5173890636976594,5.174047854231187,2,0.8,1.6,transcript,10177.0
ALDOB,ENSG00000136872,genetic disorder,EFO_0000508,0.5173686450031355,5.173727862185823,1,0.4,0.4,transcript,9659.0
PEX2,ENSG00000164751,Zellweger spectrum disorders,MONDO_0019609,0.5173376001278429,5.173419827289166,1,0.4,0.4,transcript,9127.0
PHC1,ENSG00000111752,eosinophil count,EFO_0004842,0.5173038833519954,5.173057984004461,1,0.5,0.5,transcript,26109.0
LARP4B,ENSG00000107929,eosinophil count,EFO_0004842,0.5172795046995357,5.17280605899844,1,0.5,0.5,transcript,45405.0
CDH23,ENSG00000107736,autosomal dominant nonsyndromic hearing loss,MONDO_0019587,0.5172372506231181,5.172380056934151,1,0.5,0.5,transcript,66219.0
PLEC,ENSG00000178209,platelet count,EFO_0004309,0.5172226478073135,5.172235542338779,2,0.9,1.8,transcript,198582.0
RASA2,ENSG00000155903,body weight,EFO_0004338,0.517186144391768,5.171909057297039,1,0.4,0.4,transcript,8401.0
TAF1B,ENSG00000115750,calcium measurement,EFO_0004838,0.5171313297412783,5.171367698457283,1,0.5,0.5,transcript,9191.0
PDE3B,ENSG00000152270,lipid measurement,EFO_0004529,0.5170947601736356,5.171022431032026,2,0.8,1.6,transcript,21382.0
ITGB8,ENSG00000105855,BMI-adjusted waist circumference,EFO_0007789,0.5170378473728127,5.170549000941428,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
TMEM106B,ENSG00000106460,triglyceride measurement,EFO_0004530,0.5169410339968102,5.16944321645525,2,0.8,1.6,transcript,48667.0
NAA30,ENSG00000139977,neurodegenerative disease,EFO_0005772,0.5169404563588824,5.169434318851786,1,0.4,0.4,transcript,13443.0
ROCK2,ENSG00000134318,ocular hypertension,EFO_1001069,0.5169198419410048,5.169209413011772,1,0.5,0.5,transcript,45481.0
PDE11A,ENSG00000128655,sitting height measurement,EFO_0011011,0.5168810258750706,5.168874041888039,2,0.8,1.6,transcript,25085.0
SEMA3C,ENSG00000075223,BMI-adjusted waist-hip ratio,EFO_0007788,0.5168712774205851,5.168746492489591,1,0.4,0.4,transcript,11863.0
PTAR1,ENSG00000188647,cognitive function measurement,EFO_0008354,0.5168529605028813,5.168597298377942,2,0.8,1.6,transcript,23636.0
PTAR1,ENSG00000188647,major depressive disorder,MONDO_0002009,0.5168529605028813,5.168597298377942,2,0.8,1.6,transcript,23636.0
GPATCH2L,ENSG00000089916,hemoglobin measurement,EFO_0004509,0.5167793795736179,5.1679362680765095,4,1.6,6.4,transcript,44921.0
AKR1C1,ENSG00000187134,body weight,EFO_0004338,0.5167775669160579,5.167914860113167,2,0.8,1.6,transcript,11495.0
PDE1A,ENSG00000115252,metabolite measurement,EFO_0004725,0.5167472254366914,5.167598805497085,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
DCUN1D1,ENSG00000043093,neurodegenerative disease,EFO_0005772,0.5167404633857925,5.167428911595239,1,0.4,0.4,transcript,16476.0
PALM2AKAP2,ENSG00000157654,diastolic blood pressure,EFO_0006336,0.5167166098034363,5.1671740852548105,1,0.4,0.4,transcript,50080.0
LHFPL2,ENSG00000145685,systolic blood pressure,EFO_0006335,0.5166889398261879,5.166916290826085,1,0.4,0.4,transcript,14874.0
ROCK2,ENSG00000134318,open-angle glaucoma,EFO_0004190,0.516683871951088,5.166849713112604,1,0.5,0.5,transcript,45481.0
ZNF682,ENSG00000197124,total cholesterol measurement,EFO_0004574,0.5166064031042606,5.16609000506858,1,0.5,0.5,transcript,19250.0
ETV5,ENSG00000244405,lipid measurement,EFO_0004529,0.5165633830141229,5.16566600258553,1,0.4,0.4,transcript,12433.0
FNDC3B,ENSG00000075420,body weight,EFO_0004338,0.5165326325942162,5.165379943448278,2,0.8,1.6,transcript,29841.0
PDE1A,ENSG00000115252,systolic blood pressure,EFO_0006335,0.5165044722119192,5.1651712732493635,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
NLRP10,ENSG00000182261,atopic eczema,EFO_0000274,0.5164528674313863,5.164575408745455,1,0.4,0.4,transcript,8559.0
FIGN,ENSG00000182263,heart rate,OBA_1001087,0.5164039623481154,5.164076378052504,1,0.4,0.4,transcript,10883.0
ABCA13,ENSG00000179869,metabolite measurement,EFO_0004725,0.5163744268154739,5.16375460001406,1,0.5,0.5,transcript,48394.0
FGFR1OP2,ENSG00000111790,neurodegenerative disease,EFO_0005772,0.516363133987283,5.163667473567499,1,0.4,0.4,transcript,11070.0
MYO3A,ENSG00000095777,alkaline phosphatase measurement,EFO_0004533,0.5163548309973115,5.163572025763088,1,0.5,0.5,transcript,21083.0
TTC39B,ENSG00000155158,cholesteryl ester 22:1 measurement,EFO_0021442,0.5161601142188827,5.161754797914637,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
LPP,ENSG00000145012,respiratory system disease,EFO_0000684,0.5159971970387391,5.160040870568254,4,1.6,6.4,transcript,92888.0
PDE1A,ENSG00000115252,cystatin C measurement,EFO_0004617,0.5159949603074296,5.160076154204468,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
TTC39B,ENSG00000155158,cholesteryl ester 24:1 measurement,EFO_0021446,0.5159699282539163,5.159852938264973,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
NEK1,ENSG00000137601,orofaciodigital syndrome type II,MONDO_0009642,0.5159401710606811,5.159415970475086,2,0.8,1.6,transcript,112203.0
ARFIP1,ENSG00000164144,mean corpuscular hemoglobin concentration,EFO_0004528,0.515930233271087,5.159329385328211,1,0.4,0.4,transcript,14786.0
PPARG,ENSG00000132170,glucose measurement,EFO_0004468,0.5159281225635671,5.184812219829894,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,glucose measurement,EFO_0004468,0.5159281225635671,5.184812219829894,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,glucose measurement,EFO_0004468,0.5159281225635671,5.184812219829894,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,glucose measurement,EFO_0004468,0.5159281225635671,5.184812219829894,59,24.0,1416.0,gene_variant,55462.0
AFF1,ENSG00000172493,urate measurement,EFO_0004531,0.5158806890118595,5.158817112715645,1,0.4,0.4,transcript,39129.0
CEP68,ENSG00000011523,HbA1c measurement,EFO_0004541,0.5158306501808544,5.158343268917505,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,HbA1c measurement,EFO_0004541,0.5158306501808544,5.158343268917505,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,HbA1c measurement,EFO_0004541,0.5158306501808544,5.158343268917505,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,HbA1c measurement,EFO_0004541,0.5158306501808544,5.158343268917505,3,1.5,4.5,gene_variant,122392.0
RFX7,ENSG00000181827,prostate carcinoma,EFO_0001663,0.5158029297275284,5.158038889601423,1,0.4,0.4,transcript,41700.0
PLCL2,ENSG00000154822,rheumatoid arthritis,EFO_0000685,0.5157887717894041,5.15802627002428,2,0.8,1.6,transcript,11548.0
PPARG,ENSG00000132170,hemoglobin measurement,EFO_0004509,0.5157740716369987,5.1832717105642105,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,hemoglobin measurement,EFO_0004509,0.5157740716369987,5.1832717105642105,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,hemoglobin measurement,EFO_0004509,0.5157740716369987,5.1832717105642105,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,hemoglobin measurement,EFO_0004509,0.5157740716369987,5.1832717105642105,59,24.0,1416.0,transcript,55462.0
IL4R,ENSG00000077238,IGF-1 measurement,EFO_0004627,0.5157463133587722,5.157481697656966,1,0.4,0.4,transcript,21547.0
GRIA4,ENSG00000152578,Lennox-Gastaut syndrome,MONDO_0016532,0.5156905810464592,5.156915101986078,1,0.4,0.4,transcript,43050.0
KITLG,ENSG00000049130,testicular carcinoma,EFO_0005088,0.5156065053208551,5.156234409185405,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
GCH1,ENSG00000131979,Spastic paraplegia,HP_0001258,0.5155125667497862,5.155159431319926,1,0.4,0.4,transcript,11847.0
PDE1A,ENSG00000115252,urate measurement,EFO_0004531,0.5154336339848556,5.154462890978728,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
FGA,ENSG00000171560,stroke,EFO_0000712,0.5154097869516886,5.154166093975355,1,0.4,0.4,transcript,5863.0
CEP85L,ENSG00000111860,heart rate,OBA_1001087,0.5153822460300211,5.153837863280688,1,0.4,0.4,transcript,25969.0
CYTL1,ENSG00000170891,anthropometric measurement,EFO_0004302,0.5152923235785672,5.153142173935644,1,0.4,0.4,transcript,1827.0
GRB14,ENSG00000115290,BMI-adjusted waist-hip ratio,EFO_0007788,0.5152875970931078,5.152916338273897,1,0.4,0.4,transcript,9909.0
TTC39B,ENSG00000155158,platelet volume,OBA_0003277,0.5152346361719913,5.152500017445722,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
TYR,ENSG00000077498,skin disease,EFO_0000701,0.5152247325658702,5.1523711493337885,1,0.5,0.5,transcript,4038.0
PLCL2,ENSG00000154822,neuroticism measurement,EFO_0007660,0.5151727603898069,5.151866156028308,2,0.8,1.6,transcript,11548.0
PKHD1L1,ENSG00000205038,female infertility,EFO_0008560,0.5150940140462746,5.15095618667584,1,0.4,0.4,transcript,24928.0
ACVR1C,ENSG00000123612,eosinophil count,EFO_0004842,0.5150541786494385,5.150661100439202,2,0.8,1.6,transcript,13410.0
ADAMTS3,ENSG00000156140,free cholesterol measurement,EFO_0008591,0.5150508546939503,5.150557862683554,1,0.4,0.4,transcript,8111.0
PDE1A,ENSG00000115252,gout,EFO_0004274,0.5150120411577457,5.150246962707628,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
COL24A1,ENSG00000171502,intraocular pressure measurement,EFO_0004695,0.514924994734701,5.149274343541204,1,0.4,0.4,transcript,16396.0
LYPLAL1,ENSG00000143353,ethylmalonate measurement,EFO_0020009,0.5149094246707453,5.149122043016103,1,0.5,0.5,transcript,17988.0
PLXND1,ENSG00000004399,waist-hip ratio,EFO_0004343,0.5148379812788065,5.148403493758038,1,0.5,0.5,transcript,21114.0
CERKL,ENSG00000188452,Cone rod dystrophy,Orphanet_1872,0.5145966778030502,5.14598685190235,1,0.5,0.5,transcript,24908.0
TBX5,ENSG00000089225,atrial flutter,EFO_0003911,0.5144580038531559,5.144705332188567,2,0.8,1.6,transcript,12770.0
RCL1,ENSG00000120158,Red cell distribution width,EFO_0009188,0.5144546569162575,5.1445852426615595,1,0.4,0.4,transcript,10343.0
GAN,ENSG00000261609,genetic disorder,EFO_0000508,0.514425273995744,5.144263404064721,1,0.4,0.4,transcript,37509.0
FAT3,ENSG00000165323,brain attribute,OBA_2045210,0.5144247212789821,5.144255541785136,1,0.4,0.4,transcript,48025.0
QKI,ENSG00000112531,cataract,MONDO_0005129,0.5143789217316475,5.143824789472369,2,0.8,1.6,transcript,44979.0
SP8,ENSG00000164651,prostate carcinoma,EFO_0001663,0.5142941417185586,5.143016323552628,1,0.4,0.4,transcript,5340.0
FAM210A,ENSG00000177150,heel bone mineral density,EFO_0009270,0.5142921798376753,5.1429439443185085,1,0.4,0.4,transcript,18062.0
KCNQ1,ENSG00000053918,Seizure,HP_0001250,0.514280633900837,5.143000012346008,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
ZNF236,ENSG00000130856,neuroimaging measurement,EFO_0004346,0.5142574577653275,5.142633545712243,2,0.9,1.8,transcript,30525.0
ADK,ENSG00000156110,platelet count,EFO_0004309,0.5142266724022582,5.142285707459533,1,0.4,0.4,transcript,21071.0
IREB2,ENSG00000136381,"neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia",MONDO_0032758,0.514167564329084,5.141775499054736,2,0.9,1.8,transcript,18026.0
PLCL2,ENSG00000154822,hematocrit,EFO_0004348,0.5140947061221756,5.141085613351994,2,0.8,1.6,transcript,11548.0
ONECUT2,ENSG00000119547,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.5140789441683323,5.141951267409465,7,2.8000000000000003,19.6,transcript,16870.0
SLC30A8,ENSG00000164756,alanine measurement,EFO_0009765,0.5139905333041397,5.140215500725801,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,alanine measurement,EFO_0009765,0.5139905333041397,5.140215500725801,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,alanine measurement,EFO_0009765,0.5139905333041397,5.140215500725801,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,alanine measurement,EFO_0009765,0.5139905333041397,5.140215500725801,4,1.6,6.4,gene_variant,20634.0
CP,ENSG00000047457,Hermansky-Pudlak syndrome,MONDO_0019312,0.5138925533735783,5.138946591687265,1,0.5,0.5,transcript,23744.0
IQGAP2,ENSG00000145703,mean corpuscular hemoglobin,EFO_0004527,0.5138512399830909,5.138527070761927,1,0.5,0.5,transcript,34081.0
CBLB,ENSG00000114423,sex hormone-binding globulin measurement,EFO_0004696,0.5137915733519777,5.137924225187328,1,0.4,0.4,transcript,47105.0
PDE11A,ENSG00000128655,glomerular filtration rate,OBA_0003747,0.5136926626605275,5.136990409742608,2,0.8,1.6,transcript,25085.0
TYR,ENSG00000077498,actinic keratosis,EFO_0002496,0.5136145042022655,5.136268865697741,1,0.5,0.5,transcript,4038.0
CACNA1D,ENSG00000157388,blood sodium bicarbonate amount,OBA_2050094,0.5135744553654231,5.135748518918516,1,0.4,0.4,transcript,100876.0
CFHR4,ENSG00000134365,age-related macular degeneration,EFO_0001365,0.513568523372668,5.135725742517088,1,0.5,0.5,transcript,12343.0
FNDC3B,ENSG00000075420,body fat percentage,EFO_0007800,0.5134893424528041,5.134947042034157,2,0.8,1.6,transcript,29841.0
KCNQ1,ENSG00000053918,serum creatinine amount,OBA_2050096,0.5133758681830415,5.133952355168052,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
ZNF682,ENSG00000197124,esterified cholesterol measurement,EFO_0008589,0.5133490758449882,5.133516732475856,1,0.5,0.5,transcript,19250.0
CACNA1D,ENSG00000157388,Agents acting on the renin-angiotensin system use measurement,EFO_0009931,0.5133451511562975,5.13345547682726,1,0.4,0.4,transcript,100876.0
PALM2AKAP2,ENSG00000157654,lymphocyte count,EFO_0004587,0.5131635418399796,5.131643405620244,1,0.4,0.4,transcript,50080.0
TMEM106B,ENSG00000106460,neuroticism measurement,EFO_0007660,0.5131554253947009,5.131587130434157,2,0.8,1.6,transcript,48667.0
BPTF,ENSG00000171634,body weight,EFO_0004338,0.5130967838498175,5.13098746269481,2,0.8,1.6,transcript,81532.0
GFRAL,ENSG00000187871,bone tissue density,OBA_1000110,0.5129995830636773,5.130205145131802,1,0.4,0.4,transcript,1911.0
STARD13,ENSG00000133121,HbA1c measurement,EFO_0004541,0.5128836308883576,5.1288511253446645,1,0.4,0.4,transcript,26997.0
SYT13,ENSG00000019505,body mass index,EFO_0004340,0.5128451913333931,5.128667198586891,2,0.8,1.6,transcript,7432.0
BANK1,ENSG00000153064,total blood protein measurement,EFO_0004536,0.5128228373316369,5.128440861057461,3,1.3,3.9000000000000004,transcript,18354.0
BIRC6,ENSG00000115760,neurodegenerative disease,EFO_0005772,0.5128117563880494,5.128124746137447,1,0.5,0.5,transcript,69616.0
GRSF1,ENSG00000132463,neurodegenerative disease,EFO_0005772,0.5127889365318073,5.127980455554338,2,0.8,1.6,transcript,17565.0
UNC80,ENSG00000144406,metabolite measurement,EFO_0004725,0.5127839639202157,5.12784430120682,1,0.4,0.4,transcript,85800.0
PPFIBP2,ENSG00000166387,prostate carcinoma,EFO_0001663,0.5126918881972686,5.126932564858134,1,0.5,0.5,transcript,36542.0
ETV5,ENSG00000244405,serum alanine aminotransferase measurement,EFO_0004735,0.5126408059329359,5.12644023177366,1,0.4,0.4,transcript,12433.0
ACVR1C,ENSG00000123612,alkaline phosphatase measurement,EFO_0004533,0.5126081008849748,5.126200322794565,2,0.8,1.6,transcript,13410.0
LRBA,ENSG00000198589,glomerular filtration rate,OBA_0003747,0.5125718132773173,5.125722074281194,1,0.4,0.4,transcript,101484.0
SP4,ENSG00000105866,erythrocyte volume,OBA_0003460,0.5125123639261673,5.12514763158413,1,0.4,0.4,transcript,16672.0
SPAST,ENSG00000021574,Rare hereditary ataxia,Orphanet_183518,0.5123256073883665,5.123261250202009,1,0.4,0.4,transcript,77275.0
LHFPL2,ENSG00000145685,testosterone measurement,EFO_0004908,0.5123239098896964,5.12326599146117,1,0.4,0.4,transcript,14874.0
FAS,ENSG00000026103,lymphoma,EFO_0000574,0.5121873449715821,5.121875657940353,1,0.4,0.4,transcript,181141.0
KITLG,ENSG00000049130,autosomal dominant nonsyndromic hearing loss 69,MONDO_0014738,0.5121118389338336,5.121287745315191,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
STARD13,ENSG00000133121,erythrocyte count,EFO_0004305,0.5120862908115056,5.120877724576144,1,0.4,0.4,transcript,26997.0
AKAP6,ENSG00000151320,cognitive function measurement,EFO_0008354,0.511986739088383,5.12044217094248,7,2.8000000000000003,19.6,transcript,34100.0
TBX5,ENSG00000089225,PR interval,EFO_0004462,0.5117227442774012,5.1173527364310205,2,0.8,1.6,transcript,12770.0
ADAMTS3,ENSG00000156140,vitamin D measurement,EFO_0004631,0.5116993170120978,5.117042485865029,1,0.4,0.4,transcript,8111.0
SLC30A8,ENSG00000164756,glucose tolerance test,EFO_0004307,0.5116769399793116,5.1170795674775205,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,glucose tolerance test,EFO_0004307,0.5116769399793116,5.1170795674775205,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,glucose tolerance test,EFO_0004307,0.5116769399793116,5.1170795674775205,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,glucose tolerance test,EFO_0004307,0.5116769399793116,5.1170795674775205,4,1.6,6.4,gene_variant,20634.0
ALPK3,ENSG00000136383,cardiomyopathy,EFO_0000318,0.5116541102638811,5.116578398676107,1,0.4,0.4,transcript,10725.0
TMCC1,ENSG00000172765,monocyte count,EFO_0005091,0.5116530724762139,5.1165409262413535,1,0.4,0.4,transcript,39210.0
RSBN1L,ENSG00000187257,body weight,EFO_0004338,0.5115878135524966,5.116014852606056,2,0.8,1.6,transcript,11703.0
IL17A,ENSG00000112115,immune system disease,EFO_0000540,0.5115658272425814,5.115872061843237,1,0.4,0.4,transcript,1871.0
SLC7A2,ENSG00000003989,alanine measurement,EFO_0009765,0.5113493781977078,5.113614777598189,3,1.4,4.199999999999999,transcript,34712.0
SLC22A5,ENSG00000197375,carnitine measurement,EFO_0010469,0.5113319153218749,5.113324722155221,1,0.4,0.4,transcript,71827.0
SEMA3C,ENSG00000075223,neuroimaging measurement,EFO_0004346,0.5112469498769081,5.11250321705282,1,0.4,0.4,transcript,11863.0
GREM1,ENSG00000166923,Red cell distribution width,EFO_0009188,0.5111795020981481,5.111813245046359,1,0.4,0.4,transcript,21949.0
CBLB,ENSG00000114423,serum creatinine amount,OBA_2050096,0.5111443384281864,5.111451875949416,1,0.4,0.4,transcript,47105.0
RANBP17,ENSG00000204764,body mass index,EFO_0004340,0.5110755838886513,5.110765353181741,1,0.4,0.4,transcript,42042.0
CD86,ENSG00000114013,multiple sclerosis,MONDO_0005301,0.5110009589167441,5.110041423628245,1,0.4,0.4,transcript,12565.0
PKP2,ENSG00000057294,atrial fibrillation,EFO_0000275,0.5109844804573493,5.110000905941819,4,1.6,6.4,transcript,40999.0
TECRL,ENSG00000205678,heart rate,OBA_1001087,0.510920702813263,5.109609802802579,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
OXSR1,ENSG00000172939,Red cell distribution width,EFO_0009188,0.5109027239852102,5.109067816033884,1,0.4,0.4,transcript,9858.0
GRB14,ENSG00000115290,body mass index,EFO_0004340,0.510874431026769,5.10878467761051,1,0.4,0.4,transcript,9909.0
ANKH,ENSG00000154122,glaucoma,MONDO_0005041,0.5108288706071193,5.109057148694144,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,glaucoma,MONDO_0005041,0.5108288706071193,5.109057148694144,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,glaucoma,MONDO_0005041,0.5108288706071193,5.109057148694144,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,glaucoma,MONDO_0005041,0.5108288706071193,5.109057148694144,5,2.4,12.0,gene_variant,15616.0
VPS13A,ENSG00000197969,reticulocyte count,EFO_0007986,0.5106752737254764,5.10675948250358,1,0.4,0.4,transcript,59301.0
PDE3B,ENSG00000152270,cardiovascular disease,EFO_0000319,0.5106348826259786,5.106423655555455,2,0.8,1.6,transcript,21382.0
MTCH2,ENSG00000109919,body mass index,EFO_0004340,0.510560509135705,5.105664544389155,1,0.4,0.4,transcript,6728.0
BCAS3,ENSG00000141376,glomerular filtration rate,OBA_0003747,0.5104293561173338,5.104303960291492,1,0.5,0.5,transcript,48081.0
GFPT1,ENSG00000198380,congenital myasthenic syndrome,MONDO_0018940,0.51042344796053,5.104249583634299,1,0.4,0.4,transcript,26483.0
SP4,ENSG00000105866,erythrocyte count,EFO_0004305,0.5104217982221426,5.104241974543883,1,0.4,0.4,transcript,16672.0
PIP4K2A,ENSG00000150867,neurodegenerative disease,EFO_0005772,0.5103900105074125,5.10394355027886,1,0.4,0.4,transcript,9207.0
AOX1,ENSG00000138356,7-methylguanine measurement,EFO_0021123,0.5103366143807383,5.10339424553564,1,0.4,0.4,transcript,14234.0
TTC39B,ENSG00000155158,HDL particle size,OBA_2050115,0.5103315133757361,5.103468789483171,3,1.2000000000000002,3.6000000000000005,transcript,23429.0
NID2,ENSG00000087303,BMI-adjusted waist-hip ratio,EFO_0007788,0.5103282420367348,5.1033275548681605,1,0.5,0.5,transcript,11078.0
KITLG,ENSG00000049130,erythrocyte count,EFO_0004305,0.5102928247778925,5.10309760375578,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
HHLA2,ENSG00000114455,educational attainment,EFO_0011015,0.5102904249199121,5.102938053539598,1,0.5,0.5,transcript,14791.0
CDH23,ENSG00000107736,genetic disorder,EFO_0000508,0.5102319936824155,5.102327487527125,1,0.5,0.5,transcript,66219.0
FIGN,ENSG00000182263,mean arterial pressure,EFO_0006340,0.5102015196036709,5.102051950608058,1,0.4,0.4,transcript,10883.0
ZNF507,ENSG00000168813,neurodegenerative disease,EFO_0005772,0.5101790785489131,5.101805184337223,1,0.4,0.4,transcript,27780.0
ATP10D,ENSG00000145246,glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement,EFO_0800476,0.5101781948691174,5.101813771501765,1,0.5,0.5,transcript,15712.0
THEM4,ENSG00000159445,metabolite measurement,EFO_0004725,0.5101232411120669,5.101386761882775,2,0.8,1.6,transcript,10366.0
ATP10D,ENSG00000145246,glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) measurement,EFO_0800520,0.5101229187035204,5.1012610098457944,1,0.5,0.5,transcript,15712.0
SERPINB9,ENSG00000170542,platelet count,EFO_0004309,0.5100393136019467,5.100440851634401,1,0.4,0.4,transcript,8383.0
PRKCB,ENSG00000166501,lymphocyte count,EFO_0004587,0.5100219162092255,5.10024312853923,1,0.4,0.4,transcript,16690.0
NEDD4,ENSG00000069869,Keloid,EFO_0004212,0.5099791777937407,5.0998000878989735,1,0.4,0.4,transcript,48135.0
TNFRSF11A,ENSG00000141655,osteoporosis,EFO_0003882,0.5099364136721843,5.0994887279070165,2,0.8,1.6,transcript,12842.0
STXBP5,ENSG00000164506,neutrophil count,EFO_0004833,0.5099016433430869,5.099030263839327,2,0.9,1.8,transcript,130148.0
GHR,ENSG00000112964,short bowel syndrome,MONDO_0015183,0.5098764739658445,5.098773601175093,1,0.4,0.4,transcript,45139.0
MTR,ENSG00000116984,isolated spina bifida,MONDO_0019351,0.5097107967605969,5.097112380035784,1,0.4,0.4,transcript,90653.0
DPYD,ENSG00000188641,educational attainment,EFO_0011015,0.5096904679018375,5.096962899791547,1,0.5,0.5,transcript,8588.0
ST8SIA4,ENSG00000113532,HbA1c measurement,EFO_0004541,0.509674350590616,5.096786382956219,1,0.4,0.4,transcript,9329.0
SEMA6D,ENSG00000137872,attention deficit hyperactivity disorder,EFO_0003888,0.5096623471544376,5.096632898392039,1,0.5,0.5,transcript,53040.0
SHH,ENSG00000164690,cystatin C measurement,EFO_0004617,0.5096401793632741,5.096454942715919,1,0.4,0.4,transcript,7526.0
PEX7,ENSG00000112357,Joubert syndrome and related disorders,MONDO_0015369,0.5096360464747923,5.096403008887468,1,0.4,0.4,transcript,9402.0
FAS,ENSG00000026103,erythrocyte volume,OBA_0003460,0.5096037793900136,5.096040002124668,1,0.4,0.4,transcript,181141.0
ULK4,ENSG00000168038,hemoglobin measurement,EFO_0004509,0.5095474397559475,5.0955153576643335,1,0.5,0.5,transcript,12207.0
BICC1,ENSG00000122870,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5094849939659359,5.094898033924118,1,0.4,0.4,transcript,8317.0
SLC25A37,ENSG00000147454,platelet count,EFO_0004309,0.5094765909838671,5.094785079780203,1,0.4,0.4,transcript,20866.0
PALM2AKAP2,ENSG00000157654,triglyceride measurement,EFO_0004530,0.5094360674857209,5.094368662077657,1,0.4,0.4,transcript,50080.0
GHR,ENSG00000112964,appendicular lean mass,EFO_0004980,0.5094292811399527,5.094301672916175,1,0.4,0.4,transcript,45139.0
PPDPFL,ENSG00000168333,glutarylcarnitine (C5-DC) measurement,EFO_0800030,0.5093873248216734,5.094198649884417,2,0.8,1.6,transcript,4917.0
UGT2B15,ENSG00000196620,Red cell distribution width,EFO_0009188,0.5093432514293745,5.09436972141652,2,1.0,2.0,transcript,2134.0
GALNT3,ENSG00000115339,serum gamma-glutamyl transferase measurement,EFO_0004532,0.5092255481883736,5.092284389884025,1,0.4,0.4,transcript,13837.0
CBLB,ENSG00000114423,serum albumin amount,OBA_2050068,0.5092150745160897,5.092159236828448,1,0.4,0.4,transcript,47105.0
GALC,ENSG00000054983,genetic disorder,EFO_0000508,0.5091737792730024,5.091810685668521,2,0.8,1.6,transcript,21950.0
TRIT1,ENSG00000043514,neurodegenerative disease,EFO_0005772,0.5091720777419477,5.09173598018638,1,0.4,0.4,transcript,26311.0
RTKN2,ENSG00000182010,hypothyroidism,EFO_0004705,0.5091635240311454,5.091670498134284,1,0.4,0.4,transcript,11345.0
FNDC3B,ENSG00000075420,glaucoma,MONDO_0005041,0.5091629736936425,5.091683354442541,2,0.8,1.6,transcript,29841.0
LRRC7,ENSG00000033122,lymphocyte count,EFO_0004587,0.509111498602131,5.09117908972686,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
HECW2,ENSG00000138411,genetic disorder,EFO_0000508,0.5089732999087501,5.089738815238953,1,0.4,0.4,transcript,68774.0
ELAPOR1,ENSG00000116299,prostate specific antigen amount,OBA_2050200,0.5089287454839772,5.089300548129461,1,0.4,0.4,transcript,30550.0
AFF1,ENSG00000172493,low density lipoprotein cholesterol measurement,EFO_0004611,0.5089181806195858,5.089192028792909,1,0.4,0.4,transcript,39129.0
UNC80,ENSG00000144406,glycine measurement,EFO_0009767,0.5088296019660902,5.088300681665564,1,0.4,0.4,transcript,85800.0
FNDC3B,ENSG00000075420,central corneal thickness,EFO_0005213,0.5088249667009384,5.0883032845155,2,0.8,1.6,transcript,29841.0
AFF1,ENSG00000172493,platelet volume,OBA_0003277,0.5088057511380965,5.088067733978015,1,0.4,0.4,transcript,39129.0
KRT74,ENSG00000170484,"ectodermal dysplasia 7, hair/nail type",MONDO_0013975,0.5087882666159393,5.087946686645949,1,0.4,0.4,transcript,6248.0
ATP5F1A,ENSG00000152234,mitochondrial complex V (ATP synthase) deficiency nuclear type 4B,MONDO_0014091,0.5087882666159393,5.08789646687703,1,0.4,0.4,transcript,28984.0
SLC30A8,ENSG00000164756,chloride measurement,EFO_0009284,0.508732572705504,5.087635894739444,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,chloride measurement,EFO_0009284,0.508732572705504,5.087635894739444,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,chloride measurement,EFO_0009284,0.508732572705504,5.087635894739444,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,chloride measurement,EFO_0009284,0.508732572705504,5.087635894739444,4,1.6,6.4,gene_variant,20634.0
ENPEP,ENSG00000138792,pulse pressure measurement,EFO_0005763,0.5087222700144048,5.087265099974449,1,0.4,0.4,transcript,9434.0
C4orf33,ENSG00000151470,X-26054 measurement,EFO_0800939,0.5087174722040733,5.087625775673828,4,1.6,6.4,transcript,14189.0
NEK7,ENSG00000151414,C-reactive protein measurement,EFO_0004458,0.5086753292300596,5.086798556530538,1,0.4,0.4,transcript,8837.0
ATP10D,ENSG00000145246,"glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement",EFO_0800551,0.5085162456390342,5.085194279200932,1,0.5,0.5,transcript,15712.0
AFF1,ENSG00000172493,cholesteryl ester measurement,EFO_0010351,0.5084979825705824,5.084990048302875,1,0.4,0.4,transcript,39129.0
RAD23B,ENSG00000119318,platelet volume,OBA_0003277,0.5083939536502455,5.08397981036472,1,0.4,0.4,transcript,9932.0
EXO1,ENSG00000174371,age at menopause,EFO_0004704,0.5082897504516223,5.0830269375993185,2,1.0,2.0,transcript,15452.0
CEP85L,ENSG00000111860,cardiomyopathy,EFO_0000318,0.5082675150110494,5.082690553090971,1,0.4,0.4,transcript,25969.0
BMPR2,ENSG00000204217,Pulmonary arterial hypertension associated with congenital heart disease,EFO_0009054,0.5082504091036433,5.0825218624954696,1,0.4,0.4,transcript,22508.0
RCOR3,ENSG00000117625,glomerular filtration rate,OBA_0003747,0.5081885058999778,5.081949414240707,2,0.8,1.6,transcript,24862.0
TYR,ENSG00000077498,temperature-sensitive oculocutaneous albinism type 1,MONDO_0018137,0.5081723001914649,5.081846825589735,1,0.5,0.5,transcript,4038.0
GBE1,ENSG00000114480,"glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form",MONDO_0017700,0.5081723001914649,5.081783881008767,1,0.5,0.5,transcript,8213.0
GBE1,ENSG00000114480,"glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form",MONDO_0017697,0.5081723001914649,5.081783881008767,1,0.5,0.5,transcript,8213.0
GBE1,ENSG00000114480,"glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form",MONDO_0017699,0.5081723001914649,5.081783881008767,1,0.5,0.5,transcript,8213.0
AKAP10,ENSG00000108599,platelet count,EFO_0004309,0.5081047655755395,5.081082836054427,1,0.4,0.4,transcript,11370.0
MCL1,ENSG00000143384,vital capacity,EFO_0004312,0.5080846868724879,5.080863638103993,1,0.4,0.4,transcript,23853.0
TLK1,ENSG00000198586,neurodegenerative disease,EFO_0005772,0.5080288168190298,5.080302063351308,1,0.4,0.4,transcript,28787.0
ITGB8,ENSG00000105855,platelet count,EFO_0004309,0.5080129456835449,5.08029998404875,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
SNX13,ENSG00000071189,phospholipids:total lipids ratio,EFO_0020946,0.5079767233171404,5.0797795583085215,1,0.4,0.4,transcript,32454.0
SLC22A5,ENSG00000197375,genetic disorder,EFO_0000508,0.5078834943218679,5.078840512155151,1,0.4,0.4,transcript,71827.0
STXBP5,ENSG00000164506,von Willebrand factor quality,OBA_1000199,0.5078589124718933,5.0786029551273915,2,0.9,1.8,transcript,130148.0
SLC25A37,ENSG00000147454,chloride measurement,EFO_0009284,0.5078052977678951,5.078072147620483,1,0.4,0.4,transcript,20866.0
FAM76B,ENSG00000077458,high density lipoprotein cholesterol measurement,EFO_0004612,0.5077559561802961,5.077581257306568,1,0.4,0.4,transcript,18437.0
RSBN1L,ENSG00000187257,body mass index,EFO_0004340,0.507751728174108,5.07765399882217,2,0.8,1.6,transcript,11703.0
CR2,ENSG00000117322,systemic lupus erythematosus,MONDO_0007915,0.5076980694108422,5.076999020035026,1,0.4,0.4,transcript,21827.0
TSPAN9,ENSG00000011105,platelet component distribution width,EFO_0007984,0.5076942776788776,5.076978260430817,1,0.5,0.5,transcript,14091.0
PKN2,ENSG00000065243,serum alanine aminotransferase measurement,EFO_0004735,0.5076537477854042,5.076568289747432,1,0.4,0.4,transcript,12982.0
PTK2,ENSG00000169398,neuroimaging measurement,EFO_0004346,0.5076226711242358,5.0762315534470135,1,0.4,0.4,transcript,82607.0
DENND1B,ENSG00000213047,psoriasis,EFO_0000676,0.5075680072274673,5.076116829786903,5,2.0,10.0,transcript,22896.0
RCL1,ENSG00000120158,IGF-1 measurement,EFO_0004627,0.50753580378062,5.075396711305185,1,0.4,0.4,transcript,10343.0
TYR,ENSG00000077498,Abnormality of the skin,HP_0000951,0.507513006604888,5.0752538897239665,1,0.5,0.5,transcript,4038.0
PLXND1,ENSG00000004399,type 2 diabetes mellitus,MONDO_0005148,0.5074986185123623,5.075009866093596,1,0.5,0.5,transcript,21114.0
ZNF436,ENSG00000125945,glomerular filtration rate,OBA_0003747,0.5073769588164972,5.0738032298807,1,0.4,0.4,transcript,11890.0
KLHL3,ENSG00000146021,potassium measurement,EFO_0009283,0.5072952468896114,5.072999779579457,2,0.8,1.6,transcript,33819.0
ARAP1,ENSG00000186635,diabetes mellitus,EFO_0000400,0.5072741409991357,5.072750419609124,1,0.4,0.4,transcript,44397.0
GRB14,ENSG00000115290,low density lipoprotein cholesterol measurement,EFO_0004611,0.5071627827354745,5.0716681946975655,1,0.4,0.4,transcript,9909.0
PPARG,ENSG00000132170,erythrocyte count,EFO_0004305,0.5070975210241585,5.096506204435808,59,24.0,1416.0,gene_variant,55462.0
PPARG,ENSG00000132170,erythrocyte count,EFO_0004305,0.5070975210241585,5.096506204435808,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,erythrocyte count,EFO_0004305,0.5070975210241585,5.096506204435808,59,24.0,1416.0,transcript,55462.0
PPARG,ENSG00000132170,erythrocyte count,EFO_0004305,0.5070975210241585,5.096506204435808,59,24.0,1416.0,gene_variant,55462.0
ID4,ENSG00000172201,BMI-adjusted waist circumference,EFO_0007789,0.5070731718162067,5.071144834609266,2,0.8,1.6,transcript,3873.0
FAM8A1,ENSG00000137414,skin disease,EFO_0000701,0.5070601362232601,5.070620604102911,1,0.4,0.4,transcript,20788.0
FAM8A1,ENSG00000137414,neutrophil count,EFO_0004833,0.5070601362232601,5.070620604102911,1,0.4,0.4,transcript,20788.0
KIAA0586,ENSG00000100578,Joubert syndrome and related disorders,MONDO_0015369,0.507051031786532,5.070515968923764,1,0.5,0.5,transcript,88479.0
NRK,ENSG00000123572,sitting height measurement,EFO_0011011,0.5069950407532573,5.0699756250335195,1,0.4,0.4,transcript,15862.0
ETV5,ENSG00000244405,Abnormality of the skeletal system,HP_0000924,0.5069350063848173,5.0693822362924745,1,0.4,0.4,transcript,12433.0
IMPG2,ENSG00000081148,autosomal recessive retinitis pigmentosa,EFO_0020026,0.5069349723984921,5.0695652412263,2,0.9,1.8,transcript,8352.0
GHR,ENSG00000112964,pituitary gland disease,EFO_0009607,0.506889036807143,5.068899229588079,1,0.4,0.4,transcript,45139.0
ASPM,ENSG00000066279,macular degeneration,EFO_0009606,0.5068591656771502,5.068626655118802,2,0.9,1.8,transcript,51431.0
PPDPFL,ENSG00000168333,monocyte count,EFO_0005091,0.5067868922027118,5.068194323694801,2,0.8,1.6,transcript,4917.0
KIAA0586,ENSG00000100578,genetic disorder,EFO_0000508,0.5067802144947494,5.067807796005938,1,0.5,0.5,transcript,88479.0
RASA2,ENSG00000155903,mean corpuscular hemoglobin concentration,EFO_0004528,0.5067706490340128,5.067754103719487,1,0.4,0.4,transcript,8401.0
HTR2C,ENSG00000147246,mental or behavioural disorder,EFO_0000677,0.5067668617698207,5.06770804054769,1,0.5,0.5,transcript,12683.0
ENPEP,ENSG00000138792,Increased blood pressure,HP_0032263,0.5067634194539224,5.067676594369625,1,0.4,0.4,transcript,9434.0
PEAK1,ENSG00000173517,glucose measurement,EFO_0004468,0.5066965653856728,5.066972576307967,1,0.4,0.4,transcript,57783.0
FLRT2,ENSG00000185070,pulse pressure measurement,EFO_0005763,0.50666045006765,5.066940019446721,7,2.8000000000000003,19.6,transcript,58417.0
ADAMTS3,ENSG00000156140,triglyceride measurement,EFO_0004530,0.5066307629068314,5.066356944812365,1,0.4,0.4,transcript,8111.0
UGT2B15,ENSG00000196620,cortolone glucuronide (1) measurement,EFO_0800552,0.5065764422486161,5.066701629608936,2,1.0,2.0,transcript,2134.0
BPTF,ENSG00000171634,Global developmental delay,HP_0001263,0.5064941583314532,5.064961207511167,2,0.8,1.6,transcript,81532.0
SMAD2,ENSG00000175387,eosinophil count,EFO_0004842,0.5064876030762097,5.065369827817603,9,3.6,32.4,transcript,65614.0
APOBEC3H,ENSG00000100298,monocyte count,EFO_0005091,0.506480970477305,5.064886289111553,1,0.4,0.4,transcript,5223.0
SMAD2,ENSG00000175387,prostate carcinoma,EFO_0001663,0.5064487676728494,5.064981473784001,9,3.6,32.4,transcript,65614.0
ACVR1C,ENSG00000123612,type 2 diabetes mellitus,MONDO_0005148,0.5063918589249796,5.064037903194614,2,0.8,1.6,transcript,13410.0
C4orf33,ENSG00000151470,N-acetylgalactosamine measurement,EFO_0800149,0.5063861118661147,5.064312172294243,4,1.6,6.4,transcript,14189.0
AFF1,ENSG00000172493,lipid measurement,EFO_0004529,0.506309559439797,5.063105816995021,1,0.4,0.4,transcript,39129.0
PTPRJ,ENSG00000149177,eosinophil count,EFO_0004842,0.506294984491026,5.0630250328801845,2,0.8,1.6,transcript,21280.0
ATP12A,ENSG00000075673,systolic blood pressure,EFO_0006335,0.5062431169485372,5.062480321611201,1,0.4,0.4,transcript,8138.0
ATP10D,ENSG00000145246,glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement,EFO_0800275,0.506235819714602,5.06239001995661,1,0.5,0.5,transcript,15712.0
ETV5,ENSG00000244405,cholesteryl ester measurement,EFO_0010351,0.5061663181466156,5.061695353910458,1,0.4,0.4,transcript,12433.0
BPTF,ENSG00000171634,body mass index,EFO_0004340,0.5061481262642795,5.06150088683943,2,0.8,1.6,transcript,81532.0
MYO5A,ENSG00000197535,Griscelli syndrome type 3,MONDO_0012220,0.5060986982109755,5.060989021770967,1,0.4,0.4,transcript,196111.0
PDE3B,ENSG00000152270,waist-hip ratio,EFO_0004343,0.5060757434592813,5.060832263888482,2,0.8,1.6,transcript,21382.0
PKN2,ENSG00000065243,aspartate aminotransferase measurement,EFO_0004736,0.5060612246820956,5.060643058714346,1,0.4,0.4,transcript,12982.0
CYSLTR1,ENSG00000173198,"Rhinitis, Allergic, Perennial",EFO_1001417,0.50602705045956,5.060460641256325,2,0.8,1.6,transcript,8415.0
SLC15A5,ENSG00000188991,body mass index,EFO_0004340,0.50599492762424,5.061180887600594,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
TBX5,ENSG00000089225,QRS duration,OBA_1001086,0.5059485703606961,5.059610997263969,2,0.8,1.6,transcript,12770.0
REEP3,ENSG00000165476,alkaline phosphatase measurement,EFO_0004533,0.5059399493796042,5.059469277466662,1,0.4,0.4,transcript,5732.0
MACF1,ENSG00000127603,neutrophil count,EFO_0004833,0.5059041988173488,5.059047315025818,2,0.8,1.6,gene_variant,300365.0
RIF1,ENSG00000080345,glomerular filtration rate,OBA_0003747,0.5058638609611362,5.058700152928389,3,1.3,3.9000000000000004,transcript,63370.0
OTULIN,ENSG00000154124,craniometaphyseal dysplasia,MONDO_0015465,0.5058445561387868,5.058464795856034,1,0.4,0.4,transcript,20796.0
BPTF,ENSG00000171634,Expressive language delay,HP_0002474,0.5057601316756211,5.057620940952845,2,0.8,1.6,transcript,81532.0
ABCA10,ENSG00000154263,total cholesterol measurement,EFO_0004574,0.505705250625115,5.057152442403053,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
EXO1,ENSG00000174371,mean corpuscular hemoglobin,EFO_0004527,0.5056315667364669,5.056445100447765,2,1.0,2.0,transcript,15452.0
LTBP1,ENSG00000049323,BMI-adjusted hip circumference,EFO_0008039,0.5055735149023377,5.05574780845307,1,0.4,0.4,transcript,31597.0
CYSLTR1,ENSG00000173198,Airway obstruction,HP_0006536,0.5055339106732991,5.055529243393717,2,0.8,1.6,transcript,8415.0
SV2C,ENSG00000122012,platelet volume,OBA_0003277,0.5055133127859148,5.055161156728884,1,0.4,0.4,transcript,14271.0
FAM76B,ENSG00000077458,sex hormone-binding globulin measurement,EFO_0004696,0.505498542793431,5.055007123437917,1,0.4,0.4,transcript,18437.0
BMERB1,ENSG00000166780,lipid measurement,EFO_0004529,0.5054297162908018,5.05433343750673,1,0.4,0.4,transcript,11027.0
BPTF,ENSG00000171634,Secondary microcephaly,HP_0005484,0.5053905518209364,5.0539251424059985,2,0.8,1.6,transcript,81532.0
TMEM106B,ENSG00000106460,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.505337845187955,5.053411328366698,2,0.8,1.6,transcript,48667.0
VPS13A,ENSG00000197969,HbA1c measurement,EFO_0004541,0.5052971182289531,5.052977927538346,1,0.4,0.4,transcript,59301.0
DNAJC21,ENSG00000168724,3-aminoisobutyrate measurement,EFO_0010980,0.5052537103527204,5.052546126558491,1,0.4,0.4,transcript,44331.0
ABCA10,ENSG00000154263,low density lipoprotein cholesterol measurement,EFO_0004611,0.5052183689315255,5.052283625467158,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
SLC22A2,ENSG00000112499,free cholesterol:total lipids ratio,EFO_0020945,0.5052109093635391,5.052148815581766,1,0.4,0.4,transcript,10070.0
SENP6,ENSG00000112701,neurodegenerative disease,EFO_0005772,0.5052081981160464,5.052510998321151,5,2.2,11.0,transcript,25640.0
SLC30A8,ENSG00000164756,body mass index,EFO_0004340,0.5051739030221825,5.0520491979062285,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,body mass index,EFO_0004340,0.5051739030221825,5.0520491979062285,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,body mass index,EFO_0004340,0.5051739030221825,5.0520491979062285,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,body mass index,EFO_0004340,0.5051739030221825,5.0520491979062285,4,1.6,6.4,gene_variant,20634.0
GALC,ENSG00000054983,basophil count,EFO_0005090,0.5051378296387447,5.0514511893259435,2,0.8,1.6,transcript,21950.0
FBN1,ENSG00000166147,Myopia,HP_0000545,0.5051246585371979,5.051253250594514,1,0.4,0.4,transcript,60013.0
ZNF236,ENSG00000130856,monocyte count,EFO_0005091,0.5051179264079338,5.0512382321383065,2,0.9,1.8,transcript,30525.0
EVI5,ENSG00000067208,neutrophil count,EFO_0004833,0.505088082113835,5.050886477086994,1,0.4,0.4,transcript,70722.0
NEBL,ENSG00000078114,taste liking measurement,EFO_0010155,0.5050855139312814,5.050862961131778,1,0.4,0.4,transcript,51139.0
PLCL1,ENSG00000115896,body mass index,EFO_0004340,0.5050791605191386,5.050881115680896,2,0.8,1.6,transcript,17875.0
ADAMTS3,ENSG00000156140,phospholipids:total lipids ratio,EFO_0020946,0.5050648399753156,5.050697715497207,1,0.4,0.4,transcript,8111.0
AKAP11,ENSG00000023516,eosinophil count,EFO_0004842,0.5050441177057049,5.050841177057049,1,0.4,0.4,transcript,1000.0
YEATS2,ENSG00000163872,systolic blood pressure,EFO_0006335,0.5049771031848572,5.04980477231689,1,0.5,0.5,transcript,14819.0
FBN1,ENSG00000166147,heart valve disease,EFO_0009551,0.5049617347115586,5.04962401233812,1,0.4,0.4,transcript,60013.0
PRTG,ENSG00000166450,Dupuytren Contracture,EFO_0004229,0.5049520257979943,5.049738334064266,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
FAT1,ENSG00000083857,cervical squamous cell carcinoma,EFO_1000172,0.5048078583124891,5.04809977854668,1,0.5,0.5,transcript,23590.0
STARD13,ENSG00000133121,brain aneurysm,EFO_0003870,0.504766563068767,5.047680447148758,1,0.4,0.4,transcript,26997.0
MED10,ENSG00000133398,neurodegenerative disease,EFO_0005772,0.5046844182110037,5.0469937707413015,1,0.4,0.4,transcript,2674.0
BICC1,ENSG00000122870,pulse pressure measurement,EFO_0005763,0.5046418599871793,5.0464666941365515,1,0.4,0.4,transcript,8317.0
CYP24A1,ENSG00000019186,"hypercalcemia, infantile",MONDO_0000212,0.5045993766886447,5.046183971356252,2,0.8,1.6,transcript,8412.0
TRDN,ENSG00000186439,growth differentiation factor 15 amount,OBA_2050135,0.5045156178006891,5.045175381448148,1,0.5,0.5,transcript,26037.0
GRB14,ENSG00000115290,diabetes mellitus,EFO_0000400,0.5044622973938584,5.044663341281403,1,0.4,0.4,transcript,9909.0
PPDPFL,ENSG00000168333,metabolite measurement,EFO_0004725,0.5044562874820129,5.044888276487812,2,0.8,1.6,transcript,4917.0
LMO4,ENSG00000143013,heart rate,OBA_1001087,0.5043075934339906,5.043127414391386,1,0.4,0.4,transcript,7770.0
SECISBP2L,ENSG00000138593,diastolic blood pressure,EFO_0006336,0.504290140765924,5.042920491628706,1,0.4,0.4,transcript,20960.0
GRB14,ENSG00000115290,apolipoprotein A 1 measurement,EFO_0004614,0.5041820104408687,5.041860471751507,1,0.4,0.4,transcript,9909.0
SLC22A2,ENSG00000112499,low density lipoprotein cholesterol measurement,EFO_0004611,0.5041582646855481,5.041622368801857,1,0.4,0.4,transcript,10070.0
FGA,ENSG00000171560,hypertrophic cardiomyopathy,EFO_0000538,0.5041479862182315,5.041548086640784,1,0.4,0.4,transcript,5863.0
FAT4,ENSG00000196159,Periventricular heterotopia,HP_0007165,0.5040966556828587,5.040975266871266,1,0.4,0.4,transcript,45924.0
DOK5,ENSG00000101134,erythrocyte volume,OBA_0003460,0.5040924791954209,5.041012626824653,1,0.4,0.4,transcript,4554.0
SLC30A8,ENSG00000164756,blood urea nitrogen measurement,EFO_0004741,0.5040567288621169,5.040877456305573,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,blood urea nitrogen measurement,EFO_0004741,0.5040567288621169,5.040877456305573,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,blood urea nitrogen measurement,EFO_0004741,0.5040567288621169,5.040877456305573,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,blood urea nitrogen measurement,EFO_0004741,0.5040567288621169,5.040877456305573,4,1.6,6.4,transcript,20634.0
DPYD,ENSG00000188641,glomerular filtration rate,OBA_0003747,0.5040051833271476,5.040110054044648,1,0.5,0.5,transcript,8588.0
FBXO22,ENSG00000167196,blood urea nitrogen measurement,EFO_0004741,0.5039956898703206,5.039978097494875,1,0.4,0.4,transcript,18869.0
DPYD,ENSG00000188641,self reported educational attainment,EFO_0004784,0.5039927323178051,5.0399855439512224,1,0.5,0.5,transcript,8588.0
ABCB5,ENSG00000004846,eosinophil count,EFO_0004842,0.503980232515114,5.039829237618341,1,0.4,0.4,transcript,14863.0
RIF1,ENSG00000080345,neurodegenerative disease,EFO_0005772,0.5038900380429348,5.038961923746374,3,1.3,3.9000000000000004,transcript,63370.0
SHH,ENSG00000164690,urate measurement,EFO_0004531,0.503810184895352,5.038154998036698,1,0.4,0.4,transcript,7526.0
ACTN2,ENSG00000077522,heart rate,OBA_1001087,0.5038088884622868,5.038105570234656,2,0.8,1.6,transcript,95891.0
CACNA1D,ENSG00000157388,diastolic blood pressure change measurement,EFO_0006945,0.5037878637410477,5.037882602674761,1,0.4,0.4,transcript,100876.0
ASPM,ENSG00000066279,Microcephaly,HP_0000252,0.5037655554204101,5.0376905525514015,2,0.9,1.8,transcript,51431.0
RPS6KA5,ENSG00000100784,body mass index,EFO_0004340,0.5036669326441612,5.036679191293145,1,0.4,0.4,transcript,40548.0
MAP3K7,ENSG00000135341,frontometaphyseal dysplasia,MONDO_0015942,0.5036467178750477,5.036556565473755,4,1.6,6.4,transcript,71599.0
KCNJ15,ENSG00000157551,monocyte count,EFO_0005091,0.5036435310845512,5.036445144895912,1,0.4,0.4,transcript,40675.0
ADAMTS3,ENSG00000156140,cholesteryl esters:total lipids ratio,EFO_0020944,0.5035456552320444,5.0355058680644955,1,0.4,0.4,transcript,8111.0
GPR180,ENSG00000152749,phospholipids:total lipids ratio,EFO_0020946,0.5035122847824158,5.035167872587778,1,0.4,0.4,transcript,8884.0
ARHGAP29,ENSG00000137962,Cleft palate,HP_0000175,0.5033930929140988,5.033951154860012,1,0.5,0.5,transcript,24721.0
PF4V1,ENSG00000109272,protein measurement,EFO_0004747,0.50338302189889,5.034368576996975,1,0.4,0.4,transcript,743.0
CPPED1,ENSG00000103381,taste liking measurement,EFO_0010155,0.5033536278612724,5.033574007343152,1,0.4,0.4,transcript,10602.0
LHFPL2,ENSG00000145685,pulse pressure measurement,EFO_0005763,0.5033245604312083,5.033272496876289,1,0.4,0.4,transcript,14874.0
MAP4K3,ENSG00000011566,serum albumin amount,OBA_2050068,0.5032043132568291,5.032065940186036,1,0.4,0.4,transcript,17538.0
MAP2K6,ENSG00000108984,neurodegenerative disease,EFO_0005772,0.5031510086267872,5.031527388802694,1,0.4,0.4,transcript,23118.0
AKAP11,ENSG00000023516,Alzheimer disease,MONDO_0004975,0.5030645579618515,5.031045579618515,1,0.4,0.4,transcript,1000.0
AKAP11,ENSG00000023516,Parkinson disease,MONDO_0005180,0.5030534368197492,5.030934368197492,1,0.4,0.4,transcript,1000.0
IQGAP1,ENSG00000140575,Costello syndrome,MONDO_0009026,0.5030392466541774,5.030446564459004,2,0.8,1.6,transcript,29576.0
LRRK2,ENSG00000188906,Young adult-onset Parkinsonism,Orphanet_2828,0.5030392466541774,5.030411224357531,2,0.9,1.8,transcript,95960.0
AP1S2,ENSG00000182287,HIV infection,EFO_0000764,0.5030392466541774,5.0304132760309015,1,0.4,0.4,transcript,19222.0
TRMT6,ENSG00000089195,neurodegenerative disease,EFO_0005772,0.5030392466541774,5.030425947750445,1,0.4,0.4,transcript,11947.0
IQGAP1,ENSG00000140575,hypertrophic cardiomyopathy,EFO_0000538,0.5030392466541774,5.030446564459004,2,0.8,1.6,transcript,29576.0
SIX4,ENSG00000100625,neurodegenerative disease,EFO_0005772,0.5030392466541774,5.030432200325424,1,0.4,0.4,transcript,10067.0
PDE10A,ENSG00000112541,"striatal degeneration, autosomal dominant",MONDO_0000211,0.5030392466541774,5.030412178635691,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
BMPR2,ENSG00000204217,tibia fracture,EFO_0003944,0.5030392466541774,5.030410238000811,1,0.4,0.4,transcript,22508.0
HTR2C,ENSG00000147246,Muscle spasm,HP_0003394,0.5030392466541774,5.030431889391258,1,0.5,0.5,transcript,12683.0
FGA,ENSG00000171560,Costello syndrome,MONDO_0009026,0.5030392466541774,5.0304606910002425,1,0.4,0.4,transcript,5863.0
GHR,ENSG00000112964,HIV infection,EFO_0000764,0.5030129528493231,5.0301383900098795,1,0.4,0.4,transcript,45139.0
GRIN2B,ENSG00000273079,autism spectrum disorder,EFO_0003756,0.5029838279474792,5.029842549101733,1,0.4,0.4,transcript,93685.0
TMCC1,ENSG00000172765,eosinophil count,EFO_0004842,0.5029823291744089,5.029833493223303,1,0.4,0.4,transcript,39210.0
LHFPL2,ENSG00000145685,platelet count,EFO_0004309,0.5029696730679356,5.029723623243562,1,0.4,0.4,transcript,14874.0
RPS20,ENSG00000008988,Duchenne muscular dystrophy,MONDO_0010679,0.5029345600175246,5.029362809657671,1,0.4,0.4,transcript,23243.0
CCBE1,ENSG00000183287,mean corpuscular hemoglobin concentration,EFO_0004528,0.5028290690125466,5.028304480375759,1,0.4,0.4,transcript,29006.0
PRTG,ENSG00000166450,Keloid,EFO_0004212,0.5028136916170249,5.028354992254572,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
TBX5,ENSG00000089225,cardiac arrhythmia,EFO_0004269,0.5028044037054928,5.028169330711937,2,0.8,1.6,transcript,12770.0
EVI5,ENSG00000067208,eosinophil count,EFO_0004842,0.502737439030458,5.027380046253223,1,0.4,0.4,transcript,70722.0
CD2AP,ENSG00000198087,platelet count,EFO_0004309,0.5027036713640165,5.027088783413661,1,0.4,0.4,transcript,7682.0
AKAP11,ENSG00000023516,lysosomal storage disease,MONDO_0002561,0.5026949781071668,5.027349781071668,1,0.4,0.4,transcript,1000.0
AKAP11,ENSG00000023516,multiple sclerosis,MONDO_0005301,0.5026949781071668,5.027349781071668,1,0.4,0.4,transcript,1000.0
QSER1,ENSG00000060749,type 2 diabetes mellitus,MONDO_0005148,0.5026869203274625,5.026895878477356,1,0.5,0.5,transcript,18744.0
ADAMTS3,ENSG00000156140,free cholesterol:total lipids ratio,EFO_0020945,0.5025779555979378,5.025828871723429,1,0.4,0.4,transcript,8111.0
UGT2B15,ENSG00000196620,omega-3 polyunsaturated fatty acid measurement,EFO_0010119,0.5025457161123651,5.026394368246425,2,1.0,2.0,transcript,2134.0
POF1B,ENSG00000124429,primary ovarian insufficiency,EFO_0004266,0.5024479610847941,5.024565300650854,1,0.5,0.5,transcript,5835.0
TGFBR1,ENSG00000106799,IGF-1 measurement,EFO_0004627,0.5023064011535139,5.023068259127285,1,0.4,0.4,transcript,94171.0
SNX13,ENSG00000071189,low density lipoprotein cholesterol measurement,EFO_0004611,0.5022563345750545,5.022575670887662,1,0.4,0.4,transcript,32454.0
LINGO2,ENSG00000174482,body mass index,EFO_0004340,0.5022503243931993,5.022514962796436,1,0.4,0.4,transcript,34133.0
QKI,ENSG00000112531,body weight,EFO_0004338,0.5021845254256911,5.021880826412806,2,0.8,1.6,transcript,44979.0
UMPS,ENSG00000114491,cystatin C measurement,EFO_0004617,0.5021418122636961,5.021436978998627,1,0.4,0.4,transcript,21213.0
C12orf42,ENSG00000179088,hypothyroidism,EFO_0004705,0.5021190021075889,5.021225160579719,1,0.5,0.5,transcript,14229.0
STXBP5,ENSG00000164506,systolic blood pressure,EFO_0006335,0.5020987996736167,5.021001827144626,2,0.9,1.8,transcript,130148.0
TRIT1,ENSG00000043514,genetic disorder,EFO_0000508,0.5020844573510014,5.020859776276917,1,0.4,0.4,transcript,26311.0
ALDOB,ENSG00000136872,cystatin C measurement,EFO_0004617,0.5020492510887661,5.020533923042128,1,0.4,0.4,transcript,9659.0
RPS6KA5,ENSG00000100784,BMI-adjusted waist-hip ratio,EFO_0007788,0.5020402736938423,5.020412601789957,1,0.4,0.4,transcript,40548.0
PDCD5,ENSG00000105185,platelet count,EFO_0004309,0.5020350147646054,5.020428257390245,1,0.4,0.4,transcript,5121.0
DCDC2,ENSG00000146038,cystatin C measurement,EFO_0004617,0.5019790493006486,5.019836270072176,1,0.4,0.4,transcript,8738.0
GHR,ENSG00000112964,growth hormone insensitivity syndrome,MONDO_0015892,0.5018937550341653,5.018946411858302,1,0.4,0.4,transcript,45139.0
DNAJC21,ENSG00000168724,neurodegenerative disease,EFO_0005772,0.5018491542473773,5.018500565505061,1,0.4,0.4,transcript,44331.0
LATS1,ENSG00000131023,brain volume,OBA_2050009,0.5018050031264875,5.01806738785604,1,0.4,0.4,transcript,23046.0
GLB1,ENSG00000170266,aspartate aminotransferase measurement,EFO_0004736,0.5017966298874393,5.0179972069537655,1,0.5,0.5,transcript,16177.0
GABRG1,ENSG00000163285,body mass index,EFO_0004340,0.5017300866184974,5.019431674116315,6,2.4000000000000004,14.400000000000002,transcript,6758.0
PPA2,ENSG00000138777,genetic disorder,EFO_0000508,0.5016469052223109,5.0164964584936635,1,0.5,0.5,transcript,18244.0
GPR180,ENSG00000152749,cholesterol:total lipids ratio,EFO_0020943,0.5016055588976467,5.016100613740087,1,0.4,0.4,transcript,8884.0
ASTN2,ENSG00000148219,glomerular filtration rate,OBA_0003747,0.5015698470396295,5.015757224802876,2,0.8,1.6,transcript,27232.0
UGT2B15,ENSG00000196620,X-12844 measurement,EFO_0021339,0.5014336938973918,5.015274146096692,2,1.0,2.0,transcript,2134.0
LPP,ENSG00000145012,glomerular filtration rate,OBA_0003747,0.5014048120824236,5.014117021005099,4,1.6,6.4,transcript,92888.0
BANK1,ENSG00000153064,level of serum globulin type protein,OBA_2045206,0.5012180320211262,5.012392807952355,3,1.3,3.9000000000000004,transcript,18354.0
SNX13,ENSG00000071189,erythrocyte count,EFO_0004305,0.5011725807290858,5.011738132427975,1,0.4,0.4,transcript,32454.0
PARP8,ENSG00000151883,HbA1c measurement,EFO_0004541,0.5011286495410165,5.0113335722336565,2,0.8,1.6,transcript,33987.0
IL4R,ENSG00000077238,Eczematoid dermatitis,HP_0000964,0.5010558443466703,5.010577007535947,1,0.4,0.4,transcript,21547.0
LPP,ENSG00000145012,metabolite measurement,EFO_0004725,0.5009440050562801,5.0095089507436645,4,1.6,6.4,transcript,92888.0
IL17A,ENSG00000112115,spondyloarthropathy,EFO_0000706,0.50084509958141,5.008664785231523,1,0.4,0.4,transcript,1871.0
FRS2,ENSG00000166225,neurodegenerative disease,EFO_0005772,0.500788083469234,5.007896943588478,1,0.4,0.4,transcript,24831.0
UGT2B15,ENSG00000196620,bilirubin measurement,EFO_0004570,0.5006986036194591,5.007923243317365,2,1.0,2.0,transcript,2134.0
SEMA6D,ENSG00000137872,neurodegenerative disease,EFO_0005772,0.5006163818393788,5.006173245241451,1,0.5,0.5,transcript,53040.0
IQGAP2,ENSG00000145703,erythrocyte volume,OBA_0003460,0.5006134450575885,5.006149121506903,1,0.5,0.5,transcript,34081.0
SFRP1,ENSG00000104332,erythrocyte volume,OBA_0003460,0.5006120993863025,5.006168972752314,1,0.4,0.4,transcript,8337.0
BCAS3,ENSG00000141376,serum creatinine amount,OBA_2050096,0.5005210888268627,5.0052212873867825,1,0.5,0.5,transcript,48081.0
RET,ENSG00000165731,colorectal neoplasm,EFO_0004142,0.5005134013725242,5.005144025990267,1,0.4,0.4,transcript,39951.0
DENND1B,ENSG00000213047,lymphocyte count,EFO_0004587,0.5005076784565806,5.0055135420780354,5,2.0,10.0,transcript,22896.0
KCNIP4,ENSG00000185774,educational attainment,EFO_0011015,0.5003997757258415,5.004130405243824,2,0.8,1.6,transcript,12062.0
PARP11,ENSG00000111224,calcium measurement,EFO_0004838,0.5003481775150113,5.003499723637953,1,0.4,0.4,transcript,22286.0
CEP85L,ENSG00000111860,atrial fibrillation,EFO_0000275,0.5002295552036761,5.002310955017237,1,0.4,0.4,transcript,25969.0
GSAP,ENSG00000186088,allergic rhinitis,EFO_0005854,0.5002229332098586,5.002254846207888,1,0.5,0.5,transcript,19597.0
GSAP,ENSG00000186088,body mass index,EFO_0004340,0.500168394360016,5.001709457709463,1,0.5,0.5,transcript,19597.0
MFAP3,ENSG00000037749,Red cell distribution width,EFO_0009188,0.5001381747817286,5.00139433751891,1,0.4,0.4,transcript,31772.0
ADAMTS3,ENSG00000156140,neuroimaging measurement,EFO_0004346,0.49993247390211093,4.99937405476516,1,0.4,0.4,transcript,8111.0
LONRF1,ENSG00000154359,high density lipoprotein cholesterol measurement,EFO_0004612,0.4999158729143115,4.999194022430332,1,0.5,0.5,transcript,14167.0
ITGA8,ENSG00000077943,neurodegenerative disease,EFO_0005772,0.4998977383118773,4.9994421391218715,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
C2CD4A,ENSG00000198535,body weight,EFO_0004338,0.49985125552980403,4.99862866560283,1,0.4,0.4,transcript,3445.0
RANBP17,ENSG00000204764,smoking status measurement,EFO_0006527,0.49982614239886564,4.998270938283885,1,0.4,0.4,transcript,42042.0
SNX13,ENSG00000071189,neutrophil count,EFO_0004833,0.4997398736866262,4.997411062003379,1,0.4,0.4,transcript,32454.0
CFAP299,ENSG00000197826,lean body mass,EFO_0004995,0.4996810529823557,4.996875667916314,1,0.5,0.5,transcript,7676.0
GABRA4,ENSG00000109158,major depressive disorder,MONDO_0002009,0.49961686759512547,4.996193826856688,1,0.4,0.4,transcript,15904.0
EXOC6,ENSG00000138190,high density lipoprotein cholesterol measurement,EFO_0004612,0.49954505850583264,4.995473202328874,1,0.5,0.5,transcript,22107.0
TMEM170B,ENSG00000205269,platelet count,EFO_0004309,0.49946493954446364,4.994694384759674,1,0.4,0.4,transcript,8891.0
HTR2C,ENSG00000147246,insomnia,EFO_0004698,0.4994377810606024,4.994417233455508,1,0.5,0.5,transcript,12683.0
ADK,ENSG00000156110,body mass index,EFO_0004340,0.49942517091642613,4.994270692601213,1,0.4,0.4,transcript,21071.0
ARAP1,ENSG00000186635,body weight,EFO_0004338,0.4994116794184998,4.994125803802765,1,0.4,0.4,transcript,44397.0
MRPL32,ENSG00000106591,neurodegenerative disease,EFO_0005772,0.49934218902811256,4.993505033078881,1,0.4,0.4,transcript,4811.0
POU2F1,ENSG00000143190,neutrophil count,EFO_0004833,0.4993289208845182,4.99330422090174,2,0.8,1.6,transcript,106581.0
ZNF682,ENSG00000197124,low density lipoprotein cholesterol measurement,EFO_0004611,0.4992514363974291,4.992540338000264,1,0.5,0.5,transcript,19250.0
BTAF1,ENSG00000095564,glomerular filtration rate,OBA_0003747,0.49924194914549314,4.992456235897335,1,0.4,0.4,transcript,10886.0
PTAR1,ENSG00000188647,neurodegenerative disease,EFO_0005772,0.4992249851109295,4.992317544458424,2,0.8,1.6,transcript,23636.0
SH3TC2,ENSG00000169247,peripheral neuropathy,EFO_0003100,0.4992095642369087,4.992100065777765,1,0.4,0.4,transcript,90428.0
GALNT3,ENSG00000115339,spine bone mineral density,EFO_0007701,0.4991526399806994,4.991555307807283,1,0.4,0.4,transcript,13837.0
CCDC66,ENSG00000180376,platelet volume,OBA_0003277,0.4991203558861659,4.991218788370355,1,0.5,0.5,transcript,32831.0
MYO1B,ENSG00000128641,alkaline phosphatase measurement,EFO_0004533,0.49905349500504803,4.990548358470968,1,0.4,0.4,transcript,29832.0
ACTN2,ENSG00000077522,neurodegenerative disease,EFO_0005772,0.49900833934686173,4.990100079080405,2,0.8,1.6,transcript,95891.0
COLEC10,ENSG00000184374,alkaline phosphatase measurement,EFO_0004533,0.49900412869569905,4.990146467077947,1,0.4,0.4,transcript,3803.0
DBR1,ENSG00000138231,xerosis and growth failure with immune and pulmonary dysfunction syndrome,MONDO_0957786,0.49893280382434735,4.989346469724444,1,0.4,0.4,transcript,21702.0
LSM11,ENSG00000155858,Aicardi-Goutieres syndrome 8,MONDO_0030361,0.49893280382434735,4.989388948857148,1,0.4,0.4,transcript,6567.0
UGT2B15,ENSG00000196620,apolipoprotein A 1 measurement,EFO_0004614,0.4989237909692664,4.990175116815439,2,1.0,2.0,transcript,2134.0
TMEM106B,ENSG00000106460,type 2 diabetes mellitus,MONDO_0005148,0.4989165830647151,4.989198707134299,2,0.8,1.6,transcript,48667.0
CAV2,ENSG00000105971,intraocular pressure measurement,EFO_0004695,0.4988748161182924,4.98877233474913,1,0.4,0.4,transcript,16547.0
SP4,ENSG00000105866,apolipoprotein B measurement,EFO_0004615,0.4988651276217888,4.988675268540345,1,0.4,0.4,transcript,16672.0
COL25A1,ENSG00000188517,high density lipoprotein cholesterol measurement,EFO_0004612,0.49886070576440456,4.98862201930479,1,0.4,0.4,transcript,26735.0
CYBRD1,ENSG00000071967,BMI-adjusted waist-hip ratio,EFO_0007788,0.49883868676619686,4.98842097698234,1,0.4,0.4,transcript,11727.0
NID2,ENSG00000087303,heart rate,OBA_1001087,0.4988362220087393,4.9884073545882055,1,0.5,0.5,transcript,11078.0
FAS,ENSG00000026103,eosinophil count,EFO_0004842,0.4987337966806211,4.987340175030743,1,0.4,0.4,transcript,181141.0
F13B,ENSG00000143278,systolic blood pressure,EFO_0006335,0.49871871188941,4.987295017038252,1,0.5,0.5,transcript,4634.0
KCNQ1,ENSG00000053918,glomerular filtration rate,OBA_0003747,0.49867597354893867,4.986953408827024,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
QKI,ENSG00000112531,neurodegenerative disease,EFO_0005772,0.4986520147405695,4.98655571956159,2,0.8,1.6,transcript,44979.0
ETV5,ENSG00000244405,waist circumference,OBA_1001085,0.49864176744528715,4.986449846897173,1,0.4,0.4,transcript,12433.0
CERKL,ENSG00000188452,autosomal recessive retinitis pigmentosa,EFO_0020026,0.498557317815409,4.9855932520259385,1,0.5,0.5,transcript,24908.0
PALM2AKAP2,ENSG00000157654,neutrophil count,EFO_0004833,0.49842163167291204,4.984224303949568,1,0.4,0.4,transcript,50080.0
ATG16L1,ENSG00000085978,inflammatory bowel disease,EFO_0003767,0.4984115854961518,4.984127846447563,1,0.4,0.4,transcript,33357.0
CD2AP,ENSG00000198087,Red cell distribution width,EFO_0009188,0.4982071748606499,4.982123818379995,1,0.4,0.4,transcript,7682.0
TSPAN3,ENSG00000140391,FEV/FVC ratio,EFO_0004713,0.49820254601031494,4.982047370707882,1,0.4,0.4,transcript,18256.0
FITM2,ENSG00000197296,heart rate,OBA_1001087,0.49818335586571777,4.981919989080686,1,0.4,0.4,transcript,4628.0
SPRED1,ENSG00000166068,monocyte count,EFO_0005091,0.49800676021064355,4.980112175317935,1,0.4,0.4,transcript,8974.0
FAM8A1,ENSG00000137414,monocyte count,EFO_0005091,0.49798628543752355,4.979882096245545,1,0.4,0.4,transcript,20788.0
SGCZ,ENSG00000185053,metabolite measurement,EFO_0004725,0.49796941443216036,4.979742853527644,1,0.4,0.4,transcript,8212.0
TNRC6B,ENSG00000100354,body mass index,EFO_0004340,0.497866962869191,4.978676080512937,1,0.4,0.4,transcript,61998.0
FARSB,ENSG00000116120,cirrhosis of liver,EFO_0001422,0.49781379815321886,4.978189001940351,1,0.4,0.4,transcript,7840.0
RNF144B,ENSG00000137393,"osteoarthritis, hand",EFO_1000789,0.49776458834460463,4.977718756464811,1,0.4,0.4,transcript,5489.0
PAQR3,ENSG00000163291,mean corpuscular hemoglobin concentration,EFO_0004528,0.49773563173989305,4.977371369139288,1,0.4,0.4,transcript,26575.0
MAP3K7,ENSG00000135341,eosinophil count,EFO_0004842,0.49773164686726074,4.977405855395886,4,1.6,6.4,transcript,71599.0
BTC,ENSG00000174808,serum albumin amount,OBA_2050068,0.49771463896829343,4.977268452545308,1,0.4,0.4,transcript,3277.0
MMP12,ENSG00000262406,macrophage metalloelastase measurement,EFO_0008220,0.49767795374542817,4.976999076422448,1,0.4,0.4,transcript,1822.0
MTMR6,ENSG00000139505,multiple sclerosis,MONDO_0005301,0.4976720718834108,4.976774343887733,1,0.5,0.5,transcript,9324.0
MTMR6,ENSG00000139505,Parkinson disease,MONDO_0005180,0.4976720718834108,4.976774343887733,1,0.5,0.5,transcript,9324.0
MTMR6,ENSG00000139505,lysosomal storage disease,MONDO_0002561,0.4976720718834108,4.976774343887733,1,0.5,0.5,transcript,9324.0
MTMR6,ENSG00000139505,Alzheimer disease,MONDO_0004975,0.4976720718834108,4.976774343887733,1,0.5,0.5,transcript,9324.0
GJB2,ENSG00000165474,hereditary palmoplantar keratoderma,MONDO_0019272,0.49764748721861063,4.976561677741661,1,0.4,0.4,transcript,4608.0
ASPM,ENSG00000066279,"microcephaly 1, primary, autosomal recessive",MONDO_0009617,0.49764748721861063,4.976509870533406,2,0.9,1.8,transcript,51431.0
NEDD4,ENSG00000069869,Dupuytren Contracture,EFO_0004229,0.4975874661721731,4.975882971683298,1,0.4,0.4,transcript,48135.0
INF2,ENSG00000203485,genetic disorder,EFO_0000508,0.49756804418045436,4.97568350468549,1,0.4,0.4,transcript,130596.0
SYNE2,ENSG00000054654,HbA1c measurement,EFO_0004541,0.49754258472550594,4.975438482770968,2,1.0,2.0,transcript,158284.0
C2CD4A,ENSG00000198535,type 2 diabetes mellitus,MONDO_0005148,0.49752611248475787,4.975377235152369,1,0.4,0.4,transcript,3445.0
MMADHC,ENSG00000168288,"Methylmalonic acidemia with homocystinuria, type cblC",Orphanet_79282,0.4974626972912683,4.974708538981198,1,0.4,0.4,transcript,4904.0
MMADHC,ENSG00000168288,methylmalonic aciduria and homocystinuria type cblC,MONDO_0010184,0.4974626972912683,4.974708538981198,1,0.4,0.4,transcript,4904.0
EVI5,ENSG00000067208,monocyte percentage of leukocytes,EFO_0007989,0.497398997473991,4.973995630688554,1,0.4,0.4,transcript,70722.0
TXK,ENSG00000074966,platelet count,EFO_0004309,0.4973577048440156,4.973606440754065,1,0.4,0.4,transcript,13609.0
FARSB,ENSG00000116120,Cerebral calcification,HP_0002514,0.497351823334863,4.973569253756793,1,0.4,0.4,transcript,7840.0
FARSB,ENSG00000116120,Vascular dilatation,HP_0002617,0.497351823334863,4.973569253756793,1,0.4,0.4,transcript,7840.0
FARSB,ENSG00000116120,Interstitial pneumonitis,HP_0006515,0.497351823334863,4.973569253756793,1,0.4,0.4,transcript,7840.0
PDE1A,ENSG00000115252,monocyte count,EFO_0005091,0.4972478134885348,4.9726046860155195,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
MEOX2,ENSG00000106511,heart rate,OBA_1001087,0.4971705478851309,4.9718741840389935,1,0.4,0.4,transcript,2371.0
UGT2B15,ENSG00000196620,X-24418 measurement,EFO_0800879,0.49705650731710793,4.971502280293854,2,1.0,2.0,transcript,2134.0
ITGB8,ENSG00000105855,BMI-adjusted waist-hip ratio,EFO_0007788,0.4970346407526056,4.970516934739358,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
GJB2,ENSG00000165474,nonsyndromic deafness,EFO_0009076,0.49697591513479134,4.969845956903469,1,0.4,0.4,transcript,4608.0
ADAMTS3,ENSG00000156140,phospholipid measurement,EFO_0004639,0.4968027774410386,4.968077090154437,1,0.4,0.4,transcript,8111.0
NID2,ENSG00000087303,body mass index,EFO_0004340,0.4967093707520831,4.967138842021644,1,0.5,0.5,transcript,11078.0
REEP3,ENSG00000165476,neutrophil count,EFO_0004833,0.49665329120086843,4.966602695679305,1,0.4,0.4,transcript,5732.0
LRP2,ENSG00000081479,blood urea nitrogen measurement,EFO_0004741,0.4965926741734883,4.96594333043466,1,0.5,0.5,transcript,30141.0
STXBP5,ENSG00000164506,platelet volume,OBA_0003277,0.4965879068737741,4.9658928991461995,2,0.9,1.8,transcript,130148.0
PAFAH1B2,ENSG00000168092,high density lipoprotein cholesterol measurement,EFO_0004612,0.49654920171452355,4.965625807595942,2,0.8,1.6,transcript,11959.0
ZFP90,ENSG00000184939,eosinophil count,EFO_0004842,0.4965463734832827,4.965477089979567,1,0.4,0.4,transcript,29951.0
CNTN1,ENSG00000018236,contactin-1 measurement,EFO_0020286,0.4964765719328825,4.964782246205659,1,0.4,0.4,transcript,24203.0
TENM4,ENSG00000149256,self reported educational attainment,EFO_0004784,0.4963972711028719,4.963990161512969,1,0.4,0.4,transcript,22922.0
ENPEP,ENSG00000138792,Calcium channel blocker use measurement,EFO_0009930,0.4963730237668611,4.963772637499011,1,0.4,0.4,transcript,9434.0
EVI5,ENSG00000067208,alkaline phosphatase measurement,EFO_0004533,0.49633621912442755,4.963367847192919,1,0.4,0.4,transcript,70722.0
PPDPFL,ENSG00000168333,lysine in blood amount,OBA_2020005,0.49624060450836865,4.96273144675137,2,0.8,1.6,transcript,4917.0
BICC1,ENSG00000122870,erythrocyte count,EFO_0004305,0.49618973786204434,4.961945472885203,1,0.4,0.4,transcript,8317.0
PRTG,ENSG00000166450,brain attribute,OBA_2045210,0.4961322838757916,4.96154091484224,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
CNTNAP2,ENSG00000174469,childhood epilepsy with centrotemporal spikes,MONDO_0007295,0.49606855995054094,4.960693281176941,1,0.4,0.4,transcript,52072.0
CNTNAP2,ENSG00000174469,Rolandic epilepsy,Orphanet_1945,0.49606855995054094,4.960693281176941,1,0.4,0.4,transcript,52072.0
GCH1,ENSG00000131979,Autosomal recessive dopa-responsive dystonia,Orphanet_101150,0.49606855995054094,4.960719363327474,1,0.4,0.4,transcript,11847.0
IQGAP2,ENSG00000145703,monocyte count,EFO_0005091,0.49602258159581636,4.960240486889181,1,0.5,0.5,transcript,34081.0
MANSC4,ENSG00000205693,HbA1c measurement,EFO_0004541,0.49598959357101285,4.960195875722126,1,0.5,0.5,transcript,1667.0
OTOGL,ENSG00000165899,central nervous system origin vertigo,MONDO_0002317,0.49597556628693995,4.959770520827322,1,0.5,0.5,transcript,33652.0
OTOGL,ENSG00000165899,peripheral vertigo,MONDO_0004900,0.49597556628693995,4.959770520827322,1,0.5,0.5,transcript,33652.0
ATG16L1,ENSG00000085978,neurodegenerative disease,EFO_0005772,0.49593622066093535,4.959374198095398,1,0.4,0.4,transcript,33357.0
TBL2,ENSG00000106638,lipid measurement,EFO_0004529,0.4959315908752343,4.959331087289891,1,0.4,0.4,transcript,26353.0
MUC16,ENSG00000181143,ovarian cancer,MONDO_0008170,0.4958993331716417,4.958996152065803,1,0.5,0.5,transcript,177283.0
CASQ2,ENSG00000118729,QRS duration,OBA_1001086,0.4958989817239099,4.959002468260668,1,0.4,0.4,transcript,31618.0
YIPF4,ENSG00000119820,Red cell distribution width,EFO_0009188,0.4958708957352358,4.958827134470313,2,0.8,1.6,transcript,13539.0
DDR2,ENSG00000162733,colorectal neoplasm,EFO_0004142,0.4958229919027531,4.958243959534393,1,0.4,0.4,transcript,28489.0
UNC80,ENSG00000144406,glomerular filtration rate,OBA_0003747,0.495792369390753,4.957928355912192,1,0.4,0.4,transcript,85800.0
SLC25A46,ENSG00000164209,asthma,MONDO_0004979,0.4957569939894804,4.957589893004995,1,0.4,0.4,transcript,20047.0
EXOC6,ENSG00000138190,triglyceride measurement,EFO_0004530,0.49569400019923826,4.956962619262931,1,0.5,0.5,transcript,22107.0
GCNT1,ENSG00000187210,monocyte count,EFO_0005091,0.49559213094726756,4.955940407109344,1,0.4,0.4,transcript,20945.0
RASA2,ENSG00000155903,total blood protein measurement,EFO_0004536,0.49555900754364846,4.955637688815844,1,0.4,0.4,transcript,8401.0
SLC25A46,ENSG00000164209,genetic disorder,EFO_0000508,0.4954897869349858,4.9549178224600485,1,0.4,0.4,transcript,20047.0
AFF1,ENSG00000172493,triglycerides:total lipids ratio,EFO_0020947,0.4952896284661138,4.952906507258189,1,0.4,0.4,transcript,39129.0
UBE2U,ENSG00000177414,neutrophil count,EFO_0004833,0.4952731473090759,4.952798688684777,1,0.4,0.4,transcript,5951.0
GBE1,ENSG00000114480,genetic disorder,EFO_0000508,0.4952607003691109,4.952667882785228,1,0.5,0.5,transcript,8213.0
SNX13,ENSG00000071189,Red cell distribution width,EFO_0009188,0.4951818793605518,4.951831118742636,1,0.4,0.4,transcript,32454.0
NBEAL1,ENSG00000144426,cystatin C measurement,EFO_0004617,0.4951785704177224,4.951789557778897,1,0.4,0.4,transcript,103799.0
CNTN5,ENSG00000149972,contactin-5 measurement,EFO_0008101,0.49515609541222266,4.951573934813448,1,0.4,0.4,transcript,30815.0
MLLT3,ENSG00000171843,glomerular filtration rate,OBA_0003747,0.4951491733936129,4.9515949730637585,2,0.8,1.6,transcript,15498.0
GPR180,ENSG00000152749,high density lipoprotein cholesterol measurement,EFO_0004612,0.4951416780581494,4.951461805345113,1,0.4,0.4,transcript,8884.0
CEP68,ENSG00000011523,atrial flutter,EFO_0003911,0.4950259303881554,4.950296070990515,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,atrial flutter,EFO_0003911,0.4950259303881554,4.950296070990515,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,atrial flutter,EFO_0003911,0.4950259303881554,4.950296070990515,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,atrial flutter,EFO_0003911,0.4950259303881554,4.950296070990515,3,1.5,4.5,gene_variant,122392.0
IQGAP2,ENSG00000145703,lymphocyte count,EFO_0004587,0.4949682506546505,4.949697177477523,1,0.5,0.5,transcript,34081.0
LARP4B,ENSG00000107929,basophil count,EFO_0005090,0.4949341468940064,4.949352480943148,1,0.5,0.5,transcript,45405.0
LY75-CD302,ENSG00000248672,neurodegenerative disease,EFO_0005772,0.4947633883813623,4.9476787993723725,1,0.5,0.5,transcript,11132.0
LTBP1,ENSG00000049323,"osteoarthritis, knee",EFO_0004616,0.49475912136249556,4.947603873054648,1,0.4,0.4,transcript,31597.0
FAS,ENSG00000026103,erythrocyte count,EFO_0004305,0.49475710346321805,4.947573242856713,1,0.4,0.4,transcript,181141.0
LRPAP1,ENSG00000163956,cholesteryl ester measurement,EFO_0010351,0.4947490240564353,4.947720876735792,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
PEX13,ENSG00000162928,Peroxisome biogenesis disorder-Zellweger syndrome spectrum,Orphanet_79189,0.49469084838113303,4.946954313325537,1,0.4,0.4,transcript,8728.0
FBXO28,ENSG00000143756,platelet volume,OBA_0003277,0.494664138857263,4.947690376299473,5,2.0,10.0,transcript,9533.0
RFX7,ENSG00000181827,BMI-adjusted waist-hip ratio,EFO_0007788,0.4946640122785558,4.946649715111697,1,0.4,0.4,transcript,41700.0
STXBP5,ENSG00000164506,tissue plasminogen activator amount,OBA_2050207,0.4946635442799968,4.946649273208426,2,0.9,1.8,transcript,130148.0
SMARCC1,ENSG00000173473,reticulocyte count,EFO_0007986,0.4945808707138845,4.9459228542459295,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,reticulocyte count,EFO_0007986,0.4945808707138845,4.9459228542459295,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,reticulocyte count,EFO_0007986,0.4945808707138845,4.9459228542459295,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,reticulocyte count,EFO_0007986,0.4945808707138845,4.9459228542459295,2,0.8,1.6,transcript,14017.0
NID2,ENSG00000087303,body weight,EFO_0004338,0.49448901413209584,4.944935275821771,1,0.5,0.5,transcript,11078.0
SP4,ENSG00000105866,neurodegenerative disease,EFO_0005772,0.49445471346598835,4.94457112698234,1,0.4,0.4,transcript,16672.0
CERKL,ENSG00000188452,cone-rod dystrophy,MONDO_0015993,0.49439518449738534,4.943971918845702,1,0.5,0.5,transcript,24908.0
QKI,ENSG00000112531,platelet count,EFO_0004309,0.4943933613458569,4.943969185614463,2,0.8,1.6,transcript,44979.0
ACTN2,ENSG00000077522,Rare familial disorder with hypertrophic cardiomyopathy,Orphanet_99739,0.4943756998451825,4.943773684063613,2,0.8,1.6,transcript,95891.0
LRP2,ENSG00000081479,hemoglobin measurement,EFO_0004509,0.4943594551853595,4.943611140553372,1,0.5,0.5,transcript,30141.0
DLC1,ENSG00000164741,FEV/FVC ratio,EFO_0004713,0.49425206303493513,4.942532309522466,1,0.4,0.4,transcript,34249.0
UGT2B15,ENSG00000196620,fatty acid measurement,EFO_0005110,0.49415496375516765,4.942486844674451,2,1.0,2.0,transcript,2134.0
AOX1,ENSG00000138356,hydantoin-5-propionate measurement,EFO_0800051,0.4940508441421546,4.940536543149802,1,0.4,0.4,transcript,14234.0
RASGRP3,ENSG00000152689,total blood protein measurement,EFO_0004536,0.4939921677860645,4.939932880773402,1,0.4,0.4,transcript,35705.0
PAQR3,ENSG00000163291,erythrocyte volume,OBA_0003460,0.4939413187439798,4.939428239180155,1,0.4,0.4,transcript,26575.0
FMN1,ENSG00000248905,hematocrit,EFO_0004348,0.4938635836446639,4.938671533999125,2,0.8,1.6,transcript,44821.0
FAT3,ENSG00000165323,retinal detachment,EFO_0005773,0.49377362893873855,4.9377446183827,1,0.4,0.4,transcript,48025.0
GALC,ENSG00000054983,eosinophil count,EFO_0004842,0.49376684130967596,4.937741306035257,2,0.8,1.6,transcript,21950.0
IL4R,ENSG00000077238,eosinophil percentage of leukocytes,EFO_0007991,0.4937316401079676,4.93733496514892,1,0.4,0.4,transcript,21547.0
PALM2AKAP2,ENSG00000157654,BMI-adjusted waist-hip ratio,EFO_0007788,0.49371750903781536,4.937183077598601,1,0.4,0.4,transcript,50080.0
PPDPFL,ENSG00000168333,alanine measurement,EFO_0009765,0.49362732862887115,4.936598687956395,2,0.8,1.6,transcript,4917.0
FAM171B,ENSG00000144369,heart rate,OBA_1001087,0.4936088837364759,4.936158633211906,1,0.4,0.4,transcript,5731.0
GABRA4,ENSG00000109158,depressive disorder,MONDO_0002050,0.49349802625745215,4.935005413479955,1,0.4,0.4,transcript,15904.0
GABRA1,ENSG00000022355,genetic disorder,EFO_0000508,0.4934708493475464,4.934717177046148,1,0.4,0.4,transcript,46064.0
IQCB1,ENSG00000173226,calcium measurement,EFO_0004838,0.49329679573982016,4.933009576376455,1,0.4,0.4,transcript,9611.0
RCL1,ENSG00000120158,eosinophil count,EFO_0004842,0.4932450657758878,4.932489331257862,1,0.4,0.4,transcript,10343.0
SNX13,ENSG00000071189,creatine kinase measurement,EFO_0004534,0.4932301603224553,4.93231392836167,1,0.4,0.4,transcript,32454.0
TLK1,ENSG00000198586,platelet count,EFO_0004309,0.4931157884146785,4.931171779307795,1,0.4,0.4,transcript,28787.0
SAMD9L,ENSG00000177409,serum urea amount,OBA_2050065,0.4931062736193305,4.931071189100049,1,0.4,0.4,transcript,47321.0
GBE1,ENSG00000114480,body fat percentage,EFO_0007800,0.4930725272579653,4.930786151673772,1,0.5,0.5,transcript,8213.0
UBXN2A,ENSG00000173960,lymphocyte count,EFO_0004587,0.49302996305505187,4.930456847805112,2,0.8,1.6,transcript,10177.0
NDFIP2,ENSG00000102471,neuroimaging measurement,EFO_0004346,0.4929835591760831,4.929850073626819,2,0.8,1.6,transcript,110483.0
SLC22A2,ENSG00000112499,cholesteryl ester measurement,EFO_0010351,0.49297453734860197,4.929785095432395,1,0.4,0.4,transcript,10070.0
MARCKS,ENSG00000277443,monocyte count,EFO_0005091,0.4929221255473953,4.9293143653436,1,0.4,0.4,transcript,4296.0
DYNLT5,ENSG00000152760,neutrophil count,EFO_0004833,0.4928955281298038,4.929025444427314,1,0.4,0.4,transcript,5701.0
SORL1,ENSG00000137642,alcohol consumption quality,OBA_1000840,0.4928908897653827,4.928955907316924,2,0.9,1.8,transcript,38290.0
AKR1C1,ENSG00000187134,BMI-adjusted waist-hip ratio,EFO_0007788,0.4928758239526807,4.928897430479395,2,0.8,1.6,transcript,11495.0
FAM76B,ENSG00000077458,hypothyroidism,EFO_0004705,0.4928352090818756,4.928373786322363,1,0.4,0.4,transcript,18437.0
LRRK2,ENSG00000188906,serum gamma-glutamyl transferase measurement,EFO_0004532,0.4927304972567756,4.927323730383512,2,0.9,1.8,transcript,95960.0
DPYD,ENSG00000188641,sleep duration trait,OBA_2040171,0.49269238368379203,4.9269820576110925,1,0.5,0.5,transcript,8588.0
ALG10B,ENSG00000175548,IGF-1 measurement,EFO_0004627,0.49264200566434324,4.92712587256664,5,2.0,10.0,transcript,14168.0
KLHL31,ENSG00000124743,BMI-adjusted hip circumference,EFO_0008039,0.4926279303562012,4.9263313801145445,1,0.4,0.4,transcript,7681.0
DSC2,ENSG00000134755,neurodegenerative disease,EFO_0005772,0.4926016189770447,4.926028631837075,2,0.8,1.6,transcript,128596.0
PPA2,ENSG00000138777,monocyte count,EFO_0005091,0.4925804236715078,4.925831642985632,1,0.5,0.5,transcript,18244.0
TMEM131,ENSG00000075568,eosinophil count,EFO_0004842,0.4925786813979685,4.925808262850938,1,0.4,0.4,transcript,18649.0
PKN2,ENSG00000065243,erythrocyte count,EFO_0004305,0.4925284602488353,4.9253154143817435,1,0.4,0.4,transcript,12982.0
SH3TC2,ENSG00000169247,hypertension,EFO_0000537,0.492498212345679,4.924986546865468,1,0.4,0.4,transcript,90428.0
FAT4,ENSG00000196159,van Maldergem syndrome,MONDO_0017813,0.49248170095060173,4.924825719548696,1,0.4,0.4,transcript,45924.0
ONECUT1,ENSG00000169856,type 2 diabetes mellitus,MONDO_0005148,0.49240272986919337,4.924080145831582,1,0.4,0.4,transcript,7569.0
GHR,ENSG00000112964,"hypercholesterolemia, familial, 1",MONDO_0007750,0.4924001931120328,4.9240107926369765,1,0.4,0.4,transcript,45139.0
PLXND1,ENSG00000004399,HbA1c measurement,EFO_0004541,0.4923864644879945,4.9238883258499175,1,0.5,0.5,transcript,21114.0
CCDC88C,ENSG00000015133,white matter hyperintensity measurement,EFO_0005665,0.4922314041556781,4.922333364294813,1,0.4,0.4,transcript,20701.0
PKN2,ENSG00000065243,platelet count,EFO_0004309,0.4921913096040347,4.921943907933738,1,0.4,0.4,transcript,12982.0
PLXND1,ENSG00000004399,hip circumference,OBA_1000032,0.49214564843800607,4.921480165350033,1,0.5,0.5,transcript,21114.0
TC2N,ENSG00000165929,von Willebrand factor quality,OBA_1000199,0.49212300823709487,4.92125284715383,1,0.4,0.4,transcript,17571.0
OTOGL,ENSG00000165899,Vertigo,HP_0002321,0.4920816761299929,4.920831619257851,1,0.5,0.5,transcript,33652.0
REEP3,ENSG00000165476,triglycerides:total lipids ratio,EFO_0020947,0.49207226114686575,4.920792395139278,1,0.4,0.4,transcript,5732.0
ARHGAP29,ENSG00000137962,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.4920605622859735,4.9206258485787595,1,0.5,0.5,transcript,24721.0
TNPO3,ENSG00000064419,lysosomal storage disease,MONDO_0002561,0.4920323638838886,4.920350311195655,1,0.5,0.5,transcript,18746.0
NEBL,ENSG00000078114,body mass index,EFO_0004340,0.4919990496200244,4.919998318019208,1,0.4,0.4,transcript,51139.0
ATP10D,ENSG00000145246,"glycosyl ceramide (d18:2/24:1, d18:1/24:2) measurement",EFO_0800532,0.49195329598556586,4.9195647826662485,1,0.5,0.5,transcript,15712.0
C12orf42,ENSG00000179088,lean body mass,EFO_0004995,0.49184759251802845,4.918511064684115,1,0.5,0.5,transcript,14229.0
CCBE1,ENSG00000183287,platelet count,EFO_0004309,0.49180656794444166,4.918079469694709,1,0.4,0.4,transcript,29006.0
AKR1C1,ENSG00000187134,lean body mass,EFO_0004995,0.4917810634064649,4.917949825017237,2,0.8,1.6,transcript,11495.0
PLA2R1,ENSG00000153246,glomerular filtration rate,OBA_0003747,0.4917806207524419,4.91788539976358,2,0.8,1.6,transcript,20204.0
KYNU,ENSG00000115919,cataract,MONDO_0005129,0.49177079061594703,4.9178661548737,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
DMRTA1,ENSG00000176399,brain attribute,OBA_2045210,0.49176262132423537,4.917697820832759,1,0.4,0.4,transcript,5586.0
SLAIN2,ENSG00000109171,neurodegenerative disease,EFO_0005772,0.49171860562581815,4.917321799025637,2,0.8,1.6,transcript,11787.0
DPYD,ENSG00000188641,body fat percentage,EFO_0007800,0.49170200857130686,4.917078306486241,1,0.5,0.5,transcript,8588.0
OTULINL,ENSG00000145569,childhood onset asthma,MONDO_0005405,0.49168105143777285,4.916860489390222,1,0.4,0.4,transcript,8004.0
UMPS,ENSG00000114491,orotate measurement,EFO_0800642,0.4916416255851552,4.916435112213216,1,0.4,0.4,transcript,21213.0
AR,ENSG00000169083,carcinoma,EFO_0000313,0.4916209397270485,4.916250727056346,2,0.8,1.6,transcript,38713.0
LRBA,ENSG00000198589,Cholecystitis,HP_0001082,0.49159826221799074,4.9159865636879285,1,0.4,0.4,transcript,101484.0
SLC25A37,ENSG00000147454,eosinophil count,EFO_0004842,0.491594968919058,4.9159688591321125,1,0.4,0.4,transcript,20866.0
SLC4A8,ENSG00000050438,neurodegenerative disease,EFO_0005772,0.4915894013166526,4.915925521013949,2,0.8,1.6,transcript,50781.0
IL4R,ENSG00000077238,allergic rhinitis,EFO_0005854,0.4915784273954485,4.915802838023729,1,0.4,0.4,transcript,21547.0
GRIA4,ENSG00000152578,partial epilepsy,EFO_0004263,0.49157200505187704,4.915729342040256,1,0.4,0.4,transcript,43050.0
MYO3A,ENSG00000095777,nonsyndromic genetic hearing loss,MONDO_0019497,0.4915412067306534,4.915435783096506,1,0.5,0.5,transcript,21083.0
SV2C,ENSG00000122012,monocyte count,EFO_0005091,0.49151990460863515,4.915227074956087,1,0.4,0.4,transcript,14271.0
GHR,ENSG00000112964,body weight,EFO_0004338,0.4914890630829625,4.914899492346273,1,0.4,0.4,transcript,45139.0
LPP,ENSG00000145012,skin cancer,MONDO_0002898,0.4914281311750917,4.91435021193178,4,1.6,6.4,transcript,92888.0
SYNJ2,ENSG00000078269,hearing process quality,OBA_2045262,0.4914162818185744,4.914213965810577,2,0.8,1.6,transcript,31282.0
ALG10B,ENSG00000175548,BMI-adjusted waist-hip ratio,EFO_0007788,0.4913413895550568,4.914119711473775,5,2.0,10.0,transcript,14168.0
PALM2AKAP2,ENSG00000157654,high density lipoprotein cholesterol measurement,EFO_0004612,0.4912999791449583,4.913007778670031,1,0.4,0.4,transcript,50080.0
OTULINL,ENSG00000145569,respiratory system disease,EFO_0000684,0.49129606978573587,4.913010672869852,1,0.4,0.4,transcript,8004.0
CASQ2,ENSG00000118729,cardiovascular measurement,EFO_0004298,0.491261628518614,4.912628936207709,1,0.4,0.4,transcript,31618.0
C6,ENSG00000039537,blood urea nitrogen measurement,EFO_0004741,0.49125260734545156,4.9125556365125185,1,0.5,0.5,transcript,16913.0
ULK4,ENSG00000168038,diastolic blood pressure change measurement,EFO_0006945,0.4910928791466668,4.9109697515715265,1,0.5,0.5,transcript,12207.0
LPP,ENSG00000145012,allergic disease,MONDO_0005271,0.49083508894957445,4.908419789676607,4,1.6,6.4,transcript,92888.0
HHLA2,ENSG00000114455,body mass index,EFO_0004340,0.4908102207247838,4.908136011588315,1,0.5,0.5,transcript,14791.0
ITGB8,ENSG00000105855,FEV/FVC ratio,EFO_0004713,0.4907730348957556,4.907900876170857,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
SLC22A5,ENSG00000197375,acylcarnitine measurement,EFO_0005059,0.4907407514671422,4.907413083607894,1,0.4,0.4,transcript,71827.0
FIGN,ENSG00000182263,hypertension,EFO_0000537,0.49073171497970836,4.907353904368434,1,0.4,0.4,transcript,10883.0
RASA2,ENSG00000155903,eosinophil count,EFO_0004842,0.49072670142472197,4.907314627626579,1,0.4,0.4,transcript,8401.0
GABRA4,ENSG00000109158,Lennox-Gastaut syndrome,MONDO_0016532,0.49071991816468735,4.907224332552307,1,0.4,0.4,transcript,15904.0
PAFAH1B2,ENSG00000168092,phospholipids:total lipids ratio,EFO_0020946,0.49070465160592014,4.907180306509908,2,0.8,1.6,transcript,11959.0
UBE2U,ENSG00000177414,neuroimaging measurement,EFO_0004346,0.4906411470733454,4.906478686327472,1,0.4,0.4,transcript,5951.0
ACVR1C,ENSG00000123612,diastolic blood pressure,EFO_0006336,0.4906233151441615,4.9063524653864325,2,0.8,1.6,transcript,13410.0
ADAMTS3,ENSG00000156140,cholesterol:total lipids ratio,EFO_0020943,0.49053348959948984,4.90538421173895,1,0.4,0.4,transcript,8111.0
CP,ENSG00000047457,neurodegeneration with brain iron accumulation,MONDO_0018307,0.49052934470603693,4.905314505011852,1,0.5,0.5,transcript,23744.0
MCL1,ENSG00000143384,neurodegenerative disease,EFO_0005772,0.4905031567260761,4.905048336639875,1,0.4,0.4,transcript,23853.0
CYP24A1,ENSG00000019186,blood sodium bicarbonate amount,OBA_2050094,0.49049090935009415,4.905099297970747,2,0.8,1.6,transcript,8412.0
ANKRD36,ENSG00000135976,eosinophil count,EFO_0004842,0.49042730756473113,4.904348462002381,2,1.0,2.0,transcript,26530.0
GRB14,ENSG00000115290,fatty acid measurement,EFO_0005110,0.4904138891329004,4.904179258671824,1,0.4,0.4,transcript,9909.0
KLF10,ENSG00000155090,lymphocyte count,EFO_0004587,0.49040968910605476,4.904157736816556,1,0.4,0.4,transcript,6574.0
ZNF623,ENSG00000183309,neurodegenerative disease,EFO_0005772,0.49039431886364243,4.903972923991762,1,0.4,0.4,transcript,13452.0
LONRF1,ENSG00000154359,triglyceride measurement,EFO_0004530,0.49037986282939977,4.903833921581215,1,0.5,0.5,transcript,14167.0
SLC22A2,ENSG00000112499,cholesterol in chylomicrons and extremely large VLDL measurement ,EFO_0021898,0.4903537582936969,4.903577304883345,1,0.4,0.4,transcript,10070.0
SLC22A2,ENSG00000112499,free cholesterol in chylomicrons and extremely large VLDL measurement ,EFO_0022263,0.4903486121792854,4.90352584373923,1,0.4,0.4,transcript,10070.0
GCNT1,ENSG00000187210,neutrophil count,EFO_0004833,0.4903024093356622,4.90304319099329,1,0.4,0.4,transcript,20945.0
AGA,ENSG00000038002,genetic disorder,EFO_0000508,0.49027299905978516,4.902827972177315,1,0.5,0.5,transcript,5103.0
CA8,ENSG00000178538,erythrocyte count,EFO_0004305,0.4902656523519054,4.902697477752698,1,0.4,0.4,transcript,9767.0
GRB14,ENSG00000115290,BMI-adjusted waist circumference,EFO_0007789,0.4901809588814847,4.901849956157667,1,0.4,0.4,transcript,9909.0
DCLK1,ENSG00000133083,cup-to-disc ratio measurement,EFO_0006939,0.4901168940094934,4.9012191377481935,2,0.8,1.6,transcript,31874.0
TC2N,ENSG00000165929,venous thromboembolism,EFO_0004286,0.49011397388102823,4.901162503593163,1,0.4,0.4,transcript,17571.0
DCDC2,ENSG00000146038,alkaline phosphatase measurement,EFO_0004533,0.4900628223288414,4.900674000354104,1,0.4,0.4,transcript,8738.0
TSPAN9,ENSG00000011105,vital capacity,EFO_0004312,0.49001848820821764,4.900220365724217,1,0.5,0.5,transcript,14091.0
CNTN1,ENSG00000018236,"Congenital lethal myopathy, Compton-North type",Orphanet_210163,0.48992144316999814,4.899230958576815,1,0.4,0.4,transcript,24203.0
CYP24A1,ENSG00000019186,blood urea nitrogen measurement,EFO_0004741,0.4899026343457809,4.899216547927614,2,0.8,1.6,transcript,8412.0
SHH,ENSG00000164690,systolic blood pressure,EFO_0006335,0.4898934924513025,4.898988073596203,1,0.4,0.4,transcript,7526.0
LONRF1,ENSG00000154359,type 2 diabetes mellitus,MONDO_0005148,0.4898874567971705,4.898909861258922,1,0.5,0.5,transcript,14167.0
LMO4,ENSG00000143013,eosinophil count,EFO_0004842,0.4898860333177604,4.898911813229085,1,0.4,0.4,transcript,7770.0
RCL1,ENSG00000120158,platelet crit,EFO_0007985,0.4897479440511258,4.897518114010243,1,0.4,0.4,transcript,10343.0
BTC,ENSG00000174808,FEV/FVC ratio,EFO_0004713,0.4897348805138919,4.897470868001293,1,0.4,0.4,transcript,3277.0
GFRAL,ENSG00000187871,blood urea nitrogen measurement,EFO_0004741,0.4897291945015391,4.89750125951042,1,0.4,0.4,transcript,1911.0
LRP2,ENSG00000081479,hematocrit,EFO_0004348,0.4897116454448195,4.8971330431479725,1,0.5,0.5,transcript,30141.0
UBXN2A,ENSG00000173960,HbA1c measurement,EFO_0004541,0.48968786379406976,4.897035855195291,2,0.8,1.6,transcript,10177.0
QSER1,ENSG00000060749,C-reactive protein measurement,EFO_0004458,0.489540896398681,4.895435639189541,1,0.5,0.5,transcript,18744.0
UMPS,ENSG00000114491,platelet count,EFO_0004309,0.489513672725653,4.895155583618195,1,0.4,0.4,transcript,21213.0
BPTF,ENSG00000171634,triglyceride measurement,EFO_0004530,0.4895029444271186,4.895049068467821,2,0.8,1.6,transcript,81532.0
ZNF682,ENSG00000197124,phospholipids in VLDL measurement ,EFO_0022301,0.4894037246338852,4.894063220364826,1,0.5,0.5,transcript,19250.0
CYBRD1,ENSG00000071967,lean body mass,EFO_0004995,0.4893776615793177,4.893810725113549,1,0.4,0.4,transcript,11727.0
TECRL,ENSG00000205678,body mass index,EFO_0004340,0.4893437161859679,4.893839936529628,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
SLC25A37,ENSG00000147454,diastolic blood pressure,EFO_0006336,0.4891666425925734,4.8916855958672665,1,0.4,0.4,transcript,20866.0
RSBN1L,ENSG00000187257,serum gamma-glutamyl transferase measurement,EFO_0004532,0.489159387992645,4.89173059700754,2,0.8,1.6,transcript,11703.0
ZNF483,ENSG00000173258,age at menarche,EFO_0004703,0.48909843437914646,4.891067824956027,2,0.8,1.6,transcript,19166.0
AFF1,ENSG00000172493,mean corpuscular hemoglobin,EFO_0004527,0.4890949036175214,4.890959258772265,1,0.4,0.4,transcript,39129.0
SLC22A2,ENSG00000112499,phospholipids in chylomicrons and extremely large VLDL measurement ,EFO_0022292,0.4890382253388516,4.890421975334892,1,0.4,0.4,transcript,10070.0
SLC22A2,ENSG00000112499,concentration of chylomicrons and extremely large VLDL particles measurement ,EFO_0022260,0.4890382253388516,4.890421975334892,1,0.4,0.4,transcript,10070.0
DENND1B,ENSG00000213047,primary biliary cirrhosis,EFO_1001486,0.4889497642947472,4.889934400459701,5,2.0,10.0,transcript,22896.0
SLC25A37,ENSG00000147454,body fat percentage,EFO_0007800,0.4889462859850351,4.889482029791883,1,0.4,0.4,transcript,20866.0
SI,ENSG00000090402,"1,5 anhydroglucitol measurement",EFO_0008009,0.48894032860127146,4.889475332122225,1,0.5,0.5,transcript,6940.0
NID2,ENSG00000087303,waist-hip ratio,EFO_0004343,0.4888839346436283,4.8888844809370955,1,0.5,0.5,transcript,11078.0
STX7,ENSG00000079950,neurodegenerative disease,EFO_0005772,0.4888619223991605,4.888707739149826,2,0.8,1.6,transcript,18076.0
DENND1B,ENSG00000213047,major depressive disorder,MONDO_0002009,0.4888247611942929,4.8886843694551585,5,2.0,10.0,transcript,22896.0
THEM4,ENSG00000159445,X-18921 measurement,EFO_0800796,0.48871139815567577,4.887268332318865,2,0.8,1.6,transcript,10366.0
ZNF682,ENSG00000197124,lipid measurement,EFO_0004529,0.48867224773806817,4.886748451406655,1,0.5,0.5,transcript,19250.0
C12orf42,ENSG00000179088,body weight,EFO_0004338,0.4886633222269531,4.886668361773361,1,0.5,0.5,transcript,14229.0
FMN1,ENSG00000248905,hemoglobin measurement,EFO_0004509,0.4886283327448288,4.886319025000774,2,0.8,1.6,transcript,44821.0
SEMA6D,ENSG00000137872,body mass index,EFO_0004340,0.48860321013463587,4.8860415281940215,1,0.5,0.5,transcript,53040.0
ZNF117,ENSG00000152926,neurodegenerative disease,EFO_0005772,0.48858979883776094,4.888025112354954,13,5.2,67.60000000000001,transcript,31780.0
SLC25A46,ENSG00000164209,eosinophil count,EFO_0004842,0.48856007004759977,4.885620653586188,1,0.4,0.4,transcript,20047.0
PTBP3,ENSG00000119314,hemoglobin measurement,EFO_0004509,0.48855555053351823,4.885788942937312,5,2.0,10.0,transcript,42838.0
UNC80,ENSG00000144406,serum creatinine amount,OBA_2050096,0.4885080615371549,4.885085277376212,1,0.4,0.4,transcript,85800.0
BANK1,ENSG00000153064,mitochondrial DNA measurement,EFO_0006312,0.48850034965380523,4.885215984279145,3,1.3,3.9000000000000004,transcript,18354.0
GJB2,ENSG00000165474,Sensorineural hearing impairment,HP_0000407,0.48848354721074877,4.884922277663043,1,0.4,0.4,transcript,4608.0
SECISBP2L,ENSG00000138593,calcium measurement,EFO_0004838,0.48838382711476586,4.883857355117125,1,0.4,0.4,transcript,20960.0
LAMA1,ENSG00000101680,genetic disorder,EFO_0000508,0.48830251306897743,4.883041025908493,1,0.5,0.5,transcript,31456.0
CCBE1,ENSG00000183287,reticulocyte measurement,EFO_0010700,0.4882905624086554,4.882919414336847,1,0.4,0.4,transcript,29006.0
LPP,ENSG00000145012,type 2 diabetes mellitus,MONDO_0005148,0.4882848363698832,4.882917263879695,4,1.6,6.4,transcript,92888.0
UBXN2A,ENSG00000173960,erythrocyte volume,OBA_0003460,0.4881776131047242,4.8819333483018355,2,0.8,1.6,transcript,10177.0
EPHA5,ENSG00000145242,neuroimaging measurement,EFO_0004346,0.4881732786096914,4.881743510820082,1,0.4,0.4,transcript,37297.0
SNX13,ENSG00000071189,mean corpuscular hemoglobin concentration,EFO_0004528,0.4881285225783587,4.881297550920705,1,0.4,0.4,transcript,32454.0
ID4,ENSG00000172201,chronic obstructive pulmonary disease,EFO_0000341,0.4881277636693826,4.881690753141024,2,0.8,1.6,transcript,3873.0
PAQR3,ENSG00000163291,Red cell distribution width,EFO_0009188,0.4880766196115085,4.880781247855442,1,0.4,0.4,transcript,26575.0
PICALM,ENSG00000073921,family history of Alzheimerâs disease,EFO_0009268,0.4879737923357395,4.879751191675968,1,0.4,0.4,transcript,30147.0
YEATS2,ENSG00000163872,platelet count,EFO_0004309,0.48794596010641567,4.879493341532474,1,0.5,0.5,transcript,14819.0
NBAS,ENSG00000151779,body weight,EFO_0004338,0.48790498253145537,4.879083371104557,2,1.0,2.0,transcript,59620.0
AKAP6,ENSG00000151320,mathematical ability,EFO_0004875,0.48776770385628565,4.878251818621507,7,2.8000000000000003,19.6,transcript,34100.0
CCDC88C,ENSG00000015133,brain attribute,OBA_2045210,0.48775147430960736,4.877534065834105,1,0.4,0.4,transcript,20701.0
TENM4,ENSG00000149256,educational attainment,EFO_0011015,0.48774424489125584,4.877459899396809,1,0.4,0.4,transcript,22922.0
FZD6,ENSG00000164930,Autosomal dominant nail dysplasia,Orphanet_79153,0.4876400860423148,4.876480752568751,2,0.8,1.6,transcript,20027.0
FIGN,ENSG00000182263,serum creatinine amount,OBA_2050096,0.48763118770971825,4.876348631668533,1,0.4,0.4,transcript,10883.0
FNDC3B,ENSG00000075420,high density lipoprotein cholesterol measurement,EFO_0004612,0.48761845050982366,4.876238122604352,2,0.8,1.6,transcript,29841.0
SLC25A37,ENSG00000147454,neurodegenerative disease,EFO_0005772,0.48755352046126743,4.8755543745542065,1,0.4,0.4,transcript,20866.0
FAS,ENSG00000026103,neurodegenerative disease,EFO_0005772,0.4874709309125062,4.874711517349594,1,0.4,0.4,transcript,181141.0
SMARCC1,ENSG00000173473,reticulocyte measurement,EFO_0010700,0.4874234542008312,4.874348689115397,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,reticulocyte measurement,EFO_0010700,0.4874234542008312,4.874348689115397,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,reticulocyte measurement,EFO_0010700,0.4874234542008312,4.874348689115397,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,reticulocyte measurement,EFO_0010700,0.4874234542008312,4.874348689115397,2,0.8,1.6,transcript,14017.0
MAP3K7,ENSG00000135341,neurodegenerative disease,EFO_0005772,0.4873946563607149,4.874035950330427,4,1.6,6.4,transcript,71599.0
STXBP4,ENSG00000166263,erythrocyte count,EFO_0004305,0.4873904237446437,4.874295948833487,5,2.0,10.0,transcript,25529.0
SYDE2,ENSG00000097096,HbA1c measurement,EFO_0004541,0.4872799584137157,4.872833737142622,1,0.5,0.5,transcript,14640.0
ARL3,ENSG00000138175,chloride measurement,EFO_0009284,0.4872352418147934,4.872456747829728,1,0.4,0.4,transcript,3834.0
FMN1,ENSG00000248905,erythrocyte count,EFO_0004305,0.4872111591174108,4.872147288726595,2,0.8,1.6,transcript,44821.0
GJA3,ENSG00000121743,Developmental cataract,HP_0000519,0.48717646644022383,4.871841380934652,1,0.4,0.4,transcript,5214.0
TBL2,ENSG00000106638,triglyceride measurement,EFO_0004530,0.48708977918932495,4.870912970430797,1,0.4,0.4,transcript,26353.0
LUZP2,ENSG00000187398,educational attainment,EFO_0011015,0.48704436741181567,4.870760454142381,4,1.7000000000000002,6.800000000000001,transcript,21466.0
SLC22A5,ENSG00000197375,glomerular filtration rate,OBA_0003747,0.4870095749504537,4.87010131844101,1,0.4,0.4,transcript,71827.0
TMTC3,ENSG00000139324,strand of hair color,OBA_0002313,0.48700912926023227,4.870130301769477,1,0.4,0.4,transcript,10254.0
PARP1,ENSG00000143799,mean corpuscular hemoglobin concentration,EFO_0004528,0.48699394777444427,4.86994534732242,1,0.5,0.5,transcript,85185.0
SMC6,ENSG00000163029,alpha fetoprotein measurement,EFO_0010583,0.4869668496533268,4.869684906116465,1,0.4,0.4,transcript,24376.0
STXBP4,ENSG00000166263,platelet count,EFO_0004309,0.4869147071602242,4.869538782989292,5,2.0,10.0,transcript,25529.0
NEK7,ENSG00000151414,monocyte count,EFO_0005091,0.4868315684840213,4.868360949070155,1,0.4,0.4,transcript,8837.0
ACTN2,ENSG00000077522,"cardiomyopathy, familial hypertrophic, 23, with or without ventricular noncompaction",MONDO_0800347,0.4868290635834234,4.868307321446022,2,0.8,1.6,transcript,95891.0
AKR1B10,ENSG00000198074,diastolic blood pressure,EFO_0006336,0.4868264572855892,4.868396708162447,1,0.5,0.5,transcript,3784.0
FMN1,ENSG00000248905,balding measurement,EFO_0007825,0.48676370835962934,4.86767278114878,2,0.8,1.6,transcript,44821.0
OTULINL,ENSG00000145569,HbA1c measurement,EFO_0004541,0.48669523482116805,4.867002323224174,1,0.4,0.4,transcript,8004.0
GREM1,ENSG00000166923,erythrocyte volume,OBA_0003460,0.4866748877588187,4.866767101653064,1,0.4,0.4,transcript,21949.0
CCBE1,ENSG00000183287,monocyte count,EFO_0005091,0.48659520643112536,4.865965854561546,1,0.4,0.4,transcript,29006.0
SLC25A37,ENSG00000147454,neuroimaging measurement,EFO_0004346,0.4863927139592215,4.863946309533747,1,0.4,0.4,transcript,20866.0
CENPC,ENSG00000145241,self reported educational attainment,EFO_0004784,0.4861834344395917,4.862033151552975,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
ZNF257,ENSG00000197134,type 2 diabetes mellitus,MONDO_0005148,0.4861809180787518,4.861836763189945,1,0.4,0.4,transcript,14502.0
ENPEP,ENSG00000138792,mean arterial pressure,EFO_0006340,0.4861743710495134,4.861786110325534,1,0.4,0.4,transcript,9434.0
SLC22A5,ENSG00000197375,acetylcarnitine measurement,EFO_0021038,0.48615241334779785,4.86152970241445,1,0.4,0.4,transcript,71827.0
MAP2K6,ENSG00000108984,osteoarthritis,MONDO_0005178,0.4861243790359756,4.861261092894578,1,0.4,0.4,transcript,23118.0
PTPRJ,ENSG00000149177,intraocular pressure measurement,EFO_0004695,0.4860402675240946,4.860477863210871,2,0.8,1.6,transcript,21280.0
SKI,ENSG00000157933,platelet count,EFO_0004309,0.4860063649938314,4.860116170946718,1,0.4,0.4,transcript,7616.0
TSPAN9,ENSG00000011105,appendicular lean mass,EFO_0004980,0.48597987714351826,4.8598342550772236,1,0.5,0.5,transcript,14091.0
RNF144B,ENSG00000137393,citrate measurement,EFO_0010114,0.4858826781370156,4.858899654388921,1,0.4,0.4,transcript,5489.0
SLC22A5,ENSG00000197375,neutrophil count,EFO_0004833,0.4858678335151055,4.858683904087527,1,0.4,0.4,transcript,71827.0
SYT13,ENSG00000019505,blood urea nitrogen measurement,EFO_0004741,0.4858367837509081,4.858583122762041,2,0.8,1.6,transcript,7432.0
LPP,ENSG00000145012,intraocular pressure measurement,EFO_0004695,0.4858206973684366,4.858275873865229,4,1.6,6.4,transcript,92888.0
RET,ENSG00000165731,colorectal cancer,MONDO_0005575,0.4857789166684767,4.857799178949793,1,0.4,0.4,transcript,39951.0
FGA,ENSG00000171560,heart disease,EFO_0003777,0.48573738085007345,4.857442032959203,1,0.4,0.4,transcript,5863.0
YWHAG,ENSG00000170027,genetic disorder,EFO_0000508,0.48572314387528265,4.857339400966052,1,0.4,0.4,transcript,3705.0
AFF1,ENSG00000172493,total cholesterol measurement,EFO_0004574,0.485719377512971,4.857203997726761,1,0.4,0.4,transcript,39129.0
QSOX1,ENSG00000116260,pulse pressure measurement,EFO_0005763,0.4857123483847266,4.857152547278204,1,0.4,0.4,transcript,13763.0
LTBP1,ENSG00000049323,autosomal recessive cutis laxa type 2,MONDO_0019573,0.4857090522528263,4.857103181957956,1,0.4,0.4,transcript,31597.0
SLC30A8,ENSG00000164756,insulin measurement,EFO_0004467,0.48566441823135714,4.8569543499979755,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,insulin measurement,EFO_0004467,0.48566441823135714,4.8569543499979755,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,insulin measurement,EFO_0004467,0.48566441823135714,4.8569543499979755,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,insulin measurement,EFO_0004467,0.48566441823135714,4.8569543499979755,4,1.6,6.4,transcript,20634.0
LTBP1,ENSG00000049323,"osteoarthritis, hip",EFO_1000786,0.48561818997850437,4.856194559214737,1,0.4,0.4,transcript,31597.0
CCDC88C,ENSG00000015133,breast carcinoma,EFO_0000305,0.48554509644810384,4.85547028721907,1,0.4,0.4,transcript,20701.0
PKP2,ENSG00000057294,cardiac arrhythmia,EFO_0004269,0.485543233672333,4.855588438091655,4,1.6,6.4,transcript,40999.0
FAM210A,ENSG00000177150,bone fracture,EFO_0003931,0.48553855397114565,4.855407685653212,1,0.4,0.4,transcript,18062.0
MFAP3,ENSG00000037749,body mass index,EFO_0004340,0.48548622242368494,4.854874813938474,1,0.4,0.4,transcript,31772.0
LARP4B,ENSG00000107929,cystatin C measurement,EFO_0004617,0.4854013040666999,4.854024052670082,1,0.5,0.5,transcript,45405.0
ZNF682,ENSG00000197124,free cholesterol measurement,EFO_0008591,0.4853617935594796,4.85364390962077,1,0.5,0.5,transcript,19250.0
DNAH14,ENSG00000185842,feeling nervous measurement,EFO_0009597,0.4853135870147939,4.853193848631479,3,1.5,4.5,transcript,77615.0
BCAS3,ENSG00000141376,cystatin C measurement,EFO_0004617,0.4852695839100429,4.852706238218584,1,0.5,0.5,transcript,48081.0
DLC1,ENSG00000164741,body height,OBA_VT0001253,0.48526325700700335,4.8526442492431485,1,0.4,0.4,transcript,34249.0
FGA,ENSG00000171560,total cholesterol measurement,EFO_0004574,0.48516891347848407,4.851757359243309,1,0.4,0.4,transcript,5863.0
GPR180,ENSG00000152749,cholesteryl esters:total lipids ratio,EFO_0020944,0.48498871228403,4.84993214760392,1,0.4,0.4,transcript,8884.0
AR,ENSG00000169083,ovarian cancer,MONDO_0008170,0.4849028112437846,4.849069442223707,2,0.8,1.6,transcript,38713.0
FMN1,ENSG00000248905,urate measurement,EFO_0004531,0.48485564785494295,4.848592176101916,2,0.8,1.6,transcript,44821.0
GPATCH2L,ENSG00000089916,hematocrit,EFO_0004348,0.4848095506629239,4.8482379789695695,4,1.6,6.4,transcript,44921.0
FAM8A1,ENSG00000137414,platelet volume,OBA_0003277,0.4847989595110194,4.848008836980504,1,0.4,0.4,transcript,20788.0
SLC6A5,ENSG00000165970,hyperekplexia,MONDO_0017658,0.48474983218419593,4.847536957986072,1,0.4,0.4,transcript,10353.0
SLCO5A1,ENSG00000137571,ceramide measurement,EFO_0010222,0.4847198593558293,4.847629145525915,5,2.0,10.0,transcript,23226.0
FREM2,ENSG00000150893,strand of hair color,OBA_0002313,0.484672118431935,4.847612291073939,6,2.5,15.0,transcript,16833.0
CAV2,ENSG00000105971,open-angle glaucoma,EFO_0004190,0.4846712697581489,4.846736871147694,1,0.4,0.4,transcript,16547.0
BCKDHB,ENSG00000083123,genetic disorder,EFO_0000508,0.4846196472522797,4.851923849384194,10,4.0,40.0,transcript,6984.0
SHOC1,ENSG00000165181,male infertility,EFO_0004248,0.4846013183482407,4.84612955623328,3,1.3,3.9000000000000004,transcript,33513.0
KYNU,ENSG00000115919,Catel-Manzke syndrome,MONDO_0014507,0.4846013183482407,4.846171432196637,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
TLK1,ENSG00000198586,platelet component distribution width,EFO_0007984,0.4845466341448403,4.845480236609413,1,0.4,0.4,transcript,28787.0
ID4,ENSG00000172201,BMI-adjusted hip circumference,EFO_0008039,0.4845268477001237,4.845681593448436,2,0.8,1.6,transcript,3873.0
KITLG,ENSG00000049130,monocyte count,EFO_0005091,0.48449812863482744,4.845150642325129,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
LTBP1,ENSG00000049323,lean body mass,EFO_0004995,0.48449411802385906,4.844953839668284,1,0.4,0.4,transcript,31597.0
LPP,ENSG00000145012,allergic rhinitis,EFO_0005854,0.48435646456265335,4.843633545807396,4,1.6,6.4,transcript,92888.0
BICC1,ENSG00000122870,glaucoma,MONDO_0005041,0.48434964336586017,4.843544527923361,1,0.4,0.4,transcript,8317.0
SMAD2,ENSG00000175387,cancer,MONDO_0004992,0.4843272863568434,4.843766660623941,9,3.6,32.4,transcript,65614.0
TRDN,ENSG00000186439,familial long QT syndrome,MONDO_0019171,0.4842743704299464,4.842762907740721,1,0.5,0.5,transcript,26037.0
U2SURP,ENSG00000163714,platelet volume,OBA_0003277,0.4842265525336097,4.842315933325763,2,0.8,1.6,transcript,31741.0
PLCL1,ENSG00000115896,allergic rhinitis,EFO_0005854,0.4841609051673008,4.841698562162518,2,0.8,1.6,transcript,17875.0
ASPM,ENSG00000066279,Abnormality of the nervous system,HP_0000707,0.48404694856621366,4.840504484009437,2,0.9,1.8,transcript,51431.0
ITGB8,ENSG00000105855,respiratory system disease,EFO_0000684,0.4840462440334084,4.840632967547386,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
SLC30A8,ENSG00000164756,diabetic neuropathy,EFO_1000783,0.4839841558275197,4.8401517259596005,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,diabetic neuropathy,EFO_1000783,0.4839841558275197,4.8401517259596005,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,diabetic neuropathy,EFO_1000783,0.4839841558275197,4.8401517259596005,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,diabetic neuropathy,EFO_1000783,0.4839841558275197,4.8401517259596005,4,1.6,6.4,gene_variant,20634.0
PEX7,ENSG00000112357,genetic disorder,EFO_0000508,0.48391586720755964,4.839201216215141,1,0.4,0.4,transcript,9402.0
REEP3,ENSG00000165476,diastolic blood pressure,EFO_0006336,0.4839106013264965,4.839175796935586,1,0.4,0.4,transcript,5732.0
ID4,ENSG00000172201,vital capacity,EFO_0004312,0.4838253323346451,4.838666439793649,2,0.8,1.6,transcript,3873.0
DYNC1I2,ENSG00000077380,neurodegenerative disease,EFO_0005772,0.48377297238367367,4.837740910770398,1,0.4,0.4,transcript,35756.0
KCNQ1,ENSG00000053918,short QT syndrome,MONDO_0000453,0.483728595591113,4.837479629248767,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
DENND1B,ENSG00000213047,sex hormone-binding globulin measurement,EFO_0004696,0.4836287722033112,4.8367244795453415,5,2.0,10.0,transcript,22896.0
KLHL3,ENSG00000146021,chloride measurement,EFO_0009284,0.4835892942763104,4.835940253446448,2,0.8,1.6,transcript,33819.0
FGA,ENSG00000171560,low density lipoprotein cholesterol measurement,EFO_0004611,0.48358448630524814,4.83591308751095,1,0.4,0.4,transcript,5863.0
RASGRP3,ENSG00000152689,level of serum globulin type protein,OBA_2045206,0.4835130527830664,4.8351417307434215,1,0.4,0.4,transcript,35705.0
KITLG,ENSG00000049130,lymphocyte count,EFO_0004587,0.4835076278729347,4.835245634706202,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
NBAS,ENSG00000151779,major depressive disorder,MONDO_0002009,0.48348737833270755,4.834907329117079,2,1.0,2.0,transcript,59620.0
STARD13,ENSG00000133121,lymphocyte count,EFO_0004587,0.4834397550431556,4.834412366892645,1,0.4,0.4,transcript,26997.0
PDE1A,ENSG00000115252,body weights and measures,EFO_0004324,0.4834059895729894,4.834186446860065,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
GPR158,ENSG00000151025,diverticular disease,EFO_0009959,0.48330350757403157,4.833060747044931,1,0.5,0.5,transcript,19477.0
SFRP1,ENSG00000104332,cardiovascular measurement,EFO_0004298,0.483291038642839,4.832958365317679,1,0.4,0.4,transcript,8337.0
LIN54,ENSG00000189308,erythrocyte count,EFO_0004305,0.48326489086564167,4.832661835233459,1,0.4,0.4,transcript,30944.0
PARP1,ENSG00000143799,breast neoplasm,EFO_0003869,0.48322727508938285,4.832278620471806,1,0.5,0.5,transcript,85185.0
AFF1,ENSG00000172493,basophil count,EFO_0005090,0.48318628189088814,4.831873041505932,1,0.4,0.4,transcript,39129.0
PLEKHA6,ENSG00000143850,platelet count,EFO_0004309,0.4831708732282733,4.831715546941063,1,0.4,0.4,transcript,58697.0
FYCO1,ENSG00000163820,Developmental cataract,HP_0000519,0.48315452399520914,4.831569850793167,1,0.4,0.4,transcript,16253.0
STXBP5,ENSG00000164506,factor VIII measurement,EFO_0004630,0.4830748707372354,4.830762537780812,2,0.9,1.8,transcript,130148.0
MFAP3,ENSG00000037749,high density lipoprotein cholesterol measurement,EFO_0004612,0.48299925405870586,4.830005130288683,1,0.4,0.4,transcript,31772.0
ADAMTS3,ENSG00000156140,vitamin D-binding protein measurement,EFO_0005675,0.4829860237065347,4.829909552809398,1,0.4,0.4,transcript,8111.0
ARFIP1,ENSG00000164144,platelet volume,OBA_0003277,0.4828836337286531,4.828863389903872,1,0.4,0.4,transcript,14786.0
CADPS,ENSG00000163618,body weight,EFO_0004338,0.4828742372365072,4.828751690075711,1,0.4,0.4,transcript,42929.0
PARP1,ENSG00000143799,neutrophil count,EFO_0004833,0.48287406282265033,4.828746497804481,1,0.5,0.5,transcript,85185.0
CCBE1,ENSG00000183287,platelet volume,OBA_0003277,0.4828654516033428,4.828668306283721,1,0.4,0.4,transcript,29006.0
FLRT2,ENSG00000185070,cup-to-disc ratio measurement,EFO_0006939,0.48285821116263034,4.828917630396525,7,2.8000000000000003,19.6,transcript,58417.0
AGA,ENSG00000038002,asparagine measurement,EFO_0009766,0.4828552967774477,4.82865094935394,1,0.5,0.5,transcript,5103.0
LRRK2,ENSG00000188906,low density lipoprotein cholesterol measurement,EFO_0004611,0.4828415072036641,4.828433829852398,2,0.9,1.8,transcript,95960.0
ENPEP,ENSG00000138792,essential hypertension,MONDO_0001134,0.48279765941767266,4.828018994007127,1,0.4,0.4,transcript,9434.0
ANKRD17,ENSG00000132466,low density lipoprotein cholesterol measurement,EFO_0004611,0.4827955288471116,4.827964478380595,1,0.4,0.4,transcript,43526.0
SNX13,ENSG00000071189,erythrocyte volume,OBA_0003460,0.48278301019166353,4.827842427053753,1,0.4,0.4,transcript,32454.0
C2CD4A,ENSG00000198535,glucose measurement,EFO_0004468,0.48274762723012127,4.827592382606002,1,0.4,0.4,transcript,3445.0
CYP24A1,ENSG00000019186,chloride measurement,EFO_0009284,0.4826679489117339,4.8268696935871445,2,0.8,1.6,transcript,8412.0
CTBP2,ENSG00000175029,urate measurement,EFO_0004531,0.48264694715870887,4.826483534801237,1,0.4,0.4,transcript,28443.0
PRKCB,ENSG00000166501,ulcerative colitis,EFO_0000729,0.48255328239607803,4.825556790407755,1,0.4,0.4,transcript,16690.0
KITLG,ENSG00000049130,Non-syndromic genetic deafness,Orphanet_87884,0.48250703250502724,4.825239681027127,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
TRDN,ENSG00000186439,Prolonged QT interval,HP_0001657,0.48250703250502724,4.825089528491529,1,0.5,0.5,transcript,26037.0
FAT3,ENSG00000165323,caudate nucleus volume,EFO_0004830,0.4824942824251347,4.824951153246662,1,0.4,0.4,transcript,48025.0
BCKDHB,ENSG00000083123,BMI-adjusted waist circumference,EFO_0007789,0.48244393523590895,4.830166729220487,10,4.0,40.0,transcript,6984.0
EPHA5,ENSG00000145242,medullary thyroid gland carcinoma,MONDO_0015277,0.4824297224333841,4.824307949057009,1,0.4,0.4,transcript,37297.0
KIF20B,ENSG00000138182,neurodegenerative disease,EFO_0005772,0.4823590421895098,4.823617733852273,1,0.5,0.5,transcript,18307.0
FAM76B,ENSG00000077458,erythrocyte volume,OBA_0003460,0.48233442949681504,4.823365990471757,1,0.4,0.4,transcript,18437.0
TSPAN3,ENSG00000140391,Abnormality of the skeletal system,HP_0000924,0.48230487478147815,4.823070658419514,1,0.4,0.4,transcript,18256.0
HLA-E,ENSG00000204592,COVID-19,MONDO_0100096,0.482215277509207,4.822248445984201,1,0.4,0.4,transcript,4181.0
CWH43,ENSG00000109182,HbA1c measurement,EFO_0004541,0.4822133616248855,4.8221956894952855,1,0.5,0.5,transcript,8055.0
GIPC2,ENSG00000137960,Red cell distribution width,EFO_0009188,0.482168571908562,4.82207691712963,2,0.8,1.6,transcript,4090.0
STXBP5,ENSG00000164506,diastolic blood pressure,EFO_0006336,0.48214692882947746,4.821483118703233,2,0.9,1.8,transcript,130148.0
TMEM106B,ENSG00000106460,depressive symptom measurement,EFO_0007006,0.4820573376658069,4.8206062531452165,2,0.8,1.6,transcript,48667.0
FMN1,ENSG00000248905,androgenetic alopecia,EFO_0004191,0.48203358338841396,4.820371531436626,2,0.8,1.6,transcript,44821.0
YEATS2,ENSG00000163872,benign adult familial myoclonic epilepsy,MONDO_0019448,0.48199274350692484,4.819961175537566,1,0.5,0.5,transcript,14819.0
AKAP6,ENSG00000151320,waist circumference,OBA_1001085,0.4819808135403493,4.820382915462144,7,2.8000000000000003,19.6,transcript,34100.0
NID2,ENSG00000087303,hip circumference,OBA_1000032,0.4818965072780711,4.819010207281523,1,0.5,0.5,transcript,11078.0
DOK5,ENSG00000101134,mean corpuscular hemoglobin concentration,EFO_0004528,0.48186307253039873,4.818718560174431,1,0.4,0.4,transcript,4554.0
TLK1,ENSG00000198586,C-reactive protein measurement,EFO_0004458,0.48182355967484636,4.818249491909474,1,0.4,0.4,transcript,28787.0
GIPC2,ENSG00000137960,lymphocyte count,EFO_0004587,0.48182337649026574,4.818624962946668,2,0.8,1.6,transcript,4090.0
CD163L1,ENSG00000177675,L lactate dehydrogenase measurement,EFO_0004808,0.4817497122099096,4.81752699736984,1,0.4,0.4,transcript,13389.0
COLEC10,ENSG00000184374,lymphocyte count,EFO_0004587,0.48173420826794733,4.81744726280043,1,0.4,0.4,transcript,3803.0
GREM1,ENSG00000166923,colonic neoplasm,EFO_0004288,0.48171454035527705,4.817163627617648,1,0.4,0.4,transcript,21949.0
CCBE1,ENSG00000183287,mean corpuscular hemoglobin,EFO_0004527,0.48168747396584494,4.816888529908742,1,0.4,0.4,transcript,29006.0
PIP4K2A,ENSG00000150867,body weight,EFO_0004338,0.4816789976645501,4.8168334218502356,1,0.4,0.4,transcript,9207.0
RNF144B,ENSG00000137393,grip strength measurement,EFO_0006941,0.48154645584980854,4.815537431516851,1,0.4,0.4,transcript,5489.0
PEX13,ENSG00000162928,neurodegenerative disease,EFO_0005772,0.4815345125567582,4.815390955081789,1,0.4,0.4,transcript,8728.0
LPP,ENSG00000145012,glucose measurement,EFO_0004468,0.4814699520279039,4.8147684204599015,4,1.6,6.4,transcript,92888.0
ZNF148,ENSG00000163848,serum creatinine amount,OBA_2050096,0.4814043075898928,4.814054944278597,1,0.4,0.4,transcript,33703.0
SYNJ2,ENSG00000078269,platelet volume,OBA_0003277,0.48131359511160726,4.813187098740905,2,0.8,1.6,transcript,31282.0
CASQ2,ENSG00000118729,neutrophil count,EFO_0004833,0.4813104170074337,4.813116821095907,1,0.4,0.4,transcript,31618.0
CEP68,ENSG00000011523,diabetes mellitus,EFO_0000400,0.48128222552669514,4.812859022375912,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,diabetes mellitus,EFO_0000400,0.48128222552669514,4.812859022375912,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,diabetes mellitus,EFO_0000400,0.48128222552669514,4.812859022375912,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,diabetes mellitus,EFO_0000400,0.48128222552669514,4.812859022375912,3,1.5,4.5,gene_variant,122392.0
KCNN3,ENSG00000143603,atrial fibrillation,EFO_0000275,0.4811956207628821,4.812075243438761,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
KLHL3,ENSG00000146021,blood sodium bicarbonate amount,OBA_2050094,0.4810821786297941,4.810869096981285,2,0.8,1.6,transcript,33819.0
SLC25A37,ENSG00000147454,prostate carcinoma,EFO_0001663,0.48107490133313935,4.810768183272925,1,0.4,0.4,transcript,20866.0
CFHR4,ENSG00000134365,retinopathy,EFO_0003839,0.4809921807837626,4.809962316628034,1,0.5,0.5,transcript,12343.0
EPHA5,ENSG00000145242,brain volume,OBA_2050009,0.48096192708740515,4.80962999559722,1,0.4,0.4,transcript,37297.0
ZNF682,ENSG00000197124,intermediate density lipoprotein measurement,EFO_0008595,0.4809525126012549,4.809551100038522,1,0.5,0.5,transcript,19250.0
ADAMTS3,ENSG00000156140,diastolic blood pressure,EFO_0006336,0.48087152946658884,4.8087646104099395,1,0.4,0.4,transcript,8111.0
CBLB,ENSG00000114423,eosinophil count,EFO_0004842,0.4808703578984446,4.808712070651998,1,0.4,0.4,transcript,47105.0
PPA2,ENSG00000138777,platelet count,EFO_0004309,0.4807711340429212,4.8077387466997665,1,0.5,0.5,transcript,18244.0
SLC25A37,ENSG00000147454,calcium measurement,EFO_0004838,0.48076634072975266,4.807682577239059,1,0.4,0.4,transcript,20866.0
ADGRV1,ENSG00000164199,generalised epilepsy,EFO_0005917,0.48074139277417205,4.807418352912089,1,0.5,0.5,transcript,112990.0
SLC7A2,ENSG00000003989,diastolic blood pressure,EFO_0006336,0.48072331788303174,4.8073541744514285,3,1.4,4.199999999999999,transcript,34712.0
ALG10B,ENSG00000175548,high density lipoprotein cholesterol measurement,EFO_0004612,0.4806146588351812,4.806852404275019,5,2.0,10.0,transcript,14168.0
CYP24A1,ENSG00000019186,neurodegenerative disease,EFO_0005772,0.4805561465451824,4.805751669921629,2,0.8,1.6,transcript,8412.0
ADAMTS3,ENSG00000156140,serum albumin amount,OBA_2050068,0.4805551172860795,4.8056004886048465,1,0.4,0.4,transcript,8111.0
PTK2,ENSG00000169398,low density lipoprotein cholesterol measurement,EFO_0004611,0.48054491828582724,4.805454025062928,1,0.4,0.4,transcript,82607.0
EPHA5,ENSG00000145242,self reported educational attainment,EFO_0004784,0.480531780972625,4.805328534449418,1,0.4,0.4,transcript,37297.0
DNAJC21,ENSG00000168724,serum creatinine amount,OBA_2050096,0.4805121664315971,4.805130687347258,1,0.4,0.4,transcript,44331.0
SLC22A24,ENSG00000197658,metabolite ratio,EFO_0022223,0.4804550125246484,4.804635420367603,1,0.5,0.5,transcript,5862.0
GHR,ENSG00000112964,Short stature,HP_0004322,0.4804316203832859,4.8043250653495075,1,0.4,0.4,transcript,45139.0
FNDC3B,ENSG00000075420,intraocular pressure measurement,EFO_0004695,0.48043054641043903,4.804359081610506,2,0.8,1.6,transcript,29841.0
ATP10D,ENSG00000145246,sphingolipid measurement,EFO_0004622,0.4802932787453351,4.802964610263941,1,0.5,0.5,transcript,15712.0
ADAMTS3,ENSG00000156140,apolipoprotein B measurement,EFO_0004615,0.48026325570727413,4.802681872816792,1,0.4,0.4,transcript,8111.0
AKAP10,ENSG00000108599,platelet volume,OBA_0003277,0.48024922070168097,4.802527387315842,1,0.4,0.4,transcript,11370.0
GSAP,ENSG00000186088,Eczematoid dermatitis,HP_0000964,0.48022258238008714,4.802251337910174,1,0.5,0.5,transcript,19597.0
SLC22A5,ENSG00000197375,tryptophan betaine measurement,EFO_0021017,0.48021609536853593,4.802166522621831,1,0.4,0.4,transcript,71827.0
SYNE2,ENSG00000054654,cardiac arrhythmia,EFO_0004269,0.48021154612800604,4.802128096795968,2,1.0,2.0,transcript,158284.0
PLCL2,ENSG00000154822,platelet volume,OBA_0003277,0.4802066271092982,4.802204823223221,2,0.8,1.6,transcript,11548.0
FNDC3B,ENSG00000075420,electrocardiography,EFO_0004327,0.48018422641006675,4.801895881606783,2,0.8,1.6,transcript,29841.0
RASA2,ENSG00000155903,mean corpuscular hemoglobin,EFO_0004527,0.4801722351112836,4.801769964492196,1,0.4,0.4,transcript,8401.0
SKIL,ENSG00000136603,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.4800953460644839,4.800969920466415,1,0.5,0.5,transcript,30377.0
PIP4K2A,ENSG00000150867,eosinophil count,EFO_0004842,0.4800873560420401,4.800917005625136,1,0.4,0.4,transcript,9207.0
RPS6KA5,ENSG00000100784,body weight,EFO_0004338,0.4800598277317247,4.80060814216878,1,0.4,0.4,transcript,40548.0
TSPAN9,ENSG00000011105,Abnormality of the skeletal system,HP_0000924,0.48004883400811893,4.80052382372323,1,0.5,0.5,transcript,14091.0
RANBP17,ENSG00000204764,body fat percentage,EFO_0007800,0.4800252520668615,4.800262034963843,1,0.4,0.4,transcript,42042.0
PPP1R2,ENSG00000184203,platelet volume,OBA_0003277,0.4800217592467607,4.800264077069583,1,0.4,0.4,transcript,8605.0
MLLT3,ENSG00000171843,systolic blood pressure,EFO_0006335,0.4799871273863313,4.799974512990942,2,0.8,1.6,transcript,15498.0
CD93,ENSG00000125810,glomerular filtration rate,OBA_0003747,0.4799820738947462,4.7998470564683515,1,0.4,0.4,transcript,15199.0
RET,ENSG00000165731,Ondine syndrome,Orphanet_661,0.47995897031446144,4.79959971540964,1,0.4,0.4,transcript,39951.0
DPYD,ENSG00000188641,sodium measurement,EFO_0009282,0.47993527154474797,4.799410936220652,1,0.5,0.5,transcript,8588.0
CYP24A1,ENSG00000019186,alkaline phosphatase measurement,EFO_0004533,0.4798794985982152,4.798985190451957,2,0.8,1.6,transcript,8412.0
STX7,ENSG00000079950,reticulocyte measurement,EFO_0010700,0.47975741471635036,4.7976626623217244,2,0.8,1.6,transcript,18076.0
VPS13A,ENSG00000197969,mean reticulocyte volume,EFO_0010701,0.4796876459990151,4.7968832052389665,1,0.4,0.4,transcript,59301.0
PEX2,ENSG00000164751,lean body mass,EFO_0004995,0.47966833919254537,4.796727217936191,1,0.4,0.4,transcript,9127.0
CNTN5,ENSG00000149972,matrix metalloproteinase 12 measurement,EFO_0010590,0.4796680880638081,4.796693861329302,1,0.4,0.4,transcript,30815.0
DUSP22,ENSG00000112679,total blood protein measurement,EFO_0004536,0.47960779725916497,4.796101576982066,1,0.4,0.4,transcript,16946.0
ST8SIA4,ENSG00000113532,systemic lupus erythematosus,MONDO_0007915,0.47957580314944775,4.795800908544536,1,0.4,0.4,transcript,9329.0
ACVR1C,ENSG00000123612,high density lipoprotein cholesterol measurement,EFO_0004612,0.4794654134398686,4.794773448343503,2,0.8,1.6,transcript,13410.0
AFF1,ENSG00000172493,bone tissue density,OBA_1000110,0.4794509726490847,4.794519949087897,1,0.4,0.4,transcript,39129.0
MAGI2,ENSG00000187391,neurodegenerative disease,EFO_0005772,0.4794462212107143,4.7944667755041355,1,0.4,0.4,transcript,87654.0
AR,ENSG00000169083,azoospermia,EFO_0000279,0.47941665238321435,4.794207853618004,2,0.8,1.6,transcript,38713.0
SLAMF7,ENSG00000026751,SLAM family member 7 measurement,EFO_0008287,0.47941631378015276,4.794179334100673,1,0.4,0.4,transcript,24697.0
RAD18,ENSG00000070950,alpha fetoprotein measurement,EFO_0010583,0.47939576176098375,4.793991098818509,1,0.4,0.4,transcript,11947.0
ABCB5,ENSG00000004846,glomerular filtration rate,OBA_0003747,0.47934542753529297,4.79348118782013,1,0.4,0.4,transcript,14863.0
MDM4,ENSG00000198625,diastolic blood pressure,EFO_0006336,0.4792997921857019,4.793003792727228,1,0.4,0.4,transcript,68133.0
FAT4,ENSG00000196159,Hennekam syndrome,MONDO_0016256,0.4792242693158554,4.792251403201233,1,0.4,0.4,transcript,45924.0
MMADHC,ENSG00000168288,erythrocyte volume,OBA_0003460,0.47919310377792357,4.792012603847751,1,0.4,0.4,transcript,4904.0
CYP24A1,ENSG00000019186,cystatin B measurement,EFO_0010593,0.4791608547124082,4.791798751593888,2,0.8,1.6,transcript,8412.0
QKI,ENSG00000112531,Red cell distribution width,EFO_0009188,0.47911513062668554,4.79118687842275,2,0.8,1.6,transcript,44979.0
LHX9,ENSG00000143355,sex hormone-binding globulin measurement,EFO_0004696,0.47903008075535936,4.79037507417075,2,0.8,1.6,transcript,21544.0
MEOX2,ENSG00000106511,high density lipoprotein cholesterol measurement,EFO_0004612,0.47901715729876126,4.7903402781752975,1,0.4,0.4,transcript,2371.0
COL24A1,ENSG00000171502,glaucoma,MONDO_0005041,0.4789869300993457,4.789893697187651,1,0.4,0.4,transcript,16396.0
CYBRD1,ENSG00000071967,body weight,EFO_0004338,0.47897915400309066,4.789825649351278,1,0.4,0.4,transcript,11727.0
GLB1,ENSG00000170266,atopic eczema,EFO_0000274,0.4789565544575047,4.789596452654419,1,0.5,0.5,transcript,16177.0
PLXNA4,ENSG00000221866,brain volume,OBA_2050009,0.4788572305446334,4.788584552843762,1,0.4,0.4,transcript,32660.0
AKR1B10,ENSG00000198074,systolic blood pressure,EFO_0006335,0.4787960229643496,4.78809236495005,1,0.5,0.5,transcript,3784.0
UGT2B15,ENSG00000196620,hemoglobin measurement,EFO_0004509,0.47879088907500106,4.788846097872785,2,1.0,2.0,transcript,2134.0
SEMA6D,ENSG00000137872,sleep duration trait,OBA_2040171,0.47878652841746383,4.787874711022301,1,0.5,0.5,transcript,53040.0
MACF1,ENSG00000127603,HbA1c measurement,EFO_0004541,0.47869086733666294,4.786914000218959,2,0.8,1.6,gene_variant,300365.0
ID4,ENSG00000172201,hip circumference,OBA_1000032,0.4786633758092187,4.787046874539385,2,0.8,1.6,transcript,3873.0
DUSP22,ENSG00000112679,monocyte count,EFO_0005091,0.47862694153497864,4.786293019740203,1,0.4,0.4,transcript,16946.0
HEPHL1,ENSG00000181333,serum alanine aminotransferase measurement,EFO_0004735,0.47859137982829986,4.7859826569505834,1,0.4,0.4,transcript,5809.0
BANK1,ENSG00000153064,amygdala volume,OBA_2050034,0.47854833740422076,4.7856958617833,3,1.3,3.9000000000000004,transcript,18354.0
PCDH10,ENSG00000138650,metabolite measurement,EFO_0004725,0.47852392590041787,4.785353121799511,2,0.8,1.6,transcript,14052.0
GSAP,ENSG00000186088,body weight,EFO_0004338,0.4784378432346561,4.784403946455863,1,0.5,0.5,transcript,19597.0
STXBP4,ENSG00000166263,breast carcinoma,EFO_0000305,0.4784239776562191,4.784631487949241,5,2.0,10.0,transcript,25529.0
PDE1A,ENSG00000115252,potassium measurement,EFO_0009283,0.47833760187730695,4.783502569903241,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
AOX1,ENSG00000138356,X-12026 measurement,EFO_0800700,0.47833355030364566,4.783363604764713,1,0.4,0.4,transcript,14234.0
PAG1,ENSG00000076641,monocyte count,EFO_0005091,0.4782236567381874,4.782366659259263,2,0.8,1.6,transcript,12299.0
DTHD1,ENSG00000197057,lymphocyte count,EFO_0004587,0.47821625146665636,4.782188915215695,1,0.5,0.5,transcript,18939.0
CNTN5,ENSG00000149972,neuroticism measurement,EFO_0007660,0.4781904066921418,4.781917047612639,1,0.4,0.4,transcript,30815.0
FAM210A,ENSG00000177150,bone tissue density,OBA_1000110,0.47816327596696095,4.781654905611365,1,0.4,0.4,transcript,18062.0
MACF1,ENSG00000127603,triglyceride measurement,EFO_0004530,0.47815240940309905,4.78152942088332,2,0.8,1.6,gene_variant,300365.0
LPP,ENSG00000145012,serum creatinine amount,OBA_2050096,0.47808681464894265,4.78093704667029,4,1.6,6.4,transcript,92888.0
AKAP6,ENSG00000151320,self reported educational attainment,EFO_0004784,0.47807879747786847,4.781362754837335,7,2.8000000000000003,19.6,transcript,34100.0
MDM4,ENSG00000198625,breast carcinoma,EFO_0000305,0.47799465445946465,4.779952415464856,1,0.4,0.4,transcript,68133.0
PEX2,ENSG00000164751,neuroimaging measurement,EFO_0004346,0.47795347674013233,4.77957859341206,1,0.4,0.4,transcript,9127.0
GFPT1,ENSG00000198380,spinal stenosis,EFO_0007490,0.47790809591000005,4.779096063129001,1,0.4,0.4,transcript,26483.0
CCDC126,ENSG00000169193,alkaline phosphatase measurement,EFO_0004533,0.4779040937096311,4.779083399941322,1,0.4,0.4,transcript,9420.0
ZFP1,ENSG00000184517,lymphocyte count,EFO_0004587,0.47789829622983265,4.77901131500601,1,0.4,0.4,transcript,14108.0
ZPLD1,ENSG00000170044,body mass index,EFO_0004340,0.4778860369856428,4.779019352368351,2,0.8,1.6,transcript,10064.0
FAS,ENSG00000026103,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.47788289964117403,4.778831204636273,1,0.4,0.4,transcript,181141.0
UGT2B15,ENSG00000196620,X-15492 measurement,EFO_0800752,0.4778396253897252,4.779333461020026,2,1.0,2.0,transcript,2134.0
UGT2B15,ENSG00000196620,"5alpha-androstan-3alpha,17beta-diol 17-glucuronide measurement",EFO_0800360,0.47779876260553206,4.778924833178095,2,1.0,2.0,transcript,2134.0
TMEM170B,ENSG00000205269,cognitive function measurement,EFO_0008354,0.4777482192657285,4.777527181972323,1,0.4,0.4,transcript,8891.0
ANO5,ENSG00000171714,Elevated circulating creatine kinase concentration,HP_0003236,0.4777415056010096,4.77742010237356,1,0.4,0.4,transcript,79265.0
CD2AP,ENSG00000198087,reticulocyte count,EFO_0007986,0.4777340932608651,4.777393002382147,1,0.4,0.4,transcript,7682.0
RTKN2,ENSG00000182010,Graves disease,EFO_0004237,0.477704370413077,4.7770789619536,1,0.4,0.4,transcript,11345.0
RCL1,ENSG00000120158,HbA1c measurement,EFO_0004541,0.47762310695757026,4.776269743074687,1,0.4,0.4,transcript,10343.0
CNTN5,ENSG00000149972,metabolite measurement,EFO_0004725,0.4776182903340361,4.776195884031583,1,0.4,0.4,transcript,30815.0
RASA2,ENSG00000155903,fat pad mass,OBA_0004528,0.47759979207947406,4.7760455341740995,1,0.4,0.4,transcript,8401.0
ATXN3,ENSG00000066427,Spinocerebellar ataxia type 3,Orphanet_98757,0.47757964203368997,4.77580214353445,1,0.4,0.4,transcript,69891.0
LINGO2,ENSG00000174482,restless legs syndrome,EFO_0004270,0.47757700925654745,4.775781811429917,1,0.4,0.4,transcript,34133.0
TNFRSF11A,ENSG00000141655,allergic rhinitis,EFO_0005854,0.477534809805834,4.7754726892435135,2,0.8,1.6,transcript,12842.0
EPHA5,ENSG00000145242,mathematical ability,EFO_0004875,0.47749836073314844,4.774994332054653,1,0.4,0.4,transcript,37297.0
DPYD,ENSG00000188641,cystatin C measurement,EFO_0004617,0.4774877603060976,4.774935823834148,1,0.5,0.5,transcript,8588.0
GBE1,ENSG00000114480,body weight,EFO_0004338,0.47748454280705466,4.774906307164666,1,0.5,0.5,transcript,8213.0
CTBP2,ENSG00000175029,platelet count,EFO_0004309,0.47744687713429584,4.774482834557106,1,0.4,0.4,transcript,28443.0
ATAD2B,ENSG00000119778,HbA1c measurement,EFO_0004541,0.47743940094842846,4.7744121871711735,1,0.4,0.4,transcript,22005.0
PTPRJ,ENSG00000149177,lean body mass,EFO_0004995,0.47743340928522565,4.774409280822181,2,0.8,1.6,transcript,21280.0
LTBP1,ENSG00000049323,platelet volume,OBA_0003277,0.4773890616242003,4.773903275671696,1,0.4,0.4,transcript,31597.0
ATAD2B,ENSG00000119778,erythrocyte volume,OBA_0003460,0.4773530654817094,4.773548832503983,1,0.4,0.4,transcript,22005.0
KLF10,ENSG00000155090,basophil measurement,EFO_0803539,0.4773277204645028,4.773338050401037,1,0.4,0.4,transcript,6574.0
RPS6KA5,ENSG00000100784,BMI-adjusted waist circumference,EFO_0007789,0.4773048879572428,4.773058744423962,1,0.4,0.4,transcript,40548.0
PAFAH1B2,ENSG00000168092,cholesteryl ester measurement,EFO_0010351,0.4772360146397725,4.772493936848432,2,0.8,1.6,transcript,11959.0
C12orf42,ENSG00000179088,fat pad mass,OBA_0004528,0.4772351682664125,4.772386822167955,1,0.5,0.5,transcript,14229.0
BMPR2,ENSG00000204217,idiopathic pulmonary arterial hypertension,MONDO_0017147,0.47723472198803896,4.772364991339426,1,0.4,0.4,transcript,22508.0
GRB14,ENSG00000115290,triglyceride measurement,EFO_0004530,0.4772239955097048,4.772280322439867,1,0.4,0.4,transcript,9909.0
STXBP4,ENSG00000166263,erythrocyte volume,OBA_0003460,0.4771957108283148,4.772348819670198,5,2.0,10.0,transcript,25529.0
FAM76B,ENSG00000077458,Red cell distribution width,EFO_0009188,0.4771396627574781,4.771418323078388,1,0.4,0.4,transcript,18437.0
SH3TC2,ENSG00000169247,Tip-toe gait,HP_0030051,0.4771001229958003,4.771005653366681,1,0.4,0.4,transcript,90428.0
COL25A1,ENSG00000188517,testosterone measurement,EFO_0004908,0.4770830310455497,4.770845272116241,1,0.4,0.4,transcript,26735.0
BCAS3,ENSG00000141376,hemoglobin measurement,EFO_0004509,0.4768953949314463,4.768964348432618,1,0.5,0.5,transcript,48081.0
SLC25A37,ENSG00000147454,potassium measurement,EFO_0009283,0.47688466710706534,4.768865841012185,1,0.4,0.4,transcript,20866.0
LTBP1,ENSG00000049323,FEV/FVC ratio,EFO_0004713,0.47688225922264105,4.768835251656103,1,0.4,0.4,transcript,31597.0
ENPEP,ENSG00000138792,Agents acting on the renin-angiotensin system use measurement,EFO_0009931,0.4768793716361882,4.768836116192283,1,0.4,0.4,transcript,9434.0
CEP68,ENSG00000011523,serum alanine aminotransferase measurement,EFO_0004735,0.47678438024638015,4.767880569572762,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,serum alanine aminotransferase measurement,EFO_0004735,0.47678438024638015,4.767880569572762,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,serum alanine aminotransferase measurement,EFO_0004735,0.47678438024638015,4.767880569572762,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,serum alanine aminotransferase measurement,EFO_0004735,0.47678438024638015,4.767880569572762,3,1.5,4.5,gene_variant,122392.0
CWH43,ENSG00000109182,fat pad mass,OBA_0004528,0.4767735314270051,4.767797387516482,1,0.5,0.5,transcript,8055.0
DMRTA1,ENSG00000176399,cerebral cortex area attribute,OBA_2045267,0.47675719353615237,4.767643542951928,1,0.4,0.4,transcript,5586.0
ONECUT1,ENSG00000169856,total cholesterol measurement,EFO_0004574,0.47675491102999357,4.767601957439584,1,0.4,0.4,transcript,7569.0
PLCL2,ENSG00000154822,C-C motif chemokine 17 measurement,EFO_0008045,0.47670470918203883,4.7671856439506275,2,0.8,1.6,transcript,11548.0
EXOC6,ENSG00000138190,platelet count,EFO_0004309,0.4766119245039932,4.76614186231048,1,0.5,0.5,transcript,22107.0
GALR1,ENSG00000166573,body weight,EFO_0004338,0.47659942848850784,4.766138898044876,2,0.8,1.6,transcript,11064.0
BIRC6,ENSG00000115760,urate measurement,EFO_0004531,0.4765559634463901,4.765566816720854,1,0.5,0.5,transcript,69616.0
SPAST,ENSG00000021574,X-11470 measurement,EFO_0021241,0.47651700326606955,4.76517520897904,1,0.4,0.4,transcript,77275.0
NDUFS4,ENSG00000164258,triglyceride measurement,EFO_0004530,0.4764694323446804,4.764800904848349,1,0.4,0.4,transcript,3753.0
PDE10A,ENSG00000112541,thyroid disease,EFO_1000627,0.4764304047005356,4.764323759099273,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
ATF7IP2,ENSG00000166669,neurodegenerative disease,EFO_0005772,0.476380595221426,4.763822161245932,1,0.5,0.5,transcript,30847.0
PEX7,ENSG00000112357,neurodegenerative disease,EFO_0005772,0.47629877805881027,4.763030324727647,1,0.4,0.4,transcript,9402.0
PDCD4,ENSG00000150593,type 2 diabetes mellitus,MONDO_0005148,0.47626025279531087,4.762637539506922,1,0.5,0.5,transcript,14281.0
GCH1,ENSG00000131979,Parkinson disease,MONDO_0005180,0.47622323495929675,4.7622661134150315,1,0.4,0.4,transcript,11847.0
SMC3,ENSG00000108055,genetic disorder,EFO_0000508,0.47620649705683793,4.762073583090987,1,0.4,0.4,transcript,46444.0
FNDC3B,ENSG00000075420,waist-hip ratio,EFO_0004343,0.4761780455132749,4.761834072638865,2,0.8,1.6,transcript,29841.0
LYPLAL1,ENSG00000143353,open-angle glaucoma,EFO_0004190,0.47615586278409733,4.761586424149623,1,0.5,0.5,transcript,17988.0
GHR,ENSG00000112964,metabolite measurement,EFO_0004725,0.47612877543283144,4.761296615844963,1,0.4,0.4,transcript,45139.0
ETV5,ENSG00000244405,obesity,EFO_0001073,0.47604859069581557,4.760518079402457,1,0.4,0.4,transcript,12433.0
DLC1,ENSG00000164741,platelet count,EFO_0004309,0.47600093885691674,4.760021067742282,1,0.4,0.4,transcript,34249.0
NHLH2,ENSG00000177551,neutrophil count,EFO_0004833,0.4758614191584151,4.758651952369576,1,0.4,0.4,transcript,10593.0
HHLA2,ENSG00000114455,mathematical ability,EFO_0004875,0.475826577445967,4.758299578800147,1,0.5,0.5,transcript,14791.0
PLXND1,ENSG00000004399,Moebius syndrome,Orphanet_570,0.47581832931179024,4.758206974087875,1,0.5,0.5,transcript,21114.0
ATG16L1,ENSG00000085978,bilirubin measurement,EFO_0004570,0.4758026324323661,4.7580383158097055,1,0.4,0.4,transcript,33357.0
TRIM44,ENSG00000166326,aniridia,MONDO_0019172,0.4757908311889839,4.75793765676549,1,0.4,0.4,transcript,13631.0
RPS6KA5,ENSG00000100784,bone tissue density,OBA_1000110,0.47578714079373463,4.75788127278888,1,0.4,0.4,transcript,40548.0
SKP2,ENSG00000145604,Red cell distribution width,EFO_0009188,0.47574002277969774,4.757405250650963,1,0.4,0.4,transcript,79636.0
SORL1,ENSG00000137642,smoking status measurement,EFO_0006527,0.475722499294004,4.757272002603138,2,0.9,1.8,transcript,38290.0
HTR2C,ENSG00000147246,post operative nausea and vomiting,EFO_0004888,0.4756955654534638,4.756995077384121,1,0.5,0.5,transcript,12683.0
SLC22A5,ENSG00000197375,platelet count,EFO_0004309,0.47569391368405267,4.7569447057769985,1,0.4,0.4,transcript,71827.0
SECISBP2L,ENSG00000138593,lung adenocarcinoma,EFO_0000571,0.47569225444548485,4.756941628424315,1,0.4,0.4,transcript,20960.0
TBX5,ENSG00000089225,Brugada syndrome,MONDO_0015263,0.47563122586567985,4.756437552313807,2,0.8,1.6,transcript,12770.0
SEMA3C,ENSG00000075223,high density lipoprotein cholesterol measurement,EFO_0004612,0.47562200816353856,4.756253799919125,1,0.4,0.4,transcript,11863.0
SHH,ENSG00000164690,cystatin B measurement,EFO_0010593,0.47559653972254656,4.756018546308644,1,0.4,0.4,transcript,7526.0
ZNF236,ENSG00000130856,HbA1c measurement,EFO_0004541,0.4755571496456972,4.7556304645159395,2,0.9,1.8,transcript,30525.0
PLPP4,ENSG00000203805,body mass index,EFO_0004340,0.4755340234715049,4.755421124502714,1,0.4,0.4,transcript,4945.0
REEP3,ENSG00000165476,mean corpuscular hemoglobin concentration,EFO_0004528,0.47551716932039306,4.755241476874551,1,0.4,0.4,transcript,5732.0
QKI,ENSG00000112531,high density lipoprotein cholesterol measurement,EFO_0004612,0.4755080795080529,4.755116367236424,2,0.8,1.6,transcript,44979.0
ALG10B,ENSG00000175548,lymphocyte count,EFO_0004587,0.4753989429202538,4.754695245125745,5,2.0,10.0,transcript,14168.0
HEATR1,ENSG00000119285,neurodegenerative disease,EFO_0005772,0.47539176923599924,4.753947283411659,1,0.5,0.5,transcript,16897.0
MAGI2,ENSG00000187391,C-C motif chemokine 24 measurement,EFO_0020197,0.47524778735808565,4.752482436977849,1,0.4,0.4,transcript,87654.0
ENPEP,ENSG00000138792,Diuretic use measurement,EFO_0009928,0.4752343902354632,4.752386302185032,1,0.4,0.4,transcript,9434.0
ADK,ENSG00000156110,glomerular filtration rate,OBA_0003747,0.4752016644271231,4.7520356277081826,1,0.4,0.4,transcript,21071.0
ACTN2,ENSG00000077522,smoking initiation,EFO_0005670,0.4751338712883661,4.751355398495449,2,0.8,1.6,transcript,95891.0
ENPEP,ENSG00000138792,cardiovascular disease,EFO_0000319,0.47512095474799326,4.751251947310333,1,0.4,0.4,transcript,9434.0
GKAP1,ENSG00000165113,lipid measurement,EFO_0004529,0.4751124437997708,4.751181564532984,1,0.4,0.4,transcript,7002.0
SEMA6D,ENSG00000137872,smoking status measurement,EFO_0006527,0.47508578921690214,4.750867319016684,1,0.5,0.5,transcript,53040.0
TMEM106B,ENSG00000106460,Alzheimer disease,MONDO_0004975,0.4750655766521532,4.75068864300868,2,0.8,1.6,transcript,48667.0
PKP2,ENSG00000057294,left ventricular noncompaction,MONDO_0018901,0.47504670952786177,4.750623196646943,4,1.6,6.4,transcript,40999.0
FMN1,ENSG00000248905,glomerular filtration rate,OBA_0003747,0.47495752889797704,4.749610986532256,2,0.8,1.6,transcript,44821.0
SKI,ENSG00000157933,genetic disorder,EFO_0000508,0.47491832615550145,4.749235782563418,1,0.4,0.4,transcript,7616.0
PLA2R1,ENSG00000153246,serum creatinine amount,OBA_2050096,0.47483159806031355,4.748395172842296,2,0.8,1.6,transcript,20204.0
KCNQ3,ENSG00000184156,Rolandic epilepsy,Orphanet_1945,0.47478948651171554,4.747951242847952,2,0.8,1.6,transcript,28380.0
DYNC1I2,ENSG00000077380,sodium measurement,EFO_0009282,0.47463122434279126,4.746323430361573,1,0.4,0.4,transcript,35756.0
ETV5,ENSG00000244405,body fat percentage,EFO_0007800,0.4746068420669666,4.746100593113968,1,0.4,0.4,transcript,12433.0
ONECUT2,ENSG00000119547,alkaline phosphatase measurement,EFO_0004533,0.47460482074777516,4.747210033203893,7,2.8000000000000003,19.6,transcript,16870.0
ADGRV1,ENSG00000164199,glomerular filtration rate,OBA_0003747,0.4745564294955062,4.745568720125431,1,0.5,0.5,transcript,112990.0
SLC22A2,ENSG00000112499,coronary artery disease,EFO_0001645,0.47450218984773984,4.745061620423774,1,0.4,0.4,transcript,10070.0
ADGRV1,ENSG00000164199,Usher syndrome type 2A,MONDO_0010169,0.4744481384514859,4.744485809685228,1,0.5,0.5,transcript,112990.0
TGFBR1,ENSG00000106799,Alzheimer disease,MONDO_0004975,0.4744440731266008,4.744444978858154,1,0.4,0.4,transcript,94171.0
TULP4,ENSG00000130338,serum gamma-glutamyl transferase measurement,EFO_0004532,0.47440016990126227,4.744020624069398,1,0.4,0.4,transcript,21136.0
GALNT3,ENSG00000115339,type 2 diabetes mellitus,MONDO_0005148,0.47439197489629004,4.743948656963189,1,0.4,0.4,transcript,13837.0
COLEC10,ENSG00000184374,tumor necrosis factor receptor superfamily member 11B amount,OBA_2050271,0.47439045036334143,4.7440096837543715,1,0.4,0.4,transcript,3803.0
CEP68,ENSG00000011523,heart rate,OBA_1001087,0.4743827430626394,4.743864197735355,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,heart rate,OBA_1001087,0.4743827430626394,4.743864197735355,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,heart rate,OBA_1001087,0.4743827430626394,4.743864197735355,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,heart rate,OBA_1001087,0.4743827430626394,4.743864197735355,3,1.5,4.5,transcript,122392.0
PLCL2,ENSG00000154822,educational attainment,EFO_0011015,0.47436677560911567,4.743806308221395,2,0.8,1.6,transcript,11548.0
VAT1L,ENSG00000171724,potassium measurement,EFO_0009283,0.4742668604124568,4.742759389417351,1,0.4,0.4,transcript,4406.0
CENPC,ENSG00000145241,body mass index,EFO_0004340,0.4742429740056773,4.7426285472138305,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
IQGAP2,ENSG00000145703,mean reticulocyte volume,EFO_0010701,0.47415419610311477,4.741556631962165,1,0.5,0.5,transcript,34081.0
CYP24A1,ENSG00000019186,erythrocyte count,EFO_0004305,0.4741235520712474,4.741425725182279,2,0.8,1.6,transcript,8412.0
QKI,ENSG00000112531,hematocrit,EFO_0004348,0.4741114789810512,4.741150361966406,2,0.8,1.6,transcript,44979.0
BCAS3,ENSG00000141376,phosphate measurement,EFO_0010968,0.4740806668985046,4.740817068103201,1,0.5,0.5,transcript,48081.0
GALR1,ENSG00000166573,reticulocyte measurement,EFO_0010700,0.4740401446200658,4.740546059360455,2,0.8,1.6,transcript,11064.0
GIPC2,ENSG00000137960,neutrophil count,EFO_0004833,0.4740394167025697,4.740785365069708,2,0.8,1.6,transcript,4090.0
CA8,ENSG00000178538,hemoglobin measurement,EFO_0004509,0.4739645240496665,4.739686194730308,1,0.4,0.4,transcript,9767.0
TBL2,ENSG00000106638,glomerular filtration rate,OBA_0003747,0.47395495657866227,4.739564744324171,1,0.4,0.4,transcript,26353.0
SPRED1,ENSG00000166068,lean body mass,EFO_0004995,0.47391883206940216,4.7392328939055215,1,0.4,0.4,transcript,8974.0
FBXO22,ENSG00000167196,gout,EFO_0004274,0.47389045886208203,4.738925787412489,1,0.4,0.4,transcript,18869.0
CENPE,ENSG00000138778,high density lipoprotein cholesterol measurement,EFO_0004612,0.4738411043981877,4.738436737712607,1,0.5,0.5,transcript,19460.0
SYNE2,ENSG00000054654,heart rate,OBA_1001087,0.47375018040711436,4.737514439587052,2,1.0,2.0,transcript,158284.0
FRMD4B,ENSG00000114541,neuroimaging measurement,EFO_0004346,0.47373440823561846,4.737420178617955,2,0.8,1.6,transcript,21026.0
TSPAN9,ENSG00000011105,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.4737157240406022,4.737192724048063,1,0.5,0.5,transcript,14091.0
MACF1,ENSG00000127603,body mass index,EFO_0004340,0.47370527381652894,4.737058065017619,2,0.8,1.6,gene_variant,300365.0
PDE11A,ENSG00000128655,refractive error,MONDO_0004892,0.47370080114506125,4.737071794587945,2,0.8,1.6,transcript,25085.0
ONECUT1,ENSG00000169856,low density lipoprotein cholesterol measurement,EFO_0004611,0.47367188556558104,4.736771702795459,1,0.4,0.4,transcript,7569.0
KITLG,ENSG00000049130,mean corpuscular hemoglobin,EFO_0004527,0.47365424078343266,4.736711763811181,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
LRBA,ENSG00000198589,low density lipoprotein cholesterol measurement,EFO_0004611,0.4736341445485408,4.736345386993429,1,0.4,0.4,transcript,101484.0
PTK2,ENSG00000169398,atrial fibrillation,EFO_0000275,0.4735894937864083,4.735899780068739,1,0.4,0.4,transcript,82607.0
KCNQ3,ENSG00000184156,Intellectual disability,HP_0001249,0.47357522818612396,4.735808659592037,2,0.8,1.6,transcript,28380.0
FRRS1L,ENSG00000260230,Seizure,HP_0001250,0.47352418881477415,4.735327794188009,2,0.8,1.6,transcript,18625.0
FRRS1L,ENSG00000260230,chorea,EFO_0004152,0.47352418881477415,4.735327794188009,2,0.8,1.6,transcript,18625.0
FRRS1L,ENSG00000260230,Progressive encephalopathy,HP_0002448,0.47352418881477415,4.735327794188009,2,0.8,1.6,transcript,18625.0
KCNQ3,ENSG00000184156,childhood epilepsy with centrotemporal spikes,MONDO_0007295,0.47352418881477415,4.735298265878538,2,0.8,1.6,transcript,28380.0
FRRS1L,ENSG00000260230,Benign familial chorea,Orphanet_1429,0.47352418881477415,4.735327794188009,2,0.8,1.6,transcript,18625.0
CTBP2,ENSG00000175029,Pulmonary artery atresia,HP_0004935,0.47352418881477415,4.735255951361889,1,0.4,0.4,transcript,28443.0
PYHIN1,ENSG00000163564,monocyte count,EFO_0005091,0.4734726144774479,4.734763901995548,1,0.4,0.4,transcript,10594.0
PKN2,ENSG00000065243,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.47342056057102544,4.734236417603645,1,0.4,0.4,transcript,12982.0
PKN2,ENSG00000065243,glomerular filtration rate,OBA_0003747,0.47341002105407076,4.734131022434098,1,0.4,0.4,transcript,12982.0
SLC44A1,ENSG00000070214,triglyceride measurement,EFO_0004530,0.4733499463062393,4.733509071979468,1,0.4,0.4,transcript,41628.0
GSAP,ENSG00000186088,HbA1c measurement,EFO_0004541,0.47334614846378825,4.7334869987471855,1,0.5,0.5,transcript,19597.0
PDE10A,ENSG00000112541,red blood cell density,OBA_2045260,0.47328340481304315,4.732853760224349,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
PARP1,ENSG00000143799,"chromosome, telomeric region length",OBA_0003784,0.4732766713787948,4.732772583365925,1,0.5,0.5,transcript,85185.0
ONECUT1,ENSG00000169856,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.47323236495706417,4.73237649671029,1,0.4,0.4,transcript,7569.0
SLC25A37,ENSG00000147454,testosterone measurement,EFO_0004908,0.47321491097204244,4.732168279661956,1,0.4,0.4,transcript,20866.0
SYT13,ENSG00000019505,HbA1c measurement,EFO_0004541,0.47318062415121864,4.732021526765147,2,0.8,1.6,transcript,7432.0
IL4R,ENSG00000077238,Inhalant adrenergic use measurement,EFO_0009941,0.47315335701795813,4.731552134248825,1,0.4,0.4,transcript,21547.0
PTPRJ,ENSG00000149177,apolipoprotein A 1 measurement,EFO_0004614,0.4731438846398411,4.7315140343683355,2,0.8,1.6,transcript,21280.0
CDH23,ENSG00000107736,Sensorineural hearing impairment,HP_0000407,0.47306221399641835,4.730629690667154,1,0.5,0.5,transcript,66219.0
IL4R,ENSG00000077238,lower respiratory tract disease,EFO_0009433,0.472926231717569,4.729280881244933,1,0.4,0.4,transcript,21547.0
UBXN2A,ENSG00000173960,acylcarnitine measurement,EFO_0005059,0.47287354836997203,4.728892700954314,2,0.8,1.6,transcript,10177.0
PPA2,ENSG00000138777,calcium measurement,EFO_0004838,0.4727627715376276,4.72765512164683,1,0.5,0.5,transcript,18244.0
CRYGD,ENSG00000118231,Autosomal dominant optic atrophy and cataract,Orphanet_67036,0.47273641908840663,4.727987243843568,1,0.4,0.4,transcript,642.0
ENPEP,ENSG00000138792,potassium measurement,EFO_0009283,0.47271968952073645,4.727239295037765,1,0.4,0.4,transcript,9434.0
FBXO22,ENSG00000167196,urate measurement,EFO_0004531,0.4726873449575058,4.726894648366727,1,0.4,0.4,transcript,18869.0
DNAJC10,ENSG00000077232,HbA1c measurement,EFO_0004541,0.4726546145426993,4.726565397157525,4,1.7000000000000002,6.800000000000001,transcript,353215.0
PLXND1,ENSG00000004399,bone tissue density,OBA_1000110,0.4725854189512261,4.7258778704822335,1,0.5,0.5,transcript,21114.0
PLCL2,ENSG00000154822,monocyte count,EFO_0005091,0.47251786184416317,4.725317170571871,2,0.8,1.6,transcript,11548.0
ETV5,ENSG00000244405,glucose measurement,EFO_0004468,0.47244460297577606,4.724478202202063,1,0.4,0.4,transcript,12433.0
SEMA6D,ENSG00000137872,restless legs syndrome,EFO_0004270,0.4724117570867337,4.7241269977149996,1,0.5,0.5,transcript,53040.0
ARAP1,ENSG00000186635,insulin measurement,EFO_0004467,0.47238189227815175,4.723827932399285,1,0.4,0.4,transcript,44397.0
DLG1,ENSG00000075711,serum creatinine amount,OBA_2050096,0.47237840766740696,4.723799486445578,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
RASA2,ENSG00000155903,hematocrit,EFO_0004348,0.47235715873506834,4.723619200730043,1,0.4,0.4,transcript,8401.0
AGPAT5,ENSG00000155189,high density lipoprotein cholesterol measurement,EFO_0004612,0.4722677759942368,4.722715132641611,1,0.4,0.4,transcript,10703.0
TMEM106B,ENSG00000106460,mood instability measurement,EFO_0008475,0.4722319624010608,4.722352500497756,2,0.8,1.6,transcript,48667.0
HTR2C,ENSG00000147246,migraine disorder,MONDO_0005277,0.47202673992553024,4.720306822104786,1,0.5,0.5,transcript,12683.0
PLXND1,ENSG00000004399,high density lipoprotein cholesterol measurement,EFO_0004612,0.4720083554279769,4.720107235249742,1,0.5,0.5,transcript,21114.0
DENND3,ENSG00000105339,reticulocyte measurement,EFO_0010700,0.4719255401794684,4.719266218452337,1,0.5,0.5,transcript,46225.0
SLC15A5,ENSG00000188991,mood instability measurement,EFO_0008475,0.47191483260671074,4.720379937425301,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
ETV5,ENSG00000244405,self reported educational attainment,EFO_0004784,0.47190851872067424,4.719117359651044,1,0.4,0.4,transcript,12433.0
ADK,ENSG00000156110,systolic blood pressure,EFO_0006335,0.471902708129229,4.719046064729241,1,0.4,0.4,transcript,21071.0
SLCO6A1,ENSG00000205359,diabetes mellitus,EFO_0000400,0.4718978393942122,4.719019648067535,1,0.5,0.5,transcript,12120.0
SNX13,ENSG00000071189,neuroimaging measurement,EFO_0004346,0.4718955931668459,4.718968256805576,1,0.4,0.4,transcript,32454.0
FRAS1,ENSG00000138759,congenital anomaly of kidney and urinary tract,MONDO_0019719,0.47189093498416496,4.7189414863862575,2,0.9,1.8,transcript,56011.0
PFAS,ENSG00000178921,Coats plus syndrome,MONDO_0012815,0.4718592753342297,4.71861607967773,1,0.4,0.4,transcript,17148.0
NBAS,ENSG00000151779,body mass index,EFO_0004340,0.4718338050739775,4.718371596529779,2,1.0,2.0,transcript,59620.0
KCNIP4,ENSG00000185774,mathematical ability,EFO_0004875,0.47180776670500735,4.718210315035482,2,0.8,1.6,transcript,12062.0
FIGN,ENSG00000182263,Increased blood pressure,HP_0032263,0.4717966681981578,4.7180034365529275,1,0.4,0.4,transcript,10883.0
PDCD5,ENSG00000105185,mean reticulocyte volume,EFO_0010701,0.4717725122355621,4.717803232099812,1,0.4,0.4,transcript,5121.0
LRP2,ENSG00000081479,Hearing impairment,HP_0000365,0.47176868450502185,4.717703433749996,1,0.5,0.5,transcript,30141.0
FAM210A,ENSG00000177150,bone quantitative ultrasound measurement,EFO_0004514,0.4717319642048238,4.7173417879899935,1,0.4,0.4,transcript,18062.0
CD2AP,ENSG00000198087,family history of Alzheimerâs disease,EFO_0009268,0.471686913311097,4.716921202884467,1,0.4,0.4,transcript,7682.0
RBM28,ENSG00000106344,neurodegenerative disease,EFO_0005772,0.4716835713658489,4.716907948421468,2,0.8,1.6,transcript,22150.0
SORL1,ENSG00000137642,Dementia,HP_0000726,0.4716733333650574,4.716780343313672,2,0.9,1.8,transcript,38290.0
KCNQ1,ENSG00000053918,glucose measurement,EFO_0004468,0.4716575708205414,4.716769381543052,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
ATAD2B,ENSG00000119778,platelet volume,OBA_0003277,0.4716315094551926,4.716333272238815,1,0.4,0.4,transcript,22005.0
BANK1,ENSG00000153064,diastolic blood pressure change measurement,EFO_0006945,0.47162616272557856,4.716474114996878,3,1.3,3.9000000000000004,transcript,18354.0
QSER1,ENSG00000060749,HbA1c measurement,EFO_0004541,0.471620514208386,4.716231817286591,1,0.5,0.5,transcript,18744.0
CENPC,ENSG00000145241,educational attainment,EFO_0011015,0.47160961352087494,4.716294942365807,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
EPHA5,ENSG00000145242,thyroid cancer,MONDO_0002108,0.4716044267918286,4.716054992641454,1,0.4,0.4,transcript,37297.0
SKI,ENSG00000157933,serum alanine aminotransferase measurement,EFO_0004735,0.47160111753956147,4.716063696404018,1,0.4,0.4,transcript,7616.0
AKAP10,ENSG00000108599,neuroimaging measurement,EFO_0004346,0.4715858130182133,4.715893310481165,1,0.4,0.4,transcript,11370.0
PLCL2,ENSG00000154822,hemoglobin measurement,EFO_0004509,0.47153760588175053,4.715514610947745,2,0.8,1.6,transcript,11548.0
TTL,ENSG00000114999,smoking initiation,EFO_0005670,0.47153198957650894,4.7153396644712275,1,0.4,0.4,transcript,20234.0
TMEM17,ENSG00000186889,platelet volume,OBA_0003277,0.4715250644794262,4.715314644794262,1,0.4,0.4,transcript,6250.0
LARP4B,ENSG00000107929,prostate carcinoma,EFO_0001663,0.4714923084129103,4.714934096132186,1,0.5,0.5,transcript,45405.0
PARP1,ENSG00000143799,erythrocyte count,EFO_0004305,0.4714634624290331,4.714640493868308,1,0.5,0.5,transcript,85185.0
PRKCB,ENSG00000166501,mast-cell leukemia,EFO_0007359,0.47144530213217267,4.714476987768701,1,0.4,0.4,transcript,16690.0
COLEC10,ENSG00000184374,brain attribute,OBA_2045210,0.4713422686640339,4.713527866761296,1,0.4,0.4,transcript,3803.0
AFF1,ENSG00000172493,sex hormone-binding globulin measurement,EFO_0004696,0.4713212272840195,4.713222495437246,1,0.4,0.4,transcript,39129.0
PTPN4,ENSG00000088179,platelet count,EFO_0004309,0.4713091343845676,4.713554950707057,5,2.0,10.0,transcript,21570.0
SKI,ENSG00000157933,familial thoracic aortic aneurysm and aortic dissection,MONDO_0019625,0.4712925589015016,4.71297811002342,1,0.4,0.4,transcript,7616.0
SKI,ENSG00000157933,Rare disease with thoracic aortic aneurysm and aortic dissection,Orphanet_285014,0.4712925589015016,4.71297811002342,1,0.4,0.4,transcript,7616.0
FAM76B,ENSG00000077458,diastolic blood pressure,EFO_0006336,0.4712799616497682,4.712821312001289,1,0.4,0.4,transcript,18437.0
ATF6,ENSG00000118217,Retinal dystrophy,HP_0000556,0.47127753508645914,4.712781703297573,1,0.4,0.4,transcript,62968.0
SLC22A2,ENSG00000112499,metabolite measurement,EFO_0004725,0.47126785476354016,4.712718269581777,1,0.4,0.4,transcript,10070.0
SLC22A2,ENSG00000112499,urate measurement,EFO_0004531,0.47124528417698114,4.712492563716187,1,0.4,0.4,transcript,10070.0
FAT1,ENSG00000083857,retinal layer thickness,OBA_2050110,0.471232672384254,4.712347919264329,1,0.5,0.5,transcript,23590.0
BPTF,ENSG00000171634,fat pad mass,OBA_0004528,0.47117886868596476,4.7118083110562825,2,0.8,1.6,transcript,81532.0
AGPAT5,ENSG00000155189,serum alanine aminotransferase measurement,EFO_0004735,0.47113277498503636,4.711365122549607,1,0.4,0.4,transcript,10703.0
LYPLAL1,ENSG00000143353,pulse pressure measurement,EFO_0005763,0.4710824641575241,4.710852437883891,1,0.5,0.5,transcript,17988.0
LPP,ENSG00000145012,body mass index,EFO_0004340,0.4710597825449454,4.710666725630317,4,1.6,6.4,transcript,92888.0
RFX7,ENSG00000181827,mean corpuscular hemoglobin concentration,EFO_0004528,0.4710412817775013,4.710422410101152,1,0.4,0.4,transcript,41700.0
SLC25A37,ENSG00000147454,sex hormone-binding globulin measurement,EFO_0004696,0.47101021392124387,4.710121309153971,1,0.4,0.4,transcript,20866.0
SI,ENSG00000090402,genetic disorder,EFO_0000508,0.47092440205261726,4.709316066635683,1,0.5,0.5,transcript,6940.0
GABRA1,ENSG00000022355,amnesia,EFO_1001454,0.47089606540368295,4.708969337607513,1,0.4,0.4,transcript,46064.0
GABRG1,ENSG00000163285,amnesia,EFO_1001454,0.47089606540368295,4.71109146196817,6,2.4000000000000004,14.400000000000002,transcript,6758.0
SLCO1C1,ENSG00000139155,triglyceride measurement,EFO_0004530,0.4708668863450978,4.708699754344344,1,0.5,0.5,transcript,16186.0
FNDC3B,ENSG00000075420,BMI-adjusted hip circumference,EFO_0008039,0.47083661365488616,4.708419754054978,2,0.8,1.6,transcript,29841.0
ANKRD17,ENSG00000132466,genetic disorder,EFO_0000508,0.4707886051091713,4.707895241001193,1,0.4,0.4,transcript,43526.0
PALM2AKAP2,ENSG00000157654,erythrocyte volume,OBA_0003460,0.47078542575573856,4.707862244777833,1,0.4,0.4,transcript,50080.0
TNRC6B,ENSG00000100354,erythrocyte volume,OBA_0003460,0.470746433991013,4.707470791731157,1,0.4,0.4,transcript,61998.0
FNDC3B,ENSG00000075420,appendicular lean mass,EFO_0004980,0.4707231314569843,4.707284932075959,2,0.8,1.6,transcript,29841.0
SGCB,ENSG00000163069,qualitative or quantitative defects of beta-sarcoglycan,MONDO_0016142,0.47070777814232334,4.70715037670454,1,0.4,0.4,transcript,5510.0
FMN1,ENSG00000248905,cystatin C measurement,EFO_0004617,0.470622066124016,4.706256358792647,2,0.8,1.6,transcript,44821.0
CYP24A1,ENSG00000019186,genetic disorder,EFO_0000508,0.4705471050157471,4.705661254627277,2,0.8,1.6,transcript,8412.0
LMO4,ENSG00000143013,platelet count,EFO_0004309,0.4705463799459889,4.70551527951137,1,0.4,0.4,transcript,7770.0
KCNQ3,ENSG00000184156,genetic disorder,EFO_0000508,0.47049950638062826,4.705051441537079,2,0.8,1.6,transcript,28380.0
ANKH,ENSG00000154122,intraocular pressure measurement,EFO_0004695,0.47048962730714633,4.705664715694414,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,intraocular pressure measurement,EFO_0004695,0.47048962730714633,4.705664715694414,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,intraocular pressure measurement,EFO_0004695,0.47048962730714633,4.705664715694414,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,intraocular pressure measurement,EFO_0004695,0.47048962730714633,4.705664715694414,5,2.4,12.0,gene_variant,15616.0
LTBP1,ENSG00000049323,pulse pressure measurement,EFO_0005763,0.4704749151596848,4.7047618110265415,1,0.4,0.4,transcript,31597.0
FRAS1,ENSG00000138759,congenital hydronephrosis,MONDO_0007741,0.47046907915433633,4.704722928087971,2,0.9,1.8,transcript,56011.0
NEMF,ENSG00000165525,genetic disorder,EFO_0000508,0.47040690940195135,4.704089277283551,1,0.5,0.5,transcript,24773.0
ADK,ENSG00000156110,HbA1c measurement,EFO_0004541,0.4704065817636378,4.704084801073329,1,0.4,0.4,transcript,21071.0
NEDD1,ENSG00000139350,body mass index,EFO_0004340,0.4703933238087889,4.70395249477959,1,0.4,0.4,transcript,20772.0
IL4R,ENSG00000077238,Chronic Obstructive Asthma,EFO_0009759,0.4703740474855219,4.703759038924463,1,0.4,0.4,transcript,21547.0
DCK,ENSG00000156136,glucose measurement,EFO_0004468,0.4703681620609708,4.703718606277762,1,0.4,0.4,transcript,10815.0
RFX7,ENSG00000181827,mean corpuscular hemoglobin,EFO_0004527,0.47033977639663294,4.703407356292468,1,0.4,0.4,transcript,41700.0
PAFAH1B2,ENSG00000168092,Red cell distribution width,EFO_0009188,0.4702931719896901,4.703065510347607,2,0.8,1.6,transcript,11959.0
BANK1,ENSG00000153064,Crohn's disease,EFO_0000384,0.4702725180814362,4.702937668555454,3,1.3,3.9000000000000004,transcript,18354.0
CCBE1,ENSG00000183287,triglyceride measurement,EFO_0004530,0.4701758371907168,4.701772162157461,1,0.4,0.4,transcript,29006.0
HTR1F,ENSG00000179097,post operative nausea and vomiting,EFO_0004888,0.4701261073730898,4.701379207221742,1,0.4,0.4,transcript,3386.0
TNFRSF19,ENSG00000127863,bone tissue density,OBA_1000110,0.4701176775160614,4.701209776282652,1,0.5,0.5,transcript,15151.0
NDUFS4,ENSG00000164258,appendicular lean mass,EFO_0004980,0.4700912457795426,4.7010190391969715,1,0.4,0.4,transcript,3753.0
NPS,ENSG00000214285,metabolite measurement,EFO_0004725,0.4700849252267231,4.701174191341154,1,0.4,0.4,transcript,1231.0
BPTF,ENSG00000171634,body fat percentage,EFO_0007800,0.4700449168080873,4.7004687922775075,2,0.8,1.6,transcript,81532.0
VPS13A,ENSG00000197969,reticulocyte measurement,EFO_0010700,0.4699756710536149,4.699763455784964,1,0.4,0.4,transcript,59301.0
TAF2,ENSG00000064313,glomerular filtration rate,OBA_0003747,0.4699603220469248,4.6996060134532724,1,0.5,0.5,transcript,179020.0
SEMA6D,ENSG00000137872,high density lipoprotein cholesterol measurement,EFO_0004612,0.4699435948237369,4.699445375085031,1,0.5,0.5,transcript,53040.0
CEP68,ENSG00000011523,glucose measurement,EFO_0004468,0.4699248288722979,4.69928505583194,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,glucose measurement,EFO_0004468,0.4699248288722979,4.69928505583194,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,glucose measurement,EFO_0004468,0.4699248288722979,4.69928505583194,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,glucose measurement,EFO_0004468,0.4699248288722979,4.69928505583194,3,1.5,4.5,gene_variant,122392.0
COLEC10,ENSG00000184374,bone tissue density,OBA_1000110,0.4699071537328751,4.699176717449708,1,0.4,0.4,transcript,3803.0
SPAST,ENSG00000021574,X-11444 measurement,EFO_0021237,0.4699019035653695,4.699024211972039,1,0.4,0.4,transcript,77275.0
BANK1,ENSG00000153064,eosinophil count,EFO_0004842,0.46985951088538824,4.698807596594975,3,1.3,3.9000000000000004,transcript,18354.0
FGA,ENSG00000171560,triglyceride measurement,EFO_0004530,0.46983488989932,4.6984171234516685,1,0.4,0.4,transcript,5863.0
CFAP299,ENSG00000197826,body height,OBA_VT0001253,0.4697861685153962,4.697926823246719,1,0.5,0.5,transcript,7676.0
PPA2,ENSG00000138777,erythrocyte volume,OBA_0003460,0.4697600252415702,4.697627658686256,1,0.5,0.5,transcript,18244.0
TTL,ENSG00000114999,alcohol consumption quality,OBA_1000840,0.469734669256317,4.697366461269308,1,0.4,0.4,transcript,20234.0
CEP85L,ENSG00000111860,dilated cardiomyopathy,EFO_0000407,0.4697257291971815,4.697272694952291,1,0.4,0.4,transcript,25969.0
NDUFAF2,ENSG00000164182,brain volume,OBA_2050009,0.4697086979392103,4.697127184437837,1,0.4,0.4,transcript,9949.0
PKN2,ENSG00000065243,pulse pressure measurement,EFO_0005763,0.46969741017092276,4.697004913602618,1,0.4,0.4,transcript,12982.0
CLSTN2,ENSG00000158258,level of calsyntenin-2 in blood serum,OBA_2041057,0.4696568846439776,4.696592932668475,1,0.4,0.4,transcript,16607.0
RIF1,ENSG00000080345,serum creatinine amount,OBA_2050096,0.4696514722795105,4.696576266112132,3,1.3,3.9000000000000004,transcript,63370.0
TRPC6,ENSG00000137672,age at menarche,EFO_0004703,0.46963062271565253,4.69633511428009,1,0.4,0.4,transcript,13847.0
LRBA,ENSG00000198589,myeloid leukocyte count,OBA_2045223,0.46962942472650215,4.696298188773043,1,0.4,0.4,transcript,101484.0
CD69,ENSG00000110848,neutrophil count,EFO_0004833,0.4696230562492437,4.69707503821376,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
KLF10,ENSG00000155090,C-reactive protein measurement,EFO_0004458,0.4696123317771052,4.696184163527061,1,0.4,0.4,transcript,6574.0
LRPAP1,ENSG00000163956,triglyceride measurement,EFO_0004530,0.4695772048703698,4.696002684875137,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
QKI,ENSG00000112531,erythrocyte volume,OBA_0003460,0.4695701337272799,4.695736909428693,2,0.8,1.6,transcript,44979.0
CENPE,ENSG00000138778,glomerular filtration rate,OBA_0003747,0.46955644529501644,4.695590146680894,1,0.5,0.5,transcript,19460.0
BANK1,ENSG00000153064,body weight,EFO_0004338,0.4694347637251573,4.694560124992665,3,1.3,3.9000000000000004,transcript,18354.0
CENPE,ENSG00000138778,diastolic blood pressure,EFO_0006336,0.46940903670441786,4.694116060774908,1,0.5,0.5,transcript,19460.0
KYNU,ENSG00000115919,blood protein measurement,EFO_0007937,0.46929513591446537,4.693109607858883,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
AGPAT5,ENSG00000155189,low density lipoprotein cholesterol measurement,EFO_0004611,0.46924748881006423,4.6925122607998855,1,0.4,0.4,transcript,10703.0
PHIP,ENSG00000146247,diastolic blood pressure,EFO_0006336,0.4692438801112612,4.692446778266045,1,0.5,0.5,transcript,62679.0
GREM1,ENSG00000166923,rectosigmoid junction neoplasm,MONDO_0002423,0.4691542576591052,4.691560800655929,1,0.4,0.4,transcript,21949.0
PRTG,ENSG00000166450,cerebral cortex area attribute,OBA_2045267,0.46907953772824035,4.691013453366726,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
TET1,ENSG00000138336,HbA1c measurement,EFO_0004541,0.4690017620536123,4.69005923518448,1,0.4,0.4,transcript,9612.0
AKAP6,ENSG00000151320,neurodegenerative disease,EFO_0005772,0.46899623657851314,4.690537145843782,7,2.8000000000000003,19.6,transcript,34100.0
PRDM5,ENSG00000138738,Abnormality of the cardiovascular system,HP_0001626,0.468964133849875,4.689721947093641,2,0.8,1.6,transcript,19849.0
AMTN,ENSG00000187689,Hypocalcified amelogenesis imperfecta,Orphanet_100032,0.4689582350322861,4.689808339023426,1,0.4,0.4,transcript,1770.0
PARP11,ENSG00000111224,mean corpuscular hemoglobin,EFO_0004527,0.46893079299621077,4.689325878449948,1,0.4,0.4,transcript,22286.0
LPP,ENSG00000145012,eosinophil percentage of leukocytes,EFO_0007991,0.4689253848627877,4.689322748808739,4,1.6,6.4,transcript,92888.0
PIP4K2A,ENSG00000150867,pulse pressure measurement,EFO_0005763,0.4689199541843884,4.689242987048619,1,0.4,0.4,transcript,9207.0
PLXND1,ENSG00000004399,triglyceride measurement,EFO_0004530,0.4688645574300694,4.688669255270666,1,0.5,0.5,transcript,21114.0
TBXT,ENSG00000164458,spina bifida,EFO_0003105,0.46879515221801366,4.688411998005155,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
SMAD2,ENSG00000175387,genetic disorder,EFO_0000508,0.4687034691141584,4.68752848819709,9,3.6,32.4,transcript,65614.0
PARP11,ENSG00000111224,amygdala volume,OBA_2050034,0.4686858636323492,4.6868765848113325,1,0.4,0.4,transcript,22286.0
IL4R,ENSG00000077238,allergic asthma,MONDO_0004784,0.46856656080255304,4.685684172094774,1,0.4,0.4,transcript,21547.0
LARP4B,ENSG00000107929,blood urea nitrogen measurement,EFO_0004741,0.4684953686656143,4.684964698659226,1,0.5,0.5,transcript,45405.0
PLCL2,ENSG00000154822,urate measurement,EFO_0004531,0.46840468985733585,4.684185450703597,2,0.8,1.6,transcript,11548.0
LPP,ENSG00000145012,erythrocyte count,EFO_0004305,0.4683604831319906,4.683673731500769,4,1.6,6.4,transcript,92888.0
TMEM106B,ENSG00000106460,feeling tense measurement,EFO_0009596,0.4681898573484017,4.681931449971165,2,0.8,1.6,transcript,48667.0
UBXN2A,ENSG00000173960,hematocrit,EFO_0004348,0.468175332588289,4.681910543137484,2,0.8,1.6,transcript,10177.0
CEP68,ENSG00000011523,hypertension,EFO_0000537,0.4681315540276379,4.68135230738534,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,hypertension,EFO_0000537,0.4681315540276379,4.68135230738534,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,hypertension,EFO_0000537,0.4681315540276379,4.68135230738534,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,hypertension,EFO_0000537,0.4681315540276379,4.68135230738534,3,1.5,4.5,gene_variant,122392.0
SGTB,ENSG00000197860,neurodegenerative disease,EFO_0005772,0.4681193479176785,4.681256620455396,1,0.4,0.4,transcript,6335.0
AFF1,ENSG00000172493,gout,EFO_0004274,0.46808954735342584,4.680905696131309,1,0.4,0.4,transcript,39129.0
GRIA4,ENSG00000152578,obesity,EFO_0001073,0.4680860273503629,4.680869565025116,1,0.4,0.4,transcript,43050.0
RPS6KA5,ENSG00000100784,lean body mass,EFO_0004995,0.4680172464673831,4.680182329525365,1,0.4,0.4,transcript,40548.0
STAM,ENSG00000136738,aspartate aminotransferase measurement,EFO_0004736,0.46800798176038794,4.680145813314158,1,0.4,0.4,transcript,6061.0
MEOX2,ENSG00000106511,bone tissue density,OBA_1000110,0.4679364491943708,4.679533197131392,1,0.4,0.4,transcript,2371.0
MMP12,ENSG00000262406,stroke,EFO_0000712,0.4679295667900092,4.679515206868259,1,0.4,0.4,transcript,1822.0
PDE1A,ENSG00000115252,mean arterial pressure,EFO_0006340,0.4679244460070258,4.67937101120043,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
NEDD1,ENSG00000139350,lean body mass,EFO_0004995,0.4678388992789381,4.678408249481082,1,0.4,0.4,transcript,20772.0
TNRC6B,ENSG00000100354,uterine fibroid,EFO_0000731,0.46779755960346214,4.677982047855648,1,0.4,0.4,transcript,61998.0
BCKDHB,ENSG00000083123,BMI-adjusted waist-hip ratio,EFO_0007788,0.4677796609871012,4.68352398673241,10,4.0,40.0,transcript,6984.0
TNFRSF11A,ENSG00000141655,heel bone mineral density,EFO_0009270,0.46774591902415,4.677583781426674,2,0.8,1.6,transcript,12842.0
MAGI2,ENSG00000187391,metabolite measurement,EFO_0004725,0.4676917333613837,4.676921897010829,1,0.4,0.4,transcript,87654.0
BTC,ENSG00000174808,chronic obstructive pulmonary disease,EFO_0000341,0.46761385273059664,4.67626059016834,1,0.4,0.4,transcript,3277.0
RCL1,ENSG00000120158,neutrophil count,EFO_0004833,0.46758239573318666,4.675862630830851,1,0.4,0.4,transcript,10343.0
SLC25A37,ENSG00000147454,hip circumference,OBA_1000032,0.46757266116892116,4.675745781630743,1,0.4,0.4,transcript,20866.0
BANK1,ENSG00000153064,cholesteryl ester measurement,EFO_0010351,0.46753434232991004,4.675555911040193,3,1.3,3.9000000000000004,transcript,18354.0
BCAS3,ENSG00000141376,hematocrit,EFO_0004348,0.4674836557375135,4.67484695649329,1,0.5,0.5,transcript,48081.0
GALC,ENSG00000054983,inflammatory bowel disease,EFO_0003767,0.46745790623463673,4.674651955284864,2,0.8,1.6,transcript,21950.0
CTBP2,ENSG00000175029,hearing process quality,OBA_2045262,0.4674415850185345,4.674429913399493,1,0.4,0.4,transcript,28443.0
KLF10,ENSG00000155090,erythrocyte volume,OBA_0003460,0.4673982766564441,4.67404361232045,1,0.4,0.4,transcript,6574.0
ID4,ENSG00000172201,body weights and measures,EFO_0004324,0.4673733358563008,4.674146475010207,2,0.8,1.6,transcript,3873.0
BCKDHB,ENSG00000083123,diastolic blood pressure,EFO_0006336,0.4673622226231587,4.679349603092985,10,4.0,40.0,transcript,6984.0
BICC1,ENSG00000122870,serum urea amount,OBA_2050065,0.46733136819146953,4.673361776179455,1,0.4,0.4,transcript,8317.0
SOS1,ENSG00000115904,cystatin C measurement,EFO_0004617,0.4673298002623082,4.673321610496308,2,0.8,1.6,transcript,67774.0
IQGAP1,ENSG00000140575,lymphocyte count,EFO_0004587,0.4672398338839636,4.672452436756867,2,0.8,1.6,transcript,29576.0
PKN2,ENSG00000065243,systolic blood pressure,EFO_0006335,0.46720762410929445,4.672107052986335,1,0.4,0.4,transcript,12982.0
DLC1,ENSG00000164741,lean body mass,EFO_0004995,0.46718731136869407,4.671884792860055,1,0.4,0.4,transcript,34249.0
REEP3,ENSG00000165476,monocyte count,EFO_0005091,0.46716321353880075,4.671701919058628,1,0.4,0.4,transcript,5732.0
TMEM170B,ENSG00000205269,intelligence,EFO_0004337,0.4671282556510471,4.671327545825509,1,0.4,0.4,transcript,8891.0
ATXN7L3B,ENSG00000253719,cigarettes per day measurement,EFO_0006525,0.4671260292061413,4.6713129513557785,1,0.4,0.4,transcript,7596.0
FAS,ENSG00000026103,lymphocyte count,EFO_0004587,0.4670818416156466,4.670820624380998,1,0.4,0.4,transcript,181141.0
VAT1L,ENSG00000171724,glomerular filtration rate,OBA_0003747,0.46701422144814697,4.670232999774252,1,0.4,0.4,transcript,4406.0
CEP85L,ENSG00000111860,Abnormality of the cardiovascular system,HP_0001626,0.46697167338082873,4.669732136788764,1,0.4,0.4,transcript,25969.0
RCOR3,ENSG00000117625,serum creatinine amount,OBA_2050096,0.4669642364382574,4.6697067196235045,2,0.8,1.6,transcript,24862.0
SEMA6D,ENSG00000137872,self reported educational attainment,EFO_0004784,0.46695132945770307,4.669522721424693,1,0.5,0.5,transcript,53040.0
IMPG2,ENSG00000081148,vitelliform macular dystrophy 2,MONDO_0007931,0.466859278110354,4.668808298344919,2,0.9,1.8,transcript,8352.0
LTBP1,ENSG00000049323,sexual dimorphism measurement,EFO_0021796,0.4668092506516327,4.66810516594602,1,0.4,0.4,transcript,31597.0
UBXN2A,ENSG00000173960,birth weight,EFO_0004344,0.4667998022954914,4.668155240209508,2,0.8,1.6,transcript,10177.0
CENPC,ENSG00000145241,cigarettes per day measurement,EFO_0006525,0.4667844537477222,4.66804334463428,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
ANKH,ENSG00000154122,hemoglobin A1 measurement,EFO_0007629,0.46673656259186674,4.668134068541618,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,hemoglobin A1 measurement,EFO_0007629,0.46673656259186674,4.668134068541618,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,hemoglobin A1 measurement,EFO_0007629,0.46673656259186674,4.668134068541618,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,hemoglobin A1 measurement,EFO_0007629,0.46673656259186674,4.668134068541618,5,2.4,12.0,gene_variant,15616.0
CYP24A1,ENSG00000019186,nephrolithiasis,EFO_0004253,0.4667064110975485,4.66725431544529,2,0.8,1.6,transcript,8412.0
IQGAP2,ENSG00000145703,mean corpuscular hemoglobin concentration,EFO_0004528,0.4666981521951468,4.666996192882486,1,0.5,0.5,transcript,34081.0
DGKH,ENSG00000102780,serum creatinine amount,OBA_2050096,0.4666648618503426,4.666676011542171,2,0.8,1.6,transcript,58409.0
TBL2,ENSG00000106638,total cholesterol measurement,EFO_0004574,0.4666437807423295,4.666452985960842,1,0.4,0.4,transcript,26353.0
LRP2,ENSG00000081479,cystatin B measurement,EFO_0010593,0.4666078332007308,4.666094920707085,1,0.5,0.5,transcript,30141.0
LRRIQ3,ENSG00000162620,self reported educational attainment,EFO_0004784,0.4665714343177824,4.665741239358566,1,0.5,0.5,transcript,18590.0
CNTNAP2,ENSG00000174469,Cortical dysplasia - focal epilepsy syndrome,Orphanet_163681,0.4664536071298156,4.664543752969688,1,0.4,0.4,transcript,52072.0
SHH,ENSG00000164690,Absent tibia - polydactyly,Orphanet_988,0.46644735056398656,4.664526654723043,1,0.4,0.4,transcript,7526.0
MARCKS,ENSG00000277443,neurodegenerative disease,EFO_0005772,0.4664354093181842,4.6644472030514885,1,0.4,0.4,transcript,4296.0
SYNJ2,ENSG00000078269,age-related hearing impairment,EFO_0005782,0.4664327147336559,4.6643782949613914,2,0.8,1.6,transcript,31282.0
PKN2,ENSG00000065243,hypertension,EFO_0000537,0.46639568498634,4.66398766175679,1,0.4,0.4,transcript,12982.0
MDM4,ENSG00000198625,prostate specific antigen amount,OBA_2050200,0.46631993976718233,4.663205268542033,1,0.4,0.4,transcript,68133.0
GRB14,ENSG00000115290,mean corpuscular hemoglobin concentration,EFO_0004528,0.46629296230502826,4.662969990393102,1,0.4,0.4,transcript,9909.0
NDUFS4,ENSG00000164258,glomerular filtration rate,OBA_0003747,0.4662719478829209,4.6628260602307545,1,0.4,0.4,transcript,3753.0
NDUFS4,ENSG00000164258,genetic disorder,EFO_0000508,0.46626627369009976,4.662769318302543,1,0.4,0.4,transcript,3753.0
FIGN,ENSG00000182263,BMI-adjusted waist circumference,EFO_0007789,0.46621788595694724,4.662215614140822,1,0.4,0.4,transcript,10883.0
PPFIBP2,ENSG00000166387,strand of hair color,OBA_0002313,0.4662009458436645,4.662023141322092,1,0.5,0.5,transcript,36542.0
ITGB8,ENSG00000105855,chronic obstructive pulmonary disease,EFO_0000341,0.4661403647298352,4.661574174511653,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
ULK4,ENSG00000168038,aortic measurement,EFO_0020865,0.466111458291931,4.661155543024169,1,0.5,0.5,transcript,12207.0
SLC22A24,ENSG00000197658,testosterone measurement,EFO_0004908,0.466094394955567,4.661029244676789,1,0.5,0.5,transcript,5862.0
PAFAH1B2,ENSG00000168092,triglyceride measurement,EFO_0004530,0.46608606611439785,4.660994451594685,2,0.8,1.6,transcript,11959.0
PARP1,ENSG00000143799,Fallopian Tube Carcinoma,EFO_1000251,0.46608126118570725,4.66081848143505,1,0.5,0.5,transcript,85185.0
PARP1,ENSG00000143799,peritoneal neoplasm,EFO_1001100,0.46608126118570725,4.66081848143505,1,0.5,0.5,transcript,85185.0
DLGAP1,ENSG00000170579,testosterone measurement,EFO_0004908,0.4659736299555635,4.659764453699573,2,0.8,1.6,transcript,56830.0
TBX5,ENSG00000089225,congenital heart disease,EFO_0005207,0.46597099517529345,4.659835245409943,2,0.8,1.6,transcript,12770.0
SGCZ,ENSG00000185053,erythrocyte volume,OBA_0003460,0.4659247538904332,4.659296248110372,1,0.4,0.4,transcript,8212.0
KYNU,ENSG00000115919,xanthurenate measurement,EFO_0010551,0.46591503820390523,4.659308630753282,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
BICC1,ENSG00000122870,chronic kidney disease,EFO_0003884,0.4658929152323164,4.658977246587924,1,0.4,0.4,transcript,8317.0
ANO5,ENSG00000171714,cardiac troponin I measurement,EFO_0010071,0.46587822634282644,4.6587873097917285,1,0.4,0.4,transcript,79265.0
MATN2,ENSG00000132561,calcium measurement,EFO_0004838,0.4658706297523882,4.658723252998804,1,0.5,0.5,transcript,29489.0
GFRAL,ENSG00000187871,serum creatinine amount,OBA_2050096,0.4658554435327756,4.658763749822785,1,0.4,0.4,transcript,1911.0
CYP24A1,ENSG00000019186,urolithiasis,MONDO_0024647,0.465796929236194,4.658159496831745,2,0.8,1.6,transcript,8412.0
MLLT3,ENSG00000171843,serum creatinine amount,OBA_2050096,0.4656888884488133,4.656992123615762,2,0.8,1.6,transcript,15498.0
CEP85L,ENSG00000111860,Lissencephaly,HP_0001339,0.4656449516350379,4.656464919330856,1,0.4,0.4,transcript,25969.0
MSX2,ENSG00000120149,craniosynostosis,MONDO_0015469,0.4656186964890764,4.656305203140837,1,0.4,0.4,transcript,3383.0
C12orf42,ENSG00000179088,Thyroid preparation use measurement,EFO_0009933,0.46554829732939224,4.655518112797752,1,0.5,0.5,transcript,14229.0
PLCL1,ENSG00000115896,educational attainment,EFO_0011015,0.46553102610627195,4.65539977155223,2,0.8,1.6,transcript,17875.0
DPYD,ENSG00000188641,intelligence,EFO_0004337,0.46539957994237835,4.654054020196956,1,0.5,0.5,transcript,8588.0
NID2,ENSG00000087303,hearing loss,EFO_0004238,0.4653271469545659,4.653316604046472,1,0.5,0.5,transcript,11078.0
BPTF,ENSG00000171634,high density lipoprotein cholesterol measurement,EFO_0004612,0.4652514873630412,4.652534497827047,2,0.8,1.6,transcript,81532.0
FRAS1,ENSG00000138759,renal agenesis,MONDO_0018470,0.46518559908528695,4.651888127397477,2,0.9,1.8,transcript,56011.0
FAT1,ENSG00000083857,reticulocyte measurement,EFO_0010700,0.46513770439233626,4.651398239345152,1,0.5,0.5,transcript,23590.0
ZNF682,ENSG00000197124,free cholesterol:total lipids ratio,EFO_0020945,0.46513391499388024,4.651365123964776,1,0.5,0.5,transcript,19250.0
SORL1,ENSG00000137642,low density lipoprotein cholesterol measurement,EFO_0004611,0.46507188197565813,4.6507658294196785,2,0.9,1.8,transcript,38290.0
BANK1,ENSG00000153064,sleep duration trait,OBA_2040171,0.4650659853153575,4.650872340894667,3,1.3,3.9000000000000004,transcript,18354.0
PLPP4,ENSG00000203805,erythrocyte volume,OBA_0003460,0.46499016467570237,4.649982536544688,1,0.4,0.4,transcript,4945.0
TET1,ENSG00000138336,glucose measurement,EFO_0004468,0.46498338254748167,4.649875440123173,1,0.4,0.4,transcript,9612.0
ADK,ENSG00000156110,cystatin C measurement,EFO_0004617,0.46497184939791464,4.649737477416098,1,0.4,0.4,transcript,21071.0
TNFRSF11A,ENSG00000141655,asthma,MONDO_0004979,0.4649459214656294,4.649583805841467,2,0.8,1.6,transcript,12842.0
SORL1,ENSG00000137642,family history of Alzheimerâs disease,EFO_0009268,0.4649437611240361,4.649484620903459,2,0.9,1.8,transcript,38290.0
STXBP5,ENSG00000164506,platelet count,EFO_0004309,0.4649114783408196,4.6491286138166545,2,0.9,1.8,transcript,130148.0
AFF1,ENSG00000172493,phospholipid measurement,EFO_0004639,0.46489057855061616,4.648916008103212,1,0.4,0.4,transcript,39129.0
INF2,ENSG00000203485,kidney disease,EFO_0003086,0.46487910553358575,4.648794118216804,1,0.4,0.4,transcript,130596.0
ATAD2B,ENSG00000119778,body weight,EFO_0004338,0.46486530545316385,4.648671232218527,1,0.4,0.4,transcript,22005.0
BCKDHB,ENSG00000083123,glomerular filtration rate,OBA_0003747,0.4647756581703129,4.653483958564527,10,4.0,40.0,transcript,6984.0
ALG10B,ENSG00000175548,heart rate,OBA_1001087,0.4647466306670975,4.648172122594182,5,2.0,10.0,transcript,14168.0
MSX2,ENSG00000120149,brain attribute,OBA_2045210,0.46467020858496355,4.646820324099709,1,0.4,0.4,transcript,3383.0
BPTF,ENSG00000171634,HbA1c measurement,EFO_0004541,0.464658607476666,4.6466056989632945,2,0.8,1.6,transcript,81532.0
COL25A1,ENSG00000188517,cholesteryl ester measurement,EFO_0010351,0.464657725006706,4.646592211727804,1,0.4,0.4,transcript,26735.0
ARHGAP29,ENSG00000137962,cleft palate,MONDO_0016064,0.46464841747862295,4.646504400505253,1,0.5,0.5,transcript,24721.0
FUT2,ENSG00000176920,vitamin B12 measurement,EFO_0004620,0.46458758883488704,4.6459989147995575,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
OTULIN,ENSG00000154124,allergic rhinitis,EFO_0005854,0.4645699263649241,4.645718498117408,1,0.4,0.4,transcript,20796.0
AGPAT5,ENSG00000155189,total cholesterol measurement,EFO_0004574,0.46455077646124915,4.645545137311735,1,0.4,0.4,transcript,10703.0
CCDC14,ENSG00000175455,neurodegenerative disease,EFO_0005772,0.4645470297799514,4.6454789633107785,1,0.4,0.4,transcript,46160.0
BCKDHB,ENSG00000083123,appendicular lean mass,EFO_0004980,0.4644813730325617,4.650541107187014,10,4.0,40.0,transcript,6984.0
AFF1,ENSG00000172493,intermediate density lipoprotein measurement,EFO_0008595,0.4644734385703254,4.6447446083003046,1,0.4,0.4,transcript,39129.0
FANCF,ENSG00000183161,leukemia,EFO_0000565,0.46446948237499897,4.644816367353758,1,0.4,0.4,transcript,3291.0
GPATCH2L,ENSG00000089916,FEV/FVC ratio,EFO_0004713,0.46444957078437976,4.6446381801841286,4,1.6,6.4,transcript,44921.0
TMTC3,ENSG00000139324,cobblestone lissencephaly,MONDO_0018869,0.46444171362878983,4.644456145455052,1,0.4,0.4,transcript,10254.0
GLB1,ENSG00000170266,mucopolysaccharidosis,MONDO_0019249,0.4644201023999702,4.644231932079075,1,0.5,0.5,transcript,16177.0
KITLG,ENSG00000049130,familial progressive hyper- and hypopigmentation,MONDO_0017239,0.46438963487553,4.644065704732155,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
ADGRV1,ENSG00000164199,serum creatinine amount,OBA_2050096,0.4643787353501455,4.643791778671824,1,0.5,0.5,transcript,112990.0
PTPRJ,ENSG00000149177,N-acetyl-aspartyl-glutamate (NAAG) measurement,EFO_0800033,0.46436649677694547,4.64374015573938,2,0.8,1.6,transcript,21280.0
SLC22A24,ENSG00000197658,androsterone glucuronide measurement,EFO_0800317,0.46431770015050583,4.643262296626177,1,0.5,0.5,transcript,5862.0
THEM4,ENSG00000159445,cis-4-decenoate (10:1n6) measurement,EFO_0800318,0.4642894238907943,4.64304858967005,2,0.8,1.6,transcript,10366.0
PRDM5,ENSG00000138738,prostate specific antigen amount,OBA_2050200,0.4642688615955367,4.642769224550259,2,0.8,1.6,transcript,19849.0
TXNL1,ENSG00000091164,Fuchs' endothelial dystrophy,MONDO_0005321,0.46424499429635513,4.642532141781944,2,0.8,1.6,transcript,19465.0
GPM6A,ENSG00000150625,self reported educational attainment,EFO_0004784,0.46420156479246816,4.642033819005407,1,0.4,0.4,transcript,22013.0
C2CD4A,ENSG00000198535,HbA1c measurement,EFO_0004541,0.4641932443341611,4.642048553646401,1,0.4,0.4,transcript,3445.0
BCAS3,ENSG00000141376,heel bone mineral density,EFO_0009270,0.46417287380562877,4.641739137174443,1,0.5,0.5,transcript,48081.0
AGO3,ENSG00000126070,cancer,MONDO_0004992,0.4641178682076948,4.641191848200512,1,0.4,0.4,transcript,30381.0
PTPRJ,ENSG00000149177,erythrocyte volume,OBA_0003460,0.464095786519802,4.641033053167945,2,0.8,1.6,transcript,21280.0
HACD1,ENSG00000165996,congenital myopathy,MONDO_0019952,0.46409555260339547,4.64102021954843,1,0.4,0.4,transcript,6183.0
FANCF,ENSG00000183161,acute myeloid leukemia,EFO_0000222,0.464094769466777,4.641069238271538,1,0.4,0.4,transcript,3291.0
GRB14,ENSG00000115290,body weight,EFO_0004338,0.464064364153301,4.640684008875829,1,0.4,0.4,transcript,9909.0
ACTN2,ENSG00000077522,congenital myopathy,MONDO_0019952,0.4639586088108698,4.639602773720487,2,0.8,1.6,transcript,95891.0
PFAS,ENSG00000178921,mean corpuscular hemoglobin concentration,EFO_0004528,0.46395833158025235,4.639606642137957,1,0.4,0.4,transcript,17148.0
ANO5,ENSG00000171714,myopathy,EFO_0004145,0.46393727819415265,4.6393778283049905,1,0.4,0.4,transcript,79265.0
TNFRSF11A,ENSG00000141655,spine bone mineral density,EFO_0007701,0.46389656309561267,4.6390902221413,2,0.8,1.6,transcript,12842.0
ID4,ENSG00000172201,body composition measurement,EFO_0005106,0.4637748282753945,4.6381613992011435,2,0.8,1.6,transcript,3873.0
GRB14,ENSG00000115290,sex hormone-binding globulin measurement,EFO_0004696,0.4637648512200682,4.637688879543502,1,0.4,0.4,transcript,9909.0
UMPS,ENSG00000114491,Intellectual disability,HP_0001249,0.46374572182624146,4.63747607462408,1,0.4,0.4,transcript,21213.0
FAT4,ENSG00000196159,cup-to-disc ratio measurement,EFO_0006939,0.46374464827238077,4.637455192766486,1,0.4,0.4,transcript,45924.0
ONECUT1,ENSG00000169856,body weight,EFO_0004338,0.4637327832000962,4.637380679140611,1,0.4,0.4,transcript,7569.0
REEP3,ENSG00000165476,cholesteryl esters:total lipids ratio,EFO_0020944,0.4637113316343227,4.637183100013848,1,0.4,0.4,transcript,5732.0
AR,ENSG00000169083,complete androgen insensitivity syndrome,MONDO_0021023,0.46370469134465836,4.637088243232444,2,0.8,1.6,transcript,38713.0
ATP10D,ENSG00000145246,lipid measurement,EFO_0004529,0.4637039521721898,4.6370713445324885,1,0.5,0.5,transcript,15712.0
LTBP1,ENSG00000049323,body height,OBA_VT0001253,0.46368599074857275,4.636872566915421,1,0.4,0.4,transcript,31597.0
LDLRAP1,ENSG00000157978,Hypercholesterolemia,HP_0003124,0.46366180276235186,4.636643941072599,1,0.4,0.4,transcript,15436.0
C12orf42,ENSG00000179088,obesity,EFO_0001073,0.4636503907278947,4.636539046782778,1,0.5,0.5,transcript,14229.0
CERKL,ENSG00000188452,maturity-onset diabetes of the young type 6,MONDO_0011668,0.4636412247514276,4.636432321386124,1,0.5,0.5,transcript,24908.0
MYO5A,ENSG00000197535,Griscelli syndrome,MONDO_0018306,0.46358983267705317,4.635900366431744,1,0.4,0.4,transcript,196111.0
GPD2,ENSG00000115159,intelligence,EFO_0004337,0.46347485781231124,4.634766244407009,1,0.4,0.4,transcript,22642.0
SV2C,ENSG00000122012,reticulocyte measurement,EFO_0010700,0.46346083618971096,4.634636390766845,1,0.4,0.4,transcript,14271.0
GJB2,ENSG00000165474,ear malformation,MONDO_0007500,0.4634428716675415,4.63451552223097,1,0.4,0.4,transcript,4608.0
CCDC80,ENSG00000091986,atopic eczema,EFO_0000274,0.4634427020680538,4.634506228601331,2,0.8,1.6,transcript,20200.0
DENND3,ENSG00000105339,reticulocyte count,EFO_0007986,0.4634053477945578,4.634064294603231,1,0.5,0.5,transcript,46225.0
SKI,ENSG00000157933,mean corpuscular hemoglobin concentration,EFO_0004528,0.4633939571695111,4.633992092703514,1,0.4,0.4,transcript,7616.0
TET1,ENSG00000138336,serum creatinine amount,OBA_2050096,0.4633938699732838,4.633980314381194,1,0.4,0.4,transcript,9612.0
ZNF682,ENSG00000197124,phospholipid measurement,EFO_0004639,0.46337235867102966,4.63374956073627,1,0.5,0.5,transcript,19250.0
LTBP1,ENSG00000049323,aortic valve stenosis,MONDO_0042981,0.4633441963658114,4.6334546230878075,1,0.4,0.4,transcript,31597.0
RCL1,ENSG00000120158,reticulocyte measurement,EFO_0010700,0.4632652018931914,4.632690692430899,1,0.4,0.4,transcript,10343.0
BICC1,ENSG00000122870,refractive error,MONDO_0004892,0.4632624226765707,4.632672321030466,1,0.4,0.4,transcript,8317.0
NDUFAF2,ENSG00000164182,neuroimaging measurement,EFO_0004346,0.46325795804929676,4.632619785538701,1,0.4,0.4,transcript,9949.0
LIN54,ENSG00000189308,erythrocyte volume,OBA_0003460,0.46323910608531144,4.632403987430157,1,0.4,0.4,transcript,30944.0
SMARCC1,ENSG00000173473,Aqueductal stenosis,HP_0002410,0.4632221503654381,4.632335650761466,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,Aqueductal stenosis,HP_0002410,0.4632221503654381,4.632335650761466,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,Aqueductal stenosis,HP_0002410,0.4632221503654381,4.632335650761466,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,Aqueductal stenosis,HP_0002410,0.4632221503654381,4.632335650761466,2,0.8,1.6,transcript,14017.0
CR1L,ENSG00000197721,erythrocyte count,EFO_0004305,0.46316152017259665,4.631708485308057,1,0.5,0.5,transcript,5360.0
TNRC6B,ENSG00000100354,lean body mass,EFO_0004995,0.46315992713073434,4.63160572312837,1,0.4,0.4,transcript,61998.0
CRYGD,ENSG00000118231,Cataract,HP_0000518,0.46313362922055923,4.631959345165094,1,0.4,0.4,transcript,642.0
SC5D,ENSG00000109929,Intellectual disability,HP_0001249,0.4631246223482297,4.631269066266832,1,0.4,0.4,transcript,17511.0
KCNQ1,ENSG00000053918,type 2 diabetes mellitus,MONDO_0005148,0.46304990996646855,4.630692773002323,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
TRIM36,ENSG00000152503,anencephaly 1,MONDO_0008791,0.46300142906333464,4.630040451522816,1,0.4,0.4,transcript,15290.0
TNPO3,ENSG00000064419,Alzheimer disease,MONDO_0004975,0.4629911629562602,4.629938301919371,1,0.5,0.5,transcript,18746.0
BICC1,ENSG00000122870,Cystic renal dysplasia,HP_0000800,0.46297720105063866,4.629820104771146,1,0.4,0.4,transcript,8317.0
TRPC6,ENSG00000137672,nephrotic syndrome,EFO_0004255,0.4629718600373977,4.629747487497541,1,0.4,0.4,transcript,13847.0
SNX13,ENSG00000071189,free cholesterol:total lipids ratio,EFO_0020945,0.4629704921714083,4.6297172468512,1,0.4,0.4,transcript,32454.0
FGFR1OP2,ENSG00000111790,acute lymphoblastic leukemia,EFO_0000220,0.462898767992589,4.62902381362056,1,0.4,0.4,transcript,11070.0
MACF1,ENSG00000127603,Intellectual disability,HP_0001249,0.462898767992589,4.62899300677822,2,0.8,1.6,gene_variant,300365.0
HEATR1,ENSG00000119285,Alzheimer disease,MONDO_0004975,0.462898767992589,4.629017270977556,1,0.5,0.5,transcript,16897.0
SLC25A46,ENSG00000164209,cerebellar ataxia,MONDO_0000437,0.46284743745721607,4.628494327682351,1,0.4,0.4,transcript,20047.0
UMPS,ENSG00000114491,glomerular filtration rate,OBA_0003747,0.4628040317254369,4.628059173616034,1,0.4,0.4,transcript,21213.0
ID4,ENSG00000172201,endometriosis,EFO_0001065,0.46279913632287467,4.628404479675945,2,0.8,1.6,transcript,3873.0
GRIN2B,ENSG00000273079,developmental disorder of mental health,EFO_0005548,0.46279610692184325,4.6279653388453745,1,0.4,0.4,transcript,93685.0
GJB2,ENSG00000165474,Abnormality of the ear,HP_0000598,0.46279610692184325,4.628047874773988,1,0.4,0.4,transcript,4608.0
TBL2,ENSG00000106638,cystatin C measurement,EFO_0004617,0.4627237012830397,4.627252191367945,1,0.4,0.4,transcript,26353.0
YEATS2,ENSG00000163872,platelet crit,EFO_0007985,0.4627224830079948,4.627258570548266,1,0.5,0.5,transcript,14819.0
CD86,ENSG00000114013,immune system disease,EFO_0000540,0.4627107955720535,4.627139790181339,1,0.4,0.4,transcript,12565.0
C2CD4A,ENSG00000198535,Drugs used in diabetes use measurement,EFO_0009924,0.4626984674306213,4.627100784611002,1,0.4,0.4,transcript,3445.0
SEC22A,ENSG00000121542,monocyte count,EFO_0005091,0.4626832092803582,4.626954127736082,2,0.8,1.6,transcript,13111.0
ALDOB,ENSG00000136872,acute liver failure,MONDO_0019542,0.46266778058341107,4.626719217988578,1,0.4,0.4,transcript,9659.0
SLC35D3,ENSG00000182747,tea consumption measurement,EFO_0010091,0.46262255964334353,4.626396317730918,1,0.4,0.4,transcript,2343.0
DLG2,ENSG00000150672,metabolite measurement,EFO_0004725,0.46261351334082906,4.626137906333449,1,0.4,0.4,transcript,144252.0
PIP4K2A,ENSG00000150867,metabolite measurement,EFO_0004725,0.46261277639500464,4.626171209154782,1,0.4,0.4,transcript,9207.0
GBE1,ENSG00000114480,neuroticism measurement,EFO_0007660,0.46259638138377396,4.626024692931859,1,0.5,0.5,transcript,8213.0
FUT2,ENSG00000176920,serum carcinoembryonic antigen measurement,EFO_0005760,0.46258024954687704,4.6259255219194575,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
SLC35F5,ENSG00000115084,BMI-adjusted waist-hip ratio,EFO_0007788,0.46253150343544164,4.6253857932435025,2,0.8,1.6,transcript,22612.0
BMPR2,ENSG00000204217,bone disease,EFO_0004260,0.4625291881379043,4.625309652838079,1,0.4,0.4,transcript,22508.0
NAF1,ENSG00000145414,dyskeratosis congenita,MONDO_0015780,0.4625291881379043,4.625353831571088,1,0.5,0.5,transcript,8071.0
MGA,ENSG00000174197,body weight,EFO_0004338,0.46252299065212665,4.625235828306329,1,0.5,0.5,transcript,84434.0
BPTF,ENSG00000171634,Intellectual disability,HP_0001249,0.4624958346966975,4.62497797116361,2,0.8,1.6,transcript,81532.0
RASA2,ENSG00000155903,Noonan syndrome,MONDO_0018997,0.46249161418601126,4.624963755239472,1,0.4,0.4,transcript,8401.0
COL25A1,ENSG00000188517,chylomicron amount,OBA_2050296,0.46248635038244645,4.624878465485208,1,0.4,0.4,transcript,26735.0
DENND1B,ENSG00000213047,inflammatory bowel disease,EFO_0003767,0.46248384472129084,4.6252752047251375,5,2.0,10.0,transcript,22896.0
HEG1,ENSG00000173706,glomerular filtration rate,OBA_0003747,0.4624766337231718,4.624788203519369,1,0.4,0.4,transcript,18293.0
TSPAN9,ENSG00000011105,monocyte count,EFO_0005091,0.4624574490085476,4.624609973727517,1,0.5,0.5,transcript,14091.0
GALC,ENSG00000054983,Crohn's disease,EFO_0000384,0.4624409260235266,4.624482153173763,2,0.8,1.6,transcript,21950.0
SC5D,ENSG00000109929,Cataract,HP_0000518,0.46243679317423314,4.624390774526867,1,0.4,0.4,transcript,17511.0
CP,ENSG00000047457,Dystonia,HP_0001332,0.46243679317423314,4.624388989693814,1,0.5,0.5,transcript,23744.0
PTPRJ,ENSG00000149177,neutrophil count,EFO_0004833,0.4624015371243863,4.624090559213788,2,0.8,1.6,transcript,21280.0
MYO1B,ENSG00000128641,platelet count,EFO_0004309,0.46238024620985796,4.623815870519067,1,0.4,0.4,transcript,29832.0
SLCO1C1,ENSG00000139155,appendicular lean mass,EFO_0004980,0.46236795579333523,4.623710448826717,1,0.5,0.5,transcript,16186.0
PTCHD4,ENSG00000244694,metabolite measurement,EFO_0004725,0.46236769148648676,4.624090755536209,6,2.4000000000000004,14.400000000000002,transcript,34796.0
FIGN,ENSG00000182263,diet measurement,EFO_0008111,0.4623640112857886,4.623676867429236,1,0.4,0.4,transcript,10883.0
RPS20,ENSG00000008988,influenza,EFO_0007328,0.4623443982105619,4.623461191588044,1,0.4,0.4,transcript,23243.0
CYTL1,ENSG00000170891,triglyceride measurement,EFO_0004530,0.46231905354648656,4.623409473614838,1,0.4,0.4,transcript,1827.0
CERKL,ENSG00000188452,monocyte count,EFO_0005091,0.46231802967658164,4.623200370637665,1,0.5,0.5,transcript,24908.0
SEMA6D,ENSG00000137872,fish consumption measurement,EFO_0010139,0.4622717719491769,4.6227271463394315,1,0.5,0.5,transcript,53040.0
FUT2,ENSG00000176920,protein measurement,EFO_0004747,0.4622380684547678,4.622503710998365,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
SHH,ENSG00000164690,polydactyly of a triphalangeal thumb,MONDO_0008270,0.46218014049736866,4.621854554056864,1,0.4,0.4,transcript,7526.0
HS6ST3,ENSG00000185352,body weight,EFO_0004338,0.46208797155190023,4.620926575875141,1,0.4,0.4,transcript,8536.0
DLG1,ENSG00000075711,body fat percentage,EFO_0007800,0.4620774121664892,4.620789531436399,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
RTF1,ENSG00000137815,eosinophil count,EFO_0004842,0.4620749340373755,4.620801060053093,1,0.4,0.4,transcript,7734.0
MEOX2,ENSG00000106511,type 2 diabetes mellitus,MONDO_0005148,0.4620676982949741,4.620845688137426,1,0.4,0.4,transcript,2371.0
PAG1,ENSG00000076641,metabolite measurement,EFO_0004725,0.46202682715587823,4.620398363436171,2,0.8,1.6,transcript,12299.0
SEMA3A,ENSG00000075213,brain connectivity attribute,OBA_2045295,0.4620224520414938,4.62025472505135,1,0.4,0.4,transcript,13243.0
COL24A1,ENSG00000171502,neutrophil count,EFO_0004833,0.4620205115287679,4.620229511481872,1,0.4,0.4,transcript,16396.0
GCH1,ENSG00000131979,dystonic disorder,MONDO_0003441,0.46197481835587734,4.6197819473808375,1,0.4,0.4,transcript,11847.0
HTR2C,ENSG00000147246,spinal cord disease,EFO_0009488,0.4619748183558772,4.619787606408256,1,0.5,0.5,transcript,12683.0
FBXO28,ENSG00000143756,neurodegenerative disease,EFO_0005772,0.4619748183558772,4.6207971712856155,5,2.0,10.0,transcript,9533.0
HEATR1,ENSG00000119285,Parkinson disease,MONDO_0005180,0.4619748183558772,4.619777774610438,1,0.5,0.5,transcript,16897.0
HTR2C,ENSG00000147246,cerebral palsy,EFO_1000632,0.4619748183558772,4.619787606408256,1,0.5,0.5,transcript,12683.0
HEATR1,ENSG00000119285,multiple sclerosis,MONDO_0005301,0.4619748183558772,4.619777774610438,1,0.5,0.5,transcript,16897.0
MTR,ENSG00000116984,methylmalonic aciduria and homocystinuria type cblG,EFO_0005597,0.4619748183558772,4.619752595988587,1,0.4,0.4,transcript,90653.0
HTR2C,ENSG00000147246,bipolar II disorder,EFO_0009964,0.4619748183558772,4.619787606408256,1,0.5,0.5,transcript,12683.0
HEATR1,ENSG00000119285,lysosomal storage disease,MONDO_0002561,0.4619748183558772,4.619777774610438,1,0.5,0.5,transcript,16897.0
HTR2C,ENSG00000147246,Spasticity,HP_0001257,0.4619748183558772,4.619787606408256,1,0.5,0.5,transcript,12683.0
DYNC1I2,ENSG00000077380,viral disease,EFO_0000763,0.4619748183558772,4.619759370492433,1,0.4,0.4,transcript,35756.0
OTUD7A,ENSG00000169918,developmental and epileptic encephalopathy,MONDO_0100062,0.4619748183558772,4.619765910126466,1,0.4,0.4,transcript,22565.0
RBM18,ENSG00000119446,neurodegenerative disease,EFO_0005772,0.4619748183558772,4.619809911953834,1,0.4,0.4,transcript,6480.0
SH3GL3,ENSG00000140600,listeriosis,EFO_0007347,0.4619748183558772,4.619799876502685,1,0.4,0.4,transcript,7738.0
COL24A1,ENSG00000171502,Abnormality of connective tissue,HP_0003549,0.4619748183558772,4.619772579752966,1,0.4,0.4,transcript,16396.0
COL24A1,ENSG00000171502,Skin ulcer,HP_0200042,0.4619748183558772,4.619772579752966,1,0.4,0.4,transcript,16396.0
GABRA4,ENSG00000109158,anxiety disorder,EFO_0006788,0.4619748183558772,4.619773334464205,1,0.4,0.4,transcript,15904.0
ARL3,ENSG00000138175,cone-rod dystrophy,MONDO_0015993,0.4619748183558772,4.619852513240566,1,0.4,0.4,transcript,3834.0
GABRA1,ENSG00000022355,cerebral palsy,EFO_1000632,0.4619748183558772,4.619756867129456,1,0.4,0.4,transcript,46064.0
DNAJC21,ENSG00000168724,Pancytopenia,HP_0001876,0.4619748183558772,4.61975720659006,1,0.4,0.4,transcript,44331.0
SKI,ENSG00000157933,Schinzel-Giedion syndrome,MONDO_0010010,0.4619748183558772,4.619800704567176,1,0.4,0.4,transcript,7616.0
FGA,ENSG00000171560,AL amyloidosis,MONDO_0019438,0.4619748183558772,4.619816408017241,1,0.4,0.4,transcript,5863.0
MACF1,ENSG00000127603,Seizure,HP_0001250,0.4619748183558772,4.619753510411102,2,0.8,1.6,gene_variant,300365.0
KPNA4,ENSG00000186432,influenza,EFO_0007328,0.4619748183558772,4.619757176768898,1,0.4,0.4,transcript,44478.0
GABRG1,ENSG00000163285,cerebral palsy,EFO_1000632,0.4619748183558772,4.621878991490113,6,2.4000000000000004,14.400000000000002,transcript,6758.0
TNPO3,ENSG00000064419,Parkinson disease,MONDO_0005180,0.4619748183558772,4.619774855915542,1,0.5,0.5,transcript,18746.0
MACF1,ENSG00000127603,Brainstem dysplasia,HP_0002508,0.4619748183558772,4.619753510411102,2,0.8,1.6,gene_variant,300365.0
DOCK1,ENSG00000150760,cutaneous Leishmaniasis,EFO_0005046,0.4619748183558772,4.619773271366098,1,0.4,0.4,transcript,15944.0
TNPO3,ENSG00000064419,multiple sclerosis,MONDO_0005301,0.4619748183558772,4.619774855915542,1,0.5,0.5,transcript,18746.0
FAT1,ENSG00000083857,nasopharyngeal neoplasm,EFO_0004252,0.4619748183558772,4.619769378980561,1,0.5,0.5,transcript,23590.0
FANCF,ENSG00000183161,myelodysplastic syndrome,EFO_0000198,0.4619748183558772,4.61986972716254,1,0.4,0.4,transcript,3291.0
FGFR1OP2,ENSG00000111790,myelodysplastic syndrome,EFO_0000198,0.4619748183558772,4.619784317253442,1,0.4,0.4,transcript,11070.0
PAFAH1B2,ENSG00000168092,neurodegenerative disease,EFO_0005772,0.4619748183558772,4.619881974009479,2,0.8,1.6,transcript,11959.0
FGFR1OP2,ENSG00000111790,leukemia,EFO_0000565,0.4619748183558772,4.619784317253442,1,0.4,0.4,transcript,11070.0
LAMA1,ENSG00000101680,autosomal recessive non-syndromic intellectual disability,MONDO_0019502,0.4619748183558772,4.61976407877749,1,0.5,0.5,transcript,31456.0
HTR2C,ENSG00000147246,ventricular tachycardia,EFO_0005306,0.4619748183558772,4.619787606408256,1,0.5,0.5,transcript,12683.0
YWHAG,ENSG00000170027,undetermined early-onset epileptic encephalopathy,MONDO_0018614,0.46197481835587717,4.619856145771997,1,0.4,0.4,transcript,3705.0
TNRC6B,ENSG00000100354,complex neurodevelopmental disorder,MONDO_0100038,0.46197481835587717,4.619754635379798,1,0.4,0.4,transcript,61998.0
COL25A1,ENSG00000188517,congenital fibrosis of extraocular muscles,MONDO_0007614,0.46197481835587717,4.619763145219515,1,0.4,0.4,transcript,26735.0
LMO4,ENSG00000143013,pulse pressure measurement,EFO_0005763,0.4619435032685665,4.619486512737145,1,0.4,0.4,transcript,7770.0
KCNJ15,ENSG00000157551,BMI-adjusted waist-hip ratio,EFO_0007788,0.4618989834006207,4.618999668056607,1,0.4,0.4,transcript,40675.0
C4orf33,ENSG00000151470,metabolite ratio,EFO_0022223,0.4618972197228033,4.619423250861129,4,1.6,6.4,transcript,14189.0
FRRS1L,ENSG00000260230,body mass index,EFO_0004340,0.4618962648581942,4.61904855462221,2,0.8,1.6,transcript,18625.0
HTR2C,ENSG00000147246,Parkinson disease,MONDO_0005180,0.4618770157205105,4.618809580054588,1,0.5,0.5,transcript,12683.0
SGCB,ENSG00000163069,genetic disorder,EFO_0000508,0.46186734119363404,4.618746007217647,1,0.4,0.4,transcript,5510.0
TENM4,ENSG00000149256,body weight,EFO_0004338,0.4617894945814536,4.617912396298786,1,0.4,0.4,transcript,22922.0
TMEM131,ENSG00000075568,platelet count,EFO_0004309,0.4617787049996055,4.6178084988673085,1,0.4,0.4,transcript,18649.0
SGTB,ENSG00000197860,neuroimaging measurement,EFO_0004346,0.46175964549444687,4.6176595962230795,1,0.4,0.4,transcript,6335.0
TAF2,ENSG00000064313,neurodegenerative disease,EFO_0005772,0.46169239120292277,4.6169267050132525,1,0.5,0.5,transcript,179020.0
TENM4,ENSG00000149256,body mass index,EFO_0004340,0.46169217024016024,4.616939152885853,1,0.4,0.4,transcript,22922.0
DLC1,ENSG00000164741,body weight,EFO_0004338,0.46165047498552775,4.616516429028392,1,0.4,0.4,transcript,34249.0
PLA2R1,ENSG00000153246,hemoglobin measurement,EFO_0004509,0.46151941854152734,4.615273377654434,2,0.8,1.6,transcript,20204.0
HS6ST3,ENSG00000185352,lean body mass,EFO_0004995,0.46145310272664175,4.6145778876225565,1,0.4,0.4,transcript,8536.0
PAG1,ENSG00000076641,urinary bladder cancer,MONDO_0001187,0.46141870578973365,4.614317149774725,2,0.8,1.6,transcript,12299.0
CNTN5,ENSG00000149972,mathematical ability,EFO_0004875,0.46138510526613913,4.613864033352613,1,0.4,0.4,transcript,30815.0
RANBP17,ENSG00000204764,smoking initiation,EFO_0005670,0.46137457330175147,4.613755247312744,1,0.4,0.4,transcript,42042.0
BTAF1,ENSG00000095564,serum creatinine amount,OBA_2050096,0.4613404204735803,4.613440949178207,1,0.4,0.4,transcript,10886.0
MAN1A2,ENSG00000198162,alkaline phosphatase measurement,EFO_0004533,0.46131260189697865,4.613253539492621,2,0.8,1.6,transcript,12547.0
CNTN5,ENSG00000149972,depressive symptom measurement,EFO_0007006,0.4612688836311564,4.612701817002786,1,0.4,0.4,transcript,30815.0
BIRC6,ENSG00000115760,reticulocyte count,EFO_0007986,0.4612112820575456,4.612120002832409,1,0.5,0.5,transcript,69616.0
FIGN,ENSG00000182263,cardiovascular disease,EFO_0000319,0.46119889549383636,4.612025709509713,1,0.4,0.4,transcript,10883.0
MGA,ENSG00000174197,body mass index,EFO_0004340,0.4611871799308638,4.611877721093701,1,0.5,0.5,transcript,84434.0
TRHDE,ENSG00000072657,wellbeing measurement,EFO_0007869,0.4610437386808542,4.610536957410321,2,0.8,1.6,transcript,16069.0
BICC1,ENSG00000122870,Myopia,HP_0000545,0.46104365365746475,4.610484630839407,1,0.4,0.4,transcript,8317.0
BCAS3,ENSG00000141376,erythrocyte count,EFO_0004305,0.4610357810932353,4.610368210050508,1,0.5,0.5,transcript,48081.0
HHLA2,ENSG00000114455,body weight,EFO_0004338,0.46103279455987156,4.610361749939193,1,0.5,0.5,transcript,14791.0
GPM6A,ENSG00000150625,educational attainment,EFO_0011015,0.46102718383074087,4.610290009388134,1,0.4,0.4,transcript,22013.0
MAP2K6,ENSG00000108984,BMI-adjusted waist-hip ratio,EFO_0007788,0.4608674950466421,4.608692253001243,1,0.4,0.4,transcript,23118.0
FUT2,ENSG00000176920,serum gamma-glutamyl transferase measurement,EFO_0004532,0.46085948089340534,4.6087178353847404,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
TNFRSF11A,ENSG00000141655,osteopetrosis,MONDO_0017198,0.460786134663032,4.607985937815493,2,0.8,1.6,transcript,12842.0
HS6ST3,ENSG00000185352,glomerular filtration rate,OBA_0003747,0.46077933390895953,4.607840199445734,1,0.4,0.4,transcript,8536.0
RCL1,ENSG00000120158,erythrocyte attribute,OBA_2045276,0.46065441895417314,4.606582863040716,1,0.4,0.4,transcript,10343.0
HTR2C,ENSG00000147246,Alzheimer disease,MONDO_0004975,0.4605877370890943,4.605916793740426,1,0.5,0.5,transcript,12683.0
MAGOHB,ENSG00000111196,neurodegenerative disease,EFO_0005772,0.4605287858357373,4.605318069837736,1,0.4,0.4,transcript,13240.0
NDFIP2,ENSG00000102471,total cortical area measurement,EFO_0008381,0.4605175702159084,4.605190184025072,2,0.8,1.6,transcript,110483.0
AMTN,ENSG00000187689,amelogenesis imperfecta type 3B,MONDO_0021547,0.46048746476291275,4.605100636329693,1,0.4,0.4,transcript,1770.0
TSPAN9,ENSG00000011105,forced expiratory volume,EFO_0004314,0.4604545927489751,4.604581411131791,1,0.5,0.5,transcript,14091.0
SKIL,ENSG00000136603,aspartate aminotransferase measurement,EFO_0004736,0.46045033575038813,4.604519817325457,1,0.5,0.5,transcript,30377.0
LIN54,ENSG00000189308,lymphocyte count,EFO_0004587,0.46044644797368434,4.604477406313886,1,0.4,0.4,transcript,30944.0
CASQ2,ENSG00000118729,pulse pressure measurement,EFO_0005763,0.4604328820720241,4.604341471741811,1,0.4,0.4,transcript,31618.0
PLCL1,ENSG00000115896,self reported educational attainment,EFO_0004784,0.4604292621867367,4.604382132356877,2,0.8,1.6,transcript,17875.0
DLG1,ENSG00000075711,glomerular filtration rate,OBA_0003747,0.4604163297212979,4.604178706984487,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
RAPGEF4,ENSG00000091428,glucose measurement,EFO_0004468,0.46034656397383505,4.603478825827026,1,0.4,0.4,transcript,30335.0
GRIN2B,ENSG00000273079,autism,EFO_0003758,0.46031057531497854,4.603110022776727,1,0.4,0.4,transcript,93685.0
ARHGAP12,ENSG00000165322,systolic blood pressure,EFO_0006335,0.46017213336843615,4.601733396046775,1,0.4,0.4,transcript,33161.0
SYNJ2,ENSG00000078269,cholelithiasis,EFO_0004799,0.4601674835952548,4.6017259835773805,2,0.8,1.6,transcript,31282.0
CBLB,ENSG00000114423,myxedema,EFO_1001055,0.46014978547764246,4.601506346443976,1,0.4,0.4,transcript,47105.0
CTBP2,ENSG00000175029,Sensorineural hearing impairment,HP_0000407,0.46012371799603113,4.601251243174459,1,0.4,0.4,transcript,28443.0
IQGAP1,ENSG00000140575,basophil count,EFO_0005090,0.45998236886229327,4.599877786540163,2,0.8,1.6,transcript,29576.0
ACTN2,ENSG00000077522,intrinsic cardiomyopathy,MONDO_0000591,0.45991003185707413,4.5991170041825296,2,0.8,1.6,transcript,95891.0
NDST3,ENSG00000164100,schizophrenia,MONDO_0005090,0.4598725642437733,4.598775705015956,1,0.4,0.4,transcript,7990.0
LRRK2,ENSG00000188906,platelet count,EFO_0004309,0.45985698711897266,4.598588629005484,2,0.9,1.8,transcript,95960.0
SORL1,ENSG00000137642,glomerular filtration rate,OBA_0003747,0.45984788537104915,4.598525863373589,2,0.9,1.8,transcript,38290.0
CD69,ENSG00000110848,hypothyroidism,EFO_0004705,0.4598357769866394,4.599202245587716,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
PDE12,ENSG00000174840,neurodegenerative disease,EFO_0005772,0.45982048708282314,4.598223924798603,1,0.4,0.4,transcript,20993.0
LUZP2,ENSG00000187398,schizophrenia,MONDO_0005090,0.45981605562201605,4.598477336244385,4,1.7000000000000002,6.800000000000001,transcript,21466.0
CDH23,ENSG00000107736,sensorineural hearing loss,EFO_1001176,0.4597618609537639,4.597626160240609,1,0.5,0.5,transcript,66219.0
BCKDHB,ENSG00000083123,forced expiratory volume,EFO_0004314,0.45969760054487463,4.6027033823101435,10,4.0,40.0,transcript,6984.0
GRB14,ENSG00000115290,serum albumin amount,OBA_2050068,0.4596600240193602,4.596640607536421,1,0.4,0.4,transcript,9909.0
CYBRD1,ENSG00000071967,pulse pressure measurement,EFO_0005763,0.4596577958324371,4.596612067644743,1,0.4,0.4,transcript,11727.0
NDFIP2,ENSG00000102471,brain volume,OBA_2050009,0.4596143973014105,4.596158454880094,2,0.8,1.6,transcript,110483.0
UBXN2A,ENSG00000173960,body weight,EFO_0004338,0.45957510625474857,4.595908279802079,2,0.8,1.6,transcript,10177.0
EVI5,ENSG00000067208,Red cell distribution width,EFO_0009188,0.45956418549014855,4.595647510850129,1,0.4,0.4,transcript,70722.0
PKN2,ENSG00000065243,serum urea amount,OBA_2050065,0.459508822348039,4.595119035373781,1,0.4,0.4,transcript,12982.0
APOBEC3H,ENSG00000100298,neutrophil count,EFO_0004833,0.4594854523694046,4.594931108032549,1,0.4,0.4,transcript,5223.0
NEK7,ENSG00000151414,mean corpuscular hemoglobin concentration,EFO_0004528,0.4594195891388795,4.594241155618737,1,0.4,0.4,transcript,8837.0
DCDC2,ENSG00000146038,dyslexia,EFO_0005424,0.4594116774010946,4.594162551076637,1,0.4,0.4,transcript,8738.0
TMEM106B,ENSG00000106460,glucose measurement,EFO_0004468,0.4593898604230753,4.593931480717901,2,0.8,1.6,transcript,48667.0
DGKH,ENSG00000102780,mean corpuscular hemoglobin concentration,EFO_0004528,0.4593641168571435,4.593668561610179,2,0.8,1.6,transcript,58409.0
MEOX2,ENSG00000106511,serum albumin amount,OBA_2050068,0.4593514951869462,4.593683657057147,1,0.4,0.4,transcript,2371.0
UBXN2A,ENSG00000173960,erythrocyte count,EFO_0004305,0.45932894558193527,4.593446673073946,2,0.8,1.6,transcript,10177.0
CBLB,ENSG00000114423,metabolite measurement,EFO_0004725,0.4592554883116983,4.592563374784534,1,0.4,0.4,transcript,47105.0
IL4R,ENSG00000077238,infection,EFO_0000544,0.4591923447166614,4.591942011235858,1,0.4,0.4,transcript,21547.0
CD93,ENSG00000125810,cystatin C measurement,EFO_0004617,0.45911788616076854,4.5912051791285755,1,0.4,0.4,transcript,15199.0
LHFPL2,ENSG00000145685,hypertension,EFO_0000537,0.4591161765564261,4.591188658128467,1,0.4,0.4,transcript,14874.0
DDR2,ENSG00000162733,hepatocellular carcinoma,EFO_0000182,0.4591097204473596,4.591111244980458,1,0.4,0.4,transcript,28489.0
RCN2,ENSG00000117906,blood urea nitrogen measurement,EFO_0004741,0.45908113436282194,4.590838658569493,1,0.4,0.4,transcript,14644.0
BACH1,ENSG00000156273,aspartate aminotransferase measurement,EFO_0004736,0.4590147119086762,4.590504980862651,4,1.6,6.4,transcript,17884.0
TBX5,ENSG00000089225,neurodegenerative disease,EFO_0005772,0.45901448390823624,4.590270132739371,2,0.8,1.6,transcript,12770.0
FSIP2,ENSG00000188738,heart rate,OBA_1001087,0.45899948792561296,4.5902738192840244,4,2.0,8.0,transcript,28680.0
TENT4B,ENSG00000121274,vital capacity,EFO_0004312,0.4589302462061302,4.589551877493882,4,1.6,6.4,transcript,25660.0
REEP3,ENSG00000165476,triglyceride measurement,EFO_0004530,0.45889713523326475,4.589041136003268,1,0.4,0.4,transcript,5732.0
NEBL,ENSG00000078114,systolic blood pressure,EFO_0006335,0.4588746100830188,4.588753922649151,1,0.4,0.4,transcript,51139.0
U2SURP,ENSG00000163714,glomerular filtration rate,OBA_0003747,0.45882546693388193,4.588305077328485,2,0.8,1.6,transcript,31741.0
PLCL1,ENSG00000115896,high density lipoprotein cholesterol measurement,EFO_0004612,0.45881090360935484,4.588198546583059,2,0.8,1.6,transcript,17875.0
GPD2,ENSG00000115159,educational attainment,EFO_0011015,0.4587736638892635,4.587754305176532,1,0.4,0.4,transcript,22642.0
BCKDHB,ENSG00000083123,vital capacity,EFO_0004312,0.45875039735785067,4.593231350439904,10,4.0,40.0,transcript,6984.0
ASTN2,ENSG00000148219,body mass index,EFO_0004340,0.458616640895413,4.5862251633607105,2,0.8,1.6,transcript,27232.0
BACE2,ENSG00000182240,essential tremor,EFO_0003108,0.4585466515906685,4.585600071833229,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
PRDM5,ENSG00000138738,IGF-1 measurement,EFO_0004627,0.4584861949278976,4.584942557873868,2,0.8,1.6,transcript,19849.0
UBXN2A,ENSG00000173960,total cholesterol measurement,EFO_0004574,0.458483398023597,4.584991197490564,2,0.8,1.6,transcript,10177.0
SP4,ENSG00000105866,cognitive function measurement,EFO_0008354,0.45839684672755715,4.583992459598028,1,0.4,0.4,transcript,16672.0
TLK1,ENSG00000198586,basophil measurement,EFO_0803539,0.4582917935740747,4.5829318309017575,1,0.4,0.4,transcript,28787.0
PSD3,ENSG00000156011,platelet count,EFO_0004309,0.45818167375103064,4.581826180603864,1,0.4,0.4,transcript,42359.0
ABCA10,ENSG00000154263,cholesteryl ester measurement,EFO_0010351,0.4581797911179098,4.5818978473310015,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
PTPRO,ENSG00000151490,self reported educational attainment,EFO_0004784,0.4581412824015794,4.581417272612263,1,0.4,0.4,transcript,89916.0
LARP4B,ENSG00000107929,blood sodium bicarbonate amount,OBA_2050094,0.4581197253423994,4.581208265427078,1,0.5,0.5,transcript,45405.0
REEP3,ENSG00000165476,prothrombin time measurement,EFO_0008390,0.45804018632198606,4.580471646890481,1,0.4,0.4,transcript,5732.0
SEC63,ENSG00000025796,polycystic liver disease 1,MONDO_0008265,0.4579909464906698,4.580184989168139,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
DPYD,ENSG00000188641,cognitive function measurement,EFO_0008354,0.45797552682698717,4.579813489043044,1,0.5,0.5,transcript,8588.0
ALG10B,ENSG00000175548,neutrophil count,EFO_0004833,0.45796910205585245,4.580396836481731,5,2.0,10.0,transcript,14168.0
HEPHL1,ENSG00000181333,Pili torti - developmental delay - neurological abnormalities,Orphanet_2891,0.45793760889508384,4.579444947618423,1,0.4,0.4,transcript,5809.0
MAP1LC3B2,ENSG00000258102,eosinophil count,EFO_0004842,0.4579111710254189,4.579277961293258,1,0.4,0.4,transcript,2406.0
FAM76B,ENSG00000077458,eosinophil count,EFO_0004842,0.4579074319815385,4.579096015318992,1,0.4,0.4,transcript,18437.0
AGPAT5,ENSG00000155189,alkaline phosphatase measurement,EFO_0004533,0.45788364427447875,4.57887381544403,1,0.4,0.4,transcript,10703.0
TOPAZ1,ENSG00000173769,body mass index,EFO_0004340,0.45783659726117604,4.578459710894475,1,0.5,0.5,transcript,5334.0
LYPLAL1,ENSG00000143353,appendicular lean mass,EFO_0004980,0.45780811034254526,4.578108899734103,1,0.5,0.5,transcript,17988.0
ANKRD36,ENSG00000135976,reticulocyte measurement,EFO_0010700,0.45778221032852573,4.577897489640327,2,1.0,2.0,transcript,26530.0
DYNC1I2,ENSG00000077380,body mass index,EFO_0004340,0.4577786274426175,4.577797461359836,1,0.4,0.4,transcript,35756.0
EXOC6,ENSG00000138190,bilirubin measurement,EFO_0004570,0.45770215212828097,4.577044138553358,1,0.5,0.5,transcript,22107.0
C2CD4A,ENSG00000198535,lean body mass,EFO_0004995,0.457662895962783,4.5767450699326195,1,0.4,0.4,transcript,3445.0
AFF1,ENSG00000172493,free cholesterol measurement,EFO_0008591,0.45762699143948793,4.57628013699193,1,0.4,0.4,transcript,39129.0
SHH,ENSG00000164690,hippocampal volume,EFO_0005035,0.4575993976183767,4.576047125266945,1,0.4,0.4,transcript,7526.0
WDR12,ENSG00000138442,neurodegenerative disease,EFO_0005772,0.45748836316786595,4.5749035708641435,1,0.4,0.4,transcript,20061.0
MAP2K6,ENSG00000108984,appendicular lean mass,EFO_0004980,0.4574868645095235,4.574885947630057,1,0.4,0.4,transcript,23118.0
FUT2,ENSG00000176920,glomerular filtration rate,OBA_0003747,0.45745522480209244,4.574675274471612,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
SLCO1C1,ENSG00000139155,body height,OBA_VT0001253,0.4573827765100232,4.573858655993597,1,0.5,0.5,transcript,16186.0
CCDC62,ENSG00000130783,high density lipoprotein cholesterol measurement,EFO_0004612,0.457350709155709,4.573534027584026,1,0.4,0.4,transcript,14850.0
MFAP3,ENSG00000037749,mean corpuscular hemoglobin concentration,EFO_0004528,0.45727771195484435,4.572789709250068,1,0.4,0.4,transcript,31772.0
GHR,ENSG00000112964,vital capacity,EFO_0004312,0.45727415172935354,4.572750378810184,1,0.4,0.4,transcript,45139.0
ST8SIA4,ENSG00000113532,eosinophil count,EFO_0004842,0.45725469704404237,4.572589847490483,1,0.4,0.4,transcript,9329.0
TMEM106B,ENSG00000106460,mental or behavioural disorder,EFO_0000677,0.4572069405746471,4.572102282233619,2,0.8,1.6,transcript,48667.0
ZFP90,ENSG00000184939,sodium measurement,EFO_0009282,0.45720510998521,4.57206445499884,1,0.4,0.4,transcript,29951.0
DPYD,ENSG00000188641,gastroesophageal reflux disease,EFO_0003948,0.4571848794967531,4.571907015740703,1,0.5,0.5,transcript,8588.0
GRB14,ENSG00000115290,body fat percentage,EFO_0007800,0.4571767534468124,4.571807901810944,1,0.4,0.4,transcript,9909.0
NDUFS4,ENSG00000164258,reticulocyte measurement,EFO_0010700,0.4571695623569253,4.5718022049707985,1,0.4,0.4,transcript,3753.0
CST9,ENSG00000173335,cystatin C measurement,EFO_0004617,0.45715829673493846,4.571827915297946,1,0.4,0.4,transcript,1633.0
EVI5,ENSG00000067208,multiple sclerosis,MONDO_0005301,0.45708495292402984,4.570855185188942,1,0.4,0.4,transcript,70722.0
ITGB8,ENSG00000105855,allergic rhinitis,EFO_0005854,0.45704967122382545,4.570667239451556,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
CD2AP,ENSG00000198087,reticulocyte measurement,EFO_0010700,0.4570218760521919,4.570270830295415,1,0.4,0.4,transcript,7682.0
RPS6KA5,ENSG00000100784,waist-hip ratio,EFO_0004343,0.4569959302330187,4.569969167181721,1,0.4,0.4,transcript,40548.0
BICC1,ENSG00000122870,heel bone mineral density,EFO_0009270,0.45692599956982666,4.569308089963026,1,0.4,0.4,transcript,8317.0
SLC30A8,ENSG00000164756,gestational diabetes,EFO_0004593,0.4569251601635996,4.5695617693204,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,gestational diabetes,EFO_0004593,0.4569251601635996,4.5695617693204,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,gestational diabetes,EFO_0004593,0.4569251601635996,4.5695617693204,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,gestational diabetes,EFO_0004593,0.4569251601635996,4.5695617693204,4,1.6,6.4,transcript,20634.0
GRIN2B,ENSG00000273079,Seizure,HP_0001250,0.4568976580682179,4.568980850309121,1,0.4,0.4,transcript,93685.0
BCAS3,ENSG00000141376,Red cell distribution width,EFO_0009188,0.45686206008855873,4.568631000003743,1,0.5,0.5,transcript,48081.0
LARP4B,ENSG00000107929,serum urea amount,OBA_2050065,0.45685263893651673,4.568537401368251,1,0.5,0.5,transcript,45405.0
ZNF483,ENSG00000173258,monocyte count,EFO_0005091,0.4568427471055976,4.568510952220539,2,0.8,1.6,transcript,19166.0
TMCC1,ENSG00000172765,basophil measurement,EFO_0803539,0.4568114261484638,4.568124462963852,1,0.4,0.4,transcript,39210.0
CFHR4,ENSG00000134365,drug use measurement,EFO_0007010,0.45677098419035367,4.567750350693944,1,0.5,0.5,transcript,12343.0
MMP12,ENSG00000262406,atopic eczema,EFO_0000274,0.4567158136833636,4.5673776758018025,1,0.4,0.4,transcript,1822.0
CADPS,ENSG00000163618,liver disease,EFO_0001421,0.456680649549341,4.566815813204049,1,0.4,0.4,transcript,42929.0
NEDD4,ENSG00000069869,high density lipoprotein cholesterol measurement,EFO_0004612,0.4566670426439958,4.566678736401525,1,0.4,0.4,transcript,48135.0
PKN2,ENSG00000065243,BMI-adjusted waist circumference,EFO_0007789,0.4566391245051415,4.5664220569448055,1,0.4,0.4,transcript,12982.0
DGKH,ENSG00000102780,nephrolithiasis,EFO_0004253,0.45663218423394114,4.566349235378155,2,0.8,1.6,transcript,58409.0
EXO1,ENSG00000174371,alpha fetoprotein measurement,EFO_0010583,0.45652404079955045,4.5653698410786,2,1.0,2.0,transcript,15452.0
DOCK1,ENSG00000150760,metabolite measurement,EFO_0004725,0.45647223038704526,4.564747391677779,1,0.4,0.4,transcript,15944.0
SEMA3C,ENSG00000075223,coronary artery disease,EFO_0001645,0.4564419132649558,4.564452850933297,1,0.4,0.4,transcript,11863.0
CYP24A1,ENSG00000019186,phosphate measurement,EFO_0010968,0.4564394764785294,4.564584969255099,2,0.8,1.6,transcript,8412.0
SEMA3A,ENSG00000075213,brain attribute,OBA_2045210,0.45636090057119677,4.563639210348379,1,0.4,0.4,transcript,13243.0
ITM2A,ENSG00000078596,body weight,EFO_0004338,0.45635859912058263,4.5639859912058265,1,0.4,0.4,transcript,1000.0
BMERB1,ENSG00000166780,phospholipids in very large HDL measurement ,EFO_0022298,0.45634973352828984,4.563533609881611,1,0.4,0.4,transcript,11027.0
CNTLN,ENSG00000044459,BMI-adjusted waist-hip ratio,EFO_0007788,0.45625826372916645,4.5627040978549385,2,0.8,1.6,transcript,13173.0
KLF10,ENSG00000155090,schizophrenia,MONDO_0005090,0.45621537117212546,4.5622145574772635,1,0.4,0.4,transcript,6574.0
NDUFS4,ENSG00000164258,mitochondrial disease,MONDO_0044970,0.4562131764973646,4.562238346375191,1,0.4,0.4,transcript,3753.0
PLCL1,ENSG00000115896,lean body mass,EFO_0004995,0.4562066321648353,4.562155832137863,2,0.8,1.6,transcript,17875.0
LYPLAL1,ENSG00000143353,intraocular pressure measurement,EFO_0004695,0.4561614077283348,4.561641873591999,1,0.5,0.5,transcript,17988.0
KIF20B,ENSG00000138182,erythrocyte count,EFO_0004305,0.45615024843011037,4.561529796258279,1,0.5,0.5,transcript,18307.0
LHFPL2,ENSG00000145685,neurodegenerative disease,EFO_0005772,0.45613138847823864,4.561340777346592,1,0.4,0.4,transcript,14874.0
AFF1,ENSG00000172493,phospholipids:total lipids ratio,EFO_0020946,0.45611473258489477,4.5611575484459985,1,0.4,0.4,transcript,39129.0
PARP11,ENSG00000111224,brain volume,OBA_2050009,0.4560885507854395,4.560903456342235,1,0.4,0.4,transcript,22286.0
PALM2AKAP2,ENSG00000157654,mean corpuscular hemoglobin concentration,EFO_0004528,0.45606627813653333,4.560670768585781,1,0.4,0.4,transcript,50080.0
BMERB1,ENSG00000166780,high density lipoprotein cholesterol measurement,EFO_0004612,0.4560132323576105,4.560168598174817,1,0.4,0.4,transcript,11027.0
ATP9A,ENSG00000054793,eosinophil count,EFO_0004842,0.45600067119333615,4.560032078158233,1,0.4,0.4,transcript,15769.0
SGCD,ENSG00000170624,HbA1c measurement,EFO_0004541,0.45596156319993,4.559634421045287,1,0.4,0.4,transcript,21289.0
LUZP2,ENSG00000187398,self reported educational attainment,EFO_0004784,0.45592272639239445,4.559544043948169,4,1.7000000000000002,6.800000000000001,transcript,21466.0
DYNC2H1,ENSG00000187240,autosomal recessive retinitis pigmentosa,EFO_0020026,0.4558870168606542,4.558880325015235,1,0.5,0.5,transcript,49230.0
CASQ2,ENSG00000118729,erythrocyte volume,OBA_0003460,0.45582592112758447,4.558271862297414,1,0.4,0.4,transcript,31618.0
NEK7,ENSG00000151414,lymphocyte count,EFO_0004587,0.45581081952683955,4.558153459498338,1,0.4,0.4,transcript,8837.0
GSAP,ENSG00000186088,heat shock 27 kDa protein measurement,EFO_0010915,0.455738013058667,4.557405644695973,1,0.5,0.5,transcript,19597.0
RCL1,ENSG00000120158,reticulocyte count,EFO_0007986,0.4556423873502242,4.556462547001226,1,0.4,0.4,transcript,10343.0
TLK1,ENSG00000198586,alkaline phosphatase measurement,EFO_0004533,0.4556249579433747,4.556263474594758,1,0.4,0.4,transcript,28787.0
KYNU,ENSG00000115919,kynureninase measurement,EFO_0008201,0.45559664579744613,4.556124706688691,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
SPRED1,ENSG00000166068,appendicular lean mass,EFO_0004980,0.4555592809144871,4.5556373823563705,1,0.4,0.4,transcript,8974.0
CYP24A1,ENSG00000019186,multiple sclerosis,MONDO_0005301,0.4555580208545314,4.55577041301512,2,0.8,1.6,transcript,8412.0
LINGO2,ENSG00000174482,high density lipoprotein cholesterol measurement,EFO_0004612,0.45555481717635893,4.5555598906280315,1,0.4,0.4,transcript,34133.0
U2SURP,ENSG00000163714,Red cell distribution width,EFO_0009188,0.4555114837651679,4.555165245641345,2,0.8,1.6,transcript,31741.0
YWHAG,ENSG00000170027,Intellectual disability,HP_0001249,0.45550575645747576,4.555165526787983,1,0.4,0.4,transcript,3705.0
FAT1,ENSG00000083857,cutaneous squamous cell carcinoma,EFO_1001927,0.4554745724983616,4.554766920405405,1,0.5,0.5,transcript,23590.0
SLC22A24,ENSG00000197658,metabolite measurement,EFO_0004725,0.45546575967485137,4.554742891869632,1,0.5,0.5,transcript,5862.0
ARAP1,ENSG00000186635,mathematical ability,EFO_0004875,0.4553880453321628,4.553889462939396,1,0.4,0.4,transcript,44397.0
RCN2,ENSG00000117906,serum creatinine amount,OBA_2050096,0.45535816860428663,4.55360900098414,1,0.4,0.4,transcript,14644.0
ULK4,ENSG00000168038,multiple myeloma,EFO_0001378,0.45535617325692085,4.553602692674066,1,0.5,0.5,transcript,12207.0
FAM114A1,ENSG00000197712,erythrocyte count,EFO_0004305,0.45532911569829,4.553339836549652,1,0.4,0.4,transcript,8217.0
BACH1,ENSG00000156273,total cholesterol measurement,EFO_0004574,0.455322773737746,4.553585599153349,4,1.6,6.4,transcript,17884.0
TMEM106B,ENSG00000106460,alkaline phosphatase measurement,EFO_0004533,0.4552732663048061,4.5527655395352085,2,0.8,1.6,transcript,48667.0
CDH23,ENSG00000107736,age-related hearing impairment,EFO_0005782,0.45527142044485636,4.552721755151534,1,0.5,0.5,transcript,66219.0
SEMA3C,ENSG00000075223,intraocular pressure measurement,EFO_0004695,0.4552375482582171,4.5524092008659105,1,0.4,0.4,transcript,11863.0
LRRIQ3,ENSG00000162620,educational attainment,EFO_0011015,0.4552077427658441,4.552104323839183,1,0.5,0.5,transcript,18590.0
BPTF,ENSG00000171634,low density lipoprotein cholesterol measurement,EFO_0004611,0.4551331756440909,4.551351380637544,2,0.8,1.6,transcript,81532.0
RCOR3,ENSG00000117625,erythrocyte volume,OBA_0003460,0.45510627826745204,4.551127137915451,2,0.8,1.6,transcript,24862.0
TNFRSF11A,ENSG00000141655,childhood onset asthma,MONDO_0005405,0.45509767120880196,4.551101303273192,2,0.8,1.6,transcript,12842.0
LPP,ENSG00000145012,skin neoplasm,EFO_0004198,0.45508129131269565,4.55088181330782,4,1.6,6.4,transcript,92888.0
CADPS,ENSG00000163618,eosinophil count,EFO_0004842,0.4550575758940529,4.550585076651167,1,0.4,0.4,transcript,42929.0
TGFBR1,ENSG00000106799,Parkinson disease,MONDO_0005180,0.4550552578485969,4.5505568260781155,1,0.4,0.4,transcript,94171.0
MAP2K6,ENSG00000108984,lean body mass,EFO_0004995,0.4550522060758213,4.550539363293035,1,0.4,0.4,transcript,23118.0
FAM76B,ENSG00000077458,reticulocyte count,EFO_0007986,0.4550232940434156,4.550254635937764,1,0.4,0.4,transcript,18437.0
MGA,ENSG00000174197,sex hormone-binding globulin measurement,EFO_0004696,0.4550226970480722,4.550232892265785,1,0.5,0.5,transcript,84434.0
PDE11A,ENSG00000128655,anthropometric measurement,EFO_0004302,0.4550150627598034,4.550214410735367,2,0.8,1.6,transcript,25085.0
SEMA3C,ENSG00000075223,BMI-adjusted hip circumference,EFO_0008039,0.4550067629686579,4.550101347970318,1,0.4,0.4,transcript,11863.0
TC2N,ENSG00000165929,platelet count,EFO_0004309,0.45496362347374225,4.549658999520304,1,0.4,0.4,transcript,17571.0
SEMA6D,ENSG00000137872,smoking initiation,EFO_0005670,0.45491068277899493,4.549116254637612,1,0.5,0.5,transcript,53040.0
RANBP17,ENSG00000204764,fat pad mass,OBA_0004528,0.45490718745365105,4.549081388831739,1,0.4,0.4,transcript,42042.0
IQGAP2,ENSG00000145703,red blood cell density,OBA_2045260,0.4548869051367644,4.548883722298662,1,0.5,0.5,transcript,34081.0
PTPN4,ENSG00000088179,Dupuytren Contracture,EFO_0004229,0.4548057105720299,4.548520712581681,5,2.0,10.0,transcript,21570.0
TNFRSF11A,ENSG00000141655,Eczematoid dermatitis,HP_0000964,0.4547902825903939,4.548027417089112,2,0.8,1.6,transcript,12842.0
PDE10A,ENSG00000112541,glomerular filtration rate,OBA_0003747,0.4546864667692831,4.546884379786748,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
RSBN1L,ENSG00000187257,eosinophil count,EFO_0004842,0.4546853586886988,4.546990303968078,2,0.8,1.6,transcript,11703.0
PHIP,ENSG00000146247,platelet volume,OBA_0003277,0.45466180506990217,4.546626027852454,1,0.5,0.5,transcript,62679.0
FRMD4B,ENSG00000114541,serum creatinine amount,OBA_2050096,0.45463303283911394,4.54640642465291,2,0.8,1.6,transcript,21026.0
SLC22A5,ENSG00000197375,low density lipoprotein cholesterol measurement,EFO_0004611,0.4546130748446247,4.546136317382719,1,0.4,0.4,transcript,71827.0
SPART,ENSG00000133104,Neurodevelopmental delay,HP_0012758,0.45458322126218326,4.545846477957069,1,0.4,0.4,transcript,28040.0
GRIN2B,ENSG00000273079,autosomal dominant non-syndromic intellectual disability,MONDO_0015802,0.4545832212621832,4.545836482248774,1,0.4,0.4,transcript,93685.0
ADGRV1,ENSG00000164199,urate measurement,EFO_0004531,0.454561627311891,4.545620698289278,1,0.5,0.5,transcript,112990.0
ATP12A,ENSG00000075673,diastolic blood pressure,EFO_0006336,0.45455131447190616,4.54556229684489,1,0.4,0.4,transcript,8138.0
AKAP6,ENSG00000151320,eye measurement,EFO_0004731,0.4545049141662422,4.545623921721073,7,2.8000000000000003,19.6,transcript,34100.0
SLCO6A1,ENSG00000205359,type 2 diabetes mellitus,MONDO_0005148,0.45450286178856136,4.545069872011026,1,0.5,0.5,transcript,12120.0
TGFBR1,ENSG00000106799,multiple sclerosis,MONDO_0005301,0.4545008880665698,4.545013128257844,1,0.4,0.4,transcript,94171.0
TGFBR1,ENSG00000106799,neurodegenerative disease,EFO_0005772,0.4545008880665698,4.545013128257844,1,0.4,0.4,transcript,94171.0
FIGN,ENSG00000182263,mathematical ability,EFO_0004875,0.45444325410540076,4.544469295625357,1,0.4,0.4,transcript,10883.0
SEMA6D,ENSG00000137872,major depressive disorder,MONDO_0002009,0.4544421446819463,4.5444308736671255,1,0.5,0.5,transcript,53040.0
KCNQ1,ENSG00000053918,atrial fibrillation,EFO_0000275,0.45440448988583687,4.544238572196006,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
TBC1D9B,ENSG00000197226,neutrophil count,EFO_0004833,0.4543343615625495,4.543355830484872,1,0.4,0.4,transcript,32747.0
TNRC6B,ENSG00000100354,erythrocyte count,EFO_0004305,0.4543150914024893,4.54315736584592,1,0.4,0.4,transcript,61998.0
ZNF236,ENSG00000130856,type 2 diabetes mellitus,MONDO_0005148,0.45424981560166666,4.542557124075635,2,0.9,1.8,transcript,30525.0
GREM1,ENSG00000166923,mean corpuscular hemoglobin,EFO_0004527,0.45420223453422864,4.542040569407164,1,0.4,0.4,transcript,21949.0
PLA2R1,ENSG00000153246,erythrocyte count,EFO_0004305,0.4541967174425625,4.542046366664787,2,0.8,1.6,transcript,20204.0
LONRF1,ENSG00000154359,glucose measurement,EFO_0004468,0.4541957617635636,4.541992910922853,1,0.5,0.5,transcript,14167.0
QKI,ENSG00000112531,hemoglobin measurement,EFO_0004509,0.4541331741678931,4.541367313834826,2,0.8,1.6,transcript,44979.0
TGFBR1,ENSG00000106799,lysosomal storage disease,MONDO_0002561,0.45413130821188513,4.541317329710997,1,0.4,0.4,transcript,94171.0
ITGB8,ENSG00000105855,Inhalant adrenergic use measurement,EFO_0009941,0.45407163587561444,4.540886885969446,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
TSPAN9,ENSG00000011105,body fat percentage,EFO_0007800,0.4539948799036963,4.539984282679003,1,0.5,0.5,transcript,14091.0
AKR1C1,ENSG00000187134,BMI-adjusted waist circumference,EFO_0007789,0.45385897259327795,4.5387289168853675,2,0.8,1.6,transcript,11495.0
PDE11A,ENSG00000128655,age at onset,EFO_0004847,0.45384666408446545,4.538530423981987,2,0.8,1.6,transcript,25085.0
PDE11A,ENSG00000128655,smoking initiation,EFO_0005670,0.45384666408446545,4.538530423981987,2,0.8,1.6,transcript,25085.0
EXO1,ENSG00000174371,breast carcinoma,EFO_0000305,0.4538429443696199,4.538558876779295,2,1.0,2.0,transcript,15452.0
UHMK1,ENSG00000152332,monocyte count,EFO_0005091,0.4538414330813137,4.538540948708467,3,1.2000000000000002,3.6000000000000005,transcript,28432.0
F13B,ENSG00000143278,sex hormone-binding globulin measurement,EFO_0004696,0.45377820541399355,4.537889952284087,1,0.5,0.5,transcript,4634.0
KRT74,ENSG00000170484,pure hair and nail ectodermal dysplasia,MONDO_0019071,0.4537048987680251,4.5371130081668065,1,0.4,0.4,transcript,6248.0
SP8,ENSG00000164651,glomerular filtration rate,OBA_0003747,0.4537044036473582,4.537118942840624,1,0.4,0.4,transcript,5340.0
GRB14,ENSG00000115290,neuroimaging measurement,EFO_0004346,0.4537000539722091,4.5370409070649105,1,0.4,0.4,transcript,9909.0
RPS20,ENSG00000008988,Blackfan-Diamond anemia,Orphanet_124,0.4536777506182057,4.536794715664482,1,0.4,0.4,transcript,23243.0
CWH43,ENSG00000109182,platelet volume,OBA_0003277,0.4536748127326616,4.536810200573047,1,0.5,0.5,transcript,8055.0
MRPL32,ENSG00000106591,neuroimaging measurement,EFO_0004346,0.45357244167584,4.535807559556155,1,0.4,0.4,transcript,4811.0
FAM114A1,ENSG00000197712,restless legs syndrome,EFO_0004270,0.45355538434807824,4.535602523047534,1,0.4,0.4,transcript,8217.0
ZNF143,ENSG00000166478,neurodegenerative disease,EFO_0005772,0.45350603978327175,4.535086677660322,1,0.5,0.5,transcript,19026.0
GOLT1B,ENSG00000111711,neurodegenerative disease,EFO_0005772,0.45347043816485727,4.534743674379418,1,0.4,0.4,transcript,10180.0
ARHGAP29,ENSG00000137962,glomerular filtration rate,OBA_0003747,0.45345279795952415,4.534548205314265,1,0.5,0.5,transcript,24721.0
FAT3,ENSG00000165323,mathematical ability,EFO_0004875,0.4534457968997019,4.534466297992334,1,0.4,0.4,transcript,48025.0
SV2C,ENSG00000122012,HbA1c measurement,EFO_0004541,0.4534178605371412,4.534206634241148,1,0.4,0.4,transcript,14271.0
ID4,ENSG00000172201,body mass index,EFO_0004340,0.45341421657507286,4.534555282197927,2,0.8,1.6,transcript,3873.0
RCN2,ENSG00000117906,serum urea amount,OBA_2050065,0.4534104604721901,4.534131919663174,1,0.4,0.4,transcript,14644.0
FBXO28,ENSG00000143756,erythrocyte volume,OBA_0003460,0.4533945939548835,4.534994927275679,5,2.0,10.0,transcript,9533.0
MAP2K6,ENSG00000108984,total hip arthroplasty,EFO_0009806,0.4533810648524699,4.5338279510595205,1,0.4,0.4,transcript,23118.0
MLLT3,ENSG00000171843,neurodegenerative disease,EFO_0005772,0.45334689321125987,4.533572171240228,2,0.8,1.6,transcript,15498.0
DPYD,ENSG00000188641,genetic disorder,EFO_0000508,0.45325159358764266,4.532574156649599,1,0.5,0.5,transcript,8588.0
PAQR3,ENSG00000163291,mean corpuscular hemoglobin,EFO_0004527,0.45323925118998604,4.532407563640217,1,0.4,0.4,transcript,26575.0
LATS1,ENSG00000131023,neuroimaging measurement,EFO_0004346,0.4532037660763692,4.532055017354857,1,0.4,0.4,transcript,23046.0
LARP4B,ENSG00000107929,high density lipoprotein cholesterol measurement,EFO_0004612,0.45317218542146387,4.531732866217722,1,0.5,0.5,transcript,45405.0
FRMD4B,ENSG00000114541,retinal layer thickness,OBA_2050110,0.4530669942381242,4.530746038643013,2,0.8,1.6,transcript,21026.0
ACTN2,ENSG00000077522,familial hypertrophic cardiomyopathy,MONDO_0024573,0.45302911283804764,4.530307813992264,2,0.8,1.6,transcript,95891.0
ATAD2B,ENSG00000119778,birth weight,EFO_0004344,0.45302701933137823,4.530288371000672,1,0.4,0.4,transcript,22005.0
SLC22A5,ENSG00000197375,serum creatinine amount,OBA_2050096,0.4529996971363754,4.5300025403002255,1,0.4,0.4,transcript,71827.0
ATXN7L3B,ENSG00000253719,smoking cessation,EFO_0004319,0.4529938969117221,4.529991628411586,1,0.4,0.4,transcript,7596.0
GCH1,ENSG00000131979,3-methoxytyrosine measurement,EFO_0021009,0.45299282772841715,4.529962041106236,1,0.4,0.4,transcript,11847.0
REEP3,ENSG00000165476,atrial fibrillation,EFO_0000275,0.4528070795471364,4.528140579141985,1,0.4,0.4,transcript,5732.0
ID4,ENSG00000172201,HbA1c measurement,EFO_0004541,0.45278252798055246,4.528238396252723,2,0.8,1.6,transcript,3873.0
ASTN2,ENSG00000148219,lipid measurement,EFO_0004529,0.4527353799024327,4.527412553430907,2,0.8,1.6,transcript,27232.0
NEK1,ENSG00000137601,"short rib-polydactyly syndrome, Majewski type",MONDO_0019662,0.45273532198875965,4.527367479755871,2,0.8,1.6,transcript,112203.0
C6,ENSG00000039537,immunodeficiency due to a late component of complement deficiency,MONDO_0015700,0.45273532198875965,4.527382782945599,1,0.5,0.5,transcript,16913.0
DPP8,ENSG00000074603,mean corpuscular hemoglobin concentration,EFO_0004528,0.45272838533211873,4.527465573415455,4,1.6,6.4,transcript,35219.0
LRBA,ENSG00000198589,erythrocyte count,EFO_0004305,0.45270189071394196,4.527022848647441,1,0.4,0.4,transcript,101484.0
PPP1R9A,ENSG00000158528,mean corpuscular hemoglobin concentration,EFO_0004528,0.4526726792762325,4.526805800906241,3,1.3,3.9000000000000004,transcript,49362.0
ATP12A,ENSG00000075673,glomerular filtration rate,OBA_0003747,0.45263903651916704,4.526439517317499,1,0.4,0.4,transcript,8138.0
PLCL2,ENSG00000154822,major depressive disorder,MONDO_0002009,0.45263085524896646,4.526447104619904,2,0.8,1.6,transcript,11548.0
SP4,ENSG00000105866,schizophrenia,MONDO_0005090,0.45256826465248723,4.525706638847329,1,0.4,0.4,transcript,16672.0
BMPR2,ENSG00000204217,genetic non-acquired premature ovarian failure,EFO_0010646,0.4525607981684918,4.525625753143955,1,0.4,0.4,transcript,22508.0
SENP6,ENSG00000112701,"osteoarthritis, hip",EFO_1000786,0.4525505120033219,4.5259341371939055,5,2.2,11.0,transcript,25640.0
BIRC6,ENSG00000115760,glomerular filtration rate,OBA_0003747,0.4524074438057228,4.52408162031418,1,0.5,0.5,transcript,69616.0
FAM76B,ENSG00000077458,brain attribute,OBA_2045210,0.4523983761126164,4.524005456629771,1,0.4,0.4,transcript,18437.0
DYNC2H1,ENSG00000187240,body mass index,EFO_0004340,0.45229074374869166,4.5229175938956105,1,0.5,0.5,transcript,49230.0
ATAD2B,ENSG00000119778,mean corpuscular hemoglobin concentration,EFO_0004528,0.45220124206293516,4.522030598316241,1,0.4,0.4,transcript,22005.0
AKAP6,ENSG00000151320,FEV/FVC ratio,EFO_0004713,0.45210908012240486,4.5216655812827,7,2.8000000000000003,19.6,transcript,34100.0
CASQ2,ENSG00000118729,systolic blood pressure,EFO_0006335,0.4521020611675929,4.5210332626974985,1,0.4,0.4,transcript,31618.0
CPPED1,ENSG00000103381,metabolite measurement,EFO_0004725,0.45204625025059214,4.520500231236349,1,0.4,0.4,transcript,10602.0
MEOX2,ENSG00000106511,lipid measurement,EFO_0004529,0.4520308641363564,4.520477346551249,1,0.4,0.4,transcript,2371.0
BMP10,ENSG00000163217,diastolic blood pressure,EFO_0006336,0.4520191725735035,4.5202579947873875,1,0.4,0.4,transcript,6036.0
PDHX,ENSG00000110435,genetic disorder,EFO_0000508,0.45199870205389114,4.520031788306119,1,0.4,0.4,transcript,8935.0
WRN,ENSG00000165392,ovarian cancer,MONDO_0008170,0.4519636523152923,4.519663924917596,1,0.5,0.5,transcript,18247.0
SKP2,ENSG00000145604,mean corpuscular hemoglobin concentration,EFO_0004528,0.4518304796418246,4.518309819272232,1,0.4,0.4,transcript,79636.0
CNTLN,ENSG00000044459,BMI-adjusted waist circumference,EFO_0007789,0.45165567482682223,4.516678208831496,2,0.8,1.6,transcript,13173.0
GHR,ENSG00000112964,diastolic blood pressure,EFO_0006336,0.45161555032281897,4.516164364744838,1,0.4,0.4,transcript,45139.0
LRRK2,ENSG00000188906,total cholesterol measurement,EFO_0004574,0.45160100719326923,4.516028829748449,2,0.9,1.8,transcript,95960.0
SKIL,ENSG00000136603,eosinophil count,EFO_0004842,0.451590423097837,4.515920690799946,1,0.5,0.5,transcript,30377.0
CTBP2,ENSG00000175029,age-related hearing impairment,EFO_0005782,0.4515412441238295,4.515426504452443,1,0.4,0.4,transcript,28443.0
ARAP1,ENSG00000186635,Drugs used in diabetes use measurement,EFO_0009924,0.45151257076088314,4.515134717226599,1,0.4,0.4,transcript,44397.0
BANK1,ENSG00000153064,low density lipoprotein cholesterol measurement,EFO_0004611,0.4514887874486832,4.515100362227924,3,1.3,3.9000000000000004,transcript,18354.0
SECISBP2L,ENSG00000138593,neurodegenerative disease,EFO_0005772,0.4514519832035507,4.514538916004973,1,0.4,0.4,transcript,20960.0
ONECUT1,ENSG00000169856,body fat percentage,EFO_0007800,0.4514339014324377,4.514391861464025,1,0.4,0.4,transcript,7569.0
OTULINL,ENSG00000145569,allergic disease,MONDO_0005271,0.4513670590099284,4.513720565111778,1,0.4,0.4,transcript,8004.0
PARP8,ENSG00000151883,glucose measurement,EFO_0004468,0.4512408524851969,4.51245560167546,2,0.8,1.6,transcript,33987.0
KCNQ1,ENSG00000053918,HbA1c measurement,EFO_0004541,0.45120541763548033,4.512247849692441,3,1.2000000000000002,3.6000000000000005,transcript,18588.0
FAT1,ENSG00000083857,urinary bladder cancer,MONDO_0001187,0.4511982130801876,4.512003326223665,1,0.5,0.5,transcript,23590.0
COL25A1,ENSG00000188517,sex hormone-binding globulin measurement,EFO_0004696,0.45119021732080733,4.511917134868817,1,0.4,0.4,transcript,26735.0
GALNT3,ENSG00000115339,cognitive function measurement,EFO_0008354,0.45118281574167085,4.511857065416997,1,0.4,0.4,transcript,13837.0
PFAS,ENSG00000178921,erythrocyte count,EFO_0004305,0.4511744595664613,4.511767922000046,1,0.4,0.4,transcript,17148.0
SV2C,ENSG00000122012,low density lipoprotein cholesterol measurement,EFO_0004611,0.4511634553326882,4.511662582196617,1,0.4,0.4,transcript,14271.0
SP8,ENSG00000164651,smoking initiation,EFO_0005670,0.45115731446809537,4.511648051047995,1,0.4,0.4,transcript,5340.0
ITGA8,ENSG00000077943,FEV/FVC ratio,EFO_0004713,0.451136265293617,4.5118274089392685,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
SLC30A8,ENSG00000164756,hemoglobin A1 measurement,EFO_0007629,0.4510734980786914,4.511045148471318,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,hemoglobin A1 measurement,EFO_0007629,0.4510734980786914,4.511045148471318,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,hemoglobin A1 measurement,EFO_0007629,0.4510734980786914,4.511045148471318,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,hemoglobin A1 measurement,EFO_0007629,0.4510734980786914,4.511045148471318,4,1.6,6.4,transcript,20634.0
TXK,ENSG00000074966,alopecia areata,EFO_0004192,0.4510722126426785,4.510751518740695,1,0.4,0.4,transcript,13609.0
TBX5,ENSG00000089225,prostate carcinoma,EFO_0001663,0.45105754787932595,4.510700772450268,2,0.8,1.6,transcript,12770.0
NDFIP2,ENSG00000102471,cerebral cortex area attribute,OBA_2045267,0.45104141293226935,4.510428611188682,2,0.8,1.6,transcript,110483.0
LTBP1,ENSG00000049323,intraocular pressure measurement,EFO_0004695,0.45102266212431696,4.510239280672863,1,0.4,0.4,transcript,31597.0
GMCL1,ENSG00000087338,atrial fibrillation,EFO_0000275,0.4509914074607274,4.510168487073485,2,0.8,1.6,transcript,6289.0
DCUN1D1,ENSG00000043093,body mass index,EFO_0004340,0.4509671107978685,4.509695385715999,1,0.4,0.4,transcript,16476.0
ULK4,ENSG00000168038,platelet count,EFO_0004309,0.4509236618458491,4.509277578563349,1,0.5,0.5,transcript,12207.0
CYTL1,ENSG00000170891,body height,OBA_VT0001253,0.45090119792798466,4.509230917429819,1,0.4,0.4,transcript,1827.0
BICC1,ENSG00000122870,Increased blood pressure,HP_0032263,0.45086372342546555,4.508685328519414,1,0.4,0.4,transcript,8317.0
CYBRD1,ENSG00000071967,body weights and measures,EFO_0004324,0.4508633557992574,4.508667667312946,1,0.4,0.4,transcript,11727.0
SEMA3C,ENSG00000075223,HbA1c measurement,EFO_0004541,0.45085222081932513,4.5085559264769905,1,0.4,0.4,transcript,11863.0
NEK1,ENSG00000137601,short rib-polydactyly syndrome,MONDO_0015461,0.45082874621001207,4.508301721968396,2,0.8,1.6,transcript,112203.0
PPP1R2,ENSG00000184203,erythrocyte volume,OBA_0003460,0.45082785816557625,4.508325066257738,1,0.4,0.4,transcript,8605.0
SMC6,ENSG00000163029,low density lipoprotein cholesterol measurement,EFO_0004611,0.4507875289738771,4.507891699321967,1,0.4,0.4,transcript,24376.0
GIPC2,ENSG00000137960,body mass index,EFO_0004340,0.4507354630280696,4.5077458283247065,2,0.8,1.6,transcript,4090.0
GCH1,ENSG00000131979,dopa-responsive dystonia,MONDO_0016812,0.45072282102653993,4.507261974087464,1,0.4,0.4,transcript,11847.0
CNTN5,ENSG00000149972,major depressive disorder,MONDO_0002009,0.4506751478404066,4.506764459095288,1,0.4,0.4,transcript,30815.0
ITGB8,ENSG00000105855,prostate carcinoma,EFO_0001663,0.45062464951848824,4.506417022398184,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
BPTF,ENSG00000171634,type 2 diabetes mellitus,MONDO_0005148,0.45059002857298663,4.505919909926501,2,0.8,1.6,transcript,81532.0
PLCL2,ENSG00000154822,mood disorder,EFO_0004247,0.45040609308562235,4.504199482986462,2,0.8,1.6,transcript,11548.0
OTUD7A,ENSG00000169918,platelet volume,OBA_0003277,0.45037615452902563,4.50377927185795,1,0.4,0.4,transcript,22565.0
KIAA0586,ENSG00000100578,neurodegenerative disease,EFO_0005772,0.45037056303288525,4.503711281387296,1,0.5,0.5,transcript,88479.0
SI,ENSG00000090402,body mass index,EFO_0004340,0.45028730572409925,4.502945103350503,1,0.5,0.5,transcript,6940.0
SHH,ENSG00000164690,pulse pressure measurement,EFO_0005763,0.45024748017035454,4.502527950786724,1,0.4,0.4,transcript,7526.0
XKR4,ENSG00000206579,metabolite measurement,EFO_0004725,0.4502110727594411,4.502129679551201,1,0.4,0.4,transcript,21106.0
CYP24A1,ENSG00000019186,hematocrit,EFO_0004348,0.4501679721628815,4.50186992609862,2,0.8,1.6,transcript,8412.0
AKR1C1,ENSG00000187134,waist-hip ratio,EFO_0004343,0.45012056328886757,4.501344823841263,2,0.8,1.6,transcript,11495.0
MAP3K7,ENSG00000135341,serum alanine aminotransferase measurement,EFO_0004735,0.4500732404927847,4.500821791651125,4,1.6,6.4,transcript,71599.0
SYT13,ENSG00000019505,glucose measurement,EFO_0004468,0.45006528798562595,4.500868165109219,2,0.8,1.6,transcript,7432.0
FAM76B,ENSG00000077458,diet measurement,EFO_0008111,0.4499526973082739,4.499548668586346,1,0.4,0.4,transcript,18437.0
LRBA,ENSG00000198589,vital capacity,EFO_0004312,0.4499225246178368,4.49922918768639,1,0.4,0.4,transcript,101484.0
PRKCB,ENSG00000166501,body mass index,EFO_0004340,0.44991816505169313,4.499205616963906,1,0.4,0.4,transcript,16690.0
BCKDHB,ENSG00000083123,cystatin C measurement,EFO_0004617,0.44991084786291735,4.504835855490571,10,4.0,40.0,transcript,6984.0
PTK2,ENSG00000169398,total cholesterol measurement,EFO_0004574,0.4498932885977708,4.498937728182364,1,0.4,0.4,transcript,82607.0
FNDC3B,ENSG00000075420,FEV/FVC ratio,EFO_0004713,0.44986647387522705,4.498718356258387,2,0.8,1.6,transcript,29841.0
ATRNL1,ENSG00000107518,neuroimaging measurement,EFO_0004346,0.44985541435026505,4.49857100264452,1,0.4,0.4,transcript,23726.0
DPYD,ENSG00000188641,uracil measurement,EFO_0800644,0.44971079155206234,4.497166136293796,1,0.5,0.5,transcript,8588.0
MANSC4,ENSG00000205693,type 2 diabetes mellitus,MONDO_0005148,0.4497008154999644,4.497308095011641,1,0.5,0.5,transcript,1667.0
ARMC1,ENSG00000104442,educational attainment,EFO_0011015,0.44967572089072566,4.496801757297946,1,0.4,0.4,transcript,8979.0
DUSP22,ENSG00000112679,eosinophil count,EFO_0004842,0.4496257057862813,4.49628066225323,1,0.4,0.4,transcript,16946.0
TMEM131,ENSG00000075568,neurodegenerative disease,EFO_0005772,0.44962472323110425,4.496268681182296,1,0.4,0.4,transcript,18649.0
PARP11,ENSG00000111224,neuroimaging measurement,EFO_0004346,0.4495350189231017,4.495368137718857,1,0.4,0.4,transcript,22286.0
NDUFS4,ENSG00000164258,HbA1c measurement,EFO_0004541,0.4495343788258263,4.4954503696598085,1,0.4,0.4,transcript,3753.0
FAS,ENSG00000026103,lymphoid leukemia,EFO_0004289,0.4495327705653833,4.495329913878366,1,0.4,0.4,transcript,181141.0
TCERG1L,ENSG00000176769,self reported educational attainment,EFO_0004784,0.44952977682331646,4.4955259484955725,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,self reported educational attainment,EFO_0004784,0.44952977682331646,4.4955259484955725,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,self reported educational attainment,EFO_0004784,0.44952977682331646,4.4955259484955725,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,self reported educational attainment,EFO_0004784,0.44952977682331646,4.4955259484955725,2,0.8,1.6,transcript,7012.0
DMRTA1,ENSG00000176399,schizophrenia,MONDO_0005090,0.4495276490636683,4.495348098227088,1,0.4,0.4,transcript,5586.0
AFF1,ENSG00000172493,lymphocyte count,EFO_0004587,0.4494930470256766,4.494940692853817,1,0.4,0.4,transcript,39129.0
SLC25A16,ENSG00000122912,lean body mass,EFO_0004995,0.4494093673458284,4.4941247100815,1,0.4,0.4,transcript,12888.0
RCL1,ENSG00000120158,mean reticulocyte volume,EFO_0010701,0.44933815791187026,4.493420252617687,1,0.4,0.4,transcript,10343.0
VPS13A,ENSG00000197969,Red cell distribution width,EFO_0009188,0.44932076971589946,4.49321444240781,1,0.4,0.4,transcript,59301.0
GCH1,ENSG00000131979,genetic disorder,EFO_0000508,0.4493054588615032,4.493088352437097,1,0.4,0.4,transcript,11847.0
FAT4,ENSG00000196159,low density lipoprotein cholesterol measurement,EFO_0004611,0.4492944297631397,4.4929530076740765,1,0.4,0.4,transcript,45924.0
ACTN2,ENSG00000077522,heart failure,EFO_0003144,0.44925595157973663,4.492576201409155,2,0.8,1.6,transcript,95891.0
ALG10B,ENSG00000175548,chronotype measurement,EFO_0008328,0.4492541487491764,4.493247303414972,5,2.0,10.0,transcript,14168.0
ONECUT1,ENSG00000169856,glucose measurement,EFO_0004468,0.4492421772653645,4.492474619793293,1,0.4,0.4,transcript,7569.0
FAT3,ENSG00000165323,brain connectivity attribute,OBA_2045295,0.4492292875025522,4.492301204020837,1,0.4,0.4,transcript,48025.0
RASA2,ENSG00000155903,body fat percentage,EFO_0007800,0.4492049703997397,4.492097317376756,1,0.4,0.4,transcript,8401.0
LIN54,ENSG00000189308,hematocrit,EFO_0004348,0.4491455868955424,4.491468795532467,1,0.4,0.4,transcript,30944.0
TBXT,ENSG00000164458,blood urea nitrogen measurement,EFO_0004741,0.4491081503687263,4.491541979512282,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
SEMA6D,ENSG00000137872,alcohol consumption quality,OBA_1000840,0.4491055120184083,4.491064547031746,1,0.5,0.5,transcript,53040.0
DENND1B,ENSG00000213047,depressive symptom measurement,EFO_0007006,0.44910409249873373,4.491477682499567,5,2.0,10.0,transcript,22896.0
AKAP10,ENSG00000108599,neutrophil count,EFO_0004833,0.44905893128434743,4.490624493142507,1,0.4,0.4,transcript,11370.0
PICALM,ENSG00000073921,dementia,MONDO_0001627,0.44903129580280365,4.4903262263466095,1,0.4,0.4,transcript,30147.0
AFF1,ENSG00000172493,apolipoprotein B measurement,EFO_0004615,0.44902089826738606,4.490219205270911,1,0.4,0.4,transcript,39129.0
TNRC6B,ENSG00000100354,diastolic blood pressure,EFO_0006336,0.44901580677550856,4.490164519576113,1,0.4,0.4,transcript,61998.0
ACVR1C,ENSG00000123612,HbA1c measurement,EFO_0004541,0.44895501435891,4.4896694575339176,2,0.8,1.6,transcript,13410.0
PAFAH1B2,ENSG00000168092,body mass index,EFO_0004340,0.4489329390360528,4.489463180811234,2,0.8,1.6,transcript,11959.0
WDR59,ENSG00000103091,neurodegenerative disease,EFO_0005772,0.44889799944015685,4.489053649053321,2,0.8,1.6,transcript,21723.0
U2SURP,ENSG00000163714,serum creatinine amount,OBA_2050096,0.44888634850997905,4.488913893089457,2,0.8,1.6,transcript,31741.0
TSPAN9,ENSG00000011105,body weight,EFO_0004338,0.44887353593066537,4.4887708429486946,1,0.5,0.5,transcript,14091.0
PEX2,ENSG00000164751,appendicular lean mass,EFO_0004980,0.4488729648258087,4.4887734742688234,1,0.4,0.4,transcript,9127.0
PHIP,ENSG00000146247,glucose measurement,EFO_0004468,0.4488018370616836,4.488026347770269,1,0.5,0.5,transcript,62679.0
RFX3,ENSG00000080298,genetic disorder,EFO_0000508,0.4487927537800967,4.487984038966304,2,0.8,1.6,transcript,28318.0
ASPM,ENSG00000066279,drug use measurement,EFO_0007010,0.44879193338943507,4.487954332241651,2,0.9,1.8,transcript,51431.0
LHFPL2,ENSG00000145685,hematocrit,EFO_0004348,0.4487912334322775,4.487939226886981,1,0.4,0.4,transcript,14874.0
ETV5,ENSG00000244405,morbid obesity,EFO_0001074,0.4487700179222648,4.487732351666949,1,0.4,0.4,transcript,12433.0
KITLG,ENSG00000049130,Testicular Germ Cell Tumor,EFO_1000566,0.4487600896200958,4.487770252177812,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
LTBP1,ENSG00000049323,body weight,EFO_0004338,0.4485643860022254,4.485656519451947,1,0.4,0.4,transcript,31597.0
WAPL,ENSG00000062650,erythrocyte volume,OBA_0003460,0.448491256888273,4.48504632577957,2,0.8,1.6,transcript,11962.0
REEP3,ENSG00000165476,urate measurement,EFO_0004531,0.4484713950801932,4.484783734472552,1,0.4,0.4,transcript,5732.0
DMRTA1,ENSG00000176399,HbA1c measurement,EFO_0004541,0.44846569401563763,4.484728547746781,1,0.4,0.4,transcript,5586.0
TMED5,ENSG00000117500,eosinophil count,EFO_0004842,0.4484541815206664,4.484573782472184,1,0.5,0.5,transcript,15641.0
DPYD,ENSG00000188641,smoking cessation,EFO_0004319,0.44837109915861756,4.4837692123593476,1,0.5,0.5,transcript,8588.0
MACF1,ENSG00000127603,type 2 diabetes mellitus,MONDO_0005148,0.44835638316046006,4.48356915845693,2,0.8,1.6,gene_variant,300365.0
STAU2,ENSG00000040341,Inguinal hernia,HP_0000023,0.44835622775784045,4.483573845761274,1,0.5,0.5,transcript,43222.0
IQGAP2,ENSG00000145703,brain attribute,OBA_2045210,0.4483469005219622,4.483483676150639,1,0.5,0.5,transcript,34081.0
PRKCB,ENSG00000166501,neoplasm,EFO_0000616,0.44829470012287326,4.4829709676757075,1,0.4,0.4,transcript,16690.0
STXBP5,ENSG00000164506,IGF-1 measurement,EFO_0004627,0.44824502613432365,4.482464091751695,2,0.9,1.8,transcript,130148.0
ASTN2,ENSG00000148219,autosomal recessive limb-girdle muscular dystrophy,MONDO_0015152,0.44822644776160636,4.482323232022645,2,0.8,1.6,transcript,27232.0
NDUFS4,ENSG00000164258,reticulocyte count,EFO_0007986,0.44822075985926774,4.482314179994223,1,0.4,0.4,transcript,3753.0
TBX5,ENSG00000089225,hematocrit,EFO_0004348,0.44818685491601673,4.481993842817176,2,0.8,1.6,transcript,12770.0
SKI,ENSG00000157933,forced expiratory volume,EFO_0004314,0.4481798431702693,4.481850952711097,1,0.4,0.4,transcript,7616.0
DPYD,ENSG00000188641,C-reactive protein measurement,EFO_0004458,0.44809991424066403,4.481057363179812,1,0.5,0.5,transcript,8588.0
DCLK1,ENSG00000133083,optic cup area,OBA_2045265,0.4480933658086549,4.480983855739809,2,0.8,1.6,transcript,31874.0
AKAP11,ENSG00000023516,bone tissue density,OBA_1000110,0.44803123868701555,4.480712386870155,1,0.4,0.4,transcript,1000.0
RTKN2,ENSG00000182010,anti-citrullinated protein antibody seropositivity,EFO_0007837,0.4479515544655822,4.479550802478651,1,0.4,0.4,transcript,11345.0
RTKN2,ENSG00000182010,rheumatoid factor seropositivity measurement,EFO_0007791,0.4479515544655822,4.479550802478651,1,0.4,0.4,transcript,11345.0
PLCL2,ENSG00000154822,self reported educational attainment,EFO_0004784,0.44794803712850984,4.479618923415337,2,0.8,1.6,transcript,11548.0
SLC22A2,ENSG00000112499,serum metabolite measurement,EFO_0005653,0.44788238198185887,4.478863541764964,1,0.4,0.4,transcript,10070.0
BCAS3,ENSG00000141376,systolic blood pressure,EFO_0006335,0.44777726106428617,4.4777830097610165,1,0.5,0.5,transcript,48081.0
GABRG1,ENSG00000163285,smoking initiation,EFO_0005670,0.4477220746151554,4.4793515540828945,6,2.4000000000000004,14.400000000000002,transcript,6758.0
TBXT,ENSG00000164458,glomerular filtration rate,OBA_0003747,0.4476457460170289,4.476917935995308,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
ARAP1,ENSG00000186635,platelet count,EFO_0004309,0.44764136522102527,4.47642266182802,1,0.4,0.4,transcript,44397.0
SEMA6D,ENSG00000137872,beverage consumption measurement,EFO_0010088,0.44760656728121956,4.476075099659858,1,0.5,0.5,transcript,53040.0
FIGN,ENSG00000182263,smoking initiation,EFO_0005670,0.447567988210974,4.475716636681089,1,0.4,0.4,transcript,10883.0
RNF144B,ENSG00000137393,triglyceride measurement,EFO_0004530,0.4475398084717955,4.47547095773672,1,0.4,0.4,transcript,5489.0
ATAD2B,ENSG00000119778,reticulocyte measurement,EFO_0010700,0.44751169445770783,4.475135122263968,1,0.4,0.4,transcript,22005.0
SLC35F5,ENSG00000115084,calcium measurement,EFO_0004838,0.4473894916186082,4.473965675075168,2,0.8,1.6,transcript,22612.0
SEMA6D,ENSG00000137872,smoking behavior trait,OBA_2050116,0.44738149689006,4.473824395748262,1,0.5,0.5,transcript,53040.0
CA8,ENSG00000178538,body mass index,EFO_0004340,0.44737777007147805,4.473818654948424,1,0.4,0.4,transcript,9767.0
ZNF507,ENSG00000168813,erythrocyte count,EFO_0004305,0.44732421076138706,4.473256506461963,1,0.4,0.4,transcript,27780.0
SP4,ENSG00000105866,smoking initiation,EFO_0005670,0.44729933022527163,4.473017294575173,1,0.4,0.4,transcript,16672.0
NDUFS4,ENSG00000164258,high density lipoprotein cholesterol measurement,EFO_0004612,0.4472148313613582,4.472254895015127,1,0.4,0.4,transcript,3753.0
BPTF,ENSG00000171634,serum alanine aminotransferase measurement,EFO_0004735,0.4471923566625765,4.4719431908224,2,0.8,1.6,transcript,81532.0
SYNE2,ENSG00000054654,atrial flutter,EFO_0003911,0.4471480270083916,4.471492905599824,2,1.0,2.0,transcript,158284.0
ULK4,ENSG00000168038,heart rate,OBA_1001087,0.4471249093479952,4.47129005358481,1,0.5,0.5,transcript,12207.0
SGCZ,ENSG00000185053,bone tissue density,OBA_1000110,0.44706457926334675,4.470694501839508,1,0.4,0.4,transcript,8212.0
COL25A1,ENSG00000188517,low density lipoprotein cholesterol measurement,EFO_0004611,0.44699577336294055,4.469972695290149,1,0.4,0.4,transcript,26735.0
FAM76B,ENSG00000077458,educational attainment,EFO_0011015,0.44699522061994235,4.46997390170303,1,0.4,0.4,transcript,18437.0
SUMF1,ENSG00000144455,bone tissue density,OBA_1000110,0.44698636430433164,4.469895992416547,1,0.4,0.4,transcript,12365.0
FMN1,ENSG00000248905,nevus count,EFO_0004632,0.44694518565194896,4.469487554071976,2,0.8,1.6,transcript,44821.0
GIPC2,ENSG00000137960,mean corpuscular hemoglobin concentration,EFO_0004528,0.4469311127298317,4.469702325342327,2,0.8,1.6,transcript,4090.0
HTR2C,ENSG00000147246,epilepsy,EFO_0000474,0.44689323113239765,4.4689717341734605,1,0.5,0.5,transcript,12683.0
MAGI2,ENSG00000187391,Red cell distribution width,EFO_0009188,0.44686510875904106,4.468655650987404,1,0.4,0.4,transcript,87654.0
ARMC1,ENSG00000104442,self reported educational attainment,EFO_0004784,0.4468208001933475,4.468252550324165,1,0.4,0.4,transcript,8979.0
ALDOB,ENSG00000136872,serum alanine aminotransferase measurement,EFO_0004735,0.4467806735177311,4.467848147331778,1,0.4,0.4,transcript,9659.0
ETV5,ENSG00000244405,blood urea nitrogen measurement,EFO_0004741,0.4466913030321216,4.466945202765518,1,0.4,0.4,transcript,12433.0
RCL1,ENSG00000120158,Thrombocytopenia,HP_0001873,0.44668078511484544,4.466846524647439,1,0.4,0.4,transcript,10343.0
RFX7,ENSG00000181827,mean reticulocyte volume,EFO_0010701,0.44664177947566114,4.46642738708275,1,0.4,0.4,transcript,41700.0
ID4,ENSG00000172201,waist circumference,OBA_1001085,0.44656979029139476,4.466111019361146,2,0.8,1.6,transcript,3873.0
DNAH14,ENSG00000185842,body mass index,EFO_0004340,0.4464949029611049,4.465007008094589,3,1.5,4.5,transcript,77615.0
LUZP2,ENSG00000187398,triglyceride measurement,EFO_0004530,0.4464658695498769,4.464975475522993,4,1.7000000000000002,6.800000000000001,transcript,21466.0
GFRAL,ENSG00000187871,erythrocyte count,EFO_0004305,0.4464579794854523,4.464789109349552,1,0.4,0.4,transcript,1911.0
TFEC,ENSG00000105967,atrial fibrillation,EFO_0000275,0.44645366462935426,4.464552343648538,1,0.4,0.4,transcript,25482.0
ID4,ENSG00000172201,grip strength measurement,EFO_0006941,0.44643759582664677,4.464789074713666,2,0.8,1.6,transcript,3873.0
MFAP3,ENSG00000037749,serum creatinine amount,OBA_2050096,0.4463929556368578,4.4639421460702025,1,0.4,0.4,transcript,31772.0
PHC1,ENSG00000111752,erythrocyte volume,OBA_0003460,0.4463474255991038,4.463493406475545,1,0.5,0.5,transcript,26109.0
GSAP,ENSG00000186088,asthma,MONDO_0004979,0.4463262234823733,4.463287748933035,1,0.5,0.5,transcript,19597.0
CBLB,ENSG00000114423,urticaria,EFO_0005531,0.4463257529517826,4.463266021185378,1,0.4,0.4,transcript,47105.0
CD69,ENSG00000110848,lymphocyte percentage of leukocytes,EFO_0007993,0.4463043051564868,4.46388752728619,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
YEATS2,ENSG00000163872,diastolic blood pressure,EFO_0006336,0.4462611126398617,4.462644866866935,1,0.5,0.5,transcript,14819.0
CENPC,ENSG00000145241,smoking initiation,EFO_0005670,0.4462572994957071,4.462771802114129,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
UBXN2A,ENSG00000173960,mean corpuscular hemoglobin concentration,EFO_0004528,0.4462182713770507,4.462339931025101,2,0.8,1.6,transcript,10177.0
SGCD,ENSG00000170624,total cholesterol measurement,EFO_0004574,0.4462138532545723,4.462157321591709,1,0.4,0.4,transcript,21289.0
SEC22A,ENSG00000121542,glucose measurement,EFO_0004468,0.4462096601575564,4.462218636508064,2,0.8,1.6,transcript,13111.0
TMCC1,ENSG00000172765,eosinophil percentage of leukocytes,EFO_0007991,0.44618948334136826,4.461905034892897,1,0.4,0.4,transcript,39210.0
ANKH,ENSG00000154122,blood phosphate measurement,EFO_0010972,0.4461167723681097,4.4619361663040475,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,blood phosphate measurement,EFO_0010972,0.4461167723681097,4.4619361663040475,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,blood phosphate measurement,EFO_0010972,0.4461167723681097,4.4619361663040475,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,blood phosphate measurement,EFO_0010972,0.4461167723681097,4.4619361663040475,5,2.4,12.0,transcript,15616.0
TBXT,ENSG00000164458,serum urea amount,OBA_2050065,0.446096187842653,4.461422354251549,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
ID4,ENSG00000172201,blood urea nitrogen measurement,EFO_0004741,0.44606434421794666,4.461056558626665,2,0.8,1.6,transcript,3873.0
ID4,ENSG00000172201,body fat distribution,EFO_0004341,0.44606434421794666,4.461056558626665,2,0.8,1.6,transcript,3873.0
RP2,ENSG00000102218,Leber congenital amaurosis,MONDO_0018998,0.44600075574783843,4.460115665586493,1,0.4,0.4,transcript,3700.0
POU2F1,ENSG00000143190,eosinophil count,EFO_0004842,0.44597768209968375,4.459791833053395,2,0.8,1.6,transcript,106581.0
CIAO2A,ENSG00000166797,hemoglobin measurement,EFO_0004509,0.4459669331344953,4.45988996013701,2,0.8,1.6,transcript,7252.0
SLC22A2,ENSG00000112499,N1-methyladenosine measurement,EFO_0021122,0.4459610248588981,4.459649970535357,1,0.4,0.4,transcript,10070.0
CRYGD,ENSG00000118231,early-onset non-syndromic cataract,MONDO_0011060,0.44595487402215755,4.460171793181077,1,0.4,0.4,transcript,642.0
PLXNA4,ENSG00000221866,protein measurement,EFO_0004747,0.4459497421180662,4.4595096685780895,1,0.4,0.4,transcript,32660.0
KYNU,ENSG00000115919,N-formylanthranilic acid measurement,EFO_0800069,0.44592194201090807,4.45937766882331,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
FRMD4B,ENSG00000114541,brain attribute,OBA_2045210,0.4458671816655538,4.458747912917309,2,0.8,1.6,transcript,21026.0
SH3TC2,ENSG00000169247,mean arterial pressure,EFO_0006340,0.4458496560641565,4.458500984050244,1,0.4,0.4,transcript,90428.0
SPRED1,ENSG00000166068,high density lipoprotein cholesterol measurement,EFO_0004612,0.44581401476487714,4.458184720860271,1,0.4,0.4,transcript,8974.0
PDCD5,ENSG00000105185,hemoglobin A1 measurement,EFO_0007629,0.44574005670748756,4.457478676819067,1,0.4,0.4,transcript,5121.0
GFRAL,ENSG00000187871,uric acid measurement,EFO_0004761,0.4456790224417903,4.456999538912932,1,0.4,0.4,transcript,1911.0
FLRT2,ENSG00000185070,leucine-rich repeat transmembrane protein FLRT2 measurement,EFO_0021860,0.445655639480486,4.456891913575081,7,2.8000000000000003,19.6,transcript,58417.0
BANK1,ENSG00000153064,neuroimaging measurement,EFO_0004346,0.4456178209389739,4.456390697130831,3,1.3,3.9000000000000004,transcript,18354.0
SLC6A5,ENSG00000165970,glomerular filtration rate,OBA_0003747,0.445609463641433,4.456133272558443,1,0.4,0.4,transcript,10353.0
SAMD11,ENSG00000187634,retinitis pigmentosa,MONDO_0019200,0.44560817981330664,4.456144627002932,2,0.8,1.6,transcript,25466.0
COLEC10,ENSG00000184374,white matter integrity,EFO_0004641,0.4456047760164088,4.456152940285045,1,0.4,0.4,transcript,3803.0
NUP153,ENSG00000124789,monocyte count,EFO_0005091,0.4455372921918205,4.455400906470731,1,0.5,0.5,transcript,17867.0
PTK2,ENSG00000169398,mathematical ability,EFO_0004875,0.44550376155020616,4.455042457706718,1,0.4,0.4,transcript,82607.0
CFAP299,ENSG00000197826,serum creatinine amount,OBA_2050096,0.4454595492663267,4.454660630756024,1,0.5,0.5,transcript,7676.0
ASPM,ENSG00000066279,age-related macular degeneration,EFO_0001365,0.44540525614725496,4.4540875598198495,2,0.9,1.8,transcript,51431.0
LDLRAP1,ENSG00000157978,mean corpuscular hemoglobin concentration,EFO_0004528,0.4453107246564196,4.453133160013276,1,0.4,0.4,transcript,15436.0
SYNE2,ENSG00000054654,basophil measurement,EFO_0803539,0.44530743025100894,4.453086938025997,2,1.0,2.0,transcript,158284.0
SOS1,ENSG00000115904,endometrial cancer,MONDO_0011962,0.44529959210273234,4.453019528900549,2,0.8,1.6,transcript,67774.0
SV2C,ENSG00000122012,total cholesterol measurement,EFO_0004574,0.4452723572048148,4.452751600917884,1,0.4,0.4,transcript,14271.0
SEMA3C,ENSG00000075223,neurodegenerative disease,EFO_0005772,0.4452527078700913,4.452560796984653,1,0.4,0.4,transcript,11863.0
FAM8A1,ENSG00000137414,drug use measurement,EFO_0007010,0.44522353424481376,4.452254584318447,1,0.4,0.4,transcript,20788.0
FAM8A1,ENSG00000137414,seborrheic dermatitis,EFO_1000764,0.44522353424481376,4.452254584318447,1,0.4,0.4,transcript,20788.0
FAM8A1,ENSG00000137414,psoriasis vulgaris,EFO_1001494,0.44522353424481376,4.452254584318447,1,0.4,0.4,transcript,20788.0
FAM8A1,ENSG00000137414,macular degeneration,EFO_0009606,0.44522353424481376,4.452254584318447,1,0.4,0.4,transcript,20788.0
FAM8A1,ENSG00000137414,psoriasis,EFO_0000676,0.44522353424481376,4.452254584318447,1,0.4,0.4,transcript,20788.0
MAGI2,ENSG00000187391,mean corpuscular hemoglobin concentration,EFO_0004528,0.44518198571673456,4.451824420564338,1,0.4,0.4,transcript,87654.0
PTK2,ENSG00000169398,diastolic blood pressure,EFO_0006336,0.44518029463146724,4.451807788519329,1,0.4,0.4,transcript,82607.0
PEX2,ENSG00000164751,IGF-1 measurement,EFO_0004627,0.4450514744787739,4.450558570798476,1,0.4,0.4,transcript,9127.0
CCDC62,ENSG00000130783,spermatogenic failure 67,MONDO_0030718,0.44504884380198234,4.450515374046759,1,0.4,0.4,transcript,14850.0
SLC30A8,ENSG00000164756,sodium measurement,EFO_0009282,0.4450226977442261,4.450537145126665,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,sodium measurement,EFO_0009282,0.4450226977442261,4.450537145126665,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,sodium measurement,EFO_0009282,0.4450226977442261,4.450537145126665,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,sodium measurement,EFO_0009282,0.4450226977442261,4.450537145126665,4,1.6,6.4,transcript,20634.0
BCAS3,ENSG00000141376,platelet count,EFO_0004309,0.44502082231322904,4.450218622250445,1,0.5,0.5,transcript,48081.0
FGA,ENSG00000171560,neutrophil count,EFO_0004833,0.4450111283624464,4.4501795080829325,1,0.4,0.4,transcript,5863.0
KLHL3,ENSG00000146021,hemoglobin measurement,EFO_0004509,0.44498781142064114,4.449925424889755,2,0.8,1.6,transcript,33819.0
IL17A,ENSG00000112115,glomerular filtration rate,OBA_0003747,0.4449875061846991,4.450088851264415,1,0.4,0.4,transcript,1871.0
YBX3,ENSG00000060138,coronary artery disease,EFO_0001645,0.4449189781325494,4.449210235406083,1,0.4,0.4,transcript,19556.0
POU2F1,ENSG00000143190,monocyte count,EFO_0005091,0.44491486401755914,4.44916365223215,2,0.8,1.6,transcript,106581.0
ANKRD10,ENSG00000088448,body mass index,EFO_0004340,0.4448782694865611,4.448960789255637,2,0.8,1.6,transcript,8984.0
GALNT3,ENSG00000115339,glucose measurement,EFO_0004468,0.4448317194243797,4.448346102244086,1,0.4,0.4,transcript,13837.0
ANO5,ENSG00000171714,muscular dystrophy,MONDO_0020121,0.44483145642600047,4.448319610623469,1,0.4,0.4,transcript,79265.0
SGCZ,ENSG00000185053,lymphocyte count,EFO_0004587,0.44477952505932944,4.447843959799335,1,0.4,0.4,transcript,8212.0
ATAD2B,ENSG00000119778,vital capacity,EFO_0004312,0.4447757726795789,4.447775904482678,1,0.4,0.4,transcript,22005.0
KITLG,ENSG00000049130,platelet count,EFO_0004309,0.44470990574249897,4.4472684134018445,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
LMNTD1,ENSG00000152936,metabolite measurement,EFO_0004725,0.4446762968352013,4.446917634102142,2,0.9,1.8,transcript,11638.0
ZNF257,ENSG00000197134,systolic blood pressure,EFO_0006335,0.4446633840258937,4.446661422661364,1,0.4,0.4,transcript,14502.0
CHL1,ENSG00000134121,mathematical ability,EFO_0004875,0.44465051821524954,4.446552382577299,2,0.8,1.6,transcript,33898.0
TRDN,ENSG00000186439,body mass index,EFO_0004340,0.44464841723424975,4.446503375783754,1,0.5,0.5,transcript,26037.0
FRMD4B,ENSG00000114541,amygdala volume,OBA_2050034,0.44462898076956053,4.446365903957377,2,0.8,1.6,transcript,21026.0
TNFRSF11A,ENSG00000141655,femoral neck bone mineral density,EFO_0007785,0.4446025225154226,4.446149816339399,2,0.8,1.6,transcript,12842.0
FUT2,ENSG00000176920,low density lipoprotein cholesterol measurement,EFO_0004611,0.44454155376308585,4.445538564081546,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
TMEM106B,ENSG00000106460,body mass index,EFO_0004340,0.4444525722748855,4.444558599236003,2,0.8,1.6,transcript,48667.0
KIAA0232,ENSG00000170871,platelet volume,OBA_0003277,0.444408206252176,4.444105350831029,1,0.4,0.4,transcript,17176.0
MSX2,ENSG00000120149,cerebral cortex area attribute,OBA_2045267,0.4444009647955584,4.444127886205657,1,0.4,0.4,transcript,3383.0
TET1,ENSG00000138336,triglyceride measurement,EFO_0004530,0.44439892987586505,4.444030913407007,1,0.4,0.4,transcript,9612.0
ID4,ENSG00000172201,sexual dimorphism measurement,EFO_0021796,0.444223447719627,4.442647593643469,2,0.8,1.6,transcript,3873.0
AKAP11,ENSG00000023516,neutrophil percentage of leukocytes,EFO_0007990,0.44421773296413225,4.442577329641322,1,0.4,0.4,transcript,1000.0
COL25A1,ENSG00000188517,triglycerides:total lipids ratio,EFO_0020947,0.44419726193842574,4.441987581045002,1,0.4,0.4,transcript,26735.0
PDCD5,ENSG00000105185,neurodegenerative disease,EFO_0005772,0.4441794486746252,4.441872596490443,1,0.4,0.4,transcript,5121.0
GRB14,ENSG00000115290,cholesteryl esters:total lipids ratio,EFO_0020944,0.44415802107477853,4.441620578090605,1,0.4,0.4,transcript,9909.0
FIGN,ENSG00000182263,neurodegenerative disease,EFO_0005772,0.4441570670170259,4.441607424741609,1,0.4,0.4,transcript,10883.0
BTC,ENSG00000174808,total cholesterol measurement,EFO_0004574,0.4441206855081394,4.441328917943768,1,0.4,0.4,transcript,3277.0
LRBA,ENSG00000198589,high density lipoprotein cholesterol measurement,EFO_0004612,0.444092933982025,4.440933281328271,1,0.4,0.4,transcript,101484.0
CASQ2,ENSG00000118729,electrocardiography,EFO_0004327,0.44406754550633204,4.44068810608489,1,0.4,0.4,transcript,31618.0
SLC30A8,ENSG00000164756,diabetic retinopathy,EFO_0003770,0.4440581274164759,4.440891441849162,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,diabetic retinopathy,EFO_0003770,0.4440581274164759,4.440891441849162,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,diabetic retinopathy,EFO_0003770,0.4440581274164759,4.440891441849162,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,diabetic retinopathy,EFO_0003770,0.4440581274164759,4.440891441849162,4,1.6,6.4,transcript,20634.0
HEATR1,ENSG00000119285,platelet count,EFO_0004309,0.4440430255089146,4.440459846140812,1,0.5,0.5,transcript,16897.0
SNX13,ENSG00000071189,cholesteryl ester measurement,EFO_0010351,0.4440409774521155,4.440422099658273,1,0.4,0.4,transcript,32454.0
QKI,ENSG00000112531,erythrocyte count,EFO_0004305,0.44401680587432535,4.440203630899148,2,0.8,1.6,transcript,44979.0
PDHX,ENSG00000110435,mitochondrial disease,MONDO_0044970,0.4439064699046252,4.43910946681346,1,0.4,0.4,transcript,8935.0
GFRAL,ENSG00000187871,alcohol consumption quality,OBA_1000840,0.44390372785947707,4.4392465930898,1,0.4,0.4,transcript,1911.0
YTHDC2,ENSG00000047188,body mass index,EFO_0004340,0.4438980997771931,4.439001206936787,1,0.4,0.4,transcript,19793.0
EXO1,ENSG00000174371,estrogen-receptor positive breast cancer,EFO_1000649,0.44389678633207025,4.439097296403799,2,1.0,2.0,transcript,15452.0
CNTNAP2,ENSG00000174469,mathematical ability,EFO_0004875,0.44384265388920924,4.438434220563624,1,0.4,0.4,transcript,52072.0
MEOX2,ENSG00000106511,bone quantitative ultrasound measurement,EFO_0004514,0.4437912833798823,4.438081538986507,1,0.4,0.4,transcript,2371.0
RPS6KA5,ENSG00000100784,heel bone mineral density,EFO_0009270,0.4437848726753833,4.437858591605367,1,0.4,0.4,transcript,40548.0
FAT3,ENSG00000165323,retinal perforation,MONDO_0001539,0.4437313925929514,4.437322254924829,1,0.4,0.4,transcript,48025.0
ZNF257,ENSG00000197134,"chromosome, telomeric region length",OBA_0003784,0.4436457054689922,4.436484637092349,1,0.4,0.4,transcript,14502.0
PEX2,ENSG00000164751,age at menarche,EFO_0004703,0.443610628710295,4.436150113113687,1,0.4,0.4,transcript,9127.0
CCDC66,ENSG00000180376,lymphocyte count,EFO_0004587,0.44352975142770024,4.4353127437856985,1,0.5,0.5,transcript,32831.0
TSPAN9,ENSG00000011105,BMI-adjusted waist-hip ratio,EFO_0007788,0.44351771323922967,4.435212616034337,1,0.5,0.5,transcript,14091.0
OTOGL,ENSG00000165899,nonsyndromic genetic hearing loss,MONDO_0019497,0.44349582562164214,4.434973114174344,1,0.5,0.5,transcript,33652.0
SLC22A2,ENSG00000112499,cystatin C measurement,EFO_0004617,0.4434756965259879,4.434796687206255,1,0.4,0.4,transcript,10070.0
ZNF507,ENSG00000168813,hematocrit,EFO_0004348,0.4434755046004144,4.434769444852236,1,0.4,0.4,transcript,27780.0
FLRT2,ENSG00000185070,diastolic blood pressure change measurement,EFO_0006945,0.4434402698911028,4.434738217681249,7,2.8000000000000003,19.6,transcript,58417.0
FLRT2,ENSG00000185070,blood protein measurement,EFO_0007937,0.44336270947750867,4.433962613545308,7,2.8000000000000003,19.6,transcript,58417.0
FAM114A1,ENSG00000197712,erythrocyte volume,OBA_0003460,0.44334813629358044,4.433530042502556,1,0.4,0.4,transcript,8217.0
IKZF3,ENSG00000161405,chronic lymphocytic leukemia,EFO_0000095,0.4433234579570118,4.433242320406903,1,0.4,0.4,transcript,51674.0
LYPLAL1,ENSG00000143353,acne,EFO_0003894,0.4432847350562461,4.432875146871112,1,0.5,0.5,transcript,17988.0
NDFIP2,ENSG00000102471,brain attribute,OBA_2045210,0.44327527409864703,4.432767222852458,2,0.8,1.6,transcript,110483.0
ZFP90,ENSG00000184939,high density lipoprotein cholesterol measurement,EFO_0004612,0.44327117742826744,4.432725129429414,1,0.4,0.4,transcript,29951.0
EXD1,ENSG00000178997,glomerular filtration rate,OBA_0003747,0.4432331235833855,4.432373020018542,1,0.4,0.4,transcript,9573.0
FAM76B,ENSG00000077458,apolipoprotein A 1 measurement,EFO_0004614,0.4432282740061081,4.432304435564688,1,0.4,0.4,transcript,18437.0
PTPRO,ENSG00000151490,endometriosis,EFO_0001065,0.4431820234049966,4.431824682646433,1,0.4,0.4,transcript,89916.0
RPS6KA5,ENSG00000100784,body weights and measures,EFO_0004324,0.4431267786961162,4.431277651812696,1,0.4,0.4,transcript,40548.0
SGCD,ENSG00000170624,schizophrenia,MONDO_0005090,0.44309528103054174,4.430971599351404,1,0.4,0.4,transcript,21289.0
AFF1,ENSG00000172493,erythrocyte count,EFO_0004305,0.4430842536062306,4.4308527586593565,1,0.4,0.4,transcript,39129.0
PFAS,ENSG00000178921,hematocrit,EFO_0004348,0.4430776937853682,4.4308002641891155,1,0.4,0.4,transcript,17148.0
CEP85L,ENSG00000111860,diastolic blood pressure,EFO_0006336,0.44303422751133753,4.430357678093852,1,0.4,0.4,transcript,25969.0
INF2,ENSG00000203485,Proteinuria,HP_0000093,0.4430338508032862,4.430341570913808,1,0.4,0.4,transcript,130596.0
SLF1,ENSG00000133302,brain connectivity attribute,OBA_2045295,0.4429863598547299,4.42989851170083,1,0.4,0.4,transcript,11457.0
GRB14,ENSG00000115290,phospholipids:total lipids ratio,EFO_0020946,0.44287045901406885,4.428744957483508,1,0.4,0.4,transcript,9909.0
GRB14,ENSG00000115290,systolic blood pressure,EFO_0006335,0.4427794175548141,4.4278345428909605,1,0.4,0.4,transcript,9909.0
LMO4,ENSG00000143013,erythrocyte count,EFO_0004305,0.4427744237465447,4.427795717516927,1,0.4,0.4,transcript,7770.0
RPS6KA5,ENSG00000100784,fat pad mass,OBA_0004528,0.4426998570461355,4.427008435312889,1,0.4,0.4,transcript,40548.0
REEP3,ENSG00000165476,bilirubin measurement,EFO_0004570,0.44267157123746265,4.426785496045247,1,0.4,0.4,transcript,5732.0
GALR1,ENSG00000166573,whole body water mass,EFO_0009805,0.4426319051890123,4.42646366504992,2,0.8,1.6,transcript,11064.0
RNF144B,ENSG00000137393,Red cell distribution width,EFO_0009188,0.44250850145520676,4.425157887570832,1,0.4,0.4,transcript,5489.0
HTR2C,ENSG00000147246,Nausea and vomiting,HP_0002017,0.4424692149141846,4.424731571991329,1,0.5,0.5,transcript,12683.0
PDE1C,ENSG00000154678,cardiovascular disease,EFO_0000319,0.4424692149141846,4.424746508046514,2,0.8,1.6,transcript,29434.0
AKAP6,ENSG00000151320,HbA1c measurement,EFO_0004541,0.4424243097356559,4.42481787741521,7,2.8000000000000003,19.6,transcript,34100.0
FAT1,ENSG00000083857,heel bone mineral density,EFO_0009270,0.44241137798781205,4.42413497529991,1,0.5,0.5,transcript,23590.0
GAGE1,ENSG00000205777,eosinophil percentage of leukocytes,EFO_0007991,0.4423769072863213,4.423834410988008,1,0.4,0.4,transcript,6122.0
SV2C,ENSG00000122012,reticulocyte count,EFO_0007986,0.4423331820535798,4.423359849405533,1,0.4,0.4,transcript,14271.0
RTKN2,ENSG00000182010,Thyrotoxicosis,EFO_0009190,0.44229730402354195,4.423008298058249,1,0.4,0.4,transcript,11345.0
BPTF,ENSG00000171634,neuroimaging measurement,EFO_0004346,0.4422774765484611,4.422794389681246,2,0.8,1.6,transcript,81532.0
EXO1,ENSG00000174371,Uterine leiomyoma,HP_0000131,0.44225486263665803,4.422678059449677,2,1.0,2.0,transcript,15452.0
DENND1B,ENSG00000213047,heart rate,OBA_1001087,0.44225447629375675,4.422981520449797,5,2.0,10.0,transcript,22896.0
GREM1,ENSG00000166923,polyp of colon,MONDO_0021400,0.4422516193500887,4.422534417565765,1,0.4,0.4,transcript,21949.0
HS6ST3,ENSG00000185352,fat pad mass,OBA_0004528,0.4422250634111367,4.4222974944675055,1,0.4,0.4,transcript,8536.0
SKI,ENSG00000157933,vital capacity,EFO_0004312,0.4421958882572461,4.422011403580865,1,0.4,0.4,transcript,7616.0
ID4,ENSG00000172201,sitting height measurement,EFO_0011011,0.44217711385798797,4.422184255027078,2,0.8,1.6,transcript,3873.0
FAS,ENSG00000026103,diffuse large B-cell lymphoma,EFO_0000403,0.44217276160383534,4.4217298242628855,1,0.4,0.4,transcript,181141.0
DPYD,ENSG00000188641,fat pad mass,OBA_0004528,0.44216249807972463,4.421683201570419,1,0.5,0.5,transcript,8588.0
ZFP90,ENSG00000184939,erythrocyte volume,OBA_0003460,0.44213001132106916,4.4213134683574316,1,0.4,0.4,transcript,29951.0
GABRG1,ENSG00000163285,educational attainment,EFO_0011015,0.4421258797577871,4.423389605509212,6,2.4000000000000004,14.400000000000002,transcript,6758.0
CCDC66,ENSG00000180376,platelet count,EFO_0004309,0.4421081042195633,4.421096271704329,1,0.5,0.5,transcript,32831.0
WRN,ENSG00000165392,melanoma,EFO_0000756,0.44210419393643574,4.421069341129031,1,0.5,0.5,transcript,18247.0
GIPC2,ENSG00000137960,HbA1c measurement,EFO_0004541,0.4420975676803782,4.421366874847792,2,0.8,1.6,transcript,4090.0
PFAS,ENSG00000178921,HbA1c measurement,EFO_0004541,0.44206721592473114,4.420695485582744,1,0.4,0.4,transcript,17148.0
GAGE1,ENSG00000205777,eosinophil count,EFO_0004842,0.44203251478897687,4.420390486014565,1,0.4,0.4,transcript,6122.0
SHH,ENSG00000164690,serum urea amount,OBA_2050065,0.44201472685653614,4.420200417648539,1,0.4,0.4,transcript,7526.0
NXPH2,ENSG00000144227,growth differentiation factor 15 amount,OBA_2050135,0.4419890953685021,4.420038609646631,1,0.4,0.4,transcript,2709.0
NEDD1,ENSG00000139350,educational attainment,EFO_0011015,0.4419470750462924,4.419490007154625,1,0.4,0.4,transcript,20772.0
SKI,ENSG00000157933,urate measurement,EFO_0004531,0.4419439419758143,4.419491940766547,1,0.4,0.4,transcript,7616.0
HACD4,ENSG00000188921,platelet count,EFO_0004309,0.4419407675067325,4.419450214682342,1,0.4,0.4,transcript,9403.0
FNDC3B,ENSG00000075420,body height,OBA_VT0001253,0.4419354407104669,4.419408024610785,2,0.8,1.6,transcript,29841.0
SORL1,ENSG00000137642,high density lipoprotein cholesterol measurement,EFO_0004612,0.44191252166880446,4.419172226351142,2,0.9,1.8,transcript,38290.0
CIAO2A,ENSG00000166797,erythrocyte count,EFO_0004305,0.44190246058266547,4.419245234618712,2,0.8,1.6,transcript,7252.0
DOCK1,ENSG00000150760,blood sodium bicarbonate amount,OBA_2050094,0.44186490881961066,4.4186741760034325,1,0.4,0.4,transcript,15944.0
DLGAP1,ENSG00000170579,neuroimaging measurement,EFO_0004346,0.44183448076816983,4.418372961825637,2,0.8,1.6,transcript,56830.0
STXBP5,ENSG00000164506,venous thromboembolism,EFO_0004286,0.44175840386267146,4.417597869035173,2,0.9,1.8,transcript,130148.0
CWH43,ENSG00000109182,body fat percentage,EFO_0007800,0.44173048788715646,4.4173669521179955,1,0.5,0.5,transcript,8055.0
TSPAN9,ENSG00000011105,myeloid leukocyte count,OBA_2045223,0.44165702999512424,4.416605783593283,1,0.5,0.5,transcript,14091.0
CD69,ENSG00000110848,monocyte count,EFO_0005091,0.4416165729247557,4.4170102049688795,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
GSAP,ENSG00000186088,lymphocyte count,EFO_0004587,0.44156428448638446,4.415668358973147,1,0.5,0.5,transcript,19597.0
NDUFS4,ENSG00000164258,sex hormone-binding globulin measurement,EFO_0004696,0.44150400118856076,4.415146593287153,1,0.4,0.4,transcript,3753.0
ANO5,ENSG00000171714,protein measurement,EFO_0004747,0.4414981060872096,4.41498610723556,1,0.4,0.4,transcript,79265.0
BCKDHB,ENSG00000083123,body weights and measures,EFO_0004324,0.44146350444462146,4.420362421307612,10,4.0,40.0,transcript,6984.0
OTULIN,ENSG00000154124,citrate measurement,EFO_0010114,0.4414605059537149,4.414624294005315,1,0.4,0.4,transcript,20796.0
AKAP6,ENSG00000151320,hip circumference,OBA_1000032,0.4414443725351464,4.4150185054101145,7,2.8000000000000003,19.6,transcript,34100.0
RCL1,ENSG00000120158,red blood cell density,OBA_2045260,0.4413961952647466,4.414000626146451,1,0.4,0.4,transcript,10343.0
ETV5,ENSG00000244405,diet measurement,EFO_0008111,0.44139205400078263,4.413952712452128,1,0.4,0.4,transcript,12433.0
EXO1,ENSG00000174371,eosinophil percentage of leukocytes,EFO_0007991,0.4413803729174866,4.413933162257962,2,1.0,2.0,transcript,15452.0
KCNJ15,ENSG00000157551,basophil count,EFO_0005090,0.441376895281127,4.41377878686167,1,0.4,0.4,transcript,40675.0
LRPAP1,ENSG00000163956,alpha-2-macroglobulin receptor-associated protein measurement,EFO_0008021,0.44132182409861004,4.413448877157539,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
PDE10A,ENSG00000112541,diastolic blood pressure,EFO_0006336,0.44132020322049365,4.413221744298854,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
PEX2,ENSG00000164751,vital capacity,EFO_0004312,0.4413025455573346,4.413069281584083,1,0.4,0.4,transcript,9127.0
DPP8,ENSG00000074603,erythrocyte volume,OBA_0003460,0.4412848007141256,4.413029727235523,4,1.6,6.4,transcript,35219.0
IQGAP2,ENSG00000145703,blood protein measurement,EFO_0007937,0.4412535013341916,4.412549684272934,1,0.5,0.5,transcript,34081.0
TMEM170B,ENSG00000205269,executive function measurement,EFO_0009332,0.4412470120727485,4.4125151100425235,1,0.4,0.4,transcript,8891.0
THEM4,ENSG00000159445,X-21353 measurement,EFO_0800809,0.44122529721785453,4.412407322940652,2,0.8,1.6,transcript,10366.0
COL25A1,ENSG00000188517,phospholipids:total lipids ratio,EFO_0020946,0.4412220165255463,4.412235126916207,1,0.4,0.4,transcript,26735.0
EXO1,ENSG00000174371,lipoma,EFO_0000759,0.44121857209762755,4.412315154059371,2,1.0,2.0,transcript,15452.0
TMEM17,ENSG00000186889,cigarettes per day measurement,EFO_0006525,0.4412066755835867,4.412130755835867,1,0.4,0.4,transcript,6250.0
PTPRO,ENSG00000151490,intelligence,EFO_0004337,0.44107527040159117,4.41075715261238,1,0.4,0.4,transcript,89916.0
BACE2,ENSG00000182240,type 2 diabetes mellitus,MONDO_0005148,0.4410425428781432,4.410558984707976,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
SYNE2,ENSG00000054654,X-08402 measurement,EFO_0021205,0.44098132940364754,4.409825929552383,2,1.0,2.0,transcript,158284.0
GIPC2,ENSG00000137960,FEV/FVC ratio,EFO_0004713,0.44097618762957436,4.410153074339753,2,0.8,1.6,transcript,4090.0
DPYD,ENSG00000188641,autism spectrum disorder,EFO_0003756,0.4409317877334403,4.409376098107575,1,0.5,0.5,transcript,8588.0
PAQR3,ENSG00000163291,reticulocyte measurement,EFO_0010700,0.4408606471337992,4.408621523078349,1,0.4,0.4,transcript,26575.0
PALM2AKAP2,ENSG00000157654,reticulocyte measurement,EFO_0010700,0.4408520905298983,4.408528892519431,1,0.4,0.4,transcript,50080.0
AHNAK2,ENSG00000185567,systemic lupus erythematosus,MONDO_0007915,0.4408261281725302,4.408309111451477,2,1.0,2.0,transcript,41815.0
PLCL1,ENSG00000115896,intelligence,EFO_0004337,0.4408114180798311,4.408203691287821,2,0.8,1.6,transcript,17875.0
LIN54,ENSG00000189308,eosinophil count,EFO_0004842,0.44078398585763284,4.407852785153371,1,0.4,0.4,transcript,30944.0
DOK5,ENSG00000101134,body mass index,EFO_0004340,0.44078336095502246,4.407921444420668,1,0.4,0.4,transcript,4554.0
DYNC2H1,ENSG00000187240,Retinal dystrophy,HP_0000556,0.44075499339382646,4.4075600903469585,1,0.5,0.5,transcript,49230.0
CFHR4,ENSG00000134365,systolic blood pressure,EFO_0006335,0.4407439725715562,4.407480234505969,1,0.5,0.5,transcript,12343.0
PIP4K2A,ENSG00000150867,B-cell acute lymphoblastic leukemia,EFO_0000094,0.44073799748784503,4.407423420083186,1,0.4,0.4,transcript,9207.0
FAM76B,ENSG00000077458,reticulocyte measurement,EFO_0010700,0.440726657135389,4.407288266857497,1,0.4,0.4,transcript,18437.0
CNTN5,ENSG00000149972,wellbeing measurement,EFO_0007869,0.4407245967004202,4.407258947695423,1,0.4,0.4,transcript,30815.0
SLC22A2,ENSG00000112499,free cholesterol in very large VLDL measurement ,EFO_0022274,0.4406806246669269,4.406845968615645,1,0.4,0.4,transcript,10070.0
RFX3,ENSG00000080298,attention deficit hyperactivity disorder,EFO_0003888,0.4406701027553556,4.4067575287188925,2,0.8,1.6,transcript,28318.0
LRRK2,ENSG00000188906,potassium measurement,EFO_0009283,0.4406659054893366,4.406677812709122,2,0.9,1.8,transcript,95960.0
SKP2,ENSG00000145604,erythrocyte count,EFO_0004305,0.44065402972904943,4.40654532014448,1,0.4,0.4,transcript,79636.0
PLEC,ENSG00000178209,neurodegenerative disease,EFO_0005772,0.44058445440774424,4.405853608343087,2,0.9,1.8,transcript,198582.0
LRRC7,ENSG00000033122,monocyte count,EFO_0005091,0.440571926314651,4.405783366852059,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
NEBL,ENSG00000078114,FEV/FVC ratio,EFO_0004713,0.4404854540275337,4.404862362094301,1,0.4,0.4,transcript,51139.0
TTLL7,ENSG00000137941,intelligence,EFO_0004337,0.4404737008742219,4.4047659821772,2,0.8,1.6,transcript,55223.0
PTPRJ,ENSG00000149177,monocyte count,EFO_0005091,0.44035095737425356,4.403584761712461,2,0.8,1.6,transcript,21280.0
IREB2,ENSG00000136381,chronic obstructive pulmonary disease,EFO_0000341,0.44030188881078636,4.403118743871761,2,0.9,1.8,transcript,18026.0
TAF2,ENSG00000064313,cystatin C measurement,EFO_0004617,0.44029964677124533,4.402999260696478,1,0.5,0.5,transcript,179020.0
QSER1,ENSG00000060749,triglyceride measurement,EFO_0004530,0.4402972533067692,4.4029992082704235,1,0.5,0.5,transcript,18744.0
SLC22A5,ENSG00000197375,triglyceride measurement,EFO_0004530,0.4401865124896874,4.401870693833346,1,0.4,0.4,transcript,71827.0
DNAH14,ENSG00000185842,Neurodevelopmental disorder,EFO_0010642,0.44014550252909357,4.401513003774476,3,1.5,4.5,transcript,77615.0
ACVR1C,ENSG00000123612,hemoglobin measurement,EFO_0004509,0.4401446795585015,4.401566109529832,2,0.8,1.6,transcript,13410.0
FBXO22,ENSG00000167196,hematocrit,EFO_0004348,0.4401431769345473,4.401452968137142,1,0.4,0.4,transcript,18869.0
PF4V1,ENSG00000109272,neutrophil count,EFO_0004833,0.44014036555308517,4.401942013538927,1,0.4,0.4,transcript,743.0
PDE11A,ENSG00000128655,Progressive visual loss,HP_0000529,0.4401226262414651,4.401290045551984,2,0.8,1.6,transcript,25085.0
DENND1B,ENSG00000213047,Crohn's disease,EFO_0000384,0.44008864545692056,4.401323212081435,5,2.0,10.0,transcript,22896.0
ATRNL1,ENSG00000107518,age at menarche,EFO_0004703,0.4400257325905302,4.400274185047172,1,0.4,0.4,transcript,23726.0
TNRC6B,ENSG00000100354,pulse pressure measurement,EFO_0005763,0.4399899875661357,4.399906327482384,1,0.4,0.4,transcript,61998.0
GRB14,ENSG00000115290,glomerular filtration rate,OBA_0003747,0.4399626986743339,4.399667354086159,1,0.4,0.4,transcript,9909.0
FNDC3B,ENSG00000075420,diastolic blood pressure,EFO_0006336,0.43995543321137554,4.399607949619871,2,0.8,1.6,transcript,29841.0
QSOX1,ENSG00000116260,glomerular filtration rate,OBA_0003747,0.43995490679800353,4.399578131410974,1,0.4,0.4,transcript,13763.0
TMEM106B,ENSG00000106460,smoking initiation,EFO_0005670,0.4399493139097218,4.399526015584366,2,0.8,1.6,transcript,48667.0
ING1,ENSG00000153487,body mass index,EFO_0004340,0.43993924387269023,4.39941892177775,1,0.4,0.4,transcript,15104.0
DLG2,ENSG00000150672,waist circumference,OBA_1001085,0.43987281587472543,4.3987309316724135,1,0.4,0.4,transcript,144252.0
ID4,ENSG00000172201,basal cell carcinoma,EFO_0004193,0.43984957724248125,4.398908888872011,2,0.8,1.6,transcript,3873.0
PDE1A,ENSG00000115252,self reported educational attainment,EFO_0004784,0.4397926703411984,4.398053254542155,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
GALC,ENSG00000054983,body mass index,EFO_0004340,0.43976053715363544,4.397678264474851,2,0.8,1.6,transcript,21950.0
BANK1,ENSG00000153064,calcineurin measurement,EFO_0008061,0.4397505637307127,4.397718125048219,3,1.3,3.9000000000000004,transcript,18354.0
USP6,ENSG00000129204,hepatocellular carcinoma,EFO_0000182,0.4397042100754324,4.397053397317345,1,0.4,0.4,transcript,35409.0
PEX2,ENSG00000164751,sexual dimorphism measurement,EFO_0021796,0.4397024504186501,4.3970683301972375,1,0.4,0.4,transcript,9127.0
GBE1,ENSG00000114480,loneliness measurement,EFO_0007865,0.43966316024161156,4.396692481510234,1,0.5,0.5,transcript,8213.0
ID4,ENSG00000172201,appendicular lean mass,EFO_0004980,0.43952872433992723,4.395700359846471,2,0.8,1.6,transcript,3873.0
KITLG,ENSG00000049130,sodium measurement,EFO_0009282,0.4394595988417812,4.394765344394667,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
FRS2,ENSG00000166225,lean body mass,EFO_0004995,0.43942689281089264,4.394285037005065,1,0.4,0.4,transcript,24831.0
PRTG,ENSG00000166450,platelet count,EFO_0004309,0.4394265868282291,4.394483944366614,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
FMN1,ENSG00000248905,prostate carcinoma,EFO_0001663,0.4394156285818298,4.394191983370784,2,0.8,1.6,transcript,44821.0
RCOR3,ENSG00000117625,blood urea nitrogen measurement,EFO_0004741,0.43938443287529666,4.393908683993897,2,0.8,1.6,transcript,24862.0
IQGAP2,ENSG00000145703,hematocrit,EFO_0004348,0.43937367895777574,4.393751460508775,1,0.5,0.5,transcript,34081.0
ANO5,ENSG00000171714,atrial fibrillation,EFO_0000275,0.43936061245459934,4.393611170909457,1,0.4,0.4,transcript,79265.0
TBXT,ENSG00000164458,serum creatinine amount,OBA_2050096,0.43935432390267865,4.394003714851805,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
KLF10,ENSG00000155090,neurodegenerative disease,EFO_0005772,0.43927448410077974,4.392805686763806,1,0.4,0.4,transcript,6574.0
FUT2,ENSG00000176920,total cholesterol measurement,EFO_0004574,0.43927210251420756,4.392844051592763,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
AKAP6,ENSG00000151320,type 2 diabetes mellitus,MONDO_0005148,0.4392226905620851,4.392801685679502,7,2.8000000000000003,19.6,transcript,34100.0
BIRC6,ENSG00000115760,Red cell distribution width,EFO_0009188,0.43917503576797634,4.391757539936716,1,0.5,0.5,transcript,69616.0
NEK7,ENSG00000151414,vein disorder,MONDO_0004634,0.43913886783916606,4.391433942621602,1,0.4,0.4,transcript,8837.0
NEK7,ENSG00000151414,lymphatic system disease,EFO_0007352,0.43913886783916606,4.391433942621602,1,0.4,0.4,transcript,8837.0
TMEM106B,ENSG00000106460,metabolite measurement,EFO_0004725,0.43913803424354186,4.391413218922566,2,0.8,1.6,transcript,48667.0
PYHIN1,ENSG00000163564,lymphocyte count,EFO_0004587,0.4391293535051985,4.391331292273054,1,0.4,0.4,transcript,10594.0
KITLG,ENSG00000049130,Abnormality of skin pigmentation,HP_0001000,0.4390670438518941,4.390839794495796,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
SLC30A8,ENSG00000164756,BMI-adjusted fasting blood glucose measurement,EFO_0008036,0.4390229225971861,4.390539393656265,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,BMI-adjusted fasting blood glucose measurement,EFO_0008036,0.4390229225971861,4.390539393656265,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,BMI-adjusted fasting blood glucose measurement,EFO_0008036,0.4390229225971861,4.390539393656265,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,BMI-adjusted fasting blood glucose measurement,EFO_0008036,0.4390229225971861,4.390539393656265,4,1.6,6.4,gene_variant,20634.0
ARL3,ENSG00000138175,sodium measurement,EFO_0009282,0.4390121222833641,4.390225552515435,1,0.4,0.4,transcript,3834.0
CSMD3,ENSG00000164796,prostate adenocarcinoma,EFO_0000673,0.4389796238654592,4.389804347376333,1,0.5,0.5,transcript,61662.0
GBE1,ENSG00000114480,guilt measurement,EFO_0009595,0.4389632782277924,4.389693661372043,1,0.5,0.5,transcript,8213.0
SEMA3C,ENSG00000075223,open-angle glaucoma,EFO_0004190,0.4389378831043182,4.389412549326921,1,0.4,0.4,transcript,11863.0
FMN1,ENSG00000248905,Hereditary breast and ovarian cancer syndrome,Orphanet_145,0.43891508864496676,4.389186584002154,2,0.8,1.6,transcript,44821.0
CDH23,ENSG00000107736,hearing process quality,OBA_2045262,0.43889196778246253,4.388927228527596,1,0.5,0.5,transcript,66219.0
USP6,ENSG00000129204,colorectal adenocarcinoma,EFO_0000365,0.4388760774380833,4.388772070943854,1,0.4,0.4,transcript,35409.0
SPAST,ENSG00000021574,Spastic paraparesis,HP_0002313,0.4388381007845215,4.388386184163559,1,0.4,0.4,transcript,77275.0
SNX13,ENSG00000071189,lean body mass,EFO_0004995,0.438811282048357,4.388125145620688,1,0.4,0.4,transcript,32454.0
CWH43,ENSG00000109182,body weight,EFO_0004338,0.4387895317641028,4.3879573908874585,1,0.5,0.5,transcript,8055.0
BCAS3,ENSG00000141376,coronary artery disease,EFO_0001645,0.4387539313180574,4.387549712298729,1,0.5,0.5,transcript,48081.0
CPPED1,ENSG00000103381,cerebrospinal fluid composition attribute,OBA_2045291,0.4386931023805144,4.386968752535572,1,0.4,0.4,transcript,10602.0
BICC1,ENSG00000122870,chronotype measurement,EFO_0008328,0.43869265499828425,4.386974644247601,1,0.4,0.4,transcript,8317.0
ATAD2B,ENSG00000119778,reticulocyte count,EFO_0007986,0.43868762159781954,4.386894393665084,1,0.4,0.4,transcript,22005.0
DPYD,ENSG00000188641,executive function measurement,EFO_0009332,0.43858347105025347,4.385892931275707,1,0.5,0.5,transcript,8588.0
LATS1,ENSG00000131023,hippocampal volume,EFO_0005035,0.4385758071789342,4.385775428380507,1,0.4,0.4,transcript,23046.0
USP15,ENSG00000135655,platelet count,EFO_0004309,0.43852119360485164,4.385295053891147,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
PDE11A,ENSG00000128655,age of onset of myopia,OBA_2001030,0.438503971348391,4.385103496621243,2,0.8,1.6,transcript,25085.0
CENPE,ENSG00000138778,serum creatinine amount,OBA_2050096,0.43849792813217264,4.385004975052456,1,0.5,0.5,transcript,19460.0
CDH19,ENSG00000071991,heart rate,OBA_1001087,0.4384817792077576,4.385092349734684,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
RGS4,ENSG00000117152,IGF-1 measurement,EFO_0004627,0.4384055639130092,4.384151908684846,2,0.8,1.6,transcript,16620.0
DDR2,ENSG00000162733,Dupuytren Contracture,EFO_0004229,0.4383869832400767,4.383883872907629,1,0.4,0.4,transcript,28489.0
PALM2AKAP2,ENSG00000157654,systolic blood pressure,EFO_0006335,0.43837943807037655,4.383802367924213,1,0.4,0.4,transcript,50080.0
RALGPS2,ENSG00000116191,high density lipoprotein cholesterol measurement,EFO_0004612,0.43830629709172564,4.3831425056391335,2,0.8,1.6,transcript,20117.0
AKAP6,ENSG00000151320,lean body mass,EFO_0004995,0.43830484337692904,4.383623213827941,7,2.8000000000000003,19.6,transcript,34100.0
KIF20B,ENSG00000138182,vitamin D measurement,EFO_0004631,0.43825862848627334,4.382613596819908,1,0.5,0.5,transcript,18307.0
DLGAP1,ENSG00000170579,brain volume,OBA_2050009,0.43820854608016746,4.382113614945612,2,0.8,1.6,transcript,56830.0
SLC30A8,ENSG00000164756,type 2 diabetes nephropathy,EFO_0004997,0.43819994086239766,4.382309576308381,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,type 2 diabetes nephropathy,EFO_0004997,0.43819994086239766,4.382309576308381,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,type 2 diabetes nephropathy,EFO_0004997,0.43819994086239766,4.382309576308381,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,type 2 diabetes nephropathy,EFO_0004997,0.43819994086239766,4.382309576308381,4,1.6,6.4,gene_variant,20634.0
ITGB8,ENSG00000105855,bone tissue density,OBA_1000110,0.43819575316248166,4.382128058838118,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
WRN,ENSG00000165392,gastric carcinoma,EFO_0000178,0.4381779821570123,4.381807223334796,1,0.5,0.5,transcript,18247.0
DPYD,ENSG00000188641,chloride measurement,EFO_0009284,0.4381641868975277,4.381700089748449,1,0.5,0.5,transcript,8588.0
TNRC6B,ENSG00000100354,aortic measurement,EFO_0020865,0.43816072244009086,4.381613676221935,1,0.4,0.4,transcript,61998.0
DYNC2H1,ENSG00000187240,Narrow chest,HP_0000774,0.43815744994286315,4.381584655837325,1,0.5,0.5,transcript,49230.0
NEK1,ENSG00000137601,smoking initiation,EFO_0005670,0.43810939686500006,4.381108228518276,2,0.8,1.6,transcript,112203.0
DGKH,ENSG00000102780,urolithiasis,MONDO_0024647,0.4380596475989083,4.380623869027827,2,0.8,1.6,transcript,58409.0
NDUFAF2,ENSG00000164182,total cortical area measurement,EFO_0008381,0.4380252050276913,4.380292255322646,1,0.4,0.4,transcript,9949.0
GFPT1,ENSG00000198380,serum creatinine amount,OBA_2050096,0.4379716238286272,4.379731342315272,1,0.4,0.4,transcript,26483.0
PEAK1,ENSG00000173517,level of cathepsin H in blood serum,OBA_2044953,0.43796625406730794,4.379669463124319,1,0.4,0.4,transcript,57783.0
ALAD,ENSG00000148218,reticulocyte count,EFO_0007986,0.4379395723540781,4.379433033493211,1,0.4,0.4,transcript,10721.0
ALAD,ENSG00000148218,reticulocyte measurement,EFO_0010700,0.4379395723540781,4.379433033493211,1,0.4,0.4,transcript,10721.0
FGA,ENSG00000171560,thrombotic disease,MONDO_0000831,0.4379277339346968,4.379345563805437,1,0.4,0.4,transcript,5863.0
CYP24A1,ENSG00000019186,hemoglobin measurement,EFO_0004509,0.43779461359567373,4.3781363404265425,2,0.8,1.6,transcript,8412.0
AGBL3,ENSG00000146856,hemoglobin measurement,EFO_0004509,0.4377875498367781,4.377911451484916,1,0.5,0.5,transcript,13907.0
EXD1,ENSG00000178997,blood sodium bicarbonate amount,OBA_2050094,0.4377855716382393,4.377897500567079,1,0.4,0.4,transcript,9573.0
EXD1,ENSG00000178997,serum creatinine amount,OBA_2050096,0.4377792528410863,4.3778343125955494,1,0.4,0.4,transcript,9573.0
ABCB5,ENSG00000004846,asthma,MONDO_0004979,0.4376931644486445,4.376958556953645,1,0.4,0.4,transcript,14863.0
LNPEP,ENSG00000113441,neutrophil count,EFO_0004833,0.4376856472532594,4.376877134756883,1,0.4,0.4,transcript,19359.0
FAM76B,ENSG00000077458,erythrocyte count,EFO_0004305,0.43766571022783446,4.376678797781952,1,0.4,0.4,transcript,18437.0
TSPAN9,ENSG00000011105,hematocrit,EFO_0004348,0.4375688498708875,4.375723982350916,1,0.5,0.5,transcript,14091.0
SKP2,ENSG00000145604,Alzheimer disease,MONDO_0004975,0.437566911571868,4.375674138572666,1,0.4,0.4,transcript,79636.0
DDR2,ENSG00000162733,neoplasm,EFO_0000616,0.43751082914905154,4.375122331997377,1,0.4,0.4,transcript,28489.0
FIGN,ENSG00000182263,smoking status measurement,EFO_0006527,0.4374690876003261,4.374727630574611,1,0.4,0.4,transcript,10883.0
SV2C,ENSG00000122012,platelet count,EFO_0004309,0.4373769878078372,4.373797906948107,1,0.4,0.4,transcript,14271.0
DENND1B,ENSG00000213047,systolic blood pressure,EFO_0006335,0.4373753480860658,4.374190238372888,5,2.0,10.0,transcript,22896.0
ZNF507,ENSG00000168813,glomerular filtration rate,OBA_0003747,0.4373508278376544,4.373522677224637,1,0.4,0.4,transcript,27780.0
UMPS,ENSG00000114491,open-angle glaucoma,EFO_0004190,0.43732542561013893,4.373273112463054,1,0.4,0.4,transcript,21213.0
SEMA6D,ENSG00000137872,chronotype measurement,EFO_0008328,0.43732309831364874,4.37324040998415,1,0.5,0.5,transcript,53040.0
TMEM106B,ENSG00000106460,aspartate aminotransferase measurement,EFO_0004736,0.437298183097696,4.373014707464108,2,0.8,1.6,transcript,48667.0
CAVIN2,ENSG00000168497,QRS duration,OBA_1001086,0.4372820174456551,4.372951150226034,1,0.4,0.4,transcript,3054.0
ETV5,ENSG00000244405,smoking behavior,EFO_0004318,0.43724811471534597,4.372513319597761,1,0.4,0.4,transcript,12433.0
ADGRV1,ENSG00000164199,cerebral cortex area attribute,OBA_2045267,0.43724208924596863,4.372425317630055,1,0.5,0.5,transcript,112990.0
CNTLN,ENSG00000044459,alcohol use disorder measurement,EFO_0009458,0.43722391327620447,4.372360593325318,2,0.8,1.6,transcript,13173.0
SLC22A2,ENSG00000112499,phospholipids in very large VLDL measurement ,EFO_0022299,0.43720939311015844,4.37213365304796,1,0.4,0.4,transcript,10070.0
SLC9B1,ENSG00000164037,Wolfram syndrome,MONDO_0018105,0.43719636291501995,4.372008601267487,1,0.5,0.5,transcript,11118.0
TULP4,ENSG00000130338,vital capacity,EFO_0004312,0.43719498104189686,4.371968735475743,1,0.4,0.4,transcript,21136.0
KITLG,ENSG00000049130,hair color,EFO_0003924,0.4371764695368097,4.371934051344952,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
DMRTA1,ENSG00000176399,cortical thickness,EFO_0004840,0.43715563898303617,4.371627997420767,1,0.4,0.4,transcript,5586.0
TSPAN9,ENSG00000011105,erythrocyte volume,OBA_0003460,0.4371478184793029,4.371513668435069,1,0.5,0.5,transcript,14091.0
AKAP6,ENSG00000151320,obesity,EFO_0001073,0.43709819999503474,4.371556780008998,7,2.8000000000000003,19.6,transcript,34100.0
BANK1,ENSG00000153064,osteoarthritis,MONDO_0005178,0.4370806984928641,4.371019472669733,3,1.3,3.9000000000000004,transcript,18354.0
GREM1,ENSG00000166923,benign colon neoplasm,MONDO_0002278,0.4370693491850233,4.370711715915111,1,0.4,0.4,transcript,21949.0
ETV5,ENSG00000244405,smoking status measurement,EFO_0006527,0.4370410432909787,4.370442605354088,1,0.4,0.4,transcript,12433.0
UTP20,ENSG00000120800,neurodegenerative disease,EFO_0005772,0.43703558300334483,4.370398510357819,1,0.5,0.5,transcript,11715.0
C2CD4A,ENSG00000198535,diabetes mellitus,EFO_0000400,0.43701640126393354,4.370280122944125,1,0.4,0.4,transcript,3445.0
NCKAP1,ENSG00000061676,Intellectual disability,HP_0001249,0.43698483237923386,4.369858153009687,1,0.4,0.4,transcript,40695.0
MCL1,ENSG00000143384,body weight,EFO_0004338,0.43695511048633506,4.369567874242464,1,0.4,0.4,transcript,23853.0
ETV5,ENSG00000244405,Red cell distribution width,EFO_0009188,0.43689930801915555,4.369025252635857,1,0.4,0.4,transcript,12433.0
ADGRV1,ENSG00000164199,triglyceride measurement,EFO_0004530,0.43684684806287,4.368472905799068,1,0.5,0.5,transcript,112990.0
RPS6KA5,ENSG00000100784,spine bone mineral density,EFO_0007701,0.43683720969490414,4.3683819618005755,1,0.4,0.4,transcript,40548.0
SNX13,ENSG00000071189,metabolic syndrome,EFO_0000195,0.4368262009371079,4.368274334508196,1,0.4,0.4,transcript,32454.0
DPYD,ENSG00000188641,physical activity measurement,EFO_0008002,0.43675990193421793,4.367657240115352,1,0.5,0.5,transcript,8588.0
LIN54,ENSG00000189308,basophil measurement,EFO_0803539,0.4365431951948627,4.365444878525669,1,0.4,0.4,transcript,30944.0
CSMD3,ENSG00000164796,systolic blood pressure,EFO_0006335,0.4365227732427529,4.36523584114927,1,0.5,0.5,transcript,61662.0
GBE1,ENSG00000114480,arthrogryposis multiplex congenita,MONDO_0015168,0.4365148728109311,4.36520960720343,1,0.5,0.5,transcript,8213.0
SORL1,ENSG00000137642,neurodegenerative disease,EFO_0005772,0.43651231318568007,4.365170141519898,2,0.9,1.8,transcript,38290.0
PARP1,ENSG00000143799,cutaneous melanoma,EFO_0000389,0.4364997258385159,4.365003127963136,1,0.5,0.5,transcript,85185.0
TRIT1,ENSG00000043514,mitochondrial disease,MONDO_0044970,0.4364920592396543,4.364935795163446,1,0.4,0.4,transcript,26311.0
FRAS1,ENSG00000138759,metabolite measurement,EFO_0004725,0.4364748568973183,4.3647807055177905,2,0.9,1.8,transcript,56011.0
LRRK2,ENSG00000188906,blood sodium bicarbonate amount,OBA_2050094,0.43646351958174295,4.364653953633186,2,0.9,1.8,transcript,95960.0
RCL1,ENSG00000120158,lymphocyte count,EFO_0004587,0.43646150605598244,4.364653734058809,1,0.4,0.4,transcript,10343.0
CLSTN2,ENSG00000158258,intelligence,EFO_0004337,0.4364328271120714,4.3643523573494125,1,0.4,0.4,transcript,16607.0
KCNQ3,ENSG00000184156,neuroimaging measurement,EFO_0004346,0.4364328271120714,4.364384648851511,2,0.8,1.6,transcript,28380.0
RASA2,ENSG00000155903,myeloid leukocyte count,OBA_2045223,0.43631270401675204,4.36317465354688,1,0.4,0.4,transcript,8401.0
ABCB1,ENSG00000085563,inflammatory bowel disease,EFO_0003767,0.436276777225738,4.362791819968038,1,0.5,0.5,transcript,20792.0
CBLB,ENSG00000114423,serum gamma-glutamyl transferase measurement,EFO_0004532,0.43627536647895726,4.362762156457124,1,0.4,0.4,transcript,47105.0
MCL1,ENSG00000143384,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.4362548166462749,4.362564935841863,1,0.4,0.4,transcript,23853.0
CYTIP,ENSG00000115165,urate measurement,EFO_0004531,0.43624779493885524,4.362505736814741,1,0.4,0.4,gene_variant,14395.0
KCNIP4,ENSG00000185774,self reported educational attainment,EFO_0004784,0.4361977889322746,4.362110537308156,2,0.8,1.6,transcript,12062.0
CDH23,ENSG00000107736,retinitis pigmentosa,MONDO_0019200,0.4361533353636127,4.361540904339098,1,0.5,0.5,transcript,66219.0
TENT4B,ENSG00000121274,"chromosome, telomeric region length",OBA_0003784,0.43614812415100307,4.361730656942611,4,1.6,6.4,transcript,25660.0
SOS1,ENSG00000115904,genetic disorder,EFO_0000508,0.43610422852794817,4.361065893152707,2,0.8,1.6,transcript,67774.0
ANO5,ENSG00000171714,Abnormality of the musculature,HP_0003011,0.43610422852794817,4.361047331642945,1,0.4,0.4,transcript,79265.0
SGCB,ENSG00000163069,Abnormality of the musculature,HP_0003011,0.43610422852794817,4.3611148805607876,1,0.4,0.4,transcript,5510.0
GRIN2B,ENSG00000273079,Atypical behavior,HP_0000708,0.43610422852794817,4.361046554906423,1,0.4,0.4,transcript,93685.0
INF2,ENSG00000203485,Renal insufficiency,HP_0000083,0.43610422852794806,4.3610453481604265,1,0.4,0.4,transcript,130596.0
SLC22A5,ENSG00000197375,"N,N,N-trimethyl-5-aminovalerate measurement",EFO_0800090,0.43607851802378556,4.360790749174328,1,0.4,0.4,transcript,71827.0
ALG10B,ENSG00000175548,heart rate response to recovery post exercise,EFO_0009185,0.43598608012214246,4.360566617144632,5,2.0,10.0,transcript,14168.0
ROCK2,ENSG00000134318,erythrocyte volume,OBA_0003460,0.4359735900305076,4.3597468939068005,1,0.5,0.5,transcript,45481.0
FAS,ENSG00000026103,mean corpuscular hemoglobin concentration,EFO_0004528,0.43596726319292317,4.3596748401537635,1,0.4,0.4,transcript,181141.0
CCDC66,ENSG00000180376,mathematical ability,EFO_0004875,0.4359568406531755,4.359583636040451,1,0.5,0.5,transcript,32831.0
MAP4K3,ENSG00000011566,glomerular filtration rate,OBA_0003747,0.4359481065160162,4.359503872777906,1,0.4,0.4,transcript,17538.0
TMEM106B,ENSG00000106460,coronary artery disease,EFO_0001645,0.4359275638543441,4.359308515030589,2,0.8,1.6,transcript,48667.0
SLC44A1,ENSG00000070214,BMI-adjusted waist-hip ratio,EFO_0007788,0.4358689136975322,4.358698745892397,1,0.4,0.4,transcript,41628.0
SOS1,ENSG00000115904,glomerular filtration rate,OBA_0003747,0.4358112849305464,4.35813645717869,2,0.8,1.6,transcript,67774.0
LAMA1,ENSG00000101680,glucose measurement,EFO_0004468,0.43577090621167625,4.35772495733548,1,0.5,0.5,transcript,31456.0
SEMA3A,ENSG00000075213,brain volume,OBA_2050009,0.4357692598076767,4.3577228027131785,1,0.4,0.4,transcript,13243.0
TSPAN9,ENSG00000011105,erythrocyte count,EFO_0004305,0.4357410212429479,4.35744569607152,1,0.5,0.5,transcript,14091.0
VWDE,ENSG00000146530,brain aneurysm,EFO_0003870,0.4357394041510169,4.35742066416072,1,0.5,0.5,transcript,18781.0
BACH1,ENSG00000156273,hemoglobin measurement,EFO_0004509,0.4356569674881146,4.356927536657035,4,1.6,6.4,transcript,17884.0
MDM4,ENSG00000198625,triple-negative breast cancer,EFO_0005537,0.43564509854350275,4.356456856305237,1,0.4,0.4,transcript,68133.0
WRN,ENSG00000165392,platelet count,EFO_0004309,0.4356194310683214,4.356221712447887,1,0.5,0.5,transcript,18247.0
PDE10A,ENSG00000112541,myxedema,EFO_1001055,0.4356095697831393,4.3561154099253105,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
PLCL1,ENSG00000115896,mathematical ability,EFO_0004875,0.43558173342626305,4.35590684475214,2,0.8,1.6,transcript,17875.0
ETV5,ENSG00000244405,hip circumference,OBA_1000032,0.43556225413217087,4.35565471376601,1,0.4,0.4,transcript,12433.0
PLEC,ENSG00000178209,total cholesterol measurement,EFO_0004574,0.43552060404541826,4.355215104719827,2,0.9,1.8,transcript,198582.0
PTPN4,ENSG00000088179,lymphocyte count,EFO_0004587,0.4355044079235763,4.355507686097145,5,2.0,10.0,transcript,21570.0
DCDC2,ENSG00000146038,Red cell distribution width,EFO_0009188,0.43547392189058687,4.354784995971559,1,0.4,0.4,transcript,8738.0
DMRTA1,ENSG00000176399,total cortical area measurement,EFO_0008381,0.43544186302135945,4.354490237803999,1,0.4,0.4,transcript,5586.0
PKN2,ENSG00000065243,mean corpuscular hemoglobin concentration,EFO_0004528,0.43541883161165496,4.35421912800994,1,0.4,0.4,transcript,12982.0
SLC22A5,ENSG00000197375,butyrylcarnitine measurement,EFO_0020010,0.43541208675047705,4.354126436441242,1,0.4,0.4,transcript,71827.0
LNPEP,ENSG00000113441,aspartate aminotransferase measurement,EFO_0004736,0.43539055285499606,4.353926190774249,1,0.4,0.4,transcript,19359.0
SP4,ENSG00000105866,Red cell distribution width,EFO_0009188,0.4353756825913825,4.353780818236282,1,0.4,0.4,transcript,16672.0
PTK2,ENSG00000169398,left ventricular structural measurement,EFO_0008205,0.4352155365898388,4.352160208103044,1,0.4,0.4,transcript,82607.0
SRGN,ENSG00000122862,protein measurement,EFO_0004747,0.4351930030061937,4.352053410691178,1,0.4,0.4,transcript,3242.0
TMEM131,ENSG00000075568,calcium measurement,EFO_0004838,0.435146483350824,4.3514862823794935,1,0.4,0.4,transcript,18649.0
GREM1,ENSG00000166923,polyp,EFO_0000662,0.43514352343325535,4.351453458397431,1,0.4,0.4,transcript,21949.0
DPYD,ENSG00000188641,age at menarche,EFO_0004703,0.4350885942220917,4.350944162994089,1,0.5,0.5,transcript,8588.0
ATP10D,ENSG00000145246,glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement,EFO_0800533,0.435017224437607,4.35020406718666,1,0.5,0.5,transcript,15712.0
CPPED1,ENSG00000103381,phosphoenolpyruvic acid measurement,EFO_0010522,0.43497550958714426,4.34979282460187,1,0.4,0.4,transcript,10602.0
C12orf42,ENSG00000179088,body fat percentage,EFO_0007800,0.4348183963055475,4.348219102559305,1,0.5,0.5,transcript,14229.0
STXBP4,ENSG00000166263,mean corpuscular hemoglobin concentration,EFO_0004528,0.43479375735100384,4.348329284897089,5,2.0,10.0,transcript,25529.0
NEK7,ENSG00000151414,Varicose veins,HP_0002619,0.4347898490844355,4.347943755074297,1,0.4,0.4,transcript,8837.0
LINGO2,ENSG00000174482,body weight,EFO_0004338,0.4347478011481155,4.347489730345598,1,0.4,0.4,transcript,34133.0
LUZP2,ENSG00000187398,testosterone measurement,EFO_0004908,0.43474638463831233,4.3477806264073475,4,1.7000000000000002,6.800000000000001,transcript,21466.0
SORL1,ENSG00000137642,lymphocyte count,EFO_0004587,0.4347012385879624,4.347059395542721,2,0.9,1.8,transcript,38290.0
TNRC6B,ENSG00000100354,grip strength measurement,EFO_0006941,0.4346872419271246,4.346878871092273,1,0.4,0.4,transcript,61998.0
DMAC1,ENSG00000137038,erythrocyte volume,OBA_0003460,0.4346697573300959,4.346813146834619,1,0.4,0.4,transcript,3461.0
PTPN4,ENSG00000088179,Intellectual disability,HP_0001249,0.4346669735375076,4.347133342236457,5,2.0,10.0,transcript,21570.0
MLLT3,ENSG00000171843,cerebral cortex area attribute,OBA_2045267,0.43464771825341697,4.346580421661798,2,0.8,1.6,transcript,15498.0
TMEM106B,ENSG00000106460,Sleep Disorder,EFO_0008568,0.434630849588719,4.346341372374337,2,0.8,1.6,transcript,48667.0
DOCK1,ENSG00000150760,high density lipoprotein cholesterol measurement,EFO_0004612,0.43459835592257984,4.346008647033124,1,0.4,0.4,transcript,15944.0
PDE1A,ENSG00000115252,QRS duration,OBA_1001086,0.4345905291310338,4.346031842440509,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
RASA2,ENSG00000155903,basophil count,EFO_0005090,0.43451932364113,4.345240849790659,1,0.4,0.4,transcript,8401.0
GPD2,ENSG00000115159,systemic lupus erythematosus,MONDO_0007915,0.43446502124891273,4.344667878773024,1,0.4,0.4,transcript,22642.0
FNDC3B,ENSG00000075420,sexual dimorphism measurement,EFO_0021796,0.4344344737527137,4.3443983550332534,2,0.8,1.6,transcript,29841.0
DTHD1,ENSG00000197057,myeloid leukocyte count,OBA_2045223,0.43442378731096326,4.344264273658764,1,0.5,0.5,transcript,18939.0
CCDC88C,ENSG00000015133,level of serpin A12 in blood serum,OBA_2045007,0.4343762250079437,4.343781572817469,1,0.4,0.4,transcript,20701.0
SKP2,ENSG00000145604,Parkinson disease,MONDO_0005180,0.434313838892612,4.3431434117801055,1,0.4,0.4,transcript,79636.0
TBX5,ENSG00000089225,Abnormal radial ray morphology,HP_0410049,0.4342563292545246,4.342688586202255,2,0.8,1.6,transcript,12770.0
GABRA4,ENSG00000109158,Focal-onset seizure,HP_0007359,0.4342563292545246,4.342588443450679,1,0.4,0.4,transcript,15904.0
GABRG1,ENSG00000163285,Focal-onset seizure,HP_0007359,0.4342563292545246,4.344694100476587,6,2.4000000000000004,14.400000000000002,transcript,6758.0
FGA,ENSG00000171560,Recurrent thrombophlebitis,HP_0004419,0.4342563292545246,4.342631517003714,1,0.4,0.4,transcript,5863.0
PDE1C,ENSG00000154678,autosomal dominant nonsyndromic hearing loss,MONDO_0019587,0.4342563292545246,4.342617651449914,2,0.8,1.6,transcript,29434.0
LYPLAL1,ENSG00000143353,diverticular disease,EFO_0009959,0.43422263105164655,4.3422541068251155,1,0.5,0.5,transcript,17988.0
PLCL1,ENSG00000115896,eosinophil count,EFO_0004842,0.4342204447780437,4.342293958269948,2,0.8,1.6,transcript,17875.0
GLB1,ENSG00000170266,allergic rhinitis,EFO_0005854,0.43415217951004137,4.3415527031797865,1,0.5,0.5,transcript,16177.0
AGBL3,ENSG00000146856,hematocrit,EFO_0004348,0.4341384246911469,4.341420200028604,1,0.5,0.5,transcript,13907.0
REEP3,ENSG00000165476,high density lipoprotein cholesterol measurement,EFO_0004612,0.43412146954286435,4.341284479099264,1,0.4,0.4,transcript,5732.0
SGCD,ENSG00000170624,alcohol consumption quality,OBA_1000840,0.43409175093354024,4.340936298381389,1,0.4,0.4,transcript,21289.0
RAD18,ENSG00000070950,neurodegenerative disease,EFO_0005772,0.4340343932957524,4.340377414166195,1,0.4,0.4,transcript,11947.0
USP37,ENSG00000135913,triglyceride measurement,EFO_0004530,0.4340226391901267,4.340366018787199,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
MDM4,ENSG00000198625,diastolic blood pressure change measurement,EFO_0006945,0.4339862018088122,4.339867888958332,1,0.4,0.4,transcript,68133.0
LMO4,ENSG00000143013,basophil percentage of leukocytes,EFO_0007992,0.433975257122552,4.339804051277,1,0.4,0.4,transcript,7770.0
DGKH,ENSG00000102780,erythrocyte volume,OBA_0003460,0.4339734871615065,4.339762264653809,2,0.8,1.6,transcript,58409.0
COQ3,ENSG00000132423,glomerular filtration rate,OBA_0003747,0.4339732192250406,4.339882737978671,1,0.4,0.4,transcript,2657.0
SKP2,ENSG00000145604,multiple sclerosis,MONDO_0005301,0.4339442590379273,4.33944761323326,1,0.4,0.4,transcript,79636.0
SKP2,ENSG00000145604,lysosomal storage disease,MONDO_0002561,0.4339442590379273,4.33944761323326,1,0.4,0.4,transcript,79636.0
TULP4,ENSG00000130338,forced expiratory volume,EFO_0004314,0.43392907285299803,4.3393096535867555,1,0.4,0.4,transcript,21136.0
BPTF,ENSG00000171634,triglycerides:total lipids ratio,EFO_0020947,0.43391275445027566,4.339147168699392,2,0.8,1.6,transcript,81532.0
GPATCH2L,ENSG00000089916,erythrocyte count,EFO_0004305,0.4339055795160498,4.339198267500828,4,1.6,6.4,transcript,44921.0
ELMOD1,ENSG00000110675,neurodegenerative disease,EFO_0005772,0.43388334577696896,4.3388738210391145,1,0.4,0.4,transcript,9910.0
TBXT,ENSG00000164458,sitting height measurement,EFO_0011011,0.43383509611335974,4.338811436958617,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
CA8,ENSG00000178538,lymphocyte count,EFO_0004587,0.4338210769462971,4.338251723696615,1,0.4,0.4,transcript,9767.0
RCC1L,ENSG00000274523,HbA1c measurement,EFO_0004541,0.4337081738478888,4.337124800164753,1,0.4,0.4,transcript,9289.0
FRMD4B,ENSG00000114541,platelet volume,OBA_0003277,0.43368695459295925,4.336945642191363,2,0.8,1.6,transcript,21026.0
BMERB1,ENSG00000166780,omega-3 polyunsaturated fatty acid measurement,EFO_0010119,0.43368312161781514,4.336867490776863,1,0.4,0.4,transcript,11027.0
DNAH14,ENSG00000185842,neutrophil count,EFO_0004833,0.43358651103118123,4.335923088795353,3,1.5,4.5,transcript,77615.0
LMO4,ENSG00000143013,cerebral cortex area attribute,OBA_2045267,0.4335623037553394,4.3356745176048745,1,0.4,0.4,transcript,7770.0
LRRK2,ENSG00000188906,neurodegenerative disease,EFO_0005772,0.4335616708733557,4.335635466549314,2,0.9,1.8,transcript,95960.0
MAGI2,ENSG00000187391,taste liking measurement,EFO_0010155,0.43355893221074054,4.335593885504398,1,0.4,0.4,transcript,87654.0
PDE1C,ENSG00000154678,neurodegenerative disease,EFO_0005772,0.4335311015753855,4.335365374658523,2,0.8,1.6,transcript,29434.0
GSAP,ENSG00000186088,allergic disease,MONDO_0005271,0.4335234030551437,4.335259544660739,1,0.5,0.5,transcript,19597.0
MACF1,ENSG00000127603,total cholesterol measurement,EFO_0004574,0.4334899839937896,4.334905166790225,2,0.8,1.6,gene_variant,300365.0
RNF144B,ENSG00000137393,erythrocyte volume,OBA_0003460,0.43338247390099105,4.333897612028676,1,0.4,0.4,transcript,5489.0
TBX5,ENSG00000089225,prostate specific antigen amount,OBA_2050200,0.43338068845155125,4.333932178172521,2,0.8,1.6,transcript,12770.0
GBE1,ENSG00000114480,bone tissue density,OBA_1000110,0.4333538802737807,4.333599681831926,1,0.5,0.5,transcript,8213.0
IQGAP2,ENSG00000145703,cerebral cortex area attribute,OBA_2045267,0.43334026693153804,4.333417340246398,1,0.5,0.5,transcript,34081.0
PDE10A,ENSG00000112541,Thyroid preparation use measurement,EFO_0009933,0.4333234350464442,4.3332540625583595,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
IMPG2,ENSG00000081148,mean corpuscular hemoglobin concentration,EFO_0004528,0.4333227944796579,4.333443462037958,2,0.9,1.8,transcript,8352.0
C4orf33,ENSG00000151470,N-acetylglucosamine measurement,EFO_0801068,0.43327242556749623,4.333175309308059,4,1.6,6.4,transcript,14189.0
TNRC6B,ENSG00000100354,body weight,EFO_0004338,0.43325603574219973,4.332566809243024,1,0.4,0.4,transcript,61998.0
PRTG,ENSG00000166450,testicular carcinoma,EFO_0005088,0.4332108289977378,4.332326366061701,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
CAV2,ENSG00000105971,glaucoma,MONDO_0005041,0.43317903381307005,4.331814511696906,1,0.4,0.4,transcript,16547.0
BPTF,ENSG00000171634,serum gamma-glutamyl transferase measurement,EFO_0004532,0.4331274647846392,4.331294272043027,2,0.8,1.6,transcript,81532.0
TENM4,ENSG00000149256,serum gamma-glutamyl transferase measurement,EFO_0004532,0.43299024077435655,4.329919858227816,1,0.4,0.4,transcript,22922.0
RNF150,ENSG00000170153,QT interval,EFO_0004682,0.43297276878992735,4.329986346913945,4,1.6,6.4,transcript,24743.0
CCDC62,ENSG00000130783,platelet volume,OBA_0003277,0.4329240052467164,4.3292669884941,1,0.4,0.4,transcript,14850.0
MYLK3,ENSG00000140795,Dilated cardiomyopathy,HP_0001644,0.4328802739387517,4.32882966997393,1,0.4,0.4,transcript,14853.0
CWH43,ENSG00000109182,body mass index,EFO_0004340,0.43280652155626453,4.3281272888090765,1,0.5,0.5,transcript,8055.0
TTL,ENSG00000114999,smoking status measurement,EFO_0006527,0.43278745126184515,4.327894281324589,1,0.4,0.4,transcript,20234.0
DENND3,ENSG00000105339,retinal vasculature measurement,EFO_0010554,0.43277840425179576,4.327794859175611,1,0.5,0.5,transcript,46225.0
PARP11,ENSG00000111224,hippocampal volume,EFO_0005035,0.4327548566788352,4.3275665152761915,1,0.4,0.4,transcript,22286.0
IL4R,ENSG00000077238,respiratory tract infectious disorder,MONDO_0024355,0.43273514575877053,4.327370021656949,1,0.4,0.4,transcript,21547.0
CCDC50,ENSG00000152492,neurodegenerative disease,EFO_0005772,0.4327194134645356,4.327230581114604,1,0.4,0.4,transcript,10975.0
DENND3,ENSG00000105339,metabolite measurement,EFO_0004725,0.43268149053236626,4.326825721981316,1,0.5,0.5,transcript,46225.0
GRB14,ENSG00000115290,C-reactive protein measurement,EFO_0004458,0.4325632765387933,4.325673132730753,1,0.4,0.4,transcript,9909.0
C2CD2,ENSG00000157617,platelet crit,EFO_0007985,0.43255662573201253,4.325580238445606,1,0.4,0.4,transcript,28610.0
KCNIP4,ENSG00000185774,smoking initiation,EFO_0005670,0.43252350860803046,4.325367734065714,2,0.8,1.6,transcript,12062.0
PEX2,ENSG00000164751,body weights and measures,EFO_0004324,0.43251792818892987,4.325223107900036,1,0.4,0.4,transcript,9127.0
MYLK3,ENSG00000140795,dilated cardiomyopathy,EFO_0000407,0.43251047354550626,4.325131666041476,1,0.4,0.4,transcript,14853.0
RPS6KA5,ENSG00000100784,alkaline phosphatase measurement,EFO_0004533,0.43248431667875076,4.324853031639042,1,0.4,0.4,transcript,40548.0
PDE1C,ENSG00000154678,chronotype measurement,EFO_0008328,0.4324823778028416,4.324878136933084,2,0.8,1.6,transcript,29434.0
APOBEC3H,ENSG00000100298,myeloid leukocyte count,OBA_2045223,0.4324785411214578,4.32486199555308,1,0.4,0.4,transcript,5223.0
NDST3,ENSG00000164100,glucose measurement,EFO_0004468,0.4324699609338513,4.324749671916735,1,0.4,0.4,transcript,7990.0
FNDC3B,ENSG00000075420,PR interval,EFO_0004462,0.4324523314392487,4.324576931898603,2,0.8,1.6,transcript,29841.0
TMEM132B,ENSG00000139364,lean body mass,EFO_0004995,0.4324412331100779,4.324501694387362,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
GPR180,ENSG00000152749,total cholesterol measurement,EFO_0004574,0.4323630964914662,4.323675989678281,1,0.4,0.4,transcript,8884.0
PLCL1,ENSG00000115896,body weights and measures,EFO_0004324,0.43235311769855655,4.323620687475076,2,0.8,1.6,transcript,17875.0
DYNC1I2,ENSG00000077380,lysosomal storage disease,MONDO_0002561,0.4323445554980858,4.323456741914519,1,0.4,0.4,transcript,35756.0
ING1,ENSG00000153487,body weight,EFO_0004338,0.4323372480238805,4.323398963289653,1,0.4,0.4,transcript,15104.0
CEP68,ENSG00000011523,sex hormone-binding globulin measurement,EFO_0004696,0.4323177228354473,4.323213995463433,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,sex hormone-binding globulin measurement,EFO_0004696,0.4323177228354473,4.323213995463433,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,sex hormone-binding globulin measurement,EFO_0004696,0.4323177228354473,4.323213995463433,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,sex hormone-binding globulin measurement,EFO_0004696,0.4323177228354473,4.323213995463433,3,1.5,4.5,transcript,122392.0
MCL1,ENSG00000143384,pulse pressure measurement,EFO_0005763,0.4323097841102672,4.323114610481786,1,0.4,0.4,transcript,23853.0
U2SURP,ENSG00000163714,urate measurement,EFO_0004531,0.4322882814616697,4.322933222606363,2,0.8,1.6,transcript,31741.0
PTPRJ,ENSG00000149177,heart rate,OBA_1001087,0.4322558329568873,4.322633517538797,2,0.8,1.6,transcript,21280.0
PTPRJ,ENSG00000149177,low density lipoprotein cholesterol measurement,EFO_0004611,0.4322294862055169,4.322370050025094,2,0.8,1.6,transcript,21280.0
TC2N,ENSG00000165929,factor VIII measurement,EFO_0004630,0.43215087698825483,4.3215315346654295,1,0.4,0.4,transcript,17571.0
PCDH18,ENSG00000189184,Diuretic use measurement,EFO_0009928,0.43207013439200503,4.320778515578759,2,0.8,1.6,transcript,20733.0
PARP1,ENSG00000143799,breast cancer,MONDO_0007254,0.4320493758955467,4.320499628533445,1,0.5,0.5,transcript,85185.0
CYBRD1,ENSG00000071967,appendicular lean mass,EFO_0004980,0.43201257956442596,4.3201599049646315,1,0.4,0.4,transcript,11727.0
RBM25,ENSG00000119707,decadienedioic acid (C10:2-DC) measurement,EFO_0800598,0.43198741370624194,4.319886827015149,1,0.4,0.4,transcript,31521.0
NDFIP2,ENSG00000102471,platelet count,EFO_0004309,0.43196816022139023,4.31969608407989,2,0.8,1.6,transcript,110483.0
CEP68,ENSG00000011523,left ventricular structural measurement,EFO_0008205,0.4319609950123033,4.3196467172319934,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,left ventricular structural measurement,EFO_0008205,0.4319609950123033,4.3196467172319934,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,left ventricular structural measurement,EFO_0008205,0.4319609950123033,4.3196467172319934,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,left ventricular structural measurement,EFO_0008205,0.4319609950123033,4.3196467172319934,3,1.5,4.5,transcript,122392.0
AKAP11,ENSG00000023516,alkaline phosphatase measurement,EFO_0004533,0.4319242387546102,4.319642387546102,1,0.4,0.4,transcript,1000.0
MDM4,ENSG00000198625,neurodegenerative disease,EFO_0005772,0.43192311886060564,4.319237059476266,1,0.4,0.4,transcript,68133.0
DLG1,ENSG00000075711,vital capacity,EFO_0004312,0.43188248619620406,4.318840271733548,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
CFAP299,ENSG00000197826,androgenetic alopecia,EFO_0004191,0.43187637951881436,4.3188289332809005,1,0.5,0.5,transcript,7676.0
BCAS3,ENSG00000141376,bone tissue density,OBA_1000110,0.4318715412800983,4.318725811919138,1,0.5,0.5,transcript,48081.0
PTK2,ENSG00000169398,Red cell distribution width,EFO_0009188,0.43185778405209907,4.318582682725647,1,0.4,0.4,transcript,82607.0
HS3ST3A1,ENSG00000153976,Dupuytren Contracture,EFO_0004229,0.431842995517736,4.318510992454507,1,0.4,0.4,transcript,4936.0
RNF150,ENSG00000170153,JT interval,EFO_0007885,0.431837343776693,4.3186320967816005,4,1.6,6.4,transcript,24743.0
TNRC6B,ENSG00000100354,glucose measurement,EFO_0004468,0.43177549444884333,4.31776139630946,1,0.4,0.4,transcript,61998.0
AKAP11,ENSG00000023516,heel bone mineral density,EFO_0009270,0.43175871098321755,4.317987109832176,1,0.4,0.4,transcript,1000.0
TGFBR1,ENSG00000106799,asthma,MONDO_0004979,0.431743713451039,4.317441382102537,1,0.4,0.4,transcript,94171.0
GHR,ENSG00000112964,whole body water mass,EFO_0009805,0.43173895168218457,4.317398378338495,1,0.4,0.4,transcript,45139.0
PARP8,ENSG00000151883,body weights and measures,EFO_0004324,0.43173827848575935,4.3174298616810844,2,0.8,1.6,transcript,33987.0
PEX2,ENSG00000164751,body weight,EFO_0004338,0.43173149685362133,4.3173587945469505,1,0.4,0.4,transcript,9127.0
AFF1,ENSG00000172493,fatty acid measurement,EFO_0005110,0.43170976716690795,4.3171078942661305,1,0.4,0.4,transcript,39129.0
MANSC4,ENSG00000205693,blood urea nitrogen measurement,EFO_0004741,0.43163155525345603,4.316615492546558,1,0.5,0.5,transcript,1667.0
CYTIP,ENSG00000115165,aging,EFO_0022597,0.43163073046988637,4.316335092125053,1,0.4,0.4,gene_variant,14395.0
CYP24A1,ENSG00000019186,ureterolithiasis,EFO_1001228,0.43156982106893005,4.3158884151591055,2,0.8,1.6,transcript,8412.0
FYCO1,ENSG00000163820,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.4315353830523998,4.315378441365073,1,0.4,0.4,transcript,16253.0
GRB14,ENSG00000115290,hypertension,EFO_0000537,0.4315136469976611,4.315176837319431,1,0.4,0.4,transcript,9909.0
C12orf42,ENSG00000179088,myxedema,EFO_1001055,0.43146955129192804,4.314730652423111,1,0.5,0.5,transcript,14229.0
REEP3,ENSG00000165476,testosterone measurement,EFO_0004908,0.43145147128542083,4.314584496524829,1,0.4,0.4,transcript,5732.0
SGCZ,ENSG00000185053,body mass index,EFO_0004340,0.4313945358221715,4.313994067427755,1,0.4,0.4,transcript,8212.0
EVI5,ENSG00000067208,body mass index,EFO_0004340,0.431354081716101,4.313546473109654,1,0.4,0.4,transcript,70722.0
SYNE2,ENSG00000054654,calcium measurement,EFO_0004838,0.43133363450170514,4.313348980532959,2,1.0,2.0,transcript,158284.0
SH3TC2,ENSG00000169247,platelet count,EFO_0004309,0.43131643236799405,4.313168747088619,1,0.4,0.4,transcript,90428.0
GSAP,ENSG00000186088,waist circumference,OBA_1001085,0.4312830430841139,4.312855944950441,1,0.5,0.5,transcript,19597.0
NDUFS4,ENSG00000164258,BMI-adjusted waist circumference,EFO_0007789,0.43124574582190905,4.312564039620636,1,0.4,0.4,transcript,3753.0
BANK1,ENSG00000153064,waist circumference,OBA_1001085,0.4311768323208884,4.311980810949976,3,1.3,3.9000000000000004,transcript,18354.0
PTK2,ENSG00000169398,erythrocyte volume,OBA_0003460,0.431160078869202,4.3116056308966755,1,0.4,0.4,transcript,82607.0
MSX2,ENSG00000120149,urinary bladder cancer,MONDO_0001187,0.4311269101000039,4.311387339250113,1,0.4,0.4,transcript,3383.0
RANBP17,ENSG00000204764,C-reactive protein measurement,EFO_0004458,0.4311248573545551,4.31125808784078,1,0.4,0.4,transcript,42042.0
TRDMT1,ENSG00000107614,platelet component distribution width,EFO_0007984,0.43106521201588044,4.310665911835528,1,0.4,0.4,transcript,29003.0
FAM98A,ENSG00000119812,platelet count,EFO_0004309,0.4310418774707569,4.310426127919084,1,0.4,0.4,transcript,54398.0
MAGI2,ENSG00000187391,high density lipoprotein cholesterol measurement,EFO_0004612,0.4310400038272437,4.31040460166943,1,0.4,0.4,transcript,87654.0
TMEM132B,ENSG00000139364,smoking initiation,EFO_0005670,0.4310311155862038,4.3104005191486205,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
C2CD4A,ENSG00000198535,body mass index,EFO_0004340,0.4310251064693853,4.3103671749986425,1,0.4,0.4,transcript,3445.0
FAM76B,ENSG00000077458,myxedema,EFO_1001055,0.4309584672921753,4.30960636842536,1,0.4,0.4,transcript,18437.0
ATAD2B,ENSG00000119778,erythrocyte count,EFO_0004305,0.4309443444840664,4.309461622527553,1,0.4,0.4,transcript,22005.0
TSPAN3,ENSG00000140391,neutrophil count,EFO_0004833,0.43089581377736846,4.308980048378417,1,0.4,0.4,transcript,18256.0
IQGAP2,ENSG00000145703,metabolite measurement,EFO_0004725,0.4308864365017873,4.308879035948891,1,0.5,0.5,transcript,34081.0
PICALM,ENSG00000073921,erythrocyte count,EFO_0004305,0.43080294276115716,4.308042695930144,1,0.4,0.4,transcript,30147.0
CENPE,ENSG00000138778,testosterone measurement,EFO_0004908,0.4307899437232868,4.307925130963597,1,0.5,0.5,transcript,19460.0
CYTL1,ENSG00000170891,sex hormone-binding globulin measurement,EFO_0004696,0.4307454166737122,4.307673104887094,1,0.4,0.4,transcript,1827.0
RCL1,ENSG00000120158,hemoglobin measurement,EFO_0004509,0.4307004833318322,4.3070435068173065,1,0.4,0.4,transcript,10343.0
CCDC7,ENSG00000216937,platelet volume,OBA_0003277,0.43068299364243195,4.306848533463671,1,0.5,0.5,transcript,26886.0
TNFRSF11A,ENSG00000141655,neuroimaging measurement,EFO_0004346,0.4306662315578396,4.30678690676357,2,0.8,1.6,transcript,12842.0
CEP68,ENSG00000011523,essential hypertension,MONDO_0001134,0.4306615827945359,4.30665259505432,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,essential hypertension,MONDO_0001134,0.4306615827945359,4.30665259505432,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,essential hypertension,MONDO_0001134,0.4306615827945359,4.30665259505432,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,essential hypertension,MONDO_0001134,0.4306615827945359,4.30665259505432,3,1.5,4.5,transcript,122392.0
TULP4,ENSG00000130338,lymphocyte count,EFO_0004587,0.4306608070905292,4.306626995962067,1,0.4,0.4,transcript,21136.0
PLCL1,ENSG00000115896,glomerular filtration rate,OBA_0003747,0.43065276849143297,4.30661719540384,2,0.8,1.6,transcript,17875.0
DTHD1,ENSG00000197057,neutrophil percentage of leukocytes,EFO_0007990,0.43059695169557816,4.305995917504913,1,0.5,0.5,transcript,18939.0
NEDD1,ENSG00000139350,self reported educational attainment,EFO_0004784,0.43057993975639053,4.3058186542556065,1,0.4,0.4,transcript,20772.0
SARAF,ENSG00000133872,balding measurement,EFO_0007825,0.43057993975639053,4.305825850840805,1,0.4,0.4,transcript,15121.0
FIGNL1,ENSG00000132436,erythrocyte volume,OBA_0003460,0.43056126530824324,4.305628835621473,1,0.4,0.4,transcript,24718.0
NCKAP1,ENSG00000061676,Neurodevelopmental disorder,EFO_0010642,0.4305442301200109,4.305452130417458,1,0.4,0.4,transcript,40695.0
ARHGAP20,ENSG00000137727,open-angle glaucoma,EFO_0004190,0.4304499405818792,4.3045096504083675,1,0.4,0.4,transcript,39045.0
ATXN3,ENSG00000066427,high density lipoprotein cholesterol measurement,EFO_0004612,0.43043828813751867,4.304388604572737,1,0.4,0.4,transcript,69891.0
BANK1,ENSG00000153064,Abnormality of the skeletal system,HP_0000924,0.43040172829802564,4.304229770721348,3,1.3,3.9000000000000004,transcript,18354.0
BANK1,ENSG00000153064,body weights and measures,EFO_0004324,0.43040172829802564,4.304229770721348,3,1.3,3.9000000000000004,transcript,18354.0
SHH,ENSG00000164690,cerebral cortex area attribute,OBA_2045267,0.43038548703574053,4.303908019440583,1,0.4,0.4,transcript,7526.0
TRIM36,ENSG00000152503,hypertension,EFO_0000537,0.43035582388606286,4.303584399750099,1,0.4,0.4,transcript,15290.0
MACF1,ENSG00000127603,triglycerides:total lipids ratio,EFO_0020947,0.4303549015447718,4.303554342300048,2,0.8,1.6,gene_variant,300365.0
SYNE2,ENSG00000054654,metabolite measurement,EFO_0004725,0.430282369864021,4.302836334156119,2,1.0,2.0,transcript,158284.0
REEP3,ENSG00000165476,low density lipoprotein cholesterol measurement,EFO_0004611,0.4302783691162664,4.3028534748332845,1,0.4,0.4,transcript,5732.0
GRB14,ENSG00000115290,sleep duration trait,OBA_2040171,0.4302720200291893,4.302760567634713,1,0.4,0.4,transcript,9909.0
LONRF1,ENSG00000154359,placenta praevia,EFO_0007442,0.4302474871671707,4.302510164958925,1,0.5,0.5,transcript,14167.0
BCKDHB,ENSG00000083123,body weight,EFO_0004338,0.43022981922649856,4.308025569126383,10,4.0,40.0,transcript,6984.0
IL4R,ENSG00000077238,wheezing,EFO_0009715,0.4302250552462043,4.302269116531287,1,0.4,0.4,transcript,21547.0
SORL1,ENSG00000137642,educational attainment,EFO_0011015,0.4301391290758942,4.301438300422039,2,0.9,1.8,transcript,38290.0
SMAD2,ENSG00000175387,asthma,MONDO_0004979,0.43010288402031105,4.301522637258617,9,3.6,32.4,transcript,65614.0
PTK2,ENSG00000169398,Dupuytren Contracture,EFO_0004229,0.43001031904546866,4.300108032659343,1,0.4,0.4,transcript,82607.0
AKAP10,ENSG00000108599,brain attribute,OBA_2045210,0.4300080555324403,4.300115735623435,1,0.4,0.4,transcript,11370.0
ASTN2,ENSG00000148219,cystatin C measurement,EFO_0004617,0.43000486972835816,4.300107451690162,2,0.8,1.6,transcript,27232.0
FAM76B,ENSG00000077458,mean corpuscular hemoglobin concentration,EFO_0004528,0.42997971903003906,4.299818885803997,1,0.4,0.4,transcript,18437.0
CASQ2,ENSG00000118729,atrial flutter,EFO_0003911,0.4299156719421341,4.299169370442911,1,0.4,0.4,transcript,31618.0
ATXN7L3B,ENSG00000253719,self reported educational attainment,EFO_0004784,0.42988404721256523,4.298893131420018,1,0.4,0.4,transcript,7596.0
BCAS3,ENSG00000141376,bone quantitative ultrasound measurement,EFO_0004514,0.4298415262527943,4.298425661646098,1,0.5,0.5,transcript,48081.0
TLK1,ENSG00000198586,total blood protein measurement,EFO_0004536,0.42983294532504085,4.298343348411419,1,0.4,0.4,transcript,28787.0
TRPC6,ENSG00000137672,smoking initiation,EFO_0005670,0.42980396425681106,4.298068529691675,1,0.4,0.4,transcript,13847.0
DLC1,ENSG00000164741,peak expiratory flow,EFO_0009718,0.4298018184883583,4.298029864056698,1,0.4,0.4,transcript,34249.0
PROK2,ENSG00000163421,eosinophil count,EFO_0004842,0.42976802039181333,4.298195667835659,2,0.8,1.6,transcript,3104.0
FUT2,ENSG00000176920,serum creatinine amount,OBA_2050096,0.4297575197923682,4.297698224374369,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
CHL1,ENSG00000134121,neuroimaging measurement,EFO_0004346,0.4296829024528775,4.2968762249535795,2,0.8,1.6,transcript,33898.0
GREM1,ENSG00000166923,mean corpuscular hemoglobin concentration,EFO_0004528,0.42967806720388524,4.29679889610373,1,0.4,0.4,transcript,21949.0
RGS7BP,ENSG00000186479,mean corpuscular hemoglobin concentration,EFO_0004528,0.4296616932734384,4.296705053989231,1,0.5,0.5,transcript,5674.0
PDE10A,ENSG00000112541,diglyceride measurement,EFO_0010223,0.4296516717781694,4.296536429875611,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
ACTN2,ENSG00000077522,hypertrophic cardiomyopathy,EFO_0000538,0.42962012920051496,4.296217977616938,2,0.8,1.6,transcript,95891.0
TGFBR1,ENSG00000106799,Marfan syndrome,MONDO_0007947,0.42958320287396573,4.295836276331804,1,0.4,0.4,transcript,94171.0
NID2,ENSG00000087303,fat pad mass,OBA_0004528,0.42957523917776314,4.295797526278443,1,0.5,0.5,transcript,11078.0
LYPLAL1,ENSG00000143353,corneal resistance factor,EFO_0010067,0.4295538961107639,4.295566757416289,1,0.5,0.5,transcript,17988.0
OXSR1,ENSG00000172939,potassium measurement,EFO_0009283,0.42953276344165026,4.295368210598284,1,0.4,0.4,transcript,9858.0
ZNF398,ENSG00000197024,eosinophil count,EFO_0004842,0.42948208068423693,4.294846300787557,1,0.4,0.4,transcript,15690.0
PTK2,ENSG00000169398,brain volume,OBA_2050009,0.42944786283252134,4.29448347052987,1,0.4,0.4,transcript,82607.0
TBX5,ENSG00000089225,"osteoarthritis, knee",EFO_0004616,0.4294396400181013,4.294521693838021,2,0.8,1.6,transcript,12770.0
PRTG,ENSG00000166450,cortical thickness,EFO_0004840,0.4294266193202803,4.294484269287127,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
FNDC3B,ENSG00000075420,smoking behavior,EFO_0004318,0.4294113191500205,4.294166809006321,2,0.8,1.6,transcript,29841.0
PTK2,ENSG00000169398,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.4294058033493667,4.294062875698323,1,0.4,0.4,transcript,82607.0
GREM1,ENSG00000166923,hemoglobin measurement,EFO_0004509,0.4292585770437573,4.292603994502451,1,0.4,0.4,transcript,21949.0
PTK2,ENSG00000169398,mean corpuscular hemoglobin,EFO_0004527,0.42925375129832943,4.29254235518795,1,0.4,0.4,transcript,82607.0
ARHGAP28,ENSG00000088756,cystatin C measurement,EFO_0004617,0.4292175340793973,4.292187642430091,1,0.4,0.4,transcript,32516.0
RNF144B,ENSG00000137393,atrial fibrillation,EFO_0000275,0.4292154777369155,4.29222765038792,1,0.4,0.4,transcript,5489.0
ZNF436,ENSG00000125945,BMI-adjusted waist-hip ratio,EFO_0007788,0.42918314436933586,4.2918650854090865,1,0.4,0.4,transcript,11890.0
DENND1B,ENSG00000213047,worry measurement,EFO_0009589,0.4291778295653419,4.292215053165648,5,2.0,10.0,transcript,22896.0
KLHL3,ENSG00000146021,erythrocyte count,EFO_0004305,0.4291678702554331,4.291726013237675,2,0.8,1.6,transcript,33819.0
TBL2,ENSG00000106638,serum albumin amount,OBA_2050068,0.4291339001867568,4.291354180405116,1,0.4,0.4,transcript,26353.0
ALAD,ENSG00000148218,erythrocyte volume,OBA_0003460,0.4291328395698256,4.291365705650686,1,0.4,0.4,transcript,10721.0
CD2AP,ENSG00000198087,serum alanine aminotransferase measurement,EFO_0004735,0.42907852714072353,4.2908373411807315,1,0.4,0.4,transcript,7682.0
PHIP,ENSG00000146247,platelet count,EFO_0004309,0.4290756161964017,4.29076413911745,1,0.5,0.5,transcript,62679.0
AGBL3,ENSG00000146856,neuroimaging measurement,EFO_0004346,0.4290529697612688,4.290565650729823,1,0.5,0.5,transcript,13907.0
LRBA,ENSG00000198589,total cholesterol measurement,EFO_0004574,0.42900916323791827,4.2900955738872035,1,0.4,0.4,transcript,101484.0
SLC22A2,ENSG00000112499,kidney failure,EFO_1002048,0.4289738146303172,4.289777868249548,1,0.4,0.4,transcript,10070.0
DENND1B,ENSG00000213047,feeling emotionally hurt measurement,EFO_0009599,0.4288347933561979,4.288784691074208,5,2.0,10.0,transcript,22896.0
ALPK3,ENSG00000136383,HbA1c measurement,EFO_0004541,0.4288206914601136,4.288244210638432,1,0.4,0.4,transcript,10725.0
PRTG,ENSG00000166450,brain volume,OBA_2050009,0.42876806563552294,4.287898732439553,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
CENPC,ENSG00000145241,high density lipoprotein cholesterol measurement,EFO_0004612,0.42876081722440984,4.287806979401156,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
RAPGEF4,ENSG00000091428,educational attainment,EFO_0011015,0.42870107943353736,4.28702398042405,1,0.4,0.4,transcript,30335.0
HS6ST3,ENSG00000185352,smoking status measurement,EFO_0006527,0.4286816750267518,4.286863610623657,1,0.4,0.4,transcript,8536.0
PHIP,ENSG00000146247,hypertension,EFO_0000537,0.428612877792763,4.286136755081063,1,0.5,0.5,transcript,62679.0
PDE1A,ENSG00000115252,diastolic blood pressure change measurement,EFO_0006945,0.4286063381897135,4.286189933027306,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
LRRC7,ENSG00000033122,self reported educational attainment,EFO_0004784,0.4286063381897135,4.286127485602685,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
PTCHD4,ENSG00000244694,HbA1c measurement,EFO_0004541,0.4286063381897135,4.286477222568476,6,2.4000000000000004,14.400000000000002,transcript,34796.0
MYO5A,ENSG00000197535,Griscelli disease,Orphanet_381,0.4285905136073502,4.285907175734714,1,0.4,0.4,transcript,196111.0
TNFRSF19,ENSG00000127863,nasopharyngeal neoplasm,EFO_0004252,0.4285334422060103,4.285367423182141,1,0.5,0.5,transcript,15151.0
DTHD1,ENSG00000197057,FEV/FVC ratio,EFO_0004713,0.42853141243991555,4.285340524948287,1,0.5,0.5,transcript,18939.0
PDE1C,ENSG00000154678,FEV/FVC ratio,EFO_0004713,0.4285021326896457,4.285075685801125,2,0.8,1.6,transcript,29434.0
QKI,ENSG00000112531,type 2 diabetes mellitus,MONDO_0005148,0.4284886310366186,4.284921882522081,2,0.8,1.6,transcript,44979.0
MAGI2,ENSG00000187391,body weight,EFO_0004338,0.42847239268444764,4.284728490241469,1,0.4,0.4,transcript,87654.0
TNRC6B,ENSG00000100354,mean corpuscular hemoglobin,EFO_0004527,0.4284574795622452,4.284581247443479,1,0.4,0.4,transcript,61998.0
BACH1,ENSG00000156273,Red cell distribution width,EFO_0009188,0.4284340609986655,4.284698471762544,4,1.6,6.4,transcript,17884.0
HS6ST3,ENSG00000185352,cystatin C measurement,EFO_0004617,0.4283619109953203,4.283665970309341,1,0.4,0.4,transcript,8536.0
C12orf42,ENSG00000179088,autoimmune disease,EFO_0005140,0.4282592020188625,4.282627159692455,1,0.5,0.5,transcript,14229.0
KITLG,ENSG00000049130,testicular neoplasm,EFO_0004281,0.42825859795008087,4.282755335477663,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
NOL9,ENSG00000162408,mean corpuscular hemoglobin concentration,EFO_0004528,0.42825126187246126,4.282555321831263,1,0.4,0.4,transcript,9367.0
CNTN5,ENSG00000149972,lymphocyte count,EFO_0004587,0.4282459110274956,4.282472090966177,1,0.4,0.4,transcript,30815.0
PKP2,ENSG00000057294,ventricular tachycardia,EFO_0005306,0.42823387153083126,4.282494816676638,4,1.6,6.4,transcript,40999.0
TECRL,ENSG00000205678,metabolite measurement,EFO_0004725,0.42822385248704187,4.2826412995403675,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
TBX5,ENSG00000089225,atrioventricular block,MONDO_0000465,0.4281972659962414,4.282097953619423,2,0.8,1.6,transcript,12770.0
ITGB8,ENSG00000105855,allergic disease,MONDO_0005271,0.42817688334004383,4.281939360613739,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
METTL2B,ENSG00000165055,monocyte count,EFO_0005091,0.42814716378829315,4.28157426119125,2,0.8,1.6,transcript,15591.0
MDGA2,ENSG00000139915,high density lipoprotein cholesterol measurement,EFO_0004612,0.4281336012369815,4.281359103058495,1,0.4,0.4,transcript,17323.0
MACF1,ENSG00000127603,phospholipids:total lipids ratio,EFO_0020946,0.4281121487358992,4.281126814211322,2,0.8,1.6,gene_variant,300365.0
CNTN5,ENSG00000149972,self reported educational attainment,EFO_0004784,0.4280923690913007,4.280936671604229,1,0.4,0.4,transcript,30815.0
CWH43,ENSG00000109182,hip circumference,OBA_1000032,0.4280702693124907,4.2807647663713375,1,0.5,0.5,transcript,8055.0
PTPRJ,ENSG00000149177,IGF-1 measurement,EFO_0004627,0.42805250617962953,4.28060024976622,2,0.8,1.6,transcript,21280.0
TBX5,ENSG00000089225,vital capacity,EFO_0004312,0.4280329980647875,4.280455274304884,2,0.8,1.6,transcript,12770.0
ATP9A,ENSG00000054793,"osteoarthritis, knee",EFO_0004616,0.4280237271059098,4.28026263728397,1,0.4,0.4,transcript,15769.0
UBXN2A,ENSG00000173960,cystatin C measurement,EFO_0004617,0.4280110579338936,4.28026779659353,2,0.8,1.6,transcript,10177.0
CHL1,ENSG00000134121,serum alanine aminotransferase measurement,EFO_0004735,0.4279885320067624,4.279932520492428,2,0.8,1.6,transcript,33898.0
SGCZ,ENSG00000185053,self reported educational attainment,EFO_0004784,0.427981222749679,4.27986093670283,1,0.4,0.4,transcript,8212.0
LIN54,ENSG00000189308,platelet count,EFO_0004309,0.4279740306939009,4.279753233516051,1,0.4,0.4,transcript,30944.0
COL24A1,ENSG00000171502,open-angle glaucoma,EFO_0004190,0.42795647134679643,4.279589109662158,1,0.4,0.4,transcript,16396.0
USP15,ENSG00000135655,triglyceride measurement,EFO_0004530,0.42795579084501656,4.279641026292795,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
STT3B,ENSG00000163527,alcohol consumption quality,OBA_1000840,0.42794493033676195,4.279469026260968,1,0.4,0.4,transcript,20281.0
SLC22A5,ENSG00000197375,3-dehydrocarnitine measurement,EFO_0021037,0.42793626418803743,4.2793682108168465,1,0.4,0.4,transcript,71827.0
RPS6KA5,ENSG00000100784,hip circumference,OBA_1000032,0.4279284439903145,4.2792943047546785,1,0.4,0.4,transcript,40548.0
FLRT2,ENSG00000185070,PR interval,EFO_0004462,0.4279239966135019,4.27957548490524,7,2.8000000000000003,19.6,transcript,58417.0
SGCD,ENSG00000170624,monocyte count,EFO_0005091,0.4279076865921566,4.279095654967553,1,0.4,0.4,transcript,21289.0
CENPC,ENSG00000145241,fat pad mass,OBA_0004528,0.4279030145567344,4.279228952724401,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
GFPT1,ENSG00000198380,musculoskeletal system disease,EFO_0009676,0.4278827647413263,4.278842751442263,1,0.4,0.4,transcript,26483.0
ABCA10,ENSG00000154263,apolipoprotein B measurement,EFO_0004615,0.4278538379581413,4.278638315733316,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
NEBL,ENSG00000078114,neurodegenerative disease,EFO_0005772,0.42781381454335043,4.278145967252469,1,0.4,0.4,transcript,51139.0
IKZF3,ENSG00000161405,neurodegenerative disease,EFO_0005772,0.42777261238923214,4.2777338647291065,1,0.4,0.4,transcript,51674.0
PLCL1,ENSG00000115896,chronotype measurement,EFO_0008328,0.4277656211394487,4.277745721883997,2,0.8,1.6,transcript,17875.0
TAF2,ENSG00000064313,erythrocyte count,EFO_0004305,0.4277138393137119,4.277141186121143,1,0.5,0.5,transcript,179020.0
CCBE1,ENSG00000183287,total cholesterol measurement,EFO_0004574,0.4276867885482899,4.276881675733192,1,0.4,0.4,transcript,29006.0
GREM1,ENSG00000166923,colon carcinoma,EFO_1001950,0.42766702612872276,4.276688485352105,1,0.4,0.4,transcript,21949.0
CD69,ENSG00000110848,type 1 diabetes mellitus,MONDO_0005147,0.4276612442734011,4.277456918455333,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
HEG1,ENSG00000173706,neutrophil count,EFO_0004833,0.42763863012819603,4.276408167569611,1,0.4,0.4,transcript,18293.0
CASQ2,ENSG00000118729,heart rate,OBA_1001087,0.4275634654374524,4.2756473053960935,1,0.4,0.4,transcript,31618.0
SP4,ENSG00000105866,self reported educational attainment,EFO_0004784,0.42751889246185865,4.275212916941043,1,0.4,0.4,transcript,16672.0
TNFRSF11A,ENSG00000141655,sitting height measurement,EFO_0011011,0.42750320305373274,4.275156621722501,2,0.8,1.6,transcript,12842.0
TLR10,ENSG00000174123,asthma,MONDO_0004979,0.4274262793715049,4.274424235932189,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
SLC7A2,ENSG00000003989,lysine in blood amount,OBA_2020005,0.4273489171311579,4.27361016693269,3,1.4,4.199999999999999,transcript,34712.0
MACF1,ENSG00000127603,diabetes mellitus,EFO_0000400,0.4273463813735924,4.2734691405882534,2,0.8,1.6,gene_variant,300365.0
SEMA6D,ENSG00000137872,taste liking measurement,EFO_0010155,0.4272738087636459,4.272747514484122,1,0.5,0.5,transcript,53040.0
MEOX2,ENSG00000106511,body weights and measures,EFO_0004324,0.4272625447031726,4.272794152219411,1,0.4,0.4,transcript,2371.0
FLRT2,ENSG00000185070,smoking initiation,EFO_0005670,0.4272396704009535,4.272732222779756,7,2.8000000000000003,19.6,transcript,58417.0
IREB2,ENSG00000136381,erythrocyte volume,OBA_0003460,0.42723229553423453,4.272422811106242,2,0.9,1.8,transcript,18026.0
TBL2,ENSG00000106638,fatty acid measurement,EFO_0005110,0.4272024078868276,4.272039257405824,1,0.4,0.4,transcript,26353.0
GSAP,ENSG00000186088,sodium measurement,EFO_0009282,0.42718238983798523,4.271849412489155,1,0.5,0.5,transcript,19597.0
MCL1,ENSG00000143384,monocyte count,EFO_0005091,0.4271782756176281,4.271799525555394,1,0.4,0.4,transcript,23853.0
SEC22A,ENSG00000121542,erythrocyte volume,OBA_0003460,0.427168220662093,4.271804241553429,2,0.8,1.6,transcript,13111.0
IL4R,ENSG00000077238,interleukin-4 receptor subunit alpha measurement,EFO_0020507,0.42713290518823765,4.27134761595162,1,0.4,0.4,transcript,21547.0
CASQ2,ENSG00000118729,left ventricular structural measurement,EFO_0008205,0.4271301456211717,4.2713141072332865,1,0.4,0.4,transcript,31618.0
CSMD3,ENSG00000164796,insomnia,EFO_0004698,0.4271158682856098,4.27116679157784,1,0.5,0.5,transcript,61662.0
LRBA,ENSG00000198589,immunodeficiency disease,MONDO_0021094,0.4270700543023221,4.270704484531242,1,0.4,0.4,transcript,101484.0
SP4,ENSG00000105866,body mass index,EFO_0004340,0.4270692456691442,4.270716449013899,1,0.4,0.4,transcript,16672.0
TNRC6B,ENSG00000100354,body weights and measures,EFO_0004324,0.4270610827945218,4.2706172797662445,1,0.4,0.4,transcript,61998.0
PPP1R9A,ENSG00000158528,HbA1c measurement,EFO_0004541,0.42703630817888805,4.270442089932796,3,1.3,3.9000000000000004,transcript,49362.0
ZNF507,ENSG00000168813,body height,OBA_VT0001253,0.4270003032544794,4.270017431392887,1,0.4,0.4,transcript,27780.0
SLCO5A1,ENSG00000137571,basophil count,EFO_0005090,0.4269999608469479,4.270430160437102,5,2.0,10.0,transcript,23226.0
CERKL,ENSG00000188452,cone dystrophy,MONDO_0000455,0.4269571271245018,4.269591345116866,1,0.5,0.5,transcript,24908.0
PDE10A,ENSG00000112541,heart rate,OBA_1001087,0.42688213001225683,4.268841012216486,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
IL1A,ENSG00000115008,monocyte count,EFO_0005091,0.4268364860706314,4.268563175034524,1,0.4,0.4,transcript,2017.0
GBE1,ENSG00000114480,"feeling ""fed-up"" measurement",EFO_0009588,0.4268312003691862,4.268372882785981,1,0.5,0.5,transcript,8213.0
FUT2,ENSG00000176920,C-reactive protein measurement,EFO_0004458,0.42681938257210694,4.268316852171757,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
BANK1,ENSG00000153064,systolic blood pressure,EFO_0006335,0.4267842889003514,4.2680553767446066,3,1.3,3.9000000000000004,transcript,18354.0
GFPT1,ENSG00000198380,"osteoarthritis, hip",EFO_1000786,0.42678165291448006,4.267831633173801,1,0.4,0.4,transcript,26483.0
SLF1,ENSG00000133302,neuroimaging measurement,EFO_0004346,0.4267423685969938,4.2674585991234695,1,0.4,0.4,transcript,11457.0
MSX2,ENSG00000120149,hair color,EFO_0003924,0.4266875811304018,4.266994049554091,1,0.4,0.4,transcript,3383.0
ULK4,ENSG00000168038,potassium measurement,EFO_0009283,0.42667683401967804,4.266809300301638,1,0.5,0.5,transcript,12207.0
ARSJ,ENSG00000180801,body height,OBA_VT0001253,0.4266680158132021,4.266858391394803,2,0.8,1.6,transcript,8977.0
MFAP3,ENSG00000037749,HbA1c measurement,EFO_0004541,0.42663070455106045,4.266319635212229,1,0.4,0.4,transcript,31772.0
LYPLAL1,ENSG00000143353,serum albumin amount,OBA_2050068,0.42662649660274043,4.266292762336055,1,0.5,0.5,transcript,17988.0
USP15,ENSG00000135655,aortic measurement,EFO_0020865,0.42658079970741797,4.265891114916809,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
PRKCB,ENSG00000166501,inflammatory bowel disease,EFO_0003767,0.42647769991124107,4.2648009655593855,1,0.4,0.4,transcript,16690.0
RNF144B,ENSG00000137393,IGF-1 measurement,EFO_0004627,0.42646682364005106,4.264741109419275,1,0.4,0.4,transcript,5489.0
GSAP,ENSG00000186088,serum gamma-glutamyl transferase measurement,EFO_0004532,0.42645632791205684,4.264588793229871,1,0.5,0.5,transcript,19597.0
NDUFAF2,ENSG00000164182,brain attribute,OBA_2045210,0.4264489745214274,4.264529950260007,1,0.4,0.4,transcript,9949.0
SP8,ENSG00000164651,metabolite measurement,EFO_0004725,0.4263915203653368,4.263990110020409,1,0.4,0.4,transcript,5340.0
HFE,ENSG00000010704,cardiomyopathy,EFO_0000318,0.42638545895205404,4.263862874696289,1,0.4,0.4,transcript,48279.0
FAM76B,ENSG00000077458,rheumatoid arthritis,EFO_0000685,0.4263556549043541,4.263578244547148,1,0.4,0.4,transcript,18437.0
GCH1,ENSG00000131979,erythrocyte volume,OBA_0003460,0.42635077821907047,4.263541546012769,1,0.4,0.4,transcript,11847.0
CNTN5,ENSG00000149972,educational attainment,EFO_0011015,0.42632437853834454,4.263256766074667,1,0.4,0.4,transcript,30815.0
AKAP11,ENSG00000023516,eosinophil percentage of leukocytes,EFO_0007991,0.42628632275080336,4.263263227508033,1,0.4,0.4,transcript,1000.0
RASA2,ENSG00000155903,alcohol consumption quality,OBA_1000840,0.42627653196587956,4.262812933038155,1,0.4,0.4,transcript,8401.0
TMEM106B,ENSG00000106460,frontotemporal dementia,MONDO_0017276,0.42622648131342916,4.262297689621439,2,0.8,1.6,transcript,48667.0
ZNF507,ENSG00000168813,diastolic blood pressure,EFO_0006336,0.4262099324586993,4.262113723435085,1,0.4,0.4,transcript,27780.0
HS6ST3,ENSG00000185352,urate measurement,EFO_0004531,0.4262034944753369,4.262081805109507,1,0.4,0.4,transcript,8536.0
LDLRAP1,ENSG00000157978,platelet component distribution width,EFO_0007984,0.42619499585421283,4.261975871991209,1,0.4,0.4,transcript,15436.0
TMEM131,ENSG00000075568,eosinophil percentage of leukocytes,EFO_0007991,0.4261849117480041,4.261870566351295,1,0.4,0.4,transcript,18649.0
MORF4L2,ENSG00000123562,serum creatinine amount,OBA_2050096,0.4261816651975948,4.261847501891111,1,0.4,0.4,transcript,12966.0
LRRIQ3,ENSG00000162620,neutrophil count,EFO_0004833,0.42615565737150213,4.261583469895763,1,0.5,0.5,transcript,18590.0
DENND1B,ENSG00000213047,cortical thickness,EFO_0004840,0.426143480573196,4.261871563244189,5,2.0,10.0,transcript,22896.0
PTAR1,ENSG00000188647,JT interval,EFO_0007885,0.42612048214249426,4.261272514774071,2,0.8,1.6,transcript,23636.0
PLEKHA6,ENSG00000143850,lymphocyte count,EFO_0004587,0.42605487370638373,4.260555551722168,1,0.4,0.4,transcript,58697.0
CNTN5,ENSG00000149972,systolic blood pressure,EFO_0006335,0.4260252835469937,4.260265816161159,1,0.4,0.4,transcript,30815.0
NEDD4,ENSG00000069869,neurodegenerative disease,EFO_0005772,0.4259945063736471,4.259953373698038,1,0.4,0.4,transcript,48135.0
TBX5,ENSG00000089225,electrocardiography,EFO_0004327,0.42597361578206977,4.259861451477707,2,0.8,1.6,transcript,12770.0
TMEM68,ENSG00000167904,platelet volume,OBA_0003277,0.42592826807502976,4.25930135227156,1,0.4,0.4,transcript,21423.0
UBXN2A,ENSG00000173960,vital capacity,EFO_0004312,0.42589337055441395,4.259090922798733,2,0.8,1.6,transcript,10177.0
MDM4,ENSG00000198625,eosinophil count,EFO_0004842,0.425892202032334,4.25892789119355,1,0.4,0.4,transcript,68133.0
PDE10A,ENSG00000112541,platelet count,EFO_0004309,0.4258884223317808,4.258903935411725,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
NDFIP2,ENSG00000102471,diverticular disease,EFO_0009959,0.42588759268073817,4.25889040867337,2,0.8,1.6,transcript,110483.0
ST8SIA4,ENSG00000113532,monocyte count,EFO_0005091,0.42583996382699746,4.258442515320033,1,0.4,0.4,transcript,9329.0
SYNJ2,ENSG00000078269,hearing loss,EFO_0004238,0.42579473907983634,4.2579985384231955,2,0.8,1.6,transcript,31282.0
BTC,ENSG00000174808,serum creatinine amount,OBA_2050096,0.42577099840945887,4.257832046956963,1,0.4,0.4,transcript,3277.0
TMEM132B,ENSG00000139364,type 2 diabetes mellitus,MONDO_0005148,0.42570628913526126,4.2571522546391956,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
ROCK2,ENSG00000134318,lymphocyte count,EFO_0004587,0.4256989352564684,4.257000346166408,1,0.5,0.5,transcript,45481.0
CBLB,ENSG00000114423,multiple sclerosis,MONDO_0005301,0.42569550785269133,4.256963570194465,1,0.4,0.4,transcript,47105.0
LNPEP,ENSG00000113441,low density lipoprotein cholesterol measurement,EFO_0004611,0.42568733111046475,4.256893973328936,1,0.4,0.4,transcript,19359.0
DBR1,ENSG00000138231,mean reticulocyte volume,EFO_0010701,0.4256668774271525,4.2566872057524945,1,0.4,0.4,transcript,21702.0
GIPC2,ENSG00000137960,protein measurement,EFO_0004747,0.4256290410723353,4.256681608767363,2,0.8,1.6,transcript,4090.0
HFM1,ENSG00000162669,habitual abortion,EFO_1000954,0.42556381107234037,4.255767947129533,2,1.0,2.0,transcript,15404.0
CADPS,ENSG00000163618,glucose measurement,EFO_0004468,0.42550803449665975,4.255089662677236,1,0.4,0.4,transcript,42929.0
PROK2,ENSG00000163421,monocyte percentage of leukocytes,EFO_0007989,0.42543098182973,4.254825282214826,2,0.8,1.6,transcript,3104.0
LTBP1,ENSG00000049323,diverticular disease,EFO_0009959,0.42541313265118025,4.254143985941496,1,0.4,0.4,transcript,31597.0
DLC1,ENSG00000164741,heel bone mineral density,EFO_0009270,0.42540739492828444,4.254085628455959,1,0.4,0.4,transcript,34249.0
ZNF682,ENSG00000197124,choline measurement,EFO_0010116,0.4253553471726611,4.253579445752584,1,0.5,0.5,transcript,19250.0
SIX4,ENSG00000100625,prostate carcinoma,EFO_0001663,0.4252091079844381,4.252130813628031,1,0.4,0.4,transcript,10067.0
DENND3,ENSG00000105339,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.4252025097594393,4.252035914252046,1,0.5,0.5,transcript,46225.0
PTAR1,ENSG00000188647,injury,EFO_0000546,0.425161386026049,4.251681553609619,2,0.8,1.6,transcript,23636.0
SLC22A24,ENSG00000197658,etiocholanolone glucuronide measurement,EFO_0800362,0.4251195636953675,4.251280932074794,1,0.5,0.5,transcript,5862.0
LTBP1,ENSG00000049323,carpal tunnel syndrome,EFO_0004143,0.4250466746599204,4.250479406028897,1,0.4,0.4,transcript,31597.0
PARP11,ENSG00000111224,mean corpuscular hemoglobin concentration,EFO_0004528,0.4250380114834886,4.250398063322725,1,0.4,0.4,transcript,22286.0
DYNC2H1,ENSG00000187240,IMAGe syndrome,MONDO_0013873,0.42501683288740705,4.250178485282764,1,0.5,0.5,transcript,49230.0
CERKL,ENSG00000188452,Retinal pigment epithelial atrophy,HP_0007722,0.42501683288740705,4.250188402745919,1,0.5,0.5,transcript,24908.0
KIAA0586,ENSG00000100578,Neurodevelopmental disorder,EFO_0010642,0.42501683288740705,4.250173979932514,1,0.5,0.5,transcript,88479.0
DYNC1I2,ENSG00000077380,"neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies",MONDO_0060490,0.42501683288740705,4.250179515807732,1,0.4,0.4,transcript,35756.0
NCKAP1,ENSG00000061676,Autistic behavior,HP_0000729,0.42501683288740705,4.250178158091419,1,0.4,0.4,transcript,40695.0
ALPK3,ENSG00000136383,Neurodevelopmental disorder,EFO_0010642,0.42501683288740705,4.250205624911366,1,0.4,0.4,transcript,10725.0
SPAST,ENSG00000021574,Tip-toe gait,HP_0030051,0.42501683288740705,4.250173505192414,1,0.4,0.4,transcript,77275.0
CDH23,ENSG00000107736,Usher syndrome type 2,MONDO_0016484,0.42501683288740705,4.250175879577041,1,0.5,0.5,transcript,66219.0
DYNC2H1,ENSG00000187240,fetal growth restriction,EFO_0000495,0.42501683288740705,4.250178485282764,1,0.5,0.5,transcript,49230.0
DYNC2H1,ENSG00000187240,Bowing of the long bones,HP_0006487,0.42501683288740705,4.250178485282764,1,0.5,0.5,transcript,49230.0
CFHR4,ENSG00000134365,eosinophil count,EFO_0004842,0.424995260111964,4.249993109910047,1,0.5,0.5,transcript,12343.0
FSIP2,ENSG00000188738,bone tissue density,OBA_1000110,0.4249945804933013,4.250224744960907,4,2.0,8.0,transcript,28680.0
LRBA,ENSG00000198589,triglyceride measurement,EFO_0004530,0.4249812907191237,4.2498168486992585,1,0.4,0.4,transcript,101484.0
LTBP1,ENSG00000049323,sitting height measurement,EFO_0011011,0.42497656732295236,4.249778332659217,1,0.4,0.4,transcript,31597.0
ENSG00000285458,ENSG00000285458,neurodegenerative disease,EFO_0005772,0.4249155799703551,4.249321692205211,1,0.5,0.5,transcript,3014.0
DCK,ENSG00000156136,triglyceride measurement,EFO_0004530,0.42490969403280776,4.249133925996131,1,0.4,0.4,transcript,10815.0
DENND1B,ENSG00000213047,cystatin C measurement,EFO_0004617,0.42482363676139917,4.2486731251262215,5,2.0,10.0,transcript,22896.0
LUZP2,ENSG00000187398,growth differentiation factor 15 amount,OBA_2050135,0.4247811227815537,4.248128007839762,4,1.7000000000000002,6.800000000000001,transcript,21466.0
NDUFAF2,ENSG00000164182,platelet volume,OBA_0003277,0.42476034679009633,4.247643672946697,1,0.4,0.4,transcript,9949.0
ITM2A,ENSG00000078596,"osteoarthritis, hip",EFO_1000786,0.42473077670003395,4.24770776700034,1,0.4,0.4,transcript,1000.0
KPNA4,ENSG00000186432,eosinophil count,EFO_0004842,0.42469164552674304,4.2469254484775565,1,0.4,0.4,transcript,44478.0
FBXO28,ENSG00000143756,erythrocyte count,EFO_0004305,0.4246560995532619,4.247609983259462,5,2.0,10.0,transcript,9533.0
LRRIQ3,ENSG00000162620,lymphocyte count,EFO_0004587,0.42465526056965736,4.246579501877315,1,0.5,0.5,transcript,18590.0
TRHDE,ENSG00000072657,metabolite measurement,EFO_0004725,0.42464191143691643,4.246518684970944,2,0.8,1.6,transcript,16069.0
SORL1,ENSG00000137642,serum creatinine amount,OBA_2050096,0.42462308008813376,4.246277810544435,2,0.9,1.8,transcript,38290.0
SLC22A24,ENSG00000197658,pregnanediol-3-glucuronide measurement,EFO_0800341,0.4245987359179652,4.246072654300771,1,0.5,0.5,transcript,5862.0
THEM4,ENSG00000159445,3-hydroxydecanoate measurement,EFO_0800198,0.4245258521479567,4.2454128722416735,2,0.8,1.6,transcript,10366.0
RBM25,ENSG00000119707,cognitive function measurement,EFO_0008354,0.4245240338613816,4.2452530285665455,1,0.4,0.4,transcript,31521.0
TNFRSF11A,ENSG00000141655,"osteoarthritis, hip",EFO_1000786,0.4244825862231053,4.244950453416227,2,0.8,1.6,transcript,12842.0
MAP2K6,ENSG00000108984,medical procedure,EFO_0002571,0.42448254152619397,4.244842717796762,1,0.4,0.4,transcript,23118.0
VPS13A,ENSG00000197969,central nervous system cancer,EFO_0000326,0.42448003890228225,4.244807134271638,1,0.4,0.4,transcript,59301.0
IL4R,ENSG00000077238,Nasal Cavity Polyp,EFO_1000391,0.42447518364873016,4.244770400556545,1,0.4,0.4,transcript,21547.0
PLCL1,ENSG00000115896,allergic disease,MONDO_0005271,0.42444158771653634,4.244505387654874,2,0.8,1.6,transcript,17875.0
DLC1,ENSG00000164741,appendicular lean mass,EFO_0004980,0.4244384012337591,4.2443956915107055,1,0.4,0.4,transcript,34249.0
FBXO28,ENSG00000143756,monocyte count,EFO_0005091,0.42442637559861346,4.245312743712978,5,2.0,10.0,transcript,9533.0
THEM4,ENSG00000159445,X-23680 measurement,EFO_0800862,0.4243660904411343,4.24381525517345,2,0.8,1.6,transcript,10366.0
LRP2,ENSG00000081479,erythrocyte count,EFO_0004305,0.4243507916030966,4.243524504730743,1,0.5,0.5,transcript,30141.0
GPM6A,ENSG00000150625,mathematical ability,EFO_0004875,0.42433475106961943,4.24336568177692,1,0.4,0.4,transcript,22013.0
COL24A1,ENSG00000171502,cerebral cortex area attribute,OBA_2045267,0.4243217191951885,4.243241588146079,1,0.4,0.4,transcript,16396.0
QSER1,ENSG00000060749,brain attribute,OBA_2045210,0.4243201680363871,4.243228355566602,1,0.5,0.5,transcript,18744.0
NEBL,ENSG00000078114,smoking initiation,EFO_0005670,0.4242348094488693,4.242355916307657,1,0.4,0.4,transcript,51139.0
C2CD4A,ENSG00000198535,body weights and measures,EFO_0004324,0.4242257234117288,4.242373344422077,1,0.4,0.4,transcript,3445.0
DCK,ENSG00000156136,vitamin D-binding protein measurement,EFO_0005675,0.4242252352549244,4.242289338217297,1,0.4,0.4,transcript,10815.0
PYHIN1,ENSG00000163564,neutrophil count,EFO_0004833,0.4242070850303694,4.242108607524763,1,0.4,0.4,transcript,10594.0
CNTNAP2,ENSG00000174469,contactin-associated protein-like 2 measurement,EFO_0801496,0.4241261905649655,4.241269587321186,1,0.4,0.4,transcript,52072.0
HEG1,ENSG00000173706,hematocrit,EFO_0004348,0.42408806928553583,4.240902559143009,1,0.4,0.4,transcript,18293.0
KCNIP4,ENSG00000185774,Abruptio Placentae,EFO_1001754,0.4240744046133857,4.240876694119266,2,0.8,1.6,transcript,12062.0
CSMD3,ENSG00000164796,ovarian dysfunction,EFO_0009003,0.4240682470890994,4.240690579612735,1,0.5,0.5,transcript,61662.0
C12orf42,ENSG00000179088,waist circumference,OBA_1001085,0.42402747371325855,4.240309876636416,1,0.5,0.5,transcript,14229.0
STXBP5,ENSG00000164506,coronary artery disease,EFO_0001645,0.42402503883473286,4.2402642187557875,2,0.9,1.8,transcript,130148.0
FRMD4B,ENSG00000114541,PR interval,EFO_0004462,0.42402370156561336,4.240313111917905,2,0.8,1.6,transcript,21026.0
TNRC6B,ENSG00000100354,autism spectrum disorder,EFO_0003756,0.4239902221799495,4.239908673620522,1,0.4,0.4,transcript,61998.0
TNFRSF11A,ENSG00000141655,Myasthenia gravis,EFO_0004991,0.42393448745599743,4.239469465745148,2,0.8,1.6,transcript,12842.0
ALDOB,ENSG00000136872,lipoprotein measurement,EFO_0004732,0.4239136779271153,4.23917819142562,1,0.4,0.4,transcript,9659.0
TULP4,ENSG00000130338,lipoprotein A measurement,EFO_0006925,0.4238945797682699,4.238964722739474,1,0.4,0.4,transcript,21136.0
RGS7BP,ENSG00000186479,self reported educational attainment,EFO_0004784,0.42387774288886065,4.238865550143453,1,0.5,0.5,transcript,5674.0
STXBP5,ENSG00000164506,Ischemic stroke,HP_0002140,0.423828515442972,4.2382989848381785,2,0.9,1.8,transcript,130148.0
PDE1A,ENSG00000115252,Increased blood pressure,HP_0032263,0.42381915971031664,4.238318148233338,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
PCMTD1,ENSG00000168300,primary angle closure glaucoma,EFO_1001506,0.4237823913633716,4.23802876170473,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
SLC22A5,ENSG00000197375,homostachydrine measurement,EFO_0021164,0.4237624452745485,4.237630021681957,1,0.4,0.4,transcript,71827.0
TBX5,ENSG00000089225,Barrett's esophagus,EFO_0000280,0.4237517827935462,4.237643121592471,2,0.8,1.6,transcript,12770.0
TMEM131,ENSG00000075568,heart rate,OBA_1001087,0.42374916066398355,4.237513055511089,1,0.4,0.4,transcript,18649.0
DAG1,ENSG00000173402,educational attainment,EFO_0011015,0.42369426907956614,4.236948878914474,1,0.4,0.4,transcript,64640.0
FIGN,ENSG00000182263,liver disease,EFO_0001421,0.4236801655274124,4.236838409845474,1,0.4,0.4,transcript,10883.0
FAM76B,ENSG00000077458,thyroid disease,EFO_1000627,0.4236533466733514,4.236555162237121,1,0.4,0.4,transcript,18437.0
GRIA4,ENSG00000152578,refractive error,MONDO_0004892,0.423652637970298,4.236535671224466,1,0.4,0.4,transcript,43050.0
NID2,ENSG00000087303,age-related hearing impairment,EFO_0005782,0.4236498484054119,4.236543618554932,1,0.5,0.5,transcript,11078.0
MAP2K6,ENSG00000108984,metabolite measurement,EFO_0004725,0.42364077104892706,4.236425013024093,1,0.4,0.4,transcript,23118.0
KRTAP19-1,ENSG00000184351,neurodegenerative disease,EFO_0005772,0.42362910056421,4.23689523524935,1,0.4,0.4,transcript,662.0
MACF1,ENSG00000127603,cortical thickness,EFO_0004840,0.42351237602626635,4.235129087114993,2,0.8,1.6,gene_variant,300365.0
COLEC10,ENSG00000184374,self reported educational attainment,EFO_0004784,0.42348585801873057,4.234963760308262,1,0.4,0.4,transcript,3803.0
RBM25,ENSG00000119707,C-reactive protein measurement,EFO_0004458,0.42345002033067625,4.234512893259492,1,0.4,0.4,transcript,31521.0
CEP68,ENSG00000011523,Drugs used in diabetes use measurement,EFO_0009924,0.42343909538544855,4.234427720963446,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,Drugs used in diabetes use measurement,EFO_0009924,0.42343909538544855,4.234427720963446,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,Drugs used in diabetes use measurement,EFO_0009924,0.42343909538544855,4.234427720963446,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,Drugs used in diabetes use measurement,EFO_0009924,0.42343909538544855,4.234427720963446,3,1.5,4.5,transcript,122392.0
LIN54,ENSG00000189308,mean corpuscular hemoglobin concentration,EFO_0004528,0.42343619926061665,4.234374919183209,1,0.4,0.4,transcript,30944.0
SKIL,ENSG00000136603,neurodegenerative disease,EFO_0005772,0.4234188028997757,4.234204488819333,1,0.5,0.5,transcript,30377.0
FGFR1OP2,ENSG00000111790,triglyceride measurement,EFO_0004530,0.4234087456921288,4.234123590615958,1,0.4,0.4,transcript,11070.0
POU2F1,ENSG00000143190,lymphocyte count,EFO_0004587,0.4233879816331993,4.233894828388551,2,0.8,1.6,transcript,106581.0
SH3GL3,ENSG00000140600,forced expiratory volume,EFO_0004314,0.42336285998917966,4.233680292835709,1,0.4,0.4,transcript,7738.0
MYO3A,ENSG00000095777,autosomal dominant nonsyndromic hearing loss,MONDO_0019587,0.4233331913271767,4.23335562906174,1,0.5,0.5,transcript,21083.0
LYPLAL1,ENSG00000143353,heel bone mineral density,EFO_0009270,0.4233186663734742,4.233214460043392,1,0.5,0.5,transcript,17988.0
PICALM,ENSG00000073921,platelet volume,OBA_0003277,0.4233172985404798,4.23318625372337,1,0.4,0.4,transcript,30147.0
SYNE2,ENSG00000054654,IGF-1 measurement,EFO_0004627,0.42329323383912015,4.232944973907109,2,1.0,2.0,transcript,158284.0
OTULINL,ENSG00000145569,Inhalant adrenergic use measurement,EFO_0009941,0.42327997403876594,4.232849715400153,1,0.4,0.4,transcript,8004.0
ADGRV1,ENSG00000164199,blood urea nitrogen measurement,EFO_0004741,0.42327401112308216,4.23274453640119,1,0.5,0.5,transcript,112990.0
SLCO1C1,ENSG00000139155,serum creatinine amount,OBA_2050096,0.4232533512524636,4.232564403418001,1,0.5,0.5,transcript,16186.0
FAT4,ENSG00000196159,glomerular filtration rate,OBA_0003747,0.42323891794447377,4.232397889487417,1,0.4,0.4,transcript,45924.0
ITGB8,ENSG00000105855,Hammer Toe Syndrome,EFO_1001336,0.4231919719269326,4.2320902464826275,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
SEMA3A,ENSG00000075213,white matter microstructure measurement,EFO_0005674,0.42318844973446545,4.231914701981066,1,0.4,0.4,transcript,13243.0
RASA2,ENSG00000155903,red blood cell density,OBA_2045260,0.4231777509749529,4.231825123128888,1,0.4,0.4,transcript,8401.0
SPATA22,ENSG00000141255,mild Canavan disease,MONDO_0017831,0.4231689336139835,4.2317230084410005,1,0.5,0.5,transcript,14849.0
MACF1,ENSG00000127603,low density lipoprotein cholesterol measurement,EFO_0004611,0.4231416101306013,4.231421428158343,2,0.8,1.6,gene_variant,300365.0
GIPC2,ENSG00000137960,serum creatinine amount,OBA_2050096,0.4231237531280826,4.231628729324836,2,0.8,1.6,transcript,4090.0
FAS,ENSG00000026103,cutaneous melanoma,EFO_0000389,0.423090135245171,4.230903560676242,1,0.4,0.4,transcript,181141.0
LYPLAL1,ENSG00000143353,heart rate,OBA_1001087,0.4230868038562239,4.230895834870889,1,0.5,0.5,transcript,17988.0
ANKRD36,ENSG00000135976,cortical thickness,EFO_0004840,0.4229663992290917,4.229739378645986,2,1.0,2.0,transcript,26530.0
IL17A,ENSG00000112115,hidradenitis suppurativa,EFO_1000710,0.42293549185305285,4.229568707947952,1,0.4,0.4,transcript,1871.0
ACVR1C,ENSG00000123612,systolic blood pressure,EFO_0006335,0.42289445287396754,4.229063842684493,2,0.8,1.6,transcript,13410.0
RNF144B,ENSG00000137393,calcific tendinitis,MONDO_0001903,0.42288034789716555,4.2288763519904204,1,0.4,0.4,transcript,5489.0
GLB1,ENSG00000170266,eosinophil percentage of leukocytes,EFO_0007991,0.42286981269269147,4.228729035006287,1,0.5,0.5,transcript,16177.0
PLXNA4,ENSG00000221866,neuroimaging measurement,EFO_0004346,0.4228363726087113,4.228375973484541,1,0.4,0.4,transcript,32660.0
PEAK1,ENSG00000173517,neurodegenerative disease,EFO_0005772,0.4227575363473927,4.227582285925167,1,0.4,0.4,transcript,57783.0
SLC22A5,ENSG00000197375,isovalerylcarnitine (C5) measurement,EFO_0800024,0.42274917531050465,4.227497322041518,1,0.4,0.4,transcript,71827.0
CEP68,ENSG00000011523,metabolic syndrome,EFO_0000195,0.4227470359004898,4.227507126113859,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,metabolic syndrome,EFO_0000195,0.4227470359004898,4.227507126113859,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,metabolic syndrome,EFO_0000195,0.4227470359004898,4.227507126113859,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,metabolic syndrome,EFO_0000195,0.4227470359004898,4.227507126113859,3,1.5,4.5,transcript,122392.0
CLASP2,ENSG00000163539,neurodegenerative disease,EFO_0005772,0.42273645516163155,4.227370671005601,1,0.4,0.4,transcript,65366.0
SEMA6D,ENSG00000137872,smoking cessation,EFO_0004319,0.4226607899166103,4.226617326013765,1,0.5,0.5,transcript,53040.0
PARP1,ENSG00000143799,clonal hematopoiesis,EFO_0010819,0.42264400929436213,4.226445962521598,1,0.5,0.5,transcript,85185.0
UBE2J1,ENSG00000198833,glomerular filtration rate,OBA_0003747,0.4226404161763717,4.226836438420778,2,0.9,1.8,transcript,4164.0
SPRED1,ENSG00000166068,body weights and measures,EFO_0004324,0.42258859395780196,4.225930512789519,1,0.4,0.4,transcript,8974.0
EXD1,ENSG00000178997,chloride measurement,EFO_0009284,0.42257908775858843,4.225832661770571,1,0.4,0.4,transcript,9573.0
CSMD3,ENSG00000164796,esophageal cancer,MONDO_0007576,0.4225748631524459,4.2257567402462,1,0.5,0.5,transcript,61662.0
RPAP3,ENSG00000005175,platelet count,EFO_0004309,0.4225535672576596,4.225684040529118,2,0.8,1.6,transcript,10784.0
FIGN,ENSG00000182263,BMI-adjusted waist-hip ratio,EFO_0007788,0.42255056055900064,4.225542360161357,1,0.4,0.4,transcript,10883.0
ATP10D,ENSG00000145246,preeclampsia,EFO_0000668,0.4225023410366002,4.225055233176593,1,0.5,0.5,transcript,15712.0
PLXNA4,ENSG00000221866,smoking status measurement,EFO_0006527,0.42249396266687506,4.2249518740661784,1,0.4,0.4,transcript,32660.0
BHLHE41,ENSG00000123095,heart rate,OBA_1001087,0.422440800740236,4.22449628813509,1,0.4,0.4,transcript,4531.0
PCDH10,ENSG00000138650,placenta praevia,EFO_0007442,0.4223892287403631,4.224006150198963,2,0.8,1.6,transcript,14052.0
FAM76B,ENSG00000077458,Thyroid preparation use measurement,EFO_0009933,0.4223742471016528,4.223764166520135,1,0.4,0.4,transcript,18437.0
FAM98A,ENSG00000119812,neuroimaging measurement,EFO_0004346,0.4223035264849264,4.223042618060779,1,0.4,0.4,transcript,54398.0
SGCZ,ENSG00000185053,high density lipoprotein cholesterol measurement,EFO_0004612,0.42230237101949936,4.223072419401034,1,0.4,0.4,transcript,8212.0
GCH1,ENSG00000131979,mean corpuscular hemoglobin,EFO_0004527,0.4222603953179811,4.222637717001875,1,0.4,0.4,transcript,11847.0
STXBP4,ENSG00000166263,red blood cell density,OBA_2045260,0.42221269108656073,4.222518622252657,5,2.0,10.0,transcript,25529.0
RANBP17,ENSG00000204764,body weight,EFO_0004338,0.422139455667882,4.2214040709740495,1,0.4,0.4,transcript,42042.0
CP,ENSG00000047457,blood copper measurement,EFO_0007578,0.42213297996713606,4.221350857622843,1,0.5,0.5,transcript,23744.0
ATF6,ENSG00000118217,lymphocyte count,EFO_0004587,0.42204256205400437,4.220431972973025,1,0.4,0.4,transcript,62968.0
CA8,ENSG00000178538,hematocrit,EFO_0004348,0.4220143807693987,4.22018476192763,1,0.4,0.4,transcript,9767.0
TSPAN9,ENSG00000011105,platelet volume,OBA_0003277,0.42201185864600516,4.220154070102092,1,0.5,0.5,transcript,14091.0
SGCZ,ENSG00000185053,smoking initiation,EFO_0005670,0.4219437677450212,4.219486386656252,1,0.4,0.4,transcript,8212.0
NBEAL1,ENSG00000144426,platelet count,EFO_0004309,0.4219432543638597,4.219436397240269,1,0.4,0.4,transcript,103799.0
SLC22A5,ENSG00000197375,diastolic blood pressure,EFO_0006336,0.42190008992632344,4.219006468199706,1,0.4,0.4,transcript,71827.0
ATP12A,ENSG00000075673,serum creatinine amount,OBA_2050096,0.4218970841092056,4.219019993217885,1,0.4,0.4,transcript,8138.0
TMEM132B,ENSG00000139364,total cholesterol measurement,EFO_0004574,0.42186010557448944,4.218690419031478,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
PEX2,ENSG00000164751,brain attribute,OBA_2045210,0.4218589690391889,4.218633516402626,1,0.4,0.4,transcript,9127.0
TRDMT1,ENSG00000107614,vitamin B deficiency,MONDO_0042976,0.42185833592467475,4.218597150923471,1,0.4,0.4,transcript,29003.0
KCNIP4,ENSG00000185774,COVID-19,MONDO_0100096,0.421794490813328,4.218077556118689,2,0.8,1.6,transcript,12062.0
RPS6KA5,ENSG00000100784,triglyceride measurement,EFO_0004530,0.42177254627955,4.217735327647034,1,0.4,0.4,transcript,40548.0
PLA2R1,ENSG00000153246,myeloid leukocyte count,OBA_2045223,0.4217718483232224,4.217797675471385,2,0.8,1.6,transcript,20204.0
SEMA3A,ENSG00000075213,open-angle glaucoma,EFO_0004190,0.4217435663080149,4.217465867716561,1,0.4,0.4,transcript,13243.0
CD69,ENSG00000110848,lymphocyte measurement,EFO_0803546,0.4217050017718795,4.2178944934401175,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
ZNF682,ENSG00000197124,total lipids in very small VLDL measurement,EFO_0022156,0.4216882812687401,4.2169087867133745,1,0.5,0.5,transcript,19250.0
NHLH2,ENSG00000177551,platelet volume,OBA_0003277,0.4216497234502623,4.216534995288048,1,0.4,0.4,transcript,10593.0
LRP2,ENSG00000081479,retinal layer thickness,OBA_2050110,0.421584745663989,4.215864045339668,1,0.5,0.5,transcript,30141.0
CEP68,ENSG00000011523,cardiac arrhythmia,EFO_0004269,0.4215660552021808,4.215697319130769,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,cardiac arrhythmia,EFO_0004269,0.4215660552021808,4.215697319130769,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,cardiac arrhythmia,EFO_0004269,0.4215660552021808,4.215697319130769,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,cardiac arrhythmia,EFO_0004269,0.4215660552021808,4.215697319130769,3,1.5,4.5,gene_variant,122392.0
BANK1,ENSG00000153064,cerebellar volume measurement,EFO_0020864,0.421494695730512,4.215159445046212,3,1.3,3.9000000000000004,transcript,18354.0
DBR1,ENSG00000138231,erythrocyte volume,OBA_0003460,0.4214624971336812,4.214643402817782,1,0.4,0.4,transcript,21702.0
CENPE,ENSG00000138778,cystatin C measurement,EFO_0004617,0.4214452490100338,4.214478183831067,1,0.5,0.5,transcript,19460.0
TBX5,ENSG00000089225,First degree atrioventricular block,HP_0011705,0.42143370800631463,4.2144623737201545,2,0.8,1.6,transcript,12770.0
AKR1B10,ENSG00000198074,Agents acting on the renin-angiotensin system use measurement,EFO_0009931,0.42135482453329787,4.213680380639532,1,0.5,0.5,transcript,3784.0
PCDH18,ENSG00000189184,cardiovascular disease,EFO_0000319,0.4213255273435993,4.213332445094702,2,0.8,1.6,transcript,20733.0
DUSP22,ENSG00000112679,eosinophil percentage of leukocytes,EFO_0007991,0.42130394789072656,4.2130630832976825,1,0.4,0.4,transcript,16946.0
SNX13,ENSG00000071189,intermediate density lipoprotein measurement,EFO_0008595,0.42125496121751005,4.212561937312218,1,0.4,0.4,transcript,32454.0
DCUN1D1,ENSG00000043093,Red cell distribution width,EFO_0009188,0.4212527918285397,4.2125521960227115,1,0.4,0.4,transcript,16476.0
TBXT,ENSG00000164458,appendicular lean mass,EFO_0004980,0.4212306494923969,4.212766970748988,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
DNAH14,ENSG00000185842,platelet volume,OBA_0003277,0.42119801858017525,4.212038164285293,3,1.5,4.5,transcript,77615.0
FAM76B,ENSG00000077458,taste liking measurement,EFO_0010155,0.42117650653310934,4.2117867608347,1,0.4,0.4,transcript,18437.0
DMRTA1,ENSG00000176399,diet measurement,EFO_0008111,0.42116666856132373,4.211738293203642,1,0.4,0.4,transcript,5586.0
C12orf42,ENSG00000179088,lichen planus,EFO_1000726,0.4210688177909641,4.210723317413471,1,0.5,0.5,transcript,14229.0
LIN9,ENSG00000183814,Red cell distribution width,EFO_0009188,0.42106723396290674,4.210777175168316,2,0.8,1.6,transcript,15262.0
TMEM106B,ENSG00000106460,aging,EFO_0022597,0.4210457837938199,4.2104907144253465,2,0.8,1.6,transcript,48667.0
KLHL3,ENSG00000146021,glomerular filtration rate,OBA_0003747,0.42102728246297944,4.210320135313138,2,0.8,1.6,transcript,33819.0
PALM2AKAP2,ENSG00000157654,hypertension,EFO_0000537,0.4209958273874852,4.2099662610953,1,0.4,0.4,transcript,50080.0
CEP68,ENSG00000011523,apolipoprotein A 1 measurement,EFO_0004614,0.42098008570991197,4.209837624208081,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,apolipoprotein A 1 measurement,EFO_0004614,0.42098008570991197,4.209837624208081,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,apolipoprotein A 1 measurement,EFO_0004614,0.42098008570991197,4.209837624208081,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,apolipoprotein A 1 measurement,EFO_0004614,0.42098008570991197,4.209837624208081,3,1.5,4.5,transcript,122392.0
PTPRJ,ENSG00000149177,free cholesterol to total lipids in medium HDL percentage ,EFO_0022282,0.420959356848652,4.209668756456445,2,0.8,1.6,transcript,21280.0
ADGRV1,ENSG00000164199,brain volume,OBA_2050009,0.42094955236762077,4.2094999488465765,1,0.5,0.5,transcript,112990.0
PRRG4,ENSG00000135378,platelet count,EFO_0004309,0.42092103754467575,4.209282538535338,1,0.4,0.4,transcript,5543.0
F13B,ENSG00000143278,total cholesterol measurement,EFO_0004574,0.42088881692975455,4.2089960674416975,1,0.5,0.5,transcript,4634.0
IYD,ENSG00000009765,platelet count,EFO_0004309,0.42086298186457316,4.2086472220568005,1,0.4,0.4,transcript,22984.0
GPR180,ENSG00000152749,lipid measurement,EFO_0004529,0.42085977597424584,4.208642784506078,1,0.4,0.4,transcript,8884.0
ID4,ENSG00000172201,smoking status measurement,EFO_0006527,0.4208430706944165,4.208843823391364,2,0.8,1.6,transcript,3873.0
PTPN4,ENSG00000088179,Neurodevelopmental disorder,EFO_0010642,0.42075896497822707,4.208053256643653,5,2.0,10.0,transcript,21570.0
TNFRSF11A,ENSG00000141655,Osteopetrosis,HP_0011002,0.4207448963448871,4.2075735546340445,2,0.8,1.6,transcript,12842.0
ANKRD36B,ENSG00000196912,calcium measurement,EFO_0004838,0.4206968155661026,4.206997694267986,1,0.5,0.5,transcript,16927.0
RFX3,ENSG00000080298,Neurodevelopmental disorder,EFO_0010642,0.420694801809011,4.207004519255446,2,0.8,1.6,transcript,28318.0
TMEM106B,ENSG00000106460,brain attribute,OBA_2045210,0.42067620393913524,4.2067949158785005,2,0.8,1.6,transcript,48667.0
PEAK1,ENSG00000173517,vitamin D measurement,EFO_0004631,0.42067559616289835,4.206762884080224,1,0.4,0.4,transcript,57783.0
TMEM170B,ENSG00000205269,erythrocyte volume,OBA_0003460,0.420652867844092,4.206573667755958,1,0.4,0.4,transcript,8891.0
PDE10A,ENSG00000112541,fetal genotype effect measurement,EFO_0007959,0.4206491261051149,4.2065109731450665,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
FUT2,ENSG00000176920,apolipoprotein B measurement,EFO_0004615,0.42053338364383336,4.2054568628890205,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
SYNE2,ENSG00000054654,blood sodium bicarbonate amount,OBA_2050094,0.42051265996653747,4.205139235181283,2,1.0,2.0,transcript,158284.0
ANOS1,ENSG00000011201,hypogonadotropic hypogonadism,MONDO_0018555,0.4204681743526539,4.204733250093626,1,0.4,0.4,transcript,7766.0
PLXND1,ENSG00000004399,cortical thickness,EFO_0004840,0.4204563038114284,4.204586719084256,1,0.5,0.5,transcript,21114.0
UMPS,ENSG00000114491,carpal tunnel syndrome,EFO_0004143,0.4203810524548865,4.20382938091053,1,0.4,0.4,transcript,21213.0
ASTN2,ENSG00000148219,glucose measurement,EFO_0004468,0.42034930233406304,4.203551777747212,2,0.8,1.6,transcript,27232.0
SNX13,ENSG00000071189,cholesterol:total lipids ratio,EFO_0020943,0.4203181075660249,4.203193400797366,1,0.4,0.4,transcript,32454.0
EPHA5,ENSG00000145242,mean corpuscular hemoglobin concentration,EFO_0004528,0.4203093753939927,4.2031044786630956,1,0.4,0.4,transcript,37297.0
WRN,ENSG00000165392,intelligence,EFO_0004337,0.42029841878583524,4.203011589623026,1,0.5,0.5,transcript,18247.0
RASA2,ENSG00000155903,monocyte percentage of leukocytes,EFO_0007989,0.42029509058270925,4.202998519206452,1,0.4,0.4,transcript,8401.0
SGCZ,ENSG00000185053,mathematical ability,EFO_0004875,0.4202635027612693,4.202683736818733,1,0.4,0.4,transcript,8212.0
CCBE1,ENSG00000183287,reticulocyte count,EFO_0007986,0.42026339985546474,4.20264778880494,1,0.4,0.4,transcript,29006.0
ITGA8,ENSG00000077943,heart rate,OBA_1001087,0.4202277826248135,4.202742582251233,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
MACF1,ENSG00000127603,body weight,EFO_0004338,0.420183385394141,4.2018391807937405,2,0.8,1.6,gene_variant,300365.0
C2CD4A,ENSG00000198535,insulin measurement,EFO_0004467,0.42017080492542164,4.201824159559006,1,0.4,0.4,transcript,3445.0
PTPRO,ENSG00000151490,hypertension,EFO_0000537,0.42016734651330234,4.201677913729491,1,0.4,0.4,transcript,89916.0
LYPLAL1,ENSG00000143353,cerebrospinal fluid composition attribute,OBA_2045291,0.4201208168852647,4.201235965161297,1,0.5,0.5,transcript,17988.0
ID4,ENSG00000172201,body height,OBA_VT0001253,0.4201159255046772,4.20157237149397,2,0.8,1.6,transcript,3873.0
TM9SF3,ENSG00000077147,neurodegenerative disease,EFO_0005772,0.42010662274005317,4.201091740858881,1,0.4,0.4,transcript,15678.0
STT3B,ENSG00000163527,platelet count,EFO_0004309,0.4200810852669145,4.2008305755624935,1,0.4,0.4,transcript,20281.0
CD2AP,ENSG00000198087,HbA1c measurement,EFO_0004541,0.42007618146066283,4.200813884380125,1,0.4,0.4,transcript,7682.0
KCNJ15,ENSG00000157551,appendicular lean mass,EFO_0004980,0.42007546429469683,4.200764476997368,1,0.4,0.4,transcript,40675.0
GRIA4,ENSG00000152578,Myopia,HP_0000545,0.4200653076085772,4.200662367607258,1,0.4,0.4,transcript,43050.0
CCDC77,ENSG00000120647,triglyceride measurement,EFO_0004530,0.4200543060869032,4.200571425639986,1,0.4,0.4,transcript,14102.0
MARCKS,ENSG00000277443,educational attainment,EFO_0011015,0.42002070803726244,4.200300190242271,1,0.4,0.4,transcript,4296.0
DUSP22,ENSG00000112679,blood protein measurement,EFO_0007937,0.41994889442979294,4.199512548688346,1,0.4,0.4,transcript,16946.0
TNFRSF19,ENSG00000127863,heel bone mineral density,EFO_0009270,0.4199457270504857,4.199490271626895,1,0.5,0.5,transcript,15151.0
PEX2,ENSG00000164751,snoring measurement,EFO_0008341,0.4199355076786886,4.199398902797623,1,0.4,0.4,transcript,9127.0
PALM2AKAP2,ENSG00000157654,myeloid leukocyte count,OBA_2045223,0.41988466876345554,4.198854674855003,1,0.4,0.4,transcript,50080.0
PLA2R1,ENSG00000153246,erythrocyte volume,OBA_0003460,0.41984921385414675,4.198571330780629,2,0.8,1.6,transcript,20204.0
ANKH,ENSG00000154122,chondrocalcinosis,MONDO_0001314,0.41978721187349455,4.198640561357896,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,chondrocalcinosis,MONDO_0001314,0.41978721187349455,4.198640561357896,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,chondrocalcinosis,MONDO_0001314,0.41978721187349455,4.198640561357896,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,chondrocalcinosis,MONDO_0001314,0.41978721187349455,4.198640561357896,5,2.4,12.0,gene_variant,15616.0
CADPS,ENSG00000163618,educational attainment,EFO_0011015,0.4197864814537779,4.197874132248417,1,0.4,0.4,transcript,42929.0
SLC22A5,ENSG00000197375,eosinophil percentage of leukocytes,EFO_0007991,0.41967838569345584,4.196789425871031,1,0.4,0.4,transcript,71827.0
TBX5,ENSG00000089225,QRS complex,EFO_0005054,0.4196773345677394,4.196898639334403,2,0.8,1.6,transcript,12770.0
DAG1,ENSG00000173402,reticulocyte measurement,EFO_0010700,0.4196402737926795,4.196408926045607,1,0.4,0.4,transcript,64640.0
RBM25,ENSG00000119707,erythrocyte volume,OBA_0003460,0.419638442530369,4.19639711525642,1,0.4,0.4,transcript,31521.0
DENND1B,ENSG00000213047,brain attribute,OBA_2045210,0.41963650116822254,4.196801769194455,5,2.0,10.0,transcript,22896.0
TTLL7,ENSG00000137941,body mass index,EFO_0004340,0.4194778099180953,4.1948070726159346,2,0.8,1.6,transcript,55223.0
BACE2,ENSG00000182240,Abnormality of movement,HP_0100022,0.4194771433680386,4.19490498960693,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
XKR4,ENSG00000206579,body mass index,EFO_0004340,0.4194585589519804,4.194604541476594,1,0.4,0.4,transcript,21106.0
DENND1B,ENSG00000213047,platelet count,EFO_0004309,0.41944474787659036,4.194884236278133,5,2.0,10.0,transcript,22896.0
CRYGD,ENSG00000118231,Developmental cataract,HP_0000519,0.41944307251128804,4.195053778072382,1,0.4,0.4,transcript,642.0
NBEAL1,ENSG00000144426,pulse pressure measurement,EFO_0005763,0.4194077795444834,4.194081649046506,1,0.4,0.4,transcript,103799.0
CYBRD1,ENSG00000071967,Abnormality of the skeletal system,HP_0000924,0.41937078701762953,4.193741979496667,1,0.4,0.4,transcript,11727.0
FRS2,ENSG00000166225,BMI-adjusted hip circumference,EFO_0008039,0.41934554793444123,4.19347158824055,1,0.4,0.4,transcript,24831.0
PAQR3,ENSG00000163291,reticulocyte count,EFO_0007986,0.41932764202752526,4.19329147201561,1,0.4,0.4,transcript,26575.0
SEMA3C,ENSG00000075223,cerebral cortex area attribute,OBA_2045267,0.41925241632651966,4.192557881548936,1,0.4,0.4,transcript,11863.0
PDE1A,ENSG00000115252,Abnormality of the skeletal system,HP_0000924,0.41925241632651966,4.192650714395368,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
PDE1A,ENSG00000115252,whole body water mass,EFO_0009805,0.41925241632651966,4.192650714395368,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
ADK,ENSG00000156110,serum creatinine amount,OBA_2050096,0.4192522500223751,4.192541483660702,1,0.4,0.4,transcript,21071.0
SP4,ENSG00000105866,chylomicron amount,OBA_2050296,0.41923895858210414,4.192413578143499,1,0.4,0.4,transcript,16672.0
CNTN5,ENSG00000149972,diet measurement,EFO_0008111,0.41917362901668026,4.191749270858024,1,0.4,0.4,transcript,30815.0
TMED5,ENSG00000117500,monocyte count,EFO_0005091,0.4191409497905745,4.191441465171265,1,0.5,0.5,transcript,15641.0
PLEC,ENSG00000178209,platelet volume,OBA_0003277,0.4191296647450504,4.191305711716148,2,0.9,1.8,transcript,198582.0
LTBP1,ENSG00000049323,osteoarthritis,MONDO_0005178,0.41908340646753495,4.190846724105042,1,0.4,0.4,transcript,31597.0
MYO3A,ENSG00000095777,Red cell distribution width,EFO_0009188,0.4190670573732072,4.190694289522045,1,0.5,0.5,transcript,21083.0
SLC35B4,ENSG00000205060,platelet component distribution width,EFO_0007984,0.41903066153074425,4.190348535240371,1,0.4,0.4,transcript,9542.0
QKI,ENSG00000112531,triglyceride measurement,EFO_0004530,0.4190192357726722,4.190227929882616,2,0.8,1.6,transcript,44979.0
LDLRAP1,ENSG00000157978,Crohn's disease,EFO_0000384,0.419016905590007,4.190194969349149,1,0.4,0.4,transcript,15436.0
TMEM17,ENSG00000186889,smoking cessation,EFO_0004319,0.41900273455642245,4.190091345564225,1,0.4,0.4,transcript,6250.0
AKR1C1,ENSG00000187134,sitting height measurement,EFO_0011011,0.4189948060854467,4.190087251807055,2,0.8,1.6,transcript,11495.0
CNTNAP2,ENSG00000174469,lymphocyte count,EFO_0004587,0.4189807013592636,4.189814695264167,1,0.4,0.4,transcript,52072.0
NHLH2,ENSG00000177551,hypogonadotropic hypogonadism,MONDO_0018555,0.4189592899443114,4.189630660228539,1,0.4,0.4,transcript,10593.0
TEX15,ENSG00000133863,azoospermia,EFO_0000279,0.41895624485629457,4.189577372154158,1,0.5,0.5,transcript,33504.0
SEMA6D,ENSG00000137872,neuroimaging measurement,EFO_0004346,0.4189364140793972,4.189373567641634,1,0.5,0.5,transcript,53040.0
KCNIP4,ENSG00000185774,lymphocyte count,EFO_0004587,0.4189109394193053,4.189242042178462,2,0.8,1.6,transcript,12062.0
REEP3,ENSG00000165476,body mass index,EFO_0004340,0.41889340588955876,4.189003842566208,1,0.4,0.4,transcript,5732.0
ITGB8,ENSG00000105855,body fat distribution,EFO_0004341,0.41886275109464766,4.188798038159778,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
LTBP1,ENSG00000049323,vital capacity,EFO_0004312,0.4188408375705306,4.188421035134999,1,0.4,0.4,transcript,31597.0
STXBP5,ENSG00000164506,monocyte count,EFO_0005091,0.41877127217215476,4.187726552130006,2,0.9,1.8,transcript,130148.0
FRS2,ENSG00000166225,hip geometry,EFO_0004685,0.41874925120157186,4.187508620911856,1,0.4,0.4,transcript,24831.0
CADPS,ENSG00000163618,fat pad mass,OBA_0004528,0.418705713023764,4.187066447948279,1,0.4,0.4,transcript,42929.0
PSD3,ENSG00000156011,HbA1c measurement,EFO_0004541,0.41869432471014956,4.186952690195054,1,0.4,0.4,transcript,42359.0
TBXT,ENSG00000164458,body mass index,EFO_0004340,0.41869308567722596,4.1873913325972785,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
PTPRO,ENSG00000151490,aortic measurement,EFO_0020865,0.41866158314548446,4.186620280051312,1,0.4,0.4,transcript,89916.0
PDCD5,ENSG00000105185,erythrocyte count,EFO_0004305,0.4186291954029207,4.186370063773398,1,0.4,0.4,transcript,5121.0
PTPRJ,ENSG00000149177,colon carcinoma,EFO_1001950,0.41859538291226034,4.186029017092528,2,0.8,1.6,transcript,21280.0
BTC,ENSG00000174808,asthma,MONDO_0004979,0.4184974239744308,4.1850963026066825,1,0.4,0.4,transcript,3277.0
TCERG1L,ENSG00000176769,neurodegenerative disease,EFO_0005772,0.41848807663222565,4.1851089465846645,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,neurodegenerative disease,EFO_0005772,0.41848807663222565,4.1851089465846645,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,neurodegenerative disease,EFO_0005772,0.41848807663222565,4.1851089465846645,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,neurodegenerative disease,EFO_0005772,0.41848807663222565,4.1851089465846645,2,0.8,1.6,transcript,7012.0
DCK,ENSG00000156136,vitamin D measurement,EFO_0004631,0.4184649342511688,4.184686328179742,1,0.4,0.4,transcript,10815.0
OTULIN,ENSG00000154124,Eczematoid dermatitis,HP_0000964,0.41841397339532077,4.184158968421374,1,0.4,0.4,transcript,20796.0
TRHDE,ENSG00000072657,smoking initiation,EFO_0005670,0.4183718522861954,4.183818093463733,2,0.8,1.6,transcript,16069.0
TSPAN19,ENSG00000231738,neuroimaging measurement,EFO_0004346,0.41836674788785827,4.1837166551756075,1,0.4,0.4,transcript,8134.0
RPAP3,ENSG00000005175,neurodegenerative disease,EFO_0005772,0.41836474639893834,4.1837958319419055,2,0.8,1.6,transcript,10784.0
RPS6KA5,ENSG00000100784,alcohol consumption quality,OBA_1000840,0.41832787294375473,4.183288594289081,1,0.4,0.4,transcript,40548.0
ATRNL1,ENSG00000107518,lymphocyte count,EFO_0004587,0.41827525523798165,4.1827694115216865,1,0.4,0.4,transcript,23726.0
LATS1,ENSG00000131023,brain attribute,OBA_2045210,0.4182677775376354,4.182695131967519,1,0.4,0.4,transcript,23046.0
PLCL1,ENSG00000115896,BMI-adjusted waist circumference,EFO_0007789,0.41821703431948626,4.182259853684373,2,0.8,1.6,transcript,17875.0
UBXN2A,ENSG00000173960,platelet volume,OBA_0003277,0.41818548260591315,4.182012043313725,2,0.8,1.6,transcript,10177.0
ATP9A,ENSG00000054793,Failure to thrive,HP_0001508,0.4181796055757401,4.1818214219822725,1,0.4,0.4,transcript,15769.0
FARSB,ENSG00000116120,interstitial lung disease,EFO_0004244,0.41814938870959445,4.181544907504108,1,0.4,0.4,transcript,7840.0
AKAP6,ENSG00000151320,PR interval,EFO_0004462,0.41812712051311907,4.181845985189842,7,2.8000000000000003,19.6,transcript,34100.0
AKAP6,ENSG00000151320,atrial flutter,EFO_0003911,0.41807219227426146,4.181296702801266,7,2.8000000000000003,19.6,transcript,34100.0
LUZP2,ENSG00000187398,smoking initiation,EFO_0005670,0.4180054009099809,4.180370789124034,4,1.7000000000000002,6.800000000000001,transcript,21466.0
SLC30A8,ENSG00000164756,diabetic eye disease,EFO_0009486,0.41794894017757894,4.179799569460194,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,diabetic eye disease,EFO_0009486,0.41794894017757894,4.179799569460194,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,diabetic eye disease,EFO_0009486,0.41794894017757894,4.179799569460194,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,diabetic eye disease,EFO_0009486,0.41794894017757894,4.179799569460194,4,1.6,6.4,transcript,20634.0
ENPEP,ENSG00000138792,diastolic blood pressure change measurement,EFO_0006945,0.41790222519653736,4.179064651795774,1,0.4,0.4,transcript,9434.0
PCDH18,ENSG00000189184,Increased blood pressure,HP_0032263,0.4178833768275103,4.178910939933812,2,0.8,1.6,transcript,20733.0
ESF1,ENSG00000089048,neurodegenerative disease,EFO_0005772,0.4178615010270648,4.178677471232547,1,0.4,0.4,transcript,6404.0
LTBP1,ENSG00000049323,5-methyluridine (ribothymidine) measurement,EFO_0020013,0.4178248791439797,4.17826145086949,1,0.4,0.4,transcript,31597.0
UBXN2A,ENSG00000173960,forced expiratory volume,EFO_0004314,0.41773115488684637,4.177468766123058,2,0.8,1.6,transcript,10177.0
TSPAN9,ENSG00000011105,aspartate aminotransferase measurement,EFO_0004736,0.4176774961851843,4.176810445493883,1,0.5,0.5,transcript,14091.0
SEMA6D,ENSG00000137872,neuroticism measurement,EFO_0007660,0.4175772615378271,4.175782042225934,1,0.5,0.5,transcript,53040.0
PARP1,ENSG00000143799,taste liking measurement,EFO_0010155,0.4175630336067023,4.1756362056450005,1,0.5,0.5,transcript,85185.0
CD2AP,ENSG00000198087,dementia,MONDO_0001627,0.41755715921906517,4.175623661964148,1,0.4,0.4,transcript,7682.0
BICC1,ENSG00000122870,Calcium channel blocker use measurement,EFO_0009930,0.41752889115280584,4.175337005792818,1,0.4,0.4,transcript,8317.0
DMRTA1,ENSG00000176399,lymphoid leukemia,EFO_0004289,0.41752389761364267,4.175310583726832,1,0.4,0.4,transcript,5586.0
LINGO2,ENSG00000174482,revision of total knee arthroplasty,EFO_0020972,0.41751616769018435,4.1751733957662855,1,0.4,0.4,transcript,34133.0
PRTG,ENSG00000166450,self reported educational attainment,EFO_0004784,0.41751465890270717,4.1753646651113945,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
HFE,ENSG00000010704,cystic fibrosis,MONDO_0009061,0.4175111095066514,4.175119380242263,1,0.4,0.4,transcript,48279.0
RGS7BP,ENSG00000186479,chronotype measurement,EFO_0008328,0.41750729292609545,4.175161050515801,1,0.5,0.5,transcript,5674.0
LRRK2,ENSG00000188906,genetic disorder,EFO_0000508,0.4174992454233494,4.175011212049251,2,0.9,1.8,transcript,95960.0
SFRP1,ENSG00000104332,corneal resistance factor,EFO_0010067,0.4174829010754691,4.17487698964398,1,0.4,0.4,transcript,8337.0
C2orf73,ENSG00000177994,brain attribute,OBA_2045210,0.4174696808182252,4.174745117360996,1,0.4,0.4,transcript,8280.0
FRMD4B,ENSG00000114541,white matter microstructure measurement,EFO_0005674,0.41740146537045075,4.174090749966278,2,0.8,1.6,transcript,21026.0
OR5A1,ENSG00000172320,vitamin B deficiency,MONDO_0042976,0.41735730068168975,4.173619453635291,1,0.4,0.4,transcript,8612.0
ZNF507,ENSG00000168813,hemoglobin measurement,EFO_0004509,0.4171367308136085,4.171381706984178,1,0.4,0.4,transcript,27780.0
BICC1,ENSG00000122870,erythrocyte volume,OBA_0003460,0.41711876581690427,4.171235752433802,1,0.4,0.4,transcript,8317.0
CD86,ENSG00000114013,non-Hodgkins lymphoma,EFO_0005952,0.4171106748586588,4.171138583047392,1,0.4,0.4,transcript,12565.0
CCDC77,ENSG00000120647,monocyte count,EFO_0005091,0.41702902608796594,4.170318625650614,1,0.4,0.4,transcript,14102.0
ITGB8,ENSG00000105855,childhood onset asthma,MONDO_0005405,0.41700823450920266,4.170252872305328,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
SKIL,ENSG00000136603,prostate specific antigen amount,OBA_2050200,0.4170009842611692,4.170026302433268,1,0.5,0.5,transcript,30377.0
TSPAN9,ENSG00000011105,whole body water mass,EFO_0009805,0.41694628548906487,4.169498338532689,1,0.5,0.5,transcript,14091.0
FRAS1,ENSG00000138759,genetic disorder,EFO_0000508,0.41691008559242526,4.16913299246886,2,0.9,1.8,transcript,56011.0
RASEF,ENSG00000165105,erythrocyte volume,OBA_0003460,0.4168832238120716,4.168886659889424,1,0.4,0.4,transcript,7350.0
SPAST,ENSG00000021574,metabolite ratio,EFO_0022223,0.4168200129107465,4.168205305425809,1,0.4,0.4,transcript,77275.0
PDE10A,ENSG00000112541,aspartate aminotransferase measurement,EFO_0004736,0.41679718812485994,4.167991593342516,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
FARSB,ENSG00000116120,Microcephaly,HP_0000252,0.4167936811206724,4.167987831614887,1,0.4,0.4,transcript,7840.0
GALR1,ENSG00000166573,appendicular lean mass,EFO_0004980,0.4167900602487234,4.168045215647031,2,0.8,1.6,transcript,11064.0
BMERB1,ENSG00000166780,docosahexaenoic acid measurement,EFO_0007761,0.4167521202167814,4.167557476766526,1,0.4,0.4,transcript,11027.0
AKAP11,ENSG00000023516,alcohol consumption quality,OBA_1000840,0.4167092896507299,4.167492896507299,1,0.4,0.4,transcript,1000.0
VPS13A,ENSG00000197969,genetic disorder,EFO_0000508,0.4166903029456066,4.166909774704881,1,0.4,0.4,transcript,59301.0
DLG2,ENSG00000150672,bone tissue density,OBA_1000110,0.416544201553917,4.165444788464329,1,0.4,0.4,transcript,144252.0
ZNF398,ENSG00000197024,neutrophil count,EFO_0004833,0.41654175887679806,4.1654430827131685,1,0.4,0.4,transcript,15690.0
AOX1,ENSG00000138356,Hydantoin-5-propionic acid measurement,EFO_0022099,0.4165181026108394,4.1652091278366505,1,0.4,0.4,transcript,14234.0
PRTG,ENSG00000166450,Red cell distribution width,EFO_0009188,0.4165149613558111,4.1653676896424345,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
PLXND1,ENSG00000004399,body weight,EFO_0004338,0.41649923350666246,4.165016016036597,1,0.5,0.5,transcript,21114.0
STXBP5,ENSG00000164506,circulating fibrinogen levels,OBA_0000061,0.41648487928722366,4.164862623280695,2,0.9,1.8,transcript,130148.0
PCDH10,ENSG00000138650,mathematical ability,EFO_0004875,0.41645863293437835,4.164700192139115,2,0.8,1.6,transcript,14052.0
LRP2,ENSG00000081479,genetic disorder,EFO_0000508,0.41645223918114094,4.164538980511187,1,0.5,0.5,transcript,30141.0
BPTF,ENSG00000171634,glucose measurement,EFO_0004468,0.41638596989301707,4.163879323126806,2,0.8,1.6,transcript,81532.0
DYNC2H1,ENSG00000187240,short-rib thoracic dysplasia 6 with or without polydactyly,MONDO_0009894,0.41633170630231653,4.163327219431859,1,0.5,0.5,transcript,49230.0
DGKH,ENSG00000102780,IGF-1 measurement,EFO_0004627,0.4162956210548739,4.162983603587483,2,0.8,1.6,transcript,58409.0
CLSTN2,ENSG00000158258,protein measurement,EFO_0004747,0.41622674361310474,4.162291522359746,1,0.4,0.4,transcript,16607.0
IMPG2,ENSG00000081148,Posterior column ataxia - retinitis pigmentosa,Orphanet_88628,0.416176359737623,4.161979114617609,2,0.9,1.8,transcript,8352.0
PTBP3,ENSG00000119314,hematocrit,EFO_0004348,0.41611658704844734,4.161399308086603,5,2.0,10.0,transcript,42838.0
ARMC1,ENSG00000104442,cognitive function measurement,EFO_0008354,0.41609459148253625,4.160990463216051,1,0.4,0.4,transcript,8979.0
ID4,ENSG00000172201,FEV/FVC ratio,EFO_0004713,0.41606918389500225,4.161104955397221,2,0.8,1.6,transcript,3873.0
TNFRSF11A,ENSG00000141655,hypothyroidism,EFO_0004705,0.4160523919864431,4.1606485110496045,2,0.8,1.6,transcript,12842.0
TMEM132B,ENSG00000139364,brain volume,OBA_2050009,0.4160453958294111,4.160543321580694,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
STAU2,ENSG00000040341,body mass index,EFO_0004340,0.41599254175578315,4.159936985740701,1,0.5,0.5,transcript,43222.0
SYNE2,ENSG00000054654,PR interval,EFO_0004462,0.41599081817611533,4.159920817277062,2,1.0,2.0,transcript,158284.0
FAT1,ENSG00000083857,genetic disorder,EFO_0000508,0.4159893622170605,4.159914817592394,1,0.5,0.5,transcript,23590.0
NDUFS4,ENSG00000164258,metabolic syndrome,EFO_0000195,0.4159608959683119,4.1597155410846645,1,0.4,0.4,transcript,3753.0
HNRNPA0,ENSG00000177733,potassium measurement,EFO_0009283,0.41591142502655676,4.159137204471925,1,0.4,0.4,transcript,17426.0
KITLG,ENSG00000049130,myeloid leukocyte count,OBA_2045223,0.4158993732970734,4.159163088947588,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
PARP1,ENSG00000143799,prostate cancer,MONDO_0008315,0.41584987064942025,4.15850457607218,1,0.5,0.5,transcript,85185.0
ID4,ENSG00000172201,asthma,MONDO_0004979,0.4158380830390617,4.1587939468378154,2,0.8,1.6,transcript,3873.0
LIN54,ENSG00000189308,platelet volume,OBA_0003277,0.4158270975216815,4.158283901793857,1,0.4,0.4,transcript,30944.0
ATP9A,ENSG00000054793,Secondary microcephaly,HP_0005484,0.4157773365202895,4.157798731427766,1,0.4,0.4,transcript,15769.0
FARSB,ENSG00000116120,microcephaly,MONDO_0001149,0.4157773365202895,4.1578243856110575,1,0.4,0.4,transcript,7840.0
SLC6A5,ENSG00000165970,Exaggerated startle response,HP_0002267,0.4157773365202895,4.157812001347007,1,0.4,0.4,transcript,10353.0
ATF6,ENSG00000118217,Sensorineural hearing impairment,HP_0000407,0.4157773365202895,4.157779717635876,1,0.4,0.4,transcript,62968.0
GJB2,ENSG00000165474,autism spectrum disorder,EFO_0003756,0.4157773365202895,4.1578601707584495,1,0.4,0.4,transcript,4608.0
FARSB,ENSG00000116120,Intellectual disability,HP_0001249,0.4157773365202895,4.1578243856110575,1,0.4,0.4,transcript,7840.0
ZNF429,ENSG00000197013,hepatocellular carcinoma,EFO_0000182,0.4157773365202895,4.15792917394766,2,0.8,1.6,transcript,10269.0
ARFIP1,ENSG00000164144,reticulocyte measurement,EFO_0010700,0.4157750010108562,4.157777062725903,1,0.4,0.4,transcript,14786.0
PICALM,ENSG00000073921,mean corpuscular hemoglobin concentration,EFO_0004528,0.41575227406576226,4.157536008976195,1,0.4,0.4,transcript,30147.0
NEDD1,ENSG00000139350,response to antihypertensive drug,EFO_0005405,0.415741135824313,4.157430614934831,1,0.4,0.4,transcript,20772.0
MACF1,ENSG00000127603,free cholesterol:total lipids ratio,EFO_0020945,0.41567405192992585,4.156745846151589,2,0.8,1.6,gene_variant,300365.0
PLCL1,ENSG00000115896,Abnormality of the skeletal system,HP_0000924,0.41564028056690705,4.156492316158581,2,0.8,1.6,transcript,17875.0
TMEM68,ENSG00000167904,neurodegenerative disease,EFO_0005772,0.4156108215045999,4.156126886567261,1,0.4,0.4,transcript,21423.0
FAT4,ENSG00000196159,colorectal adenocarcinoma,EFO_0000365,0.4156058766845054,4.156067476887733,1,0.4,0.4,transcript,45924.0
AKR1B10,ENSG00000198074,metabolite measurement,EFO_0004725,0.41557577675429275,4.155889902849482,1,0.5,0.5,transcript,3784.0
PLPP4,ENSG00000203805,behavior,GO_0007610,0.4155646367689545,4.15572725747721,1,0.4,0.4,transcript,4945.0
MTR,ENSG00000116984,disorders of vitamin D metabolism,MONDO_0017322,0.41555938121862207,4.1555982246160355,1,0.4,0.4,transcript,90653.0
ANKH,ENSG00000154122,serum creatinine amount,OBA_2050096,0.41553476610612705,4.156116103684221,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,serum creatinine amount,OBA_2050096,0.41553476610612705,4.156116103684221,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,serum creatinine amount,OBA_2050096,0.41553476610612705,4.156116103684221,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,serum creatinine amount,OBA_2050096,0.41553476610612705,4.156116103684221,5,2.4,12.0,gene_variant,15616.0
PALM2AKAP2,ENSG00000157654,reticulocyte count,EFO_0007986,0.4154988931159606,4.1549969183800535,1,0.4,0.4,transcript,50080.0
TNFRSF11A,ENSG00000141655,myxedema,EFO_1001055,0.4154980222044161,4.155104813229334,2,0.8,1.6,transcript,12842.0
MLLT3,ENSG00000171843,gout,EFO_0004274,0.41546493327780937,4.154752571905723,2,0.8,1.6,transcript,15498.0
TNFRSF11A,ENSG00000141655,atopic eczema,EFO_0000274,0.4154327103560314,4.154451694745488,2,0.8,1.6,transcript,12842.0
TMEM106B,ENSG00000106460,insomnia,EFO_0004698,0.4154249899001918,4.154282775489065,2,0.8,1.6,transcript,48667.0
BCKDHB,ENSG00000083123,sexual dimorphism measurement,EFO_0021796,0.4154054371297003,4.159781748158401,10,4.0,40.0,transcript,6984.0
FYCO1,ENSG00000163820,genetic disorder,EFO_0000508,0.41534813004078996,4.153505911248975,1,0.4,0.4,transcript,16253.0
ONECUT1,ENSG00000169856,free androgen index,EFO_0007005,0.41533152949406466,4.153368142080295,1,0.4,0.4,transcript,7569.0
LUZP2,ENSG00000187398,pernicious anemia,EFO_0005576,0.41531460067730747,4.1534627867972995,4,1.7000000000000002,6.800000000000001,transcript,21466.0
KCNIP4,ENSG00000185774,triglyceride measurement,EFO_0004530,0.41530712472311665,4.153203895216576,2,0.8,1.6,transcript,12062.0
FRS2,ENSG00000166225,hematocrit,EFO_0004348,0.4152755469844338,4.152771578740476,1,0.4,0.4,transcript,24831.0
DPP8,ENSG00000074603,erythrocyte count,EFO_0004305,0.41524510545008136,4.152632774595081,4,1.6,6.4,transcript,35219.0
PTPRO,ENSG00000151490,neurodegenerative disease,EFO_0005772,0.41523906878213307,4.152395136417799,1,0.4,0.4,transcript,89916.0
SLCO1C1,ENSG00000139155,BMI-adjusted waist circumference,EFO_0007789,0.41521970639425554,4.15222795483592,1,0.5,0.5,transcript,16186.0
EPRS1,ENSG00000136628,genetic disorder,EFO_0000508,0.4151915763805109,4.1519604785251945,1,0.5,0.5,transcript,11182.0
SLC6A5,ENSG00000165970,genetic disorder,EFO_0000508,0.41514266197852023,4.151465255929315,1,0.4,0.4,transcript,10353.0
TET1,ENSG00000138336,glomerular filtration rate,OBA_0003747,0.41504595389301197,4.150501153578476,1,0.4,0.4,transcript,9612.0
ATAD2B,ENSG00000119778,forced expiratory volume,EFO_0004314,0.41503332696399353,4.150351447326824,1,0.4,0.4,transcript,22005.0
IGFBPL1,ENSG00000137142,level of insulin-like growth factor-binding protein-like 1 in blood serum,OBA_2041991,0.41501386772897886,4.151933405276329,4,1.6,6.4,transcript,3566.0
MFAP3,ENSG00000037749,triglyceride measurement,EFO_0004530,0.41500782519328533,4.150090841634477,1,0.4,0.4,transcript,31772.0
TENM4,ENSG00000149256,metabolite measurement,EFO_0004725,0.4150011827419886,4.150029277904137,1,0.4,0.4,transcript,22922.0
MTR,ENSG00000116984,genetic disorder,EFO_0000508,0.414960684950817,4.149611261937984,1,0.4,0.4,transcript,90653.0
ARHGAP28,ENSG00000088756,glomerular filtration rate,OBA_0003747,0.41494777023285717,4.149490003964689,1,0.4,0.4,transcript,32516.0
SEMA6D,ENSG00000137872,risk-taking behaviour,EFO_0008579,0.4149380994143528,4.14939042099119,1,0.5,0.5,transcript,53040.0
SPART,ENSG00000133104,genetic disorder,EFO_0000508,0.41491341906351165,4.149148455970352,1,0.4,0.4,transcript,28040.0
PCDH18,ENSG00000189184,diastolic blood pressure change measurement,EFO_0006945,0.41488022471564,4.148879418815109,2,0.8,1.6,transcript,20733.0
DCLK1,ENSG00000133083,cerebral cortex area attribute,OBA_2045267,0.4148676287996658,4.148726485649918,2,0.8,1.6,transcript,31874.0
WWTR1,ENSG00000018408,high density lipoprotein cholesterol measurement,EFO_0004612,0.41478565186344285,4.147941354265393,2,0.8,1.6,transcript,18860.0
CEP68,ENSG00000011523,testosterone measurement,EFO_0004908,0.41477160056284773,4.147752772737438,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,testosterone measurement,EFO_0004908,0.41477160056284773,4.147752772737438,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,testosterone measurement,EFO_0004908,0.41477160056284773,4.147752772737438,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,testosterone measurement,EFO_0004908,0.41477160056284773,4.147752772737438,3,1.5,4.5,transcript,122392.0
BPTF,ENSG00000171634,syndromic intellectual disability,MONDO_0000508,0.41474020829089026,4.147421707105537,2,0.8,1.6,transcript,81532.0
ZNF682,ENSG00000197124,apolipoprotein B measurement,EFO_0004615,0.4146883532829605,4.146909506855579,1,0.5,0.5,transcript,19250.0
LINGO2,ENSG00000174482,glucose measurement,EFO_0004468,0.4146767925286265,4.146779644150707,1,0.4,0.4,transcript,34133.0
PHIP,ENSG00000146247,diastolic blood pressure change measurement,EFO_0006945,0.41466977253621906,4.146705702515623,1,0.5,0.5,transcript,62679.0
SUMF1,ENSG00000144455,heel bone mineral density,EFO_0009270,0.4146246328561399,4.14627867793463,1,0.4,0.4,transcript,12365.0
PLCL1,ENSG00000115896,neuroimaging measurement,EFO_0004346,0.4146054176951815,4.1461436874413256,2,0.8,1.6,transcript,17875.0
SMARCC1,ENSG00000173473,genetic disorder,EFO_0000508,0.4145650042409364,4.1457641895164485,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,genetic disorder,EFO_0000508,0.4145650042409364,4.1457641895164485,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,genetic disorder,EFO_0000508,0.4145650042409364,4.1457641895164485,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,genetic disorder,EFO_0000508,0.4145650042409364,4.1457641895164485,2,0.8,1.6,transcript,14017.0
ZNF148,ENSG00000163848,glomerular filtration rate,OBA_0003747,0.4145446893269692,4.145458761649361,1,0.4,0.4,transcript,33703.0
ANOS1,ENSG00000011201,genetic disorder,EFO_0000508,0.4145285203420858,4.145336709987945,1,0.4,0.4,transcript,7766.0
NEDD4,ENSG00000069869,lymphocyte count,EFO_0004587,0.4145149882200627,4.145158192162194,1,0.4,0.4,transcript,48135.0
TRMT9B,ENSG00000250305,metabolite measurement,EFO_0004725,0.4145070846674465,4.145211973335644,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
NEDD4,ENSG00000069869,neutrophil count,EFO_0004833,0.41449529984935396,4.144961308455106,1,0.4,0.4,transcript,48135.0
TRDMT1,ENSG00000107614,deficiency anemia,MONDO_0001639,0.41448634817622465,4.14487727343897,1,0.4,0.4,transcript,29003.0
ITGB8,ENSG00000105855,forced expiratory volume,EFO_0004314,0.41437332344837857,4.143903761697087,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
IL17A,ENSG00000112115,rheumatoid arthritis,EFO_0000685,0.41435375848492506,4.143751374266674,1,0.4,0.4,transcript,1871.0
SHH,ENSG00000164690,genetic disorder,EFO_0000508,0.4143446613901849,4.143499762985027,1,0.4,0.4,transcript,7526.0
ZNF236,ENSG00000130856,prostate carcinoma,EFO_0001663,0.41431423220809616,4.14320129013993,2,0.9,1.8,transcript,30525.0
PTPN4,ENSG00000088179,genetic disorder,EFO_0000508,0.4143140635765389,4.14360424262677,5,2.0,10.0,transcript,21570.0
CNTNAP2,ENSG00000174469,family history of Alzheimerâs disease,EFO_0009268,0.4142962241188602,4.142969922860134,1,0.4,0.4,transcript,52072.0
G3BP2,ENSG00000138757,total cholesterol measurement,EFO_0004574,0.41429110796232066,4.142912832863414,1,0.4,0.4,transcript,228149.0
CTBP2,ENSG00000175029,age at menarche,EFO_0004703,0.41423481999071,4.142362263121248,1,0.4,0.4,transcript,28443.0
DUSP22,ENSG00000112679,level of serum globulin type protein,OBA_2045206,0.4141758577542278,4.141782181932695,1,0.4,0.4,transcript,16946.0
FAT1,ENSG00000083857,hemoglobin measurement,EFO_0004509,0.41413821378618826,4.141403333283672,1,0.5,0.5,transcript,23590.0
FRRS1L,ENSG00000260230,genetic disorder,EFO_0000508,0.41403697298420095,4.140455635882278,2,0.8,1.6,transcript,18625.0
ELAPOR1,ENSG00000116299,total cholesterol measurement,EFO_0004574,0.41402690603654607,4.14028215365515,1,0.4,0.4,transcript,30550.0
KCNJ15,ENSG00000157551,whole body water mass,EFO_0009805,0.41401753401961416,4.140185174246541,1,0.4,0.4,transcript,40675.0
IL4R,ENSG00000077238,adult onset asthma,EFO_1002011,0.4140138996278583,4.140157560347826,1,0.4,0.4,transcript,21547.0
FAT4,ENSG00000196159,Genu varum,HP_0002970,0.4140050759450431,4.14005946949311,1,0.4,0.4,transcript,45924.0
FAT4,ENSG00000196159,Genu valgum,HP_0002857,0.4140050759450431,4.14005946949311,1,0.4,0.4,transcript,45924.0
SGCD,ENSG00000170624,lymphocyte count,EFO_0004587,0.4140050759450431,4.140069548496418,1,0.4,0.4,transcript,21289.0
LMO4,ENSG00000143013,erythrocyte volume,OBA_0003460,0.41400042838216544,4.140055763873135,1,0.4,0.4,transcript,7770.0
MDM4,ENSG00000198625,prostate cancer,MONDO_0008315,0.4139602535624622,4.1396084064948315,1,0.4,0.4,transcript,68133.0
ALPK3,ENSG00000136383,left ventricular structural measurement,EFO_0008205,0.4139302612340981,4.139339908378277,1,0.4,0.4,transcript,10725.0
FAM76B,ENSG00000077458,total cholesterol measurement,EFO_0004574,0.4138935159505079,4.1389568550086855,1,0.4,0.4,transcript,18437.0
PPA2,ENSG00000138777,prostate carcinoma,EFO_0001663,0.4138646402019824,4.1386738082903785,1,0.5,0.5,transcript,18244.0
ARHGAP29,ENSG00000137962,diastolic blood pressure,EFO_0006336,0.4138634538363326,4.13865476408235,1,0.5,0.5,transcript,24721.0
TMEM106B,ENSG00000106460,cortical thickness,EFO_0004840,0.41384593666365693,4.138492243123717,2,0.8,1.6,transcript,48667.0
BCKDHB,ENSG00000083123,waist-hip ratio,EFO_0004343,0.4138346775063688,4.144074151925086,10,4.0,40.0,transcript,6984.0
BICC1,ENSG00000122870,Abnormality of refraction,HP_0000539,0.4137899644058122,4.1379477383228815,1,0.4,0.4,transcript,8317.0
PDE1A,ENSG00000115252,blood urea nitrogen measurement,EFO_0004741,0.41375557804855256,4.137682331615697,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
DENND1B,ENSG00000213047,lymphocyte percentage of leukocytes,EFO_0007993,0.41373875579087444,4.137824315420974,5,2.0,10.0,transcript,22896.0
PTPRO,ENSG00000151490,educational attainment,EFO_0011015,0.41370166235444766,4.137021072140945,1,0.4,0.4,transcript,89916.0
FMN1,ENSG00000248905,red blood cell density,OBA_2045260,0.41369660828817945,4.137001780434281,2,0.8,1.6,transcript,44821.0
PEX2,ENSG00000164751,genetic disorder,EFO_0000508,0.41367583292196364,4.136802155230374,1,0.4,0.4,transcript,9127.0
DNAJC21,ENSG00000168724,genetic disorder,EFO_0000508,0.41363989912162913,4.1364080142475785,1,0.4,0.4,transcript,44331.0
PDE10A,ENSG00000112541,chloride measurement,EFO_0009284,0.4136358476163234,4.136378188257151,3,1.2000000000000002,3.6000000000000005,transcript,182629.0
ZNF682,ENSG00000197124,phospholipids:total lipids ratio,EFO_0020946,0.4136173076260703,4.136199050286677,1,0.5,0.5,transcript,19250.0
AKAP11,ENSG00000023516,osteoporosis,EFO_0003882,0.4136129702223152,4.136529702223152,1,0.4,0.4,transcript,1000.0
NID2,ENSG00000087303,eosinophil count,EFO_0004842,0.4135767874909735,4.135813009410548,1,0.5,0.5,transcript,11078.0
CERKL,ENSG00000188452,Posterior column ataxia - retinitis pigmentosa,Orphanet_88628,0.4135730336263429,4.1357504101352776,1,0.5,0.5,transcript,24908.0
FAM76B,ENSG00000077458,lymphocyte measurement,EFO_0803546,0.4135628245779654,4.135649941283261,1,0.4,0.4,transcript,18437.0
TOPAZ1,ENSG00000173769,body fat percentage,EFO_0007800,0.4135174453585044,4.135268191867758,1,0.5,0.5,transcript,5334.0
CDH23,ENSG00000107736,neutrophil count,EFO_0004833,0.41349929400660557,4.135000490769026,1,0.5,0.5,transcript,66219.0
TLR10,ENSG00000174123,lymphocyte count,EFO_0004587,0.41345709895365595,4.134732431753699,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
PARP1,ENSG00000143799,non-small cell lung carcinoma,EFO_0003060,0.4134425806226718,4.134431675804695,1,0.5,0.5,transcript,85185.0
PTPRJ,ENSG00000149177,mean corpuscular hemoglobin concentration,EFO_0004528,0.4133749258244582,4.133824446214507,2,0.8,1.6,transcript,21280.0
LRRC7,ENSG00000033122,body mass index,EFO_0004340,0.4133726842011889,4.133790945717439,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
CTBP2,ENSG00000175029,erythrocyte count,EFO_0004305,0.4133630370582578,4.133644433796726,1,0.4,0.4,transcript,28443.0
SEMA6D,ENSG00000137872,cognitive function measurement,EFO_0008354,0.41332497974548604,4.133259224302523,1,0.5,0.5,transcript,53040.0
GABRG1,ENSG00000163285,schizophrenia,MONDO_0005090,0.4133195444063962,4.135326251995302,6,2.4000000000000004,14.400000000000002,transcript,6758.0
PLCL1,ENSG00000115896,Crohn's disease,EFO_0000384,0.4133143224706129,4.133232735195639,2,0.8,1.6,transcript,17875.0
PICALM,ENSG00000073921,reticulocyte measurement,EFO_0010700,0.4132612275257277,4.132625543575849,1,0.4,0.4,transcript,30147.0
PARP1,ENSG00000143799,breast carcinoma,EFO_0000305,0.4132526759664373,4.13253262924235,1,0.5,0.5,transcript,85185.0
TNRC6B,ENSG00000100354,level of neuronal pentraxin receptor in blood serum,OBA_2042624,0.41322318179386924,4.1322382697597195,1,0.4,0.4,transcript,61998.0
GPR180,ENSG00000152749,free cholesterol in small LDL measurement ,EFO_0022271,0.4132205589413919,4.132250614177539,1,0.4,0.4,transcript,8884.0
MAN1A2,ENSG00000198162,neutrophil count,EFO_0004833,0.41318370458998377,4.131964566422671,2,0.8,1.6,transcript,12547.0
ZNF257,ENSG00000197134,uterine fibroid,EFO_0000731,0.41315386712754576,4.131566253677884,1,0.4,0.4,transcript,14502.0
LRPAP1,ENSG00000163956,total lipids in LDL measurement ,EFO_0022308,0.41313986963758503,4.1316293325472895,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
REEP3,ENSG00000165476,calcium measurement,EFO_0004838,0.41313498358487744,4.131419619519395,1,0.4,0.4,transcript,5732.0
PLXND1,ENSG00000004399,BMI-adjusted waist circumference,EFO_0007789,0.41310726294027333,4.131096310372706,1,0.5,0.5,transcript,21114.0
RASSF2,ENSG00000101265,erythrocyte volume,OBA_0003460,0.4130431963852592,4.130532763953393,2,0.8,1.6,transcript,15873.0
GPD2,ENSG00000115159,erythrocyte volume,OBA_0003460,0.41297516320512995,4.129769298335196,1,0.4,0.4,transcript,22642.0
PEAK1,ENSG00000173517,glomerular filtration rate,OBA_0003747,0.41294990555533495,4.129505978004589,1,0.4,0.4,transcript,57783.0
CAV2,ENSG00000105971,lymphocyte count,EFO_0004587,0.4129062321179448,4.129086494745653,1,0.4,0.4,transcript,16547.0
C2orf73,ENSG00000177994,cystatin C measurement,EFO_0004617,0.4128749375376056,4.1287976845548,1,0.4,0.4,transcript,8280.0
AKAP10,ENSG00000108599,physical activity measurement,EFO_0008002,0.41282789124008473,4.128314092699879,1,0.4,0.4,transcript,11370.0
SLC30A9,ENSG00000014824,neurodegenerative disease,EFO_0005772,0.4128276559866955,4.128628323193373,3,1.3,3.9000000000000004,transcript,11087.0
IQCB1,ENSG00000173226,genetic disorder,EFO_0000508,0.41277502919501763,4.127791910928431,1,0.4,0.4,transcript,9611.0
NDFIP2,ENSG00000102471,alcohol consumption quality,OBA_1000840,0.41276330370178704,4.127647518883859,2,0.8,1.6,transcript,110483.0
ASPM,ENSG00000066279,retinopathy,EFO_0003839,0.4127370731836098,4.127405730183399,2,0.9,1.8,transcript,51431.0
SGCD,ENSG00000170624,platelet count,EFO_0004309,0.41273253359532125,4.127344124999199,1,0.4,0.4,transcript,21289.0
KCNN3,ENSG00000143603,atrial flutter,EFO_0003911,0.41266016333425715,4.126720669152511,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
CAVIN2,ENSG00000168497,QT interval,EFO_0004682,0.4126538763322858,4.12666973909234,1,0.4,0.4,transcript,3054.0
HEG1,ENSG00000173706,reticulocyte measurement,EFO_0010700,0.41262022725930764,4.126224138880727,1,0.4,0.4,transcript,18293.0
ANKRD36,ENSG00000135976,alcohol consumption quality,OBA_1000840,0.41261820470286126,4.126257433383682,2,1.0,2.0,transcript,26530.0
PTPRJ,ENSG00000149177,prothrombin time measurement,EFO_0008390,0.4125967511524076,4.126042699494001,2,0.8,1.6,transcript,21280.0
LYPLAL1,ENSG00000143353,glaucoma,MONDO_0005041,0.41259456622057045,4.125973458514355,1,0.5,0.5,transcript,17988.0
EPHA5,ENSG00000145242,risk-taking behaviour,EFO_0008579,0.4125648828570405,4.125659553293573,1,0.4,0.4,transcript,37297.0
QKI,ENSG00000112531,smoking initiation,EFO_0005670,0.4125608461371612,4.125644033527506,2,0.8,1.6,transcript,44979.0
GFRAL,ENSG00000187871,HbA1c measurement,EFO_0004541,0.4124500375317825,4.124709689812854,1,0.4,0.4,transcript,1911.0
DUSP22,ENSG00000112679,inflammatory bowel disease,EFO_0003767,0.412437070026341,4.124394304653826,1,0.4,0.4,transcript,16946.0
ARFIP1,ENSG00000164144,reticulocyte count,EFO_0007986,0.41243642315889556,4.124391284206297,1,0.4,0.4,transcript,14786.0
TBL2,ENSG00000106638,triglycerides in medium HDL measurement ,EFO_0022321,0.41242803428239677,4.124295521361516,1,0.4,0.4,transcript,26353.0
LRBA,ENSG00000198589,blood urea nitrogen measurement,EFO_0004741,0.4124219121640434,4.124223063148455,1,0.4,0.4,transcript,101484.0
STAU2,ENSG00000040341,asthma,MONDO_0004979,0.4123347221391123,4.1233587895739925,1,0.5,0.5,transcript,43222.0
DMAC1,ENSG00000137038,diabetes mellitus,EFO_0000400,0.4123262082014712,4.1233776555483725,1,0.4,0.4,transcript,3461.0
RFX7,ENSG00000181827,erythrocyte count,EFO_0004305,0.41231506776286386,4.123160269954777,1,0.4,0.4,transcript,41700.0
PTK2,ENSG00000169398,PR interval,EFO_0004462,0.41229565421598946,4.12296138436455,1,0.4,0.4,transcript,82607.0
KLHL3,ENSG00000146021,body mass index,EFO_0004340,0.41227190896483346,4.122766400331678,2,0.8,1.6,transcript,33819.0
MUC16,ENSG00000181143,ovarian neoplasm,EFO_0003893,0.4122661124541374,4.12266394489076,1,0.5,0.5,transcript,177283.0
RFX3,ENSG00000080298,autism spectrum disorder,EFO_0003756,0.41226055321555544,4.122662033320891,2,0.8,1.6,transcript,28318.0
NEK7,ENSG00000151414,erythrocyte volume,OBA_0003460,0.412212063016264,4.122165894392582,1,0.4,0.4,transcript,8837.0
SLC25A46,ENSG00000164209,allergic rhinitis,EFO_0005854,0.41221112973366236,4.122131250446814,1,0.4,0.4,transcript,20047.0
SERPINB9,ENSG00000170542,monocyte count,EFO_0005091,0.41220640003928793,4.122111716007814,1,0.4,0.4,transcript,8383.0
LNPEP,ENSG00000113441,diastolic blood pressure,EFO_0006336,0.4121573152170944,4.121593814395233,1,0.4,0.4,transcript,19359.0
WRN,ENSG00000165392,neutrophil count,EFO_0004833,0.4121258650262029,4.1212860520267025,1,0.5,0.5,transcript,18247.0
NDUFS4,ENSG00000164258,colorectal cancer,MONDO_0005575,0.41204891101683017,4.120595691569847,1,0.4,0.4,transcript,3753.0
NEDD4,ENSG00000069869,free cholesterol:total lipids ratio,EFO_0020945,0.41204211862662954,4.120429496227862,1,0.4,0.4,transcript,48135.0
PRDM5,ENSG00000138738,Ehlers-Danlos syndrome,MONDO_0020066,0.4120153309747817,4.120233918342708,2,0.8,1.6,transcript,19849.0
CIAO2A,ENSG00000166797,hematocrit,EFO_0004348,0.41198461443804285,4.120066773172486,2,0.8,1.6,transcript,7252.0
CTBP2,ENSG00000175029,gout,EFO_0004274,0.41194616980341714,4.119475761248319,1,0.4,0.4,transcript,28443.0
CCDC126,ENSG00000169193,forced expiratory volume,EFO_0004314,0.41191196087723986,4.119162071617409,1,0.4,0.4,transcript,9420.0
FLRT2,ENSG00000185070,thyroid stimulating hormone amount,OBA_1000983,0.411905400624313,4.119389525013352,7,2.8000000000000003,19.6,transcript,58417.0
NEK7,ENSG00000151414,platelet count,EFO_0004309,0.4118112045896877,4.1181573101268185,1,0.4,0.4,transcript,8837.0
UBE2U,ENSG00000177414,lymphocyte count,EFO_0004587,0.41180448131975345,4.118112028791552,1,0.4,0.4,transcript,5951.0
TBXT,ENSG00000164458,IGF-1 measurement,EFO_0004627,0.41169279205404347,4.117388396365453,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
ADGRV1,ENSG00000164199,serum urea amount,OBA_2050065,0.4116463702778375,4.116468127948744,1,0.5,0.5,transcript,112990.0
ARMC1,ENSG00000104442,sodium measurement,EFO_0009282,0.41164150491941937,4.116459597584883,1,0.4,0.4,transcript,8979.0
FAT3,ENSG00000165323,placental retention,EFO_0009578,0.41159588359632915,4.115967164958606,1,0.4,0.4,transcript,48025.0
CDH23,ENSG00000107736,Hearing impairment,HP_0000365,0.41156662482974815,4.115673799000452,1,0.5,0.5,transcript,66219.0
SLC25A46,ENSG00000164209,allergic disease,MONDO_0005271,0.41155118346381997,4.115531787748391,1,0.4,0.4,transcript,20047.0
TBL2,ENSG00000106638,triglycerides in very small VLDL measurement,EFO_0022144,0.4115257350348196,4.115272528885744,1,0.4,0.4,transcript,26353.0
CFAP299,ENSG00000197826,glomerular filtration rate,OBA_0003747,0.4115227431613758,4.115292569706515,1,0.5,0.5,transcript,7676.0
ADK,ENSG00000156110,glucose measurement,EFO_0004468,0.411521730971282,4.1152362931497715,1,0.4,0.4,transcript,21071.0
ZFP1,ENSG00000184517,BMI-adjusted waist circumference,EFO_0007789,0.4114328548335073,4.114356901042757,1,0.4,0.4,transcript,14108.0
TET1,ENSG00000138336,diastolic blood pressure,EFO_0006336,0.4114266706413352,4.114308321061708,1,0.4,0.4,transcript,9612.0
F13B,ENSG00000143278,high density lipoprotein cholesterol measurement,EFO_0004612,0.4114209463364541,4.114317361508693,1,0.5,0.5,transcript,4634.0
LYPD6,ENSG00000187123,metabolite measurement,EFO_0004725,0.41141545930142365,4.1141873423183135,1,0.4,0.4,transcript,12214.0
SYT13,ENSG00000019505,nontoxic goiter,MONDO_0001658,0.4114018198344073,4.114233483597033,2,0.8,1.6,transcript,7432.0
UBE2J1,ENSG00000198833,cystatin C measurement,EFO_0004617,0.41139603744332587,4.114392651090319,2,0.9,1.8,transcript,4164.0
CNTLN,ENSG00000044459,pleural empyema,EFO_0009680,0.4113712498372456,4.11383395893573,2,0.8,1.6,transcript,13173.0
CNTLN,ENSG00000044459,pneumothorax,MONDO_0002076,0.4113712498372456,4.11383395893573,2,0.8,1.6,transcript,13173.0
HFE,ENSG00000010704,genetic disorder,EFO_0000508,0.4113675507624949,4.113683792800698,1,0.4,0.4,transcript,48279.0
SI,ENSG00000090402,body weight,EFO_0004338,0.4113010571616822,4.113082617726333,1,0.5,0.5,transcript,6940.0
GFPT1,ENSG00000198380,calcium measurement,EFO_0004838,0.4112805485734593,4.112820589763593,1,0.4,0.4,transcript,26483.0
TENT4B,ENSG00000121274,platelet count,EFO_0004309,0.4112762737779049,4.113012153211629,4,1.6,6.4,transcript,25660.0
PARD6B,ENSG00000124171,serum gamma-glutamyl transferase measurement,EFO_0004532,0.4112594138981047,4.11267255497791,1,0.4,0.4,transcript,5101.0
PALM2AKAP2,ENSG00000157654,waist-hip ratio,EFO_0004343,0.4112156453106552,4.112164440327,1,0.4,0.4,transcript,50080.0
TMEM17,ENSG00000186889,platelet component distribution width,EFO_0007984,0.4112132727610667,4.112196727610667,1,0.4,0.4,transcript,6250.0
ACTN2,ENSG00000077522,smoking status measurement,EFO_0006527,0.4111691595468489,4.111708281080277,2,0.8,1.6,transcript,95891.0
MARCKS,ENSG00000277443,self reported educational attainment,EFO_0004784,0.41116568916175966,4.111750001487243,1,0.4,0.4,transcript,4296.0
TNRC6B,ENSG00000100354,Global developmental delay,HP_0001263,0.41116301796669463,4.111636631487973,1,0.4,0.4,transcript,61998.0
LMO4,ENSG00000143013,eosinophil percentage of leukocytes,EFO_0007991,0.41112419666503625,4.1112934467018425,1,0.4,0.4,transcript,7770.0
GPD2,ENSG00000115159,metabolite measurement,EFO_0004725,0.41109367759218546,4.110954442205752,1,0.4,0.4,transcript,22642.0
GLB1,ENSG00000170266,Eczematoid dermatitis,HP_0000964,0.4110337773715681,4.1103686817950535,1,0.5,0.5,transcript,16177.0
ZFP1,ENSG00000184517,high density lipoprotein cholesterol measurement,EFO_0004612,0.4110078499826882,4.110106852534566,1,0.4,0.4,transcript,14108.0
REEP3,ENSG00000165476,diet measurement,EFO_0008111,0.41099070275042615,4.1099768111748824,1,0.4,0.4,transcript,5732.0
MFAP3,ENSG00000037749,apolipoprotein A 1 measurement,EFO_0004614,0.41098186539861387,4.109831243687763,1,0.4,0.4,transcript,31772.0
ITGB8,ENSG00000105855,eosinophil percentage of leukocytes,EFO_0007991,0.41094378431881196,4.109608370401421,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
PRKCB,ENSG00000166501,eosinophil count,EFO_0004842,0.41093262326986285,4.109350199145603,1,0.4,0.4,transcript,16690.0
ARSJ,ENSG00000180801,body mass index,EFO_0004340,0.41091813656065657,4.109359598869348,2,0.8,1.6,transcript,8977.0
COQ3,ENSG00000132423,serum creatinine amount,OBA_2050096,0.41091304283189445,4.109280974047209,1,0.4,0.4,transcript,2657.0
KCNJ15,ENSG00000157551,waist-hip ratio,EFO_0004343,0.4108322696425766,4.108332530476166,1,0.4,0.4,transcript,40675.0
TNFRSF11A,ENSG00000141655,pelvis bone mineral density,EFO_0020104,0.4108160224483682,4.108284815668855,2,0.8,1.6,transcript,12842.0
CCDC88C,ENSG00000015133,white matter integrity,EFO_0004641,0.4108002329846295,4.108021652584327,1,0.4,0.4,transcript,20701.0
FBXO22,ENSG00000167196,uric acid measurement,EFO_0004761,0.41076815527166005,4.10770275150827,1,0.4,0.4,transcript,18869.0
TBL2,ENSG00000106638,total lipids in small VLDL,EFO_0022148,0.41072120199206297,4.107227198458177,1,0.4,0.4,transcript,26353.0
GPD2,ENSG00000115159,polycystic ovary syndrome,EFO_0000660,0.41072040147471744,4.1072216810310715,1,0.4,0.4,transcript,22642.0
NDUFAF2,ENSG00000164182,polycystic ovary syndrome,EFO_0000660,0.41072040147471744,4.107244219792908,1,0.4,0.4,transcript,9949.0
NDUFAF4,ENSG00000123545,polycystic ovary syndrome,EFO_0000660,0.41072040147471744,4.107315559643996,1,0.4,0.4,transcript,3586.0
NDUFS4,ENSG00000164258,polycystic ovary syndrome,EFO_0000660,0.41072040147471744,4.10731059614872,1,0.4,0.4,transcript,3753.0
FAT3,ENSG00000165323,platelet volume,OBA_0003277,0.410692686775608,4.106935196751395,1,0.4,0.4,transcript,48025.0
FZD3,ENSG00000104290,neuroimaging measurement,EFO_0004346,0.410621718554662,4.106231302363278,1,0.4,0.4,transcript,28335.0
C2orf73,ENSG00000177994,eosinophil count,EFO_0004842,0.410566853631573,4.105716845494474,1,0.4,0.4,transcript,8280.0
MC2R,ENSG00000185231,genetic disorder,EFO_0000508,0.4105510752130848,4.105605359510224,1,0.4,0.4,transcript,4228.0
THEM4,ENSG00000159445,X-21607 measurement,EFO_0800819,0.4104555083050449,4.104709433812555,2,0.8,1.6,transcript,10366.0
TBL2,ENSG00000106638,cholesteryl ester measurement,EFO_0010351,0.41041411616816836,4.104156340219231,1,0.4,0.4,transcript,26353.0
LTBP1,ENSG00000049323,temporal measurement,EFO_0000719,0.4104106475966,4.104119135395693,1,0.4,0.4,transcript,31597.0
STAU2,ENSG00000040341,body weights and measures,EFO_0004324,0.4103546954881916,4.103558523064785,1,0.5,0.5,transcript,43222.0
HEPHL1,ENSG00000181333,aspartate aminotransferase measurement,EFO_0004736,0.4103280909824007,4.103349768491592,1,0.4,0.4,transcript,5809.0
PLEC,ENSG00000178209,Junctional epidermolysis bullosa - pyloric atresia,Orphanet_79403,0.41032340932960276,4.103243157561671,2,0.9,1.8,transcript,198582.0
DCLK1,ENSG00000133083,mathematical ability,EFO_0004875,0.41031534979623624,4.103203695615623,2,0.8,1.6,transcript,31874.0
TNFRSF11A,ENSG00000141655,trunk bone mineral density,EFO_0020105,0.410311297849682,4.103237569681993,2,0.8,1.6,transcript,12842.0
U2SURP,ENSG00000163714,reticulocyte count,EFO_0007986,0.41028472268690797,4.102897634858746,2,0.8,1.6,transcript,31741.0
GBE1,ENSG00000114480,alcohol consumption quality,OBA_1000840,0.41025617095503625,4.102622588644481,1,0.5,0.5,transcript,8213.0
BPTF,ENSG00000171634,dizziness,EFO_0009847,0.41023720680258335,4.102391692222469,2,0.8,1.6,transcript,81532.0
SERPINB9,ENSG00000170542,erythrocyte volume,OBA_0003460,0.4102358875086043,4.102406590700978,1,0.4,0.4,transcript,8383.0
DLGAP1,ENSG00000170579,age at menarche,EFO_0004703,0.4101818924442108,4.101847078586046,2,0.8,1.6,transcript,56830.0
FZD6,ENSG00000164930,sodium measurement,EFO_0009282,0.4101334189945573,4.101414082091176,2,0.8,1.6,transcript,20027.0
TMEM131,ENSG00000075568,blood urea nitrogen measurement,EFO_0004741,0.4101205727568057,4.10122717643931,1,0.4,0.4,transcript,18649.0
CNR2,ENSG00000188822,lymphocyte count,EFO_0004587,0.4100768864636939,4.100844838046245,1,0.4,0.4,transcript,5265.0
SLC44A1,ENSG00000070214,total cholesterol measurement,EFO_0004574,0.4100548546105037,4.100558155022113,1,0.4,0.4,transcript,41628.0
DENND1B,ENSG00000213047,cerebral cortex area attribute,OBA_2045267,0.4100034500919662,4.100471258431892,5,2.0,10.0,transcript,22896.0
RANBP17,ENSG00000204764,high density lipoprotein cholesterol measurement,EFO_0004612,0.40998692460686814,4.099878760363911,1,0.4,0.4,transcript,42042.0
LONRF1,ENSG00000154359,apolipoprotein A 1 measurement,EFO_0004614,0.4099820551385871,4.099855844673089,1,0.5,0.5,transcript,14167.0
SLC22A15,ENSG00000163393,lymphocyte count,EFO_0004587,0.40997978273692026,4.100046854606557,2,0.8,1.6,transcript,6425.0
EPHA5,ENSG00000145242,neoplasm,EFO_0000616,0.409963859608947,4.099649320812638,1,0.4,0.4,transcript,37297.0
PHIP,ENSG00000146247,systolic blood pressure,EFO_0006335,0.40995326683576255,4.099540645511058,1,0.5,0.5,transcript,62679.0
SPRED1,ENSG00000166068,sodium measurement,EFO_0009282,0.4099419314167352,4.099463887378851,1,0.4,0.4,transcript,8974.0
CAV2,ENSG00000105971,Inguinal hernia,HP_0000023,0.4098682194872104,4.09870636843831,1,0.4,0.4,transcript,16547.0
PRDM5,ENSG00000138738,"osteoarthritis, knee",EFO_0004616,0.40980946824574266,4.098175291052318,2,0.8,1.6,transcript,19849.0
C12orf42,ENSG00000179088,Red cell distribution width,EFO_0009188,0.4097850451264514,4.097885590768344,1,0.5,0.5,transcript,14229.0
PLEC,ENSG00000178209,junctional epidermolysis bullosa with pyloric atresia,MONDO_0009183,0.4097690395475757,4.097699459741401,2,0.9,1.8,transcript,198582.0
APIP,ENSG00000149089,type 2 diabetes mellitus,MONDO_0005148,0.4097552211483001,4.097624981094412,1,0.5,0.5,transcript,6871.0
PIGB,ENSG00000069943,neurodegenerative disease,EFO_0005772,0.40975429720756895,4.097583123043329,1,0.5,0.5,transcript,12453.0
CERKL,ENSG00000188452,type 2 diabetes mellitus,MONDO_0005148,0.409753263929138,4.097552713163228,1,0.5,0.5,transcript,24908.0
FUT2,ENSG00000176920,serum alanine aminotransferase measurement,EFO_0004735,0.40968867611109583,4.097009787561646,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
SLCO5A1,ENSG00000137571,Red cell distribution width,EFO_0009188,0.4096021191096085,4.0964517430637075,5,2.0,10.0,transcript,23226.0
LATS1,ENSG00000131023,cervical squamous cell carcinoma,EFO_1000172,0.4095802708404738,4.095820064995904,1,0.4,0.4,transcript,23046.0
FAS,ENSG00000026103,genetic disorder,EFO_0000508,0.4094711329881531,4.094713538106062,1,0.4,0.4,transcript,181141.0
SUMF1,ENSG00000144455,spinocerebellar ataxia type 15/16,MONDO_0011694,0.40946214075336473,4.094653756906879,1,0.4,0.4,transcript,12365.0
KIF20B,ENSG00000138182,erythrocyte volume,OBA_0003460,0.40942925569990324,4.094319868956207,1,0.5,0.5,transcript,18307.0
FRMD4B,ENSG00000114541,atrial flutter,EFO_0003911,0.40940976716977645,4.094173767959536,2,0.8,1.6,transcript,21026.0
BCAS3,ENSG00000141376,Global developmental delay,HP_0001263,0.4093561299980929,4.093571699099084,1,0.5,0.5,transcript,48081.0
FAM76B,ENSG00000077458,cup-to-disc ratio measurement,EFO_0006939,0.4093371302819436,4.093392998323043,1,0.4,0.4,transcript,18437.0
CENPC,ENSG00000145241,age at initiation of smoking,EFO_0021784,0.4093080963784616,4.093279770941674,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
SGCD,ENSG00000170624,neutrophil count,EFO_0004833,0.4093074038742686,4.093092827788673,1,0.4,0.4,transcript,21289.0
HFM1,ENSG00000162669,eosinophil count,EFO_0004842,0.4092969239032776,4.0930990754389045,2,1.0,2.0,transcript,15404.0
ATF7IP2,ENSG00000166669,IGF-1 measurement,EFO_0004627,0.40928842358799233,4.092900444911596,1,0.5,0.5,transcript,30847.0
WDR12,ENSG00000138442,coronary artery disease,EFO_0001645,0.40928640995560334,4.092884038741517,1,0.4,0.4,transcript,20061.0
SENP6,ENSG00000112701,atrial fibrillation,EFO_0000275,0.4092509313049069,4.092938330209756,5,2.2,11.0,transcript,25640.0
SEMA6D,ENSG00000137872,depressive symptom measurement,EFO_0007006,0.4090887770936596,4.090897197784258,1,0.5,0.5,transcript,53040.0
PDHX,ENSG00000110435,serum gamma-glutamyl transferase measurement,EFO_0004532,0.4090823569826364,4.090868337593572,1,0.4,0.4,transcript,8935.0
LONRF1,ENSG00000154359,sex hormone-binding globulin measurement,EFO_0004696,0.4090585920953621,4.090621214240838,1,0.5,0.5,transcript,14167.0
FAT3,ENSG00000165323,bone tissue density,OBA_1000110,0.4090332156726078,4.090340485721393,1,0.4,0.4,transcript,48025.0
NEK1,ENSG00000137601,amyotrophic lateral sclerosis,MONDO_0004976,0.40898582240458947,4.089872483914169,2,0.8,1.6,transcript,112203.0
GPD2,ENSG00000115159,age of onset of myopia,OBA_2001030,0.4089350550897244,4.089368217181141,1,0.4,0.4,transcript,22642.0
PEAK1,ENSG00000173517,diabetes mellitus,EFO_0000400,0.40893158082176173,4.089322730668857,1,0.4,0.4,transcript,57783.0
GALNT3,ENSG00000115339,trunk bone mineral density,EFO_0020105,0.4088241783693653,4.088270691693942,1,0.4,0.4,transcript,13837.0
SYT13,ENSG00000019505,schizophrenia,MONDO_0005090,0.40880658419798455,4.088281127232805,2,0.8,1.6,transcript,7432.0
AKAP6,ENSG00000151320,cardiac arrhythmia,EFO_0004269,0.40875200498218556,4.088094829880506,7,2.8000000000000003,19.6,transcript,34100.0
TFEC,ENSG00000105967,chronotype measurement,EFO_0008328,0.40873903250295346,4.08740602238453,1,0.4,0.4,transcript,25482.0
LHFPL2,ENSG00000145685,Increased blood pressure,HP_0032263,0.4087337281512496,4.0873641740767015,1,0.4,0.4,transcript,14874.0
TCERG1L,ENSG00000176769,hematologic disease,EFO_0005803,0.4087009818538072,4.08723799880048,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,hematologic disease,EFO_0005803,0.4087009818538072,4.08723799880048,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,hematologic disease,EFO_0005803,0.4087009818538072,4.08723799880048,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,hematologic disease,EFO_0005803,0.4087009818538072,4.08723799880048,2,0.8,1.6,transcript,7012.0
LHFPL2,ENSG00000145685,Abdominal Aortic Aneurysm,EFO_0004214,0.40867356403063215,4.0867625328705275,1,0.4,0.4,transcript,14874.0
CCDC66,ENSG00000180376,body weight,EFO_0004338,0.40865146310026534,4.08652986051135,1,0.5,0.5,transcript,32831.0
MACF1,ENSG00000127603,sex hormone-binding globulin measurement,EFO_0004696,0.4086458386195586,4.086463713047916,2,0.8,1.6,gene_variant,300365.0
WRN,ENSG00000165392,cognitive function measurement,EFO_0008354,0.4086314070206449,4.086341471971122,1,0.5,0.5,transcript,18247.0
CD163L1,ENSG00000177675,protein measurement,EFO_0004747,0.4086271694859543,4.086301570130288,1,0.4,0.4,transcript,13389.0
GKAP1,ENSG00000165113,eosinophil count,EFO_0004842,0.40862279185586947,4.0862850450939705,1,0.4,0.4,transcript,7002.0
SEMA6D,ENSG00000137872,alcohol use disorder measurement,EFO_0009458,0.4085713662186571,4.085723089034233,1,0.5,0.5,transcript,53040.0
AKR1B10,ENSG00000198074,hypertension,EFO_0000537,0.4085665040905392,4.085797176211946,1,0.5,0.5,transcript,3784.0
SFRP1,ENSG00000104332,cortical thickness,EFO_0004840,0.4085576427235459,4.085624406124748,1,0.4,0.4,transcript,8337.0
KLF10,ENSG00000155090,monocyte count,EFO_0005091,0.40853218920130135,4.085382737769022,1,0.4,0.4,transcript,6574.0
PARP1,ENSG00000143799,mean corpuscular hemoglobin,EFO_0004527,0.40852301812234276,4.085236050801405,1,0.5,0.5,transcript,85185.0
GPR180,ENSG00000152749,esterified cholesterol measurement,EFO_0008589,0.40846716936275507,4.08471671839117,1,0.4,0.4,transcript,8884.0
RPS6KA5,ENSG00000100784,blood phosphate measurement,EFO_0010972,0.4084213959321253,4.084223824172787,1,0.4,0.4,transcript,40548.0
MAP2K6,ENSG00000108984,triglyceride measurement,EFO_0004530,0.4083916407881848,4.0839337104166695,1,0.4,0.4,transcript,23118.0
FAM91A1,ENSG00000176853,prostate specific antigen amount,OBA_2050200,0.40838635190029293,4.083893891983126,1,0.5,0.5,transcript,16462.0
TENM4,ENSG00000149256,bipolar disorder,MONDO_0004985,0.408329886438188,4.0833163148661304,1,0.4,0.4,transcript,22922.0
FITM2,ENSG00000197296,type 2 diabetes mellitus,MONDO_0005148,0.4083261749328223,4.083348179751732,1,0.4,0.4,transcript,4628.0
CCDC126,ENSG00000169193,lymphocyte count,EFO_0004587,0.4083237979907003,4.083280442752014,1,0.4,0.4,transcript,9420.0
SUMF1,ENSG00000144455,urate measurement,EFO_0004531,0.4082853791111652,4.082886140484883,1,0.4,0.4,transcript,12365.0
ONECUT1,ENSG00000169856,systolic blood pressure,EFO_0006335,0.4082788999112867,4.082841846252515,1,0.4,0.4,transcript,7569.0
TMED5,ENSG00000117500,platelet count,EFO_0004309,0.4082635914623981,4.082667881889501,1,0.5,0.5,transcript,15641.0
TRDMT1,ENSG00000107614,HbA1c measurement,EFO_0004541,0.40820976425167405,4.082111434193464,1,0.4,0.4,transcript,29003.0
ADK,ENSG00000156110,blood urea nitrogen measurement,EFO_0004741,0.4082053248270261,4.082072231707213,1,0.4,0.4,transcript,21071.0
SMAD2,ENSG00000175387,colon adenocarcinoma,EFO_1001949,0.4081778441241907,4.0822722382974135,9,3.6,32.4,transcript,65614.0
PARP1,ENSG00000143799,lymphocyte count,EFO_0004587,0.40814728075185,4.081478677096477,1,0.5,0.5,transcript,85185.0
SEMA6D,ENSG00000137872,intelligence,EFO_0004337,0.4081159312881577,4.0811687397292395,1,0.5,0.5,transcript,53040.0
CNTLN,ENSG00000044459,smoking initiation,EFO_0005670,0.4080616508853133,4.080737969416407,2,0.8,1.6,transcript,13173.0
GIPC2,ENSG00000137960,heart rate,OBA_1001087,0.4079912379469151,4.0803035775131615,2,0.8,1.6,transcript,4090.0
TOPAZ1,ENSG00000173769,fat pad mass,OBA_0004528,0.4079896140368483,4.079989878651197,1,0.5,0.5,transcript,5334.0
ALG10B,ENSG00000175548,heart rate variability measurement,EFO_0008003,0.40795138959814176,4.080219711904625,5,2.0,10.0,transcript,14168.0
PROK2,ENSG00000163421,genetic disorder,EFO_0000508,0.4079378294261426,4.079893758178952,2,0.8,1.6,transcript,3104.0
MLLT3,ENSG00000171843,hemoglobin measurement,EFO_0004509,0.40792324294835214,4.079335668611151,2,0.8,1.6,transcript,15498.0
MLLT3,ENSG00000171843,hematocrit,EFO_0004348,0.40792324294835214,4.079335668611151,2,0.8,1.6,transcript,15498.0
BIRC6,ENSG00000115760,serum creatinine amount,OBA_2050096,0.40788083282699816,4.078815510526934,1,0.5,0.5,transcript,69616.0
ANKRD17,ENSG00000132466,free cholesterol:total lipids ratio,EFO_0020945,0.40786820242874317,4.078691214196911,1,0.4,0.4,transcript,43526.0
GABRA4,ENSG00000109158,insomnia,EFO_0004698,0.4078305849629355,4.078331000534788,1,0.4,0.4,transcript,15904.0
FRS2,ENSG00000166225,high density lipoprotein cholesterol measurement,EFO_0004612,0.40779882242188287,4.078004333114967,1,0.4,0.4,transcript,24831.0
SMAD2,ENSG00000175387,cervical carcinoma,EFO_0001061,0.40771470804733134,4.07764087752882,9,3.6,32.4,transcript,65614.0
SGCD,ENSG00000170624,dilated cardiomyopathy,EFO_0000407,0.4076278263964373,4.07629705301036,1,0.4,0.4,transcript,21289.0
COL25A1,ENSG00000188517,lipid measurement,EFO_0004529,0.4076015352484022,4.0760303141447665,1,0.4,0.4,transcript,26735.0
OTULIN,ENSG00000154124,chondrocalcinosis 2,MONDO_0007319,0.40759734546079734,4.07599268907614,1,0.4,0.4,transcript,20796.0
FRMD4B,ENSG00000114541,cerebral cortex area attribute,OBA_2045267,0.4075286600092766,4.075362696354537,2,0.8,1.6,transcript,21026.0
PEX7,ENSG00000112357,peroxisome biogenesis disorder,MONDO_0019234,0.4074790899521067,4.074833443660611,1,0.4,0.4,transcript,9402.0
RCL1,ENSG00000120158,neutrophil percentage of leukocytes,EFO_0007990,0.40745274171068463,4.074566090605831,1,0.4,0.4,transcript,10343.0
SGCD,ENSG00000170624,smoking cessation,EFO_0004319,0.4073991695184208,4.074010484230195,1,0.4,0.4,transcript,21289.0
TENM4,ENSG00000149256,heart rate,OBA_1001087,0.4073411181796333,4.073428632280583,1,0.4,0.4,transcript,22922.0
TMED5,ENSG00000117500,high density lipoprotein cholesterol measurement,EFO_0004612,0.40732955262623105,4.07332749352783,1,0.5,0.5,transcript,15641.0
GRIA4,ENSG00000152578,Abnormality of refraction,HP_0000539,0.40728061263052523,4.072815417826739,1,0.4,0.4,transcript,43050.0
PRTG,ENSG00000166450,platelet volume,OBA_0003277,0.4072690688502437,4.07290876458676,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
MEOX2,ENSG00000106511,FEV/FVC ratio,EFO_0004713,0.4072558040862296,4.07272674604998,1,0.4,0.4,transcript,2371.0
TBL2,ENSG00000106638,triglycerides in HDL measurement ,EFO_0022317,0.4072173510270136,4.072188688807684,1,0.4,0.4,transcript,26353.0
ALG10B,ENSG00000175548,blood urea nitrogen measurement,EFO_0004741,0.4071878626898069,4.0725844428212765,5,2.0,10.0,transcript,14168.0
SPAST,ENSG00000021574,Spasticity,HP_0001257,0.40718460489887026,4.0718512253070465,1,0.4,0.4,transcript,77275.0
DLC1,ENSG00000164741,PR interval,EFO_0004462,0.40709991328064155,4.07101081197953,1,0.4,0.4,transcript,34249.0
MAGI2,ENSG00000187391,schizophrenia,MONDO_0005090,0.4070724672760829,4.070729236157822,1,0.4,0.4,transcript,87654.0
BTBD8,ENSG00000189195,lymphocyte count,EFO_0004587,0.4070709166201181,4.0707256482686915,1,0.5,0.5,transcript,30336.0
NEK1,ENSG00000137601,connective tissue disease,EFO_1001986,0.40704278099662056,4.07044206983448,2,0.8,1.6,transcript,112203.0
EVI5,ENSG00000067208,granulocyte percentage of myeloid white cells,EFO_0007997,0.40703595131462245,4.070365169094868,1,0.4,0.4,transcript,70722.0
PTK2,ENSG00000169398,self reported educational attainment,EFO_0004784,0.40700366001513943,4.07004144235605,1,0.4,0.4,transcript,82607.0
LARP4B,ENSG00000107929,cystatin B measurement,EFO_0010593,0.406982251240592,4.069833524409003,1,0.5,0.5,transcript,45405.0
SORL1,ENSG00000137642,blood urea nitrogen measurement,EFO_0004741,0.4069710263400774,4.069757273063871,2,0.9,1.8,transcript,38290.0
MACF1,ENSG00000127603,lean body mass,EFO_0004995,0.40693808674126947,4.069386194265024,2,0.8,1.6,gene_variant,300365.0
RCOR3,ENSG00000117625,mean corpuscular hemoglobin concentration,EFO_0004528,0.40693237594707027,4.069388114711633,2,0.8,1.6,transcript,24862.0
SPRED1,ENSG00000166068,genetic disorder,EFO_0000508,0.4069074200078567,4.069118773290066,1,0.4,0.4,transcript,8974.0
PTK2,ENSG00000169398,pallidum volume,OBA_2050027,0.4068989154915976,4.068993997120632,1,0.4,0.4,transcript,82607.0
PPA2,ENSG00000138777,smoking initiation,EFO_0005670,0.40689761674335556,4.06900357370411,1,0.5,0.5,transcript,18244.0
PTK2,ENSG00000169398,restless legs syndrome,EFO_0004270,0.40689702020605795,4.068975044265235,1,0.4,0.4,transcript,82607.0
COL25A1,ENSG00000188517,free cholesterol:total lipids ratio,EFO_0020945,0.4068560690550776,4.06857565221152,1,0.4,0.4,transcript,26735.0
NBEAL1,ENSG00000144426,glomerular filtration rate,OBA_0003747,0.406853590965915,4.068539763260823,1,0.4,0.4,transcript,103799.0
UBXN2A,ENSG00000173960,guilt measurement,EFO_0009595,0.4068400952099463,4.0685581693540565,2,0.8,1.6,transcript,10177.0
CRYGD,ENSG00000118231,genetic disorder,EFO_0000508,0.40683074116683715,4.068930464627873,1,0.4,0.4,transcript,642.0
DNAH14,ENSG00000185842,lymphocyte count,EFO_0004587,0.40680474970874275,4.068105475570968,3,1.5,4.5,transcript,77615.0
FIGN,ENSG00000182263,cognitive function measurement,EFO_0008354,0.4067619290542816,4.067656045114166,1,0.4,0.4,transcript,10883.0
LRRC7,ENSG00000033122,erythrocyte volume,OBA_0003460,0.4066734784237335,4.066798887942885,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
PRDM5,ENSG00000138738,triglyceride measurement,EFO_0004530,0.4066397137040383,4.066477745635274,2,0.8,1.6,transcript,19849.0
FUT2,ENSG00000176920,cancer biomarker measurement,EFO_0005127,0.4066135176134673,4.06625820258536,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
SLC9B1,ENSG00000164037,high density lipoprotein cholesterol measurement,EFO_0004612,0.40659127183690064,4.065957690486293,1,0.5,0.5,transcript,11118.0
LRBA,ENSG00000198589,severe combined immunodeficiency due to CORO1A deficiency,MONDO_0014168,0.406537840153172,4.065382343039741,1,0.4,0.4,transcript,101484.0
SGCD,ENSG00000170624,Abnormality of the musculature,HP_0003011,0.406537840153172,4.065397190577706,1,0.4,0.4,transcript,21289.0
GALC,ENSG00000054983,spastic ataxia,MONDO_0017845,0.406537840153172,4.065451294470217,2,0.8,1.6,transcript,21950.0
ASPM,ENSG00000066279,fetal akinesia deformation sequence 1,MONDO_0100101,0.406537840153172,4.06541339987902,2,0.9,1.8,transcript,51431.0
SOS1,ENSG00000115904,Noonan syndrome 3,MONDO_0012371,0.406537840153172,4.065402009404946,2,0.8,1.6,transcript,67774.0
TGFBR1,ENSG00000106799,Familial hemophagocytic lymphohistiocytosis,Orphanet_540,0.406537840153172,4.065382649123866,1,0.4,0.4,transcript,94171.0
ASPM,ENSG00000066279,fetal akinesia deformation sequence,MONDO_0008824,0.406537840153172,4.06541339987902,2,0.9,1.8,transcript,51431.0
ASPM,ENSG00000066279,arthrogryposis multiplex congenita,MONDO_0015168,0.406537840153172,4.06541339987902,2,0.9,1.8,transcript,51431.0
SMARCC1,ENSG00000173473,SMARCC1-associated developmental dysgenesis syndrome,MONDO_0700123,0.40653784015317196,4.0654925486388045,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,SMARCC1-associated developmental dysgenesis syndrome,MONDO_0700123,0.40653784015317196,4.0654925486388045,2,0.8,1.6,gene_variant,14017.0
TNRC6B,ENSG00000100354,Autistic behavior,HP_0000729,0.40653784015317196,4.065384853352747,1,0.4,0.4,transcript,61998.0
SMARCC1,ENSG00000173473,SMARCC1-associated developmental dysgenesis syndrome,MONDO_0700123,0.40653784015317196,4.0654925486388045,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,SMARCC1-associated developmental dysgenesis syndrome,MONDO_0700123,0.40653784015317196,4.0654925486388045,2,0.8,1.6,transcript,14017.0
EPHA5,ENSG00000145242,cognitive function measurement,EFO_0008354,0.4065253185972062,4.06526391069523,1,0.4,0.4,transcript,37297.0
STXBP5,ENSG00000164506,alcohol consumption quality,OBA_1000840,0.4064750720870304,4.0647645512787625,2,0.9,1.8,transcript,130148.0
ATP5F1A,ENSG00000152234,eosinophil count,EFO_0004842,0.4064648813360313,4.0646626140779505,1,0.4,0.4,transcript,28984.0
SECISBP2L,ENSG00000138593,low density lipoprotein cholesterol measurement,EFO_0004611,0.40646304527503624,4.064649536719829,1,0.4,0.4,transcript,20960.0
GALNT3,ENSG00000115339,pelvis bone mineral density,EFO_0020104,0.40645687348968124,4.064597642897101,1,0.4,0.4,transcript,13837.0
MAN1A2,ENSG00000198162,smoking initiation,EFO_0005670,0.406414129023948,4.0642688107623135,2,0.8,1.6,transcript,12547.0
ST8SIA4,ENSG00000113532,worry measurement,EFO_0009589,0.4063958612482272,4.06400148953233,1,0.4,0.4,transcript,9329.0
LMO4,ENSG00000143013,aortic stenosis,EFO_0000266,0.4063881734779536,4.0639332148310165,1,0.4,0.4,transcript,7770.0
FAM210A,ENSG00000177150,C-reactive protein measurement,EFO_0004458,0.4063768880036594,4.06379102597835,1,0.4,0.4,transcript,18062.0
SYNE2,ENSG00000054654,strand of hair color,OBA_0002313,0.4063096885559922,4.06310952107583,2,1.0,2.0,transcript,158284.0
RANBP17,ENSG00000204764,mathematical ability,EFO_0004875,0.4062922575777972,4.0629320900732,1,0.4,0.4,transcript,42042.0
LINGO2,ENSG00000174482,HbA1c measurement,EFO_0004541,0.40625981463951705,4.0626098652596125,1,0.4,0.4,transcript,34133.0
STARD13,ENSG00000133121,red blood cell density,OBA_2045260,0.40623382183221557,4.062353034783244,1,0.4,0.4,transcript,26997.0
CCDC88C,ENSG00000015133,brain volume,OBA_2050009,0.40623007327808297,4.062320055518861,1,0.4,0.4,transcript,20701.0
FGFR1OP2,ENSG00000111790,basophil count,EFO_0005090,0.4062214547952757,4.062250681647427,1,0.4,0.4,transcript,11070.0
GALNT3,ENSG00000115339,intelligence,EFO_0004337,0.40619810957836927,4.062010003783981,1,0.4,0.4,transcript,13837.0
TLR10,ENSG00000174123,allergic rhinitis,EFO_0005854,0.40618256367077715,4.061987078924911,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
SYNE2,ENSG00000054654,hair color,EFO_0003924,0.4061810548453685,4.061823183969593,2,1.0,2.0,transcript,158284.0
NDUFAF2,ENSG00000164182,genetic disorder,EFO_0000508,0.4061750841698619,4.061791046744353,1,0.4,0.4,transcript,9949.0
PLCL1,ENSG00000115896,appendicular lean mass,EFO_0004980,0.40617209769326584,4.061810487422169,2,0.8,1.6,transcript,17875.0
CD86,ENSG00000114013,platelet volume,OBA_0003277,0.40615770465269946,4.061608880987798,1,0.4,0.4,transcript,12565.0
TRIM36,ENSG00000152503,diastolic blood pressure,EFO_0006336,0.40611204377227217,4.061146598612192,1,0.4,0.4,transcript,15290.0
PLXND1,ENSG00000004399,glucose measurement,EFO_0004468,0.40609159318109384,4.060939612780911,1,0.5,0.5,transcript,21114.0
CSMD3,ENSG00000164796,gastric adenocarcinoma,EFO_0000503,0.4060820469434714,4.060828578156455,1,0.5,0.5,transcript,61662.0
AHNAK2,ENSG00000185567,hypothyroidism,EFO_0004705,0.4060658223953625,4.0607060536798,2,1.0,2.0,transcript,41815.0
CWH43,ENSG00000109182,erythrocyte volume,OBA_0003460,0.4060637599673314,4.060699672919745,1,0.5,0.5,transcript,8055.0
BTAF1,ENSG00000095564,brain cancer,MONDO_0001657,0.4059977543327534,4.0600142877699374,1,0.4,0.4,transcript,10886.0
TENM4,ENSG00000149256,HbA1c measurement,EFO_0004541,0.4059608538878778,4.059625989363028,1,0.4,0.4,transcript,22922.0
PPFIBP2,ENSG00000166387,hair color,EFO_0003924,0.40592232625449276,4.059236945430374,1,0.5,0.5,transcript,36542.0
TMPRSS4,ENSG00000137648,neurodegenerative disease,EFO_0005772,0.40592203315017245,4.059230663147556,1,0.4,0.4,transcript,38716.0
BIRC6,ENSG00000115760,alkaline phosphatase measurement,EFO_0004533,0.4059203326037069,4.059210508294022,1,0.5,0.5,transcript,69616.0
GBE1,ENSG00000114480,sodium measurement,EFO_0009282,0.4058814326126748,4.0588752052208665,1,0.5,0.5,transcript,8213.0
SKP2,ENSG00000145604,mean corpuscular hemoglobin,EFO_0004527,0.4057888474107444,4.05789349696143,1,0.4,0.4,transcript,79636.0
GABRG1,ENSG00000163285,obesity,EFO_0001073,0.4057768687216911,4.059899495148252,6,2.4000000000000004,14.400000000000002,transcript,6758.0
PDE1A,ENSG00000115252,myocardial infarction,EFO_0000612,0.4057500498979581,4.057627050109753,3,1.2000000000000002,3.6000000000000005,transcript,28447.0
TRIM36,ENSG00000152503,systolic blood pressure,EFO_0006335,0.4056912955497334,4.056939116386803,1,0.4,0.4,transcript,15290.0
PCDH18,ENSG00000189184,Beta blocking agent use measurement,EFO_0009929,0.4056825809947915,4.0569029816066235,2,0.8,1.6,transcript,20733.0
SEMA3A,ENSG00000075213,cortical thickness,EFO_0004840,0.4056178305098459,4.056208509734871,1,0.4,0.4,transcript,13243.0
GRIA4,ENSG00000152578,restless legs syndrome,EFO_0004270,0.4056088146627845,4.056097438149331,1,0.4,0.4,transcript,43050.0
DENND1B,ENSG00000213047,metabolite measurement,EFO_0004725,0.40558531053155744,4.0562898628278035,5,2.0,10.0,transcript,22896.0
FUT2,ENSG00000176920,cancer antigen 19.9 measurement,EFO_0010584,0.4055602508773311,4.055725535223998,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
SHH,ENSG00000164690,uric acid measurement,EFO_0004761,0.4055111873520848,4.055165022604026,1,0.4,0.4,transcript,7526.0
PEAK1,ENSG00000173517,bone tissue density,OBA_1000110,0.4054999251494193,4.055006173945433,1,0.4,0.4,transcript,57783.0
LARP4B,ENSG00000107929,triglyceride measurement,EFO_0004530,0.4054902322479115,4.054913334482198,1,0.5,0.5,transcript,45405.0
FAM76B,ENSG00000077458,glucose measurement,EFO_0004468,0.40546968326964417,4.054718528200048,1,0.4,0.4,transcript,18437.0
SLC44A1,ENSG00000070214,erythrocyte volume,OBA_0003460,0.40546878150605953,4.054697423977671,1,0.4,0.4,transcript,41628.0
RTKN2,ENSG00000182010,thyroid disease,EFO_1000627,0.40546329246119706,4.0546681824348,1,0.4,0.4,transcript,11345.0
FREM2,ENSG00000150893,PR interval,EFO_0004462,0.40545535829082113,4.0554446896628,6,2.5,15.0,transcript,16833.0
DLG2,ENSG00000150672,glucose measurement,EFO_0004468,0.40543951675283335,4.054397940453493,1,0.4,0.4,transcript,144252.0
GABRA4,ENSG00000109158,obesity,EFO_0001073,0.40543818904934154,4.054407041398848,1,0.4,0.4,transcript,15904.0
TTL,ENSG00000114999,erythrocyte volume,OBA_0003460,0.40542498122536946,4.054269580959833,1,0.4,0.4,transcript,20234.0
TBL2,ENSG00000106638,serum alanine aminotransferase measurement,EFO_0004735,0.4054247591946047,4.054262770483595,1,0.4,0.4,transcript,26353.0
GBE1,ENSG00000114480,emotional symptom measurement,EFO_0007803,0.4053744861796359,4.0538057408904775,1,0.5,0.5,transcript,8213.0
BCKDHB,ENSG00000083123,sitting height measurement,EFO_0011011,0.4053170951192541,4.058898328053939,10,4.0,40.0,transcript,6984.0
NEDD4,ENSG00000069869,lean body mass,EFO_0004995,0.40529687107281226,4.052977020689689,1,0.4,0.4,transcript,48135.0
TLK1,ENSG00000198586,age at menopause,EFO_0004704,0.4052617892155663,4.052631787316673,1,0.4,0.4,transcript,28787.0
SGCD,ENSG00000170624,triglyceride measurement,EFO_0004530,0.40524137145432,4.052432503589187,1,0.4,0.4,transcript,21289.0
SLC22A2,ENSG00000112499,monocyte count,EFO_0005091,0.40521917470869917,4.052231469033368,1,0.4,0.4,transcript,10070.0
STXBP4,ENSG00000166263,platelet volume,OBA_0003277,0.40520951319232174,4.052486843310268,5,2.0,10.0,transcript,25529.0
TSPAN9,ENSG00000011105,cup-to-disc ratio measurement,EFO_0006939,0.40518202256048386,4.05185570924688,1,0.5,0.5,transcript,14091.0
LYPLAL1,ENSG00000143353,neutrophil count,EFO_0004833,0.40515357313342426,4.051563527642893,1,0.5,0.5,transcript,17988.0
EXO1,ENSG00000174371,prostate specific antigen amount,OBA_2050200,0.4051165460504787,4.051294893587883,2,1.0,2.0,transcript,15452.0
MSX2,ENSG00000120149,calcium measurement,EFO_0004838,0.4051097363394511,4.051215601644584,1,0.4,0.4,transcript,3383.0
PDE1C,ENSG00000154678,intelligence,EFO_0004337,0.405082725968339,4.0508816185880585,2,0.8,1.6,transcript,29434.0
PARP8,ENSG00000151883,schizophrenia,MONDO_0005090,0.4050378461321395,4.050425538144886,2,0.8,1.6,transcript,33987.0
MACF1,ENSG00000127603,intermediate density lipoprotein measurement,EFO_0008595,0.4050221121496971,4.050226448349301,2,0.8,1.6,gene_variant,300365.0
PDE1C,ENSG00000154678,educational attainment,EFO_0011015,0.4050084353796961,4.05013871270163,2,0.8,1.6,transcript,29434.0
LIN9,ENSG00000183814,platelet volume,OBA_0003277,0.4049908560953006,4.050013396492254,2,0.8,1.6,transcript,15262.0
MACF1,ENSG00000127603,cholesteryl ester measurement,EFO_0010351,0.40498468322450853,4.049852159097416,2,0.8,1.6,gene_variant,300365.0
LSM6,ENSG00000164167,body mass index,EFO_0004340,0.40490079227755926,4.049173331645643,2,0.8,1.6,transcript,9673.0
EXO1,ENSG00000174371,systolic blood pressure,EFO_0006335,0.4048547625088157,4.048677058171252,2,1.0,2.0,transcript,15452.0
SYNE2,ENSG00000054654,cutaneous melanoma,EFO_0000389,0.4047729232563714,4.047741868079622,2,1.0,2.0,transcript,158284.0
CD69,ENSG00000110848,neutrophil measurement,EFO_0803548,0.40477264616452574,4.04857093736658,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
ENPEP,ENSG00000138792,Antihypertensive use measurement,EFO_0009927,0.4047722936200694,4.047765336031095,1,0.4,0.4,transcript,9434.0
FAT4,ENSG00000196159,lung adenocarcinoma,EFO_0000571,0.4047464993889619,4.047473703932298,1,0.4,0.4,transcript,45924.0
KYNU,ENSG00000115919,X-15503 measurement,EFO_0800753,0.40474008307233833,4.047559079437613,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
SKI,ENSG00000157933,alkaline phosphatase measurement,EFO_0004533,0.40469743891325033,4.047026910140907,1,0.4,0.4,transcript,7616.0
LARP4B,ENSG00000107929,basophil measurement,EFO_0803539,0.40465803924113086,4.046591404414392,1,0.5,0.5,transcript,45405.0
TRDMT1,ENSG00000107614,vitamin B12 measurement,EFO_0004620,0.40464841084231534,4.046497900099877,1,0.4,0.4,transcript,29003.0
ARMC1,ENSG00000104442,erythrocyte volume,OBA_0003460,0.4046306200398216,4.046350748788905,1,0.4,0.4,transcript,8979.0
ZNF429,ENSG00000197013,erythrocyte volume,OBA_0003460,0.4046222968711364,4.0463787774561295,2,0.8,1.6,transcript,10269.0
TMEM123,ENSG00000152558,total blood protein measurement,EFO_0004536,0.40462168711539614,4.046256593100337,1,0.4,0.4,transcript,10070.0
LMO4,ENSG00000143013,neuroimaging measurement,EFO_0004346,0.40457450821827234,4.045796562234203,1,0.4,0.4,transcript,7770.0
RASEF,ENSG00000165105,heart rate,OBA_1001087,0.40453311940574416,4.045385615826149,1,0.4,0.4,transcript,7350.0
ANKRD17,ENSG00000132466,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.4045294417847444,4.0453036077569235,1,0.4,0.4,transcript,43526.0
ANKRD17,ENSG00000132466,high density lipoprotein cholesterol measurement,EFO_0004612,0.40450875021569505,4.04509669206643,1,0.4,0.4,transcript,43526.0
MEOX2,ENSG00000106511,calcium measurement,EFO_0004838,0.40446887503878143,4.044857455575499,1,0.4,0.4,transcript,2371.0
LMO4,ENSG00000143013,alcohol consumption quality,OBA_1000840,0.4044267019622405,4.044318499673885,1,0.4,0.4,transcript,7770.0
MAP2K6,ENSG00000108984,total cholesterol measurement,EFO_0004574,0.404407838638595,4.0440956889207715,1,0.4,0.4,transcript,23118.0
FRMD4B,ENSG00000114541,mean fractional anisotropy measurement,EFO_0008399,0.4043963788560993,4.044039884822764,2,0.8,1.6,transcript,21026.0
PLA2R1,ENSG00000153246,blood urea nitrogen measurement,EFO_0004741,0.4043709529583074,4.043788721822235,2,0.8,1.6,transcript,20204.0
BPTF,ENSG00000171634,pain measurement,EFO_0010639,0.40427867655540434,4.0428063897506785,2,0.8,1.6,transcript,81532.0
SKI,ENSG00000157933,erythrocyte volume,OBA_0003460,0.40424330422583404,4.0424855632667445,1,0.4,0.4,transcript,7616.0
FAM210A,ENSG00000177150,erythrocyte count,EFO_0004305,0.4042349672845955,4.042371818787711,1,0.4,0.4,transcript,18062.0
SLC25A46,ENSG00000164209,optic atrophy,MONDO_0003608,0.4042279660613926,4.042299613724117,1,0.4,0.4,transcript,20047.0
TRIM36,ENSG00000152503,atrial fibrillation,EFO_0000275,0.4041983599186514,4.042009760075984,1,0.4,0.4,transcript,15290.0
PARP8,ENSG00000151883,metabolite measurement,EFO_0004725,0.4041592637466964,4.041639714290455,2,0.8,1.6,transcript,33987.0
ATXN3,ENSG00000066427,heart rate,OBA_1001087,0.4041142371620753,4.041148094818303,1,0.4,0.4,transcript,69891.0
CNTN5,ENSG00000149972,arterial stiffness measurement,EFO_0004517,0.4041136905687345,4.041149886378566,1,0.4,0.4,transcript,30815.0
TBL2,ENSG00000106638,triglycerides in very large HDL measurement ,EFO_0022324,0.4041036628214549,4.041051806752097,1,0.4,0.4,transcript,26353.0
KLF10,ENSG00000155090,urate measurement,EFO_0004531,0.40410195992806486,4.041080445036657,1,0.4,0.4,transcript,6574.0
MACF1,ENSG00000127603,platelet count,EFO_0004309,0.4040550269681778,4.040555596534108,2,0.8,1.6,gene_variant,300365.0
HS3ST3A1,ENSG00000153976,ovarian neoplasm,EFO_0003893,0.40401508553190196,4.040231892596167,1,0.4,0.4,transcript,4936.0
SV2C,ENSG00000122012,lymphocyte count,EFO_0004587,0.40399947983734685,4.040022827243204,1,0.4,0.4,transcript,14271.0
TXNL1,ENSG00000091164,corneal disease,EFO_0009464,0.4039776140732674,4.039858339551065,2,0.8,1.6,transcript,19465.0
NEDD4,ENSG00000069869,Palmar Fibromatosis,EFO_1000438,0.40397139716470815,4.039722281608649,1,0.4,0.4,transcript,48135.0
CNTN5,ENSG00000149972,matrix metalloproteinase 7 measurement,EFO_0010591,0.40392408905443994,4.039253871235621,1,0.4,0.4,transcript,30815.0
MYO1B,ENSG00000128641,strand of hair color,OBA_0002313,0.40392108631524476,4.039224271572936,1,0.4,0.4,transcript,29832.0
DAG1,ENSG00000173402,qualitative or quantitative defects of alpha-dystroglycan,MONDO_0018282,0.40392080403878816,4.039214228506694,1,0.4,0.4,transcript,64640.0
NAF1,ENSG00000145414,lung adenocarcinoma,EFO_0000571,0.40391474693397206,4.039209419531766,1,0.5,0.5,transcript,8071.0
FAM76B,ENSG00000077458,alcohol consumption quality,OBA_1000840,0.40388140048455035,4.038835700349111,1,0.4,0.4,transcript,18437.0
PSD3,ENSG00000156011,high density lipoprotein cholesterol measurement,EFO_0004612,0.4038739216499893,4.038748659593451,1,0.4,0.4,transcript,42359.0
TLK1,ENSG00000198586,lean body mass,EFO_0004995,0.40384929671221365,4.038506862283147,1,0.4,0.4,transcript,28787.0
PDE1C,ENSG00000154678,smoking cessation,EFO_0004319,0.40383395498405145,4.038393908745182,2,0.8,1.6,transcript,29434.0
ATG16L1,ENSG00000085978,alkaline phosphatase measurement,EFO_0004533,0.40379083807669386,4.037920372252984,1,0.4,0.4,transcript,33357.0
RNF144B,ENSG00000137393,crystal arthropathy,MONDO_0022208,0.4037852597711423,4.037925470730189,1,0.4,0.4,transcript,5489.0
MLLT3,ENSG00000171843,body mass index,EFO_0004340,0.403668687073278,4.0367901098604095,2,0.8,1.6,transcript,15498.0
RAD23B,ENSG00000119318,IGF-1 measurement,EFO_0004627,0.4036523139102432,4.0365634129646955,1,0.4,0.4,transcript,9932.0
DZIP3,ENSG00000198919,reticulocyte count,EFO_0007986,0.4036247506713816,4.036269641626107,1,0.4,0.4,transcript,18071.0
FAM210A,ENSG00000177150,alkaline phosphatase measurement,EFO_0004533,0.40361447431840686,4.036166889125824,1,0.4,0.4,transcript,18062.0
UBE2J1,ENSG00000198833,metabolite measurement,EFO_0004725,0.40360773326348515,4.036509609291913,2,0.9,1.8,transcript,4164.0
TMEM131,ENSG00000075568,bone tissue density,OBA_1000110,0.40357982109372664,4.03581965980852,1,0.4,0.4,transcript,18649.0
GFPT1,ENSG00000198380,body weight,EFO_0004338,0.4034433801351871,4.034448905380871,1,0.4,0.4,transcript,26483.0
SLC9B1,ENSG00000164037,triglyceride measurement,EFO_0004530,0.40343082569399924,4.034353229057279,1,0.5,0.5,transcript,11118.0
PRKCB,ENSG00000166501,glioblastoma multiforme,EFO_0000519,0.40341156423059094,4.034139608752884,1,0.4,0.4,transcript,16690.0
PTK2,ENSG00000169398,ventral diencephalon volume,OBA_2045253,0.4033733760595664,4.03373860280032,1,0.4,0.4,transcript,82607.0
CCDC88C,ENSG00000015133,cortical thickness,EFO_0004840,0.40331576446118006,4.033176967349832,1,0.4,0.4,transcript,20701.0
ZDHHC21,ENSG00000175893,HbA1c measurement,EFO_0004541,0.40329655591663605,4.033313139680128,4,1.6,6.4,transcript,18413.0
RTKN2,ENSG00000182010,myxedema,EFO_1001055,0.40329137066768533,4.032948964499683,1,0.4,0.4,transcript,11345.0
UBXN2A,ENSG00000173960,pulse pressure measurement,EFO_0005763,0.40327908569891935,4.032948074243787,2,0.8,1.6,transcript,10177.0
LRP2,ENSG00000081479,Proteinuria,HP_0000093,0.4032450031977021,4.032466620676798,1,0.5,0.5,transcript,30141.0
TET1,ENSG00000138336,body fat percentage,EFO_0007800,0.40321322234104956,4.032173838058852,1,0.4,0.4,transcript,9612.0
PRDM5,ENSG00000138738,white matter integrity,EFO_0004641,0.4031636015922854,4.031716624517745,2,0.8,1.6,transcript,19849.0
ARAP1,ENSG00000186635,total blood protein measurement,EFO_0004536,0.4031453549728299,4.031462559346067,1,0.4,0.4,transcript,44397.0
NEDD4,ENSG00000069869,triglyceride measurement,EFO_0004530,0.40313020447718745,4.031310354733441,1,0.4,0.4,transcript,48135.0
LAMA1,ENSG00000101680,Retinal dystrophy,HP_0000556,0.4031191868368386,4.031207763587104,1,0.5,0.5,transcript,31456.0
CYTL1,ENSG00000170891,type 2 diabetes mellitus,MONDO_0005148,0.40310227702920337,4.031241708442006,1,0.4,0.4,transcript,1827.0
FIGN,ENSG00000182263,angina pectoris,EFO_0003913,0.40303147813988704,4.030351535970221,1,0.4,0.4,transcript,10883.0
CYTIP,ENSG00000115165,HbA1c measurement,EFO_0004541,0.40298487779708253,4.029876565397014,1,0.4,0.4,gene_variant,14395.0
C4orf33,ENSG00000151470,body mass index,EFO_0004340,0.402949564771897,4.029946701352066,4,1.6,6.4,transcript,14189.0
GFRAL,ENSG00000187871,chronotype measurement,EFO_0008328,0.40291005473246727,4.029309861819701,1,0.4,0.4,transcript,1911.0
SLC44A1,ENSG00000070214,BMI-adjusted waist circumference,EFO_0007789,0.40286382060728537,4.028647814989929,1,0.4,0.4,transcript,41628.0
SKP2,ENSG00000145604,mean reticulocyte volume,EFO_0010701,0.4028317841638808,4.028322864492794,1,0.4,0.4,transcript,79636.0
DLC1,ENSG00000164741,forced expiratory volume,EFO_0004314,0.4027817452382557,4.027829131555672,1,0.4,0.4,transcript,34249.0
MANSC4,ENSG00000205693,Drugs used in diabetes use measurement,EFO_0009924,0.4027646704635611,4.027946644647608,1,0.5,0.5,transcript,1667.0
FYCO1,ENSG00000163820,erythrocyte volume,OBA_0003460,0.4026870067838599,4.026894678679674,1,0.4,0.4,transcript,16253.0
ARHGAP28,ENSG00000088756,cerebral cortex area attribute,OBA_2045267,0.40265812528662387,4.026593554502356,1,0.4,0.4,transcript,32516.0
SLC7A2,ENSG00000003989,L-arginine measurement,EFO_0006524,0.40265517628376696,4.026672758458781,3,1.4,4.199999999999999,transcript,34712.0
NBAS,ENSG00000151779,Retinal dystrophy,HP_0000556,0.40265466148828016,4.026580160672805,2,1.0,2.0,transcript,59620.0
SEMA3C,ENSG00000075223,ovarian dysfunction,EFO_0009003,0.40263038824886704,4.026337600772409,1,0.4,0.4,transcript,11863.0
PRDM5,ENSG00000138738,smoking initiation,EFO_0005670,0.40262441077954503,4.0263247163903415,2,0.8,1.6,transcript,19849.0
DMRTA1,ENSG00000176399,glucose measurement,EFO_0004468,0.4026058839273433,4.026130446863838,1,0.4,0.4,transcript,5586.0
RFX7,ENSG00000181827,BMI-adjusted waist circumference,EFO_0007789,0.40249767822426874,4.024986374568826,1,0.4,0.4,transcript,41700.0
SLC22A24,ENSG00000197658,17alpha-hydroxypregnanolone glucuronide measurement,EFO_0800363,0.4024512852033208,4.024598147154327,1,0.5,0.5,transcript,5862.0
NEDD1,ENSG00000139350,body weight,EFO_0004338,0.4024079893095362,4.024099149787062,1,0.4,0.4,transcript,20772.0
NEDD1,ENSG00000139350,hip circumference,OBA_1000032,0.4024079893095362,4.024099149787062,1,0.4,0.4,transcript,20772.0
TC2N,ENSG00000165929,deep vein thrombosis,EFO_0003907,0.4024001306751188,4.024024071534069,1,0.4,0.4,transcript,17571.0
GMCL1,ENSG00000087338,trait in response to apixaban,OBA_2050328,0.40238123841347506,4.024066796600961,2,0.8,1.6,transcript,6289.0
CNTN5,ENSG00000149972,blood protein measurement,EFO_0007937,0.40234010846445534,4.023414065335775,1,0.4,0.4,transcript,30815.0
GCH1,ENSG00000131979,serum metabolite measurement,EFO_0005653,0.4023275177449595,4.02330894127166,1,0.4,0.4,transcript,11847.0
PTPRJ,ENSG00000149177,Alzheimer disease,MONDO_0004975,0.40230635137930937,4.023138701763019,2,0.8,1.6,transcript,21280.0
FRS2,ENSG00000166225,BMI-adjusted waist circumference,EFO_0007789,0.40228627370184533,4.022878845914591,1,0.4,0.4,transcript,24831.0
PLCL1,ENSG00000115896,urinary microalbumin measurement,EFO_0010967,0.4022712273594637,4.022801784084147,2,0.8,1.6,transcript,17875.0
CCDC66,ENSG00000180376,self reported educational attainment,EFO_0004784,0.40222907513287304,4.022305980837427,1,0.5,0.5,transcript,32831.0
PEX2,ENSG00000164751,total cortical area measurement,EFO_0008381,0.4022277183764959,4.022321009775696,1,0.4,0.4,transcript,9127.0
MMADHC,ENSG00000168288,reticulocyte measurement,EFO_0010700,0.4022277183764959,4.022358749833474,1,0.4,0.4,transcript,4904.0
BTC,ENSG00000174808,betacellulin measurement,EFO_0021883,0.40222371822982556,4.022359245160629,1,0.4,0.4,transcript,3277.0
QKI,ENSG00000112531,smoking status measurement,EFO_0006527,0.4020841121688893,4.020876693844787,2,0.8,1.6,transcript,44979.0
QKI,ENSG00000112531,mathematical ability,EFO_0004875,0.4020841121688893,4.020876693844787,2,0.8,1.6,transcript,44979.0
AKAP6,ENSG00000151320,high density lipoprotein cholesterol measurement,EFO_0004612,0.40207643156692485,4.0213390957279,7,2.8000000000000003,19.6,transcript,34100.0
PTPN4,ENSG00000088179,platelet volume,OBA_0003277,0.40202943742505987,4.02075798111198,5,2.0,10.0,transcript,21570.0
TULP4,ENSG00000130338,sitting height measurement,EFO_0011011,0.40199307384105354,4.01994966346731,1,0.4,0.4,transcript,21136.0
PDE11A,ENSG00000128655,body height,OBA_VT0001253,0.4019645739319296,4.019709522456629,2,0.8,1.6,transcript,25085.0
MAN1A2,ENSG00000198162,level of lysophosphatidic acid phosphatase type 6 in blood serum,OBA_2040483,0.4019273916423017,4.01940143694585,2,0.8,1.6,transcript,12547.0
MDGA2,ENSG00000139915,platelet volume,OBA_0003277,0.40192439078769704,4.019266998565651,1,0.4,0.4,transcript,17323.0
TGFBR1,ENSG00000106799,age-related macular degeneration,EFO_0001365,0.40190308340475006,4.019035081639647,1,0.4,0.4,transcript,94171.0
PICALM,ENSG00000073921,body mass index,EFO_0004340,0.4018864158198044,4.0188774265166165,1,0.4,0.4,transcript,30147.0
BCAS3,ENSG00000141376,anemia,MONDO_0002280,0.4017879331417673,4.017889730535828,1,0.5,0.5,transcript,48081.0
MANSC4,ENSG00000205693,pulse pressure measurement,EFO_0005763,0.40176879139611066,4.0179878539731035,1,0.5,0.5,transcript,1667.0
BTAF1,ENSG00000095564,platelet count,EFO_0004309,0.4017644289096424,4.017681033538827,1,0.4,0.4,transcript,10886.0
LTBP1,ENSG00000049323,corneal resistance factor,EFO_0010067,0.40176135814912173,4.01762624092091,1,0.4,0.4,transcript,31597.0
RNF144B,ENSG00000137393,body mass index,EFO_0004340,0.4017416684144958,4.0174895571637235,1,0.4,0.4,transcript,5489.0
MGA,ENSG00000174197,chronic lymphocytic leukemia,EFO_0000095,0.40173866240620615,4.017392545847125,1,0.5,0.5,transcript,84434.0
PEX2,ENSG00000164751,brain volume,OBA_2050009,0.4017122705417398,4.017166531428135,1,0.4,0.4,transcript,9127.0
RASA2,ENSG00000155903,hip circumference,OBA_1000032,0.4016928036885942,4.016975650265302,1,0.4,0.4,transcript,8401.0
EXOC6,ENSG00000138190,type 2 diabetes mellitus,MONDO_0005148,0.40163573666598085,4.0163799839303564,1,0.5,0.5,transcript,22107.0
CNTN5,ENSG00000149972,protein measurement,EFO_0004747,0.4016250752131558,4.01626373282278,1,0.4,0.4,transcript,30815.0
PLCL1,ENSG00000115896,mood instability measurement,EFO_0008475,0.4016150661896278,4.016240172385788,2,0.8,1.6,transcript,17875.0
MGA,ENSG00000174197,feeling nervous measurement,EFO_0009597,0.4015831297423854,4.015837219208917,1,0.5,0.5,transcript,84434.0
RFX7,ENSG00000181827,lymphocyte measurement,EFO_0803546,0.4015600186570728,4.0156097788968665,1,0.4,0.4,transcript,41700.0
CD69,ENSG00000110848,monocyte percentage of leukocytes,EFO_0007989,0.4015177308805741,4.016021784527063,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
SGCD,ENSG00000170624,low density lipoprotein cholesterol measurement,EFO_0004611,0.4015100710833759,4.015119499879745,1,0.4,0.4,transcript,21289.0
PRTG,ENSG00000166450,Palmar Fibromatosis,EFO_1000438,0.4014995397885158,4.015213473969482,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
SAMD11,ENSG00000187634,glomerular filtration rate,OBA_0003747,0.4014835457262733,4.014898286132599,2,0.8,1.6,transcript,25466.0
LHFPL2,ENSG00000145685,potassium measurement,EFO_0009283,0.40140003981068695,4.014027290671075,1,0.4,0.4,transcript,14874.0
SP4,ENSG00000105866,HMG CoA reductase inhibitor use measurement,EFO_0009932,0.4013163898759144,4.013187891081601,1,0.4,0.4,transcript,16672.0
TRHDE,ENSG00000072657,risk-taking behaviour,EFO_0008579,0.40131317838297653,4.013231354431545,2,0.8,1.6,transcript,16069.0
DCLK1,ENSG00000133083,protein measurement,EFO_0004747,0.4012880047375263,4.012930245028523,2,0.8,1.6,transcript,31874.0
TMEM131,ENSG00000075568,eosinophil measurement,EFO_0803540,0.40125315150073226,4.012552963878576,1,0.4,0.4,transcript,18649.0
ZNF507,ENSG00000168813,systolic blood pressure,EFO_0006335,0.4012356047265476,4.012370446113569,1,0.4,0.4,transcript,27780.0
CSMD3,ENSG00000164796,metabolite measurement,EFO_0004725,0.4011639390757763,4.011647499479504,1,0.5,0.5,transcript,61662.0
TSPAN3,ENSG00000140391,BMI-adjusted waist circumference,EFO_0007789,0.4010767389174326,4.010789299779058,1,0.4,0.4,transcript,18256.0
TPRG1,ENSG00000188001,bone tissue density,OBA_1000110,0.4010476543087372,4.010576399543716,2,0.8,1.6,transcript,16023.0
NEDD1,ENSG00000139350,glucose measurement,EFO_0004468,0.40103916045642335,4.010410861255934,1,0.4,0.4,transcript,20772.0
NEBL,ENSG00000078114,heel bone mineral density,EFO_0009270,0.4010210505715642,4.010218327534606,1,0.4,0.4,transcript,51139.0
RALGPS2,ENSG00000116191,mean corpuscular hemoglobin concentration,EFO_0004528,0.40099429610531867,4.010022495775064,2,0.8,1.6,transcript,20117.0
PLEKHA6,ENSG00000143850,monocyte count,EFO_0005091,0.40098584537978466,4.009865268456177,1,0.4,0.4,transcript,58697.0
DNAJC21,ENSG00000168724,metabolite measurement,EFO_0004725,0.4009793346142884,4.009802369174172,1,0.4,0.4,transcript,44331.0
NEDD4,ENSG00000069869,triglycerides:total lipids ratio,EFO_0020947,0.4009759398825329,4.009767708786896,1,0.4,0.4,transcript,48135.0
CSMD3,ENSG00000164796,prostate specific antigen amount,OBA_2050200,0.4009759398825329,4.00976750754707,1,0.5,0.5,transcript,61662.0
MCL1,ENSG00000143384,eosinophil count,EFO_0004842,0.40095529561015,4.009569725480613,1,0.4,0.4,transcript,23853.0
PLXND1,ENSG00000004399,coronary artery disease,EFO_0001645,0.40095367019616834,4.009560382931656,1,0.5,0.5,transcript,21114.0
NDFIP2,ENSG00000102471,smoking initiation,EFO_0005670,0.4009252350919351,4.00926683278534,2,0.8,1.6,transcript,110483.0
TBL2,ENSG00000106638,triglycerides:total lipids ratio,EFO_0020947,0.4009048572069859,4.009063750607407,1,0.4,0.4,transcript,26353.0
SH3TC2,ENSG00000169247,Increased blood pressure,HP_0032263,0.400901128114029,4.009015704548968,1,0.4,0.4,transcript,90428.0
REEP3,ENSG00000165476,eosinophil count,EFO_0004842,0.40087499446599456,4.008819728330566,1,0.4,0.4,transcript,5732.0
EVI5,ENSG00000067208,erythrocyte volume,OBA_0003460,0.4008657785562723,4.008663441511366,1,0.4,0.4,transcript,70722.0
PTPRJ,ENSG00000149177,cholesteryl ester measurement,EFO_0010351,0.400860027975872,4.0086754677286445,2,0.8,1.6,transcript,21280.0
FARSB,ENSG00000116120,neurodegenerative disease,EFO_0005772,0.40084181320525647,4.008469152460728,1,0.4,0.4,transcript,7840.0
SGCD,ENSG00000170624,pulse pressure measurement,EFO_0005763,0.4008364481217517,4.008383270263503,1,0.4,0.4,transcript,21289.0
COL19A1,ENSG00000082293,erythrocyte volume,OBA_0003460,0.40081351853869374,4.008272524442731,2,0.8,1.6,transcript,11650.0
ITGA8,ENSG00000077943,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.40081351853869374,4.0085999413900355,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
LTBP1,ENSG00000049323,multinodular goiter,MONDO_0000334,0.4008054366550185,4.008067025979878,1,0.4,0.4,transcript,31597.0
FAT3,ENSG00000165323,putamen volume,OBA_2050016,0.40079790482865774,4.007987377281892,1,0.4,0.4,transcript,48025.0
TCERG1L,ENSG00000176769,preeclampsia,EFO_0000668,0.4007436413196038,4.007664593458446,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,preeclampsia,EFO_0000668,0.4007436413196038,4.007664593458446,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,preeclampsia,EFO_0000668,0.4007436413196038,4.007664593458446,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,preeclampsia,EFO_0000668,0.4007436413196038,4.007664593458446,2,0.8,1.6,gene_variant,7012.0
PEX7,ENSG00000112357,platelet count,EFO_0004309,0.40073709486656184,4.0074134928051635,1,0.4,0.4,transcript,9402.0
ZNF507,ENSG00000168813,nervous system benign neoplasm,MONDO_0000648,0.4006971271703507,4.006985670551599,1,0.4,0.4,transcript,27780.0
GLB1,ENSG00000170266,Glucocorticoid use measurement,EFO_0009942,0.40064101056740836,4.006441013753456,1,0.5,0.5,transcript,16177.0
ACTN2,ENSG00000077522,left ventricular noncompaction,MONDO_0018901,0.4006394322967241,4.006411008579029,2,0.8,1.6,transcript,95891.0
ALDOB,ENSG00000136872,alkaline phosphatase measurement,EFO_0004533,0.4006297518183996,4.0063389303384636,1,0.4,0.4,transcript,9659.0
PLXNA4,ENSG00000221866,alcohol consumption quality,OBA_1000840,0.40061280036601893,4.006140251057617,1,0.4,0.4,transcript,32660.0
FRS2,ENSG00000166225,systolic blood pressure,EFO_0006335,0.40061181716836547,4.006134280579793,1,0.4,0.4,transcript,24831.0
PCDH18,ENSG00000189184,metabolite measurement,EFO_0004725,0.40059404375618024,4.006017609220511,2,0.8,1.6,transcript,20733.0
GNA13,ENSG00000120063,white matter microstructure measurement,EFO_0005674,0.40058025909501616,4.005854197194517,1,0.4,0.4,transcript,7751.0
CYTL1,ENSG00000170891,high density lipoprotein cholesterol measurement,EFO_0004612,0.40057933985598587,4.006012336709831,1,0.4,0.4,transcript,1827.0
GPD2,ENSG00000115159,gestational diabetes,EFO_0004593,0.4005532107661267,4.005549773945164,1,0.4,0.4,transcript,22642.0
NEBL,ENSG00000078114,atrial flutter,EFO_0003911,0.4004101293424045,4.004109115243009,1,0.4,0.4,transcript,51139.0
FSIP2,ENSG00000188738,triglyceride measurement,EFO_0004530,0.4003985070195069,4.004264010222964,4,2.0,8.0,transcript,28680.0
BCAS3,ENSG00000141376,mean corpuscular hemoglobin concentration,EFO_0004528,0.4003908019756156,4.003918418874311,1,0.5,0.5,transcript,48081.0
GIPC2,ENSG00000137960,self reported educational attainment,EFO_0004784,0.40034058177760745,4.003797015820084,2,0.8,1.6,transcript,4090.0
DDR2,ENSG00000162733,colorectal cancer,MONDO_0005575,0.4003103144320206,4.003117184827068,1,0.4,0.4,transcript,28489.0
HS6ST3,ENSG00000185352,waist circumference,OBA_1001085,0.4002776685880269,4.0028235462364075,1,0.4,0.4,transcript,8536.0
TNRC6B,ENSG00000100354,Neurodevelopmental disorder,EFO_0010642,0.40022418430230833,4.00224829484411,1,0.4,0.4,transcript,61998.0
CNTN5,ENSG00000149972,insomnia,EFO_0004698,0.40013810133724087,4.00139399406363,1,0.4,0.4,transcript,30815.0
XKR4,ENSG00000206579,serum creatinine amount,OBA_2050096,0.40004507289768654,4.000469680933655,1,0.4,0.4,transcript,21106.0
CENPC,ENSG00000145241,chronic obstructive pulmonary disease,EFO_0000341,0.4000054459223314,4.000253266380372,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
PTK2,ENSG00000169398,hypertension,EFO_0000537,0.3999547541962771,3.9995523841674268,1,0.4,0.4,transcript,82607.0
CBLB,ENSG00000114423,Thyroid preparation use measurement,EFO_0009933,0.39989705195088954,3.9989790111764467,1,0.4,0.4,transcript,47105.0
DLG2,ENSG00000150672,blood sodium bicarbonate amount,OBA_2050094,0.3998833553286334,3.9988363262114928,1,0.4,0.4,transcript,144252.0
CR2,ENSG00000117322,common variable immunodeficiency,MONDO_0015517,0.39985550565984834,3.998573382525088,1,0.4,0.4,transcript,21827.0
CEP68,ENSG00000011523,cardiovascular disease,EFO_0000319,0.3998117464485717,3.9981542315946785,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,cardiovascular disease,EFO_0000319,0.3998117464485717,3.9981542315946785,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,cardiovascular disease,EFO_0000319,0.3998117464485717,3.9981542315946785,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,cardiovascular disease,EFO_0000319,0.3998117464485717,3.9981542315946785,3,1.5,4.5,transcript,122392.0
SKP2,ENSG00000145604,HbA1c measurement,EFO_0004541,0.3998079225284987,3.998084248138973,1,0.4,0.4,transcript,79636.0
EVI5,ENSG00000067208,total blood protein measurement,EFO_0004536,0.3997860941838133,3.997866597786777,1,0.4,0.4,transcript,70722.0
LATS1,ENSG00000131023,subiculum volume,OBA_2050024,0.3996696279673962,3.9967136362651274,1,0.4,0.4,transcript,23046.0
NDUFS4,ENSG00000164258,gestational diabetes,EFO_0004593,0.39962926112941494,3.9963991926956948,1,0.4,0.4,transcript,3753.0
NDUFAF4,ENSG00000123545,gestational diabetes,EFO_0004593,0.39962926112941494,3.9964041561909704,1,0.4,0.4,transcript,3586.0
NDUFAF2,ENSG00000164182,gestational diabetes,EFO_0004593,0.39962926112941494,3.9963328163398826,1,0.4,0.4,transcript,9949.0
DMRTA1,ENSG00000176399,hemoglobin measurement,EFO_0004509,0.3995739905924584,3.9958115135149885,1,0.4,0.4,transcript,5586.0
KCNIP4,ENSG00000185774,arterial stiffness measurement,EFO_0004517,0.3995556597357739,3.9956892453431476,2,0.8,1.6,transcript,12062.0
CYBRD1,ENSG00000071967,corneal resistance factor,EFO_0010067,0.3995106669086341,3.995140778406713,1,0.4,0.4,transcript,11727.0
DMRTA1,ENSG00000176399,dental caries,EFO_0003819,0.3995095067646718,3.995166675237122,1,0.4,0.4,transcript,5586.0
ABCB1,ENSG00000085563,serum alanine aminotransferase measurement,EFO_0004735,0.3993471035395394,3.9934950831060516,1,0.5,0.5,transcript,20792.0
CNOT6L,ENSG00000138767,neuroimaging measurement,EFO_0004346,0.399292878265486,3.9930586715277134,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
FAS,ENSG00000026103,ulcerative colitis,EFO_0000729,0.39929075674440706,3.9929097756686027,1,0.4,0.4,transcript,181141.0
PTPRJ,ENSG00000149177,glomerular filtration rate,OBA_0003747,0.399282440178196,3.9928995897518846,2,0.8,1.6,transcript,21280.0
ARHGAP12,ENSG00000165322,monocyte count,EFO_0005091,0.3992624946722818,3.992637009085232,1,0.4,0.4,transcript,33161.0
U2SURP,ENSG00000163714,alkaline phosphatase measurement,EFO_0004533,0.39924217659292743,3.992472173918941,2,0.8,1.6,transcript,31741.0
IQGAP2,ENSG00000145703,HbA1c measurement,EFO_0004541,0.3992206366807554,3.992221037738571,1,0.5,0.5,transcript,34081.0
DENND1B,ENSG00000213047,diastolic blood pressure,EFO_0006336,0.3992106024368598,3.992542781880827,5,2.0,10.0,transcript,22896.0
NCKAP1,ENSG00000061676,complex neurodevelopmental disorder,MONDO_0100038,0.3991462430594779,3.9914722598121273,1,0.4,0.4,transcript,40695.0
FGA,ENSG00000171560,AFib amyloidosis,MONDO_0019733,0.3991462430594779,3.9915306550532472,1,0.4,0.4,transcript,5863.0
DLC1,ENSG00000164741,HbA1c measurement,EFO_0004541,0.3991213193520419,3.9912248726935338,1,0.4,0.4,transcript,34249.0
LYPLAL1,ENSG00000143353,BMI-adjusted hip circumference,EFO_0008039,0.39908950212801086,3.9909228175887588,1,0.5,0.5,transcript,17988.0
GPD2,ENSG00000115159,self reported educational attainment,EFO_0004784,0.3990679330733841,3.9906969970177384,1,0.4,0.4,transcript,22642.0
SORL1,ENSG00000137642,alcohol use disorder measurement,EFO_0009458,0.3990679330733841,3.9907263403969386,2,0.9,1.8,transcript,38290.0
YTHDC2,ENSG00000047188,waist circumference,OBA_1001085,0.39902705013855,3.9902907105503562,1,0.4,0.4,transcript,19793.0
RTKN2,ENSG00000182010,neurodegenerative disease,EFO_0005772,0.3990125516931222,3.9901607747540515,1,0.4,0.4,transcript,11345.0
CTBP2,ENSG00000175029,prostate carcinoma,EFO_0001663,0.39894359568549714,3.989450020069119,1,0.4,0.4,transcript,28443.0
LARP4B,ENSG00000107929,reticulocyte measurement,EFO_0010700,0.3989310543495352,3.989321555498435,1,0.5,0.5,transcript,45405.0
REEP3,ENSG00000165476,phospholipids:total lipids ratio,EFO_0020946,0.3989211490403886,3.989281274074507,1,0.4,0.4,transcript,5732.0
BCKDHB,ENSG00000083123,whole body water mass,EFO_0009805,0.3989119242253126,3.994846619114523,10,4.0,40.0,transcript,6984.0
EPRS1,ENSG00000136628,bone tissue density,OBA_1000110,0.3988098192291169,3.988142907011255,1,0.5,0.5,transcript,11182.0
MDGA2,ENSG00000139915,cigarettes per day measurement,EFO_0006525,0.39875888140656185,3.9876119047542984,1,0.4,0.4,transcript,17323.0
NDUFAF2,ENSG00000164182,schizophrenia,MONDO_0005090,0.39873259968556457,3.987366201901379,1,0.4,0.4,transcript,9949.0
DLG2,ENSG00000150672,body mass index,EFO_0004340,0.39866113484181254,3.986614121343284,1,0.4,0.4,transcript,144252.0
DLC1,ENSG00000164741,vital capacity,EFO_0004312,0.39858422475572086,3.985853926730323,1,0.4,0.4,transcript,34249.0
MAP2K6,ENSG00000108984,low density lipoprotein cholesterol measurement,EFO_0004611,0.3985043565021997,3.985060867556818,1,0.4,0.4,transcript,23118.0
AP1S2,ENSG00000182287,genetic disorder,EFO_0000508,0.39848544214765586,3.9848752309656854,1,0.4,0.4,transcript,19222.0
SYT13,ENSG00000019505,hypertrophic cardiomyopathy,EFO_0000538,0.39843147736678597,3.98453005892082,2,0.8,1.6,transcript,7432.0
HECW2,ENSG00000138411,metabolite measurement,EFO_0004725,0.3984143234615983,3.984149050767435,1,0.4,0.4,transcript,68774.0
SEMA3C,ENSG00000075223,glaucoma,MONDO_0005041,0.39830512089751086,3.9830849272588478,1,0.4,0.4,transcript,11863.0
UHMK1,ENSG00000152332,neutrophil count,EFO_0004833,0.39828029124845044,3.9829295303798338,3,1.2000000000000002,3.6000000000000005,transcript,28432.0
FAS,ENSG00000026103,neutrophil count,EFO_0004833,0.3982348140450207,3.982350348674739,1,0.4,0.4,transcript,181141.0
SLC11A2,ENSG00000110911,ferritin measurement,EFO_0004459,0.39815101017778387,3.9815380630514747,2,0.8,1.6,transcript,57222.0
ITGB8,ENSG00000105855,deep vein thrombosis,EFO_0003907,0.39814097789641156,3.981580306177417,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
SFRP1,ENSG00000104332,cerebral cortex area attribute,OBA_2045267,0.3981215472017311,3.9812634509066,1,0.4,0.4,transcript,8337.0
ADGRV1,ENSG00000164199,blood sodium bicarbonate amount,OBA_2050094,0.39808259642860866,3.980830389456456,1,0.5,0.5,transcript,112990.0
IQGAP2,ENSG00000145703,BMI-adjusted waist circumference,EFO_0007789,0.39801097997259766,3.980124470656994,1,0.5,0.5,transcript,34081.0
WRN,ENSG00000165392,self reported educational attainment,EFO_0004784,0.3979767550988609,3.9797949527532825,1,0.5,0.5,transcript,18247.0
YIPF4,ENSG00000119820,age at menopause,EFO_0004704,0.39785627971995,3.978680974317456,2,0.8,1.6,transcript,13539.0
DSC2,ENSG00000134755,triglyceride measurement,EFO_0004530,0.39776655984304093,3.9776780404970364,2,0.8,1.6,transcript,128596.0
GPD2,ENSG00000115159,vital capacity,EFO_0004312,0.39772450568784184,3.9772627231623154,1,0.4,0.4,transcript,22642.0
SPRED1,ENSG00000166068,neurofibromatosis-Noonan syndrome,MONDO_0011035,0.39770898806903743,3.9771344539018743,1,0.4,0.4,transcript,8974.0
FRS2,ENSG00000166225,forced expiratory volume,EFO_0004314,0.3977035615662353,3.977051724558491,1,0.4,0.4,transcript,24831.0
PEAK1,ENSG00000173517,eosinophil count,EFO_0004842,0.3976785739316198,3.976792661767438,1,0.4,0.4,transcript,57783.0
IQGAP1,ENSG00000140575,balding measurement,EFO_0007825,0.39767553015497514,3.9768093994669815,2,0.8,1.6,transcript,29576.0
RFX3,ENSG00000080298,smoking initiation,EFO_0005670,0.3976687703263966,3.9767442044293024,2,0.8,1.6,transcript,28318.0
SAMD9L,ENSG00000177409,level of serum paraoxonase/arylesterase 1 in blood serum,OBA_2044998,0.39766308984462884,3.9766393513530316,1,0.4,0.4,transcript,47321.0
ATAD2B,ENSG00000119778,cerebral cortex area attribute,OBA_2045267,0.3974931906643414,3.974950084330304,1,0.4,0.4,transcript,22005.0
TULP4,ENSG00000130338,smoking initiation,EFO_0005670,0.3974786499877512,3.974805424934287,1,0.4,0.4,transcript,21136.0
TSPAN9,ENSG00000011105,red blood cell density,OBA_2045260,0.3974513999771206,3.974549483413247,1,0.5,0.5,transcript,14091.0
TRIM36,ENSG00000152503,neurodegenerative disease,EFO_0005772,0.3973174815760925,3.973200976650395,1,0.4,0.4,transcript,15290.0
HFM1,ENSG00000162669,genetic non-acquired premature ovarian failure,EFO_0010646,0.39729834378605444,3.9731132742666726,2,1.0,2.0,transcript,15404.0
GFRAL,ENSG00000187871,heel bone mineral density,EFO_0009270,0.3971542671857033,3.9717519863520616,1,0.4,0.4,transcript,1911.0
ANKRD36,ENSG00000135976,reticulocyte count,EFO_0007986,0.3971528509334459,3.9716038956895283,2,1.0,2.0,transcript,26530.0
PLEKHA6,ENSG00000143850,diastolic blood pressure change measurement,EFO_0006945,0.39701599322072484,3.9701667468655786,1,0.4,0.4,transcript,58697.0
NID2,ENSG00000087303,HbA1c measurement,EFO_0004541,0.3969555604105304,3.969600738606116,1,0.5,0.5,transcript,11078.0
PTPRJ,ENSG00000149177,cholesterol to total lipids in medium HDL percentage ,EFO_0022237,0.39692304408060325,3.9693056287759574,2,0.8,1.6,transcript,21280.0
SLAMF7,ENSG00000026751,neoplasm,EFO_0000616,0.3969026564897769,3.969042761196915,1,0.4,0.4,transcript,24697.0
SKI,ENSG00000157933,serum gamma-glutamyl transferase measurement,EFO_0004532,0.39689941445700855,3.969046665578489,1,0.4,0.4,transcript,7616.0
FAT1,ENSG00000083857,non-small cell lung carcinoma,EFO_0003060,0.3968907378598939,3.9689285740207283,1,0.5,0.5,transcript,23590.0
LRBA,ENSG00000198589,body mass index,EFO_0004340,0.39686894817388757,3.9686934232468967,1,0.4,0.4,transcript,101484.0
NDFIP2,ENSG00000102471,high density lipoprotein cholesterol measurement,EFO_0004612,0.39681952666782433,3.968209748544232,2,0.8,1.6,transcript,110483.0
C2orf73,ENSG00000177994,cerebral cortex area attribute,OBA_2045267,0.3967824889837315,3.9678731990160587,1,0.4,0.4,transcript,8280.0
TULP4,ENSG00000130338,neuroimaging measurement,EFO_0004346,0.3967781779060994,3.9678007041177694,1,0.4,0.4,transcript,21136.0
NEK1,ENSG00000137601,motor neuron disease,EFO_0003782,0.3967552266447045,3.9675665263153195,2,0.8,1.6,transcript,112203.0
HFM1,ENSG00000162669,neurodegenerative disease,EFO_0005772,0.39674423424883615,3.9675721788944895,2,1.0,2.0,transcript,15404.0
PCDH18,ENSG00000189184,platelet volume,OBA_0003277,0.3967357359679448,3.9674345313381565,2,0.8,1.6,transcript,20733.0
F13B,ENSG00000143278,macular degeneration,EFO_0009606,0.39667678028134395,3.9668757009575915,1,0.5,0.5,transcript,4634.0
TRHDE,ENSG00000072657,obesity,EFO_0001073,0.3966681415945188,3.9667809865469676,2,0.8,1.6,transcript,16069.0
GCNT1,ENSG00000187210,myeloid leukocyte count,OBA_2045223,0.39666209900399857,3.9666400876766534,1,0.4,0.4,transcript,20945.0
SKI,ENSG00000157933,platelet crit,EFO_0007985,0.3966573353262117,3.9666258742705205,1,0.4,0.4,transcript,7616.0
GCH1,ENSG00000131979,mathematical ability,EFO_0004875,0.3966300575635186,3.9663343394572506,1,0.4,0.4,transcript,11847.0
AKAP11,ENSG00000023516,bone quantitative ultrasound measurement,EFO_0004514,0.3966120121833065,3.966520121833065,1,0.4,0.4,transcript,1000.0
PEX13,ENSG00000162928,lysosomal storage disease,MONDO_0002561,0.3965995193238952,3.966041022753159,1,0.4,0.4,transcript,8728.0
LTBP1,ENSG00000049323,hip circumference,OBA_1000032,0.39645722630633046,3.964584922492997,1,0.4,0.4,transcript,31597.0
FGFR1OP2,ENSG00000111790,platelet count,EFO_0004309,0.3964367740494941,3.9644038741896113,1,0.4,0.4,transcript,11070.0
PLCL1,ENSG00000115896,Eczematoid dermatitis,HP_0000964,0.3964306662312489,3.9643961728019996,2,0.8,1.6,transcript,17875.0
AKAP11,ENSG00000023516,spinal stenosis,EFO_0007490,0.39638371869478706,3.9642371869478703,1,0.4,0.4,transcript,1000.0
ARHGAP29,ENSG00000137962,platelet crit,EFO_0007985,0.3963746982801576,3.9637672085206,1,0.5,0.5,transcript,24721.0
FAT1,ENSG00000083857,oral squamous cell carcinoma,EFO_0000199,0.3963260054558931,3.9632812499807195,1,0.5,0.5,transcript,23590.0
SYT13,ENSG00000019505,serum creatinine amount,OBA_2050096,0.3963144464437352,3.963359749690312,2,0.8,1.6,transcript,7432.0
TNRC6B,ENSG00000100354,chronotype measurement,EFO_0008328,0.39627190109078575,3.962725462728884,1,0.4,0.4,transcript,61998.0
GABRA4,ENSG00000109158,West syndrome,MONDO_0018097,0.39627173307859687,3.9627424816914014,1,0.4,0.4,transcript,15904.0
FAT4,ENSG00000196159,melanoma,EFO_0000756,0.39626150548850547,3.962623764927734,1,0.4,0.4,transcript,45924.0
RAD18,ENSG00000070950,age at menopause,EFO_0004704,0.3961731574001361,3.9617650552100327,1,0.4,0.4,transcript,11947.0
PRDM5,ENSG00000138738,type 2 diabetes mellitus,MONDO_0005148,0.39615838934156905,3.961664502010582,2,0.8,1.6,transcript,19849.0
MANSC4,ENSG00000205693,diabetes mellitus,EFO_0000400,0.3961487611957298,3.9617875519692953,1,0.5,0.5,transcript,1667.0
WAPL,ENSG00000062650,platelet count,EFO_0004309,0.39611123345002114,3.9612460913970513,2,0.8,1.6,transcript,11962.0
ULK4,ENSG00000168038,red blood cell density,OBA_2045260,0.39601255569727556,3.9601665170776132,1,0.5,0.5,transcript,12207.0
FAT1,ENSG00000083857,nephrotic syndrome,EFO_0004255,0.39600586185660425,3.9600798139878313,1,0.5,0.5,transcript,23590.0
RNF150,ENSG00000170153,body mass index,EFO_0004340,0.3960032099608407,3.960290758623078,4,1.6,6.4,transcript,24743.0
PCMTD1,ENSG00000168300,peak expiratory flow,EFO_0009718,0.39598390975806186,3.9600439456516328,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
ARAP1,ENSG00000186635,body fat percentage,EFO_0007800,0.39595852536505277,3.959594263268295,1,0.4,0.4,transcript,44397.0
TSPAN9,ENSG00000011105,cystatin C measurement,EFO_0004617,0.39593749815946006,3.9594104652366418,1,0.5,0.5,transcript,14091.0
HEG1,ENSG00000173706,cystatin C measurement,EFO_0004617,0.3959291262211308,3.9593131284989593,1,0.4,0.4,transcript,18293.0
LINGO2,ENSG00000174482,alcohol consumption quality,OBA_1000840,0.3959264995942067,3.959276714806509,1,0.4,0.4,transcript,34133.0
DYNLT5,ENSG00000152760,lymphocyte count,EFO_0004587,0.3957783496044066,3.9578536591733418,1,0.4,0.4,transcript,5701.0
AKAP11,ENSG00000023516,"osteoarthritis, knee",EFO_0004616,0.3957093049265041,3.957493049265041,1,0.4,0.4,transcript,1000.0
MMP12,ENSG00000262406,peripheral vascular disease,EFO_0003875,0.3956548118525258,3.956767657493425,1,0.4,0.4,transcript,1822.0
PLCL1,ENSG00000115896,erythrocyte volume,OBA_0003460,0.39560341655993164,3.956123676088827,2,0.8,1.6,transcript,17875.0
MEOX2,ENSG00000106511,metabolite measurement,EFO_0004725,0.3955888571028079,3.9560572762157635,1,0.4,0.4,transcript,2371.0
PLEC,ENSG00000178209,multiple sclerosis,MONDO_0005301,0.39552267390883405,3.955235803353984,2,0.9,1.8,transcript,198582.0
TSPAN3,ENSG00000140391,hematocrit,EFO_0004348,0.39546707189959857,3.9546926296007183,1,0.4,0.4,transcript,18256.0
DMAC1,ENSG00000137038,metabolite measurement,EFO_0004725,0.395405912528384,3.9541746988175004,1,0.4,0.4,transcript,3461.0
CNTN5,ENSG00000149972,bone tissue density,OBA_1000110,0.3953413922579416,3.953426903270638,1,0.4,0.4,transcript,30815.0
ARAP1,ENSG00000186635,platelet component distribution width,EFO_0007984,0.3953403979066025,3.9534129886837923,1,0.4,0.4,transcript,44397.0
PRDM5,ENSG00000138738,cerebral cortex area attribute,OBA_2045267,0.39531647244392054,3.953245333034097,2,0.8,1.6,transcript,19849.0
DENND1B,ENSG00000213047,autoimmune disease,EFO_0005140,0.3952865288383728,3.9533020458959567,5,2.0,10.0,transcript,22896.0
BCAS3,ENSG00000141376,blood phosphate measurement,EFO_0010972,0.3952149775445472,3.952160174563627,1,0.5,0.5,transcript,48081.0
PLCL1,ENSG00000115896,erythrocyte count,EFO_0004305,0.39519853391022663,3.952074849591777,2,0.8,1.6,transcript,17875.0
TBL2,ENSG00000106638,linoleic acid measurement,EFO_0006807,0.39519849955354835,3.9520001740730315,1,0.4,0.4,transcript,26353.0
PLA2R1,ENSG00000153246,high density lipoprotein cholesterol measurement,EFO_0004612,0.3951707000988809,3.9517861932279694,2,0.8,1.6,transcript,20204.0
APOBEC3H,ENSG00000100298,glomerular filtration rate,OBA_0003747,0.39516845682148277,3.9517611525533307,1,0.4,0.4,transcript,5223.0
IL1A,ENSG00000115008,endometriosis,EFO_0001065,0.39510088803514926,3.9512071946797027,1,0.4,0.4,transcript,2017.0
NDST3,ENSG00000164100,smoking initiation,EFO_0005670,0.3950883202494,3.950933265072223,1,0.4,0.4,transcript,7990.0
TGFBR1,ENSG00000106799,respiratory system disease,EFO_0000684,0.3950513155314883,3.950517402907029,1,0.4,0.4,transcript,94171.0
MRPL32,ENSG00000106591,brain volume,OBA_2050009,0.3950495512746737,3.950578655544492,1,0.4,0.4,transcript,4811.0
ANKRD10,ENSG00000088448,high density lipoprotein cholesterol measurement,EFO_0004612,0.39503705895443386,3.9505486839343655,2,0.8,1.6,transcript,8984.0
C12orf42,ENSG00000179088,overnutrition,MONDO_0003916,0.39500381126629497,3.95007325216678,1,0.5,0.5,transcript,14229.0
SH3GL3,ENSG00000140600,vital capacity,EFO_0004312,0.3949017352023925,3.949069044967838,1,0.4,0.4,transcript,7738.0
NDUFS4,ENSG00000164258,erythrocyte volume,OBA_0003460,0.3948351003114108,3.948457584515653,1,0.4,0.4,transcript,3753.0
PCDH10,ENSG00000138650,injury,EFO_0000546,0.3948200218677712,3.9483140814730437,2,0.8,1.6,transcript,14052.0
DCK,ENSG00000156136,erythrocyte volume,OBA_0003460,0.3948192829910848,3.9482298155789017,1,0.4,0.4,transcript,10815.0
PARP11,ENSG00000111224,mean reticulocyte volume,EFO_0010701,0.3947885815780481,3.947903764268321,1,0.4,0.4,transcript,22286.0
ARHGAP12,ENSG00000165322,uterine fibroid,EFO_0000731,0.39478292589313124,3.9478413212937262,1,0.4,0.4,transcript,33161.0
LRRK2,ENSG00000188906,body mass index,EFO_0004340,0.3947734695066516,3.9477534528822726,2,0.9,1.8,transcript,95960.0
STXBP4,ENSG00000166263,aging,EFO_0022597,0.3947298347027731,3.947690058414781,5,2.0,10.0,transcript,25529.0
CCDC88C,ENSG00000015133,cerebral cortex area attribute,OBA_2045267,0.39467297490789316,3.9467490718169635,1,0.4,0.4,transcript,20701.0
KLHL3,ENSG00000146021,erythrocyte volume,OBA_0003460,0.3946640937960513,3.9466882486438566,2,0.8,1.6,transcript,33819.0
NEBL,ENSG00000078114,placenta praevia,EFO_0007442,0.3946592084533096,3.94659990635206,1,0.4,0.4,transcript,51139.0
RANBP17,ENSG00000204764,waist circumference,OBA_1001085,0.39463000967636724,3.946309611058901,1,0.4,0.4,transcript,42042.0
RPS6KA5,ENSG00000100784,Abnormality of the skeletal system,HP_0000924,0.39462193824505537,3.9462292473020875,1,0.4,0.4,transcript,40548.0
TULP4,ENSG00000130338,smoking status measurement,EFO_0006527,0.3945945910344199,3.945964835400974,1,0.4,0.4,transcript,21136.0
PROK2,ENSG00000163421,neuroimaging measurement,EFO_0004346,0.3945895245439398,3.9464107093569236,2,0.8,1.6,transcript,3104.0
PLEC,ENSG00000178209,calcium measurement,EFO_0004838,0.39454367186798023,3.9454457829454457,2,0.9,1.8,transcript,198582.0
TNRC6B,ENSG00000100354,lymphocyte count,EFO_0004587,0.3944865202835936,3.9448716546569624,1,0.4,0.4,transcript,61998.0
FAT1,ENSG00000083857,esophageal squamous cell carcinoma,EFO_0005922,0.39445241233415873,3.944545318763376,1,0.5,0.5,transcript,23590.0
PSD3,ENSG00000156011,EDTA measurement,EFO_0800946,0.394302739666675,3.9430368397603073,1,0.4,0.4,transcript,42359.0
FAT4,ENSG00000196159,gastric adenocarcinoma,EFO_0000503,0.3942672995752942,3.9426817057956214,1,0.4,0.4,transcript,45924.0
NUDCD1,ENSG00000120526,platelet count,EFO_0004309,0.39424916530360166,3.942502641443247,1,0.4,0.4,transcript,36402.0
MANSC4,ENSG00000205693,diabetic retinopathy,EFO_0003770,0.39424597284833046,3.9427596684953023,1,0.5,0.5,transcript,1667.0
USP37,ENSG00000135913,high density lipoprotein cholesterol measurement,EFO_0004612,0.3942026522631421,3.9421661495173534,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
FAM210A,ENSG00000177150,metabolite measurement,EFO_0004725,0.39417815250338367,3.9418036709755926,1,0.4,0.4,transcript,18062.0
TLR10,ENSG00000174123,high density lipoprotein cholesterol measurement,EFO_0004612,0.3941625888697048,3.9417873309141873,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
NAF1,ENSG00000145414,pulmonary fibrosis,EFO_0009448,0.3941517819676972,3.9415797698690174,1,0.5,0.5,transcript,8071.0
IL17A,ENSG00000112115,Arthritis,HP_0001369,0.3941455319923151,3.941669109340575,1,0.4,0.4,transcript,1871.0
CAPN7,ENSG00000131375,high density lipoprotein cholesterol measurement,EFO_0004612,0.3941284198875601,3.941322846218596,1,0.4,0.4,transcript,10350.0
AKAP11,ENSG00000023516,spine bone mineral density,EFO_0007701,0.39410449202552206,3.9414449202552206,1,0.4,0.4,transcript,1000.0
PLXND1,ENSG00000004399,cerebral cortex area attribute,OBA_2045267,0.3940903913540349,3.9409275945103213,1,0.5,0.5,transcript,21114.0
ANKH,ENSG00000154122,cerebrospinal fluid composition attribute,OBA_2045291,0.3940274243783898,3.941042686406848,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,cerebrospinal fluid composition attribute,OBA_2045291,0.3940274243783898,3.941042686406848,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,cerebrospinal fluid composition attribute,OBA_2045291,0.3940274243783898,3.941042686406848,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,cerebrospinal fluid composition attribute,OBA_2045291,0.3940274243783898,3.941042686406848,5,2.4,12.0,transcript,15616.0
ARMC1,ENSG00000104442,type 1 diabetes mellitus,MONDO_0005147,0.3940064871123282,3.9401094195139716,1,0.4,0.4,transcript,8979.0
SORL1,ENSG00000137642,atrial fibrillation,EFO_0000275,0.39394448663532133,3.9394918760163105,2,0.9,1.8,transcript,38290.0
FUT2,ENSG00000176920,COVID-19,MONDO_0100096,0.3939298776727677,3.939421803178364,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
ADK,ENSG00000156110,pulse pressure measurement,EFO_0005763,0.39386954782865885,3.93871446172354,1,0.4,0.4,transcript,21071.0
RSBN1L,ENSG00000187257,BMI-adjusted waist-hip ratio,EFO_0007788,0.39384886680836806,3.938625385164771,2,0.8,1.6,transcript,11703.0
FAT1,ENSG00000083857,multiple myeloma,EFO_0001378,0.39375227070749724,3.937543902496761,1,0.5,0.5,transcript,23590.0
MAGI2,ENSG00000187391,arterial stiffness measurement,EFO_0004517,0.3937303878674168,3.937308442071161,1,0.4,0.4,transcript,87654.0
PIP4K2A,ENSG00000150867,"osteoarthritis, hip",EFO_1000786,0.39366149908354414,3.936658436040177,1,0.4,0.4,transcript,9207.0
SFRP1,ENSG00000104332,mean reticulocyte volume,EFO_0010701,0.3936265157955528,3.9363131368448165,1,0.4,0.4,transcript,8337.0
PARP8,ENSG00000151883,heel bone mineral density,EFO_0009270,0.393540328414295,3.9354503609664415,2,0.8,1.6,transcript,33987.0
SYNE2,ENSG00000054654,X-10510 measurement,EFO_0021217,0.3935247159183082,3.93525979469899,2,1.0,2.0,transcript,158284.0
LINS1,ENSG00000140471,genetic disorder,EFO_0000508,0.39352113014642137,3.9352385895720565,1,0.5,0.5,transcript,18323.0
PHIP,ENSG00000146247,HbA1c measurement,EFO_0004541,0.39351325206810406,3.9351404978344733,1,0.5,0.5,transcript,62679.0
PDHX,ENSG00000110435,FEV/FVC ratio,EFO_0004713,0.39350657379100784,3.935110505677286,1,0.4,0.4,transcript,8935.0
GCH1,ENSG00000131979,dopamine 3-O-sulfate measurement,EFO_0800082,0.3933825423624764,3.9338591874468283,1,0.4,0.4,transcript,11847.0
LMO4,ENSG00000143013,platelet crit,EFO_0007985,0.3933748006019292,3.933799486070772,1,0.4,0.4,transcript,7770.0
TNPO3,ENSG00000064419,serum creatinine amount,OBA_2050096,0.3933734217632166,3.9337608899889354,1,0.5,0.5,transcript,18746.0
DMXL1,ENSG00000172869,neurodegenerative disease,EFO_0005772,0.3933277145612418,3.9332878302292413,1,0.4,0.4,transcript,37437.0
QKI,ENSG00000112531,platelet component distribution width,EFO_0007984,0.393322299053613,3.933258562692025,2,0.8,1.6,transcript,44979.0
SLC22A24,ENSG00000197658,uric acid measurement,EFO_0004761,0.3933200013879508,3.933285309000627,1,0.5,0.5,transcript,5862.0
ITGB8,ENSG00000105855,Abnormal thrombosis,HP_0001977,0.3932401826409193,3.9325723536224944,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
MDM4,ENSG00000198625,actinic keratosis,EFO_0002496,0.39323489117075766,3.9323547825777863,1,0.4,0.4,transcript,68133.0
NDST3,ENSG00000164100,alcohol consumption quality,OBA_1000840,0.39317104694187843,3.9317605319970075,1,0.4,0.4,transcript,7990.0
TENT4B,ENSG00000121274,mean corpuscular hemoglobin concentration,EFO_0004528,0.3931652117711652,3.931901533144232,4,1.6,6.4,transcript,25660.0
ARHGAP29,ENSG00000137962,serum creatinine amount,OBA_2050096,0.3930846536560101,3.9308667622791256,1,0.5,0.5,transcript,24721.0
SEC22A,ENSG00000121542,Red cell distribution width,EFO_0009188,0.39307940394715557,3.9309160744040548,2,0.8,1.6,transcript,13111.0
NID2,ENSG00000087303,hearing process quality,OBA_2045262,0.39304411287667157,3.930486263267528,1,0.5,0.5,transcript,11078.0
CSMD3,ENSG00000164796,arterial stiffness measurement,EFO_0004517,0.39304327246814663,3.9304408334032077,1,0.5,0.5,transcript,61662.0
TRDMT1,ENSG00000107614,vitamin B12 deficiency,EFO_0000734,0.392998983343175,3.930003625108473,1,0.4,0.4,transcript,29003.0
SERPINB10,ENSG00000242550,neutrophil count,EFO_0004833,0.3929942694558564,3.930174713120049,1,0.5,0.5,transcript,2155.0
PLCL1,ENSG00000115896,asthma,MONDO_0004979,0.3929073527329401,3.9291630378189115,2,0.8,1.6,transcript,17875.0
RCN2,ENSG00000117906,erythrocyte count,EFO_0004305,0.3928934142869089,3.9289614578103618,1,0.4,0.4,transcript,14644.0
ZNF682,ENSG00000197124,free cholesterol in large VLDL measurement ,EFO_0022265,0.39286010696869206,3.9286270437128947,1,0.5,0.5,transcript,19250.0
PHC1,ENSG00000111752,free cholesterol measurement,EFO_0008591,0.39281410256312443,3.9281601761157514,1,0.5,0.5,transcript,26109.0
MGA,ENSG00000174197,forced expiratory volume,EFO_0004314,0.39278124810733817,3.927818402858444,1,0.5,0.5,transcript,84434.0
MYO3A,ENSG00000095777,Rare genetic deafness,Orphanet_96210,0.3927484051306027,3.9275077670960004,1,0.5,0.5,transcript,21083.0
ZNF436,ENSG00000125945,appendicular lean mass,EFO_0004980,0.39271380384631105,3.9271716801788377,1,0.4,0.4,transcript,11890.0
KITLG,ENSG00000049130,cancer,MONDO_0004992,0.3926811125850912,3.9269804818277665,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
MAP2K6,ENSG00000108984,total blood protein measurement,EFO_0004536,0.3926733500561094,3.9267508030959157,1,0.4,0.4,transcript,23118.0
SYT13,ENSG00000019505,Thyrotoxicosis,EFO_0009190,0.39262831718374464,3.9264984570904065,2,0.8,1.6,transcript,7432.0
SV2C,ENSG00000122012,apolipoprotein B measurement,EFO_0004615,0.3926241301283695,3.926269330153431,1,0.4,0.4,transcript,14271.0
GJA3,ENSG00000121743,cataract,MONDO_0005129,0.39239493177130735,3.9240260342454865,1,0.4,0.4,transcript,5214.0
ARHGAP29,ENSG00000137962,systolic blood pressure,EFO_0006335,0.3923636691457132,3.923656917176156,1,0.5,0.5,transcript,24721.0
ATP5F1A,ENSG00000152234,genetic disorder,EFO_0000508,0.3923330233800426,3.9233440345180632,1,0.4,0.4,transcript,28984.0
RPAP3,ENSG00000005175,age at menarche,EFO_0004703,0.39229328217496046,3.9230811897021267,2,0.8,1.6,transcript,10784.0
VWDE,ENSG00000146530,coronary artery disease,EFO_0001645,0.3922174756527966,3.922201379178517,1,0.5,0.5,transcript,18781.0
NEBL,ENSG00000078114,hypertrophic cardiomyopathy,EFO_0000538,0.3922126140779723,3.922133962598687,1,0.4,0.4,transcript,51139.0
GCH1,ENSG00000131979,metabolite measurement,EFO_0004725,0.39219440670529376,3.921977830875002,1,0.4,0.4,transcript,11847.0
TWSG1,ENSG00000128791,Tietze syndrome,MONDO_0001858,0.3921736107075556,3.9217918173819624,1,0.4,0.4,transcript,7180.0
SECISBP2L,ENSG00000138593,lung cancer,MONDO_0008903,0.3921055781236168,3.9210748652056338,1,0.4,0.4,transcript,20960.0
TTLL7,ENSG00000137941,osteoarthritis,MONDO_0005178,0.3920762054544654,3.920791027979636,2,0.8,1.6,transcript,55223.0
CEP85L,ENSG00000111860,Tachycardia,HP_0001649,0.3920570220896567,3.920585623877044,1,0.4,0.4,transcript,25969.0
PAFAH1B2,ENSG00000168092,"monounsaturated fatty acids; 16:1, 18:1 measurement",EFO_0022187,0.3920407401200245,3.9205411916509516,2,0.8,1.6,transcript,11959.0
OXSR1,ENSG00000172939,erythrocyte count,EFO_0004305,0.3920407401200245,3.920447977382026,1,0.4,0.4,transcript,9858.0
GALNT3,ENSG00000115339,trochanter bone mineral density,EFO_0020095,0.3919738030440171,3.91976693844046,1,0.4,0.4,transcript,13837.0
FAS,ENSG00000026103,Hashimoto's thyroiditis,EFO_0003779,0.3919527987513686,3.9195301957382185,1,0.4,0.4,transcript,181141.0
SP4,ENSG00000105866,bilirubin measurement,EFO_0004570,0.39194153782850394,3.9194393706074964,1,0.4,0.4,transcript,16672.0
C2CD4A,ENSG00000198535,apolipoprotein B measurement,EFO_0004615,0.39194031460434847,3.9195192563482744,1,0.4,0.4,transcript,3445.0
LYPD6,ENSG00000187123,neuroimaging measurement,EFO_0004346,0.39181395293625654,3.918172278666643,1,0.4,0.4,transcript,12214.0
PLCL1,ENSG00000115896,cognitive function measurement,EFO_0008354,0.3917653278947857,3.9177427894373675,2,0.8,1.6,transcript,17875.0
KCNJ15,ENSG00000157551,body weights and measures,EFO_0004324,0.3917366938383185,3.917376772433584,1,0.4,0.4,transcript,40675.0
ALG10B,ENSG00000175548,alcohol consumption quality,OBA_1000840,0.39171316685724483,3.9178374844956556,5,2.0,10.0,transcript,14168.0
DLC1,ENSG00000164741,preeclampsia,EFO_0000668,0.3916687756309713,3.9166994354828275,1,0.4,0.4,transcript,34249.0
ZNF507,ENSG00000168813,serum creatinine amount,OBA_2050096,0.3915606341075928,3.91562073992402,1,0.4,0.4,transcript,27780.0
NEDD1,ENSG00000139350,IGF-1 measurement,EFO_0004627,0.391554438273503,3.9155636394267304,1,0.4,0.4,transcript,20772.0
DDR2,ENSG00000162733,gastrointestinal stromal tumor,MONDO_0011719,0.39153215544794884,3.915335594986351,1,0.4,0.4,transcript,28489.0
BACH1,ENSG00000156273,high density lipoprotein cholesterol measurement,EFO_0004612,0.39150906341188596,3.915448495894749,4,1.6,6.4,transcript,17884.0
CDH23,ENSG00000107736,lymphocyte count,EFO_0004587,0.3914952891574691,3.9149604422776614,1,0.5,0.5,transcript,66219.0
GFPT1,ENSG00000198380,Dupuytren Contracture,EFO_0004229,0.3914916552488525,3.914931656517525,1,0.4,0.4,transcript,26483.0
KYNU,ENSG00000115919,respiratory system disease,EFO_0000684,0.3914647878299306,3.9148061270135353,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
GNA13,ENSG00000120063,brain attribute,OBA_2045210,0.39143474730915295,3.9143990793358854,1,0.4,0.4,transcript,7751.0
ASTN2,ENSG00000148219,Retinal dystrophy,HP_0000556,0.3914158644323229,3.9142173987298094,2,0.8,1.6,transcript,27232.0
AKAP6,ENSG00000151320,cortical thickness,EFO_0004840,0.3914146135457751,3.9147209155164022,7,2.8000000000000003,19.6,transcript,34100.0
LMO4,ENSG00000143013,high density lipoprotein cholesterol measurement,EFO_0004612,0.39136485836888785,3.9137000637403583,1,0.4,0.4,transcript,7770.0
ANKRD17,ENSG00000132466,cholesteryl esters:total lipids ratio,EFO_0020944,0.3913593024124055,3.9136022140335345,1,0.4,0.4,transcript,43526.0
ASTN2,ENSG00000148219,cortical thickness,EFO_0004840,0.3913448632767176,3.9135073871737562,2,0.8,1.6,transcript,27232.0
EVI5,ENSG00000067208,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.39132653678409207,3.913271023789565,1,0.4,0.4,transcript,70722.0
KCNIP4,ENSG00000185774,insomnia,EFO_0004698,0.39125859731264484,3.912718621111857,2,0.8,1.6,transcript,12062.0
MAP4K3,ENSG00000011566,hemoglobin measurement,EFO_0004509,0.39121824598934585,3.9122052675112027,1,0.4,0.4,transcript,17538.0
KITLG,ENSG00000049130,familial progressive hyperpigmentation,MONDO_0013648,0.39119012409739834,3.912070596950838,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
PEX7,ENSG00000112357,connective tissue disease,EFO_1001986,0.3911674246411182,3.9117167905507264,1,0.4,0.4,transcript,9402.0
CADPS,ENSG00000163618,hearing loss,EFO_0004238,0.3910891205167398,3.9109005228780362,1,0.4,0.4,transcript,42929.0
SKI,ENSG00000157933,PR interval,EFO_0004462,0.3910439482877217,3.9104920038856203,1,0.4,0.4,transcript,7616.0
RCN2,ENSG00000117906,hemoglobin measurement,EFO_0004509,0.3909934923093726,3.9099622380349985,1,0.4,0.4,transcript,14644.0
SLC44A1,ENSG00000070214,platelet volume,OBA_0003277,0.3909741699730848,3.909751308647923,1,0.4,0.4,transcript,41628.0
LARP4B,ENSG00000107929,type 2 diabetes mellitus,MONDO_0005148,0.3909300755634711,3.909311767637794,1,0.5,0.5,transcript,45405.0
LATS1,ENSG00000131023,S-adenosylhomocysteine measurement,EFO_0010531,0.390906269216163,3.9090800487527955,1,0.4,0.4,transcript,23046.0
CSMD3,ENSG00000164796,testosterone measurement,EFO_0004908,0.39089112390987496,3.9089193478204907,1,0.5,0.5,transcript,61662.0
RCL1,ENSG00000120158,thrombocytopenia 4,MONDO_0012775,0.3908242977219234,3.908281650718219,1,0.4,0.4,transcript,10343.0
KYNU,ENSG00000115919,alcohol consumption quality,OBA_1000840,0.3908219239434715,3.9083774881489437,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
GABRA4,ENSG00000109158,partial epilepsy,EFO_0004263,0.39082124874399954,3.908237638345428,1,0.4,0.4,transcript,15904.0
DMRTA1,ENSG00000176399,platelet count,EFO_0004309,0.3908191858982517,3.9082634665729215,1,0.4,0.4,transcript,5586.0
LRBA,ENSG00000198589,monocyte count,EFO_0005091,0.39059978234358944,3.906001764943915,1,0.4,0.4,transcript,101484.0
UNC80,ENSG00000144406,FEV/FVC ratio,EFO_0004713,0.3905957443490871,3.905962105495533,1,0.4,0.4,transcript,85800.0
FGA,ENSG00000171560,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.3905927971403195,3.905996195861664,1,0.4,0.4,transcript,5863.0
CYSLTR1,ENSG00000173198,body weight,EFO_0004338,0.3905288973378921,3.905479110039646,2,0.8,1.6,transcript,8415.0
EPHA5,ENSG00000145242,non-small cell lung carcinoma,EFO_0003060,0.3905174809061098,3.9051855337842665,1,0.4,0.4,transcript,37297.0
SEMA3A,ENSG00000075213,amygdala volume,OBA_2050034,0.39050871767347944,3.905117381371206,1,0.4,0.4,transcript,13243.0
NMRK1,ENSG00000106733,erythrocyte count,EFO_0004305,0.3904922558702224,3.9049685304296116,1,0.4,0.4,transcript,8701.0
SERPINB9,ENSG00000170542,lymphocyte count,EFO_0004587,0.390462961529412,3.9046773309090548,1,0.4,0.4,transcript,8383.0
HHLA2,ENSG00000114455,smoking initiation,EFO_0005670,0.3904355556045962,3.9043893603864395,1,0.5,0.5,transcript,14791.0
ATG2B,ENSG00000066739,Sjogren syndrome,EFO_0000699,0.3904295215395933,3.904323850640192,1,0.5,0.5,transcript,17461.0
TSPAN3,ENSG00000140391,glomerular filtration rate,OBA_0003747,0.39041557129342946,3.9041776235390273,1,0.4,0.4,transcript,18256.0
CD86,ENSG00000114013,cancer,MONDO_0004992,0.3903853977296672,3.9038858117574757,1,0.4,0.4,transcript,12565.0
RPS6KA5,ENSG00000100784,femoral neck bone mineral density,EFO_0007785,0.39035009089014766,3.9035107737530104,1,0.4,0.4,transcript,40548.0
RFX7,ENSG00000181827,body mass index,EFO_0004340,0.3903434831266077,3.9034444235922163,1,0.4,0.4,transcript,41700.0
LDLRAP1,ENSG00000157978,low density lipoprotein cholesterol measurement,EFO_0004611,0.39033907556773506,3.9034166691264307,1,0.4,0.4,transcript,15436.0
ARL3,ENSG00000138175,erythrocyte volume,OBA_0003460,0.3902926830999455,3.90303116068125,1,0.4,0.4,transcript,3834.0
FAT3,ENSG00000165323,retinopathy,EFO_0003839,0.39028984691034024,3.902906798098717,1,0.4,0.4,transcript,48025.0
PRKCB,ENSG00000166501,systemic mastocytosis,MONDO_0016586,0.39026349391320186,3.902658905578993,1,0.4,0.4,transcript,16690.0
HFE,ENSG00000010704,Alzheimer disease,MONDO_0004975,0.39018829022702134,3.9018911874459627,1,0.4,0.4,transcript,48279.0
KITLG,ENSG00000049130,aging rate,OBA_0005494,0.39016148310138776,3.9017841869907324,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
CYBRD1,ENSG00000071967,sitting height measurement,EFO_0011011,0.39001383856933924,3.900172495013764,1,0.4,0.4,transcript,11727.0
STXBP4,ENSG00000166263,platelet crit,EFO_0007985,0.38999290722866764,3.9003207836737266,5,2.0,10.0,transcript,25529.0
REEP3,ENSG00000165476,cholelithiasis,EFO_0004799,0.3899688281161547,3.899758064832168,1,0.4,0.4,transcript,5732.0
MEOX2,ENSG00000106511,brain attribute,OBA_2045210,0.3899397053294655,3.8995657584823396,1,0.4,0.4,transcript,2371.0
SYNJ2,ENSG00000078269,brain cancer,MONDO_0001657,0.3899308295204124,3.8993594428289566,2,0.8,1.6,transcript,31282.0
FAM114A1,ENSG00000197712,lymphocyte count,EFO_0004587,0.3899028381323991,3.8990770608907432,1,0.4,0.4,transcript,8217.0
TNRC6B,ENSG00000100354,neutrophil count,EFO_0004833,0.38990231260752456,3.899029577896272,1,0.4,0.4,transcript,61998.0
DUSP22,ENSG00000112679,systemic lupus erythematosus,MONDO_0007915,0.3898054184270748,3.898077788661164,1,0.4,0.4,transcript,16946.0
FBXO22,ENSG00000167196,lymphocyte count,EFO_0004587,0.3897132371026129,3.8971535698177977,1,0.4,0.4,transcript,18869.0
SEPTIN7,ENSG00000122545,open-angle glaucoma,EFO_0004190,0.38968550066230423,3.8968646829499085,1,0.4,0.4,transcript,41338.0
FBXO28,ENSG00000143756,neutrophil count,EFO_0004833,0.38967529057197137,3.8978018934465575,5,2.0,10.0,transcript,9533.0
SLC35F5,ENSG00000115084,monocyte count,EFO_0005091,0.3896665850255241,3.8967366091443263,2,0.8,1.6,transcript,22612.0
STARD13,ENSG00000133121,colorectal cancer,MONDO_0005575,0.3896602829755981,3.8966176462170696,1,0.4,0.4,transcript,26997.0
ROCK2,ENSG00000134318,graft versus host disease,MONDO_0013730,0.3896544539683169,3.8965555332848925,1,0.5,0.5,transcript,45481.0
GLB1,ENSG00000170266,adult onset asthma,EFO_1002011,0.38961026188560716,3.8961335269354436,1,0.5,0.5,transcript,16177.0
TNRC6B,ENSG00000100354,mean corpuscular hemoglobin concentration,EFO_0004528,0.389568928772369,3.895695739544716,1,0.4,0.4,transcript,61998.0
LIMA1,ENSG00000050405,HbA1c measurement,EFO_0004541,0.38956768218042737,3.895690226180802,1,0.4,0.4,transcript,29841.0
DDR2,ENSG00000162733,metastatic colorectal cancer,EFO_1001480,0.38955734124302194,3.895587452937082,1,0.4,0.4,transcript,28489.0
CCDC34,ENSG00000109881,neuroimaging measurement,EFO_0004346,0.38954871961629167,3.8955807196606957,1,0.4,0.4,transcript,4277.0
PAFAH1B2,ENSG00000168092,apolipoprotein A 1 measurement,EFO_0004614,0.38954816375464685,3.895615427997175,2,0.8,1.6,transcript,11959.0
NEDD1,ENSG00000139350,HbA1c measurement,EFO_0004541,0.3895459100780874,3.8954783574725744,1,0.4,0.4,transcript,20772.0
CRYGD,ENSG00000118231,pulverulent cataract,MONDO_0011430,0.38952626821270775,3.895885735086579,1,0.4,0.4,transcript,642.0
PPA2,ENSG00000138777,body weight,EFO_0004338,0.38948544727079404,3.894881878978495,1,0.5,0.5,transcript,18244.0
TSPAN3,ENSG00000140391,BMI-adjusted hip circumference,EFO_0008039,0.38942896723293513,3.894311582934084,1,0.4,0.4,transcript,18256.0
PLXNA4,ENSG00000221866,erythrocyte volume,OBA_0003460,0.38942002184792746,3.8942124658767026,1,0.4,0.4,transcript,32660.0
SKP2,ENSG00000145604,lean body mass,EFO_0004995,0.389376230312521,3.8937673259791956,1,0.4,0.4,transcript,79636.0
IL17A,ENSG00000112115,arthritis,EFO_0005856,0.38935973926298934,3.893811182047317,1,0.4,0.4,transcript,1871.0
KCNN3,ENSG00000143603,cardiac arrhythmia,EFO_0004269,0.3893507436845839,3.8936264726557788,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
CD69,ENSG00000110848,neutrophil percentage of leukocytes,EFO_0007990,0.389303427191452,3.893878747635843,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
QKI,ENSG00000112531,lean body mass,EFO_0004995,0.3892069915713475,3.89210548786937,2,0.8,1.6,transcript,44979.0
DDR2,ENSG00000162733,pancreatic carcinoma,EFO_0002618,0.38919672968891184,3.891981337395981,1,0.4,0.4,transcript,28489.0
ALPK3,ENSG00000136383,left ventricular systolic function measurement,EFO_0008206,0.38917965005434224,3.8918337965807184,1,0.4,0.4,transcript,10725.0
TLR10,ENSG00000174123,C-reactive protein measurement,EFO_0004458,0.3891787286637849,3.8919487288549885,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
BIRC6,ENSG00000115760,testosterone measurement,EFO_0004908,0.38917362519946114,3.8917434342515635,1,0.5,0.5,transcript,69616.0
NBEAL1,ENSG00000144426,coronary artery bypass,EFO_0003776,0.3890794906728787,3.8907987603304597,1,0.4,0.4,transcript,103799.0
ZNF236,ENSG00000130856,potassium measurement,EFO_0009283,0.3890306360555561,3.8903653286145294,2,0.9,1.8,transcript,30525.0
DSC2,ENSG00000134755,cardiomyopathy,EFO_0000318,0.3890261633494019,3.890274075560646,2,0.8,1.6,transcript,128596.0
RANBP17,ENSG00000204764,hypertension,EFO_0000537,0.38887218200832097,3.888731334378438,1,0.4,0.4,transcript,42042.0
PEAK1,ENSG00000173517,diabetic eye disease,EFO_0009486,0.38871917773874315,3.887198699838671,1,0.4,0.4,transcript,57783.0
PAQR3,ENSG00000163291,erythrocyte count,EFO_0004305,0.3886411097648254,3.886426149388612,1,0.4,0.4,transcript,26575.0
TMCC1,ENSG00000172765,HbA1c measurement,EFO_0004541,0.38859159502343404,3.8859261517135546,1,0.4,0.4,transcript,39210.0
EDEM1,ENSG00000134109,metabolite measurement,EFO_0004725,0.38853803547824883,3.8855133335058927,2,0.8,1.6,transcript,12032.0
RIF1,ENSG00000080345,grip strength measurement,EFO_0006941,0.3885156226928081,3.885217770245108,3,1.3,3.9000000000000004,transcript,63370.0
SLC25A46,ENSG00000164209,atopic eczema,EFO_0000274,0.3885125917848428,3.8851458709586195,1,0.4,0.4,transcript,20047.0
IPP,ENSG00000197429,erythrocyte count,EFO_0004305,0.38848580159292323,3.8849387913734974,1,0.5,0.5,transcript,6190.0
TBC1D9B,ENSG00000197226,mean fractional anisotropy measurement,EFO_0008399,0.38846450115970005,3.884657226456377,1,0.4,0.4,transcript,32747.0
LYPLAL1,ENSG00000143353,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.38845383057200616,3.884566102028712,1,0.5,0.5,transcript,17988.0
BCAS3,ENSG00000141376,lymphocyte measurement,EFO_0803546,0.38842529303662066,3.884263329484361,1,0.5,0.5,transcript,48081.0
FAT1,ENSG00000083857,esophageal cancer,MONDO_0007576,0.3883687811915183,3.883709007336972,1,0.5,0.5,transcript,23590.0
USP6,ENSG00000129204,aneurysmal bone cyst,EFO_1001760,0.38834136608449465,3.8834249574079673,1,0.4,0.4,transcript,35409.0
TULP4,ENSG00000130338,systolic blood pressure,EFO_0006335,0.3883306122907371,3.883325047964146,1,0.4,0.4,transcript,21136.0
GRSF1,ENSG00000132463,Drugs used in diabetes use measurement,EFO_0009924,0.3883141307544301,3.8832323977805667,2,0.8,1.6,transcript,17565.0
ULK4,ENSG00000168038,medical procedure,EFO_0002571,0.3882777911381568,3.8828188714864256,1,0.5,0.5,transcript,12207.0
ULK4,ENSG00000168038,complication,EFO_0009518,0.3882777911381568,3.8828188714864256,1,0.5,0.5,transcript,12207.0
ULK4,ENSG00000168038,trauma complication,EFO_0009888,0.3882777911381568,3.8828188714864256,1,0.5,0.5,transcript,12207.0
FBXO28,ENSG00000143756,ceramide measurement,EFO_0010222,0.38826895931010824,3.8837385808279263,5,2.0,10.0,transcript,9533.0
MYO5A,ENSG00000197535,neuroectodermal melanolysosomal disease,MONDO_0009742,0.38826690927503615,3.882671132411574,1,0.4,0.4,transcript,196111.0
PDHX,ENSG00000110435,metabolite measurement,EFO_0004725,0.3882578954231996,3.8826237219992037,1,0.4,0.4,transcript,8935.0
SKA3,ENSG00000165480,neurodegenerative disease,EFO_0005772,0.3882295397959952,3.8824417572720633,2,0.8,1.6,transcript,10932.0
FUT2,ENSG00000176920,peptic ulcer disease,MONDO_0004247,0.3881730684957673,3.88185371140836,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
BPTF,ENSG00000171634,major depressive disorder,MONDO_0002009,0.3881331154669416,3.8813507788660506,2,0.8,1.6,transcript,81532.0
ATPSCKMT,ENSG00000150756,platelet volume,OBA_0003277,0.3880766420583493,3.880814130507157,1,0.4,0.4,transcript,8384.0
MC2R,ENSG00000185231,West syndrome,MONDO_0018097,0.38805884741893687,3.880683081568744,1,0.4,0.4,transcript,4228.0
DDR2,ENSG00000162733,bile duct carcinoma,EFO_0005540,0.38805884741893687,3.880602514696231,1,0.4,0.4,transcript,28489.0
FGA,ENSG00000171560,congenital fibrinogen deficiency,MONDO_0018060,0.38805884741893687,3.880656698647837,1,0.4,0.4,transcript,5863.0
EPHA5,ENSG00000145242,thyroid neoplasm,EFO_0003841,0.38805884741893687,3.880599198912537,1,0.4,0.4,transcript,37297.0
EPHA5,ENSG00000145242,thyroid carcinoma,EFO_0002892,0.38805884741893687,3.880599198912537,1,0.4,0.4,transcript,37297.0
PTPRO,ENSG00000151490,Parkinson disease,MONDO_0005180,0.38805884741893687,3.8805929227858362,1,0.4,0.4,transcript,89916.0
COL24A1,ENSG00000171502,ulcer disease,MONDO_0043839,0.38805884741893687,3.8806128703835623,1,0.4,0.4,transcript,16396.0
KCNJ15,ENSG00000157551,reticulocyte measurement,EFO_0010700,0.3880479149633123,3.8804889836835224,1,0.4,0.4,transcript,40675.0
SYT13,ENSG00000019505,glomerular filtration rate,OBA_0003747,0.38799402995265697,3.88015558477953,2,0.8,1.6,transcript,7432.0
FZD6,ENSG00000164930,neurodegenerative disease,EFO_0005772,0.38799037934415936,3.8799836855871974,2,0.8,1.6,transcript,20027.0
FAT3,ENSG00000165323,self reported educational attainment,EFO_0004784,0.3879648794002459,3.8796571229977737,1,0.4,0.4,transcript,48025.0
MAGI2,ENSG00000187391,familial idiopathic steroid-resistant nephrotic syndrome,MONDO_0019006,0.3879611394530555,3.8796159579275478,1,0.4,0.4,transcript,87654.0
DLG2,ENSG00000150672,smoking initiation,EFO_0005670,0.38796028483034267,3.8796056212285857,1,0.4,0.4,transcript,144252.0
CENPC,ENSG00000145241,mathematical ability,EFO_0004875,0.387956950942344,3.8797683165804977,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
CNMD,ENSG00000136110,platelet volume,OBA_0003277,0.3878794010564538,3.8792347819144,2,0.8,1.6,transcript,3630.0
FRAS1,ENSG00000138759,FEV/FVC ratio,EFO_0004713,0.3878618251283865,3.8786503878284724,2,0.9,1.8,transcript,56011.0
NID2,ENSG00000087303,Tinnitus,HP_0000360,0.38779393199898315,3.877984454490644,1,0.5,0.5,transcript,11078.0
NDUFAF2,ENSG00000164182,cerebral cortex area attribute,OBA_2045267,0.3877331997417443,3.8773722024631763,1,0.4,0.4,transcript,9949.0
CYTIP,ENSG00000115165,type 2 diabetes mellitus,MONDO_0005148,0.38764480478051055,3.8764758352312954,1,0.4,0.4,gene_variant,14395.0
SYNE2,ENSG00000054654,mean corpuscular hemoglobin concentration,EFO_0004528,0.3875638000801804,3.875650636317712,2,1.0,2.0,transcript,158284.0
SHH,ENSG00000164690,syndactyly type 4,MONDO_0008515,0.38753127217637445,3.8753658708469225,1,0.4,0.4,transcript,7526.0
ZNF436,ENSG00000125945,neurodegenerative disease,EFO_0005772,0.3874168514509312,3.874202156225039,1,0.4,0.4,transcript,11890.0
BCKDHB,ENSG00000083123,body height,OBA_VT0001253,0.38740305110696716,3.879757887931069,10,4.0,40.0,transcript,6984.0
COLEC10,ENSG00000184374,neuroimaging measurement,EFO_0004346,0.38737285033819874,3.8738336835029448,1,0.4,0.4,transcript,3803.0
PICALM,ENSG00000073921,Red cell distribution width,EFO_0009188,0.3873601438736716,3.8736147070552884,1,0.4,0.4,transcript,30147.0
GCH1,ENSG00000131979,Dopamine sulfate (2) measurement,EFO_0022094,0.3873561486515359,3.8735952503374236,1,0.4,0.4,transcript,11847.0
ITGB8,ENSG00000105855,smoking status measurement,EFO_0006527,0.3873228523414565,3.8733990506278664,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
IL4R,ENSG00000077238,psoriasis,EFO_0000676,0.38731677308751356,3.8731862949443796,1,0.4,0.4,transcript,21547.0
MEOX2,ENSG00000106511,HbA1c measurement,EFO_0004541,0.3873081123853323,3.873249829041008,1,0.4,0.4,transcript,2371.0
SI,ENSG00000090402,arterial stiffness measurement,EFO_0004517,0.3872940600230122,3.873012646339632,1,0.5,0.5,transcript,6940.0
KITLG,ENSG00000049130,Waardenburg syndrome type 2,MONDO_0019517,0.3872824347751312,3.8729937037281665,3,1.2000000000000002,3.6000000000000005,transcript,21257.0
ITGB8,ENSG00000105855,musculoskeletal system disease,EFO_0009676,0.38725743430666576,3.8727448702799587,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
ACTN2,ENSG00000077522,cardiomyopathy,EFO_0000318,0.3871905763439191,3.8719224490509796,2,0.8,1.6,transcript,95891.0
ZNF396,ENSG00000186496,wellbeing measurement,EFO_0007869,0.3871883679465582,3.871918245659844,1,0.4,0.4,transcript,11572.0
ANKRD17,ENSG00000132466,total cholesterol measurement,EFO_0004574,0.38714891751071623,3.8714983650166412,1,0.4,0.4,transcript,43526.0
LMO4,ENSG00000143013,smoking status measurement,EFO_0006527,0.3871355142481909,3.871406622533389,1,0.4,0.4,transcript,7770.0
CNTNAP2,ENSG00000174469,Alzheimer disease,MONDO_0004975,0.38709525819061447,3.8709602635776763,1,0.4,0.4,transcript,52072.0
SYNC,ENSG00000162520,neutrophil count,EFO_0004833,0.38706909744126883,3.8709391133705044,2,0.8,1.6,transcript,6448.0
PROK2,ENSG00000163421,monocyte count,EFO_0005091,0.3870670382259252,3.8711858461767776,2,0.8,1.6,transcript,3104.0
NID2,ENSG00000087303,platelet count,EFO_0004309,0.38700451904340766,3.870090324934889,1,0.5,0.5,transcript,11078.0
RALGPS2,ENSG00000116191,erythrocyte volume,OBA_0003460,0.3869651263427204,3.8697307981490807,2,0.8,1.6,transcript,20117.0
ATAD2B,ENSG00000119778,lymphocyte count,EFO_0004587,0.38694756161994737,3.869493793886363,1,0.4,0.4,transcript,22005.0
RGS7BP,ENSG00000186479,systolic blood pressure,EFO_0006335,0.38693997056967067,3.8694878269515534,1,0.5,0.5,transcript,5674.0
SLC7A2,ENSG00000003989,amino acid measurement,EFO_0005134,0.38692137661681547,3.8693347617892657,3,1.4,4.199999999999999,transcript,34712.0
RASA2,ENSG00000155903,mean reticulocyte volume,EFO_0010701,0.3869184202460902,3.8692318158402617,1,0.4,0.4,transcript,8401.0
C12orf42,ENSG00000179088,hip circumference,OBA_1000032,0.3868955826738406,3.8689909662422366,1,0.5,0.5,transcript,14229.0
GCH1,ENSG00000131979,pulse pressure measurement,EFO_0005763,0.386863335250687,3.8686671163289343,1,0.4,0.4,transcript,11847.0
ROCK2,ENSG00000134318,immune system disease,EFO_0000540,0.3867139873921675,3.8671508675233985,1,0.5,0.5,transcript,45481.0
KLHL31,ENSG00000124743,low density lipoprotein cholesterol measurement,EFO_0004611,0.38659585493550896,3.8660106259076215,1,0.4,0.4,transcript,7681.0
MARCKS,ENSG00000277443,PR interval,EFO_0004462,0.3865852553081191,3.8659456629508373,1,0.4,0.4,transcript,4296.0
TSPAN9,ENSG00000011105,metabolite measurement,EFO_0004725,0.386433328049305,3.8643687641350914,1,0.5,0.5,transcript,14091.0
NBAS,ENSG00000151779,alcohol consumption quality,OBA_1000840,0.3864313838534748,3.864347384324751,2,1.0,2.0,transcript,59620.0
CADPS,ENSG00000163618,neuroimaging measurement,EFO_0004346,0.38634659135633154,3.863475231273954,1,0.4,0.4,transcript,42929.0
RPS20,ENSG00000008988,reticulocyte count,EFO_0007986,0.38629855052075207,3.8630027146899457,1,0.4,0.4,transcript,23243.0
IREB2,ENSG00000136381,lung disease,EFO_0003818,0.3862901116318871,3.8630009720827676,2,0.9,1.8,transcript,18026.0
TBL2,ENSG00000106638,triglycerides to total lipids in medium LDL percentage ,EFO_0022334,0.3862696528095505,3.8627117066330525,1,0.4,0.4,transcript,26353.0
SHC4,ENSG00000185634,type 1 diabetes mellitus,MONDO_0005147,0.3862506275987934,3.8625400512138057,1,0.4,0.4,transcript,11843.0
SPAST,ENSG00000021574,gout,EFO_0004274,0.3862506275987934,3.862511452306278,1,0.4,0.4,transcript,77275.0
CYBRD1,ENSG00000071967,IGF-1 measurement,EFO_0004627,0.386111534444276,3.8611494537631317,1,0.4,0.4,transcript,11727.0
FSIP2,ENSG00000188738,cognitive function measurement,EFO_0008354,0.3860711948685606,3.8609908887135003,4,2.0,8.0,transcript,28680.0
SLC22A24,ENSG00000197658,11beta-hydroxyandrosterone glucuronide measurement,EFO_0800573,0.3860468286173395,3.860553581294514,1,0.5,0.5,transcript,5862.0
SLC15A5,ENSG00000188991,major depressive disorder,MONDO_0002009,0.38602511022805286,3.8614827136387224,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
TBXT,ENSG00000164458,sodium measurement,EFO_0009282,0.38601418529298265,3.8606023287548457,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
RASA2,ENSG00000155903,HbA1c measurement,EFO_0004541,0.3860083353175009,3.8601309665543684,1,0.4,0.4,transcript,8401.0
SLCO1C1,ENSG00000139155,bilirubin measurement,EFO_0004570,0.38595274075585995,3.859558298451964,1,0.5,0.5,transcript,16186.0
TCERG1L,ENSG00000176769,body mass index,EFO_0004340,0.3859153843061689,3.859382023324096,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,body mass index,EFO_0004340,0.3859153843061689,3.859382023324096,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,body mass index,EFO_0004340,0.3859153843061689,3.859382023324096,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,body mass index,EFO_0004340,0.3859153843061689,3.859382023324096,2,0.8,1.6,transcript,7012.0
STXBP4,ENSG00000166263,mean corpuscular hemoglobin,EFO_0004527,0.38586219962679197,3.8590137076549698,5,2.0,10.0,transcript,25529.0
CR2,ENSG00000117322,recurrent infections associated with rare immunoglobulin isotypes deficiency,MONDO_0013576,0.3858257766407091,3.858276092333696,1,0.4,0.4,transcript,21827.0
MDM4,ENSG00000198625,benign colon neoplasm,MONDO_0002278,0.3858207231217806,3.8582131020880155,1,0.4,0.4,transcript,68133.0
FGA,ENSG00000171560,IGF-1 measurement,EFO_0004627,0.3857869303615251,3.8579375280737196,1,0.4,0.4,transcript,5863.0
LRPAP1,ENSG00000163956,vital capacity,EFO_0004312,0.38577471750087355,3.857977811180175,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
U2SURP,ENSG00000163714,reticulocyte measurement,EFO_0010700,0.3857646580421139,3.8576969884108054,2,0.8,1.6,transcript,31741.0
LTBP1,ENSG00000049323,hip geometry,EFO_0004685,0.38569207050632864,3.856933364492979,1,0.4,0.4,transcript,31597.0
ARMC1,ENSG00000104442,body mass index,EFO_0004340,0.3856030673094117,3.856075221484806,1,0.4,0.4,transcript,8979.0
FAT1,ENSG00000083857,melanoma,EFO_0000756,0.38559715839980996,3.8559927794198883,1,0.5,0.5,transcript,23590.0
GJA3,ENSG00000121743,pulverulent cataract,MONDO_0011430,0.3855780426443658,3.855857142976071,1,0.4,0.4,transcript,5214.0
GFPT1,ENSG00000198380,radiculitis,MONDO_0021765,0.38554501141559633,3.855465218184963,1,0.4,0.4,transcript,26483.0
PEAK1,ENSG00000173517,total blood protein measurement,EFO_0004536,0.3854865205263091,3.854872127714331,1,0.4,0.4,transcript,57783.0
EXOC6,ENSG00000138190,open-angle glaucoma,EFO_0004190,0.3854843897975555,3.854866515246103,1,0.5,0.5,transcript,22107.0
CYSLTR1,ENSG00000173198,neurodegenerative disease,EFO_0005772,0.3854329995283215,3.8545201319439397,2,0.8,1.6,transcript,8415.0
CYBRD1,ENSG00000071967,hip circumference,OBA_1000032,0.38536141587975314,3.853648268117903,1,0.4,0.4,transcript,11727.0
SORL1,ENSG00000137642,body mass index,EFO_0004340,0.38533211844356363,3.8533681940987337,2,0.9,1.8,transcript,38290.0
DGKH,ENSG00000102780,blood urea nitrogen measurement,EFO_0004741,0.3853223897487958,3.853251290526702,2,0.8,1.6,transcript,58409.0
HTR1F,ENSG00000179097,major depressive disorder,MONDO_0002009,0.38523566797342873,3.852474813225132,1,0.4,0.4,transcript,3386.0
PLXND1,ENSG00000004399,low density lipoprotein cholesterol measurement,EFO_0004611,0.38522662794304463,3.8522899604004186,1,0.5,0.5,transcript,21114.0
GPAT3,ENSG00000138678,heel bone mineral density,EFO_0009270,0.38522165590971386,3.8523636855339203,2,0.8,1.6,transcript,10875.0
P3H4,ENSG00000141696,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.3852204300407574,3.852244276421965,1,0.4,0.4,transcript,10006.0
MFAP3,ENSG00000037749,glomerular filtration rate,OBA_0003747,0.38516093359276865,3.8516219256293103,1,0.4,0.4,transcript,31772.0
UHMK1,ENSG00000152332,lymphocyte count,EFO_0004587,0.38515440890364205,3.85167070693175,3,1.2000000000000002,3.6000000000000005,transcript,28432.0
C18orf54,ENSG00000166845,bone remodeling disease,MONDO_0000833,0.38512642042375894,3.8513496788890134,2,0.8,1.6,transcript,18719.0
SORL1,ENSG00000137642,monocyte count,EFO_0005091,0.38512162060768595,3.851263215739957,2,0.9,1.8,transcript,38290.0
AKAP10,ENSG00000108599,IGF-1 measurement,EFO_0004627,0.3850843800249608,3.8508789805486408,1,0.4,0.4,transcript,11370.0
MFAP3,ENSG00000037749,taste liking measurement,EFO_0010155,0.38507607767635676,3.8507733664651913,1,0.4,0.4,transcript,31772.0
C6,ENSG00000039537,protein measurement,EFO_0004747,0.3850599468547152,3.850629031605154,1,0.5,0.5,transcript,16913.0
IQGAP1,ENSG00000140575,allergic rhinitis,EFO_0005854,0.3850568815064689,3.850622912981919,2,0.8,1.6,transcript,29576.0
NBEAL1,ENSG00000144426,systolic blood pressure,EFO_0006335,0.38504542618192583,3.8504581154209307,1,0.4,0.4,transcript,103799.0
GPD2,ENSG00000115159,metabolic syndrome,EFO_0000195,0.3850131774555937,3.850149440839834,1,0.4,0.4,transcript,22642.0
NDUFAF2,ENSG00000164182,metabolic syndrome,EFO_0000195,0.3850131774555937,3.85017197960167,1,0.4,0.4,transcript,9949.0
NDUFAF4,ENSG00000123545,metabolic syndrome,EFO_0000195,0.3850131774555937,3.850243319452758,1,0.4,0.4,transcript,3586.0
RASA2,ENSG00000155903,serum creatinine amount,OBA_2050096,0.3849909260595021,3.8499568739743806,1,0.4,0.4,transcript,8401.0
SORL1,ENSG00000137642,early-onset autosomal dominant Alzheimer disease,MONDO_0015140,0.38493131572729344,3.849360166936032,2,0.9,1.8,transcript,38290.0
BTBD8,ENSG00000189195,mean corpuscular hemoglobin concentration,EFO_0004528,0.384851480291537,3.8485312849828803,1,0.5,0.5,transcript,30336.0
ATAD2B,ENSG00000119778,pulse pressure measurement,EFO_0005763,0.3848144679788814,3.8481628574757036,1,0.4,0.4,transcript,22005.0
NEDD1,ENSG00000139350,migraine disorder,MONDO_0005277,0.3847780160577929,3.8477994172696293,1,0.4,0.4,transcript,20772.0
KCNJ15,ENSG00000157551,BMI-adjusted hip circumference,EFO_0008039,0.3847568365067445,3.847578199117845,1,0.4,0.4,transcript,40675.0
GPD2,ENSG00000115159,schizophrenia,MONDO_0005090,0.3847533892881305,3.8475515591652023,1,0.4,0.4,transcript,22642.0
LIMA1,ENSG00000050405,neutrophil count,EFO_0004833,0.38471717290604446,3.847185133436973,1,0.4,0.4,transcript,29841.0
GALC,ENSG00000054983,high density lipoprotein cholesterol measurement,EFO_0004612,0.3846914270670201,3.8469871636086976,2,0.8,1.6,transcript,21950.0
FRAS1,ENSG00000138759,bilirubin measurement,EFO_0004570,0.38467748785173567,3.8468070150619638,2,0.9,1.8,transcript,56011.0
ATAD2B,ENSG00000119778,mean corpuscular hemoglobin,EFO_0004527,0.38461848674550736,3.846203045141963,1,0.4,0.4,transcript,22005.0
FAT4,ENSG00000196159,platelet volume,OBA_0003277,0.3846072670001881,3.84608138004456,1,0.4,0.4,transcript,45924.0
TFEC,ENSG00000105967,smoking status measurement,EFO_0006527,0.38459478345123066,3.8459635318673024,1,0.4,0.4,transcript,25482.0
SLCO6A1,ENSG00000205359,BMI-adjusted waist circumference,EFO_0007789,0.3845694656130306,3.845735910255719,1,0.5,0.5,transcript,12120.0
ULK4,ENSG00000168038,Tietze syndrome,MONDO_0001858,0.3845687394738785,3.8457283548436423,1,0.5,0.5,transcript,12207.0
FBXO28,ENSG00000143756,sphingomyelin measurement,EFO_0010118,0.38455135428442844,3.8465625305711284,5,2.0,10.0,transcript,9533.0
ZNF573,ENSG00000189144,serum creatinine amount,OBA_2050096,0.38435908849551365,3.8436185016356115,1,0.5,0.5,transcript,18105.0
CWH43,ENSG00000109182,systolic blood pressure,EFO_0006335,0.3843327555319819,3.84338962856625,1,0.5,0.5,transcript,8055.0
FSIP2,ENSG00000188738,self reported educational attainment,EFO_0004784,0.38428067929210796,3.8430857329489734,4,2.0,8.0,transcript,28680.0
COLEC10,ENSG00000184374,serum gamma-glutamyl transferase measurement,EFO_0004532,0.3842295414094706,3.842400594215663,1,0.4,0.4,transcript,3803.0
DENND1B,ENSG00000213047,self reported educational attainment,EFO_0004784,0.38421207866034757,3.8425575441157047,5,2.0,10.0,transcript,22896.0
PLXND1,ENSG00000004399,persistent truncus arteriosus,MONDO_0018072,0.38418188750029303,3.841842555972903,1,0.5,0.5,transcript,21114.0
MRPL32,ENSG00000106591,total cortical area measurement,EFO_0008381,0.38414118735732733,3.841495016371028,1,0.4,0.4,transcript,4811.0
ASTN2,ENSG00000148219,guilt measurement,EFO_0009595,0.3841388518994468,3.8414472734010485,2,0.8,1.6,transcript,27232.0
ZNF429,ENSG00000197013,erythrocyte count,EFO_0004305,0.384058100011973,3.8407368088644955,2,0.8,1.6,transcript,10269.0
PDE11A,ENSG00000128655,heart rate,OBA_1001087,0.3840546733713068,3.840610516850401,2,0.8,1.6,transcript,25085.0
SGCB,ENSG00000163069,dilated cardiomyopathy,EFO_0000407,0.38392899786497675,3.839362573931074,1,0.4,0.4,transcript,5510.0
GRIA4,ENSG00000152578,bipolar disorder,MONDO_0004985,0.3839135924189932,3.8391452157114183,1,0.4,0.4,transcript,43050.0
SHH,ENSG00000164690,radial hemimelia,MONDO_0019671,0.38390938960046433,3.8391470450878216,1,0.4,0.4,transcript,7526.0
UBXN2A,ENSG00000173960,erythrocyte attribute,OBA_2045276,0.3838960159626281,3.839117376880875,2,0.8,1.6,transcript,10177.0
BCAS3,ENSG00000141376,blood urea nitrogen measurement,EFO_0004741,0.38382669190661917,3.838277318184346,1,0.5,0.5,transcript,48081.0
IPP,ENSG00000197429,platelet volume,OBA_0003277,0.38378609938868896,3.8379417693311546,1,0.5,0.5,transcript,6190.0
ANKRD10,ENSG00000088448,smoking initiation,EFO_0005670,0.3837855336984671,3.8380334313746975,2,0.8,1.6,transcript,8984.0
SYNE2,ENSG00000054654,sphingomyelin measurement,EFO_0010118,0.38376489749007325,3.8376616104166406,2,1.0,2.0,transcript,158284.0
SKI,ENSG00000157933,reticulocyte measurement,EFO_0010700,0.38376162464891295,3.8376687674975325,1,0.4,0.4,transcript,7616.0
KCNQ3,ENSG00000184156,benign familial infantile epilepsy,MONDO_0017615,0.38376057587655055,3.8376621364963017,2,0.8,1.6,transcript,28380.0
SLC22A2,ENSG00000112499,total cholesterol measurement,EFO_0004574,0.3837007158193636,3.837046880140011,1,0.4,0.4,transcript,10070.0
TBXT,ENSG00000164458,Chordoma,HP_0010762,0.38367592118363986,3.8372196876614177,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
STXBP5,ENSG00000164506,body mass index,EFO_0004340,0.38366281676303804,3.8366419980388384,2,0.9,1.8,transcript,130148.0
LHFPL2,ENSG00000145685,platelet component distribution width,EFO_0007984,0.3836274911872244,3.83630180443645,1,0.4,0.4,transcript,14874.0
FZD6,ENSG00000164930,erythrocyte count,EFO_0004305,0.3835954270769799,3.8360341629154027,2,0.8,1.6,transcript,20027.0
RFX3,ENSG00000080298,brain connectivity attribute,OBA_2045295,0.3835738826236534,3.8357953274018706,2,0.8,1.6,transcript,28318.0
ZNF682,ENSG00000197124,triglycerides in large VLDL measurement,EFO_0022178,0.3835712484695703,3.835738458721677,1,0.5,0.5,transcript,19250.0
TTLL7,ENSG00000137941,health study participation,EFO_0010130,0.38357062102532336,3.8357351836882154,2,0.8,1.6,transcript,55223.0
FAT1,ENSG00000083857,monocyte count,EFO_0005091,0.3835118840217604,3.8351400356393928,1,0.5,0.5,transcript,23590.0
ULK4,ENSG00000168038,alcohol consumption quality,OBA_1000840,0.38344080574115236,3.834449017516381,1,0.5,0.5,transcript,12207.0
GPM6A,ENSG00000150625,neuroimaging measurement,EFO_0004346,0.38339761156332863,3.8339942867140113,1,0.4,0.4,transcript,22013.0
CNOT6L,ENSG00000138767,body fat percentage,EFO_0007800,0.383375824595112,3.8338881348239733,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
CLASP2,ENSG00000163539,lean body mass,EFO_0004995,0.38335273145522913,3.8335334339415765,1,0.4,0.4,transcript,65366.0
CDH23,ENSG00000107736,protein measurement,EFO_0004747,0.38328203655403836,3.832827916243354,1,0.5,0.5,transcript,66219.0
PTK2,ENSG00000169398,cardiac arrhythmia,EFO_0004269,0.383271698571052,3.832721827915176,1,0.4,0.4,transcript,82607.0
QKI,ENSG00000112531,heel bone mineral density,EFO_0009270,0.3832692686973043,3.832728259128938,2,0.8,1.6,transcript,44979.0
NOM1,ENSG00000146909,type 2 diabetes mellitus,MONDO_0005148,0.3832673513115537,3.8335548809984914,5,2.0,10.0,transcript,11346.0
ATXN3,ENSG00000066427,sitting height measurement,EFO_0011011,0.3832179412096846,3.8321851352943965,1,0.4,0.4,transcript,69891.0
SHOC1,ENSG00000165181,male infertility with azoospermia or oligozoospermia due to single gene mutation,EFO_0700088,0.38320626392692675,3.83217901202014,3,1.3,3.9000000000000004,transcript,33513.0
C2CD6,ENSG00000155754,male infertility due to globozoospermia,MONDO_0015746,0.3830436487908655,3.830477411136679,1,0.5,0.5,transcript,12218.0
DPY19L2,ENSG00000177990,triglyceride measurement,EFO_0004530,0.3830158483064792,3.8302992290183457,2,0.8,1.6,transcript,11368.0
SLC4A8,ENSG00000050438,HbA1c measurement,EFO_0004541,0.3828979184989946,3.8290106928373695,2,0.8,1.6,transcript,50781.0
NDFIP2,ENSG00000102471,cuneus cortex volume,OBA_2050028,0.3828953033879425,3.8289675157454135,2,0.8,1.6,transcript,110483.0
HEG1,ENSG00000173706,reticulocyte count,EFO_0007986,0.3828050101809091,3.8280719680967423,1,0.4,0.4,transcript,18293.0
CCDC88C,ENSG00000015133,prostate carcinoma,EFO_0001663,0.38275072262968124,3.827526549034844,1,0.4,0.4,transcript,20701.0
BMERB1,ENSG00000166780,smoking initiation,EFO_0005670,0.3827276720280128,3.8273129948788402,1,0.4,0.4,transcript,11027.0
PLXND1,ENSG00000004399,physical activity measurement,EFO_0008002,0.3827102222064682,3.8271259030346547,1,0.5,0.5,transcript,21114.0
LRPAP1,ENSG00000163956,total cholesterol measurement,EFO_0004574,0.38270028171939796,3.827233453365419,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
SORL1,ENSG00000137642,HbA1c measurement,EFO_0004541,0.3826250239838637,3.8262972495017347,2,0.9,1.8,transcript,38290.0
PTK2,ENSG00000169398,systolic blood pressure,EFO_0006335,0.382585317674076,3.825858018945416,1,0.4,0.4,transcript,82607.0
MDGA2,ENSG00000139915,smoking initiation,EFO_0005670,0.38257381964689763,3.8257612871576563,1,0.4,0.4,transcript,17323.0
BCKDHB,ENSG00000083123,metabolite measurement,EFO_0004725,0.38250425679557043,3.830769944817102,10,4.0,40.0,transcript,6984.0
TTLL7,ENSG00000137941,phosphatidylcholine measurement,EFO_0010226,0.3824620098376944,3.824649071811926,2,0.8,1.6,transcript,55223.0
PCDH10,ENSG00000138650,glomerular filtration rate,OBA_0003747,0.3824620098376944,3.8247339611722757,2,0.8,1.6,transcript,14052.0
CSMD3,ENSG00000164796,glomerular filtration rate,OBA_0003747,0.3824620098376944,3.8246282070986855,1,0.5,0.5,transcript,61662.0
LATS1,ENSG00000131023,5-methylthioadenosine (MTA) measurement,EFO_0800130,0.3824155767832983,3.824173124424149,1,0.4,0.4,transcript,23046.0
AKAP6,ENSG00000151320,cystatin C measurement,EFO_0004617,0.3823772730615225,3.824347510673876,7,2.8000000000000003,19.6,transcript,34100.0
USP37,ENSG00000135913,apolipoprotein A 1 measurement,EFO_0004614,0.38234563578529634,3.823595984738896,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
GABRA4,ENSG00000109158,acute respiratory distress syndrome,EFO_1000637,0.38220653784926123,3.8220905293980447,1,0.4,0.4,transcript,15904.0
COL24A1,ENSG00000171502,Peyronie disease,MONDO_0008231,0.38220653784926123,3.822089774686806,1,0.4,0.4,transcript,16396.0
CYBRD1,ENSG00000071967,whole body water mass,EFO_0009805,0.3821671267021768,3.8217053763421394,1,0.4,0.4,transcript,11727.0
PKN2,ENSG00000065243,corneal resistance factor,EFO_0010067,0.38215997465507795,3.8216305584441703,1,0.4,0.4,transcript,12982.0
STXBP5,ENSG00000164506,hypertension,EFO_0000537,0.38212754747673844,3.8212893051758425,2,0.9,1.8,transcript,130148.0
TBL2,ENSG00000106638,cholesterol:total lipids ratio,EFO_0020943,0.3821170139693239,3.821185318230787,1,0.4,0.4,transcript,26353.0
MMP12,ENSG00000262406,aortic aneurysm,EFO_0001666,0.3821153426494558,3.8213729654627246,1,0.4,0.4,transcript,1822.0
KIAA0319,ENSG00000137261,uric acid measurement,EFO_0004761,0.3820894007007351,3.8209063943598642,1,0.4,0.4,transcript,32291.0
PHIP,ENSG00000146247,Obesity,HP_0001513,0.3819593855400571,3.8196018325540035,1,0.5,0.5,transcript,62679.0
QSER1,ENSG00000060749,cortical thickness,EFO_0004840,0.38195218850123464,3.819548560215078,1,0.5,0.5,transcript,18744.0
PLEKHA6,ENSG00000143850,platelet crit,EFO_0007985,0.38194157956380154,3.8194226102963453,1,0.4,0.4,transcript,58697.0
FRS2,ENSG00000166225,thyroid stimulating hormone amount,OBA_1000983,0.3819351155351933,3.819367264248071,1,0.4,0.4,transcript,24831.0
RIF1,ENSG00000080345,HbA1c measurement,EFO_0004541,0.38183859382546853,3.818447481571712,3,1.3,3.9000000000000004,transcript,63370.0
BCAS3,ENSG00000141376,Calcium channel blocker use measurement,EFO_0009930,0.38181474748110206,3.818157873929175,1,0.5,0.5,transcript,48081.0
EPHA5,ENSG00000145242,CXCL1 measurement,EFO_0010777,0.38180907011198584,3.8181014258430266,1,0.4,0.4,transcript,37297.0
GPD2,ENSG00000115159,mathematical ability,EFO_0004875,0.3818066087666789,3.818083753950686,1,0.4,0.4,transcript,22642.0
DCK,ENSG00000156136,Red cell distribution width,EFO_0009188,0.38180110916470944,3.818048077315148,1,0.4,0.4,transcript,10815.0
PDE11A,ENSG00000128655,Carney complex,MONDO_0015285,0.38179712943590155,3.8180350774963485,2,0.8,1.6,transcript,25085.0
PPP1R9A,ENSG00000158528,mathematical ability,EFO_0004875,0.3817655653365872,3.8177346615097885,3,1.3,3.9000000000000004,transcript,49362.0
CCDC34,ENSG00000109881,male infertility with azoospermia or oligozoospermia due to single gene mutation,EFO_0700088,0.3817538150980158,3.817631674477937,1,0.4,0.4,transcript,4277.0
SORL1,ENSG00000137642,smoking initiation,EFO_0005670,0.3817043425605771,3.8170904352688684,2,0.9,1.8,transcript,38290.0
ZFP90,ENSG00000184939,mean corpuscular hemoglobin concentration,EFO_0004528,0.3816909891053622,3.8169232462003615,1,0.4,0.4,transcript,29951.0
SYNJ2,ENSG00000078269,intraocular pressure measurement,EFO_0004695,0.3816657781871085,3.8167089294959173,2,0.8,1.6,transcript,31282.0
MGA,ENSG00000174197,high density lipoprotein cholesterol measurement,EFO_0004612,0.3815721565319977,3.81572748710504,1,0.5,0.5,transcript,84434.0
TAF2,ENSG00000064313,Red cell distribution width,EFO_0009188,0.3815569471301038,3.8155722642850622,1,0.5,0.5,transcript,179020.0
ATF6,ENSG00000118217,Cone rod dystrophy,Orphanet_1872,0.38153676678088805,3.8153740202418622,1,0.4,0.4,transcript,62968.0
SV2C,ENSG00000122012,mean corpuscular hemoglobin,EFO_0004527,0.38152213653289574,3.8152493941986934,1,0.4,0.4,transcript,14271.0
LINGO2,ENSG00000174482,protein measurement,EFO_0004747,0.38148259106998156,3.8148376295642574,1,0.4,0.4,transcript,34133.0
SKI,ENSG00000157933,reticulocyte count,EFO_0007986,0.38134659337243293,3.8135184547327325,1,0.4,0.4,transcript,7616.0
MAGI2,ENSG00000187391,diet measurement,EFO_0008111,0.3813310813175341,3.813315376572334,1,0.4,0.4,transcript,87654.0
FIGNL1,ENSG00000132436,monocyte count,EFO_0005091,0.38131236935802093,3.8131398761192496,1,0.4,0.4,transcript,24718.0
SLC15A5,ENSG00000188991,waist circumference,OBA_1001085,0.38130091190785825,3.8142407304367762,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
GPD2,ENSG00000115159,type 1 diabetes mellitus,MONDO_0005147,0.38119136338398946,3.8119313001237916,1,0.4,0.4,transcript,22642.0
GFPT1,ENSG00000198380,Low back pain,HP_0003419,0.38111308753246964,3.8111459793536966,1,0.4,0.4,transcript,26483.0
PEX7,ENSG00000112357,neutrophil count,EFO_0004833,0.3811128358634512,3.8111709027740566,1,0.4,0.4,transcript,9402.0
ZNF682,ENSG00000197124,fatty acid measurement,EFO_0005110,0.3811073493431067,3.811099467457041,1,0.5,0.5,transcript,19250.0
MAN1A2,ENSG00000198162,pain measurement,EFO_0010639,0.38109702167804155,3.8110977373032497,2,0.8,1.6,transcript,12547.0
SLF1,ENSG00000133302,brain attribute,OBA_2045210,0.38103803868231956,3.810415299976726,1,0.4,0.4,transcript,11457.0
CENPE,ENSG00000138778,pulse pressure measurement,EFO_0005763,0.3810251253604332,3.810276947335062,1,0.5,0.5,transcript,19460.0
GRIA4,ENSG00000152578,Intellectual disability,HP_0001249,0.38081292638463105,3.8081385553677967,1,0.4,0.4,transcript,43050.0
DLG1,ENSG00000075711,forced expiratory volume,EFO_0004314,0.3807649591981036,3.8076650017525435,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
CWH43,ENSG00000109182,glomerular filtration rate,OBA_0003747,0.38074118393657636,3.8074739126121946,1,0.5,0.5,transcript,8055.0
C2orf76,ENSG00000186132,neuroimaging measurement,EFO_0004346,0.380727510838229,3.807364374171176,1,0.4,0.4,transcript,4481.0
GABRA4,ENSG00000109158,Headache,HP_0002315,0.3806980486464665,3.807005637370098,1,0.4,0.4,transcript,15904.0
GRIA4,ENSG00000152578,Headache,HP_0002315,0.3806980486464665,3.8069897779861517,1,0.4,0.4,transcript,43050.0
RTKN2,ENSG00000182010,goiter,EFO_0004283,0.3806707765049174,3.806743022872003,1,0.4,0.4,transcript,11345.0
SLF1,ENSG00000133302,body mass index,EFO_0004340,0.38066254374224884,3.806660350576019,1,0.4,0.4,transcript,11457.0
SNIP1,ENSG00000163877,asthma,MONDO_0004979,0.38065637094652105,3.806609205370579,1,0.4,0.4,transcript,8792.0
PRDM5,ENSG00000138738,osteoarthritis,MONDO_0005178,0.3806483734383143,3.8065643429780347,2,0.8,1.6,transcript,19849.0
RCOR3,ENSG00000117625,mean reticulocyte volume,EFO_0010701,0.3806150088299858,3.806214443540788,2,0.8,1.6,transcript,24862.0
TXK,ENSG00000074966,low density lipoprotein cholesterol measurement,EFO_0004611,0.38061056455972847,3.8061350379111945,1,0.4,0.4,transcript,13609.0
GASK1B,ENSG00000164125,monocyte count,EFO_0005091,0.38060022413371103,3.806175127088443,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
NDUFAF2,ENSG00000164182,obesity,EFO_0001073,0.3805680304380745,3.8057205094264783,1,0.4,0.4,transcript,9949.0
NDUFS4,ENSG00000164258,obesity,EFO_0001073,0.3805680304380745,3.8057868857822905,1,0.4,0.4,transcript,3753.0
GPD2,ENSG00000115159,obesity,EFO_0001073,0.3805680304380745,3.8056979706646423,1,0.4,0.4,transcript,22642.0
NDUFAF4,ENSG00000123545,obesity,EFO_0001073,0.3805680304380745,3.805791849277566,1,0.4,0.4,transcript,3586.0
LHFPL2,ENSG00000145685,platelet crit,EFO_0007985,0.38054304959112495,3.8054573884754554,1,0.4,0.4,transcript,14874.0
BCAS3,ENSG00000141376,calcium measurement,EFO_0004838,0.3805344086048582,3.805354485166737,1,0.5,0.5,transcript,48081.0
FBXO28,ENSG00000143756,lymphocyte count,EFO_0004587,0.38050512221462823,3.8061002098731262,5,2.0,10.0,transcript,9533.0
KLHL31,ENSG00000124743,total cholesterol measurement,EFO_0004574,0.3804852753092565,3.804904829645097,1,0.4,0.4,transcript,7681.0
RPS20,ENSG00000008988,cystic fibrosis,MONDO_0009061,0.3804499352828751,3.804516562311176,1,0.4,0.4,transcript,23243.0
GABRA4,ENSG00000109158,bipolar disorder,MONDO_0004985,0.3804256825404064,3.8042819763094964,1,0.4,0.4,transcript,15904.0
SI,ENSG00000090402,type 2 diabetes mellitus,MONDO_0005148,0.380416504908392,3.8042370951934306,1,0.5,0.5,transcript,6940.0
KYNU,ENSG00000115919,platelet volume,OBA_0003277,0.3803433200730735,3.803591449444964,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
PPA2,ENSG00000138777,mean corpuscular hemoglobin concentration,EFO_0004528,0.3803266903218703,3.8032943094892575,1,0.5,0.5,transcript,18244.0
PPDPFL,ENSG00000168333,mean reticulocyte volume,EFO_0010701,0.38022170477148853,3.802542449382569,2,0.8,1.6,transcript,4917.0
ANKRD10,ENSG00000088448,body weight,EFO_0004338,0.3802143587628872,3.8023216820188988,2,0.8,1.6,transcript,8984.0
MMP12,ENSG00000262406,Abdominal Aortic Aneurysm,EFO_0004214,0.38016452482735036,3.8018647872416707,1,0.4,0.4,transcript,1822.0
UBXN2A,ENSG00000173960,platelet count,EFO_0004309,0.3801169897651411,3.8013271149060044,2,0.8,1.6,transcript,10177.0
GREM1,ENSG00000166923,benign neoplasm of rectum,MONDO_0021462,0.3800729899391187,3.8007481234560645,1,0.4,0.4,transcript,21949.0
RGS4,ENSG00000117152,neutrophil count,EFO_0004833,0.380040172577191,3.8004979953266633,2,0.8,1.6,transcript,16620.0
PICALM,ENSG00000073921,reticulocyte count,EFO_0007986,0.37997900892617403,3.7998033575803127,1,0.4,0.4,transcript,30147.0
PARP8,ENSG00000151883,neutrophil count,EFO_0004833,0.37997522017891583,3.79979927861265,2,0.8,1.6,transcript,33987.0
TRAM1,ENSG00000067167,heel bone mineral density,EFO_0009270,0.3799529648687732,3.799720147556645,2,0.8,1.6,transcript,8399.0
NDFIP2,ENSG00000102471,pericalcarine cortex volume,OBA_2050023,0.37992040924781456,3.7992185743441342,2,0.8,1.6,transcript,110483.0
SKI,ENSG00000157933,total cholesterol measurement,EFO_0004574,0.3798763118793418,3.798815639801821,1,0.4,0.4,transcript,7616.0
ADGRV1,ENSG00000164199,serum albumin amount,OBA_2050068,0.3797239474471696,3.797243899642065,1,0.5,0.5,transcript,112990.0
EPHA5,ENSG00000145242,intelligence,EFO_0004337,0.3797075541794934,3.7970862665181024,1,0.4,0.4,transcript,37297.0
ANKRD17,ENSG00000132466,serum albumin amount,OBA_2050068,0.37965965288033743,3.7966057187128537,1,0.4,0.4,transcript,43526.0
CENPE,ENSG00000138778,Testicular Germ Cell Tumor,EFO_1000566,0.3796591611334469,3.7966173050651983,1,0.5,0.5,transcript,19460.0
ANO5,ENSG00000171714,Distal anoctaminopathy,Orphanet_399096,0.37958408628128737,3.795845909176338,1,0.4,0.4,transcript,79265.0
RPS6KA5,ENSG00000100784,BMI-adjusted hip circumference,EFO_0008039,0.37957055857098987,3.7957154505614326,1,0.4,0.4,transcript,40548.0
C2CD4A,ENSG00000198535,type 2 diabetes nephropathy,EFO_0004997,0.37954369047738207,3.7955530150786103,1,0.4,0.4,transcript,3445.0
FRS2,ENSG00000166225,sexual dimorphism measurement,EFO_0021796,0.37951387712306284,3.7951548801267663,1,0.4,0.4,transcript,24831.0
ITM2A,ENSG00000078596,Graves disease,EFO_0004237,0.37949277838844003,3.7953277838844004,1,0.4,0.4,transcript,1000.0
PHC1,ENSG00000111752,mean corpuscular hemoglobin concentration,EFO_0004528,0.3794006155229382,3.794025305713889,1,0.5,0.5,transcript,26109.0
C2orf73,ENSG00000177994,neuroimaging measurement,EFO_0004346,0.3793627699551775,3.7936760087305186,1,0.4,0.4,transcript,8280.0
FUT2,ENSG00000176920,taste liking measurement,EFO_0010155,0.3793455303298133,3.7935783297488195,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
LMO4,ENSG00000143013,lymphocyte count,EFO_0004587,0.379344156018491,3.7934930402363896,1,0.4,0.4,transcript,7770.0
CCDC126,ENSG00000169193,metabolite measurement,EFO_0004725,0.3793376734156728,3.7934191970017386,1,0.4,0.4,transcript,9420.0
SLCO1C1,ENSG00000139155,vital capacity,EFO_0004312,0.37933305672120976,3.7933614581054624,1,0.5,0.5,transcript,16186.0
ADGRV1,ENSG00000164199,sodium measurement,EFO_0009282,0.3793140930329172,3.7931453554995413,1,0.5,0.5,transcript,112990.0
IL17A,ENSG00000112115,Tendinopathy,EFO_1001434,0.37931122644540255,3.7933260538714495,1,0.4,0.4,transcript,1871.0
SHH,ENSG00000164690,spermatocele,EFO_1001189,0.37929199185383283,3.7929730676215065,1,0.4,0.4,transcript,7526.0
DNAH14,ENSG00000185842,urate measurement,EFO_0004531,0.37923563525277587,3.792414331011299,3,1.5,4.5,transcript,77615.0
AKAP11,ENSG00000023516,bone disease,EFO_0004260,0.3791997775020881,3.792397775020881,1,0.4,0.4,transcript,1000.0
PRKCB,ENSG00000166501,body weight,EFO_0004338,0.3791593100818668,3.7916170672656424,1,0.4,0.4,transcript,16690.0
SENP6,ENSG00000112701,atrial flutter,EFO_0003911,0.37912425269948963,3.7916715441555824,5,2.2,11.0,transcript,25640.0
FIGN,ENSG00000182263,response to xenobiotic stimulus,GO_0009410,0.3791211614865956,3.791248369437306,1,0.4,0.4,transcript,10883.0
FRS2,ENSG00000166225,"osteoarthritis, knee",EFO_0004616,0.3791201038617768,3.791217147513906,1,0.4,0.4,transcript,24831.0
FUT2,ENSG00000176920,cholelithiasis,EFO_0004799,0.3791146735063506,3.791269761514193,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
CENPE,ENSG00000138778,triglyceride measurement,EFO_0004530,0.37911430623369374,3.791168756067667,1,0.5,0.5,transcript,19460.0
RTF1,ENSG00000137815,hemoglobin measurement,EFO_0004509,0.379000624348841,3.7900579631677482,1,0.4,0.4,transcript,7734.0
ACTN2,ENSG00000077522,Abnormality of the cardiovascular system,HP_0001626,0.37899089523367263,3.7899256379485147,2,0.8,1.6,transcript,95891.0
HIPK3,ENSG00000110422,high density lipoprotein cholesterol measurement,EFO_0004612,0.3789880982127523,3.7898958156215525,1,0.4,0.4,transcript,26966.0
BCAS3,ENSG00000141376,retinal layer thickness,OBA_2050110,0.37897244300606636,3.789734829178818,1,0.5,0.5,transcript,48081.0
LUZP2,ENSG00000187398,secondary malignant neoplasm,EFO_0009812,0.37892709763810023,3.789587756405227,4,1.7000000000000002,6.800000000000001,transcript,21466.0
FIGN,ENSG00000182263,diastolic blood pressure change measurement,EFO_0006945,0.3788828804022085,3.788865558593435,1,0.4,0.4,transcript,10883.0
THEM4,ENSG00000159445,indoleacetylglutamine measurement,EFO_0800035,0.3788701050712155,3.7888554014742617,2,0.8,1.6,transcript,10366.0
MEOX2,ENSG00000106511,esterified cholesterol measurement,EFO_0008589,0.3788673661042288,3.7888423662299724,1,0.4,0.4,transcript,2371.0
MEOX2,ENSG00000106511,total cholesterol measurement,EFO_0004574,0.3788673661042288,3.7888423662299724,1,0.4,0.4,transcript,2371.0
LARP4B,ENSG00000107929,neutrophil measurement,EFO_0803548,0.378848951148614,3.788500523489223,1,0.5,0.5,transcript,45405.0
CDH23,ENSG00000107736,Abnormality of the ear,HP_0000598,0.3788193510518193,3.788201061221163,1,0.5,0.5,transcript,66219.0
CDH23,ENSG00000107736,ear malformation,MONDO_0007500,0.3788193510518193,3.788201061221163,1,0.5,0.5,transcript,66219.0
NDUFAF2,ENSG00000164182,cortical thickness,EFO_0004840,0.3787999669036158,3.788039874081891,1,0.4,0.4,transcript,9949.0
KLRD1,ENSG00000134539,aspartate aminotransferase measurement,EFO_0004736,0.37875037411488577,3.7876682307473097,4,1.7000000000000002,6.800000000000001,transcript,41340.0
COL19A1,ENSG00000082293,body mass index,EFO_0004340,0.37874347390829044,3.7875720781386986,2,0.8,1.6,transcript,11650.0
ZFP90,ENSG00000184939,blood urea nitrogen measurement,EFO_0004741,0.37868639487556155,3.7868773039023553,1,0.4,0.4,transcript,29951.0
CBLB,ENSG00000114423,erythrocyte volume,OBA_0003460,0.3786814318501958,3.7868228101695096,1,0.4,0.4,transcript,47105.0
NDUFAF2,ENSG00000164182,type 1 diabetes mellitus,MONDO_0005147,0.3786448272315516,3.786488477361249,1,0.4,0.4,transcript,9949.0
NDUFS4,ENSG00000164258,type 1 diabetes mellitus,MONDO_0005147,0.3786448272315516,3.7865548537170612,1,0.4,0.4,transcript,3753.0
NDUFAF4,ENSG00000123545,type 1 diabetes mellitus,MONDO_0005147,0.3786448272315516,3.786559817212337,1,0.4,0.4,transcript,3586.0
SP4,ENSG00000105866,metabolite measurement,EFO_0004725,0.3785886292869363,3.78591028519182,1,0.4,0.4,transcript,16672.0
UMPS,ENSG00000114491,platelet crit,EFO_0007985,0.3785151399933089,3.785170256294754,1,0.4,0.4,transcript,21213.0
CBLB,ENSG00000114423,esophageal adenocarcinoma,EFO_0000478,0.37847676822709586,3.7847761739385097,1,0.4,0.4,transcript,47105.0
SGCD,ENSG00000170624,familial isolated dilated cardiomyopathy,EFO_0700036,0.3783592241327368,3.7836110303733546,1,0.4,0.4,transcript,21289.0
USP15,ENSG00000135655,eosinophil count,EFO_0004842,0.37833870474532616,3.783470165295892,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
GPD2,ENSG00000115159,sleep apnea,EFO_0003877,0.378330760076339,3.783325267047287,1,0.4,0.4,transcript,22642.0
GPR158,ENSG00000151025,corneal resistance factor,EFO_0010067,0.3782202018442374,3.7822276897469895,1,0.5,0.5,transcript,19477.0
MDGA2,ENSG00000139915,metabolite measurement,EFO_0004725,0.3782139120198761,3.782162210887441,1,0.4,0.4,transcript,17323.0
GALC,ENSG00000054983,adult Krabbe disease,MONDO_0016091,0.3782095442915896,3.7821683358543927,2,0.8,1.6,transcript,21950.0
LYPLAL1,ENSG00000143353,Epidermal Inclusion Cyst,EFO_1000243,0.3781774199590642,3.781801995899292,1,0.5,0.5,transcript,17988.0
SMAD2,ENSG00000175387,gastric carcinoma,EFO_0000178,0.37806170146531365,3.781110811708643,9,3.6,32.4,transcript,65614.0
RFX7,ENSG00000181827,genetic disorder,EFO_0000508,0.37805738939814404,3.7805834863075796,1,0.4,0.4,transcript,41700.0
SLC4A8,ENSG00000050438,smoking initiation,EFO_0005670,0.3780317905941895,3.780349413789318,2,0.8,1.6,transcript,50781.0
ASTN2,ENSG00000148219,bone tissue density,OBA_1000110,0.37797460181069803,3.7798047725135606,2,0.8,1.6,transcript,27232.0
SLC30A9,ENSG00000014824,major depressive disorder,MONDO_0002009,0.37796362220753776,3.779987985401796,3,1.3,3.9000000000000004,transcript,11087.0
ACTN2,ENSG00000077522,autosomal dominant distal myopathy,MONDO_0016108,0.3779402665376354,3.7794193509881424,2,0.8,1.6,transcript,95891.0
SECISBP2L,ENSG00000138593,total cholesterol measurement,EFO_0004574,0.3779241171912349,3.7792602558818147,1,0.4,0.4,transcript,20960.0
ATAD2B,ENSG00000119778,appendicular lean mass,EFO_0004980,0.3779187056377712,3.779205234064601,1,0.4,0.4,transcript,22005.0
SV2C,ENSG00000122012,Parkinson disease,MONDO_0005180,0.3778921631788835,3.778949660658571,1,0.4,0.4,transcript,14271.0
EXO1,ENSG00000174371,breast cancer,MONDO_0007254,0.3778787455123859,3.7789168882069553,2,1.0,2.0,transcript,15452.0
DBR1,ENSG00000138231,HbA1c measurement,EFO_0004541,0.37783388303001436,3.778357261781113,1,0.4,0.4,transcript,21702.0
LRRK2,ENSG00000188906,leprosy,EFO_0001054,0.377796520788966,3.7779839657054164,2,0.9,1.8,transcript,95960.0
TMEM131,ENSG00000075568,neuroimaging measurement,EFO_0004346,0.3777796873981545,3.777818322852798,1,0.4,0.4,transcript,18649.0
XKR4,ENSG00000206579,lean body mass,EFO_0004995,0.3777220024540217,3.777238976497007,1,0.4,0.4,transcript,21106.0
SPRED1,ENSG00000166068,cancer,MONDO_0004992,0.37770625045097694,3.7771070777212694,1,0.4,0.4,transcript,8974.0
CBLB,ENSG00000114423,bronchial disease,EFO_1002018,0.377699531999329,3.7770038116608413,1,0.4,0.4,transcript,47105.0
CAVIN2,ENSG00000168497,PR interval,EFO_0004462,0.37765714969191416,3.776702472688624,1,0.4,0.4,transcript,3054.0
CENPC,ENSG00000145241,smoking status measurement,EFO_0006527,0.3776316974189597,3.7765157813466548,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
GMCL2,ENSG00000244234,platelet volume,OBA_0003277,0.37761721314026464,3.7763116500632674,1,0.4,0.4,transcript,2867.0
BCAS3,ENSG00000141376,lymphocyte count,EFO_0004587,0.3775172952234674,3.7751833513528283,1,0.5,0.5,transcript,48081.0
ANKH,ENSG00000154122,Chondrocalcinosis,HP_0000934,0.37751153082223876,3.7758837508453382,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,Chondrocalcinosis,HP_0000934,0.37751153082223876,3.7758837508453382,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,Chondrocalcinosis,HP_0000934,0.37751153082223876,3.7758837508453382,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,Chondrocalcinosis,HP_0000934,0.37751153082223876,3.7758837508453382,5,2.4,12.0,transcript,15616.0
BTAF1,ENSG00000095564,smoking initiation,EFO_0005670,0.3775074636969,3.7751113814114032,1,0.4,0.4,transcript,10886.0
UBXN2A,ENSG00000173960,cerebral cortex area attribute,OBA_2045267,0.3774579832999913,3.774737050254507,2,0.8,1.6,transcript,10177.0
ANKRD17,ENSG00000132466,alpha fetoprotein measurement,EFO_0010583,0.37742281317678694,3.7742373216773486,1,0.4,0.4,transcript,43526.0
PHIP,ENSG00000146247,Global developmental delay,HP_0001263,0.37739935804149205,3.774001557568353,1,0.5,0.5,transcript,62679.0
ASTN2,ENSG00000148219,serum creatinine amount,OBA_2050096,0.37732834660428966,3.773342220449477,2,0.8,1.6,transcript,27232.0
BMPR2,ENSG00000204217,heart rate,OBA_1001087,0.3772978918020844,3.7729966894798808,1,0.4,0.4,transcript,22508.0
ATXN3,ENSG00000066427,heel bone mineral density,EFO_0009270,0.37723094572967214,3.772315180494272,1,0.4,0.4,transcript,69891.0
DENND3,ENSG00000105339,lymphocyte count,EFO_0004587,0.37722777634360716,3.7722885800937243,1,0.5,0.5,transcript,46225.0
PKN2,ENSG00000065243,body height,OBA_VT0001253,0.3771543679873352,3.771574491766743,1,0.4,0.4,transcript,12982.0
CYBRD1,ENSG00000071967,high density lipoprotein cholesterol measurement,EFO_0004612,0.3771333227873129,3.7713673371935004,1,0.4,0.4,transcript,11727.0
PALM2AKAP2,ENSG00000157654,diastolic blood pressure change measurement,EFO_0006945,0.37711699470276505,3.7711779342480978,1,0.4,0.4,transcript,50080.0
SLC30A8,ENSG00000164756,type 1 diabetes mellitus,MONDO_0005147,0.3771045533453635,3.7713557011380394,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,type 1 diabetes mellitus,MONDO_0005147,0.3771045533453635,3.7713557011380394,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,type 1 diabetes mellitus,MONDO_0005147,0.3771045533453635,3.7713557011380394,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,type 1 diabetes mellitus,MONDO_0005147,0.3771045533453635,3.7713557011380394,4,1.6,6.4,gene_variant,20634.0
FIGNL1,ENSG00000132436,B-cell acute lymphoblastic leukemia,EFO_0000094,0.3770597643905701,3.770613826444741,1,0.4,0.4,transcript,24718.0
ACTN2,ENSG00000077522,dilated cardiomyopathy,EFO_0000407,0.37701107895170366,3.7701274751288247,2,0.8,1.6,transcript,95891.0
SYT13,ENSG00000019505,multinodular goiter,MONDO_0000334,0.376998411493182,3.77019940018478,2,0.8,1.6,transcript,7432.0
STXBP4,ENSG00000166263,monocyte count,EFO_0005091,0.3769672734838509,3.7700644462255593,5,2.0,10.0,transcript,25529.0
LIN54,ENSG00000189308,red blood cell density,OBA_2045260,0.3768647932994452,3.7686608595714945,1,0.4,0.4,transcript,30944.0
STAU2,ENSG00000040341,BMI-adjusted waist circumference,EFO_0007789,0.3768243467275808,3.768255035458678,1,0.5,0.5,transcript,43222.0
NDUFAF2,ENSG00000164182,prediabetes syndrome,EFO_1001121,0.3767957290816783,3.767997495862516,1,0.4,0.4,transcript,9949.0
GPD2,ENSG00000115159,prediabetes syndrome,EFO_1001121,0.3767957290816783,3.76797495710068,1,0.4,0.4,transcript,22642.0
NDUFAF4,ENSG00000123545,prediabetes syndrome,EFO_1001121,0.3767957290816783,3.768068835713604,1,0.4,0.4,transcript,3586.0
NDUFS4,ENSG00000164258,prediabetes syndrome,EFO_1001121,0.3767957290816783,3.7680638722183284,1,0.4,0.4,transcript,3753.0
CNTN1,ENSG00000018236,erythrocyte volume,OBA_0003460,0.37679024482460044,3.7679189751228375,1,0.4,0.4,transcript,24203.0
FLRT2,ENSG00000185070,brain attribute,OBA_2045210,0.3767693091425792,3.7680286101960134,7,2.8000000000000003,19.6,transcript,58417.0
FLRT2,ENSG00000185070,cortical thickness,EFO_0004840,0.3767693091425792,3.7680286101960134,7,2.8000000000000003,19.6,transcript,58417.0
LYPLAL1,ENSG00000143353,cortical thickness,EFO_0004840,0.3767693091425792,3.7677208877344426,1,0.5,0.5,transcript,17988.0
SP8,ENSG00000164651,mathematical ability,EFO_0004875,0.3767693091425792,3.7677679977928333,1,0.4,0.4,transcript,5340.0
LRRC7,ENSG00000033122,smoking initiation,EFO_0005670,0.3767693091425792,3.7677571951313427,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
FLRT2,ENSG00000185070,cerebral cortex area attribute,OBA_2045267,0.3767693091425792,3.7680286101960134,7,2.8000000000000003,19.6,transcript,58417.0
TRIM36,ENSG00000152503,generalised epilepsy,EFO_0005917,0.3767693091425792,3.7677192523152625,1,0.4,0.4,transcript,15290.0
PEX2,ENSG00000164751,cortical thickness,EFO_0004840,0.3767693091425792,3.7677369174365296,1,0.4,0.4,transcript,9127.0
ULK4,ENSG00000168038,smoking initiation,EFO_0005670,0.37676629208207196,3.7677038809255774,1,0.5,0.5,transcript,12207.0
LNPEP,ENSG00000113441,inflammatory bowel disease,EFO_0003767,0.3767009703930715,3.7670303661550033,1,0.4,0.4,transcript,19359.0
PIP4K2A,ENSG00000150867,heart rate,OBA_1001087,0.3766662837622851,3.766706282827587,1,0.4,0.4,transcript,9207.0
AGO3,ENSG00000126070,monocyte count,EFO_0005091,0.37665481682499147,3.766561334373479,1,0.4,0.4,transcript,30381.0
PARP1,ENSG00000143799,small cell lung carcinoma,EFO_0000702,0.37660342866986596,3.7660401562766372,1,0.5,0.5,transcript,85185.0
DENND1B,ENSG00000213047,complement factor H-related protein 5 measurement,EFO_0008098,0.3765964656259371,3.7664014137716,5,2.0,10.0,transcript,22896.0
BTF3L4,ENSG00000134717,neutrophil count,EFO_0004833,0.3765857333050923,3.765893492877356,1,0.4,0.4,transcript,11062.0
SGCZ,ENSG00000185053,attention deficit hyperactivity disorder,EFO_0003888,0.376555506942707,3.76560377863311,1,0.4,0.4,transcript,8212.0
RNF144B,ENSG00000137393,Chondrocalcinosis,HP_0000934,0.3765059969045252,3.7651328420640167,1,0.4,0.4,transcript,5489.0
CCBE1,ENSG00000183287,total blood protein measurement,EFO_0004536,0.3764937157295503,3.7649509475457963,1,0.4,0.4,transcript,29006.0
FAM114A1,ENSG00000197712,Death in infancy,HP_0001522,0.37638779299698166,3.7639266095365684,1,0.4,0.4,transcript,8217.0
PAG1,ENSG00000076641,cigarettes per day measurement,EFO_0006525,0.376340965225293,3.763539744130318,2,0.8,1.6,transcript,12299.0
GALC,ENSG00000054983,ulcerative colitis,EFO_0000729,0.37631502673235817,3.7632231602620783,2,0.8,1.6,transcript,21950.0
BMERB1,ENSG00000166780,phosphatidylcholine measurement,EFO_0010226,0.37621810551536977,3.76221732975241,1,0.4,0.4,transcript,11027.0
PKN2,ENSG00000065243,mean corpuscular hemoglobin,EFO_0004527,0.37616500243338935,3.7616808362272844,1,0.4,0.4,transcript,12982.0
FAM114A1,ENSG00000197712,monocyte measurement,EFO_0803547,0.37615017562527747,3.7615504358195264,1,0.4,0.4,transcript,8217.0
SEMA3A,ENSG00000075213,Brugada syndrome,MONDO_0015263,0.37604236908814676,3.760453895517879,1,0.4,0.4,transcript,13243.0
SARAF,ENSG00000133872,metabolite measurement,EFO_0004725,0.37603938126086034,3.760420265885503,1,0.4,0.4,transcript,15121.0
UBXN2A,ENSG00000173960,chronotype measurement,EFO_0008328,0.37601802386188066,3.7603374558734,2,0.8,1.6,transcript,10177.0
LATS1,ENSG00000131023,amygdala volume,OBA_2050034,0.3759290703965471,3.7593080605566365,1,0.4,0.4,transcript,23046.0
COL24A1,ENSG00000171502,lymphocyte count,EFO_0004587,0.3758750438791635,3.7587748349858288,1,0.4,0.4,transcript,16396.0
GJA3,ENSG00000121743,Cataract,HP_0000518,0.3757724861592345,3.7578015781247576,1,0.4,0.4,transcript,5214.0
CFHR4,ENSG00000134365,low density lipoprotein cholesterol measurement,EFO_0004611,0.3757341627078575,3.757382135868982,1,0.5,0.5,transcript,12343.0
APIP,ENSG00000149089,prostate specific antigen amount,OBA_2050200,0.37570547203656435,3.757127489977054,1,0.5,0.5,transcript,6871.0
HEG1,ENSG00000173706,serum creatinine amount,OBA_2050096,0.37567415129027754,3.7567633791904265,1,0.4,0.4,transcript,18293.0
PYHIN1,ENSG00000163564,serum amyloid P-component amount,OBA_2050090,0.37565772577123846,3.756615014933453,1,0.4,0.4,transcript,10594.0
BIRC6,ENSG00000115760,mean corpuscular hemoglobin concentration,EFO_0004528,0.3756249571892092,3.756256754149044,1,0.5,0.5,transcript,69616.0
HHLA2,ENSG00000114455,lipid measurement,EFO_0004529,0.37560475424559675,3.756081346796445,1,0.5,0.5,transcript,14791.0
HECW2,ENSG00000138411,Neurodevelopmental disorder,EFO_0010642,0.37558123808093874,3.7558181969608397,1,0.4,0.4,transcript,68774.0
GPAT3,ENSG00000138678,bone tissue density,OBA_1000110,0.37557296403051904,3.755876766741972,2,0.8,1.6,transcript,10875.0
SP4,ENSG00000105866,Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement,EFO_0009923,0.37557223539243334,3.75574634624679,1,0.4,0.4,transcript,16672.0
TULP4,ENSG00000130338,platelet crit,EFO_0007985,0.37554447029488675,3.7554636280056424,1,0.4,0.4,transcript,21136.0
SMAD2,ENSG00000175387,congenital heart disease,EFO_0005207,0.37553872334064164,3.7558810304619232,9,3.6,32.4,transcript,65614.0
PARP1,ENSG00000143799,influenza,EFO_0007328,0.37553536697284734,3.755359539306451,1,0.5,0.5,transcript,85185.0
PAFAH1B2,ENSG00000168092,omega-6 polyunsaturated fatty acid measurement,EFO_0005680,0.3754606823186787,3.7547406136374937,2,0.8,1.6,transcript,11959.0
GABRA4,ENSG00000109158,status epilepticus,EFO_0008526,0.37536962480617814,3.753721398967214,1,0.4,0.4,transcript,15904.0
FBXO45,ENSG00000174013,erythrocyte volume,OBA_0003460,0.3753054630167535,3.7532210195186164,2,0.8,1.6,transcript,9616.0
ZNF697,ENSG00000143067,uric acid measurement,EFO_0004761,0.3753035948612049,3.753681225543399,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
DDR2,ENSG00000162733,neurodegenerative disease,EFO_0005772,0.3753030941772899,3.7530449822797616,1,0.4,0.4,transcript,28489.0
SMC6,ENSG00000163029,total cholesterol measurement,EFO_0004574,0.3753020927875648,3.753037337458845,1,0.4,0.4,transcript,24376.0
DCDC2,ENSG00000146038,ciliopathy,EFO_0003900,0.37523931968142715,3.7524389738799617,1,0.4,0.4,transcript,8738.0
PROK2,ENSG00000163421,Kallmann syndrome,MONDO_0018800,0.3752320174519678,3.752835638437204,2,0.8,1.6,transcript,3104.0
LRRK2,ENSG00000188906,Crohn's disease,EFO_0000384,0.3752085156630248,3.752103914446005,2,0.9,1.8,transcript,95960.0
PDE11A,ENSG00000128655,systolic blood pressure,EFO_0006335,0.3751984062268846,3.7520478454061794,2,0.8,1.6,transcript,25085.0
SGTB,ENSG00000197860,HbA1c measurement,EFO_0004541,0.37518346802881636,3.7518978215667746,1,0.4,0.4,transcript,6335.0
ZNF507,ENSG00000168813,schizophrenia,MONDO_0005090,0.3751039291931922,3.751053690780014,1,0.4,0.4,transcript,27780.0
DYNC1I2,ENSG00000077380,fat pad mass,OBA_0004528,0.37510130159391586,3.7510242028728205,1,0.4,0.4,transcript,35756.0
OTULINL,ENSG00000145569,glucose measurement,EFO_0004468,0.3750466723269111,3.7505166982816043,1,0.4,0.4,transcript,8004.0
ANO5,ENSG00000171714,glomerular filtration rate,OBA_0003747,0.37503987990623466,3.750403845425811,1,0.4,0.4,transcript,79265.0
ITGB8,ENSG00000105855,lymphocyte count,EFO_0004587,0.37493775353035363,3.749548062516838,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
ZNF257,ENSG00000197134,Drugs used in diabetes use measurement,EFO_0009924,0.37493360282669513,3.749363610669379,1,0.4,0.4,transcript,14502.0
DLG1,ENSG00000075711,diastolic blood pressure,EFO_0006336,0.3748800602231844,3.748816012003351,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
LIN54,ENSG00000189308,high density lipoprotein cholesterol measurement,EFO_0004612,0.3748585908036404,3.7485988346134467,1,0.4,0.4,transcript,30944.0
FAT1,ENSG00000083857,lung carcinoma,EFO_0001071,0.3748408172655805,3.7484293680775935,1,0.5,0.5,transcript,23590.0
LSM11,ENSG00000155858,mean corpuscular hemoglobin concentration,EFO_0004528,0.3748233896784236,3.7482948073979108,1,0.4,0.4,transcript,6567.0
TENM4,ENSG00000149256,high density lipoprotein cholesterol measurement,EFO_0004612,0.37479435310707554,3.7479609815550066,1,0.4,0.4,transcript,22922.0
IL17A,ENSG00000112115,serum creatinine amount,OBA_2050096,0.37476824360060046,3.7478962254234287,1,0.4,0.4,transcript,1871.0
NDFIP2,ENSG00000102471,smoking status measurement,EFO_0006527,0.37475607133423644,3.747575195208353,2,0.8,1.6,transcript,110483.0
FAT3,ENSG00000165323,heel bone mineral density,EFO_0009270,0.37475571764199117,3.7475655054152264,1,0.4,0.4,transcript,48025.0
CCDC34,ENSG00000109881,potassium measurement,EFO_0009283,0.37474288132044364,3.7475223367022155,1,0.4,0.4,transcript,4277.0
LARP4B,ENSG00000107929,basophil percentage of leukocytes,EFO_0007992,0.37461442056714733,3.7461552176745565,1,0.5,0.5,transcript,45405.0
SGCD,ENSG00000170624,trait in response to paliperidone,OBA_2040132,0.3745905527911523,3.745924316957509,1,0.4,0.4,transcript,21289.0
SGCD,ENSG00000170624,schizophrenia symptom severity measurement,EFO_0007927,0.3745905527911523,3.745924316957509,1,0.4,0.4,transcript,21289.0
FAT1,ENSG00000083857,Nephropathy,HP_0000112,0.37457646851628235,3.7457858805846125,1,0.5,0.5,transcript,23590.0
NBAS,ENSG00000151779,metabolite measurement,EFO_0004725,0.3745635966654311,3.745669512444314,2,1.0,2.0,transcript,59620.0
IQCB1,ENSG00000173226,ciliopathy,EFO_0003900,0.3745516325130834,3.7455579441090876,1,0.4,0.4,transcript,9611.0
PEX2,ENSG00000164751,BMI-adjusted waist circumference,EFO_0007789,0.3745016520633542,3.745060346644279,1,0.4,0.4,transcript,9127.0
C4orf33,ENSG00000151470,lifestyle measurement,EFO_0010724,0.3745007739442157,3.745458793075253,4,1.6,6.4,transcript,14189.0
PTPRO,ENSG00000151490,nephrotic syndrome,EFO_0004255,0.3744023584829834,3.744028033426302,1,0.4,0.4,transcript,89916.0
FUT2,ENSG00000176920,vitamin B deficiency,MONDO_0042976,0.37439484769040987,3.744071503354786,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
BHLHE41,ENSG00000123095,platelet count,EFO_0004309,0.3743788509203898,3.7438767899366283,1,0.4,0.4,transcript,4531.0
TOPAZ1,ENSG00000173769,HbA1c measurement,EFO_0004541,0.37437016724433253,3.74379541072604,1,0.5,0.5,transcript,5334.0
FAT4,ENSG00000196159,skin basal cell carcinoma,MONDO_0005341,0.37433819531376733,3.743390663180352,1,0.4,0.4,transcript,45924.0
CBLB,ENSG00000114423,pancreatic ductal adenocarcinoma,MONDO_0005184,0.37427877285837335,3.742796220251285,1,0.4,0.4,transcript,47105.0
NEDD1,ENSG00000139350,erythrocyte volume,OBA_0003460,0.37425324778696223,3.7425517345613226,1,0.4,0.4,transcript,20772.0
PKN2,ENSG00000065243,taste liking measurement,EFO_0010155,0.37421381071826704,3.7421689190760614,1,0.4,0.4,transcript,12982.0
MDM4,ENSG00000198625,gastric carcinoma,EFO_0000178,0.374206686482142,3.7420727356916297,1,0.4,0.4,transcript,68133.0
QKI,ENSG00000112531,fat pad mass,OBA_0004528,0.3741165390642502,3.741200962798397,2,0.8,1.6,transcript,44979.0
RTKN2,ENSG00000182010,diastolic blood pressure,EFO_0006336,0.37411210529237227,3.741156310746552,1,0.4,0.4,transcript,11345.0
CCBE1,ENSG00000183287,hydrops fetalis,MONDO_0015193,0.37410720790458935,3.7410858692961866,1,0.4,0.4,transcript,29006.0
GALNT3,ENSG00000115339,Hyperphosphatemia,HP_0002905,0.3740953601861789,3.740982509862078,1,0.4,0.4,transcript,13837.0
CRYGD,ENSG00000118231,coralliform cataract,EFO_0700129,0.3740734292696282,3.741357345655784,1,0.4,0.4,transcript,642.0
SLC22A24,ENSG00000197658,epiandrosterone sulfate measurement,EFO_0021120,0.37402240657292707,3.7403093608503895,1,0.5,0.5,transcript,5862.0
PIGN,ENSG00000197563,Fryns syndrome,MONDO_0009253,0.3739258563956434,3.7392611037841066,1,0.4,0.4,transcript,157491.0
ZNF148,ENSG00000163848,genetic disorder,EFO_0000508,0.3738940708895015,3.7389525772746843,1,0.4,0.4,transcript,33703.0
PDP1,ENSG00000164951,systolic blood pressure,EFO_0006335,0.3738700138085341,3.7387235053011367,1,0.4,0.4,transcript,17118.0
MFAP3,ENSG00000037749,C-reactive protein measurement,EFO_0004458,0.3738622395314444,3.7386349850160676,1,0.4,0.4,transcript,31772.0
NBAS,ENSG00000151779,Immunodeficiency,HP_0002721,0.3738486559979162,3.7385201057691653,2,1.0,2.0,transcript,59620.0
APOBEC3H,ENSG00000100298,serum creatinine amount,OBA_2050096,0.3737733908054615,3.737810492393118,1,0.4,0.4,transcript,5223.0
APOBEC3H,ENSG00000100298,serum albumin amount,OBA_2050068,0.3737733908054615,3.737810492393118,1,0.4,0.4,transcript,5223.0
SUMF1,ENSG00000144455,placenta praevia,EFO_0007442,0.3737545093361931,3.737577442735162,1,0.4,0.4,transcript,12365.0
TOPAZ1,ENSG00000173769,insomnia,EFO_0004698,0.37368685449496675,3.736962283232382,1,0.5,0.5,transcript,5334.0
EPRS1,ENSG00000136628,leukodystrophy,MONDO_0019046,0.3736193007484486,3.7362377222045717,1,0.5,0.5,transcript,11182.0
TOPAZ1,ENSG00000173769,metabolite measurement,EFO_0004725,0.37360846375528123,3.736178375835527,1,0.5,0.5,transcript,5334.0
MRPL35,ENSG00000132313,systolic blood pressure,EFO_0006335,0.373605778402103,3.736121600230347,1,0.4,0.4,transcript,6268.0
UNC80,ENSG00000144406,lymphocyte count,EFO_0004587,0.37357339240067394,3.735738586011401,1,0.4,0.4,transcript,85800.0
CASQ2,ENSG00000118729,diastolic blood pressure,EFO_0006336,0.37354300257370754,3.7354426767586455,1,0.4,0.4,transcript,31618.0
DLG1,ENSG00000075711,high density lipoprotein cholesterol measurement,EFO_0004612,0.37351022194804673,3.7351176292519743,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
LATS1,ENSG00000131023,metabolite ratio,EFO_0022223,0.3734781019332621,3.7347983759237864,1,0.4,0.4,transcript,23046.0
ADGRV1,ENSG00000164199,Hearing impairment,HP_0000365,0.3734682030957345,3.7346864561277138,1,0.5,0.5,transcript,112990.0
SKI,ENSG00000157933,platelet component distribution width,EFO_0007984,0.3733824226773204,3.7338767477816073,1,0.4,0.4,transcript,7616.0
QKI,ENSG00000112531,heart rate,OBA_1001087,0.37337273636925766,3.7337629358484716,2,0.8,1.6,transcript,44979.0
GALC,ENSG00000054983,infantile Krabbe disease,MONDO_0016089,0.37336804819521996,3.7337533748906964,2,0.8,1.6,transcript,21950.0
PICALM,ENSG00000073921,educational attainment,EFO_0011015,0.37333022296669216,3.733315497985494,1,0.4,0.4,transcript,30147.0
KERA,ENSG00000139330,cornea plana,MONDO_0000733,0.3733110944879486,3.733837227221746,2,0.8,1.6,transcript,2203.0
AKAP6,ENSG00000151320,serum albumin amount,OBA_2050068,0.3732962505497846,3.7335372855564968,7,2.8000000000000003,19.6,transcript,34100.0
NDUFAF4,ENSG00000123545,mitochondrial disease,MONDO_0044970,0.3732756532315488,3.7328680772123093,1,0.4,0.4,transcript,3586.0
TXK,ENSG00000074966,platelet component distribution width,EFO_0007984,0.3732736016463115,3.7327654087770252,1,0.4,0.4,transcript,13609.0
TGFBR1,ENSG00000106799,COVID-19,MONDO_0100096,0.37324898787610544,3.7324941263532003,1,0.4,0.4,transcript,94171.0
OTULIN,ENSG00000154124,autoinflammatory syndrome,MONDO_0019751,0.3731673590747631,3.731692825215798,1,0.4,0.4,transcript,20796.0
DMRTA1,ENSG00000176399,lymphocyte count,EFO_0004587,0.3731164987047834,3.7312365946382386,1,0.4,0.4,transcript,5586.0
IREB2,ENSG00000136381,family history of lung cancer,EFO_0006953,0.3731154957551479,3.731254813315376,2,0.9,1.8,transcript,18026.0
LRRK2,ENSG00000188906,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.3730616979438303,3.73063573725406,2,0.9,1.8,transcript,95960.0
AGBL3,ENSG00000146856,erythrocyte count,EFO_0004305,0.37304492372232084,3.7304851903403438,1,0.5,0.5,transcript,13907.0
CFAP54,ENSG00000188596,histidine measurement,EFO_0009769,0.37303304771424123,3.730399108966989,2,1.0,2.0,transcript,29141.0
CBLB,ENSG00000114423,body weight,EFO_0004338,0.3730104246611771,3.7301127382793227,1,0.4,0.4,transcript,47105.0
TNPO3,ENSG00000064419,glomerular filtration rate,OBA_0003747,0.3729787339509236,3.7298140118660057,1,0.5,0.5,transcript,18746.0
PKN2,ENSG00000065243,insomnia,EFO_0004698,0.3729700757352386,3.729731569245777,1,0.4,0.4,transcript,12982.0
FIGN,ENSG00000182263,restless legs syndrome,EFO_0004270,0.3729700757352386,3.729737511923736,1,0.4,0.4,transcript,10883.0
FAS,ENSG00000026103,adult T-cell leukemia/lymphoma,MONDO_0019471,0.37293339901572825,3.7293361983818145,1,0.4,0.4,transcript,181141.0
PEAK1,ENSG00000173517,erythrocyte count,EFO_0004305,0.37292676025652444,3.7292745250164843,1,0.4,0.4,transcript,57783.0
SKI,ENSG00000157933,Red cell distribution width,EFO_0009188,0.3728535025995551,3.728587547003954,1,0.4,0.4,transcript,7616.0
LINGO2,ENSG00000174482,body fat percentage,EFO_0007800,0.3728249861380127,3.7282615802445687,1,0.4,0.4,transcript,34133.0
TC2N,ENSG00000165929,platelet component distribution width,EFO_0007984,0.3728190101643014,3.728212866425895,1,0.4,0.4,transcript,17571.0
NCKAP1,ENSG00000061676,Autism,HP_0000717,0.3727677087760807,3.727686916978155,1,0.4,0.4,transcript,40695.0
DUSP22,ENSG00000112679,IGA glomerulonephritis,EFO_0004194,0.37274049240854346,3.7274285284758513,1,0.4,0.4,transcript,16946.0
WWTR1,ENSG00000018408,pancreatic ductal adenocarcinoma,MONDO_0005184,0.37272243524388177,3.727309188069783,2,0.8,1.6,transcript,18860.0
LINGO2,ENSG00000174482,alkaline phosphatase measurement,EFO_0004533,0.3727174834261378,3.72718655312582,1,0.4,0.4,transcript,34133.0
PKN2,ENSG00000065243,hemoglobin measurement,EFO_0004509,0.3727153034975052,3.727183846868443,1,0.4,0.4,transcript,12982.0
IMPG2,ENSG00000081148,vitelliform macular dystrophy,MONDO_0000390,0.37269536394437075,3.727169156685087,2,0.9,1.8,transcript,8352.0
MAP3K7,ENSG00000135341,COVID-19,MONDO_0100096,0.3726460810725147,3.726550197448425,4,1.6,6.4,transcript,71599.0
BMPR2,ENSG00000204217,triglyceride measurement,EFO_0004530,0.3726443211340471,3.726460982799508,1,0.4,0.4,transcript,22508.0
GPD2,ENSG00000115159,cognitive function measurement,EFO_0008354,0.3726280472021359,3.726298138305256,1,0.4,0.4,transcript,22642.0
RPS20,ENSG00000008988,reticulocyte measurement,EFO_0010700,0.3726075018205262,3.726092227687687,1,0.4,0.4,transcript,23243.0
TBL2,ENSG00000106638,uric acid measurement,EFO_0004761,0.3725942422534668,3.725957601072216,1,0.4,0.4,transcript,26353.0
CLSTN2,ENSG00000158258,attention deficit hyperactivity disorder,EFO_0003888,0.3725792798864329,3.7258168850930278,1,0.4,0.4,transcript,16607.0
IL17A,ENSG00000112115,uveitis,EFO_1001231,0.37255525652059684,3.7257663546233926,1,0.4,0.4,transcript,1871.0
GNA13,ENSG00000120063,lymphoma,EFO_0000574,0.37253457492562664,3.725397355500622,1,0.4,0.4,transcript,7751.0
DAG1,ENSG00000173402,congenital muscular dystrophy,MONDO_0019950,0.37251412108762133,3.7251473989950252,1,0.4,0.4,transcript,64640.0
LATS1,ENSG00000131023,skin basal cell carcinoma,MONDO_0005341,0.37251118756824053,3.725129232273571,1,0.4,0.4,transcript,23046.0
PICALM,ENSG00000073921,serum albumin amount,OBA_2050068,0.37246706244830985,3.724683892801671,1,0.4,0.4,transcript,30147.0
PARP14,ENSG00000173193,COVID-19,MONDO_0100096,0.37243862301041236,3.7244002180744693,1,0.4,0.4,transcript,28596.0
NDST3,ENSG00000164100,lymphocyte count,EFO_0004587,0.37241811257483937,3.7242311883266166,1,0.4,0.4,transcript,7990.0
GPR158,ENSG00000151025,Red cell distribution width,EFO_0009188,0.37239098798561476,3.7239355511607637,1,0.5,0.5,transcript,19477.0
HECW2,ENSG00000138411,complex neurodevelopmental disorder,MONDO_0100038,0.37235170359483705,3.723522852099823,1,0.4,0.4,transcript,68774.0
FAT1,ENSG00000083857,skin basal cell carcinoma,MONDO_0005341,0.37235170359483705,3.7235382313701595,1,0.5,0.5,transcript,23590.0
NEMF,ENSG00000165525,Global developmental delay,HP_0001263,0.37235170359483705,3.723537219212408,1,0.5,0.5,transcript,24773.0
ATRNL1,ENSG00000107518,breast disease,EFO_0009483,0.3723514155785192,3.7235310149270617,1,0.4,0.4,transcript,23726.0
TRAM1,ENSG00000067167,prostate carcinoma,EFO_0001663,0.3723364049169423,3.723554548038336,2,0.8,1.6,transcript,8399.0
HFM1,ENSG00000162669,Premature ovarian insufficiency,HP_0008209,0.37224282838662537,3.722558120272382,2,1.0,2.0,transcript,15404.0
ONECUT1,ENSG00000169856,neonatal diabetes mellitus,MONDO_0016391,0.37221311114933026,3.722183958632951,1,0.4,0.4,transcript,7569.0
EXO1,ENSG00000174371,breast neoplasm,EFO_0003869,0.3722000125903871,3.7221295589869667,2,1.0,2.0,transcript,15452.0
CBLB,ENSG00000114423,thyroid disease,EFO_1000627,0.3721707293442076,3.721715785109627,1,0.4,0.4,transcript,47105.0
OXSR1,ENSG00000172939,uric acid measurement,EFO_0004761,0.3721287567566031,3.7213281437478125,1,0.4,0.4,transcript,9858.0
ROCK2,ENSG00000134318,erythrocyte count,EFO_0004305,0.37210349654753716,3.7210459590770952,1,0.5,0.5,transcript,45481.0
TRPC6,ENSG00000137672,kidney failure,EFO_1002048,0.3720668191235176,3.7206970783587408,1,0.4,0.4,transcript,13847.0
HS6ST3,ENSG00000185352,insomnia,EFO_0004698,0.3720346274752801,3.7203931351089397,1,0.4,0.4,transcript,8536.0
F13B,ENSG00000143278,retinopathy,EFO_0003839,0.3720317690120948,3.7204255882650994,1,0.5,0.5,transcript,4634.0
TET1,ENSG00000138336,kidney neoplasm,EFO_0003865,0.3719821237401523,3.7198628520498795,1,0.4,0.4,transcript,9612.0
PAFAH1B2,ENSG00000168092,free cholesterol in HDL measurement ,EFO_0022264,0.3719318325672414,3.7194521161231204,2,0.8,1.6,transcript,11959.0
MFAP3,ENSG00000037749,body weight,EFO_0004338,0.37192640749784606,3.7192766646800846,1,0.4,0.4,transcript,31772.0
NDUFS4,ENSG00000164258,glucose measurement,EFO_0004468,0.3719111931548931,3.7192185129504765,1,0.4,0.4,transcript,3753.0
LARP4B,ENSG00000107929,eosinophil percentage of leukocytes,EFO_0007991,0.37190575323946534,3.7190685443977367,1,0.5,0.5,transcript,45405.0
SMAD2,ENSG00000175387,familial thoracic aortic aneurysm and aortic dissection,MONDO_0019625,0.37188972877648113,3.7193910848203178,9,3.6,32.4,transcript,65614.0
LIN54,ENSG00000189308,mean corpuscular hemoglobin,EFO_0004527,0.3718254664832181,3.718267591409224,1,0.4,0.4,transcript,30944.0
TET1,ENSG00000138336,type 2 diabetes mellitus,MONDO_0005148,0.37182434421962746,3.7182850568446306,1,0.4,0.4,transcript,9612.0
MAGI2,ENSG00000187391,serum albumin amount,OBA_2050068,0.37181136352393096,3.7181181986363026,1,0.4,0.4,transcript,87654.0
CYBRD1,ENSG00000071967,hereditary hemochromatosis,MONDO_0006507,0.37176976931531475,3.7177318024735193,1,0.4,0.4,transcript,11727.0
OTULIN,ENSG00000154124,asthma,MONDO_0004979,0.3717475595960008,3.717494830428175,1,0.4,0.4,transcript,20796.0
ANO6,ENSG00000177119,COVID-19,MONDO_0100096,0.3717234859915975,3.717242281066253,1,0.4,0.4,transcript,53900.0
CCDC50,ENSG00000152492,hearing loss,EFO_0004238,0.37172290453651935,3.717265491834442,1,0.4,0.4,transcript,10975.0
FAT1,ENSG00000083857,colorectal adenocarcinoma,EFO_0000365,0.37170493884913886,3.7170705839131775,1,0.5,0.5,transcript,23590.0
HEG1,ENSG00000173706,hemoglobin measurement,EFO_0004509,0.37170062244702023,3.7170280907578537,1,0.4,0.4,transcript,18293.0
FAS,ENSG00000026103,marginal zone B-cell lymphoma,EFO_1000630,0.371631176869808,3.716313976922612,1,0.4,0.4,transcript,181141.0
CWH43,ENSG00000109182,waist circumference,OBA_1001085,0.37162309639951524,3.7162930372415834,1,0.5,0.5,transcript,8055.0
TRPC6,ENSG00000137672,Proteinuria,HP_0000093,0.3716125438854676,3.716154325978241,1,0.4,0.4,transcript,13847.0
IKZF3,ENSG00000161405,cutaneous melanoma,EFO_0000389,0.3716074108319304,3.716081849156088,1,0.4,0.4,transcript,51674.0
LRRK2,ENSG00000188906,"Parkinson disease, dominant",EFO_0022609,0.37159201167131845,3.7159388745289412,2,0.9,1.8,transcript,95960.0
FAT1,ENSG00000083857,ptosis,MONDO_0000728,0.37158431209101256,3.7158643163319143,1,0.5,0.5,transcript,23590.0
GREM1,ENSG00000166923,benign neoplasm,EFO_0002422,0.37157917208257446,3.7158099448906223,1,0.4,0.4,transcript,21949.0
SP4,ENSG00000105866,hypertension,EFO_0000537,0.371564952435261,3.715673516675067,1,0.4,0.4,transcript,16672.0
PLEKHA6,ENSG00000143850,serum creatinine amount,OBA_2050096,0.3715494966180997,3.715501780839327,1,0.4,0.4,transcript,58697.0
LARP4B,ENSG00000107929,erythrocyte count,EFO_0004305,0.37152344270351867,3.7152454390382696,1,0.5,0.5,transcript,45405.0
VPS50,ENSG00000004766,level of serum paraoxonase/arylesterase 1 in blood serum,OBA_2044998,0.3715219658554468,3.715230820514508,1,0.4,0.4,transcript,35836.0
TMTC3,ENSG00000139324,periventricular nodular heterotopia,MONDO_0020341,0.37152014892179647,3.715240498385119,1,0.4,0.4,transcript,10254.0
ACER3,ENSG00000078124,leukodystrophy,MONDO_0019046,0.37149612623124195,3.7153612623124195,1,0.4,0.4,transcript,1000.0
ADGRV1,ENSG00000164199,hearing loss,EFO_0004238,0.37147865327486507,3.71479095791902,1,0.5,0.5,transcript,112990.0
GRSF1,ENSG00000132463,influenza,EFO_0007328,0.3714457196455058,3.7145482866913238,2,0.8,1.6,transcript,17565.0
SEMA3C,ENSG00000075223,platelet count,EFO_0004309,0.3714316697238666,3.7143504155224054,1,0.4,0.4,transcript,11863.0
PLEC,ENSG00000178209,aplasia cutis congenita,MONDO_0007145,0.3714277539581253,3.714286603846896,2,0.9,1.8,transcript,198582.0
AP1S2,ENSG00000182287,X-linked syndromic intellectual disability,MONDO_0020119,0.3714277539581253,3.7142983490703796,1,0.4,0.4,transcript,19222.0
CTBP2,ENSG00000175029,red blood cell density,OBA_2045260,0.3714257259216003,3.7142713224301502,1,0.4,0.4,transcript,28443.0
PTPRO,ENSG00000151490,Alzheimer disease,MONDO_0004975,0.37142102930637844,3.714214741660252,1,0.4,0.4,transcript,89916.0
ARHGAP12,ENSG00000165322,Uterine leiomyoma,HP_0000131,0.37135809690484467,3.7135930314108605,1,0.4,0.4,transcript,33161.0
TMEM17,ENSG00000186889,mathematical ability,EFO_0004875,0.3712294332449632,3.7123583324496323,1,0.4,0.4,transcript,6250.0
MYO5A,ENSG00000197535,acrocephalopolydactyly,MONDO_0008709,0.3712153995332877,3.712156034994089,1,0.4,0.4,transcript,196111.0
FRS2,ENSG00000166225,heel bone mineral density,EFO_0009270,0.37120290652961546,3.7120451741922924,1,0.4,0.4,transcript,24831.0
LINGO2,ENSG00000174482,smoking initiation,EFO_0005670,0.37116933607444824,3.7117050796089246,1,0.4,0.4,transcript,34133.0
ANKRD17,ENSG00000132466,Neurodevelopmental disorder,EFO_0010642,0.37115056906711175,3.7115148805805966,1,0.4,0.4,transcript,43526.0
QKI,ENSG00000112531,esophageal adenocarcinoma,EFO_0000478,0.3711043715852762,3.711079288008657,2,0.8,1.6,transcript,44979.0
FAT1,ENSG00000083857,skin squamous cell carcinoma,MONDO_0002529,0.37107928777266785,3.7108140731484673,1,0.5,0.5,transcript,23590.0
WRN,ENSG00000165392,esophageal adenocarcinoma,EFO_0000478,0.37105817410344055,3.7106091427990795,1,0.5,0.5,transcript,18247.0
ACVR1C,ENSG00000123612,triglyceride measurement,EFO_0004530,0.37105769081460266,3.710696222090844,2,0.8,1.6,transcript,13410.0
ATP9A,ENSG00000054793,Intellectual disability,HP_0001249,0.3710530410499033,3.7105557767239046,1,0.4,0.4,transcript,15769.0
CD86,ENSG00000114013,kidney transplant,EFO_0010134,0.3710530410499033,3.7105622449598368,1,0.4,0.4,transcript,12565.0
DNAH14,ENSG00000185842,monocyte count,EFO_0005091,0.3710466880368047,3.710524858851587,3,1.5,4.5,transcript,77615.0
PAFAH1B2,ENSG00000168092,phospholipids in VLDL measurement ,EFO_0022301,0.37101655529674726,3.7102993434181792,2,0.8,1.6,transcript,11959.0
NEMF,ENSG00000165525,Intellectual disability,HP_0001249,0.37101197662160496,3.710139949480087,1,0.5,0.5,transcript,24773.0
ATP5F1A,ENSG00000152234,erythrocyte volume,OBA_0003460,0.37099790380838893,3.7099928388015266,1,0.4,0.4,transcript,28984.0
NSUN7,ENSG00000179299,monocyte count,EFO_0005091,0.37096518994418576,3.7096909284013453,1,0.5,0.5,transcript,12811.0
FUT2,ENSG00000176920,deficiency anemia,MONDO_0001639,0.37092200199510345,3.709343046401721,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
ANKRD10,ENSG00000088448,ocular hypotension,MONDO_0004390,0.3708989865102775,3.7091679594928015,2,0.8,1.6,transcript,8984.0
DLG2,ENSG00000150672,placenta praevia,EFO_0007442,0.3708943261906852,3.7089460348320107,1,0.4,0.4,transcript,144252.0
FAS,ENSG00000026103,lymphoid neoplasm,EFO_0001642,0.37083950130872334,3.7083972213117655,1,0.4,0.4,transcript,181141.0
WRN,ENSG00000165392,sarcoma,EFO_0000691,0.3708357300857164,3.7083847026218377,1,0.5,0.5,transcript,18247.0
MC2R,ENSG00000185231,alternating hemiplegia of childhood,MONDO_0016241,0.3708271866942627,3.7083664743220024,1,0.4,0.4,transcript,4228.0
RFX3,ENSG00000080298,Intellectual disability,HP_0001249,0.3708271866942627,3.7083283681079635,2,0.8,1.6,transcript,28318.0
OTUD7A,ENSG00000169918,Intellectual disability,HP_0001249,0.37082205364072535,3.708238262974947,1,0.4,0.4,transcript,22565.0
YWHAG,ENSG00000170027,COVID-19,MONDO_0100096,0.37082205364072535,3.708328498620479,1,0.4,0.4,transcript,3705.0
GMCL1,ENSG00000087338,Red cell distribution width,EFO_0009188,0.37081521362225417,3.7084065486887527,2,0.8,1.6,transcript,6289.0
NEBL,ENSG00000078114,cup-to-disc ratio measurement,EFO_0006939,0.3708026061094134,3.708033882913098,1,0.4,0.4,transcript,51139.0
ONECUT1,ENSG00000169856,lifestyle measurement,EFO_0010724,0.3707993538658677,3.7080463857983252,1,0.4,0.4,transcript,7569.0
PLEC,ENSG00000178209,free cholesterol to total lipids in medium VLDL percentage ,EFO_0022284,0.3707856717511799,3.7078657817774423,2,0.9,1.8,transcript,198582.0
HTR1F,ENSG00000179097,psychosis,EFO_0005407,0.3707809892124271,3.7079280256151153,1,0.4,0.4,transcript,3386.0
STXBP4,ENSG00000166263,age at menarche,EFO_0004703,0.37076669182592753,3.7080586296463256,5,2.0,10.0,transcript,25529.0
FUT2,ENSG00000176920,cholesteryl ester measurement,EFO_0010351,0.3707635657626537,3.707758684077224,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
SMAD2,ENSG00000175387,kidney neoplasm,EFO_0003865,0.37068859424875583,3.707379739543065,9,3.6,32.4,transcript,65614.0
PRKCB,ENSG00000166501,Mastocytosis,EFO_0009001,0.37068859424875583,3.7069099089345325,1,0.4,0.4,transcript,16690.0
HFM1,ENSG00000162669,premature menopause,EFO_0009005,0.37068859424875583,3.7070157788936866,2,1.0,2.0,transcript,15404.0
DCUN1D1,ENSG00000043093,heel bone mineral density,EFO_0009270,0.3706878527733479,3.706902805470794,1,0.4,0.4,transcript,16476.0
USP6,ENSG00000129204,Osteoblastoma,EFO_1000410,0.3706834611952186,3.7068459085152066,1,0.4,0.4,transcript,35409.0
WWTR1,ENSG00000018408,kidney neoplasm,EFO_0003865,0.3706834611952186,3.706919447583151,2,0.8,1.6,transcript,18860.0
WRN,ENSG00000165392,thyroid cancer,MONDO_0002108,0.3706834611952186,3.7068620137168597,1,0.5,0.5,transcript,18247.0
CENPE,ENSG00000138778,autosomal recessive primary microcephaly,MONDO_0016660,0.3706680620346067,3.706706314076797,1,0.5,0.5,transcript,19460.0
QKI,ENSG00000112531,pilocytic astrocytoma,MONDO_0016691,0.3706423967669203,3.706459539825098,2,0.8,1.6,transcript,44979.0
USP6,ENSG00000129204,chondroblastoma,EFO_0000331,0.3706423967669203,3.7064352642322236,1,0.4,0.4,transcript,35409.0
SLC25A46,ENSG00000164209,deep vein thrombosis,EFO_0003907,0.3706287323704291,3.7063072768144822,1,0.4,0.4,transcript,20047.0
PAFAH1B2,ENSG00000168092,total lipids in very large HDL measurement ,EFO_0022312,0.3706121691001439,3.7062554814521453,2,0.8,1.6,transcript,11959.0
PAFAH1B2,ENSG00000168092,free cholesterol in very large HDL measurement ,EFO_0022273,0.3706121691001439,3.7062554814521453,2,0.8,1.6,transcript,11959.0
DMAC1,ENSG00000137038,poisoning,EFO_0008546,0.37061081235886023,3.706223697122263,1,0.4,0.4,transcript,3461.0
KCNQ3,ENSG00000184156,prostate carcinoma,EFO_0001663,0.37060355965312347,3.706091974262031,2,0.8,1.6,transcript,28380.0
SFRP1,ENSG00000104332,neuroimaging measurement,EFO_0004346,0.37057494429524135,3.705797421841702,1,0.4,0.4,transcript,8337.0
SLC7A2,ENSG00000003989,glomerular filtration rate,OBA_0003747,0.3705611041809286,3.705732037430397,3,1.4,4.199999999999999,transcript,34712.0
GCH1,ENSG00000131979,autosomal dominant dopa-responsive dystonia,MONDO_0971063,0.3705365532029814,3.7053992958518784,1,0.4,0.4,transcript,11847.0
CPD,ENSG00000108582,Red cell distribution width,EFO_0009188,0.3705048706718768,3.7050689250770374,1,0.4,0.4,transcript,19784.0
KYNU,ENSG00000115919,neurodegenerative disease,EFO_0005772,0.37050380432141355,3.7051962919283645,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
SEMA3A,ENSG00000075213,congenital heart disease,EFO_0005207,0.37050380432141355,3.705068247850547,1,0.4,0.4,transcript,13243.0
TET1,ENSG00000138336,cutaneous melanoma,EFO_0000389,0.37050380432141355,3.7050796578624916,1,0.4,0.4,transcript,9612.0
TRDN,ENSG00000186439,Romano-Ward syndrome,Orphanet_101016,0.37050380432141355,3.705057246655392,1,0.5,0.5,transcript,26037.0
IKZF3,ENSG00000161405,prostate adenocarcinoma,EFO_0000673,0.37050380432141355,3.70504578405092,1,0.4,0.4,transcript,51674.0
PARP8,ENSG00000151883,COVID-19,MONDO_0100096,0.37050380432141355,3.705085120037627,2,0.8,1.6,transcript,33987.0
FRRS1L,ENSG00000260230,autosomal recessive non-syndromic intellectual disability,MONDO_0019502,0.37050380432141355,3.705123949254404,2,0.8,1.6,transcript,18625.0
NUP43,ENSG00000120253,COVID-19,MONDO_0100096,0.37050380432141355,3.7052402421273163,2,0.8,1.6,transcript,7913.0
CNTNAP2,ENSG00000174469,complex neurodevelopmental disorder,MONDO_0100038,0.37050380432141355,3.705045724885667,1,0.4,0.4,transcript,52072.0
FAT4,ENSG00000196159,cutaneous melanoma,EFO_0000389,0.37050380432141355,3.7050467532568145,1,0.4,0.4,transcript,45924.0
WRN,ENSG00000165392,colorectal adenocarcinoma,EFO_0000365,0.37050380432141355,3.705065444978809,1,0.5,0.5,transcript,18247.0
WWTR1,ENSG00000018408,prostate adenocarcinoma,EFO_0000673,0.37050380432141355,3.7051228788451005,2,0.8,1.6,transcript,18860.0
ITGA8,ENSG00000077943,congenital anomaly of kidney and urinary tract,MONDO_0019719,0.3704986712678762,3.7054514686818605,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
ULK4,ENSG00000168038,major depressive disorder,MONDO_0002009,0.37049816713717915,3.7050226314766492,1,0.5,0.5,transcript,12207.0
WWTR1,ENSG00000018408,neurodegenerative disease,EFO_0005772,0.3704758651883753,3.704843487514718,2,0.8,1.6,transcript,18860.0
YTHDC2,ENSG00000047188,systolic blood pressure,EFO_0006335,0.3704331437096239,3.7043516462610953,1,0.4,0.4,transcript,19793.0
FMN1,ENSG00000248905,hereditary breast ovarian cancer syndrome,MONDO_0003582,0.37040114325066775,3.704047130059164,2,0.8,1.6,transcript,44821.0
ZNF257,ENSG00000197134,prostate specific antigen amount,OBA_2050200,0.3703786176332036,3.7038137587344635,1,0.4,0.4,transcript,14502.0
CAV2,ENSG00000105971,heart rate response to exercise,EFO_0009184,0.3703761616949299,3.703785790515504,1,0.4,0.4,transcript,16547.0
IL4R,ENSG00000077238,Nasal polyposis,HP_0100582,0.3703695718287276,3.70371428235652,1,0.4,0.4,transcript,21547.0
CR2,ENSG00000117322,lupus erythematosus,MONDO_0004670,0.37031901439407117,3.703208469867316,1,0.4,0.4,transcript,21827.0
AP1S2,ENSG00000182287,fried syndrome,MONDO_0019428,0.37031901439407117,3.7032109534298385,1,0.4,0.4,transcript,19222.0
ULK4,ENSG00000168038,alcohol drinking,EFO_0004329,0.3702926586402197,3.702967546507055,1,0.5,0.5,transcript,12207.0
ATP5F1A,ENSG00000152234,Mitochondrial encephalopathy,HP_0006789,0.3702907825996161,3.702921626713798,1,0.4,0.4,transcript,28984.0
EXOC6,ENSG00000138190,eosinophil count,EFO_0004842,0.37028880612771203,3.7029106785476684,1,0.5,0.5,transcript,22107.0
RPS20,ENSG00000008988,COVID-19,MONDO_0100096,0.37027281691223557,3.7027453786047806,1,0.4,0.4,transcript,23243.0
ARHGAP12,ENSG00000165322,pulse pressure measurement,EFO_0005763,0.3702400654075679,3.7024127164380927,1,0.4,0.4,transcript,33161.0
HFE,ENSG00000010704,iron metabolism disease,MONDO_0002279,0.37022661943040003,3.7022744794797497,1,0.4,0.4,transcript,48279.0
SEMA3A,ENSG00000075213,skeletal dysplasia,MONDO_0018230,0.37022661943040003,3.702296398940412,1,0.4,0.4,transcript,13243.0
SEMA3A,ENSG00000075213,Skeletal dysplasia,HP_0002652,0.37022661943040003,3.702296398940412,1,0.4,0.4,transcript,13243.0
ADGRV1,ENSG00000164199,systolic blood pressure,EFO_0006335,0.3702219797759458,3.7022242229298272,1,0.5,0.5,transcript,112990.0
MFAP3,ENSG00000037749,blood urea nitrogen measurement,EFO_0004741,0.3701803100985518,3.7018156906871416,1,0.4,0.4,transcript,31772.0
NBAS,ENSG00000151779,Global developmental delay,HP_0001263,0.37013422446672883,3.7013757904572917,2,1.0,2.0,transcript,59620.0
ZNF148,ENSG00000163848,Neurodevelopmental disorder,EFO_0010642,0.37013422446672883,3.701354113046958,1,0.4,0.4,transcript,33703.0
GBE1,ENSG00000114480,multiple pterygium syndrome,MONDO_0017415,0.37013422446672883,3.701403123761408,1,0.5,0.5,transcript,8213.0
SLC6A5,ENSG00000165970,brain disease,EFO_0005774,0.37013422446672883,3.7013808808114015,1,0.4,0.4,transcript,10353.0
ANOS1,ENSG00000011201,congenital anomaly of kidney and urinary tract,MONDO_0019719,0.37013422446672883,3.701393751234376,1,0.4,0.4,transcript,7766.0
FYB1,ENSG00000082074,blood platelet disease,MONDO_0002245,0.37013422446672883,3.701361894893266,1,0.5,0.5,transcript,25445.0
SPRED1,ENSG00000166068,birth weight,EFO_0004344,0.3700800157474176,3.700844730685676,1,0.4,0.4,transcript,8974.0
TMPRSS4,ENSG00000137648,autosomal recessive cerebral atrophy,MONDO_0018218,0.37004182950305764,3.7004286266764077,1,0.4,0.4,transcript,38716.0
FANCF,ENSG00000183161,head and neck malignant neoplasia,EFO_0006859,0.37004182950305764,3.700539838634344,1,0.4,0.4,transcript,3291.0
GLB1,ENSG00000170266,Lysosomal disease,Orphanet_68366,0.37004182950305764,3.7004492031099483,1,0.5,0.5,transcript,16177.0
IREB2,ENSG00000136381,mean corpuscular hemoglobin,EFO_0004527,0.37001088594056153,3.700208715169512,2,0.9,1.8,transcript,18026.0
SLC22A2,ENSG00000112499,prostate carcinoma,EFO_0001663,0.3699941818140131,3.6999815400865064,1,0.4,0.4,transcript,10070.0
USP37,ENSG00000135913,monocyte count,EFO_0005091,0.36998247162701237,3.699964343156056,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
DDR2,ENSG00000162733,gastric carcinoma,EFO_0000178,0.36994943453938645,3.6995083859007267,1,0.4,0.4,transcript,28489.0
WWTR1,ENSG00000018408,esophageal adenocarcinoma,EFO_0000478,0.36994943453938645,3.6995791810248293,2,0.8,1.6,transcript,18860.0
MTR,ENSG00000116984,homocystinuria without methylmalonic aciduria,MONDO_0018964,0.36994943453938645,3.699498757823679,1,0.4,0.4,transcript,90653.0
PDHX,ENSG00000110435,Leigh syndrome,MONDO_0009723,0.36994943453938645,3.6995391131610718,1,0.4,0.4,transcript,8935.0
TGFBR1,ENSG00000106799,emphysema,EFO_0000464,0.36994943453938645,3.6994985929860102,1,0.4,0.4,transcript,94171.0
SLC25A46,ENSG00000164209,Optic atrophy,HP_0000648,0.36994943453938645,3.6995142985040554,1,0.4,0.4,transcript,20047.0
SYT13,ENSG00000019505,neurodegenerative disease,EFO_0005772,0.36994943453938645,3.6997096306468245,2,0.8,1.6,transcript,7432.0
QKI,ENSG00000112531,gastric carcinoma,EFO_0000178,0.36994943453938645,3.6995299175497594,2,0.8,1.6,transcript,44979.0
NDUFAF2,ENSG00000164182,mitochondrial disease,MONDO_0044970,0.36994943453938645,3.6995345504395973,1,0.4,0.4,transcript,9949.0
DLC1,ENSG00000164741,triglyceride measurement,EFO_0004530,0.36989568421113606,3.698968521284475,1,0.4,0.4,transcript,34249.0
ROCK2,ENSG00000134318,uterine fibroid,EFO_0000731,0.369876079817048,3.6987717917722036,1,0.5,0.5,transcript,45481.0
TBL2,ENSG00000106638,cholesteryl esters to total lipids in very small VLDL percentage ,EFO_0022259,0.3698273239398172,3.6982884179357196,1,0.4,0.4,transcript,26353.0
HS6ST3,ENSG00000185352,alcohol consumption quality,OBA_1000840,0.3697427183629775,3.6974740439859137,1,0.4,0.4,transcript,8536.0
FAM186A,ENSG00000185958,mean corpuscular hemoglobin concentration,EFO_0004528,0.3697086622877151,3.6971975245074047,2,1.0,2.0,transcript,18034.0
GREM1,ENSG00000166923,rectal neoplasm,MONDO_0002165,0.3697004581789218,3.6970228058540955,1,0.4,0.4,transcript,21949.0
GREM1,ENSG00000166923,anal neoplasm,EFO_0003835,0.3697004581789218,3.6970228058540955,1,0.4,0.4,transcript,21949.0
YWHAG,ENSG00000170027,Seizure,HP_0001250,0.369672249648373,3.6968304586969554,1,0.4,0.4,transcript,3705.0
CNTN1,ENSG00000018236,Parkinson disease,MONDO_0005180,0.36959813845896067,3.69599791146644,1,0.4,0.4,transcript,24203.0
GBE1,ENSG00000114480,"glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form",MONDO_0017695,0.3695798546847018,3.695859425941137,1,0.5,0.5,transcript,8213.0
IKZF3,ENSG00000161405,lymphoid neoplasm,EFO_0001642,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
CRYGD,ENSG00000118231,early-onset nuclear cataract,MONDO_0020376,0.3695798546847018,3.6964215998065195,1,0.4,0.4,transcript,642.0
AKAP11,ENSG00000023516,neuroinflammatory disorder,EFO_0020092,0.3695798546847018,3.6961985468470178,1,0.4,0.4,transcript,1000.0
GBE1,ENSG00000114480,"glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form",MONDO_0017696,0.3695798546847018,3.695859425941137,1,0.5,0.5,transcript,8213.0
AP1S2,ENSG00000182287,Dystonia,HP_0001332,0.3695798546847018,3.695819356336145,1,0.4,0.4,transcript,19222.0
ANKRD17,ENSG00000132466,syndromic complex neurodevelopmental disorder,MONDO_0800439,0.3695798546847018,3.695807736756497,1,0.4,0.4,transcript,43526.0
CBLB,ENSG00000114423,Uterine Carcinosarcoma,EFO_1000613,0.3695798546847018,3.695807038514569,1,0.4,0.4,transcript,47105.0
TRIM44,ENSG00000166326,isolated aniridia,MONDO_0007119,0.3695798546847018,3.695827891722669,1,0.4,0.4,transcript,13631.0
PARP14,ENSG00000173193,severe acute respiratory syndrome,EFO_0000694,0.3695798546847018,3.6958125348173634,1,0.4,0.4,transcript,28596.0
CRYGD,ENSG00000118231,cerulean cataract,MONDO_0020374,0.3695798546847018,3.6964215998065195,1,0.4,0.4,transcript,642.0
TULP4,ENSG00000130338,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.695817471903793,1,0.4,0.4,transcript,21136.0
CR2,ENSG00000117322,Recurrent infections,HP_0002719,0.3695798546847018,3.6958168727736225,1,0.4,0.4,transcript,21827.0
CBLB,ENSG00000114423,bladder transitional cell carcinoma,EFO_0006544,0.3695798546847018,3.695807038514569,1,0.4,0.4,transcript,47105.0
CBLB,ENSG00000114423,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,EFO_1000417,0.3695798546847018,3.695807038514569,1,0.4,0.4,transcript,47105.0
SMAD2,ENSG00000175387,Endometrial Endometrioid Adenocarcinoma,EFO_1000233,0.3695798546847018,3.6962923439025244,9,3.6,32.4,transcript,65614.0
BCKDHB,ENSG00000083123,classic maple syrup urine disease,MONDO_0017051,0.3695798546847018,3.7015259237084153,10,4.0,40.0,transcript,6984.0
NUP153,ENSG00000124789,Histiocytosis,HP_0100727,0.3695798546847018,3.6958265313995446,1,0.5,0.5,transcript,17867.0
COL25A1,ENSG00000188517,Neurogenic arthrogryposis multiplex congenita,Orphanet_1143,0.3695798546847018,3.6958135085077624,1,0.4,0.4,transcript,26735.0
ONECUT2,ENSG00000119547,lysosomal storage disease,MONDO_0002561,0.3695798546847018,3.696960372573159,7,2.8000000000000003,19.6,transcript,16870.0
BCKDHB,ENSG00000083123,intermediate maple syrup urine disease,MONDO_0017052,0.3695798546847018,3.7015259237084153,10,4.0,40.0,transcript,6984.0
FANCF,ENSG00000183161,Abnormal radial ray morphology,HP_0410049,0.3695798546847018,3.6959200904507856,1,0.4,0.4,transcript,3291.0
FANCF,ENSG00000183161,superficial spreading melanoma,MONDO_0020638,0.3695798546847018,3.6959200904507856,1,0.4,0.4,transcript,3291.0
CCDC88C,ENSG00000015133,congenital non-communicating hydrocephalus,MONDO_0017117,0.3695798546847018,3.6958178695850497,1,0.4,0.4,transcript,20701.0
RFX7,ENSG00000181827,complex neurodevelopmental disorder,MONDO_0100038,0.3695798546847018,3.695808139173157,1,0.4,0.4,transcript,41700.0
FANCF,ENSG00000183161,prostate carcinoma,EFO_0001663,0.3695798546847018,3.6959200904507856,1,0.4,0.4,transcript,3291.0
SEMA3A,ENSG00000075213,Abnormality of the skeletal system,HP_0000924,0.3695798546847018,3.6958287514834294,1,0.4,0.4,transcript,13243.0
RFX7,ENSG00000181827,lysosomal storage disease,MONDO_0002561,0.3695798546847018,3.695808139173157,1,0.4,0.4,transcript,41700.0
G3BP2,ENSG00000138757,COVID-19,MONDO_0100096,0.3695798546847018,3.695800300087225,1,0.4,0.4,transcript,228149.0
ITGA8,ENSG00000077943,bilateral renal agenesis,MONDO_0015986,0.3695798546847018,3.696263302850116,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
LSM11,ENSG00000155858,Aicardi-GoutiÃ¨res syndrome,Orphanet_51,0.3695798546847018,3.6958594574606924,1,0.4,0.4,transcript,6567.0
CBLB,ENSG00000114423,lymphoid neoplasm,EFO_0001642,0.3695798546847018,3.695807038514569,1,0.4,0.4,transcript,47105.0
CBLB,ENSG00000114423,nodular melanoma,EFO_0008515,0.3695798546847018,3.695807038514569,1,0.4,0.4,transcript,47105.0
KIAA0586,ENSG00000100578,Joubert syndrome with Jeune asphyxiating thoracic dystrophy,MONDO_0018342,0.3695798546847018,3.695804197905461,1,0.5,0.5,transcript,88479.0
PEX13,ENSG00000162928,"peroxisome biogenesis disorder, complementation group 7",EFO_0010956,0.3695798546847018,3.695844376361225,1,0.4,0.4,transcript,8728.0
SLC5A7,ENSG00000115665,hereditary motor and sensory neuropathy,MONDO_0015358,0.3695798546847018,3.6958541101196944,1,0.4,0.4,transcript,7199.0
IKZF3,ENSG00000161405,breast ductal adenocarcinoma,EFO_0006318,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
CBLB,ENSG00000114423,breast ductal adenocarcinoma,EFO_0006318,0.3695798546847018,3.695807038514569,1,0.4,0.4,transcript,47105.0
IKZF3,ENSG00000161405,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,EFO_1000417,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
IKZF3,ENSG00000161405,esophageal adenocarcinoma,EFO_0000478,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
ANKRD17,ENSG00000132466,complex neurodevelopmental disorder,MONDO_0100038,0.3695798546847018,3.695807736756497,1,0.4,0.4,transcript,43526.0
CBLB,ENSG00000114423,superficial spreading melanoma,MONDO_0020638,0.3695798546847018,3.695807038514569,1,0.4,0.4,transcript,47105.0
FREM2,ENSG00000150893,"renal agenesis, unilateral",MONDO_0019636,0.3695798546847018,3.696689653601607,6,2.5,15.0,transcript,16833.0
FREM2,ENSG00000150893,Polydactyly,HP_0010442,0.3695798546847018,3.696689653601607,6,2.5,15.0,transcript,16833.0
FAS,ENSG00000026103,Thyroid Gland Mucosa-Associated Lymphoid Tissue Lymphoma,EFO_1000591,0.3695798546847018,3.69580075507155,1,0.4,0.4,transcript,181141.0
SLC11A2,ENSG00000110911,Hypochromic microcytic anemia,HP_0004840,0.3695798546847018,3.695826508120654,2,0.8,1.6,transcript,57222.0
COL24A1,ENSG00000171502,Penile Fibromatosis,EFO_1000466,0.3695798546847018,3.6958229430412115,1,0.4,0.4,transcript,16396.0
SMAD2,ENSG00000175387,cecum adenocarcinoma,EFO_1000020,0.3695798546847018,3.6962923439025244,9,3.6,32.4,transcript,65614.0
NUP43,ENSG00000120253,Histiocytosis,HP_0100727,0.3695798546847018,3.6960007457601987,2,0.8,1.6,transcript,7913.0
ACTN2,ENSG00000077522,familial isolated dilated cardiomyopathy,EFO_0700036,0.3695798546847018,3.695815232458806,2,0.8,1.6,transcript,95891.0
SMAD2,ENSG00000175387,bile duct carcinoma,EFO_0005540,0.3695798546847018,3.6962923439025244,9,3.6,32.4,transcript,65614.0
NCKAP1,ENSG00000061676,autism,EFO_0003758,0.3695798546847018,3.6958083760643663,1,0.4,0.4,transcript,40695.0
HTR1F,ENSG00000179097,Nausea and vomiting,HP_0002017,0.3695798546847018,3.6959166803378625,1,0.4,0.4,transcript,3386.0
HTR1F,ENSG00000179097,obesity,EFO_0001073,0.3695798546847018,3.6959166803378625,1,0.4,0.4,transcript,3386.0
OR4X1,ENSG00000176567,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.696343209156386,1,0.5,0.5,transcript,918.0
SMAD2,ENSG00000175387,lymphoid neoplasm,EFO_0001642,0.3695798546847018,3.6962923439025244,9,3.6,32.4,transcript,65614.0
ANO5,ENSG00000171714,Distal muscle weakness,HP_0002460,0.3695798546847018,3.6958035932104822,1,0.4,0.4,transcript,79265.0
SMAD2,ENSG00000175387,Hepatobiliary Neoplasm,EFO_0008550,0.3695798546847018,3.6962923439025244,9,3.6,32.4,transcript,65614.0
SMAD2,ENSG00000175387,carcinoma of liver and intrahepatic biliary tract,MONDO_0018531,0.3695798546847018,3.6962923439025244,9,3.6,32.4,transcript,65614.0
IKZF3,ENSG00000161405,skin squamous cell carcinoma,MONDO_0002529,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
ANO5,ENSG00000171714,Skeletal dysplasia,HP_0002652,0.3695798546847018,3.6958035932104822,1,0.4,0.4,transcript,79265.0
FYCO1,ENSG00000163820,total early-onset cataract,MONDO_0021548,0.3695798546847018,3.695823157688093,1,0.4,0.4,transcript,16253.0
SMAD2,ENSG00000175387,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,EFO_1000417,0.3695798546847018,3.6962923439025244,9,3.6,32.4,transcript,65614.0
MUC16,ENSG00000181143,radiologic finding,EFO_0006887,0.3695798546847018,3.6958013671964025,1,0.5,0.5,transcript,177283.0
COL24A1,ENSG00000171502,Abnormal retinal morphology,HP_0000479,0.3695798546847018,3.6958229430412115,1,0.4,0.4,transcript,16396.0
ANO5,ENSG00000171714,COVID-19,MONDO_0100096,0.3695798546847018,3.6958035932104822,1,0.4,0.4,transcript,79265.0
KCNQ3,ENSG00000184156,small cell carcinoma,EFO_0008524,0.3695798546847018,3.695854924577814,2,0.8,1.6,transcript,28380.0
KCNQ3,ENSG00000184156,complex neurodevelopmental disorder,MONDO_0100038,0.3695798546847018,3.695854924577814,2,0.8,1.6,transcript,28380.0
KCNQ3,ENSG00000184156,Muscle weakness,HP_0001324,0.3695798546847018,3.695854924577814,2,0.8,1.6,transcript,28380.0
FREM2,ENSG00000150893,polydactyly,MONDO_0021003,0.3695798546847018,3.696689653601607,6,2.5,15.0,transcript,16833.0
KRT74,ENSG00000170484,hypotrichosis simplex of the scalp,MONDO_0019575,0.3695798546847018,3.6958625673335734,1,0.4,0.4,transcript,6248.0
NUP153,ENSG00000124789,COVID-19,MONDO_0100096,0.3695798546847018,3.6958265313995446,1,0.5,0.5,transcript,17867.0
IKZF3,ENSG00000161405,hemangioblastoma,MONDO_0016748,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
SH3TC2,ENSG00000169247,autosomal recessive hereditary demyelinating motor and sensory neuropathy,EFO_0700032,0.3695798546847018,3.6958029702556967,1,0.4,0.4,transcript,90428.0
FAS,ENSG00000026103,neoplasm of mature B-cells,EFO_0000096,0.3695798546847018,3.69580075507155,1,0.4,0.4,transcript,181141.0
MMADHC,ENSG00000168288,inborn disorder of cobalamin metabolism and transport,MONDO_0019220,0.3695798546847018,3.695880112915533,1,0.4,0.4,transcript,4904.0
LAMA1,ENSG00000101680,Abnormal retinal morphology,HP_0000479,0.3695798546847018,3.695814442065736,1,0.5,0.5,transcript,31456.0
LAMA1,ENSG00000101680,eye disease,EFO_0003966,0.3695798546847018,3.695814442065736,1,0.5,0.5,transcript,31456.0
PLCXD2,ENSG00000240891,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.6958295666221246,1,0.4,0.4,transcript,12895.0
FREM2,ENSG00000150893,complete cryptophthalmia,MONDO_0020360,0.3695798546847018,3.696689653601607,6,2.5,15.0,transcript,16833.0
IKZF3,ENSG00000161405,HER2 Positive Breast Carcinoma,EFO_1000294,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
IKZF3,ENSG00000161405,carcinoma of liver and intrahepatic biliary tract,MONDO_0018531,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
IKZF3,ENSG00000161405,bile duct carcinoma,EFO_0005540,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
DSC2,ENSG00000134755,"familial isolated arrhythmogenic ventricular dysplasia, right dominant form",MONDO_0017403,0.3695798546847018,3.695810988913645,2,0.8,1.6,transcript,128596.0
DSC2,ENSG00000134755,"familial isolated arrhythmogenic ventricular dysplasia, left dominant form",MONDO_0017401,0.3695798546847018,3.695810988913645,2,0.8,1.6,transcript,128596.0
GNA13,ENSG00000120063,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.6958501530913734,1,0.4,0.4,transcript,7751.0
DSC2,ENSG00000134755,"familial isolated arrhythmogenic ventricular dysplasia, biventricular form",MONDO_0017402,0.3695798546847018,3.695810988913645,2,0.8,1.6,transcript,128596.0
MMADHC,ENSG00000168288,methylcobalamin deficiency type cblDv1,MONDO_0017683,0.3695798546847018,3.695880112915533,1,0.4,0.4,transcript,4904.0
LINS1,ENSG00000140471,complex neurodevelopmental disorder,MONDO_0100038,0.3695798546847018,3.6958258349548605,1,0.5,0.5,transcript,18323.0
IKZF3,ENSG00000161405,skin carcinoma,EFO_0009259,0.3695798546847018,3.6958062876838023,1,0.4,0.4,transcript,51674.0
FAS,ENSG00000026103,Thyroid Gland Diffuse Large B-Cell Lymphoma,EFO_1000587,0.3695798546847018,3.69580075507155,1,0.4,0.4,transcript,181141.0
COL24A1,ENSG00000171502,Palmar Fibromatosis,EFO_1000438,0.3695798546847018,3.6958229430412115,1,0.4,0.4,transcript,16396.0
COL24A1,ENSG00000171502,eye disease,EFO_0003966,0.3695798546847018,3.6958229430412115,1,0.4,0.4,transcript,16396.0
KLHL3,ENSG00000146021,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.6958458575303617,2,0.8,1.6,transcript,33819.0
SMAD2,ENSG00000175387,superficial spreading melanoma,MONDO_0020638,0.3695798546847018,3.6962923439025244,9,3.6,32.4,transcript,65614.0
LATS1,ENSG00000131023,Endometrial Endometrioid Adenocarcinoma,EFO_1000233,0.3695798546847018,3.6958159034381834,1,0.4,0.4,transcript,23046.0
AMTN,ENSG00000187689,hypocalcified amelogenesis imperfecta,MONDO_0968955,0.3695798546847018,3.6960245355475827,1,0.4,0.4,transcript,1770.0
SMAD2,ENSG00000175387,nodular melanoma,EFO_0008515,0.3695798546847018,3.6962923439025244,9,3.6,32.4,transcript,65614.0
LATS1,ENSG00000131023,Hepatobiliary Neoplasm,EFO_0008550,0.3695798546847018,3.6958159034381834,1,0.4,0.4,transcript,23046.0
LATS1,ENSG00000131023,skin squamous cell carcinoma,MONDO_0002529,0.3695798546847018,3.6958159034381834,1,0.4,0.4,transcript,23046.0
LATS1,ENSG00000131023,colorectal adenocarcinoma,EFO_0000365,0.3695798546847018,3.6958159034381834,1,0.4,0.4,transcript,23046.0
LATS1,ENSG00000131023,carcinoma of liver and intrahepatic biliary tract,MONDO_0018531,0.3695798546847018,3.6958159034381834,1,0.4,0.4,transcript,23046.0
PEX2,ENSG00000164751,peroxisome biogenesis disorder type 3B,MONDO_0009959,0.3695798546847018,3.695842372857755,1,0.4,0.4,transcript,9127.0
USP6,ENSG00000129204,Endometrial Endometrioid Adenocarcinoma,EFO_1000233,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
MLLT3,ENSG00000171843,B-cell acute lymphoblastic leukemia,EFO_0000094,0.3695798546847018,3.6959017859746472,2,0.8,1.6,transcript,15498.0
GFPT1,ENSG00000198380,lysosomal storage disease,MONDO_0002561,0.3695798546847018,3.6958136508760178,1,0.4,0.4,transcript,26483.0
STAM,ENSG00000136738,listeriosis,EFO_0007347,0.3695798546847018,3.6958645425572967,1,0.4,0.4,transcript,6061.0
WWTR1,ENSG00000018408,skin carcinoma,EFO_0009259,0.3695798546847018,3.695883382477983,2,0.8,1.6,transcript,18860.0
HFE,ENSG00000010704,Porphyria variegata,Orphanet_79473,0.3695798546847018,3.6958068320227673,1,0.4,0.4,transcript,48279.0
ATP9A,ENSG00000054793,Global developmental delay,HP_0001263,0.3695798546847018,3.6958239130718895,1,0.4,0.4,transcript,15769.0
GABRA4,ENSG00000109158,Fever,HP_0001945,0.3695798546847018,3.6958236977524503,1,0.4,0.4,transcript,15904.0
WWTR1,ENSG00000018408,carcinoma of liver and intrahepatic biliary tract,MONDO_0018531,0.3695798546847018,3.695883382477983,2,0.8,1.6,transcript,18860.0
WWTR1,ENSG00000018408,bile duct carcinoma,EFO_0005540,0.3695798546847018,3.695883382477983,2,0.8,1.6,transcript,18860.0
WWTR1,ENSG00000018408,pancreatic neuroendocrine tumor,EFO_1000045,0.3695798546847018,3.695883382477983,2,0.8,1.6,transcript,18860.0
WWTR1,ENSG00000018408,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,EFO_1000417,0.3695798546847018,3.695883382477983,2,0.8,1.6,transcript,18860.0
PARP8,ENSG00000151883,severe acute respiratory syndrome,EFO_0000694,0.3695798546847018,3.6958456236705093,2,0.8,1.6,transcript,33987.0
WWTR1,ENSG00000018408,breast ductal adenocarcinoma,EFO_0006318,0.3695798546847018,3.695883382477983,2,0.8,1.6,transcript,18860.0
ARPC5,ENSG00000162704,Combined immunodeficiency,HP_0005387,0.3695798546847018,3.6958252758814316,1,0.4,0.4,transcript,14965.0
ARPC5,ENSG00000162704,cutaneous Leishmaniasis,EFO_0005046,0.3695798546847018,3.6958252758814316,1,0.4,0.4,transcript,14965.0
ARPC5,ENSG00000162704,combined immunodeficiency,MONDO_0015131,0.3695798546847018,3.6958252758814316,1,0.4,0.4,transcript,14965.0
CP,ENSG00000047457,infantile epileptic encephalopathy,EFO_1000643,0.3695798546847018,3.6958196047985004,1,0.5,0.5,transcript,23744.0
TBXT,ENSG00000164458,chordoma,MONDO_0008978,0.3695798546847018,3.696259022672037,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
MC2R,ENSG00000185231,X-linked adrenal hypoplasia congenita,MONDO_0010264,0.3695798546847018,3.6958931542263933,1,0.4,0.4,transcript,4228.0
INF2,ENSG00000203485,familial idiopathic steroid-resistant nephrotic syndrome,MONDO_0019006,0.3695798546847018,3.6958016097279636,1,0.4,0.4,transcript,130596.0
INF2,ENSG00000203485,kidney failure,EFO_1002048,0.3695798546847018,3.6958016097279636,1,0.4,0.4,transcript,130596.0
WWTR1,ENSG00000018408,Hepatobiliary Neoplasm,EFO_0008550,0.3695798546847018,3.695883382477983,2,0.8,1.6,transcript,18860.0
WWTR1,ENSG00000018408,HER2 Positive Breast Carcinoma,EFO_1000294,0.3695798546847018,3.695883382477983,2,0.8,1.6,transcript,18860.0
WWTR1,ENSG00000018408,lymphoid neoplasm,EFO_0001642,0.3695798546847018,3.695883382477983,2,0.8,1.6,transcript,18860.0
ATXN3,ENSG00000066427,Machado-Joseph disease type 3,MONDO_0017176,0.3695798546847018,3.6958042700445684,1,0.4,0.4,transcript,69891.0
GFPT1,ENSG00000198380,congenital myasthenic syndromes with glycosylation defect,EFO_0700079,0.3695798546847018,3.6958136508760178,1,0.4,0.4,transcript,26483.0
RPS20,ENSG00000008988,severe acute respiratory syndrome,EFO_0000694,0.3695798546847018,3.6958157563294427,1,0.4,0.4,transcript,23243.0
ATXN3,ENSG00000066427,Machado-Joseph disease type 1,MONDO_0017174,0.3695798546847018,3.6958042700445684,1,0.4,0.4,transcript,69891.0
NEMF,ENSG00000165525,Tremor,HP_0001337,0.3695798546847018,3.695818730111055,1,0.5,0.5,transcript,24773.0
NEMF,ENSG00000165525,Kyphosis,HP_0002808,0.3695798546847018,3.695818730111055,1,0.5,0.5,transcript,24773.0
NEMF,ENSG00000165525,Ataxia,HP_0001251,0.3695798546847018,3.695818730111055,1,0.5,0.5,transcript,24773.0
NEMF,ENSG00000165525,scoliosis,EFO_0004273,0.3695798546847018,3.695818730111055,1,0.5,0.5,transcript,24773.0
NEMF,ENSG00000165525,Hypotonia,HP_0001252,0.3695798546847018,3.695818730111055,1,0.5,0.5,transcript,24773.0
NEMF,ENSG00000165525,axonal neuropathy,MONDO_0004183,0.3695798546847018,3.695818730111055,1,0.5,0.5,transcript,24773.0
PHIP,ENSG00000146247,Atypical behavior,HP_0000708,0.3695798546847018,3.6958065240004503,1,0.5,0.5,transcript,62679.0
NEMF,ENSG00000165525,Respiratory distress,HP_0002098,0.3695798546847018,3.695818730111055,1,0.5,0.5,transcript,24773.0
SLC25A46,ENSG00000164209,pontocerebellar hypoplasia type 1,MONDO_0016396,0.3695798546847018,3.695818499957209,1,0.4,0.4,transcript,20047.0
MTR,ENSG00000116984,methylmalonic aciduria and homocystinuria type cblE,EFO_0005568,0.3695798546847018,3.6958029592768327,1,0.4,0.4,transcript,90653.0
SLC25A46,ENSG00000164209,hereditary motor and sensory neuropathy type 6,MONDO_0019551,0.3695798546847018,3.695818499957209,1,0.4,0.4,transcript,20047.0
ATXN3,ENSG00000066427,Machado-Joseph disease type 2,MONDO_0017175,0.3695798546847018,3.6958042700445684,1,0.4,0.4,transcript,69891.0
PHIP,ENSG00000146247,Abnormal facial shape,HP_0001999,0.3695798546847018,3.6958065240004503,1,0.5,0.5,transcript,62679.0
PHIP,ENSG00000146247,obesity,EFO_0001073,0.3695798546847018,3.6958065240004503,1,0.5,0.5,transcript,62679.0
DCDC2,ENSG00000146038,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.695844323912708,1,0.4,0.4,transcript,8738.0
HACD1,ENSG00000165996,congenital fiber-type disproportion myopathy,MONDO_0009711,0.3695798546847018,3.695863240361493,1,0.4,0.4,transcript,6183.0
NRCAM,ENSG00000091129,complex neurodevelopmental disorder,MONDO_0100038,0.3695798546847018,3.695810200160929,1,0.4,0.4,transcript,34325.0
MYO5A,ENSG00000197535,melanocytic neoplasm,MONDO_0021143,0.3695798546847018,3.69580058650823,1,0.4,0.4,transcript,196111.0
DDR2,ENSG00000162733,kidney neoplasm,EFO_0003865,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
RFX3,ENSG00000080298,complex neurodevelopmental disorder,MONDO_0100038,0.3695798546847018,3.6958550480123544,2,0.8,1.6,transcript,28318.0
PIAS2,ENSG00000078043,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.6958119368647595,1,0.4,0.4,transcript,29873.0
FRAS1,ENSG00000138759,"renal agenesis, unilateral",MONDO_0019636,0.3695798546847018,3.695830683391625,2,0.9,1.8,transcript,56011.0
FRAS1,ENSG00000138759,Polydactyly,HP_0010442,0.3695798546847018,3.695830683391625,2,0.9,1.8,transcript,56011.0
FRAS1,ENSG00000138759,polydactyly,MONDO_0021003,0.3695798546847018,3.695830683391625,2,0.9,1.8,transcript,56011.0
IQGAP1,ENSG00000140575,cardiofaciocutaneous syndrome,MONDO_0015280,0.3695798546847018,3.695852644764248,2,0.8,1.6,transcript,29576.0
PKP2,ENSG00000057294,"familial isolated arrhythmogenic ventricular dysplasia, biventricular form",MONDO_0017402,0.3695798546847018,3.695954648215344,4,1.6,6.4,transcript,40999.0
SPATA22,ENSG00000141255,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.695832219148183,1,0.5,0.5,transcript,14849.0
IL17A,ENSG00000112115,parapsoriasis,EFO_1000747,0.3695798546847018,3.6960123362644417,1,0.4,0.4,transcript,1871.0
WRN,ENSG00000165392,skin carcinoma,EFO_0009259,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
STT3B,ENSG00000163527,COVID-19,MONDO_0100096,0.3695798546847018,3.695818269740366,1,0.4,0.4,transcript,20281.0
DDR2,ENSG00000162733,Atypical Meningioma,EFO_1000101,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
DDR2,ENSG00000162733,superficial spreading melanoma,MONDO_0020638,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
DDR2,ENSG00000162733,skin squamous cell carcinoma,MONDO_0002529,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
DDR2,ENSG00000162733,carcinoma of liver and intrahepatic biliary tract,MONDO_0018531,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
DDR2,ENSG00000162733,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,EFO_1000417,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
DDR2,ENSG00000162733,lymphoid neoplasm,EFO_0001642,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
SUMF1,ENSG00000144455,inherited retinal dystrophy,MONDO_0019118,0.3695798546847018,3.6958308962202486,1,0.4,0.4,transcript,12365.0
FSIP2,ENSG00000188738,non-syndromic male infertility due to sperm motility disorder,EFO_0700067,0.3695798546847018,3.6960774868749118,4,2.0,8.0,transcript,28680.0
WRN,ENSG00000165392,kidney neoplasm,EFO_0003865,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
AKAP10,ENSG00000108599,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.6958337271460504,1,0.4,0.4,transcript,11370.0
DDR2,ENSG00000162733,Endometrial Endometrioid Adenocarcinoma,EFO_1000233,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
DDR2,ENSG00000162733,esophageal adenocarcinoma,EFO_0000478,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
HECW2,ENSG00000138411,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.6958043629984703,1,0.4,0.4,transcript,68774.0
MYO5A,ENSG00000197535,cutaneous Leishmaniasis,EFO_0005046,0.3695798546847018,3.69580058650823,1,0.4,0.4,transcript,196111.0
PKP2,ENSG00000057294,"familial isolated arrhythmogenic ventricular dysplasia, left dominant form",MONDO_0017401,0.3695798546847018,3.695954648215344,4,1.6,6.4,transcript,40999.0
MYO5A,ENSG00000197535,spitz nevus,MONDO_0044793,0.3695798546847018,3.69580058650823,1,0.4,0.4,transcript,196111.0
PKP2,ENSG00000057294,Left ventricular noncompaction,HP_0030682,0.3695798546847018,3.695954648215344,4,1.6,6.4,transcript,40999.0
PKP2,ENSG00000057294,"familial isolated arrhythmogenic ventricular dysplasia, right dominant form",MONDO_0017403,0.3695798546847018,3.695954648215344,4,1.6,6.4,transcript,40999.0
DDR2,ENSG00000162733,Hepatobiliary Neoplasm,EFO_0008550,0.3695798546847018,3.6958125873538803,1,0.4,0.4,transcript,28489.0
RNMT,ENSG00000101654,HIV infection,EFO_0000764,0.3695798546847018,3.6958149685565176,1,0.4,0.4,transcript,24358.0
WRN,ENSG00000165392,breast ductal adenocarcinoma,EFO_0006318,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
WRN,ENSG00000165392,prostate carcinoma,EFO_0001663,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
WRN,ENSG00000165392,lung carcinoma,EFO_0001071,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
WRN,ENSG00000165392,hemangioblastoma,MONDO_0016748,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
WRN,ENSG00000165392,lymphoid neoplasm,EFO_0001642,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
WRN,ENSG00000165392,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,EFO_1000417,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
WRN,ENSG00000165392,bile duct carcinoma,EFO_0005540,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
WRN,ENSG00000165392,desmoplastic melanoma,MONDO_0044785,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
WRN,ENSG00000165392,carcinoma of liver and intrahepatic biliary tract,MONDO_0018531,0.3695798546847018,3.6958259486116916,1,0.5,0.5,transcript,18247.0
GFPT1,ENSG00000198380,congenital disorder of glycosylation type I,EFO_0005545,0.3695798546847018,3.6958136508760178,1,0.4,0.4,transcript,26483.0
NEMF,ENSG00000165525,autosomal recessive non-syndromic intellectual disability,MONDO_0019502,0.3695798546847018,3.695818730111055,1,0.5,0.5,transcript,24773.0
MAP2K6,ENSG00000108984,neuroinflammatory disorder,EFO_0020092,0.3695798546847018,3.695815849381839,1,0.4,0.4,transcript,23118.0
USP6,ENSG00000129204,breast adenocarcinoma,EFO_0000304,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
TGFBR1,ENSG00000106799,Marfan syndrome type 2,Orphanet_284973,0.3695798546847018,3.695802794439164,1,0.4,0.4,transcript,94171.0
USP6,ENSG00000129204,Hepatobiliary Neoplasm,EFO_0008550,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
USP6,ENSG00000129204,skin basal cell carcinoma,MONDO_0005341,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
ARHGAP20,ENSG00000137727,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.695808791436594,1,0.4,0.4,transcript,39045.0
NBAS,ENSG00000151779,Acute infantile liver failure-multisystemic involvement syndrome,Orphanet_370088,0.3695798546847018,3.695832092637021,2,1.0,2.0,transcript,59620.0
GRIA4,ENSG00000152578,complex neurodevelopmental disorder,MONDO_0100038,0.3695798546847018,3.6958078383685042,1,0.4,0.4,transcript,43050.0
MDM4,ENSG00000198625,skin basal cell carcinoma,MONDO_0005341,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
MDM4,ENSG00000198625,superficial spreading melanoma,MONDO_0020638,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
MDM4,ENSG00000198625,Transitional Meningioma,EFO_1000602,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
BCKDHB,ENSG00000083123,intermittent maple syrup urine disease,MONDO_0017053,0.3695798546847018,3.7015259237084153,10,4.0,40.0,transcript,6984.0
MDM4,ENSG00000198625,Hepatobiliary Neoplasm,EFO_0008550,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
MDM4,ENSG00000198625,hemangioblastoma,MONDO_0016748,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
MDM4,ENSG00000198625,carcinoma of liver and intrahepatic biliary tract,MONDO_0018531,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
PRDM10,ENSG00000170325,Birt-Hogg-DubÃ© syndrome,Orphanet_122,0.3695798546847018,3.69580994935557,1,0.4,0.4,transcript,35080.0
KERA,ENSG00000139330,congenital cornea plana,EFO_0700098,0.3695798546847018,3.6965248291892783,2,0.8,1.6,transcript,2203.0
TET1,ENSG00000138336,skin basal cell carcinoma,MONDO_0005341,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
TET1,ENSG00000138336,lymphoid neoplasm,EFO_0001642,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
USP6,ENSG00000129204,cutaneous melanoma,EFO_0000389,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
USP6,ENSG00000129204,superficial spreading melanoma,MONDO_0020638,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
FAT4,ENSG00000196159,superficial spreading melanoma,MONDO_0020638,0.3695798546847018,3.695807256889697,1,0.4,0.4,transcript,45924.0
USP6,ENSG00000129204,thyroid neoplasm,EFO_0003841,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
TET1,ENSG00000138336,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,EFO_1000417,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
TET1,ENSG00000138336,skin carcinoma,EFO_0009259,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
TET1,ENSG00000138336,oral cavity carcinoma,MONDO_0044925,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
TET1,ENSG00000138336,skin squamous cell carcinoma,MONDO_0002529,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
TET1,ENSG00000138336,bile duct carcinoma,EFO_0005540,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
FBXO28,ENSG00000143756,undetermined early-onset epileptic encephalopathy,MONDO_0018614,0.3695798546847018,3.6968475345738616,5,2.0,10.0,transcript,9533.0
CEP85L,ENSG00000111860,lissencephaly 9 with complex brainstem malformation,MONDO_0032677,0.3695798546847018,3.6958139498274947,1,0.4,0.4,transcript,25969.0
MDM4,ENSG00000198625,nodular melanoma,EFO_0008515,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
USP6,ENSG00000129204,leiomyosarcoma,EFO_0000564,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
USP6,ENSG00000129204,lung carcinoma,EFO_0001071,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
GJA3,ENSG00000121743,early-onset nuclear cataract,MONDO_0020376,0.3695798546847018,3.6958752633794307,1,0.4,0.4,transcript,5214.0
GJA3,ENSG00000121743,early-onset posterior polar cataract,MONDO_0020378,0.3695798546847018,3.6958752633794307,1,0.4,0.4,transcript,5214.0
USP6,ENSG00000129204,gastrointestinal stromal tumor,MONDO_0011719,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
USP6,ENSG00000129204,nodular melanoma,EFO_0008515,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
USP6,ENSG00000129204,carcinoma of liver and intrahepatic biliary tract,MONDO_0018531,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
USP6,ENSG00000129204,skin squamous cell carcinoma,MONDO_0002529,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
USP6,ENSG00000129204,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,EFO_1000417,0.3695798546847018,3.6958098434100384,1,0.4,0.4,transcript,35409.0
FGFR1OP2,ENSG00000111790,chronic myelogenous leukemia,EFO_0000339,0.3695798546847018,3.695834680541688,1,0.4,0.4,transcript,11070.0
TET1,ENSG00000138336,hemangioblastoma,MONDO_0016748,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
TET1,ENSG00000138336,Endometrial Endometrioid Adenocarcinoma,EFO_1000233,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
ZBTB21,ENSG00000173276,neurodegenerative disease,EFO_0005772,0.3695798546847018,3.6958128489065145,1,0.4,0.4,transcript,27968.0
SPAST,ENSG00000021574,developmental disorder of mental health,EFO_0005548,0.3695798546847018,3.6958037231653615,1,0.4,0.4,transcript,77275.0
FAT4,ENSG00000196159,desmoplastic melanoma,MONDO_0044785,0.3695798546847018,3.695807256889697,1,0.4,0.4,transcript,45924.0
FAT4,ENSG00000196159,colon adenocarcinoma,EFO_1001949,0.3695798546847018,3.695807256889697,1,0.4,0.4,transcript,45924.0
NBAS,ENSG00000151779,Neurodevelopmental disorder,EFO_0010642,0.3695798546847018,3.695832092637021,2,1.0,2.0,transcript,59620.0
PTPRO,ENSG00000151490,multiple sclerosis,MONDO_0005301,0.3695798546847018,3.6958029954434855,1,0.4,0.4,transcript,89916.0
FAT4,ENSG00000196159,lymphoid neoplasm,EFO_0001642,0.3695798546847018,3.695807256889697,1,0.4,0.4,transcript,45924.0
DAG1,ENSG00000173402,muscle-eye-brain disease with bilateral multicystic leucodystrophy,MONDO_0018280,0.3695798546847018,3.69580473496583,1,0.4,0.4,transcript,64640.0
SPAST,ENSG00000021574,Autosomal recessive spastic ataxia of Charlevoix-Saguenay,Orphanet_98,0.3695798546847018,3.6958037231653615,1,0.4,0.4,transcript,77275.0
ATP9A,ENSG00000054793,Abnormal abdomen morphology,HP_0001438,0.3695798546847018,3.6958239130718895,1,0.4,0.4,transcript,15769.0
ATP9A,ENSG00000054793,complex neurodevelopmental disorder,MONDO_0100038,0.3695798546847018,3.6958239130718895,1,0.4,0.4,transcript,15769.0
YWHAG,ENSG00000170027,severe acute respiratory syndrome,EFO_0000694,0.3695798546847018,3.695906509060243,1,0.4,0.4,transcript,3705.0
FAT4,ENSG00000196159,Cerebro-facio-articular syndrome,Orphanet_314679,0.3695798546847018,3.695807256889697,1,0.4,0.4,transcript,45924.0
PTPRO,ENSG00000151490,lysosomal storage disease,MONDO_0002561,0.3695798546847018,3.6958029954434855,1,0.4,0.4,transcript,89916.0
FAT4,ENSG00000196159,Endometrial Endometrioid Adenocarcinoma,EFO_1000233,0.3695798546847018,3.695807256889697,1,0.4,0.4,transcript,45924.0
DYNC2H1,ENSG00000187240,retinitis pigmentosa,MONDO_0019200,0.3695798546847018,3.695808703255712,1,0.5,0.5,transcript,49230.0
TET1,ENSG00000138336,esophageal adenocarcinoma,EFO_0000478,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
FAT4,ENSG00000196159,breast ductal adenocarcinoma,EFO_0006318,0.3695798546847018,3.695807256889697,1,0.4,0.4,transcript,45924.0
MDM4,ENSG00000198625,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,EFO_1000417,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
TET1,ENSG00000138336,colorectal adenocarcinoma,EFO_0000365,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
MDM4,ENSG00000198625,bile duct carcinoma,EFO_0005540,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
MDM4,ENSG00000198625,lymphoid neoplasm,EFO_0001642,0.3695798546847018,3.6958044177172273,1,0.4,0.4,transcript,68133.0
MAP2K6,ENSG00000108984,anthrax infection,EFO_0000778,0.3695798546847018,3.695815849381839,1,0.4,0.4,transcript,23118.0
SPAST,ENSG00000021574,cerebral palsy,EFO_1000632,0.3695798546847018,3.6958037231653615,1,0.4,0.4,transcript,77275.0
TET1,ENSG00000138336,Hepatobiliary Neoplasm,EFO_0008550,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
NBAS,ENSG00000151779,Increased susceptibility to fractures,HP_0002659,0.3695798546847018,3.695832092637021,2,1.0,2.0,transcript,59620.0
GLB1,ENSG00000170266,Seizure,HP_0001250,0.3695798546847018,3.6958294549263897,1,0.5,0.5,transcript,16177.0
TET1,ENSG00000138336,carcinoma of liver and intrahepatic biliary tract,MONDO_0018531,0.3695798546847018,3.695840161495374,1,0.4,0.4,transcript,9612.0
FAT4,ENSG00000196159,rectal adenocarcinoma,EFO_0005631,0.3695798546847018,3.695807256889697,1,0.4,0.4,transcript,45924.0
GALC,ENSG00000054983,late-infantile/juvenile Krabbe disease,MONDO_0016090,0.3695798546847018,3.6958714397855146,2,0.8,1.6,transcript,21950.0
PDE1C,ENSG00000154678,Recurrent thrombophlebitis,HP_0004419,0.3695798546847018,3.695852905751686,2,0.8,1.6,transcript,29434.0
SP8,ENSG00000164651,brain attribute,OBA_2045210,0.3695760035873485,3.695834942240526,1,0.4,0.4,transcript,5340.0
PHIP,ENSG00000146247,ovarian neoplasm,EFO_0003893,0.36955187590703514,3.695526736223784,1,0.5,0.5,transcript,62679.0
ZNF682,ENSG00000197124,triglycerides in small VLDL measurement,EFO_0022145,0.3695456691881593,3.695482665907567,1,0.5,0.5,transcript,19250.0
MAN1A2,ENSG00000198162,insomnia,EFO_0004698,0.36954021928085945,3.6955297133314287,2,0.8,1.6,transcript,12547.0
SLCO6A1,ENSG00000205359,diastolic blood pressure,EFO_0006336,0.36952518983081434,3.695293152433556,1,0.5,0.5,transcript,12120.0
PARP11,ENSG00000111224,intraocular pressure measurement,EFO_0004695,0.36951648809758036,3.6951828294636435,1,0.4,0.4,transcript,22286.0
NRK,ENSG00000123572,lean body mass,EFO_0004995,0.36945965826312666,3.694621800132212,1,0.4,0.4,transcript,15862.0
RCC1L,ENSG00000274523,lymphocyte count,EFO_0004587,0.36945121696887423,3.6945552313746073,1,0.4,0.4,transcript,9289.0
GAN,ENSG00000261609,health study participation,EFO_0010130,0.3694445981149288,3.694456645256569,1,0.4,0.4,transcript,37509.0
CNTN5,ENSG00000149972,smoking initiation,EFO_0005670,0.3694186019934364,3.694199000625586,1,0.4,0.4,transcript,30815.0
PEX2,ENSG00000164751,pericalcarine cortex volume,OBA_2050023,0.3693928025906594,3.6939718519173312,1,0.4,0.4,transcript,9127.0
MEOX2,ENSG00000106511,reticulocyte count,EFO_0007986,0.3693928025906594,3.6940967310942785,1,0.4,0.4,transcript,2371.0
PEX2,ENSG00000164751,whole body water mass,EFO_0009805,0.3693928025906594,3.6939718519173312,1,0.4,0.4,transcript,9127.0
SRGN,ENSG00000122862,basophil measurement,EFO_0803539,0.36938388492591673,3.6939622298884087,1,0.4,0.4,transcript,3242.0
TET1,ENSG00000138336,appendicular lean mass,EFO_0004980,0.36937600412681115,3.693801655916468,1,0.4,0.4,transcript,9612.0
RGS7BP,ENSG00000186479,disorder of appendix,EFO_0009542,0.369361198962982,3.693700110884666,1,0.5,0.5,transcript,5674.0
LMO4,ENSG00000143013,blood sodium bicarbonate amount,OBA_2050094,0.369361198962982,3.6936634696812995,1,0.4,0.4,transcript,7770.0
GFPT1,ENSG00000198380,body mass index,EFO_0004340,0.3693593295862169,3.6936083998911693,1,0.4,0.4,transcript,26483.0
THAP1,ENSG00000131931,nicotine dependence,EFO_0003768,0.369349702466844,3.693576389747805,1,0.4,0.4,transcript,5040.0
ONECUT1,ENSG00000169856,obesity,EFO_0001073,0.3693489288657453,3.693542135797101,1,0.4,0.4,transcript,7569.0
POU2F1,ENSG00000143190,prostate carcinoma,EFO_0001663,0.3693442194620256,3.693457206676814,2,0.8,1.6,transcript,106581.0
TLR10,ENSG00000174123,BMI-adjusted hip circumference,EFO_0008039,0.36931389297698397,3.6933003719869792,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
PTBP3,ENSG00000119314,Red cell distribution width,EFO_0009188,0.3692766610199837,3.693000047801966,5,2.0,10.0,transcript,42838.0
PARP14,ENSG00000173193,neurodegenerative disease,EFO_0005772,0.3692017530292365,3.692031518262711,1,0.4,0.4,transcript,28596.0
SKI,ENSG00000157933,platelet volume,OBA_0003277,0.36916985287722065,3.69175104978061,1,0.4,0.4,transcript,7616.0
RPS6KA5,ENSG00000100784,basophil measurement,EFO_0803539,0.3691168698087033,3.6911785629385667,1,0.4,0.4,transcript,40548.0
ZBTB21,ENSG00000173276,hypertrophic cardiomyopathy,EFO_0000538,0.36902629924029984,3.6902772944624953,1,0.4,0.4,transcript,27968.0
ADK,ENSG00000156110,platelet crit,EFO_0007985,0.3689961192419829,3.68998017585678,1,0.4,0.4,transcript,21071.0
KLHL3,ENSG00000146021,serum creatinine amount,OBA_2050096,0.36895390780804893,3.6895863887638334,2,0.8,1.6,transcript,33819.0
SLC22A24,ENSG00000197658,X-24418 measurement,EFO_0800879,0.36893372012605713,3.6894224963816904,1,0.5,0.5,transcript,5862.0
TTLL7,ENSG00000137941,monocyte count,EFO_0005091,0.3688301628272092,3.688330601707074,2,0.8,1.6,transcript,55223.0
FAM114A1,ENSG00000197712,systolic blood pressure,EFO_0006335,0.3688233329147983,3.6882820087147348,1,0.4,0.4,transcript,8217.0
MARCKS,ENSG00000277443,preeclampsia,EFO_0000668,0.3688214634964546,3.6883077448341925,1,0.4,0.4,transcript,4296.0
DLG1,ENSG00000075711,heel bone mineral density,EFO_0009270,0.36877102662824285,3.687725676053936,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
HS6ST3,ENSG00000185352,glucose measurement,EFO_0004468,0.3687226051728623,3.6872729120847616,1,0.4,0.4,transcript,8536.0
PROK2,ENSG00000163421,Red cell distribution width,EFO_0009188,0.36867361386179015,3.687251602535427,2,0.8,1.6,transcript,3104.0
LSM11,ENSG00000155858,mean reticulocyte volume,EFO_0010701,0.3685916726588023,3.685977637201698,1,0.4,0.4,transcript,6567.0
FREM2,ENSG00000150893,congenital hydronephrosis,MONDO_0007741,0.36845920643644114,3.685483171119001,6,2.5,15.0,transcript,16833.0
DGKH,ENSG00000102780,magnesium measurement,EFO_0004845,0.36842304608158805,3.6842578538546245,2,0.8,1.6,transcript,58409.0
LYPLAL1,ENSG00000143353,balding measurement,EFO_0007825,0.36841868143211415,3.684214610629792,1,0.5,0.5,transcript,17988.0
MAP4K3,ENSG00000011566,hematocrit,EFO_0004348,0.3683725018829546,3.6837478264472905,1,0.4,0.4,transcript,17538.0
PKN2,ENSG00000065243,red blood cell density,OBA_2045260,0.3682587074900018,3.6826178867934085,1,0.4,0.4,transcript,12982.0
TLK1,ENSG00000198586,forced expiratory volume,EFO_0004314,0.3682585272879249,3.682599168040259,1,0.4,0.4,transcript,28787.0
TMED5,ENSG00000117500,brain attribute,OBA_2045210,0.36824589723833284,3.6824909396488485,1,0.5,0.5,transcript,15641.0
CCDC50,ENSG00000152492,serum gamma-glutamyl transferase measurement,EFO_0004532,0.3682210115541924,3.6822465620111724,1,0.4,0.4,transcript,10975.0
OR10A6,ENSG00000279000,taste liking measurement,EFO_0010155,0.36817409101322945,3.6817738156933344,1,0.4,0.4,transcript,12156.0
MEOX2,ENSG00000106511,glucose measurement,EFO_0004468,0.36814513168684665,3.6816200220561512,1,0.4,0.4,transcript,2371.0
GPR180,ENSG00000152749,free cholesterol:total lipids ratio,EFO_0020945,0.36812042197517514,3.6812492445153713,1,0.4,0.4,transcript,8884.0
MCF2L2,ENSG00000053524,erythrocyte volume,OBA_0003460,0.3679881768175408,3.6799232178787835,2,0.8,1.6,transcript,38601.0
PKN2,ENSG00000065243,hematocrit,EFO_0004348,0.3679640903208509,3.6796717151019003,1,0.4,0.4,transcript,12982.0
FAM114A1,ENSG00000197712,neutrophil percentage of granulocytes,EFO_0007994,0.36791341769875713,3.679182856554323,1,0.4,0.4,transcript,8217.0
FAM114A1,ENSG00000197712,eosinophil percentage of leukocytes,EFO_0007991,0.36791341769875713,3.679182856554323,1,0.4,0.4,transcript,8217.0
FAM114A1,ENSG00000197712,eosinophil count,EFO_0004842,0.36791341769875713,3.679182856554323,1,0.4,0.4,transcript,8217.0
FAM114A1,ENSG00000197712,eosinophil percentage of granulocytes,EFO_0007996,0.36791341769875713,3.679182856554323,1,0.4,0.4,transcript,8217.0
STXBP5,ENSG00000164506,myeloid leukocyte count,OBA_2045223,0.36791089551391315,3.6791227855475896,2,0.9,1.8,transcript,130148.0
CIAO2A,ENSG00000166797,body mass index,EFO_0004340,0.3679089866437709,3.6793104952297666,2,0.8,1.6,transcript,7252.0
CYTL1,ENSG00000170891,body fat percentage,EFO_0007800,0.36787898558202786,3.6790087939702514,1,0.4,0.4,transcript,1827.0
HEG1,ENSG00000173706,HbA1c measurement,EFO_0004541,0.36787640011915324,3.6787858674791836,1,0.4,0.4,transcript,18293.0
TMEM131,ENSG00000075568,ST2 protein measurement,EFO_0010599,0.36786657439448434,3.6786871928160965,1,0.4,0.4,transcript,18649.0
ADK,ENSG00000156110,serum urea amount,OBA_2050065,0.3678316248989122,3.678335232426073,1,0.4,0.4,transcript,21071.0
RAD18,ENSG00000070950,vital capacity,EFO_0004312,0.3678274113513019,3.678307594721691,1,0.4,0.4,transcript,11947.0
BCKDHB,ENSG00000083123,breast carcinoma,EFO_0000305,0.3678211256615445,3.6839386334768425,10,4.0,40.0,transcript,6984.0
DMRTA1,ENSG00000176399,nutritional deficiency disease,EFO_1001067,0.3677977911387386,3.6780495189777906,1,0.4,0.4,transcript,5586.0
PLEC,ENSG00000178209,free cholesterol in LDL measurement ,EFO_0022266,0.3677445110619377,3.6774541748850202,2,0.9,1.8,transcript,198582.0
CNTN5,ENSG00000149972,HbA1c measurement,EFO_0004541,0.3677297002101951,3.677309982793173,1,0.4,0.4,transcript,30815.0
SYNE2,ENSG00000054654,erythrocyte volume,OBA_0003460,0.3676616808395079,3.6766294439109872,2,1.0,2.0,transcript,158284.0
RPAP3,ENSG00000005175,erythrocyte volume,OBA_0003460,0.3676187815961827,3.676336183914349,2,0.8,1.6,transcript,10784.0
ZNF398,ENSG00000197024,neuroimaging measurement,EFO_0004346,0.3676080532873215,3.6761060268184025,1,0.4,0.4,transcript,15690.0
LDLRAP1,ENSG00000157978,total cholesterol measurement,EFO_0004574,0.36760049703597053,3.676030883808785,1,0.4,0.4,transcript,15436.0
C4orf33,ENSG00000151470,alcohol consumption quality,OBA_1000840,0.3675976744499191,3.676427798132287,4,1.6,6.4,transcript,14189.0
RFX7,ENSG00000181827,red blood cell density,OBA_2045260,0.3675511680513473,3.675521272839612,1,0.4,0.4,transcript,41700.0
KLRD1,ENSG00000134539,monocyte count,EFO_0005091,0.3674929872472636,3.675094362071088,4,1.7000000000000002,6.800000000000001,transcript,41340.0
TRHDE,ENSG00000072657,arterial stiffness measurement,EFO_0004517,0.367467115662616,3.6747707272279393,2,0.8,1.6,transcript,16069.0
MCL1,ENSG00000143384,forced expiratory volume,EFO_0004314,0.3674637941427726,3.6746547108068395,1,0.4,0.4,transcript,23853.0
AKAP11,ENSG00000023516,lichen planus,EFO_1000726,0.3674559869105026,3.6749598691050256,1,0.4,0.4,transcript,1000.0
FAM98A,ENSG00000119812,blood sodium bicarbonate amount,OBA_2050094,0.36740267946833993,3.674034147894915,1,0.4,0.4,transcript,54398.0
RPS6KA5,ENSG00000100784,phosphate measurement,EFO_0010968,0.367392151771696,3.673931382568494,1,0.4,0.4,transcript,40548.0
YIPF4,ENSG00000119820,neurodegenerative disease,EFO_0005772,0.36725975127588467,3.672715689876802,2,0.8,1.6,transcript,13539.0
PKN2,ENSG00000065243,neuroinflammatory disorder,EFO_0020092,0.36725949558648374,3.672625767758228,1,0.4,0.4,transcript,12982.0
LINGO2,ENSG00000174482,migraine disorder,MONDO_0005277,0.36723007487403014,3.6723124676047436,1,0.4,0.4,transcript,34133.0
CENPE,ENSG00000138778,amygdala volume,OBA_2050034,0.36706049468244606,3.6706306405551903,1,0.5,0.5,transcript,19460.0
KIF20B,ENSG00000138182,mathematical ability,EFO_0004875,0.3670184414028715,3.6702117259858897,1,0.5,0.5,transcript,18307.0
PLEC,ENSG00000178209,"level of apoptosis-inducing factor 1, mitochondrial in blood serum",OBA_2040542,0.3669956051288603,3.6699651155542465,2,0.9,1.8,transcript,198582.0
LNPEP,ENSG00000113441,cystatin C measurement,EFO_0004617,0.3669867090682194,3.6698877529064826,1,0.4,0.4,transcript,19359.0
RAB40B,ENSG00000141542,HbA1c measurement,EFO_0004541,0.36695757504515475,3.66960413736518,1,0.4,0.4,transcript,14091.0
YTHDC2,ENSG00000047188,hip geometry,EFO_0004685,0.3669259415460127,3.6692796246249832,1,0.4,0.4,transcript,19793.0
PKN2,ENSG00000065243,blood sodium bicarbonate amount,OBA_2050094,0.3668720922621671,3.668751734515062,1,0.4,0.4,transcript,12982.0
STX7,ENSG00000079950,glomerular filtration rate,OBA_0003747,0.3668490620321843,3.668579135480064,2,0.8,1.6,transcript,18076.0
NEDD1,ENSG00000139350,Polyarteritis Nodosa,EFO_0009012,0.36677027192435246,3.667721975935225,1,0.4,0.4,transcript,20772.0
AGA,ENSG00000038002,breast benign neoplasm,MONDO_0000620,0.3667055690064259,3.6671536716437227,1,0.5,0.5,transcript,5103.0
MTCH2,ENSG00000109919,body fat percentage,EFO_0007800,0.36668109807837285,3.666870433815833,1,0.4,0.4,transcript,6728.0
ZNF793,ENSG00000188227,glomerular filtration rate,OBA_0003747,0.3666604553747039,3.666618878342369,1,0.4,0.4,transcript,27924.0
PARP8,ENSG00000151883,breast carcinoma,EFO_0000305,0.36664211266687297,3.666468203492221,2,0.8,1.6,transcript,33987.0
RAD23B,ENSG00000119318,prostate carcinoma,EFO_0001663,0.36661585475704433,3.666198821432707,1,0.4,0.4,transcript,9932.0
TGFBR1,ENSG00000106799,sitting height measurement,EFO_0011011,0.36650909459663134,3.6650951935584595,1,0.4,0.4,transcript,94171.0
CASQ2,ENSG00000118729,lymphocyte count,EFO_0004587,0.3664151090513248,3.664163741534818,1,0.4,0.4,transcript,31618.0
KLF10,ENSG00000155090,glomerular filtration rate,OBA_0003747,0.3663546072711978,3.6636069184679867,1,0.4,0.4,transcript,6574.0
DYNC1I2,ENSG00000077380,chloride measurement,EFO_0009284,0.3663232617788716,3.6632438047223777,1,0.4,0.4,transcript,35756.0
SORL1,ENSG00000137642,dementia,MONDO_0001627,0.3662679170795311,3.6627261804584084,2,0.9,1.8,transcript,38290.0
FRS2,ENSG00000166225,sitting height measurement,EFO_0011011,0.36623769677935614,3.6623930766896993,1,0.4,0.4,transcript,24831.0
ELMOD1,ENSG00000110675,erythrocyte volume,OBA_0003460,0.36617303789795125,3.6617707422489376,1,0.4,0.4,transcript,9910.0
IQGAP1,ENSG00000140575,neutrophil count,EFO_0004833,0.36617112215127356,3.661765319429966,2,0.8,1.6,transcript,29576.0
TRDMT1,ENSG00000107614,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.3661231597437253,3.661245389113976,1,0.4,0.4,transcript,29003.0
UBXN2A,ENSG00000173960,"feeling ""fed-up"" measurement",EFO_0009588,0.36609985840039455,3.661155801258539,2,0.8,1.6,transcript,10177.0
LRP2,ENSG00000081479,chronic kidney disease,EFO_0003884,0.36604118796029755,3.6604284683027535,1,0.5,0.5,transcript,30141.0
FUT2,ENSG00000176920,prostate specific antigen amount,OBA_2050200,0.36603704706552154,3.6604934971059024,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
ATXN3,ENSG00000066427,BMI-adjusted waist circumference,EFO_0007789,0.3660337992283587,3.6603437154811376,1,0.4,0.4,transcript,69891.0
ABCB5,ENSG00000004846,serum creatinine amount,OBA_2050096,0.3659838354794238,3.6598652672614387,1,0.4,0.4,transcript,14863.0
POM121L2,ENSG00000158553,mean corpuscular hemoglobin,EFO_0004527,0.36597744957378797,3.659866259903973,1,0.4,0.4,transcript,4359.0
RASGRP3,ENSG00000152689,osteoarthritis,MONDO_0005178,0.365867389352175,3.6586850964345077,1,0.4,0.4,transcript,35705.0
KLRD1,ENSG00000134539,lymphocyte count,EFO_0004587,0.36586442593155744,3.658808748914026,4,1.7000000000000002,6.800000000000001,transcript,41340.0
TRHDE,ENSG00000072657,esophageal ulcer,MONDO_0044782,0.3657093268503732,3.657192839105512,2,0.8,1.6,transcript,16069.0
FIGNL1,ENSG00000132436,body mass index,EFO_0004340,0.36551355962366266,3.655151778775667,1,0.4,0.4,transcript,24718.0
CYTL1,ENSG00000170891,hip geometry,EFO_0004685,0.3654816967399337,3.6550359055493096,1,0.4,0.4,transcript,1827.0
PCDH18,ENSG00000189184,body height,OBA_VT0001253,0.36546050720574896,3.654682243716198,2,0.8,1.6,transcript,20733.0
MSX2,ENSG00000120149,glomerular filtration rate,OBA_0003747,0.36542663315076174,3.6543845697576915,1,0.4,0.4,transcript,3383.0
EPHA5,ENSG00000145242,glomerular filtration rate,OBA_0003747,0.36542663315076174,3.654277056230786,1,0.4,0.4,transcript,37297.0
MMADHC,ENSG00000168288,platelet count,EFO_0004309,0.36542663315076174,3.654347897576133,1,0.4,0.4,transcript,4904.0
CFHR4,ENSG00000134365,hemopexin measurement,EFO_0008149,0.3654178316859282,3.6542188256496893,1,0.5,0.5,transcript,12343.0
PDE11A,ENSG00000128655,smoking status measurement,EFO_0006527,0.36540070633412214,3.6540708464785543,2,0.8,1.6,transcript,25085.0
SPRED1,ENSG00000166068,neurofibromatosis type 1,MONDO_0018975,0.36539718814654143,3.6540164546769143,1,0.4,0.4,transcript,8974.0
DLG2,ENSG00000150672,hematocrit,EFO_0004348,0.365316006717825,3.6531628401034086,1,0.4,0.4,transcript,144252.0
ZNF33B,ENSG00000196693,arterial stiffness measurement,EFO_0004517,0.36530387026635347,3.653069828161543,1,0.5,0.5,transcript,16064.0
PDE11A,ENSG00000128655,self reported educational attainment,EFO_0004784,0.3652996293064419,3.653060076201752,2,0.8,1.6,transcript,25085.0
TRDMT1,ENSG00000107614,neurodegenerative disease,EFO_0005772,0.36528998740530183,3.652913665729741,1,0.4,0.4,transcript,29003.0
RNMT,ENSG00000101654,triglyceride measurement,EFO_0004530,0.36528377354926844,3.652854157202184,1,0.4,0.4,transcript,24358.0
MAGI2,ENSG00000187391,type 2 diabetes mellitus,MONDO_0005148,0.3652192732981787,3.65219729637878,1,0.4,0.4,transcript,87654.0
PLXND1,ENSG00000004399,body mass index,EFO_0004340,0.3652192251662657,3.65221593263263,1,0.5,0.5,transcript,21114.0
RSBN1L,ENSG00000187257,pallidum volume,OBA_2050027,0.36518501941881426,3.651986911269233,2,0.8,1.6,transcript,11703.0
C4orf33,ENSG00000151470,serum alanine aminotransferase measurement,EFO_0004735,0.3651795487264356,3.652246540897452,4,1.6,6.4,transcript,14189.0
DMRTA1,ENSG00000176399,dentures,EFO_0010078,0.36516792429158573,3.6517508505062617,1,0.4,0.4,transcript,5586.0
GIPC2,ENSG00000137960,lean body mass,EFO_0004995,0.36509234941411434,3.651314692185153,2,0.8,1.6,transcript,4090.0
CSMD3,ENSG00000164796,hepatocellular carcinoma,EFO_0000182,0.36508286882057983,3.6508367969275395,1,0.5,0.5,transcript,61662.0
CA8,ENSG00000178538,body fat percentage,EFO_0007800,0.36503582166692766,3.6503991709029204,1,0.4,0.4,transcript,9767.0
ZNF682,ENSG00000197124,omega-3 polyunsaturated fatty acid measurement,EFO_0010119,0.36498704498007833,3.6498964238267573,1,0.5,0.5,transcript,19250.0
GCNT1,ENSG00000187210,platelet component distribution width,EFO_0007984,0.36498280394115923,3.64984713704826,1,0.4,0.4,transcript,20945.0
LINGO2,ENSG00000174482,type 2 diabetes mellitus,MONDO_0005148,0.36494779969006175,3.649489715765059,1,0.4,0.4,transcript,34133.0
PPA2,ENSG00000138777,taste liking measurement,EFO_0010155,0.3648885484597874,3.648912890868429,1,0.5,0.5,transcript,18244.0
FSIP2,ENSG00000188738,educational attainment,EFO_0011015,0.3648196930390182,3.6484758704180758,4,2.0,8.0,transcript,28680.0
FUT2,ENSG00000176920,total blood protein measurement,EFO_0004536,0.3647743179420568,3.6478662058712548,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
QSER1,ENSG00000060749,platelet crit,EFO_0007985,0.3647551506007863,3.6475781812105943,1,0.5,0.5,transcript,18744.0
CPA4,ENSG00000128510,carboxypeptidase A4 measurement,EFO_0801452,0.36474916064196217,3.6475335527283463,1,0.5,0.5,transcript,11920.0
SGCZ,ENSG00000185053,educational attainment,EFO_0011015,0.3647240313419249,3.6472890226252885,1,0.4,0.4,transcript,8212.0
ABCA10,ENSG00000154263,mean corpuscular hemoglobin,EFO_0004527,0.3647205261564474,3.647305197716377,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
LYPLAL1,ENSG00000143353,hip geometry,EFO_0004685,0.3647183807410424,3.6472116037190743,1,0.5,0.5,transcript,17988.0
CENPC,ENSG00000145241,alcohol consumption quality,OBA_1000840,0.36469774996856424,3.6471763068427,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
CHL1,ENSG00000134121,generalised epilepsy,EFO_0005917,0.3646212388446658,3.646259588871462,2,0.8,1.6,transcript,33898.0
UNC80,ENSG00000144406,Encephalopathy,HP_0001298,0.3645905266464583,3.6459099284692447,1,0.4,0.4,transcript,85800.0
MMADHC,ENSG00000168288,mean corpuscular hemoglobin concentration,EFO_0004528,0.36458431432194993,3.645924709288015,1,0.4,0.4,transcript,4904.0
COL24A1,ENSG00000171502,trait in response to triamcinolone acetonide,OBA_2040119,0.3645344428739101,3.645368824933295,1,0.4,0.4,transcript,16396.0
COL24A1,ENSG00000171502,ocular hypertension,EFO_1001069,0.3645344428739101,3.645368824933295,1,0.4,0.4,transcript,16396.0
CA8,ENSG00000178538,monocyte count,EFO_0005091,0.3645280815008283,3.645321769241927,1,0.4,0.4,transcript,9767.0
KBTBD3,ENSG00000182359,neurodegenerative disease,EFO_0005772,0.364468170538725,3.644801081646296,2,0.8,1.6,transcript,13403.0
MMP12,ENSG00000262406,Ischemic stroke,HP_0002140,0.36442427676735556,3.6444623066417225,1,0.4,0.4,transcript,1822.0
MYO5A,ENSG00000197535,platelet volume,OBA_0003277,0.36439593645018403,3.643961404163053,1,0.4,0.4,transcript,196111.0
C12orf42,ENSG00000179088,phenylalanine measurement,EFO_0005001,0.3643426324138415,3.6434614636422453,1,0.5,0.5,transcript,14229.0
LHX9,ENSG00000143355,bone tissue density,OBA_1000110,0.36430486623866865,3.643122929003842,2,0.8,1.6,transcript,21544.0
SP8,ENSG00000164651,triglyceride measurement,EFO_0004530,0.3642794516883396,3.642869423250437,1,0.4,0.4,transcript,5340.0
ADK,ENSG00000156110,eosinophil count,EFO_0004842,0.36416253116733327,3.641644295110284,1,0.4,0.4,transcript,21071.0
NEBL,ENSG00000078114,cardiac arrhythmia,EFO_0004269,0.36415006771885505,3.6415084990075144,1,0.4,0.4,transcript,51139.0
GCNT1,ENSG00000187210,monocyte percentage of leukocytes,EFO_0007989,0.36411769752572104,3.641196072893878,1,0.4,0.4,transcript,20945.0
PDE11A,ENSG00000128655,body surface area,EFO_0022196,0.3640120502078428,3.640184285215761,2,0.8,1.6,transcript,25085.0
PDE11A,ENSG00000128655,body weights and measures,EFO_0004324,0.3640120502078428,3.640184285215761,2,0.8,1.6,transcript,25085.0
PDE11A,ENSG00000128655,whole body water mass,EFO_0009805,0.3640120502078428,3.640184285215761,2,0.8,1.6,transcript,25085.0
ING1,ENSG00000153487,endometrial cancer,MONDO_0011962,0.3639997454768861,3.640023937819709,1,0.4,0.4,transcript,15104.0
SFRP1,ENSG00000104332,appendicular lean mass,EFO_0004980,0.36399818042328486,3.640029783122137,1,0.4,0.4,transcript,8337.0
AKAP11,ENSG00000023516,lymphocyte percentage of leukocytes,EFO_0007993,0.3639971445282052,3.640371445282052,1,0.4,0.4,transcript,1000.0
ONECUT2,ENSG00000119547,erythrocyte volume,OBA_0003460,0.3639653713482974,3.6408155392091146,7,2.8000000000000003,19.6,transcript,16870.0
RPRD2,ENSG00000163125,neutrophil count,EFO_0004833,0.36392844339364944,3.639302940460044,1,0.4,0.4,transcript,21614.0
SHOC1,ENSG00000165181,monocyte count,EFO_0005091,0.36391363465375265,3.639252719288399,3,1.3,3.9000000000000004,transcript,33513.0
PLA2R1,ENSG00000153246,secretory phospholipase A2 receptor measurement,EFO_0802043,0.3639129058702533,3.6392082509416936,2,0.8,1.6,transcript,20204.0
SLCO1C1,ENSG00000139155,high density lipoprotein cholesterol measurement,EFO_0004612,0.36385824413004103,3.638613332193775,1,0.5,0.5,transcript,16186.0
ST8SIA4,ENSG00000113532,glucose measurement,EFO_0004468,0.363803911404489,3.638081991094949,1,0.4,0.4,transcript,9329.0
EXO1,ENSG00000174371,neurodegenerative disease,EFO_0005772,0.3638010997651638,3.6381404307347336,2,1.0,2.0,transcript,15452.0
DTHD1,ENSG00000197057,lymphocyte percentage of leukocytes,EFO_0007993,0.3637567295198901,3.637593695748032,1,0.5,0.5,transcript,18939.0
CYTL1,ENSG00000170891,body mass index,EFO_0004340,0.3637406132904686,3.6376250710546585,1,0.4,0.4,transcript,1827.0
ENPEP,ENSG00000138792,glycine measurement,EFO_0009767,0.3637325817938256,3.6373682177686573,1,0.4,0.4,transcript,9434.0
DLGAP1,ENSG00000170579,lymphocyte count,EFO_0004587,0.36368896248176585,3.6369177789615965,2,0.8,1.6,transcript,56830.0
ASTN2,ENSG00000148219,ocular hypotension,MONDO_0004390,0.36368771837599956,3.6369359381665762,2,0.8,1.6,transcript,27232.0
PF4V1,ENSG00000109272,myeloid leukocyte count,OBA_2045223,0.36364673949694243,3.6370057529774997,1,0.4,0.4,transcript,743.0
STARD13,ENSG00000133121,placenta praevia,EFO_0007442,0.36362834289398516,3.6362982454009396,1,0.4,0.4,transcript,26997.0
TNPO3,ENSG00000064419,rheumatoid arthritis,EFO_0000685,0.3636141512528501,3.6361681848852707,1,0.5,0.5,transcript,18746.0
SEMA3A,ENSG00000075213,PR interval,EFO_0004462,0.3635940144496543,3.6359703491329545,1,0.4,0.4,transcript,13243.0
ENPEP,ENSG00000138792,drug use measurement,EFO_0007010,0.3635090365821998,3.635132765652399,1,0.4,0.4,transcript,9434.0
ENPEP,ENSG00000138792,X-14189--leucylalanine measurement,EFO_0021364,0.3635090365821998,3.635132765652399,1,0.4,0.4,transcript,9434.0
TBL2,ENSG00000106638,free cholesterol to total lipids in small LDL percentage ,EFO_0022286,0.3634838333846701,3.634853512384249,1,0.4,0.4,transcript,26353.0
NPFFR1,ENSG00000148734,IGF-1 measurement,EFO_0004627,0.3634706624024505,3.634749871943199,1,0.4,0.4,transcript,9249.0
ZNF573,ENSG00000189144,glomerular filtration rate,OBA_0003747,0.36345808378635536,3.6346084545440283,1,0.5,0.5,transcript,18105.0
LINGO2,ENSG00000174482,diabetes mellitus,EFO_0000400,0.3634380533209014,3.634392252073456,1,0.4,0.4,transcript,34133.0
MAGI2,ENSG00000187391,platelet count,EFO_0004309,0.3634199158981865,3.634203722378858,1,0.4,0.4,transcript,87654.0
AGBL3,ENSG00000146856,high density lipoprotein cholesterol measurement,EFO_0004612,0.3633654524818554,3.6336904779356898,1,0.5,0.5,transcript,13907.0
SENP6,ENSG00000112701,forced expiratory volume,EFO_0004314,0.3633632723159267,3.6340617403199533,5,2.2,11.0,transcript,25640.0
MRPL35,ENSG00000132313,Parkinson disease,MONDO_0005180,0.36332527254274216,3.633316541636739,1,0.4,0.4,transcript,6268.0
MRPL35,ENSG00000132313,multiple sclerosis,MONDO_0005301,0.36332527254274216,3.633316541636739,1,0.4,0.4,transcript,6268.0
MRPL35,ENSG00000132313,lysosomal storage disease,MONDO_0002561,0.36332527254274216,3.633316541636739,1,0.4,0.4,transcript,6268.0
MRPL35,ENSG00000132313,Alzheimer disease,MONDO_0004975,0.36332527254274216,3.633316541636739,1,0.4,0.4,transcript,6268.0
BTAF1,ENSG00000095564,neurodegenerative disease,EFO_0005772,0.36330231056513945,3.6330598500937974,1,0.4,0.4,transcript,10886.0
ACVR1C,ENSG00000123612,serum creatinine amount,OBA_2050096,0.3632754275999412,3.6328735899442295,2,0.8,1.6,transcript,13410.0
ABCB1,ENSG00000085563,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.36325717044598266,3.6325957521704844,1,0.5,0.5,transcript,20792.0
PTK2,ENSG00000169398,ovarian cancer,MONDO_0008170,0.363221305034662,3.632217892551276,1,0.4,0.4,transcript,82607.0
LRBA,ENSG00000198589,cystatin B measurement,EFO_0010593,0.363188725908187,3.631891200589891,1,0.4,0.4,transcript,101484.0
PPP1R2,ENSG00000184203,mean corpuscular hemoglobin concentration,EFO_0004528,0.36314366011473453,3.6314830857493208,1,0.4,0.4,transcript,8605.0
C2CD4A,ENSG00000198535,low density lipoprotein cholesterol measurement,EFO_0004611,0.3631298752023784,3.6314148623285734,1,0.4,0.4,transcript,3445.0
IQGAP2,ENSG00000145703,cholelithiasis,EFO_0004799,0.3630955587809317,3.630970258740334,1,0.5,0.5,transcript,34081.0
PLA2R1,ENSG00000153246,hemorrhoid,EFO_0009552,0.3630646995429827,3.6307261876689876,2,0.8,1.6,transcript,20204.0
LMO4,ENSG00000143013,systolic blood pressure,EFO_0006335,0.36306374381463496,3.6306889181978295,1,0.4,0.4,transcript,7770.0
PTAR1,ENSG00000188647,information processing speed,EFO_0004363,0.3630576893288532,3.63064458663766,2,0.8,1.6,transcript,23636.0
PTAR1,ENSG00000188647,executive function measurement,EFO_0009332,0.3630576893288532,3.63064458663766,2,0.8,1.6,transcript,23636.0
PEAK1,ENSG00000173517,diabetic neuropathy,EFO_1000783,0.36294508512368556,3.6294577736880953,1,0.4,0.4,transcript,57783.0
PLPP4,ENSG00000203805,bilirubin measurement,EFO_0004570,0.36288028787887006,3.6288837685763653,1,0.4,0.4,transcript,4945.0
CSMD3,ENSG00000164796,sialadenitis,EFO_1001179,0.3628330770853719,3.62833887957546,1,0.5,0.5,transcript,61662.0
FUT2,ENSG00000176920,lipid measurement,EFO_0004529,0.3627800000944614,3.6279230273953007,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
TLR10,ENSG00000174123,allergic disease,MONDO_0005271,0.3627302018664332,3.6274634608814713,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
PALM2AKAP2,ENSG00000157654,BMI-adjusted hip circumference,EFO_0008039,0.3626984869790979,3.6269928570114263,1,0.4,0.4,transcript,50080.0
ING1,ENSG00000153487,pulse pressure measurement,EFO_0005763,0.3626943856967947,3.6269703400187945,1,0.4,0.4,transcript,15104.0
GPM6A,ENSG00000150625,smoking initiation,EFO_0005670,0.3626532673286159,3.6265508443668844,1,0.4,0.4,transcript,22013.0
CDH19,ENSG00000071991,placenta praevia,EFO_0007442,0.3625508086478749,3.6257826441358576,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
PALM2AKAP2,ENSG00000157654,body weights and measures,EFO_0004324,0.3625406127305525,3.6254141145259724,1,0.4,0.4,transcript,50080.0
GIPC2,ENSG00000137960,body weight,EFO_0004338,0.36253179639795974,3.625709162023607,2,0.8,1.6,transcript,4090.0
MED10,ENSG00000133398,erythrocyte volume,OBA_0003460,0.3625108538272438,3.6252581269037023,1,0.4,0.4,transcript,2674.0
ALPK3,ENSG00000136383,eosinophil count,EFO_0004842,0.362503662665134,3.625073922688636,1,0.4,0.4,transcript,10725.0
EPHA5,ENSG00000145242,response to antihypertensive drug,EFO_0005405,0.3624603050338829,3.624613775061997,1,0.4,0.4,transcript,37297.0
ENPEP,ENSG00000138792,"fibrinopeptide A, des-ala(1) measurement",EFO_0800673,0.36245041451646676,3.6245465449950687,1,0.4,0.4,transcript,9434.0
SEMA3C,ENSG00000075223,atrial fibrillation,EFO_0000275,0.3624308054903505,3.6243417731872443,1,0.4,0.4,transcript,11863.0
AGPAT5,ENSG00000155189,lipid measurement,EFO_0004529,0.3624098021280545,3.6241353939797887,1,0.4,0.4,transcript,10703.0
DNAH14,ENSG00000185842,body weight,EFO_0004338,0.3623593576769762,3.623651555253302,3,1.5,4.5,transcript,77615.0
GSTA5,ENSG00000182793,glomerular filtration rate,OBA_0003747,0.36234986647420586,3.623848804798081,1,0.5,0.5,transcript,1428.0
AKR1B10,ENSG00000198074,Increased blood pressure,HP_0032263,0.3623360675426246,3.6234928107327997,1,0.5,0.5,transcript,3784.0
DNAJC10,ENSG00000077232,neuromuscular disease,EFO_1001902,0.36233537644328084,3.623373016163341,4,1.7000000000000002,6.800000000000001,transcript,353215.0
CENPC,ENSG00000145241,cognitive function measurement,EFO_0008354,0.3623238609941912,3.62343741709897,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
SEMA3C,ENSG00000075223,waist-hip ratio,EFO_0004343,0.36229007347037506,3.62293445298749,1,0.4,0.4,transcript,11863.0
NEDD1,ENSG00000139350,body fat percentage,EFO_0007800,0.3622875716538308,3.622894973230008,1,0.4,0.4,transcript,20772.0
TTLL7,ENSG00000137941,neutrophil count,EFO_0004833,0.3622875716538308,3.6229046899732897,2,0.8,1.6,transcript,55223.0
ENPEP,ENSG00000138792,aspartate measurement,EFO_0010462,0.3622129797700577,3.6221721975309777,1,0.4,0.4,transcript,9434.0
MATN2,ENSG00000132561,QT interval,EFO_0004682,0.36219042945180363,3.621921249992959,1,0.5,0.5,transcript,29489.0
PLEC,ENSG00000178209,Abnormality of the musculature,HP_0003011,0.3621882575910077,3.6218916401757206,2,0.9,1.8,transcript,198582.0
SKIL,ENSG00000136603,creatine kinase measurement,EFO_0004534,0.3621752836342778,3.6217692961643535,1,0.5,0.5,transcript,30377.0
LRBA,ENSG00000198589,gallbladder disease,EFO_0003832,0.3621615125711536,3.6216190672195565,1,0.4,0.4,transcript,101484.0
ALPK3,ENSG00000136383,body mass index,EFO_0004340,0.3621356547774975,3.6213938438122706,1,0.4,0.4,transcript,10725.0
SECISBP2L,ENSG00000138593,lung carcinoma,EFO_0001071,0.3621016521425812,3.621035605395278,1,0.4,0.4,transcript,20960.0
ABCB5,ENSG00000004846,allergic disease,MONDO_0005271,0.3620243141185777,3.6202700536529777,1,0.4,0.4,transcript,14863.0
ARL3,ENSG00000138175,diastolic blood pressure,EFO_0006336,0.36202178980356364,3.620322227717431,1,0.4,0.4,transcript,3834.0
UBXN2A,ENSG00000173960,neuroticism measurement,EFO_0007660,0.3619586620099515,3.619743837354109,2,0.8,1.6,transcript,10177.0
RNF144B,ENSG00000137393,metabolite measurement,EFO_0004725,0.36194903057800115,3.619563178798776,1,0.4,0.4,transcript,5489.0
GIPC2,ENSG00000137960,forced expiratory volume,EFO_0004314,0.36194266799188984,3.619817877962908,2,0.8,1.6,transcript,4090.0
EXOC6,ENSG00000138190,pituitary gland disease,EFO_0009607,0.3619288728189497,3.619311345460045,1,0.5,0.5,transcript,22107.0
MATN2,ENSG00000132561,protein kinase C-binding protein NELL2 measurement,EFO_0802949,0.3619283003729849,3.619299959204772,1,0.5,0.5,transcript,29489.0
IQGAP1,ENSG00000140575,Eczematoid dermatitis,HP_0000964,0.3618902889385316,3.6189569873025462,2,0.8,1.6,transcript,29576.0
ANKH,ENSG00000154122,metabolite measurement,EFO_0004725,0.3618454218627419,3.6192226612503693,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,metabolite measurement,EFO_0004725,0.3618454218627419,3.6192226612503693,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,metabolite measurement,EFO_0004725,0.3618454218627419,3.6192226612503693,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,metabolite measurement,EFO_0004725,0.3618454218627419,3.6192226612503693,5,2.4,12.0,transcript,15616.0
FANCF,ENSG00000183161,sodium measurement,EFO_0009282,0.36183360468611164,3.6184575904648844,1,0.4,0.4,transcript,3291.0
GIPC2,ENSG00000137960,serum urea amount,OBA_2050065,0.3618280726071863,3.6186719241158727,2,0.8,1.6,transcript,4090.0
GALR1,ENSG00000166573,bone remodeling disease,MONDO_0000833,0.361818682013958,3.6183314332993777,2,0.8,1.6,transcript,11064.0
PLXND1,ENSG00000004399,protein measurement,EFO_0004747,0.3617806755914641,3.6178304368846135,1,0.5,0.5,transcript,21114.0
GABRA4,ENSG00000109158,cancer,MONDO_0004992,0.36175708109387555,3.617595961844188,1,0.4,0.4,transcript,15904.0
OR4X1,ENSG00000176567,deep vein thrombosis,EFO_0003907,0.3617442253737116,3.617986916046484,1,0.5,0.5,transcript,918.0
NAF1,ENSG00000145414,mean corpuscular hemoglobin concentration,EFO_0004528,0.36173913851218514,3.617453335313897,1,0.5,0.5,transcript,8071.0
TCERG1L,ENSG00000176769,mathematical ability,EFO_0004875,0.3617229729133167,3.617457909395574,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,cognitive function measurement,EFO_0008354,0.3617229729133167,3.617457909395574,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,mathematical ability,EFO_0004875,0.3617229729133167,3.617457909395574,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,mathematical ability,EFO_0004875,0.3617229729133167,3.617457909395574,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,mathematical ability,EFO_0004875,0.3617229729133167,3.617457909395574,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,cognitive function measurement,EFO_0008354,0.3617229729133167,3.617457909395574,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,cognitive function measurement,EFO_0008354,0.3617229729133167,3.617457909395574,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,cognitive function measurement,EFO_0008354,0.3617229729133167,3.617457909395574,2,0.8,1.6,gene_variant,7012.0
DGKH,ENSG00000102780,bone tissue density,OBA_1000110,0.3616777696837346,3.61680508987609,2,0.8,1.6,transcript,58409.0
C6,ENSG00000039537,complement component C6 measurement,EFO_0020281,0.36167517562981005,3.616781319356103,1,0.5,0.5,transcript,16913.0
FBXO42,ENSG00000037637,lysosomal storage disease,MONDO_0002561,0.3616478077634733,3.616513648999784,1,0.4,0.4,transcript,11245.0
GALNT3,ENSG00000115339,chloride measurement,EFO_0009284,0.36144450305740233,3.6144739385743123,1,0.4,0.4,transcript,13837.0
OTULINL,ENSG00000145569,eosinophil percentage of leukocytes,EFO_0007991,0.36135540596744015,3.613604034686895,1,0.4,0.4,transcript,8004.0
GRIA4,ENSG00000152578,matrix metalloproteinase 12 measurement,EFO_0010590,0.361351379996474,3.6135230914862264,1,0.4,0.4,transcript,43050.0
PPA2,ENSG00000138777,mean reticulocyte volume,EFO_0010701,0.3613512965032341,3.613540371302896,1,0.5,0.5,transcript,18244.0
FANCF,ENSG00000183161,systolic blood pressure,EFO_0006335,0.36133442759022627,3.6134658195060303,1,0.4,0.4,transcript,3291.0
TSPAN3,ENSG00000140391,total blood protein measurement,EFO_0004536,0.3613339005743552,3.613360916348285,1,0.4,0.4,transcript,18256.0
SLC30A8,ENSG00000164756,metabolic syndrome,EFO_0000195,0.3613134797122941,3.6134449648073454,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,metabolic syndrome,EFO_0000195,0.3613134797122941,3.6134449648073454,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,metabolic syndrome,EFO_0000195,0.3613134797122941,3.6134449648073454,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,metabolic syndrome,EFO_0000195,0.3613134797122941,3.6134449648073454,4,1.6,6.4,transcript,20634.0
ARMC1,ENSG00000104442,body weight,EFO_0004338,0.36129725580456584,3.613017106436348,1,0.4,0.4,transcript,8979.0
OTULINL,ENSG00000145569,Abnormal thrombosis,HP_0001977,0.36129254600550614,3.612975435067555,1,0.4,0.4,transcript,8004.0
KIF20B,ENSG00000138182,eosinophil count,EFO_0004842,0.3612783585324397,3.6128108972815722,1,0.5,0.5,transcript,18307.0
ROCK2,ENSG00000134318,platelet count,EFO_0004309,0.3612488684514086,3.6124996781158094,1,0.5,0.5,transcript,45481.0
RBM25,ENSG00000119707,metabolite measurement,EFO_0004725,0.36124750491229957,3.6124877390757257,1,0.4,0.4,transcript,31521.0
CCDC66,ENSG00000180376,hematocrit,EFO_0004348,0.3611866127362998,3.6118813568716943,1,0.5,0.5,transcript,32831.0
SKI,ENSG00000157933,triglyceride measurement,EFO_0004530,0.36116173941635693,3.6116699151719724,1,0.4,0.4,transcript,7616.0
CENPC,ENSG00000145241,attention deficit hyperactivity disorder,EFO_0003888,0.3611108644015768,3.611307451172826,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
NEDD1,ENSG00000139350,age at menarche,EFO_0004703,0.36107800418214536,3.610799298513154,1,0.4,0.4,transcript,20772.0
PRTG,ENSG00000166450,Fasciitis,HP_0100537,0.3610694239879784,3.6109123159641068,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
CCDC88C,ENSG00000015133,white matter microstructure measurement,EFO_0005674,0.36105807038968607,3.6106000266348923,1,0.4,0.4,transcript,20701.0
RASGRP3,ENSG00000152689,body weight,EFO_0004338,0.36103562564337105,3.610367459346468,1,0.4,0.4,transcript,35705.0
NAF1,ENSG00000145414,glucose measurement,EFO_0004468,0.3610236531679295,3.6102984818713404,1,0.5,0.5,transcript,8071.0
MEOX2,ENSG00000106511,body height,OBA_VT0001253,0.3609397794903831,3.6095665000915154,1,0.4,0.4,transcript,2371.0
EVI5,ENSG00000067208,allergic rhinitis,EFO_0005854,0.3608863951269965,3.608869607218609,1,0.4,0.4,transcript,70722.0
C4orf33,ENSG00000151470,high density lipoprotein cholesterol measurement,EFO_0004612,0.36083945634871806,3.6088456171202767,4,1.6,6.4,transcript,14189.0
CYSLTR1,ENSG00000173198,COVID-19,MONDO_0100096,0.3608074661894774,3.6082647985554988,2,0.8,1.6,transcript,8415.0
PRKCB,ENSG00000166501,diabetic neuropathy,EFO_1000783,0.3608039378057917,3.608063344504891,1,0.4,0.4,transcript,16690.0
GABRA4,ENSG00000109158,self reported educational attainment,EFO_0004784,0.3607702208534542,3.607727359439975,1,0.4,0.4,transcript,15904.0
GABRA4,ENSG00000109158,educational attainment,EFO_0011015,0.3607702208534542,3.607727359439975,1,0.4,0.4,transcript,15904.0
PYHIN1,ENSG00000163564,myeloid leukocyte count,OBA_2045223,0.3607008533765875,3.607046290986944,1,0.4,0.4,transcript,10594.0
STXBP4,ENSG00000166263,mean reticulocyte volume,EFO_0010701,0.360684289168697,3.60723460307402,5,2.0,10.0,transcript,25529.0
GABRA4,ENSG00000109158,esophageal cancer,MONDO_0007576,0.36066834688535193,3.606708619758952,1,0.4,0.4,transcript,15904.0
SEMA3C,ENSG00000075223,mean corpuscular hemoglobin concentration,EFO_0004528,0.3606414905246808,3.6064486235305475,1,0.4,0.4,transcript,11863.0
ZNF236,ENSG00000130856,glucose measurement,EFO_0004468,0.3606322689361083,3.606381657420051,2,0.9,1.8,transcript,30525.0
IL4R,ENSG00000077238,atopic asthma,EFO_0010638,0.360587662702495,3.6058951910941937,1,0.4,0.4,transcript,21547.0
FDCSP,ENSG00000181617,neurodegenerative disease,EFO_0005772,0.3605752488735569,3.606532215831086,1,0.4,0.4,transcript,513.0
OTUD7A,ENSG00000169918,neurodegenerative disease,EFO_0005772,0.3605552648150209,3.6055703747179026,1,0.4,0.4,transcript,22565.0
MRPL32,ENSG00000106591,brain attribute,OBA_2045210,0.3605469582346839,3.605552725144594,1,0.4,0.4,transcript,4811.0
DSC2,ENSG00000134755,desmocollin-2 measurement,EFO_0021936,0.3605235050080506,3.605247492147133,2,0.8,1.6,transcript,128596.0
DZIP3,ENSG00000198919,reticulocyte measurement,EFO_0010700,0.3604972650031422,3.6049947849437123,1,0.4,0.4,transcript,18071.0
ASTN2,ENSG00000148219,major depressive disorder,MONDO_0002009,0.3604908549971695,3.6049673043782753,2,0.8,1.6,transcript,27232.0
DNAJC10,ENSG00000077232,DnaJ homolog subfamily C member 10 measurement,EFO_0802488,0.36048460083461364,3.604865260076669,4,1.7000000000000002,6.800000000000001,transcript,353215.0
FREM2,ENSG00000150893,congenital anomaly of kidney and urinary tract,MONDO_0019719,0.360478950763091,3.6056806143854994,6,2.5,15.0,transcript,16833.0
SLCO1C1,ENSG00000139155,benign neoplasm of eye,MONDO_0021454,0.3604631901940318,3.6046627928336825,1,0.5,0.5,transcript,16186.0
CENPE,ENSG00000138778,cervical carcinoma,EFO_0001061,0.3604128183583616,3.6041538773143458,1,0.5,0.5,transcript,19460.0
ACVR1C,ENSG00000123612,BMI-adjusted hip circumference,EFO_0008039,0.3603922594302152,3.6040419082469692,2,0.8,1.6,transcript,13410.0
TBL2,ENSG00000106638,triglycerides to total lipids in very small VLDL percentage ,EFO_0022341,0.3603828982952105,3.6038441614896524,1,0.4,0.4,transcript,26353.0
TBL2,ENSG00000106638,cholesterol to total lipids in very small VLDL percentage ,EFO_0022245,0.3603828982952105,3.6038441614896524,1,0.4,0.4,transcript,26353.0
TENM4,ENSG00000149256,glucuronate measurement,EFO_0010486,0.36035534103935984,3.6035708608778494,1,0.4,0.4,transcript,22922.0
RAD21L1,ENSG00000244588,azoospermia,EFO_0000279,0.3603042317735694,3.6031065355625627,1,0.5,0.5,transcript,7786.0
CA8,ENSG00000178538,basophil measurement,EFO_0803539,0.36024754477149057,3.6025164019485496,1,0.4,0.4,transcript,9767.0
NEBL,ENSG00000078114,dilated cardiomyopathy,EFO_0000407,0.3602449012576009,3.6024568343949728,1,0.4,0.4,transcript,51139.0
SEMA3C,ENSG00000075223,semaphorin-3C measurement,EFO_0802048,0.3602283564713073,3.6023172829968124,1,0.4,0.4,transcript,11863.0
SHOC1,ENSG00000165181,azoospermia,EFO_0000279,0.3601961400715896,3.602077773466769,3,1.3,3.9000000000000004,transcript,33513.0
QSER1,ENSG00000060749,urate measurement,EFO_0004531,0.36018866365641744,3.6019133117669058,1,0.5,0.5,transcript,18744.0
ZNF507,ENSG00000168813,anorectal malformation,MONDO_0019938,0.3601767382163553,3.601781781011645,1,0.4,0.4,transcript,27780.0
CPB1,ENSG00000153002,blood protein measurement,EFO_0007937,0.3601401210674727,3.6014467895261397,1,0.5,0.5,transcript,10970.0
CCDC50,ENSG00000152492,body mass index,EFO_0004340,0.360131951835154,3.6013559648207885,1,0.4,0.4,transcript,10975.0
GLCE,ENSG00000138604,blood protein measurement,EFO_0007937,0.3600830709263134,3.600961034261098,2,0.8,1.6,transcript,12277.0
ZNF148,ENSG00000163848,vitamin D measurement,EFO_0004631,0.3600817243972593,3.6008291123522618,1,0.4,0.4,transcript,33703.0
PRKCB,ENSG00000166501,psoriasis,EFO_0000676,0.3600744523942015,3.600768490388989,1,0.4,0.4,transcript,16690.0
SLC30A8,ENSG00000164756,hematocrit,EFO_0004348,0.3600508820028157,3.6008189877125614,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,hematocrit,EFO_0004348,0.3600508820028157,3.6008189877125614,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,hematocrit,EFO_0004348,0.3600508820028157,3.6008189877125614,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,hematocrit,EFO_0004348,0.3600508820028157,3.6008189877125614,4,1.6,6.4,gene_variant,20634.0
NEDD1,ENSG00000139350,body height,OBA_VT0001253,0.36004734275398126,3.600492684231513,1,0.4,0.4,transcript,20772.0
SLC9B1,ENSG00000164037,glucose measurement,EFO_0004468,0.3600389344611278,3.6004343167285655,1,0.5,0.5,transcript,11118.0
FAM174A,ENSG00000174132,heel bone mineral density,EFO_0009270,0.3599909684032446,3.6000100604439895,1,0.4,0.4,transcript,3985.0
CPD,ENSG00000108582,high density lipoprotein cholesterol measurement,EFO_0004612,0.3599654075302485,3.5996742936607546,1,0.4,0.4,transcript,19784.0
MFAP3,ENSG00000037749,glucose measurement,EFO_0004468,0.3598724830813447,3.5987374205150706,1,0.4,0.4,transcript,31772.0
IL4R,ENSG00000077238,immunoglobulin E measurement,EFO_0020464,0.3598360544930196,3.5983791089994397,1,0.4,0.4,transcript,21547.0
TBL2,ENSG00000106638,low density lipoprotein cholesterol measurement,EFO_0004611,0.35982472370380275,3.5982624155755754,1,0.4,0.4,transcript,26353.0
LIN9,ENSG00000183814,erythrocyte volume,OBA_0003460,0.3598026047676551,3.5981308832157985,2,0.8,1.6,transcript,15262.0
RSBN1L,ENSG00000187257,blood urea nitrogen measurement,EFO_0004741,0.35978735852726623,3.5980103023537526,2,0.8,1.6,transcript,11703.0
SKIL,ENSG00000136603,glomerular filtration rate,OBA_0003747,0.35976102261402415,3.597626685961817,1,0.5,0.5,transcript,30377.0
MTCH2,ENSG00000109919,apolipoprotein A 1 measurement,EFO_0004614,0.35973262290494956,3.5973856820816,1,0.4,0.4,transcript,6728.0
AGA,ENSG00000038002,metabolite ratio,EFO_0022223,0.35964406829376233,3.5965386645170865,1,0.5,0.5,transcript,5103.0
AGA,ENSG00000038002,cerebrospinal fluid composition attribute,OBA_2045291,0.35964406829376233,3.5965386645170865,1,0.5,0.5,transcript,5103.0
SLC44A1,ENSG00000070214,body mass index,EFO_0004340,0.35961399994502674,3.5961496083673423,1,0.4,0.4,transcript,41628.0
NEDD1,ENSG00000139350,sleep apnea,EFO_0003877,0.35959081065933945,3.595927363285095,1,0.4,0.4,transcript,20772.0
WDR12,ENSG00000138442,stroke,EFO_0000712,0.35958315438496447,3.5958514830351294,1,0.4,0.4,transcript,20061.0
CCDC34,ENSG00000109881,diastolic blood pressure,EFO_0006336,0.3595405644972882,3.595499168470661,1,0.4,0.4,transcript,4277.0
SPOCK3,ENSG00000196104,blood protein measurement,EFO_0007937,0.3594989356574389,3.595071721358868,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
SH3TC2,ENSG00000169247,diastolic blood pressure change measurement,EFO_0006945,0.35942454798229506,3.5942499032316295,1,0.4,0.4,transcript,90428.0
ABCB1,ENSG00000085563,myelodysplastic syndrome,EFO_0000198,0.3594132485756633,3.594156533467291,1,0.5,0.5,transcript,20792.0
LNPEP,ENSG00000113441,erythrocyte volume,OBA_0003460,0.35939147621242523,3.593935424348541,1,0.4,0.4,transcript,19359.0
MTCH2,ENSG00000109919,C-reactive protein measurement,EFO_0004458,0.3593913039057305,3.593972492089409,1,0.4,0.4,transcript,6728.0
ROCK2,ENSG00000134318,glomerular filtration rate,OBA_0003747,0.3593557209121293,3.593568202723017,1,0.5,0.5,transcript,45481.0
HPSE,ENSG00000173083,hepatocellular carcinoma,EFO_0000182,0.3593436292065189,3.593524139795789,2,0.9,1.8,transcript,20490.0
TOPAZ1,ENSG00000173769,monocyte count,EFO_0005091,0.35930432771749143,3.593137015457629,1,0.5,0.5,transcript,5334.0
NOL9,ENSG00000162408,platelet count,EFO_0004309,0.35926507785244005,3.5926934816310516,1,0.4,0.4,transcript,9367.0
TLR10,ENSG00000174123,adolescent idiopathic scoliosis,EFO_0005423,0.3592335312275157,3.5924967544922968,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
LYPLAL1,ENSG00000143353,serum alanine aminotransferase measurement,EFO_0004735,0.35916488032247756,3.591676599533426,1,0.5,0.5,transcript,17988.0
C6,ENSG00000039537,carbonic anhydrase 4 measurement,EFO_0020230,0.35916343223762437,3.5916638854342464,1,0.5,0.5,transcript,16913.0
C4orf33,ENSG00000151470,level of N-acetylgalactosamine in blood,OBA_2050402,0.3591605763000495,3.5920568166335913,4,1.6,6.4,transcript,14189.0
C4orf33,ENSG00000151470,level of N-acetylglucosamine in blood,OBA_2050401,0.3591605763000495,3.5920568166335913,4,1.6,6.4,transcript,14189.0
ONECUT2,ENSG00000119547,Headache,HP_0002315,0.35912760709418107,3.5924378966679518,7,2.8000000000000003,19.6,transcript,16870.0
CNTNAP2,ENSG00000174469,ovarian dysfunction,EFO_0009003,0.3590983333907522,3.590991015579054,1,0.4,0.4,transcript,52072.0
CNTNAP2,ENSG00000174469,growth differentiation factor 15 amount,OBA_2050135,0.35906792284285016,3.5906869101000334,1,0.4,0.4,transcript,52072.0
KLHL31,ENSG00000124743,neurofibrillary tangles measurement,EFO_0006797,0.3590556449916008,3.59060852646854,1,0.4,0.4,transcript,7681.0
MLLT3,ENSG00000171843,Abruptio Placentae,EFO_1001754,0.35903177865572194,3.590421025684849,2,0.8,1.6,transcript,15498.0
SP8,ENSG00000164651,serum creatinine amount,OBA_2050096,0.3589834865312582,3.5899097716796233,1,0.4,0.4,transcript,5340.0
SP8,ENSG00000164651,alcohol use disorder measurement,EFO_0009458,0.3589834865312582,3.5899097716796233,1,0.4,0.4,transcript,5340.0
SP8,ENSG00000164651,alcohol consumption quality,OBA_1000840,0.3589834865312582,3.5899097716796233,1,0.4,0.4,transcript,5340.0
TBL2,ENSG00000106638,high density lipoprotein cholesterol measurement,EFO_0004612,0.3589439686381172,3.5894548649187197,1,0.4,0.4,transcript,26353.0
ITGB8,ENSG00000105855,inflammatory bowel disease,EFO_0003767,0.35889332080108205,3.5891037352241217,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
SKI,ENSG00000157933,IGF-1 measurement,EFO_0004627,0.35887184623506424,3.5887709833590455,1,0.4,0.4,transcript,7616.0
CPB1,ENSG00000153002,carboxypeptidase B measurement,EFO_0801453,0.3588646369934025,3.588691948785438,1,0.5,0.5,transcript,10970.0
PARP11,ENSG00000111224,hippocampal CA4 volume,EFO_0009396,0.3588556823914615,3.588574772402455,1,0.4,0.4,transcript,22286.0
LRRIQ3,ENSG00000162620,mathematical ability,EFO_0004875,0.3588535202779101,3.5885620989598435,1,0.5,0.5,transcript,18590.0
SLC22A15,ENSG00000163393,neutrophil count,EFO_0004833,0.35883518218191524,3.5886008490565064,2,0.8,1.6,transcript,6425.0
ANKRD17,ENSG00000132466,esterified cholesterol measurement,EFO_0008589,0.358822467860065,3.588233868510129,1,0.4,0.4,transcript,43526.0
PTCHD4,ENSG00000244694,platelet volume,OBA_0003277,0.3587994893357822,3.5884087340291635,6,2.4000000000000004,14.400000000000002,transcript,34796.0
OTULINL,ENSG00000145569,chronic obstructive pulmonary disease,EFO_0000341,0.3587380693386168,3.5874306683986616,1,0.4,0.4,transcript,8004.0
SNTG2,ENSG00000172554,growth differentiation factor 15 amount,OBA_2050135,0.3587345150418929,3.5873950406603976,1,0.5,0.5,transcript,10022.0
RIF1,ENSG00000080345,erythrocyte count,EFO_0004305,0.35870382498547265,3.5870997931717534,3,1.3,3.9000000000000004,transcript,63370.0
KIF20B,ENSG00000138182,glomerular filtration rate,OBA_0003747,0.35867942817730597,3.586821593730235,1,0.5,0.5,transcript,18307.0
SLC9B1,ENSG00000164037,alkaline phosphatase measurement,EFO_0004533,0.358660732411455,3.5866522962318377,1,0.5,0.5,transcript,11118.0
SORL1,ENSG00000137642,liver disease,EFO_0001421,0.35859132166347246,3.585960226297822,2,0.9,1.8,transcript,38290.0
NEDD4,ENSG00000069869,open-angle glaucoma,EFO_0004190,0.35858572896189256,3.585865599580492,1,0.4,0.4,transcript,48135.0
MAP2K6,ENSG00000108984,total knee arthroplasty,EFO_0020975,0.3585751181223308,3.585768483758129,1,0.4,0.4,transcript,23118.0
ABCB5,ENSG00000004846,allergic rhinitis,EFO_0005854,0.35850588312561504,3.5850857437233508,1,0.4,0.4,transcript,14863.0
LRPAP1,ENSG00000163956,esterified cholesterol measurement,EFO_0008589,0.3584926377637294,3.585157013808734,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
TXNL1,ENSG00000091164,schizophrenia,MONDO_0005090,0.3584813663529086,3.5848958623474783,2,0.8,1.6,transcript,19465.0
SYT13,ENSG00000019505,sodium measurement,EFO_0009282,0.3584646415674505,3.584861700927465,2,0.8,1.6,transcript,7432.0
AGA,ENSG00000038002,triacylglycerol 50:0 measurement,EFO_0021480,0.35842577997855646,3.5843557813650277,1,0.5,0.5,transcript,5103.0
SLC35F5,ENSG00000115084,waist-hip ratio,EFO_0004343,0.35842412847919947,3.5843120436810803,2,0.8,1.6,transcript,22612.0
FYCO1,ENSG00000163820,liver disease,EFO_0001421,0.358422758046728,3.5842521913083556,1,0.4,0.4,transcript,16253.0
HS6ST3,ENSG00000185352,smoking initiation,EFO_0005670,0.35841252095345794,3.584172069890718,1,0.4,0.4,transcript,8536.0
GRIA4,ENSG00000152578,Parkinson disease,MONDO_0005180,0.35840601565602886,3.584069448081775,1,0.4,0.4,transcript,43050.0
SYNE2,ENSG00000054654,gestational diabetes,EFO_0004593,0.35839378937144406,3.583950529230349,2,1.0,2.0,transcript,158284.0
MDM4,ENSG00000198625,head and neck squamous cell carcinoma,EFO_0000181,0.35834536924172794,3.583459563287489,1,0.4,0.4,transcript,68133.0
SLC30A8,ENSG00000164756,psoriasis,EFO_0000676,0.35829462443793647,3.583256412063769,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,psoriasis,EFO_0000676,0.35829462443793647,3.583256412063769,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,psoriasis,EFO_0000676,0.35829462443793647,3.583256412063769,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,psoriasis,EFO_0000676,0.35829462443793647,3.583256412063769,4,1.6,6.4,gene_variant,20634.0
OR4X1,ENSG00000176567,thrombophilia,EFO_0009315,0.35829327095344743,3.5834773718438426,1,0.5,0.5,transcript,918.0
LIN9,ENSG00000183814,mean corpuscular hemoglobin concentration,EFO_0004528,0.3582925863797003,3.583030699336251,2,0.8,1.6,transcript,15262.0
PLA2R1,ENSG00000153246,triglyceride measurement,EFO_0004530,0.3582522723898021,3.5826019161371816,2,0.8,1.6,transcript,20204.0
RASEF,ENSG00000165105,type 2 diabetes mellitus,MONDO_0005148,0.3582351169242322,3.5824055910110295,1,0.4,0.4,transcript,7350.0
PDE1C,ENSG00000154678,"Hepatitis, Alcoholic",EFO_1001345,0.35822554026022174,3.5823097615068855,2,0.8,1.6,transcript,29434.0
PRTG,ENSG00000166450,urate measurement,EFO_0004531,0.3582157943421677,3.582376019506,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
PRTG,ENSG00000166450,heel bone mineral density,EFO_0009270,0.3582157943421677,3.582376019506,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
RFX7,ENSG00000181827,arterial stiffness measurement,EFO_0004517,0.35819157347004,3.581925327026539,1,0.4,0.4,transcript,41700.0
SLC30A8,ENSG00000164756,calcium measurement,EFO_0004838,0.3581515861851835,3.581826029536239,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,calcium measurement,EFO_0004838,0.3581515861851835,3.581826029536239,4,1.6,6.4,gene_variant,20634.0
SLC30A8,ENSG00000164756,calcium measurement,EFO_0004838,0.3581515861851835,3.581826029536239,4,1.6,6.4,transcript,20634.0
SLC30A8,ENSG00000164756,calcium measurement,EFO_0004838,0.3581515861851835,3.581826029536239,4,1.6,6.4,gene_variant,20634.0
HEATR1,ENSG00000119285,erythrocyte volume,OBA_0003460,0.358051312839805,3.580542719449716,1,0.5,0.5,transcript,16897.0
HEATR1,ENSG00000119285,mean corpuscular hemoglobin concentration,EFO_0004528,0.358051312839805,3.580542719449716,1,0.5,0.5,transcript,16897.0
SYNE2,ENSG00000054654,psoriasis,EFO_0000676,0.358020838530209,3.5802210208179983,2,1.0,2.0,transcript,158284.0
PSD3,ENSG00000156011,lymphocyte count,EFO_0004587,0.35794139317590373,3.5794233748525945,1,0.4,0.4,transcript,42359.0
PARP11,ENSG00000111224,body mass index,EFO_0004340,0.35793814194014173,3.5793993678892573,1,0.4,0.4,transcript,22286.0
IREB2,ENSG00000136381,chronic lung disease,EFO_0009910,0.3579370351825997,3.579470207589894,2,0.9,1.8,transcript,18026.0
CNTLN,ENSG00000044459,wellbeing measurement,EFO_0007869,0.3578853152434505,3.5789746129977784,2,0.8,1.6,transcript,13173.0
PRKCB,ENSG00000166501,diabetic retinopathy,EFO_0003770,0.35786282999287744,3.5786522663757485,1,0.4,0.4,transcript,16690.0
OTULINL,ENSG00000145569,atopic asthma,EFO_0010638,0.357861894242209,3.5786689174345834,1,0.4,0.4,transcript,8004.0
OTULINL,ENSG00000145569,Eczematoid dermatitis,HP_0000964,0.357861894242209,3.5786689174345834,1,0.4,0.4,transcript,8004.0
LYPLAL1,ENSG00000143353,diastolic blood pressure change measurement,EFO_0006945,0.3578542725843495,3.578570522152145,1,0.5,0.5,transcript,17988.0
CNTNAP2,ENSG00000174469,metabolite measurement,EFO_0004725,0.35782426892809577,3.5782503709524893,1,0.4,0.4,transcript,52072.0
THEM4,ENSG00000159445,X-13431 measurement,EFO_0800735,0.35781707452255634,3.5783250959876702,2,0.8,1.6,transcript,10366.0
HS6ST3,ENSG00000185352,protein measurement,EFO_0004747,0.35781174564926116,3.57816431684875,1,0.4,0.4,transcript,8536.0
PLEC,ENSG00000178209,myopathy,EFO_0004145,0.3577817524816722,3.5778265890823655,2,0.9,1.8,transcript,198582.0
FMN1,ENSG00000248905,aging rate,OBA_0005494,0.3577721302950623,3.577757000503109,2,0.8,1.6,transcript,44821.0
XG,ENSG00000124343,glycoprotein Xg measurement,EFO_0801646,0.3577004947448328,3.577217741702883,2,0.8,1.6,transcript,7519.0
GPD2,ENSG00000115159,insulin resistance,EFO_0002614,0.3576711704781947,3.576729371065844,1,0.4,0.4,transcript,22642.0
TTLL7,ENSG00000137941,lymphocyte count,EFO_0004587,0.3576069685389686,3.576098658824668,2,0.8,1.6,transcript,55223.0
QSOX1,ENSG00000116260,blood protein measurement,EFO_0007937,0.35759366715098323,3.57596573494077,1,0.4,0.4,transcript,13763.0
STX7,ENSG00000079950,syntaxin-7 measurement,EFO_0802112,0.35759249989974196,3.5760135141556404,2,0.8,1.6,transcript,18076.0
IMPG2,ENSG00000081148,Cone rod dystrophy,Orphanet_1872,0.35758650207595133,3.576080538000893,2,0.9,1.8,transcript,8352.0
MGA,ENSG00000174197,lung adenocarcinoma,EFO_0000571,0.3575823013961134,3.575828935746197,1,0.5,0.5,transcript,84434.0
C2orf73,ENSG00000177994,bone tissue density,OBA_1000110,0.357497345559445,3.575021764773194,1,0.4,0.4,transcript,8280.0
IL4R,ENSG00000077238,allergic disease,MONDO_0005271,0.3574959600890639,3.5749781649598833,1,0.4,0.4,transcript,21547.0
NDUFAF4,ENSG00000123545,COVID-19,MONDO_0100096,0.35748638055085236,3.5749753504053445,1,0.4,0.4,transcript,3586.0
CYTIP,ENSG00000115165,platelet count,EFO_0004309,0.3574794495529969,3.5748222829561587,1,0.4,0.4,gene_variant,14395.0
CNTN5,ENSG00000149972,hyperuricemia,EFO_0009104,0.3574774570216866,3.5747875509080878,1,0.4,0.4,transcript,30815.0
TLR10,ENSG00000174123,childhood onset asthma,MONDO_0005405,0.3574684145060428,3.5748455872775673,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
NID2,ENSG00000087303,cell growth regulator with EF hand domain protein 1 measurement,EFO_0801461,0.3574650157905744,3.574695292406556,1,0.5,0.5,transcript,11078.0
CD86,ENSG00000114013,neurodegenerative disease,EFO_0005772,0.35745856830899164,3.5746175175507204,1,0.4,0.4,transcript,12565.0
ZNF143,ENSG00000166478,systolic blood pressure,EFO_0006335,0.3573649146291765,3.5736754261193693,1,0.5,0.5,transcript,19026.0
ANKRD17,ENSG00000132466,apolipoprotein B measurement,EFO_0004615,0.35736080604797954,3.5736172503892747,1,0.4,0.4,transcript,43526.0
UHMK1,ENSG00000152332,body mass index,EFO_0004340,0.35733811887193745,3.573507806614704,3,1.2000000000000002,3.6000000000000005,transcript,28432.0
PNLIPRP3,ENSG00000203837,hyperpituitarism,EFO_1000973,0.35733811887193745,3.5735496807160048,1,0.4,0.4,transcript,2374.0
POF1B,ENSG00000124429,vein disorder,MONDO_0004634,0.35731322475853833,3.573217937388297,1,0.5,0.5,transcript,5835.0
POF1B,ENSG00000124429,lymphatic system disease,EFO_0007352,0.35731322475853833,3.573217937388297,1,0.5,0.5,transcript,5835.0
GREM1,ENSG00000166923,colorectal adenoma,EFO_0005406,0.3573075011585246,3.5730932356501235,1,0.4,0.4,transcript,21949.0
MATN2,ENSG00000132561,protein measurement,EFO_0004747,0.3573042193303199,3.573059148778122,1,0.5,0.5,transcript,29489.0
C6,ENSG00000039537,kallikrein-14 measurement,EFO_0020513,0.35730013053382653,3.573030868396268,1,0.5,0.5,transcript,16913.0
C6,ENSG00000039537,tyrosine-protein kinase ZAP-70 measurement,EFO_0020833,0.35730013053382653,3.573030868396268,1,0.5,0.5,transcript,16913.0
SENP6,ENSG00000112701,high density lipoprotein cholesterol measurement,EFO_0004612,0.35729941757976774,3.5734231929583635,5,2.2,11.0,transcript,25640.0
HS3ST3A1,ENSG00000153976,retinal layer thickness,OBA_2050110,0.3572667538223294,3.572748575500442,1,0.4,0.4,transcript,4936.0
BTC,ENSG00000174808,phospholipid measurement,EFO_0004639,0.35725583223311586,3.5726803851935327,1,0.4,0.4,transcript,3277.0
UBXN2A,ENSG00000173960,feeling miserable measurement,EFO_0009598,0.35722442105054514,3.572401427760045,2,0.8,1.6,transcript,10177.0
C4orf33,ENSG00000151470,hip bone size,OBA_2050103,0.35719898360706365,3.5724408897037327,4,1.6,6.4,transcript,14189.0
FYCO1,ENSG00000163820,"N,N-dimethylalanine measurement",EFO_0800098,0.3571774553388817,3.5717991642298923,1,0.4,0.4,transcript,16253.0
MTCH2,ENSG00000109919,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.35715756136334975,3.571635066665602,1,0.4,0.4,transcript,6728.0
NDUFAF2,ENSG00000164182,insulin resistance,EFO_0002614,0.3571168006961676,3.571208212007409,1,0.4,0.4,transcript,9949.0
RPRD2,ENSG00000163125,prostate carcinoma,EFO_0001663,0.357115983469921,3.5711783412227596,1,0.4,0.4,transcript,21614.0
SV2C,ENSG00000122012,platelet component distribution width,EFO_0007984,0.35710531646696875,3.5710811935394235,1,0.4,0.4,transcript,14271.0
USP15,ENSG00000135655,platelet crit,EFO_0007985,0.35708459555611727,3.570929073403803,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
OR10A6,ENSG00000279000,smoking initiation,EFO_0005670,0.3570764892234197,3.570797797795237,1,0.4,0.4,transcript,12156.0
SV2C,ENSG00000122012,mean corpuscular hemoglobin concentration,EFO_0004528,0.3570461276977952,3.570489305847688,1,0.4,0.4,transcript,14271.0
LINGO2,ENSG00000174482,fat pad mass,OBA_0004528,0.3570435395426828,3.57044711429127,1,0.4,0.4,transcript,34133.0
CEP68,ENSG00000011523,serum albumin amount,OBA_2050068,0.3570213581452889,3.5702503485618506,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,serum albumin amount,OBA_2050068,0.3570213581452889,3.5702503485618506,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,serum albumin amount,OBA_2050068,0.3570213581452889,3.5702503485618506,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,serum albumin amount,OBA_2050068,0.3570213581452889,3.5702503485618506,3,1.5,4.5,gene_variant,122392.0
GIPC2,ENSG00000137960,body weights and measures,EFO_0004324,0.3570212044554094,3.570603242598104,2,0.8,1.6,transcript,4090.0
CENPC,ENSG00000145241,intelligence,EFO_0004337,0.3570171158045813,3.570369965202871,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
CEP85L,ENSG00000111860,QT interval,EFO_0004682,0.3570014482692043,3.57002988567252,1,0.4,0.4,transcript,25969.0
TENM4,ENSG00000149256,monocyte count,EFO_0005091,0.35699089352710056,3.5699263857552563,1,0.4,0.4,transcript,22922.0
RBM25,ENSG00000119707,Red cell distribution width,EFO_0009188,0.35694565518739974,3.5694692418267273,1,0.4,0.4,transcript,31521.0
TENM4,ENSG00000149256,liver disease,EFO_0001421,0.3569400426126245,3.5694178766104963,1,0.4,0.4,transcript,22922.0
DLGAP1,ENSG00000170579,high density lipoprotein cholesterol measurement,EFO_0004612,0.35693775668920247,3.5694057210359627,2,0.8,1.6,transcript,56830.0
KLHL31,ENSG00000124743,blood protein measurement,EFO_0007937,0.3569192378991719,3.569244455544251,1,0.4,0.4,transcript,7681.0
DUSP22,ENSG00000112679,lymphoid leukemia,EFO_0004289,0.35690222374098685,3.569045841800285,1,0.4,0.4,transcript,16946.0
PAG1,ENSG00000076641,blood protein measurement,EFO_0007937,0.3568798483172347,3.568928575049735,2,0.8,1.6,transcript,12299.0
BTC,ENSG00000174808,diastolic blood pressure,EFO_0006336,0.3568514753743573,3.568636816605947,1,0.4,0.4,transcript,3277.0
BTC,ENSG00000174808,free cholesterol measurement,EFO_0008591,0.3568514753743573,3.568636816605947,1,0.4,0.4,transcript,3277.0
BTC,ENSG00000174808,lipid measurement,EFO_0004529,0.3568514753743573,3.568636816605947,1,0.4,0.4,transcript,3277.0
OTOGL,ENSG00000165899,dizziness,EFO_0009847,0.3568492347318777,3.568507205276699,1,0.5,0.5,transcript,33652.0
FREM2,ENSG00000150893,hair color,EFO_0003924,0.3568096692594486,3.5689877993490757,6,2.5,15.0,transcript,16833.0
TULP4,ENSG00000130338,platelet count,EFO_0004309,0.35675010333410806,3.5675199583978556,1,0.4,0.4,transcript,21136.0
GPD2,ENSG00000115159,COVID-19,MONDO_0100096,0.3567472208414829,3.567489874698726,1,0.4,0.4,transcript,22642.0
TXK,ENSG00000074966,Vitiligo,EFO_0004208,0.3567472208414829,3.567501600728739,1,0.4,0.4,transcript,13609.0
NDUFAF4,ENSG00000123545,insulin resistance,EFO_0002614,0.3567472208414829,3.56758375331165,1,0.4,0.4,transcript,3586.0
NDUFAF2,ENSG00000164182,COVID-19,MONDO_0100096,0.3567472208414829,3.567512413460562,1,0.4,0.4,transcript,9949.0
ATXN7L3B,ENSG00000253719,metabolite measurement,EFO_0004725,0.3567376105035967,3.5674287643303324,1,0.4,0.4,transcript,7596.0
GCNT1,ENSG00000187210,body mass index,EFO_0004340,0.35669607256308883,3.566979823267556,1,0.4,0.4,transcript,20945.0
PLPP4,ENSG00000203805,phosphatidylcholine measurement,EFO_0010226,0.3566880200082447,3.5669610898701114,1,0.4,0.4,transcript,4945.0
CFAP46,ENSG00000171811,C34:2 phosphatidylethanolamine measurement,EFO_0801132,0.35668296848641534,3.5668510450828816,1,0.5,0.5,transcript,23408.0
KCNN3,ENSG00000143603,prostate carcinoma,EFO_0001663,0.3566518621890482,3.5666376577004217,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
GFPT1,ENSG00000198380,systolic blood pressure,EFO_0006335,0.3566494290438625,3.5665093944676247,1,0.4,0.4,transcript,26483.0
LRRK2,ENSG00000188906,Alzheimer disease,MONDO_0004975,0.3566223979257251,3.5662427370730074,2,0.9,1.8,transcript,95960.0
ULK4,ENSG00000168038,body mass index,EFO_0004340,0.35661310010866487,3.566171961191506,1,0.5,0.5,transcript,12207.0
PLXNA4,ENSG00000221866,body weight,EFO_0004338,0.35656936158047864,3.5657058632022145,1,0.4,0.4,transcript,32660.0
ABCB5,ENSG00000004846,Glucocorticoid use measurement,EFO_0009942,0.35654807843365943,3.565507696803795,1,0.4,0.4,transcript,14863.0
EXO1,ENSG00000174371,cutaneous melanoma,EFO_0000389,0.3565117166139564,3.56524659922266,2,1.0,2.0,transcript,15452.0
TECRL,ENSG00000205678,high density lipoprotein cholesterol measurement,EFO_0004612,0.3565016528976775,3.565419303646723,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
ZNF143,ENSG00000166478,heart rate,OBA_1001087,0.35650094645027086,3.565035744330313,1,0.5,0.5,transcript,19026.0
CNTN5,ENSG00000149972,gout,EFO_0004274,0.3564611124213037,3.564624104904259,1,0.4,0.4,transcript,30815.0
LDLRAP1,ENSG00000157978,protein measurement,EFO_0004747,0.35646016148231596,3.5646275282722395,1,0.4,0.4,transcript,15436.0
CYTL1,ENSG00000170891,vital capacity,EFO_0004312,0.35643910150402663,3.564609953190239,1,0.4,0.4,transcript,1827.0
PRTG,ENSG00000166450,Testicular Germ Cell Tumor,EFO_1000566,0.3564126181309107,3.5643442573934294,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
ZNF507,ENSG00000168813,alcohol consumption quality,OBA_1000840,0.35639220781484815,3.5639364769965733,1,0.4,0.4,transcript,27780.0
FLRT2,ENSG00000185070,lobe attachment,EFO_0007667,0.3563706069520161,3.564041588290382,7,2.8000000000000003,19.6,transcript,58417.0
FLRT2,ENSG00000185070,atrial fibrillation,EFO_0000275,0.3563706069520161,3.564041588290382,7,2.8000000000000003,19.6,transcript,58417.0
FLRT2,ENSG00000185070,electrocardiography,EFO_0004327,0.3563691920609797,3.5640274393800184,7,2.8000000000000003,19.6,transcript,58417.0
FLRT2,ENSG00000185070,cardiac arrhythmia,EFO_0004269,0.3563691920609797,3.5640274393800184,7,2.8000000000000003,19.6,transcript,58417.0
RBM18,ENSG00000119446,anthropometric measurement,EFO_0004302,0.35635590765887554,3.563620804983817,1,0.4,0.4,transcript,6480.0
RBM18,ENSG00000119446,lean body mass,EFO_0004995,0.35635590765887554,3.563620804983817,1,0.4,0.4,transcript,6480.0
TGFBR1,ENSG00000106799,body height,OBA_VT0001253,0.3563431385918065,3.563435633510211,1,0.4,0.4,transcript,94171.0
FMN1,ENSG00000248905,melanocytic nevus,EFO_0009675,0.3562934687365699,3.5629703849181857,2,0.8,1.6,transcript,44821.0
RPRD2,ENSG00000163125,appendicular lean mass,EFO_0004980,0.35625264484087044,3.562544954932254,1,0.4,0.4,transcript,21614.0
TNPO3,ENSG00000064419,systemic lupus erythematosus,MONDO_0007915,0.3562367697794825,3.562394370151594,1,0.5,0.5,transcript,18746.0
DMAC1,ENSG00000137038,mean corpuscular hemoglobin concentration,EFO_0004528,0.356228426504001,3.5623998385736706,1,0.4,0.4,transcript,3461.0
ARAP1,ENSG00000186635,cystatin C measurement,EFO_0004617,0.3562137964048643,3.5621469736664095,1,0.4,0.4,transcript,44397.0
POF1B,ENSG00000124429,Varicose veins,HP_0002619,0.3561831063430729,3.561916753233642,1,0.5,0.5,transcript,5835.0
FAM8A1,ENSG00000137414,erythematosquamous dermatosis,EFO_1000695,0.356178827395851,3.56180751582882,1,0.4,0.4,transcript,20788.0
FAM8A1,ENSG00000137414,psoriatic arthritis,EFO_0003778,0.356178827395851,3.56180751582882,1,0.4,0.4,transcript,20788.0
CENPQ,ENSG00000031691,deficiency anemia,MONDO_0001639,0.35614873174957284,3.5617170705112366,1,0.4,0.4,transcript,1741.0
GFPT1,ENSG00000198380,Back pain,HP_0003418,0.3561415597726037,3.561430701755037,1,0.4,0.4,transcript,26483.0
FLRT2,ENSG00000185070,metabolite measurement,EFO_0004725,0.35610252946165016,3.561360813386723,7,2.8000000000000003,19.6,transcript,58417.0
SLAMF7,ENSG00000026751,multiple sclerosis,MONDO_0005301,0.3560881033448963,3.560897229748109,1,0.4,0.4,transcript,24697.0
EXO1,ENSG00000174371,melanoma,EFO_0000756,0.3560813814427824,3.5609432475109197,2,1.0,2.0,transcript,15452.0
GPR180,ENSG00000152749,free cholesterol to total lipids in small LDL percentage ,EFO_0022286,0.3560723815126059,3.560768839889679,1,0.4,0.4,transcript,8884.0
LMO4,ENSG00000143013,age at first sexual intercourse measurement,EFO_0009749,0.35605016549512486,3.5605531350027286,1,0.4,0.4,transcript,7770.0
CCDC80,ENSG00000091986,coiled-coil domain-containing protein 80 measurement,EFO_0020268,0.35604719089984865,3.5605511169192785,2,0.8,1.6,transcript,20200.0
LRP2,ENSG00000081479,hyperuricemia,EFO_0009104,0.3560077631744367,3.560094220444145,1,0.5,0.5,transcript,30141.0
ARSJ,ENSG00000180801,fat pad mass,OBA_0004528,0.35595663466949184,3.559744579957701,2,0.8,1.6,transcript,8977.0
SPRED1,ENSG00000166068,self reported educational attainment,EFO_0004784,0.35595663466949184,3.5596109199064183,1,0.4,0.4,transcript,8974.0
ATAD2B,ENSG00000119778,smoking cessation,EFO_0004319,0.3559551558777493,3.559569736464382,1,0.4,0.4,transcript,22005.0
GASK1B,ENSG00000164125,metabolite measurement,EFO_0004725,0.3559514686604063,3.5596875723553953,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
ENPEP,ENSG00000138792,response to xenobiotic stimulus,GO_0009410,0.35592208291440464,3.5592632289744475,1,0.4,0.4,transcript,9434.0
C6,ENSG00000039537,tropomyosin beta chain measurement,EFO_0020787,0.35591465080411927,3.5591760710991953,1,0.5,0.5,transcript,16913.0
TMED5,ENSG00000117500,educational attainment,EFO_0011015,0.3559049036875477,3.559081004140997,1,0.5,0.5,transcript,15641.0
AKAP11,ENSG00000023516,myeloid leukocyte count,OBA_2045223,0.3558347246724874,3.5587472467248737,1,0.4,0.4,transcript,1000.0
MMP12,ENSG00000262406,cerebrovascular disorder,EFO_0003763,0.35582698355233855,3.5584893744915527,1,0.4,0.4,transcript,1822.0
ATP10D,ENSG00000145246,IGF-1 measurement,EFO_0004627,0.3557666317036102,3.557698139846693,1,0.5,0.5,transcript,15712.0
ENPEP,ENSG00000138792,X-14205--alpha-glutamyltyrosine measurement,EFO_0021365,0.35573968335638745,3.5574392333942755,1,0.4,0.4,transcript,9434.0
MEOX2,ENSG00000106511,preeclampsia,EFO_0000668,0.3556804710441816,3.5569734156295008,1,0.4,0.4,transcript,2371.0
SECISBP2L,ENSG00000138593,alcohol consumption quality,OBA_1000840,0.35563184915810536,3.5563375755505193,1,0.4,0.4,transcript,20960.0
MAGI2,ENSG00000187391,"membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 measurement",EFO_0802739,0.3555587239541874,3.555591802938867,1,0.4,0.4,transcript,87654.0
NCKAP1,ENSG00000061676,bone tissue density,OBA_1000110,0.3555004955195826,3.5550147844131748,1,0.4,0.4,transcript,40695.0
MGA,ENSG00000174197,diastolic blood pressure,EFO_0006336,0.35546478704803114,3.5546537922653743,1,0.5,0.5,transcript,84434.0
HFM1,ENSG00000162669,Cachexia,HP_0004326,0.3554591331768613,3.554721168174741,2,1.0,2.0,transcript,15404.0
EXO1,ENSG00000174371,luminal A breast carcinoma,MONDO_0021116,0.3554029770499023,3.554159203582119,2,1.0,2.0,transcript,15452.0
SP8,ENSG00000164651,smoking status measurement,EFO_0006527,0.35539804930350766,3.5540553994021176,1,0.4,0.4,transcript,5340.0
ARL3,ENSG00000138175,blood sodium bicarbonate amount,OBA_2050094,0.35533845882227555,3.55348891790455,1,0.4,0.4,transcript,3834.0
SLC44A1,ENSG00000070214,high density lipoprotein cholesterol measurement,EFO_0004612,0.3553316127210376,3.5533257361274506,1,0.4,0.4,transcript,41628.0
EPHA5,ENSG00000145242,body mass index,EFO_0004340,0.35530691035073897,3.553079828230558,1,0.4,0.4,transcript,37297.0
F13B,ENSG00000143278,wet macular degeneration,EFO_0004683,0.35528687373626666,3.5529766355068184,1,0.5,0.5,transcript,4634.0
OTULINL,ENSG00000145569,atopic eczema,EFO_0000274,0.3552456941671421,3.5525069166839143,1,0.4,0.4,transcript,8004.0
ROCK2,ENSG00000134318,Fuchs endothelial corneal dystrophy,Orphanet_98974,0.35517650645907295,3.5517760581924533,1,0.5,0.5,transcript,45481.0
MLLT3,ENSG00000171843,open-angle glaucoma,EFO_0004190,0.3551635617293718,3.5517388564213475,2,0.8,1.6,transcript,15498.0
TECRL,ENSG00000205678,platelet count,EFO_0004309,0.35515985462827365,3.552001320952685,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
ANKRD17,ENSG00000132466,phospholipids in VLDL measurement ,EFO_0022301,0.35514821169433297,3.551491306852809,1,0.4,0.4,transcript,43526.0
MCL1,ENSG00000143384,small cell lung carcinoma,EFO_0000702,0.3550787979204398,3.5508047485835115,1,0.4,0.4,transcript,23853.0
SLCO6A1,ENSG00000205359,metabolite measurement,EFO_0004725,0.3550247115896179,3.5502883700215917,1,0.5,0.5,transcript,12120.0
RIF1,ENSG00000080345,mean corpuscular hemoglobin,EFO_0004527,0.35502141814676974,3.5502757247847243,3,1.3,3.9000000000000004,transcript,63370.0
PPA2,ENSG00000138777,social interaction measurement,EFO_0009592,0.3549618334662847,3.5496457409334017,1,0.5,0.5,transcript,18244.0
CFAP299,ENSG00000197826,neuroimaging measurement,EFO_0004346,0.3549343120742334,3.549408258835091,1,0.5,0.5,transcript,7676.0
SYNE2,ENSG00000054654,ceramide measurement,EFO_0010222,0.3549282951675542,3.54929558719145,2,1.0,2.0,transcript,158284.0
PTPN4,ENSG00000088179,serum albumin amount,OBA_2050068,0.35491507996041965,3.549614406465578,5,2.0,10.0,transcript,21570.0
GALR1,ENSG00000166573,BMI-adjusted waist-hip ratio,EFO_0007788,0.35490941111298485,3.5492387242896464,2,0.8,1.6,transcript,11064.0
GALR1,ENSG00000166573,BMI-adjusted waist circumference,EFO_0007789,0.35490941111298485,3.5492387242896464,2,0.8,1.6,transcript,11064.0
PF4V1,ENSG00000109272,platelet factor 4 variant measurement,EFO_0801887,0.35489075169723233,3.5494458749803988,1,0.4,0.4,transcript,743.0
TNFRSF19,ENSG00000127863,tumor necrosis factor receptor superfamily member 19 amount,OBA_2050293,0.35489059330049594,3.5489389341269977,1,0.5,0.5,transcript,15151.0
PF4V1,ENSG00000109272,beta-soluble NSF attachment protein measurement,EFO_0801423,0.35486363710995517,3.549174729107627,1,0.4,0.4,transcript,743.0
CADPS,ENSG00000163618,placenta praevia,EFO_0007442,0.35479895355285695,3.547998853239208,1,0.4,0.4,transcript,42929.0
GPR180,ENSG00000152749,triglycerides in medium HDL measurement ,EFO_0022321,0.3547905265082223,3.547950289845843,1,0.4,0.4,transcript,8884.0
COL24A1,ENSG00000171502,balding measurement,EFO_0007825,0.3547099230904974,3.547123627099168,1,0.4,0.4,transcript,16396.0
RAD23B,ENSG00000119318,brain attribute,OBA_2045210,0.3546978522426866,3.547018796289129,1,0.4,0.4,transcript,9932.0
B4GALT6,ENSG00000118276,blood protein measurement,EFO_0007937,0.3546515577398305,3.5465468151960398,1,0.4,0.4,transcript,12805.0
MAP4K3,ENSG00000011566,cystatin C measurement,EFO_0004617,0.35459427871222055,3.5459655947399495,1,0.4,0.4,transcript,17538.0
CENPQ,ENSG00000031691,vitamin B12 deficiency,EFO_0000734,0.35458715945194613,3.5461013475349694,1,0.4,0.4,transcript,1741.0
TCERG1L,ENSG00000176769,pulse wave reflection index measurement,EFO_0009804,0.35454895491102406,3.545717729372648,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,pulse wave reflection index measurement,EFO_0009804,0.35454895491102406,3.545717729372648,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,pulse wave reflection index measurement,EFO_0009804,0.35454895491102406,3.545717729372648,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,pulse wave reflection index measurement,EFO_0009804,0.35454895491102406,3.545717729372648,2,0.8,1.6,transcript,7012.0
HFM1,ENSG00000162669,brain aneurysm,EFO_0003870,0.3545431615959692,3.54556145236582,2,1.0,2.0,transcript,15404.0
ALAD,ENSG00000148218,protein measurement,EFO_0004747,0.35453422547380775,3.5453795646905073,1,0.4,0.4,transcript,10721.0
ADGRV1,ENSG00000164199,cortical thickness,EFO_0004840,0.3544659602857965,3.5446640280283344,1,0.5,0.5,transcript,112990.0
RNF144B,ENSG00000137393,pulse pressure measurement,EFO_0005763,0.3544611672018959,3.544684545037724,1,0.4,0.4,transcript,5489.0
FIGNL1,ENSG00000132436,lean body mass,EFO_0004995,0.3543908101950647,3.5439242844896874,1,0.4,0.4,transcript,24718.0
SPOCK3,ENSG00000196104,testican-3 measurement,EFO_0802124,0.35436914759779914,3.54377384076247,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
DLC1,ENSG00000164741,high density lipoprotein cholesterol measurement,EFO_0004612,0.35428244054319963,3.542836084605111,1,0.4,0.4,transcript,34249.0
ZNF189,ENSG00000136870,alkaline phosphatase measurement,EFO_0004533,0.35420411665709733,3.5420751888555695,1,0.4,0.4,transcript,11757.0
TTLL7,ENSG00000137941,attention deficit hyperactivity disorder,EFO_0003888,0.3541747339733611,3.541776313168593,2,0.8,1.6,transcript,55223.0
IMPG2,ENSG00000081148,mean corpuscular hemoglobin,EFO_0004527,0.35417290888047653,3.541944606046145,2,0.9,1.8,transcript,8352.0
KYNU,ENSG00000115919,monocyte count,EFO_0005091,0.3541624118295838,3.541782367010067,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
PF4V1,ENSG00000109272,protein LDOC1 measurement,EFO_0801951,0.3541529421613389,3.5420677796214646,1,0.4,0.4,transcript,743.0
POU2F1,ENSG00000143190,total cholesterol measurement,EFO_0004574,0.35411010495209866,3.5411160615775445,2,0.8,1.6,transcript,106581.0
GALNT3,ENSG00000115339,osteoporosis,EFO_0003882,0.35410665442958794,3.5410954522961684,1,0.4,0.4,transcript,13837.0
GALR1,ENSG00000166573,reticulocyte count,EFO_0007986,0.35408447137026916,3.5409893268624892,2,0.8,1.6,transcript,11064.0
POU2F1,ENSG00000143190,body mass index,EFO_0004340,0.35399325758163647,3.5399475878729225,2,0.8,1.6,transcript,106581.0
CD69,ENSG00000110848,eosinophil count,EFO_0004842,0.3539886704446381,3.5407311801677044,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
EXO1,ENSG00000174371,skin cancer,MONDO_0002898,0.3539752371286717,3.539881804369813,2,1.0,2.0,transcript,15452.0
CLASP2,ENSG00000163539,bone tissue density,OBA_1000110,0.3539650030181243,3.539656149570528,1,0.4,0.4,transcript,65366.0
ATAD2B,ENSG00000119778,Red cell distribution width,EFO_0009188,0.35396359881400674,3.5396541658269567,1,0.4,0.4,transcript,22005.0
CA8,ENSG00000178538,protein measurement,EFO_0004747,0.3539418428165548,3.539459382399192,1,0.4,0.4,transcript,9767.0
MSX2,ENSG00000120149,neuroimaging measurement,EFO_0004346,0.3539269922662392,3.5393881609124658,1,0.4,0.4,transcript,3383.0
GREM1,ENSG00000166923,benign neoplasm of anus,MONDO_0021469,0.3539182978021585,3.5392012020864625,1,0.4,0.4,transcript,21949.0
NDUFAF4,ENSG00000123545,breast cancer,MONDO_0007254,0.35388450095864693,3.53895655448329,1,0.4,0.4,transcript,3586.0
CYTL1,ENSG00000170891,protein measurement,EFO_0004747,0.35386481863444497,3.538867124494422,1,0.4,0.4,transcript,1827.0
MTCH2,ENSG00000109919,high density lipoprotein cholesterol measurement,EFO_0004612,0.35386431587669,3.538702611799004,1,0.4,0.4,transcript,6728.0
GALR1,ENSG00000166573,high density lipoprotein cholesterol measurement,EFO_0004612,0.3538479271619499,3.538623884779297,2,0.8,1.6,transcript,11064.0
LYPLAL1,ENSG00000143353,bone tissue density,OBA_1000110,0.3538195241338246,3.5382230376468966,1,0.5,0.5,transcript,17988.0
HFM1,ENSG00000162669,azoospermia,EFO_0000279,0.35380857941592647,3.538215630565393,2,1.0,2.0,transcript,15404.0
MRPL35,ENSG00000132313,neutrophil count,EFO_0004833,0.3537159779026799,3.537223595236116,1,0.4,0.4,transcript,6268.0
CPA4,ENSG00000128510,hydantoin-5-propionate measurement,EFO_0800051,0.3537007782012835,3.5370497283215596,1,0.5,0.5,transcript,11920.0
DNAH14,ENSG00000185842,N-acetylmethionine measurement,EFO_0021427,0.3536407143536342,3.5364651220198824,3,1.5,4.5,transcript,77615.0
ABCB1,ENSG00000085563,leukemia,EFO_0000565,0.3536333419577245,3.536357467287903,1,0.5,0.5,transcript,20792.0
PDE1C,ENSG00000154678,metabolite measurement,EFO_0004725,0.353596006783588,3.536014426740548,2,0.8,1.6,transcript,29434.0
DUSP22,ENSG00000112679,neurodegenerative disease,EFO_0005772,0.3535708053358812,3.5357316577492286,1,0.4,0.4,transcript,16946.0
COLEC10,ENSG00000184374,metabolite measurement,EFO_0004725,0.3535440579110201,3.5355457592311583,1,0.4,0.4,transcript,3803.0
ATP9A,ENSG00000054793,systolic blood pressure,EFO_0006335,0.3535440579110201,3.5354659453350727,1,0.4,0.4,transcript,15769.0
BMPR2,ENSG00000204217,type 2 diabetes mellitus,MONDO_0005148,0.3535315048839027,3.535332820298064,1,0.4,0.4,transcript,22508.0
SLC4A8,ENSG00000050438,alcohol consumption quality,OBA_1000840,0.3534404074801037,3.53443558264846,2,0.8,1.6,transcript,50781.0
NEBL,ENSG00000078114,schizophrenia,MONDO_0005090,0.35337592245054694,3.5337670463244333,1,0.4,0.4,transcript,51139.0
ST8SIA4,ENSG00000113532,myeloid leukocyte count,OBA_2045223,0.35334106106092483,3.5334534876593073,1,0.4,0.4,transcript,9329.0
SORL1,ENSG00000137642,retinal layer thickness,OBA_2050110,0.3532806467837565,3.5328534775006624,2,0.9,1.8,transcript,38290.0
SORL1,ENSG00000137642,macula attribute,OBA_2045216,0.3532806467837565,3.5328534775006624,2,0.9,1.8,transcript,38290.0
CTBP2,ENSG00000175029,white matter microstructure measurement,EFO_0005674,0.35325583071553657,3.5325723703695133,1,0.4,0.4,transcript,28443.0
FAT3,ENSG00000165323,cerebral cortex area attribute,OBA_2045267,0.35321950333117047,3.5322033623070195,1,0.4,0.4,transcript,48025.0
ZNF436,ENSG00000125945,neuroimaging measurement,EFO_0004346,0.35321449295960966,3.532178571311824,1,0.4,0.4,transcript,11890.0
NEK7,ENSG00000151414,triglyceride measurement,EFO_0004530,0.35316663478594046,3.5317116120893473,1,0.4,0.4,transcript,8837.0
SRGN,ENSG00000122862,level of amyloid beta precursor like protein 1 in blood serum,OBA_2040617,0.35315869939887296,3.5317103746179708,1,0.4,0.4,transcript,3242.0
EXO1,ENSG00000174371,keratinocyte carcinoma,EFO_0010176,0.3531185020319452,3.531314453402548,2,1.0,2.0,transcript,15452.0
RAPGEF4,ENSG00000091428,glucose tolerance test,EFO_0004307,0.35311424027438904,3.5311555888325667,1,0.4,0.4,transcript,30335.0
CHL1,ENSG00000134121,strand of hair color,OBA_0002313,0.3531087832449681,3.531135032874485,2,0.8,1.6,transcript,33898.0
HACD4,ENSG00000188921,urate measurement,EFO_0004531,0.3531074737674367,3.531117277289383,1,0.4,0.4,transcript,9403.0
RASGRP3,ENSG00000152689,brain connectivity attribute,OBA_2045295,0.353051301395899,3.530524216871748,1,0.4,0.4,transcript,35705.0
EXO1,ENSG00000174371,Red cell distribution width,EFO_0009188,0.3530474835421655,3.5306042685047507,2,1.0,2.0,transcript,15452.0
TMEM132B,ENSG00000139364,lymphocyte count,EFO_0004587,0.3530460458875989,3.5305498221625724,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
CENPE,ENSG00000138778,puberty onset measurement,EFO_0005677,0.35301559130809507,3.5301816068116803,1,0.5,0.5,transcript,19460.0
PHC1,ENSG00000111752,phospholipid measurement,EFO_0004639,0.35301219255000094,3.5301410759845164,1,0.5,0.5,transcript,26109.0
C4orf33,ENSG00000151470,smoking initiation,EFO_0005670,0.3530063425958623,3.530514479591719,4,1.6,6.4,transcript,14189.0
MDGA2,ENSG00000139915,mathematical ability,EFO_0004875,0.3530063425958623,3.5300865166473026,1,0.4,0.4,transcript,17323.0
LYPLAL1,ENSG00000143353,Inguinal hernia,HP_0000023,0.35297251894357234,3.529752985744374,1,0.5,0.5,transcript,17988.0
HHLA2,ENSG00000114455,monocyte count,EFO_0005091,0.35296037356024856,3.529637539942963,1,0.5,0.5,transcript,14791.0
MLLT3,ENSG00000171843,brain attribute,OBA_2045210,0.35295383832810584,3.529641622408688,2,0.8,1.6,transcript,15498.0
GPR158,ENSG00000151025,reticulocyte count,EFO_0007986,0.3529279219547945,3.529304890852561,1,0.5,0.5,transcript,19477.0
PALM2AKAP2,ENSG00000157654,bone tissue density,OBA_1000110,0.35286757852251366,3.528683772445584,1,0.4,0.4,transcript,50080.0
PALM2AKAP2,ENSG00000157654,preeclampsia,EFO_0000668,0.35286757852251366,3.528683772445584,1,0.4,0.4,transcript,50080.0
GREM1,ENSG00000166923,colorectal carcinoma,EFO_1001951,0.35286102583781304,3.528628482443008,1,0.4,0.4,transcript,21949.0
LINGO2,ENSG00000174482,lean body mass,EFO_0004995,0.352848005875533,3.528491777619772,1,0.4,0.4,transcript,34133.0
GALR1,ENSG00000166573,body weights and measures,EFO_0004324,0.35282125490874866,3.5283571622472842,2,0.8,1.6,transcript,11064.0
C4orf33,ENSG00000151470,serum metabolite measurement,EFO_0005653,0.352811807801058,3.528569131643676,4,1.6,6.4,transcript,14189.0
NDST3,ENSG00000164100,executive function measurement,EFO_0009332,0.35281104057066415,3.5281604682848644,1,0.4,0.4,transcript,7990.0
IPP,ENSG00000197429,HbA1c measurement,EFO_0004541,0.35277881658729304,3.5278689413171955,1,0.5,0.5,transcript,6190.0
TRIM36,ENSG00000152503,high density lipoprotein cholesterol measurement,EFO_0004612,0.35276626921529364,3.5276888530424064,1,0.4,0.4,transcript,15290.0
MTR,ENSG00000116984,glomerular filtration rate,OBA_0003747,0.3527442024911254,3.527446437341069,1,0.4,0.4,transcript,90653.0
PHC1,ENSG00000111752,eosinophil percentage of leukocytes,EFO_0007991,0.3527357249444014,3.5273763999285213,1,0.5,0.5,transcript,26109.0
SKIL,ENSG00000136603,"chromosome, telomeric region length",OBA_0003784,0.3527206113514704,3.52722257333628,1,0.5,0.5,transcript,30377.0
TMED5,ENSG00000117500,platelet volume,OBA_0003277,0.3526952539125097,3.526984506390617,1,0.5,0.5,transcript,15641.0
GIPC2,ENSG00000137960,reticulocyte measurement,EFO_0010700,0.3526925358469978,3.5273165565139872,2,0.8,1.6,transcript,4090.0
RGS7BP,ENSG00000186479,metabolite measurement,EFO_0004725,0.352630318886453,3.5263913101193767,1,0.5,0.5,transcript,5674.0
QSER1,ENSG00000060749,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.35261442395746184,3.52617091477735,1,0.5,0.5,transcript,18744.0
AKAP10,ENSG00000108599,cortical thickness,EFO_0004840,0.35257279135286507,3.5257630938276834,1,0.4,0.4,transcript,11370.0
CSMD3,ENSG00000164796,head and neck squamous cell carcinoma,EFO_0000181,0.3525601327851342,3.5256094365730832,1,0.5,0.5,transcript,61662.0
TXNL1,ENSG00000091164,blood sodium bicarbonate amount,OBA_2050094,0.35255559460399466,3.5256381448583385,2,0.8,1.6,transcript,19465.0
CNTN1,ENSG00000018236,blood protein measurement,EFO_0007937,0.3525545488289549,3.525562015166382,1,0.4,0.4,transcript,24203.0
ARSJ,ENSG00000180801,liver disease,EFO_0001421,0.3525120407983227,3.52529864124601,2,0.8,1.6,transcript,8977.0
CHL1,ENSG00000134121,educational attainment,EFO_0011015,0.3524480477360563,3.524527677785367,2,0.8,1.6,transcript,33898.0
GSAP,ENSG00000186088,hip circumference,OBA_1000032,0.3524311422568703,3.5243369366780053,1,0.5,0.5,transcript,19597.0
PEAK1,ENSG00000173517,mean corpuscular hemoglobin concentration,EFO_0004528,0.3524087182268278,3.524094104719518,1,0.4,0.4,transcript,57783.0
MDM4,ENSG00000198625,gastric adenocarcinoma,EFO_0000503,0.3523929321043186,3.5239351919133957,1,0.4,0.4,transcript,68133.0
IREB2,ENSG00000136381,monocyte count,EFO_0005091,0.3523793442784626,3.523893298548523,2,0.9,1.8,transcript,18026.0
ABCA10,ENSG00000154263,Red cell distribution width,EFO_0009188,0.3523754053624423,3.5238539897763252,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
XKR4,ENSG00000206579,sleep quality,OBA_2040170,0.35231098162023583,3.523128768159148,1,0.4,0.4,transcript,21106.0
CR2,ENSG00000117322,HbA1c measurement,EFO_0004541,0.35226421240367023,3.5226604499633067,1,0.4,0.4,transcript,21827.0
SORL1,ENSG00000137642,platelet count,EFO_0004309,0.3522438819750245,3.522485829413342,2,0.9,1.8,transcript,38290.0
SLC25A46,ENSG00000164209,respiratory system disease,EFO_0000684,0.35223699902672617,3.522389943377453,1,0.4,0.4,transcript,20047.0
SP4,ENSG00000105866,body weight,EFO_0004338,0.35214952573887864,3.5215192497112433,1,0.4,0.4,transcript,16672.0
SP4,ENSG00000105866,bipolar disorder,MONDO_0004985,0.3521451847224527,3.5214758395469836,1,0.4,0.4,transcript,16672.0
PDCD5,ENSG00000105185,programmed cell death protein 5 measurement,EFO_0801927,0.35214169362647413,3.5214950460089316,1,0.4,0.4,transcript,5121.0
KCNQ3,ENSG00000184156,atrial fibrillation,EFO_0000275,0.3521274726579242,3.5213311043100384,2,0.8,1.6,transcript,28380.0
KCNQ3,ENSG00000184156,atrial flutter,EFO_0003911,0.3521274726579242,3.5213311043100384,2,0.8,1.6,transcript,28380.0
CD86,ENSG00000114013,chronic renal failure syndrome,MONDO_0024327,0.3521274726579242,3.521306561040046,1,0.4,0.4,transcript,12565.0
FIGLA,ENSG00000183733,genetic non-acquired premature ovarian failure,EFO_0010646,0.3521274726579242,3.5219672473548655,1,0.5,0.5,transcript,722.0
GRIA4,ENSG00000152578,type 2 diabetes mellitus,MONDO_0005148,0.3521274726579242,3.5212840181007286,1,0.4,0.4,transcript,43050.0
LYPLAL1,ENSG00000143353,oxaloacetic acid measurement,EFO_0801212,0.3521236594568611,3.521264390877261,1,0.5,0.5,transcript,17988.0
ZNF471,ENSG00000196263,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.3521218713666939,3.5212489525541475,1,0.4,0.4,transcript,13228.0
PKP2,ENSG00000057294,Parkinson disease,MONDO_0005180,0.35211906258813563,3.5213467272496826,4,1.6,6.4,transcript,40999.0
MCL1,ENSG00000143384,appendicular lean mass,EFO_0004980,0.3520943778600863,3.5209605479799766,1,0.4,0.4,transcript,23853.0
CR1L,ENSG00000197721,hematocrit,EFO_0004348,0.35203127127463335,3.520405996328423,1,0.5,0.5,transcript,5360.0
ALDOB,ENSG00000136872,carbohydrate metabolism disease,MONDO_0037792,0.3520237572092487,3.5202789842469544,1,0.4,0.4,transcript,9659.0
LIN54,ENSG00000189308,myeloid leukocyte count,OBA_2045223,0.35199628746322525,3.519975801209295,1,0.4,0.4,transcript,30944.0
LDLRAP1,ENSG00000157978,Red cell distribution width,EFO_0009188,0.3519567936707421,3.519593850156501,1,0.4,0.4,transcript,15436.0
STX7,ENSG00000079950,erythrocyte volume,OBA_0003460,0.35194611226023387,3.5195496377605595,2,0.8,1.6,transcript,18076.0
GALR1,ENSG00000166573,body height,OBA_VT0001253,0.3519452300535304,3.5195969136951017,2,0.8,1.6,transcript,11064.0
ITGA8,ENSG00000077943,lobe attachment,EFO_0007667,0.3519410687175144,3.5198754431782424,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
NAA30,ENSG00000139977,gait quality,OBA_1000869,0.3519353409406993,3.519383164669955,1,0.4,0.4,transcript,13443.0
MRPL32,ENSG00000106591,cerebral cortex area attribute,OBA_2045267,0.35189035737231134,3.5189867165208684,1,0.4,0.4,transcript,4811.0
PCDH18,ENSG00000189184,response to xenobiotic stimulus,GO_0009410,0.3518851346716545,3.5189285183752532,2,0.8,1.6,transcript,20733.0
FAT3,ENSG00000165323,retinal break,EFO_0010698,0.3518626507373078,3.518634836368393,1,0.4,0.4,transcript,48025.0
ANKRD36,ENSG00000135976,cervical carcinoma,EFO_0001061,0.35183454202333986,3.518420806588468,2,1.0,2.0,transcript,26530.0
RCN2,ENSG00000117906,attempted suicide,EFO_0004321,0.35181423647346516,3.5181696796759243,1,0.4,0.4,transcript,14644.0
PTAR1,ENSG00000188647,citrate measurement,EFO_0010114,0.35180689049834635,3.518136598332592,2,0.8,1.6,transcript,23636.0
PTAR1,ENSG00000188647,isocitrate measurement,EFO_0010505,0.35180689049834635,3.518136598332592,2,0.8,1.6,transcript,23636.0
SPOCK3,ENSG00000196104,medical procedure,EFO_0002571,0.35179956742994256,3.5180780390839046,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
SPOCK3,ENSG00000196104,complication,EFO_0009518,0.35179956742994256,3.5180780390839046,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
SPOCK3,ENSG00000196104,trauma complication,EFO_0009888,0.35179956742994256,3.5180780390839046,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
ATP10D,ENSG00000145246,platelet volume,OBA_0003277,0.3517789461755177,3.5178212845657675,1,0.5,0.5,transcript,15712.0
SENP6,ENSG00000112701,appendicular lean mass,EFO_0004980,0.3516395764213004,3.5168247813736904,5,2.2,11.0,transcript,25640.0
ARHGAP29,ENSG00000137962,neurodegenerative disease,EFO_0005772,0.3516091018964679,3.5161112446837035,1,0.5,0.5,transcript,24721.0
RFX3,ENSG00000080298,neuroimaging measurement,EFO_0004346,0.35159922350967876,3.516048736262124,2,0.8,1.6,transcript,28318.0
PLXND1,ENSG00000004399,lymphocyte count,EFO_0004587,0.3515550070941795,3.5155737519117674,1,0.5,0.5,transcript,21114.0
AGBL3,ENSG00000146856,apolipoprotein A 1 measurement,EFO_0004614,0.35155401704486816,3.515576123565817,1,0.5,0.5,transcript,13907.0
DIRAS2,ENSG00000165023,Alzheimer disease,MONDO_0004975,0.35154624085457936,3.515538657116133,1,0.4,0.4,transcript,5246.0
AHCTF1,ENSG00000153207,4-acetamidobenzoate measurement,EFO_0801014,0.3515443063804127,3.5154563302744495,1,0.5,0.5,transcript,37689.0
ADGRV1,ENSG00000164199,cystatin C measurement,EFO_0004617,0.3515190780621663,3.515195205792032,1,0.5,0.5,transcript,112990.0
GRSF1,ENSG00000132463,high density lipoprotein cholesterol measurement,EFO_0004612,0.35151573233850536,3.515248413621319,2,0.8,1.6,transcript,17565.0
CRYGD,ENSG00000118231,eye measurement,EFO_0004731,0.35151573233850536,3.5157803763445554,1,0.4,0.4,transcript,642.0
ZNF436,ENSG00000125945,systolic blood pressure,EFO_0006335,0.3515141726743556,3.5151753684592832,1,0.4,0.4,transcript,11890.0
KERA,ENSG00000139330,HbA1c measurement,EFO_0004541,0.35150878858389023,3.5158141681811625,2,0.8,1.6,transcript,2203.0
MED10,ENSG00000133398,high density lipoprotein cholesterol measurement,EFO_0004612,0.3514914594806645,3.515064183437909,1,0.4,0.4,transcript,2674.0
MAGI2,ENSG00000187391,attention deficit hyperactivity disorder,EFO_0003888,0.35148562159208546,3.5148607793178472,1,0.4,0.4,transcript,87654.0
LRP2,ENSG00000081479,arterial stiffness measurement,EFO_0004517,0.35147982888294427,3.5148148775292207,1,0.5,0.5,transcript,30141.0
PKN2,ENSG00000065243,heel bone mineral density,EFO_0009270,0.35141399311078175,3.5141707430012086,1,0.4,0.4,transcript,12982.0
UBXN2A,ENSG00000173960,glomerular filtration rate,OBA_0003747,0.3514125572293274,3.5142827895478677,2,0.8,1.6,transcript,10177.0
NUP153,ENSG00000124789,liver disease,EFO_0001421,0.3513973633426871,3.514001617979398,1,0.5,0.5,transcript,17867.0
GFPT1,ENSG00000198380,response to antihypertensive drug,EFO_0005405,0.3513973633426871,3.513988737455871,1,0.4,0.4,transcript,26483.0
ANKRD34B,ENSG00000189127,neurodegenerative disease,EFO_0005772,0.351392379065249,3.5140174236112918,1,0.4,0.4,transcript,4272.0
NBAS,ENSG00000151779,retinal nerve fibre layer thickness,OBA_2050111,0.351388836218448,3.5139219079744834,2,1.0,2.0,transcript,59620.0
PDE1C,ENSG00000154678,high density lipoprotein cholesterol measurement,EFO_0004612,0.351388836218448,3.5139427210891485,2,0.8,1.6,transcript,29434.0
DCDC2,ENSG00000146038,uric acid measurement,EFO_0004761,0.3513655602606651,3.5137013796723413,1,0.4,0.4,transcript,8738.0
MSX2,ENSG00000120149,platelet count,EFO_0004309,0.3513536457683896,3.5136546959339703,1,0.4,0.4,transcript,3383.0
PIP4K2A,ENSG00000150867,IGF-1 measurement,EFO_0004627,0.35133449026710406,3.513388347875776,1,0.4,0.4,transcript,9207.0
CHL1,ENSG00000134121,X-24970 measurement,EFO_0800913,0.3513062390381164,3.513109590805968,2,0.8,1.6,transcript,33898.0
BTC,ENSG00000174808,nephrotic syndrome,EFO_0004255,0.35130407825810905,3.513162845443465,1,0.4,0.4,transcript,3277.0
PCDH10,ENSG00000138650,iminodiacetate (IDA) measurement,EFO_0800945,0.3512973404028611,3.5130872668239426,2,0.8,1.6,transcript,14052.0
HS6ST3,ENSG00000185352,breast cancer,MONDO_0007254,0.3512945967181489,3.5129928275376274,1,0.4,0.4,transcript,8536.0
UBL3,ENSG00000122042,HbA1c measurement,EFO_0004541,0.35127716637562006,3.5136055761953946,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
DCLK1,ENSG00000133083,bone tissue density,OBA_1000110,0.35124378592752253,3.5124880569284853,2,0.8,1.6,transcript,31874.0
GNA13,ENSG00000120063,neuroimaging measurement,EFO_0004346,0.3511938996693002,3.5119906029373578,1,0.4,0.4,transcript,7751.0
PALM2AKAP2,ENSG00000157654,COVID-19,MONDO_0100096,0.35118647086811067,3.511872695901554,1,0.4,0.4,transcript,50080.0
NEDD4,ENSG00000069869,sitting height measurement,EFO_0011011,0.3511842976467967,3.5118512864295335,1,0.4,0.4,transcript,48135.0
ZNF148,ENSG00000163848,total cholesterol measurement,EFO_0004574,0.3511331216530422,3.5113430849100915,1,0.4,0.4,transcript,33703.0
ATPSCKMT,ENSG00000150756,body mass index,EFO_0004340,0.3511062404443543,3.511110114367207,1,0.4,0.4,transcript,8384.0
PARP8,ENSG00000151883,reticulocyte measurement,EFO_0010700,0.35109676916885624,3.511014768512054,2,0.8,1.6,transcript,33987.0
IYD,ENSG00000009765,metabolite measurement,EFO_0004725,0.3510929771129763,3.510947174540832,1,0.4,0.4,transcript,22984.0
DIRAS2,ENSG00000165023,polygenic risk score,EFO_0030082,0.3510842660362235,3.5109189089325743,1,0.4,0.4,transcript,5246.0
UNC80,ENSG00000144406,growth differentiation factor 15 amount,OBA_2050135,0.3510769138967408,3.51077380097207,1,0.4,0.4,transcript,85800.0
SPOCK3,ENSG00000196104,low density lipoprotein cholesterol measurement,EFO_0004611,0.3510769138967408,3.510851503751887,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
CA8,ENSG00000178538,blood protein measurement,EFO_0007937,0.35107108069684373,3.5107517612020813,1,0.4,0.4,transcript,9767.0
DLGAP1,ENSG00000170579,Abruptio Placentae,EFO_1001754,0.35105781638526107,3.5106063179965488,2,0.8,1.6,transcript,56830.0
SHC4,ENSG00000185634,Red cell distribution width,EFO_0009188,0.351048630746059,3.5105200826864618,1,0.4,0.4,transcript,11843.0
FITM2,ENSG00000197296,body mass index,EFO_0004340,0.351045195765418,3.5105383880776886,1,0.4,0.4,transcript,4628.0
ARL3,ENSG00000138175,schizophrenia,MONDO_0005090,0.35103845496033037,3.510488879285098,1,0.4,0.4,transcript,3834.0
UMPS,ENSG00000114491,chloride measurement,EFO_0009284,0.35100662176944086,3.5100850740560734,1,0.4,0.4,transcript,21213.0
SYT13,ENSG00000019505,Toxic Nodular Goiter,EFO_0009191,0.3509832558637537,3.5100478438904967,2,0.8,1.6,transcript,7432.0
ADGRV1,ENSG00000164199,retinitis pigmentosa,MONDO_0019200,0.3509572818090598,3.509577243260967,1,0.5,0.5,transcript,112990.0
LONRF1,ENSG00000154359,adolescent idiopathic scoliosis,EFO_0005423,0.350916425720043,3.5091995504876468,1,0.5,0.5,transcript,14167.0
FUT2,ENSG00000176920,blood urea nitrogen measurement,EFO_0004741,0.35089545709770503,3.509077597427737,1,0.6000000000000001,0.6000000000000001,transcript,4877.0
GALNT3,ENSG00000115339,HbA1c measurement,EFO_0004541,0.3508907036742292,3.508935944742581,1,0.4,0.4,transcript,13837.0
QSER1,ENSG00000060749,serum creatinine amount,OBA_2050096,0.3508725058767135,3.5087517339698664,1,0.5,0.5,transcript,18744.0
QSER1,ENSG00000060749,cystatin B measurement,EFO_0010593,0.3508725058767135,3.5087517339698664,1,0.5,0.5,transcript,18744.0
RTKN2,ENSG00000182010,Thyroid preparation use measurement,EFO_0009933,0.35084425171891653,3.5084777750119946,1,0.4,0.4,transcript,11345.0
CCDC80,ENSG00000091986,body height,OBA_VT0001253,0.35083005382315324,3.5083797461523245,2,0.8,1.6,transcript,20200.0
LGSN,ENSG00000146166,arterial stiffness measurement,EFO_0004517,0.35081470603466297,3.508177657761148,1,0.4,0.4,transcript,13073.0
IQGAP1,ENSG00000140575,basophil percentage of leukocytes,EFO_0007992,0.3508098354352462,3.5081524522696923,2,0.8,1.6,transcript,29576.0
GPD2,ENSG00000115159,breast cancer,MONDO_0007254,0.3508046688362744,3.5080643546466415,1,0.4,0.4,transcript,22642.0
DLGAP1,ENSG00000170579,Red cell distribution width,EFO_0009188,0.3507738135370475,3.507766289514413,2,0.8,1.6,transcript,56830.0
SPRED1,ENSG00000166068,mathematical ability,EFO_0004875,0.3507456534610949,3.5075011078224487,1,0.4,0.4,transcript,8974.0
TRMT9B,ENSG00000250305,IGA glomerulonephritis,EFO_0004194,0.35073776695056247,3.5075187961668033,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
PLA2R1,ENSG00000153246,lymphocyte count,EFO_0004587,0.35070992079273383,3.5071784001664987,2,0.8,1.6,transcript,20204.0
IL17A,ENSG00000112115,COVID-19,MONDO_0100096,0.35063056136981446,3.5065194031155684,1,0.4,0.4,transcript,1871.0
NDUFAF4,ENSG00000123545,non-small cell lung carcinoma,EFO_0003060,0.3506125581290476,3.506237126187297,1,0.4,0.4,transcript,3586.0
SFRP1,ENSG00000104332,sitting height measurement,EFO_0011011,0.3505983034477052,3.5060310133663406,1,0.4,0.4,transcript,8337.0
ZNF682,ENSG00000197124,cholesteryl ester measurement,EFO_0010351,0.35057714921346017,3.5057974661605757,1,0.5,0.5,transcript,19250.0
LNPEP,ENSG00000113441,glomerular filtration rate,OBA_0003747,0.350570218109825,3.505722843322539,1,0.4,0.4,transcript,19359.0
NAF1,ENSG00000145414,infectious disease,EFO_0005741,0.3505552514636252,3.5056144648282976,1,0.5,0.5,transcript,8071.0
CD93,ENSG00000125810,complement C1q subcomponent measurement,EFO_0008089,0.3505471682521572,3.505498000042462,1,0.4,0.4,transcript,15199.0
ANKRD30B,ENSG00000180777,body height,OBA_VT0001253,0.3505470065686073,3.5054946320890608,1,0.5,0.5,transcript,20353.0
TMTC3,ENSG00000139324,hair color,EFO_0003924,0.35054103824475835,3.5054493916147376,1,0.4,0.4,transcript,10254.0
AKAP11,ENSG00000023516,Drugs affecting bone structure and mineralization use measurement,EFO_0009936,0.3505086806174919,3.505486806174919,1,0.4,0.4,transcript,1000.0
RPS20,ENSG00000008988,neurodegenerative disease,EFO_0005772,0.35048991463185486,3.5049163558009733,1,0.4,0.4,transcript,23243.0
WWTR1,ENSG00000018408,platelet count,EFO_0004309,0.3504884592095403,3.504969427726368,2,0.8,1.6,transcript,18860.0
WWTR1,ENSG00000018408,platelet crit,EFO_0007985,0.3504884592095403,3.504969427726368,2,0.8,1.6,transcript,18860.0
LDLRAP1,ENSG00000157978,monocyte count,EFO_0005091,0.35047971406397843,3.504823054088864,1,0.4,0.4,transcript,15436.0
SAMD11,ENSG00000187634,Abnormal erythrocyte morphology,HP_0001877,0.3504664953157247,3.504727782027113,2,0.8,1.6,transcript,25466.0
DNAJC10,ENSG00000077232,muscular dystrophy,MONDO_0020121,0.35042495541172874,3.5042688058478197,4,1.7000000000000002,6.800000000000001,transcript,353215.0
NID2,ENSG00000087303,blood protein measurement,EFO_0007937,0.35041569330556166,3.504202067556429,1,0.5,0.5,transcript,11078.0
KIF20B,ENSG00000138182,cortical thickness,EFO_0004840,0.3504007078946208,3.504034390903383,1,0.5,0.5,transcript,18307.0
DIRAS2,ENSG00000165023,body height,OBA_VT0001253,0.3503862516952951,3.5039387655232903,1,0.4,0.4,transcript,5246.0
PDHX,ENSG00000110435,glucose measurement,EFO_0004468,0.3503788336087005,3.503833103854212,1,0.4,0.4,transcript,8935.0
MAGI2,ENSG00000187391,social inhibition quality,OBA_1000278,0.3503768820280314,3.5037733836773066,1,0.4,0.4,transcript,87654.0
MAGI2,ENSG00000187391,substance abuse,MONDO_0002491,0.3503768820280314,3.5037733836773066,1,0.4,0.4,transcript,87654.0
NEDD4,ENSG00000069869,blood urea nitrogen measurement,EFO_0004741,0.35035433597110793,3.5035516696726456,1,0.4,0.4,transcript,48135.0
UMPS,ENSG00000114491,blood sodium bicarbonate amount,OBA_2050094,0.3503453319642078,3.503472176003743,1,0.4,0.4,transcript,21213.0
METTL14,ENSG00000145388,low density lipoprotein cholesterol measurement,EFO_0004611,0.35030893418167347,3.503114928716242,1,0.4,0.4,transcript,15633.0
PPDPFL,ENSG00000168333,serum creatinine amount,OBA_2050096,0.3502908360397779,3.5032337620654626,2,0.8,1.6,transcript,4917.0
CFAP299,ENSG00000197826,Abnormal meniscus morphology,HP_0032190,0.3502556286820778,3.5026214249135346,1,0.5,0.5,transcript,7676.0
PTPN4,ENSG00000088179,lymphocyte percentage of leukocytes,EFO_0007993,0.35024749756393697,3.502938582500751,5,2.0,10.0,transcript,21570.0
CTBP2,ENSG00000175029,BMI-adjusted hip circumference,EFO_0008039,0.3502218856080529,3.5022329192946766,1,0.4,0.4,transcript,28443.0
COLEC10,ENSG00000184374,Microscopic hematuria,HP_0002907,0.35021835667960105,3.502288746916968,1,0.4,0.4,transcript,3803.0
ANKRD10,ENSG00000088448,hematocrit,EFO_0004348,0.35021131995031674,3.5022912938931943,2,0.8,1.6,transcript,8984.0
NBAS,ENSG00000151779,cystatin C measurement,EFO_0004617,0.3501619644829665,3.501653190619668,2,1.0,2.0,transcript,59620.0
IMPG2,ENSG00000081148,alpha fetoprotein measurement,EFO_0010583,0.35012417075412683,3.501457224782648,2,0.9,1.8,transcript,8352.0
IMPG2,ENSG00000081148,basophil measurement,EFO_0803539,0.3501226128303921,3.5014416455453,2,0.9,1.8,transcript,8352.0
CCDC7,ENSG00000216937,atrial fibrillation,EFO_0000275,0.3501184808416372,3.5012034054557235,1,0.5,0.5,transcript,26886.0
MAP2K6,ENSG00000108984,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.3500987233388593,3.501004535923414,1,0.4,0.4,transcript,23118.0
CADPS,ENSG00000163618,HbA1c measurement,EFO_0004541,0.35006853870645577,3.500694704775196,1,0.4,0.4,transcript,42929.0
C6,ENSG00000039537,serum urea amount,OBA_2050065,0.3500637328415632,3.5006668914736347,1,0.5,0.5,transcript,16913.0
PALM2AKAP2,ENSG00000157654,glaucoma,MONDO_0005041,0.3500574956179543,3.50058294339999,1,0.4,0.4,transcript,50080.0
KCNQ3,ENSG00000184156,cerebellar volume measurement,EFO_0020864,0.35004804684618207,3.500536846192617,2,0.8,1.6,transcript,28380.0
SP4,ENSG00000105866,response to xenobiotic stimulus,GO_0009410,0.35004804684618207,3.5005044607842777,1,0.4,0.4,transcript,16672.0
CA8,ENSG00000178538,myeloid leukocyte count,OBA_2045223,0.3500100465217847,3.500141419451491,1,0.4,0.4,transcript,9767.0
CWH43,ENSG00000109182,lean body mass,EFO_0004995,0.349998014786955,3.500042221115981,1,0.5,0.5,transcript,8055.0
PALM2AKAP2,ENSG00000157654,platelet component distribution width,EFO_0007984,0.34998474831719684,3.4998554703924154,1,0.4,0.4,transcript,50080.0
TRHDE,ENSG00000072657,blood dibutyl sulfosuccinate measurement,EFO_0022212,0.34997847514172126,3.499884322018992,2,0.8,1.6,transcript,16069.0
GASK1B,ENSG00000164125,complication,EFO_0009518,0.3499583692310703,3.499756578062036,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
GKAP1,ENSG00000165113,neurodegenerative disease,EFO_0005772,0.3499160407795578,3.4992175343308536,1,0.4,0.4,transcript,7002.0
MAGI2,ENSG00000187391,body fat percentage,EFO_0007800,0.3498825325724103,3.4988298891210956,1,0.4,0.4,transcript,87654.0
CMYA5,ENSG00000164309,neurodegenerative disease,EFO_0005772,0.34988234564917176,3.4988510731721925,1,0.5,0.5,transcript,18105.0
PARD6B,ENSG00000124171,neurodegenerative disease,EFO_0005772,0.3498822578582569,3.4989009945794325,1,0.4,0.4,transcript,5101.0
ABCB5,ENSG00000004846,cardiomyopathy,EFO_0000318,0.34985744766330107,3.4986013891002115,1,0.4,0.4,transcript,14863.0
PLXND1,ENSG00000004399,monocyte count,EFO_0005091,0.34984801205339444,3.498503801503917,1,0.5,0.5,transcript,21114.0
FAT3,ENSG00000165323,type 2 diabetes mellitus,MONDO_0005148,0.3498033473752763,3.4980418027480775,1,0.4,0.4,transcript,48025.0
FAS,ENSG00000026103,head and neck squamous cell carcinoma,EFO_0000181,0.34978883305720704,3.4978905387966024,1,0.4,0.4,transcript,181141.0
NDUFAF2,ENSG00000164182,breast cancer,MONDO_0007254,0.34978832423589146,3.4979234474046477,1,0.4,0.4,transcript,9949.0
PLA2R1,ENSG00000153246,blood protein measurement,EFO_0007937,0.34978322188258953,3.497911411065056,2,0.8,1.6,transcript,20204.0
AHNAK2,ENSG00000185567,lymphocyte count,EFO_0004587,0.349781754200394,3.4978653717301147,2,1.0,2.0,transcript,41815.0
DTHD1,ENSG00000197057,basophil percentage of leukocytes,EFO_0007992,0.3497767608845987,3.4977940093951183,1,0.5,0.5,transcript,18939.0
LIN9,ENSG00000183814,mean corpuscular hemoglobin,EFO_0004527,0.3497686565513104,3.4977914010523516,2,0.8,1.6,transcript,15262.0
FAM171B,ENSG00000144369,FEV/FVC ratio,EFO_0004713,0.34976091093190115,3.4976789051661585,1,0.4,0.4,transcript,5731.0
TC2N,ENSG00000165929,sialate O-acetylesterase measurement,EFO_0803073,0.3497514319331073,3.4975370841139544,1,0.4,0.4,transcript,17571.0
BTC,ENSG00000174808,triglycerides in small LDL measurement ,EFO_0022323,0.3497144336906635,3.497266399769009,1,0.4,0.4,transcript,3277.0
ATAD2B,ENSG00000119778,myeloid leukocyte count,OBA_2045223,0.3497042242901876,3.4970604205887654,1,0.4,0.4,transcript,22005.0
GFRAL,ENSG00000187871,blood protein measurement,EFO_0007937,0.34969718122579846,3.4971811267530133,1,0.4,0.4,transcript,1911.0
MCL1,ENSG00000143384,glucose measurement,EFO_0004468,0.3496958295181051,3.4969750645601643,1,0.4,0.4,transcript,23853.0
CD2AP,ENSG00000198087,mean corpuscular hemoglobin concentration,EFO_0004528,0.349694693950091,3.4969990092744068,1,0.4,0.4,transcript,7682.0
DMRTA1,ENSG00000176399,brain volume,OBA_2050009,0.3496861693492325,3.4969333010827297,1,0.4,0.4,transcript,5586.0
FBXO28,ENSG00000143756,basophil measurement,EFO_0803539,0.3496424594967891,3.497473582694735,5,2.0,10.0,transcript,9533.0
FSIP2,ENSG00000188738,urate measurement,EFO_0004531,0.3496407186647855,3.496686126675749,4,2.0,8.0,transcript,28680.0
CADPS,ENSG00000163618,ovarian dysfunction,EFO_0009003,0.34958481264205854,3.4958574441312242,1,0.4,0.4,transcript,42929.0
ANO5,ENSG00000171714,"myosin-binding protein C, slow-type measurement",EFO_0802772,0.34958481264205854,3.49585317278405,1,0.4,0.4,transcript,79265.0
SLC4A8,ENSG00000050438,Red cell distribution width,EFO_0009188,0.3495803321461313,3.4958348293087362,2,0.8,1.6,transcript,50781.0
NEK7,ENSG00000151414,high density lipoprotein cholesterol measurement,EFO_0004612,0.3495242409781974,3.4952876740119163,1,0.4,0.4,transcript,8837.0
MAGI2,ENSG00000187391,pancreatic intraductal papillary-mucinous neoplasm,MONDO_0004286,0.3495239851417406,3.495244414814399,1,0.4,0.4,transcript,87654.0
C6,ENSG00000039537,apolipoprotein D measurement,EFO_0020156,0.3494950582777877,3.4949801458358793,1,0.5,0.5,transcript,16913.0
SYNE2,ENSG00000054654,Red cell distribution width,EFO_0009188,0.34949105879672976,3.4949232234832057,2,1.0,2.0,transcript,158284.0
PRKCB,ENSG00000166501,diffuse large B-cell lymphoma,EFO_0000403,0.3494872900694632,3.4948968671416063,1,0.4,0.4,transcript,16690.0
F13B,ENSG00000143278,level of cadherin-related family member 5 in blood serum,OBA_2042462,0.34944036287576996,3.494511526901851,1,0.5,0.5,transcript,4634.0
C2orf73,ENSG00000177994,body mass index,EFO_0004340,0.3494156450841512,3.494204760020256,1,0.4,0.4,transcript,8280.0
SH3TC2,ENSG00000169247,Antihypertensive use measurement,EFO_0009927,0.34941054381409453,3.494109861549624,1,0.4,0.4,transcript,90428.0
RASGRP3,ENSG00000152689,white matter microstructure measurement,EFO_0005674,0.3494073550985708,3.4940847538984654,1,0.4,0.4,transcript,35705.0
ADAT2,ENSG00000189007,triglyceride measurement,EFO_0004530,0.34938959019806476,3.4939257104611605,1,0.4,0.4,transcript,13419.0
INF2,ENSG00000203485,neurodegenerative disease,EFO_0005772,0.3493857570339729,3.4938606332206747,1,0.4,0.4,transcript,130596.0
COLEC10,ENSG00000184374,eosinophil percentage of leukocytes,EFO_0007991,0.34934570559800354,3.493562236100993,1,0.4,0.4,transcript,3803.0
PARP8,ENSG00000151883,heart rate,OBA_1001087,0.3493361983836971,3.4934090606604626,2,0.8,1.6,transcript,33987.0
PALM2AKAP2,ENSG00000157654,open-angle glaucoma,EFO_0004190,0.3492596034054708,3.4926040212751555,1,0.4,0.4,transcript,50080.0
PLXND1,ENSG00000004399,metabolic syndrome,EFO_0000195,0.34923405621905723,3.492364243160545,1,0.5,0.5,transcript,21114.0
TECRL,ENSG00000205678,insulin-like growth factor-binding protein 7 amount,OBA_2050142,0.3492081939183338,3.4924847138532864,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
IL1A,ENSG00000115008,neutrophil percentage of leukocytes,EFO_0007990,0.3492033571299787,3.492231885627997,1,0.4,0.4,transcript,2017.0
OXSR1,ENSG00000172939,protein S100-A11 measurement,EFO_0801958,0.34919732901366324,3.4920138663184135,1,0.4,0.4,transcript,9858.0
CA8,ENSG00000178538,eosinophil count,EFO_0004842,0.3491935506134508,3.4919764603681522,1,0.4,0.4,transcript,9767.0
MAGI2,ENSG00000187391,insomnia,EFO_0004698,0.34915347976298733,3.491539361026866,1,0.4,0.4,transcript,87654.0
TPRG1,ENSG00000188001,allantoin measurement,EFO_0010456,0.3491494256201636,3.4915941126579804,2,0.8,1.6,transcript,16023.0
PIP4K2A,ENSG00000150867,neuroticism measurement,EFO_0007660,0.3491494256201636,3.4915377014063718,1,0.4,0.4,transcript,9207.0
UNC80,ENSG00000144406,"chromosome, telomeric region length",OBA_0003784,0.34914626168965707,3.4914672789012324,1,0.4,0.4,transcript,85800.0
CLSTN2,ENSG00000158258,autism spectrum disorder,EFO_0003756,0.34914626168965707,3.491486703125269,1,0.4,0.4,transcript,16607.0
CNTN1,ENSG00000018236,heart rate,OBA_1001087,0.34914626168965707,3.491479143773404,1,0.4,0.4,transcript,24203.0
PF4V1,ENSG00000109272,ER membrane protein complex subunit 1 measurement,EFO_0801579,0.34914419557288195,3.491980313736895,1,0.4,0.4,transcript,743.0
SP4,ENSG00000105866,smoking status measurement,EFO_0006527,0.3491419817706627,3.4914438100290837,1,0.4,0.4,transcript,16672.0
MRPL32,ENSG00000106591,heart rate,OBA_1001087,0.34913281155884585,3.4914112583862136,1,0.4,0.4,transcript,4811.0
FMN1,ENSG00000248905,nevus,EFO_0000625,0.3491258170058745,3.491293867611231,2,0.8,1.6,transcript,44821.0
FMN1,ENSG00000248905,Hamartoma,HP_0010566,0.3491258170058745,3.491293867611231,2,0.8,1.6,transcript,44821.0
PLXNA4,ENSG00000221866,type 1 diabetes mellitus,MONDO_0005147,0.3490924601620367,3.490936849017795,1,0.4,0.4,transcript,32660.0
SGCD,ENSG00000170624,calcium measurement,EFO_0004838,0.34907920244075274,3.4908108134535136,1,0.4,0.4,transcript,21289.0
BTC,ENSG00000174808,low density lipoprotein cholesterol measurement,EFO_0004611,0.3490768405351284,3.490890468213658,1,0.4,0.4,transcript,3277.0
BTC,ENSG00000174808,triglycerides in large LDL measurement ,EFO_0022319,0.3490768405351284,3.490890468213658,1,0.4,0.4,transcript,3277.0
BTC,ENSG00000174808,triglyceride measurement,EFO_0004530,0.3490768405351284,3.490890468213658,1,0.4,0.4,transcript,3277.0
KCNQ3,ENSG00000184156,brain volume,OBA_2050009,0.3490768405351284,3.49082478308208,2,0.8,1.6,transcript,28380.0
GFRAL,ENSG00000187871,GDNF family receptor alpha-like measurement,EFO_0801620,0.34905906683365373,3.490799982831566,1,0.4,0.4,transcript,1911.0
BTC,ENSG00000174808,triglycerides in medium LDL measurement ,EFO_0022322,0.34905484297702877,3.490670492632662,1,0.4,0.4,transcript,3277.0
PAFAH1B2,ENSG00000168092,total cholesterol measurement,EFO_0004574,0.34904366487940014,3.490570439244708,2,0.8,1.6,transcript,11959.0
DNAH14,ENSG00000185842,metabolite measurement,EFO_0004725,0.3490108087735901,3.4901660662194414,3,1.5,4.5,transcript,77615.0
CD86,ENSG00000114013,Thyroid preparation use measurement,EFO_0009933,0.34896153620967646,3.4896471965575686,1,0.4,0.4,transcript,12565.0
ZNF398,ENSG00000197024,hippocampal CA4 volume,EFO_0009396,0.3489609577744797,3.489635071689985,1,0.4,0.4,transcript,15690.0
DZIP3,ENSG00000198919,body mass index,EFO_0004340,0.34895715521912807,3.489593687103571,1,0.4,0.4,transcript,18071.0
AGA,ENSG00000038002,metabolite measurement,EFO_0004725,0.3489143821246397,3.4892418028258603,1,0.5,0.5,transcript,5103.0
KIF20B,ENSG00000138182,trait in response to triamcinolone acetonide,OBA_2040119,0.348902627531547,3.489053587272645,1,0.5,0.5,transcript,18307.0
KIF20B,ENSG00000138182,ocular hypertension,EFO_1001069,0.348902627531547,3.489053587272645,1,0.5,0.5,transcript,18307.0
GALNT3,ENSG00000115339,educational attainment,EFO_0011015,0.34888962456667777,3.4889251536670667,1,0.4,0.4,transcript,13837.0
ONECUT2,ENSG00000119547,migraine disorder,MONDO_0005277,0.34887405276605643,3.489902353386705,7,2.8000000000000003,19.6,transcript,16870.0
FRMD4B,ENSG00000114541,erythrocyte count,EFO_0004305,0.34883762694794224,3.4884523657411934,2,0.8,1.6,transcript,21026.0
SFRP1,ENSG00000104332,brain attribute,OBA_2045210,0.34883178115606434,3.488365790449932,1,0.4,0.4,transcript,8337.0
METTL14,ENSG00000145388,total cholesterol measurement,EFO_0004574,0.34882966068091104,3.488322193708618,1,0.4,0.4,transcript,15633.0
NUP153,ENSG00000124789,neurodegenerative disease,EFO_0005772,0.34881965268299736,3.4882245113825006,1,0.5,0.5,transcript,17867.0
TMEM132B,ENSG00000139364,arterial stiffness measurement,EFO_0004517,0.3487898431629154,3.487987794915737,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
LUZP2,ENSG00000187398,arterial stiffness measurement,EFO_0004517,0.3487898431629154,3.4882152116533787,4,1.7000000000000002,6.800000000000001,transcript,21466.0
PLXNA4,ENSG00000221866,arterial stiffness measurement,EFO_0004517,0.3487898431629154,3.4879106790265824,1,0.4,0.4,transcript,32660.0
TWSG1,ENSG00000128791,Red cell distribution width,EFO_0009188,0.3487836201259867,3.4878919115662734,1,0.4,0.4,transcript,7180.0
PRTG,ENSG00000166450,"chromosome, telomeric region length",OBA_0003784,0.34866736705422535,3.486891746626576,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
GPD2,ENSG00000115159,age at first sexual intercourse measurement,EFO_0009749,0.3486234573154719,3.486252239438616,1,0.4,0.4,transcript,22642.0
RCOR3,ENSG00000117625,alcohol consumption quality,OBA_1000840,0.3486149850320514,3.4862142055614442,2,0.8,1.6,transcript,24862.0
PARP8,ENSG00000151883,eosinophil count,EFO_0004842,0.348595018125515,3.485997258078642,2,0.8,1.6,transcript,33987.0
ONECUT1,ENSG00000169856,waist circumference,OBA_1001085,0.34852046080045146,3.485257455144163,1,0.4,0.4,transcript,7569.0
DLG2,ENSG00000150672,brain volume,OBA_2050009,0.34851462705418523,3.485149043467011,1,0.4,0.4,transcript,144252.0
TNPO3,ENSG00000064419,platelet count,EFO_0004309,0.34848732306664176,3.4848999030231873,1,0.5,0.5,transcript,18746.0
B4GALT6,ENSG00000118276,"beta-1,4-galactosyltransferase 6 measurement",EFO_0801411,0.34847742789684594,3.4848055167661944,1,0.4,0.4,transcript,12805.0
SP4,ENSG00000105866,cholesteryl ester measurement,EFO_0010351,0.3484507565674039,3.4845315579964957,1,0.4,0.4,transcript,16672.0
RCN2,ENSG00000117906,cystatin C measurement,EFO_0004617,0.3484190810900548,3.4842181258418212,1,0.4,0.4,transcript,14644.0
FAM171B,ENSG00000144369,neuromuscular disease,EFO_1001902,0.3483956746133374,3.4840265419805214,1,0.4,0.4,transcript,5731.0
C2orf73,ENSG00000177994,cortical thickness,EFO_0004840,0.34839438057108135,3.4839921148895576,1,0.4,0.4,transcript,8280.0
CNTLN,ENSG00000044459,hemolytic anemia,EFO_0005558,0.3483717667883236,3.4838391284465096,2,0.8,1.6,transcript,13173.0
NEDD1,ENSG00000139350,secondary malignant neoplasm,EFO_0009812,0.3483717667883236,3.4837369245749366,1,0.4,0.4,transcript,20772.0
COL19A1,ENSG00000082293,arterial stiffness measurement,EFO_0004517,0.3483717667883236,3.4838550069390304,2,0.8,1.6,transcript,11650.0
DNAJC10,ENSG00000077232,response to antihypertensive drug,EFO_0005405,0.34836857147537065,3.4837049664842388,4,1.7000000000000002,6.800000000000001,transcript,353215.0
ANKRD36,ENSG00000135976,cystatin C measurement,EFO_0004617,0.34835061666009814,3.4835815529560508,2,1.0,2.0,transcript,26530.0
NAA30,ENSG00000139977,astrocytoma,EFO_0000272,0.34828946893227164,3.482924444585678,1,0.4,0.4,transcript,13443.0
RTKN2,ENSG00000182010,systemic lupus erythematosus,MONDO_0007915,0.34827628169322594,3.4827980747550886,1,0.4,0.4,transcript,11345.0
FYB1,ENSG00000082074,age-related macular degeneration,EFO_0001365,0.3482707146064336,3.4827267962903137,1,0.5,0.5,transcript,25445.0
AKAP11,ENSG00000023516,skeletal system disease,EFO_0002461,0.34824469362436666,3.4828469362436665,1,0.4,0.4,transcript,1000.0
HECW2,ENSG00000138411,eosinophil count,EFO_0004842,0.34821950338246693,3.4822008499761217,1,0.4,0.4,transcript,68774.0
SKI,ENSG00000157933,coronary artery disease,EFO_0001645,0.3482139236732796,3.482191757741199,1,0.4,0.4,transcript,7616.0
TCERG1L,ENSG00000176769,X-11787 measurement,EFO_0021258,0.34820868406473093,3.4823150209097165,2,0.8,1.6,transcript,7012.0
SLC15A5,ENSG00000188991,ovarian neoplasm,EFO_0003893,0.34820868406473093,3.483318452005503,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
TCERG1L,ENSG00000176769,X-11787 measurement,EFO_0021258,0.34820868406473093,3.4823150209097165,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,X-11787 measurement,EFO_0021258,0.34820868406473093,3.4823150209097165,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,X-11787 measurement,EFO_0021258,0.34820868406473093,3.4823150209097165,2,0.8,1.6,gene_variant,7012.0
ADGRV1,ENSG00000164199,temporomandibular joint disorder,EFO_0005279,0.3481909751344977,3.4819141765153465,1,0.5,0.5,transcript,112990.0
HECW2,ENSG00000138411,bone tissue density,OBA_1000110,0.3481867972987208,3.481873789138661,1,0.4,0.4,transcript,68774.0
QSOX1,ENSG00000116260,metabolite measurement,EFO_0004725,0.34816367177382834,3.4816657811692213,1,0.4,0.4,transcript,13763.0
FRS2,ENSG00000166225,C-reactive protein measurement,EFO_0004458,0.34814791853865396,3.4814952942826776,1,0.4,0.4,transcript,24831.0
PDHX,ENSG00000110435,type 2 diabetes mellitus,MONDO_0005148,0.34814342257450137,3.4814789935122215,1,0.4,0.4,transcript,8935.0
CTBP2,ENSG00000175029,COVID-19,MONDO_0100096,0.34809527144494035,3.480966777663551,1,0.4,0.4,transcript,28443.0
CNTLN,ENSG00000044459,body fat percentage,EFO_0007800,0.34807945326504913,3.4809159932137645,2,0.8,1.6,transcript,13173.0
CSMD3,ENSG00000164796,lymphocyte count,EFO_0004587,0.34807875232948154,3.4807956320165565,1,0.5,0.5,transcript,61662.0
PPDPFL,ENSG00000168333,serum metabolite measurement,EFO_0005653,0.3480734197352568,3.4810595990202517,2,0.8,1.6,transcript,4917.0
ATP10D,ENSG00000145246,"glycosyl ceramide (d16:1/24:1, d18:1/22:1) measurement",EFO_0800530,0.3480346245975654,3.4803780687862447,1,0.5,0.5,transcript,15712.0
DCDC2,ENSG00000146038,blood urea nitrogen measurement,EFO_0004741,0.3480286364568946,3.480332141634636,1,0.4,0.4,transcript,8738.0
NDUFAF2,ENSG00000164182,non-small cell lung carcinoma,EFO_0003060,0.34802549914625475,3.4802951965082807,1,0.4,0.4,transcript,9949.0
COLEC10,ENSG00000184374,platelet count,EFO_0004309,0.34800600611062404,3.4801652412271977,1,0.4,0.4,transcript,3803.0
CD86,ENSG00000114013,multiple myeloma,EFO_0001378,0.3479823248735083,3.4798550831958868,1,0.4,0.4,transcript,12565.0
MEOX2,ENSG00000106511,forced expiratory volume,EFO_0004314,0.34797194144878735,3.4798881196755582,1,0.4,0.4,transcript,2371.0
ATP5F1A,ENSG00000152234,mean corpuscular hemoglobin concentration,EFO_0004528,0.34797174027015504,3.4797312034191874,1,0.4,0.4,transcript,28984.0
DIRAS2,ENSG00000165023,high density lipoprotein cholesterol measurement,EFO_0004612,0.34796482465863504,3.47972449515669,1,0.4,0.4,transcript,5246.0
PDE1C,ENSG00000154678,cigarettes per day measurement,EFO_0006525,0.34794758530913833,3.4795302119960514,2,0.8,1.6,transcript,29434.0
HNRNPA0,ENSG00000177733,neurodegenerative disease,EFO_0005772,0.347917324830803,3.4791962025143883,1,0.4,0.4,transcript,17426.0
STT3B,ENSG00000163527,Splenomegaly,HP_0001744,0.3479118198457132,3.47913792135048,1,0.4,0.4,transcript,20281.0
DLG2,ENSG00000150672,erythrocyte count,EFO_0004305,0.3478695008232607,3.4786977811577655,1,0.4,0.4,transcript,144252.0
TFEC,ENSG00000105967,total cholesterol measurement,EFO_0004574,0.34786256128210863,3.4786413101760822,1,0.4,0.4,transcript,25482.0
CCDC66,ENSG00000180376,body mass index,EFO_0004340,0.34786227632828964,3.4786379927915925,1,0.5,0.5,transcript,32831.0
GJA3,ENSG00000121743,nutritional deficiency disease,EFO_1001067,0.34785204285300503,3.478597145062463,1,0.4,0.4,transcript,5214.0
C4orf33,ENSG00000151470,urinary metabolite measurement,EFO_0005116,0.3478453852407261,3.4789049060403574,4,1.6,6.4,transcript,14189.0
KCNIP4,ENSG00000185774,pulse wave reflection index measurement,EFO_0009804,0.347838908997916,3.4785217379645683,2,0.8,1.6,transcript,12062.0
GRIA4,ENSG00000152578,alcohol dependence,MONDO_0007079,0.34782085017178915,3.478217793239378,1,0.4,0.4,transcript,43050.0
CPD,ENSG00000108582,neurodegenerative disease,EFO_0005772,0.34777407135151484,3.4777609318734175,1,0.4,0.4,transcript,19784.0
RAD18,ENSG00000070950,body height,OBA_VT0001253,0.3477469547289252,3.4775030284979236,1,0.4,0.4,transcript,11947.0
COL19A1,ENSG00000082293,neuroticism measurement,EFO_0007660,0.3477213870072696,3.4773512091284906,2,0.8,1.6,transcript,11650.0
COL19A1,ENSG00000082293,depressive symptom measurement,EFO_0007006,0.3477213870072696,3.4773512091284906,2,0.8,1.6,transcript,11650.0
COL19A1,ENSG00000082293,wellbeing measurement,EFO_0007869,0.3477213870072696,3.4773512091284906,2,0.8,1.6,transcript,11650.0
GCH1,ENSG00000131979,mean corpuscular hemoglobin concentration,EFO_0004528,0.34760943763625923,3.476128140184657,1,0.4,0.4,transcript,11847.0
CTBP2,ENSG00000175029,eosinophil count,EFO_0004842,0.3476074306964553,3.4760883701787004,1,0.4,0.4,transcript,28443.0
RTKN2,ENSG00000182010,sex hormone-binding globulin measurement,EFO_0004696,0.3475943060847262,3.475978318670091,1,0.4,0.4,transcript,11345.0
TRHDE,ENSG00000072657,small integral membrane protein 9 measurement,EFO_0802075,0.3475829301989442,3.4759288725912216,2,0.8,1.6,transcript,16069.0
CD69,ENSG00000110848,myeloid leukocyte count,OBA_2045223,0.34754957677514603,3.4763402434727833,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
PTPRO,ENSG00000151490,Ovarian Endometriosis,EFO_1000418,0.3475495304675355,3.475499753271823,1,0.4,0.4,transcript,89916.0
RBM25,ENSG00000119707,age at menopause,EFO_0004704,0.3475317322527739,3.475330012480469,1,0.4,0.4,transcript,31521.0
NRK,ENSG00000123572,serum creatinine amount,OBA_2050096,0.34752581063758925,3.475283323876838,1,0.4,0.4,transcript,15862.0
TCERG1L,ENSG00000176769,sweat gland disease,EFO_1000772,0.34752581063758925,3.4754862866382994,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,sweat gland disease,EFO_1000772,0.34752581063758925,3.4754862866382994,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,sweat gland disease,EFO_1000772,0.34752581063758925,3.4754862866382994,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,sweat gland disease,EFO_1000772,0.34752581063758925,3.4754862866382994,2,0.8,1.6,gene_variant,7012.0
TENM4,ENSG00000149256,bone tissue density,OBA_1000110,0.34752581063758925,3.4752755568601432,1,0.4,0.4,transcript,22922.0
RPAP3,ENSG00000005175,kidney disease,EFO_0003086,0.34749178912833356,3.4750662592358577,2,0.8,1.6,transcript,10784.0
TULP4,ENSG00000130338,appendicular lean mass,EFO_0004980,0.34747060367478994,3.4747249618046743,1,0.4,0.4,transcript,21136.0
SLAMF7,ENSG00000026751,level of serum globulin type protein,OBA_2045206,0.3474622305109579,3.4746385014087253,1,0.4,0.4,transcript,24697.0
TRDMT1,ENSG00000107614,erythrocyte volume,OBA_0003460,0.3474209952519197,3.47422374419592,1,0.4,0.4,transcript,29003.0
FSIP2,ENSG00000188738,non-alcoholic fatty liver disease,EFO_0003095,0.3474165350864651,3.474444290892545,4,2.0,8.0,transcript,28680.0
FSIP2,ENSG00000188738,type 2 diabetes mellitus,MONDO_0005148,0.3474165350864651,3.474444290892545,4,2.0,8.0,transcript,28680.0
ZNF682,ENSG00000197124,triglycerides in very small VLDL measurement,EFO_0022144,0.34740106721517494,3.4740366461777232,1,0.5,0.5,transcript,19250.0
PRTG,ENSG00000166450,coronary artery disease,EFO_0001645,0.34735215357233595,3.4737396118076824,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
AKR1C1,ENSG00000187134,high density lipoprotein cholesterol measurement,EFO_0004612,0.3473404235741784,3.473543426694372,2,0.8,1.6,transcript,11495.0
HFM1,ENSG00000162669,Red cell distribution width,EFO_0009188,0.34733778722638153,3.4735077086699433,2,1.0,2.0,transcript,15404.0
EPHA5,ENSG00000145242,ephrin type-A receptor 5 amount,OBA_2050307,0.3473252165385624,3.473262890108792,1,0.4,0.4,transcript,37297.0
SAMD11,ENSG00000187634,cystatin C measurement,EFO_0004617,0.34732126512597983,3.473275480129664,2,0.8,1.6,transcript,25466.0
SPRED1,ENSG00000166068,bone tissue density,OBA_1000110,0.3473009310715882,3.473053883927382,1,0.4,0.4,transcript,8974.0
FREM2,ENSG00000150893,tooth disease,EFO_1001216,0.3472800606772205,3.4736917135267946,6,2.5,15.0,transcript,16833.0
CTBP2,ENSG00000175029,connective tissue disease,EFO_1001986,0.3472800606772205,3.4728146699863527,1,0.4,0.4,transcript,28443.0
KCNIP4,ENSG00000185774,cognitive function measurement,EFO_0008354,0.347277996459216,3.4729126125775687,2,0.8,1.6,transcript,12062.0
SLCO1C1,ENSG00000139155,monocyte count,EFO_0005091,0.34725871951402526,3.4726180860336173,1,0.5,0.5,transcript,16186.0
DMXL1,ENSG00000172869,X-24736 measurement,EFO_0800904,0.3472557179487212,3.4725678641040347,1,0.4,0.4,transcript,37437.0
BMPR2,ENSG00000204217,pulmonary hypertension,MONDO_0005149,0.3472370952499215,3.472388723958252,1,0.4,0.4,transcript,22508.0
CEP68,ENSG00000011523,diabetic retinopathy,EFO_0003770,0.3472193824707546,3.4722305918165075,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,diabetic retinopathy,EFO_0003770,0.3472193824707546,3.4722305918165075,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,diabetic retinopathy,EFO_0003770,0.3472193824707546,3.4722305918165075,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,diabetic retinopathy,EFO_0003770,0.3472193824707546,3.4722305918165075,3,1.5,4.5,gene_variant,122392.0
ANKRD30B,ENSG00000180777,glomerular filtration rate,OBA_0003747,0.3472033838540922,3.4720584049439096,1,0.5,0.5,transcript,20353.0
PPDPFL,ENSG00000168333,glutaroyl carnitine measurement,EFO_0021005,0.3471706749956598,3.4720321516242816,2,0.8,1.6,transcript,4917.0
SLC15A5,ENSG00000188991,body weight,EFO_0004338,0.34716259807038896,3.472857592062083,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
CADPS,ENSG00000163618,mathematical ability,EFO_0004875,0.34710881842413455,3.4710975019519843,1,0.4,0.4,transcript,42929.0
CCDC66,ENSG00000180376,educational attainment,EFO_0011015,0.34710502717501207,3.4710655012588165,1,0.5,0.5,transcript,32831.0
GPD2,ENSG00000115159,non-small cell lung carcinoma,EFO_0003060,0.347101549509543,3.471033161379327,1,0.4,0.4,transcript,22642.0
PTPN4,ENSG00000088179,neutrophil count,EFO_0004833,0.3470689328677502,3.4711529355388837,5,2.0,10.0,transcript,21570.0
EXOC6,ENSG00000138190,metabolic syndrome,EFO_0000195,0.3470416289246804,3.4704389065173515,1,0.5,0.5,transcript,22107.0
TWSG1,ENSG00000128791,mean corpuscular hemoglobin concentration,EFO_0004528,0.34702795816476567,3.4703352919540635,1,0.4,0.4,transcript,7180.0
ACADSB,ENSG00000196177,protein measurement,EFO_0004747,0.347024485848063,3.4702916804401287,1,0.4,0.4,transcript,8543.0
APOBEC3H,ENSG00000100298,level of serum globulin type protein,OBA_2045206,0.3470196554052067,3.47027313839057,1,0.4,0.4,transcript,5223.0
DLC1,ENSG00000164741,sitting height measurement,EFO_0011011,0.3470115146109167,3.4701268252822817,1,0.4,0.4,transcript,34249.0
CTBP2,ENSG00000175029,refractive error,MONDO_0004892,0.34696803985643876,3.469694461778535,1,0.4,0.4,transcript,28443.0
DGKH,ENSG00000102780,alkaline phosphatase measurement,EFO_0004533,0.3469561300057092,3.4695886930958357,2,0.8,1.6,transcript,58409.0
NEDD1,ENSG00000139350,mathematical ability,EFO_0004875,0.3469486841220686,3.469506097912386,1,0.4,0.4,transcript,20772.0
CYSLTR1,ENSG00000173198,Alzheimer disease,MONDO_0004975,0.3469280729470256,3.469470866130981,2,0.8,1.6,transcript,8415.0
LAMA1,ENSG00000101680,high density lipoprotein cholesterol measurement,EFO_0004612,0.34691247597134894,3.4691406549322075,1,0.5,0.5,transcript,31456.0
BIRC6,ENSG00000115760,11beta-hydroxyandrosterone glucuronide measurement,EFO_0800573,0.3469109477192268,3.4691166594492207,1,0.5,0.5,transcript,69616.0
BACH1,ENSG00000156273,serum alanine aminotransferase measurement,EFO_0004735,0.3469050946406742,3.469408808182631,4,1.6,6.4,transcript,17884.0
ATG16L1,ENSG00000085978,psoriasis,EFO_0000676,0.34689640820735207,3.4689760735595656,1,0.4,0.4,transcript,33357.0
NRK,ENSG00000123572,body weights and measures,EFO_0004324,0.3468959115043732,3.468984332544678,1,0.4,0.4,transcript,15862.0
ATP8A1,ENSG00000124406,growth differentiation factor 15 amount,OBA_2050135,0.3468938131033414,3.4691158939976114,4,1.6,6.4,transcript,36003.0
FAM8A1,ENSG00000137414,Intrahepatic cholestasis of pregnancy,EFO_0009048,0.3468543297233672,3.4685625391039823,1,0.4,0.4,transcript,20788.0
ZNF534,ENSG00000198633,erythrocyte volume,OBA_0003460,0.34684805498404414,3.4685266115631497,1,0.5,0.5,transcript,10855.0
HACD4,ENSG00000188921,cytokine measurement,EFO_0004873,0.3467611892370311,3.467654431985327,1,0.4,0.4,transcript,9403.0
PDHX,ENSG00000110435,HbA1c measurement,EFO_0004541,0.3467486026916642,3.4675307946838494,1,0.4,0.4,transcript,8935.0
TGFBR1,ENSG00000106799,age of onset of myopia,OBA_2001030,0.34674068048232437,3.4674110524153896,1,0.4,0.4,transcript,94171.0
TSPAN3,ENSG00000140391,inflammatory bowel disease,EFO_0003767,0.34668294559286533,3.466851366533386,1,0.4,0.4,transcript,18256.0
STARD13,ENSG00000133121,nervous system benign neoplasm,MONDO_0000648,0.34666034096280557,3.466618226089144,1,0.4,0.4,transcript,26997.0
LATS1,ENSG00000131023,hippocampal CA1 volume,EFO_0009394,0.346653860149456,3.4665559580857255,1,0.4,0.4,transcript,23046.0
ZBTB21,ENSG00000173276,rheumatoid arthritis,EFO_0000685,0.34664010468362805,3.466415348895777,1,0.4,0.4,transcript,27968.0
CTBP2,ENSG00000175029,Abnormality of refraction,HP_0000539,0.3466394623329278,3.4664086865434256,1,0.4,0.4,transcript,28443.0
CADPS,ENSG00000163618,Abnormal mastoid morphology,HP_0000264,0.3466347018192622,3.4663563359032605,1,0.4,0.4,transcript,42929.0
CADPS,ENSG00000163618,middle ear disorder,MONDO_0003276,0.3466347018192622,3.4663563359032605,1,0.4,0.4,transcript,42929.0
NBAS,ENSG00000151779,retinal layer thickness,OBA_2050110,0.3466347018192622,3.466380563982625,2,1.0,2.0,transcript,59620.0
TMEM170B,ENSG00000205269,cup-to-disc ratio measurement,EFO_0006939,0.34661874698160916,3.4662324591311293,1,0.4,0.4,transcript,8891.0
TWSG1,ENSG00000128791,Abruptio Placentae,EFO_1001754,0.34659198022323506,3.4659755125387575,1,0.4,0.4,transcript,7180.0
QSOX1,ENSG00000116260,protein measurement,EFO_0004747,0.34658156971912313,3.465844760622169,1,0.4,0.4,transcript,13763.0
TTL,ENSG00000114999,educational attainment,EFO_0011015,0.34657077257119995,3.4657274944181378,1,0.4,0.4,transcript,20234.0
ZNF682,ENSG00000197124,total cholesterol in IDL,EFO_0022184,0.34655905671876963,3.4656165412136706,1,0.5,0.5,transcript,19250.0
ZNF682,ENSG00000197124,VLDL particle size,OBA_2050114,0.34655905671876963,3.4656165412136706,1,0.5,0.5,transcript,19250.0
ZNF682,ENSG00000197124,total lipids in IDL,EFO_0022161,0.34655905671876963,3.4656165412136706,1,0.5,0.5,transcript,19250.0
DNAH14,ENSG00000185842,erythrocyte volume,OBA_0003460,0.34655720756554387,3.465630054138979,3,1.5,4.5,transcript,77615.0
GPR180,ENSG00000152749,"alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase measurement",EFO_0801370,0.34652457863289915,3.4652908110926117,1,0.4,0.4,transcript,8884.0
SYT13,ENSG00000019505,systolic blood pressure,EFO_0006335,0.34651656858044655,3.4653809710574257,2,0.8,1.6,transcript,7432.0
TMCC1,ENSG00000172765,prostate carcinoma,EFO_0001663,0.3464286262633597,3.4642964641128113,1,0.4,0.4,transcript,39210.0
ATG16L1,ENSG00000085978,ulcerative colitis,EFO_0000729,0.34641307827534834,3.4641427742395283,1,0.4,0.4,transcript,33357.0
CA8,ENSG00000178538,insomnia,EFO_0004698,0.3464065300423896,3.4641062546575396,1,0.4,0.4,transcript,9767.0
GLB1,ENSG00000170266,Inhalant adrenergic use measurement,EFO_0009941,0.34640104716951403,3.464041379774512,1,0.5,0.5,transcript,16177.0
CEP68,ENSG00000011523,prothrombin time measurement,EFO_0008390,0.346369266003803,3.463729427146992,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,prothrombin time measurement,EFO_0008390,0.346369266003803,3.463729427146992,3,1.5,4.5,transcript,122392.0
CEP68,ENSG00000011523,prothrombin time measurement,EFO_0008390,0.346369266003803,3.463729427146992,3,1.5,4.5,gene_variant,122392.0
CEP68,ENSG00000011523,prothrombin time measurement,EFO_0008390,0.346369266003803,3.463729427146992,3,1.5,4.5,gene_variant,122392.0
SGCD,ENSG00000170624,coronary artery disease,EFO_0001645,0.3463583877877844,3.4636026669238302,1,0.4,0.4,transcript,21289.0
ELMOD1,ENSG00000110675,obesity,EFO_0001073,0.34635327981126574,3.4635731613820826,1,0.4,0.4,transcript,9910.0
DMAC1,ENSG00000137038,vital capacity,EFO_0004312,0.34632823733572016,3.4633979468908622,1,0.4,0.4,transcript,3461.0
SYT13,ENSG00000019505,arachidonic acid measurement,EFO_0006808,0.34632375898488477,3.4634528751018077,2,0.8,1.6,transcript,7432.0
NMRK1,ENSG00000106733,3-methylcytidine measurement,EFO_0800633,0.34628424504493605,3.462888422176748,1,0.4,0.4,transcript,8701.0
GSAP,ENSG00000186088,metabolic syndrome,EFO_0000195,0.346276180198282,3.4627873160921228,1,0.5,0.5,transcript,19597.0
SMAD2,ENSG00000175387,blood urea nitrogen measurement,EFO_0004741,0.34624744969797827,3.4629682940352895,9,3.6,32.4,transcript,65614.0
RPAP3,ENSG00000005175,lymphocyte count,EFO_0004587,0.34623786043432786,3.4625269722958008,2,0.8,1.6,transcript,10784.0
PF4V1,ENSG00000109272,blood protein measurement,EFO_0007937,0.346216671732094,3.462705075329015,1,0.4,0.4,transcript,743.0
ITGA8,ENSG00000077943,amygdala volume,OBA_2050034,0.3461887705553122,3.4623524615562205,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
ZDHHC21,ENSG00000175893,educational attainment,EFO_0011015,0.3461853389148731,3.462200969662498,4,1.6,6.4,transcript,18413.0
QSOX1,ENSG00000116260,monocyte percentage of leukocytes,EFO_0007989,0.346088241631253,3.460911479743468,1,0.4,0.4,transcript,13763.0
GSAP,ENSG00000186088,type 2 diabetes mellitus,MONDO_0005148,0.3460587387052862,3.4606129011621647,1,0.5,0.5,transcript,19597.0
NDUFAF2,ENSG00000164182,intelligence,EFO_0004337,0.3459931228343245,3.459971433388978,1,0.4,0.4,transcript,9949.0
ARHGAP28,ENSG00000088756,asparaginase hypersensitivity,EFO_0004881,0.34599025442818954,3.4599148459180133,1,0.4,0.4,transcript,32516.0
DGKH,ENSG00000102780,bladder calculus,EFO_1000839,0.34597697360884494,3.4597971291271934,2,0.8,1.6,transcript,58409.0
CERKL,ENSG00000188452,Stargardt disease,MONDO_0019353,0.3459678084131792,3.4596981580036403,1,0.5,0.5,transcript,24908.0
CTBP2,ENSG00000175029,potassium measurement,EFO_0009283,0.34593728428734416,3.459386906087589,1,0.4,0.4,transcript,28443.0
CHL1,ENSG00000134121,triglyceride measurement,EFO_0004530,0.34593365660241804,3.459383766448984,2,0.8,1.6,transcript,33898.0
OTULIN,ENSG00000154124,glucose measurement,EFO_0004468,0.34589811216859917,3.4590003561541587,1,0.4,0.4,transcript,20796.0
METTL25,ENSG00000127720,injury,EFO_0000546,0.34588025598017436,3.4588545078536916,1,0.5,0.5,transcript,9625.0
DMRTA1,ENSG00000176399,growth differentiation factor 15 amount,OBA_2050135,0.34588025598017436,3.458874167392148,1,0.4,0.4,transcript,5586.0
GALC,ENSG00000054983,protein measurement,EFO_0004747,0.3458646039753005,3.458718932691502,2,0.8,1.6,transcript,21950.0
EPHA5,ENSG00000145242,smoking initiation,EFO_0005670,0.34580871751655573,3.4580978998887257,1,0.4,0.4,transcript,37297.0
ITGB8,ENSG00000105855,body height,OBA_VT0001253,0.34580689700522566,3.458239497265558,3,1.2000000000000002,3.6000000000000005,transcript,21111.0
ATP9A,ENSG00000054793,Visual field defect,HP_0001123,0.3457823611488073,3.4578489777129446,1,0.4,0.4,transcript,15769.0
PKP2,ENSG00000057294,arrhythmogenic right ventricular dysplasia 1,MONDO_0007152,0.34576248627168765,3.457780964085203,4,1.6,6.4,transcript,40999.0
MGA,ENSG00000174197,HbA1c measurement,EFO_0004541,0.3457139499402114,3.4571454211871764,1,0.5,0.5,transcript,84434.0
FLRT2,ENSG00000185070,systolic blood pressure,EFO_0006335,0.3456616539936997,3.456952058707218,7,2.8000000000000003,19.6,transcript,58417.0
HS6ST3,ENSG00000185352,trait in response to tamoxifen,OBA_2040069,0.345602040345297,3.456067263809109,1,0.4,0.4,transcript,8536.0
METTL25,ENSG00000127720,triacylglycerol 48:1 measurement,EFO_0010404,0.3455784511568218,3.455836459620166,1,0.5,0.5,transcript,9625.0
CD86,ENSG00000114013,level of serum globulin type protein,OBA_2045206,0.3455690841936522,3.455722676397326,1,0.4,0.4,transcript,12565.0
FMN1,ENSG00000248905,high density lipoprotein cholesterol measurement,EFO_0004612,0.3455666848128507,3.4557025456809933,2,0.8,1.6,transcript,44821.0
LIN9,ENSG00000183814,neutrophil count,EFO_0004833,0.3455578968368047,3.455683803907295,2,0.8,1.6,transcript,15262.0
WBP2NL,ENSG00000183066,serum creatinine amount,OBA_2050096,0.3455075554292515,3.455117709254154,1,0.5,0.5,transcript,11861.0
SP4,ENSG00000105866,intelligence,EFO_0004337,0.34547593111420555,3.454783303464512,1,0.4,0.4,transcript,16672.0
ATP9A,ENSG00000054793,deep vein thrombosis,EFO_0003907,0.34542378374498656,3.454263203674737,1,0.4,0.4,transcript,15769.0
LINGO2,ENSG00000174482,arterial stiffness measurement,EFO_0004517,0.34539247904711656,3.4539365093356076,1,0.4,0.4,transcript,34133.0
CD86,ENSG00000114013,eosinophil percentage of leukocytes,EFO_0007991,0.3453301886577104,3.4533337210379083,1,0.4,0.4,transcript,12565.0
TENM4,ENSG00000149256,mathematical ability,EFO_0004875,0.3453180961889078,3.453198412373329,1,0.4,0.4,transcript,22922.0
SKP2,ENSG00000145604,eosinophil count,EFO_0004842,0.3453048905541656,3.4530539283956414,1,0.4,0.4,transcript,79636.0
RCOR3,ENSG00000117625,self reported educational attainment,EFO_0004784,0.3453045399489991,3.4531097547309213,2,0.8,1.6,transcript,24862.0
LONRF1,ENSG00000154359,neuroticism measurement,EFO_0007660,0.3453041959709411,3.4530772529966276,1,0.5,0.5,transcript,14167.0
PARP11,ENSG00000111224,platelet crit,EFO_0007985,0.3452910752559151,3.452928701046991,1,0.4,0.4,transcript,22286.0
CNTN1,ENSG00000018236,iminodiacetate (IDA) measurement,EFO_0800945,0.3452697391374802,3.4527139182516353,1,0.4,0.4,transcript,24203.0
QSER1,ENSG00000060749,sitting height measurement,EFO_0011011,0.3452409389246132,3.4524360644488636,1,0.5,0.5,transcript,18744.0
RASGRP3,ENSG00000152689,hip geometry,EFO_0004685,0.3452199067129876,3.452210270042633,1,0.4,0.4,transcript,35705.0
DYNC2H1,ENSG00000187240,matrix metalloproteinase 12 measurement,EFO_0010590,0.345202698164192,3.4520371380506143,1,0.5,0.5,transcript,49230.0
SOS1,ENSG00000115904,acute myeloid leukemia,EFO_0000222,0.34519265797738813,3.451950187647107,2,0.8,1.6,transcript,67774.0
GSAP,ENSG00000186088,hemoglobin A1 measurement,EFO_0007629,0.34518772922467017,3.451902806356004,1,0.5,0.5,transcript,19597.0
CCDC88C,ENSG00000015133,luminal A breast carcinoma,MONDO_0021116,0.3451756140970815,3.4517754637088465,1,0.4,0.4,transcript,20701.0
CA8,ENSG00000178538,skin disease,EFO_0000701,0.34516877996024575,3.4517287538361017,1,0.4,0.4,transcript,9767.0
DCDC2,ENSG00000146038,platelet count,EFO_0004309,0.34513196260376766,3.4513654031033667,1,0.4,0.4,transcript,8738.0
TTL,ENSG00000114999,social inhibition quality,OBA_1000278,0.3451111855760697,3.4511316244668353,1,0.4,0.4,transcript,20234.0
TTL,ENSG00000114999,nicotine dependence,EFO_0003768,0.3451111855760697,3.4511316244668353,1,0.4,0.4,transcript,20234.0
TTL,ENSG00000114999,attention deficit hyperactivity disorder,EFO_0003888,0.3451111855760697,3.4511316244668353,1,0.4,0.4,transcript,20234.0
TTL,ENSG00000114999,substance abuse,MONDO_0002491,0.3451111855760697,3.4511316244668353,1,0.4,0.4,transcript,20234.0
FIGNL1,ENSG00000132436,blood urea nitrogen measurement,EFO_0004741,0.3451009476215558,3.4510256587545984,1,0.4,0.4,transcript,24718.0
DMAC1,ENSG00000137038,duodenitis,MONDO_0004627,0.3450964866612833,3.4510804401464936,1,0.4,0.4,transcript,3461.0
TRPC6,ENSG00000137672,preeclampsia,EFO_0000668,0.34509038798358255,3.45093276695939,1,0.4,0.4,transcript,13847.0
TC2N,ENSG00000165929,body height,OBA_VT0001253,0.3450808496853748,3.450831261636629,1,0.4,0.4,transcript,17571.0
APIP,ENSG00000149089,serum gamma-glutamyl transferase measurement,EFO_0004532,0.34506304664650456,3.450703236076456,1,0.5,0.5,transcript,6871.0
ROCK2,ENSG00000134318,glaucoma,MONDO_0005041,0.34505436200943074,3.450554613696031,1,0.5,0.5,transcript,45481.0
ZNF681,ENSG00000196172,low density lipoprotein cholesterol measurement,EFO_0004611,0.3450259912257311,3.450808860107265,3,1.4000000000000001,4.2,transcript,7651.0
TTLL7,ENSG00000137941,autism spectrum disorder,EFO_0003756,0.3449943703829931,3.4499726772649124,2,0.8,1.6,transcript,55223.0
DNAH14,ENSG00000185842,mean corpuscular hemoglobin concentration,EFO_0004528,0.34496804681546306,3.449738446638171,3,1.5,4.5,transcript,77615.0
RASGRP3,ENSG00000152689,blood protein measurement,EFO_0007937,0.3449616322917839,3.4496275258305964,1,0.4,0.4,transcript,35705.0
BHLHE41,ENSG00000123095,systolic blood pressure,EFO_0006335,0.34490486985655033,3.449136979298234,1,0.4,0.4,transcript,4531.0
DLGAP1,ENSG00000170579,arterial stiffness measurement,EFO_0004517,0.3449034824046405,3.4490629781903435,2,0.8,1.6,transcript,56830.0
SEMA3C,ENSG00000075223,CCL24 measurement,EFO_0009418,0.344885412594978,3.4488878442335196,1,0.4,0.4,transcript,11863.0
DMAC1,ENSG00000137038,high density lipoprotein cholesterol measurement,EFO_0004612,0.344885412594978,3.448969699483441,1,0.4,0.4,transcript,3461.0
RGS7BP,ENSG00000186479,pulse pressure measurement,EFO_0005763,0.34488513975138047,3.448939518768651,1,0.5,0.5,transcript,5674.0
SLF1,ENSG00000133302,smoking initiation,EFO_0005670,0.3448780309981299,3.4488152231348295,1,0.4,0.4,transcript,11457.0
TTL,ENSG00000114999,smoking behavior trait,OBA_2050116,0.34486671476258085,3.4486869163319467,1,0.4,0.4,transcript,20234.0
LRPAP1,ENSG00000163956,concentration of large LDL particles measurement,EFO_0022160,0.3448458729916339,3.4486893660877787,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
PTPN4,ENSG00000088179,erythrocyte volume,OBA_0003460,0.3448425220503726,3.4488888273651073,5,2.0,10.0,transcript,21570.0
CNTN5,ENSG00000149972,multinodular goiter,MONDO_0000334,0.3448417940271541,3.4484309209627626,1,0.4,0.4,transcript,30815.0
CNTNAP2,ENSG00000174469,gastroesophageal reflux disease,EFO_0003948,0.3447908879222084,3.4479165608936158,1,0.4,0.4,transcript,52072.0
CNTNAP2,ENSG00000174469,Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement,EFO_0009923,0.3447908879222084,3.4479165608936158,1,0.4,0.4,transcript,52072.0
CNTNAP2,ENSG00000174469,peptic ulcer disease,MONDO_0004247,0.3447908879222084,3.4479165608936158,1,0.4,0.4,transcript,52072.0
IREB2,ENSG00000136381,diastolic blood pressure,EFO_0006336,0.34475907332754324,3.447690589039329,2,0.9,1.8,transcript,18026.0
STT3B,ENSG00000163527,trauma complication,EFO_0009888,0.3447193535641973,3.4472132585353212,1,0.4,0.4,transcript,20281.0
ALPK3,ENSG00000136383,electrocardiography,EFO_0004327,0.34471123558944733,3.447149651931769,1,0.4,0.4,transcript,10725.0
GSAP,ENSG00000186088,body fat percentage,EFO_0007800,0.3446971993766517,3.4469975078758197,1,0.5,0.5,transcript,19597.0
GPAT3,ENSG00000138678,metabolite measurement,EFO_0004725,0.34468886849297026,3.4470358113664843,2,0.8,1.6,transcript,10875.0
RNF144B,ENSG00000137393,total cholesterol measurement,EFO_0004574,0.34468886849297026,3.4469615579484674,1,0.4,0.4,transcript,5489.0
RPS6KA5,ENSG00000100784,heart rate,OBA_1001087,0.3446242649621671,3.446252514473205,1,0.4,0.4,transcript,40548.0
DLG2,ENSG00000150672,urate measurement,EFO_0004531,0.3445979366018247,3.445982138943406,1,0.4,0.4,transcript,144252.0
CNTN5,ENSG00000149972,basal cell carcinoma,EFO_0004193,0.3445979366018247,3.445992346709469,1,0.4,0.4,transcript,30815.0
COLEC10,ENSG00000184374,tumor necrosis factor ligand superfamily member 11 measurement,EFO_0010617,0.3445731464259714,3.4458366443806714,1,0.4,0.4,transcript,3803.0
SENP6,ENSG00000112701,alcohol consumption quality,OBA_1000840,0.344570681782999,3.446135834990676,5,2.2,11.0,transcript,25640.0
MYO1B,ENSG00000128641,erythrocyte count,EFO_0004305,0.34451351447781287,3.445148553198617,1,0.4,0.4,transcript,29832.0
PLEC,ENSG00000178209,low density lipoprotein cholesterol measurement,EFO_0004611,0.34450017863202614,3.4450108505859047,2,0.9,1.8,transcript,198582.0
KLF10,ENSG00000155090,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.3444647793805532,3.444708639561541,1,0.4,0.4,transcript,6574.0
SP4,ENSG00000105866,mean corpuscular hemoglobin concentration,EFO_0004528,0.344464295552029,3.4446669478427467,1,0.4,0.4,transcript,16672.0
TCERG1L,ENSG00000176769,metabolite measurement,EFO_0004725,0.3444538657106305,3.444766837368712,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,metabolite measurement,EFO_0004725,0.3444538657106305,3.444766837368712,2,0.8,1.6,gene_variant,7012.0
DIRAS2,ENSG00000165023,bone neoplasm,EFO_0003820,0.3444538657106305,3.4446149056766444,1,0.4,0.4,transcript,5246.0
TCERG1L,ENSG00000176769,metabolite measurement,EFO_0004725,0.3444538657106305,3.444766837368712,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,metabolite measurement,EFO_0004725,0.3444538657106305,3.444766837368712,2,0.8,1.6,transcript,7012.0
DIRAS2,ENSG00000165023,connective tissue neoplasm,MONDO_0021581,0.3444538657106305,3.4446149056766444,1,0.4,0.4,transcript,5246.0
CYBRD1,ENSG00000071967,luminal A breast carcinoma,MONDO_0021116,0.34445029478661704,3.444537057186542,1,0.4,0.4,transcript,11727.0
BMERB1,ENSG00000166780,total cholesterol measurement,EFO_0004574,0.34444269316283477,3.44446320622706,1,0.4,0.4,transcript,11027.0
STXBP5,ENSG00000164506,protein measurement,EFO_0004747,0.34440471247853705,3.4440609551938284,2,0.9,1.8,transcript,130148.0
MATN2,ENSG00000132561,trait in response to apixaban,OBA_2050328,0.3443856805880501,3.4438737613554236,1,0.5,0.5,transcript,29489.0
ZNF507,ENSG00000168813,cognitive function measurement,EFO_0008354,0.3443617358642093,3.443631757490185,1,0.4,0.4,transcript,27780.0
ZNF507,ENSG00000168813,neuroticism measurement,EFO_0007660,0.3443617358642093,3.443631757490185,1,0.4,0.4,transcript,27780.0
LMO4,ENSG00000143013,pulse wave reflection index measurement,EFO_0009804,0.3443213826384205,3.4432653064356846,1,0.4,0.4,transcript,7770.0
GRIA4,ENSG00000152578,level of stromelysin-1 in blood serum,OBA_2042390,0.3443213826384205,3.443223117905691,1,0.4,0.4,transcript,43050.0
FRMD4B,ENSG00000114541,body mass index,EFO_0004340,0.3443204890298901,3.443280986560672,2,0.8,1.6,transcript,21026.0
TCERG1L,ENSG00000176769,educational attainment,EFO_0011015,0.3442835141063396,3.4430633213258033,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,educational attainment,EFO_0011015,0.3442835141063396,3.4430633213258033,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,educational attainment,EFO_0011015,0.3442835141063396,3.4430633213258033,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,educational attainment,EFO_0011015,0.3442835141063396,3.4430633213258033,2,0.8,1.6,gene_variant,7012.0
LINS1,ENSG00000140471,Intellectual disability,HP_0001249,0.34428226762314007,3.4428499643392434,1,0.5,0.5,transcript,18323.0
SEMA3A,ENSG00000075213,lymphocyte count,EFO_0004587,0.34426926604009656,3.442722865037377,1,0.4,0.4,transcript,13243.0
ONECUT2,ENSG00000119547,testosterone measurement,EFO_0004908,0.34426898708930054,3.4438516966191464,7,2.8000000000000003,19.6,transcript,16870.0
FZD3,ENSG00000104290,neurodegenerative disease,EFO_0005772,0.34425613681510164,3.442575484967674,1,0.4,0.4,transcript,28335.0
HS6ST3,ENSG00000185352,hip circumference,OBA_1000032,0.3442233557522909,3.4422804178790476,1,0.4,0.4,transcript,8536.0
NEDD4,ENSG00000069869,retinal vasculature measurement,EFO_0010554,0.34418051498590274,3.441813459820594,1,0.4,0.4,transcript,48135.0
ANO5,ENSG00000171714,creatine kinase m-type:creatine kinase b-type heterodimer measurement,EFO_0020292,0.3441801502163061,3.4418065485265257,1,0.4,0.4,transcript,79265.0
UBL3,ENSG00000122042,butyrobetaine measurement,EFO_0801118,0.34415192903290237,3.4423532027682175,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
FYB1,ENSG00000082074,erythrocyte volume,OBA_0003460,0.344117182949463,3.441191479720607,1,0.5,0.5,transcript,25445.0
ANOS1,ENSG00000011201,Micropenis,HP_0000054,0.3440942438720692,3.44099394528778,1,0.4,0.4,transcript,7766.0
CERKL,ENSG00000188452,lymphocyte count,EFO_0004587,0.3440773427739672,3.44079350161152,1,0.5,0.5,transcript,24908.0
SLC35F5,ENSG00000115084,body height,OBA_VT0001253,0.34407581984644436,3.440828957353529,2,0.8,1.6,transcript,22612.0
DLG2,ENSG00000150672,protein measurement,EFO_0004747,0.34402890530096497,3.4402918259348088,1,0.4,0.4,transcript,144252.0
UMPS,ENSG00000114491,hematocrit,EFO_0004348,0.343988870698585,3.439907563347515,1,0.4,0.4,transcript,21213.0
ZNF485,ENSG00000198298,neurodegenerative disease,EFO_0005772,0.34398607697539124,3.439958102827691,1,0.5,0.5,transcript,5137.0
PTCHD4,ENSG00000244694,erythrocyte count,EFO_0004305,0.34397866718942244,3.440200512565566,6,2.4000000000000004,14.400000000000002,transcript,34796.0
MGA,ENSG00000174197,prostate adenocarcinoma,EFO_0000673,0.3439632262290151,3.4396381840752137,1,0.5,0.5,transcript,84434.0
DAG1,ENSG00000173402,erythrocyte volume,OBA_0003460,0.3439081366126348,3.43908755424516,1,0.4,0.4,transcript,64640.0
PPDPFL,ENSG00000168333,lysine-to-glutaroyl carnitine ratio,EFO_0021390,0.3439036040734904,3.439361442402588,2,0.8,1.6,transcript,4917.0
USP37,ENSG00000135913,intermediate density lipoprotein measurement,EFO_0008595,0.34389469647145837,3.439086591600516,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
YIPF4,ENSG00000119820,heart rate,OBA_1001087,0.3438931856213255,3.43905003333121,2,0.8,1.6,transcript,13539.0
RNF144B,ENSG00000137393,serum creatinine amount,OBA_2050096,0.3438843898230999,3.4389167712497635,1,0.4,0.4,transcript,5489.0
FREM2,ENSG00000150893,cryptophthalmia,MONDO_0020153,0.34388186020279393,3.439709708782529,6,2.5,15.0,transcript,16833.0
PKD2L2,ENSG00000078795,potassium measurement,EFO_0009283,0.3438731409815588,3.438770786095317,1,0.5,0.5,transcript,12698.0
ITGA8,ENSG00000077943,hypertension,EFO_0000537,0.3438640372907516,3.4391051289106143,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
DYNC2H1,ENSG00000187240,short rib-polydactyly syndrome,MONDO_0015461,0.3438372010079953,3.438382166488647,1,0.5,0.5,transcript,49230.0
ATRNL1,ENSG00000107518,benign chondrogenic neoplasm,MONDO_0024470,0.34379314802928285,3.437948339434698,1,0.4,0.4,transcript,23726.0
ATRNL1,ENSG00000107518,systolic blood pressure,EFO_0006335,0.3437704250610127,3.4377211097519966,1,0.4,0.4,transcript,23726.0
CYTIP,ENSG00000115165,high density lipoprotein cholesterol measurement,EFO_0004612,0.34376649943661697,3.4376927817923595,1,0.4,0.4,gene_variant,14395.0
TMEM132B,ENSG00000139364,palmitoyl sphingomyelin (d18:1/16:0) measurement,EFO_0800300,0.34372133742253547,3.4373027375119376,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
SNTG2,ENSG00000172554,N-acetylalanine measurement,EFO_0800118,0.34372133742253547,3.4372632644668233,1,0.5,0.5,transcript,10022.0
ALPK3,ENSG00000136383,QT interval,EFO_0004682,0.34368565263426487,3.4368938223799446,1,0.4,0.4,transcript,10725.0
QSOX1,ENSG00000116260,knee fracture,EFO_0009617,0.3436669520874458,3.436698584305396,1,0.4,0.4,transcript,13763.0
TTLL7,ENSG00000137941,obesity,EFO_0001073,0.34366630605150583,3.43669203395004,2,0.8,1.6,transcript,55223.0
CENPC,ENSG00000145241,lymphocyte count,EFO_0004587,0.3436567686200352,3.4367664933574096,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
SEMA3A,ENSG00000075213,platelet count,EFO_0004309,0.3436233821572547,3.4362640262089585,1,0.4,0.4,transcript,13243.0
TRDN,ENSG00000186439,vital capacity,EFO_0004312,0.34360111468152515,3.4360303502565084,1,0.5,0.5,transcript,26037.0
RNF150,ENSG00000170153,blood urea nitrogen measurement,EFO_0004741,0.34360111468152515,3.4362698058299226,4,1.6,6.4,transcript,24743.0
FSIP2,ENSG00000188738,HbA1c measurement,EFO_0004541,0.34358891490967725,3.4361680891246666,4,2.0,8.0,transcript,28680.0
CAV2,ENSG00000105971,response to xenobiotic stimulus,GO_0009410,0.34358503085470515,3.4358744821132565,1,0.4,0.4,transcript,16547.0
ARHGAP28,ENSG00000088756,heart rate,OBA_1001087,0.34358152732425923,3.43582757487871,1,0.4,0.4,transcript,32516.0
NBAS,ENSG00000151779,low density lipoprotein cholesterol measurement,EFO_0004611,0.34356792476095416,3.435712793399545,2,1.0,2.0,transcript,59620.0
ZNF507,ENSG00000168813,high density lipoprotein cholesterol measurement,EFO_0004612,0.3435631370159773,3.435645769007865,1,0.4,0.4,transcript,27780.0
DPP8,ENSG00000074603,bone tissue density,OBA_1000110,0.3435135692686775,3.435317412781042,4,1.6,6.4,transcript,35219.0
COL24A1,ENSG00000171502,diastolic blood pressure change measurement,EFO_0006945,0.3435038698019102,3.435063094213296,1,0.4,0.4,transcript,16396.0
TRDN,ENSG00000186439,amyotrophic lateral sclerosis,MONDO_0004976,0.34349589456331714,3.434978149074428,1,0.5,0.5,transcript,26037.0
TMEM132B,ENSG00000139364,major depressive disorder,MONDO_0002009,0.34346397928989153,3.4347291561854982,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
SYNJ2,ENSG00000078269,neurodegenerative disease,EFO_0005772,0.34345039770987257,3.434555124723558,2,0.8,1.6,transcript,31282.0
RAPGEF4,ENSG00000091428,schizophrenia,MONDO_0005090,0.34343944033379786,3.4344075894266552,1,0.4,0.4,transcript,30335.0
PLEC,ENSG00000178209,total lipids in medium LDL,EFO_0022180,0.34342548986105037,3.434263962876147,2,0.9,1.8,transcript,198582.0
DCDC2,ENSG00000146038,systolic blood pressure,EFO_0006335,0.3434141050668116,3.434186827733806,1,0.4,0.4,transcript,8738.0
TMEM132B,ENSG00000139364,smoking status measurement,EFO_0006527,0.3433883029727864,3.433972393014447,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
TMEM132B,ENSG00000139364,risk-taking behaviour,EFO_0008579,0.3433883029727864,3.433972393014447,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
RASGRP3,ENSG00000152689,puberty onset measurement,EFO_0005677,0.3433527005288024,3.4335382082007815,1,0.4,0.4,transcript,35705.0
DCLK1,ENSG00000133083,neurodegenerative disease,EFO_0005772,0.3432810862215481,3.432861059868741,2,0.8,1.6,transcript,31874.0
GALR1,ENSG00000166573,total cholesterol measurement,EFO_0004574,0.34324892764374637,3.4326338895972612,2,0.8,1.6,transcript,11064.0
TMEM17,ENSG00000186889,EH domain-binding protein 1 measurement,EFO_0801561,0.34324452309633974,3.4325092309633973,1,0.4,0.4,transcript,6250.0
MCL1,ENSG00000143384,induced myeloid leukemia cell differentiation protein Mcl-1 measurement,EFO_0021910,0.3432125110055817,3.4321418794349308,1,0.4,0.4,transcript,23853.0
ZFP90,ENSG00000184939,Red cell distribution width,EFO_0009188,0.34320459234425715,3.4320592785893114,1,0.4,0.4,transcript,29951.0
PLXNA4,ENSG00000221866,substance abuse,MONDO_0002491,0.343201214643933,3.432024393836758,1,0.4,0.4,transcript,32660.0
PLXNA4,ENSG00000221866,social inhibition quality,OBA_1000278,0.343201214643933,3.432024393836758,1,0.4,0.4,transcript,32660.0
PLXNA4,ENSG00000221866,attention deficit hyperactivity disorder,EFO_0003888,0.343201214643933,3.432024393836758,1,0.4,0.4,transcript,32660.0
KCNN3,ENSG00000143603,monocyte count,EFO_0005091,0.3431927778913995,3.4320468147239347,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
FAM210A,ENSG00000177150,ovarian dysfunction,EFO_0009003,0.343154884756981,3.431570993511566,1,0.4,0.4,transcript,18062.0
BIRC6,ENSG00000115760,lymphocyte count,EFO_0004587,0.3431536506220292,3.431543688477244,1,0.5,0.5,transcript,69616.0
ATP10D,ENSG00000145246,serum metabolite measurement,EFO_0005653,0.3431210437389118,3.4312422601997086,1,0.5,0.5,transcript,15712.0
ARHGAP29,ENSG00000137962,myeloid leukocyte count,OBA_2045223,0.34311373301383635,3.431157555857388,1,0.5,0.5,transcript,24721.0
GRIA4,ENSG00000152578,cocaine dependence,EFO_0002610,0.3431029360022049,3.431038651543535,1,0.4,0.4,transcript,43050.0
PF4V1,ENSG00000109272,"neuroligin-4, x-linked measurement",EFO_0020601,0.343100824260966,3.431546600617735,1,0.4,0.4,transcript,743.0
CYSLTR1,ENSG00000173198,Bronchiolitis,HP_0011950,0.343072766218149,3.4309177988422146,2,0.8,1.6,transcript,8415.0
LIN54,ENSG00000189308,pulse pressure measurement,EFO_0005763,0.34301002617805193,3.430113188357562,1,0.4,0.4,transcript,30944.0
DCLK1,ENSG00000133083,platelet volume,OBA_0003277,0.3429983957487164,3.4300341551404236,2,0.8,1.6,transcript,31874.0
CCDC126,ENSG00000169193,coiled-coil domain-containing protein 126 measurement,EFO_0801482,0.3429629518736504,3.429671981581514,1,0.4,0.4,transcript,9420.0
COL25A1,ENSG00000188517,free androgen index,EFO_0007005,0.3429608635468299,3.429623597129044,1,0.4,0.4,transcript,26735.0
DCLK1,ENSG00000133083,generalized dystonia,MONDO_0000476,0.3429608635468299,3.429658833121559,2,0.8,1.6,transcript,31874.0
SEMA3A,ENSG00000075213,bone tissue density,OBA_1000110,0.3429608635468299,3.429638840104711,1,0.4,0.4,transcript,13243.0
STXBP5,ENSG00000164506,neuroimaging measurement,EFO_0004346,0.3429608635468299,3.4296224658767573,2,0.9,1.8,transcript,130148.0
LRRC7,ENSG00000033122,protozoa infectious disease,MONDO_0002428,0.3429608635468299,3.4296727391738497,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
DLC1,ENSG00000164741,systolic blood pressure,EFO_0006335,0.34294745143771566,3.429486193550271,1,0.4,0.4,transcript,34249.0
STARD13,ENSG00000133121,type 2 diabetes mellitus,MONDO_0005148,0.3429368759324019,3.429383575785107,1,0.4,0.4,transcript,26997.0
FAM98A,ENSG00000119812,brain volume,OBA_2050009,0.34292996067144194,3.4293069599259347,1,0.4,0.4,transcript,54398.0
CR2,ENSG00000117322,protein measurement,EFO_0004747,0.3429109761620947,3.429128087547552,1,0.4,0.4,transcript,21827.0
TRHDE,ENSG00000072657,neuroticism measurement,EFO_0007660,0.34289451409639343,3.429044711565714,2,0.8,1.6,transcript,16069.0
TRHDE,ENSG00000072657,depressive symptom measurement,EFO_0007006,0.34289451409639343,3.429044711565714,2,0.8,1.6,transcript,16069.0
TTLL7,ENSG00000137941,schizophrenia,MONDO_0005090,0.34289026430167346,3.4289316164517167,2,0.8,1.6,transcript,55223.0
RAPGEF4,ENSG00000091428,self reported educational attainment,EFO_0004784,0.3428850705517708,3.4288638916063845,1,0.4,0.4,transcript,30335.0
RAPGEF4,ENSG00000091428,intelligence,EFO_0004337,0.3428850705517708,3.4288638916063845,1,0.4,0.4,transcript,30335.0
DLGAP1,ENSG00000170579,4-acetaminophen sulfate measurement,EFO_0021156,0.3428850705517708,3.428878859661646,2,0.8,1.6,transcript,56830.0
CSMD3,ENSG00000164796,brain connectivity attribute,OBA_2045295,0.3428850705517708,3.428858814239449,1,0.5,0.5,transcript,61662.0
TCERG1L,ENSG00000176769,2-stearoyl-GPE (18:0) measurement,EFO_0800343,0.3428850705517708,3.429078885780115,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,2-stearoyl-GPE (18:0) measurement,EFO_0800343,0.3428850705517708,3.429078885780115,2,0.8,1.6,gene_variant,7012.0
PIP4K2A,ENSG00000150867,sitting height measurement,EFO_0011011,0.3428850705517708,3.4288941507224435,1,0.4,0.4,transcript,9207.0
CFAP54,ENSG00000188596,gut microbiome measurement,EFO_0007874,0.3428850705517708,3.428919337342285,2,1.0,2.0,transcript,29141.0
COL25A1,ENSG00000188517,vaginal microbiome measurement,EFO_0011013,0.3428850705517708,3.4288656671784525,1,0.4,0.4,transcript,26735.0
CLSTN2,ENSG00000158258,serum alanine aminotransferase measurement,EFO_0004735,0.3428850705517708,3.4288747917464066,1,0.4,0.4,transcript,16607.0
TCERG1L,ENSG00000176769,2-stearoyl-GPE (18:0) measurement,EFO_0800343,0.3428850705517708,3.429078885780115,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,2-stearoyl-GPE (18:0) measurement,EFO_0800343,0.3428850705517708,3.429078885780115,2,0.8,1.6,gene_variant,7012.0
STXBP5,ENSG00000164506,protein wnt-7a measurement,EFO_0020689,0.3428850705517708,3.428864535926166,2,0.9,1.8,transcript,130148.0
STXBP5,ENSG00000164506,wellbeing measurement,EFO_0007869,0.3428850705517708,3.428864535926166,2,0.9,1.8,transcript,130148.0
KCNQ3,ENSG00000184156,insomnia,EFO_0004698,0.3428850705517708,3.4289070832485042,2,0.8,1.6,transcript,28380.0
RANBP17,ENSG00000204764,protein measurement,EFO_0004747,0.3428850705517708,3.4288602198129365,1,0.4,0.4,transcript,42042.0
ATRNL1,ENSG00000107518,restless legs syndrome,EFO_0004270,0.3428850705517708,3.4288675646595776,1,0.4,0.4,transcript,23726.0
ABCB1,ENSG00000085563,non-small cell lung carcinoma,EFO_0003060,0.3428166888599013,3.428190936309671,1,0.5,0.5,transcript,20792.0
TENM4,ENSG00000149256,serum alanine aminotransferase measurement,EFO_0004735,0.342807342474902,3.4280908752332713,1,0.4,0.4,transcript,22922.0
MANSC4,ENSG00000205693,diastolic blood pressure,EFO_0006336,0.3428019573015611,3.4283195130276085,1,0.5,0.5,transcript,1667.0
EPRS1,ENSG00000136628,Global developmental delay,HP_0001263,0.3427853152200609,3.4278978669206945,1,0.5,0.5,transcript,11182.0
ANO5,ENSG00000171714,myomesin-2 measurement,EFO_0802771,0.3427821705743785,3.4278267521072494,1,0.4,0.4,transcript,79265.0
DLC1,ENSG00000164741,acne,EFO_0003894,0.3427765076910515,3.4277767560836296,1,0.4,0.4,transcript,34249.0
PIP4K2A,ENSG00000150867,cognitive function measurement,EFO_0008354,0.3427741966724707,3.4277854119294426,1,0.4,0.4,transcript,9207.0
PTK2,ENSG00000169398,brain connectivity attribute,OBA_2045295,0.3427741966724707,3.427746808929363,1,0.4,0.4,transcript,82607.0
ABCB5,ENSG00000004846,Eczematoid dermatitis,HP_0000964,0.34276660045180757,3.427692916985276,1,0.4,0.4,transcript,14863.0
SLC35B4,ENSG00000205060,blood protein measurement,EFO_0007937,0.3427594643537352,3.4276365634702803,1,0.4,0.4,transcript,9542.0
ASTN2,ENSG00000148219,arterial stiffness measurement,EFO_0004517,0.3427418566000122,3.4274773204067026,2,0.8,1.6,transcript,27232.0
UNC80,ENSG00000144406,brain attribute,OBA_2045210,0.34271229248032176,3.4271275868078797,1,0.4,0.4,transcript,85800.0
SEC22A,ENSG00000121542,polycystic ovary syndrome,EFO_0000660,0.3427087426676839,3.4272094616093383,2,0.8,1.6,transcript,13111.0
COL24A1,ENSG00000171502,corneal resistance factor,EFO_0010067,0.3426905372720797,3.4269297689149907,1,0.4,0.4,transcript,16396.0
LRRC7,ENSG00000033122,metabolite measurement,EFO_0004725,0.3426834463231824,3.4268985669373744,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
EPHA5,ENSG00000145242,cerebellar volume measurement,EFO_0020864,0.3426834463231824,3.426845187954992,1,0.4,0.4,transcript,37297.0
CD86,ENSG00000114013,calcium measurement,EFO_0004838,0.3426819648247153,3.426851482707957,1,0.4,0.4,transcript,12565.0
IL17A,ENSG00000112115,temporal arteritis,EFO_1001209,0.34267006315564696,3.4269144209738935,1,0.4,0.4,transcript,1871.0
ABCA13,ENSG00000179869,wellbeing measurement,EFO_0007869,0.34264115908244863,3.4264219226838075,1,0.5,0.5,transcript,48394.0
PRDM5,ENSG00000138738,inflammatory spondylopathy,MONDO_0001434,0.34260388518045015,3.426119460399393,2,0.8,1.6,transcript,19849.0
LAMA1,ENSG00000101680,brain attribute,OBA_2045210,0.34259554910278656,3.4259713862465837,1,0.5,0.5,transcript,31456.0
NXPH2,ENSG00000144227,heart rate,OBA_1001087,0.3425830387762689,3.4259780437242986,1,0.4,0.4,transcript,2709.0
IKZF3,ENSG00000161405,diffuse large B-cell lymphoma,EFO_0000403,0.342581049506199,3.4258182358987743,1,0.4,0.4,transcript,51674.0
SGCZ,ENSG00000185053,intelligence,EFO_0004337,0.3425787846403109,3.425836555609149,1,0.4,0.4,transcript,8212.0
KCNQ3,ENSG00000184156,Neurodevelopmental disorder,EFO_0010642,0.3425661529478579,3.4257179072093753,2,0.8,1.6,transcript,28380.0
ATG16L1,ENSG00000085978,urolithiasis,MONDO_0024647,0.34255086171952637,3.4255206086813086,1,0.4,0.4,transcript,33357.0
KPNA4,ENSG00000186432,total cholesterol measurement,EFO_0004574,0.34254590769976945,3.425468070207821,1,0.4,0.4,transcript,44478.0
NXPH2,ENSG00000144227,bilirubin measurement,EFO_0004570,0.3425276172003526,3.4254238279651354,1,0.4,0.4,transcript,2709.0
PARP8,ENSG00000151883,Abruptio Placentae,EFO_1001754,0.3425276172003526,3.4253232488270173,2,0.8,1.6,transcript,33987.0
GALC,ENSG00000054983,multiple sclerosis,MONDO_0005301,0.3425186837574414,3.4252597305129107,2,0.8,1.6,transcript,21950.0
PARP11,ENSG00000111224,eosinophil count,EFO_0004842,0.34250294486576577,3.4250473971454976,1,0.4,0.4,transcript,22286.0
QSER1,ENSG00000060749,high density lipoprotein cholesterol measurement,EFO_0004612,0.34249829956675326,3.425009670870264,1,0.5,0.5,transcript,18744.0
WAPL,ENSG00000062650,HbA1c measurement,EFO_0004541,0.34248217893553606,3.4249555462522006,2,0.8,1.6,transcript,11962.0
CD69,ENSG00000110848,Hashimoto's thyroiditis,EFO_0003779,0.34247839261038937,3.4256284018252168,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
ATP9A,ENSG00000054793,medical procedure,EFO_0002571,0.3424694523674068,3.4247198898989395,1,0.4,0.4,transcript,15769.0
CP,ENSG00000047457,genetic disorder,EFO_0000508,0.3424580414319269,3.4246014722707514,1,0.5,0.5,transcript,23744.0
CCDC34,ENSG00000109881,cystatin C measurement,EFO_0004617,0.3424286581263247,3.4243801047610263,1,0.4,0.4,transcript,4277.0
AKAP10,ENSG00000108599,cerebral cortex area attribute,OBA_2045267,0.34242589141779023,3.424294094476935,1,0.4,0.4,transcript,11370.0
CFAP299,ENSG00000197826,mean corpuscular hemoglobin concentration,EFO_0004528,0.3423969210688099,3.424034348780856,1,0.5,0.5,transcript,7676.0
PPFIBP2,ENSG00000166387,Abnormality of the integument,HP_0001574,0.3423723499267657,3.4237371821531037,1,0.5,0.5,transcript,36542.0
ZNF257,ENSG00000197134,Uterine leiomyoma,HP_0000131,0.3423254704984294,3.423282287386721,1,0.4,0.4,transcript,14502.0
EPHA5,ENSG00000145242,stroke,EFO_0000712,0.3423251429980301,3.423262154703469,1,0.4,0.4,transcript,37297.0
EPHA5,ENSG00000145242,appendicitis,EFO_0007149,0.3423251429980301,3.423262154703469,1,0.4,0.4,transcript,37297.0
EPHA5,ENSG00000145242,Abdominal Aortic Aneurysm,EFO_0004214,0.3423251429980301,3.423262154703469,1,0.4,0.4,transcript,37297.0
ATAD2B,ENSG00000119778,risk-taking behaviour,EFO_0008579,0.34230979494192426,3.423116127106132,1,0.4,0.4,transcript,22005.0
HEG1,ENSG00000173706,red blood cell density,OBA_2045260,0.34227777094736034,3.4227995757612546,1,0.4,0.4,transcript,18293.0
STARD13,ENSG00000133121,metabolite measurement,EFO_0004725,0.34227263189838575,3.4227411354449457,1,0.4,0.4,transcript,26997.0
FAM174A,ENSG00000174132,bone tissue density,OBA_1000110,0.3422324764013064,3.4224251404246075,1,0.4,0.4,transcript,3985.0
TNPO3,ENSG00000064419,systemic scleroderma,EFO_0000717,0.34220398127403817,3.422066485097151,1,0.5,0.5,transcript,18746.0
SLCO1C1,ENSG00000139155,peak expiratory flow,EFO_0009718,0.3421930783110358,3.4219616740037226,1,0.5,0.5,transcript,16186.0
MAP4K3,ENSG00000011566,placenta praevia,EFO_0007442,0.3421661473694211,3.421684281311955,1,0.4,0.4,transcript,17538.0
ZDHHC21,ENSG00000175893,glucose measurement,EFO_0004468,0.3421587340303853,3.4219349208176206,4,1.6,6.4,transcript,18413.0
GSAP,ENSG00000186088,platelet count,EFO_0004309,0.3421485244218773,3.421510758328076,1,0.5,0.5,transcript,19597.0
FAM98A,ENSG00000119812,body height,OBA_VT0001253,0.342143680705312,3.421444160264635,1,0.4,0.4,transcript,54398.0
CADPS,ENSG00000163618,bone remodeling disease,MONDO_0000833,0.3421235283044852,3.421244600755491,1,0.4,0.4,transcript,42929.0
CIAO2A,ENSG00000166797,lymphocyte count,EFO_0004587,0.3421109041025568,3.421329669817625,2,0.8,1.6,transcript,7252.0
CTBP2,ENSG00000175029,diet measurement,EFO_0008111,0.3420953661798978,3.420967725013125,1,0.4,0.4,transcript,28443.0
RANBP17,ENSG00000204764,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.3420925448758333,3.4209349630535617,1,0.4,0.4,transcript,42042.0
FSIP2,ENSG00000188738,Abnormal sperm morphology,HP_0012864,0.3420838684030299,3.421117624058193,4,2.0,8.0,transcript,28680.0
PYGO1,ENSG00000171016,erythrocyte volume,OBA_0003460,0.3420726825733343,3.421054660996123,4,1.6,6.4,transcript,19522.0
LRRC7,ENSG00000033122,educational attainment,EFO_0011015,0.34204554255229663,3.4205195292285167,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
NDST3,ENSG00000164100,pathological myopia,EFO_0004207,0.34204554255229663,3.420505488101189,1,0.4,0.4,transcript,7990.0
ATP9A,ENSG00000054793,nutritional deficiency disease,EFO_1001067,0.342039895664782,3.420424322872692,1,0.4,0.4,transcript,15769.0
DYNC2H1,ENSG00000187240,genetic disorder,EFO_0000508,0.3420290425700945,3.420300582109639,1,0.5,0.5,transcript,49230.0
ABCA13,ENSG00000179869,neutrophil collagenase measurement,EFO_0008248,0.34199757117872454,3.4199860436465666,1,0.5,0.5,transcript,48394.0
CYSLTR1,ENSG00000173198,multiple myeloma,EFO_0001378,0.34197911154612287,3.4199812521219535,2,0.8,1.6,transcript,8415.0
CA8,ENSG00000178538,schizophrenia,MONDO_0005090,0.3419729229433952,3.419770183667596,1,0.4,0.4,transcript,9767.0
HHLA2,ENSG00000114455,social inhibition quality,OBA_1000278,0.3419282014978332,3.41931581931881,1,0.5,0.5,transcript,14791.0
HHLA2,ENSG00000114455,attention deficit hyperactivity disorder,EFO_0003888,0.3419282014978332,3.41931581931881,1,0.5,0.5,transcript,14791.0
HHLA2,ENSG00000114455,substance abuse,MONDO_0002491,0.3419282014978332,3.41931581931881,1,0.5,0.5,transcript,14791.0
GFRAL,ENSG00000187871,Abruptio Placentae,EFO_1001754,0.3419238310075197,3.4194476245702257,1,0.4,0.4,transcript,1911.0
FIGLA,ENSG00000183733,neurodegenerative disease,EFO_0005772,0.3419075208069058,3.4197677288446813,1,0.5,0.5,transcript,722.0
MATN2,ENSG00000132561,Abnormality of the skeletal system,HP_0000924,0.34188250352428845,3.4188419907178074,1,0.5,0.5,transcript,29489.0
MYO1B,ENSG00000128641,metabolite measurement,EFO_0004725,0.3418683016584306,3.4186964250047938,1,0.4,0.4,transcript,29832.0
ZNF148,ENSG00000163848,Intellectual disability,HP_0001249,0.3418613655833491,3.4186255242131605,1,0.4,0.4,transcript,33703.0
RP2,ENSG00000102218,Cone rod dystrophy,Orphanet_1872,0.3418613655833491,3.4187217639415994,1,0.4,0.4,transcript,3700.0
NUDCD1,ENSG00000120526,educational attainment,EFO_0011015,0.34183152814759676,3.418326269883198,1,0.4,0.4,transcript,36402.0
GCNT1,ENSG00000187210,pericarditis,EFO_0007427,0.3418171972544114,3.4181910701807814,1,0.4,0.4,transcript,20945.0
CTBP2,ENSG00000175029,Spinal cord injury,EFO_1001919,0.3418171972544114,3.418186035758261,1,0.4,0.4,transcript,28443.0
COL25A1,ENSG00000188517,obesity,EFO_0001073,0.3418171972544114,3.4181869342048583,1,0.4,0.4,transcript,26735.0
DLG1,ENSG00000075711,ovarian neoplasm,EFO_0003893,0.3418171972544114,3.418187382315621,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
OTOGL,ENSG00000165899,genetic disorder,EFO_0000508,0.3417692297835781,3.4177071557937033,1,0.5,0.5,transcript,33652.0
COL24A1,ENSG00000171502,body mass index,EFO_0004340,0.3417620866289016,3.4176452624832097,1,0.4,0.4,transcript,16396.0
COL24A1,ENSG00000171502,parental genotype effect measurement,EFO_0005939,0.3417620866289016,3.4176452624832097,1,0.4,0.4,transcript,16396.0
COL24A1,ENSG00000171502,premature birth,EFO_0003917,0.3417620866289016,3.4176452624832097,1,0.4,0.4,transcript,16396.0
RFX3,ENSG00000080298,protein measurement,EFO_0004747,0.3417620866289016,3.4176773674543526,2,0.8,1.6,transcript,28318.0
GSAP,ENSG00000186088,pigment dispersion syndrome,MONDO_0010896,0.3417564245507614,3.4175897596169165,1,0.5,0.5,transcript,19597.0
GSAP,ENSG00000186088,pigmentary glaucoma,EFO_0021425,0.3417564245507614,3.4175897596169165,1,0.5,0.5,transcript,19597.0
MFAP3,ENSG00000037749,body fat percentage,EFO_0007800,0.3417131484457401,3.4171440741590247,1,0.4,0.4,transcript,31772.0
MDGA2,ENSG00000139915,alcohol consumption quality,OBA_1000840,0.3417097772406128,3.417120863094808,1,0.4,0.4,transcript,17323.0
HFM1,ENSG00000162669,obesity,EFO_0001073,0.341683157964225,3.416961416048378,2,1.0,2.0,transcript,15404.0
CADPS,ENSG00000163618,erythrocyte volume,OBA_0003460,0.341683157964225,3.4168408973528885,1,0.4,0.4,transcript,42929.0
DOK5,ENSG00000101134,vascular disease,EFO_0004264,0.341683157964225,3.4169194145126935,1,0.4,0.4,transcript,4554.0
PIP4K2A,ENSG00000150867,prostate specific antigen amount,OBA_2050200,0.341683157964225,3.4168750248469855,1,0.4,0.4,transcript,9207.0
TCERG1L,ENSG00000176769,protein measurement,EFO_0004747,0.34168113206842593,3.4170395009466663,2,0.8,1.6,transcript,7012.0
SGCD,ENSG00000170624,T-cell immunoglobulin and mucin domain 1 measurement,EFO_0010812,0.34168113206842593,3.4168301097302454,1,0.4,0.4,transcript,21289.0
TCERG1L,ENSG00000176769,protein measurement,EFO_0004747,0.34168113206842593,3.4170395009466663,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,protein measurement,EFO_0004747,0.34168113206842593,3.4170395009466663,2,0.8,1.6,transcript,7012.0
PRDM5,ENSG00000138738,DNA methylation,EFO_0022599,0.34168113206842593,3.4168919292791506,2,0.8,1.6,transcript,19849.0
TCERG1L,ENSG00000176769,protein measurement,EFO_0004747,0.34168113206842593,3.4170395009466663,2,0.8,1.6,gene_variant,7012.0
ABCA13,ENSG00000179869,taxonomic microbiome measurement,EFO_0007883,0.34168113206842593,3.4168216525435806,1,0.5,0.5,transcript,48394.0
ABCA13,ENSG00000179869,gut microbiome measurement,EFO_0007874,0.34168113206842593,3.4168216525435806,1,0.5,0.5,transcript,48394.0
BHLHE41,ENSG00000123095,HbA1c measurement,EFO_0004541,0.3416689937286966,3.416778218019696,1,0.4,0.4,transcript,4531.0
CR2,ENSG00000117322,"immunodeficiency, common variable, 2",MONDO_0009413,0.34165420508703753,3.41656037679698,1,0.4,0.4,transcript,21827.0
LRRK2,ENSG00000188906,Abruptio Placentae,EFO_1001754,0.341635812033074,3.416376878146497,2,0.9,1.8,transcript,95960.0
PHC1,ENSG00000111752,waist-hip ratio,EFO_0004343,0.34152426432953636,3.415261793779871,1,0.5,0.5,transcript,26109.0
SLC36A4,ENSG00000180773,body mass index,EFO_0004340,0.34152139396616144,3.4153244750674867,2,0.8,1.6,transcript,14475.0
KIAA0319,ENSG00000137261,eosinophil count,EFO_0004842,0.3415068430296344,3.415080817648857,1,0.4,0.4,transcript,32291.0
UBL3,ENSG00000122042,epilepsy,EFO_0000474,0.3415004875755936,3.41583878819513,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
BMP10,ENSG00000163217,hemoglobin measurement,EFO_0004509,0.34148752186336495,3.414941487686002,1,0.4,0.4,transcript,6036.0
IL1A,ENSG00000115008,lymphocyte percentage of leukocytes,EFO_0007993,0.3414847791463701,3.415046105791911,1,0.4,0.4,transcript,2017.0
SLCO5A1,ENSG00000137571,sphingolipid measurement,EFO_0004622,0.34146892951479546,3.415119847115577,5,2.0,10.0,transcript,23226.0
ABCB1,ENSG00000085563,appendicular lean mass,EFO_0004980,0.34144354709167135,3.4144595186273716,1,0.5,0.5,transcript,20792.0
RIF1,ENSG00000080345,mean corpuscular hemoglobin concentration,EFO_0004528,0.34144239455644904,3.4144854888815175,3,1.3,3.9000000000000004,transcript,63370.0
OTOGL,ENSG00000165899,wellbeing measurement,EFO_0007869,0.34143763047037057,3.414391162661628,1,0.5,0.5,transcript,33652.0
STAU2,ENSG00000040341,neurodegenerative disease,EFO_0005772,0.34137357771170096,3.4137473452998797,1,0.5,0.5,transcript,43222.0
SGCZ,ENSG00000185053,urinary microalbumin measurement,EFO_0010967,0.34137282257252366,3.4137769349312763,1,0.4,0.4,transcript,8212.0
ITM2A,ENSG00000078596,body height,OBA_VT0001253,0.34136866686295947,3.4140866686295945,1,0.4,0.4,transcript,1000.0
DOK5,ENSG00000101134,smoking initiation,EFO_0005670,0.3413597702161224,3.4136855370316677,1,0.4,0.4,transcript,4554.0
ZNF507,ENSG00000168813,smoking initiation,EFO_0005670,0.3413597702161224,3.413612101009316,1,0.4,0.4,transcript,27780.0
LONRF1,ENSG00000154359,neurotic disorder,EFO_0004257,0.3413168056327767,3.413203349614984,1,0.5,0.5,transcript,14167.0
LONRF1,ENSG00000154359,wellbeing measurement,EFO_0007869,0.3413168056327767,3.413203349614984,1,0.5,0.5,transcript,14167.0
LONRF1,ENSG00000154359,alcohol consumption quality,OBA_1000840,0.3413168056327767,3.413203349614984,1,0.5,0.5,transcript,14167.0
EXD1,ENSG00000178997,sitting height measurement,EFO_0011011,0.3412873420740025,3.4129152049247113,1,0.4,0.4,transcript,9573.0
TRIM36,ENSG00000152503,atrial flutter,EFO_0003911,0.34126207644593837,3.412646925348854,1,0.4,0.4,transcript,15290.0
SLCO6A1,ENSG00000205359,Drugs used in diabetes use measurement,EFO_0009924,0.3412493819931994,3.4125350740574065,1,0.5,0.5,transcript,12120.0
PCDH18,ENSG00000189184,nephritis,EFO_1002050,0.3412428220603328,3.412505392262036,2,0.8,1.6,transcript,20733.0
SFRP1,ENSG00000104332,mean corpuscular hemoglobin concentration,EFO_0004528,0.34119240875675694,3.411972066456858,1,0.4,0.4,transcript,8337.0
MCL1,ENSG00000143384,lean body mass,EFO_0004995,0.34118719420682986,3.4118887114474123,1,0.4,0.4,transcript,23853.0
SEMA3A,ENSG00000075213,major depressive disorder,MONDO_0002009,0.3411871108428286,3.4119013130646976,1,0.4,0.4,transcript,13243.0
ITM2A,ENSG00000078596,medical procedure,EFO_0002571,0.34113334454097766,3.4117334454097765,1,0.4,0.4,transcript,1000.0
DTHD1,ENSG00000197057,erythrocyte volume,OBA_0003460,0.3411248449227171,3.4112748497763024,1,0.5,0.5,transcript,18939.0
RNF144B,ENSG00000137393,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.3411248449227171,3.4113213222459358,1,0.4,0.4,transcript,5489.0
HS6ST3,ENSG00000185352,blood urea nitrogen measurement,EFO_0004741,0.34110820246692725,3.411128885025411,1,0.4,0.4,transcript,8536.0
LINGO2,ENSG00000174482,waist circumference,OBA_1001085,0.34110264435246196,3.4110381623890613,1,0.4,0.4,transcript,34133.0
ASPM,ENSG00000066279,Lissencephaly,HP_0001339,0.3410760083921442,3.4107950822687423,2,0.9,1.8,transcript,51431.0
DLC1,ENSG00000164741,platelet crit,EFO_0007985,0.34105606532524146,3.410572332425529,1,0.4,0.4,transcript,34249.0
WDR12,ENSG00000138442,pulse pressure measurement,EFO_0005763,0.3410422410317073,3.4104423495025578,1,0.4,0.4,transcript,20061.0
SOS1,ENSG00000115904,ptosis,MONDO_0000728,0.3409374159466374,3.4093977673395996,2,0.8,1.6,transcript,67774.0
SYT13,ENSG00000019505,thyroid stimulating hormone amount,OBA_1000983,0.340900786057604,3.409223145829,2,0.8,1.6,transcript,7432.0
LRRK2,ENSG00000188906,multiple sclerosis,MONDO_0005301,0.34089971647820544,3.409015922597811,2,0.9,1.8,transcript,95960.0
COL24A1,ENSG00000171502,monocyte count,EFO_0005091,0.3408901967620052,3.408926363814246,1,0.4,0.4,transcript,16396.0
TCERG1L,ENSG00000176769,tricuspid valve disease,EFO_0009568,0.3408901967620052,3.4091301478824594,2,0.8,1.6,gene_variant,7012.0
SGCD,ENSG00000170624,diabetic ketoacidosis,EFO_1000897,0.3408901967620052,3.4089207566660384,1,0.4,0.4,transcript,21289.0
TCERG1L,ENSG00000176769,tricuspid valve disease,EFO_0009568,0.3408901967620052,3.4091301478824594,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,tricuspid valve disease,EFO_0009568,0.3408901967620052,3.4091301478824594,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,tricuspid valve disease,EFO_0009568,0.3408901967620052,3.4091301478824594,2,0.8,1.6,gene_variant,7012.0
HS6ST3,ENSG00000185352,FEV/FVC ratio,EFO_0004713,0.3408901967620052,3.408948827976191,1,0.4,0.4,transcript,8536.0
ACVR1C,ENSG00000123612,glomerular filtration rate,OBA_0003747,0.34088501044912367,3.408969418436054,2,0.8,1.6,transcript,13410.0
ENPEP,ENSG00000138792,metabolite measurement,EFO_0004725,0.3408835588484618,3.4088779883150186,1,0.4,0.4,transcript,9434.0
DCLK1,ENSG00000133083,secondary malignant neoplasm,EFO_0009812,0.3408527754999469,3.408577952652729,2,0.8,1.6,transcript,31874.0
PIP4K2A,ENSG00000150867,diastolic blood pressure change measurement,EFO_0006945,0.3408192079296739,3.4082355245014746,1,0.4,0.4,transcript,9207.0
PLPP4,ENSG00000203805,injury,EFO_0000546,0.34080900250170837,3.408170914804748,1,0.4,0.4,transcript,4945.0
XKR4,ENSG00000206579,cardiomyopathy,EFO_0000318,0.34080900250170837,3.4081089769738733,1,0.4,0.4,transcript,21106.0
SH3GL3,ENSG00000140600,acute tonsillitis,MONDO_0020686,0.34080900250170837,3.4081417179609965,1,0.4,0.4,transcript,7738.0
DOK5,ENSG00000101134,Phenotypic abnormality,HP_0000118,0.34080900250170837,3.408177859887527,1,0.4,0.4,transcript,4554.0
GPM6A,ENSG00000150625,cancer antigen 125 measurement,EFO_0010603,0.34080691846936984,3.4080873557744233,1,0.4,0.4,transcript,22013.0
SP8,ENSG00000164651,cerebral cortex area attribute,OBA_2045267,0.3408027813664258,3.408102720031299,1,0.4,0.4,transcript,5340.0
SP8,ENSG00000164651,diet measurement,EFO_0008111,0.3408027813664258,3.408102720031299,1,0.4,0.4,transcript,5340.0
SOS1,ENSG00000115904,Pulmonic stenosis,HP_0001642,0.3408026732912836,3.408050340786062,2,0.8,1.6,transcript,67774.0
EDEM1,ENSG00000134109,vascular disease,EFO_0004264,0.3407919970979735,3.408052949703139,2,0.8,1.6,transcript,12032.0
KIAA0586,ENSG00000100578,Retinal dystrophy,HP_0000556,0.34075262601929507,3.407531911251394,1,0.5,0.5,transcript,88479.0
HFE,ENSG00000010704,peripheral neuropathy,EFO_0003100,0.34075262601929507,3.4075345453687,1,0.4,0.4,transcript,48279.0
ARAP1,ENSG00000186635,hip circumference,OBA_1000032,0.34072124844723645,3.4072214940901313,1,0.4,0.4,transcript,44397.0
GREM1,ENSG00000166923,hemorrhoid,EFO_0009552,0.3407166086643933,3.4071843107088107,1,0.4,0.4,transcript,21949.0
PPP1R2,ENSG00000184203,metabolite measurement,EFO_0004725,0.3407166086643933,3.4072125712459087,1,0.4,0.4,transcript,8605.0
SLC35D3,ENSG00000182747,coffee consumption measurement,EFO_0006781,0.3407166086643933,3.407336807941415,1,0.4,0.4,transcript,2343.0
SLC35D3,ENSG00000182747,diet measurement,EFO_0008111,0.3407166086643933,3.407336807941415,1,0.4,0.4,transcript,2343.0
KPNA4,ENSG00000186432,systolic blood pressure,EFO_0006335,0.3407129612326302,3.4071386055364283,1,0.4,0.4,transcript,44478.0
EVI5,ENSG00000067208,mean corpuscular hemoglobin concentration,EFO_0004528,0.3407079075163878,3.4070847311125223,1,0.4,0.4,transcript,70722.0
TRPC6,ENSG00000137672,genetic disorder,EFO_0000508,0.3407014019774555,3.40704290689812,1,0.4,0.4,transcript,13847.0
LNPEP,ENSG00000113441,total cholesterol measurement,EFO_0004574,0.34067683256766434,3.406788987900932,1,0.4,0.4,transcript,19359.0
SMU1,ENSG00000122692,metabolite measurement,EFO_0004725,0.3406739930852658,3.407244415157591,3,1.2000000000000002,3.6000000000000005,transcript,7136.0
GIPC2,ENSG00000137960,fat pad mass,OBA_0004528,0.34066041701603506,3.40699536820436,2,0.8,1.6,transcript,4090.0
MYO3A,ENSG00000095777,sensorineural hearing loss,EFO_1001176,0.3406602310556239,3.406626026346212,1,0.5,0.5,transcript,21083.0
RFX3,ENSG00000080298,blood metabolite measurement,EFO_0005664,0.34064373366236644,3.406493837789001,2,0.8,1.6,transcript,28318.0
KCNIP4,ENSG00000185774,free androgen index,EFO_0007005,0.34064373366236644,3.406569984609073,2,0.8,1.6,transcript,12062.0
UHMK1,ENSG00000152332,eosinophil count,EFO_0004842,0.34063246061302116,3.406451224025541,3,1.2000000000000002,3.6000000000000005,transcript,28432.0
ATG16L1,ENSG00000085978,ankylosing spondylitis,EFO_0003898,0.3405884078728614,3.405896070214659,1,0.4,0.4,transcript,33357.0
TFEC,ENSG00000105967,platelet crit,EFO_0007985,0.3405828401755031,3.405844099110027,1,0.4,0.4,transcript,25482.0
HFE,ENSG00000010704,hereditary neoplastic syndrome,MONDO_0015356,0.3405678360919527,3.405686646095276,1,0.4,0.4,transcript,48279.0
CENPE,ENSG00000138778,sex hormone-binding globulin measurement,EFO_0004696,0.3405440726468636,3.4054664201993656,1,0.5,0.5,transcript,19460.0
GALC,ENSG00000054983,Fabry disease,MONDO_0010526,0.34053960429749763,3.405468935913473,2,0.8,1.6,transcript,21950.0
LINGO2,ENSG00000174482,diet measurement,EFO_0008111,0.34053863950778923,3.405398113942334,1,0.4,0.4,transcript,34133.0
GREM1,ENSG00000166923,hypospadias,EFO_0004209,0.3405167442441325,3.4051856665062026,1,0.4,0.4,transcript,21949.0
SYNJ2,ENSG00000078269,lipoprotein A measurement,EFO_0006925,0.34050071506176455,3.4050582982424777,2,0.8,1.6,transcript,31282.0
TCERG1L,ENSG00000176769,neurofibrillary tangles measurement,EFO_0006797,0.3404951102282146,3.405179282544553,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,neurofibrillary tangles measurement,EFO_0006797,0.3404951102282146,3.405179282544553,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,neurofibrillary tangles measurement,EFO_0006797,0.3404951102282146,3.405179282544553,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,neurofibrillary tangles measurement,EFO_0006797,0.3404951102282146,3.405179282544553,2,0.8,1.6,transcript,7012.0
PLA2R1,ENSG00000153246,gastrointestinal disease,EFO_0010282,0.34049421133974306,3.4050213056365912,2,0.8,1.6,transcript,20204.0
SGCZ,ENSG00000185053,1-palmitoyl-GPC (16:0) measurement,EFO_0800214,0.34045501576089454,3.404598866814985,1,0.4,0.4,transcript,8212.0
GRIA4,ENSG00000152578,genetic disorder,EFO_0000508,0.3404469468218029,3.404478759739515,1,0.4,0.4,transcript,43050.0
LUZP2,ENSG00000187398,bone tissue density,OBA_1000110,0.34039538273472164,3.404270607371441,4,1.7000000000000002,6.800000000000001,transcript,21466.0
GCH1,ENSG00000131979,Intellectual disability,HP_0001249,0.3403830461646103,3.4038642254681672,1,0.4,0.4,transcript,11847.0
SPAST,ENSG00000021574,Seizure,HP_0001250,0.3403830461646103,3.4038356379644465,1,0.4,0.4,transcript,77275.0
TMEM170B,ENSG00000205269,growth differentiation factor 15 amount,OBA_2050135,0.3403457386890602,3.40350237620564,1,0.4,0.4,transcript,8891.0
FZD3,ENSG00000104290,colorectal cancer,MONDO_0005575,0.34034387233215185,3.4034528401381765,1,0.4,0.4,transcript,28335.0
ARAP1,ENSG00000186635,hemoglobin A1 measurement,EFO_0007629,0.3402869921830602,3.402878931448369,1,0.4,0.4,transcript,44397.0
SMARCC1,ENSG00000173473,apolipoprotein A 1 measurement,EFO_0004614,0.34025589656327526,3.4026731127398366,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,apolipoprotein A 1 measurement,EFO_0004614,0.34025589656327526,3.4026731127398366,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,apolipoprotein A 1 measurement,EFO_0004614,0.34025589656327526,3.4026731127398366,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,apolipoprotein A 1 measurement,EFO_0004614,0.34025589656327526,3.4026731127398366,2,0.8,1.6,gene_variant,14017.0
PDCD5,ENSG00000105185,blood protein measurement,EFO_0007937,0.3402516839035742,3.402594948779932,1,0.4,0.4,transcript,5121.0
SLF1,ENSG00000133302,brain cancer,MONDO_0001657,0.3402319505190589,3.4023544183441197,1,0.4,0.4,transcript,11457.0
CCDC34,ENSG00000109881,response to beta blocker,EFO_0007766,0.34018872193216065,3.4019807428193856,1,0.4,0.4,transcript,4277.0
PRKCB,ENSG00000166501,Crohn's disease,EFO_0000384,0.3401698408863211,3.4017223753101846,1,0.4,0.4,transcript,16690.0
DYNC2H1,ENSG00000187240,erythrocyte count,EFO_0004305,0.3401669725526002,3.401679881934696,1,0.5,0.5,transcript,49230.0
SMAD2,ENSG00000175387,musculoskeletal system disease,EFO_0009676,0.3401639513457135,3.4021333105126415,9,3.6,32.4,transcript,65614.0
TRDMT1,ENSG00000107614,total cholesterol measurement,EFO_0004574,0.3401469450381359,3.4014832420580823,1,0.4,0.4,transcript,29003.0
COLEC10,ENSG00000184374,thyroid stimulating hormone amount,OBA_1000983,0.34013478518432927,3.40145303196425,1,0.4,0.4,transcript,3803.0
BMPR2,ENSG00000204217,neurodegenerative disease,EFO_0005772,0.34011029736873033,3.40112074514634,1,0.4,0.4,transcript,22508.0
TRDMT1,ENSG00000107614,vitamin deficiency disorder,MONDO_0024298,0.34010883018294635,3.401102093506186,1,0.4,0.4,transcript,29003.0
YWHAG,ENSG00000170027,Spasticity,HP_0001257,0.3400134663099256,3.400242625312482,1,0.4,0.4,transcript,3705.0
GLB1,ENSG00000170266,spondyloepiphyseal dysplasia,MONDO_0016761,0.3400134663099256,3.4001655711786283,1,0.5,0.5,transcript,16177.0
YWHAG,ENSG00000170027,Hypotonia,HP_0001252,0.3400134663099256,3.400242625312482,1,0.4,0.4,transcript,3705.0
YWHAG,ENSG00000170027,Failure to thrive,HP_0001508,0.3400134663099256,3.400242625312482,1,0.4,0.4,transcript,3705.0
GLB1,ENSG00000170266,spastic ataxia,MONDO_0017845,0.3400134663099256,3.4001655711786283,1,0.5,0.5,transcript,16177.0
GFPT1,ENSG00000198380,Abnormality of the musculature,HP_0003011,0.3400134663099256,3.4001497671282563,1,0.4,0.4,transcript,26483.0
SOS1,ENSG00000115904,Abnormal sternum morphology,HP_0000766,0.3400134663099256,3.400158270972482,2,0.8,1.6,transcript,67774.0
GLB1,ENSG00000170266,progressive familial intrahepatic cholestasis,MONDO_0015762,0.3400134663099256,3.4001655711786283,1,0.5,0.5,transcript,16177.0
YWHAG,ENSG00000170027,Microcephaly,HP_0000252,0.3400134663099256,3.400242625312482,1,0.4,0.4,transcript,3705.0
SOS1,ENSG00000115904,Short stature,HP_0004322,0.3400134663099256,3.400158270972482,2,0.8,1.6,transcript,67774.0
GALC,ENSG00000054983,Angiokeratoma corporis diffusum,HP_0001071,0.3400134663099256,3.400207556037753,2,0.8,1.6,transcript,21950.0
ANOS1,ENSG00000011201,Cataract - intellectual disability - hypogonadism,Orphanet_1387,0.3400134663099256,3.400186169666344,1,0.4,0.4,transcript,7766.0
SOS1,ENSG00000115904,Neonatal hypotonia,HP_0001319,0.3400134663099256,3.400158270972482,2,0.8,1.6,transcript,67774.0
PROK2,ENSG00000163421,male infertility with azoospermia or oligozoospermia due to single gene mutation,EFO_0700088,0.3400134663099256,3.400650127016782,2,0.8,1.6,transcript,3104.0
SOS1,ENSG00000115904,cystic lymphangioma,EFO_1000888,0.3400134663099256,3.400158270972482,2,0.8,1.6,transcript,67774.0
GALC,ENSG00000054983,Abnormality of the nervous system,HP_0000707,0.3400134663099256,3.400207556037753,2,0.8,1.6,transcript,21950.0
SPAST,ENSG00000021574,Pes valgus,HP_0008081,0.3400134663099256,3.4001398394176,1,0.4,0.4,transcript,77275.0
CERKL,ENSG00000188452,isolated macular dystrophy,MONDO_0957048,0.3400134663099256,3.4001547369711047,1,0.5,0.5,transcript,24908.0
FREM2,ENSG00000150893,Finger syndactyly,HP_0006101,0.3400134663099256,3.4010257698538457,6,2.5,15.0,transcript,16833.0
RP2,ENSG00000102218,cone-rod dystrophy,MONDO_0015993,0.3400134663099256,3.4002427712073646,1,0.4,0.4,transcript,3700.0
HFE,ENSG00000010704,peripheral nervous system disease,EFO_0009387,0.3400134663099256,3.400142948275006,1,0.4,0.4,transcript,48279.0
HFE,ENSG00000010704,Abnormality of the nervous system,HP_0000707,0.3400134663099256,3.400142948275006,1,0.4,0.4,transcript,48279.0
FREM2,ENSG00000150893,Abnormality of the anus,HP_0004378,0.3400134663099256,3.4010257698538457,6,2.5,15.0,transcript,16833.0
RASGRP3,ENSG00000152689,lip and oral cavity carcinoma,MONDO_0023644,0.3400134663099256,3.400145866012014,1,0.4,0.4,transcript,35705.0
HFE,ENSG00000010704,Inherited cancer-predisposing syndrome,Orphanet_140162,0.3400134663099256,3.400142948275006,1,0.4,0.4,transcript,48279.0
HFE,ENSG00000010704,pain,EFO_0003843,0.3400134663099256,3.400142948275006,1,0.4,0.4,transcript,48279.0
FREM2,ENSG00000150893,Toe syndactyly,HP_0001770,0.3400134663099256,3.4010257698538457,6,2.5,15.0,transcript,16833.0
FREM2,ENSG00000150893,Ambiguous genitalia,HP_0000062,0.3400134663099256,3.4010257698538457,6,2.5,15.0,transcript,16833.0
HFE,ENSG00000010704,Atypical behavior,HP_0000708,0.3400134663099256,3.400142948275006,1,0.4,0.4,transcript,48279.0
HFE,ENSG00000010704,Abdominal pain,HP_0002027,0.3400134663099256,3.400142948275006,1,0.4,0.4,transcript,48279.0
SPAST,ENSG00000021574,Abnormal central motor function,HP_0011442,0.3400134663099256,3.4001398394176,1,0.4,0.4,transcript,77275.0
SPAST,ENSG00000021574,Flexion contracture,HP_0001371,0.3400134663099256,3.4001398394176,1,0.4,0.4,transcript,77275.0
SPAST,ENSG00000021574,Inherited congenital spastic tetraplegia,Orphanet_210141,0.3400134663099256,3.4001398394176,1,0.4,0.4,transcript,77275.0
SPAST,ENSG00000021574,Abnormal myelination,HP_0012447,0.3400134663099256,3.4001398394176,1,0.4,0.4,transcript,77275.0
YWHAG,ENSG00000170027,Severe global developmental delay,HP_0011344,0.3400134663099256,3.400242625312482,1,0.4,0.4,transcript,3705.0
ASTN2,ENSG00000148219,myopathy,EFO_0004145,0.3400134663099256,3.400193417505837,2,0.8,1.6,transcript,27232.0
KCNQ3,ENSG00000184156,"seizures, benign familial infantile, 5",MONDO_0014903,0.3400134663099256,3.4001910408300526,2,0.8,1.6,transcript,28380.0
NCKAP1,ENSG00000061676,Neurodevelopmental abnormality,HP_0012759,0.3400134663099256,3.400144492316605,1,0.4,0.4,transcript,40695.0
CEP85L,ENSG00000111860,sudden infant death syndrome,EFO_0005303,0.3400134663099256,3.4001500660797332,1,0.4,0.4,transcript,25969.0
DCDC2,ENSG00000146038,chylomicron retention disease,MONDO_0009528,0.3400134663099256,3.4001804401649465,1,0.4,0.4,transcript,8738.0
PHIP,ENSG00000146247,schizophrenia,MONDO_0005090,0.3400134663099256,3.400142640252689,1,0.5,0.5,transcript,62679.0
MYO3A,ENSG00000095777,Sensorineural hearing impairment,HP_0000407,0.3400134663099256,3.4001583788892296,1,0.5,0.5,transcript,21083.0
FBXO22,ENSG00000167196,Neurodevelopmental disorder,EFO_0010642,0.3400134663099256,3.400155861890925,1,0.4,0.4,transcript,18869.0
FREM2,ENSG00000150893,Unilateral renal agenesis,Orphanet_93100,0.3400134663099256,3.4010257698538457,6,2.5,15.0,transcript,16833.0
FSIP2,ENSG00000188738,Reduced sperm motility,HP_0012207,0.3400134663099256,3.4004136031271504,4,2.0,8.0,transcript,28680.0
UNC80,ENSG00000144406,"hypotonia, infantile, with psychomotor retardation and characteristic facies 1",MONDO_0024567,0.3400134663099256,3.4001393251039183,1,0.4,0.4,transcript,85800.0
UMPS,ENSG00000114491,cardiomyopathy,EFO_0000318,0.3400134663099256,3.4001535194609214,1,0.4,0.4,transcript,21213.0
KCNQ3,ENSG00000184156,"Intellectual disability, severe",HP_0010864,0.3400134663099256,3.4001910408300526,2,0.8,1.6,transcript,28380.0
CEP85L,ENSG00000111860,Neurodevelopmental disorder,EFO_0010642,0.3400134663099256,3.4001500660797332,1,0.4,0.4,transcript,25969.0
SLC9B1,ENSG00000164037,Usher syndrome,MONDO_0019501,0.3400134663099256,3.400179635216544,1,0.5,0.5,transcript,11118.0
GJA3,ENSG00000121743,congenital cataracts-facial dysmorphism-neuropathy syndrome,MONDO_0011402,0.3400134663099256,3.4002113796316693,1,0.4,0.4,transcript,5214.0
CEP85L,ENSG00000111860,intrinsic cardiomyopathy,MONDO_0000591,0.3400134663099256,3.4001500660797332,1,0.4,0.4,transcript,25969.0
GJA3,ENSG00000121743,Congenital cataracts - facial dysmorphism - neuropathy,Orphanet_48431,0.3400134663099256,3.4002113796316693,1,0.4,0.4,transcript,5214.0
IMPG2,ENSG00000081148,cone-rod dystrophy,MONDO_0015993,0.3400134663099256,3.4003501803406357,2,0.9,1.8,transcript,8352.0
CLDN16,ENSG00000113946,thrombocytopenia 5,MONDO_0014536,0.3400134663099256,3.4002350395108,1,0.4,0.4,transcript,3985.0
ANKRD17,ENSG00000132466,lip and oral cavity carcinoma,MONDO_0023644,0.3400134663099256,3.4001438530087356,1,0.4,0.4,transcript,43526.0
SPAST,ENSG00000021574,Fatigue,HP_0012378,0.3400134663099256,3.4001398394176,1,0.4,0.4,transcript,77275.0
YWHAG,ENSG00000170027,Constipation,HP_0002019,0.3400134663099256,3.400242625312482,1,0.4,0.4,transcript,3705.0
EPRS1,ENSG00000136628,Intellectual disability,HP_0001249,0.3400134663099256,3.400179377819342,1,0.5,0.5,transcript,11182.0
SPRED1,ENSG00000166068,Male infertility with spermatogenesis disorder,Orphanet_399775,0.3400134663099256,3.4001792363107564,1,0.4,0.4,transcript,8974.0
SPRED1,ENSG00000166068,Neurodevelopmental delay,HP_0012758,0.3400134663099256,3.4001792363107564,1,0.4,0.4,transcript,8974.0
RAD18,ENSG00000070950,uterine fibroid,EFO_0000731,0.3399913248247737,3.3999467294564085,1,0.4,0.4,transcript,11947.0
SEMA3A,ENSG00000075213,alcohol dependence,MONDO_0007079,0.33998161636228247,3.399846368259236,1,0.4,0.4,transcript,13243.0
DUSP22,ENSG00000112679,eosinophil percentage of granulocytes,EFO_0007996,0.3399388032555999,3.3994116369464153,1,0.4,0.4,transcript,16946.0
CHL1,ENSG00000134121,"N6,N6,N6-trimethyllysine measurement",EFO_0800126,0.3399203301918401,3.3992505023432047,2,0.8,1.6,transcript,33898.0
ANKRD36,ENSG00000135976,eosinophil percentage of leukocytes,EFO_0007991,0.33989054081561754,3.398980794511245,2,1.0,2.0,transcript,26530.0
VPS13A,ENSG00000197969,metabolite measurement,EFO_0004725,0.33987217135350856,3.398728458783901,1,0.4,0.4,transcript,59301.0
ALG10B,ENSG00000175548,urinary bladder carcinoma,MONDO_0004986,0.3398576334062101,3.399282149985308,5,2.0,10.0,transcript,14168.0
ALG10B,ENSG00000175548,vascular cell adhesion protein 1 amount,OBA_2050220,0.3398576334062101,3.399282149985308,5,2.0,10.0,transcript,14168.0
LAMA1,ENSG00000101680,diastolic blood pressure,EFO_0006336,0.3398314680060098,3.3983305752788158,1,0.5,0.5,transcript,31456.0
ANKRD36,ENSG00000135976,schizophrenia,MONDO_0005090,0.3398189905200105,3.398265291555175,2,1.0,2.0,transcript,26530.0
THEM4,ENSG00000159445,dodecadienoate (12:2) measurement,EFO_0800572,0.3398076001780403,3.3982303525425097,2,0.8,1.6,transcript,10366.0
CFAP299,ENSG00000197826,hematocrit,EFO_0004348,0.33978269028861535,3.39789204097891,1,0.5,0.5,transcript,7676.0
CFAP299,ENSG00000197826,heel bone mineral density,EFO_0009270,0.33978269028861535,3.39789204097891,1,0.5,0.5,transcript,7676.0
MMP12,ENSG00000262406,matrix metalloproteinase 12 measurement,EFO_0010590,0.33977916335309893,3.398011172499156,1,0.4,0.4,transcript,1822.0
CYTIP,ENSG00000115165,glomerular filtration rate,OBA_0003747,0.3397706104404578,3.397733891830768,1,0.4,0.4,gene_variant,14395.0
CYTIP,ENSG00000115165,serum creatinine amount,OBA_2050096,0.3397706104404578,3.397733891830768,1,0.4,0.4,gene_variant,14395.0
TNFRSF19,ENSG00000127863,blood protein measurement,EFO_0007937,0.3397424105464719,3.3974571065867574,1,0.5,0.5,transcript,15151.0
SLCO5A1,ENSG00000137571,metabolite measurement,EFO_0004725,0.33968342126278955,3.397264764595518,5,2.0,10.0,transcript,23226.0
SLC22A24,ENSG00000197658,brain connectivity attribute,OBA_2045295,0.33967759428354954,3.3968612379566143,1,0.5,0.5,transcript,5862.0
DLG2,ENSG00000150672,glucuronate measurement,EFO_0010486,0.33966754936781596,3.3966782666033186,1,0.4,0.4,transcript,144252.0
USP15,ENSG00000135655,platelet component distribution width,EFO_0007984,0.3396605032785272,3.3966881506279023,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
CLSTN2,ENSG00000158258,pseudouridine measurement,EFO_0021126,0.33965123093414007,3.3965363955700996,1,0.4,0.4,transcript,16607.0
CSMD3,ENSG00000164796,hemolytic anemia,EFO_0005558,0.3396481755853851,3.3964898645755923,1,0.5,0.5,transcript,61662.0
RAPGEF4,ENSG00000091428,HbA1c measurement,EFO_0004541,0.3396481755853851,3.3964949419425277,1,0.4,0.4,transcript,30335.0
COLEC10,ENSG00000184374,basal cell carcinoma,EFO_0004193,0.3396297303620704,3.396402483741661,1,0.4,0.4,transcript,3803.0
COL24A1,ENSG00000171502,neuroimaging measurement,EFO_0004346,0.33959809089009824,3.396005305095176,1,0.4,0.4,transcript,16396.0
NEK7,ENSG00000151414,neurodegenerative disease,EFO_0005772,0.33959174211482757,3.395962685378218,1,0.4,0.4,transcript,8837.0
RBM28,ENSG00000106344,protein measurement,EFO_0004747,0.3395621429439275,3.3956936642022546,2,0.8,1.6,transcript,22150.0
PRKCB,ENSG00000166501,sclerosing cholangitis,EFO_0004268,0.33953428555687215,3.3953668220156956,1,0.4,0.4,transcript,16690.0
PRKCB,ENSG00000166501,ankylosing spondylitis,EFO_0003898,0.33953428555687215,3.3953668220156956,1,0.4,0.4,transcript,16690.0
LRRC58,ENSG00000163428,high density lipoprotein cholesterol measurement,EFO_0004612,0.3395312612569459,3.3955146837995676,2,0.8,1.6,transcript,7918.0
SV2C,ENSG00000122012,immune system disease,EFO_0000540,0.33951673562451307,3.3951953851148664,1,0.4,0.4,transcript,14271.0
TRAM1,ENSG00000067167,BMI-adjusted waist-hip ratio,EFO_0007788,0.33951506217911914,3.3953411206601043,2,0.8,1.6,transcript,8399.0
ZPLD1,ENSG00000170044,response to antihypertensive drug,EFO_0005405,0.3395003474082341,3.3951624565942646,2,0.8,1.6,transcript,10064.0
NBAS,ENSG00000151779,lymphocyte count,EFO_0004587,0.3395003474082341,3.395037019872344,2,1.0,2.0,transcript,59620.0
STXBP5,ENSG00000164506,aspartate aminotransferase measurement,EFO_0004736,0.3395003474082341,3.395017304490799,2,0.9,1.8,transcript,130148.0
STARD13,ENSG00000133121,pulse wave reflection index measurement,EFO_0009804,0.3395003474082341,3.395018290543429,1,0.4,0.4,transcript,26997.0
TPRG1,ENSG00000188001,neuroimaging measurement,EFO_0004346,0.3395003474082341,3.395103330538685,2,0.8,1.6,transcript,16023.0
NEBL,ENSG00000078114,response to selective serotonin reuptake inhibitor,EFO_0005658,0.3395003474082341,3.395011295901305,1,0.4,0.4,transcript,51139.0
NEBL,ENSG00000078114,triglyceride measurement,EFO_0004530,0.3395003474082341,3.395011295901305,1,0.4,0.4,transcript,51139.0
LMO4,ENSG00000143013,ankylosing spondylitis,EFO_0003898,0.3395003474082341,3.395054954133821,1,0.4,0.4,transcript,7770.0
METTL25,ENSG00000127720,high density lipoprotein cholesterol measurement,EFO_0004612,0.3395003474082341,3.395055422134289,1,0.5,0.5,transcript,9625.0
CLASP2,ENSG00000163539,stricture or kinking of ureter,MONDO_0002674,0.3395003474082341,3.395009593471626,1,0.4,0.4,transcript,65366.0
LHFPL2,ENSG00000145685,free androgen index,EFO_0007005,0.33946891525476514,3.3947160451118576,1,0.4,0.4,transcript,14874.0
KLHL3,ENSG00000146021,genetic disorder,EFO_0000508,0.33945099096247855,3.3945572203081293,2,0.8,1.6,transcript,33819.0
EXD1,ENSG00000178997,neurodegenerative disease,EFO_0005772,0.3394303289600824,3.39434507378551,1,0.4,0.4,transcript,9573.0
TRPC6,ENSG00000137672,daytime rest measurement,EFO_0007828,0.3394179355280188,3.3942082424037525,1,0.4,0.4,transcript,13847.0
CNTLN,ENSG00000044459,adolescent idiopathic scoliosis,EFO_0005423,0.339386141065582,3.3939828712190936,2,0.8,1.6,transcript,13173.0
SUMF1,ENSG00000144455,genetic disorder,EFO_0000508,0.33938609188255314,3.393893268198762,1,0.4,0.4,transcript,12365.0
LRRK2,ENSG00000188906,erythrocyte volume,OBA_0003460,0.3393859364157222,3.3938781219729783,2,0.9,1.8,transcript,95960.0
DCK,ENSG00000156136,bone tissue density,OBA_1000110,0.33936495098301306,3.393686495498184,1,0.4,0.4,transcript,10815.0
DCK,ENSG00000156136,urate measurement,EFO_0004531,0.33936495098301306,3.393686495498184,1,0.4,0.4,transcript,10815.0
RASGRP3,ENSG00000152689,vascular disease,EFO_0004264,0.33935722168139537,3.393583419726711,1,0.4,0.4,transcript,35705.0
FAM171B,ENSG00000144369,metabolite measurement,EFO_0004725,0.3393352845415267,3.3934226412624144,1,0.4,0.4,transcript,5731.0
TMEM131,ENSG00000075568,erythrocyte count,EFO_0004305,0.3393300900481054,3.393322349352307,1,0.4,0.4,transcript,18649.0
ONECUT2,ENSG00000119547,Fuchs' endothelial dystrophy,MONDO_0005321,0.3393267302563457,3.3944291282895978,7,2.8000000000000003,19.6,transcript,16870.0
PROK2,ENSG00000163421,granulocyte percentage of myeloid white cells,EFO_0007997,0.3393027525344485,3.393542989262011,2,0.8,1.6,transcript,3104.0
CNTLN,ENSG00000044459,gestational age,EFO_0005112,0.3392905698389858,3.3930271589531316,2,0.8,1.6,transcript,13173.0
SKP2,ENSG00000145604,appendicular lean mass,EFO_0004980,0.3392824315903837,3.3928293387578226,1,0.4,0.4,transcript,79636.0
TOPAZ1,ENSG00000173769,threitol measurement,EFO_0021031,0.3392695103326413,3.3927888416091276,1,0.5,0.5,transcript,5334.0
NEK7,ENSG00000151414,synovial bursa disorder,MONDO_0056802,0.33923906400150955,3.392435904245038,1,0.4,0.4,transcript,8837.0
NCKAP1,ENSG00000061676,genetic disorder,EFO_0000508,0.33921741850819725,3.392184014299321,1,0.4,0.4,transcript,40695.0
RSBN1L,ENSG00000187257,systolic blood pressure,EFO_0006335,0.33919533133863305,3.392090030467421,2,0.8,1.6,transcript,11703.0
NDUFAF4,ENSG00000123545,chronic kidney disease,EFO_0003884,0.33917164552981044,3.3918280001949253,1,0.4,0.4,transcript,3586.0
DTHD1,ENSG00000197057,growth differentiation factor 15 amount,OBA_2050135,0.33913579781526826,3.391384378701814,1,0.5,0.5,transcript,18939.0
ARHGAP12,ENSG00000165322,neuroimaging measurement,EFO_0004346,0.33913506697774687,3.3913627321398825,1,0.4,0.4,transcript,33161.0
RTKN2,ENSG00000182010,autoimmune disease,EFO_0005140,0.33912289265022305,3.3912641843250597,1,0.4,0.4,transcript,11345.0
NEK1,ENSG00000137601,placental retention,EFO_0009578,0.33910472997047064,3.391061559572981,2,0.8,1.6,transcript,112203.0
LRRC58,ENSG00000163428,total cholesterol measurement,EFO_0004574,0.3390972234777226,3.3911743060073345,2,0.8,1.6,transcript,7918.0
NDUFAF4,ENSG00000123545,aging,EFO_0022597,0.3390970591192279,3.3910821360891,1,0.4,0.4,transcript,3586.0
ANKRD36,ENSG00000135976,neuroimaging measurement,EFO_0004346,0.33908892872416513,3.390964673596721,2,1.0,2.0,transcript,26530.0
SPRED1,ENSG00000166068,adolescent idiopathic scoliosis,EFO_0005423,0.33901837470450885,3.3902283202565884,1,0.4,0.4,transcript,8974.0
FLRT2,ENSG00000185070,polygenic risk score,EFO_0030082,0.33897300076999404,3.3900655264701616,7,2.8000000000000003,19.6,transcript,58417.0
FLRT2,ENSG00000185070,Alzheimer disease,MONDO_0004975,0.33897300076999404,3.3900655264701616,7,2.8000000000000003,19.6,transcript,58417.0
SKIL,ENSG00000136603,eosinophil percentage of leukocytes,EFO_0007991,0.3389635238270091,3.3896516980916664,1,0.5,0.5,transcript,30377.0
C18orf54,ENSG00000166845,heart rate,OBA_1001087,0.33896131801331414,3.3896986547845653,2,0.8,1.6,transcript,18719.0
TNFRSF19,ENSG00000127863,bone remodeling disease,MONDO_0000833,0.3389539134003732,3.38957213512577,1,0.5,0.5,transcript,15151.0
ENPEP,ENSG00000138792,hypertensive heart disease,MONDO_0001302,0.33895149425342136,3.3895573423646144,1,0.4,0.4,transcript,9434.0
TC2N,ENSG00000165929,coronary artery disease,EFO_0001645,0.3389403614687789,3.38942637947067,1,0.4,0.4,transcript,17571.0
FLRT2,ENSG00000185070,urinary microalbumin measurement,EFO_0010967,0.3389222238031849,3.38955775680207,7,2.8000000000000003,19.6,transcript,58417.0
VPS50,ENSG00000004766,heart rate,OBA_1001087,0.33890913729186134,3.3891025348786536,1,0.4,0.4,transcript,35836.0
PRTG,ENSG00000166450,neurodegenerative disease,EFO_0005772,0.33890445891082244,3.3892626651925473,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
STARD13,ENSG00000133121,aneurysm,EFO_0009659,0.33889367176934165,3.3889515341545047,1,0.4,0.4,transcript,26997.0
STARD13,ENSG00000133121,medical procedure,EFO_0002571,0.33889367176934165,3.3889515341545047,1,0.4,0.4,transcript,26997.0
FRMD4B,ENSG00000114541,high density lipoprotein cholesterol measurement,EFO_0004612,0.3388821979142559,3.38889807540433,2,0.8,1.6,transcript,21026.0
MAGI2,ENSG00000187391,rosacea,EFO_1000760,0.33885050232378744,3.388509586634867,1,0.4,0.4,transcript,87654.0
LHFPL2,ENSG00000145685,age of onset of Parkinson disease,OBA_2001009,0.33877492260669667,3.387776118631173,1,0.4,0.4,transcript,14874.0
STARD13,ENSG00000133121,BRCA2 mutation carier statu,EFO_0011022,0.33877492260669667,3.387764042528055,1,0.4,0.4,transcript,26997.0
UMPS,ENSG00000114491,genetic disorder,EFO_0000508,0.33876824597420496,3.3877013161037146,1,0.4,0.4,transcript,21213.0
YEATS2,ENSG00000163872,heart rate,OBA_1001087,0.3387496341216457,3.387530081684775,1,0.5,0.5,transcript,14819.0
DNAH14,ENSG00000185842,blood protein measurement,EFO_0007937,0.33874644450668134,3.3875224235503536,3,1.5,4.5,transcript,77615.0
GSTA5,ENSG00000182793,blood urea nitrogen measurement,EFO_0004741,0.3387446067317975,3.3877962073739973,1,0.5,0.5,transcript,1428.0
CYSLTR1,ENSG00000173198,Parkinson disease,MONDO_0005180,0.33872918697057974,3.3874820063665223,2,0.8,1.6,transcript,8415.0
CADPS,ENSG00000163618,metabolite measurement,EFO_0004725,0.33872266931993295,3.387236010909968,1,0.4,0.4,transcript,42929.0
GFRAL,ENSG00000187871,glomerular filtration rate,OBA_0003747,0.3386936860243587,3.3871461747386156,1,0.4,0.4,transcript,1911.0
SPOCK3,ENSG00000196104,arterial stiffness measurement,EFO_0004517,0.3386903023372029,3.386985388156508,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
CTBP2,ENSG00000175029,monocyte count,EFO_0005091,0.338675003423941,3.3867640974535576,1,0.4,0.4,transcript,28443.0
ITGA8,ENSG00000077943,growth differentiation factor 15 amount,OBA_2050135,0.33867321958517954,3.387196951854894,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
CCDC80,ENSG00000091986,hip geometry,EFO_0004685,0.3386670218029834,3.3867494259506263,2,0.8,1.6,transcript,20200.0
SEMA3A,ENSG00000075213,eye measurement,EFO_0004731,0.3386549204872852,3.386579409509263,1,0.4,0.4,transcript,13243.0
DLC1,ENSG00000164741,platelet volume,OBA_0003277,0.3386432816269044,3.386444495442158,1,0.4,0.4,transcript,34249.0
GALNT3,ENSG00000115339,diabetes mellitus,EFO_0000400,0.33860401795169753,3.3860690875172645,1,0.4,0.4,transcript,13837.0
FANCF,ENSG00000183161,cigarettes per day measurement,EFO_0006525,0.3385894225532628,3.386015769136396,1,0.4,0.4,transcript,3291.0
IREB2,ENSG00000136381,mean corpuscular hemoglobin concentration,EFO_0004528,0.3385893189743769,3.3859930455076657,2,0.9,1.8,transcript,18026.0
TRMT9B,ENSG00000250305,COVID-19,MONDO_0100096,0.3385812886813928,3.3859540134751067,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
TRMT9B,ENSG00000250305,severe acute respiratory syndrome,EFO_0000694,0.3385812886813928,3.3859540134751067,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
CPD,ENSG00000108582,appendicular lean mass,EFO_0004980,0.33857153200947,3.3857355384529693,1,0.4,0.4,transcript,19784.0
TC2N,ENSG00000165929,sexual dimorphism measurement,EFO_0021796,0.3385448148671972,3.385470913454853,1,0.4,0.4,transcript,17571.0
SAXO1,ENSG00000155875,prostate carcinoma,EFO_0001663,0.338528611479632,3.3853127903548392,1,0.4,0.4,transcript,14995.0
LUZP2,ENSG00000187398,Abruptio Placentae,EFO_1001754,0.3385182233813483,3.3854990138377072,4,1.7000000000000002,6.800000000000001,transcript,21466.0
FMN1,ENSG00000248905,albuminuria,EFO_0004285,0.3385171901660174,3.3852075992126602,2,0.8,1.6,transcript,44821.0
FREM2,ENSG00000150893,sialolithiasis,EFO_1001180,0.3385171901660174,3.386063008414763,6,2.5,15.0,transcript,16833.0
CPO,ENSG00000144410,Abruptio Placentae,EFO_1001754,0.33848719056398774,3.38527351206558,1,0.5,0.5,transcript,1245.0
TFEC,ENSG00000105967,intraocular pressure measurement,EFO_0004695,0.33848392877348316,3.3848549850898273,1,0.4,0.4,transcript,25482.0
TOPAZ1,ENSG00000173769,hip circumference,OBA_1000032,0.33845766750406314,3.384670413323346,1,0.5,0.5,transcript,5334.0
CFAP299,ENSG00000197826,hemoglobin measurement,EFO_0004509,0.33845377530620124,3.384602891154769,1,0.5,0.5,transcript,7676.0
DGKH,ENSG00000102780,insulin measurement,EFO_0004467,0.33838142208065075,3.3838416138452514,2,0.8,1.6,transcript,58409.0
LSM11,ENSG00000155858,erythrocyte volume,OBA_0003460,0.33835583466347413,3.383619257248416,1,0.4,0.4,transcript,6567.0
DLGAP1,ENSG00000170579,chondromalacia,MONDO_0002342,0.3383552974250234,3.383581128394172,2,0.8,1.6,transcript,56830.0
TRDN,ENSG00000186439,cervical carcinoma,EFO_0001061,0.3383552974250234,3.383572177691491,1,0.5,0.5,transcript,26037.0
PDE1C,ENSG00000154678,obesity,EFO_0001073,0.3383552974250234,3.3836073331549024,2,0.8,1.6,transcript,29434.0
RNF150,ENSG00000170153,gastritis,EFO_0000217,0.3383552974250234,3.383811633264905,4,1.6,6.4,transcript,24743.0
COLEC10,ENSG00000184374,keratinocyte carcinoma,EFO_0010176,0.338350195240506,3.3836071325260177,1,0.4,0.4,transcript,3803.0
CASQ2,ENSG00000118729,heart function attribute,OBA_2045275,0.3383289732839695,3.383302383861265,1,0.4,0.4,transcript,31618.0
HEPHL1,ENSG00000181333,frozen shoulder,EFO_1000941,0.3383266401477928,3.383335260145513,1,0.4,0.4,transcript,5809.0
DAG1,ENSG00000173402,Red cell distribution width,EFO_0009188,0.3383260401364372,3.383266589483184,1,0.4,0.4,transcript,64640.0
LUZP2,ENSG00000187398,drug use measurement,EFO_0007010,0.33829150418761844,3.383231821900409,4,1.7000000000000002,6.800000000000001,transcript,21466.0
NBAS,ENSG00000151779,placenta praevia,EFO_0007442,0.33829150418761844,3.3829485876661876,2,1.0,2.0,transcript,59620.0
LUZP2,ENSG00000187398,amyotrophic lateral sclerosis,MONDO_0004976,0.33829150418761844,3.383231821900409,4,1.7000000000000002,6.800000000000001,transcript,21466.0
PLPP4,ENSG00000203805,Abnormality of the integument,HP_0001574,0.33829150418761844,3.382995931663849,1,0.4,0.4,transcript,4945.0
TRPC6,ENSG00000137672,matrix metalloproteinase 7 measurement,EFO_0010591,0.33829150418761844,3.382943928999749,1,0.4,0.4,transcript,13847.0
CNMD,ENSG00000136110,body mass index,EFO_0004340,0.33829021543149035,3.383342925664766,2,0.8,1.6,transcript,3630.0
ANKRD17,ENSG00000132466,CXCL1 measurement,EFO_0010777,0.33829021543149035,3.3829113442243828,1,0.4,0.4,transcript,43526.0
MTCH2,ENSG00000109919,cholesterol to total lipids in medium HDL percentage ,EFO_0022237,0.3382807149409847,3.382866602441952,1,0.4,0.4,transcript,6728.0
DMAC1,ENSG00000137038,placenta praevia,EFO_0007442,0.3382656999355172,3.3827725728888325,1,0.4,0.4,transcript,3461.0
BACE2,ENSG00000182240,extrapyramidal and movement disease,MONDO_0001815,0.3382539845018576,3.3826734009451207,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
CHL1,ENSG00000134121,appendicular lean mass,EFO_0004980,0.33824952093840843,3.382542409808888,2,0.8,1.6,transcript,33898.0
MAP2K6,ENSG00000108984,brain volume,OBA_2050009,0.33823445721984713,3.382361874733293,1,0.4,0.4,transcript,23118.0
LIN54,ENSG00000189308,protein measurement,EFO_0004747,0.33822830973677853,3.3822960239448276,1,0.4,0.4,transcript,30944.0
HHLA2,ENSG00000114455,smoking status measurement,EFO_0006527,0.33820240208287927,3.3820578251692703,1,0.5,0.5,transcript,14791.0
ABCB1,ENSG00000085563,phosphate measurement,EFO_0010968,0.33812222857674834,3.3812463334781415,1,0.5,0.5,transcript,20792.0
NDST3,ENSG00000164100,cognitive function measurement,EFO_0008354,0.3381205564709729,3.3812556272879517,1,0.4,0.4,transcript,7990.0
LONRF1,ENSG00000154359,smoking cessation,EFO_0004319,0.33811908902827115,3.3812261835699284,1,0.5,0.5,transcript,14167.0
GCH1,ENSG00000131979,chronotype measurement,EFO_0008328,0.33810251400346536,3.381058903856718,1,0.4,0.4,transcript,11847.0
PRDM5,ENSG00000138738,spondyloarthropathy,EFO_0000706,0.33809117224637614,3.380992331058653,2,0.8,1.6,transcript,19849.0
LRRK2,ENSG00000188906,lysosomal storage disease,MONDO_0002561,0.33805677791926453,3.380586537008402,2,0.9,1.8,transcript,95960.0
ONECUT2,ENSG00000119547,serum gamma-glutamyl transferase measurement,EFO_0004532,0.3380345474110175,3.3815072998363163,7,2.8000000000000003,19.6,transcript,16870.0
RASGRP3,ENSG00000152689,liver disease,EFO_0001421,0.3380324893055709,3.3803360959684663,1,0.4,0.4,transcript,35705.0
ZNF507,ENSG00000168813,body mass index,EFO_0004340,0.3379945707762802,3.379960106610894,1,0.4,0.4,transcript,27780.0
VPS13A,ENSG00000197969,alpha-hydroxycaproate measurement,EFO_0800261,0.33797396484587666,3.379746393707582,1,0.4,0.4,transcript,59301.0
KCNN3,ENSG00000143603,genetic disorder,EFO_0000508,0.33797331892378457,3.3798522250477854,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
NRCAM,ENSG00000091129,blood protein measurement,EFO_0007937,0.33797204737442554,3.3797321270581664,1,0.4,0.4,transcript,34325.0
CYBRD1,ENSG00000071967,pericarditis,EFO_0007427,0.33796689317637657,3.3797030410841375,1,0.4,0.4,transcript,11727.0
TRDMT1,ENSG00000107614,protein measurement,EFO_0004747,0.3379628937933007,3.37964272960973,1,0.4,0.4,transcript,29003.0
ITPRID2,ENSG00000138434,glutamine measurement,EFO_0009768,0.3379543606730581,3.3795523942698504,1,0.4,0.4,transcript,45519.0
ZNF236,ENSG00000130856,prostate specific antigen amount,OBA_2050200,0.33795339081746784,3.3795928762336467,2,0.9,1.8,transcript,30525.0
NID2,ENSG00000087303,polyp of colon,MONDO_0021400,0.3379347290385175,3.3793924248859875,1,0.5,0.5,transcript,11078.0
TRMT9B,ENSG00000250305,glucose measurement,EFO_0004468,0.3379027026598525,3.3791681532597035,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
MYO5A,ENSG00000197535,breast adenocarcinoma,EFO_0000304,0.3378471315304391,3.378473354965603,1,0.4,0.4,transcript,196111.0
SPOCK3,ENSG00000196104,Hypercholesterolemia,HP_0003124,0.3378232205269041,3.37831457005352,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
PLXNA4,ENSG00000221866,electrocardiography,EFO_0004327,0.3378232205269041,3.378244452666469,1,0.4,0.4,transcript,32660.0
LHFPL2,ENSG00000145685,ovarian dysfunction,EFO_0009003,0.3378232205269041,3.378259097833247,1,0.4,0.4,transcript,14874.0
CENPQ,ENSG00000031691,neurodegenerative disease,EFO_0005772,0.33780477301786505,3.3782774831941587,1,0.4,0.4,transcript,1741.0
RASSF2,ENSG00000101265,mean corpuscular hemoglobin concentration,EFO_0004528,0.33778988662034914,3.3779996663042913,2,0.8,1.6,transcript,15873.0
CPPED1,ENSG00000103381,complication,EFO_0009518,0.3377731104660613,3.377768833391041,1,0.4,0.4,transcript,10602.0
CPPED1,ENSG00000103381,Herpes Zoster,EFO_0006510,0.3377731104660613,3.377768833391041,1,0.4,0.4,transcript,10602.0
CPPED1,ENSG00000103381,nervous system disease,EFO_0000618,0.3377731104660613,3.377768833391041,1,0.4,0.4,transcript,10602.0
MORF4L2,ENSG00000123562,body height,OBA_VT0001253,0.3377609755081795,3.377640604996958,1,0.4,0.4,transcript,12966.0
RSBN1L,ENSG00000187257,hip circumference,OBA_1000032,0.3377571281213768,3.377707998294859,2,0.8,1.6,transcript,11703.0
TMCC1,ENSG00000172765,wellbeing measurement,EFO_0007869,0.33774440979583026,3.3774542994375167,1,0.4,0.4,transcript,39210.0
RAPGEF4,ENSG00000091428,placenta praevia,EFO_0007442,0.3377153767094484,3.3771669531831603,1,0.4,0.4,transcript,30335.0
PTK2,ENSG00000169398,arterial stiffness measurement,EFO_0004517,0.3377153767094484,3.3771586092991397,1,0.4,0.4,transcript,82607.0
TXK,ENSG00000074966,metabolite measurement,EFO_0004725,0.3377000173070076,3.377029565383986,1,0.4,0.4,transcript,13609.0
ENPEP,ENSG00000138792,protein measurement,EFO_0004747,0.337695066603114,3.376993065861541,1,0.4,0.4,transcript,9434.0
AHCTF1,ENSG00000153207,erythrocyte volume,OBA_0003460,0.3376940597505493,3.3769538639758157,1,0.5,0.5,transcript,37689.0
PDE1C,ENSG00000154678,chronic kidney disease,EFO_0003884,0.33769332611107167,3.376987620015385,2,0.8,1.6,transcript,29434.0
SLC7A2,ENSG00000003989,Splenomegaly,HP_0001744,0.3376826371632457,3.376947367253568,3,1.4,4.199999999999999,transcript,34712.0
ST8SIA4,ENSG00000113532,ovarian dysfunction,EFO_0009003,0.33766217543624094,3.3766646314124684,1,0.4,0.4,transcript,9329.0
BTC,ENSG00000174808,connective tissue disease,EFO_1001986,0.33766217543624094,3.3767438172247837,1,0.4,0.4,transcript,3277.0
LUZP2,ENSG00000187398,serum creatinine amount,OBA_2050096,0.33766217543624094,3.376938534386634,4,1.7000000000000002,6.800000000000001,transcript,21466.0
RANBP17,ENSG00000204764,lymphocyte count,EFO_0004587,0.33766217543624094,3.376631268657638,1,0.4,0.4,transcript,42042.0
HS3ST3A1,ENSG00000153976,breast neoplasm,EFO_0003869,0.33766217543624094,3.376702791639557,1,0.4,0.4,transcript,4936.0
SLC44A1,ENSG00000070214,benign chondrogenic neoplasm,MONDO_0024470,0.33766217543624094,3.3766313632794844,1,0.4,0.4,transcript,41628.0
UNC80,ENSG00000144406,threitol measurement,EFO_0021031,0.33766217543624094,3.3766264163670714,1,0.4,0.4,transcript,85800.0
FAT3,ENSG00000165323,Spinal cord injury,EFO_1001919,0.33766217543624094,3.3766300833577243,1,0.4,0.4,transcript,48025.0
SEMA3C,ENSG00000075223,arterial stiffness measurement,EFO_0004517,0.33766217543624094,3.376655472646149,1,0.4,0.4,transcript,11863.0
CLSTN2,ENSG00000158258,arterial stiffness measurement,EFO_0004517,0.33766217543624094,3.376645840591108,1,0.4,0.4,transcript,16607.0
DLG2,ENSG00000150672,platelet volume,OBA_0003277,0.3375917657896386,3.375920430821545,1,0.4,0.4,transcript,144252.0
SYNJ2,ENSG00000078269,corneal resistance factor,EFO_0010067,0.3375907336675565,3.3759584843003974,2,0.8,1.6,transcript,31282.0
LRPAP1,ENSG00000163956,free cholesterol in small LDL measurement ,EFO_0022271,0.3375643158119895,3.3758737942913344,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
TRDN,ENSG00000186439,intraocular pressure measurement,EFO_0004695,0.3375513224150969,3.3755324275922254,1,0.5,0.5,transcript,26037.0
PEX13,ENSG00000162928,lymphocyte count,EFO_0004587,0.33751746736920923,3.3752205032062994,1,0.4,0.4,transcript,8728.0
BIRC6,ENSG00000115760,metabolite ratio,EFO_0022223,0.3374898712896268,3.3749058951532205,1,0.5,0.5,transcript,69616.0
ZNF143,ENSG00000166478,lean body mass,EFO_0004995,0.3374842867375366,3.3748691472029706,1,0.5,0.5,transcript,19026.0
HHLA2,ENSG00000114455,insomnia,EFO_0004698,0.33747500790862,3.3747838834266775,1,0.5,0.5,transcript,14791.0
COLEC10,ENSG00000184374,osteoporosis,EFO_0003882,0.33746534993459554,3.3747586794669124,1,0.4,0.4,transcript,3803.0
SLC25A46,ENSG00000164209,contracture,EFO_0003899,0.33746115940245996,3.3746315471347907,1,0.4,0.4,transcript,20047.0
ATP10D,ENSG00000145246,platelet count,EFO_0004309,0.33746115940245996,3.37464341683519,1,0.5,0.5,transcript,15712.0
CHL1,ENSG00000134121,Abnormality of the gastrointestinal tract,HP_0011024,0.33746115940245996,3.3746587944494033,2,0.8,1.6,transcript,33898.0
ZBTB21,ENSG00000173276,red blood cell density,OBA_2045260,0.33745071031253987,3.3745214051848955,1,0.4,0.4,transcript,27968.0
HS6ST3,ENSG00000185352,major depressive disorder,MONDO_0002009,0.3374180154541754,3.374227014897892,1,0.4,0.4,transcript,8536.0
TMEM132B,ENSG00000139364,Skull Fractures,EFO_1001425,0.337405318412172,3.3741425474083027,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
SH3GL3,ENSG00000140600,heart rate,OBA_1001087,0.3373994994808357,3.37404668775227,1,0.4,0.4,transcript,7738.0
COL25A1,ENSG00000188517,skin disease,EFO_0000701,0.337394853046412,3.3739634921248642,1,0.4,0.4,transcript,26735.0
FMN1,ENSG00000248905,hypertrophic cardiomyopathy,EFO_0000538,0.337394853046412,3.373984228016606,2,0.8,1.6,transcript,44821.0
MDGA2,ENSG00000139915,caproate 6:0 measurement,EFO_0021102,0.337394853046412,3.3739716211527995,1,0.4,0.4,transcript,17323.0
CADPS,ENSG00000163618,hearing process quality,OBA_2045262,0.337394853046412,3.3739578481747583,1,0.4,0.4,transcript,42929.0
HS6ST3,ENSG00000185352,metabolite measurement,EFO_0004725,0.3373581673329534,3.373628533685672,1,0.4,0.4,transcript,8536.0
CNMD,ENSG00000136110,suberate (C8-DC) measurement,EFO_0800181,0.33731977876020985,3.373638558951961,2,0.8,1.6,transcript,3630.0
RTKN2,ENSG00000182010,B-cell acute lymphoblastic leukemia,EFO_0000094,0.3373015418007289,3.373050675830118,1,0.4,0.4,transcript,11345.0
C15orf61,ENSG00000189227,liver disease,EFO_0001421,0.3372945754893358,3.3745672888644944,5,2.0,10.0,transcript,6167.0
PTCHD4,ENSG00000244694,lysophosphatidylcholine measurement,EFO_0010224,0.3372945754893358,3.373359595564699,6,2.4000000000000004,14.400000000000002,transcript,34796.0
GSTA5,ENSG00000182793,total cholesterol measurement,EFO_0004574,0.3372786315876877,3.3731364559328996,1,0.5,0.5,transcript,1428.0
SLCO6A1,ENSG00000205359,Abruptio Placentae,EFO_1001754,0.3372730895816598,3.3727721499420107,1,0.5,0.5,transcript,12120.0
MAP3K7,ENSG00000135341,chiro-inositol measurement,EFO_0800270,0.33725923458719237,3.372681732595202,4,1.6,6.4,transcript,71599.0
PAFAH1B2,ENSG00000168092,fatty acid measurement,EFO_0005110,0.33724993969207107,3.3726331873714175,2,0.8,1.6,transcript,11959.0
OTUD7A,ENSG00000169918,body mass index,EFO_0004340,0.3372497791362667,3.3725155179303603,1,0.4,0.4,transcript,22565.0
GPAT3,ENSG00000138678,alcohol consumption quality,OBA_1000840,0.33723982633595606,3.372545389796342,2,0.8,1.6,transcript,10875.0
CTBP2,ENSG00000175029,HbA1c measurement,EFO_0004541,0.33723406444012816,3.372354707615429,1,0.4,0.4,transcript,28443.0
CNTN1,ENSG00000018236,body weight,EFO_0004338,0.3372313125979125,3.3723296528559583,1,0.4,0.4,transcript,24203.0
PRKCB,ENSG00000166501,systemic lupus erythematosus,MONDO_0007915,0.3372290432469981,3.3723143989169553,1,0.4,0.4,transcript,16690.0
KIAA0586,ENSG00000100578,body mass index,EFO_0004340,0.3372196069914275,3.3722017209727184,1,0.5,0.5,transcript,88479.0
KIAA0586,ENSG00000100578,body weight,EFO_0004338,0.3372196069914275,3.3722017209727184,1,0.5,0.5,transcript,88479.0
MATN2,ENSG00000132561,eosinophilic esophagitis,EFO_0004232,0.3372196069914275,3.3722130253891978,1,0.5,0.5,transcript,29489.0
TENT4B,ENSG00000121274,hypertrophic cardiomyopathy,EFO_0000538,0.3372189820491565,3.372439235924145,4,1.6,6.4,transcript,25660.0
TRDMT1,ENSG00000107614,hemoglobin A1 measurement,EFO_0007629,0.33720152015020066,3.3720289931787293,1,0.4,0.4,transcript,29003.0
RNMT,ENSG00000101654,bone tissue density,OBA_1000110,0.33719396085640774,3.3719560302735774,1,0.4,0.4,transcript,24358.0
SLC15A5,ENSG00000188991,Myasthenia gravis,EFO_0004991,0.3371640240354752,3.3728718517129455,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
ONECUT2,ENSG00000119547,level of serum globulin type protein,OBA_2045206,0.33715240434717686,3.3726858691979094,7,2.8000000000000003,19.6,transcript,16870.0
TBXT,ENSG00000164458,urate measurement,EFO_0004531,0.3371432496845901,3.37189297267092,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
RNF144B,ENSG00000137393,low density lipoprotein cholesterol measurement,EFO_0004611,0.33714009400177375,3.371473813036502,1,0.4,0.4,transcript,5489.0
COQ3,ENSG00000132423,2-hydroxyglutarate measurement,EFO_0021506,0.3371029293775089,3.371179839503354,1,0.4,0.4,transcript,2657.0
LSM6,ENSG00000164167,attention deficit hyperactivity disorder,EFO_0003888,0.3371013622321255,3.3711790311913057,2,0.8,1.6,transcript,9673.0
THEM4,ENSG00000159445,indoleacetoylcarnitine measurement,EFO_0800106,0.3370960461880735,3.3711148126428414,2,0.8,1.6,transcript,10366.0
COQ3,ENSG00000132423,Benign Thyroid Gland Neoplasm,EFO_1000122,0.33704796581444,3.370630203872665,1,0.4,0.4,transcript,2657.0
DAG1,ENSG00000173402,serum creatinine amount,OBA_2050096,0.33702887642596674,3.3702949523784795,1,0.4,0.4,transcript,64640.0
ARHGAP29,ENSG00000137962,arterial stiffness measurement,EFO_0004517,0.3369745115522684,3.3697653412417083,1,0.5,0.5,transcript,24721.0
SPOCK3,ENSG00000196104,multinodular goiter,MONDO_0000334,0.33694346341223863,3.369516998906865,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
LMO4,ENSG00000143013,prostate specific antigen amount,OBA_2050200,0.3369277029524168,3.3693285095756482,1,0.4,0.4,transcript,7770.0
PIP4K2A,ENSG00000150867,lean body mass,EFO_0004995,0.33692557842646786,3.3692992294694144,1,0.4,0.4,transcript,9207.0
HPSE,ENSG00000173083,protein measurement,EFO_0004747,0.3368826010547038,3.3689138582776383,2,0.9,1.8,transcript,20490.0
HPSE,ENSG00000173083,protrudin measurement,EFO_0802976,0.3368826010547038,3.3689138582776383,2,0.9,1.8,transcript,20490.0
GPR180,ENSG00000152749,erythrocyte volume,OBA_0003460,0.3368354402090409,3.368399426854029,1,0.4,0.4,transcript,8884.0
GREM1,ENSG00000166923,pelvic organ prolapse,EFO_0004710,0.336827281600942,3.368291040074298,1,0.4,0.4,transcript,21949.0
DLG2,ENSG00000150672,neuroimaging measurement,EFO_0004346,0.3367835780527827,3.3678385534529856,1,0.4,0.4,transcript,144252.0
IGFBPL1,ENSG00000137142,high density lipoprotein cholesterol measurement,EFO_0004612,0.33675868752653393,3.369381603251879,4,1.6,6.4,transcript,3566.0
MTR,ENSG00000116984,heart rate,OBA_1001087,0.336745659523784,3.367461007667655,1,0.4,0.4,transcript,90653.0
SLCO5A1,ENSG00000137571,neutrophil measurement,EFO_0803548,0.3367163848676747,3.367594400644369,5,2.0,10.0,transcript,23226.0
PLPP4,ENSG00000203805,Parkinson disease,MONDO_0005180,0.3366954625526122,3.3670355153137863,1,0.4,0.4,transcript,4945.0
DNAH14,ENSG00000185842,high density lipoprotein cholesterol measurement,EFO_0004612,0.33667380593890256,3.366796037872566,3,1.5,4.5,transcript,77615.0
NUP153,ENSG00000124789,bone tissue density,OBA_1000110,0.3366208277919808,3.366236262472335,1,0.5,0.5,transcript,17867.0
NUP153,ENSG00000124789,urate measurement,EFO_0004531,0.3366208277919808,3.366236262472335,1,0.5,0.5,transcript,17867.0
STARD13,ENSG00000133121,ovarian neoplasm,EFO_0003893,0.33661568435142825,3.366171659975371,1,0.4,0.4,transcript,26997.0
DCDC2,ENSG00000146038,lymphocyte count,EFO_0004587,0.33659210819812346,3.3659668590469245,1,0.4,0.4,transcript,8738.0
THEM4,ENSG00000159445,Eczematoid dermatitis,HP_0000964,0.3365648962753125,3.3658033135152317,2,0.8,1.6,transcript,10366.0
IMPG2,ENSG00000081148,Macular dystrophy,HP_0007754,0.33653325601164463,3.3655480773578255,2,0.9,1.8,transcript,8352.0
SLC15A5,ENSG00000188991,hip circumference,OBA_1000032,0.3365308625459037,3.366540236817231,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
C12orf42,ENSG00000179088,type 2 diabetes mellitus,MONDO_0005148,0.3364921297191972,3.364956436695802,1,0.5,0.5,transcript,14229.0
SGCZ,ENSG00000185053,Splenomegaly,HP_0001744,0.33643995494929135,3.3644482586989533,1,0.4,0.4,transcript,8212.0
NEK7,ENSG00000151414,ovarian dysfunction,EFO_0009003,0.33643995494929135,3.364444813722856,1,0.4,0.4,transcript,8837.0
PCDH18,ENSG00000189184,essential hypertension,MONDO_0001134,0.3364283829240541,3.364361000899249,2,0.8,1.6,transcript,20733.0
UBE2U,ENSG00000177414,body mass index,EFO_0004340,0.33641062942919575,3.3641735098859753,1,0.4,0.4,transcript,5951.0
STARD13,ENSG00000133121,high density lipoprotein cholesterol measurement,EFO_0004612,0.33641012797323,3.3641160961933885,1,0.4,0.4,transcript,26997.0
RFX3,ENSG00000080298,phosphatidylcholine measurement,EFO_0010226,0.33639937073640025,3.3640502085293393,2,0.8,1.6,transcript,28318.0
SNTG2,ENSG00000172554,orotate measurement,EFO_0800642,0.33639937073640025,3.3640435976054714,1,0.5,0.5,transcript,10022.0
XKR4,ENSG00000206579,glomerular filtration rate,OBA_0003747,0.33639937073640025,3.3640126593207924,1,0.4,0.4,transcript,21106.0
FRAS1,ENSG00000138759,platelet volume,OBA_0003277,0.33639937073640025,3.36402584390861,2,0.9,1.8,transcript,56011.0
PTPRO,ENSG00000151490,lagophthalmos,MONDO_0001604,0.33639937073640025,3.3639981559604704,1,0.4,0.4,transcript,89916.0
MORF4L2,ENSG00000123562,platelet volume,OBA_0003277,0.33637678400918364,3.363798690006999,1,0.4,0.4,transcript,12966.0
COLEC10,ENSG00000184374,femoral neck bone mineral density,EFO_0007785,0.33637268232347056,3.363832003355663,1,0.4,0.4,transcript,3803.0
MAP2K6,ENSG00000108984,body height,OBA_VT0001253,0.33635466214171816,3.363563923952003,1,0.4,0.4,transcript,23118.0
ARAP1,ENSG00000186635,rheumatoid arthritis,EFO_0000685,0.33635103993813237,3.3635194089990907,1,0.4,0.4,transcript,44397.0
MDGA2,ENSG00000139915,arterial stiffness measurement,EFO_0004517,0.3363400085923712,3.3634231766123914,1,0.4,0.4,transcript,17323.0
FBXO28,ENSG00000143756,genetic disorder,EFO_0000508,0.3363258864991671,3.364307852718515,5,2.0,10.0,transcript,9533.0
OXSR1,ENSG00000172939,neuroinflammatory disorder,EFO_0020092,0.3363061015912304,3.3631015920940857,1,0.4,0.4,transcript,9858.0
PKP2,ENSG00000057294,neurodegenerative disease,EFO_0005772,0.3363060994907256,3.3632170962755823,4,1.6,6.4,transcript,40999.0
KPNA4,ENSG00000186432,glutamine measurement,EFO_0009768,0.33627714018163346,3.3627803950264608,1,0.4,0.4,transcript,44478.0
CCDC88C,ENSG00000015133,triglyceride measurement,EFO_0004530,0.33624084419584777,3.3624277646965095,1,0.4,0.4,transcript,20701.0
KIF20B,ENSG00000138182,colorectal cancer,MONDO_0005575,0.3362192395736919,3.3622197076940936,1,0.5,0.5,transcript,18307.0
NDUFAF4,ENSG00000123545,Autosomal dominant polycystic kidney disease,EFO_1001496,0.33621500669233284,3.3622616118201494,1,0.4,0.4,transcript,3586.0
ANKRD29,ENSG00000154065,neutrophil count,EFO_0004833,0.3361929542850143,3.3619631534710988,1,0.4,0.4,transcript,11901.0
STXBP5,ENSG00000164506,urethritis,EFO_0003878,0.3361870790163467,3.361884620571925,2,0.9,1.8,transcript,130148.0
STXBP5,ENSG00000164506,urethral syndrome,MONDO_0001730,0.3361870790163467,3.361884620571925,2,0.9,1.8,transcript,130148.0
MYO1B,ENSG00000128641,ovarian neoplasm,EFO_0003893,0.33617842746853593,3.3617976831058476,1,0.4,0.4,transcript,29832.0
SEPTIN7,ENSG00000122545,vitamin B6 measurement,EFO_0004621,0.3361714933849821,3.361724610176687,1,0.4,0.4,transcript,41338.0
LUZP2,ENSG00000187398,inherited retinal dystrophy,MONDO_0019118,0.3361675671861431,3.3619924518856554,4,1.7000000000000002,6.800000000000001,transcript,21466.0
ANKH,ENSG00000154122,diabetic neuropathy,EFO_1000783,0.336138055455034,3.3621489971732905,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,diabetic neuropathy,EFO_1000783,0.336138055455034,3.3621489971732905,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,diabetic neuropathy,EFO_1000783,0.336138055455034,3.3621489971732905,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,diabetic neuropathy,EFO_1000783,0.336138055455034,3.3621489971732905,5,2.4,12.0,transcript,15616.0
YTHDC2,ENSG00000047188,diastolic blood pressure change measurement,EFO_0006945,0.33607977495624625,3.360817958727319,1,0.4,0.4,transcript,19793.0
PARP8,ENSG00000151883,lymphocyte count,EFO_0004587,0.33605374314258163,3.3605845082493078,2,0.8,1.6,transcript,33987.0
BHLHE41,ENSG00000123095,sensorineural hearing loss,EFO_1001176,0.33604738609184726,3.3605621416512026,1,0.4,0.4,transcript,4531.0
RGS7BP,ENSG00000186479,educational attainment,EFO_0011015,0.3360342409681911,3.3604305309367577,1,0.5,0.5,transcript,5674.0
TRPC6,ENSG00000137672,risk-taking behaviour,EFO_0008579,0.3360342409681911,3.360371296805476,1,0.4,0.4,transcript,13847.0
TC2N,ENSG00000165929,Ischemic stroke,HP_0002140,0.3360234730080753,3.360257494863634,1,0.4,0.4,transcript,17571.0
LIN54,ENSG00000189308,monocyte count,EFO_0005091,0.33600187593001724,3.360031685877215,1,0.4,0.4,transcript,30944.0
MYO1B,ENSG00000128641,colorectal cancer,MONDO_0005575,0.335997519213958,3.359988600560068,1,0.4,0.4,transcript,29832.0
COL19A1,ENSG00000082293,Red cell distribution width,EFO_0009188,0.33596997759625985,3.3598371150183928,2,0.8,1.6,transcript,11650.0
CCDC7,ENSG00000216937,intestinal disease,EFO_0009431,0.33596997759625985,3.3597183730019498,1,0.5,0.5,transcript,26886.0
XKR4,ENSG00000206579,preeclampsia,EFO_0000668,0.33596997759625985,3.3597187279193883,1,0.4,0.4,transcript,21106.0
TENM4,ENSG00000149256,type 2 diabetes mellitus,MONDO_0005148,0.33595883541420757,3.3596058046263266,1,0.4,0.4,transcript,22922.0
DTHD1,ENSG00000197057,high density lipoprotein cholesterol measurement,EFO_0004612,0.3359485390684906,3.3595117912340373,1,0.5,0.5,transcript,18939.0
PDHX,ENSG00000110435,alanine measurement,EFO_0009765,0.33592606017789894,3.3593053695461967,1,0.4,0.4,transcript,8935.0
TRIT1,ENSG00000043514,IGF-1 measurement,EFO_0004627,0.3358914597340749,3.358929800107653,1,0.4,0.4,transcript,26311.0
ACVR1C,ENSG00000123612,eosinophil percentage of leukocytes,EFO_0007991,0.3358862823766891,3.3589821377117084,2,0.8,1.6,transcript,13410.0
GSTA5,ENSG00000182793,serum creatinine amount,OBA_2050096,0.335852391405199,3.3588740541080124,1,0.5,0.5,transcript,1428.0
ZBTB34,ENSG00000177125,schizophrenia,MONDO_0005090,0.3357726270329902,3.3577565986337916,1,0.4,0.4,transcript,13189.0
ARL3,ENSG00000138175,systolic blood pressure,EFO_0006335,0.3357471397373292,3.357575727055087,1,0.4,0.4,transcript,3834.0
CD86,ENSG00000114013,total blood protein measurement,EFO_0004536,0.3357403507237782,3.357435341698586,1,0.4,0.4,transcript,12565.0
DCDC2,ENSG00000146038,sialadenitis,EFO_1001179,0.3357403507237782,3.3574492843034722,1,0.4,0.4,transcript,8738.0
GALR1,ENSG00000166573,smoking status measurement,EFO_0006527,0.33573455413576,3.3574901545173974,2,0.8,1.6,transcript,11064.0
STX7,ENSG00000079950,BMI-adjusted waist-hip ratio,EFO_0007788,0.3357270579437181,3.357359094595402,2,0.8,1.6,transcript,18076.0
COQ3,ENSG00000132423,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.33572692520186714,3.357419797746936,1,0.4,0.4,transcript,2657.0
AKR1C1,ENSG00000187134,Peyronie disease,MONDO_0008231,0.3357263447377305,3.3574026383298934,2,0.8,1.6,transcript,11495.0
SUMF1,ENSG00000144455,lower respiratory tract disease,EFO_0009433,0.3357223062422452,3.3572554117956828,1,0.4,0.4,transcript,12365.0
ARL3,ENSG00000138175,body mass index,EFO_0004340,0.3357218219199949,3.3573225488817435,1,0.4,0.4,transcript,3834.0
DAG1,ENSG00000173402,placenta praevia,EFO_0007442,0.3357122190341436,3.3571283784602484,1,0.4,0.4,transcript,64640.0
ZNF675,ENSG00000197372,beta-Ala-His dipeptidase measurement,EFO_0008033,0.3357105380733093,3.3571481779598327,1,0.5,0.5,transcript,11683.0
ABCB5,ENSG00000004846,arterial stiffness measurement,EFO_0004517,0.335681687034668,3.3568437828138804,1,0.4,0.4,transcript,14863.0
DCK,ENSG00000156136,childhood trauma measurement,EFO_0007979,0.3356616257537057,3.3566532432051104,1,0.4,0.4,transcript,10815.0
DCK,ENSG00000156136,alcohol consumption quality,OBA_1000840,0.3356616257537057,3.3566532432051104,1,0.4,0.4,transcript,10815.0
CENPE,ENSG00000138778,diastolic blood pressure change measurement,EFO_0006945,0.33563729087965655,3.356398602527295,1,0.5,0.5,transcript,19460.0
ARHGAP20,ENSG00000137727,Abnormality of limbs,HP_0040064,0.3356191267820189,3.3562015124097653,1,0.4,0.4,transcript,39045.0
DOCK1,ENSG00000150760,amputation,EFO_0009632,0.3356191267820189,3.356216355627515,1,0.4,0.4,transcript,15944.0
NPS,ENSG00000214285,fumarate measurement,EFO_0010480,0.3356191267820189,3.3565162068941126,1,0.4,0.4,transcript,1231.0
PDE1C,ENSG00000154678,corneal neovascularization,EFO_1000880,0.3356191267820189,3.3562456267248573,2,0.8,1.6,transcript,29434.0
APIP,ENSG00000149089,metabolite measurement,EFO_0004725,0.3356188296409302,3.3562610660207124,1,0.5,0.5,transcript,6871.0
ANKRD30B,ENSG00000180777,level of Phosphatidylcholine (14:0_18:2) in blood serum,OBA_2045063,0.3355464218026298,3.3554887844292853,1,0.5,0.5,transcript,20353.0
MAP2K6,ENSG00000108984,apolipoprotein A 1 measurement,EFO_0004614,0.3355329048602971,3.355346351137792,1,0.4,0.4,transcript,23118.0
ARHGAP29,ENSG00000137962,level of serum globulin type protein,OBA_2045206,0.3355329048602971,3.3553492743219953,1,0.5,0.5,transcript,24721.0
VPS13A,ENSG00000197969,arterial stiffness measurement,EFO_0004517,0.3355108769776735,3.3551155150255507,1,0.4,0.4,transcript,59301.0
NXPH2,ENSG00000144227,bone tissue density,OBA_1000110,0.3355108769776735,3.355256425738345,1,0.4,0.4,transcript,2709.0
NXPH2,ENSG00000144227,urate measurement,EFO_0004531,0.3355108769776735,3.355256425738345,1,0.4,0.4,transcript,2709.0
FMN1,ENSG00000248905,idiopathic pulmonary fibrosis,EFO_0000768,0.3355108769776735,3.3551444673292217,2,0.8,1.6,transcript,44821.0
UBL3,ENSG00000122042,bone tissue density,OBA_1000110,0.3355108769776735,3.3559426822159293,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
DLG1,ENSG00000075711,sex hormone-binding globulin measurement,EFO_0004696,0.3354709872001084,3.3547252817725908,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
DLG1,ENSG00000075711,serum alanine aminotransferase measurement,EFO_0004735,0.3354709872001084,3.3547252817725908,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
DLG1,ENSG00000075711,body mass index,EFO_0004340,0.3354709872001084,3.3547252817725908,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
DLG1,ENSG00000075711,aspartate aminotransferase measurement,EFO_0004736,0.3354709872001084,3.3547252817725908,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
DLG1,ENSG00000075711,low density lipoprotein triglyceride measurement,EFO_0009946,0.3354709872001084,3.3547252817725908,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
DLG2,ENSG00000150672,platelet count,EFO_0004309,0.33544605872412797,3.3544633601664384,1,0.4,0.4,transcript,144252.0
RASGRP3,ENSG00000152689,"osteoarthritis, knee",EFO_0004616,0.3354321761712235,3.3543329646249926,1,0.4,0.4,transcript,35705.0
SEMA3C,ENSG00000075223,brain attribute,OBA_2045210,0.33540193306121574,3.3540530488958966,1,0.4,0.4,transcript,11863.0
TENM4,ENSG00000149256,insomnia,EFO_0004698,0.33540193306121574,3.3540367810964082,1,0.4,0.4,transcript,22922.0
TENM4,ENSG00000149256,total blood protein measurement,EFO_0004536,0.33540193306121574,3.3540367810964082,1,0.4,0.4,transcript,22922.0
ALPK3,ENSG00000136383,aspartate aminotransferase measurement,EFO_0004736,0.33535899779781186,3.3536272740154143,1,0.4,0.4,transcript,10725.0
DMRTA1,ENSG00000176399,vital capacity,EFO_0004312,0.3353582978188032,3.3536545857784366,1,0.4,0.4,transcript,5586.0
MAP4K3,ENSG00000011566,red blood cell density,OBA_2045260,0.3353582978188032,3.3536057858057764,1,0.4,0.4,transcript,17538.0
FAM114A1,ENSG00000197712,neurodegenerative disease,EFO_0005772,0.33534989051859093,3.3535475847526612,1,0.4,0.4,transcript,8217.0
PRTG,ENSG00000166450,N-acetylalanine measurement,EFO_0800118,0.3353373127418956,3.3535912035032784,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
ARHGAP29,ENSG00000137962,total blood protein measurement,EFO_0004536,0.33529140941048463,3.352934319823871,1,0.5,0.5,transcript,24721.0
LRP2,ENSG00000081479,triglyceride measurement,EFO_0004530,0.335280421673091,3.3528208054306883,1,0.5,0.5,transcript,30141.0
KLF10,ENSG00000155090,triglyceride measurement,EFO_0004530,0.3352792189285556,3.352853035041565,1,0.4,0.4,transcript,6574.0
SKIL,ENSG00000136603,drug use measurement,EFO_0007010,0.3352634321597185,3.3526507814187605,1,0.5,0.5,transcript,30377.0
LNPEP,ENSG00000113441,cystatin B measurement,EFO_0010593,0.33526187108395367,3.352639373063825,1,0.4,0.4,transcript,19359.0
PHIP,ENSG00000146247,mean corpuscular hemoglobin concentration,EFO_0004528,0.33524548486663824,3.352462825819815,1,0.5,0.5,transcript,62679.0
FRAS1,ENSG00000138759,COVID-19,MONDO_0100096,0.3352343618699828,3.352375755244435,2,0.9,1.8,transcript,56011.0
ACTN2,ENSG00000077522,erythrocyte volume,OBA_0003460,0.3352087569358369,3.352104254970157,2,0.8,1.6,transcript,95891.0
GPR180,ENSG00000152749,cholesterol to total lipids in small HDL percentage ,EFO_0022240,0.3351859622217195,3.351904646980815,1,0.4,0.4,transcript,8884.0
RNF144B,ENSG00000137393,heart rate,OBA_1001087,0.33517552987363425,3.3518281717551073,1,0.4,0.4,transcript,5489.0
SFRP1,ENSG00000104332,Graves disease,EFO_0004237,0.3351652974990875,3.351700953880164,1,0.4,0.4,transcript,8337.0
FBXO42,ENSG00000037637,hemoglobin measurement,EFO_0004509,0.33516392685293284,3.3516748398943794,1,0.4,0.4,transcript,11245.0
PTCHD4,ENSG00000244694,t-tau measurement,EFO_0004760,0.3351580514400355,3.351994355071697,6,2.4000000000000004,14.400000000000002,transcript,34796.0
USP37,ENSG00000135913,erythrocyte volume,OBA_0003460,0.33513059617567187,3.351445588642651,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
AKAP10,ENSG00000108599,myeloid leukocyte count,OBA_2045223,0.33511254527950884,3.351160633094121,1,0.4,0.4,transcript,11370.0
RSBN1L,ENSG00000187257,waist-hip ratio,EFO_0004343,0.33511138379229455,3.351250555004036,2,0.8,1.6,transcript,11703.0
USP6,ENSG00000129204,acute myeloid leukemia,EFO_0000222,0.3350735221348845,3.350746517911866,1,0.4,0.4,transcript,35409.0
CNTNAP2,ENSG00000174469,immune system disease,EFO_0000540,0.3350462891264361,3.3504705729358926,1,0.4,0.4,transcript,52072.0
GREM1,ENSG00000166923,colorectal adenocarcinoma,EFO_0000365,0.3350195120167634,3.3502133442325115,1,0.4,0.4,transcript,21949.0
THEM4,ENSG00000159445,beta-hydroxyisovalerate measurement,EFO_0800125,0.3350161702666913,3.3503160534290197,2,0.8,1.6,transcript,10366.0
ATRNL1,ENSG00000107518,N-formylphenylalanine measurement,EFO_0800075,0.33500084747160336,3.350025333857903,1,0.4,0.4,transcript,23726.0
RFX3,ENSG00000080298,magnesium measurement,EFO_0004845,0.33498721895270206,3.3499286906923573,2,0.8,1.6,transcript,28318.0
LRRC7,ENSG00000033122,basophil measurement,EFO_0803539,0.3349588049698254,3.349652153403804,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
RNF150,ENSG00000170153,liver disease,EFO_0001421,0.3349349492883654,3.349608151898325,4,1.6,6.4,transcript,24743.0
CNTLN,ENSG00000044459,diastolic blood pressure change measurement,EFO_0006945,0.3349349492883654,3.3494709534469274,2,0.8,1.6,transcript,13173.0
SGCZ,ENSG00000185053,ulcerative colitis,EFO_0000729,0.3349349492883654,3.3493982020896937,1,0.4,0.4,transcript,8212.0
NEK1,ENSG00000137601,asphyxiating thoracic dystrophy 3,MONDO_0013127,0.33493174330801095,3.3493316929483843,2,0.8,1.6,transcript,112203.0
RFX3,ENSG00000080298,taste liking measurement,EFO_0010155,0.33492082650446336,3.3492647662099704,2,0.8,1.6,transcript,28318.0
DENND3,ENSG00000105339,neutrophil count,EFO_0004833,0.33490377522879855,3.3490485689456384,1,0.5,0.5,transcript,46225.0
CLHC1,ENSG00000162994,brain attribute,OBA_2045210,0.3349018043705396,3.3490433345501103,1,0.4,0.4,transcript,15816.0
NEK1,ENSG00000137601,Parkinson disease,MONDO_0005180,0.33488607691271827,3.348875028995457,2,0.8,1.6,transcript,112203.0
DLC1,ENSG00000164741,platelet component distribution width,EFO_0007984,0.33485422117987573,3.3485538909718717,1,0.4,0.4,transcript,34249.0
IL1A,ENSG00000115008,lymphocyte count,EFO_0004587,0.33483981399631313,3.3485964542913416,1,0.4,0.4,transcript,2017.0
ANKH,ENSG00000154122,eosinophil count,EFO_0004842,0.3348377871522881,3.3491463141458317,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,eosinophil count,EFO_0004842,0.3348377871522881,3.3491463141458317,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,eosinophil count,EFO_0004842,0.3348377871522881,3.3491463141458317,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,eosinophil count,EFO_0004842,0.3348377871522881,3.3491463141458317,5,2.4,12.0,transcript,15616.0
DLC1,ENSG00000164741,hemoglobin measurement,EFO_0004509,0.33483268946110767,3.3483385737841913,1,0.4,0.4,transcript,34249.0
ANKRD17,ENSG00000132466,tooth disease,EFO_1001216,0.3348151585912775,3.348160775822254,1,0.4,0.4,transcript,43526.0
IL1A,ENSG00000115008,myeloid leukocyte count,OBA_2045223,0.33481193238979345,3.348317638226145,1,0.4,0.4,transcript,2017.0
F13B,ENSG00000143278,cholesteatoma,EFO_1000675,0.3347931508625042,3.348039406769194,1,0.5,0.5,transcript,4634.0
BMERB1,ENSG00000166780,cholesteryl esters to total lipids in large VLDL percentage ,EFO_0022250,0.33478298131761014,3.347866087774814,1,0.4,0.4,transcript,11027.0
ROCK2,ENSG00000134318,serum creatinine amount,OBA_2050096,0.33477078662446397,3.3477188598463634,1,0.5,0.5,transcript,45481.0
KCNJ15,ENSG00000157551,body height,OBA_VT0001253,0.3347433971346767,3.3474438053971665,1,0.4,0.4,transcript,40675.0
PAFAH1B2,ENSG00000168092,phosphatidylethanolamine measurement,EFO_0010228,0.33472890288475926,3.3474228192982993,2,0.8,1.6,transcript,11959.0
CEP85L,ENSG00000111860,cardiovascular measurement,EFO_0004298,0.3347206424809898,3.347221827790375,1,0.4,0.4,transcript,25969.0
MLLT3,ENSG00000171843,iminodiacetate (IDA) measurement,EFO_0800945,0.3346963599668998,3.347066838796627,2,0.8,1.6,transcript,15498.0
KCNIP4,ENSG00000185774,response to antihypertensive drug,EFO_0005405,0.33467670927175136,3.346899740702922,2,0.8,1.6,transcript,12062.0
TMEM131,ENSG00000075568,multiple births measurement,EFO_0009439,0.3346725902063105,3.3467473509343586,1,0.4,0.4,transcript,18649.0
DLC1,ENSG00000164741,colon carcinoma,EFO_1001950,0.3346545584169974,3.346557263343089,1,0.4,0.4,transcript,34249.0
UMPS,ENSG00000114491,sialic acid-binding Ig-like lectin 12 measurement,EFO_0802066,0.33464387177078053,3.34645757406947,1,0.4,0.4,transcript,21213.0
UMPS,ENSG00000114491,vesicular integral-membrane protein VIP36 measurement,EFO_0022012,0.33464387177078053,3.34645757406947,1,0.4,0.4,transcript,21213.0
PCDH18,ENSG00000189184,pulse pressure measurement,EFO_0005763,0.3346134493825955,3.3462116654846636,2,0.8,1.6,transcript,20733.0
ANKRD36,ENSG00000135976,retinal layer thickness,OBA_2050110,0.33459414321597575,3.346016818514827,2,1.0,2.0,transcript,26530.0
PNLIPRP3,ENSG00000203837,influenza A (H1N1),EFO_1001488,0.33458380534948734,3.3460065454915036,1,0.4,0.4,transcript,2374.0
TNFRSF19,ENSG00000127863,neuroimaging measurement,EFO_0004346,0.33457416811002316,3.34577468222227,1,0.5,0.5,transcript,15151.0
MCL1,ENSG00000143384,systolic blood pressure,EFO_0006335,0.33455127689851033,3.345529538364217,1,0.4,0.4,transcript,23853.0
CCDC127,ENSG00000164366,idiopathic pulmonary fibrosis,EFO_0000768,0.3345120464112834,3.3451610361789665,1,0.4,0.4,transcript,9859.0
CCDC7,ENSG00000216937,Tietze syndrome,MONDO_0001858,0.3343349055045667,3.3433676520850177,1,0.5,0.5,transcript,26886.0
MSX2,ENSG00000120149,chin morphology trait,OBA_2050101,0.33432924181431667,3.3434106563932406,1,0.4,0.4,transcript,3383.0
ZNF398,ENSG00000197024,neutrophil percentage of leukocytes,EFO_0007990,0.3343231455732007,3.343256949677195,1,0.4,0.4,transcript,15690.0
ATXN7L3B,ENSG00000253719,educational attainment,EFO_0011015,0.3343112764207975,3.3431654235023402,1,0.4,0.4,transcript,7596.0
DIRAS2,ENSG00000165023,haemophilus influenzae seropositivity,EFO_0803628,0.3343112764207975,3.343189012778314,1,0.4,0.4,transcript,5246.0
CTBP2,ENSG00000175029,bronchial disease,EFO_1002018,0.33430080565551434,3.343022119769291,1,0.4,0.4,transcript,28443.0
F13B,ENSG00000143278,factor XIII deficiency,MONDO_0002241,0.33428497856231276,3.3429576837672794,1,0.5,0.5,transcript,4634.0
SENP6,ENSG00000112701,type 2 diabetes mellitus,MONDO_0005148,0.33427240482593373,3.3431530654200237,5,2.2,11.0,transcript,25640.0
RSBN1L,ENSG00000187257,pharynx cancer,EFO_0005577,0.334249898121184,3.34263569829293,2,0.8,1.6,transcript,11703.0
CFHR4,ENSG00000134365,wet macular degeneration,EFO_0004683,0.3342408645600477,3.3424491543908843,1,0.5,0.5,transcript,12343.0
PPP1R9A,ENSG00000158528,pregnancy disorder,EFO_0009682,0.3342272416076753,3.3423514242206696,3,1.3,3.9000000000000004,transcript,49362.0
PPP1R9A,ENSG00000158528,urinary tract infection,EFO_0003103,0.3342272416076753,3.3423514242206696,3,1.3,3.9000000000000004,transcript,49362.0
CDKL2,ENSG00000138769,monocyte count,EFO_0005091,0.3342154004011248,3.3423181065753504,2,0.8,1.6,transcript,9750.0
BIRC6,ENSG00000115760,reticulocyte measurement,EFO_0010700,0.3342067889303986,3.3420750715609384,1,0.5,0.5,transcript,69616.0
CD86,ENSG00000114013,blood protein measurement,EFO_0007937,0.3341952398905752,3.341984233366556,1,0.4,0.4,transcript,12565.0
ARHGAP20,ENSG00000137727,bone tissue density,OBA_1000110,0.33417517936745095,3.341762038264086,1,0.4,0.4,transcript,39045.0
CCDC7,ENSG00000216937,preeclampsia,EFO_0000668,0.3341617449052984,3.3416360460923347,1,0.5,0.5,transcript,26886.0
PIGN,ENSG00000197563,bone tissue density,OBA_1000110,0.33415985493071304,3.341601089134803,1,0.4,0.4,transcript,157491.0
BHLHE41,ENSG00000123095,neurodegenerative disease,EFO_0005772,0.3341511366456996,3.3415996471897262,1,0.4,0.4,transcript,4531.0
KCNIP4,ENSG00000185774,spontaneous abortion,EFO_1001255,0.3341085662543257,3.341218310528666,2,0.8,1.6,transcript,12062.0
TRDN,ENSG00000186439,drug use measurement,EFO_0007010,0.3341085662543257,3.341104865984514,1,0.5,0.5,transcript,26037.0
RASEF,ENSG00000165105,hearing process quality,OBA_2045262,0.3341085662543257,3.3411400843119647,1,0.4,0.4,transcript,7350.0
SEMA3A,ENSG00000075213,high density lipoprotein cholesterol measurement,EFO_0004612,0.3341085662543257,3.341115867179669,1,0.4,0.4,transcript,13243.0
RNF150,ENSG00000170153,preeclampsia,EFO_0000668,0.3341085662543257,3.341344321557928,4,1.6,6.4,transcript,24743.0
ZFP90,ENSG00000184939,total cholesterol measurement,EFO_0004574,0.3340992384218696,3.3410057393654355,1,0.4,0.4,transcript,29951.0
TTLL7,ENSG00000137941,type 2 diabetes mellitus,MONDO_0005148,0.3340932842214304,3.340961815649286,2,0.8,1.6,transcript,55223.0
C12orf42,ENSG00000179088,oral lichen planus,EFO_0008517,0.33407395894558006,3.340774728959631,1,0.5,0.5,transcript,14229.0
IREB2,ENSG00000136381,systolic blood pressure,EFO_0006335,0.33405997684482824,3.340699624212179,2,0.9,1.8,transcript,18026.0
STXBP4,ENSG00000166263,ovarian carcinoma,EFO_0001075,0.33404479071338883,3.3408396185209384,5,2.0,10.0,transcript,25529.0
DLGAP1,ENSG00000170579,free androgen index,EFO_0007005,0.3340320394574974,3.3403485487189117,2,0.8,1.6,transcript,56830.0
LINGO2,ENSG00000174482,aseptic loosening,EFO_0010725,0.33401293415214744,3.3401410603859163,1,0.4,0.4,transcript,34133.0
GALC,ENSG00000054983,leukodystrophy,MONDO_0019046,0.33398972218016215,3.3399701147401184,2,0.8,1.6,transcript,21950.0
ATP12A,ENSG00000075673,mean arterial pressure,EFO_0006340,0.33395606777527803,3.3396098298786097,1,0.4,0.4,transcript,8138.0
PTPRO,ENSG00000151490,X-12544 measurement,EFO_0021315,0.33395218298920964,3.339526278488564,1,0.4,0.4,transcript,89916.0
VPS13A,ENSG00000197969,esophageal ulcer,MONDO_0044782,0.3339468489296014,3.3394752345448295,1,0.4,0.4,transcript,59301.0
LUZP2,ENSG00000187398,metabolite measurement,EFO_0004725,0.3339099209232572,3.3394159892567967,4,1.7000000000000002,6.800000000000001,transcript,21466.0
RFX3,ENSG00000080298,adolescent idiopathic scoliosis,EFO_0005423,0.33389562685111956,3.339012769676532,2,0.8,1.6,transcript,28318.0
DCLK1,ENSG00000133083,brain attribute,OBA_2045210,0.33389562685111956,3.3390064661644554,2,0.8,1.6,transcript,31874.0
AHNAK2,ENSG00000185567,neurodegenerative disease,EFO_0005772,0.3338908213602725,3.3389560433288996,2,1.0,2.0,transcript,41815.0
CLASP2,ENSG00000163539,urate measurement,EFO_0004531,0.3338889428527588,3.3388955479168727,1,0.4,0.4,transcript,65366.0
PRTG,ENSG00000166450,joint hypermobility measurement,EFO_0007905,0.3338798330448348,3.339016406532671,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
CD86,ENSG00000114013,temporal arteritis,EFO_1001209,0.33387690080609844,3.3388008425217883,1,0.4,0.4,transcript,12565.0
TMEM131,ENSG00000075568,cervical carcinoma,EFO_0001061,0.3338563957595769,3.338585406467022,1,0.4,0.4,transcript,18649.0
DENND3,ENSG00000105339,high density lipoprotein cholesterol measurement,EFO_0004612,0.3338178698112166,3.3381895147698186,1,0.5,0.5,transcript,46225.0
ARHGAP29,ENSG00000137962,neutrophil count,EFO_0004833,0.33379218952417544,3.3379421209607787,1,0.5,0.5,transcript,24721.0
ABCA10,ENSG00000154263,phospholipids in LDL measurement ,EFO_0022294,0.3337807237528572,3.337907173680475,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
GKAP1,ENSG00000165113,cholesterol to total lipids in large HDL percentage ,EFO_0022234,0.33373752149837554,3.337432341519031,1,0.4,0.4,transcript,7002.0
GKAP1,ENSG00000165113,cholesteryl esters to total lipids in large HDL percentage ,EFO_0022248,0.33373752149837554,3.337432341519031,1,0.4,0.4,transcript,7002.0
GKAP1,ENSG00000165113,total cholesterol measurement,EFO_0004574,0.33373752149837554,3.337432341519031,1,0.4,0.4,transcript,7002.0
GKAP1,ENSG00000165113,triglycerides in small HDL measurement,EFO_0022158,0.33373752149837554,3.337432341519031,1,0.4,0.4,transcript,7002.0
RCL1,ENSG00000120158,psychosis,EFO_0005407,0.33373060878028565,3.3373447613018414,1,0.4,0.4,transcript,10343.0
UNC80,ENSG00000144406,Neurodevelopmental delay,HP_0012758,0.33373060878028565,3.3373107498075183,1,0.4,0.4,transcript,85800.0
TRPC6,ENSG00000137672,prostate specific antigen amount,OBA_2050200,0.3337302920136032,3.3373318072595968,1,0.4,0.4,transcript,13847.0
THEM4,ENSG00000159445,3-hydroxylaurate measurement,EFO_0800204,0.3337217903117782,3.3373722538798885,2,0.8,1.6,transcript,10366.0
TRAM1,ENSG00000067167,Forceps delivery,HP_0011411,0.3337211476666547,3.33740197553546,2,0.8,1.6,transcript,8399.0
TRAM1,ENSG00000067167,Ventouse delivery,HP_0011412,0.3337211476666547,3.33740197553546,2,0.8,1.6,transcript,8399.0
ACVR1C,ENSG00000123612,hematocrit,EFO_0004348,0.3337165077266642,3.3372843912114596,2,0.8,1.6,transcript,13410.0
FBXO28,ENSG00000143756,behenoyl dihydrosphingomyelin (d18:0/22:0) measurement,EFO_0800427,0.3337115924792528,3.338164912519372,5,2.0,10.0,transcript,9533.0
WDR59,ENSG00000103091,flatfoot,EFO_0003874,0.3337098687821964,3.3371723424737154,2,0.8,1.6,transcript,21723.0
PTPRO,ENSG00000151490,FEV/FVC ratio,EFO_0004713,0.33370614669134957,3.3370659155099633,1,0.4,0.4,transcript,89916.0
RGS7BP,ENSG00000186479,hypertension,EFO_0000537,0.33370614669134957,3.337149588168342,1,0.5,0.5,transcript,5674.0
RGS7BP,ENSG00000186479,cardiovascular disease,EFO_0000319,0.33370614669134957,3.337149588168342,1,0.5,0.5,transcript,5674.0
MLLT3,ENSG00000171843,N-acetylalanine measurement,EFO_0800118,0.3336994669368457,3.337097908496087,2,0.8,1.6,transcript,15498.0
DSC2,ENSG00000134755,arterial stiffness measurement,EFO_0004517,0.33369752435713335,3.3369876856379608,2,0.8,1.6,transcript,128596.0
AKR1C1,ENSG00000187134,peak expiratory flow,EFO_0009718,0.3336604836960468,3.3367440279130562,2,0.8,1.6,transcript,11495.0
KLHDC10,ENSG00000128607,serum creatinine amount,OBA_2050096,0.3336508027325934,3.336557760012742,1,0.4,0.4,transcript,8043.0
CLSTN2,ENSG00000158258,self reported educational attainment,EFO_0004784,0.33360816847147645,3.336105770943463,1,0.4,0.4,transcript,16607.0
GIPC2,ENSG00000137960,physical activity measurement,EFO_0008002,0.33357363997280176,3.3361275977720273,2,0.8,1.6,transcript,4090.0
TRDN,ENSG00000186439,erythrocyte volume,OBA_0003460,0.3335674023794788,3.3356932272360447,1,0.5,0.5,transcript,26037.0
SGCZ,ENSG00000185053,urate measurement,EFO_0004531,0.33355596499179724,3.335608359124012,1,0.4,0.4,transcript,8212.0
SGCZ,ENSG00000185053,heel bone mineral density,EFO_0009270,0.33355596499179724,3.335608359124012,1,0.4,0.4,transcript,8212.0
EDEM1,ENSG00000134109,body mass index,EFO_0004340,0.3335507822996348,3.3356408017197525,2,0.8,1.6,transcript,12032.0
GALC,ENSG00000054983,Global developmental delay,HP_0001263,0.3335458188529434,3.3355310814679306,2,0.8,1.6,transcript,21950.0
GALC,ENSG00000054983,status epilepticus,EFO_0008526,0.3335458188529434,3.3355310814679306,2,0.8,1.6,transcript,21950.0
GKAP1,ENSG00000165113,triglycerides to total lipids in very large HDL percentage ,EFO_0022339,0.333522579268898,3.3352829192242557,1,0.4,0.4,transcript,7002.0
RCL1,ENSG00000120158,mitochondrial DNA measurement,EFO_0006312,0.33348373502623463,3.3348760237613315,1,0.4,0.4,transcript,10343.0
PARP8,ENSG00000151883,Alzheimer disease,MONDO_0004975,0.3334779257843999,3.3348263346674902,2,0.8,1.6,transcript,33987.0
DOCK1,ENSG00000150760,adolescent idiopathic scoliosis,EFO_0005423,0.33347576204040175,3.3347827082113435,1,0.4,0.4,transcript,15944.0
SGCZ,ENSG00000185053,systolic blood pressure,EFO_0006335,0.33345509023181696,3.3345996115242094,1,0.4,0.4,transcript,8212.0
ARHGAP28,ENSG00000088756,macula attribute,OBA_2045216,0.3334538078902437,3.3345503805385546,1,0.4,0.4,transcript,32516.0
ARHGAP28,ENSG00000088756,retinal layer thickness,OBA_2050110,0.3334538078902437,3.3345503805385546,1,0.4,0.4,transcript,32516.0
RCL1,ENSG00000120158,lymphocyte percentage of leukocytes,EFO_0007993,0.3334317994588997,3.3343566680879824,1,0.4,0.4,transcript,10343.0
YTHDC2,ENSG00000047188,preeclampsia,EFO_0000668,0.3333926468913879,3.3339466780787355,1,0.4,0.4,transcript,19793.0
CYTL1,ENSG00000170891,atherosclerosis,EFO_0003914,0.3333867560427252,3.334086498577225,1,0.4,0.4,transcript,1827.0
PHC1,ENSG00000111752,legumain measurement,EFO_0020530,0.3333814891675245,3.333834042159752,1,0.5,0.5,transcript,26109.0
ARHGAP12,ENSG00000165322,forced expiratory volume,EFO_0004314,0.3333666051336976,3.33367811369939,1,0.4,0.4,transcript,33161.0
SNIP1,ENSG00000163877,Rolandic epilepsy,Orphanet_1945,0.333361028925601,3.3336557851613784,1,0.4,0.4,transcript,8792.0
CA8,ENSG00000178538,thyroxine measurement,EFO_0005130,0.3333588729081589,3.333629683315233,1,0.4,0.4,transcript,9767.0
HEATR1,ENSG00000119285,alcohol drinking,EFO_0004329,0.3333585679165486,3.3336152702171518,1,0.5,0.5,transcript,16897.0
CADPS,ENSG00000163618,nephrotic syndrome,EFO_0004255,0.3333449010848355,3.3334583285589936,1,0.4,0.4,transcript,42929.0
ATP10D,ENSG00000145246,high density lipoprotein cholesterol measurement,EFO_0004612,0.3333449010848355,3.3334808336589457,1,0.5,0.5,transcript,15712.0
PCMTD1,ENSG00000168300,Left bundle branch block,HP_0011713,0.3333449010848355,3.333653858919369,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
CADPS,ENSG00000163618,Abruptio Placentae,EFO_1001754,0.3333449010848355,3.3334583285589936,1,0.4,0.4,transcript,42929.0
SLCO5A1,ENSG00000137571,neutrophil count,EFO_0004833,0.3332929079784207,3.3333596317518293,5,2.0,10.0,transcript,23226.0
MAP3K7,ENSG00000135341,high density lipoprotein cholesterol measurement,EFO_0004612,0.33326072788694927,3.332696665592771,4,1.6,6.4,transcript,71599.0
BMERB1,ENSG00000166780,cholesteryl ester measurement,EFO_0010351,0.3332549238227004,3.332585512825716,1,0.4,0.4,transcript,11027.0
BMERB1,ENSG00000166780,total lipids in very large HDL measurement ,EFO_0022312,0.3332549238227004,3.332585512825716,1,0.4,0.4,transcript,11027.0
BMERB1,ENSG00000166780,free cholesterol to total lipids in medium HDL percentage ,EFO_0022282,0.3332549238227004,3.332585512825716,1,0.4,0.4,transcript,11027.0
BMERB1,ENSG00000166780,cholesterol in very large HDL measurement ,EFO_0022229,0.3332549238227004,3.332585512825716,1,0.4,0.4,transcript,11027.0
SCAMP1,ENSG00000085365,Thrombocytopenia,HP_0001873,0.33322362850237475,3.332262632013604,1,0.4,0.4,transcript,15182.0
MYO5A,ENSG00000197535,Seizure,HP_0001250,0.33317623899825866,3.331764429643799,1,0.4,0.4,transcript,196111.0
FAM98A,ENSG00000119812,protein measurement,EFO_0004747,0.33317453687244825,3.331752721935998,1,0.4,0.4,transcript,54398.0
C4orf33,ENSG00000151470,hip bone mineral density,EFO_0007702,0.3331615233405136,3.332066287038232,4,1.6,6.4,transcript,14189.0
DNAJC21,ENSG00000168724,asthma,MONDO_0004979,0.33313647615972697,3.331373784628557,1,0.4,0.4,transcript,44331.0
HACD1,ENSG00000165996,glucuronate measurement,EFO_0010486,0.33313647615972697,3.3314294551117447,1,0.4,0.4,transcript,6183.0
HPSE,ENSG00000173083,beta-defensin 121 measurement,EFO_0802324,0.333132588297379,3.3314137307043903,2,0.9,1.8,transcript,20490.0
FRAS1,ENSG00000138759,urate measurement,EFO_0004531,0.3331147429775119,3.3311795663197263,2,0.9,1.8,transcript,56011.0
FRAS1,ENSG00000138759,bone tissue density,OBA_1000110,0.3331147429775119,3.3311795663197263,2,0.9,1.8,transcript,56011.0
RALGPS2,ENSG00000116191,forced expiratory volume,EFO_0004314,0.33310975768006124,3.3311771115224893,2,0.8,1.6,transcript,20117.0
STARD13,ENSG00000133121,pain,EFO_0003843,0.3330938808134875,3.3309536245959634,1,0.4,0.4,transcript,26997.0
NEDD4,ENSG00000069869,generalized dystonia,MONDO_0000476,0.3330938808134875,3.3309471180964416,1,0.4,0.4,transcript,48135.0
CLASP2,ENSG00000163539,white matter microstructure measurement,EFO_0005674,0.33307795122329287,3.3307856316222137,1,0.4,0.4,transcript,65366.0
COLEC10,ENSG00000184374,bone disease,EFO_0004260,0.3330682320400429,3.330787500521386,1,0.4,0.4,transcript,3803.0
ACER3,ENSG00000078124,high density lipoprotein cholesterol measurement,EFO_0004612,0.3330524673612963,3.3309246736129627,1,0.4,0.4,transcript,1000.0
LSM6,ENSG00000164167,risk-taking behaviour,EFO_0008579,0.3330359838305938,3.3305252471759887,2,0.8,1.6,transcript,9673.0
GALC,ENSG00000054983,Nystagmus,HP_0000639,0.33299144907091627,3.3299873836476594,2,0.8,1.6,transcript,21950.0
GALC,ENSG00000054983,Seizure,HP_0001250,0.33299144907091627,3.3299873836476594,2,0.8,1.6,transcript,21950.0
MR1,ENSG00000153029,Immunodeficiency,HP_0002721,0.33299144907091627,3.3300475333197546,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
BMPR2,ENSG00000204217,fibrodysplasia ossificans progressiva,MONDO_0007606,0.33299144907091627,3.3299322621681995,1,0.4,0.4,transcript,22508.0
ATG16L1,ENSG00000085978,total cholesterol measurement,EFO_0004574,0.3329699433363127,3.329711424849172,1,0.4,0.4,transcript,33357.0
ANKRD10,ENSG00000088448,eosinophil count,EFO_0004842,0.3329302854902939,3.329480949292966,2,0.8,1.6,transcript,8984.0
TMEM132B,ENSG00000139364,preeclampsia,EFO_0000668,0.3329297877585282,3.329387240871865,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
MDGA2,ENSG00000139915,food allergy,EFO_1001890,0.3329297877585282,3.329320968273962,1,0.4,0.4,transcript,17323.0
CIAO2A,ENSG00000166797,red blood cell density,OBA_2045260,0.3329254411462583,3.3294750402546405,2,0.8,1.6,transcript,7252.0
TBXT,ENSG00000164458,hip circumference,OBA_1000032,0.33291062188936116,3.329566694718631,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
TMED5,ENSG00000117500,serum gamma-glutamyl transferase measurement,EFO_0004532,0.3329095031637243,3.329126998902763,1,0.5,0.5,transcript,15641.0
STT3B,ENSG00000163527,educational attainment,EFO_0011015,0.33290046574281656,3.329024380321514,1,0.4,0.4,transcript,20281.0
CCDC66,ENSG00000180376,platelet crit,EFO_0007985,0.33288929294800307,3.3289081589887264,1,0.5,0.5,transcript,32831.0
ARMC1,ENSG00000104442,neuroticism measurement,EFO_0007660,0.33287567318602895,3.3288012802509788,1,0.4,0.4,transcript,8979.0
SLC25A46,ENSG00000164209,seasonal allergic rhinitis,EFO_0003956,0.33287567318602895,3.3287766849704807,1,0.4,0.4,transcript,20047.0
ARMC1,ENSG00000104442,intelligence,EFO_0004337,0.33287567318602895,3.3288012802509788,1,0.4,0.4,transcript,8979.0
ARMC1,ENSG00000104442,mathematical ability,EFO_0004875,0.33287567318602895,3.3288012802509788,1,0.4,0.4,transcript,8979.0
COL25A1,ENSG00000188517,triglycerides to total lipids in small HDL percentage ,EFO_0022336,0.3328674580642933,3.3286895423036778,1,0.4,0.4,transcript,26735.0
COL25A1,ENSG00000188517,phospholipids in chylomicrons and extremely large VLDL measurement ,EFO_0022292,0.3328674580642933,3.3286895423036778,1,0.4,0.4,transcript,26735.0
NDFIP2,ENSG00000102471,cortical thickness,EFO_0004840,0.3328603678707824,3.3286181605738125,2,0.8,1.6,transcript,110483.0
NSUN7,ENSG00000179299,insulin-like growth factor-binding protein 7 amount,OBA_2050142,0.33285632773144114,3.328602306273899,1,0.5,0.5,transcript,12811.0
NUP153,ENSG00000124789,metabolite measurement,EFO_0004725,0.33284910303130977,3.3285190148656243,1,0.5,0.5,transcript,17867.0
THEM4,ENSG00000159445,serum metabolite measurement,EFO_0005653,0.33284520706645665,3.3286064214266733,2,0.8,1.6,transcript,10366.0
CENPC,ENSG00000145241,waist circumference,OBA_1001085,0.332842723574178,3.3286260428988377,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
NEBL,ENSG00000078114,autosomal dominant compelling helio-ophthalmic outburst syndrome,EFO_0007887,0.3328220186023127,3.328228007842091,1,0.4,0.4,transcript,51139.0
CENPC,ENSG00000145241,aging,EFO_0022597,0.3328156944109227,3.3283557512662845,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
LHFPL2,ENSG00000145685,erythrocyte count,EFO_0004305,0.3327915876685258,3.327942769249464,1,0.4,0.4,transcript,14874.0
KLF10,ENSG00000155090,mean reticulocyte volume,EFO_0010701,0.3327274223143615,3.3273350688996235,1,0.4,0.4,transcript,6574.0
CENPC,ENSG00000145241,taste liking measurement,EFO_0010155,0.3326664743607724,3.3268635507647817,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
COL25A1,ENSG00000188517,serum albumin amount,OBA_2050068,0.33266563467783994,3.326671308439144,1,0.4,0.4,transcript,26735.0
PKP2,ENSG00000057294,placental retention,EFO_0009578,0.3326480976079065,3.326637077447391,4,1.6,6.4,transcript,40999.0
GPR158,ENSG00000151025,platelet volume,OBA_0003277,0.3326252125561076,3.326277796865692,1,0.5,0.5,transcript,19477.0
DYNC2H1,ENSG00000187240,brain-lung-thyroid syndrome,MONDO_0012593,0.3326218692162316,3.32622884857101,1,0.5,0.5,transcript,49230.0
SLC25A16,ENSG00000122912,Isolated nail anomaly,Orphanet_79369,0.3326218692162316,3.3262497287855313,1,0.4,0.4,transcript,12888.0
DYNC2H1,ENSG00000187240,autosomal recessive polycystic kidney disease,MONDO_0009889,0.3326218692162316,3.32622884857101,1,0.5,0.5,transcript,49230.0
DYNC2H1,ENSG00000187240,Beemer-Langer syndrome,MONDO_0010024,0.3326218692162316,3.32622884857101,1,0.5,0.5,transcript,49230.0
SNIP1,ENSG00000163877,childhood epilepsy with centrotemporal spikes,MONDO_0007295,0.3326218692162316,3.326264188067684,1,0.4,0.4,transcript,8792.0
LARP4B,ENSG00000107929,autism spectrum disorder,EFO_0003756,0.3326218692162316,3.326229704165399,1,0.5,0.5,transcript,45405.0
LRRK2,ENSG00000188906,Spinocerebellar atrophy,HP_0007263,0.3326218692162316,3.3262374499780725,2,0.9,1.8,transcript,95960.0
LRRK2,ENSG00000188906,"Klippel-Feil syndrome 1, autosomal dominant",MONDO_0007306,0.3326218692162316,3.3262374499780725,2,0.9,1.8,transcript,95960.0
YWHAG,ENSG00000170027,Bilateral tonic-clonic seizure,HP_0002069,0.3326218692162316,3.326326654375541,1,0.4,0.4,transcript,3705.0
NEK1,ENSG00000137601,Beemer-Langer syndrome,MONDO_0010024,0.3326218692162316,3.3262329520305904,2,0.8,1.6,transcript,112203.0
NUP153,ENSG00000124789,Pulmonary artery atresia,HP_0004935,0.3326218692162316,3.3262466767148426,1,0.5,0.5,transcript,17867.0
CEP85L,ENSG00000111860,Arrhythmogenic right ventricular dysplasia,Orphanet_247,0.3326218692162316,3.3262340951427927,1,0.4,0.4,transcript,25969.0
PRKCB,ENSG00000166501,Progressive sensorineural hearing impairment,HP_0000408,0.3326218692162316,3.32624265860929,1,0.4,0.4,transcript,16690.0
MYO5A,ENSG00000197535,Dystonia,HP_0001332,0.3326218692162316,3.326220731823528,1,0.4,0.4,transcript,196111.0
THAP1,ENSG00000131931,multiple mitochondrial dysfunctions syndrome 9b,MONDO_0971174,0.3326218692162316,3.3262980572416807,1,0.4,0.4,transcript,5040.0
SLC25A16,ENSG00000122912,inherited isolated nail anomaly,MONDO_0019284,0.3326218692162316,3.3262497287855313,1,0.4,0.4,transcript,12888.0
YWHAG,ENSG00000170027,Specific learning disability,HP_0001328,0.3326218692162316,3.326326654375541,1,0.4,0.4,transcript,3705.0
GALC,ENSG00000054983,Breech presentation,HP_0001623,0.3326218692162316,3.3262915851008126,2,0.8,1.6,transcript,21950.0
PROK2,ENSG00000163421,Male infertility with spermatogenesis disorder,Orphanet_399775,0.3326218692162316,3.3267341560798416,2,0.8,1.6,transcript,3104.0
SMC3,ENSG00000108055,Wiedemann-Steiner syndrome,MONDO_0011518,0.3326218692162316,3.326227304684924,1,0.4,0.4,transcript,46444.0
BMPR2,ENSG00000204217,"tooth agenesis, selective, 1",MONDO_0007129,0.3326218692162316,3.3262364636213526,1,0.4,0.4,transcript,22508.0
LATS1,ENSG00000131023,myoepithelial tumor,MONDO_0002380,0.3326218692162316,3.3262360487534814,1,0.4,0.4,transcript,23046.0
CCDC88C,ENSG00000015133,spastic ataxia,MONDO_0017845,0.3326218692162316,3.3262380149003477,1,0.4,0.4,transcript,20701.0
IMPG2,ENSG00000081148,Abnormality of the eye,HP_0000478,0.3326218692162316,3.326434209403695,2,0.9,1.8,transcript,8352.0
LINS1,ENSG00000140471,autism,EFO_0003758,0.3326218692162316,3.3262459802701585,1,0.5,0.5,transcript,18323.0
BIRC6,ENSG00000115760,autism spectrum disorder,EFO_0003756,0.3326218692162316,3.326225874419268,1,0.5,0.5,transcript,69616.0
ASTN2,ENSG00000148219,Elevated circulating creatine kinase concentration,HP_0003236,0.3326218692162316,3.3262774465688962,2,0.8,1.6,transcript,27232.0
GALC,ENSG00000054983,Dysmyelinating leukodystrophy,HP_0006978,0.3326218692162316,3.3262915851008126,2,0.8,1.6,transcript,21950.0
MYO5A,ENSG00000197535,dystonic disorder,MONDO_0003441,0.3326218692162316,3.326220731823528,1,0.4,0.4,transcript,196111.0
NEK1,ENSG00000137601,"Short rib-polydactyly syndrome, Verma-Naumoff type",Orphanet_93271,0.3326218692162316,3.3262329520305904,2,0.8,1.6,transcript,112203.0
DCDC2,ENSG00000146038,nonsyndromic deafness,EFO_0009076,0.3326218692162316,3.326264469228006,1,0.4,0.4,transcript,8738.0
ASTN2,ENSG00000148219,isolated asymptomatic elevation of creatine phosphokinase,MONDO_0016103,0.3326218692162316,3.3262774465688962,2,0.8,1.6,transcript,27232.0
MYO5A,ENSG00000197535,Global developmental delay,HP_0001263,0.3326218692162316,3.326220731823528,1,0.4,0.4,transcript,196111.0
TRIM36,ENSG00000152503,anencephaly,MONDO_0000819,0.3326218692162316,3.326244853051786,1,0.4,0.4,transcript,15290.0
DCDC2,ENSG00000146038,autosomal dominant nonsyndromic hearing loss,MONDO_0019587,0.3326218692162316,3.326264469228006,1,0.4,0.4,transcript,8738.0
TRIM36,ENSG00000152503,Isolated anencephaly/exencephaly,Orphanet_1048,0.3326218692162316,3.326244853051786,1,0.4,0.4,transcript,15290.0
MYO5A,ENSG00000197535,Nystagmus,HP_0000639,0.3326218692162316,3.326220731823528,1,0.4,0.4,transcript,196111.0
PDE1C,ENSG00000154678,Myocardial Ischemia,EFO_1001375,0.33261160310915705,3.3261703899962387,2,0.8,1.6,transcript,29434.0
TRDMT1,ENSG00000107614,Red cell distribution width,EFO_0009188,0.3325837767631597,3.3258515593083198,1,0.4,0.4,transcript,29003.0
SPOCK3,ENSG00000196104,liver disease,EFO_0001421,0.3325786759612459,3.325869124396938,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
IMPG2,ENSG00000081148,total blood protein measurement,EFO_0004536,0.33256973437574455,3.325912860998825,2,0.9,1.8,transcript,8352.0
CNTN1,ENSG00000018236,urinary system disease,EFO_0009690,0.3325487067974678,3.325503594851511,1,0.4,0.4,transcript,24203.0
GIPC2,ENSG00000137960,QT interval,EFO_0004682,0.3324676264234718,3.3250674622787275,2,0.8,1.6,transcript,4090.0
PARP8,ENSG00000151883,polygenic risk score,EFO_0030082,0.33246474174529894,3.3246944942764807,2,0.8,1.6,transcript,33987.0
RAD23B,ENSG00000119318,eosinophil count,EFO_0004842,0.33244920711615494,3.3245323450238127,1,0.4,0.4,transcript,9932.0
FIGNL1,ENSG00000132436,primary biliary cirrhosis,EFO_1001486,0.3324248533119274,3.3242647156583143,1,0.4,0.4,transcript,24718.0
UBL3,ENSG00000122042,metabolite measurement,EFO_0004725,0.3324225749122933,3.3250596615621273,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
FAT3,ENSG00000165323,cutaneous melanoma,EFO_0000389,0.33241599552028883,3.324168284198203,1,0.4,0.4,transcript,48025.0
TMEM132B,ENSG00000139364,non-alcoholic fatty liver disease,EFO_0003095,0.3324048297204944,3.324137660491527,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
MMP12,ENSG00000262406,lung cancer,MONDO_0008903,0.33239353204953254,3.3241548594634924,1,0.4,0.4,transcript,1822.0
ING1,ENSG00000153487,erosive tooth wear attribute,OBA_2045285,0.3323852464496244,3.3238789475470916,1,0.4,0.4,transcript,15104.0
SLC25A46,ENSG00000164209,Abnormal thrombosis,HP_0001977,0.3323392130139438,3.3234120832496292,1,0.4,0.4,transcript,20047.0
AKR1C1,ENSG00000187134,forced expiratory volume,EFO_0004314,0.3323298007741817,3.3234371986944056,2,0.8,1.6,transcript,11495.0
SLC36A4,ENSG00000180773,N-acetylphenylalanine measurement,EFO_0800019,0.3323288052836962,3.323398588242834,2,0.8,1.6,transcript,14475.0
IMPG2,ENSG00000081148,blood protein measurement,EFO_0007937,0.33230224718044526,3.323237989045832,2,0.9,1.8,transcript,8352.0
HS3ST3A1,ENSG00000153976,Palmar Fibromatosis,EFO_1000438,0.33230224718044526,3.3231035090816,1,0.4,0.4,transcript,4936.0
HS3ST3A1,ENSG00000153976,lumbar disc herniation,EFO_1002005,0.33230224718044526,3.3231035090816,1,0.4,0.4,transcript,4936.0
RANBP17,ENSG00000204764,bone tissue density,OBA_1000110,0.3323018211782133,3.323027726077361,1,0.4,0.4,transcript,42042.0
IMPG2,ENSG00000081148,BMI-adjusted hip circumference,EFO_0008039,0.33229093396468556,3.323124856888235,2,0.9,1.8,transcript,8352.0
POU2F1,ENSG00000143190,platelet volume,OBA_0003277,0.3322655987648614,3.3226709997051715,2,0.8,1.6,transcript,106581.0
ASB5,ENSG00000164122,liver disease,EFO_0001421,0.3322554968959616,3.322603660377754,1,0.4,0.4,transcript,8215.0
NBEAL1,ENSG00000144426,Headache,HP_0002315,0.33224687850711826,3.322472638672855,1,0.4,0.4,transcript,103799.0
SCARA3,ENSG00000168077,goiter,EFO_0004283,0.33224421682136085,3.3225123806060957,1,0.4,0.4,transcript,5697.0
ADK,ENSG00000156110,pain,EFO_0003843,0.332217906988489,3.3221980533218414,1,0.4,0.4,transcript,21071.0
C12orf42,ENSG00000179088,thyroid disease,EFO_1000627,0.33218018492264767,3.3218369887303068,1,0.5,0.5,transcript,14229.0
PPA2,ENSG00000138777,pulse pressure measurement,EFO_0005763,0.3321576275023543,3.3216036812940977,1,0.5,0.5,transcript,18244.0
GRK7,ENSG00000114124,temporal measurement,EFO_0000719,0.33213717036999446,3.3214127377582128,1,0.4,0.4,transcript,9748.0
YIPF4,ENSG00000119820,reticulocyte measurement,EFO_0010700,0.33213717036999446,3.3214898808179,2,0.8,1.6,transcript,13539.0
GREM1,ENSG00000166923,synophrys measurement,EFO_0007906,0.33213717036999446,3.3213899277648222,1,0.4,0.4,transcript,21949.0
OTUD7A,ENSG00000169918,erythrocyte volume,OBA_0003460,0.3321338648294064,3.321356374861757,1,0.4,0.4,transcript,22565.0
QSER1,ENSG00000060749,vertebral column disorder,MONDO_0000812,0.33210406470938886,3.3210673222966203,1,0.5,0.5,transcript,18744.0
ASTN2,ENSG00000148219,metabolite measurement,EFO_0004725,0.3319858714026513,3.3199174684330934,2,0.8,1.6,transcript,27232.0
FYB1,ENSG00000082074,ulcerative colitis,EFO_0000729,0.33196922083120434,3.319711858538021,1,0.5,0.5,transcript,25445.0
GFRAL,ENSG00000187871,polycystic ovary syndrome,EFO_0000660,0.33196554083501173,3.319864722845146,1,0.4,0.4,transcript,1911.0
FREM2,ENSG00000150893,congenital diaphragmatic hernia,EFO_0007216,0.3319391730957724,3.3202828377123135,6,2.5,15.0,transcript,16833.0
C2orf73,ENSG00000177994,blood urea nitrogen measurement,EFO_0004741,0.33188871891176,3.318935498296344,1,0.4,0.4,transcript,8280.0
CPPED1,ENSG00000103381,3-hydroxypropylmercapturic acid measurement,EFO_0007014,0.331861628848915,3.3186540172195786,1,0.4,0.4,transcript,10602.0
YTHDC2,ENSG00000047188,diastolic blood pressure,EFO_0006336,0.33185250718632225,3.318545281028079,1,0.4,0.4,transcript,19793.0
CNTNAP2,ENSG00000174469,arterial stiffness measurement,EFO_0004517,0.3318403190253652,3.3184108719251837,1,0.4,0.4,transcript,52072.0
KCNN3,ENSG00000143603,chronic obstructive pulmonary disease,EFO_0000341,0.3317952965328865,3.3180720011388045,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
ACTN2,ENSG00000077522,attention deficit hyperactivity disorder,EFO_0003888,0.33176036404640247,3.317620326075813,2,0.8,1.6,transcript,95891.0
ACTN2,ENSG00000077522,substance abuse,MONDO_0002491,0.33176036404640247,3.317620326075813,2,0.8,1.6,transcript,95891.0
ACTN2,ENSG00000077522,social inhibition quality,OBA_1000278,0.33176036404640247,3.317620326075813,2,0.8,1.6,transcript,95891.0
PRDM5,ENSG00000138738,acute tonsillitis,MONDO_0020686,0.3317445875195483,3.317526483790374,2,0.8,1.6,transcript,19849.0
IYD,ENSG00000009765,bone tissue density,OBA_1000110,0.3317445875195483,3.317463278606551,1,0.4,0.4,transcript,22984.0
OTOGL,ENSG00000165899,ovarian neoplasm,EFO_0003893,0.3317445875195483,3.3174607331534047,1,0.5,0.5,transcript,33652.0
SEMA3A,ENSG00000075213,COVID-19,MONDO_0100096,0.33171879247398267,3.317218129376238,1,0.4,0.4,transcript,13243.0
HACD1,ENSG00000165996,high density lipoprotein cholesterol measurement,EFO_0004612,0.33171248435233613,3.3171895370378364,1,0.4,0.4,transcript,6183.0
BTAF1,ENSG00000095564,high density lipoprotein cholesterol measurement,EFO_0004612,0.3316972768982062,3.3170095134244653,1,0.4,0.4,transcript,10886.0
SOGA1,ENSG00000149639,pain measurement,EFO_0010639,0.33167342506897246,3.3167558014849488,1,0.5,0.5,transcript,23201.0
KLF10,ENSG00000155090,Epidermal Inclusion Cyst,EFO_1000243,0.3316062410565303,3.316123256321312,1,0.4,0.4,transcript,6574.0
RFX3,ENSG00000080298,Hashimoto's thyroiditis,EFO_0003779,0.3316041428293572,3.3160979294589086,2,0.8,1.6,transcript,28318.0
PIP4K2A,ENSG00000150867,balding measurement,EFO_0007825,0.33159814108527697,3.316024856057505,1,0.4,0.4,transcript,9207.0
PIP4K2A,ENSG00000150867,androgenetic alopecia,EFO_0004191,0.33159814108527697,3.316024856057505,1,0.4,0.4,transcript,9207.0
KCNQ3,ENSG00000184156,Lambert-Eaton myasthenic syndrome,EFO_0020094,0.33159525850877414,3.3160089628185374,2,0.8,1.6,transcript,28380.0
NDUFAF4,ENSG00000123545,metabolic disease,EFO_0000589,0.33159525850877414,3.316064129984562,1,0.4,0.4,transcript,3586.0
AKR1C1,ENSG00000187134,carpal tunnel syndrome,EFO_0004143,0.33157046050252337,3.315843795977822,2,0.8,1.6,transcript,11495.0
TFEC,ENSG00000105967,arterial stiffness measurement,EFO_0004517,0.3315485689130924,3.31550138648592,1,0.4,0.4,transcript,25482.0
MYO3A,ENSG00000095777,high density lipoprotein cholesterol measurement,EFO_0004612,0.3315485689130924,3.3155094049208973,1,0.5,0.5,transcript,21083.0
CADPS,ENSG00000163618,urinary microalbumin measurement,EFO_0010967,0.3315485689130924,3.3154950068415627,1,0.4,0.4,transcript,42929.0
SEMA3C,ENSG00000075223,glucose measurement,EFO_0004468,0.3315485689130924,3.3155194074146634,1,0.4,0.4,transcript,11863.0
CNTNAP2,ENSG00000174469,urinary microalbumin measurement,EFO_0010967,0.3315485689130924,3.315493370802456,1,0.4,0.4,transcript,52072.0
ARSJ,ENSG00000180801,head and neck malignant neoplasia,EFO_0006859,0.3315485689130924,3.315663922393707,2,0.8,1.6,transcript,8977.0
PLXNA4,ENSG00000221866,placenta praevia,EFO_0007442,0.3315485689130924,3.3154979365283523,1,0.4,0.4,transcript,32660.0
SLC44A1,ENSG00000070214,optic cup area,OBA_2045265,0.3315485689130924,3.315495298047999,1,0.4,0.4,transcript,41628.0
XKR4,ENSG00000206579,placenta growth factor measurement,EFO_0010626,0.3315485689130924,3.315504641087714,1,0.4,0.4,transcript,21106.0
CA8,ENSG00000178538,growth differentiation factor 15 amount,OBA_2050135,0.3315485689130924,3.315526643364568,1,0.4,0.4,transcript,9767.0
XKR4,ENSG00000206579,inherited hemoglobinopathy,MONDO_0019050,0.3315485689130924,3.315504641087714,1,0.4,0.4,transcript,21106.0
PLPP4,ENSG00000203805,arterial stiffness measurement,EFO_0004517,0.3315485689130924,3.3155665789185886,1,0.4,0.4,transcript,4945.0
XKR4,ENSG00000206579,familial hemolytic anemia,MONDO_0003689,0.3315485689130924,3.315504641087714,1,0.4,0.4,transcript,21106.0
XKR4,ENSG00000206579,growth differentiation factor 15 amount,OBA_2050135,0.3315485689130924,3.315504641087714,1,0.4,0.4,transcript,21106.0
ST8SIA4,ENSG00000113532,aortic aneurysm,EFO_0001666,0.3315446567001745,3.315489444051804,1,0.4,0.4,transcript,9329.0
DMRTA1,ENSG00000176399,amino acid measurement,EFO_0005134,0.3315446567001745,3.3155181745921496,1,0.4,0.4,transcript,5586.0
KCNIP4,ENSG00000185774,polycystic ovary syndrome,EFO_0000660,0.3315446567001745,3.315579214987154,2,0.8,1.6,transcript,12062.0
TPRG1,ENSG00000188001,urate measurement,EFO_0004531,0.3315446567001745,3.3155464234580894,2,0.8,1.6,transcript,16023.0
ZPLD1,ENSG00000170044,fungal infectious disease,MONDO_0002041,0.3315446567001745,3.315605549513669,2,0.8,1.6,transcript,10064.0
FRMD4B,ENSG00000114541,gastrointestinal disease,EFO_0010282,0.3315446567001745,3.315522663263516,2,0.8,1.6,transcript,21026.0
TRDN,ENSG00000186439,sign or symptom,EFO_0003765,0.3315446567001745,3.315465770443002,1,0.5,0.5,transcript,26037.0
PLPP4,ENSG00000203805,response to radiation,GO_0009314,0.3315446567001745,3.3155274567894097,1,0.4,0.4,transcript,4945.0
TMCC1,ENSG00000172765,mean corpuscular hemoglobin concentration,EFO_0004528,0.3315070111619387,3.3150803130986013,1,0.4,0.4,transcript,39210.0
ZNF483,ENSG00000173258,apolipoprotein A 1 measurement,EFO_0004614,0.33150390191080115,3.3151225002725737,2,0.8,1.6,transcript,19166.0
GKAP1,ENSG00000165113,multiple sclerosis,MONDO_0005301,0.3315011025116083,3.3150681516513587,1,0.4,0.4,transcript,7002.0
SFRP1,ENSG00000104332,high density lipoprotein cholesterol measurement,EFO_0004612,0.33149844155635344,3.3150323944528233,1,0.4,0.4,transcript,8337.0
TENT4B,ENSG00000121274,neutrophil count,EFO_0004833,0.331484008071985,3.31508949615243,4,1.6,6.4,transcript,25660.0
NID2,ENSG00000087303,nontoxic goiter,MONDO_0001658,0.3314621033499899,3.314666168000711,1,0.5,0.5,transcript,11078.0
ZNF471,ENSG00000196263,total cholesterol measurement,EFO_0004574,0.33144069683105254,3.3144372071977344,1,0.4,0.4,transcript,13228.0
DCDC2,ENSG00000146038,erythrocyte volume,OBA_0003460,0.331440646291852,3.31445223998421,1,0.4,0.4,transcript,8738.0
MFAP3,ENSG00000037749,facial pain,EFO_0009625,0.33141326013865513,3.314145191088175,1,0.4,0.4,transcript,31772.0
NEK7,ENSG00000151414,arterial stiffness measurement,EFO_0004517,0.33138141773153923,3.313859441545335,1,0.4,0.4,transcript,8837.0
ST8SIA4,ENSG00000113532,serum alanine aminotransferase measurement,EFO_0004735,0.33138141773153923,3.3138570543654513,1,0.4,0.4,transcript,9329.0
MAP3K7,ENSG00000135341,growth differentiation factor 15 amount,OBA_2050135,0.33138141773153923,3.3139035640386707,4,1.6,6.4,transcript,71599.0
AHNAK2,ENSG00000185567,serum gamma-glutamyl transferase measurement,EFO_0004532,0.3313745680447564,3.313793510173739,2,1.0,2.0,transcript,41815.0
CIAO2A,ENSG00000166797,low density lipoprotein cholesterol measurement,EFO_0004611,0.3313467222212252,3.313687851004309,2,0.8,1.6,transcript,7252.0
TMED5,ENSG00000117500,erythrocyte count,EFO_0004305,0.33133531048089804,3.3133850720745004,1,0.5,0.5,transcript,15641.0
MLLT3,ENSG00000171843,erythrocyte count,EFO_0004305,0.3313312508219416,3.313415747347045,2,0.8,1.6,transcript,15498.0
ZNF471,ENSG00000196263,low density lipoprotein cholesterol measurement,EFO_0004611,0.33130900897908705,3.3131203286780795,1,0.4,0.4,transcript,13228.0
PRDM5,ENSG00000138738,pulse wave reflection index measurement,EFO_0009804,0.33128611592564944,3.312941767851386,2,0.8,1.6,transcript,19849.0
CADPS,ENSG00000163618,platelet count,EFO_0004309,0.33128255035544035,3.3128348212650423,1,0.4,0.4,transcript,42929.0
DNAJC10,ENSG00000077232,spermatocele,EFO_1001189,0.3312233994588161,3.3122532463186936,4,1.7000000000000002,6.800000000000001,transcript,353215.0
SLC6A5,ENSG00000165970,Cervicitis,HP_0030160,0.3312233994588161,3.312272630732274,1,0.4,0.4,transcript,10353.0
SUMF1,ENSG00000144455,mean corpuscular hemoglobin,EFO_0004527,0.3312233994588161,3.312266343961392,1,0.4,0.4,transcript,12365.0
RTKN2,ENSG00000182010,connective tissue disease,EFO_1001986,0.3312233994588161,3.3122692524109905,1,0.4,0.4,transcript,11345.0
ZNF716,ENSG00000182111,serum creatinine amount,OBA_2050096,0.33118859513052973,3.3147650300001152,6,2.5,15.0,transcript,5210.0
BMERB1,ENSG00000166780,"monounsaturated fatty acids; 16:1, 18:1 measurement",EFO_0022187,0.3311760611537701,3.3117968861364133,1,0.4,0.4,transcript,11027.0
CADPS,ENSG00000163618,placental retention,EFO_0009578,0.3311692652906374,3.3117019706170128,1,0.4,0.4,transcript,42929.0
ABCA10,ENSG00000154263,total lipids in LDL measurement ,EFO_0022308,0.33114669637267247,3.311566899878627,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
ABCA10,ENSG00000154263,cholesterol in large LDL measurement ,EFO_0021901,0.33114669637267247,3.311566899878627,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
EXO1,ENSG00000174371,urinary microalbumin measurement,EFO_0010967,0.3311167611325192,3.311297044408288,2,1.0,2.0,transcript,15452.0
MATN2,ENSG00000132561,neurodegenerative disease,EFO_0005772,0.3311025233453962,3.3110421889288846,1,0.5,0.5,transcript,29489.0
PEAK1,ENSG00000173517,cervical carcinoma,EFO_0001061,0.33108467441257067,3.3108536665769464,1,0.4,0.4,transcript,57783.0
SH3TC2,ENSG00000169247,eosinophil count,EFO_0004842,0.3310418859663431,3.31042328307211,1,0.4,0.4,transcript,90428.0
CPB1,ENSG00000153002,erythrocyte volume,OBA_0003460,0.331028432784388,3.310329906695293,1,0.5,0.5,transcript,10970.0
RAD18,ENSG00000070950,clopidogrel metabolite measurement,EFO_0007966,0.330986467142013,3.309898152628802,1,0.4,0.4,transcript,11947.0
RAD18,ENSG00000070950,arterial stiffness measurement,EFO_0004517,0.330986467142013,3.309898152628802,1,0.4,0.4,transcript,11947.0
NAF1,ENSG00000145414,arterial stiffness measurement,EFO_0004517,0.330986467142013,3.309926621612176,1,0.5,0.5,transcript,8071.0
PTPRO,ENSG00000151490,endometriosis of pelvic peritoneum,MONDO_0001285,0.3309680518494755,3.3096849670912225,1,0.4,0.4,transcript,89916.0
NEDD4,ENSG00000069869,Abnormality of refraction,HP_0000539,0.33096765451434906,3.3096848551050573,1,0.4,0.4,transcript,48135.0
GALNT3,ENSG00000115339,self reported educational attainment,EFO_0004784,0.33096075962833005,3.30963650428359,1,0.4,0.4,transcript,13837.0
NEK7,ENSG00000151414,body weight,EFO_0004338,0.33096014279305697,3.3096466921605123,1,0.4,0.4,transcript,8837.0
PPA2,ENSG00000138777,self reported educational attainment,EFO_0004784,0.3309587543565009,3.309614949835564,1,0.5,0.5,transcript,18244.0
GKAP1,ENSG00000165113,phospholipids:total lipids ratio,EFO_0020946,0.3309301657846337,3.3093587843816126,1,0.4,0.4,transcript,7002.0
PLXNA4,ENSG00000221866,chronotype measurement,EFO_0008328,0.33092884095266845,3.309300656924113,1,0.4,0.4,transcript,32660.0
BMERB1,ENSG00000166780,free cholesterol to total lipids in medium VLDL percentage ,EFO_0022284,0.3308957890662232,3.3089941652609443,1,0.4,0.4,transcript,11027.0
F13B,ENSG00000143278,drug use measurement,EFO_0007010,0.3308481818878329,3.3085897170224805,1,0.5,0.5,transcript,4634.0
MFAP3,ENSG00000037749,major depressive disorder,MONDO_0002009,0.330838185200463,3.3083944417062536,1,0.4,0.4,transcript,31772.0
MATN2,ENSG00000132561,forced expiratory volume,EFO_0004314,0.3307914248076645,3.3079312035515676,1,0.5,0.5,transcript,29489.0
DNAJC10,ENSG00000077232,spondylolisthesis,EFO_0007493,0.33079016217285234,3.307920873459056,4,1.7000000000000002,6.800000000000001,transcript,353215.0
TXNL1,ENSG00000091164,corneal dystrophy,MONDO_0018102,0.33078702515605546,3.3079524503789464,2,0.8,1.6,transcript,19465.0
YIPF4,ENSG00000119820,glucuronate measurement,EFO_0010486,0.3307777820752947,3.307895997870902,2,0.8,1.6,transcript,13539.0
ZNF675,ENSG00000197372,fumarate measurement,EFO_0010480,0.3307777820752947,3.3078206179796865,1,0.5,0.5,transcript,11683.0
NCKAP1,ENSG00000061676,Global developmental delay,HP_0001263,0.3307739699428081,3.3077495286454295,1,0.4,0.4,transcript,40695.0
TC2N,ENSG00000165929,appendicular lean mass,EFO_0004980,0.330767637063223,3.3076991354151106,1,0.4,0.4,transcript,17571.0
TOPAZ1,ENSG00000173769,high density lipoprotein cholesterol measurement,EFO_0004612,0.33075868370510936,3.307680575333808,1,0.5,0.5,transcript,5334.0
WAPL,ENSG00000062650,mean corpuscular hemoglobin concentration,EFO_0004528,0.33075868370510936,3.3077205939479333,2,0.8,1.6,transcript,11962.0
NID2,ENSG00000087303,Sensorineural hearing impairment,HP_0000407,0.33075868370510936,3.307631971551906,1,0.5,0.5,transcript,11078.0
VPS50,ENSG00000004766,nutritional deficiency disease,EFO_1001067,0.3307248816610758,3.307259978570798,1,0.4,0.4,transcript,35836.0
SCARA3,ENSG00000168077,hyperaldosteronism,EFO_0009452,0.3306888005692687,3.306958218085174,1,0.4,0.4,transcript,5697.0
HECW2,ENSG00000138411,chronotype measurement,EFO_0008328,0.3306751761562603,3.3067575777140554,1,0.4,0.4,transcript,68774.0
AKR1C1,ENSG00000187134,anthropometric measurement,EFO_0004302,0.33063952465453555,3.3065344374979437,2,0.8,1.6,transcript,11495.0
QSER1,ENSG00000060749,uterine fibroid,EFO_0000731,0.3305934638012647,3.3059613132153784,1,0.5,0.5,transcript,18744.0
PKP2,ENSG00000057294,periodontal measurement,EFO_0007780,0.3305897519202855,3.306053620571181,4,1.6,6.4,transcript,40999.0
SV2C,ENSG00000122012,fatty acid measurement,EFO_0005110,0.3305397235528131,3.3054252643978668,1,0.4,0.4,transcript,14271.0
TRDMT1,ENSG00000107614,cervical carcinoma,EFO_0001061,0.33053857045978463,3.305399496274569,1,0.4,0.4,transcript,29003.0
TSPAN3,ENSG00000140391,neuroimaging measurement,EFO_0004346,0.33053760042572117,3.3053979148619446,1,0.4,0.4,transcript,18256.0
SEMA3A,ENSG00000075213,heel bone mineral density,EFO_0009270,0.3305210396690696,3.3052406013271076,1,0.4,0.4,transcript,13243.0
ITGA8,ENSG00000077943,ceramide measurement,EFO_0010222,0.3305210396690696,3.3056751526937944,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
DNAH14,ENSG00000185842,COVID-19,MONDO_0100096,0.3304998048312609,3.3050560267961493,3,1.5,4.5,transcript,77615.0
LRP2,ENSG00000081479,viral eye infection,MONDO_0020950,0.3304734408738274,3.304750997438052,1,0.5,0.5,transcript,30141.0
RPRD2,ENSG00000163125,serum alanine aminotransferase measurement,EFO_0004735,0.33045503635107465,3.3045688700342963,1,0.4,0.4,transcript,21614.0
LARP4B,ENSG00000107929,heart rate,OBA_1001087,0.3304378414863092,3.3043894268661753,1,0.5,0.5,transcript,45405.0
RASGRP3,ENSG00000152689,blood sodium bicarbonate amount,OBA_2050094,0.33040771512072925,3.30408835412005,1,0.4,0.4,transcript,35705.0
BMERB1,ENSG00000166780,free cholesterol to total lipids in small HDL percentage ,EFO_0022285,0.330403467768518,3.304070952283892,1,0.4,0.4,transcript,11027.0
C2orf73,ENSG00000177994,cystatin B measurement,EFO_0010593,0.33038967686107723,3.3039450777895163,1,0.4,0.4,transcript,8280.0
DYNC1I2,ENSG00000077380,pain,EFO_0003843,0.33038890970068274,3.303900283940489,1,0.4,0.4,transcript,35756.0
RTKN2,ENSG00000182010,total cholesterol measurement,EFO_0004574,0.33037960666135097,3.303831324436339,1,0.4,0.4,transcript,11345.0
PAFAH1B2,ENSG00000168092,cholesteryl ester 16:2 measurement,EFO_0021435,0.33032883507816607,3.3034221412323674,2,0.8,1.6,transcript,11959.0
ALDOB,ENSG00000136872,total cholesterol measurement,EFO_0004574,0.33028315230997857,3.302872935254253,1,0.4,0.4,transcript,9659.0
STARD13,ENSG00000133121,erythrocyte volume,OBA_0003460,0.33027170345609036,3.302731851021992,1,0.4,0.4,transcript,26997.0
GRK7,ENSG00000114124,erythrocyte volume,OBA_0003460,0.33026627171993733,3.3027037512576416,1,0.4,0.4,transcript,9748.0
DOK5,ENSG00000101134,placenta praevia,EFO_0007442,0.3301767070970942,3.3018549058413855,1,0.4,0.4,transcript,4554.0
GRIA4,ENSG00000152578,frozen shoulder,EFO_1000941,0.3301767070970942,3.3017763624924283,1,0.4,0.4,transcript,43050.0
HS6ST3,ENSG00000185352,urinary microalbumin measurement,EFO_0010967,0.3301767070970942,3.3018139313270805,1,0.4,0.4,transcript,8536.0
UNC80,ENSG00000144406,level of complement component C1q receptor in blood serum,OBA_2040369,0.3301767070970942,3.301771732975604,1,0.4,0.4,transcript,85800.0
RNF150,ENSG00000170153,left ventricular diastolic function measurement,EFO_0008204,0.3301767070970942,3.302025729985613,4,1.6,6.4,transcript,24743.0
XKR4,ENSG00000206579,bone tissue density,OBA_1000110,0.3301767070970942,3.3017860229277316,1,0.4,0.4,transcript,21106.0
TRPC6,ENSG00000137672,arterial stiffness measurement,EFO_0004517,0.3301767070970942,3.3017959580945067,1,0.4,0.4,transcript,13847.0
MDGA2,ENSG00000139915,protozoa infectious disease,MONDO_0002428,0.3301767070970942,3.3017901616596217,1,0.4,0.4,transcript,17323.0
NEBL,ENSG00000078114,pituitary gland disease,EFO_0009607,0.3301767070970942,3.301774892789906,1,0.4,0.4,transcript,51139.0
MAP3K7,ENSG00000135341,arterial stiffness measurement,EFO_0004517,0.3301767070970942,3.30185645769422,4,1.6,6.4,transcript,71599.0
ARSJ,ENSG00000180801,Abruptio Placentae,EFO_1001754,0.3301767070970942,3.301945304233725,2,0.8,1.6,transcript,8977.0
TNFRSF19,ENSG00000127863,male infertility,EFO_0004248,0.33013419953119616,3.301374996434,1,0.5,0.5,transcript,15151.0
C12orf42,ENSG00000179088,autoimmune thyroid disease,EFO_0006812,0.33013419953119616,3.301377134815792,1,0.5,0.5,transcript,14229.0
C12orf42,ENSG00000179088,stem Cell Growth Factor beta measurement,EFO_0008292,0.33013419953119616,3.301377134815792,1,0.5,0.5,transcript,14229.0
C12orf42,ENSG00000179088,temporal measurement,EFO_0000719,0.33013419953119616,3.301377134815792,1,0.5,0.5,transcript,14229.0
FAM98A,ENSG00000119812,metabolite measurement,EFO_0004725,0.33013419953119616,3.301349348523477,1,0.4,0.4,transcript,54398.0
PDCD5,ENSG00000105185,methionine aminopeptidase 2 measurement,EFO_0008232,0.3300948689422977,3.301026799167168,1,0.4,0.4,transcript,5121.0
FAM8A1,ENSG00000137414,cholelithiasis,EFO_0004799,0.3300784407557581,3.3008036494278907,1,0.4,0.4,transcript,20788.0
SFRP1,ENSG00000104332,hippocampal volume,EFO_0005035,0.33007482952891914,3.30079627417848,1,0.4,0.4,transcript,8337.0
ADK,ENSG00000156110,erythrocyte volume,OBA_0003460,0.3300474688464204,3.300493671901155,1,0.4,0.4,transcript,21071.0
RCL1,ENSG00000120158,neutrophil measurement,EFO_0803548,0.33002369678674176,3.3002756413664027,1,0.4,0.4,transcript,10343.0
SLAMF7,ENSG00000026751,blood protein measurement,EFO_0007937,0.3299659361754738,3.299675558053884,1,0.4,0.4,transcript,24697.0
SLAMF7,ENSG00000026751,protein measurement,EFO_0004747,0.3299659361754738,3.299675558053884,1,0.4,0.4,transcript,24697.0
GRIA4,ENSG00000152578,platelet volume,OBA_0003277,0.32994098253776394,3.299419116899126,1,0.4,0.4,transcript,43050.0
COL25A1,ENSG00000188517,cholesterol:total lipids ratio,EFO_0020943,0.3299398816393238,3.2994137780539825,1,0.4,0.4,transcript,26735.0
BACH1,ENSG00000156273,QT interval,EFO_0004682,0.3299265753440656,3.2996236152165452,4,1.6,6.4,transcript,17884.0
ANKRD17,ENSG00000132466,level of Sphingomyelin (d42:2) in blood serum,OBA_2045183,0.32992184907828187,3.2992276806922978,1,0.4,0.4,transcript,43526.0
ANKRD17,ENSG00000132466,level of Sphingomyelin (d40:2) in blood serum,OBA_2045181,0.32992184907828187,3.2992276806922978,1,0.4,0.4,transcript,43526.0
ANKRD17,ENSG00000132466,hemoglobin measurement,EFO_0004509,0.32992184907828187,3.2992276806922978,1,0.4,0.4,transcript,43526.0
ANKRD17,ENSG00000132466,level of Sphingomyelin (d40:1) in blood serum,OBA_2045182,0.32992184907828187,3.2992276806922978,1,0.4,0.4,transcript,43526.0
ANKRD17,ENSG00000132466,level of Sphingomyelin (d38:1) in blood serum,OBA_2045180,0.32992184907828187,3.2992276806922978,1,0.4,0.4,transcript,43526.0
TSPAN3,ENSG00000140391,neurodegenerative disease,EFO_0005772,0.3298337231240433,3.298359141845166,1,0.4,0.4,transcript,18256.0
CNTLN,ENSG00000044459,cerebral cortex area attribute,OBA_2045267,0.32982024906233426,3.298323951186616,2,0.8,1.6,transcript,13173.0
TMEM154,ENSG00000170006,level of cathepsin O in blood serum,OBA_2041195,0.32980390604796744,3.2980581453596782,1,0.4,0.4,transcript,20959.0
PSD3,ENSG00000156011,alpha-hydroxyisovalerate measurement,EFO_0800023,0.3297973216013593,3.29798265910715,1,0.4,0.4,transcript,42359.0
C12orf42,ENSG00000179088,platelet volume,OBA_0003277,0.3297973216013593,3.298008355517423,1,0.5,0.5,transcript,14229.0
MYO3A,ENSG00000095777,bronchiectasis,MONDO_0004822,0.3297907801008496,3.2979315167984695,1,0.5,0.5,transcript,21083.0
OTUD7A,ENSG00000169918,growth differentiation factor 15 amount,OBA_2050135,0.3297907801008496,3.2979255275761896,1,0.4,0.4,transcript,22565.0
SPOCK3,ENSG00000196104,response to antihypertensive drug,EFO_0005405,0.3297907801008496,3.2979901657929753,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
METTL25,ENSG00000127720,renal osteodystrophy,EFO_1001152,0.3297907801008496,3.2979597490604444,1,0.5,0.5,transcript,9625.0
OTUD7A,ENSG00000169918,pyruvate measurement,EFO_0010117,0.3297907801008496,3.2979255275761896,1,0.4,0.4,transcript,22565.0
OTUD7A,ENSG00000169918,placenta growth factor measurement,EFO_0010626,0.3297907801008496,3.2979255275761896,1,0.4,0.4,transcript,22565.0
MLLT3,ENSG00000171843,Red cell distribution width,EFO_0009188,0.3297492649508599,3.2975958886362284,2,0.8,1.6,transcript,15498.0
ZNF398,ENSG00000197024,dentate gyrus volume,OBA_2045237,0.3297473037992618,3.297498531937806,1,0.4,0.4,transcript,15690.0
ZFP90,ENSG00000184939,platelet crit,EFO_0007985,0.32970461583544775,3.297059513501217,1,0.4,0.4,transcript,29951.0
TBC1D9B,ENSG00000197226,brain volume,OBA_2050009,0.32966465114205507,3.296658726279927,1,0.4,0.4,transcript,32747.0
NDST3,ENSG00000164100,body mass index,EFO_0004340,0.3296478716252696,3.2965287788309188,1,0.4,0.4,transcript,7990.0
CCDC88C,ENSG00000015133,hypertension,EFO_0000537,0.32963198196546645,3.2963391423926964,1,0.4,0.4,transcript,20701.0
TAF2,ENSG00000064313,diastolic blood pressure,EFO_0006336,0.3296210725675877,3.296213518659901,1,0.5,0.5,transcript,179020.0
ABCA10,ENSG00000154263,cholesterol in small LDL measurement ,EFO_0022227,0.3296050213578392,3.2961501497302947,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
ABCA10,ENSG00000154263,total lipids in large LDL,EFO_0022163,0.3296050213578392,3.2961501497302947,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
ABCA10,ENSG00000154263,phospholipids in medium LDL measurement,EFO_0022183,0.3296050213578392,3.2961501497302947,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
ATXN3,ENSG00000066427,forced expiratory volume,EFO_0004314,0.32956415809300965,3.2956473041276473,1,0.4,0.4,transcript,69891.0
NRCAM,ENSG00000091129,protein measurement,EFO_0004747,0.32956222572838895,3.2956339105978008,1,0.4,0.4,transcript,34325.0
NDUFAF4,ENSG00000123545,body mass index,EFO_0004340,0.32955344326448366,3.2956459775416573,1,0.4,0.4,transcript,3586.0
SLC36A4,ENSG00000180773,chronotype measurement,EFO_0008328,0.3295259010117082,3.2953695455229544,2,0.8,1.6,transcript,14475.0
CHL1,ENSG00000134121,blood protein measurement,EFO_0007937,0.3295191654059455,3.295238854484259,2,0.8,1.6,transcript,33898.0
CHL1,ENSG00000134121,neural cell adhesion molecule L1-like protein amount,OBA_2050223,0.3295191654059455,3.295238854484259,2,0.8,1.6,transcript,33898.0
BACE2,ENSG00000182240,heart failure,EFO_0003144,0.3295059032477701,3.2951925884042454,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
GSTA5,ENSG00000182793,platelet count,EFO_0004309,0.3294809482469951,3.2951596225259734,1,0.5,0.5,transcript,1428.0
RIF1,ENSG00000080345,high density lipoprotein cholesterol measurement,EFO_0004612,0.32944204051703485,3.2944819484873755,3,1.3,3.9000000000000004,transcript,63370.0
YIPF4,ENSG00000119820,X-11444 measurement,EFO_0021237,0.32944129145273304,3.294531091645286,2,0.8,1.6,transcript,13539.0
GPM6A,ENSG00000150625,fumarate measurement,EFO_0010480,0.32939533871569465,3.2939715582376716,1,0.4,0.4,transcript,22013.0
LNPEP,ENSG00000113441,Crohn's disease,EFO_0000384,0.3293931783921316,3.2939524461456045,1,0.4,0.4,transcript,19359.0
SH3TC2,ENSG00000169247,polyneuropathy,EFO_0009562,0.32939302772165896,3.2939347006252686,1,0.4,0.4,transcript,90428.0
CCDC80,ENSG00000091986,central corneal thickness,EFO_0005213,0.3293863152196767,3.2939423601175593,2,0.8,1.6,transcript,20200.0
CCDC80,ENSG00000091986,corneal resistance factor,EFO_0010067,0.3293863152196767,3.2939423601175593,2,0.8,1.6,transcript,20200.0
RANBP17,ENSG00000204764,substance abuse,MONDO_0002491,0.3293545139506077,3.293554653801306,1,0.4,0.4,transcript,42042.0
RANBP17,ENSG00000204764,attention deficit hyperactivity disorder,EFO_0003888,0.3293545139506077,3.293554653801306,1,0.4,0.4,transcript,42042.0
RANBP17,ENSG00000204764,social inhibition quality,OBA_1000278,0.3293545139506077,3.293554653801306,1,0.4,0.4,transcript,42042.0
RANBP17,ENSG00000204764,restless legs syndrome,EFO_0004270,0.3293545139506077,3.293554653801306,1,0.4,0.4,transcript,42042.0
HEG1,ENSG00000173706,body mass index,EFO_0004340,0.3293203226695042,3.2932250929826927,1,0.4,0.4,transcript,18293.0
TENT4B,ENSG00000121274,neutrophil percentage of leukocytes,EFO_0007990,0.32930571124936453,3.2933065279262252,4,1.6,6.4,transcript,25660.0
GPR158,ENSG00000151025,Myasthenia gravis,EFO_0004991,0.32930503050570614,3.2930759763616773,1,0.5,0.5,transcript,19477.0
TCERG1L,ENSG00000176769,mean corpuscular hemoglobin concentration,EFO_0004528,0.32930503050570614,3.2932784853194685,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,mean corpuscular hemoglobin concentration,EFO_0004528,0.32930503050570614,3.2932784853194685,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,mean corpuscular hemoglobin concentration,EFO_0004528,0.32930503050570614,3.2932784853194685,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,mean corpuscular hemoglobin concentration,EFO_0004528,0.32930503050570614,3.2932784853194685,2,0.8,1.6,gene_variant,7012.0
ROCK2,ENSG00000134318,appendicular lean mass,EFO_0004980,0.32930070794946287,3.2930180730963525,1,0.5,0.5,transcript,45481.0
GPR180,ENSG00000152749,intermediate density lipoprotein measurement,EFO_0008595,0.3292927125400455,3.292972150164075,1,0.4,0.4,transcript,8884.0
GRIA4,ENSG00000152578,respiratory system disease,EFO_0000684,0.32928545832496864,3.292863874771173,1,0.4,0.4,transcript,43050.0
ATRNL1,ENSG00000107518,Hematemesis,HP_0002248,0.32928545832496864,3.292871442391556,1,0.4,0.4,transcript,23726.0
TULP4,ENSG00000130338,peak expiratory flow,EFO_0009718,0.32927546626138204,3.2927735876705952,1,0.4,0.4,transcript,21136.0
DLGAP1,ENSG00000170579,mean corpuscular hemoglobin concentration,EFO_0004528,0.3292473221244632,3.29250137538857,2,0.8,1.6,transcript,56830.0
CHL1,ENSG00000134121,cervical carcinoma,EFO_0001061,0.3292274206527421,3.2923214069522246,2,0.8,1.6,transcript,33898.0
BMERB1,ENSG00000166780,free cholesterol in large HDL measurement,EFO_0022157,0.3292176108934475,3.292212383533187,1,0.4,0.4,transcript,11027.0
CLSTN2,ENSG00000158258,cognitive function measurement,EFO_0008354,0.32921604731465576,3.292184559375256,1,0.4,0.4,transcript,16607.0
ZNF483,ENSG00000173258,high density lipoprotein cholesterol measurement,EFO_0004612,0.32919002144064086,3.2919836955709707,2,0.8,1.6,transcript,19166.0
DLG1,ENSG00000075711,systolic blood pressure,EFO_0006335,0.32916297970816183,3.2916452068531257,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
DLG1,ENSG00000075711,potassium measurement,EFO_0009283,0.32916297970816183,3.2916452068531257,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
CPPED1,ENSG00000103381,N-acetylglutamine measurement,EFO_0800017,0.329109591484259,3.2911336435730183,1,0.4,0.4,transcript,10602.0
VPS13A,ENSG00000197969,acute tonsillitis,MONDO_0020686,0.32903468369802286,3.290353582229044,1,0.4,0.4,transcript,59301.0
OTUD7A,ENSG00000169918,tooth disease,EFO_1001216,0.32903054451344027,3.290323171702096,1,0.4,0.4,transcript,22565.0
COL25A1,ENSG00000188517,total lipids in chylomicrons and extremely large VLDL measurement ,EFO_0022306,0.3290249660569339,3.2902646222300835,1,0.4,0.4,transcript,26735.0
PEAK1,ENSG00000173517,heel bone mineral density,EFO_0009270,0.3290108262038271,3.290115184489511,1,0.4,0.4,transcript,57783.0
FRMD4B,ENSG00000114541,retinal nerve fibre layer thickness,OBA_2050111,0.32896008329098747,3.2896769291716454,2,0.8,1.6,transcript,21026.0
CD86,ENSG00000114013,Hodgkins lymphoma,EFO_0000183,0.3289261074940981,3.289292909401785,1,0.4,0.4,transcript,12565.0
CSMD3,ENSG00000164796,phosphatidylcholine measurement,EFO_0010226,0.3289225767847113,3.2892338765688542,1,0.5,0.5,transcript,61662.0
SYNJ2,ENSG00000078269,severe acute respiratory syndrome,EFO_0000694,0.32890906535117276,3.28914180113656,2,0.8,1.6,transcript,31282.0
SYNJ2,ENSG00000078269,COVID-19,MONDO_0100096,0.32890906535117276,3.28914180113656,2,0.8,1.6,transcript,31282.0
HS3ST3A1,ENSG00000153976,arterial stiffness measurement,EFO_0004517,0.32887089649863976,3.288790002263545,1,0.4,0.4,transcript,4936.0
DGKH,ENSG00000102780,diastolic blood pressure,EFO_0006336,0.32886149289990263,3.28864232203777,2,0.8,1.6,transcript,58409.0
UBE2U,ENSG00000177414,pulse wave reflection index measurement,EFO_0009804,0.32885784079805735,3.2886456235745913,1,0.4,0.4,transcript,5951.0
SYT13,ENSG00000019505,C40:6 phosphatidylethanolamine measurement,EFO_0801151,0.32885784079805735,3.2887936932335338,2,0.8,1.6,transcript,7432.0
PTPRO,ENSG00000151490,appendicular lean mass,EFO_0004980,0.32884884849230483,3.288492933519516,1,0.4,0.4,transcript,89916.0
PTPRO,ENSG00000151490,sitting height measurement,EFO_0011011,0.32884884849230483,3.288492933519516,1,0.4,0.4,transcript,89916.0
ARHGAP28,ENSG00000088756,gastrointestinal disease,EFO_0010282,0.3288480000977545,3.2884923026136628,1,0.4,0.4,transcript,32516.0
ATRNL1,ENSG00000107518,threitol measurement,EFO_0021031,0.32884247688146645,3.288441627956534,1,0.4,0.4,transcript,23726.0
ATRNL1,ENSG00000107518,bone remodeling disease,MONDO_0000833,0.32884247688146645,3.288441627956534,1,0.4,0.4,transcript,23726.0
LONRF1,ENSG00000154359,self reported educational attainment,EFO_0004784,0.32883751111865744,3.288410404473791,1,0.5,0.5,transcript,14167.0
FRRS1L,ENSG00000260230,waist circumference,OBA_1001085,0.3288185189784069,3.2882710958243377,2,0.8,1.6,transcript,18625.0
PIP4K2A,ENSG00000150867,QT interval,EFO_0004682,0.3287955154450536,3.2879985996552716,1,0.4,0.4,transcript,9207.0
TMEM17,ENSG00000186889,Crohn's disease,EFO_0000384,0.3287933115312977,3.2879971153129772,1,0.4,0.4,transcript,6250.0
RASEF,ENSG00000165105,neurodegenerative disease,EFO_0005772,0.3287895103748045,3.287949525516752,1,0.4,0.4,transcript,7350.0
EXOC6,ENSG00000138190,serum creatinine amount,OBA_2050096,0.32878393600570904,3.2878619773276383,1,0.5,0.5,transcript,22107.0
UBL3,ENSG00000122042,strand of hair color,OBA_0002313,0.3287720868058981,3.288554780498175,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
SULT6B1,ENSG00000138068,body mass index,EFO_0004340,0.32875264945264837,3.287639591110967,1,0.5,0.5,transcript,4421.0
PLEKHA6,ENSG00000143850,IGF-1 measurement,EFO_0004627,0.32874664169758216,3.2874732316341517,1,0.4,0.4,transcript,58697.0
GPM6A,ENSG00000150625,Sepsis,HP_0100806,0.32874252777472723,3.287443448827997,1,0.4,0.4,transcript,22013.0
GPATCH2L,ENSG00000089916,secondary malignant neoplasm,EFO_0009812,0.32873482516361535,3.287490723976484,4,1.6,6.4,transcript,44921.0
RBM25,ENSG00000119707,systolic blood pressure,EFO_0006335,0.328729861216826,3.28731130212099,1,0.4,0.4,transcript,31521.0
CFAP299,ENSG00000197826,sitting height measurement,EFO_0011011,0.3287171570986543,3.2872367090792993,1,0.5,0.5,transcript,7676.0
COL25A1,ENSG00000188517,cholesterol in chylomicrons and extremely large VLDL measurement ,EFO_0021898,0.3287004665977589,3.2870196276383337,1,0.4,0.4,transcript,26735.0
COL25A1,ENSG00000188517,free cholesterol to total lipids in small LDL percentage ,EFO_0022286,0.3287004665977589,3.2870196276383337,1,0.4,0.4,transcript,26735.0
GSAP,ENSG00000186088,ovarian dysfunction,EFO_0009003,0.3286906711863612,3.2869322259729143,1,0.5,0.5,transcript,19597.0
ZNF507,ENSG00000168813,ovarian neoplasm,EFO_0003893,0.3286906711863612,3.286921110711704,1,0.4,0.4,transcript,27780.0
TMEM68,ENSG00000167904,placenta praevia,EFO_0007442,0.3286906711863612,3.2869253833848737,1,0.4,0.4,transcript,21423.0
CFAP299,ENSG00000197826,whole body water mass,EFO_0009805,0.32868952562632764,3.286960394356033,1,0.5,0.5,transcript,7676.0
RFX3,ENSG00000080298,Red cell distribution width,EFO_0009188,0.32868952562632764,3.286951757428613,2,0.8,1.6,transcript,28318.0
MYO1B,ENSG00000128641,adolescent idiopathic scoliosis,EFO_0005423,0.3286436046536096,3.286449454956584,1,0.4,0.4,transcript,29832.0
SGCZ,ENSG00000185053,X-23678 measurement,EFO_0800861,0.3285568170056789,3.285616879262829,1,0.4,0.4,transcript,8212.0
DCLK1,ENSG00000133083,high density lipoprotein cholesterol measurement,EFO_0004612,0.3285568170056789,3.285618367710049,2,0.8,1.6,transcript,31874.0
PCDH18,ENSG00000189184,smoking initiation,EFO_0005670,0.32854327966293595,3.2855099682880677,2,0.8,1.6,transcript,20733.0
KLHDC10,ENSG00000128607,systolic blood pressure,EFO_0006335,0.32851326349621834,3.2851823676489915,1,0.4,0.4,transcript,8043.0
SYNJ2,ENSG00000078269,platelet component distribution width,EFO_0007984,0.32850722742141264,3.285123421838959,2,0.8,1.6,transcript,31282.0
NRCAM,ENSG00000091129,lymphocyte count,EFO_0004587,0.3285038325194923,3.285049978508834,1,0.4,0.4,transcript,34325.0
KPNA4,ENSG00000186432,alanine measurement,EFO_0009765,0.32848181799688686,3.284827173178995,1,0.4,0.4,transcript,44478.0
PRPF4B,ENSG00000112739,skin neoplasm,EFO_0004198,0.32847111394631506,3.2847319242985344,1,0.5,0.5,transcript,24056.0
FAM186A,ENSG00000185958,intraocular pressure measurement,EFO_0004695,0.32847111394631506,3.2848220410934044,2,1.0,2.0,transcript,18034.0
ABCB1,ENSG00000085563,acute megakaryoblastic leukaemia,EFO_0003025,0.32846409585102876,3.2846650062209455,1,0.5,0.5,transcript,20792.0
STXBP4,ENSG00000166263,mosaic loss of chromosome Y measurement,EFO_0007783,0.32845670219703266,3.2849587333573766,5,2.0,10.0,transcript,25529.0
RASSF2,ENSG00000101265,suberate (C8-DC) measurement,EFO_0800181,0.32845102140276417,3.284611014128442,2,0.8,1.6,transcript,15873.0
DLG2,ENSG00000150672,temporal measurement,EFO_0000719,0.32842929702468165,3.2842957431719753,1,0.4,0.4,transcript,144252.0
DLG2,ENSG00000150672,male infertility,EFO_0004248,0.32842929702468165,3.2842957431719753,1,0.4,0.4,transcript,144252.0
RAPGEF4,ENSG00000091428,ankylosing spondylitis,EFO_0003898,0.32842379485674017,3.284251134656078,1,0.4,0.4,transcript,30335.0
ARHGAP28,ENSG00000088756,triglyceride measurement,EFO_0004530,0.32841975663827644,3.2842098680188823,1,0.4,0.4,transcript,32516.0
CAV2,ENSG00000105971,QT interval,EFO_0004682,0.3283962314247421,3.2839864878136265,1,0.4,0.4,transcript,16547.0
LHFPL2,ENSG00000145685,diastolic blood pressure change measurement,EFO_0006945,0.32839552482307804,3.2839821407949867,1,0.4,0.4,transcript,14874.0
YEATS2,ENSG00000163872,putamen volume,OBA_2050016,0.328380932339053,3.2838430638588476,1,0.5,0.5,transcript,14819.0
CERKL,ENSG00000188452,metabolite measurement,EFO_0004725,0.32833890272233385,3.2834091010951867,1,0.5,0.5,transcript,24908.0
LGSN,ENSG00000146166,high density lipoprotein cholesterol measurement,EFO_0004612,0.32832934299259486,3.283324027340467,1,0.4,0.4,transcript,13073.0
IL17A,ENSG00000112115,polymyalgia rheumatica,EFO_0008518,0.32832037035198464,3.28341749293727,1,0.4,0.4,transcript,1871.0
MCL1,ENSG00000143384,protein measurement,EFO_0004747,0.32830627197053286,3.283079489084442,1,0.4,0.4,transcript,23853.0
NRCAM,ENSG00000091129,liver disease,EFO_0001421,0.3282175384913696,3.2821870382276073,1,0.4,0.4,transcript,34325.0
LINGO2,ENSG00000174482,preeclampsia,EFO_0000668,0.3282083006625032,3.282094725489474,1,0.4,0.4,transcript,34133.0
SEPTIN7,ENSG00000122545,male reproductive system disease,EFO_0009555,0.32820550049703157,3.282064681297182,1,0.4,0.4,transcript,41338.0
ADK,ENSG00000156110,electrocardiography,EFO_0004327,0.3281964326989294,3.281983310426245,1,0.4,0.4,transcript,21071.0
GPR158,ENSG00000151025,osteitis deformans,EFO_0004261,0.32817263948142344,3.2817520661188504,1,0.5,0.5,transcript,19477.0
STARD13,ENSG00000133121,platelet crit,EFO_0007985,0.3281530312846225,3.281545129307313,1,0.4,0.4,transcript,26997.0
SLC25A36,ENSG00000114120,triacylglycerol 60:12 measurement,EFO_0010444,0.3280791857050848,3.280805523854183,1,0.4,0.4,transcript,29268.0
TRHDE,ENSG00000072657,gallbladder disease,EFO_0003832,0.3280791857050848,3.280891427652628,2,0.8,1.6,transcript,16069.0
PKP2,ENSG00000057294,JT interval,EFO_0007885,0.328071900363525,3.2808751050035765,4,1.6,6.4,transcript,40999.0
CCBE1,ENSG00000183287,appendicular lean mass,EFO_0004980,0.32805623689289737,3.280576159179267,1,0.4,0.4,transcript,29006.0
BTC,ENSG00000174808,forced expiratory volume,EFO_0004314,0.3280538679280792,3.2806607421431666,1,0.4,0.4,transcript,3277.0
SGCZ,ENSG00000185053,cognitive function measurement,EFO_0008354,0.32804878174617585,3.2805365266677984,1,0.4,0.4,transcript,8212.0
KCNIP4,ENSG00000185774,vascular disease,EFO_0004264,0.32803953768823957,3.2805280248678046,2,0.8,1.6,transcript,12062.0
U2SURP,ENSG00000163714,smoking initiation,EFO_0005670,0.328000413945452,3.2800545474441862,2,0.8,1.6,transcript,31741.0
CA8,ENSG00000178538,mean corpuscular hemoglobin concentration,EFO_0004528,0.3279708529301325,3.2797494835349688,1,0.4,0.4,transcript,9767.0
UMPS,ENSG00000114491,serum creatinine amount,OBA_2050096,0.32794675217632,3.279486378124865,1,0.4,0.4,transcript,21213.0
F13B,ENSG00000143278,protein measurement,EFO_0004747,0.3279381336278513,3.2794892344226647,1,0.5,0.5,transcript,4634.0
ONECUT1,ENSG00000169856,epilepsy,EFO_0000474,0.32789892087002,3.2790420558398483,1,0.4,0.4,transcript,7569.0
CCBE1,ENSG00000183287,blood dibutyl sulfosuccinate measurement,EFO_0022212,0.3278895112545333,3.278908902795626,1,0.4,0.4,transcript,29006.0
PPFIBP2,ENSG00000166387,cutaneous melanoma,EFO_0000389,0.3278620075333503,3.27863375821895,1,0.5,0.5,transcript,36542.0
SV2C,ENSG00000122012,serum albumin amount,OBA_2050068,0.3278542327424336,3.278570356294072,1,0.4,0.4,transcript,14271.0
LHFPL2,ENSG00000145685,metabolite measurement,EFO_0004725,0.32784976270562455,3.2785245196204515,1,0.4,0.4,transcript,14874.0
DCK,ENSG00000156136,viral load,EFO_0010125,0.327844312713442,3.2784801128024736,1,0.4,0.4,transcript,10815.0
ZNF436,ENSG00000125945,BMI-adjusted waist circumference,EFO_0007789,0.3278384143639201,3.2784177853549283,1,0.4,0.4,transcript,11890.0
PKP2,ENSG00000057294,heart rate response to recovery post exercise,EFO_0009185,0.3278346277327249,3.2785023786955754,4,1.6,6.4,transcript,40999.0
BHLHE41,ENSG00000123095,PR interval,EFO_0004462,0.3278346277327249,3.2784345580599794,1,0.4,0.4,transcript,4531.0
COL25A1,ENSG00000188517,X-23678 measurement,EFO_0800861,0.3278344259498288,3.278359221159033,1,0.4,0.4,transcript,26735.0
MLLT3,ENSG00000171843,platelet component distribution width,EFO_0007984,0.32782718609841627,3.2783751001117922,2,0.8,1.6,transcript,15498.0
CD69,ENSG00000110848,thyroid disease,EFO_1000627,0.32782501476272446,3.2790946233485676,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
TRIM36,ENSG00000152503,alcohol drinking,EFO_0004329,0.3278184137528796,3.2782102984182666,1,0.4,0.4,transcript,15290.0
ZNF485,ENSG00000198298,high density lipoprotein cholesterol measurement,EFO_0004612,0.32780446962430027,3.2781420293167813,1,0.5,0.5,transcript,5137.0
SENP6,ENSG00000112701,brain attribute,OBA_2045210,0.3277900514774689,3.2783295319353756,5,2.2,11.0,transcript,25640.0
ZNF502,ENSG00000196653,body mass index,EFO_0004340,0.3277863436649966,3.2779125043634103,1,0.5,0.5,transcript,10190.0
ATAD2B,ENSG00000119778,diet measurement,EFO_0008111,0.32775891747397684,3.277607352426658,1,0.4,0.4,transcript,22005.0
SLC25A46,ENSG00000164209,cognitive function measurement,EFO_0008354,0.3277131567103492,3.277151520213683,1,0.4,0.4,transcript,20047.0
SLC25A46,ENSG00000164209,major depressive disorder,MONDO_0002009,0.3277131567103492,3.277151520213683,1,0.4,0.4,transcript,20047.0
LATS1,ENSG00000131023,cortical thickness,EFO_0004840,0.32769510328890133,3.276968389480179,1,0.4,0.4,transcript,23046.0
TSPAN19,ENSG00000231738,total cortical area measurement,EFO_0008381,0.32768076511015276,3.2768568273985523,1,0.4,0.4,transcript,8134.0
TSPAN19,ENSG00000231738,brain volume,OBA_2050009,0.32768076511015276,3.2768568273985523,1,0.4,0.4,transcript,8134.0
MTR,ENSG00000116984,homocysteine measurement,EFO_0004578,0.3276729415018408,3.2767338274482225,1,0.4,0.4,transcript,90653.0
FAM114A1,ENSG00000197712,movement disorder,EFO_0004280,0.3276321533709216,3.276370213275968,1,0.4,0.4,transcript,8217.0
PDE1C,ENSG00000154678,self reported educational attainment,EFO_0004784,0.3276291609208529,3.2763459681131977,2,0.8,1.6,transcript,29434.0
CEP85L,ENSG00000111860,monocyte count,EFO_0005091,0.3276238137891903,3.27625354087238,1,0.4,0.4,transcript,25969.0
SV2C,ENSG00000122012,metabolite measurement,EFO_0004725,0.3276210389678877,3.276238418548613,1,0.4,0.4,transcript,14271.0
IREB2,ENSG00000136381,Abdominal Aortic Aneurysm,EFO_0004214,0.3276136060289104,3.2762359160530004,2,0.9,1.8,transcript,18026.0
IREB2,ENSG00000136381,invasive mechanical ventilation,EFO_0010720,0.3276136060289104,3.2762359160530004,2,0.9,1.8,transcript,18026.0
IREB2,ENSG00000136381,Abnormal lung morphology,HP_0002088,0.3276136060289104,3.2762359160530004,2,0.9,1.8,transcript,18026.0
IREB2,ENSG00000136381,respiratory failure,EFO_0009686,0.3276136060289104,3.2762359160530004,2,0.9,1.8,transcript,18026.0
RAPGEF4,ENSG00000091428,hearing process quality,OBA_2045262,0.32758362743559544,3.275849460444631,1,0.4,0.4,transcript,30335.0
RAPGEF4,ENSG00000091428,metabolite measurement,EFO_0004725,0.32758362743559544,3.275849460444631,1,0.4,0.4,transcript,30335.0
STARD13,ENSG00000133121,arterial stiffness measurement,EFO_0004517,0.32758362743559544,3.2758510908170426,1,0.4,0.4,transcript,26997.0
LYPD6,ENSG00000187123,urinary microalbumin measurement,EFO_0010967,0.32758362743559544,3.275869023660032,1,0.4,0.4,transcript,12214.0
CDH19,ENSG00000071991,self reported educational attainment,EFO_0004784,0.32756383842462383,3.2759129419033464,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
CDH19,ENSG00000071991,educational attainment,EFO_0011015,0.32756383842462383,3.2759129419033464,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
GFRAL,ENSG00000187871,gout,EFO_0004274,0.3275253667263605,3.2754629817586336,1,0.4,0.4,transcript,1911.0
GFRAL,ENSG00000187871,hemoglobin measurement,EFO_0004509,0.3275253667263605,3.2754629817586336,1,0.4,0.4,transcript,1911.0
BMERB1,ENSG00000166780,free cholesterol in very large HDL measurement ,EFO_0022273,0.32750058726706033,3.275042147269316,1,0.4,0.4,transcript,11027.0
NDUFAF4,ENSG00000123545,schizophrenia,MONDO_0005090,0.32748881567894406,3.2749997016862618,1,0.4,0.4,transcript,3586.0
NDUFAF4,ENSG00000123545,colorectal cancer,MONDO_0005575,0.32748881567894406,3.2749997016862618,1,0.4,0.4,transcript,3586.0
COG3,ENSG00000136152,acute tonsillitis,MONDO_0020686,0.32747240645233955,3.2747779032226525,1,0.5,0.5,transcript,9287.0
NDST3,ENSG00000164100,HbA1c measurement,EFO_0004541,0.32743199412205154,3.2743700037987384,1,0.4,0.4,transcript,7990.0
FLRT2,ENSG00000185070,erythrocyte count,EFO_0004305,0.3274279892996786,3.274615411767007,7,2.8000000000000003,19.6,transcript,58417.0
LUZP2,ENSG00000187398,blood pyridoxal measurement,EFO_0022222,0.32741901267238255,3.27450690674805,4,1.7000000000000002,6.800000000000001,transcript,21466.0
CFAP54,ENSG00000188596,skin microbiome measurement,EFO_0801228,0.3273614352705012,3.273682984529589,2,1.0,2.0,transcript,29141.0
FSIP2,ENSG00000188738,high density lipoprotein cholesterol measurement,EFO_0004612,0.32735896330687597,3.2738685730966535,4,2.0,8.0,transcript,28680.0
FBXO22,ENSG00000167196,platelet count,EFO_0004309,0.32732097010812733,3.2732308998729422,1,0.4,0.4,transcript,18869.0
SAXO1,ENSG00000155875,high grade ovarian serous adenocarcinoma,EFO_1001958,0.32731900648446055,3.273216740403125,1,0.4,0.4,transcript,14995.0
C12orf42,ENSG00000179088,glucose measurement,EFO_0004468,0.32727377227009924,3.272772862204823,1,0.5,0.5,transcript,14229.0
TAF1B,ENSG00000115750,cleft lip,EFO_0003959,0.3272623338267997,3.2726777393124973,1,0.5,0.5,transcript,9191.0
TAF1B,ENSG00000115750,Cleft palate,HP_0000175,0.3272623338267997,3.2726777393124973,1,0.5,0.5,transcript,9191.0
EVI5,ENSG00000067208,protein measurement,EFO_0004747,0.3272521303094963,3.272526959043607,1,0.4,0.4,transcript,70722.0
TFEC,ENSG00000105967,white matter microstructure measurement,EFO_0005674,0.32725190587971276,3.2725347561521234,1,0.4,0.4,transcript,25482.0
ZNF471,ENSG00000196263,platelet count,EFO_0004309,0.32724349424100285,3.2724651812972376,1,0.4,0.4,transcript,13228.0
PCDH18,ENSG00000189184,Antihypertensive use measurement,EFO_0009927,0.32723010887679466,3.2723782604266547,2,0.8,1.6,transcript,20733.0
NEBL,ENSG00000078114,bone tissue density,OBA_1000110,0.3272246583698662,3.272254405517626,1,0.4,0.4,transcript,51139.0
PCDH18,ENSG00000189184,hypertrophic cardiomyopathy,EFO_0000538,0.3272171516690537,3.272248688349245,2,0.8,1.6,transcript,20733.0
MED10,ENSG00000133398,hypertrophic cardiomyopathy,EFO_0000538,0.3272025597413338,3.272175186044602,1,0.4,0.4,transcript,2674.0
PTPRO,ENSG00000151490,brain connectivity attribute,OBA_2045295,0.3271896120497489,3.2719005690939564,1,0.4,0.4,transcript,89916.0
TRDN,ENSG00000186439,palmitoyl sphingomyelin (d18:1/16:0) measurement,EFO_0800300,0.3271896120497489,3.2719153239387455,1,0.5,0.5,transcript,26037.0
PARP8,ENSG00000151883,cellulitis,EFO_0003035,0.3271755647609999,3.2718027244334906,2,0.8,1.6,transcript,33987.0
OTOGL,ENSG00000165899,bone tissue density,OBA_1000110,0.3271755647609999,3.2717705055679214,1,0.5,0.5,transcript,33652.0
PARP8,ENSG00000151883,abscess,EFO_0003030,0.3271755647609999,3.2718027244334906,2,0.8,1.6,transcript,33987.0
SPOCK3,ENSG00000196104,metabolite measurement,EFO_0004725,0.32716016630628114,3.2716840278472903,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
IQCB1,ENSG00000173226,retinitis pigmentosa,MONDO_0019200,0.32715929046103925,3.2716345235886464,1,0.4,0.4,transcript,9611.0
RASEF,ENSG00000165105,ovarian neoplasm,EFO_0003893,0.3271566169380184,3.2716205911488916,1,0.4,0.4,transcript,7350.0
RASEF,ENSG00000165105,anxiety,EFO_0005230,0.3270906354463292,3.2709607762319997,1,0.4,0.4,transcript,7350.0
RAD23B,ENSG00000119318,cerebral cortex area attribute,OBA_2045267,0.3270826093159342,3.2708663670216054,1,0.4,0.4,transcript,9932.0
FAM114A1,ENSG00000197712,blood urea nitrogen measurement,EFO_0004741,0.3270616949563807,3.270665629130559,1,0.4,0.4,transcript,8217.0
DIRAS2,ENSG00000165023,metabolite measurement,EFO_0004725,0.32704658989760405,3.27054214754638,1,0.4,0.4,transcript,5246.0
LIMA1,ENSG00000050405,neurodegenerative disease,EFO_0005772,0.3270393483405709,3.270406887782238,1,0.4,0.4,transcript,29841.0
KCNN3,ENSG00000143603,heart disease,EFO_0003777,0.32702244703151934,3.270343506125133,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
VPS13A,ENSG00000197969,hemoglobin A1 measurement,EFO_0007629,0.32698698252099967,3.269876570458812,1,0.4,0.4,transcript,59301.0
PLPP4,ENSG00000203805,neurofibrillary tangles measurement,EFO_0006797,0.32698058511141237,3.2698867409017884,1,0.4,0.4,transcript,4945.0
GPAT3,ENSG00000138678,Peyronie disease,MONDO_0008231,0.3269749712333082,3.269896838769864,2,0.8,1.6,transcript,10875.0
CCDC80,ENSG00000091986,fumarate measurement,EFO_0010480,0.3269749712333082,3.2698289202538744,2,0.8,1.6,transcript,20200.0
CNTNAP2,ENSG00000174469,Intellectual disability,HP_0001249,0.3269747072425687,3.269754754097219,1,0.4,0.4,transcript,52072.0
TENT4B,ENSG00000121274,lymphocyte percentage of leukocytes,EFO_0007993,0.3269718086070845,3.2699675015034253,4,1.6,6.4,transcript,25660.0
OR8H2,ENSG00000181767,ovarian neoplasm,EFO_0003893,0.3269674120947396,3.269729537960419,1,0.4,0.4,transcript,7218.0
RNF144B,ENSG00000137393,ocular hypotension,MONDO_0004390,0.32695426478354056,3.2696155208541704,1,0.4,0.4,transcript,5489.0
DTHD1,ENSG00000197057,metabolite measurement,EFO_0004725,0.32695426478354056,3.269569048384537,1,0.5,0.5,transcript,18939.0
TENM4,ENSG00000149256,lymphocyte count,EFO_0004587,0.32695284781320944,3.269545928616345,1,0.4,0.4,transcript,22922.0
STARD13,ENSG00000133121,body height,OBA_VT0001253,0.32694431595432827,3.2694579760043707,1,0.4,0.4,transcript,26997.0
PICALM,ENSG00000073921,anxiety disorder measurement,EFO_0007795,0.3269413840402036,3.2694271087206084,1,0.4,0.4,transcript,30147.0
PICALM,ENSG00000073921,lifestyle measurement,EFO_0010724,0.3269413840402036,3.2694271087206084,1,0.4,0.4,transcript,30147.0
ARL3,ENSG00000138175,neurodegenerative disease,EFO_0005772,0.3268772018190936,3.2688763478727303,1,0.4,0.4,transcript,3834.0
LIN54,ENSG00000189308,neurodegenerative disease,EFO_0005772,0.3268770867206787,3.2687837937838298,1,0.4,0.4,transcript,30944.0
NDFIP2,ENSG00000102471,HbA1c measurement,EFO_0004541,0.3268687506417047,3.2687019882830355,2,0.8,1.6,transcript,110483.0
RNF144B,ENSG00000137393,HbA1c measurement,EFO_0004541,0.3268687506417047,3.2687603794358115,1,0.4,0.4,transcript,5489.0
SLC30A9,ENSG00000014824,bipolar disorder,MONDO_0004985,0.32685520389430817,3.2689038022695,3,1.3,3.9000000000000004,transcript,11087.0
PRDM5,ENSG00000138738,high density lipoprotein cholesterol measurement,EFO_0004612,0.32685341570681314,3.268614765663023,2,0.8,1.6,transcript,19849.0
MYO3A,ENSG00000095777,monocyte count,EFO_0005091,0.32683463735308577,3.2683700893208307,1,0.5,0.5,transcript,21083.0
FLRT2,ENSG00000185070,hemoglobin measurement,EFO_0004509,0.32683463735308577,3.2686818923010788,7,2.8000000000000003,19.6,transcript,58417.0
NBAS,ENSG00000151779,self reported educational attainment,EFO_0004784,0.32683072319610756,3.268340777751079,2,1.0,2.0,transcript,59620.0
SCAMP1,ENSG00000085365,hematocrit,EFO_0004348,0.3267974697372554,3.26800104436241,1,0.4,0.4,transcript,15182.0
SMARCC1,ENSG00000173473,bilirubin measurement,EFO_0004570,0.3267609898764993,3.2677240458720775,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,bilirubin measurement,EFO_0004570,0.3267609898764993,3.2677240458720775,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,bilirubin measurement,EFO_0004570,0.3267609898764993,3.2677240458720775,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,bilirubin measurement,EFO_0004570,0.3267609898764993,3.2677240458720775,2,0.8,1.6,gene_variant,14017.0
TRPC6,ENSG00000137672,educational attainment,EFO_0011015,0.32675677604043796,3.2675966475279443,1,0.4,0.4,transcript,13847.0
MGA,ENSG00000174197,erythrocyte volume,OBA_0003460,0.3267364383842265,3.267370305627328,1,0.5,0.5,transcript,84434.0
SMC6,ENSG00000163029,alcohol drinking,EFO_0004329,0.3267296200413406,3.2673126099966026,1,0.4,0.4,transcript,24376.0
SMC6,ENSG00000163029,alcohol consumption quality,OBA_1000840,0.3267296200413406,3.2673126099966026,1,0.4,0.4,transcript,24376.0
CEP85L,ENSG00000111860,smoking initiation,EFO_0005670,0.32671550877840316,3.2671704907645083,1,0.4,0.4,transcript,25969.0
TMEM170B,ENSG00000205269,Abruptio Placentae,EFO_1001754,0.3267009527768826,3.2670545170838636,1,0.4,0.4,transcript,8891.0
CCBE1,ENSG00000183287,lymphocyte count,EFO_0004587,0.3267009527768826,3.267023318019119,1,0.4,0.4,transcript,29006.0
WDR12,ENSG00000138442,coronary atherosclerosis,MONDO_0021661,0.3266986920712855,3.2670068598983395,1,0.4,0.4,transcript,20061.0
GCH1,ENSG00000131979,platelet count,EFO_0004309,0.32668611843850126,3.266894948207077,1,0.4,0.4,transcript,11847.0
IREB2,ENSG00000136381,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.3266670800714583,3.2667706564784798,2,0.9,1.8,transcript,18026.0
MTR,ENSG00000116984,neurodegenerative disease,EFO_0005772,0.3266401378012892,3.266405790442707,1,0.4,0.4,transcript,90653.0
GLCE,ENSG00000138604,Antihypertensive use measurement,EFO_0009927,0.32662596374636516,3.266389962461615,2,0.8,1.6,transcript,12277.0
PICALM,ENSG00000073921,retinopathy,EFO_0003839,0.32662596374636516,3.2662729057822237,1,0.4,0.4,transcript,30147.0
PICALM,ENSG00000073921,retinoschisis,MONDO_0004579,0.32662596374636516,3.2662729057822237,1,0.4,0.4,transcript,30147.0
ZNF236,ENSG00000130856,4-acetamidobenzoate measurement,EFO_0801014,0.3266012488258339,3.266071456317307,2,0.9,1.8,transcript,30525.0
EVI5,ENSG00000067208,lymphocyte count,EFO_0004587,0.3265823378471572,3.2658290344202157,1,0.4,0.4,transcript,70722.0
DNAH14,ENSG00000185842,smoking initiation,EFO_0005670,0.32657168423122435,3.2657748207957837,3,1.5,4.5,transcript,77615.0
PDCD4,ENSG00000150593,Tietze syndrome,MONDO_0001858,0.32655532215780686,3.265588233131881,1,0.5,0.5,transcript,14281.0
CYSLTR1,ENSG00000173198,obstructive sleep apnea,EFO_0003918,0.3265103530136663,3.265293666797388,2,0.8,1.6,transcript,8415.0
COLEC10,ENSG00000184374,eosinophil count,EFO_0004842,0.32649782432620034,3.265083423382961,1,0.4,0.4,transcript,3803.0
RFX3,ENSG00000080298,high density lipoprotein cholesterol measurement,EFO_0004612,0.3264769547907429,3.2648260490727656,2,0.8,1.6,transcript,28318.0
PLXNA4,ENSG00000221866,smoking behavior,EFO_0004318,0.32647339521556795,3.2647461995531075,1,0.4,0.4,transcript,32660.0
RPS6KA5,ENSG00000100784,educational attainment,EFO_0011015,0.3264539798631267,3.264549663482801,1,0.4,0.4,transcript,40548.0
CR1L,ENSG00000197721,platelet volume,OBA_0003277,0.3264054264365669,3.264147547947758,1,0.5,0.5,transcript,5360.0
LIN54,ENSG00000189308,neutrophil count,EFO_0004833,0.32640033155209075,3.26401624209795,1,0.4,0.4,transcript,30944.0
RPS6KA5,ENSG00000100784,neuroinflammatory disorder,EFO_0020092,0.32638588106508976,3.2638686755024313,1,0.4,0.4,transcript,40548.0
ZBTB34,ENSG00000177125,diastolic blood pressure,EFO_0006336,0.32638068144182786,3.263837142722168,1,0.4,0.4,transcript,13189.0
ANO6,ENSG00000177119,Polyarteritis Nodosa,EFO_0009012,0.32634047756076434,3.2634121967579217,1,0.4,0.4,transcript,53900.0
SI,ENSG00000090402,nephritis,EFO_1002050,0.3263263156455764,3.2633352025652744,1,0.5,0.5,transcript,6940.0
SI,ENSG00000090402,Nephropathy,HP_0000112,0.3263263156455764,3.2633352025652744,1,0.5,0.5,transcript,6940.0
TLK1,ENSG00000198586,appendicular lean mass,EFO_0004980,0.326317554470005,3.26318943986106,1,0.4,0.4,transcript,28787.0
HECW2,ENSG00000138411,systolic blood pressure,EFO_0006335,0.32629890495218733,3.262994865673326,1,0.4,0.4,transcript,68774.0
PLA2R1,ENSG00000153246,appendicular lean mass,EFO_0004980,0.32627228116249746,3.262802003864135,2,0.8,1.6,transcript,20204.0
ATXN7L3B,ENSG00000253719,polymyalgia rheumatica,EFO_0008518,0.32626381200811105,3.262690779375476,1,0.4,0.4,transcript,7596.0
LRP2,ENSG00000081479,Retinal dystrophy,HP_0000556,0.32624661672292055,3.2624827559289833,1,0.5,0.5,transcript,30141.0
PEX13,ENSG00000162928,Parkinson disease,MONDO_0005180,0.3261650429610983,3.26169625912519,1,0.4,0.4,transcript,8728.0
HFE,ENSG00000010704,hemochromatosis type 2,MONDO_0019257,0.3261561951331648,3.2615702365073975,1,0.4,0.4,transcript,48279.0
SAXO1,ENSG00000155875,Benign Thyroid Gland Neoplasm,EFO_1000122,0.3261297212001951,3.2613238875604704,1,0.4,0.4,transcript,14995.0
MYO5A,ENSG00000197535,Chondrocalcinosis,HP_0000934,0.3261297212001951,3.2612992516631634,1,0.4,0.4,transcript,196111.0
PLEKHA6,ENSG00000143850,blood urea nitrogen measurement,EFO_0004741,0.3260900459666121,3.260907274324451,1,0.4,0.4,transcript,58697.0
TFEC,ENSG00000105967,body weight,EFO_0004338,0.32604359227468843,3.2604516201018803,1,0.4,0.4,transcript,25482.0
PKP2,ENSG00000057294,heart rate,OBA_1001087,0.3260138617716677,3.260294719085003,4,1.6,6.4,transcript,40999.0
MCL1,ENSG00000143384,"keratin, type II cytoskeletal 5 measurement",EFO_0802674,0.3260005724092999,3.260022493472113,1,0.4,0.4,transcript,23853.0
CYBRD1,ENSG00000071967,vital capacity,EFO_0004312,0.3259766380607882,3.2598004899282538,1,0.4,0.4,transcript,11727.0
SPRED1,ENSG00000166068,liver disease,EFO_0001421,0.3259152354774041,3.2591969279855406,1,0.4,0.4,transcript,8974.0
IREB2,ENSG00000136381,atherosclerosis,EFO_0003914,0.32590544509765507,3.2591543067404474,2,0.9,1.8,transcript,18026.0
CNMD,ENSG00000136110,smoking initiation,EFO_0005670,0.32586625609714825,3.259103332321345,2,0.8,1.6,transcript,3630.0
DOCK1,ENSG00000150760,schizophrenia,MONDO_0005090,0.3258584528906643,3.2586096167139686,1,0.4,0.4,transcript,15944.0
DYNC2H1,ENSG00000187240,dementia,MONDO_0001627,0.3258528814816486,3.25853897122518,1,0.5,0.5,transcript,49230.0
DYNC2H1,ENSG00000187240,drug use measurement,EFO_0007010,0.3258528814816486,3.25853897122518,1,0.5,0.5,transcript,49230.0
CYSLTR1,ENSG00000173198,chronic obstructive pulmonary disease,EFO_0000341,0.32584818910735625,3.258672027734287,2,0.8,1.6,transcript,8415.0
DCK,ENSG00000156136,ovarian dysfunction,EFO_0009003,0.325815255080195,3.2581895364700033,1,0.4,0.4,transcript,10815.0
PIGN,ENSG00000197563,serum albumin amount,OBA_2050068,0.3258067971506313,3.258070511333986,1,0.4,0.4,transcript,157491.0
AHNAK2,ENSG00000185567,male infertility,EFO_0004248,0.32578924545293964,3.257940284255571,2,1.0,2.0,transcript,41815.0
PIP4K2A,ENSG00000150867,intelligence,EFO_0004337,0.32577857379871483,3.257829183191884,1,0.4,0.4,transcript,9207.0
NEK1,ENSG00000137601,Alzheimer disease,MONDO_0004975,0.3257686760856095,3.2577010207243697,2,0.8,1.6,transcript,112203.0
TXNL1,ENSG00000091164,mood disorder,EFO_0004247,0.32575355928964045,3.2576177917147966,2,0.8,1.6,transcript,19465.0
CCDC7,ENSG00000216937,EDTA measurement,EFO_0800946,0.3257409110786776,3.257427707826127,1,0.5,0.5,transcript,26886.0
LUZP2,ENSG00000187398,attention deficit hyperactivity disorder,EFO_0003888,0.3257225641861107,3.257542421885331,4,1.7000000000000002,6.800000000000001,transcript,21466.0
MUC16,ENSG00000181143,asthma,MONDO_0004979,0.3257117509391126,3.2571203297405105,1,0.5,0.5,transcript,177283.0
CFAP299,ENSG00000197826,Ischemic stroke,HP_0002140,0.3257054524222553,3.2571196623153096,1,0.5,0.5,transcript,7676.0
PYGO1,ENSG00000171016,body mass index,EFO_0004340,0.3256882083018752,3.2572099182815326,4,1.6,6.4,transcript,19522.0
NRCAM,ENSG00000091129,body mass index,EFO_0004340,0.32567981984329347,3.256809851746846,1,0.4,0.4,transcript,34325.0
CYBRD1,ENSG00000071967,bone tissue density,OBA_1000110,0.32566392179468967,3.2566733272672685,1,0.4,0.4,transcript,11727.0
MUC16,ENSG00000181143,ovarian dysfunction,EFO_0009003,0.3256630676982161,3.256633497331546,1,0.5,0.5,transcript,177283.0
LATS1,ENSG00000131023,hippocampus molecular layer volume,OBA_2050050,0.3256541489512303,3.2565588461034687,1,0.4,0.4,transcript,23046.0
CFHR4,ENSG00000134365,sex hormone-binding globulin measurement,EFO_0004696,0.3256176967999831,3.2562174767902383,1,0.5,0.5,transcript,12343.0
CD86,ENSG00000114013,t-lymphocyte activation antigen CD86 measurement,EFO_0020762,0.3255774867124609,3.255806701585413,1,0.4,0.4,transcript,12565.0
CPD,ENSG00000108582,mean corpuscular hemoglobin,EFO_0004527,0.3255516126958688,3.2555363453169575,1,0.4,0.4,transcript,19784.0
ESF1,ENSG00000089048,Abruptio Placentae,EFO_1001754,0.32554744326829277,3.2555368936448263,1,0.4,0.4,transcript,6404.0
BMERB1,ENSG00000166780,metabolite measurement,EFO_0004725,0.3254863323777682,3.254899598376394,1,0.4,0.4,transcript,11027.0
MYO1B,ENSG00000128641,hair color,EFO_0003924,0.32546468471717577,3.254660255592246,1,0.4,0.4,transcript,29832.0
SPAST,ENSG00000021574,high density lipoprotein cholesterol measurement,EFO_0004612,0.3254520504936287,3.2545256812546306,1,0.4,0.4,transcript,77275.0
KYNU,ENSG00000115919,educational attainment,EFO_0011015,0.3254421761028785,3.254580009743014,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
LGSN,ENSG00000146166,chiro-inositol measurement,EFO_0800270,0.3254334879110354,3.2543654765248724,1,0.4,0.4,transcript,13073.0
RASSF2,ENSG00000101265,DNA methylation,EFO_0022599,0.32542843363762836,3.2543851364770835,2,0.8,1.6,transcript,15873.0
SRGN,ENSG00000122862,erythrocyte count,EFO_0004305,0.3254278493408235,3.2544018740374767,1,0.4,0.4,transcript,3242.0
FARSB,ENSG00000116120,androgenetic alopecia,EFO_0004191,0.32537677398019593,3.2538187602101223,1,0.4,0.4,transcript,7840.0
MTMR6,ENSG00000139505,sebacate (C10-DC) measurement,EFO_0800212,0.325343591280972,3.253489537863345,1,0.5,0.5,transcript,9324.0
ABCA13,ENSG00000179869,Hypocalcemia,HP_0002901,0.3253387827389868,3.2533981592491896,1,0.5,0.5,transcript,48394.0
TCERG1L,ENSG00000176769,secondary malignant neoplasm,EFO_0009812,0.3253387827389868,3.2536160076522753,2,0.8,1.6,transcript,7012.0
FAT3,ENSG00000165323,ovarian dysfunction,EFO_0009003,0.3253387827389868,3.253396156385183,1,0.4,0.4,transcript,48025.0
LRRC7,ENSG00000033122,aspartate aminotransferase measurement,EFO_0004736,0.3253387827389868,3.2534519310954186,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
COL19A1,ENSG00000082293,neuroimaging measurement,EFO_0004346,0.3253387827389868,3.2535251664456624,2,0.8,1.6,transcript,11650.0
COL19A1,ENSG00000082293,urinary microalbumin measurement,EFO_0010967,0.3253387827389868,3.2535251664456624,2,0.8,1.6,transcript,11650.0
ITGA8,ENSG00000077943,pulse wave reflection index measurement,EFO_0009804,0.3253387827389868,3.2538525833929666,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
TPRG1,ENSG00000188001,hypertrophic cardiomyopathy,EFO_0000538,0.3253387827389868,3.2534876838462123,2,0.8,1.6,transcript,16023.0
TCERG1L,ENSG00000176769,secondary malignant neoplasm,EFO_0009812,0.3253387827389868,3.2536160076522753,2,0.8,1.6,gene_variant,7012.0
CNTLN,ENSG00000044459,anorexia nervosa,MONDO_0005351,0.3253387827389868,3.2535092879531415,2,0.8,1.6,transcript,13173.0
TCERG1L,ENSG00000176769,serum creatinine amount,OBA_2050096,0.3253387827389868,3.2536160076522753,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,serum creatinine amount,OBA_2050096,0.3253387827389868,3.2536160076522753,2,0.8,1.6,transcript,7012.0
PLXNA4,ENSG00000221866,Splenomegaly,HP_0001744,0.3253387827389868,3.2534000747872964,1,0.4,0.4,transcript,32660.0
TCERG1L,ENSG00000176769,secondary malignant neoplasm,EFO_0009812,0.3253387827389868,3.2536160076522753,2,0.8,1.6,gene_variant,7012.0
PTPRO,ENSG00000151490,protein measurement,EFO_0004747,0.3253387827389868,3.253392275986336,1,0.4,0.4,transcript,89916.0
TCERG1L,ENSG00000176769,secondary malignant neoplasm,EFO_0009812,0.3253387827389868,3.2536160076522753,2,0.8,1.6,transcript,7012.0
FMN1,ENSG00000248905,lymphocyte count,EFO_0004587,0.3253387827389868,3.2534235249423546,2,0.8,1.6,transcript,44821.0
GPR158,ENSG00000151025,gut microbiome measurement,EFO_0007874,0.3253387827389868,3.253413498694484,1,0.5,0.5,transcript,19477.0
CFAP299,ENSG00000197826,Abnormality of the integument,HP_0001574,0.3253387827389868,3.2534529654826247,1,0.5,0.5,transcript,7676.0
CFAP299,ENSG00000197826,CXCL1 measurement,EFO_0010777,0.3253387827389868,3.2534529654826247,1,0.5,0.5,transcript,7676.0
LUZP2,ENSG00000187398,Polyarteritis Nodosa,EFO_0009012,0.3253387827389868,3.2537046074140927,4,1.7000000000000002,6.800000000000001,transcript,21466.0
TCERG1L,ENSG00000176769,serum creatinine amount,OBA_2050096,0.3253387827389868,3.2536160076522753,2,0.8,1.6,gene_variant,7012.0
CNTNAP2,ENSG00000174469,frozen shoulder,EFO_1000941,0.3253387827389868,3.2533955090614,1,0.4,0.4,transcript,52072.0
CNTNAP2,ENSG00000174469,level of Phosphatidylethanolamine (18:1_18:1) in blood serum,OBA_2045142,0.3253387827389868,3.2533955090614,1,0.4,0.4,transcript,52072.0
TMEM132B,ENSG00000139364,bilirubin measurement,EFO_0004570,0.3253387827389868,3.2534771906764512,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
COL19A1,ENSG00000082293,brain volume,OBA_2050009,0.3253387827389868,3.2535251664456624,2,0.8,1.6,transcript,11650.0
TCERG1L,ENSG00000176769,serum creatinine amount,OBA_2050096,0.3253387827389868,3.2536160076522753,2,0.8,1.6,gene_variant,7012.0
PRRG4,ENSG00000135378,placenta praevia,EFO_0007442,0.3253375896559082,3.2534480596476625,1,0.4,0.4,transcript,5543.0
PRRG4,ENSG00000135378,respiratory tract infectious disorder,MONDO_0024355,0.3253375896559082,3.2534480596476625,1,0.4,0.4,transcript,5543.0
KCNN3,ENSG00000143603,lymphocyte count,EFO_0004587,0.3253102164228458,3.2532212000383978,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
TTLL7,ENSG00000137941,joint disease,EFO_1000999,0.3253034475909264,3.253063449344246,2,0.8,1.6,transcript,55223.0
FRS2,ENSG00000166225,diastolic blood pressure,EFO_0006336,0.3252703610543687,3.252719719439825,1,0.4,0.4,transcript,24831.0
DPP8,ENSG00000074603,blood protein measurement,EFO_0007937,0.3251492164195683,3.25167388428995,4,1.6,6.4,transcript,35219.0
BACH1,ENSG00000156273,QRS-T angle,EFO_0020097,0.325143497488501,3.2517928366608992,4,1.6,6.4,transcript,17884.0
ARHGAP12,ENSG00000165322,low density lipoprotein cholesterol measurement,EFO_0004611,0.32508550278295956,3.2508670901920094,1,0.4,0.4,transcript,33161.0
ZNF236,ENSG00000130856,smoking initiation,EFO_0005670,0.3250764812887929,3.2508237809468974,2,0.9,1.8,transcript,30525.0
NEBL,ENSG00000078114,3-methyladipate measurement,EFO_0800263,0.32506710308469566,3.2506788526659207,1,0.4,0.4,transcript,51139.0
FAM171B,ENSG00000144369,white matter integrity,EFO_0004641,0.32503497927572744,3.2504195886044216,1,0.4,0.4,transcript,5731.0
RANBP17,ENSG00000204764,self reported educational attainment,EFO_0004784,0.32503380606223775,3.250347574917606,1,0.4,0.4,transcript,42042.0
RANBP17,ENSG00000204764,smoking behavior,EFO_0004318,0.32503380606223775,3.250347574917606,1,0.4,0.4,transcript,42042.0
RANBP17,ENSG00000204764,lean body mass,EFO_0004995,0.32503380606223775,3.250347574917606,1,0.4,0.4,transcript,42042.0
UMPS,ENSG00000114491,factor VII measurement,EFO_0004619,0.3250173864628849,3.250192720990514,1,0.4,0.4,transcript,21213.0
UMPS,ENSG00000114491,von Willebrand factor quality,OBA_1000199,0.3250173864628849,3.250192720990514,1,0.4,0.4,transcript,21213.0
UMPS,ENSG00000114491,factor VIII measurement,EFO_0004630,0.3250173864628849,3.250192720990514,1,0.4,0.4,transcript,21213.0
UMPS,ENSG00000114491,factor XI measurement,EFO_0004694,0.3250173864628849,3.250192720990514,1,0.4,0.4,transcript,21213.0
DYNC2H1,ENSG00000187240,HbA1c measurement,EFO_0004541,0.3250070365652064,3.2500805220607583,1,0.5,0.5,transcript,49230.0
KCNIP4,ENSG00000185774,appendicular lean mass,EFO_0004980,0.32500519111075804,3.250184559092989,2,0.8,1.6,transcript,12062.0
SPRED1,ENSG00000166068,body weight,EFO_0004338,0.3249898198766602,3.249942771978102,1,0.4,0.4,transcript,8974.0
LNPEP,ENSG00000113441,complement C1q tumor necrosis factor-related protein 5 measurement,EFO_0801494,0.3249832229443878,3.2498528916681666,1,0.4,0.4,transcript,19359.0
NEBL,ENSG00000078114,coronary aneurysm,EFO_1000881,0.3249790388261354,3.2497982100803178,1,0.4,0.4,transcript,51139.0
FGFR1OP2,ENSG00000111790,basophil percentage of leukocytes,EFO_0007992,0.32497716383622055,3.249807772056876,1,0.4,0.4,transcript,11070.0
C2orf73,ENSG00000177994,urinary system disease,EFO_0009690,0.3249694019011582,3.249742328190326,1,0.4,0.4,transcript,8280.0
CLHC1,ENSG00000162994,metabolite measurement,EFO_0004725,0.32494932061952975,3.2495184970400115,1,0.4,0.4,transcript,15816.0
FMN1,ENSG00000248905,smoking initiation,EFO_0005670,0.32493819913711025,3.249417688923589,2,0.8,1.6,transcript,44821.0
PARP11,ENSG00000111224,systolic blood pressure,EFO_0006335,0.3249380491032565,3.249398439520405,1,0.4,0.4,transcript,22286.0
FAT3,ENSG00000165323,C36:5 phosphatidylcholine plasmalogen measurement,EFO_0801141,0.32493060924892325,3.2493144214845473,1,0.4,0.4,transcript,48025.0
DOK5,ENSG00000101134,preeclampsia,EFO_0000668,0.32493060924892325,3.249393927359676,1,0.4,0.4,transcript,4554.0
LHFPL2,ENSG00000145685,tricuspid valve disease,EFO_0009568,0.32493060924892325,3.2493329850534387,1,0.4,0.4,transcript,14874.0
TMEM131,ENSG00000075568,brain volume,OBA_2050009,0.32493060924892325,3.249327541360486,1,0.4,0.4,transcript,18649.0
LHFPL2,ENSG00000145685,connective tissue neoplasm,MONDO_0021581,0.32493060924892325,3.2493329850534387,1,0.4,0.4,transcript,14874.0
FLRT2,ENSG00000185070,bilirubin measurement,EFO_0004570,0.32493060924892325,3.2496416112594537,7,2.8000000000000003,19.6,transcript,58417.0
MMADHC,ENSG00000168288,placental retention,EFO_0009578,0.32493060924892325,3.249387658557748,1,0.4,0.4,transcript,4904.0
MAP3K7,ENSG00000135341,platelet volume,OBA_0003277,0.32493060924892325,3.249395479212511,4,1.6,6.4,transcript,71599.0
DCLK1,ENSG00000133083,heart rate,OBA_1001087,0.3249189931046813,3.249240128700073,2,0.8,1.6,transcript,31874.0
RASGRP3,ENSG00000152689,BMI-adjusted hip circumference,EFO_0008039,0.3249092198378933,3.2491034012916904,1,0.4,0.4,transcript,35705.0
FRAS1,ENSG00000138759,cup-to-disc ratio measurement,EFO_0006939,0.3248621132683971,3.248653269228578,2,0.9,1.8,transcript,56011.0
LHFPL2,ENSG00000145685,cardiovascular disease,EFO_0000319,0.32485928362814626,3.248619728845669,1,0.4,0.4,transcript,14874.0
TRPC6,ENSG00000137672,immune system disease,EFO_0000540,0.3248523362839253,3.2485522499628177,1,0.4,0.4,transcript,13847.0
METTL25,ENSG00000127720,protein measurement,EFO_0004747,0.3248453930306034,3.248505878357982,1,0.5,0.5,transcript,9625.0
RASGRP3,ENSG00000152689,systemic lupus erythematosus,MONDO_0007915,0.3248424790192438,3.248435993105195,1,0.4,0.4,transcript,35705.0
CHL1,ENSG00000134121,Paralytic ileus,HP_0002590,0.3248384964520377,3.248432164945181,2,0.8,1.6,transcript,33898.0
IQGAP1,ENSG00000140575,Red cell distribution width,EFO_0009188,0.32482819665751644,3.2483360644923946,2,0.8,1.6,transcript,29576.0
RASEF,ENSG00000165105,worry measurement,EFO_0009589,0.3247742176819157,3.2477965985878647,1,0.4,0.4,transcript,7350.0
CFAP299,ENSG00000197826,"osteoarthritis, knee",EFO_0004616,0.3247557322255777,3.2476224603485333,1,0.5,0.5,transcript,7676.0
ARHGAP20,ENSG00000137727,heel bone mineral density,EFO_0009270,0.3247486853944743,3.2474970985343194,1,0.4,0.4,transcript,39045.0
NBAS,ENSG00000151779,mathematical ability,EFO_0004875,0.3247455117130541,3.2474886629205444,2,1.0,2.0,transcript,59620.0
G3BP2,ENSG00000138757,high density lipoprotein cholesterol measurement,EFO_0004612,0.3247243456571261,3.247245209811468,1,0.4,0.4,transcript,228149.0
ARHGAP29,ENSG00000137962,retinal vasculature measurement,EFO_0010554,0.3246354200053575,3.2463744257725993,1,0.5,0.5,transcript,24721.0
GPM6A,ENSG00000150625,neuroticism measurement,EFO_0007660,0.32462783314997723,3.2462965025804973,1,0.4,0.4,transcript,22013.0
LUZP2,ENSG00000187398,social inhibition quality,OBA_1000278,0.3246138246220566,3.246455026244791,4,1.7000000000000002,6.800000000000001,transcript,21466.0
LUZP2,ENSG00000187398,substance abuse,MONDO_0002491,0.3246138246220566,3.246455026244791,4,1.7000000000000002,6.800000000000001,transcript,21466.0
NEDD4,ENSG00000069869,reactive cutaneous fibrous lesion,EFO_1000759,0.3246103968444292,3.2461122784058585,1,0.4,0.4,transcript,48135.0
NEDD4,ENSG00000069869,lumbar disc herniation,EFO_1002005,0.3246103968444292,3.2461122784058585,1,0.4,0.4,transcript,48135.0
NEDD4,ENSG00000069869,Fasciitis,HP_0100537,0.32458241273568555,3.245832437318422,1,0.4,0.4,transcript,48135.0
RGS7BP,ENSG00000186479,mathematical ability,EFO_0004875,0.3245814517025829,3.2459026382806755,1,0.5,0.5,transcript,5674.0
SLCO6A1,ENSG00000205359,"N2-acetyl,N6-methyllysine measurement",EFO_0800109,0.3245663325209997,3.24570457933541,1,0.5,0.5,transcript,12120.0
RTKN2,ENSG00000182010,drug use measurement,EFO_0007010,0.3244707364045856,3.2447426218686855,1,0.4,0.4,transcript,11345.0
LAMA1,ENSG00000101680,aortic aneurysm,EFO_0001666,0.3244405306341913,3.2444212015606313,1,0.5,0.5,transcript,31456.0
LAMA1,ENSG00000101680,Abdominal Aortic Aneurysm,EFO_0004214,0.3244405306341913,3.2444212015606313,1,0.5,0.5,transcript,31456.0
PEAK1,ENSG00000173517,blood protein measurement,EFO_0007937,0.32442778892377283,3.244284811688968,1,0.4,0.4,transcript,57783.0
PDHX,ENSG00000110435,protein measurement,EFO_0004747,0.3244152082177598,3.2441968499448057,1,0.4,0.4,transcript,8935.0
ELAPOR1,ENSG00000116299,body mass index,EFO_0004340,0.32439023131067746,3.2439154063964635,1,0.4,0.4,transcript,30550.0
NEK1,ENSG00000137601,neurodegenerative disease,EFO_0005772,0.3243792003658155,3.2438062635264298,2,0.8,1.6,transcript,112203.0
TMEM17,ENSG00000186889,educational attainment,EFO_0011015,0.3243748842521988,3.243812842521988,1,0.4,0.4,transcript,6250.0
KYNU,ENSG00000115919,self reported educational attainment,EFO_0004784,0.32437011836371993,3.2438594323514285,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
TNFRSF19,ENSG00000127863,urinary microalbumin measurement,EFO_0010967,0.32436787875615375,3.2437117886835756,1,0.5,0.5,transcript,15151.0
SRGN,ENSG00000122862,amyloid beta A4 protein measurement,EFO_0020145,0.324362763461465,3.243751015243891,1,0.4,0.4,transcript,3242.0
KYNU,ENSG00000115919,metabolite measurement,EFO_0004725,0.32436088077136677,3.2437670564278966,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
CENPE,ENSG00000138778,erythrocyte volume,OBA_0003460,0.32435366932539356,3.2435623869846655,1,0.5,0.5,transcript,19460.0
WAPL,ENSG00000062650,metabolite measurement,EFO_0004725,0.32435059714566955,3.243639728353535,2,0.8,1.6,transcript,11962.0
INIP,ENSG00000148153,lipid measurement,EFO_0004529,0.32431481810240065,3.2431984575448713,1,0.4,0.4,transcript,7956.0
PAQR3,ENSG00000163291,total blood protein measurement,EFO_0004536,0.3243112133650363,3.243127185390721,1,0.4,0.4,transcript,26575.0
FMN1,ENSG00000248905,serum creatinine amount,OBA_2050096,0.3243071842278167,3.2431075398306533,2,0.8,1.6,transcript,44821.0
SPAST,ENSG00000021574,11beta-hydroxyandrosterone glucuronide measurement,EFO_0800573,0.3243054802726497,3.243059979044841,1,0.4,0.4,transcript,77275.0
GKAP1,ENSG00000165113,polyunsaturated fatty acids to total fatty acids percentage ,EFO_0022303,0.3242783992787417,3.2428411193226925,1,0.4,0.4,transcript,7002.0
CLASP2,ENSG00000163539,lymphocyte count,EFO_0004587,0.3242722313585214,3.242728432974499,1,0.4,0.4,transcript,65366.0
PDHX,ENSG00000110435,obsessive-compulsive disorder,EFO_0004242,0.3242722313585214,3.2427670813524214,1,0.4,0.4,transcript,8935.0
PIGN,ENSG00000197563,lymphocyte count,EFO_0004587,0.3242722313585214,3.2427248534128865,1,0.4,0.4,transcript,157491.0
NCKAP1,ENSG00000061676,platelet volume,OBA_0003277,0.3242607654472904,3.2426174836902524,1,0.4,0.4,transcript,40695.0
PAQR3,ENSG00000163291,gut microbiome measurement,EFO_0007874,0.324258729231042,3.2426023440507774,1,0.4,0.4,transcript,26575.0
GPM6A,ENSG00000150625,mortality,EFO_0004352,0.32421517455483967,3.2421699166291216,1,0.4,0.4,transcript,22013.0
BMPR2,ENSG00000204217,cystatin C measurement,EFO_0004617,0.3241985172725508,3.2420029441845446,1,0.4,0.4,transcript,22508.0
PTPRO,ENSG00000151490,cognitive function measurement,EFO_0008354,0.32418652321729713,3.241869680769439,1,0.4,0.4,transcript,89916.0
PTPRO,ENSG00000151490,neuroticism measurement,EFO_0007660,0.32418652321729713,3.241869680769439,1,0.4,0.4,transcript,89916.0
CSMD3,ENSG00000164796,neuroimaging measurement,EFO_0004346,0.32418652321729713,3.2418733408947125,1,0.5,0.5,transcript,61662.0
CYTL1,ENSG00000170891,lipid measurement,EFO_0004529,0.32417472447668416,3.2419661829168143,1,0.4,0.4,transcript,1827.0
DMAC1,ENSG00000137038,protein measurement,EFO_0004747,0.32414627300079324,3.2415783035415933,1,0.4,0.4,transcript,3461.0
SENP6,ENSG00000112701,sitting height measurement,EFO_0011011,0.32414169069711113,3.2418459241317974,5,2.2,11.0,transcript,25640.0
PLPP4,ENSG00000203805,protein measurement,EFO_0004747,0.3240898719309965,3.2409796090976295,1,0.4,0.4,transcript,4945.0
CR1L,ENSG00000197721,hemoglobin measurement,EFO_0004509,0.3240644480590958,3.2407377641730473,1,0.5,0.5,transcript,5360.0
ZNF143,ENSG00000166478,beverage consumption measurement,EFO_0010088,0.3240538337131035,3.2405646169586393,1,0.5,0.5,transcript,19026.0
CFAP299,ENSG00000197826,lagophthalmos,MONDO_0001604,0.3240428136115551,3.240493274208308,1,0.5,0.5,transcript,7676.0
PYGO1,ENSG00000171016,ovarian neoplasm,EFO_0003893,0.3240376987294479,3.240704822557259,4,1.6,6.4,transcript,19522.0
PPFIBP2,ENSG00000166387,growth differentiation factor 15 amount,OBA_2050135,0.3240322366640284,3.240336049525731,1,0.5,0.5,transcript,36542.0
CASQ2,ENSG00000118729,protozoa infectious disease,MONDO_0002428,0.3240322366640284,3.240335017661854,1,0.4,0.4,transcript,31618.0
QSER1,ENSG00000060749,bronchial disease,EFO_1002018,0.3240297182703498,3.2403238579062297,1,0.5,0.5,transcript,18744.0
PTCHD4,ENSG00000244694,protein measurement,EFO_0004747,0.32400453276464475,3.240459168317789,6,2.4000000000000004,14.400000000000002,transcript,34796.0
FYCO1,ENSG00000163820,mean corpuscular hemoglobin concentration,EFO_0004528,0.3240034971581533,3.2400595824226084,1,0.4,0.4,transcript,16253.0
ZFP1,ENSG00000184517,body height,OBA_VT0001253,0.3239768489495101,3.2397968422027845,1,0.4,0.4,transcript,14108.0
RNMT,ENSG00000101654,C-reactive protein measurement,EFO_0004458,0.3239732398186465,3.239748819895965,1,0.4,0.4,transcript,24358.0
ARHGAP29,ENSG00000137962,monocyte count,EFO_0005091,0.32396498106583344,3.2396700363773587,1,0.5,0.5,transcript,24721.0
TBC1D9B,ENSG00000197226,low density lipoprotein cholesterol measurement,EFO_0004611,0.3239542255340947,3.239554470200323,1,0.4,0.4,transcript,32747.0
UMPS,ENSG00000114491,circulating fibrinogen levels,OBA_0000061,0.3239271491078658,3.239290347440323,1,0.4,0.4,transcript,21213.0
PHC1,ENSG00000111752,apolipoprotein B measurement,EFO_0004615,0.3239135858102911,3.239155008587418,1,0.5,0.5,transcript,26109.0
VPS50,ENSG00000004766,mean reticulocyte volume,EFO_0010701,0.32390073059662594,3.2390184679262997,1,0.4,0.4,transcript,35836.0
PDP1,ENSG00000164951,diastolic blood pressure,EFO_0006336,0.3238970458752774,3.23899382596857,1,0.4,0.4,transcript,17118.0
NEK1,ENSG00000137601,multiple sclerosis,MONDO_0005301,0.32387950557333783,3.238809315601653,2,0.8,1.6,transcript,112203.0
SLCO1C1,ENSG00000139155,lymphocyte count,EFO_0004587,0.3238472242283169,3.238503133176534,1,0.5,0.5,transcript,16186.0
ABCB1,ENSG00000085563,acute monocytic leukemia,EFO_0000221,0.32384434766746995,3.2384675243853573,1,0.5,0.5,transcript,20792.0
UBE2G2,ENSG00000184787,lysosomal storage disease,MONDO_0002561,0.3238405189363217,3.2384312446003194,1,0.4,0.4,transcript,15352.0
ARHGAP28,ENSG00000088756,risk-taking behaviour,EFO_0008579,0.32382671854861866,3.2382794871223046,1,0.4,0.4,transcript,32516.0
SP8,ENSG00000164651,infectious disease,EFO_0005741,0.3238089077496038,3.238163983863079,1,0.4,0.4,transcript,5340.0
ABCA13,ENSG00000179869,threonate measurement,EFO_0021032,0.32377791489576707,3.2377894808169922,1,0.5,0.5,transcript,48394.0
ABCA13,ENSG00000179869,erythronate measurement,EFO_0021025,0.32377791489576707,3.2377894808169922,1,0.5,0.5,transcript,48394.0
BMPR2,ENSG00000204217,alkaline phosphatase measurement,EFO_0004533,0.32376954330388463,3.237713204497883,1,0.4,0.4,transcript,22508.0
COLEC10,ENSG00000184374,potassium measurement,EFO_0009283,0.32376712140515923,3.2377763941725495,1,0.4,0.4,transcript,3803.0
GID4,ENSG00000141034,body mass index,EFO_0004340,0.3237482907683938,3.237540017906668,1,0.4,0.4,transcript,7004.0
CDKL2,ENSG00000138769,HbA1c measurement,EFO_0004541,0.32370977225619074,3.23726182512601,2,0.8,1.6,transcript,9750.0
FBXO22,ENSG00000167196,cystatin C measurement,EFO_0004617,0.32369434291026766,3.2369646278943454,1,0.4,0.4,transcript,18869.0
IREB2,ENSG00000136381,heart rate,OBA_1001087,0.3236935989145925,3.2370358449098218,2,0.9,1.8,transcript,18026.0
SLAMF7,ENSG00000026751,high density lipoprotein cholesterol measurement,EFO_0004612,0.3236787697567323,3.236803893866469,1,0.4,0.4,transcript,24697.0
MAN1A2,ENSG00000198162,cigarettes per day measurement,EFO_0006525,0.32366950522834076,3.2368225728062416,2,0.8,1.6,transcript,12547.0
RPAP3,ENSG00000005175,platelet volume,OBA_0003277,0.32366535832782456,3.2368019512307677,2,0.8,1.6,transcript,10784.0
TMEM170B,ENSG00000205269,escherichia seropositivity,EFO_0803621,0.3236132771686509,3.2361777610015467,1,0.4,0.4,transcript,8891.0
ZPLD1,ENSG00000170044,adolescent idiopathic scoliosis,EFO_0005423,0.32360502956846215,3.236209278196545,2,0.8,1.6,transcript,10064.0
BHLHE41,ENSG00000123095,disorder of ear,MONDO_0021205,0.32359160382194185,3.2360043189521486,1,0.4,0.4,transcript,4531.0
ONECUT1,ENSG00000169856,diabetes mellitus,EFO_0000400,0.32355454039754067,3.235598251115055,1,0.4,0.4,transcript,7569.0
GMCL2,ENSG00000244234,high density lipoprotein cholesterol measurement,EFO_0004612,0.3235460093628521,3.235599612289142,1,0.4,0.4,transcript,2867.0
LUZP2,ENSG00000187398,placenta praevia,EFO_0007442,0.32352360859628504,3.235552865987075,4,1.7000000000000002,6.800000000000001,transcript,21466.0
SHC4,ENSG00000185634,low density lipoprotein cholesterol measurement,EFO_0004611,0.3235093332739728,3.2351271079656,1,0.4,0.4,transcript,11843.0
TRPC6,ENSG00000137672,bone tissue density,OBA_1000110,0.32346555319442427,3.2346844190678072,1,0.4,0.4,transcript,13847.0
LINGO2,ENSG00000174482,adverse effect,EFO_0009658,0.32344777034173994,3.2344894222818414,1,0.4,0.4,transcript,34133.0
LINGO2,ENSG00000174482,response to stimulus,GO_0050896,0.32344777034173994,3.2344894222818414,1,0.4,0.4,transcript,34133.0
KIF20B,ENSG00000138182,high density lipoprotein cholesterol measurement,EFO_0004612,0.3233886972996277,3.2339142849534523,1,0.5,0.5,transcript,18307.0
ANKRD36,ENSG00000135976,deafness,EFO_0001063,0.3233823728491141,3.2338991148462104,2,1.0,2.0,transcript,26530.0
MTR,ENSG00000116984,homocystinuria,MONDO_0004737,0.3233823728491141,3.2338281409209557,1,0.4,0.4,transcript,90653.0
ANKRD36,ENSG00000135976,"hearing loss, autosomal recessive",MONDO_0019588,0.3233823728491141,3.2338991148462104,2,1.0,2.0,transcript,26530.0
ABCB1,ENSG00000085563,acute myeloblastic leukemia without maturation,EFO_0003027,0.3233823728491141,3.2338477762017988,1,0.5,0.5,transcript,20792.0
ABCB1,ENSG00000085563,acute erythroleukemia,EFO_0000218,0.3233823728491141,3.2338477762017988,1,0.5,0.5,transcript,20792.0
ABCB1,ENSG00000085563,acute myelomonocytic leukemia,EFO_0000223,0.3233823728491141,3.2338477762017988,1,0.5,0.5,transcript,20792.0
NDUFAF4,ENSG00000123545,mouth neoplasm,EFO_0003868,0.3233823728491141,3.233935273387962,1,0.4,0.4,transcript,3586.0
PDE1C,ENSG00000154678,Neonatal sepsis,HP_0040187,0.3233823728491141,3.233878087395809,2,0.8,1.6,transcript,29434.0
KIAA0586,ENSG00000100578,Intellectual disability,HP_0001249,0.3233823728491141,3.2338293795495843,1,0.5,0.5,transcript,88479.0
KIAA0586,ENSG00000100578,isolated cerebellar hypoplasia/agenesis,MONDO_0008939,0.3233823728491141,3.2338293795495843,1,0.5,0.5,transcript,88479.0
KIAA0586,ENSG00000100578,Cone rod dystrophy,Orphanet_1872,0.3233823728491141,3.2338293795495843,1,0.5,0.5,transcript,88479.0
FARSB,ENSG00000116120,severe early-onset pulmonary alveolar proteinosis due to MARS deficiency,MONDO_0014206,0.3233823728491141,3.233874748899304,1,0.4,0.4,transcript,7840.0
DLGAP1,ENSG00000170579,Delayed puberty,HP_0000823,0.32337995873774056,3.2338277415213437,2,0.8,1.6,transcript,56830.0
KYNU,ENSG00000115919,protein measurement,EFO_0004747,0.32336950711116524,3.2338533198258816,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
ZNF396,ENSG00000186496,mathematical ability,EFO_0004875,0.32335674362641054,3.2336020024583676,1,0.4,0.4,transcript,11572.0
TRDMT1,ENSG00000107614,megaloblastic anemia,MONDO_0001700,0.3233420683633777,3.2334344753104998,1,0.4,0.4,transcript,29003.0
PRDM5,ENSG00000138738,arthritis,EFO_0005856,0.32330950711046885,3.23317567969958,2,0.8,1.6,transcript,19849.0
PRDM5,ENSG00000138738,joint disease,EFO_1000999,0.32330950711046885,3.23317567969958,2,0.8,1.6,transcript,19849.0
LARP4B,ENSG00000107929,urate measurement,EFO_0004531,0.32330827669347506,3.233093778937834,1,0.5,0.5,transcript,45405.0
LARP4B,ENSG00000107929,bone tissue density,OBA_1000110,0.32330827669347506,3.233093778937834,1,0.5,0.5,transcript,45405.0
PLXNA4,ENSG00000221866,high density lipoprotein cholesterol measurement,EFO_0004612,0.3232863856013476,3.2328761034109044,1,0.4,0.4,transcript,32660.0
PAFAH1B2,ENSG00000168092,linoleic acid measurement,EFO_0006807,0.32328284118645334,3.23296220231524,2,0.8,1.6,transcript,11959.0
SLC4A8,ENSG00000050438,serum gamma-glutamyl transferase measurement,EFO_0004532,0.32326115349418594,3.2326430427892823,2,0.8,1.6,transcript,50781.0
GALR1,ENSG00000166573,Abruptio Placentae,EFO_1001754,0.32326005597144913,3.232745172874289,2,0.8,1.6,transcript,11064.0
PLEKHA6,ENSG00000143850,erythrocyte count,EFO_0004305,0.32322785512830265,3.2322853659413564,1,0.4,0.4,transcript,58697.0
PRDM5,ENSG00000138738,age at assessment,EFO_0008007,0.32319197136855243,3.232000322280416,2,0.8,1.6,transcript,19849.0
ARPC5,ENSG00000162704,neuroinflammatory disorder,EFO_0020092,0.32313792627878796,3.2314059918222933,1,0.4,0.4,transcript,14965.0
TENM4,ENSG00000149256,arterial stiffness measurement,EFO_0004517,0.32312202440896853,3.2312376945739363,1,0.4,0.4,transcript,22922.0
LRRK2,ENSG00000188906,body weight,EFO_0004338,0.3230862338325127,3.230881096140884,2,0.9,1.8,transcript,95960.0
NDUFAF4,ENSG00000123545,urate measurement,EFO_0004531,0.32308506287421457,3.2309621736389667,1,0.4,0.4,transcript,3586.0
VPS13A,ENSG00000197969,hematocrit,EFO_0004348,0.32307201435177074,3.230726888766523,1,0.4,0.4,transcript,59301.0
CCDC34,ENSG00000109881,carotid artery thickness,OBA_2050108,0.3230589391960073,3.230682915457852,1,0.4,0.4,transcript,4277.0
MANSC4,ENSG00000205693,alopecia,MONDO_0004907,0.3230507541943899,3.2308074819558965,1,0.5,0.5,transcript,1667.0
NEDD4,ENSG00000069869,brain connectivity attribute,OBA_2045295,0.32302126597378866,3.230220969699453,1,0.4,0.4,transcript,48135.0
IMPG2,ENSG00000081148,photoreceptor cell layer thickness measurement,EFO_0803370,0.3230113272117934,3.230328789359313,2,0.9,1.8,transcript,8352.0
CLHC1,ENSG00000162994,brain connectivity attribute,OBA_2045295,0.3229881782203968,3.229907073048682,1,0.4,0.4,transcript,15816.0
CA8,ENSG00000178538,red blood cell density,OBA_2045260,0.32296166935559306,3.2296576477895744,1,0.4,0.4,transcript,9767.0
BIRC6,ENSG00000115760,gout,EFO_0004274,0.3229589024270503,3.229596206527455,1,0.5,0.5,transcript,69616.0
NEK1,ENSG00000137601,lysosomal storage disease,MONDO_0002561,0.32295555593662606,3.229569819234535,2,0.8,1.6,transcript,112203.0
RGS7BP,ENSG00000186479,bone remodeling disease,MONDO_0000833,0.3229372108793435,3.2294602300482818,1,0.5,0.5,transcript,5674.0
TTLL7,ENSG00000137941,Arthropathy,HP_0003040,0.3228873839505455,3.228902812940437,2,0.8,1.6,transcript,55223.0
NOM1,ENSG00000146909,lymphocyte count,EFO_0004587,0.32284741249179283,3.2293554928008827,5,2.0,10.0,transcript,11346.0
KLHDC10,ENSG00000128607,diastolic blood pressure,EFO_0006336,0.3228334682410164,3.228384415096972,1,0.4,0.4,transcript,8043.0
MCL1,ENSG00000143384,body weights and measures,EFO_0004324,0.32281977869632583,3.228214556342372,1,0.4,0.4,transcript,23853.0
MTR,ENSG00000116984,hypertrophic cardiomyopathy,EFO_0000538,0.32275330080920206,3.2275374205218355,1,0.4,0.4,transcript,90653.0
DCDC2,ENSG00000146038,nervous system benign neoplasm,MONDO_0000648,0.32275330080920206,3.2275787851577107,1,0.4,0.4,transcript,8738.0
SLAIN2,ENSG00000109171,uterine fibroid,EFO_0000731,0.32275330080920206,3.2276687508594764,2,0.8,1.6,transcript,11787.0
CD86,ENSG00000114013,Hirsutism,HP_0001007,0.32275330080920206,3.2275648425528245,1,0.4,0.4,transcript,12565.0
SGCZ,ENSG00000185053,HbA1c measurement,EFO_0004541,0.3227274512680347,3.2273232218863868,1,0.4,0.4,transcript,8212.0
CCDC88C,ENSG00000015133,corpus callosum volume,OBA_2045249,0.32271666242593605,3.2271859469973925,1,0.4,0.4,transcript,20701.0
C12orf42,ENSG00000179088,body surface area,EFO_0022196,0.32271434125327175,3.227178552036548,1,0.5,0.5,transcript,14229.0
YIPF4,ENSG00000119820,reticulocyte count,EFO_0007986,0.3227121782281725,3.2272399593996806,2,0.8,1.6,transcript,13539.0
BACE2,ENSG00000182240,diabetes mellitus,EFO_0000400,0.3227116477487752,3.2272500334142964,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
PLXNA4,ENSG00000221866,sodium measurement,EFO_0009282,0.32270935691139785,3.227105816511407,1,0.4,0.4,transcript,32660.0
PIP4K2A,ENSG00000150867,lymphocyte percentage of leukocytes,EFO_0007993,0.32269502308777065,3.2269936760824423,1,0.4,0.4,transcript,9207.0
CLSTN2,ENSG00000158258,educational attainment,EFO_0011015,0.32269502308777065,3.2269743171064054,1,0.4,0.4,transcript,16607.0
RSBN1L,ENSG00000187257,C-C motif chemokine 24 measurement,EFO_0020197,0.32268482070002485,3.226984924081339,2,0.8,1.6,transcript,11703.0
LIN9,ENSG00000183814,myeloid leukocyte count,OBA_2045223,0.3226777907287706,3.226882742826954,2,0.8,1.6,transcript,15262.0
DCLK1,ENSG00000133083,Breast hypertrophy,HP_0010313,0.3226760088831624,3.2268102864848838,2,0.8,1.6,transcript,31874.0
KIAA0586,ENSG00000100578,triglyceride measurement,EFO_0004530,0.3226604853206214,3.2266105042646576,1,0.5,0.5,transcript,88479.0
TMEM123,ENSG00000152558,lymphocyte count,EFO_0004587,0.3226378126339032,3.226417848285407,1,0.4,0.4,transcript,10070.0
SLC7A2,ENSG00000003989,diastolic blood pressure change measurement,EFO_0006945,0.32263687751732184,3.226489770794329,3,1.4,4.199999999999999,transcript,34712.0
SLC7A2,ENSG00000003989,arginine measurement,EFO_0020990,0.32263687751732184,3.226489770794329,3,1.4,4.199999999999999,transcript,34712.0
SLC7A2,ENSG00000003989,metabolite ratio,EFO_0022223,0.32263687751732184,3.226489770794329,3,1.4,4.199999999999999,transcript,34712.0
KLHL31,ENSG00000124743,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.3226318255688879,3.226370332241411,1,0.4,0.4,transcript,7681.0
CFAP299,ENSG00000197826,refractive error,MONDO_0004892,0.32257125489531024,3.2257776870458588,1,0.5,0.5,transcript,7676.0
RPS6KA5,ENSG00000100784,bone fracture,EFO_0003931,0.32254969535115496,3.2255068183630833,1,0.4,0.4,transcript,40548.0
KLF10,ENSG00000155090,serum creatinine amount,OBA_2050096,0.32246397101901714,3.22470055594618,1,0.4,0.4,transcript,6574.0
ABCB1,ENSG00000085563,breast cancer,MONDO_0007254,0.32246346456893643,3.224658693400022,1,0.5,0.5,transcript,20792.0
VPS13A,ENSG00000197969,hemoglobin measurement,EFO_0004509,0.32245165158306094,3.2245232610794248,1,0.4,0.4,transcript,59301.0
RTKN2,ENSG00000182010,Abnormal erythrocyte morphology,HP_0001877,0.322438700834937,3.224422266172199,1,0.4,0.4,transcript,11345.0
SH3GL3,ENSG00000140600,protein measurement,EFO_0004747,0.322438700834937,3.2244387012932827,1,0.4,0.4,transcript,7738.0
SH3GL3,ENSG00000140600,hematological measurement,EFO_0004503,0.322438700834937,3.2244387012932827,1,0.4,0.4,transcript,7738.0
BMERB1,ENSG00000166780,sphingomyelin measurement,EFO_0010118,0.32242684944101563,3.2243047690088686,1,0.4,0.4,transcript,11027.0
CDH19,ENSG00000071991,chronotype measurement,EFO_0008328,0.32240169813355535,3.2242915389926616,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
BACE2,ENSG00000182240,monocyte count,EFO_0005091,0.3223977476463555,3.224111032390099,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
CCDC88C,ENSG00000015133,genu of corpus callosum volume,OBA_2045227,0.32239640814097614,3.223983404147793,1,0.4,0.4,transcript,20701.0
ITM2A,ENSG00000078596,birth weight,EFO_0004344,0.32237321320900275,3.2241321320900274,1,0.4,0.4,transcript,1000.0
CENPE,ENSG00000138778,ovarian dysfunction,EFO_0009003,0.3223656950211375,3.2236826439421047,1,0.5,0.5,transcript,19460.0
PDHX,ENSG00000110435,ovarian dysfunction,EFO_0009003,0.3223409745003667,3.2234545127708745,1,0.4,0.4,transcript,8935.0
CCDC66,ENSG00000180376,neutrophil count,EFO_0004833,0.3222734425683435,3.222749655192131,1,0.5,0.5,transcript,32831.0
CFAP299,ENSG00000197826,monocyte count,EFO_0005091,0.32226555459304335,3.22272068402319,1,0.5,0.5,transcript,7676.0
P3H4,ENSG00000141696,total cholesterol measurement,EFO_0004574,0.32226120367795047,3.222652012793896,1,0.4,0.4,transcript,10006.0
ANKRD10,ENSG00000088448,red blood cell density,OBA_2045260,0.3222502540336124,3.2226806347261507,2,0.8,1.6,transcript,8984.0
ABCA10,ENSG00000154263,linoleic acid measurement,EFO_0006807,0.32219220957583894,3.222022031910292,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
PAG1,ENSG00000076641,monocyte percentage of leukocytes,EFO_0007989,0.3221921497677644,3.2220515895550323,2,0.8,1.6,transcript,12299.0
CR1L,ENSG00000197721,blood sedimentation trait,OBA_2045235,0.32219015477449775,3.2219948313270668,1,0.5,0.5,transcript,5360.0
CNOT6L,ENSG00000138767,serum albumin amount,OBA_2050068,0.32218998019287975,3.222029690801651,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
PIGN,ENSG00000197563,placenta praevia,EFO_0007442,0.32218998019287975,3.2219023417564703,1,0.4,0.4,transcript,157491.0
ULK4,ENSG00000168038,monocyte count,EFO_0005091,0.3221770104370177,3.2218110644750344,1,0.5,0.5,transcript,12207.0
GLB1,ENSG00000170266,chronic venous hypertension,EFO_0010675,0.32217560191358924,3.2217869272152644,1,0.5,0.5,transcript,16177.0
WWTR1,ENSG00000018408,FEV/FVC ratio,EFO_0004713,0.32215155655441896,3.2216004011751544,2,0.8,1.6,transcript,18860.0
CD163L1,ENSG00000177675,glucose-6-phosphate isomerase measurement,EFO_0020407,0.3221324096935032,3.221353972205777,1,0.4,0.4,transcript,13389.0
HFM1,ENSG00000162669,diabetes mellitus,EFO_0000400,0.3221238199830918,3.2213680362370463,2,1.0,2.0,transcript,15404.0
LONRF1,ENSG00000154359,serum alanine aminotransferase measurement,EFO_0004735,0.3221236384196684,3.2212716774839008,1,0.5,0.5,transcript,14167.0
CFHR4,ENSG00000134365,protein measurement,EFO_0004747,0.3221222306129264,3.221262814919671,1,0.5,0.5,transcript,12343.0
ATP12A,ENSG00000075673,cystic fibrosis associated meconium ileus,EFO_0004608,0.3221181967234313,3.221231119360142,1,0.4,0.4,transcript,8138.0
SMC6,ENSG00000163029,neurodegenerative disease,EFO_0005772,0.32211640266807734,3.22118043626397,1,0.4,0.4,transcript,24376.0
SMARCC1,ENSG00000173473,high density lipoprotein cholesterol measurement,EFO_0004612,0.3220571817323261,3.2206859644303454,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,high density lipoprotein cholesterol measurement,EFO_0004612,0.3220571817323261,3.2206859644303454,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,high density lipoprotein cholesterol measurement,EFO_0004612,0.3220571817323261,3.2206859644303454,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,high density lipoprotein cholesterol measurement,EFO_0004612,0.3220571817323261,3.2206859644303454,2,0.8,1.6,transcript,14017.0
NID2,ENSG00000087303,BMI-adjusted waist circumference,EFO_0007789,0.3220508668399898,3.22055380290071,1,0.5,0.5,transcript,11078.0
OTOGL,ENSG00000165899,cystatin C measurement,EFO_0004617,0.32204199606289546,3.220434818586877,1,0.5,0.5,transcript,33652.0
FREM2,ENSG00000150893,Chondrocalcinosis,HP_0000934,0.32204199606289546,3.221311067383544,6,2.5,15.0,transcript,16833.0
OTOGL,ENSG00000165899,cervical carcinoma,EFO_0001061,0.32204199606289546,3.220434818586877,1,0.5,0.5,transcript,33652.0
FREM2,ENSG00000150893,crystal arthropathy,MONDO_0022208,0.32204199606289546,3.221311067383544,6,2.5,15.0,transcript,16833.0
PPDPFL,ENSG00000168333,ulcerative colitis,EFO_0000729,0.32204199606289546,3.2207453622966384,2,0.8,1.6,transcript,4917.0
NEDD4,ENSG00000069869,aortic valve stenosis,MONDO_0042981,0.32204199606289546,3.220428270590521,1,0.4,0.4,transcript,48135.0
ZNF507,ENSG00000168813,N-acetylmethionine measurement,EFO_0021427,0.32204199606289546,3.220434359477047,1,0.4,0.4,transcript,27780.0
PPDPFL,ENSG00000168333,type 1 diabetes nephropathy,EFO_0004996,0.32204199606289546,3.2207453622966384,2,0.8,1.6,transcript,4917.0
LINGO2,ENSG00000174482,bone tissue density,OBA_1000110,0.3220377707855023,3.2203894267194646,1,0.4,0.4,transcript,34133.0
SKIL,ENSG00000136603,insomnia,EFO_0004698,0.3220327182722565,3.2203436425441403,1,0.5,0.5,transcript,30377.0
FAT3,ENSG00000165323,total cortical area measurement,EFO_0008381,0.3220259996053397,3.2202683250487114,1,0.4,0.4,transcript,48025.0
ATRNL1,ENSG00000107518,liver disease,EFO_0001421,0.3219910975633682,3.2199278347755516,1,0.4,0.4,transcript,23726.0
SUMF1,ENSG00000144455,hypertrophic cardiomyopathy,EFO_0000538,0.3219879095547441,3.2199114449206716,1,0.4,0.4,transcript,12365.0
KLHL31,ENSG00000124743,body mass index,EFO_0004340,0.3219793628023595,3.219845704576127,1,0.4,0.4,transcript,7681.0
FRAS1,ENSG00000138759,placental retention,EFO_0009578,0.3219761201962488,3.2197933385070954,2,0.9,1.8,transcript,56011.0
TLR10,ENSG00000174123,mean corpuscular hemoglobin concentration,EFO_0004528,0.3219599132579186,3.219760574796326,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
TMEM170B,ENSG00000205269,self reported educational attainment,EFO_0004784,0.32194628557465177,3.2195078450615555,1,0.4,0.4,transcript,8891.0
DMRTA1,ENSG00000176399,cervical carcinoma,EFO_0001061,0.32194115959946273,3.219483203585032,1,0.4,0.4,transcript,5586.0
TRHDE,ENSG00000072657,sialolithiasis,EFO_1001180,0.32194115959946273,3.219511166596407,2,0.8,1.6,transcript,16069.0
NPS,ENSG00000214285,placenta praevia,EFO_0007442,0.32194115959946273,3.219736535068551,1,0.4,0.4,transcript,1231.0
ARHGAP20,ENSG00000137727,spondylolisthesis,EFO_0007493,0.32194115959946273,3.2194218405842037,1,0.4,0.4,transcript,39045.0
ARHGAP20,ENSG00000137727,musculoskeletal system disease,EFO_0009676,0.32194115959946273,3.2194218405842037,1,0.4,0.4,transcript,39045.0
DMAC1,ENSG00000137038,smoking status measurement,EFO_0006527,0.3218817556998132,3.2189331305317928,1,0.4,0.4,transcript,3461.0
LIN54,ENSG00000189308,frozen shoulder,EFO_1000941,0.32186401555819993,3.218653082159042,1,0.4,0.4,transcript,30944.0
FGFR1OP2,ENSG00000111790,ovarian dysfunction,EFO_0009003,0.32186401555819993,3.2186762892766696,1,0.4,0.4,transcript,11070.0
ZNF485,ENSG00000198298,post term pregnancy,EFO_0009681,0.32186401555819993,3.218737488655778,1,0.5,0.5,transcript,5137.0
PHC1,ENSG00000111752,ovarian neoplasm,EFO_0003893,0.32186401555819993,3.2186593060665065,1,0.5,0.5,transcript,26109.0
FAT3,ENSG00000165323,level of tubulointerstitial nephritis antigen-like in blood serum,OBA_2043857,0.32186028266289174,3.2186111556242323,1,0.4,0.4,transcript,48025.0
SKP2,ENSG00000145604,sitting height measurement,EFO_0011011,0.32185481633484725,3.2185531862024583,1,0.4,0.4,transcript,79636.0
UBE2U,ENSG00000177414,trauma complication,EFO_0009888,0.321853338950985,3.218600605103868,1,0.4,0.4,transcript,5951.0
UBE2U,ENSG00000177414,medical procedure,EFO_0002571,0.321853338950985,3.218600605103868,1,0.4,0.4,transcript,5951.0
UBE2U,ENSG00000177414,complication,EFO_0009518,0.321853338950985,3.218600605103868,1,0.4,0.4,transcript,5951.0
KYNU,ENSG00000115919,high density lipoprotein cholesterol measurement,EFO_0004612,0.321831603290119,3.218474281615419,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
SH3TC2,ENSG00000169247,cardiovascular disease,EFO_0000319,0.3218251506309078,3.2182559297177566,1,0.4,0.4,transcript,90428.0
CCDC66,ENSG00000180376,lean body mass,EFO_0004995,0.3218161295433997,3.218176524942693,1,0.5,0.5,transcript,32831.0
CWH43,ENSG00000109182,body weights and measures,EFO_0004324,0.3218071292699278,3.218133365945709,1,0.5,0.5,transcript,8055.0
ATRNL1,ENSG00000107518,risk-taking behaviour,EFO_0008579,0.32178905669962693,3.217907426138139,1,0.4,0.4,transcript,23726.0
TLK1,ENSG00000198586,vital capacity,EFO_0004312,0.3217448331686129,3.2174622268471396,1,0.4,0.4,transcript,28787.0
CYTL1,ENSG00000170891,diabetes mellitus,EFO_0000400,0.32174082084764277,3.2176271466264006,1,0.4,0.4,transcript,1827.0
EXD1,ENSG00000178997,high density lipoprotein cholesterol measurement,EFO_0004612,0.321632199291446,3.216363777099146,1,0.4,0.4,transcript,9573.0
QSER1,ENSG00000060749,strand of hair color,OBA_0002313,0.32162685313428746,3.216295206545606,1,0.5,0.5,transcript,18744.0
CD2AP,ENSG00000198087,body weight,EFO_0004338,0.3216133782631592,3.2161858524050886,1,0.4,0.4,transcript,7682.0
STAM,ENSG00000136738,diastolic blood pressure change measurement,EFO_0006945,0.321586680680048,3.2159328025107587,1,0.4,0.4,transcript,6061.0
ALG10B,ENSG00000175548,physical activity measurement,EFO_0008002,0.32158171753827347,3.2165229913059417,5,2.0,10.0,transcript,14168.0
RBM25,ENSG00000119707,linoleic acid measurement,EFO_0006807,0.3214552775656939,3.214565465609669,1,0.4,0.4,transcript,31521.0
NEBL,ENSG00000078114,mathematical ability,EFO_0004875,0.321448536113593,3.214493182954894,1,0.4,0.4,transcript,51139.0
TCERG1L,ENSG00000176769,EDTA measurement,EFO_0800946,0.32142318282992827,3.21446000856169,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,EDTA measurement,EFO_0800946,0.32142318282992827,3.21446000856169,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,EDTA measurement,EFO_0800946,0.32142318282992827,3.21446000856169,2,0.8,1.6,transcript,7012.0
LUZP2,ENSG00000187398,ocular hypotension,MONDO_0004390,0.32142318282992827,3.2145486083235073,4,1.7000000000000002,6.800000000000001,transcript,21466.0
TCERG1L,ENSG00000176769,EDTA measurement,EFO_0800946,0.32142318282992827,3.21446000856169,2,0.8,1.6,gene_variant,7012.0
DMXL1,ENSG00000172869,mean corpuscular hemoglobin,EFO_0004527,0.321411543127714,3.2141261158939627,1,0.4,0.4,transcript,37437.0
DMXL1,ENSG00000172869,mean corpuscular hemoglobin concentration,EFO_0004528,0.321411543127714,3.2141261158939627,1,0.4,0.4,transcript,37437.0
CWH43,ENSG00000109182,serum creatinine amount,OBA_2050096,0.321411543127714,3.2141775045235708,1,0.5,0.5,transcript,8055.0
TFEC,ENSG00000105967,body mass index,EFO_0004340,0.3214004500754921,3.214020198109917,1,0.4,0.4,transcript,25482.0
SH3GL3,ENSG00000140600,protozoa infectious disease,MONDO_0002428,0.32139796906214274,3.2140313835653402,1,0.4,0.4,transcript,7738.0
SLF1,ENSG00000133302,cognitive function measurement,EFO_0008354,0.3213918876424117,3.2139537895776478,1,0.4,0.4,transcript,11457.0
CWH43,ENSG00000109182,metabolite measurement,EFO_0004725,0.321382998171268,3.2138920549591106,1,0.5,0.5,transcript,8055.0
ADK,ENSG00000156110,high density lipoprotein cholesterol measurement,EFO_0004612,0.32133262568078835,3.213345240244835,1,0.4,0.4,transcript,21071.0
C18orf54,ENSG00000166845,mean corpuscular hemoglobin concentration,EFO_0004528,0.32132012941556737,3.2132867688070976,2,0.8,1.6,transcript,18719.0
ALG10B,ENSG00000175548,daytime rest measurement,EFO_0007828,0.32131807895602127,3.21388660548342,5,2.0,10.0,transcript,14168.0
RNF17,ENSG00000132972,ovarian neoplasm,EFO_0003893,0.3212883233021962,3.2129195834399917,1,0.5,0.5,transcript,13755.0
DYNC1I2,ENSG00000077380,Alzheimer disease,MONDO_0004975,0.3212753960444872,3.2127651473785335,1,0.4,0.4,transcript,35756.0
DYNC1I2,ENSG00000077380,Parkinson disease,MONDO_0005180,0.3212753960444872,3.2127651473785335,1,0.4,0.4,transcript,35756.0
DYNC1I2,ENSG00000077380,multiple sclerosis,MONDO_0005301,0.3212753960444872,3.2127651473785335,1,0.4,0.4,transcript,35756.0
ALPK3,ENSG00000136383,serum creatinine amount,OBA_2050096,0.32125003259048635,3.2125376219421593,1,0.4,0.4,transcript,10725.0
PRKCB,ENSG00000166501,daytime rest measurement,EFO_0007828,0.3212281784782055,3.2123057512290294,1,0.4,0.4,transcript,16690.0
HEG1,ENSG00000173706,erythrocyte count,EFO_0004305,0.3211951711611019,3.21197357789867,1,0.4,0.4,transcript,18293.0
LHFPL2,ENSG00000145685,appendicular lean mass,EFO_0004980,0.3211927355510794,3.2119542480750005,1,0.4,0.4,transcript,14874.0
DOK5,ENSG00000101134,adolescent idiopathic scoliosis,EFO_0005423,0.3211795784859003,3.2118836197294467,1,0.4,0.4,transcript,4554.0
NDST3,ENSG00000164100,glomerular filtration rate,OBA_0003747,0.3211795784859003,3.211845847437226,1,0.4,0.4,transcript,7990.0
WDR12,ENSG00000138442,white matter hyperintensity measurement,EFO_0005665,0.3211297710206382,3.2113176493918667,1,0.4,0.4,transcript,20061.0
FBXO42,ENSG00000037637,serum gamma-glutamyl transferase measurement,EFO_0004532,0.32112838652359316,3.211319436600983,1,0.4,0.4,transcript,11245.0
TULP4,ENSG00000130338,heel bone mineral density,EFO_0009270,0.32112026325648846,3.2112215576216596,1,0.4,0.4,transcript,21136.0
CNTLN,ENSG00000044459,diastolic blood pressure,EFO_0006336,0.3211188931030867,3.211310391594141,2,0.8,1.6,transcript,13173.0
FRS2,ENSG00000166225,chloride measurement,EFO_0009284,0.32110932485951044,3.2111093574912424,1,0.4,0.4,transcript,24831.0
CCDC66,ENSG00000180376,crush injury,EFO_0009504,0.3210921513138654,3.21093674264735,1,0.5,0.5,transcript,32831.0
NRCAM,ENSG00000091129,ovarian neoplasm,EFO_0003893,0.3210921513138654,3.2109331664525653,1,0.4,0.4,transcript,34325.0
PIP4K2A,ENSG00000150867,alkaline phosphatase measurement,EFO_0004533,0.3210505427063813,3.2105488722685482,1,0.4,0.4,transcript,9207.0
SEMA3A,ENSG00000075213,corpus callosum volume,OBA_2045249,0.3210505427063813,3.2105356317002243,1,0.4,0.4,transcript,13243.0
ACTN2,ENSG00000077522,educational attainment,EFO_0011015,0.3210463752560841,3.2104804381726293,2,0.8,1.6,transcript,95891.0
SLC22A25,ENSG00000196600,Dental malocclusion,HP_0000689,0.32098415308668465,3.209868124843311,1,0.4,0.4,transcript,15041.0
PKHD1L1,ENSG00000205038,cystatin C measurement,EFO_0004617,0.32097233066460906,3.2097393528591844,1,0.4,0.4,transcript,24928.0
PKHD1L1,ENSG00000205038,serum creatinine amount,OBA_2050096,0.32097233066460906,3.2097393528591844,1,0.4,0.4,transcript,24928.0
SHOC1,ENSG00000165181,COVID-19,MONDO_0100096,0.3209563937042034,3.209680309792907,3,1.3,3.9000000000000004,transcript,33513.0
BACE2,ENSG00000182240,C-peptide measurement,EFO_0005187,0.3209503445286465,3.2096370012130095,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
CENPQ,ENSG00000031691,erythrocyte volume,OBA_0003460,0.3209447829019424,3.209677582034932,1,0.4,0.4,transcript,1741.0
GPR180,ENSG00000152749,cholesterol esters in medium LDL measurement,EFO_0022186,0.3209260363530795,3.209305388294415,1,0.4,0.4,transcript,8884.0
GPR180,ENSG00000152749,total cholesterol in medium LDL,EFO_0022185,0.3209260363530795,3.209305388294415,1,0.4,0.4,transcript,8884.0
GPR180,ENSG00000152749,total cholesterol in small LDL,EFO_0022179,0.3209260363530795,3.209305388294415,1,0.4,0.4,transcript,8884.0
KCNJ15,ENSG00000157551,smoking initiation,EFO_0005670,0.32091311455589483,3.2091409796093475,1,0.4,0.4,transcript,40675.0
USP37,ENSG00000135913,heart rate,OBA_1001087,0.32090842097352307,3.209223836621163,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
PDHX,ENSG00000110435,vascular disease,EFO_0004264,0.32089902158884825,3.20903498365569,1,0.4,0.4,transcript,8935.0
ABCA10,ENSG00000154263,cholesterol to total lipids in medium LDL percentage ,EFO_0022238,0.3208942945585989,3.2090428817378918,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
PTPN4,ENSG00000088179,smoking initiation,EFO_0005670,0.32089168353510716,3.209380442212453,5,2.0,10.0,transcript,21570.0
TRIM44,ENSG00000166326,lagophthalmos,MONDO_0001604,0.32088754236798567,3.2089047685555077,1,0.4,0.4,transcript,13631.0
MAN1A2,ENSG00000198162,self reported educational attainment,EFO_0004784,0.3208057874514179,3.208185395037013,2,0.8,1.6,transcript,12547.0
FITM2,ENSG00000197296,Drugs used in diabetes use measurement,EFO_0009924,0.3207994286985258,3.208080717408767,1,0.4,0.4,transcript,4628.0
RNF150,ENSG00000170153,ovarian neoplasm,EFO_0003893,0.32078075190602634,3.2080661780749344,4,1.6,6.4,transcript,24743.0
CNTLN,ENSG00000044459,sex hormone-binding globulin measurement,EFO_0004696,0.32078075190602634,3.207928979623537,2,0.8,1.6,transcript,13173.0
NEDD4,ENSG00000069869,triglycerides in medium LDL measurement ,EFO_0022322,0.32078075190602634,3.20781582902183,1,0.4,0.4,transcript,48135.0
ARHGAP20,ENSG00000137727,benign chondrogenic neoplasm,MONDO_0024470,0.32078075190602634,3.2078177636498397,1,0.4,0.4,transcript,39045.0
TPRG1,ENSG00000188001,preeclampsia,EFO_0000668,0.32078075190602634,3.2079073755166077,2,0.8,1.6,transcript,16023.0
TPRG1,ENSG00000188001,ovarian neoplasm,EFO_0003893,0.32078075190602634,3.2079073755166077,2,0.8,1.6,transcript,16023.0
TRPC6,ENSG00000137672,aspartate aminotransferase measurement,EFO_0004736,0.32078075190602634,3.2078364061838283,1,0.4,0.4,transcript,13847.0
TRPC6,ENSG00000137672,visual perception quality,OBA_2045263,0.32078075190602634,3.2078364061838283,1,0.4,0.4,transcript,13847.0
NEDD4,ENSG00000069869,triglycerides in small HDL measurement,EFO_0022158,0.32078075190602634,3.20781582902183,1,0.4,0.4,transcript,48135.0
HS6ST3,ENSG00000185352,ovarian neoplasm,EFO_0003893,0.32078075190602634,3.207854379416402,1,0.4,0.4,transcript,8536.0
DCLK1,ENSG00000133083,ovarian neoplasm,EFO_0003893,0.32078075190602634,3.2078577167135234,2,0.8,1.6,transcript,31874.0
OTOGL,ENSG00000165899,high density lipoprotein cholesterol measurement,EFO_0004612,0.32078075190602634,3.2078223770181857,1,0.5,0.5,transcript,33652.0
TCERG1L,ENSG00000176769,ciliopathy,EFO_0003900,0.32078075190602634,3.2080356993226706,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,ciliopathy,EFO_0003900,0.32078075190602634,3.2080356993226706,2,0.8,1.6,transcript,7012.0
TCERG1L,ENSG00000176769,iris disorder,MONDO_0002289,0.32078075190602634,3.2080356993226706,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,iris disorder,MONDO_0002289,0.32078075190602634,3.2080356993226706,2,0.8,1.6,transcript,7012.0
LRRC7,ENSG00000033122,high density lipoprotein cholesterol measurement,EFO_0004612,0.32078075190602634,3.207871622765814,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
PPP1R9A,ENSG00000158528,viral eye infection,MONDO_0020950,0.32078075190602634,3.20788652720418,3,1.3,3.9000000000000004,transcript,49362.0
VPS13A,ENSG00000197969,cholelithiasis,EFO_0004799,0.32078075190602634,3.207814264309079,1,0.4,0.4,transcript,59301.0
GPM6A,ENSG00000150625,Nephropathy,HP_0000112,0.32078075190602634,3.2078256901409885,1,0.4,0.4,transcript,22013.0
GPM6A,ENSG00000150625,nephritis,EFO_1002050,0.32078075190602634,3.2078256901409885,1,0.4,0.4,transcript,22013.0
RANBP17,ENSG00000204764,urinary microalbumin measurement,EFO_0010967,0.32078075190602634,3.207817033355492,1,0.4,0.4,transcript,42042.0
ADK,ENSG00000156110,adolescent idiopathic scoliosis,EFO_0005423,0.32078075190602634,3.207826502497215,1,0.4,0.4,transcript,21071.0
TCERG1L,ENSG00000176769,ciliopathy,EFO_0003900,0.32078075190602634,3.2080356993226706,2,0.8,1.6,gene_variant,7012.0
TPRG1,ENSG00000188001,arterial stiffness measurement,EFO_0004517,0.32078075190602634,3.2079073755166077,2,0.8,1.6,transcript,16023.0
NEDD4,ENSG00000069869,low density lipoprotein cholesterol measurement,EFO_0004611,0.32078075190602634,3.20781582902183,1,0.4,0.4,transcript,48135.0
TCERG1L,ENSG00000176769,ciliopathy,EFO_0003900,0.32078075190602634,3.2080356993226706,2,0.8,1.6,transcript,7012.0
HECW2,ENSG00000138411,liver disease,EFO_0001421,0.32078075190602634,3.207813335211716,1,0.4,0.4,transcript,68774.0
DLGAP1,ENSG00000170579,ocular hypotension,MONDO_0004390,0.32078075190602634,3.2078356732042015,2,0.8,1.6,transcript,56830.0
ITGA8,ENSG00000077943,lymphocyte count,EFO_0004587,0.32078075190602634,3.208272275063362,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
DLGAP1,ENSG00000170579,sinusitis,EFO_0007486,0.32078075190602634,3.2078356732042015,2,0.8,1.6,transcript,56830.0
CSMD3,ENSG00000164796,immune system disease,EFO_0000540,0.32078075190602634,3.2078156277820047,1,0.5,0.5,transcript,61662.0
ITGA8,ENSG00000077943,hypopituitarism,EFO_0001380,0.32078075190602634,3.208272275063362,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
DLGAP1,ENSG00000170579,esophageal ulcer,MONDO_0044782,0.32078075190602634,3.2078356732042015,2,0.8,1.6,transcript,56830.0
TCERG1L,ENSG00000176769,iris disorder,MONDO_0002289,0.32078075190602634,3.2080356993226706,2,0.8,1.6,transcript,7012.0
SGCZ,ENSG00000185053,lysophosphatidylcholine measurement,EFO_0010224,0.32078075190602634,3.2078562282663032,1,0.4,0.4,transcript,8212.0
TCERG1L,ENSG00000176769,iris disorder,MONDO_0002289,0.32078075190602634,3.2080356993226706,2,0.8,1.6,gene_variant,7012.0
ARMC1,ENSG00000104442,smoking initiation,EFO_0005670,0.32077781070354305,3.2078226554261198,1,0.4,0.4,transcript,8979.0
SERPINB9,ENSG00000170542,neurodegenerative disease,EFO_0005772,0.320765236445064,3.2077000800655746,1,0.4,0.4,transcript,8383.0
LONRF1,ENSG00000154359,cholesteryl ester measurement,EFO_0010351,0.3207621772101165,3.207657065388382,1,0.5,0.5,transcript,14167.0
SOS1,ENSG00000115904,monocyte count,EFO_0005091,0.32074456233689264,3.2074692312421518,2,0.8,1.6,transcript,67774.0
SOS1,ENSG00000115904,lung adenocarcinoma,EFO_0000571,0.3207384509432867,3.2074081173060924,2,0.8,1.6,transcript,67774.0
AKR1B10,ENSG00000198074,placenta praevia,EFO_0007442,0.3207102472562545,3.207234607869099,1,0.5,0.5,transcript,3784.0
QSOX1,ENSG00000116260,hemolytic anemia,EFO_0005558,0.3207061877353657,3.2070909407845947,1,0.4,0.4,transcript,13763.0
CAPN7,ENSG00000131375,hypertrophic cardiomyopathy,EFO_0000538,0.3206778446079827,3.2068170934228224,1,0.4,0.4,transcript,10350.0
TCERG1L,ENSG00000176769,response to antibiotic,GO_0046677,0.32065081483095503,3.2067363285719575,2,0.8,1.6,transcript,7012.0
PLXNA4,ENSG00000221866,urinary microalbumin measurement,EFO_0010967,0.32065081483095503,3.2065203957069786,1,0.4,0.4,transcript,32660.0
OTUD7A,ENSG00000169918,visual perception quality,OBA_2045263,0.32065081483095503,3.2065258748772436,1,0.4,0.4,transcript,22565.0
DOCK1,ENSG00000150760,heart rate,OBA_1001087,0.32065081483095503,3.206533236116876,1,0.4,0.4,transcript,15944.0
TCERG1L,ENSG00000176769,bilirubin measurement,EFO_0004570,0.32065081483095503,3.2067363285719575,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,bilirubin measurement,EFO_0004570,0.32065081483095503,3.2067363285719575,2,0.8,1.6,transcript,7012.0
PLXNA4,ENSG00000221866,preeclampsia,EFO_0000668,0.32065081483095503,3.2065203957069786,1,0.4,0.4,transcript,32660.0
DLGAP1,ENSG00000170579,Abnormality of the integument,HP_0001574,0.32065081483095503,3.2065363024534883,2,0.8,1.6,transcript,56830.0
PLXNA4,ENSG00000221866,lymphocyte count,EFO_0004587,0.32065081483095503,3.2065203957069786,1,0.4,0.4,transcript,32660.0
TRDN,ENSG00000186439,placenta praevia,EFO_0007442,0.32065081483095503,3.206527351750807,1,0.5,0.5,transcript,26037.0
TCERG1L,ENSG00000176769,response to xenobiotic stimulus,GO_0009410,0.32065081483095503,3.2067363285719575,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,response to xenobiotic stimulus,GO_0009410,0.32065081483095503,3.2067363285719575,2,0.8,1.6,transcript,7012.0
RANBP17,ENSG00000204764,cervical carcinoma,EFO_0001061,0.32065081483095503,3.206517662604779,1,0.4,0.4,transcript,42042.0
HS3ST3A1,ENSG00000153976,secondary malignant neoplasm,EFO_0009812,0.32065081483095503,3.2065891855866977,1,0.4,0.4,transcript,4936.0
SEMA3C,ENSG00000075223,ovarian neoplasm,EFO_0003893,0.32065081483095503,3.2065418665932897,1,0.4,0.4,transcript,11863.0
TCERG1L,ENSG00000176769,response to xenobiotic stimulus,GO_0009410,0.32065081483095503,3.2067363285719575,2,0.8,1.6,transcript,7012.0
SEMA3C,ENSG00000075223,serum gamma-glutamyl transferase measurement,EFO_0004532,0.32065081483095503,3.2065418665932897,1,0.4,0.4,transcript,11863.0
TCERG1L,ENSG00000176769,response to xenobiotic stimulus,GO_0009410,0.32065081483095503,3.2067363285719575,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,bilirubin measurement,EFO_0004570,0.32065081483095503,3.2067363285719575,2,0.8,1.6,transcript,7012.0
CDH19,ENSG00000071991,glomerulonephritis,MONDO_0002462,0.32065081483095503,3.2067827059666585,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
CDH19,ENSG00000071991,brain aneurysm,EFO_0003870,0.32065081483095503,3.2067827059666585,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
TCERG1L,ENSG00000176769,bilirubin measurement,EFO_0004570,0.32065081483095503,3.2067363285719575,2,0.8,1.6,gene_variant,7012.0
TCERG1L,ENSG00000176769,response to antibiotic,GO_0046677,0.32065081483095503,3.2067363285719575,2,0.8,1.6,transcript,7012.0
DNAJC10,ENSG00000077232,liver disease,EFO_0001421,0.32065081483095503,3.2065274000400827,4,1.7000000000000002,6.800000000000001,transcript,353215.0
HFM1,ENSG00000162669,pulse wave reflection index measurement,EFO_0009804,0.32065081483095503,3.2066379847156785,2,1.0,2.0,transcript,15404.0
HFM1,ENSG00000162669,osteitis deformans,EFO_0004261,0.32065081483095503,3.2066379847156785,2,1.0,2.0,transcript,15404.0
HECW2,ENSG00000138411,body weights and measures,EFO_0004324,0.32065081483095503,3.206513964461003,1,0.4,0.4,transcript,68774.0
TRPC6,ENSG00000137672,Abruptio Placentae,EFO_1001754,0.32065081483095503,3.206537035433115,1,0.4,0.4,transcript,13847.0
TCERG1L,ENSG00000176769,response to antibiotic,GO_0046677,0.32065081483095503,3.2067363285719575,2,0.8,1.6,gene_variant,7012.0
DOCK1,ENSG00000150760,Tietze syndrome,MONDO_0001858,0.32065081483095503,3.206533236116876,1,0.4,0.4,transcript,15944.0
NEK7,ENSG00000151414,breast benign neoplasm,MONDO_0000620,0.32065081483095503,3.2065534125394928,1,0.4,0.4,transcript,8837.0
TCERG1L,ENSG00000176769,response to antibiotic,GO_0046677,0.32065081483095503,3.2067363285719575,2,0.8,1.6,gene_variant,7012.0
DNAH14,ENSG00000185842,placenta praevia,EFO_0007442,0.32065081483095503,3.2065661267930907,3,1.5,4.5,transcript,77615.0
ITGA8,ENSG00000077943,optic cup area,OBA_2045265,0.32065081483095503,3.2069729043126487,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
DOK5,ENSG00000101134,waist circumference,OBA_1001085,0.32065081483095503,3.206595983179994,1,0.4,0.4,transcript,4554.0
TFEC,ENSG00000105967,arterial embolism,EFO_0010671,0.32065081483095503,3.206523845664546,1,0.4,0.4,transcript,25482.0
VPS13A,ENSG00000197969,Genu valgum,HP_0002857,0.32065081483095503,3.206514893558366,1,0.4,0.4,transcript,59301.0
TENM4,ENSG00000149256,preeclampsia,EFO_0000668,0.32065081483095503,3.2065255987938013,1,0.4,0.4,transcript,22922.0
GPR158,ENSG00000151025,HbA1c measurement,EFO_0004541,0.32065081483095503,3.206533819614166,1,0.5,0.5,transcript,19477.0
GPR158,ENSG00000151025,respiratory tract infectious disorder,MONDO_0024355,0.32065081483095503,3.206533819614166,1,0.5,0.5,transcript,19477.0
VPS13A,ENSG00000197969,benign chondrogenic neoplasm,MONDO_0024470,0.32065081483095503,3.206514893558366,1,0.4,0.4,transcript,59301.0
CADPS,ENSG00000163618,polycystic ovary syndrome,EFO_0000660,0.32065081483095503,3.206517466020189,1,0.4,0.4,transcript,42929.0
DOK5,ENSG00000101134,spondylolisthesis,EFO_0007493,0.32065081483095503,3.206595983179994,1,0.4,0.4,transcript,4554.0
VPS13A,ENSG00000197969,Genu varum,HP_0002970,0.32065081483095503,3.206514893558366,1,0.4,0.4,transcript,59301.0
METTL25,ENSG00000127720,cervical carcinoma,EFO_0001061,0.32065081483095503,3.2065600963614984,1,0.5,0.5,transcript,9625.0
ADK,ENSG00000156110,arterial stiffness measurement,EFO_0004517,0.32065081483095503,3.2065271317465016,1,0.4,0.4,transcript,21071.0
ATXN7L3B,ENSG00000253719,diabetes mellitus,EFO_0000400,0.3206426115770995,3.2064787750653605,1,0.4,0.4,transcript,7596.0
PIP4K2A,ENSG00000150867,breast carcinoma,EFO_0000305,0.32063642207950216,3.206407665999757,1,0.4,0.4,transcript,9207.0
BMPR2,ENSG00000204217,low density lipoprotein cholesterol measurement,EFO_0004611,0.32058870169809023,3.205904788439939,1,0.4,0.4,transcript,22508.0
CCBE1,ENSG00000183287,platelet crit,EFO_0007985,0.3205804067443101,3.2058178576933942,1,0.4,0.4,transcript,29006.0
FGFR1OP2,ENSG00000111790,high density lipoprotein cholesterol measurement,EFO_0004612,0.3205768401322921,3.205804535017591,1,0.4,0.4,transcript,11070.0
HPSE,ENSG00000173083,blood metabolite measurement,EFO_0005664,0.3205691120654864,3.205778968385464,2,0.9,1.8,transcript,20490.0
BTC,ENSG00000174808,bone tissue density,OBA_1000110,0.32055770173628056,3.20569908022518,1,0.4,0.4,transcript,3277.0
PPDPFL,ENSG00000168333,immune system disease,EFO_0000540,0.32055770173628056,3.2059024190304894,2,0.8,1.6,transcript,4917.0
PCDH18,ENSG00000189184,X-12818 measurement,EFO_0800729,0.32055770173628056,3.205654189021514,2,0.8,1.6,transcript,20733.0
CNTLN,ENSG00000044459,liver disease,EFO_0001421,0.32055770173628056,3.205698477926079,2,0.8,1.6,transcript,13173.0
C2orf73,ENSG00000177994,cystic kidney disease,EFO_0008615,0.32050971817710994,3.2051454909498434,1,0.4,0.4,transcript,8280.0
TAF1B,ENSG00000115750,serum alanine aminotransferase measurement,EFO_0004735,0.3204944270282155,3.2049986713266554,1,0.5,0.5,transcript,9191.0
GIPC2,ENSG00000137960,diastolic blood pressure,EFO_0006336,0.32048977699234504,3.20528896796746,2,0.8,1.6,transcript,4090.0
ZFP90,ENSG00000184939,systemic lupus erythematosus,MONDO_0007915,0.32046697807491703,3.20468313589591,1,0.4,0.4,transcript,29951.0
USP37,ENSG00000135913,body weight,EFO_0004338,0.3204094020224325,3.2042336471102573,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
PIP4K2A,ENSG00000150867,luminal A breast carcinoma,MONDO_0021116,0.32039764258429076,3.204019871047643,1,0.4,0.4,transcript,9207.0
F13B,ENSG00000143278,low density lipoprotein cholesterol measurement,EFO_0004611,0.32036683111686465,3.203776209312798,1,0.5,0.5,transcript,4634.0
F13B,ENSG00000143278,pulse pressure measurement,EFO_0005763,0.32036683111686465,3.203776209312798,1,0.5,0.5,transcript,4634.0
PYGO1,ENSG00000171016,body weight,EFO_0004338,0.3203148169839394,3.203476005102174,4,1.6,6.4,transcript,19522.0
PLXNA4,ENSG00000221866,colorectal cancer,MONDO_0005575,0.32031263107266755,3.203138558124104,1,0.4,0.4,transcript,32660.0
LUZP2,ENSG00000187398,body height,OBA_VT0001253,0.3202931128743296,3.2032479087675205,4,1.7000000000000002,6.800000000000001,transcript,21466.0
ZFP1,ENSG00000184517,Hernia,HP_0100790,0.32027939673520084,3.202822320059692,1,0.4,0.4,transcript,14108.0
GCNT1,ENSG00000187210,glaucoma,MONDO_0005041,0.32027220245555577,3.2027411221922253,1,0.4,0.4,transcript,20945.0
TFEC,ENSG00000105967,lifestyle measurement,EFO_0010724,0.3202699155082955,3.2027148524379507,1,0.4,0.4,transcript,25482.0
NEK7,ENSG00000151414,protein measurement,EFO_0004747,0.3202604923869648,3.2026501880995903,1,0.4,0.4,transcript,8837.0
SLC15A5,ENSG00000188991,lymphocyte count,EFO_0004587,0.3202248499897666,3.2034801112558595,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
STT3B,ENSG00000163527,intraocular pressure measurement,EFO_0004695,0.3202248499897666,3.202268222791014,1,0.4,0.4,transcript,20281.0
ADK,ENSG00000156110,neurodegenerative disease,EFO_0005772,0.320207788084497,3.2020968642819216,1,0.4,0.4,transcript,21071.0
ST8SIA4,ENSG00000113532,high density lipoprotein cholesterol measurement,EFO_0004612,0.32019659607518913,3.2020088378019502,1,0.4,0.4,transcript,9329.0
ASTN2,ENSG00000148219,p-acetamidophenylglucuronide measurement,EFO_0021160,0.3201767508763972,3.201826263170552,2,0.8,1.6,transcript,27232.0
CDKL2,ENSG00000138769,polyp,EFO_0000662,0.32016358524562344,3.201799955020337,2,0.8,1.6,transcript,9750.0
PUS7L,ENSG00000129317,vital capacity,EFO_0004312,0.3201594552911464,3.201731471482947,3,1.2000000000000002,3.6000000000000005,transcript,26293.0
PUS7L,ENSG00000129317,forced expiratory volume,EFO_0004314,0.3201594552911464,3.201731471482947,3,1.2000000000000002,3.6000000000000005,transcript,26293.0
PTPN4,ENSG00000088179,placenta praevia,EFO_0007442,0.32012655668191636,3.201729173680545,5,2.0,10.0,transcript,21570.0
ARHGAP28,ENSG00000088756,neutrophil count,EFO_0004833,0.32012615593243626,3.2012738609604803,1,0.4,0.4,transcript,32516.0
EVI5,ENSG00000067208,heart failure,EFO_0003144,0.3201254679771732,3.201260335720376,1,0.4,0.4,transcript,70722.0
AGBL3,ENSG00000146856,serum gamma-glutamyl transferase measurement,EFO_0004532,0.32011676848265835,3.201203637943719,1,0.5,0.5,transcript,13907.0
ASTN2,ENSG00000148219,serum gamma-glutamyl transferase measurement,EFO_0004532,0.3201081704529491,3.2011404589360715,2,0.8,1.6,transcript,27232.0
DYNC1I2,ENSG00000077380,diastolic blood pressure,EFO_0006336,0.32010459113051265,3.2010570982387883,1,0.4,0.4,transcript,35756.0
METTL8,ENSG00000123600,BMI-adjusted hip circumference,EFO_0008039,0.3200714605820574,3.200726626857388,1,0.4,0.4,transcript,33275.0
GFRAL,ENSG00000187871,hip circumference,OBA_1000032,0.32006589604385294,3.200868274933558,1,0.4,0.4,transcript,1911.0
USP6,ENSG00000129204,hyperpituitarism,EFO_1000973,0.32001840752439814,3.200195371807002,1,0.4,0.4,transcript,35409.0
SECISBP2L,ENSG00000138593,alkaline phosphatase measurement,EFO_0004533,0.32001706013740766,3.2001896853435423,1,0.4,0.4,transcript,20960.0
GLCE,ENSG00000138604,platelet volume,OBA_0003277,0.31996016224035373,3.1997319474015007,2,0.8,1.6,transcript,12277.0
MLLT3,ENSG00000171843,trait in response to montelukast,OBA_2040086,0.3199434987034765,3.1995382261623946,2,0.8,1.6,transcript,15498.0
MLLT3,ENSG00000171843,FEV change measurement,EFO_0005921,0.3199434987034765,3.1995382261623946,2,0.8,1.6,transcript,15498.0
CLSTN2,ENSG00000158258,bone tissue density,OBA_1000110,0.3199430512179829,3.1994545984085274,1,0.4,0.4,transcript,16607.0
VPS13A,ENSG00000197969,bone tissue density,OBA_1000110,0.3199430512179829,3.1994372574286443,1,0.4,0.4,transcript,59301.0
PRDM5,ENSG00000138738,protein measurement,EFO_0004747,0.3199430512179829,3.19951112077472,2,0.8,1.6,transcript,19849.0
PLXNA4,ENSG00000221866,level of Phosphatidylcholine (18:2_18:2) in blood serum,OBA_2045106,0.3199430512179829,3.199442759577257,1,0.4,0.4,transcript,32660.0
DMRTA1,ENSG00000176399,systemic lupus erythematosus,MONDO_0007915,0.31992399892385565,3.1993115968289607,1,0.4,0.4,transcript,5586.0
LATS1,ENSG00000131023,hippocampal CA4 volume,EFO_0009396,0.3199105068651279,3.1991224252424444,1,0.4,0.4,transcript,23046.0
SFRP1,ENSG00000104332,central corneal thickness,EFO_0005213,0.31986675330610514,3.1987155119503403,1,0.4,0.4,transcript,8337.0
DCLK1,ENSG00000133083,platelet count,EFO_0004309,0.3198617843114335,3.1986680407675947,2,0.8,1.6,transcript,31874.0
GIPC2,ENSG00000137960,electrocardiography,EFO_0004327,0.3198290499399524,3.198681697443534,2,0.8,1.6,transcript,4090.0
HS6ST3,ENSG00000185352,Abnormality of refraction,HP_0000539,0.31978526297223314,3.19789949007847,1,0.4,0.4,transcript,8536.0
DYNC1I2,ENSG00000077380,insomnia,EFO_0004698,0.3197764286264568,3.1977754731982295,1,0.4,0.4,transcript,35756.0
ZNF148,ENSG00000163848,kidney disease,EFO_0003086,0.3197688185409239,3.1977000537889086,1,0.4,0.4,transcript,33703.0
SLC35D3,ENSG00000182747,diverticular disease,EFO_0009959,0.31976258120733164,3.1977965333707985,1,0.4,0.4,transcript,2343.0
TMEM236,ENSG00000148483,hemoglobin measurement,EFO_0004509,0.3197497649720909,3.1977877675812896,2,0.8,1.6,transcript,5515.0
BTAF1,ENSG00000095564,brain compression,MONDO_0001291,0.3197289993238031,3.197326737680434,1,0.4,0.4,transcript,10886.0
BTAF1,ENSG00000095564,edema,EFO_0009373,0.3197289993238031,3.197326737680434,1,0.4,0.4,transcript,10886.0
EVI5,ENSG00000067208,eosinophil percentage of leukocytes,EFO_0007991,0.3197289993238031,3.197295649186675,1,0.4,0.4,transcript,70722.0
LHX9,ENSG00000143355,nerve plexus disease,EFO_0009559,0.3197227834053223,3.1973021006703783,2,0.8,1.6,transcript,21544.0
ARL3,ENSG00000138175,serum creatinine amount,OBA_2050096,0.31968857087679775,3.1969900384497723,1,0.4,0.4,transcript,3834.0
HNRNPA0,ENSG00000177733,high density lipoprotein cholesterol measurement,EFO_0004612,0.3196842647644305,3.1968656018506634,1,0.4,0.4,transcript,17426.0
BMERB1,ENSG00000166780,polyunsaturated fatty acids to monounsaturated fatty acids ratio ,EFO_0022302,0.31967222942577217,3.196758568856434,1,0.4,0.4,transcript,11027.0
BMERB1,ENSG00000166780,polyunsaturated fatty acids to total fatty acids percentage ,EFO_0022303,0.31967222942577217,3.196758568856434,1,0.4,0.4,transcript,11027.0
BMERB1,ENSG00000166780,triglycerides to total lipids in medium VLDL percentage ,EFO_0022335,0.31967222942577217,3.196758568856434,1,0.4,0.4,transcript,11027.0
BMERB1,ENSG00000166780,cholesteryl esters to total lipids in medium VLDL percentage ,EFO_0022253,0.31967222942577217,3.196758568856434,1,0.4,0.4,transcript,11027.0
BMERB1,ENSG00000166780,cholesterol to total lipids in medium VLDL percentage ,EFO_0022239,0.31967222942577217,3.196758568856434,1,0.4,0.4,transcript,11027.0
SPRED1,ENSG00000166068,prostate specific antigen amount,OBA_2050200,0.31966428914599976,3.1966874646714976,1,0.4,0.4,transcript,8974.0
MLLT3,ENSG00000171843,lymphocyte percentage of leukocytes,EFO_0007993,0.3196493717042802,3.1965969561704317,2,0.8,1.6,transcript,15498.0
MAP2K6,ENSG00000108984,whole body water mass,EFO_0009805,0.31964642768252816,3.196481579360103,1,0.4,0.4,transcript,23118.0
CASQ2,ENSG00000118729,magnetic resonance imaging of the heart,EFO_0022611,0.31964208341693023,3.1964334851908722,1,0.4,0.4,transcript,31618.0
STAU2,ENSG00000040341,temporal measurement,EFO_0000719,0.3196358616225756,3.196370184408626,1,0.5,0.5,transcript,43222.0
SFRP1,ENSG00000104332,electrocardiography,EFO_0004327,0.31963470875638783,3.196395066453167,1,0.4,0.4,transcript,8337.0
INF2,ENSG00000203485,platelet count,EFO_0004309,0.31961349358078145,3.1961379986887604,1,0.4,0.4,transcript,130596.0
MUC16,ENSG00000181143,lung adenocarcinoma,EFO_0000571,0.3195971364495953,3.195974184845338,1,0.5,0.5,transcript,177283.0
EXD1,ENSG00000178997,systolic blood pressure,EFO_0006335,0.3195964447397588,3.196006231582274,1,0.4,0.4,transcript,9573.0
TMEM170B,ENSG00000205269,neuroticism measurement,EFO_0007660,0.3195781046747576,3.195826036062614,1,0.4,0.4,transcript,8891.0
TRIM36,ENSG00000152503,handedness,EFO_0009902,0.3195726635960814,3.195752796850284,1,0.4,0.4,transcript,15290.0
DLG2,ENSG00000150672,body weight,EFO_0004338,0.3195554658744432,3.195557431669591,1,0.4,0.4,transcript,144252.0
SCAMP1,ENSG00000085365,major depressive disorder,MONDO_0002009,0.3195188351748858,3.195214698738714,1,0.4,0.4,transcript,15182.0
ZNF716,ENSG00000182111,growth differentiation factor 15 amount,OBA_2050135,0.319440834774996,3.197287426444778,6,2.5,15.0,transcript,5210.0
ABCB5,ENSG00000004846,childhood onset asthma,MONDO_0005405,0.3194364186599573,3.194391099066774,1,0.4,0.4,transcript,14863.0
SLC35D3,ENSG00000182747,neurodegenerative disease,EFO_0005772,0.3194172759807238,3.1943434811047196,1,0.4,0.4,transcript,2343.0
NEBL,ENSG00000078114,preeclampsia,EFO_0000668,0.31941227637771175,3.1941305855960813,1,0.4,0.4,transcript,51139.0
FRMD4B,ENSG00000114541,eosinophil count,EFO_0004842,0.3193963874884797,3.194039971146568,2,0.8,1.6,transcript,21026.0
GCNT1,ENSG00000187210,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.31939037672429327,3.1939228648796005,1,0.4,0.4,transcript,20945.0
CSMD3,ENSG00000164796,body weight,EFO_0004338,0.31937986981757205,3.1938068068974617,1,0.5,0.5,transcript,61662.0
TMEM68,ENSG00000167904,alcohol consumption quality,OBA_1000840,0.3193441553661764,3.193460225183026,1,0.4,0.4,transcript,21423.0
SENP6,ENSG00000112701,cerebral cortex area attribute,OBA_2045267,0.31934019162546656,3.193830933415352,5,2.2,11.0,transcript,25640.0
ZBTB34,ENSG00000177125,5-methyluridine (ribothymidine) measurement,EFO_0020013,0.3193368016039247,3.1933983443431364,1,0.4,0.4,transcript,13189.0
SGCZ,ENSG00000185053,risk-taking behaviour,EFO_0008579,0.3192828599551076,3.1928773087571156,1,0.4,0.4,transcript,8212.0
THEM4,ENSG00000159445,acylcarnitine measurement,EFO_0005059,0.31926574608339847,3.1928118115960915,2,0.8,1.6,transcript,10366.0
PTPN4,ENSG00000088179,growth differentiation factor 15 amount,OBA_2050135,0.31921079815744446,3.1925715884358263,5,2.0,10.0,transcript,21570.0
CCDC66,ENSG00000180376,cognitive function measurement,EFO_0008354,0.3192105176094861,3.192120405603557,1,0.5,0.5,transcript,32831.0
TPRG1,ENSG00000188001,body height,OBA_VT0001253,0.3191809543665253,3.1919094001215975,2,0.8,1.6,transcript,16023.0
GPR85,ENSG00000164604,nervous system benign neoplasm,MONDO_0000648,0.3191625202403357,3.191648749821971,1,0.4,0.4,transcript,16987.0
SMIM36,ENSG00000261873,metabolite measurement,EFO_0004725,0.319043513536182,3.190616705947385,1,0.4,0.4,transcript,2203.0
PDE12,ENSG00000174840,triglyceride measurement,EFO_0004530,0.31903927154997885,3.1904117694701597,1,0.4,0.4,transcript,20993.0
FAM186A,ENSG00000185958,neutrophil count,EFO_0004833,0.31903737982539554,3.1904846998842094,2,1.0,2.0,transcript,18034.0
GIPC2,ENSG00000137960,systolic blood pressure,EFO_0006335,0.3189816726087854,3.190207924131864,2,0.8,1.6,transcript,4090.0
TSPAN3,ENSG00000140391,hemoglobin measurement,EFO_0004509,0.3189801133065028,3.1898230436697603,1,0.4,0.4,transcript,18256.0
SLC30A9,ENSG00000014824,diet measurement,EFO_0008111,0.3189571080261113,3.1899228435875315,3,1.3,3.9000000000000004,transcript,11087.0
NBAS,ENSG00000151779,smoking initiation,EFO_0005670,0.3189508185907842,3.189541731697845,2,1.0,2.0,transcript,59620.0
RNF17,ENSG00000132972,liver disease,EFO_0001421,0.3189305221943163,3.1893415723611924,1,0.5,0.5,transcript,13755.0
CD69,ENSG00000110848,myxedema,EFO_1001055,0.3189278553272873,3.1901230289941958,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
PICALM,ENSG00000073921,HbA1c measurement,EFO_0004541,0.31891012292562787,3.189114497574851,1,0.4,0.4,transcript,30147.0
WAPL,ENSG00000062650,ulcerative colitis,EFO_0000729,0.3189067884646677,3.1892016415435167,2,0.8,1.6,transcript,11962.0
OR2T6,ENSG00000198104,taste liking measurement,EFO_0010155,0.3189035127562938,3.189120780667863,1,0.4,0.4,transcript,4670.0
MYLK3,ENSG00000140795,erythrocyte count,EFO_0004305,0.3188909699017461,3.1889366296038744,1,0.4,0.4,transcript,14853.0
MSX2,ENSG00000120149,acute tonsillitis,MONDO_0020686,0.3188893138531865,3.189011376781939,1,0.4,0.4,transcript,3383.0
CFHR4,ENSG00000134365,serum albumin amount,OBA_2050068,0.3188466974943798,3.1885074837342056,1,0.5,0.5,transcript,12343.0
GPAT3,ENSG00000138678,systolic blood pressure,EFO_0006335,0.3188430199126491,3.1885773255632723,2,0.8,1.6,transcript,10875.0
PCDH18,ENSG00000189184,biliary tract disease,EFO_0009534,0.3187918995532909,3.1879961671916175,2,0.8,1.6,transcript,20733.0
CD86,ENSG00000114013,lymphocyte count,EFO_0004587,0.31875689091869464,3.1876007436477503,1,0.4,0.4,transcript,12565.0
PTPN4,ENSG00000088179,Fasciitis,HP_0100537,0.3187466488256819,3.1879300951182,5,2.0,10.0,transcript,21570.0
C2CD4A,ENSG00000198535,body height,OBA_VT0001253,0.31863861425131956,3.186502252817985,1,0.4,0.4,transcript,3445.0
DAG1,ENSG00000173402,platelet count,EFO_0004309,0.318618629393305,3.1861924820518617,1,0.4,0.4,transcript,64640.0
MTMR6,ENSG00000139505,triglyceride measurement,EFO_0004530,0.3185651815135342,3.185705440188967,1,0.5,0.5,transcript,9324.0
TMCC1,ENSG00000172765,sitting height measurement,EFO_0011011,0.3185333827645812,3.1853440291250266,1,0.4,0.4,transcript,39210.0
LIN9,ENSG00000183814,urate measurement,EFO_0004531,0.3185309662982842,3.18541449852209,2,0.8,1.6,transcript,15262.0
LIN9,ENSG00000183814,heel bone mineral density,EFO_0009270,0.3185309662982842,3.18541449852209,2,0.8,1.6,transcript,15262.0
RSBN1L,ENSG00000187257,hypertension,EFO_0000537,0.3185257785542261,3.1853945026233514,2,0.8,1.6,transcript,11703.0
SLC35B4,ENSG00000205060,triglyceride measurement,EFO_0004530,0.3185257785542261,3.185299705475189,1,0.4,0.4,transcript,9542.0
RSBN1L,ENSG00000187257,Antihypertensive use measurement,EFO_0009927,0.3185257785542261,3.1853945026233514,2,0.8,1.6,transcript,11703.0
CYSLTR1,ENSG00000173198,multiple sclerosis,MONDO_0005301,0.3185205947367772,3.1853960840284965,2,0.8,1.6,transcript,8415.0
BTAF1,ENSG00000095564,nervous system cancer,EFO_0007392,0.318510234685706,3.185139091299463,1,0.4,0.4,transcript,10886.0
LHFPL2,ENSG00000145685,otosclerosis,EFO_0004213,0.31847218385320686,3.1847487310962745,1,0.4,0.4,transcript,14874.0
TLK1,ENSG00000198586,immature platelet count,EFO_0803544,0.31845060967736233,3.1845199919346334,1,0.4,0.4,transcript,28787.0
DMAC1,ENSG00000137038,glycine measurement,EFO_0009767,0.31840827027779484,3.184198276311609,1,0.4,0.4,transcript,3461.0
SLF1,ENSG00000133302,smoking status measurement,EFO_0006527,0.31837856967250167,3.183820609878547,1,0.4,0.4,transcript,11457.0
PLEKHA6,ENSG00000143850,neuroimaging measurement,EFO_0004346,0.3183682672864836,3.183689487523166,1,0.4,0.4,transcript,58697.0
TRIT1,ENSG00000043514,balding measurement,EFO_0007825,0.318364700210937,3.1836622048762737,1,0.4,0.4,transcript,26311.0
YBX3,ENSG00000060138,Abnormality of refraction,HP_0000539,0.31836375073690654,3.1836579614496547,1,0.4,0.4,transcript,19556.0
LARP4B,ENSG00000107929,Cerebral degeneration,HP_0007313,0.31835383616029234,3.1835493736060063,1,0.5,0.5,transcript,45405.0
GPR180,ENSG00000152749,total lipids in small LDL,EFO_0022168,0.31830875485919435,3.1831325733555635,1,0.4,0.4,transcript,8884.0
GPR180,ENSG00000152749,free cholesterol in medium LDL measurement ,EFO_0022268,0.31830875485919435,3.1831325733555635,1,0.4,0.4,transcript,8884.0
COLEC10,ENSG00000184374,age of onset of childhood onset asthma,OBA_2001015,0.31830606132823214,3.1831657934032784,1,0.4,0.4,transcript,3803.0
ANKH,ENSG00000154122,protein measurement,EFO_0004747,0.3182702071059637,3.183470513682588,5,2.4,12.0,gene_variant,15616.0
TMCC1,ENSG00000172765,hip circumference,OBA_1000032,0.3182702071059637,3.1827122725388515,1,0.4,0.4,transcript,39210.0
ANKH,ENSG00000154122,protein measurement,EFO_0004747,0.3182702071059637,3.183470513682588,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,protein measurement,EFO_0004747,0.3182702071059637,3.183470513682588,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,protein measurement,EFO_0004747,0.3182702071059637,3.183470513682588,5,2.4,12.0,transcript,15616.0
CPD,ENSG00000108582,mental or behavioural disorder,EFO_0000677,0.3182671617956431,3.1826918363147008,1,0.4,0.4,transcript,19784.0
COQ3,ENSG00000132423,creatine kinase measurement,EFO_0004534,0.3182613049397691,3.182763595125956,1,0.4,0.4,transcript,2657.0
GLCE,ENSG00000138604,red blood cell density,OBA_2045260,0.3182165341596511,3.182295666594475,2,0.8,1.6,transcript,12277.0
NRCAM,ENSG00000091129,educational attainment,EFO_0011015,0.31821599586737337,3.182171611987645,1,0.4,0.4,transcript,34325.0
RNF150,ENSG00000170153,platelet count,EFO_0004309,0.318192281855423,3.182181477568901,4,1.6,6.4,transcript,24743.0
OR10A6,ENSG00000279000,smoking status measurement,EFO_0006527,0.3181745946034985,3.181778851596025,1,0.4,0.4,transcript,12156.0
TRPC6,ENSG00000137672,poisoning,EFO_0008546,0.31809571192260266,3.1809860063495914,1,0.4,0.4,transcript,13847.0
CCDC34,ENSG00000109881,spine bone mineral density,EFO_0007701,0.31807947229258493,3.1808882464236286,1,0.4,0.4,transcript,4277.0
DMRTA1,ENSG00000176399,systolic blood pressure,EFO_0006335,0.317995594474903,3.180027552339434,1,0.4,0.4,transcript,5586.0
SLC35B4,ENSG00000205060,insomnia,EFO_0004698,0.3179822699907734,3.179864619840662,1,0.4,0.4,transcript,9542.0
IREB2,ENSG00000136381,pneumonia,EFO_0003106,0.31797566626242396,3.1798565183881364,2,0.9,1.8,transcript,18026.0
CCDC7,ENSG00000216937,PR interval,EFO_0004462,0.31795118932141897,3.1795304902535406,1,0.5,0.5,transcript,26886.0
TENT4B,ENSG00000121274,erythrocyte volume,OBA_0003460,0.3179388278725469,3.179637694158049,4,1.6,6.4,transcript,25660.0
CFAP299,ENSG00000197826,balding measurement,EFO_0007825,0.3178961373415688,3.1790265115084444,1,0.5,0.5,transcript,7676.0
BIRC6,ENSG00000115760,chronotype measurement,EFO_0008328,0.3178906385390655,3.1789135676476072,1,0.5,0.5,transcript,69616.0
SLC6A5,ENSG00000165970,lymphocyte count,EFO_0004587,0.3178683886773821,3.178722522917934,1,0.4,0.4,transcript,10353.0
PIP4K2A,ENSG00000150867,hypothyroidism,EFO_0004705,0.31786339423049653,3.1786773875097007,1,0.4,0.4,transcript,9207.0
SARAF,ENSG00000133872,pulmonary embolism,EFO_0003827,0.3177838482632449,3.1778649359093487,1,0.4,0.4,transcript,15121.0
ANKRD30B,ENSG00000180777,level of Phosphatidylcholine (14:0_18:1) in blood serum,OBA_2045062,0.3177838482632449,3.1778630490354365,1,0.5,0.5,transcript,20353.0
TECRL,ENSG00000205678,lifestyle measurement,EFO_0010724,0.3177838482632449,3.1782412573023975,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
TECRL,ENSG00000205678,smoking initiation,EFO_0005670,0.3177838482632449,3.1782412573023975,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
TECRL,ENSG00000205678,anxiety disorder measurement,EFO_0007795,0.3177838482632449,3.1782412573023975,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
ALG10B,ENSG00000175548,hemorrhage,MP_0001914,0.3177838482632449,3.1785442985556562,5,2.0,10.0,transcript,14168.0
NEDD1,ENSG00000139350,smoking initiation,EFO_0005670,0.3177838482632449,3.1778577393241494,1,0.4,0.4,transcript,20772.0
ALG10B,ENSG00000175548,gastric ulcer,EFO_0009454,0.3177838482632449,3.1785442985556562,5,2.0,10.0,transcript,14168.0
NEDD1,ENSG00000139350,alcohol consumption quality,OBA_1000840,0.3177838482632449,3.1778577393241494,1,0.4,0.4,transcript,20772.0
ABCA13,ENSG00000179869,platelet count,EFO_0004309,0.31777192739857724,3.177729605845094,1,0.5,0.5,transcript,48394.0
BACH1,ENSG00000156273,JT interval,EFO_0007885,0.3177478098881832,3.177835960657721,4,1.6,6.4,transcript,17884.0
LNPEP,ENSG00000113441,arterial stiffness measurement,EFO_0004517,0.31772794735786813,3.17730013580297,1,0.4,0.4,transcript,19359.0
CKAP2,ENSG00000136108,Breast hypertrophy,HP_0010313,0.31772794735786813,3.1773070142010997,1,0.4,0.4,transcript,14524.0
ABCA10,ENSG00000154263,temporal measurement,EFO_0000719,0.31772794735786813,3.1773794097305843,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
TMED5,ENSG00000117500,growth differentiation factor 15 amount,OBA_2050135,0.31772794735786813,3.1773114408442016,1,0.5,0.5,transcript,15641.0
HIPK3,ENSG00000110422,gastrointestinal disease,EFO_0010282,0.31772794735786813,3.177294307072711,1,0.4,0.4,transcript,26966.0
PIAS2,ENSG00000078043,brain aneurysm,EFO_0003870,0.31772794735786813,3.1772928635964233,1,0.4,0.4,transcript,29873.0
PIAS2,ENSG00000078043,aneurysm,EFO_0009659,0.31772794735786813,3.1772928635964233,1,0.4,0.4,transcript,29873.0
ATAD2B,ENSG00000119778,Abruptio Placentae,EFO_1001754,0.31769167430316086,3.176934920718498,1,0.4,0.4,transcript,22005.0
METTL8,ENSG00000123600,appendicular lean mass,EFO_0004980,0.3176796882936338,3.176808903973152,1,0.4,0.4,transcript,33275.0
TRAM1,ENSG00000067167,prolapse of female genital organ,MONDO_0001592,0.3176481773787728,3.1766722726566408,2,0.8,1.6,transcript,8399.0
NBEAL1,ENSG00000144426,HbA1c measurement,EFO_0004541,0.3176409994456747,3.176413848058419,1,0.4,0.4,transcript,103799.0
TMEM170B,ENSG00000205269,attention deficit hyperactivity disorder,EFO_0003888,0.31763765656975246,3.1764215550125625,1,0.4,0.4,transcript,8891.0
TMEM170B,ENSG00000205269,autism spectrum disorder,EFO_0003756,0.31763765656975246,3.1764215550125625,1,0.4,0.4,transcript,8891.0
TRMT9B,ENSG00000250305,male infertility,EFO_0004248,0.31757891244397896,3.175930251100968,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
CYSLTR1,ENSG00000173198,lysosomal storage disease,MONDO_0002561,0.3175638962184975,3.1758290988457,2,0.8,1.6,transcript,8415.0
OXSR1,ENSG00000172939,neurodegenerative disease,EFO_0005772,0.3175638962184975,3.175679538366756,1,0.4,0.4,transcript,9858.0
STAU2,ENSG00000040341,Abnormality of the skeletal system,HP_0000924,0.3175513404449196,3.1755249726320662,1,0.5,0.5,transcript,43222.0
AKR1C1,ENSG00000187134,sexual dimorphism measurement,EFO_0021796,0.3175481072052693,3.1756202630052814,2,0.8,1.6,transcript,11495.0
AKR1C1,ENSG00000187134,whole body water mass,EFO_0009805,0.3175481072052693,3.1756202630052814,2,0.8,1.6,transcript,11495.0
SCAMP1,ENSG00000085365,body mass index,EFO_0004340,0.31753356278009703,3.175361974790827,1,0.4,0.4,transcript,15182.0
LRRC7,ENSG00000033122,nephritis,EFO_1002050,0.3175296711410852,3.175360815116403,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
LRRC7,ENSG00000033122,Nephropathy,HP_0000112,0.3175296711410852,3.175360815116403,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
MYO1B,ENSG00000128641,arterial embolism,EFO_0010671,0.3175296711410852,3.1753101198313405,1,0.4,0.4,transcript,29832.0
TRMT9B,ENSG00000250305,artificial cardiac pacemaker,EFO_0009719,0.3175296711410852,3.175437838072031,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
SLCO6A1,ENSG00000205359,placental retention,EFO_0009578,0.3175296711410852,3.175337965536265,1,0.5,0.5,transcript,12120.0
GPM6A,ENSG00000150625,uveitis,EFO_1001231,0.3175296711410852,3.1753148824915773,1,0.4,0.4,transcript,22013.0
CHL1,ENSG00000134121,pulse wave reflection index measurement,EFO_0009804,0.3175296711410852,3.175343911835656,2,0.8,1.6,transcript,33898.0
MGA,ENSG00000174197,total lipids in large VLDL,EFO_0022175,0.31752811882926374,3.1752871100777003,1,0.5,0.5,transcript,84434.0
DCK,ENSG00000156136,HbA1c measurement,EFO_0004541,0.3175241347494723,3.175278333162776,1,0.4,0.4,transcript,10815.0
CENPE,ENSG00000138778,cigarettes per day measurement,EFO_0006525,0.3175201909060465,3.1752276027911948,1,0.5,0.5,transcript,19460.0
FAT3,ENSG00000165323,gestational diabetes,EFO_0004593,0.3175025350852453,3.1750336798477674,1,0.4,0.4,transcript,48025.0
ITPRID2,ENSG00000138434,calcium measurement,EFO_0004838,0.3174902912213809,3.174911699753078,1,0.4,0.4,transcript,45519.0
PPP1R9A,ENSG00000158528,total cholesterol measurement,EFO_0004574,0.31748905035210595,3.174969511664976,3,1.3,3.9000000000000004,transcript,49362.0
PTPN4,ENSG00000088179,thalamus volume,EFO_0006935,0.31748132170082516,3.175276823869633,5,2.0,10.0,transcript,21570.0
GFRAL,ENSG00000187871,placental retention,EFO_0009578,0.31743190820760003,3.174528396571029,1,0.4,0.4,transcript,1911.0
CA8,ENSG00000178538,high density lipoprotein cholesterol measurement,EFO_0004612,0.3174221173415768,3.174262127649412,1,0.4,0.4,transcript,9767.0
SRSF7,ENSG00000115875,platelet count,EFO_0004309,0.3174039052804524,3.174061016345047,1,0.4,0.4,transcript,18212.0
STXBP4,ENSG00000166263,IGF-1 measurement,EFO_0004627,0.3173987878622308,3.1743795900093583,5,2.0,10.0,transcript,25529.0
CA8,ENSG00000178538,aspartate aminotransferase measurement,EFO_0004736,0.31737502424031,3.173791196636744,1,0.4,0.4,transcript,9767.0
PARP8,ENSG00000151883,diabetes mellitus,EFO_0000400,0.317366458999124,3.173711666814732,2,0.8,1.6,transcript,33987.0
CLHC1,ENSG00000162994,neuroimaging measurement,EFO_0004346,0.317335968929176,3.1733849801364737,1,0.4,0.4,transcript,15816.0
C4orf33,ENSG00000151470,mathematical ability,EFO_0004875,0.3173266679250708,3.173717732883804,4,1.6,6.4,transcript,14189.0
HECW2,ENSG00000138411,Red cell distribution width,EFO_0009188,0.31730187861865056,3.173024602337958,1,0.4,0.4,transcript,68774.0
PRDM5,ENSG00000138738,brain volume,OBA_2050009,0.3172740057054697,3.1728206656495885,2,0.8,1.6,transcript,19849.0
RIF1,ENSG00000080345,mean reticulocyte volume,EFO_0010701,0.3172119091958403,3.17218063527543,3,1.3,3.9000000000000004,transcript,63370.0
NCKAP1,ENSG00000061676,blood protein measurement,EFO_0007937,0.3172022363090349,3.1720321923076975,1,0.4,0.4,transcript,40695.0
FYB1,ENSG00000082074,sinusitis,EFO_0007486,0.3171660361588251,3.1716800118142285,1,0.5,0.5,transcript,25445.0
MIOS,ENSG00000164654,Alzheimer disease,MONDO_0004975,0.31714327951059024,3.1717941728585846,4,1.6,6.4,transcript,17710.0
GLCE,ENSG00000138604,mean reticulocyte volume,EFO_0010701,0.3171345113618189,3.1714754386161528,2,0.8,1.6,transcript,12277.0
STARD13,ENSG00000133121,kidney disease,EFO_0003086,0.3171274991380753,3.1712898078418412,1,0.4,0.4,transcript,26997.0
MAP2K6,ENSG00000108984,pulse wave reflection index measurement,EFO_0009804,0.3171274991380753,3.1712922939155743,1,0.4,0.4,transcript,23118.0
PPP1R9A,ENSG00000158528,corneal degeneration,MONDO_0001515,0.3171274991380753,3.1713539995246696,3,1.3,3.9000000000000004,transcript,49362.0
SPART,ENSG00000133104,eye disease,EFO_0003966,0.31711535479753883,3.1711678133106234,1,0.4,0.4,transcript,28040.0
LHX9,ENSG00000143355,carpal tunnel syndrome,EFO_0004143,0.3171133908100321,3.1712081747174765,2,0.8,1.6,transcript,21544.0
KCNJ15,ENSG00000157551,body mass index,EFO_0004340,0.31709067334166047,3.170916567467004,1,0.4,0.4,transcript,40675.0
OTOGL,ENSG00000165899,head and neck malignant neoplasia,EFO_0006859,0.31708098310338245,3.170824688991747,1,0.5,0.5,transcript,33652.0
GPM6A,ENSG00000150625,hemangioma of subcutaneous tissue,EFO_1000707,0.3170733639046216,3.170751810126941,1,0.4,0.4,transcript,22013.0
ZDHHC21,ENSG00000175893,neurodegenerative disease,EFO_0005772,0.3170485747265477,3.170833327779244,4,1.6,6.4,transcript,18413.0
ATRNL1,ENSG00000107518,neurofibrillary tangles measurement,EFO_0006797,0.31704777209940427,3.1704945801359123,1,0.4,0.4,transcript,23726.0
KCNN3,ENSG00000143603,neutrophil count,EFO_0004833,0.3170386420667589,3.170505456477529,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
LDLRAP1,ENSG00000157978,immature platelet measurement,EFO_0803541,0.3170342075754537,3.170367989203617,1,0.4,0.4,transcript,15436.0
ALDOB,ENSG00000136872,triglyceride measurement,EFO_0004530,0.3170177834680498,3.1702192468349657,1,0.4,0.4,transcript,9659.0
SLC22A25,ENSG00000196600,carotene diol (2) measurement,EFO_0800171,0.31701142775926056,3.17014087156907,1,0.4,0.4,transcript,15041.0
CFAP299,ENSG00000197826,vein disorder,MONDO_0004634,0.31700679899799417,3.170133128072698,1,0.5,0.5,transcript,7676.0
CFAP299,ENSG00000197826,lymphatic system disease,EFO_0007352,0.31700679899799417,3.170133128072698,1,0.5,0.5,transcript,7676.0
MGA,ENSG00000174197,Pleural Mesothelioma,EFO_1000485,0.31700248043337564,3.1700307261188194,1,0.5,0.5,transcript,84434.0
LAMA1,ENSG00000101680,amino acid measurement,EFO_0005134,0.31697839429612523,3.1697998381799706,1,0.5,0.5,transcript,31456.0
FAM186A,ENSG00000185958,cardiovascular disease,EFO_0000319,0.3169663307164091,3.1697742087943452,2,1.0,2.0,transcript,18034.0
FAM186A,ENSG00000185958,hypertension,EFO_0000537,0.3169663307164091,3.1697742087943452,2,1.0,2.0,transcript,18034.0
TGFBR1,ENSG00000106799,high density lipoprotein cholesterol measurement,EFO_0004612,0.3169484449655673,3.169488697247819,1,0.4,0.4,transcript,94171.0
WDR12,ENSG00000138442,neuroimaging measurement,EFO_0004346,0.31694002310394764,3.169420170224961,1,0.4,0.4,transcript,20061.0
LRP2,ENSG00000081479,lymphocyte count,EFO_0004587,0.31686448196676487,3.1686614083674267,1,0.5,0.5,transcript,30141.0
SKP2,ENSG00000145604,diastolic blood pressure change measurement,EFO_0006945,0.3168554217872,3.1685592407259855,1,0.4,0.4,transcript,79636.0
MAP1LC3B2,ENSG00000258102,lymphocyte count,EFO_0004587,0.31685378404833053,3.1687040915223745,1,0.4,0.4,transcript,2406.0
GSAP,ENSG00000186088,Phenotypic abnormality,HP_0000118,0.3168348294311121,3.1683738084204234,1,0.5,0.5,transcript,19597.0
ATP8A1,ENSG00000124406,neurodegenerative disease,EFO_0005772,0.31682387136267604,3.168416476590958,4,1.6,6.4,transcript,36003.0
TMEM17,ENSG00000186889,pathological myopia,EFO_0004207,0.3168169758820335,3.1682337588203353,1,0.4,0.4,transcript,6250.0
RNF150,ENSG00000170153,lymphocyte count,EFO_0004587,0.31680256796867257,3.1682843387013966,4,1.6,6.4,transcript,24743.0
NEK1,ENSG00000137601,eye injury,EFO_0009485,0.31680256796867257,3.1680399395550003,2,0.8,1.6,transcript,112203.0
HIPK3,ENSG00000110422,alcohol consumption quality,OBA_1000840,0.31678325730588036,3.1678474065528333,1,0.4,0.4,transcript,26966.0
STAM,ENSG00000136738,body weight,EFO_0004338,0.3167601816328412,3.1676678120386907,1,0.4,0.4,transcript,6061.0
PHIP,ENSG00000146247,mathematical ability,EFO_0004875,0.31670550373812106,3.167063014534643,1,0.5,0.5,transcript,62679.0
BTAF1,ENSG00000095564,adolescent idiopathic scoliosis,EFO_0005423,0.31670126590336944,3.1670494034760974,1,0.4,0.4,transcript,10886.0
ASPM,ENSG00000066279,Intellectual disability,HP_0001249,0.316698775792892,3.1670227562762205,2,0.9,1.8,transcript,51431.0
GFRAL,ENSG00000187871,taste liking measurement,EFO_0010155,0.3166513219714896,3.1667225342099248,1,0.4,0.4,transcript,1911.0
RNF144B,ENSG00000137393,mean corpuscular hemoglobin,EFO_0004527,0.31663625704478504,3.166435443466615,1,0.4,0.4,transcript,5489.0
PDHX,ENSG00000110435,cerebrospinal fluid composition attribute,OBA_2045291,0.3165875536413598,3.1659203041808057,1,0.4,0.4,transcript,8935.0
PDHX,ENSG00000110435,X-12411 measurement,EFO_0800716,0.3165875536413598,3.1659203041808057,1,0.4,0.4,transcript,8935.0
DUSP22,ENSG00000112679,lymphocyte count,EFO_0004587,0.31655166512349925,3.165540255625409,1,0.4,0.4,transcript,16946.0
PLEKHA6,ENSG00000143850,triglyceride measurement,EFO_0004530,0.31652331714900317,3.1652399861483618,1,0.4,0.4,transcript,58697.0
PHIP,ENSG00000146247,high density lipoprotein cholesterol measurement,EFO_0004612,0.3165141570055464,3.165149547208897,1,0.5,0.5,transcript,62679.0
MMP12,ENSG00000262406,coronary artery disease,EFO_0001645,0.31650822595593375,3.1653017985275045,1,0.4,0.4,transcript,1822.0
ACTN2,ENSG00000077522,high density lipoprotein cholesterol measurement,EFO_0004612,0.31650353059485414,3.16505199156033,2,0.8,1.6,transcript,95891.0
ATP12A,ENSG00000075673,blood urea nitrogen measurement,EFO_0004741,0.3165016552830695,3.1650657049565245,1,0.4,0.4,transcript,8138.0
GSAP,ENSG00000186088,deep vein thrombosis,EFO_0003907,0.31647852752788536,3.1648107893881563,1,0.5,0.5,transcript,19597.0
BTAF1,ENSG00000095564,cigarettes per day measurement,EFO_0006525,0.31644071447308086,3.1644438891732114,1,0.4,0.4,transcript,10886.0
GFPT1,ENSG00000198380,cervical disc degenerative disorder,EFO_0009537,0.31636866755277654,3.1637017795567655,1,0.4,0.4,transcript,26483.0
GFPT1,ENSG00000198380,spondyloarthropathy,EFO_0000706,0.31636866755277654,3.1637017795567655,1,0.4,0.4,transcript,26483.0
DMAC1,ENSG00000137038,hemolytic anemia,EFO_0005558,0.31632984138338105,3.163413987367471,1,0.4,0.4,transcript,3461.0
SEC22A,ENSG00000121542,pyruvate measurement,EFO_0010117,0.3163285291032037,3.163407325964536,2,0.8,1.6,transcript,13111.0
CFAP299,ENSG00000197826,eye disease,EFO_0003966,0.31631653576970314,3.163230495789788,1,0.5,0.5,transcript,7676.0
RPS20,ENSG00000008988,IGF-1 measurement,EFO_0004627,0.31628918117342797,3.162909021216705,1,0.4,0.4,transcript,23243.0
FANCF,ENSG00000183161,smoking status measurement,EFO_0006527,0.3162717542673577,3.162839086277345,1,0.4,0.4,transcript,3291.0
NDFIP2,ENSG00000102471,smoking behavior,EFO_0004318,0.3162241178171204,3.1622556600371925,2,0.8,1.6,transcript,110483.0
ARHGAP28,ENSG00000088756,N-acetylvaline measurement,EFO_0800117,0.3161934193042357,3.161946494678475,1,0.4,0.4,transcript,32516.0
RFX3,ENSG00000080298,serum creatinine amount,OBA_2050096,0.31618939623281433,3.16195046349348,2,0.8,1.6,transcript,28318.0
LHX9,ENSG00000143355,platelet volume,OBA_0003277,0.31617738605682,3.1618481271853556,2,0.8,1.6,transcript,21544.0
KCNJ15,ENSG00000157551,self reported educational attainment,EFO_0004784,0.31612962997885663,3.161306133838966,1,0.4,0.4,transcript,40675.0
KCNJ15,ENSG00000157551,educational attainment,EFO_0011015,0.31612962997885663,3.161306133838966,1,0.4,0.4,transcript,40675.0
ZNF471,ENSG00000196263,neurodegenerative disease,EFO_0005772,0.31608471522621784,3.1608773911493873,1,0.4,0.4,transcript,13228.0
FAM186A,ENSG00000185958,Increased blood pressure,HP_0032263,0.31608235778382415,3.1609344794684953,2,1.0,2.0,transcript,18034.0
WWTR1,ENSG00000018408,squamous cell lung carcinoma,EFO_0000708,0.3160608690564188,3.160693526195153,2,0.8,1.6,transcript,18860.0
QSER1,ENSG00000060749,major depressive disorder,MONDO_0002009,0.31604843767474694,3.160511051950201,1,0.5,0.5,transcript,18744.0
NID2,ENSG00000087303,able to hear with hearing aids,EFO_0009720,0.316036756839109,3.160412702891902,1,0.5,0.5,transcript,11078.0
SI,ENSG00000090402,triglyceride measurement,EFO_0004530,0.3160304151509682,3.1603761976191924,1,0.5,0.5,transcript,6940.0
THEM4,ENSG00000159445,3-hydroxyoctanoate measurement,EFO_0800193,0.3160221422435888,3.1603757731979947,2,0.8,1.6,transcript,10366.0
CAVIN2,ENSG00000168497,immature platelet count,EFO_0803544,0.31600845115684467,3.160215487337929,1,0.4,0.4,transcript,3054.0
CAVIN2,ENSG00000168497,immature platelet measurement,EFO_0803541,0.31600845115684467,3.160215487337929,1,0.4,0.4,transcript,3054.0
MUC16,ENSG00000181143,squamous cell lung carcinoma,EFO_0000708,0.3159924270298629,3.1599270906480137,1,0.5,0.5,transcript,177283.0
TFEC,ENSG00000105967,platelet component distribution width,EFO_0007984,0.31599123466799545,3.15992804403495,1,0.4,0.4,transcript,25482.0
QSER1,ENSG00000060749,cerebral cortex area attribute,OBA_2045267,0.3159653406835298,3.15968008203803,1,0.5,0.5,transcript,18744.0
VPS50,ENSG00000004766,macular degeneration,EFO_0009606,0.3159490716108705,3.159501878068745,1,0.4,0.4,transcript,35836.0
MFAP3,ENSG00000037749,lean body mass,EFO_0004995,0.3159406877265824,3.159419466967448,1,0.4,0.4,transcript,31772.0
PPFIBP2,ENSG00000166387,health study participation,EFO_0010130,0.31592656548376075,3.1592793377230546,1,0.5,0.5,transcript,36542.0
CDH19,ENSG00000071991,arterial stiffness measurement,EFO_0004517,0.31591860670635447,3.1594606247206527,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
SMIM36,ENSG00000261873,placenta praevia,EFO_0007442,0.3159047018007765,3.1592285885933302,1,0.4,0.4,transcript,2203.0
TRIM36,ENSG00000152503,educational attainment,EFO_0011015,0.3159018064880907,3.1590442257703772,1,0.4,0.4,transcript,15290.0
KYNU,ENSG00000115919,body mass index,EFO_0004340,0.3159017526345151,3.15917577505938,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
TNPO3,ENSG00000064419,aspartate aminotransferase measurement,EFO_0004736,0.31589076436272473,3.1589343159840166,1,0.5,0.5,transcript,18746.0
MRPL32,ENSG00000106591,HbA1c measurement,EFO_0004541,0.3158624626434256,3.158707769232011,1,0.4,0.4,transcript,4811.0
SLC22A24,ENSG00000197658,X-12844 measurement,EFO_0021339,0.3158620172048857,3.158705467169976,1,0.5,0.5,transcript,5862.0
PAFAH1B2,ENSG00000168092,triglycerides in LDL measurement ,EFO_0022320,0.3158530134391518,3.1586639248422244,2,0.8,1.6,transcript,11959.0
PAFAH1B2,ENSG00000168092,phospholipids in medium VLDL measurement,EFO_0022154,0.3158530134391518,3.1586639248422244,2,0.8,1.6,transcript,11959.0
PAFAH1B2,ENSG00000168092,apolipoprotein B to apolipoprotein A1 ratio ,EFO_0021897,0.3158530134391518,3.1586639248422244,2,0.8,1.6,transcript,11959.0
PAFAH1B2,ENSG00000168092,phospholipids in small VLDL measurement,EFO_0022146,0.3158530134391518,3.1586639248422244,2,0.8,1.6,transcript,11959.0
PAFAH1B2,ENSG00000168092,triglycerides in IDL measurement,EFO_0022149,0.3158530134391518,3.1586639248422244,2,0.8,1.6,transcript,11959.0
PAFAH1B2,ENSG00000168092,cholesterol to total lipids in IDL percentage ,EFO_0022233,0.3158530134391518,3.1586639248422244,2,0.8,1.6,transcript,11959.0
CD69,ENSG00000110848,lymphocyte:monocyte ratio,EFO_0600088,0.3158530134391518,3.159374610112841,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
SULT6B1,ENSG00000138068,Right bundle branch block,HP_0011712,0.3158530134391518,3.158643230976001,1,0.5,0.5,transcript,4421.0
RIF1,ENSG00000080345,liver disease,EFO_0001421,0.31584013412685,3.158462884585527,3,1.3,3.9000000000000004,transcript,63370.0
RIF1,ENSG00000080345,preeclampsia,EFO_0000668,0.31584013412685,3.158462884585527,3,1.3,3.9000000000000004,transcript,63370.0
STXBP4,ENSG00000166263,clonal hematopoiesis,EFO_0010819,0.3157838677622185,3.158230389009235,5,2.0,10.0,transcript,25529.0
TMEM17,ENSG00000186889,sexual activity behaviour attribute,OBA_2045293,0.315775106396711,3.15781506396711,1,0.4,0.4,transcript,6250.0
LRPAP1,ENSG00000163956,free cholesterol measurement,EFO_0008591,0.3157595548751019,3.1578261849224583,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
OTULINL,ENSG00000145569,growth differentiation factor 15 amount,OBA_2050135,0.3157513142599454,3.1575631176119474,1,0.4,0.4,transcript,8004.0
TECRL,ENSG00000205678,serum creatinine amount,OBA_2050096,0.3157513142599454,3.1579159172694022,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
MRPL32,ENSG00000106591,placenta praevia,EFO_0007442,0.31574767188041325,3.1575598616018876,1,0.4,0.4,transcript,4811.0
C18orf54,ENSG00000166845,corneal resistance factor,EFO_0010067,0.31574767188041325,3.1575621934555564,2,0.8,1.6,transcript,18719.0
NMRK1,ENSG00000106733,bone tissue density,OBA_1000110,0.31574767188041325,3.15752269053152,1,0.4,0.4,transcript,8701.0
APOBEC3H,ENSG00000100298,appendicular lean mass,EFO_0004980,0.3157392435691266,3.157469020029769,1,0.4,0.4,transcript,5223.0
DYNC1I2,ENSG00000077380,smoking initiation,EFO_0005670,0.3157213051171349,3.157224238105011,1,0.4,0.4,transcript,35756.0
PPP1R3G,ENSG00000219607,neuroinflammatory disorder,EFO_0020092,0.315715131798622,3.1572477732550888,1,0.4,0.4,transcript,4147.0
MAN1A2,ENSG00000198162,diet measurement,EFO_0008111,0.3157148770672294,3.157276291195128,2,0.8,1.6,transcript,12547.0
MC2R,ENSG00000185231,lymphocyte count,EFO_0004587,0.3156824219656734,3.1569188270361095,1,0.4,0.4,transcript,4228.0
SENP6,ENSG00000112701,osteoarthritis,MONDO_0005178,0.3156683388776861,3.157112405937547,5,2.2,11.0,transcript,25640.0
SLCO1C1,ENSG00000139155,vein disorder,MONDO_0004634,0.31565409808129724,3.156571871706337,1,0.5,0.5,transcript,16186.0
SLCO1C1,ENSG00000139155,lymphatic system disease,EFO_0007352,0.31565409808129724,3.156571871706337,1,0.5,0.5,transcript,16186.0
MSX2,ENSG00000120149,lymphocyte count,EFO_0004587,0.31564654251935415,3.1565836634436155,1,0.4,0.4,transcript,3383.0
XKR4,ENSG00000206579,bilirubin measurement,EFO_0004570,0.3156213973743978,3.1562329257007677,1,0.4,0.4,transcript,21106.0
KCNIP4,ENSG00000185774,growth differentiation factor 15 amount,OBA_2050135,0.3156213973743978,3.1563466217293867,2,0.8,1.6,transcript,12062.0
LIN54,ENSG00000189308,aortic measurement,EFO_0020865,0.31557768247049683,3.155789751282011,1,0.4,0.4,transcript,30944.0
SLCO5A1,ENSG00000137571,lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement,EFO_0800429,0.3155459988491834,3.155890540459456,5,2.0,10.0,transcript,23226.0
LAMA1,ENSG00000101680,erythrocyte volume,OBA_0003460,0.3155415286826752,3.1554311820454704,1,0.5,0.5,transcript,31456.0
TC2N,ENSG00000165929,Thromboembolism,HP_0001907,0.3155120840208721,3.155143604991602,1,0.4,0.4,transcript,17571.0
PCMTD1,ENSG00000168300,eosinophil count,EFO_0004842,0.31549211963829993,3.1551260444540135,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
CAV2,ENSG00000105971,heart rate response to recovery post exercise,EFO_0009185,0.3154660504831598,3.154684678397803,1,0.4,0.4,transcript,16547.0
ATRNL1,ENSG00000107518,metabolite measurement,EFO_0004725,0.3154592384580769,3.1546092437226387,1,0.4,0.4,transcript,23726.0
CSMD3,ENSG00000164796,alcohol consumption quality,OBA_1000840,0.3154592384580769,3.1546004933025102,1,0.5,0.5,transcript,61662.0
SLAIN2,ENSG00000109171,arterial stiffness measurement,EFO_0004517,0.315446641360144,3.1546021563688957,2,0.8,1.6,transcript,11787.0
VPS50,ENSG00000004766,placenta praevia,EFO_0007442,0.315446641360144,3.1544775755614802,1,0.4,0.4,transcript,35836.0
TTLL7,ENSG00000137941,smoking initiation,EFO_0005670,0.31543252091847124,3.154354182619694,2,0.8,1.6,transcript,55223.0
RASGRP3,ENSG00000152689,albumin:globulin ratio measurement,EFO_0005128,0.31541780511978146,3.1541892541105723,1,0.4,0.4,transcript,35705.0
PTBP3,ENSG00000119314,erythrocyte count,EFO_0004305,0.31540163568884977,3.1542497944906267,5,2.0,10.0,transcript,42838.0
ONECUT1,ENSG00000169856,HbA1c measurement,EFO_0004541,0.3153988644563803,3.1540414917034516,1,0.4,0.4,transcript,7569.0
TOPAZ1,ENSG00000173769,body weight,EFO_0004338,0.3153988644563803,3.154082382846518,1,0.5,0.5,transcript,5334.0
TRIM36,ENSG00000152503,facial pain,EFO_0009625,0.3153988644563803,3.1540148054532735,1,0.4,0.4,transcript,15290.0
DENND3,ENSG00000105339,humerus fracture,EFO_0003943,0.31539744559983574,3.15398527265601,1,0.5,0.5,transcript,46225.0
OTOGL,ENSG00000165899,facial morphology,EFO_0004743,0.3153769316194299,3.1537841741522215,1,0.5,0.5,transcript,33652.0
ZNF28,ENSG00000198538,neurodegenerative disease,EFO_0005772,0.3153291786167344,3.153546383055604,3,1.2000000000000002,3.6000000000000005,transcript,14140.0
ATP10D,ENSG00000145246,Parkinson disease,MONDO_0005180,0.3152895006835503,3.1529268296460935,1,0.5,0.5,transcript,15712.0
CD2AP,ENSG00000198087,wellbeing measurement,EFO_0007869,0.31528212647356507,3.152873334509147,1,0.4,0.4,transcript,7682.0
GPAT3,ENSG00000138678,eosinophil measurement,EFO_0803540,0.3152788365171696,3.1529354916084773,2,0.8,1.6,transcript,10875.0
BCAS2,ENSG00000116752,neurodegenerative disease,EFO_0005772,0.3152141017652528,3.1523256898593606,1,0.4,0.4,transcript,2166.0
MTMR6,ENSG00000139505,protein measurement,EFO_0004747,0.3151892914666321,3.151946539719946,1,0.5,0.5,transcript,9324.0
MTMR6,ENSG00000139505,mean corpuscular hemoglobin concentration,EFO_0004528,0.3151892914666321,3.151946539719946,1,0.5,0.5,transcript,9324.0
ATP9A,ENSG00000054793,vital capacity,EFO_0004312,0.31518083513999123,3.151833717624784,1,0.4,0.4,transcript,15769.0
ZFP1,ENSG00000184517,eosinophil percentage of leukocytes,EFO_0007991,0.31517000062739436,3.151728358981627,1,0.4,0.4,transcript,14108.0
TTL,ENSG00000114999,serum alanine aminotransferase measurement,EFO_0004735,0.3151620767431123,3.1516405361372613,1,0.4,0.4,transcript,20234.0
FRS2,ENSG00000166225,hemoglobin measurement,EFO_0004509,0.31515811098667146,3.1515972187628525,1,0.4,0.4,transcript,24831.0
TRIM36,ENSG00000152503,mean arterial pressure,EFO_0006340,0.31515167071953126,3.151542868084783,1,0.4,0.4,transcript,15290.0
QSER1,ENSG00000060749,metabolite measurement,EFO_0004725,0.3151286628601698,3.151313303804429,1,0.5,0.5,transcript,18744.0
SERPINB9,ENSG00000170542,infectious mononucleosis,EFO_0007326,0.31510810596156896,3.1511287752306245,1,0.4,0.4,transcript,8383.0
ULK4,ENSG00000168038,urinary microalbumin measurement,EFO_0010967,0.3150996313189904,3.1510372732947616,1,0.5,0.5,transcript,12207.0
ATRNL1,ENSG00000107518,serum alanine aminotransferase measurement,EFO_0004735,0.3150996313189904,3.1510131723317736,1,0.4,0.4,transcript,23726.0
DLG2,ENSG00000150672,osteonecrosis,EFO_0004259,0.3150996313189904,3.1509990861150627,1,0.4,0.4,transcript,144252.0
DLG2,ENSG00000150672,idiopathic pulmonary fibrosis,EFO_0000768,0.3150996313189904,3.1509990861150627,1,0.4,0.4,transcript,144252.0
ATRNL1,ENSG00000107518,bone tissue density,OBA_1000110,0.3150996313189904,3.1510131723317736,1,0.4,0.4,transcript,23726.0
DLG2,ENSG00000150672,aortic valve stenosis,MONDO_0042981,0.3150996313189904,3.1509990861150627,1,0.4,0.4,transcript,144252.0
KCNIP4,ENSG00000185774,knee fracture,EFO_0009617,0.3150996313189904,3.1511289611753126,2,0.8,1.6,transcript,12062.0
KCNIP4,ENSG00000185774,fungal infectious disease,MONDO_0002041,0.3150996313189904,3.1511289611753126,2,0.8,1.6,transcript,12062.0
ZFP90,ENSG00000184939,ulcerative colitis,EFO_0000729,0.31504860315800526,3.1504993867267923,1,0.4,0.4,transcript,29951.0
GSTA5,ENSG00000182793,hemoglobin measurement,EFO_0004509,0.31503663015037137,3.150716441559736,1,0.5,0.5,transcript,1428.0
ASTN2,ENSG00000148219,alcohol consumption quality,OBA_1000840,0.31503105015307653,3.150369255937346,2,0.8,1.6,transcript,27232.0
BACH1,ENSG00000156273,body mass index,EFO_0004340,0.314991399353281,3.1502718553086995,4,1.6,6.4,transcript,17884.0
SLC25A46,ENSG00000164209,information processing speed,EFO_0004363,0.3149831218810298,3.149851171920489,1,0.4,0.4,transcript,20047.0
ARHGAP12,ENSG00000165322,heart rate,OBA_1001087,0.3149783592183596,3.1497956545460095,1,0.4,0.4,transcript,33161.0
ANKRD36,ENSG00000135976,blood protein measurement,EFO_0007937,0.31497115202224085,3.149786906577478,2,1.0,2.0,transcript,26530.0
PDP1,ENSG00000164951,COVID-19,MONDO_0100096,0.31496729723240446,3.1496963395398407,1,0.4,0.4,transcript,17118.0
SLC25A36,ENSG00000114120,X-25433 measurement,EFO_0800928,0.3149653567879041,3.1496672346823757,1,0.4,0.4,transcript,29268.0
TSPAN3,ENSG00000140391,appendicular lean mass,EFO_0004980,0.3149652042411177,3.1496739530159097,1,0.4,0.4,transcript,18256.0
AGBL3,ENSG00000146856,response to antihypertensive drug,EFO_0005405,0.314963834279143,3.1496742959085653,1,0.5,0.5,transcript,13907.0
DOK5,ENSG00000101134,neuroimaging measurement,EFO_0004346,0.3149480455089361,3.149568289959805,1,0.4,0.4,transcript,4554.0
RANBP17,ENSG00000204764,aspartate aminotransferase measurement,EFO_0004736,0.31489122377140477,3.1489217520092763,1,0.4,0.4,transcript,42042.0
SEC22A,ENSG00000121542,type 2 diabetes mellitus,MONDO_0005148,0.31486027067935657,3.148724741726065,2,0.8,1.6,transcript,13111.0
GPM6A,ENSG00000150625,complex regional pain syndrome,EFO_1001998,0.31483940505789715,3.1484122216596964,1,0.4,0.4,transcript,22013.0
BMPR2,ENSG00000204217,mean corpuscular hemoglobin concentration,EFO_0004528,0.3148387776951925,3.1484055484109614,1,0.4,0.4,transcript,22508.0
ANKH,ENSG00000154122,dislocation,EFO_0009521,0.31483368162103786,3.1491052588333295,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,dislocation,EFO_0009521,0.31483368162103786,3.1491052588333295,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,dislocation,EFO_0009521,0.31483368162103786,3.1491052588333295,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,dislocation,EFO_0009521,0.31483368162103786,3.1491052588333295,5,2.4,12.0,transcript,15616.0
MFAP3,ENSG00000037749,pain measurement,EFO_0010639,0.31475615232797266,3.1475741129813506,1,0.4,0.4,transcript,31772.0
RASGRP3,ENSG00000152689,"osteoarthritis, hip",EFO_1000786,0.31473126035347976,3.147323806447555,1,0.4,0.4,transcript,35705.0
TRIM44,ENSG00000166326,autosomal dominant compelling helio-ophthalmic outburst syndrome,EFO_0007887,0.3147185495835195,3.1472148407108467,1,0.4,0.4,transcript,13631.0
SLC25A36,ENSG00000114120,N2-methylguanosine measurement,EFO_0800634,0.3146962433923874,3.146976100727209,1,0.4,0.4,transcript,29268.0
SFRP1,ENSG00000104332,FEV/FVC ratio,EFO_0004713,0.3146802311586176,3.1468502904754647,1,0.4,0.4,transcript,8337.0
FAM102B,ENSG00000162636,apolipoprotein B measurement,EFO_0004615,0.31465600111036063,3.1465858142257837,1,0.4,0.4,transcript,15502.0
SKIL,ENSG00000136603,arterial stiffness measurement,EFO_0004517,0.31465600111036063,3.1465764709251816,1,0.5,0.5,transcript,30377.0
SLC22A24,ENSG00000197658,"4-androsten-3alpha,17alpha-diol monosulfate (3) measurement",EFO_0022090,0.31465600111036063,3.146645306224725,1,0.5,0.5,transcript,5862.0
ABCA10,ENSG00000154263,total lipids in medium LDL,EFO_0022180,0.31465600111036063,3.146659947255509,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
ABCA10,ENSG00000154263,cholesterol in medium LDL measurement ,EFO_0022224,0.31465600111036063,3.146659947255509,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
CAPN7,ENSG00000131375,Hypercholesterolemia,HP_0003124,0.31465600111036063,3.1465986584466012,1,0.4,0.4,transcript,10350.0
SECISBP2L,ENSG00000138593,liver disease,EFO_0001421,0.31465600111036063,3.1465790950730717,1,0.4,0.4,transcript,20960.0
CENPQ,ENSG00000031691,stroke,EFO_0000712,0.31465288444535744,3.146758597469083,1,0.4,0.4,transcript,1741.0
CCDC34,ENSG00000109881,trunk bone mineral density,EFO_0020105,0.31465189887176137,3.146612512215393,1,0.4,0.4,transcript,4277.0
TXNL1,ENSG00000091164,musculoskeletal system disease,EFO_0009676,0.31460448979878586,3.1461270968062505,2,0.8,1.6,transcript,19465.0
CCDC88C,ENSG00000015133,caudate nucleus volume,EFO_0004830,0.3145938154421295,3.145957477159327,1,0.4,0.4,transcript,20701.0
ATAD2B,ENSG00000119778,hemoglobin measurement,EFO_0004509,0.3145609401378389,3.1456275790652786,1,0.4,0.4,transcript,22005.0
ARSJ,ENSG00000180801,smoking initiation,EFO_0005670,0.31453683755350276,3.1455466087978103,2,0.8,1.6,transcript,8977.0
ABCA13,ENSG00000179869,erythrocyte volume,OBA_0003460,0.3145174521219081,3.1451848530784026,1,0.5,0.5,transcript,48394.0
HFM1,ENSG00000162669,limb injury,EFO_0009509,0.31450073642569326,3.145137200663061,2,1.0,2.0,transcript,15404.0
FRS2,ENSG00000166225,appendicular lean mass,EFO_0004980,0.31449817280772435,3.1449978369733813,1,0.4,0.4,transcript,24831.0
KLHDC10,ENSG00000128607,Hypercholesterolemia,HP_0003124,0.3144272416815359,3.1443221495021674,1,0.4,0.4,transcript,8043.0
GKAP1,ENSG00000165113,omega-6 polyunsaturated fatty acid measurement,EFO_0005680,0.3143975491541898,3.1440326180771736,1,0.4,0.4,transcript,7002.0
AKR1C1,ENSG00000187134,bone tissue density,OBA_1000110,0.3143954147163465,3.1440933381160536,2,0.8,1.6,transcript,11495.0
NEU3,ENSG00000162139,level of chordin-like protein 2 in blood serum,OBA_2041016,0.3143954147163465,3.143986457341171,1,0.4,0.4,transcript,12380.0
LDLRAP1,ENSG00000157978,immature platelet count,EFO_0803544,0.31438175251578204,3.1438434386069005,1,0.4,0.4,transcript,15436.0
ROCK2,ENSG00000134318,body mass index,EFO_0004340,0.31436205904011455,3.1436315840028692,1,0.5,0.5,transcript,45481.0
TBXT,ENSG00000164458,smoking initiation,EFO_0005670,0.31432838176228933,3.1437442934479125,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
TRHDE,ENSG00000072657,attention deficit hyperactivity disorder,EFO_0003888,0.314313108748845,3.1432306580902294,2,0.8,1.6,transcript,16069.0
TRHDE,ENSG00000072657,substance abuse,MONDO_0002491,0.314313108748845,3.1432306580902294,2,0.8,1.6,transcript,16069.0
TRHDE,ENSG00000072657,social inhibition quality,OBA_1000278,0.314313108748845,3.1432306580902294,2,0.8,1.6,transcript,16069.0
NEDD1,ENSG00000139350,histidine measurement,EFO_0009769,0.3143050176914515,3.1430694336062155,1,0.4,0.4,transcript,20772.0
PRKCB,ENSG00000166501,hypertension,EFO_0000537,0.3142696888537386,3.1427208549843604,1,0.4,0.4,transcript,16690.0
LRP2,ENSG00000081479,pulse wave reflection index measurement,EFO_0009804,0.3142519259608346,3.1425358483081243,1,0.5,0.5,transcript,30141.0
PPDPFL,ENSG00000168333,monocyte percentage of leukocytes,EFO_0007989,0.3142427173500951,3.1427525751686347,2,0.8,1.6,transcript,4917.0
ATXN3,ENSG00000066427,body weight,EFO_0004338,0.31422590541392814,3.142264777336832,1,0.4,0.4,transcript,69891.0
KLHDC10,ENSG00000128607,Red cell distribution width,EFO_0009188,0.3142208328932235,3.142258061619043,1,0.4,0.4,transcript,8043.0
LATS1,ENSG00000131023,cerebrospinal fluid composition attribute,OBA_2045291,0.31421461623132424,3.142163518904408,1,0.4,0.4,transcript,23046.0
PIP4K2A,ENSG00000150867,acute lymphoblastic leukemia,EFO_0000220,0.31421426978035855,3.142186143008321,1,0.4,0.4,transcript,9207.0
C4orf33,ENSG00000151470,tricuspid valve disease,EFO_0009568,0.3141152238647154,3.14160329228025,4,1.6,6.4,transcript,14189.0
QSOX1,ENSG00000116260,cystatin C measurement,EFO_0004617,0.31407978262162745,3.1408268896472125,1,0.4,0.4,transcript,13763.0
OTOGL,ENSG00000165899,metabolite measurement,EFO_0004725,0.31403102309576936,3.1403250889156156,1,0.5,0.5,transcript,33652.0
METTL8,ENSG00000123600,body height,OBA_VT0001253,0.3138733600989543,3.138745622026357,1,0.4,0.4,transcript,33275.0
TLR10,ENSG00000174123,arterial stiffness measurement,EFO_0004517,0.3138670045056227,3.1388314872733667,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
PCNX4,ENSG00000126773,preeclampsia,EFO_0000668,0.3138670045056227,3.138679709132921,1,0.5,0.5,transcript,51738.0
DCK,ENSG00000156136,aspartate aminotransferase measurement,EFO_0004736,0.31382734245454114,3.1383104102134647,1,0.4,0.4,transcript,10815.0
BIRC6,ENSG00000115760,diffuse large B-cell lymphoma,EFO_0000403,0.31381778122671844,3.1381849945241367,1,0.5,0.5,transcript,69616.0
PARP11,ENSG00000111224,parathyroid disease,EFO_0005754,0.3138112059146497,3.138130007634337,1,0.4,0.4,transcript,22286.0
SENP6,ENSG00000112701,smoking initiation,EFO_0005670,0.31377415120952606,3.1381705292559468,5,2.2,11.0,transcript,25640.0
MARCKS,ENSG00000277443,Alzheimer disease,MONDO_0004975,0.31376642496333607,3.137757359503007,1,0.4,0.4,transcript,4296.0
MCF2L2,ENSG00000053524,mean corpuscular hemoglobin concentration,EFO_0004528,0.3137542655236817,3.137584104940192,2,0.8,1.6,transcript,38601.0
NPS,ENSG00000214285,ovarian neoplasm,EFO_0003893,0.31375105684834037,3.137835507557327,1,0.4,0.4,transcript,1231.0
GFPT1,ENSG00000198380,vital capacity,EFO_0004312,0.3137186994559763,3.137202098588763,1,0.4,0.4,transcript,26483.0
ATP10D,ENSG00000145246,lagophthalmos,MONDO_0001604,0.31367544870333136,3.136786309843904,1,0.5,0.5,transcript,15712.0
ATP10D,ENSG00000145246,vascular disease,EFO_0004264,0.31367544870333136,3.136786309843904,1,0.5,0.5,transcript,15712.0
MAP2K6,ENSG00000108984,urinary microalbumin measurement,EFO_0010967,0.31367544870333136,3.136771789568135,1,0.4,0.4,transcript,23118.0
SLCO6A1,ENSG00000205359,arterial stiffness measurement,EFO_0004517,0.31367544870333136,3.136795741158726,1,0.5,0.5,transcript,12120.0
SLC25A36,ENSG00000114120,myotonic syndrome,MONDO_0016120,0.3136655064583035,3.13666873138637,1,0.4,0.4,transcript,29268.0
DGKH,ENSG00000102780,adolescent idiopathic scoliosis,EFO_0005423,0.313657204898803,3.1365994420267738,2,0.8,1.6,transcript,58409.0
PTBP3,ENSG00000119314,body mass index,EFO_0004340,0.3135950338630345,3.136183776232474,5,2.0,10.0,transcript,42838.0
ZFP90,ENSG00000184939,cystatin C measurement,EFO_0004617,0.3135552902846428,3.1355662579931676,1,0.4,0.4,transcript,29951.0
MFAP3,ENSG00000037749,heart rate,OBA_1001087,0.3135456024790765,3.1354686144923885,1,0.4,0.4,transcript,31772.0
LONRF1,ENSG00000154359,BMI-adjusted waist-hip ratio,EFO_0007788,0.31354381987864843,3.135473492073701,1,0.5,0.5,transcript,14167.0
DAG1,ENSG00000173402,vitamin D measurement,EFO_0004631,0.31353554672401013,3.1353616553589134,1,0.4,0.4,transcript,64640.0
CSMD3,ENSG00000164796,diastolic blood pressure,EFO_0006336,0.31345862406048913,3.1345943493266324,1,0.5,0.5,transcript,61662.0
CD2AP,ENSG00000198087,bone tissue density,OBA_1000110,0.31340582799772515,3.134110349750748,1,0.4,0.4,transcript,7682.0
SLC5A7,ENSG00000115665,body height,OBA_VT0001253,0.3133718491163249,3.1337740544359254,1,0.4,0.4,transcript,7199.0
CSMD3,ENSG00000164796,growth differentiation factor 15 amount,OBA_2050135,0.3133511075654677,3.133519184376418,1,0.5,0.5,transcript,61662.0
THEM4,ENSG00000159445,eicosanoids measurement,EFO_0020044,0.31333141353000543,3.133468486062161,2,0.8,1.6,transcript,10366.0
STAM,ENSG00000136738,body mass index,EFO_0004340,0.31332620134235273,3.1333280091338063,1,0.4,0.4,transcript,6061.0
MCL1,ENSG00000143384,mean corpuscular hemoglobin,EFO_0004527,0.31330373627312474,3.1330541321103613,1,0.4,0.4,transcript,23853.0
AKAP10,ENSG00000108599,Red cell distribution width,EFO_0009188,0.31329832602554425,3.133018440554475,1,0.4,0.4,transcript,11370.0
MAP2K6,ENSG00000108984,eye color,EFO_0003949,0.3132736362003122,3.132753664537943,1,0.4,0.4,transcript,23118.0
ROCK2,ENSG00000134318,strand of hair color,OBA_0002313,0.31325009435173445,3.132511937119068,1,0.5,0.5,transcript,45481.0
SFRP1,ENSG00000104332,knee fracture,EFO_0009617,0.3132480568853606,3.132528547742895,1,0.4,0.4,transcript,8337.0
DGKH,ENSG00000102780,biliary tract disease,EFO_0009534,0.3132480568853606,3.13250796189235,2,0.8,1.6,transcript,58409.0
DLG1,ENSG00000075711,brain attribute,OBA_2045210,0.31320242167570145,3.1320396265285217,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
BMPR2,ENSG00000204217,total cholesterol measurement,EFO_0004574,0.313201095451538,3.132028725974417,1,0.4,0.4,transcript,22508.0
APIP,ENSG00000149089,X-12411 measurement,EFO_0800716,0.3131911586408895,3.1319843560203053,1,0.5,0.5,transcript,6871.0
APIP,ENSG00000149089,cerebrospinal fluid composition attribute,OBA_2045291,0.3131911586408895,3.1319843560203053,1,0.5,0.5,transcript,6871.0
TRDMT1,ENSG00000107614,triglyceride measurement,EFO_0004530,0.3131811170773045,3.131824962449768,1,0.4,0.4,transcript,29003.0
ZNF507,ENSG00000168813,risk-taking behaviour,EFO_0008579,0.31317051693673664,3.1317195682154586,1,0.4,0.4,transcript,27780.0
TTLL7,ENSG00000137941,spondylolisthesis,EFO_0007493,0.3131323611821768,3.13135258525675,2,0.8,1.6,transcript,55223.0
INF2,ENSG00000203485,diet measurement,EFO_0008111,0.3131316093434156,3.1313191563151017,1,0.4,0.4,transcript,130596.0
SGCZ,ENSG00000185053,neuroticism measurement,EFO_0007660,0.31311744994582746,3.131223208664314,1,0.4,0.4,transcript,8212.0
CENPQ,ENSG00000031691,aspartate aminotransferase measurement,EFO_0004736,0.3131094773243635,3.131324526259143,1,0.4,0.4,transcript,1741.0
EPRS1,ENSG00000136628,triglyceride measurement,EFO_0004530,0.3130933316628505,3.130978031348591,1,0.5,0.5,transcript,11182.0
MLLT3,ENSG00000171843,aging rate,OBA_0005494,0.31308590449469964,3.130962284074626,2,0.8,1.6,transcript,15498.0
TECRL,ENSG00000205678,eosinophil count,EFO_0004842,0.31304970012110245,3.1308997758809727,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
CHL1,ENSG00000134121,risk-taking behaviour,EFO_0008579,0.3130481699031641,3.130528899456445,2,0.8,1.6,transcript,33898.0
CPA4,ENSG00000128510,blood protein measurement,EFO_0007937,0.31299813919564323,3.130023338265157,1,0.5,0.5,transcript,11920.0
GPR85,ENSG00000164604,placenta praevia,EFO_0007442,0.3129803380298782,3.129826927717396,1,0.4,0.4,transcript,16987.0
CYTL1,ENSG00000170891,triglycerides to total lipids in very large HDL percentage ,EFO_0022339,0.3129803380298782,3.1300223184487543,1,0.4,0.4,transcript,1827.0
RGS4,ENSG00000117152,systemic lupus erythematosus,MONDO_0007915,0.3129803380298782,3.129899649853535,2,0.8,1.6,transcript,16620.0
TENM4,ENSG00000149256,protein measurement,EFO_0004747,0.3129662533287806,3.1296799837720566,1,0.4,0.4,transcript,22922.0
MEOX2,ENSG00000106511,blood protein measurement,EFO_0007937,0.31293992000030024,3.129567905190687,1,0.4,0.4,transcript,2371.0
ABCA13,ENSG00000179869,alopecia areata,EFO_0004192,0.31293317336827564,3.129342065542078,1,0.5,0.5,transcript,48394.0
MARCKS,ENSG00000277443,vital capacity,EFO_0004312,0.3129268125249816,3.1293612351194624,1,0.4,0.4,transcript,4296.0
RBM18,ENSG00000119446,level of protein AMBP in blood serum,OBA_2040579,0.31291822294041133,3.129243957799175,1,0.4,0.4,transcript,6480.0
BMPR2,ENSG00000204217,IGF-1 measurement,EFO_0004627,0.31291514939695353,3.129169265428572,1,0.4,0.4,transcript,22508.0
XKR4,ENSG00000206579,Red cell distribution width,EFO_0009188,0.3128738230206469,3.128757182163259,1,0.4,0.4,transcript,21106.0
TRHDE,ENSG00000072657,lymphocyte count,EFO_0004587,0.3128712964133918,3.1288125347356974,2,0.8,1.6,transcript,16069.0
MYO1B,ENSG00000128641,high density lipoprotein cholesterol measurement,EFO_0004612,0.3128712964133918,3.128726372554406,1,0.4,0.4,transcript,29832.0
ATRNL1,ENSG00000107518,arterial stiffness measurement,EFO_0004517,0.3128712964133918,3.1287298232757874,1,0.4,0.4,transcript,23726.0
CLSTN2,ENSG00000158258,diabetes mellitus,EFO_0000400,0.3128712964133918,3.1287370503626164,1,0.4,0.4,transcript,16607.0
ABCA13,ENSG00000179869,esophageal ulcer,MONDO_0044782,0.3128712964133918,3.128723295993239,1,0.5,0.5,transcript,48394.0
DOK5,ENSG00000101134,high density lipoprotein cholesterol measurement,EFO_0004612,0.3128712964133918,3.1288007990043614,1,0.4,0.4,transcript,4554.0
LRRC7,ENSG00000033122,multinodular goiter,MONDO_0000334,0.3128712964133918,3.128777067839468,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
SNTG2,ENSG00000172554,hypertrophic cardiomyopathy,EFO_0000538,0.3128712964133918,3.1287628543753865,1,0.5,0.5,transcript,10022.0
MLLT3,ENSG00000171843,head and neck malignant neoplasia,EFO_0006859,0.3128712964133918,3.128816203261547,2,0.8,1.6,transcript,15498.0
TMEM132B,ENSG00000139364,deficiency anemia,MONDO_0001639,0.3128712964133918,3.128802327420501,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
RNF150,ENSG00000170153,cervical carcinoma,EFO_0001061,0.3128712964133918,3.1289716231485887,4,1.6,6.4,transcript,24743.0
MDGA2,ENSG00000139915,lymphocyte count,EFO_0004587,0.3128712964133918,3.1287360548225975,1,0.4,0.4,transcript,17323.0
TRHDE,ENSG00000072657,kidney disease,EFO_0003086,0.3128712964133918,3.1288125347356974,2,0.8,1.6,transcript,16069.0
ASTN2,ENSG00000148219,diabetic ketoacidosis,EFO_1000897,0.3128712964133918,3.128771718540498,2,0.8,1.6,transcript,27232.0
TMEM132B,ENSG00000139364,pulse wave reflection index measurement,EFO_0009804,0.3128712964133918,3.128802327420501,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
PRKCB,ENSG00000166501,ovarian dysfunction,EFO_0009003,0.3128712964133918,3.128736930580892,1,0.4,0.4,transcript,16690.0
OTUD7A,ENSG00000169918,urinary microalbumin measurement,EFO_0010967,0.3128712964133918,3.128730690701611,1,0.4,0.4,transcript,22565.0
GPR158,ENSG00000151025,aspartate aminotransferase measurement,EFO_0004736,0.3128712964133918,3.1287386354385336,1,0.5,0.5,transcript,19477.0
PTPRO,ENSG00000151490,device complication,EFO_0009519,0.3128712964133918,3.1287174127303854,1,0.4,0.4,transcript,89916.0
DCLK1,ENSG00000133083,lymphocyte count,EFO_0004587,0.3128712964133918,3.1287631617871776,2,0.8,1.6,transcript,31874.0
DNAH14,ENSG00000185842,osteitis deformans,EFO_0004261,0.3128712964133918,3.128770942617458,3,1.5,4.5,transcript,77615.0
GPR158,ENSG00000151025,serum alanine aminotransferase measurement,EFO_0004735,0.3128712964133918,3.1287386354385336,1,0.5,0.5,transcript,19477.0
GPR158,ENSG00000151025,primary thrombocytopenia,MONDO_0004680,0.3128712964133918,3.1287386354385336,1,0.5,0.5,transcript,19477.0
ADK,ENSG00000156110,"osteoarthritis, hip",EFO_1000786,0.3128535153679063,3.128554137116014,1,0.4,0.4,transcript,21071.0
ADK,ENSG00000156110,total hip arthroplasty,EFO_0009806,0.3128535153679063,3.128554137116014,1,0.4,0.4,transcript,21071.0
PHIP,ENSG00000146247,erythrocyte count,EFO_0004305,0.3128417294600104,3.128425271753536,1,0.5,0.5,transcript,62679.0
ARPC5,ENSG00000162704,systemic lupus erythematosus,MONDO_0007915,0.312815966614464,3.128186395179054,1,0.4,0.4,transcript,14965.0
STT3B,ENSG00000163527,diabetic retinopathy,EFO_0003770,0.31279754490585593,3.1279951719519077,1,0.4,0.4,transcript,20281.0
VAT1L,ENSG00000171724,systolic blood pressure,EFO_0006335,0.31279241298632854,3.128014915156068,1,0.4,0.4,transcript,4406.0
CYSLTR1,ENSG00000173198,body height,OBA_VT0001253,0.31278244018101947,3.1280145384709197,2,0.8,1.6,transcript,8415.0
HS6ST3,ENSG00000185352,diabetic retinopathy,EFO_0003770,0.3127759834974064,3.1278066953302024,1,0.4,0.4,transcript,8536.0
RAD23B,ENSG00000119318,smoking initiation,EFO_0005670,0.3127592473337328,3.1276327471995913,1,0.4,0.4,transcript,9932.0
SYDE2,ENSG00000097096,threitol measurement,EFO_0021031,0.31274406045077685,3.127474757513233,1,0.5,0.5,transcript,14640.0
SLC22A25,ENSG00000196600,ankylosing spondylitis,EFO_0003898,0.31274406045077685,3.127467198484233,1,0.4,0.4,transcript,15041.0
ZNF396,ENSG00000186496,neuroticism measurement,EFO_0007660,0.3127302645236158,3.12733721143042,1,0.4,0.4,transcript,11572.0
ZNF396,ENSG00000186496,depressive symptom measurement,EFO_0007006,0.3127302645236158,3.12733721143042,1,0.4,0.4,transcript,11572.0
ABCA10,ENSG00000154263,total lipids in lipoprotein particles measurement ,EFO_0022309,0.3127012060011118,3.1271119961630207,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
ZNF143,ENSG00000166478,Phenotypic abnormality,HP_0000118,0.3127012060011118,3.1270383398387223,1,0.5,0.5,transcript,19026.0
SLCO5A1,ENSG00000137571,body height,OBA_VT0001253,0.3127010256698376,3.127440808665998,5,2.0,10.0,transcript,23226.0
ASB5,ENSG00000164122,preeclampsia,EFO_0000668,0.3126747005364675,3.1267956967828123,1,0.4,0.4,transcript,8215.0
TOPAZ1,ENSG00000173769,alcohol consumption quality,OBA_1000840,0.3126605454543548,3.1266991928262624,1,0.5,0.5,transcript,5334.0
TOPAZ1,ENSG00000173769,diet measurement,EFO_0008111,0.3126604440108628,3.126698178391343,1,0.5,0.5,transcript,5334.0
RIF1,ENSG00000080345,diabetes mellitus,EFO_0000400,0.31258132105622494,3.1258747538792764,3,1.3,3.9000000000000004,transcript,63370.0
SPOCK3,ENSG00000196104,growth differentiation factor 15 amount,OBA_2050135,0.3125672246616734,3.125754611401213,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
CENPC,ENSG00000145241,hip circumference,OBA_1000032,0.31254758265374494,3.125674633694507,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
APIP,ENSG00000149089,HbA1c measurement,EFO_0004541,0.3125250039117192,3.125322808728603,1,0.5,0.5,transcript,6871.0
PICALM,ENSG00000073921,Dementia,HP_0000726,0.31252066276065604,3.1252198959251327,1,0.4,0.4,transcript,30147.0
G3BP2,ENSG00000138757,cervical carcinoma,EFO_0001061,0.31250878208408966,3.125089574081104,1,0.4,0.4,transcript,228149.0
THEM4,ENSG00000159445,neutrophil count,EFO_0004833,0.31250731231856804,3.125227473947787,2,0.8,1.6,transcript,10366.0
TAF1B,ENSG00000115750,temporal measurement,EFO_0000719,0.31250213333395616,3.125075734384062,1,0.5,0.5,transcript,9191.0
ANKRD10,ENSG00000088448,worry measurement,EFO_0009589,0.31248149579116635,3.1249930523016904,2,0.8,1.6,transcript,8984.0
SLC22A25,ENSG00000196600,placental retention,EFO_0009578,0.31247604909225596,3.1247870848990242,1,0.4,0.4,transcript,15041.0
RAD18,ENSG00000070950,self reported educational attainment,EFO_0004784,0.31246832385746165,3.1247167197832884,1,0.4,0.4,transcript,11947.0
YBX3,ENSG00000060138,neurodegenerative disease,EFO_0005772,0.31246103147611226,3.124630768841712,1,0.4,0.4,transcript,19556.0
RBM28,ENSG00000106344,type 2 diabetes mellitus,MONDO_0005148,0.31245548702818093,3.1246271050447887,2,0.8,1.6,transcript,22150.0
STXBP4,ENSG00000166263,sitting height measurement,EFO_0011011,0.31242273153796624,3.1246190267667124,5,2.0,10.0,transcript,25529.0
ASB5,ENSG00000164122,chronic laryngitis,MONDO_0001369,0.31237816446679084,3.123830336086046,1,0.4,0.4,transcript,8215.0
FBXO42,ENSG00000037637,aneurysm,EFO_0009659,0.31234361723167464,3.123471743681798,1,0.4,0.4,transcript,11245.0
GALR1,ENSG00000166573,lymphocyte count,EFO_0004587,0.3123049904976469,3.1231945181362666,2,0.8,1.6,transcript,11064.0
DMXL1,ENSG00000172869,erythrocyte volume,OBA_0003460,0.31229733764857587,3.1229840611025814,1,0.4,0.4,transcript,37437.0
TNPO3,ENSG00000064419,"muscular dystrophy, limb-girdle, autosomal dominant",MONDO_0015151,0.31229497720857297,3.122976444442499,1,0.5,0.5,transcript,18746.0
YTHDC2,ENSG00000047188,body weight,EFO_0004338,0.31225630132102844,3.1225832223751406,1,0.4,0.4,transcript,19793.0
KLHL3,ENSG00000146021,heart failure,EFO_0003144,0.31224295763894616,3.1224768870728057,2,0.8,1.6,transcript,33819.0
TRIM36,ENSG00000152503,Antihypertensive use measurement,EFO_0009927,0.3122230272907036,3.1222564337965064,1,0.4,0.4,transcript,15290.0
ELAPOR1,ENSG00000116299,neutrophil count,EFO_0004833,0.31221891751231734,3.1222022684128623,1,0.4,0.4,transcript,30550.0
ASB5,ENSG00000164122,ovarian neoplasm,EFO_0003893,0.31221037494838255,3.1221524409019628,1,0.4,0.4,transcript,8215.0
LONRF1,ENSG00000154359,body mass index,EFO_0004340,0.31220749525725944,3.1221102458598113,1,0.5,0.5,transcript,14167.0
LRPAP1,ENSG00000163956,Abnormality of limbs,HP_0040064,0.31214071061983384,3.1216377423697783,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
RTKN2,ENSG00000182010,Hashimoto's thyroiditis,EFO_0003779,0.3121160335138525,3.121195592961354,1,0.4,0.4,transcript,11345.0
IGDCC3,ENSG00000174498,protein measurement,EFO_0004747,0.3121144775159868,3.1211925078567653,1,0.4,0.4,transcript,8380.0
CYBRD1,ENSG00000071967,breast carcinoma,EFO_0000305,0.3121096192475196,3.121130301795568,1,0.4,0.4,transcript,11727.0
HFM1,ENSG00000162669,erythrocyte volume,OBA_0003460,0.3120816296574678,3.120946132980806,2,1.0,2.0,transcript,15404.0
ZNF236,ENSG00000130856,Genu valgum,HP_0002857,0.31206709680427785,3.1207299361017466,2,0.9,1.8,transcript,30525.0
ZNF236,ENSG00000130856,Genu varum,HP_0002970,0.31206709680427785,3.1207299361017466,2,0.9,1.8,transcript,30525.0
RIF1,ENSG00000080345,metabolite measurement,EFO_0004725,0.3120530851755396,3.120592395072423,3,1.3,3.9000000000000004,transcript,63370.0
ZNF483,ENSG00000173258,puberty onset measurement,EFO_0005677,0.3120407468897344,3.120490950061906,2,0.8,1.6,transcript,19166.0
TRDN,ENSG00000186439,electrocardiography,EFO_0004327,0.312036823788037,3.1203874413216264,1,0.5,0.5,transcript,26037.0
CNTLN,ENSG00000044459,Abruptio Placentae,EFO_1001754,0.31194409990886857,3.119562459651959,2,0.8,1.6,transcript,13173.0
ADK,ENSG00000156110,FEV/FVC ratio,EFO_0004713,0.31190966465067127,3.119115629943664,1,0.4,0.4,transcript,21071.0
CENPQ,ENSG00000031691,Red cell distribution width,EFO_0009188,0.31190754717940467,3.1193052248095547,1,0.4,0.4,transcript,1741.0
EXOC6,ENSG00000138190,Inhalant adrenergic use measurement,EFO_0009941,0.3118802221582095,3.118824838852643,1,0.5,0.5,transcript,22107.0
CCBE1,ENSG00000183287,lipid measurement,EFO_0004529,0.31184673035628774,3.1184810938131706,1,0.4,0.4,transcript,29006.0
CD86,ENSG00000114013,urinary microalbumin measurement,EFO_0010967,0.31183393338794896,3.1183711683402935,1,0.4,0.4,transcript,12565.0
IL1A,ENSG00000115008,prostate specific antigen amount,OBA_2050200,0.3118013707079639,3.118212021407849,1,0.4,0.4,transcript,2017.0
RAPGEF4,ENSG00000091428,protein measurement,EFO_0004747,0.3117985616866453,3.1179988029551295,1,0.4,0.4,transcript,30335.0
FZD6,ENSG00000164930,ovarian dysfunction,EFO_0009003,0.3117745761675647,3.1178256538212508,2,0.8,1.6,transcript,20027.0
ULK4,ENSG00000168038,Alzheimer disease,MONDO_0004975,0.31177301081444997,3.117771068249357,1,0.5,0.5,transcript,12207.0
F13B,ENSG00000143278,mean arterial pressure,EFO_0006340,0.31177125965705665,3.117820494714718,1,0.5,0.5,transcript,4634.0
ARSJ,ENSG00000180801,educational attainment,EFO_0011015,0.3117350028236374,3.117528261499157,2,0.8,1.6,transcript,8977.0
TSPAN3,ENSG00000140391,coronary artery disease,EFO_0001645,0.31173120905007473,3.11733400110548,1,0.4,0.4,transcript,18256.0
TSPAN3,ENSG00000140391,gallstones,EFO_0004210,0.31173120905007473,3.11733400110548,1,0.4,0.4,transcript,18256.0
CREG2,ENSG00000175874,N-2-furoylglycine measurement,EFO_0021165,0.3117132956740133,3.1195912534916697,7,2.8000000000000003,19.6,transcript,7973.0
DLG2,ENSG00000150672,Red cell distribution width,EFO_0009188,0.3117128131751599,3.117130904676758,1,0.4,0.4,transcript,144252.0
ZNF236,ENSG00000130856,basophil measurement,EFO_0803539,0.3117122233704172,3.1171812017631404,2,0.9,1.8,transcript,30525.0
TXK,ENSG00000074966,erythrocyte volume,OBA_0003460,0.31166648553613246,3.1166942476752344,1,0.4,0.4,transcript,13609.0
ARHGAP12,ENSG00000165322,blood urea nitrogen measurement,EFO_0004741,0.3116480960668033,3.116493023030447,1,0.4,0.4,transcript,33161.0
ATAD2B,ENSG00000119778,feeling miserable measurement,EFO_0009598,0.3116344486693533,3.1163626643804228,1,0.4,0.4,transcript,22005.0
CPPED1,ENSG00000103381,erythrocyte volume,OBA_0003460,0.31162637952755257,3.1163015240059537,1,0.4,0.4,transcript,10602.0
TULP4,ENSG00000130338,attention deficit hyperactivity disorder,EFO_0003888,0.3115502177407364,3.1155211024641387,1,0.4,0.4,transcript,21136.0
TULP4,ENSG00000130338,social inhibition quality,OBA_1000278,0.3115502177407364,3.1155211024641387,1,0.4,0.4,transcript,21136.0
TULP4,ENSG00000130338,substance abuse,MONDO_0002491,0.3115502177407364,3.1155211024641387,1,0.4,0.4,transcript,21136.0
ACADSB,ENSG00000196177,X-23641 measurement,EFO_0800854,0.31154798826193714,3.1155267045788704,1,0.4,0.4,transcript,8543.0
SLC25A46,ENSG00000164209,hemoglobin measurement,EFO_0004509,0.3115361350096051,3.115381303206242,1,0.4,0.4,transcript,20047.0
PIGN,ENSG00000197563,cervical carcinoma,EFO_0001061,0.31152201839908866,3.115222723818559,1,0.4,0.4,transcript,157491.0
PIGN,ENSG00000197563,upper respiratory tract disorder,MONDO_0004867,0.31152201839908866,3.115222723818559,1,0.4,0.4,transcript,157491.0
NEK1,ENSG00000137601,ovarian dysfunction,EFO_0009003,0.31152201839908866,3.115234443859161,2,0.8,1.6,transcript,112203.0
SKP2,ENSG00000145604,whole body water mass,EFO_0009805,0.3115009842500168,3.1150148653541536,1,0.4,0.4,transcript,79636.0
SH3TC2,ENSG00000169247,lymphocyte count,EFO_0004587,0.31149268209811715,3.1149312443898505,1,0.4,0.4,transcript,90428.0
DENND3,ENSG00000105339,Lower limb pain,HP_0012514,0.31148976318377153,3.114908448495368,1,0.5,0.5,transcript,46225.0
DCDC2,ENSG00000146038,eosinophil count,EFO_0004842,0.3114795780582513,3.1148415576482034,1,0.4,0.4,transcript,8738.0
SHC4,ENSG00000185634,serum creatinine amount,OBA_2050096,0.31145019679519487,3.1145357431778202,1,0.4,0.4,transcript,11843.0
RPAP3,ENSG00000005175,arterial stiffness measurement,EFO_0004517,0.31145019679519487,3.1146503359044706,2,0.8,1.6,transcript,10784.0
RBM25,ENSG00000119707,obesity,EFO_0001073,0.31145019679519487,3.1145146579046785,1,0.4,0.4,transcript,31521.0
BMPR2,ENSG00000204217,urate measurement,EFO_0004531,0.31143973085786586,3.1144150800376953,1,0.4,0.4,transcript,22508.0
APIP,ENSG00000149089,alanine measurement,EFO_0009765,0.31141179786373296,3.11419074824874,1,0.5,0.5,transcript,6871.0
GFPT1,ENSG00000198380,Palmar Fibromatosis,EFO_1000438,0.31139576674003955,3.1139727714293954,1,0.4,0.4,transcript,26483.0
PDP1,ENSG00000164951,heart rate,OBA_1001087,0.3113858215697898,3.113881582913694,1,0.4,0.4,transcript,17118.0
SH3TC2,ENSG00000169247,pulse pressure measurement,EFO_0005763,0.31137881809475737,3.1137926043562527,1,0.4,0.4,transcript,90428.0
ITGA8,ENSG00000077943,Splenomegaly,HP_0001744,0.3113719016444506,3.1141837724476042,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
DYNLT5,ENSG00000152760,gamma-glutamylvaline measurement,EFO_0021145,0.3113617000037468,3.1136871631667433,1,0.4,0.4,transcript,5701.0
TMEM17,ENSG00000186889,body weight,EFO_0004338,0.3113588587312332,3.113652587312332,1,0.4,0.4,transcript,6250.0
KYNU,ENSG00000115919,Age-related cataract,HP_0011141,0.31133653528339356,3.1135236015481644,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
C2CD4A,ENSG00000198535,whole body water mass,EFO_0009805,0.3113121096744808,3.1132372070495977,1,0.4,0.4,transcript,3445.0
SFRP1,ENSG00000104332,blood urea nitrogen measurement,EFO_0004741,0.3112893676268024,3.112941655157313,1,0.4,0.4,transcript,8337.0
AGBL3,ENSG00000146856,ovarian neoplasm,EFO_0003893,0.31128649202602704,3.1129008733774057,1,0.5,0.5,transcript,13907.0
ZNF396,ENSG00000186496,monocyte count,EFO_0005091,0.31128576557954596,3.1128922219897217,1,0.4,0.4,transcript,11572.0
UHMK1,ENSG00000152332,basophil measurement,EFO_0803539,0.31128576557954596,3.112984273690789,3,1.2000000000000002,3.6000000000000005,transcript,28432.0
DAG1,ENSG00000173402,osteoporosis,EFO_0003882,0.31127264660652165,3.1127326541840286,1,0.4,0.4,transcript,64640.0
BACE2,ENSG00000182240,mast/stem cell growth factor receptor amount,OBA_2050252,0.31126434195244473,3.1127769754509917,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
PPA2,ENSG00000138777,total blood protein measurement,EFO_0004536,0.31126193575380984,3.112646763808653,1,0.5,0.5,transcript,18244.0
PPA2,ENSG00000138777,FEV/FVC ratio,EFO_0004713,0.31121019710296965,3.1121293773002514,1,0.5,0.5,transcript,18244.0
CCDC88C,ENSG00000015133,respiratory tract infectious disorder,MONDO_0024355,0.31118295769618304,3.1118488996998623,1,0.4,0.4,transcript,20701.0
CHL1,ENSG00000134121,adolescent idiopathic scoliosis,EFO_0005423,0.3111682706597984,3.111729907022788,2,0.8,1.6,transcript,33898.0
GSAP,ENSG00000186088,ocular hypotension,MONDO_0004390,0.31114703068974175,3.11149582100672,1,0.5,0.5,transcript,19597.0
ZFP90,ENSG00000184939,platelet count,EFO_0004309,0.31109458877687685,3.110959242915508,1,0.4,0.4,transcript,29951.0
RBM25,ENSG00000119707,sex hormone-binding globulin measurement,EFO_0004696,0.3110623673896572,3.1106363638493018,1,0.4,0.4,transcript,31521.0
TMEM170B,ENSG00000205269,opioid use disorder,EFO_0010702,0.31104289560336573,3.110473945348695,1,0.4,0.4,transcript,8891.0
TMEM170B,ENSG00000205269,alcohol use disorder measurement,EFO_0009458,0.31104289560336573,3.110473945348695,1,0.4,0.4,transcript,8891.0
TMEM170B,ENSG00000205269,cannabis dependence,EFO_0007191,0.31104289560336573,3.110473945348695,1,0.4,0.4,transcript,8891.0
MLLT3,ENSG00000171843,complication,EFO_0009518,0.31100437817050325,3.110147020832662,2,0.8,1.6,transcript,15498.0
NUP153,ENSG00000124789,neutrophil measurement,EFO_0803548,0.31100437817050325,3.110071766257559,1,0.5,0.5,transcript,17867.0
MLLT3,ENSG00000171843,hemorrhage,MP_0001914,0.31100437817050325,3.110147020832662,2,0.8,1.6,transcript,15498.0
FREM2,ENSG00000150893,adolescent idiopathic scoliosis,EFO_0005423,0.31097671250029746,3.110658231757564,6,2.5,15.0,transcript,16833.0
PLEKHA6,ENSG00000143850,Hypercholesterolemia,HP_0003124,0.310976152265925,3.10976833731758,1,0.4,0.4,transcript,58697.0
TSPAN3,ENSG00000140391,monocyte count,EFO_0005091,0.3108561216652627,3.10858312725736,1,0.4,0.4,transcript,18256.0
CCDC66,ENSG00000180376,appendicular lean mass,EFO_0004980,0.3108339824726396,3.108355054235092,1,0.5,0.5,transcript,32831.0
CCDC77,ENSG00000120647,neurodegenerative disease,EFO_0005772,0.31083154175432015,3.108343782314156,1,0.4,0.4,transcript,14102.0
LYPD6,ENSG00000187123,neurodegenerative disease,EFO_0005772,0.31081297863097596,3.108162535613837,1,0.4,0.4,transcript,12214.0
ARHGAP28,ENSG00000088756,disorder of ear,MONDO_0021205,0.31080969563687416,3.1081092580048595,1,0.4,0.4,transcript,32516.0
SMC6,ENSG00000163029,response to xenobiotic stimulus,GO_0009410,0.31080165805547333,3.10803299013793,1,0.4,0.4,transcript,24376.0
SMC6,ENSG00000163029,urate measurement,EFO_0004531,0.31080165805547333,3.10803299013793,1,0.4,0.4,transcript,24376.0
SMC6,ENSG00000163029,bone tissue density,OBA_1000110,0.31080165805547333,3.10803299013793,1,0.4,0.4,transcript,24376.0
LGSN,ENSG00000146166,osteitis deformans,EFO_0004261,0.31080165805547333,3.108047177969252,1,0.4,0.4,transcript,13073.0
SMARCC1,ENSG00000173473,erythrocyte volume,OBA_0003460,0.31079007342857057,3.10801488139279,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,erythrocyte volume,OBA_0003460,0.31079007342857057,3.10801488139279,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,erythrocyte volume,OBA_0003460,0.31079007342857057,3.10801488139279,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,erythrocyte volume,OBA_0003460,0.31079007342857057,3.10801488139279,2,0.8,1.6,gene_variant,14017.0
RCC1L,ENSG00000274523,mean corpuscular hemoglobin concentration,EFO_0004528,0.31078824854656,3.1079255471514653,1,0.4,0.4,transcript,9289.0
RCC1L,ENSG00000274523,erythrocyte volume,OBA_0003460,0.31078824854656,3.1079255471514653,1,0.4,0.4,transcript,9289.0
LHX9,ENSG00000143355,risk-taking behaviour,EFO_0008579,0.31077585670030167,3.107832833620172,2,0.8,1.6,transcript,21544.0
KIAA0586,ENSG00000100578,FEV/FVC ratio,EFO_0004713,0.31076361299197486,3.107641780978192,1,0.5,0.5,transcript,88479.0
SLC35B4,ENSG00000205060,platelet crit,EFO_0007985,0.3107447166435416,3.1074890863683438,1,0.4,0.4,transcript,9542.0
ATXN3,ENSG00000066427,educational attainment,EFO_0011015,0.3107416898884454,3.1074226220820047,1,0.4,0.4,transcript,69891.0
NBEAL1,ENSG00000144426,neurodegenerative disease,EFO_0005772,0.3107302442785388,3.10730629638706,1,0.4,0.4,transcript,103799.0
PPA2,ENSG00000138777,nevus count,EFO_0004632,0.3107285332385912,3.1073127386564665,1,0.5,0.5,transcript,18244.0
PPA2,ENSG00000138777,cutaneous melanoma,EFO_0000389,0.3107285332385912,3.1073127386564665,1,0.5,0.5,transcript,18244.0
CP,ENSG00000047457,serum ceruloplasmin amount,OBA_2050073,0.31072832324367344,3.107304290388217,1,0.5,0.5,transcript,23744.0
FREM2,ENSG00000150893,response to xenobiotic stimulus,GO_0009410,0.3106882332024888,3.107773438779477,6,2.5,15.0,transcript,16833.0
ZNF793,ENSG00000188227,metabolite measurement,EFO_0004725,0.3106840192768816,3.1068545173641464,1,0.4,0.4,transcript,27924.0
GPR180,ENSG00000152749,sex hormone-binding globulin measurement,EFO_0004696,0.3106456598148762,3.106501622912382,1,0.4,0.4,transcript,8884.0
GUF1,ENSG00000151806,IGF-1 measurement,EFO_0004627,0.310635021416927,3.1063921358595525,1,0.5,0.5,transcript,11927.0
FARSB,ENSG00000116120,body mass index,EFO_0004340,0.31063154550887184,3.1063664754968814,1,0.4,0.4,transcript,7840.0
SLC25A46,ENSG00000164209,childhood onset asthma,MONDO_0005405,0.31062265412010387,3.10624649431123,1,0.4,0.4,transcript,20047.0
ABCB5,ENSG00000004846,respiratory system disease,EFO_0000684,0.3105727453550553,3.1057543660177536,1,0.4,0.4,transcript,14863.0
NPS,ENSG00000214285,neurodegenerative disease,EFO_0005772,0.31053952271437607,3.1057201662176843,1,0.4,0.4,transcript,1231.0
LONRF1,ENSG00000154359,mathematical ability,EFO_0004875,0.310517530740249,3.105210600689707,1,0.5,0.5,transcript,14167.0
LONRF1,ENSG00000154359,smoking initiation,EFO_0005670,0.310517530740249,3.105210600689707,1,0.5,0.5,transcript,14167.0
FAM171B,ENSG00000144369,corpus callosum volume,OBA_2045249,0.3104750956184515,3.104820752031662,1,0.4,0.4,transcript,5731.0
FAM171B,ENSG00000144369,genu of corpus callosum volume,OBA_2045227,0.3104750956184515,3.104820752031662,1,0.4,0.4,transcript,5731.0
FAM171B,ENSG00000144369,brain volume,OBA_2050009,0.3104750956184515,3.104820752031662,1,0.4,0.4,transcript,5731.0
CWH43,ENSG00000109182,pulse pressure measurement,EFO_0005763,0.31046131364667945,3.1046752097132253,1,0.5,0.5,transcript,8055.0
ATPSCKMT,ENSG00000150756,eye injury,EFO_0009485,0.31046131364667945,3.1046608463904586,1,0.4,0.4,transcript,8384.0
ATPSCKMT,ENSG00000150756,esophageal ulcer,MONDO_0044782,0.31046131364667945,3.1046608463904586,1,0.4,0.4,transcript,8384.0
SARAF,ENSG00000133872,placental retention,EFO_0009578,0.31046131364667945,3.104639589743694,1,0.4,0.4,transcript,15121.0
SARAF,ENSG00000133872,diabetic ketoacidosis,EFO_1000897,0.31046131364667945,3.104639589743694,1,0.4,0.4,transcript,15121.0
CWH43,ENSG00000109182,high density lipoprotein cholesterol measurement,EFO_0004612,0.31046131364667945,3.1046752097132253,1,0.5,0.5,transcript,8055.0
ATPSCKMT,ENSG00000150756,body weight,EFO_0004338,0.31046131364667945,3.1046608463904586,1,0.4,0.4,transcript,8384.0
ZNF716,ENSG00000182111,arterial stiffness measurement,EFO_0004517,0.31046131364667945,3.1074922151616122,6,2.5,15.0,transcript,5210.0
ATXN3,ENSG00000066427,apolipoprotein A 1 measurement,EFO_0004614,0.31045613958704094,3.10456711906796,1,0.4,0.4,transcript,69891.0
RCC1L,ENSG00000274523,glucose measurement,EFO_0004468,0.3104420588585556,3.1044636502714207,1,0.4,0.4,transcript,9289.0
PEAK1,ENSG00000173517,urate measurement,EFO_0004531,0.3104250201682902,3.1042571241341417,1,0.4,0.4,transcript,57783.0
ABCB1,ENSG00000085563,growth differentiation factor 15 amount,OBA_2050135,0.3104245556990872,3.10426960470153,1,0.5,0.5,transcript,20792.0
CCDC177,ENSG00000267909,platelet count,EFO_0004309,0.31039993136748706,3.104118873694,1,0.5,0.5,transcript,4182.0
DLGAP1,ENSG00000170579,diabetes mellitus,EFO_0000400,0.3103631009551412,3.10365916369535,2,0.8,1.6,transcript,56830.0
CCDC34,ENSG00000109881,brain attribute,OBA_2045210,0.31036047882682427,3.1036983117660215,1,0.4,0.4,transcript,4277.0
RUFY3,ENSG00000018189,platelet count,EFO_0004309,0.3103574545839249,3.1035948741413275,1,0.4,0.4,transcript,19677.0
YIPF4,ENSG00000119820,X-11470 measurement,EFO_0021241,0.3103429070720029,3.1035472478379846,2,0.8,1.6,transcript,13539.0
TNPO3,ENSG00000064419,systolic blood pressure,EFO_0006335,0.31030513932496145,3.103078065606384,1,0.5,0.5,transcript,18746.0
NID2,ENSG00000087303,sensorineural hearing loss,EFO_1001176,0.3102999093012977,3.1030442275137893,1,0.5,0.5,transcript,11078.0
PLA2R1,ENSG00000153246,clonal hematopoiesis,EFO_0010819,0.31025521302278064,3.102631322466967,2,0.8,1.6,transcript,20204.0
SH3TC2,ENSG00000169247,response to xenobiotic stimulus,GO_0009410,0.3102142001160868,3.102146424569547,1,0.4,0.4,transcript,90428.0
ACADSB,ENSG00000196177,genetic disorder,EFO_0000508,0.3101904252582851,3.1019510745423498,1,0.4,0.4,transcript,8543.0
GID4,ENSG00000141034,linoleic acid measurement,EFO_0006807,0.31014117842846345,3.1014688945073643,1,0.4,0.4,transcript,7004.0
ADGRA1,ENSG00000197177,male infertility,EFO_0004248,0.31014117842846345,3.1014637188470857,1,0.4,0.4,transcript,7702.0
DMAC1,ENSG00000137038,phosphatidylcholine measurement,EFO_0010226,0.3101056679572821,3.1011722531064816,1,0.4,0.4,transcript,3461.0
HS3ST3A1,ENSG00000153976,hypothyroidism,EFO_0004705,0.3101056679572821,3.1011377168499683,1,0.4,0.4,transcript,4936.0
TENM4,ENSG00000149256,cognitive function measurement,EFO_0008354,0.3101056679572821,3.101074130057072,1,0.4,0.4,transcript,22922.0
C2CD4A,ENSG00000198535,glucose tolerance test,EFO_0004307,0.3101036699796031,3.1011528101008206,1,0.4,0.4,transcript,3445.0
ONECUT1,ENSG00000169856,aspartate aminotransferase measurement,EFO_0004736,0.31010002906256123,3.101053137765261,1,0.4,0.4,transcript,7569.0
ONECUT1,ENSG00000169856,low density lipoprotein triglyceride measurement,EFO_0009946,0.31010002906256123,3.101053137765261,1,0.4,0.4,transcript,7569.0
ONECUT1,ENSG00000169856,serum alanine aminotransferase measurement,EFO_0004735,0.31010002906256123,3.101053137765261,1,0.4,0.4,transcript,7569.0
ONECUT1,ENSG00000169856,educational attainment,EFO_0011015,0.31010002906256123,3.101053137765261,1,0.4,0.4,transcript,7569.0
MARCKS,ENSG00000277443,high density lipoprotein cholesterol measurement,EFO_0004612,0.3100820754016803,3.1009138638864497,1,0.4,0.4,transcript,4296.0
ZDHHC21,ENSG00000175893,major depressive disorder,MONDO_0002009,0.3100694696486346,3.101042277000113,4,1.6,6.4,transcript,18413.0
ACADSB,ENSG00000196177,high density lipoprotein cholesterol measurement,EFO_0004612,0.31001933248209007,3.1002401467803997,1,0.4,0.4,transcript,8543.0
EVI5,ENSG00000067208,white matter integrity,EFO_0004641,0.3100161416492918,3.1001670724415624,1,0.4,0.4,transcript,70722.0
DNAJC10,ENSG00000077232,neuroimaging measurement,EFO_0004346,0.30995576416413523,3.099576893371885,4,1.7000000000000002,6.800000000000001,transcript,353215.0
ADK,ENSG00000156110,liver disease,EFO_0001421,0.30993720330629954,3.0993910164999465,1,0.4,0.4,transcript,21071.0
DLG1,ENSG00000075711,acne,EFO_0003894,0.3099225293690082,3.0992407034615894,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
APIP,ENSG00000149089,kidney disease,EFO_0003086,0.3099156557236917,3.0992293268483273,1,0.5,0.5,transcript,6871.0
ZNF24,ENSG00000172466,monocyte count,EFO_0005091,0.30991038630084494,3.0991267358355308,1,0.5,0.5,transcript,21860.0
CCDC127,ENSG00000164366,erythrocyte count,EFO_0004305,0.3099091297837217,3.0991318699033497,1,0.4,0.4,transcript,9859.0
CYBRD1,ENSG00000071967,body height,OBA_VT0001253,0.30983342341379355,3.0983683434583074,1,0.4,0.4,transcript,11727.0
SYT13,ENSG00000019505,monocyte count,EFO_0005091,0.30983163729755525,3.0985316582285125,2,0.8,1.6,transcript,7432.0
TBXT,ENSG00000164458,BMI-adjusted waist-hip ratio,EFO_0007788,0.30979671788355334,3.098427654660553,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
KLF10,ENSG00000155090,cataract,MONDO_0005129,0.3097862562776984,3.097923408532993,1,0.4,0.4,transcript,6574.0
SLAMF7,ENSG00000026751,serum IgM amount,OBA_2050070,0.309776325736094,3.0977794536600856,1,0.4,0.4,transcript,24697.0
DCDC2,ENSG00000146038,mental or behavioural disorder,EFO_0000677,0.3097394661260532,3.097440438326222,1,0.4,0.4,transcript,8738.0
ARHGAP12,ENSG00000165322,IGF-1 measurement,EFO_0004627,0.3096925890489026,3.09693795285144,1,0.4,0.4,transcript,33161.0
LATS1,ENSG00000131023,eosinophil count,EFO_0004842,0.309687648223533,3.0968938388264955,1,0.4,0.4,transcript,23046.0
ARHGAP12,ENSG00000165322,platelet volume,OBA_0003277,0.30967098479899924,3.0967219103524064,1,0.4,0.4,transcript,33161.0
AGA,ENSG00000038002,type 2 diabetes mellitus,MONDO_0005148,0.3096233491977635,3.0963314735570986,1,0.5,0.5,transcript,5103.0
TMEM17,ENSG00000186889,metabolite measurement,EFO_0004725,0.30961119367704143,3.0961759367704142,1,0.4,0.4,transcript,6250.0
ZFP90,ENSG00000184939,Hepatic fibrosis,HP_0001395,0.30959697827664373,3.095983137913177,1,0.4,0.4,transcript,29951.0
ANKRD10,ENSG00000088448,Abnormality of refraction,HP_0000539,0.309595917583362,3.096137270223647,2,0.8,1.6,transcript,8984.0
LARP4B,ENSG00000107929,chronic kidney disease,EFO_0003884,0.3095949876177757,3.0959608881808403,1,0.5,0.5,transcript,45405.0
LYPD6,ENSG00000187123,brain attribute,OBA_2045210,0.30953596078579415,3.095392357162019,1,0.4,0.4,transcript,12214.0
PROK2,ENSG00000163421,smoking initiation,EFO_0005670,0.3095352785172098,3.095868249089624,2,0.8,1.6,transcript,3104.0
KPNA4,ENSG00000186432,aspartate aminotransferase measurement,EFO_0004736,0.30952525481711146,3.095261541381241,1,0.4,0.4,transcript,44478.0
AGA,ENSG00000038002,serum metabolite measurement,EFO_0005653,0.30949776519902117,3.095075633569675,1,0.5,0.5,transcript,5103.0
FAM8A1,ENSG00000137414,"cholestasis, intrahepatic, of pregnancy 3",EFO_0009150,0.3094600204692874,3.094619446563184,1,0.4,0.4,transcript,20788.0
FRRS1L,ENSG00000260230,ovarian dysfunction,EFO_0009003,0.3094479861517998,3.0945657675582665,2,0.8,1.6,transcript,18625.0
ING1,ENSG00000153487,serum gamma-glutamyl transferase measurement,EFO_0004532,0.3094425180864743,3.094451663915591,1,0.4,0.4,transcript,15104.0
HS3ST3A1,ENSG00000153976,viral load,EFO_0010125,0.3094391513184294,3.0944725504614414,1,0.4,0.4,transcript,4936.0
PDE1C,ENSG00000154678,arterial stiffness measurement,EFO_0004517,0.3094391513184294,3.0944458720889623,2,0.8,1.6,transcript,29434.0
DNAH14,ENSG00000185842,heel bone mineral density,EFO_0009270,0.30940952800950805,3.094153258578621,3,1.5,4.5,transcript,77615.0
CYBRD1,ENSG00000071967,sexual dimorphism measurement,EFO_0021796,0.3093574748882287,3.0936088582026584,1,0.4,0.4,transcript,11727.0
DNAJC21,ENSG00000168724,response to xenobiotic stimulus,GO_0009410,0.30933956042882305,3.0934046273195177,1,0.4,0.4,transcript,44331.0
DNAJC21,ENSG00000168724,poisoning,EFO_0008546,0.30933956042882305,3.0934046273195177,1,0.4,0.4,transcript,44331.0
GSAP,ENSG00000186088,Abruptio Placentae,EFO_1001754,0.30933910757858446,3.0934165898951473,1,0.5,0.5,transcript,19597.0
NOL9,ENSG00000162408,Red cell distribution width,EFO_0009188,0.3092919727908599,3.09296243101525,1,0.4,0.4,transcript,9367.0
CDKL2,ENSG00000138769,gastrointestinal disease,EFO_0010282,0.3092797344550669,3.0929614471147713,2,0.8,1.6,transcript,9750.0
GASK1B,ENSG00000164125,educational attainment,EFO_0011015,0.3092682042464953,3.092854928216286,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
ZNF507,ENSG00000168813,attention deficit hyperactivity disorder,EFO_0003888,0.3092682042464953,3.0926964413130453,1,0.4,0.4,transcript,27780.0
ZNF507,ENSG00000168813,social inhibition quality,OBA_1000278,0.3092682042464953,3.0926964413130453,1,0.4,0.4,transcript,27780.0
ZNF507,ENSG00000168813,substance abuse,MONDO_0002491,0.3092682042464953,3.0926964413130453,1,0.4,0.4,transcript,27780.0
SLCO6A1,ENSG00000205359,schizophrenia,MONDO_0005090,0.30926603797625224,3.092701633887935,1,0.5,0.5,transcript,12120.0
ANKRD36,ENSG00000135976,total blood protein measurement,EFO_0004536,0.3092575029765203,3.092650416120273,2,1.0,2.0,transcript,26530.0
PPP1R9A,ENSG00000158528,sodium measurement,EFO_0009282,0.3092403717983624,3.0924827261275403,3,1.3,3.9000000000000004,transcript,49362.0
RTF1,ENSG00000137815,heart rate,OBA_1001087,0.30920120930990364,3.0920638127783744,1,0.4,0.4,transcript,7734.0
TAF2,ENSG00000064313,red blood cell density,OBA_2045260,0.3091733275865552,3.091736068849576,1,0.5,0.5,transcript,179020.0
MYO1B,ENSG00000128641,platelet crit,EFO_0007985,0.3091513674934874,3.091527083355362,1,0.4,0.4,transcript,29832.0
RFX3,ENSG00000080298,educational attainment,EFO_0011015,0.30912697509235554,3.091326252088892,2,0.8,1.6,transcript,28318.0
DLG2,ENSG00000150672,refractive error,MONDO_0004892,0.3090149609334113,3.090152382259272,1,0.4,0.4,transcript,144252.0
KIAA0586,ENSG00000100578,lymphocyte count,EFO_0004587,0.30900050207903473,3.0900106718487907,1,0.5,0.5,transcript,88479.0
ABCA10,ENSG00000154263,platelet count,EFO_0004309,0.30900050207903473,3.09010495694225,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
CENPE,ENSG00000138778,protein measurement,EFO_0004747,0.308993141524449,3.08995710897522,1,0.5,0.5,transcript,19460.0
UBL3,ENSG00000122042,monocyte count,EFO_0005091,0.30899274051896886,3.0907613176288824,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
RSBN1L,ENSG00000187257,free androgen index,EFO_0007005,0.30897324388900377,3.089869155971128,2,0.8,1.6,transcript,11703.0
WDR59,ENSG00000103091,growth differentiation factor 15 amount,OBA_2050135,0.3089607916765359,3.08968157141711,2,0.8,1.6,transcript,21723.0
AOX1,ENSG00000138356,N-formylmethionine measurement,EFO_0800128,0.30895134672169894,3.0895415689452457,1,0.4,0.4,transcript,14234.0
DYNC2H1,ENSG00000187240,type 2 diabetes mellitus,MONDO_0005148,0.3089453230578107,3.089463386986801,1,0.5,0.5,transcript,49230.0
TNPO3,ENSG00000064419,clear cell renal carcinoma,EFO_0000349,0.3088934915721519,3.0889615880782886,1,0.5,0.5,transcript,18746.0
ATAD2B,ENSG00000119778,neutrophil-to-lymphocyte ratio,EFO_0008447,0.3088557971620372,3.0885761493072614,1,0.4,0.4,transcript,22005.0
NBEAL1,ENSG00000144426,brain volume,OBA_2050009,0.30885382348648166,3.088542088466489,1,0.4,0.4,transcript,103799.0
THAP1,ENSG00000131931,dystonic disorder,MONDO_0003441,0.3088045008032175,3.0881243731115395,1,0.4,0.4,transcript,5040.0
DYNC2H1,ENSG00000187240,Short long bone,HP_0003026,0.3088045008032175,3.0880551644408687,1,0.5,0.5,transcript,49230.0
GPR180,ENSG00000152749,Abruptio Placentae,EFO_1001754,0.30878028822548576,3.0878479070184777,1,0.4,0.4,transcript,8884.0
C2orf73,ENSG00000177994,arterial stiffness measurement,EFO_0004517,0.30878028822548576,3.0878511914336015,1,0.4,0.4,transcript,8280.0
MIOS,ENSG00000164654,growth differentiation factor 15 amount,OBA_2050135,0.3087627248624252,3.087988626376934,4,1.6,6.4,transcript,17710.0
STAU2,ENSG00000040341,electrocardiography,EFO_0004327,0.30873822423012864,3.0873938104841563,1,0.5,0.5,transcript,43222.0
PSD3,ENSG00000156011,type 1 diabetes mellitus,MONDO_0005147,0.30873822423012864,3.0873916853948438,1,0.4,0.4,transcript,42359.0
STAU2,ENSG00000040341,pulse wave reflection index measurement,EFO_0009804,0.30873822423012864,3.0873938104841563,1,0.5,0.5,transcript,43222.0
PSD3,ENSG00000156011,cataract,MONDO_0005129,0.30873822423012864,3.0873916853948438,1,0.4,0.4,transcript,42359.0
PSD3,ENSG00000156011,trauma complication,EFO_0009888,0.30873822423012864,3.0873916853948438,1,0.4,0.4,transcript,42359.0
ZFP1,ENSG00000184517,metabolite measurement,EFO_0004725,0.30871860810101437,3.087214433717827,1,0.4,0.4,transcript,14108.0
TLK1,ENSG00000198586,systolic blood pressure,EFO_0006335,0.308698789972708,3.0870017948880903,1,0.4,0.4,transcript,28787.0
TMED5,ENSG00000117500,triglyceride measurement,EFO_0004530,0.30869811858735563,3.0870131531390763,1,0.5,0.5,transcript,15641.0
KCNJ15,ENSG00000157551,body surface area,EFO_0022196,0.3086976189915934,3.086986023966334,1,0.4,0.4,transcript,40675.0
SLC35B4,ENSG00000205060,triacylglycerol 52:6 measurement,EFO_0010418,0.30862318234902675,3.0862737434231957,1,0.4,0.4,transcript,9542.0
NEDD1,ENSG00000139350,arterial stiffness measurement,EFO_0004517,0.30860103702079583,3.0860296268996588,1,0.4,0.4,transcript,20772.0
NCS1,ENSG00000107130,insomnia,EFO_0004698,0.3085727557634279,3.0857892099154136,1,0.4,0.4,transcript,6488.0
NUDCD1,ENSG00000120526,bilirubin measurement,EFO_0004570,0.3085490084277379,3.0855010726846093,1,0.4,0.4,transcript,36402.0
PIGB,ENSG00000069943,lymphocyte count,EFO_0004587,0.3085304499399645,3.0853446503672832,1,0.5,0.5,transcript,12453.0
FBXO22,ENSG00000167196,diabetes mellitus,EFO_0000400,0.3084905132072579,3.084926330864248,1,0.4,0.4,transcript,18869.0
GLB1,ENSG00000170266,lean body mass,EFO_0004995,0.3084905132072579,3.084936040151951,1,0.5,0.5,transcript,16177.0
SLCO5A1,ENSG00000137571,urinary bladder cancer,MONDO_0001187,0.30848114068452365,3.085241958812859,5,2.0,10.0,transcript,23226.0
TRDN,ENSG00000186439,drug allergy,EFO_0009482,0.30847734832333545,3.084792686674611,1,0.5,0.5,transcript,26037.0
CAV2,ENSG00000105971,TPE interval measurement,EFO_0004644,0.3084456473106291,3.0844806466724966,1,0.4,0.4,transcript,16547.0
MFAP3,ENSG00000037749,mean corpuscular hemoglobin,EFO_0004527,0.30843787923536153,3.084391382055239,1,0.4,0.4,transcript,31772.0
NUDCD1,ENSG00000120526,schizophrenia,MONDO_0005090,0.30843348713099183,3.084345859717149,1,0.4,0.4,transcript,36402.0
NUDCD1,ENSG00000120526,self reported educational attainment,EFO_0004784,0.30843348713099183,3.084345859717149,1,0.4,0.4,transcript,36402.0
NUDCD1,ENSG00000120526,intelligence,EFO_0004337,0.30843348713099183,3.084345859717149,1,0.4,0.4,transcript,36402.0
SPOCK3,ENSG00000196104,glucuronate measurement,EFO_0010486,0.3083963772024356,3.084046136808835,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
MAP1LC3B2,ENSG00000258102,high density lipoprotein cholesterol measurement,EFO_0004612,0.30837386530627864,3.0839049041018556,1,0.4,0.4,transcript,2406.0
ALPK3,ENSG00000136383,neurodegenerative disease,EFO_0005772,0.3083663161831583,3.0837004578688787,1,0.4,0.4,transcript,10725.0
AKR1B10,ENSG00000198074,Calcium channel blocker use measurement,EFO_0009930,0.3083442710329034,3.083574845635588,1,0.5,0.5,transcript,3784.0
GASK1B,ENSG00000164125,level of cathepsin O in blood serum,OBA_2041195,0.30832698131730185,3.083442698924351,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
ANKRD10,ENSG00000088448,apolipoprotein A 1 measurement,EFO_0004614,0.30831956814209255,3.0833737758109523,2,0.8,1.6,transcript,8984.0
SRGN,ENSG00000122862,lymphocyte count,EFO_0004587,0.3083118400881801,3.0832417815110422,1,0.4,0.4,transcript,3242.0
LRRC7,ENSG00000033122,bone tissue density,OBA_1000110,0.3083095554537582,3.0831596582431327,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
WAPL,ENSG00000062650,mathematical ability,EFO_0004875,0.30830858168503955,3.083219573747235,2,0.8,1.6,transcript,11962.0
CYBRD1,ENSG00000071967,metabolic rate measurement,EFO_0005115,0.30824910557949964,3.082525165115368,1,0.4,0.4,transcript,11727.0
C18orf54,ENSG00000166845,corneal dystrophy,MONDO_0018102,0.30823070140122855,3.0823924886637095,2,0.8,1.6,transcript,18719.0
BTC,ENSG00000174808,liver disease,EFO_0001421,0.30815943135851975,3.081716376447572,1,0.4,0.4,transcript,3277.0
GALNT3,ENSG00000115339,urate measurement,EFO_0004531,0.30815943135851975,3.081623221585487,1,0.4,0.4,transcript,13837.0
WDR12,ENSG00000138442,blood urea nitrogen measurement,EFO_0004741,0.3080975233774402,3.080995172959886,1,0.4,0.4,transcript,20061.0
BHLHE41,ENSG00000123095,platelet crit,EFO_0007985,0.3080961634590319,3.0810499153230495,1,0.4,0.4,transcript,4531.0
TMEM132B,ENSG00000139364,glomerular filtration rate,OBA_0003747,0.30809585551065105,3.0810479183930934,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
TMEM132B,ENSG00000139364,serum creatinine amount,OBA_2050096,0.30809585551065105,3.0810479183930934,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
CCDC7,ENSG00000216937,pulse wave reflection index measurement,EFO_0009804,0.3080264817350427,3.080283414389778,1,0.5,0.5,transcript,26886.0
TEX15,ENSG00000133863,neutrophil count,EFO_0004833,0.3080158122519509,3.080173046110722,1,0.5,0.5,transcript,33504.0
LRRC58,ENSG00000163428,appendicular lean mass,EFO_0004980,0.3080069599133238,3.0802716703633464,2,0.8,1.6,transcript,7918.0
TOPAZ1,ENSG00000173769,serum creatinine amount,OBA_2050096,0.30800127189336546,3.0801064572163694,1,0.5,0.5,transcript,5334.0
SPOCK3,ENSG00000196104,glucose measurement,EFO_0004468,0.3079958089155762,3.0800404539402413,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
LRRC7,ENSG00000033122,mathematical ability,EFO_0004875,0.30795760597737015,3.079640163479252,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
DNAJC10,ENSG00000077232,smoking initiation,EFO_0005670,0.307954455433462,3.0795638060651527,4,1.7000000000000002,6.800000000000001,transcript,353215.0
DAG1,ENSG00000173402,inflammatory bowel disease,EFO_0003767,0.30791833605535307,3.0791895486723426,1,0.4,0.4,transcript,64640.0
ZNF429,ENSG00000197013,protein measurement,EFO_0004747,0.30789339522345155,3.079089760979281,2,0.8,1.6,transcript,10269.0
HACD1,ENSG00000165996,aspartate aminotransferase measurement,EFO_0004736,0.30787753248105654,3.0788400183250406,1,0.4,0.4,transcript,6183.0
MAP1LC3B2,ENSG00000258102,gastrointestinal disease,EFO_0010282,0.3078296304404874,3.078462555443943,1,0.4,0.4,transcript,2406.0
NEDD1,ENSG00000139350,obstructive sleep apnea,EFO_0003918,0.3078224128462344,3.0782433851540443,1,0.4,0.4,transcript,20772.0
NEDD1,ENSG00000139350,squamous cell carcinoma,EFO_0000707,0.3078224128462344,3.0782433851540443,1,0.4,0.4,transcript,20772.0
ZNF716,ENSG00000182111,pulse pressure measurement,EFO_0005763,0.3078224128462344,3.081103207157162,6,2.5,15.0,transcript,5210.0
DNAJC10,ENSG00000077232,hemangioma of subcutaneous tissue,EFO_1000707,0.307772953943373,3.0777487911642627,4,1.7000000000000002,6.800000000000001,transcript,353215.0
TWSG1,ENSG00000128791,high density lipoprotein cholesterol measurement,EFO_0004612,0.3077559530746158,3.077615241052565,1,0.4,0.4,transcript,7180.0
ROCK2,ENSG00000134318,brain attribute,OBA_2045210,0.30771392902196143,3.077150283821338,1,0.5,0.5,transcript,45481.0
SGTB,ENSG00000197860,COVID-19,MONDO_0100096,0.3076884130151487,3.076947271430098,1,0.4,0.4,transcript,6335.0
SGTB,ENSG00000197860,severe acute respiratory syndrome,EFO_0000694,0.3076884130151487,3.076947271430098,1,0.4,0.4,transcript,6335.0
SLC44A1,ENSG00000070214,adrenal gland hyperfunction,EFO_1000797,0.3076858136001505,3.07686774491858,1,0.4,0.4,transcript,41628.0
FREM2,ENSG00000150893,ovarian neoplasm,EFO_0003893,0.3076858136001505,3.0777492427560946,6,2.5,15.0,transcript,16833.0
MAP3K7,ENSG00000135341,platelet count,EFO_0004309,0.3076858136001505,3.0769475227247836,4,1.6,6.4,transcript,71599.0
GPR85,ENSG00000164604,smoking initiation,EFO_0005670,0.3076294625428842,3.076318172847456,1,0.4,0.4,transcript,16987.0
GPR158,ENSG00000151025,visceral adipose tissue quantity,OBA_2045224,0.30761920103397156,3.0762176816443314,1,0.5,0.5,transcript,19477.0
KCNJ15,ENSG00000157551,reticulocyte count,EFO_0007986,0.3076037985909128,3.0760478199595274,1,0.4,0.4,transcript,40675.0
FRS2,ENSG00000166225,Toxic Nodular Goiter,EFO_0009191,0.30757497189163,3.0757658278124382,1,0.4,0.4,transcript,24831.0
TRDMT1,ENSG00000107614,diastolic blood pressure change measurement,EFO_0006945,0.30757287416848933,3.075742533361616,1,0.4,0.4,transcript,29003.0
PARP8,ENSG00000151883,body mass index,EFO_0004340,0.3075546082418891,3.075593159242383,2,0.8,1.6,transcript,33987.0
ZNF697,ENSG00000143067,"osteoarthritis, hip",EFO_1000786,0.3075193770196322,3.075839047127672,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
ZNF697,ENSG00000143067,"osteoarthritis, knee",EFO_0004616,0.3075193770196322,3.075839047127672,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
MGA,ENSG00000174197,systolic blood pressure,EFO_0006335,0.3074912475132369,3.074918396917432,1,0.5,0.5,transcript,84434.0
RSBN1L,ENSG00000187257,serum alanine aminotransferase measurement,EFO_0004735,0.30739185388269047,3.074055255907995,2,0.8,1.6,transcript,11703.0
NID2,ENSG00000087303,FEV/FVC ratio,EFO_0004713,0.3073855525807665,3.0739006603084773,1,0.5,0.5,transcript,11078.0
BIRC6,ENSG00000115760,androsterone glucuronide measurement,EFO_0800317,0.30736331720913684,3.0736403543483206,1,0.5,0.5,transcript,69616.0
SLAIN2,ENSG00000109171,body fat percentage,EFO_0007800,0.3073355140701396,3.0734908834688515,2,0.8,1.6,transcript,11787.0
SLC44A1,ENSG00000070214,hyperaldosteronism,EFO_0009452,0.30733541262663233,3.0733637351833982,1,0.4,0.4,transcript,41628.0
SPOCK3,ENSG00000196104,cervical carcinoma,EFO_0001061,0.30733541262663233,3.0734364910508023,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
RGS7BP,ENSG00000186479,hyperpituitarism,EFO_1000973,0.30733541262663233,3.07344224752117,1,0.5,0.5,transcript,5674.0
CLASP2,ENSG00000163539,placental retention,EFO_0009578,0.30731017927436083,3.0731079121328935,1,0.4,0.4,transcript,65366.0
DLG1,ENSG00000075711,peak expiratory flow,EFO_0009718,0.3073065951108203,3.0730813608797103,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
DNAJC10,ENSG00000077232,neurodegenerative disease,EFO_0005772,0.3073065848210129,3.073085099940662,4,1.7000000000000002,6.800000000000001,transcript,353215.0
FANCF,ENSG00000183161,Abnormality of the integument,HP_0001574,0.30725666798545337,3.0726882234583015,1,0.4,0.4,transcript,3291.0
MRPL32,ENSG00000106591,cortical thickness,EFO_0004840,0.3072188675270372,3.0722718180681268,1,0.4,0.4,transcript,4811.0
NMRK1,ENSG00000106733,metabolite measurement,EFO_0004725,0.30721370722158386,3.0721830439432263,1,0.4,0.4,transcript,8701.0
ARHGAP28,ENSG00000088756,multinodular goiter,MONDO_0000334,0.3071968204519323,3.071980506155441,1,0.4,0.4,transcript,32516.0
U2SURP,ENSG00000163714,high density lipoprotein cholesterol measurement,EFO_0004612,0.3071488942673229,3.071539350662895,2,0.8,1.6,transcript,31741.0
FZD3,ENSG00000104290,metabolite measurement,EFO_0004725,0.3070907225549193,3.070921342365851,1,0.4,0.4,transcript,28335.0
CMYA5,ENSG00000164309,growth differentiation factor 15 amount,OBA_2050135,0.3070907225549193,3.070934842229668,1,0.5,0.5,transcript,18105.0
LHFPL2,ENSG00000145685,COVID-19,MONDO_0100096,0.3070894460714309,3.070921353278515,1,0.4,0.4,transcript,14874.0
TULP4,ENSG00000130338,grip strength measurement,EFO_0006941,0.30705638211419445,3.0705827461987196,1,0.4,0.4,transcript,21136.0
RFX3,ENSG00000080298,"osteoarthritis, hip",EFO_1000786,0.30704433328957054,3.070499834061042,2,0.8,1.6,transcript,28318.0
MEOX2,ENSG00000106511,BMI-adjusted waist circumference,EFO_0007789,0.3069290617054432,3.0694593222421167,1,0.4,0.4,transcript,2371.0
SLC7A2,ENSG00000003989,ornithine measurement,EFO_0009776,0.30690307785037035,3.069151774124814,3,1.4,4.199999999999999,transcript,34712.0
DPP8,ENSG00000074603,reticulocyte count,EFO_0007986,0.306872552774731,3.0689072478415778,4,1.6,6.4,transcript,35219.0
TRAM1,ENSG00000067167,Benign Thyroid Gland Neoplasm,EFO_1000122,0.3068409704386584,3.0686002032554964,2,0.8,1.6,transcript,8399.0
SLC11A2,ENSG00000110911,neuroimaging measurement,EFO_0004346,0.3068082183878571,3.068110145152207,2,0.8,1.6,transcript,57222.0
PARP11,ENSG00000111224,platelet volume,OBA_0003277,0.3067971016146371,3.067988964634211,1,0.4,0.4,transcript,22286.0
CCDC77,ENSG00000120647,obstructive sleep apnea,EFO_0003918,0.30679085060769246,3.067936870847879,1,0.4,0.4,transcript,14102.0
ATXN3,ENSG00000066427,sexual dimorphism measurement,EFO_0021796,0.30679024006232636,3.067908123820814,1,0.4,0.4,transcript,69891.0
FAM171B,ENSG00000144369,systolic blood pressure,EFO_0006335,0.30676448966020076,3.0677146924491545,1,0.4,0.4,transcript,5731.0
C2CD4A,ENSG00000198535,diabetic retinopathy,EFO_0003770,0.3067408448880576,3.0675245591853653,1,0.4,0.4,transcript,3445.0
CD93,ENSG00000125810,neurodegenerative disease,EFO_0005772,0.3067359464102637,3.0673857816235266,1,0.4,0.4,transcript,15199.0
HTR1F,ENSG00000179097,connective tissue disease,EFO_1001986,0.3067317780620804,3.0674359141116487,1,0.4,0.4,transcript,3386.0
SYT13,ENSG00000019505,insomnia,EFO_0004698,0.3067269312186494,3.0674845974394542,2,0.8,1.6,transcript,7432.0
GKAP1,ENSG00000165113,esterified cholesterol measurement,EFO_0008589,0.3067143617297537,3.0672007438328124,1,0.4,0.4,transcript,7002.0
GKAP1,ENSG00000165113,free cholesterol to total lipids in medium LDL percentage ,EFO_0022283,0.3067143617297537,3.0672007438328124,1,0.4,0.4,transcript,7002.0
ROCK2,ENSG00000134318,cystatin C measurement,EFO_0004617,0.3066690464341371,3.0667014579430947,1,0.5,0.5,transcript,45481.0
CCDC34,ENSG00000109881,glomerular filtration rate,OBA_0003747,0.30665476894302945,3.0666412129280736,1,0.4,0.4,transcript,4277.0
USP6,ENSG00000129204,squamous cell lung carcinoma,EFO_0000708,0.30661039812327606,3.0661152777957814,1,0.4,0.4,transcript,35409.0
PYHIN1,ENSG00000163564,granulocyte count,EFO_0007987,0.3066019521931951,3.066057279153019,1,0.4,0.4,transcript,10594.0
TMEM123,ENSG00000152558,eye injury,EFO_0009485,0.30658810915823614,3.0659208135287366,1,0.4,0.4,transcript,10070.0
CDV3,ENSG00000091527,trauma complication,EFO_0009888,0.30658810915823614,3.065907214884347,1,0.4,0.4,transcript,15312.0
B4GALT6,ENSG00000118276,arterial stiffness measurement,EFO_0004517,0.30658810915823614,3.0659123293800965,1,0.4,0.4,transcript,12805.0
FZD3,ENSG00000104290,drug use measurement,EFO_0007010,0.30658810915823614,3.065895208399019,1,0.4,0.4,transcript,28335.0
FZD3,ENSG00000104290,amyotrophic lateral sclerosis,MONDO_0004976,0.30658810915823614,3.065895208399019,1,0.4,0.4,transcript,28335.0
DAG1,ENSG00000173402,mean corpuscular hemoglobin concentration,EFO_0004528,0.30657864640075994,3.0657926521264116,1,0.4,0.4,transcript,64640.0
MIOS,ENSG00000164654,HbA1c measurement,EFO_0004541,0.3065609647643436,3.0659710253961183,4,1.6,6.4,transcript,17710.0
DMRTA1,ENSG00000176399,beverage consumption measurement,EFO_0010088,0.3065498820593136,3.0655704281835403,1,0.4,0.4,transcript,5586.0
RBM28,ENSG00000106344,JT interval,EFO_0007885,0.30654482161555063,3.065520450918486,2,0.8,1.6,transcript,22150.0
MATN2,ENSG00000132561,poisoning,EFO_0008546,0.30654482161555063,3.065465171630429,1,0.5,0.5,transcript,29489.0
MATN2,ENSG00000132561,response to antibiotic,GO_0046677,0.30654482161555063,3.065465171630429,1,0.5,0.5,transcript,29489.0
SHC4,ENSG00000185634,Splenomegaly,HP_0001744,0.30654482161555063,3.065481991381378,1,0.4,0.4,transcript,11843.0
CYBRD1,ENSG00000071967,waist-hip ratio,EFO_0004343,0.3065346453892945,3.0653805632133166,1,0.4,0.4,transcript,11727.0
CYBRD1,ENSG00000071967,grip strength measurement,EFO_0006941,0.3065346453892945,3.0653805632133166,1,0.4,0.4,transcript,11727.0
CYBRD1,ENSG00000071967,heel bone mineral density,EFO_0009270,0.3065346453892945,3.0653805632133166,1,0.4,0.4,transcript,11727.0
SLC35B4,ENSG00000205060,triacylglycerol 54:8 measurement,EFO_0010426,0.3064967196538005,3.0650091164709328,1,0.4,0.4,transcript,9542.0
CNTLN,ENSG00000044459,waist-hip ratio,EFO_0004343,0.306492582090205,3.0650472814653233,2,0.8,1.6,transcript,13173.0
TMEM123,ENSG00000152558,neuroimaging measurement,EFO_0004346,0.3064912575483126,3.064952297429501,1,0.4,0.4,transcript,10070.0
LGSN,ENSG00000146166,lymphocyte count,EFO_0004587,0.30648160904001304,3.064846687814649,1,0.4,0.4,transcript,13073.0
MEOX2,ENSG00000106511,phosphatidylcholine measurement,EFO_0010226,0.3064443046730202,3.0646117519178864,1,0.4,0.4,transcript,2371.0
MGA,ENSG00000174197,vital capacity,EFO_0004312,0.30642431220136307,3.0642490437986933,1,0.5,0.5,transcript,84434.0
AKR1C1,ENSG00000187134,hip geometry,EFO_0004685,0.30640372387797704,3.064176429732359,2,0.8,1.6,transcript,11495.0
WWTR1,ENSG00000018408,hepatocellular carcinoma,EFO_0000182,0.3063712332194543,3.0637971678255083,2,0.8,1.6,transcript,18860.0
TMEM68,ENSG00000167904,"chromosome, telomeric region length",OBA_0003784,0.30635911553836453,3.0636098269049072,1,0.4,0.4,transcript,21423.0
IREB2,ENSG00000136381,bacterial pneumonia,EFO_1001272,0.3063391598910522,3.063491454674419,2,0.9,1.8,transcript,18026.0
BTF3L4,ENSG00000134717,knee fracture,EFO_0009617,0.306316627753618,3.0632024373626128,1,0.4,0.4,transcript,11062.0
PYGO1,ENSG00000171016,serum creatinine amount,OBA_2050096,0.306316627753618,3.0634941127989603,4,1.6,6.4,transcript,19522.0
EDEM1,ENSG00000134109,high density lipoprotein cholesterol measurement,EFO_0004612,0.3063038642879254,3.0631716216026583,2,0.8,1.6,transcript,12032.0
TBXT,ENSG00000164458,lean body mass,EFO_0004995,0.3062833776382326,3.063294252207345,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
RFX3,ENSG00000080298,glomerular filtration rate,OBA_0003747,0.3062689683870084,3.0627461850354205,2,0.8,1.6,transcript,28318.0
SLC36A4,ENSG00000180773,metabolite measurement,EFO_0004725,0.30626488799670126,3.0627594153728848,2,0.8,1.6,transcript,14475.0
LMNTD1,ENSG00000152936,aspartate aminotransferase measurement,EFO_0004736,0.30626488799670126,3.0628035457171414,2,0.9,1.8,transcript,11638.0
TULP4,ENSG00000130338,body height,OBA_VT0001253,0.30624521006661226,3.0624710257228975,1,0.4,0.4,transcript,21136.0
FRRS1L,ENSG00000260230,waist-hip ratio,EFO_0004343,0.3062307984139724,3.0623938901799925,2,0.8,1.6,transcript,18625.0
ZPLD1,ENSG00000170044,arterial stiffness measurement,EFO_0004517,0.3062201693139585,3.062360675651509,2,0.8,1.6,transcript,10064.0
PICALM,ENSG00000073921,Alzheimer's disease biomarker measurement,EFO_0006514,0.3061876477151212,3.061889745469784,1,0.4,0.4,transcript,30147.0
KPNA4,ENSG00000186432,testosterone measurement,EFO_0004908,0.3061704023955954,3.0617130171660802,1,0.4,0.4,transcript,44478.0
ZNF236,ENSG00000130856,arterial stiffness measurement,EFO_0004517,0.3061505116763633,3.061564084822601,2,0.9,1.8,transcript,30525.0
ZFP90,ENSG00000184939,erythrocyte count,EFO_0004305,0.30609274610688275,3.060940816215567,1,0.4,0.4,transcript,29951.0
SLC25A16,ENSG00000122912,secondary malignant neoplasm,EFO_0009812,0.3060244669013493,3.060275705636709,1,0.4,0.4,transcript,12888.0
FYCO1,ENSG00000163820,lean body mass,EFO_0004995,0.3060244669013493,3.0602692798545688,1,0.4,0.4,transcript,16253.0
DCLK1,ENSG00000133083,liver disease,EFO_0001421,0.306021131519078,3.06026151284404,2,0.8,1.6,transcript,31874.0
KLHL3,ENSG00000146021,hematocrit,EFO_0004348,0.3060108346086639,3.060155656769983,2,0.8,1.6,transcript,33819.0
FRMD4B,ENSG00000114541,glomerular filtration rate,OBA_0003747,0.3059737889521139,3.05981398578291,2,0.8,1.6,transcript,21026.0
TRAPPC8,ENSG00000153339,smoking initiation,EFO_0005670,0.3059697361021123,3.0597177700174085,1,0.5,0.5,transcript,24499.0
CENPC,ENSG00000145241,metabolic syndrome,EFO_0000195,0.30596960787015554,3.059894885858613,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
CENPC,ENSG00000145241,cannabis dependence,EFO_0007191,0.30596960787015554,3.059894885858613,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
CENPC,ENSG00000145241,arterial stiffness measurement,EFO_0004517,0.30596960787015554,3.059894885858613,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
CENPC,ENSG00000145241,heart failure,EFO_0003144,0.30596960787015554,3.059894885858613,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
EDEM1,ENSG00000134109,blood pantoate measurement,EFO_0022210,0.30596960787015554,3.0598290574249596,2,0.8,1.6,transcript,12032.0
TRHDE,ENSG00000072657,X-12544 measurement,EFO_0021315,0.30596960787015554,3.059795649303335,2,0.8,1.6,transcript,16069.0
CSMD3,ENSG00000164796,Abruptio Placentae,EFO_1001754,0.30596960787015554,3.0597041874232964,1,0.5,0.5,transcript,61662.0
RNF144B,ENSG00000137393,smoking initiation,EFO_0005670,0.30596960787015554,3.05976895172032,1,0.4,0.4,transcript,5489.0
RNF144B,ENSG00000137393,blood phosphate measurement,EFO_0010972,0.30596960787015554,3.05976895172032,1,0.4,0.4,transcript,5489.0
RNF144B,ENSG00000137393,cervical carcinoma,EFO_0001061,0.30596960787015554,3.05976895172032,1,0.4,0.4,transcript,5489.0
TTLL7,ENSG00000137941,muscular disease,EFO_0002970,0.30596960787015554,3.059725052136537,2,0.8,1.6,transcript,55223.0
SI,ENSG00000090402,lymphocyte count,EFO_0004587,0.30596960787015554,3.0597681248110655,1,0.5,0.5,transcript,6940.0
SI,ENSG00000090402,protein measurement,EFO_0004747,0.30596960787015554,3.0597681248110655,1,0.5,0.5,transcript,6940.0
TTLL7,ENSG00000137941,cervical carcinoma,EFO_0001061,0.30596960787015554,3.059725052136537,2,0.8,1.6,transcript,55223.0
TTLL7,ENSG00000137941,Abruptio Placentae,EFO_1001754,0.30596960787015554,3.059725052136537,2,0.8,1.6,transcript,55223.0
YTHDC2,ENSG00000047188,edema,EFO_0009373,0.30596960787015554,3.0597162878664115,1,0.4,0.4,transcript,19793.0
YTHDC2,ENSG00000047188,brain compression,MONDO_0001291,0.30596960787015554,3.0597162878664115,1,0.4,0.4,transcript,19793.0
DOK5,ENSG00000101134,lymphocyte count,EFO_0004587,0.30596960787015554,3.059783913571999,1,0.4,0.4,transcript,4554.0
DOK5,ENSG00000101134,growth differentiation factor 15 amount,OBA_2050135,0.30596960787015554,3.059783913571999,1,0.4,0.4,transcript,4554.0
CENPC,ENSG00000145241,substance abuse,MONDO_0002491,0.30596960787015554,3.059894885858613,3,1.2000000000000002,3.6000000000000005,transcript,18108.0
BTBD8,ENSG00000189195,low density lipoprotein cholesterol measurement,EFO_0004611,0.30594510976408984,3.0594675797084085,1,0.5,0.5,transcript,30336.0
TEX15,ENSG00000133863,preeclampsia,EFO_0000668,0.30594510976408984,3.059466021232111,1,0.5,0.5,transcript,33504.0
BIRC6,ENSG00000115760,X-11444 measurement,EFO_0021237,0.3059132972082151,3.059140154339103,1,0.5,0.5,transcript,69616.0
PPA2,ENSG00000138777,mean corpuscular hemoglobin,EFO_0004527,0.3059004810679881,3.059032216950436,1,0.5,0.5,transcript,18244.0
RBM25,ENSG00000119707,mean corpuscular hemoglobin,EFO_0004527,0.30588503241121545,3.0588630140648845,1,0.4,0.4,transcript,31521.0
RPRD2,ENSG00000163125,body fat percentage,EFO_0007800,0.3058177599283661,3.0581961058072102,1,0.4,0.4,transcript,21614.0
AKAP10,ENSG00000108599,inflammatory biomarker measurement,EFO_0004872,0.30574567500678723,3.057491930366905,1,0.4,0.4,transcript,11370.0
AKAP10,ENSG00000108599,diet measurement,EFO_0008111,0.30574567500678723,3.057491930366905,1,0.4,0.4,transcript,11370.0
CNTLN,ENSG00000044459,secondary malignant neoplasm,EFO_0009812,0.30574520219552076,3.057573482518481,2,0.8,1.6,transcript,13173.0
PCDH18,ENSG00000189184,pituitary gland disease,EFO_0009607,0.30574520219552076,3.0575291936139157,2,0.8,1.6,transcript,20733.0
NDFIP2,ENSG00000102471,complication,EFO_0009518,0.30574520219552076,3.057466503821196,2,0.8,1.6,transcript,110483.0
NSUN7,ENSG00000179299,serum albumin amount,OBA_2050068,0.30574520219552076,3.0574910509146953,1,0.5,0.5,transcript,12811.0
ATXN7L3B,ENSG00000253719,pulse wave reflection index measurement,EFO_0009804,0.30574520219552076,3.057504681249573,1,0.4,0.4,transcript,7596.0
NDFIP2,ENSG00000102471,hemorrhage,MP_0001914,0.30574520219552076,3.057466503821196,2,0.8,1.6,transcript,110483.0
USP37,ENSG00000135913,low density lipoprotein cholesterol measurement,EFO_0004611,0.30573952800771576,3.05753490696309,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
CENPE,ENSG00000138778,apolipoprotein A 1 measurement,EFO_0004614,0.3057341410856197,3.057367104586927,1,0.5,0.5,transcript,19460.0
SH3TC2,ENSG00000169247,placental retention,EFO_0009578,0.3057282799776131,3.05728722318481,1,0.4,0.4,transcript,90428.0
CCDC88C,ENSG00000015133,arterial stiffness measurement,EFO_0004517,0.3056618033354954,3.056637356092986,1,0.4,0.4,transcript,20701.0
WDR12,ENSG00000138442,apolipoprotein B measurement,EFO_0004615,0.3056598895831545,3.0566188350170296,1,0.4,0.4,transcript,20061.0
METTL25,ENSG00000127720,adolescent idiopathic scoliosis,EFO_0005423,0.30565181399064556,3.056570087958404,1,0.5,0.5,transcript,9625.0
LAMA1,ENSG00000101680,systolic blood pressure,EFO_0006335,0.3056435310325479,3.056451205544197,1,0.5,0.5,transcript,31456.0
AHCTF1,ENSG00000153207,lysosomal storage disease,MONDO_0002561,0.30561612107903713,3.056174477260694,1,0.5,0.5,transcript,37689.0
CCDC177,ENSG00000267909,erythrocyte volume,OBA_0003460,0.30560766373325104,3.05619619735164,1,0.5,0.5,transcript,4182.0
OTOGL,ENSG00000165899,deafness,EFO_0001063,0.30559784803811707,3.055993338339093,1,0.5,0.5,transcript,33652.0
ORMDL1,ENSG00000128699,glomerular filtration rate,OBA_0003747,0.3055922404938543,3.056049479833309,2,0.8,1.6,transcript,12591.0
RALGPS2,ENSG00000116191,total lipids in very large HDL measurement ,EFO_0022312,0.30557890955805955,3.0558686303024727,2,0.8,1.6,transcript,20117.0
SLC22A15,ENSG00000163393,level of lysophosphatidic acid phosphatase type 6 in blood serum,OBA_2040483,0.30551921524027403,3.055441179640094,2,0.8,1.6,transcript,6425.0
PLA2R1,ENSG00000153246,substance abuse,MONDO_0002491,0.305510598111188,3.055185173351041,2,0.8,1.6,transcript,20204.0
TOPAZ1,ENSG00000173769,arterial stiffness measurement,EFO_0004517,0.3054873608084191,3.0549673463669054,1,0.5,0.5,transcript,5334.0
LRPAP1,ENSG00000163956,triglycerides in large LDL measurement ,EFO_0022319,0.30544323804290907,3.0546630166005304,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
KCNIP4,ENSG00000185774,acute tonsillitis,MONDO_0020686,0.30543125494455836,3.0544451974309923,2,0.8,1.6,transcript,12062.0
ATRNL1,ENSG00000107518,triglyceride measurement,EFO_0004530,0.30543125494455836,3.0543294085874533,1,0.4,0.4,transcript,23726.0
NOM1,ENSG00000146909,potassium measurement,EFO_0009283,0.3053898771025474,3.0547801389084284,5,2.0,10.0,transcript,11346.0
F13B,ENSG00000143278,serum alanine aminotransferase measurement,EFO_0004735,0.30536357094924954,3.053743607636647,1,0.5,0.5,transcript,4634.0
LHX9,ENSG00000143355,complement factor H-related protein 5 measurement,EFO_0008098,0.305318183632941,3.0532561029465657,2,0.8,1.6,transcript,21544.0
KIAA0586,ENSG00000100578,high density lipoprotein cholesterol measurement,EFO_0004612,0.30530510740356515,3.0530567250940948,1,0.5,0.5,transcript,88479.0
CWH43,ENSG00000109182,lifestyle measurement,EFO_0010724,0.3052914142215661,3.052976215462092,1,0.5,0.5,transcript,8055.0
GNA13,ENSG00000120063,diffuse large B-cell lymphoma,EFO_0000403,0.3052658574541529,3.0527101807858847,1,0.4,0.4,transcript,7751.0
CENPQ,ENSG00000031691,vitamin B deficiency,MONDO_0042976,0.30525370369502053,3.0527667899657134,1,0.4,0.4,transcript,1741.0
USP37,ENSG00000135913,triglycerides in small LDL measurement ,EFO_0022323,0.30524332324422837,3.052572859328216,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
USP37,ENSG00000135913,BMI-adjusted waist-hip ratio,EFO_0007788,0.30524332324422837,3.052572859328216,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
USP37,ENSG00000135913,triglycerides in medium LDL measurement ,EFO_0022322,0.30524332324422837,3.052572859328216,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
C4orf33,ENSG00000151470,sexual activity behaviour attribute,OBA_2045293,0.3052240161327417,3.052691214960513,4,1.6,6.4,transcript,14189.0
ALG10B,ENSG00000175548,triglyceride measurement,EFO_0004530,0.30515219788962,3.052227794819407,5,2.0,10.0,transcript,14168.0
RAD23B,ENSG00000119318,osteoarthritis,MONDO_0005178,0.3050941391108451,3.050981664970714,1,0.4,0.4,transcript,9932.0
PPP1R2,ENSG00000184203,mean corpuscular hemoglobin,EFO_0004527,0.30507650122707125,3.0508114968726883,1,0.4,0.4,transcript,8605.0
LATS1,ENSG00000131023,multiple myeloma,EFO_0001378,0.3050676378280721,3.0506937348718868,1,0.4,0.4,transcript,23046.0
BACH1,ENSG00000156273,creatine kinase measurement,EFO_0004534,0.30505940907121154,3.0509519524880044,4,1.6,6.4,transcript,17884.0
PPA2,ENSG00000138777,multiple sclerosis,MONDO_0005301,0.3050348313279643,3.0503757195501975,1,0.5,0.5,transcript,18244.0
DYNLT5,ENSG00000152760,monocyte count,EFO_0005091,0.30501085142706263,3.050178677399902,1,0.4,0.4,transcript,5701.0
DTHD1,ENSG00000197057,cognitive function measurement,EFO_0008354,0.3050050249097313,3.0500766496464444,1,0.5,0.5,transcript,18939.0
WWTR1,ENSG00000018408,melanoma,EFO_0000756,0.3049850814368696,3.049935649999661,2,0.8,1.6,transcript,18860.0
PICALM,ENSG00000073921,insomnia,EFO_0004698,0.3049722082258039,3.0497353505766114,1,0.4,0.4,transcript,30147.0
MYO5A,ENSG00000197535,Polyarteritis Nodosa,EFO_0009012,0.30496950483865365,3.0496970880477487,1,0.4,0.4,transcript,196111.0
SMARCC1,ENSG00000173473,low density lipoprotein cholesterol measurement,EFO_0004611,0.30495453045650883,3.0496594516721727,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,low density lipoprotein cholesterol measurement,EFO_0004611,0.30495453045650883,3.0496594516721727,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,low density lipoprotein cholesterol measurement,EFO_0004611,0.30495453045650883,3.0496594516721727,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,low density lipoprotein cholesterol measurement,EFO_0004611,0.30495453045650883,3.0496594516721727,2,0.8,1.6,gene_variant,14017.0
BTC,ENSG00000174808,lung adenocarcinoma,EFO_0000571,0.3048896249359031,3.0490183122214054,1,0.4,0.4,transcript,3277.0
AKAP10,ENSG00000108599,blood urea nitrogen measurement,EFO_0004741,0.3048206122815629,3.0482413031146613,1,0.4,0.4,transcript,11370.0
QSER1,ENSG00000060749,prostate carcinoma,EFO_0001663,0.30477549049120006,3.0477815801147323,1,0.5,0.5,transcript,18744.0
LHX9,ENSG00000143355,glucose measurement,EFO_0004468,0.3047362683158017,3.0474369497751725,2,0.8,1.6,transcript,21544.0
RCC1L,ENSG00000274523,body mass index,EFO_0004340,0.30470855139660075,3.0471285756518727,1,0.4,0.4,transcript,9289.0
BACE2,ENSG00000182240,cardiomyopathy,EFO_0000318,0.30468147069110096,3.046948262837554,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
GNA13,ENSG00000120063,reticulocyte measurement,EFO_0010700,0.3046749041311488,3.0468006475558433,1,0.4,0.4,transcript,7751.0
GNA13,ENSG00000120063,reticulocyte count,EFO_0007986,0.3046749041311488,3.0468006475558433,1,0.4,0.4,transcript,7751.0
TRIM36,ENSG00000152503,pyruvate measurement,EFO_0010117,0.3046749041311488,3.046775202200958,1,0.4,0.4,transcript,15290.0
KCNIP4,ENSG00000185774,succinate measurement,EFO_0011002,0.3046370013641546,3.046502661626955,2,0.8,1.6,transcript,12062.0
LRPAP1,ENSG00000163956,phosphoglycerides measurement ,EFO_0022291,0.30461255035200135,3.0463561396914534,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
LRPAP1,ENSG00000163956,total phospholipids in lipoprotein particles measurement ,EFO_0022315,0.30461255035200135,3.0463561396914534,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
RCOR3,ENSG00000117625,platelet count,EFO_0004309,0.3046124332210901,3.0461886874518314,2,0.8,1.6,transcript,24862.0
C2CD4A,ENSG00000198535,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.3045843627449448,3.045959737754238,1,0.4,0.4,transcript,3445.0
NBEAL1,ENSG00000144426,adolescent idiopathic scoliosis,EFO_0005423,0.30454910489302406,3.045494902531913,1,0.4,0.4,transcript,103799.0
ZNF429,ENSG00000197013,metabolite measurement,EFO_0004725,0.3045458378248442,3.0456141869932076,2,0.8,1.6,transcript,10269.0
GPAT3,ENSG00000138678,sialolithiasis,EFO_1001180,0.30454323534306016,3.045579479867383,2,0.8,1.6,transcript,10875.0
FRS2,ENSG00000166225,body height,OBA_VT0001253,0.3045172957277031,3.045189066173169,1,0.4,0.4,transcript,24831.0
TRPC6,ENSG00000137672,matrix metalloproteinase 12 measurement,EFO_0010590,0.30450630600627066,3.0450919471862714,1,0.4,0.4,transcript,13847.0
OR10A6,ENSG00000279000,diet measurement,EFO_0008111,0.30449006669837864,3.0449335725448265,1,0.4,0.4,transcript,12156.0
HACD1,ENSG00000165996,lymphocyte count,EFO_0004587,0.30445344834165755,3.044599176931051,1,0.4,0.4,transcript,6183.0
GUCA1C,ENSG00000138472,gallbladder disease,EFO_0003832,0.30445344834165755,3.0447336866038266,1,0.5,0.5,transcript,2510.0
PDP1,ENSG00000164951,pulse pressure measurement,EFO_0005763,0.30439930354599254,3.0440164026757213,1,0.4,0.4,transcript,17118.0
TNPO3,ENSG00000064419,platelet volume,OBA_0003277,0.3043724185677211,3.043750858033981,1,0.5,0.5,transcript,18746.0
PDE1C,ENSG00000154678,triglyceride measurement,EFO_0004530,0.3043048296855942,3.04310265576061,2,0.8,1.6,transcript,29434.0
DIRAS2,ENSG00000165023,age at assessment,EFO_0008007,0.30429885944093227,3.0430648429796623,1,0.4,0.4,transcript,5246.0
DMAC1,ENSG00000137038,adolescent idiopathic scoliosis,EFO_0005423,0.30429885944093227,3.0431041679429836,1,0.4,0.4,transcript,3461.0
C4orf33,ENSG00000151470,pain measurement,EFO_0010639,0.30429885944093227,3.043439648042419,4,1.6,6.4,transcript,14189.0
DMRTA1,ENSG00000176399,lifestyle measurement,EFO_0010724,0.30429885944093227,3.0430602019997273,1,0.4,0.4,transcript,5586.0
AGA,ENSG00000038002,educational attainment,EFO_0011015,0.30429885944093227,3.043086575988786,1,0.5,0.5,transcript,5103.0
ZPLD1,ENSG00000170044,bone tissue density,OBA_1000110,0.30429885944093227,3.0431475769212466,2,0.8,1.6,transcript,10064.0
PDE1C,ENSG00000154678,social inhibition quality,OBA_1000278,0.30429885944093227,3.043042953313991,2,0.8,1.6,transcript,29434.0
MSX2,ENSG00000120149,tooth disease,EFO_1001216,0.30429885944093227,3.043106832659397,1,0.4,0.4,transcript,3383.0
FAM98A,ENSG00000119812,bacteria seropositivity,EFO_0803593,0.30429885944093227,3.042995947620838,1,0.4,0.4,transcript,54398.0
DMAC1,ENSG00000137038,pulse pressure measurement,EFO_0005763,0.30429885944093227,3.0431041679429836,1,0.4,0.4,transcript,3461.0
DMAC1,ENSG00000137038,systolic blood pressure,EFO_0006335,0.30429885944093227,3.0431041679429836,1,0.4,0.4,transcript,3461.0
DIRAS2,ENSG00000165023,white matter integrity,EFO_0004641,0.30429885944093227,3.0430648429796623,1,0.4,0.4,transcript,5246.0
THEM4,ENSG00000159445,tetradecadienoate (14:2) measurement,EFO_0800570,0.30415922814639473,3.041746632226054,2,0.8,1.6,transcript,10366.0
CCDC34,ENSG00000109881,heel bone mineral density,EFO_0009270,0.30415044737002744,3.0415979971980533,1,0.4,0.4,transcript,4277.0
ZNF471,ENSG00000196263,smoking initiation,EFO_0005670,0.30414869754252655,3.0415172143124742,1,0.4,0.4,transcript,13228.0
OXSR1,ENSG00000172939,pathological myopia,EFO_0004207,0.3041326788877129,3.04136736505891,1,0.4,0.4,transcript,9858.0
PAG1,ENSG00000076641,erythrocyte volume,OBA_0003460,0.3040796780376101,3.0409268722534892,2,0.8,1.6,transcript,12299.0
TRIT1,ENSG00000043514,FEV/FVC ratio,EFO_0004713,0.3040490715834403,3.0405059186013066,1,0.4,0.4,transcript,26311.0
P3H4,ENSG00000141696,low density lipoprotein cholesterol measurement,EFO_0004611,0.3040309661360173,3.0403496373745647,1,0.4,0.4,transcript,10006.0
TMEM132B,ENSG00000139364,whole body water mass,EFO_0009805,0.3039934488201664,3.0400238514882467,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
LATS1,ENSG00000131023,hepatocellular carcinoma,EFO_0000182,0.30398922521758104,3.039909608766976,1,0.4,0.4,transcript,23046.0
SLC35B4,ENSG00000205060,"beta-1,4-galactosyltransferase 7 measurement",EFO_0802314,0.3039265279201762,3.03930719913469,1,0.4,0.4,transcript,9542.0
CHL1,ENSG00000134121,pericarditis,EFO_0007427,0.3039070272572408,3.0391174729972117,2,0.8,1.6,transcript,33898.0
NSUN7,ENSG00000179299,metabolite measurement,EFO_0004725,0.3039070272572408,3.0391093015318957,1,0.5,0.5,transcript,12811.0
FAM114A1,ENSG00000197712,ocular hypotension,MONDO_0004390,0.3038747988830194,3.0387966683969454,1,0.4,0.4,transcript,8217.0
CASQ2,ENSG00000118729,neurodegenerative disease,EFO_0005772,0.30386924583104535,3.0387051093320236,1,0.4,0.4,transcript,31618.0
SMC6,ENSG00000163029,IGF-1 measurement,EFO_0004627,0.30386501062811844,3.038666515864381,1,0.4,0.4,transcript,24376.0
YTHDC2,ENSG00000047188,neurodegenerative disease,EFO_0005772,0.3038271353680836,3.038291562845692,1,0.4,0.4,transcript,19793.0
MCF2L2,ENSG00000053524,hypertrophic cardiomyopathy,EFO_0000538,0.30381948703192724,3.038236320022648,2,0.8,1.6,transcript,38601.0
ZNF675,ENSG00000197372,growth differentiation factor 15 amount,OBA_2050135,0.30381948703192724,3.0382376675460123,1,0.5,0.5,transcript,11683.0
TMEM154,ENSG00000170006,aspartate aminotransferase measurement,EFO_0004736,0.30381948703192724,3.0382139551992764,1,0.4,0.4,transcript,20959.0
OTULIN,ENSG00000154124,calcium measurement,EFO_0004838,0.30378650664134577,3.037884300881625,1,0.4,0.4,transcript,20796.0
SLCO1C1,ENSG00000139155,sitting height measurement,EFO_0011011,0.30375567647827184,3.037587655676083,1,0.5,0.5,transcript,16186.0
C15orf61,ENSG00000189227,taste liking measurement,EFO_0010155,0.3037457906485851,3.0390794404569874,5,2.0,10.0,transcript,6167.0
NUDCD1,ENSG00000120526,arterial stiffness measurement,EFO_0004517,0.30367019299900033,3.0367129183972335,1,0.4,0.4,transcript,36402.0
LRRIQ3,ENSG00000162620,urinary microalbumin measurement,EFO_0010967,0.30367019299900033,3.0367288261707452,1,0.5,0.5,transcript,18590.0
FRMD4B,ENSG00000114541,benign chondrogenic neoplasm,MONDO_0024470,0.30367019299900033,3.036778026251774,2,0.8,1.6,transcript,21026.0
ABCA13,ENSG00000179869,drug allergy,EFO_0009482,0.30367019299900033,3.0367122618493245,1,0.5,0.5,transcript,48394.0
MAN1A2,ENSG00000198162,body weight,EFO_0004338,0.30363355688325,3.036463089355334,2,0.8,1.6,transcript,12547.0
MSX2,ENSG00000120149,hemorrhage,MP_0001914,0.30362258881904297,3.0363441264405036,1,0.4,0.4,transcript,3383.0
FRS2,ENSG00000166225,multinodular goiter,MONDO_0000334,0.3036111016984503,3.0361271258806406,1,0.4,0.4,transcript,24831.0
FRS2,ENSG00000166225,bone tissue density,OBA_1000110,0.3036111016984503,3.0361271258806406,1,0.4,0.4,transcript,24831.0
TMPRSS4,ENSG00000137648,candidiasis,MONDO_0002026,0.30359803195101714,3.035990651156003,1,0.4,0.4,transcript,38716.0
FIGNL1,ENSG00000132436,erythrocyte count,EFO_0004305,0.30359769421023813,3.0359931246414216,1,0.4,0.4,transcript,24718.0
TRMT9B,ENSG00000250305,protein measurement,EFO_0004747,0.3035863802212217,3.0360049288733957,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
ATXN7L3B,ENSG00000253719,bilirubin measurement,EFO_0004570,0.30357092215736725,3.035761880868038,1,0.4,0.4,transcript,7596.0
ATXN3,ENSG00000066427,Abnormality of the skeletal system,HP_0000924,0.30356274413421225,3.0356331645396732,1,0.4,0.4,transcript,69891.0
ARMC1,ENSG00000104442,serum creatinine amount,OBA_2050096,0.3035613192892094,3.035657741282783,1,0.4,0.4,transcript,8979.0
UBL3,ENSG00000122042,neurofibrillary tangles measurement,EFO_0006797,0.3035398250740415,3.036232163179609,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
PHC1,ENSG00000111752,body height,OBA_VT0001253,0.3035204924183505,3.035224074668012,1,0.5,0.5,transcript,26109.0
HHLA2,ENSG00000114455,liver disease,EFO_0001421,0.30351640883118963,3.035197892652374,1,0.5,0.5,transcript,14791.0
FAM8A1,ENSG00000137414,temporal measurement,EFO_0000719,0.3035025173706276,3.035044415576586,1,0.4,0.4,transcript,20788.0
IL17A,ENSG00000112115,cystatin C measurement,EFO_0004617,0.30347714787527624,3.0349852681701863,1,0.4,0.4,transcript,1871.0
TSPAN3,ENSG00000140391,blood urea nitrogen measurement,EFO_0004741,0.30347410970270483,3.034763007631781,1,0.4,0.4,transcript,18256.0
PAG1,ENSG00000076641,ovarian dysfunction,EFO_0009003,0.3034676632097474,3.0348067239748624,2,0.8,1.6,transcript,12299.0
PCDH18,ENSG00000189184,Agents acting on the renin-angiotensin system use measurement,EFO_0009931,0.3034476778771722,3.03455395043043,2,0.8,1.6,transcript,20733.0
CMYA5,ENSG00000164309,cardiomyopathy,EFO_0000318,0.3034436949832436,3.0344645665129106,1,0.5,0.5,transcript,18105.0
F13B,ENSG00000143278,white matter hyperintensity measurement,EFO_0005665,0.303396431182973,3.034072209973882,1,0.5,0.5,transcript,4634.0
AGPAT5,ENSG00000155189,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.3033894654604894,3.0339320273041372,1,0.4,0.4,transcript,10703.0
CPD,ENSG00000108582,erythrocyte volume,OBA_0003460,0.3033871083012261,3.0338913013705304,1,0.4,0.4,transcript,19784.0
TULP4,ENSG00000130338,myeloid leukocyte count,OBA_2045223,0.30337495184196844,3.0337684434764594,1,0.4,0.4,transcript,21136.0
NPS,ENSG00000214285,growth differentiation factor 15 amount,OBA_2050135,0.3033595250154228,3.0339201892281515,1,0.4,0.4,transcript,1231.0
PEAK1,ENSG00000173517,response to antihypertensive drug,EFO_0005405,0.30334696220320306,3.0334765444832703,1,0.4,0.4,transcript,57783.0
FBXO28,ENSG00000143756,high density lipoprotein cholesterol measurement,EFO_0004612,0.30325824962541426,3.033631483980986,5,2.0,10.0,transcript,9533.0
TRIM36,ENSG00000152503,brain connectivity attribute,OBA_2045295,0.3032458006571965,3.032484167461435,1,0.4,0.4,transcript,15290.0
DENND3,ENSG00000105339,Alzheimer disease,MONDO_0004975,0.3032168764305209,3.032179580962862,1,0.5,0.5,transcript,46225.0
TRAM1,ENSG00000067167,bone tissue density,OBA_1000110,0.30318972533557,3.0320877522246126,2,0.8,1.6,transcript,8399.0
MORF4L2,ENSG00000123562,lymphocyte percentage of leukocytes,EFO_0007993,0.3031821610485687,3.03185246040085,1,0.4,0.4,transcript,12966.0
MORF4L2,ENSG00000123562,glomerular filtration rate,OBA_0003747,0.3031821610485687,3.03185246040085,1,0.4,0.4,transcript,12966.0
TRAM1,ENSG00000067167,hip geometry,EFO_0004685,0.30317965034502165,3.0319870023191293,2,0.8,1.6,transcript,8399.0
BTAF1,ENSG00000095564,sex hormone-binding globulin measurement,EFO_0004696,0.3031614081316349,3.031650825758752,1,0.4,0.4,transcript,10886.0
DENND3,ENSG00000105339,diastolic blood pressure change measurement,EFO_0006945,0.3031323069691158,3.031333886348811,1,0.5,0.5,transcript,46225.0
TAF1B,ENSG00000115750,spermatocele,EFO_1001189,0.3031323069691158,3.0313774707356584,1,0.5,0.5,transcript,9191.0
PRDM10,ENSG00000170325,Abruptio Placentae,EFO_1001754,0.3031323069691158,3.03133447219971,1,0.4,0.4,transcript,35080.0
DENND3,ENSG00000105339,post term pregnancy,EFO_0009681,0.3031323069691158,3.031333886348811,1,0.5,0.5,transcript,46225.0
PPP1R2,ENSG00000184203,high density lipoprotein cholesterol measurement,EFO_0004612,0.3031323069691158,3.031369554293134,1,0.4,0.4,transcript,8605.0
SOS1,ENSG00000115904,arterial stiffness measurement,EFO_0004517,0.3031323069691158,3.031346677564384,2,0.8,1.6,transcript,67774.0
CPO,ENSG00000144410,ovarian neoplasm,EFO_0003893,0.3031323069691158,3.031724676116861,1,0.5,0.5,transcript,1245.0
BHLHE41,ENSG00000123095,QT interval,EFO_0004682,0.3031268530660707,3.031356811393437,1,0.4,0.4,transcript,4531.0
ZPLD1,ENSG00000170044,neurodegenerative disease,EFO_0005772,0.3031126080149925,3.031285062661849,2,0.8,1.6,transcript,10064.0
FAM171B,ENSG00000144369,triglyceride measurement,EFO_0004530,0.30309856884043834,3.0310554842515307,1,0.4,0.4,transcript,5731.0
GANC,ENSG00000214013,triglyceride measurement,EFO_0004530,0.30308647872240446,3.0308940612287283,1,0.5,0.5,transcript,17080.0
OR2T12,ENSG00000177201,major depressive disorder,MONDO_0002009,0.30307191201826106,3.033241895235168,6,2.4000000000000004,14.400000000000002,transcript,5708.0
USP15,ENSG00000135655,smoking initiation,EFO_0005670,0.30303151609295836,3.030398278772214,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
PCDH18,ENSG00000189184,lymphocyte count,EFO_0004587,0.3029730420450947,3.029807592109655,2,0.8,1.6,transcript,20733.0
ZNF143,ENSG00000166478,platelet count,EFO_0004309,0.30296332975626983,3.029659577390303,1,0.5,0.5,transcript,19026.0
RTKN2,ENSG00000182010,BMI-adjusted waist-hip ratio,EFO_0007788,0.3029322263067781,3.02935752089061,1,0.4,0.4,transcript,11345.0
CD2AP,ENSG00000198087,late-onset Alzheimers disease,EFO_1001870,0.30287859005885887,3.028837970362085,1,0.4,0.4,transcript,7682.0
STXBP4,ENSG00000166263,prostate carcinoma,EFO_0001663,0.30287174118569177,3.029109123243968,5,2.0,10.0,transcript,25529.0
C2CD4A,ENSG00000198535,triglyceride measurement,EFO_0004530,0.3028593004623687,3.0287091149284766,1,0.4,0.4,transcript,3445.0
KIF20B,ENSG00000138182,cerebral cortex area attribute,OBA_2045267,0.30285921530161775,3.028619464973352,1,0.5,0.5,transcript,18307.0
PLEKHA6,ENSG00000143850,erythrocyte volume,OBA_0003460,0.3028362212226342,3.028369026884672,1,0.4,0.4,transcript,58697.0
NDUFAF4,ENSG00000123545,prostate cancer,MONDO_0008315,0.3027868016330148,3.027979561226969,1,0.4,0.4,transcript,3586.0
KIAA0586,ENSG00000100578,urinary microalbumin measurement,EFO_0010967,0.3027274861419058,3.0272805124775015,1,0.5,0.5,transcript,88479.0
CCDC77,ENSG00000120647,serum creatinine amount,OBA_2050096,0.30267922295678795,3.0268205943388344,1,0.4,0.4,transcript,14102.0
CCDC77,ENSG00000120647,glomerular filtration rate,OBA_0003747,0.30267922295678795,3.0268205943388344,1,0.4,0.4,transcript,14102.0
C2orf73,ENSG00000177994,mean corpuscular hemoglobin concentration,EFO_0004528,0.30267532128456937,3.0268015220244378,1,0.4,0.4,transcript,8280.0
PLA2R1,ENSG00000153246,bilirubin measurement,EFO_0004570,0.3026686537368751,3.0267657296079116,2,0.8,1.6,transcript,20204.0
ALPK3,ENSG00000136383,monocyte percentage of leukocytes,EFO_0007989,0.30265664829870936,3.0266037790243896,1,0.4,0.4,transcript,10725.0
FIGNL1,ENSG00000132436,body weights and measures,EFO_0004324,0.3026329166599111,3.0263453491381513,1,0.4,0.4,transcript,24718.0
WWTR1,ENSG00000018408,esophageal squamous cell carcinoma,EFO_0005922,0.30258020287080023,3.0258868643389674,2,0.8,1.6,transcript,18860.0
GLCE,ENSG00000138604,N-acetylglutamate measurement,EFO_0800005,0.3025663756382464,3.0257940813804276,2,0.8,1.6,transcript,12277.0
SH3TC2,ENSG00000169247,male infertility,EFO_0004248,0.30256444767620483,3.025648900170727,1,0.4,0.4,transcript,90428.0
HPSE,ENSG00000173083,lymphangioma,MONDO_0002013,0.3025445037266402,3.025532884997002,2,0.9,1.8,transcript,20490.0
HPSE,ENSG00000173083,hemangioma,EFO_1000635,0.3025445037266402,3.025532884997002,2,0.9,1.8,transcript,20490.0
CD2AP,ENSG00000198087,level of CD2-associated protein in blood serum,OBA_2040941,0.30251720254818654,3.025224095255362,1,0.4,0.4,transcript,7682.0
TENT4B,ENSG00000121274,platelet crit,EFO_0007985,0.302489941674749,3.0251488321800704,4,1.6,6.4,transcript,25660.0
ZNF429,ENSG00000197013,device complication,EFO_0009519,0.30247842534878583,3.024940062232624,2,0.8,1.6,transcript,10269.0
WWTR1,ENSG00000018408,head and neck squamous cell carcinoma,EFO_0000181,0.302422061164888,3.024305447279845,2,0.8,1.6,transcript,18860.0
PRKCB,ENSG00000166501,response to xenobiotic stimulus,GO_0009410,0.3024001185151857,3.0240251515988312,1,0.4,0.4,transcript,16690.0
SMARCC1,ENSG00000173473,heart rate,OBA_1001087,0.30237051316695535,3.023819278776638,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,heart rate,OBA_1001087,0.30237051316695535,3.023819278776638,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,heart rate,OBA_1001087,0.30237051316695535,3.023819278776638,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,heart rate,OBA_1001087,0.30237051316695535,3.023819278776638,2,0.8,1.6,transcript,14017.0
LHX9,ENSG00000143355,hypertrophic cardiomyopathy,EFO_0000538,0.30236479107348274,3.023722177351983,2,0.8,1.6,transcript,21544.0
LHX9,ENSG00000143355,urinary microalbumin measurement,EFO_0010967,0.30236479107348274,3.023722177351983,2,0.8,1.6,transcript,21544.0
RIF1,ENSG00000080345,Fuchs' endothelial dystrophy,MONDO_0005321,0.30236479107348274,3.0237094540518545,3,1.3,3.9000000000000004,transcript,63370.0
EVI5,ENSG00000067208,lymphocyte percentage of leukocytes,EFO_0007993,0.30232437886603203,3.023249444608964,1,0.4,0.4,transcript,70722.0
SMARCC1,ENSG00000173473,type 2 diabetes mellitus,MONDO_0005148,0.3022967458463348,3.0230816055704324,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,type 2 diabetes mellitus,MONDO_0005148,0.3022967458463348,3.0230816055704324,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,type 2 diabetes mellitus,MONDO_0005148,0.3022967458463348,3.0230816055704324,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,type 2 diabetes mellitus,MONDO_0005148,0.3022967458463348,3.0230816055704324,2,0.8,1.6,transcript,14017.0
WWTR1,ENSG00000018408,mean corpuscular hemoglobin concentration,EFO_0004528,0.3022899723618682,3.022984559249647,2,0.8,1.6,transcript,18860.0
CNTN1,ENSG00000018236,platelet crit,EFO_0007985,0.30225162970384106,3.022532823915244,1,0.4,0.4,transcript,24203.0
KLHDC10,ENSG00000128607,platelet volume,OBA_0003277,0.30225101620726164,3.0225598947594245,1,0.4,0.4,transcript,8043.0
UBE2U,ENSG00000177414,blood protein measurement,EFO_0007937,0.3022498807929915,3.0225660235239324,1,0.4,0.4,transcript,5951.0
DGKH,ENSG00000102780,hypertension,EFO_0000537,0.30223746860960365,3.0224020791347805,2,0.8,1.6,transcript,58409.0
GPR85,ENSG00000164604,2-aminoadipate measurement,EFO_0800137,0.302229563113882,3.022319178557434,1,0.4,0.4,transcript,16987.0
TMEM170B,ENSG00000205269,mean corpuscular hemoglobin concentration,EFO_0004528,0.302208940426179,3.022134393576828,1,0.4,0.4,transcript,8891.0
SV2C,ENSG00000122012,mean reticulocyte volume,EFO_0010701,0.3022000465629596,3.0220284944993323,1,0.4,0.4,transcript,14271.0
ARHGAP20,ENSG00000137727,cortical thickness,EFO_0004840,0.3021928425995497,3.0219386705850733,1,0.4,0.4,transcript,39045.0
GPR158,ENSG00000151025,central corneal thickness,EFO_0005213,0.3021909822940144,3.0219354942447603,1,0.5,0.5,transcript,19477.0
ROCK2,ENSG00000134318,serum gamma-glutamyl transferase measurement,EFO_0004532,0.30218792989983984,3.021890292600122,1,0.5,0.5,transcript,45481.0
MGA,ENSG00000174197,FEV/FVC ratio,EFO_0004713,0.3021710920531773,3.021716842316836,1,0.5,0.5,transcript,84434.0
ADGRA1,ENSG00000197177,blood N(8)-acetylspermidine measurement,EFO_0022205,0.3021557096103203,3.0216090306656542,1,0.4,0.4,transcript,7702.0
ADGRA1,ENSG00000197177,metabolite ratio,EFO_0022223,0.3021557096103203,3.0216090306656542,1,0.4,0.4,transcript,7702.0
ADGRA1,ENSG00000197177,blood N(1)-acetylspermidine measurement,EFO_0022204,0.3021557096103203,3.0216090306656542,1,0.4,0.4,transcript,7702.0
ADGRA1,ENSG00000197177,autoimmune thyroid disease,EFO_0006812,0.3021557096103203,3.0216090306656542,1,0.4,0.4,transcript,7702.0
CDKL2,ENSG00000138769,type 2 diabetes mellitus,MONDO_0005148,0.3020571276345804,3.0207353789099067,2,0.8,1.6,transcript,9750.0
CDH19,ENSG00000071991,smoking initiation,EFO_0005670,0.3020531076220335,3.020805633877443,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
SLC35B4,ENSG00000205060,insomnia measurement,EFO_0007876,0.3020402544513801,3.020444464446729,1,0.4,0.4,transcript,9542.0
PEAK1,ENSG00000173517,Drugs used in diabetes use measurement,EFO_0009924,0.3020261647267745,3.020268569718985,1,0.4,0.4,transcript,57783.0
GBP1,ENSG00000117228,neurodegenerative disease,EFO_0005772,0.3020154227484438,3.020258042693366,2,0.8,1.6,transcript,15412.0
CWH43,ENSG00000109182,Abruptio Placentae,EFO_1001754,0.3020142655168424,3.020204728414855,1,0.5,0.5,transcript,8055.0
IL1A,ENSG00000115008,hidradenitis suppurativa,EFO_1000710,0.3019755788855617,3.0199541031838275,1,0.4,0.4,transcript,2017.0
TRIM36,ENSG00000152503,cortical thickness,EFO_0004840,0.30192914396972537,3.019317600586724,1,0.4,0.4,transcript,15290.0
DIRAS2,ENSG00000165023,N-acetylmethionine measurement,EFO_0021427,0.30191479822779443,3.019224230848284,1,0.4,0.4,transcript,5246.0
ANKRD10,ENSG00000088448,educational attainment,EFO_0011015,0.3019007142705789,3.019185237095816,2,0.8,1.6,transcript,8984.0
C2CD4A,ENSG00000198535,arterial stiffness measurement,EFO_0004517,0.30185896329775647,3.018705743282354,1,0.4,0.4,transcript,3445.0
SLC36A4,ENSG00000180773,total cholesterol measurement,EFO_0004574,0.30182330741531427,3.018343609559015,2,0.8,1.6,transcript,14475.0
IPP,ENSG00000197429,neutrophil count,EFO_0004833,0.3018144693760835,3.0182254692051003,1,0.5,0.5,transcript,6190.0
EXD1,ENSG00000178997,hematocrit,EFO_0004348,0.3018133583376386,3.018175367561072,1,0.4,0.4,transcript,9573.0
TMED5,ENSG00000117500,self reported educational attainment,EFO_0004784,0.3017992218338227,3.018024185603747,1,0.5,0.5,transcript,15641.0
SOS1,ENSG00000115904,thyroid gland adenocarcinoma,MONDO_0024622,0.3017763930669202,3.0177875385424278,2,0.8,1.6,transcript,67774.0
KCNIP4,ENSG00000185774,ovarian dysfunction,EFO_0009003,0.30175924602718346,3.017725108257243,2,0.8,1.6,transcript,12062.0
WWTR1,ENSG00000018408,oral squamous cell carcinoma,EFO_0000199,0.30172227858358014,3.0173076214667662,2,0.8,1.6,transcript,18860.0
IQGAP1,ENSG00000140575,pancreatic adenocarcinoma,EFO_1000044,0.30169227202394583,3.0169768181566887,2,0.8,1.6,transcript,29576.0
CPD,ENSG00000108582,estrogen-receptor positive breast cancer,EFO_1000649,0.3016802095138928,3.0168223134971974,1,0.4,0.4,transcript,19784.0
KCNJ15,ENSG00000157551,BMI-adjusted waist circumference,EFO_0007789,0.3016778037854484,3.0167878719048833,1,0.4,0.4,transcript,40675.0
ATP10D,ENSG00000145246,neurodegenerative disease,EFO_0005772,0.30164584438144,3.0164902666249906,1,0.5,0.5,transcript,15712.0
ATP10D,ENSG00000145246,lysosomal storage disease,MONDO_0002561,0.30164584438144,3.0164902666249906,1,0.5,0.5,transcript,15712.0
RAD23B,ENSG00000119318,glucose measurement,EFO_0004468,0.30154592743203035,3.0154995481825666,1,0.4,0.4,transcript,9932.0
SLC25A36,ENSG00000114120,response to antihypertensive drug,EFO_0005405,0.3015354937206993,3.015368604010328,1,0.4,0.4,transcript,29268.0
ACADSB,ENSG00000196177,nutritional deficiency disease,EFO_1001067,0.3015322345958105,3.015369167917604,1,0.4,0.4,transcript,8543.0
LGSN,ENSG00000146166,cervical carcinoma,EFO_0001061,0.3015285284137684,3.015315881552203,1,0.4,0.4,transcript,13073.0
PPP1R9A,ENSG00000158528,X-21286 measurement,EFO_0800804,0.3015285284137684,3.015364292281601,3,1.3,3.9000000000000004,transcript,49362.0
CD93,ENSG00000125810,placenta praevia,EFO_0007442,0.30150595000077796,3.015085817528669,1,0.4,0.4,transcript,15199.0
SLC15A5,ENSG00000188991,severe acute respiratory syndrome,EFO_0000694,0.3015025171548556,3.0162567829067495,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
SLC15A5,ENSG00000188991,COVID-19,MONDO_0100096,0.3015025171548556,3.0162567829067495,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
SLC25A46,ENSG00000164209,mortality,EFO_0004352,0.3014850152037014,3.0148701051472053,1,0.4,0.4,transcript,20047.0
STAU2,ENSG00000040341,appendicular lean mass,EFO_0004980,0.30145947738206463,3.0146063420035163,1,0.5,0.5,transcript,43222.0
RAD18,ENSG00000070950,lignoceroylcarnitine (C24) measurement,EFO_0800541,0.30144558198495025,3.014489301058174,1,0.4,0.4,transcript,11947.0
GAGE1,ENSG00000205777,platelet component distribution width,EFO_0007984,0.3014345470628759,3.014410808753555,1,0.4,0.4,transcript,6122.0
YIPF4,ENSG00000119820,androsterone glucuronide measurement,EFO_0800317,0.3014287143978479,3.0144053210964348,2,0.8,1.6,transcript,13539.0
EDEM1,ENSG00000134109,triglyceride measurement,EFO_0004530,0.3014154473140634,3.014287451864038,2,0.8,1.6,transcript,12032.0
DIRAS2,ENSG00000165023,foot-and-mouth disease virus seropositivity,EFO_0803680,0.3014154473140634,3.014230721710973,1,0.4,0.4,transcript,5246.0
EDEM1,ENSG00000134109,sleep duration trait,OBA_2040171,0.3014154473140634,3.014287451864038,2,0.8,1.6,transcript,12032.0
SP8,ENSG00000164651,protein measurement,EFO_0004747,0.3014154473140634,3.014229379507675,1,0.4,0.4,transcript,5340.0
GPAT3,ENSG00000138678,urate measurement,EFO_0004531,0.3014154473140634,3.0143015995774154,2,0.8,1.6,transcript,10875.0
DMAC1,ENSG00000137038,alcohol consumption quality,OBA_1000840,0.3014154473140634,3.0142700466742944,1,0.4,0.4,transcript,3461.0
LRRC7,ENSG00000033122,delta-5 desaturase measurement,EFO_0007764,0.3014154473140634,3.014218576846184,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
LRRC7,ENSG00000033122,response to polyunsaturated fatty acid supplementation,EFO_0009131,0.3014154473140634,3.014218576846184,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
ITM2A,ENSG00000078596,3-hydroxy-1-methylpropylmercapturic acid measurement,EFO_0007015,0.3014154473140634,3.0145544731406337,1,0.4,0.4,transcript,1000.0
SPOCK3,ENSG00000196104,mastiha supplement exposure measurement,EFO_0600067,0.3014154473140634,3.0142368379251128,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
DLGAP1,ENSG00000170579,self reported educational attainment,EFO_0004784,0.3014154473140634,3.0141826272845718,2,0.8,1.6,transcript,56830.0
DIRAS2,ENSG00000165023,sleep quality,OBA_2040170,0.3014154473140634,3.014230721710973,1,0.4,0.4,transcript,5246.0
MSX2,ENSG00000120149,mathematical ability,EFO_0004875,0.3014154473140634,3.0142727113907077,1,0.4,0.4,transcript,3383.0
CA8,ENSG00000178538,insomnia measurement,EFO_0007876,0.3014154473140634,3.0141954273742777,1,0.4,0.4,transcript,9767.0
TRIM36,ENSG00000152503,3-hydroxy-1-methylpropylmercapturic acid measurement,EFO_0007015,0.3014154473140634,3.014180634030104,1,0.4,0.4,transcript,15290.0
MMADHC,ENSG00000168288,educational attainment,EFO_0011015,0.3014154473140634,3.014236039209149,1,0.4,0.4,transcript,4904.0
PCDH18,ENSG00000189184,educational attainment,EFO_0011015,0.3014154473140634,3.014231644799342,2,0.8,1.6,transcript,20733.0
YTHDC2,ENSG00000047188,congenital heart disease,EFO_0005207,0.3014154473140634,3.01417468230549,1,0.4,0.4,transcript,19793.0
C4orf33,ENSG00000151470,"osteoarthritis, knee",EFO_0004616,0.3014154473140634,3.01460552677373,4,1.6,6.4,transcript,14189.0
MSX2,ENSG00000120149,clostridium difficile infection,EFO_0009130,0.3014154473140634,3.0142727113907077,1,0.4,0.4,transcript,3383.0
TXNL1,ENSG00000091164,vital capacity,EFO_0004312,0.3014154473140634,3.0142366719590257,2,0.8,1.6,transcript,19465.0
FAM98A,ENSG00000119812,glucagon measurement,EFO_0008463,0.3014154473140634,3.014161826352149,1,0.4,0.4,transcript,54398.0
SPOCK3,ENSG00000196104,antioxidant measurement,EFO_0005119,0.3014154473140634,3.0142368379251128,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
SEMA3C,ENSG00000075223,bone tissue density,OBA_1000110,0.3014154473140634,3.014188191424373,1,0.4,0.4,transcript,11863.0
BTLA,ENSG00000186265,frozen shoulder,EFO_1000941,0.3014054180108465,3.014234540829908,2,0.9,1.8,transcript,9980.0
KIAA0319,ENSG00000137261,urate measurement,EFO_0004531,0.3013885829829542,3.0138982171820548,1,0.4,0.4,transcript,32291.0
SPRED1,ENSG00000166068,whole body water mass,EFO_0009805,0.30131280042758746,3.0131725774873748,1,0.4,0.4,transcript,8974.0
GLB1,ENSG00000170266,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.3012968723672338,3.01299963175171,1,0.5,0.5,transcript,16177.0
LYPD6,ENSG00000187123,lymphocyte count,EFO_0004587,0.3012392710133438,3.0124254594375155,1,0.4,0.4,transcript,12214.0
TRHDE,ENSG00000072657,high density lipoprotein cholesterol measurement,EFO_0004612,0.3012392710133438,3.0124922807352177,2,0.8,1.6,transcript,16069.0
TNPO3,ENSG00000064419,age at menopause,EFO_0004704,0.301234098436383,3.0123676567205995,1,0.5,0.5,transcript,18746.0
SAXO1,ENSG00000155875,platelet volume,OBA_0003277,0.3012288759499174,3.012315435057693,1,0.4,0.4,transcript,14995.0
PCNX4,ENSG00000126773,lifestyle measurement,EFO_0010724,0.30121571966658767,3.0121668607425707,1,0.5,0.5,transcript,51738.0
C2CD4A,ENSG00000198535,appendicular lean mass,EFO_0004980,0.30120224870606177,3.012138597365407,1,0.4,0.4,transcript,3445.0
RFX3,ENSG00000080298,metabolite measurement,EFO_0004725,0.3011579988515596,3.0116364896809324,2,0.8,1.6,transcript,28318.0
ITGA8,ENSG00000077943,blood pyridoxal measurement,EFO_0022222,0.3011579988515596,3.012044744518694,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
CLSTN2,ENSG00000158258,retinopathy,EFO_0003839,0.3011579988515596,3.0116040747442945,1,0.4,0.4,transcript,16607.0
LRRC7,ENSG00000033122,bilirubin measurement,EFO_0004570,0.3011579988515596,3.0116440922211463,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
DLGAP1,ENSG00000170579,Hypercholesterolemia,HP_0003124,0.3011579988515596,3.011608142659534,2,0.8,1.6,transcript,56830.0
MCL1,ENSG00000143384,total blood protein measurement,EFO_0004536,0.3011566928276606,3.0115836976557198,1,0.4,0.4,transcript,23853.0
SOS1,ENSG00000115904,glioblastoma multiforme,EFO_0000519,0.3011416297175595,3.0114399050488205,2,0.8,1.6,transcript,67774.0
RSBN1L,ENSG00000187257,eosinophil percentage of leukocytes,EFO_0007991,0.30113316014011826,3.011468318482273,2,0.8,1.6,transcript,11703.0
CENPQ,ENSG00000031691,mosaic loss of chromosome X measurement,EFO_0022842,0.3011191210990339,3.011420964005847,1,0.4,0.4,transcript,1741.0
ABCB5,ENSG00000004846,eosinophil percentage of leukocytes,EFO_0007991,0.3010975726425364,3.0110026388925646,1,0.4,0.4,transcript,14863.0
TNPO3,ENSG00000064419,anti-citrullinated protein antibody seropositivity,EFO_0007837,0.3010924621262244,3.010951293619014,1,0.5,0.5,transcript,18746.0
TNPO3,ENSG00000064419,renal carcinoma,EFO_0002890,0.3010924621262244,3.010951293619014,1,0.5,0.5,transcript,18746.0
TNPO3,ENSG00000064419,rheumatoid factor seropositivity measurement,EFO_0007791,0.3010924621262244,3.010951293619014,1,0.5,0.5,transcript,18746.0
ATP10D,ENSG00000145246,multiple sclerosis,MONDO_0005301,0.30109147459941293,3.01094656880472,1,0.5,0.5,transcript,15712.0
ATP10D,ENSG00000145246,Alzheimer disease,MONDO_0004975,0.30109147459941293,3.01094656880472,1,0.5,0.5,transcript,15712.0
TXK,ENSG00000074966,neurodegenerative disease,EFO_0005772,0.30109147459941293,3.010944138308039,1,0.4,0.4,transcript,13609.0
RGS4,ENSG00000117152,lymphocyte count,EFO_0004587,0.30107944571530065,3.01089072670776,2,0.8,1.6,transcript,16620.0
PTBP3,ENSG00000119314,blood sodium bicarbonate amount,OBA_2050094,0.3010700126472054,3.010933564074183,5,2.0,10.0,transcript,42838.0
XG,ENSG00000124343,erythrocyte volume,OBA_0003460,0.3010527061755844,3.010739856010399,2,0.8,1.6,transcript,7519.0
ATG16L1,ENSG00000085978,growth differentiation factor 15 amount,OBA_2050135,0.3010527061755844,3.0105390532418888,1,0.4,0.4,transcript,33357.0
TTL,ENSG00000114999,mean corpuscular hemoglobin concentration,EFO_0004528,0.30100893969717174,3.010109165677856,1,0.4,0.4,transcript,20234.0
ALG10B,ENSG00000175548,liver disease,EFO_0001421,0.301001590049358,3.0107217164167874,5,2.0,10.0,transcript,14168.0
MARCKS,ENSG00000277443,bilirubin measurement,EFO_0004570,0.301001590049358,3.0101090103632266,1,0.4,0.4,transcript,4296.0
ALG10B,ENSG00000175548,wellbeing measurement,EFO_0007869,0.301001590049358,3.0107217164167874,5,2.0,10.0,transcript,14168.0
MARCKS,ENSG00000277443,gamma-glutamylglycine measurement,EFO_0800670,0.301001590049358,3.0101090103632266,1,0.4,0.4,transcript,4296.0
TECRL,ENSG00000205678,liver disease,EFO_0001421,0.301001590049358,3.0104186751635287,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
SV2C,ENSG00000122012,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.301001590049358,3.010043929363316,1,0.4,0.4,transcript,14271.0
TECRL,ENSG00000205678,urinary microalbumin measurement,EFO_0010967,0.301001590049358,3.0104186751635287,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
TECRL,ENSG00000205678,placenta praevia,EFO_0007442,0.301001590049358,3.0104186751635287,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
ZNF507,ENSG00000168813,insulin-like growth factor-binding protein 7 amount,OBA_2050142,0.301001590049358,3.0100302993416723,1,0.4,0.4,transcript,27780.0
NPS,ENSG00000214285,chronotype measurement,EFO_0008328,0.3009996648350517,3.0103215874244404,1,0.4,0.4,transcript,1231.0
ARHGAP28,ENSG00000088756,benign neoplasm,EFO_0002422,0.3009627235311863,3.0096395369479807,1,0.4,0.4,transcript,32516.0
TGFBR1,ENSG00000106799,Abnormality of refraction,HP_0000539,0.3009250713806314,3.0092549613984603,1,0.4,0.4,transcript,94171.0
CIAO2A,ENSG00000166797,IGA glomerulonephritis,EFO_0004194,0.3009205832793932,3.0094264615859894,2,0.8,1.6,transcript,7252.0
INF2,ENSG00000203485,nephrotic syndrome,EFO_0004255,0.3009193574692274,3.0091966375732198,1,0.4,0.4,transcript,130596.0
GFRAL,ENSG00000187871,brain attribute,OBA_2045210,0.3009130060014061,3.0093393745090893,1,0.4,0.4,transcript,1911.0
TMEM236,ENSG00000148483,serum albumin amount,OBA_2050068,0.3009067677533221,3.0093577953936017,2,0.8,1.6,transcript,5515.0
ZNF236,ENSG00000130856,alkaline phosphatase measurement,EFO_0004533,0.3008994187164455,3.009053155223423,2,0.9,1.8,transcript,30525.0
KCNJ15,ENSG00000157551,peritonsillar abscess,EFO_0007429,0.3008947481967179,3.0089573160175784,1,0.4,0.4,transcript,40675.0
ATP12A,ENSG00000075673,neurodegenerative disease,EFO_0005772,0.30086632969049465,3.0087124490307757,1,0.4,0.4,transcript,8138.0
BIRC6,ENSG00000115760,neuroimaging measurement,EFO_0004346,0.3008315246459523,3.0083224287164754,1,0.5,0.5,transcript,69616.0
MAN1A2,ENSG00000198162,"mannosyl-oligosaccharide 1,2-alpha-mannosidase IB measurement",EFO_0801783,0.3008168560792582,3.008296081315416,2,0.8,1.6,transcript,12547.0
USP15,ENSG00000135655,self reported educational attainment,EFO_0004784,0.30081223929398376,3.008205510782468,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
SAXO1,ENSG00000155875,platelet count,EFO_0004309,0.3007677138660066,3.0077038142185852,1,0.4,0.4,transcript,14995.0
FYB1,ENSG00000082074,platelet component distribution width,EFO_0007984,0.3007382765046302,3.0074024152722796,1,0.5,0.5,transcript,25445.0
ARMC1,ENSG00000104442,high density lipoprotein cholesterol measurement,EFO_0004612,0.300733136938946,3.0073759177801493,1,0.4,0.4,transcript,8979.0
NPS,ENSG00000214285,renal osteodystrophy,EFO_1001152,0.30072613157497796,3.0075862548237033,1,0.4,0.4,transcript,1231.0
MRPL35,ENSG00000132313,diastolic blood pressure,EFO_0006336,0.3007212581297474,3.007276397506791,1,0.4,0.4,transcript,6268.0
TMEM170B,ENSG00000205269,smoking initiation,EFO_0005670,0.3006564754296082,3.00660974361112,1,0.4,0.4,transcript,8891.0
EXOC6,ENSG00000138190,brain attribute,OBA_2045210,0.30062663701132947,3.0062889873838428,1,0.5,0.5,transcript,22107.0
THEM4,ENSG00000159445,C9 carnitine measurement,EFO_0801155,0.30059608028576706,3.006115153619777,2,0.8,1.6,transcript,10366.0
TMEM192,ENSG00000170088,hemoglobin measurement,EFO_0004509,0.30052618061699077,3.00538519631412,2,0.8,1.6,transcript,12967.0
DGKH,ENSG00000102780,body weight,EFO_0004338,0.3005095961536687,3.0051233545754306,2,0.8,1.6,transcript,58409.0
PARP14,ENSG00000173193,total cholesterol measurement,EFO_0004574,0.30049147842989904,3.004928772269336,1,0.4,0.4,transcript,28596.0
PARP14,ENSG00000173193,low density lipoprotein cholesterol measurement,EFO_0004611,0.30049147842989904,3.004928772269336,1,0.4,0.4,transcript,28596.0
PARP14,ENSG00000173193,free cholesterol in large LDL measurement,EFO_0022176,0.30049147842989904,3.004928772269336,1,0.4,0.4,transcript,28596.0
KCNN3,ENSG00000143603,platelet count,EFO_0004309,0.30040153913503465,3.0041344271602863,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
KIAA0586,ENSG00000100578,metabolite measurement,EFO_0004725,0.30039769777480896,3.0039826288065328,1,0.5,0.5,transcript,88479.0
USP6,ENSG00000129204,prostate adenocarcinoma,EFO_0000673,0.3003296272567438,3.0033075691304583,1,0.4,0.4,transcript,35409.0
C18orf54,ENSG00000166845,depressive symptom measurement,EFO_0007006,0.3003115340724286,3.00320081537571,2,0.8,1.6,transcript,18719.0
C18orf54,ENSG00000166845,wellbeing measurement,EFO_0007869,0.3003115340724286,3.00320081537571,2,0.8,1.6,transcript,18719.0
C18orf54,ENSG00000166845,neuroticism measurement,EFO_0007660,0.3003115340724286,3.00320081537571,2,0.8,1.6,transcript,18719.0
IQGAP1,ENSG00000140575,thyroid gland adenocarcinoma,MONDO_0024622,0.30030815976759845,3.003135695593215,2,0.8,1.6,transcript,29576.0
ARMC1,ENSG00000104442,auditory system disease,EFO_1001455,0.3002914118169424,3.0029586665601133,1,0.4,0.4,transcript,8979.0
ARMC1,ENSG00000104442,lymphocyte count,EFO_0004587,0.3002914118169424,3.0029586665601133,1,0.4,0.4,transcript,8979.0
ARMC1,ENSG00000104442,arterial stiffness measurement,EFO_0004517,0.3002914118169424,3.0029586665601133,1,0.4,0.4,transcript,8979.0
USP15,ENSG00000135655,post term pregnancy,EFO_0009681,0.3002914118169424,3.0029972360120545,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
PPA2,ENSG00000138777,irritable bowel syndrome,EFO_0000555,0.3002349555803348,3.0023769620739027,1,0.5,0.5,transcript,18244.0
EDEM1,ENSG00000134109,smoking initiation,EFO_0005670,0.30021350778218264,3.0022680565452307,2,0.8,1.6,transcript,12032.0
NAF1,ENSG00000145414,mathematical ability,EFO_0004875,0.30021350778218264,3.002197028013872,1,0.5,0.5,transcript,8071.0
DCUN1D1,ENSG00000043093,bone tissue density,OBA_1000110,0.3001841775192073,3.0018660529293877,1,0.4,0.4,transcript,16476.0
PYHIN1,ENSG00000163564,neuroimaging measurement,EFO_0004346,0.30016905655905507,3.001728322811619,1,0.4,0.4,transcript,10594.0
DENND3,ENSG00000105339,angina pectoris,EFO_0003913,0.30016649695236236,3.001675786181276,1,0.5,0.5,transcript,46225.0
CCDC88C,ENSG00000015133,neurodegenerative disease,EFO_0005772,0.300161190350058,3.001631226238612,1,0.4,0.4,transcript,20701.0
TECRL,ENSG00000205678,N-acetylphenylalanine measurement,EFO_0800019,0.30015116484600946,3.0019144231300428,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
ALG10B,ENSG00000175548,spondylolisthesis,EFO_0007493,0.30015116484600946,3.0022174643833015,5,2.0,10.0,transcript,14168.0
ATPSCKMT,ENSG00000150756,prostate specific antigen amount,OBA_2050200,0.30015116484600946,3.0015593583837585,1,0.4,0.4,transcript,8384.0
SARAF,ENSG00000133872,androgenetic alopecia,EFO_0004191,0.30015116484600946,3.001538101736994,1,0.4,0.4,transcript,15121.0
PROK2,ENSG00000163421,eosinophil percentage of leukocytes,EFO_0007991,0.30015116484600946,3.00202711237762,2,0.8,1.6,transcript,3104.0
PROK2,ENSG00000163421,placenta praevia,EFO_0007442,0.30015116484600946,3.00202711237762,2,0.8,1.6,transcript,3104.0
GSTA5,ENSG00000182793,lipid measurement,EFO_0004529,0.300114707381923,3.0014972138752523,1,0.5,0.5,transcript,1428.0
MC2R,ENSG00000185231,protein measurement,EFO_0004747,0.3000450411725261,3.000545019104637,1,0.4,0.4,transcript,4228.0
SLF1,ENSG00000133302,diet measurement,EFO_0008111,0.30003594891769675,3.000394402330498,1,0.4,0.4,transcript,11457.0
SP8,ENSG00000164651,lymphocyte count,EFO_0004587,0.30003190392498774,3.0003939456169184,1,0.4,0.4,transcript,5340.0
SP8,ENSG00000164651,chronic obstructive pulmonary disease,EFO_0000341,0.30003190392498774,3.0003939456169184,1,0.4,0.4,transcript,5340.0
PLPP4,ENSG00000203805,glycochenodeoxycholate measurement,EFO_0010490,0.30003190392498774,3.000399929037542,1,0.4,0.4,transcript,4945.0
CHL1,ENSG00000134121,body mass index,EFO_0004340,0.30003190392498774,3.000366239674681,2,0.8,1.6,transcript,33898.0
LRRC7,ENSG00000033122,benign urinary system neoplasm,MONDO_0004180,0.30003190392498774,3.0003831429554277,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
CHL1,ENSG00000134121,lymphocyte count,EFO_0004587,0.30003190392498774,3.000366239674681,2,0.8,1.6,transcript,33898.0
RAD23B,ENSG00000119318,trauma complication,EFO_0009888,0.30003190392498774,3.0003593131121407,1,0.4,0.4,transcript,9932.0
GPM6A,ENSG00000150625,Abruptio Placentae,EFO_1001754,0.30003190392498774,3.0003372103306023,1,0.4,0.4,transcript,22013.0
MSX2,ENSG00000120149,response to xenobiotic stimulus,GO_0009410,0.30003190392498774,3.0004372774999513,1,0.4,0.4,transcript,3383.0
TPRG1,ENSG00000188001,blood urea nitrogen measurement,EFO_0004741,0.30003190392498774,3.0004188957062214,2,0.8,1.6,transcript,16023.0
SLC44A1,ENSG00000070214,Puerperal Infection,EFO_1001407,0.30003190392498774,3.000328648166952,1,0.4,0.4,transcript,41628.0
CDH19,ENSG00000071991,subarachnoid hemorrhage,EFO_0000713,0.30003190392498774,3.0005935969069855,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
NDST3,ENSG00000164100,urinary microalbumin measurement,EFO_0010967,0.30003190392498774,3.0003691018281002,1,0.4,0.4,transcript,7990.0
DMAC1,ENSG00000137038,liver disease,EFO_0001421,0.30002928251550737,3.000408398688734,1,0.4,0.4,transcript,3461.0
CD163L1,ENSG00000177675,level of retinal dehydrogenase 2 in blood,OBA_2050489,0.3000269882138489,3.0002997574092336,1,0.4,0.4,transcript,13389.0
ASPM,ENSG00000066279,ovarian neoplasm,EFO_0003893,0.29999568515846287,2.999991849931929,2,0.9,1.8,transcript,51431.0
SLC22A25,ENSG00000196600,crush injury,EFO_0009504,0.29999388264541804,2.999965420430645,1,0.4,0.4,transcript,15041.0
SHC4,ENSG00000185634,aging rate,OBA_0005494,0.2999913650478054,2.9999474257039256,1,0.4,0.4,transcript,11843.0
C4orf33,ENSG00000151470,ovarian neoplasm,EFO_0003893,0.299939973612538,2.999850789758476,4,1.6,6.4,transcript,14189.0
SCAMP1,ENSG00000085365,bronchiectasis,MONDO_0004822,0.29991596496699763,2.9991859966598327,1,0.4,0.4,transcript,15182.0
FAM210A,ENSG00000177150,femur fracture,EFO_0008553,0.29990452038132553,2.9990673497550113,1,0.4,0.4,transcript,18062.0
NDST3,ENSG00000164100,anxiety,EFO_0005230,0.29990370513958153,2.999087113974038,1,0.4,0.4,transcript,7990.0
RASGRP3,ENSG00000152689,pancreatic adenocarcinoma,EFO_1000044,0.29987184920830556,2.998729694995813,1,0.4,0.4,transcript,35705.0
PSD3,ENSG00000156011,glomerular filtration rate,OBA_0003747,0.2998454254799553,2.99846369789311,1,0.4,0.4,transcript,42359.0
SLC15A5,ENSG00000188991,high density lipoprotein cholesterol measurement,EFO_0004612,0.2998335893538405,2.9995675048965986,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
KPNA4,ENSG00000186432,metabolite measurement,EFO_0004725,0.2998136933557833,2.9981459267679593,1,0.4,0.4,transcript,44478.0
RPRD2,ENSG00000163125,tea consumption measurement,EFO_0010091,0.29975837595826793,2.9976022661062287,1,0.4,0.4,transcript,21614.0
ANKH,ENSG00000154122,Drugs used in diabetes use measurement,EFO_0009924,0.29975708535098883,2.998339296132839,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,Drugs used in diabetes use measurement,EFO_0009924,0.29975708535098883,2.998339296132839,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,Drugs used in diabetes use measurement,EFO_0009924,0.29975708535098883,2.998339296132839,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,Drugs used in diabetes use measurement,EFO_0009924,0.29975708535098883,2.998339296132839,5,2.4,12.0,gene_variant,15616.0
C4orf33,ENSG00000151470,heart rate,OBA_1001087,0.2997558141371319,2.9980091950044154,4,1.6,6.4,transcript,14189.0
PARP8,ENSG00000151883,smoking initiation,EFO_0005670,0.2997344129388014,2.997391206211505,2,0.8,1.6,transcript,33987.0
STXBP4,ENSG00000166263,hypothyroidism,EFO_0004705,0.29970192161018216,2.997410927488872,5,2.0,10.0,transcript,25529.0
ZNF267,ENSG00000185947,urinary microalbumin measurement,EFO_0010967,0.29969321941331867,2.996969696477083,1,0.4,0.4,transcript,10666.0
ALG10B,ENSG00000175548,heart rate response to exercise,EFO_0009184,0.29968891671736886,2.9975949830968958,5,2.0,10.0,transcript,14168.0
MSX2,ENSG00000120149,social environment measurement,EFO_0010552,0.2996805889845352,2.996924128095426,1,0.4,0.4,transcript,3383.0
MSX2,ENSG00000120149,cocaine use disorder,EFO_0010445,0.2996805889845352,2.996924128095426,1,0.4,0.4,transcript,3383.0
HFM1,ENSG00000162669,retinal vasculature measurement,EFO_0010554,0.2996545202431145,2.996675038837273,2,1.0,2.0,transcript,15404.0
PPA2,ENSG00000138777,blood protein measurement,EFO_0007937,0.2996264927082114,2.996292333352669,1,0.5,0.5,transcript,18244.0
NDFIP2,ENSG00000102471,body mass index,EFO_0004340,0.29961709457231517,2.99618542758914,2,0.8,1.6,transcript,110483.0
ZNF33B,ENSG00000196693,urinary microalbumin measurement,EFO_0010967,0.29953910489042335,2.995422174402241,1,0.5,0.5,transcript,16064.0
ZFP3,ENSG00000180787,neurodegenerative disease,EFO_0005772,0.2995208273058709,2.9952884816009187,1,0.4,0.4,transcript,4987.0
ALPK3,ENSG00000136383,body weight,EFO_0004338,0.2995106638518322,2.9951439345556183,1,0.4,0.4,transcript,10725.0
ALPK3,ENSG00000136383,appendicular lean mass,EFO_0004980,0.2995106638518322,2.9951439345556183,1,0.4,0.4,transcript,10725.0
ZFP90,ENSG00000184939,eosinophil percentage of leukocytes,EFO_0007991,0.2994805606354322,2.994818961501062,1,0.4,0.4,transcript,29951.0
PPFIBP2,ENSG00000166387,platelet count,EFO_0004309,0.2994563302225476,2.994576985110923,1,0.5,0.5,transcript,36542.0
TLR10,ENSG00000174123,Eczematoid dermatitis,HP_0000964,0.2994084096937811,2.9942455391549503,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
CWH43,ENSG00000109182,arterial stiffness measurement,EFO_0004517,0.29940259822956977,2.9940880555421288,1,0.5,0.5,transcript,8055.0
ZNF716,ENSG00000182111,diabetes mellitus,EFO_0000400,0.29940259822956977,2.9969050609905157,6,2.5,15.0,transcript,5210.0
ZNF716,ENSG00000182111,brain volume,OBA_2050009,0.29940259822956977,2.9969050609905157,6,2.5,15.0,transcript,5210.0
ZNF33B,ENSG00000196693,pulse wave reflection index measurement,EFO_0009804,0.29940259822956977,2.9940571077937057,1,0.5,0.5,transcript,16064.0
ZNF716,ENSG00000182111,metabolite measurement,EFO_0004725,0.29940259822956977,2.9969050609905157,6,2.5,15.0,transcript,5210.0
SENP6,ENSG00000112701,BMI-adjusted hip circumference,EFO_0008039,0.2993960722241657,2.9943897394023433,5,2.2,11.0,transcript,25640.0
SEMA3C,ENSG00000075223,posterior cortical atrophy,MONDO_0018899,0.2993881212688679,2.993914930972418,1,0.4,0.4,transcript,11863.0
IKZF3,ENSG00000161405,eosinophil count,EFO_0004842,0.29935007872530084,2.993508528089793,1,0.4,0.4,transcript,51674.0
AKR1B10,ENSG00000198074,white matter growth measurement,EFO_0009335,0.2993149088904379,2.9932812242109326,1,0.5,0.5,transcript,3784.0
FAM8A1,ENSG00000137414,HbA1c measurement,EFO_0004541,0.29923857902008216,2.9924050320711317,1,0.4,0.4,transcript,20788.0
APIP,ENSG00000149089,protein measurement,EFO_0004747,0.29922126790002485,2.992285448611659,1,0.5,0.5,transcript,6871.0
NSUN7,ENSG00000179299,X-23641 measurement,EFO_0800854,0.29915948189082764,2.991633847867764,1,0.5,0.5,transcript,12811.0
ABCB5,ENSG00000004846,Varicose veins,HP_0002619,0.29915948189082764,2.991621731375477,1,0.4,0.4,transcript,14863.0
RALGPS2,ENSG00000116191,retinal vasculature measurement,EFO_0010554,0.29912545038905897,2.9913340386124667,2,0.8,1.6,transcript,20117.0
DENND3,ENSG00000105339,Hirschsprung disease,MONDO_0018309,0.2991132957248186,2.9911437739058386,1,0.5,0.5,transcript,46225.0
NEK1,ENSG00000137601,schizophrenia,MONDO_0005090,0.29911236307990857,2.9911378906673605,2,0.8,1.6,transcript,112203.0
TMEM17,ENSG00000186889,type 2 diabetes mellitus,MONDO_0005148,0.2991070615913949,2.991134615913949,1,0.4,0.4,transcript,6250.0
PARP14,ENSG00000173193,sphingomyelin measurement,EFO_0010118,0.2991027608993906,2.9910415969642514,1,0.4,0.4,transcript,28596.0
APOBEC3H,ENSG00000100298,blood urea nitrogen measurement,EFO_0004741,0.29901871264436924,2.9902637107821954,1,0.4,0.4,transcript,5223.0
SLCO5A1,ENSG00000137571,lymphocyte count,EFO_0004587,0.2989794581525562,2.9902251334931846,5,2.0,10.0,transcript,23226.0
PSD3,ENSG00000156011,level of lipoprotein lipase in blood serum,OBA_2042223,0.2989794581525562,2.9898040246191195,1,0.4,0.4,transcript,42359.0
DMXL1,ENSG00000172869,growth differentiation factor 15 amount,OBA_2050135,0.2989794581525562,2.989805266142385,1,0.4,0.4,transcript,37437.0
RPAP3,ENSG00000005175,lung cancer,MONDO_0008903,0.2989616852835739,2.9897652207882612,2,0.8,1.6,transcript,10784.0
PF4V1,ENSG00000109272,eukaryotic translation initiation factor 4E-binding protein 2 amount,OBA_2050283,0.29894346724727366,2.989973030480812,1,0.4,0.4,transcript,743.0
SOS1,ENSG00000115904,cutaneous melanoma,EFO_0000389,0.29887471209385535,2.988770728811779,2,0.8,1.6,transcript,67774.0
CYTL1,ENSG00000170891,pulse wave reflection index measurement,EFO_0009804,0.29887197733184495,2.988938711468422,1,0.4,0.4,transcript,1827.0
SENP6,ENSG00000112701,glucose measurement,EFO_0004468,0.2988696815316993,2.9891258324776793,5,2.2,11.0,transcript,25640.0
EXOC6,ENSG00000138190,neurodegenerative disease,EFO_0005772,0.2988422015664179,2.9884446329347267,1,0.5,0.5,transcript,22107.0
ZNF429,ENSG00000197013,glomerular filtration rate,OBA_0003747,0.2988121363109067,2.9882771718538326,2,0.8,1.6,transcript,10269.0
ROCK2,ENSG00000134318,chronic graft versus host disease,MONDO_0020547,0.2987879974721194,2.987890968322918,1,0.5,0.5,transcript,45481.0
KIF20B,ENSG00000138182,educational attainment,EFO_0011015,0.29878795300862365,2.9879068420434116,1,0.5,0.5,transcript,18307.0
ARHGAP28,ENSG00000088756,sensorineural hearing loss,EFO_1001176,0.2987407318069636,2.9874196197057534,1,0.4,0.4,transcript,32516.0
ZNF697,ENSG00000143067,osteoarthritis,MONDO_0005178,0.2985919127891768,2.9865644048231177,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
ZNF236,ENSG00000130856,ovarian neoplasm,EFO_0003893,0.2984564608492574,2.9846235765515425,2,0.9,1.8,transcript,30525.0
RAD23B,ENSG00000119318,urinary microalbumin measurement,EFO_0010967,0.2984564608492574,2.9846048823548377,1,0.4,0.4,transcript,9932.0
SLCO5A1,ENSG00000137571,stem Cell Growth Factor beta measurement,EFO_0008292,0.2984564608492574,2.9849951604601968,5,2.0,10.0,transcript,23226.0
DUSP22,ENSG00000112679,growth differentiation factor 15 amount,OBA_2050135,0.2984564608492574,2.984588212882991,1,0.4,0.4,transcript,16946.0
MARCKS,ENSG00000277443,polygenic risk score,EFO_0030082,0.2984251976532356,2.9843450864020022,1,0.4,0.4,transcript,4296.0
SYT13,ENSG00000019505,age at menarche,EFO_0004703,0.2984251976532356,2.984467261785316,2,0.8,1.6,transcript,7432.0
SV2C,ENSG00000122012,cholelithiasis,EFO_0004799,0.2984251976532356,2.9842800054020917,1,0.4,0.4,transcript,14271.0
ALG10B,ENSG00000175548,Delayed puberty,HP_0000823,0.2984251976532356,2.984957792455563,5,2.0,10.0,transcript,14168.0
KCNJ15,ENSG00000157551,basophil percentage of leukocytes,EFO_0007992,0.2984251976532356,2.984261810582755,1,0.4,0.4,transcript,40675.0
CFHR4,ENSG00000134365,BMI-adjusted waist-hip ratio,EFO_0007788,0.2983900068599223,2.9839405773896304,1,0.5,0.5,transcript,12343.0
GLCE,ENSG00000138604,peak expiratory flow,EFO_0009718,0.2983445610351776,2.9835759353497395,2,0.8,1.6,transcript,12277.0
KLHDC10,ENSG00000128607,heel bone mineral density,EFO_0009270,0.29833948293036994,2.9834445619905074,1,0.4,0.4,transcript,8043.0
BIRC6,ENSG00000115760,cognitive function measurement,EFO_0008354,0.29833239122340205,2.9833310944909726,1,0.5,0.5,transcript,69616.0
NAA30,ENSG00000139977,basophil count,EFO_0005090,0.29829592816656936,2.9829890369286556,1,0.4,0.4,transcript,13443.0
YWHAG,ENSG00000170027,lung adenocarcinoma,EFO_0000571,0.298260864983837,2.9827166120515956,1,0.4,0.4,transcript,3705.0
MAN1A2,ENSG00000198162,smoking status measurement,EFO_0006527,0.298182084869456,2.9819483692173945,2,0.8,1.6,transcript,12547.0
RPRD2,ENSG00000163125,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.2981814190229669,2.981832696753219,1,0.4,0.4,transcript,21614.0
KCNJ15,ENSG00000157551,neck of femur size,OBA_0002725,0.2981709442027355,2.981719276077754,1,0.4,0.4,transcript,40675.0
PICALM,ENSG00000073921,acute myeloid leukemia,EFO_0000222,0.2981475024690579,2.9814882930091513,1,0.4,0.4,transcript,30147.0
RAD23B,ENSG00000119318,cortical thickness,EFO_0004840,0.2980749050228514,2.9807893240907775,1,0.4,0.4,transcript,9932.0
CPD,ENSG00000108582,BMI-adjusted waist-hip ratio,EFO_0007788,0.2980549015189211,2.9805692335474805,1,0.4,0.4,transcript,19784.0
G3BP2,ENSG00000138757,type 1 diabetes mellitus,MONDO_0005147,0.2980276206995307,2.9802779602355143,1,0.4,0.4,transcript,228149.0
LNPEP,ENSG00000113441,blood protein measurement,EFO_0007937,0.2980242062251207,2.980262724475496,1,0.4,0.4,transcript,19359.0
PCMTD1,ENSG00000168300,glaucoma,MONDO_0005041,0.29801294586278204,2.9803343066988344,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
OR5AS1,ENSG00000181785,neurodegenerative disease,EFO_0005772,0.2979951183392131,2.980002073977373,1,0.4,0.4,transcript,7860.0
NDFIP2,ENSG00000102471,urinary microalbumin measurement,EFO_0010967,0.297988362489143,2.979898106757419,2,0.8,1.6,transcript,110483.0
SENP6,ENSG00000112701,serum gamma-glutamyl transferase measurement,EFO_0004532,0.29798798268412463,2.9803088440019327,5,2.2,11.0,transcript,25640.0
C2orf73,ENSG00000177994,glomerulonephritis,MONDO_0002462,0.29796861049978685,2.9797344141766122,1,0.4,0.4,transcript,8280.0
C15orf61,ENSG00000189227,brain volume,OBA_2050009,0.29787944009731376,2.9804159349442743,5,2.0,10.0,transcript,6167.0
ZNF697,ENSG00000143067,serine measurement,EFO_0009774,0.2978568521634466,2.979213798565816,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
SYT13,ENSG00000019505,corneal resistance factor,EFO_0010067,0.29781291969117757,2.978344482164736,2,0.8,1.6,transcript,7432.0
SYT13,ENSG00000019505,ocular hypotension,MONDO_0004390,0.2978038558595239,2.9782538438481994,2,0.8,1.6,transcript,7432.0
FAM91A1,ENSG00000176853,diastolic blood pressure,EFO_0006336,0.2977920961003159,2.9779513339833557,1,0.5,0.5,transcript,16462.0
SLC7A2,ENSG00000003989,sex interaction measurement,EFO_0008343,0.29777655564413075,2.9778865520624183,3,1.4,4.199999999999999,transcript,34712.0
SLC7A2,ENSG00000003989,orofacial cleft,MONDO_0000358,0.29777655564413075,2.9778865520624183,3,1.4,4.199999999999999,transcript,34712.0
LRRC58,ENSG00000163428,ulcerative colitis,EFO_0000729,0.2977741638744105,2.977943709974214,2,0.8,1.6,transcript,7918.0
TBC1D9B,ENSG00000197226,monocyte percentage of leukocytes,EFO_0007989,0.2977538518000908,2.9775507328602844,1,0.4,0.4,transcript,32747.0
ARAP1,ENSG00000186635,deoxycholic acid (12 or 24)-sulfate measurement,EFO_0800599,0.2977282861589498,2.977291871207265,1,0.4,0.4,transcript,44397.0
TPRG1,ENSG00000188001,glomerular filtration rate,OBA_0003747,0.2977262956601335,2.977362813057679,2,0.8,1.6,transcript,16023.0
TPRG1,ENSG00000188001,serum creatinine amount,OBA_2050096,0.2977262956601335,2.977362813057679,2,0.8,1.6,transcript,16023.0
ANKH,ENSG00000154122,diabetic retinopathy,EFO_0003770,0.29770225800843103,2.977791022707261,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,diabetic retinopathy,EFO_0003770,0.29770225800843103,2.977791022707261,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,diabetic retinopathy,EFO_0003770,0.29770225800843103,2.977791022707261,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,diabetic retinopathy,EFO_0003770,0.29770225800843103,2.977791022707261,5,2.4,12.0,gene_variant,15616.0
SENP6,ENSG00000112701,lean body mass,EFO_0004995,0.2976792431519647,2.9772214486803334,5,2.2,11.0,transcript,25640.0
MCL1,ENSG00000143384,neutrophil count,EFO_0004833,0.29767800591854254,2.976796828564539,1,0.4,0.4,transcript,23853.0
GPR158,ENSG00000151025,intelligence,EFO_0004337,0.2976277019802241,2.9763026911068566,1,0.5,0.5,transcript,19477.0
CIAO2A,ENSG00000166797,Abruptio Placentae,EFO_1001754,0.29756087735194187,2.9758294023114757,2,0.8,1.6,transcript,7252.0
DPY19L2,ENSG00000177990,high density lipoprotein cholesterol measurement,EFO_0004612,0.29750713211283386,2.9752120670818925,2,0.8,1.6,transcript,11368.0
EVI5,ENSG00000067208,apolipoprotein B measurement,EFO_0004615,0.2975046405844604,2.975052061793248,1,0.4,0.4,transcript,70722.0
TENT4B,ENSG00000121274,diet measurement,EFO_0008111,0.29747514477002346,2.9750008631328146,4,1.6,6.4,transcript,25660.0
SMC3,ENSG00000108055,Intellectual disability,HP_0001249,0.2974699454921702,2.9747080674443103,1,0.4,0.4,transcript,46444.0
SMC3,ENSG00000108055,neurodegenerative disease,EFO_0005772,0.29744419875681466,2.9744506000907545,1,0.4,0.4,transcript,46444.0
SLC25A16,ENSG00000122912,whole body water mass,EFO_0009805,0.29743761059010504,2.974407142524266,1,0.4,0.4,transcript,12888.0
CENPE,ENSG00000138778,type 2 diabetes mellitus,MONDO_0005148,0.2974278492957301,2.9743041866880304,1,0.5,0.5,transcript,19460.0
LRRIQ3,ENSG00000162620,body weight,EFO_0004338,0.2974135472628873,2.9741623688096155,1,0.5,0.5,transcript,18590.0
RASEF,ENSG00000165105,body mass index,EFO_0004340,0.2974135472628873,2.974189894397581,1,0.4,0.4,transcript,7350.0
MAP3K7,ENSG00000135341,preeclampsia,EFO_0000668,0.297362141345951,2.9737108001827885,4,1.6,6.4,transcript,71599.0
RFX3,ENSG00000080298,Abruptio Placentae,EFO_1001754,0.29734181028545587,2.9734746040198954,2,0.8,1.6,transcript,28318.0
TMEM68,ENSG00000167904,ocular hypotension,MONDO_0004390,0.29734181028545587,2.9734367743758208,1,0.4,0.4,transcript,21423.0
SLF1,ENSG00000133302,metabolite measurement,EFO_0004725,0.29734181028545587,2.973453016008089,1,0.4,0.4,transcript,11457.0
SLF1,ENSG00000133302,glucose measurement,EFO_0004468,0.29734181028545587,2.973453016008089,1,0.4,0.4,transcript,11457.0
ELMOD1,ENSG00000110675,triglyceride measurement,EFO_0004530,0.29732336695530176,2.9732740328224425,1,0.4,0.4,transcript,9910.0
TTL,ENSG00000114999,high density lipoprotein cholesterol measurement,EFO_0004612,0.29730435477809375,2.973063316487076,1,0.4,0.4,transcript,20234.0
CCDC34,ENSG00000109881,ulna fracture,EFO_0003950,0.29729343105435596,2.9730278340413387,1,0.4,0.4,transcript,4277.0
CCDC34,ENSG00000109881,radius fracture,EFO_0003957,0.29729343105435596,2.9730278340413387,1,0.4,0.4,transcript,4277.0
KLF10,ENSG00000155090,device complication,EFO_0009519,0.2972668596434165,2.9727294421901735,1,0.4,0.4,transcript,6574.0
MAN1A2,ENSG00000198162,kidney disease,EFO_0003086,0.2972572824792995,2.9727003453158294,2,0.8,1.6,transcript,12547.0
STAU2,ENSG00000040341,sialolithiasis,EFO_1001180,0.2972572824792995,2.972584392975865,1,0.5,0.5,transcript,43222.0
EVI5,ENSG00000067208,sex hormone-binding globulin measurement,EFO_0004696,0.2972569926614793,2.972575582563437,1,0.4,0.4,transcript,70722.0
BTC,ENSG00000174808,prostate disease,EFO_0009602,0.29715954382813037,2.9717175011436776,1,0.4,0.4,transcript,3277.0
RAPGEF4,ENSG00000091428,cardiomyopathy,EFO_0000318,0.29715954382813037,2.97160862436998,1,0.4,0.4,transcript,30335.0
PAG1,ENSG00000076641,urinary microalbumin measurement,EFO_0010967,0.29715954382813037,2.971725530158692,2,0.8,1.6,transcript,12299.0
CHL1,ENSG00000134121,Abruptio Placentae,EFO_1001754,0.29715954382813037,2.9716426387061072,2,0.8,1.6,transcript,33898.0
CAVIN2,ENSG00000168497,protein measurement,EFO_0004747,0.29715954382813037,2.971726414050786,1,0.4,0.4,transcript,3054.0
SEPTIN7,ENSG00000122545,glaucoma,MONDO_0005041,0.2971355646094445,2.9713653224213115,1,0.4,0.4,transcript,41338.0
RSBN1L,ENSG00000187257,myopathy,EFO_0004145,0.29705745428409885,2.970711259922079,2,0.8,1.6,transcript,11703.0
DLG1,ENSG00000075711,body height,OBA_VT0001253,0.29700794515087275,2.9700948612802347,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
AKAP10,ENSG00000108599,"level of aldehyde dehydrogenase, dimeric NADP-preferring in blood serum",OBA_2040563,0.2969881870192929,2.969917050491962,1,0.4,0.4,transcript,11370.0
PEX7,ENSG00000112357,Retinal dystrophy,HP_0000556,0.2969706168409176,2.9697487125487205,1,0.4,0.4,transcript,9402.0
TRMT9B,ENSG00000250305,mean corpuscular hemoglobin,EFO_0004527,0.29693750211265496,2.9695161477877283,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
FIGNL1,ENSG00000132436,mean corpuscular hemoglobin concentration,EFO_0004528,0.2969170091627544,2.969186274166584,1,0.4,0.4,transcript,24718.0
ZNF398,ENSG00000197024,retinal degeneration,MONDO_0004580,0.2969156813231969,2.9691823071771566,1,0.4,0.4,transcript,15690.0
SV2C,ENSG00000122012,high density lipoprotein cholesterol measurement,EFO_0004612,0.296903892171346,2.969066950583196,1,0.4,0.4,transcript,14271.0
ANKRD10,ENSG00000088448,physical activity measurement,EFO_0008002,0.2968654943260227,2.968833037650254,2,0.8,1.6,transcript,8984.0
HHLA2,ENSG00000114455,self reported educational attainment,EFO_0004784,0.29685581116056986,2.968591915946176,1,0.5,0.5,transcript,14791.0
C2CD4A,ENSG00000198535,BMI-adjusted fasting blood glucose measurement,EFO_0008036,0.2968225096650988,2.9683412069557775,1,0.4,0.4,transcript,3445.0
KIF20B,ENSG00000138182,serum creatinine amount,OBA_2050096,0.29681778197093517,2.9682051316665268,1,0.5,0.5,transcript,18307.0
HS3ST3A1,ENSG00000153976,Hypocalcemia,HP_0002901,0.29680158814348645,2.968096918712012,1,0.4,0.4,transcript,4936.0
CDH19,ENSG00000071991,Abnormality of the gastrointestinal tract,HP_0011024,0.29680158814348645,2.9682904390919727,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
RFX7,ENSG00000181827,aging,EFO_0022597,0.2967656044341108,2.9676656366672476,1,0.4,0.4,transcript,41700.0
RFX7,ENSG00000181827,plasminogen activator inhibitor 1 measurement,EFO_0004792,0.2967656044341108,2.9676656366672476,1,0.4,0.4,transcript,41700.0
SPRED1,ENSG00000166068,metabolic rate measurement,EFO_0005115,0.2967322518407283,2.967367091618783,1,0.4,0.4,transcript,8974.0
DLGAP1,ENSG00000170579,"Sphingomyelin (d18:1/18:1, d18:2/18:0) measurement",EFO_0022108,0.2967322518407283,2.967350672551221,2,0.8,1.6,transcript,56830.0
NPS,ENSG00000214285,Phenotypic abnormality,HP_0000118,0.2967322518407283,2.9676474574812066,1,0.4,0.4,transcript,1231.0
CLSTN2,ENSG00000158258,bone remodeling disease,MONDO_0000833,0.2967322518407283,2.9673466046359818,1,0.4,0.4,transcript,16607.0
DMAC1,ENSG00000137038,response to antibiotic,GO_0046677,0.2967322518407283,2.9674380919409438,1,0.4,0.4,transcript,3461.0
DMAC1,ENSG00000137038,response to xenobiotic stimulus,GO_0009410,0.2967322518407283,2.9674380919409438,1,0.4,0.4,transcript,3461.0
CLSTN2,ENSG00000158258,prostate disease,EFO_0009602,0.2967322518407283,2.9673466046359818,1,0.4,0.4,transcript,16607.0
SCARA3,ENSG00000168077,appendicular lean mass,EFO_0004980,0.2967269184052269,2.9673393964447565,1,0.4,0.4,transcript,5697.0
COG3,ENSG00000136152,parental genotype effect measurement,EFO_0005939,0.2966984681484643,2.9670385201839,1,0.5,0.5,transcript,9287.0
COG3,ENSG00000136152,fatty acid measurement,EFO_0005110,0.2966984681484643,2.9670385201839,1,0.5,0.5,transcript,9287.0
NUP153,ENSG00000124789,Abnormal erythrocyte morphology,HP_0001877,0.29664829145831734,2.9665108991357,1,0.5,0.5,transcript,17867.0
MARCKS,ENSG00000277443,monocyte percentage of leukocytes,EFO_0007989,0.29664829145831734,2.9665760244528196,1,0.4,0.4,transcript,4296.0
CCBE1,ENSG00000183287,multinodular goiter,MONDO_0000334,0.29664829145831734,2.9664967048334665,1,0.4,0.4,transcript,29006.0
CCBE1,ENSG00000183287,3-hydroxy-3-methylglutarate measurement,EFO_0800602,0.29664829145831734,2.9664967048334665,1,0.4,0.4,transcript,29006.0
SNTG2,ENSG00000172554,premature birth,EFO_0003917,0.29664829145831734,2.966532804824642,1,0.5,0.5,transcript,10022.0
RASEF,ENSG00000165105,ceramide measurement,EFO_0010222,0.29664095060205997,2.9664639277893072,1,0.4,0.4,transcript,7350.0
CWH43,ENSG00000109182,sexual dimorphism measurement,EFO_0021796,0.29662721841558404,2.9663342574022713,1,0.5,0.5,transcript,8055.0
PPDPFL,ENSG00000168333,liver disease,EFO_0001421,0.2966231904384925,2.9665573060526085,2,0.8,1.6,transcript,4917.0
MED10,ENSG00000133398,placenta praevia,EFO_0007442,0.2966231904384925,2.966381493016189,1,0.4,0.4,transcript,2674.0
PCDH18,ENSG00000189184,placenta praevia,EFO_0007442,0.2966231904384925,2.966309076043633,2,0.8,1.6,transcript,20733.0
RASGRP3,ENSG00000152689,body height,OBA_VT0001253,0.2966103120076543,2.9661143229893003,1,0.4,0.4,transcript,35705.0
HEPHL1,ENSG00000181333,arterial stiffness measurement,EFO_0004517,0.29657242551906243,2.965793113858209,1,0.4,0.4,transcript,5809.0
CLHC1,ENSG00000162994,drug use measurement,EFO_0007010,0.2965655579703232,2.965680870547946,1,0.4,0.4,transcript,15816.0
CLHC1,ENSG00000162994,dementia,MONDO_0001627,0.2965655579703232,2.965680870547946,1,0.4,0.4,transcript,15816.0
DENND3,ENSG00000105339,placenta praevia,EFO_0007442,0.2965655579703232,2.9656663963608847,1,0.5,0.5,transcript,46225.0
TMEM123,ENSG00000152558,Hypocalcemia,HP_0002901,0.2965655579703232,2.9656953016496073,1,0.4,0.4,transcript,10070.0
TMEM123,ENSG00000152558,monocyte percentage of leukocytes,EFO_0007989,0.2965655579703232,2.9656953016496073,1,0.4,0.4,transcript,10070.0
ZDHHC21,ENSG00000175893,schizophrenia,MONDO_0005090,0.29653342850629094,2.965681865576677,4,1.6,6.4,transcript,18413.0
NEU3,ENSG00000162139,brain attribute,OBA_2045210,0.29652810397196055,2.965313349897311,1,0.4,0.4,transcript,12380.0
SMARCC1,ENSG00000173473,valsartan measurement,EFO_0801224,0.29652718870907036,2.965386034197788,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,valsartan measurement,EFO_0801224,0.29652718870907036,2.965386034197788,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,valsartan measurement,EFO_0801224,0.29652718870907036,2.965386034197788,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,valsartan measurement,EFO_0801224,0.29652718870907036,2.965386034197788,2,0.8,1.6,transcript,14017.0
GIPC2,ENSG00000137960,low density lipoprotein cholesterol measurement,EFO_0004611,0.2964813627282626,2.9652048253266354,2,0.8,1.6,transcript,4090.0
SLC35F5,ENSG00000115084,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.29647455375754456,2.964816296464531,2,0.8,1.6,transcript,22612.0
NEK7,ENSG00000151414,Hallux valgus,HP_0001822,0.2963973509030142,2.9640187732600847,1,0.4,0.4,transcript,8837.0
ARL3,ENSG00000138175,blood protein measurement,EFO_0007937,0.29637649646246916,2.963869294306486,1,0.4,0.4,transcript,3834.0
PAQR3,ENSG00000163291,glioblastoma multiforme,EFO_0000519,0.29634081432428633,2.963423194983221,1,0.4,0.4,transcript,26575.0
BTC,ENSG00000174808,breast adenocarcinoma,EFO_0000304,0.29631041386727625,2.9632262015351367,1,0.4,0.4,transcript,3277.0
CCDC50,ENSG00000152492,smoking initiation,EFO_0005670,0.2962960444874161,2.9629968913434093,1,0.4,0.4,transcript,10975.0
GFRAL,ENSG00000187871,red blood cell density,OBA_2045260,0.29629452883906815,2.96315460288571,1,0.4,0.4,transcript,1911.0
SERPINB10,ENSG00000242550,smoking initiation,EFO_0005670,0.2962656754765677,2.9628887733271614,1,0.5,0.5,transcript,2155.0
ZNF117,ENSG00000152926,bilirubin measurement,EFO_0004570,0.29623995794619973,2.964526703439341,13,5.2,67.60000000000001,transcript,31780.0
TWSG1,ENSG00000128791,erythrocyte volume,OBA_0003460,0.29621061695107753,2.9621618798171823,1,0.4,0.4,transcript,7180.0
TLR10,ENSG00000174123,breast cancer,MONDO_0007254,0.2961991374165456,2.9621528163825954,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
CD93,ENSG00000125810,venous thromboembolism,EFO_0004286,0.2961813420603695,2.961839738124585,1,0.4,0.4,transcript,15199.0
MMP12,ENSG00000262406,aneurysm,EFO_0009659,0.2961763901326499,2.961983440294666,1,0.4,0.4,transcript,1822.0
SHOC1,ENSG00000165181,testosterone measurement,EFO_0004908,0.2961747809694257,2.9618641824451295,3,1.3,3.9000000000000004,transcript,33513.0
KIF20B,ENSG00000138182,red blood cell density,OBA_2045260,0.2961471790116787,2.961499102073962,1,0.5,0.5,transcript,18307.0
ARMC1,ENSG00000104442,glomerular filtration rate,OBA_0003747,0.29614618519430796,2.9615064003337688,1,0.4,0.4,transcript,8979.0
CLDN1,ENSG00000163347,neurodegenerative disease,EFO_0005772,0.2961208264515103,2.9628585997394454,4,1.6,6.4,transcript,3878.0
ARHGAP12,ENSG00000165322,type 1 diabetes mellitus,MONDO_0005147,0.2961122686761463,2.961134749123877,1,0.4,0.4,transcript,33161.0
CCBE1,ENSG00000183287,N6-carbamoylthreonyladenosine measurement,EFO_0800629,0.2961122686761463,2.9611364770117565,1,0.4,0.4,transcript,29006.0
ARHGAP12,ENSG00000165322,ovarian dysfunction,EFO_0009003,0.2961122686761463,2.961134749123877,1,0.4,0.4,transcript,33161.0
TECRL,ENSG00000205678,lymphocyte count,EFO_0004587,0.2961122686761463,2.9615254614314117,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
RASGRP3,ENSG00000152689,injury,EFO_0000546,0.2961122686761463,2.9611338896742208,1,0.4,0.4,transcript,35705.0
KIF20B,ENSG00000138182,type 2 diabetes mellitus,MONDO_0005148,0.29610256429614806,2.9610529549186557,1,0.5,0.5,transcript,18307.0
IKZF3,ENSG00000161405,head and neck squamous cell carcinoma,EFO_0000181,0.2961014765618152,2.961022506454936,1,0.4,0.4,transcript,51674.0
MAN1A2,ENSG00000198162,lymphocyte count,EFO_0004587,0.296096350576207,2.961091026284904,2,0.8,1.6,transcript,12547.0
DPP8,ENSG00000074603,eosinophil count,EFO_0004842,0.2960567256205706,2.9607489762999735,4,1.6,6.4,transcript,35219.0
WBP2NL,ENSG00000183066,glomerular filtration rate,OBA_0003747,0.2960131511893465,2.960173666855104,1,0.5,0.5,transcript,11861.0
MAP4K3,ENSG00000011566,erythrocyte volume,OBA_0003460,0.2959707085914114,2.959729893531858,1,0.4,0.4,transcript,17538.0
ZBTB21,ENSG00000173276,monocyte count,EFO_0005091,0.2959430138421744,2.959444440481241,1,0.4,0.4,transcript,27968.0
PRDM10,ENSG00000170325,high density lipoprotein cholesterol measurement,EFO_0004612,0.2959375150752118,2.95938655326067,1,0.4,0.4,transcript,35080.0
ING1,ENSG00000153487,C-reactive protein measurement,EFO_0004458,0.29593005557518925,2.9593270388027397,1,0.4,0.4,transcript,15104.0
MYO1B,ENSG00000128641,cervical carcinoma,EFO_0001061,0.29587861438012336,2.9587995522217216,1,0.4,0.4,transcript,29832.0
HACD1,ENSG00000165996,monocyte count,EFO_0005091,0.2958595111997418,2.958659805511893,1,0.4,0.4,transcript,6183.0
EXOC6,ENSG00000138190,retinal layer thickness,OBA_2050110,0.2958131841983457,2.958154459254005,1,0.5,0.5,transcript,22107.0
DCLK1,ENSG00000133083,urate measurement,EFO_0004531,0.2956883876151475,2.9569340738047347,2,0.8,1.6,transcript,31874.0
OTUD7A,ENSG00000169918,bone tissue density,OBA_1000110,0.2956883876151475,2.956901602719168,1,0.4,0.4,transcript,22565.0
CPB1,ENSG00000153002,neuroinflammatory disorder,EFO_0020092,0.29568356160271214,2.9568811948785347,1,0.5,0.5,transcript,10970.0
OTOGL,ENSG00000165899,autosomal dominant nonsyndromic hearing loss,MONDO_0019587,0.2956638837477614,2.9566536954355365,1,0.5,0.5,transcript,33652.0
DOCK1,ENSG00000150760,genetic disorder,EFO_0000508,0.2956638837477614,2.95666392528494,1,0.4,0.4,transcript,15944.0
DSC2,ENSG00000134755,dilated cardiomyopathy 1A,MONDO_0007269,0.2956638837477614,2.9566512795442415,2,0.8,1.6,transcript,128596.0
DSC2,ENSG00000134755,arrhythmogenic right ventricular dysplasia 1,MONDO_0007152,0.2956638837477614,2.9566512795442415,2,0.8,1.6,transcript,128596.0
CASQ2,ENSG00000118729,Prolonged QT interval,HP_0001657,0.2956638837477614,2.956651488499184,1,0.4,0.4,transcript,31618.0
ZNF257,ENSG00000197134,age at menopause,EFO_0004704,0.2955822089904958,2.9558496723073855,1,0.4,0.4,transcript,14502.0
ZNF573,ENSG00000189144,magnesium measurement,EFO_0004845,0.29552116854590726,2.9552393021395478,1,0.5,0.5,transcript,18105.0
HTR1F,ENSG00000179097,arterial stiffness measurement,EFO_0004517,0.2955142420725275,2.95526055421612,1,0.4,0.4,transcript,3386.0
MMADHC,ENSG00000168288,high density lipoprotein cholesterol measurement,EFO_0004612,0.2955142420725275,2.955223986793791,1,0.4,0.4,transcript,4904.0
MMADHC,ENSG00000168288,reticulocyte count,EFO_0007986,0.2955142420725275,2.955223986793791,1,0.4,0.4,transcript,4904.0
NXPH2,ENSG00000144227,skin disease,EFO_0000701,0.2955142420725275,2.955290076686885,1,0.4,0.4,transcript,2709.0
NXPH2,ENSG00000144227,gut microbiome measurement,EFO_0007874,0.2955142420725275,2.955290076686885,1,0.4,0.4,transcript,2709.0
PLPP4,ENSG00000203805,post term pregnancy,EFO_0009681,0.2955142420725275,2.95522331051294,1,0.4,0.4,transcript,4945.0
PLPP4,ENSG00000203805,Abruptio Placentae,EFO_1001754,0.2955142420725275,2.95522331051294,1,0.4,0.4,transcript,4945.0
PLPP4,ENSG00000203805,pituitary gland disease,EFO_0009607,0.2955142420725275,2.95522331051294,1,0.4,0.4,transcript,4945.0
PKP2,ENSG00000057294,HbA1c measurement,EFO_0004541,0.2955142420725275,2.9552985220936017,4,1.6,6.4,transcript,40999.0
MAP3K7,ENSG00000135341,food allergy,EFO_1001890,0.2955142420725275,2.9552318074485537,4,1.6,6.4,transcript,71599.0
SP8,ENSG00000164651,nervous system benign neoplasm,MONDO_0000648,0.2955142420725275,2.9552173270923165,1,0.4,0.4,transcript,5340.0
NDST3,ENSG00000164100,alopecia areata,EFO_0004192,0.2955142420725275,2.9551924833034984,1,0.4,0.4,transcript,7990.0
DMAC1,ENSG00000137038,trauma complication,EFO_0009888,0.2955142420725275,2.955257994258936,1,0.4,0.4,transcript,3461.0
DMAC1,ENSG00000137038,educational attainment,EFO_0011015,0.2955142420725275,2.955257994258936,1,0.4,0.4,transcript,3461.0
DMAC1,ENSG00000137038,aspartate aminotransferase measurement,EFO_0004736,0.2955142420725275,2.955257994258936,1,0.4,0.4,transcript,3461.0
DMAC1,ENSG00000137038,complication,EFO_0009518,0.2955142420725275,2.955257994258936,1,0.4,0.4,transcript,3461.0
ST8SIA4,ENSG00000113532,obesity,EFO_0001073,0.2955142420725275,2.9551852977753343,1,0.4,0.4,transcript,9329.0
ATXN7L3B,ENSG00000253719,platelet count,EFO_0004309,0.2955142420725275,2.955195080019641,1,0.4,0.4,transcript,7596.0
ATXN7L3B,ENSG00000253719,cartilage disease,EFO_0005802,0.2955142420725275,2.955195080019641,1,0.4,0.4,transcript,7596.0
ATXN7L3B,ENSG00000253719,placental retention,EFO_0009578,0.2955142420725275,2.955195080019641,1,0.4,0.4,transcript,7596.0
TOPAZ1,ENSG00000173769,ovarian dysfunction,EFO_0009003,0.2955142420725275,2.95523615900799,1,0.5,0.5,transcript,5334.0
SPOCK3,ENSG00000196104,high density lipoprotein cholesterol measurement,EFO_0004612,0.2955142420725275,2.9552247855097544,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
C4orf33,ENSG00000151470,aspartate aminotransferase measurement,EFO_0004736,0.2955142420725275,2.9555934743583716,4,1.6,6.4,transcript,14189.0
MAP3K7,ENSG00000135341,skin disease,EFO_0000701,0.2955142420725275,2.9552318074485537,4,1.6,6.4,transcript,71599.0
SPOCK3,ENSG00000196104,monocyte count,EFO_0005091,0.2955142420725275,2.9552247855097544,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
SP8,ENSG00000164651,ovarian neoplasm,EFO_0003893,0.2955142420725275,2.9552173270923165,1,0.4,0.4,transcript,5340.0
PCDH10,ENSG00000138650,arterial stiffness measurement,EFO_0004517,0.2955142420725275,2.955256283520607,2,0.8,1.6,transcript,14052.0
HTR1F,ENSG00000179097,urinary microalbumin measurement,EFO_0010967,0.2955142420725275,2.95526055421612,1,0.4,0.4,transcript,3386.0
MED10,ENSG00000133398,placental retention,EFO_0009578,0.2955142420725275,2.9552920093565396,1,0.4,0.4,transcript,2674.0
ZPLD1,ENSG00000170044,preeclampsia,EFO_0000668,0.2955142420725275,2.955301403237199,2,0.8,1.6,transcript,10064.0
MDGA2,ENSG00000139915,glucose measurement,EFO_0004468,0.2955142420725275,2.9551655114139552,1,0.4,0.4,transcript,17323.0
SP8,ENSG00000164651,Benign Thyroid Gland Neoplasm,EFO_1000122,0.2955142420725275,2.9552173270923165,1,0.4,0.4,transcript,5340.0
KYNU,ENSG00000115919,Abruptio Placentae,EFO_1001754,0.2955142420725275,2.9553006694395045,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
PCDH10,ENSG00000138650,monocyte count,EFO_0005091,0.2955142420725275,2.955256283520607,2,0.8,1.6,transcript,14052.0
PKP2,ENSG00000057294,lagophthalmos,MONDO_0001604,0.2955142420725275,2.9552985220936017,4,1.6,6.4,transcript,40999.0
PKP2,ENSG00000057294,frozen shoulder,EFO_1000941,0.2955142420725275,2.9552985220936017,4,1.6,6.4,transcript,40999.0
ADGRA1,ENSG00000197177,N-acetyl-isoputreanine measurement,EFO_0800107,0.2954309616211975,2.954361550774426,1,0.4,0.4,transcript,7702.0
C2CD4A,ENSG00000198535,metabolite measurement,EFO_0004725,0.29540165516106137,2.9541326619154034,1,0.4,0.4,transcript,3445.0
CMTR2,ENSG00000180917,lung adenocarcinoma,EFO_0000571,0.29540092242036536,2.9541126435042804,2,0.8,1.6,transcript,15471.0
SLC35D3,ENSG00000182747,HbA1c measurement,EFO_0004541,0.2953645167806138,2.95381588910362,1,0.4,0.4,transcript,2343.0
UTP20,ENSG00000120800,urinary microalbumin measurement,EFO_0010967,0.29526471666110143,2.952689846935385,1,0.5,0.5,transcript,11715.0
UTP20,ENSG00000120800,serum creatinine amount,OBA_2050096,0.29526471666110143,2.952689846935385,1,0.5,0.5,transcript,11715.0
TMEM132B,ENSG00000139364,neuroimaging measurement,EFO_0004346,0.29526471666110143,2.9527365298975976,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
PNLIPRP3,ENSG00000203837,neuroimaging measurement,EFO_0004346,0.29522594102279437,2.952427902224574,1,0.4,0.4,transcript,2374.0
POU2F1,ENSG00000143190,diastolic blood pressure,EFO_0006336,0.2952120887229612,2.9521358992861697,2,0.8,1.6,transcript,106581.0
MR1,ENSG00000153029,cortical thickness,EFO_0004840,0.29520675560054654,2.952200598616057,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
FRMD4B,ENSG00000114541,mean corpuscular hemoglobin concentration,EFO_0004528,0.2951949017266857,2.952025113528628,2,0.8,1.6,transcript,21026.0
TOPAZ1,ENSG00000173769,Hypercholesterolemia,HP_0003124,0.2951855688067918,2.951949426350633,1,0.5,0.5,transcript,5334.0
BACE2,ENSG00000182240,immune system disease,EFO_0000540,0.2951855688067918,2.9519892439944626,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
SLC11A2,ENSG00000110911,neutrophil count,EFO_0004833,0.2951548222169135,2.9515761834427714,2,0.8,1.6,transcript,57222.0
ZNF148,ENSG00000163848,serum albumin amount,OBA_2050068,0.29510742258468314,2.9510860942265005,1,0.4,0.4,transcript,33703.0
TMEM68,ENSG00000167904,ovarian neoplasm,EFO_0003893,0.2950859993165987,2.9508786646872487,1,0.4,0.4,transcript,21423.0
BIRC6,ENSG00000115760,vitamin D measurement,EFO_0004631,0.29506494362500474,2.950656618507,1,0.5,0.5,transcript,69616.0
EDEM1,ENSG00000134109,placenta praevia,EFO_0007442,0.2950641302617673,2.9507742813410776,2,0.8,1.6,transcript,12032.0
TTLL7,ENSG00000137941,heart rate,OBA_1001087,0.2950641302617673,2.950670276052655,2,0.8,1.6,transcript,55223.0
YTHDC2,ENSG00000047188,hemangioma of subcutaneous tissue,EFO_1000707,0.2950641302617673,2.9506615117825294,1,0.4,0.4,transcript,19793.0
TTLL7,ENSG00000137941,retinal edema,MONDO_0004037,0.2950641302617673,2.950670276052655,2,0.8,1.6,transcript,55223.0
EDEM1,ENSG00000134109,placental retention,EFO_0009578,0.2950641302617673,2.9507742813410776,2,0.8,1.6,transcript,12032.0
TECRL,ENSG00000205678,wellbeing measurement,EFO_0007869,0.2950641302617673,2.9510440772876216,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
TECRL,ENSG00000205678,Hirsutism,HP_0001007,0.2950641302617673,2.9510440772876216,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
FAM91A1,ENSG00000176853,systolic blood pressure,EFO_0006335,0.2950557871464841,2.9505882444450378,1,0.5,0.5,transcript,16462.0
IREB2,ENSG00000136381,lung adenocarcinoma,EFO_0000571,0.29504643237387745,2.9505641795026714,2,0.9,1.8,transcript,18026.0
AGPAT5,ENSG00000155189,type 1 diabetes mellitus,MONDO_0005147,0.2950151899509925,2.9501892722091685,1,0.4,0.4,transcript,10703.0
PLA2R1,ENSG00000153246,BMI-adjusted waist circumference,EFO_0007789,0.29497398742459985,2.949819066485159,2,0.8,1.6,transcript,20204.0
DUSP22,ENSG00000112679,neutrophil percentage of granulocytes,EFO_0007994,0.29493225932835815,2.949346197673998,1,0.4,0.4,transcript,16946.0
BACH1,ENSG00000156273,pancreatic carcinoma,EFO_0002618,0.29491537939300416,2.9495116557059307,4,1.6,6.4,transcript,17884.0
PPP1R9A,ENSG00000158528,arterial stiffness measurement,EFO_0004517,0.2948932704865018,2.9490117130089346,3,1.3,3.9000000000000004,transcript,49362.0
RGS7BP,ENSG00000186479,bone tissue density,OBA_1000110,0.2948383203639071,2.9484713248939176,1,0.5,0.5,transcript,5674.0
IYD,ENSG00000009765,glomerular filtration rate,OBA_0003747,0.29481372736884887,2.9481546770995575,1,0.4,0.4,transcript,22984.0
IYD,ENSG00000009765,serum creatinine amount,OBA_2050096,0.29481372736884887,2.9481546770995575,1,0.4,0.4,transcript,22984.0
SIX4,ENSG00000100625,glucose measurement,EFO_0004468,0.29480429957622645,2.948082729545914,1,0.4,0.4,transcript,10067.0
NSUN7,ENSG00000179299,monocyte percentage of leukocytes,EFO_0007989,0.2947884431202093,2.9479234601615807,1,0.5,0.5,transcript,12811.0
HPF1,ENSG00000056050,X-24546 measurement,EFO_0800893,0.2947633699757571,2.947855626078032,1,0.5,0.5,transcript,2253.0
SLC22A15,ENSG00000163393,body mass index,EFO_0004340,0.294679941516141,2.947048442398764,2,0.8,1.6,transcript,6425.0
KYNU,ENSG00000115919,macular degeneration,EFO_0009606,0.2946635563676217,2.946793812390446,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
SEPTIN7,ENSG00000122545,bone fracture,EFO_0003931,0.2946635563676217,2.9466452400030834,1,0.4,0.4,transcript,41338.0
LONRF1,ENSG00000154359,exostosis,MONDO_0002181,0.2946531363147649,2.946566656434866,1,0.5,0.5,transcript,14167.0
RSBN1L,ENSG00000187257,ventricular fibrillation,EFO_0004287,0.29462573699546807,2.946394087035771,2,0.8,1.6,transcript,11703.0
RIF1,ENSG00000080345,age at menopause,EFO_0004704,0.29461406067517826,2.94620215006881,3,1.3,3.9000000000000004,transcript,63370.0
MTMR6,ENSG00000139505,high density lipoprotein cholesterol measurement,EFO_0004612,0.2946000138358369,2.946053763411994,1,0.5,0.5,transcript,9324.0
TTLL7,ENSG00000137941,"Sphingomyelin (d18:2/24:1, d18:1/24:2) measurement",EFO_0022117,0.29459766120271536,2.946005585462135,2,0.8,1.6,transcript,55223.0
TRMT9B,ENSG00000250305,Abnormality of metabolism/homeostasis,HP_0001939,0.2945207883473215,2.9453490101343935,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
HIPK3,ENSG00000110422,heel bone mineral density,EFO_0009270,0.2945007040337288,2.9450218738313176,1,0.4,0.4,transcript,26966.0
MANSC4,ENSG00000205693,blood protein measurement,EFO_0007937,0.29449702370404657,2.945270177052463,1,0.5,0.5,transcript,1667.0
RBM25,ENSG00000119707,protein measurement,EFO_0004747,0.294487850175867,2.9448911917114,1,0.4,0.4,transcript,31521.0
RALGPS2,ENSG00000116191,free cholesterol in large HDL measurement,EFO_0022157,0.2944675360008452,2.9447548947303286,2,0.8,1.6,transcript,20117.0
RALGPS2,ENSG00000116191,free cholesterol in very large HDL measurement ,EFO_0022273,0.2944675360008452,2.9447548947303286,2,0.8,1.6,transcript,20117.0
ARHGAP29,ENSG00000137962,chloride measurement,EFO_0009284,0.29443802204248565,2.944400446143881,1,0.5,0.5,transcript,24721.0
SMARCC1,ENSG00000173473,mathematical ability,EFO_0004875,0.2944336435933279,2.9444505830403633,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,mathematical ability,EFO_0004875,0.2944336435933279,2.9444505830403633,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,mathematical ability,EFO_0004875,0.2944336435933279,2.9444505830403633,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,mathematical ability,EFO_0004875,0.2944336435933279,2.9444505830403633,2,0.8,1.6,gene_variant,14017.0
FAM174A,ENSG00000174132,neutrophil count,EFO_0004833,0.2944149634783599,2.9442500111951424,1,0.4,0.4,transcript,3985.0
SIX4,ENSG00000100625,metabolite measurement,EFO_0004725,0.294402184393609,2.9440615777197396,1,0.4,0.4,transcript,10067.0
PARP8,ENSG00000151883,pulse wave reflection index measurement,EFO_0009804,0.2943893168473433,2.9439402452969246,2,0.8,1.6,transcript,33987.0
PLCXD2,ENSG00000240891,hemorrhoid,EFO_0009552,0.29431184169501234,2.94314943672523,1,0.4,0.4,transcript,12895.0
CYTL1,ENSG00000170891,phospholipids in very large VLDL measurement ,EFO_0022299,0.2943031884656223,2.943250822806196,1,0.4,0.4,transcript,1827.0
CYTL1,ENSG00000170891,BMI-adjusted hip circumference,EFO_0008039,0.2943031884656223,2.943250822806196,1,0.4,0.4,transcript,1827.0
CYTL1,ENSG00000170891,heel bone mineral density,EFO_0009270,0.2943031884656223,2.943250822806196,1,0.4,0.4,transcript,1827.0
BACE2,ENSG00000182240,insomnia,EFO_0004698,0.2943031884656223,2.9431654405827676,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
CYTL1,ENSG00000170891,cholesterol in very large VLDL measurement ,EFO_0022230,0.2943031884656223,2.943250822806196,1,0.4,0.4,transcript,1827.0
CYTL1,ENSG00000170891,total lipids in small VLDL,EFO_0022148,0.2943031884656223,2.943250822806196,1,0.4,0.4,transcript,1827.0
CYTL1,ENSG00000170891,total lipids in large VLDL,EFO_0022175,0.2943031884656223,2.943250822806196,1,0.4,0.4,transcript,1827.0
DYNLT5,ENSG00000152760,heart rate,OBA_1001087,0.29430279333719794,2.943098096501255,1,0.4,0.4,transcript,5701.0
DAG1,ENSG00000173402,intelligence,EFO_0004337,0.29429234845046376,2.9429296726234497,1,0.4,0.4,transcript,64640.0
KIAA0232,ENSG00000170871,heart rate,OBA_1001087,0.2942844231754042,2.9428675200633108,1,0.4,0.4,transcript,17176.0
TMEM17,ENSG00000186889,neurodegenerative disease,EFO_0005772,0.2942537819458466,2.942601819458466,1,0.4,0.4,transcript,6250.0
MAN1A2,ENSG00000198162,insomnia measurement,EFO_0007876,0.2942019612241127,2.942147132763961,2,0.8,1.6,transcript,12547.0
RNF17,ENSG00000132972,pulse wave reflection index measurement,EFO_0009804,0.2941801868426056,2.941838218844086,1,0.5,0.5,transcript,13755.0
ZNF33B,ENSG00000196693,pulse pressure measurement,EFO_0005763,0.29416908035888756,2.9417219290868837,1,0.5,0.5,transcript,16064.0
SLC9B1,ENSG00000164037,serum urea amount,OBA_2050065,0.29415856650015065,2.941630637118794,1,0.5,0.5,transcript,11118.0
PPA2,ENSG00000138777,serum alanine aminotransferase measurement,EFO_0004735,0.29414035863519766,2.9414309926225313,1,0.5,0.5,transcript,18244.0
ATF7IP2,ENSG00000166669,Red cell distribution width,EFO_0009188,0.29413186570910926,2.941334866122765,1,0.5,0.5,transcript,30847.0
C2CD4A,ENSG00000198535,open-angle glaucoma,EFO_0004190,0.2939786574873815,2.9399026851786045,1,0.4,0.4,transcript,3445.0
MYO3A,ENSG00000095777,enteritis,MONDO_0043579,0.2939329023828348,2.939352739618321,1,0.5,0.5,transcript,21083.0
TECRL,ENSG00000205678,educational attainment,EFO_0011015,0.29391721470899973,2.9395749217599456,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
TECRL,ENSG00000205678,brain attribute,OBA_2045210,0.29391721470899973,2.9395749217599456,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
CAVIN2,ENSG00000168497,arterial stiffness measurement,EFO_0004517,0.29391565074925485,2.939287483262031,1,0.4,0.4,transcript,3054.0
ZFP90,ENSG00000184939,Peyronie disease,MONDO_0008231,0.2938944561067486,2.9389579162142256,1,0.4,0.4,transcript,29951.0
LNPEP,ENSG00000113441,mean corpuscular hemoglobin concentration,EFO_0004528,0.29385003109066155,2.938520973130904,1,0.4,0.4,transcript,19359.0
CYTIP,ENSG00000115165,respiratory system disease,EFO_0000684,0.2938473734836032,2.9385015222622215,1,0.4,0.4,gene_variant,14395.0
CCDC34,ENSG00000109881,bone quantitative ultrasound measurement,EFO_0004514,0.29382962663517703,2.9383897898495492,1,0.4,0.4,transcript,4277.0
FBXO28,ENSG00000143756,red blood cell density,OBA_2045260,0.29376718759304643,2.938720863657308,5,2.0,10.0,transcript,9533.0
ZNF267,ENSG00000185947,lymphocyte count,EFO_0004587,0.2937572024752989,2.937609527096886,1,0.4,0.4,transcript,10666.0
SHOC1,ENSG00000165181,blood sodium bicarbonate amount,OBA_2050094,0.29366953097224885,2.936811682473361,3,1.3,3.9000000000000004,transcript,33513.0
DLG1,ENSG00000075711,thigh muscle volume,EFO_0020107,0.2936592816795111,2.9366082265666185,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
AKAP10,ENSG00000108599,Alzheimer disease,MONDO_0004975,0.2936487632334943,2.9365228126339757,1,0.4,0.4,transcript,11370.0
ATXN3,ENSG00000066427,vital capacity,EFO_0004312,0.2936309684487796,2.936315407685347,1,0.4,0.4,transcript,69891.0
ARHGAP28,ENSG00000088756,body mass index,EFO_0004340,0.2936087286562289,2.936099588198407,1,0.4,0.4,transcript,32516.0
RTKN2,ENSG00000182010,response to xenobiotic stimulus,GO_0009410,0.29352624541729366,2.9352977119957657,1,0.4,0.4,transcript,11345.0
RTKN2,ENSG00000182010,hypertension,EFO_0000537,0.29352624541729366,2.9352977119957657,1,0.4,0.4,transcript,11345.0
WDR12,ENSG00000138442,myocardial infarction,EFO_0000612,0.2935134706717882,2.935154645903366,1,0.4,0.4,transcript,20061.0
ARAP1,ENSG00000186635,periodontitis,EFO_0000649,0.2934699941175093,2.9347089507928596,1,0.4,0.4,transcript,44397.0
CLEC1A,ENSG00000150048,type 1 diabetes mellitus,MONDO_0005147,0.29344712088113634,2.934546272615597,1,0.5,0.5,transcript,6661.0
ADAT2,ENSG00000189007,Inguinal hernia,HP_0000023,0.29343656748926306,2.934395483373143,1,0.4,0.4,transcript,13419.0
LNPEP,ENSG00000113441,neutrophil percentage of leukocytes,EFO_0007990,0.2934354561920161,2.9343752241444494,1,0.4,0.4,transcript,19359.0
RFX7,ENSG00000181827,lymphocyte count,EFO_0004587,0.2933997712422069,2.9340073047482083,1,0.4,0.4,transcript,41700.0
RFX7,ENSG00000181827,lymphocyte percentage of leukocytes,EFO_0007993,0.2933997712422069,2.9340073047482083,1,0.4,0.4,transcript,41700.0
PEX7,ENSG00000112357,mean reticulocyte volume,EFO_0010701,0.29337341519548743,2.933776696094419,1,0.4,0.4,transcript,9402.0
PYHIN1,ENSG00000163564,neurodegenerative disease,EFO_0005772,0.29336236774640967,2.933661434685165,1,0.4,0.4,transcript,10594.0
BIRC6,ENSG00000115760,health study participation,EFO_0010130,0.2933429251427732,2.9334364336846845,1,0.5,0.5,transcript,69616.0
ATXN3,ENSG00000066427,body surface area,EFO_0022196,0.29328913564181214,2.932897079615672,1,0.4,0.4,transcript,69891.0
KLHDC10,ENSG00000128607,blood urea nitrogen measurement,EFO_0004741,0.29328483126431426,2.9328980453299507,1,0.4,0.4,transcript,8043.0
AGBL3,ENSG00000146856,ovarian dysfunction,EFO_0009003,0.2932609077672124,2.9326450307892595,1,0.5,0.5,transcript,13907.0
BIRC6,ENSG00000115760,cornea transplantation,EFO_0010676,0.2932609077672124,2.9326162599290764,1,0.5,0.5,transcript,69616.0
ADAT2,ENSG00000189007,educational attainment,EFO_0011015,0.29323893321194283,2.9324191405999414,1,0.4,0.4,transcript,13419.0
SLF1,ENSG00000133302,ovarian neoplasm,EFO_0003893,0.2932091984861526,2.9321268980150568,1,0.4,0.4,transcript,11457.0
LRPAP1,ENSG00000163956,free cholesterol in small VLDL measurement ,EFO_0022272,0.29320222045850103,2.93225284075645,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
USP15,ENSG00000135655,educational attainment,EFO_0011015,0.2931868706706701,2.9319518245493317,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
GALR1,ENSG00000166573,major depressive disorder,MONDO_0002009,0.29308046622997874,2.9309492754595854,2,0.8,1.6,transcript,11064.0
ARMC1,ENSG00000104442,Delayed puberty,HP_0000823,0.2930745223879775,2.9307897722704643,1,0.4,0.4,transcript,8979.0
SC5D,ENSG00000109929,glomerular filtration rate,OBA_0003747,0.29307359781538966,2.9307588209384323,1,0.4,0.4,transcript,17511.0
CCDC77,ENSG00000120647,pulse pressure measurement,EFO_0005763,0.29303630080471055,2.93039137281806,1,0.4,0.4,transcript,14102.0
ZNF471,ENSG00000196263,lymphocyte count,EFO_0004587,0.2930274204980247,2.930304443867456,1,0.4,0.4,transcript,13228.0
FBXO45,ENSG00000174013,gut microbiome measurement,EFO_0007874,0.2929615695787927,2.9297820851390086,2,0.8,1.6,transcript,9616.0
RBM18,ENSG00000119446,retinal vasculature measurement,EFO_0010554,0.29292129408949774,2.9292746692900393,1,0.4,0.4,transcript,6480.0
CCDC177,ENSG00000267909,neurodegenerative disease,EFO_0005772,0.2929080711864423,2.9292002718835524,1,0.5,0.5,transcript,4182.0
SMARCC1,ENSG00000173473,self reported educational attainment,EFO_0004784,0.2928558827435864,2.9286729745429487,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,self reported educational attainment,EFO_0004784,0.2928558827435864,2.9286729745429487,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,self reported educational attainment,EFO_0004784,0.2928558827435864,2.9286729745429487,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,self reported educational attainment,EFO_0004784,0.2928558827435864,2.9286729745429487,2,0.8,1.6,gene_variant,14017.0
C2orf76,ENSG00000186132,pulse wave reflection index measurement,EFO_0009804,0.2928026632800311,2.9281158985891973,1,0.4,0.4,transcript,4481.0
MYO3A,ENSG00000095777,Genu varum,HP_0002970,0.292784293773339,2.927866653523363,1,0.5,0.5,transcript,21083.0
ATXN7L3B,ENSG00000253719,placenta praevia,EFO_0007442,0.292784293773339,2.927895597027755,1,0.4,0.4,transcript,7596.0
CENPE,ENSG00000138778,frozen shoulder,EFO_1000941,0.292784293773339,2.9278686314641194,1,0.5,0.5,transcript,19460.0
ATXN7L3B,ENSG00000253719,Pathologic fracture,HP_0002756,0.292784293773339,2.927895597027755,1,0.4,0.4,transcript,7596.0
SLC44A1,ENSG00000070214,BMI-adjusted hip circumference,EFO_0008039,0.292784293773339,2.9278525466504646,1,0.4,0.4,transcript,41628.0
DLGAP1,ENSG00000170579,oophoritis,EFO_1001071,0.292784293773339,2.9278710918773276,2,0.8,1.6,transcript,56830.0
MYO3A,ENSG00000095777,Genu valgum,HP_0002857,0.292784293773339,2.927866653523363,1,0.5,0.5,transcript,21083.0
DLGAP1,ENSG00000170579,salpingitis,MONDO_0003619,0.292784293773339,2.9278710918773276,2,0.8,1.6,transcript,56830.0
SLC44A1,ENSG00000070214,lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement,EFO_0800517,0.292784293773339,2.9278525466504646,1,0.4,0.4,transcript,41628.0
PKP2,ENSG00000057294,wellbeing measurement,EFO_0007869,0.292784293773339,2.927999039101716,4,1.6,6.4,transcript,40999.0
ZPLD1,ENSG00000170044,COVID-19,MONDO_0100096,0.292784293773339,2.9280019202453134,2,0.8,1.6,transcript,10064.0
HS3ST3A1,ENSG00000153976,high density lipoprotein cholesterol measurement,EFO_0004612,0.292784293773339,2.927923975010537,1,0.4,0.4,transcript,4936.0
FRMD4B,ENSG00000114541,cutaneous melanoma,EFO_0000389,0.292784293773339,2.9279190339951606,2,0.8,1.6,transcript,21026.0
CLDN1,ENSG00000163347,Abruptio Placentae,EFO_1001754,0.29278143028028647,2.9294646380272074,4,1.6,6.4,transcript,3878.0
SLC35B4,ENSG00000205060,gastrointestinal disease,EFO_0010282,0.29278143028028647,2.9278562227357927,1,0.4,0.4,transcript,9542.0
NOL9,ENSG00000162408,HbA1c measurement,EFO_0004541,0.29273669899981386,2.92740969310479,1,0.4,0.4,transcript,9367.0
AGA,ENSG00000038002,preeclampsia,EFO_0000668,0.2927108863752941,2.927206845332404,1,0.5,0.5,transcript,5103.0
AGA,ENSG00000038002,gestational diabetes,EFO_0004593,0.2927108863752941,2.927206845332404,1,0.5,0.5,transcript,5103.0
AKAP10,ENSG00000108599,educational attainment,EFO_0011015,0.2926795559637172,2.9268307399362046,1,0.4,0.4,transcript,11370.0
MAP3K7,ENSG00000135341,erythrocyte volume,OBA_0003460,0.29265340423524977,2.926623429075776,4,1.6,6.4,transcript,71599.0
STAU2,ENSG00000040341,prostate specific antigen amount,OBA_2050200,0.29263406104819506,2.9263521786648203,1,0.5,0.5,transcript,43222.0
TRIM69,ENSG00000185880,bone tissue density,OBA_1000110,0.29256154146022073,2.9256309921393986,1,0.4,0.4,transcript,25678.0
PHIP,ENSG00000146247,total cholesterol measurement,EFO_0004574,0.2925591089945363,2.9255990670987955,1,0.5,0.5,transcript,62679.0
DLGAP1,ENSG00000170579,IGF-1 measurement,EFO_0004627,0.2925276960635226,2.9253051147791638,2,0.8,1.6,transcript,56830.0
GANC,ENSG00000214013,glomerular filtration rate,OBA_0003747,0.2925268020919809,2.925297294924493,1,0.5,0.5,transcript,17080.0
SYT13,ENSG00000019505,goiter,EFO_0004283,0.29252425028301055,2.9254577880830657,2,0.8,1.6,transcript,7432.0
FAM102B,ENSG00000162636,lymphocyte count,EFO_0004587,0.2924800253569082,2.9248260566912596,1,0.4,0.4,transcript,15502.0
OTULINL,ENSG00000145569,arterial stiffness measurement,EFO_0004517,0.29247664759116576,2.924816450924151,1,0.4,0.4,transcript,8004.0
CNTLN,ENSG00000044459,Parkinson disease,MONDO_0005180,0.29245235652755697,2.924645025838843,2,0.8,1.6,transcript,13173.0
CNTLN,ENSG00000044459,drug use measurement,EFO_0007010,0.29245235652755697,2.924645025838843,2,0.8,1.6,transcript,13173.0
MED10,ENSG00000133398,von Willebrand factor quality,OBA_1000199,0.29245235652755697,2.924673153906834,1,0.4,0.4,transcript,2674.0
MED10,ENSG00000133398,Abruptio Placentae,EFO_1001754,0.29245235652755697,2.924673153906834,1,0.4,0.4,transcript,2674.0
LIMA1,ENSG00000050405,protein measurement,EFO_0004747,0.2924452812760323,2.924466217136852,1,0.4,0.4,transcript,29841.0
CWH43,ENSG00000109182,platelet count,EFO_0004309,0.29241050913793015,2.9241671646257323,1,0.5,0.5,transcript,8055.0
TBC1D9B,ENSG00000197226,aspartate aminotransferase measurement,EFO_0004736,0.29240811999671135,2.9240934148264897,1,0.4,0.4,transcript,32747.0
ANKRD30B,ENSG00000180777,high density lipoprotein cholesterol measurement,EFO_0004612,0.29240275471250327,2.92405211352802,1,0.5,0.5,transcript,20353.0
NDST3,ENSG00000164100,platelet volume,OBA_0003277,0.29234130652060936,2.9234631277843164,1,0.4,0.4,transcript,7990.0
PPDPFL,ENSG00000168333,placental retention,EFO_0009578,0.29234130652060936,2.923738466873777,2,0.8,1.6,transcript,4917.0
NAF1,ENSG00000145414,response to xenobiotic stimulus,GO_0009410,0.29234130652060936,2.923475015398139,1,0.5,0.5,transcript,8071.0
PPDPFL,ENSG00000168333,ovarian neoplasm,EFO_0003893,0.29234130652060936,2.923738466873777,2,0.8,1.6,transcript,4917.0
PPDPFL,ENSG00000168333,ovarian dysfunction,EFO_0009003,0.29234130652060936,2.923738466873777,2,0.8,1.6,transcript,4917.0
FAM98A,ENSG00000119812,bilirubin measurement,EFO_0004570,0.29234130652060936,2.9234204184176087,1,0.4,0.4,transcript,54398.0
NXPH2,ENSG00000144227,body weight,EFO_0004338,0.29234130652060936,2.923560721167703,1,0.4,0.4,transcript,2709.0
NXPH2,ENSG00000144227,response to antihypertensive drug,EFO_0005405,0.29234130652060936,2.923560721167703,1,0.4,0.4,transcript,2709.0
MARCKS,ENSG00000277443,lymphocyte count,EFO_0004587,0.29234130652060936,2.92350617507574,1,0.4,0.4,transcript,4296.0
MARCKS,ENSG00000277443,connective tissue disease,EFO_1001986,0.29234130652060936,2.92350617507574,1,0.4,0.4,transcript,4296.0
MARCKS,ENSG00000277443,placental retention,EFO_0009578,0.29234130652060936,2.92350617507574,1,0.4,0.4,transcript,4296.0
PPDPFL,ENSG00000168333,X-12839 measurement,EFO_0800731,0.29234130652060936,2.923738466873777,2,0.8,1.6,transcript,4917.0
AGA,ENSG00000038002,urinary microalbumin measurement,EFO_0010967,0.29234130652060936,2.9235110467855567,1,0.5,0.5,transcript,5103.0
RASEF,ENSG00000165105,high density lipoprotein cholesterol measurement,EFO_0004612,0.29234130652060936,2.923467486974801,1,0.4,0.4,transcript,7350.0
GPAT3,ENSG00000138678,knee fracture,EFO_0009617,0.29234130652060936,2.923560191642875,2,0.8,1.6,transcript,10875.0
MMADHC,ENSG00000168288,type 1 diabetes nephropathy,EFO_0004996,0.29234130652060936,2.923494631274609,1,0.4,0.4,transcript,4904.0
GALR1,ENSG00000166573,multiple myeloma,EFO_0001378,0.29234130652060936,2.923557678365891,2,0.8,1.6,transcript,11064.0
ZPLD1,ENSG00000170044,3-methoxytyramine sulfate measurement,EFO_0800071,0.29234130652060936,2.923572047718017,2,0.8,1.6,transcript,10064.0
RASEF,ENSG00000165105,systolic blood pressure,EFO_0006335,0.29234130652060936,2.923467486974801,1,0.4,0.4,transcript,7350.0
PCDH10,ENSG00000138650,orchitis,EFO_1001078,0.29234130652060936,2.923526928001425,2,0.8,1.6,transcript,14052.0
PCDH10,ENSG00000138650,Epididymitis,HP_0000031,0.29234130652060936,2.923526928001425,2,0.8,1.6,transcript,14052.0
RASEF,ENSG00000165105,hip circumference,OBA_1000032,0.29234130652060936,2.923467486974801,1,0.4,0.4,transcript,7350.0
TTLL7,ENSG00000137941,arterial stiffness measurement,EFO_0004517,0.29234130652060936,2.9234420386410753,2,0.8,1.6,transcript,55223.0
TTLL7,ENSG00000137941,basophil measurement,EFO_0803539,0.29234130652060936,2.9234420386410753,2,0.8,1.6,transcript,55223.0
TXNL1,ENSG00000091164,brain aneurysm,EFO_0003870,0.29234130652060936,2.9234952640244853,2,0.8,1.6,transcript,19465.0
TXNL1,ENSG00000091164,cervical carcinoma,EFO_0001061,0.29234130652060936,2.9234952640244853,2,0.8,1.6,transcript,19465.0
MDGA2,ENSG00000139915,bone remodeling disease,MONDO_0000833,0.29234130652060936,2.9234361558947732,1,0.4,0.4,transcript,17323.0
MAP3K7,ENSG00000135341,tooth disease,EFO_1001216,0.29234130652060936,2.9235024519293717,4,1.6,6.4,transcript,71599.0
ZPLD1,ENSG00000170044,disorder of appendix,EFO_0009542,0.29234130652060936,2.923572047718017,2,0.8,1.6,transcript,10064.0
GALR1,ENSG00000166573,Hirsutism,HP_0001007,0.29234130652060936,2.923557678365891,2,0.8,1.6,transcript,11064.0
ZPLD1,ENSG00000170044,appendicitis,EFO_0007149,0.29234130652060936,2.923572047718017,2,0.8,1.6,transcript,10064.0
ZPLD1,ENSG00000170044,temporal measurement,EFO_0000719,0.29234130652060936,2.923572047718017,2,0.8,1.6,transcript,10064.0
ZPLD1,ENSG00000170044,poisoning,EFO_0008546,0.29234130652060936,2.923572047718017,2,0.8,1.6,transcript,10064.0
MED10,ENSG00000133398,Paroxysmal supraventricular tachycardia,HP_0004763,0.29234130652060936,2.9235626538373576,1,0.4,0.4,transcript,2674.0
MAP3K7,ENSG00000135341,temporal measurement,EFO_0000719,0.29234130652060936,2.9235024519293717,4,1.6,6.4,transcript,71599.0
EDEM1,ENSG00000134109,Methionine sulfoxide measurement,EFO_0021650,0.29234130652060936,2.923546043929498,2,0.8,1.6,transcript,12032.0
PCDH10,ENSG00000138650,bone remodeling disease,MONDO_0000833,0.29234130652060936,2.923526928001425,2,0.8,1.6,transcript,14052.0
TFEC,ENSG00000105967,growth differentiation factor 15 amount,OBA_2050135,0.29234130652060936,2.9234287625610893,1,0.4,0.4,transcript,25482.0
EDEM1,ENSG00000134109,Abruptio Placentae,EFO_1001754,0.29234130652060936,2.923546043929498,2,0.8,1.6,transcript,12032.0
EDEM1,ENSG00000134109,lymphocyte count,EFO_0004587,0.29234130652060936,2.923546043929498,2,0.8,1.6,transcript,12032.0
NDFIP2,ENSG00000102471,level of complement component C1q receptor in blood serum,OBA_2040369,0.29234130652060936,2.923427547072082,2,0.8,1.6,transcript,110483.0
NDFIP2,ENSG00000102471,skin disease,EFO_0000701,0.29234130652060936,2.923427547072082,2,0.8,1.6,transcript,110483.0
GALR1,ENSG00000166573,iminodiacetate (IDA) measurement,EFO_0800945,0.29234130652060936,2.923557678365891,2,0.8,1.6,transcript,11064.0
STT3B,ENSG00000163527,preeclampsia,EFO_0000668,0.29234130652060936,2.9234327880994417,1,0.4,0.4,transcript,20281.0
EDEM1,ENSG00000134109,preeclampsia,EFO_0000668,0.29234130652060936,2.923546043929498,2,0.8,1.6,transcript,12032.0
STT3B,ENSG00000163527,lymphocyte count,EFO_0004587,0.29234130652060936,2.9234327880994417,1,0.4,0.4,transcript,20281.0
KIF20B,ENSG00000138182,pulse wave reflection index measurement,EFO_0009804,0.29234130652060936,2.9234403771632684,1,0.5,0.5,transcript,18307.0
SPOCK3,ENSG00000196104,cystatin C measurement,EFO_0004617,0.29234130652060936,2.9234954299905724,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
DIRAS2,ENSG00000165023,arterial stiffness measurement,EFO_0004517,0.29234130652060936,2.923489313776433,1,0.4,0.4,transcript,5246.0
ARSJ,ENSG00000180801,growth differentiation factor 15 amount,OBA_2050135,0.29234130652060936,2.9235912984688763,2,0.8,1.6,transcript,8977.0
PHC1,ENSG00000111752,esterified cholesterol measurement,EFO_0008589,0.29233456846494676,2.9233648351339747,1,0.5,0.5,transcript,26109.0
SLAIN2,ENSG00000109171,ceramide measurement,EFO_0010222,0.29232591367968863,2.9233948795643423,2,0.8,1.6,transcript,11787.0
ABCB5,ENSG00000004846,neutrophil percentage of granulocytes,EFO_0007994,0.2922918028760361,2.922944941227562,1,0.4,0.4,transcript,14863.0
ASPM,ENSG00000066279,sex hormone-binding globulin measurement,EFO_0004696,0.2922665733070235,2.9227007314175353,2,0.9,1.8,transcript,51431.0
SNTG2,ENSG00000172554,diabetes mellitus,EFO_0000400,0.2922267522506178,2.9223174127476463,1,0.5,0.5,transcript,10022.0
CCBE1,ENSG00000183287,corneal ulcer,MONDO_0004577,0.2922267522506178,2.922281312756471,1,0.4,0.4,transcript,29006.0
MARCKS,ENSG00000277443,heel bone mineral density,EFO_0009270,0.2922160822512379,2.9222539323820254,1,0.4,0.4,transcript,4296.0
MFAP3,ENSG00000037749,cystic kidney disease,EFO_0008615,0.29220832081711895,2.9220957978728133,1,0.4,0.4,transcript,31772.0
FBXO22,ENSG00000167196,serum urea amount,OBA_2050065,0.2921881685767093,2.921902884558762,1,0.4,0.4,transcript,18869.0
CAV2,ENSG00000105971,bilirubin measurement,EFO_0004570,0.29217656998377184,2.9217898734039234,1,0.4,0.4,transcript,16547.0
ZDHHC21,ENSG00000175893,sialadenitis,EFO_1001179,0.2921305931284803,2.9216535117985702,4,1.6,6.4,transcript,18413.0
USP15,ENSG00000135655,aspartate aminotransferase measurement,EFO_0004736,0.29203147342659186,2.920397852108549,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
CD69,ENSG00000110848,neurodegenerative disease,EFO_0005772,0.29196181396057774,2.9204626153271005,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
HNRNPA0,ENSG00000177733,atrial fibrillation,EFO_0000275,0.29195911814307113,2.9196141356370697,1,0.4,0.4,transcript,17426.0
DYNC1I2,ENSG00000077380,heart rate,OBA_1001087,0.2919397349260058,2.9194085361937194,1,0.4,0.4,transcript,35756.0
GALR1,ENSG00000166573,nephritis,EFO_1002050,0.2919014797756624,2.919159410916422,2,0.8,1.6,transcript,11064.0
GALR1,ENSG00000166573,Nephropathy,HP_0000112,0.2919014797756624,2.919159410916422,2,0.8,1.6,transcript,11064.0
GALR1,ENSG00000166573,glycocholate measurement,EFO_0010491,0.2918724168807366,2.918868781967164,2,0.8,1.6,transcript,11064.0
SAXO1,ENSG00000155875,bone tissue density,OBA_1000110,0.29183659133489004,2.9183925889074196,1,0.4,0.4,transcript,14995.0
AKR1C1,ENSG00000187134,body height,OBA_VT0001253,0.29182470698621593,2.9183862608147475,2,0.8,1.6,transcript,11495.0
BACH1,ENSG00000156273,protein measurement,EFO_0004747,0.2918149699570996,2.918507561346885,4,1.6,6.4,transcript,17884.0
PDCD5,ENSG00000105185,systemic lupus erythematosus,MONDO_0007915,0.29181284056054113,2.9182065153496017,1,0.4,0.4,transcript,5121.0
RSBN1L,ENSG00000187257,myxedema,EFO_1001055,0.29177057616254665,2.917842478706557,2,0.8,1.6,transcript,11703.0
RSBN1L,ENSG00000187257,hypothyroidism,EFO_0004705,0.29177057616254665,2.917842478706557,2,0.8,1.6,transcript,11703.0
EXD1,ENSG00000178997,heart rate,OBA_1001087,0.29176966447281866,2.9177384289128727,1,0.4,0.4,transcript,9573.0
ZBTB34,ENSG00000177125,thyroid stimulating hormone amount,OBA_1000983,0.2917684868010017,2.9177151963139067,1,0.4,0.4,transcript,13189.0
PLCXD2,ENSG00000240891,arterial stiffness measurement,EFO_0004517,0.2917079684309311,2.917110704084418,1,0.4,0.4,transcript,12895.0
DPP8,ENSG00000074603,reticulocyte measurement,EFO_0010700,0.29169405775154716,2.917122297609739,4,1.6,6.4,transcript,35219.0
CYTIP,ENSG00000115165,placenta praevia,EFO_0007442,0.2916540040222547,2.9165678276487372,1,0.4,0.4,gene_variant,14395.0
FANCF,ENSG00000183161,ovarian neoplasm,EFO_0003893,0.29162692302420573,2.916390773845825,1,0.4,0.4,transcript,3291.0
AKAP10,ENSG00000108599,polygenic risk score,EFO_0030082,0.29162287721104696,2.916263952409502,1,0.4,0.4,transcript,11370.0
IQCB1,ENSG00000173226,multiple sclerosis,MONDO_0005301,0.2916207051077408,2.916248670055662,1,0.4,0.4,transcript,9611.0
ATXN3,ENSG00000066427,platelet volume,OBA_0003277,0.2916093540331404,2.9160992635289547,1,0.4,0.4,transcript,69891.0
ATXN3,ENSG00000066427,BMI-adjusted hip circumference,EFO_0008039,0.29148029864620467,2.914808709659597,1,0.4,0.4,transcript,69891.0
ZNF257,ENSG00000197134,erythrocyte volume,OBA_0003460,0.2914504501802022,2.9145320842044495,1,0.4,0.4,transcript,14502.0
CEP85L,ENSG00000111860,systolic blood pressure,EFO_0006335,0.2914363333665787,2.914378736646264,1,0.4,0.4,transcript,25969.0
HTR1F,ENSG00000179097,schizophrenia,MONDO_0005090,0.2914240332493752,2.9143584659845967,1,0.4,0.4,transcript,3386.0
FIGNL1,ENSG00000132436,hip circumference,OBA_1000032,0.29140489413234416,2.914065123862482,1,0.4,0.4,transcript,24718.0
SKIL,ENSG00000136603,glucose measurement,EFO_0004468,0.29139546610140976,2.913971120835673,1,0.5,0.5,transcript,30377.0
POF1B,ENSG00000124429,body height,OBA_VT0001253,0.29132139322723216,2.9132996220752347,1,0.5,0.5,transcript,5835.0
SCAMP1,ENSG00000085365,bipolar disorder,MONDO_0004985,0.29129433935719107,2.912969740561767,1,0.4,0.4,transcript,15182.0
SCAMP1,ENSG00000085365,mathematical ability,EFO_0004875,0.29129433935719107,2.912969740561767,1,0.4,0.4,transcript,15182.0
TMEM170B,ENSG00000205269,chronotype measurement,EFO_0008328,0.2912743289279496,2.9127882785945336,1,0.4,0.4,transcript,8891.0
MANSC4,ENSG00000205693,MANSC domain-containing protein 4 measurement,EFO_0801785,0.2912149022473559,2.912448962485557,1,0.5,0.5,transcript,1667.0
LRRC7,ENSG00000033122,psoriasis,EFO_0000676,0.2911945398525411,2.9120095022309616,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
ANKRD10,ENSG00000088448,immune system disease,EFO_0000540,0.2911840782294411,2.9120188766844377,2,0.8,1.6,transcript,8984.0
ATP12A,ENSG00000075673,lymphocyte count,EFO_0004587,0.2911840782294411,2.9118899344202402,1,0.4,0.4,transcript,8138.0
CFHR4,ENSG00000134365,neurodegenerative disease,EFO_0005772,0.2911675823125208,2.9117163319156156,1,0.5,0.5,transcript,12343.0
SP8,ENSG00000164651,severe acute respiratory syndrome,EFO_0000694,0.29112794876970655,2.9113543940641065,1,0.4,0.4,transcript,5340.0
U2SURP,ENSG00000163714,monocyte count,EFO_0005091,0.29107051937785344,2.910755601768201,2,0.8,1.6,transcript,31741.0
TNPO3,ENSG00000064419,primary biliary cirrhosis,EFO_1001486,0.2910617349859248,2.9106440222160175,1,0.5,0.5,transcript,18746.0
IQGAP1,ENSG00000140575,breast adenocarcinoma,EFO_0000304,0.2910242491476477,2.910296589393707,2,0.8,1.6,transcript,29576.0
IMPG2,ENSG00000081148,lymphocyte count,EFO_0004587,0.2909842717661547,2.9100582349029267,2,0.9,1.8,transcript,8352.0
IMPG2,ENSG00000081148,lagophthalmos,MONDO_0001604,0.2909842717661547,2.9100582349029267,2,0.9,1.8,transcript,8352.0
MAP3K7,ENSG00000135341,gamma-glutamylalanine measurement,EFO_0800675,0.2909246467121605,2.9093358538448832,4,1.6,6.4,transcript,71599.0
ALG10B,ENSG00000175548,asthma,MONDO_0004979,0.2908977958421212,2.9096837743444195,5,2.0,10.0,transcript,14168.0
CAV2,ENSG00000105971,paroxysmal tachycardia,EFO_0009493,0.29089663014624656,2.908990475028671,1,0.4,0.4,transcript,16547.0
ZFP1,ENSG00000184517,vital capacity,EFO_0004312,0.29089062949419753,2.9089346476496587,1,0.4,0.4,transcript,14108.0
DPY19L2,ENSG00000177990,mean corpuscular hemoglobin concentration,EFO_0004528,0.2907881542289427,2.908022288242981,2,0.8,1.6,transcript,11368.0
RCOR3,ENSG00000117625,body height,OBA_VT0001253,0.29075799552759507,2.907644310516881,2,0.8,1.6,transcript,24862.0
DPP8,ENSG00000074603,heel bone mineral density,EFO_0009270,0.29075664676347995,2.9077481877290667,4,1.6,6.4,transcript,35219.0
AGO3,ENSG00000126070,glioblastoma multiforme,EFO_0000519,0.2907545872664705,2.9075590387882695,1,0.4,0.4,transcript,30381.0
TLR10,ENSG00000174123,ovarian carcinoma,EFO_0001075,0.29075296761348346,2.9076911183519742,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
LAMA1,ENSG00000101680,thyroid disease,EFO_1000627,0.29060034166356435,2.9060193118543616,1,0.5,0.5,transcript,31456.0
STT3B,ENSG00000163527,ovarian neoplasm,EFO_0003893,0.2905980192484142,2.9059999153774903,1,0.4,0.4,transcript,20281.0
SP8,ENSG00000164651,COVID-19,MONDO_0100096,0.2905735789876795,2.905810696243836,1,0.4,0.4,transcript,5340.0
OXSR1,ENSG00000172939,QT interval,EFO_0004682,0.2904879629999452,2.9049202061812336,1,0.4,0.4,transcript,9858.0
ARHGAP12,ENSG00000165322,body weight,EFO_0004338,0.29046348173593667,2.9046468797217804,1,0.4,0.4,transcript,33161.0
CGAS,ENSG00000164430,diastolic blood pressure change measurement,EFO_0006945,0.29045778937487854,2.904815548884777,2,0.9,1.8,transcript,7574.0
SLC9B1,ENSG00000164037,testosterone measurement,EFO_0004908,0.2904379285955302,2.904424258072589,1,0.5,0.5,transcript,11118.0
SLC9B1,ENSG00000164037,age at menarche,EFO_0004703,0.2904379285955302,2.904424258072589,1,0.5,0.5,transcript,11118.0
ANKH,ENSG00000154122,electrocardiography,EFO_0004327,0.29043614193621975,2.905129861985148,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,electrocardiography,EFO_0004327,0.29043614193621975,2.905129861985148,5,2.4,12.0,transcript,15616.0
ANKH,ENSG00000154122,electrocardiography,EFO_0004327,0.29043614193621975,2.905129861985148,5,2.4,12.0,gene_variant,15616.0
ANKH,ENSG00000154122,electrocardiography,EFO_0004327,0.29043614193621975,2.905129861985148,5,2.4,12.0,transcript,15616.0
QSOX1,ENSG00000116260,red blood cell density,OBA_2045260,0.29040994623060074,2.904128525736945,1,0.4,0.4,transcript,13763.0
THEM4,ENSG00000159445,X-18888 measurement,EFO_0800792,0.29040933146906317,2.9042476654527385,2,0.8,1.6,transcript,10366.0
C2CD6,ENSG00000155754,multinodular goiter,MONDO_0000334,0.2903656281458653,2.903697204686677,1,0.5,0.5,transcript,12218.0
DYNC1I2,ENSG00000077380,mathematical ability,EFO_0004875,0.29028550957296273,2.902866282663289,1,0.4,0.4,transcript,35756.0
ATG16L1,ENSG00000085978,prostate specific antigen amount,OBA_2050200,0.2902852524817938,2.9028645163039832,1,0.4,0.4,transcript,33357.0
ING1,ENSG00000153487,systolic blood pressure,EFO_0006335,0.2902590686293759,2.902617169344606,1,0.4,0.4,transcript,15104.0
RGS7BP,ENSG00000186479,2'-O-methyluridine measurement,EFO_0800636,0.2902244437844425,2.9023325590992717,1,0.5,0.5,transcript,5674.0
EPRS1,ENSG00000136628,glomerular filtration rate,OBA_0003747,0.29021869742009715,2.902231688921057,1,0.5,0.5,transcript,11182.0
AGO3,ENSG00000126070,breast adenocarcinoma,EFO_0000304,0.29021650025437346,2.902178168667299,1,0.4,0.4,transcript,30381.0
LIMA1,ENSG00000050405,systolic blood pressure,EFO_0006335,0.2901703983890104,2.9017173882666327,1,0.4,0.4,transcript,29841.0
TRMT9B,ENSG00000250305,Genu valgum,HP_0002857,0.29014574738772136,2.9015986005383922,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
TRMT9B,ENSG00000250305,Genu varum,HP_0002970,0.29014574738772136,2.9015986005383922,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
UBL3,ENSG00000122042,benign endocrine neoplasm,MONDO_0000627,0.29014574738772136,2.9022913863164077,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
ARSJ,ENSG00000180801,lean body mass,EFO_0004995,0.2901266425214082,2.9014446584768647,2,0.8,1.6,transcript,8977.0
RALGPS2,ENSG00000116191,phospholipids in very large HDL measurement ,EFO_0022298,0.2900642945912724,2.900722480634601,2,0.8,1.6,transcript,20117.0
ROCK2,ENSG00000134318,Fuchs' endothelial dystrophy,MONDO_0005321,0.29001752485674515,2.900186242169175,1,0.5,0.5,transcript,45481.0
DYNLT5,ENSG00000152760,pulse pressure measurement,EFO_0005763,0.2900164777128077,2.900234940257352,1,0.4,0.4,transcript,5701.0
RASGRP3,ENSG00000152689,breast adenocarcinoma,EFO_0000304,0.29001454510591435,2.900156653971901,1,0.4,0.4,transcript,35705.0
MED10,ENSG00000133398,lymphocyte count,EFO_0004587,0.290008683061795,2.900236419249214,1,0.4,0.4,transcript,2674.0
C2orf76,ENSG00000186132,cardiac transplant,EFO_0010673,0.2899913809590333,2.9000030753792196,1,0.4,0.4,transcript,4481.0
GMCL1,ENSG00000087338,protozoa infectious disease,MONDO_0002428,0.28998859748635036,2.9001403873297145,2,0.8,1.6,transcript,6289.0
SCAMP1,ENSG00000085365,intraocular pressure measurement,EFO_0004695,0.2899796899643799,2.8998232466336553,1,0.4,0.4,transcript,15182.0
CNOT6L,ENSG00000138767,educational attainment,EFO_0011015,0.2899796899643799,2.899926788516652,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
SCAMP1,ENSG00000085365,adolescent idiopathic scoliosis,EFO_0005423,0.2899796899643799,2.8998232466336553,1,0.4,0.4,transcript,15182.0
SIX4,ENSG00000100625,type 2 diabetes mellitus,MONDO_0005148,0.2899388747309703,2.8994284810933526,1,0.4,0.4,transcript,10067.0
USP6,ENSG00000129204,osteosarcoma,EFO_0000637,0.2899365734597763,2.8993770311607836,1,0.4,0.4,transcript,35409.0
AGPAT5,ENSG00000155189,cholesteryl esters to total lipids in very small VLDL percentage ,EFO_0022259,0.2899278417024436,2.8993157897236794,1,0.4,0.4,transcript,10703.0
AGPAT5,ENSG00000155189,cholesterol in IDL measurement ,EFO_0021899,0.2899278417024436,2.8993157897236794,1,0.4,0.4,transcript,10703.0
AGPAT5,ENSG00000155189,triglycerides to total lipids in very small VLDL percentage ,EFO_0022341,0.2899278417024436,2.8993157897236794,1,0.4,0.4,transcript,10703.0
AGPAT5,ENSG00000155189,cholesterol to total lipids in IDL percentage ,EFO_0022233,0.2899278417024436,2.8993157897236794,1,0.4,0.4,transcript,10703.0
AGPAT5,ENSG00000155189,cholesterol to total lipids in very small VLDL percentage ,EFO_0022245,0.2899278417024436,2.8993157897236794,1,0.4,0.4,transcript,10703.0
AGPAT5,ENSG00000155189,cholesteryl ester measurement,EFO_0010351,0.2899278417024436,2.8993157897236794,1,0.4,0.4,transcript,10703.0
ZNF485,ENSG00000198298,coronary artery disease,EFO_0001645,0.28986722298002193,2.898769562873998,1,0.5,0.5,transcript,5137.0
MAP3K7,ENSG00000135341,ovarian cancer,MONDO_0008170,0.2898605981246706,2.8986953679699843,4,1.6,6.4,transcript,71599.0
RCOR3,ENSG00000117625,smoking initiation,EFO_0005670,0.2898461044765778,2.8985254000067084,2,0.8,1.6,transcript,24862.0
ZFP90,ENSG00000184939,neurodegenerative disease,EFO_0005772,0.2897829091879479,2.8978424470262185,1,0.4,0.4,transcript,29951.0
DCK,ENSG00000156136,type 2 diabetes mellitus,MONDO_0005148,0.28974688513564834,2.897505837024537,1,0.4,0.4,transcript,10815.0
BTAF1,ENSG00000095564,prothrombin time measurement,EFO_0008390,0.289689504805271,2.896931792495113,1,0.4,0.4,transcript,10886.0
LMNTD1,ENSG00000152936,Escherichia coli Infections,EFO_1001318,0.28967951030324374,2.8969497687825663,2,0.9,1.8,transcript,11638.0
STT3B,ENSG00000163527,neurodegenerative disease,EFO_0005772,0.28962968843855047,2.896316607278853,1,0.4,0.4,transcript,20281.0
CFAP46,ENSG00000171811,hyperpituitarism,EFO_1000973,0.28952858918450214,2.8953072520637497,1,0.5,0.5,transcript,23408.0
PFAS,ENSG00000178921,erythrocyte volume,OBA_0003460,0.28952412269591177,2.8952645532945502,1,0.4,0.4,transcript,17148.0
IKZF3,ENSG00000161405,B-cell acute lymphoblastic leukemia,EFO_0000094,0.28949250846175006,2.894932825454285,1,0.4,0.4,transcript,51674.0
ARHGAP12,ENSG00000165322,outer segment thickness measurement,EFO_0803373,0.28948839715943137,2.8948960339567273,1,0.4,0.4,transcript,33161.0
MMADHC,ENSG00000168288,metabolite measurement,EFO_0004725,0.28948088573151404,2.894890423383656,1,0.4,0.4,transcript,4904.0
RFX7,ENSG00000181827,lung adenocarcinoma,EFO_0000571,0.289462471035112,2.8946343026772596,1,0.4,0.4,transcript,41700.0
GALR1,ENSG00000166573,osteitis deformans,EFO_0004261,0.2894451350639584,2.894595963799382,2,0.8,1.6,transcript,11064.0
MR1,ENSG00000153029,neuroimaging measurement,EFO_0004346,0.2894064025636321,2.8941970682469127,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
USP37,ENSG00000135913,mean corpuscular hemoglobin concentration,EFO_0004528,0.28933598768282437,2.893499503714176,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
SKP2,ENSG00000145604,glioblastoma multiforme,EFO_0000519,0.28931324058426194,2.893137428696605,1,0.4,0.4,transcript,79636.0
PFAS,ENSG00000178921,5-oxoproline measurement,EFO_0010988,0.2893044379736423,2.8930677060718555,1,0.4,0.4,transcript,17148.0
IL1A,ENSG00000115008,dysmenorrheic pain measurement,EFO_0007889,0.289297940293849,2.8931777172667,1,0.4,0.4,transcript,2017.0
SLC30A9,ENSG00000014824,systolic blood pressure,EFO_0006335,0.28928644153659894,2.8932161786924078,3,1.3,3.9000000000000004,transcript,11087.0
YWHAG,ENSG00000170027,ovarian cancer,MONDO_0008170,0.28924985945298765,2.892606556743102,1,0.4,0.4,transcript,3705.0
ZNF143,ENSG00000166478,insomnia,EFO_0004698,0.28922928976331114,2.8923191774607155,1,0.5,0.5,transcript,19026.0
DNAJC10,ENSG00000077232,lymphocyte count,EFO_0004587,0.28920192187634997,2.892038470494032,4,1.7000000000000002,6.800000000000001,transcript,353215.0
CYTIP,ENSG00000115165,kidney disease,EFO_0003086,0.2891928414087579,2.8919562015137688,1,0.4,0.4,gene_variant,14395.0
TBC1D9B,ENSG00000197226,neutrophil percentage of leukocytes,EFO_0007990,0.2891551647093277,2.891563861952654,1,0.4,0.4,transcript,32747.0
LNPEP,ENSG00000113441,platelet crit,EFO_0007985,0.2890978904907097,2.8909995671313857,1,0.4,0.4,transcript,19359.0
DPY19L2,ENSG00000177990,brain aneurysm,EFO_0003870,0.28909301872618914,2.891070933215445,2,0.8,1.6,transcript,11368.0
CEP85L,ENSG00000111860,RR interval,EFO_0004831,0.2890718325074215,2.890733728054692,1,0.4,0.4,transcript,25969.0
PEAK1,ENSG00000173517,alcohol consumption quality,OBA_1000840,0.2890651038884297,2.890657961335537,1,0.4,0.4,transcript,57783.0
MAP4K3,ENSG00000011566,conduction system disorder,EFO_0005137,0.2890049540075519,2.890072347693263,1,0.4,0.4,transcript,17538.0
BACE2,ENSG00000182240,arterial stiffness measurement,EFO_0004517,0.28895268032805543,2.8896603592070984,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
LRRC58,ENSG00000163428,HbA1c measurement,EFO_0004541,0.28894528431349176,2.8896549143650265,2,0.8,1.6,transcript,7918.0
PROK2,ENSG00000163421,serum gamma-glutamyl transferase measurement,EFO_0004532,0.2889405872042471,2.889921335959997,2,0.8,1.6,transcript,3104.0
PARP11,ENSG00000111224,strand of hair color,OBA_0002313,0.2889405872042471,2.889423820530311,1,0.4,0.4,transcript,22286.0
ZNF436,ENSG00000125945,erythrocyte volume,OBA_0003460,0.28893214587837657,2.889355100499493,1,0.4,0.4,transcript,11890.0
ONECUT2,ENSG00000119547,serum albumin amount,OBA_2050068,0.2888472613192847,2.889634438918988,7,2.8000000000000003,19.6,transcript,16870.0
SLC6A5,ENSG00000165970,DNA methylation,EFO_0022599,0.2888472613192847,2.88851124933696,1,0.4,0.4,transcript,10353.0
OXSR1,ENSG00000172939,HbA1c measurement,EFO_0004541,0.28878163144878904,2.8878568906696716,1,0.4,0.4,transcript,9858.0
GCNT1,ENSG00000187210,riboflavin kinase measurement,EFO_0802016,0.2887292211943247,2.8873113095799146,1,0.4,0.4,transcript,20945.0
CENPE,ENSG00000138778,blood protein measurement,EFO_0007937,0.28869369792822286,2.8869626730129583,1,0.5,0.5,transcript,19460.0
MFAP3,ENSG00000037749,depressive disorder,MONDO_0002050,0.288668396613243,2.886696555834054,1,0.4,0.4,transcript,31772.0
CR2,ENSG00000117322,frozen shoulder,EFO_1000941,0.28866517549615517,2.8866700808881562,1,0.4,0.4,transcript,21827.0
TSPAN3,ENSG00000140391,sialolithiasis,EFO_1001180,0.28866517549615517,2.8866736655662844,1,0.4,0.4,transcript,18256.0
MGA,ENSG00000174197,diastolic blood pressure change measurement,EFO_0006945,0.28866326910972034,2.8866386128822663,1,0.5,0.5,transcript,84434.0
TULP4,ENSG00000130338,eye color,EFO_0003949,0.288653813958432,2.886557064641095,1,0.4,0.4,transcript,21136.0
RPAP3,ENSG00000005175,N-acetylalanine measurement,EFO_0800118,0.28863470157340587,2.8864953836865808,2,0.8,1.6,transcript,10784.0
IREB2,ENSG00000136381,cigarettes per day measurement,EFO_0006525,0.28862720702802147,2.886371926044111,2,0.9,1.8,transcript,18026.0
SLC11A2,ENSG00000110911,erythrocyte count,EFO_0004305,0.2886212919944885,2.886240881218521,2,0.8,1.6,transcript,57222.0
ZNF429,ENSG00000197013,red blood cell density,OBA_2045260,0.28861704680504224,2.886326276795188,2,0.8,1.6,transcript,10269.0
FAM98A,ENSG00000119812,EDTA measurement,EFO_0800946,0.2885982081382462,2.885989434593977,1,0.4,0.4,transcript,54398.0
PFAS,ENSG00000178921,hemoglobin A1 measurement,EFO_0007629,0.2885814220612439,2.8858375469478714,1,0.4,0.4,transcript,17148.0
GID4,ENSG00000141034,FEV/FVC ratio,EFO_0004713,0.2884823880596377,2.884880990819107,1,0.4,0.4,transcript,7004.0
IL1A,ENSG00000115008,neoplasm,EFO_0000616,0.2884739824973846,2.884938139302056,1,0.4,0.4,transcript,2017.0
SIX4,ENSG00000100625,vital capacity,EFO_0004312,0.28845780719152747,2.8846178056989245,1,0.4,0.4,transcript,10067.0
TRAM1,ENSG00000067167,waist-hip ratio,EFO_0004343,0.28842920567269853,2.884482555595898,2,0.8,1.6,transcript,8399.0
SFRP1,ENSG00000104332,idiopathic pulmonary fibrosis,EFO_0000768,0.28840742232007577,2.884122202090046,1,0.4,0.4,transcript,8337.0
CNR2,ENSG00000188822,neutrophil count,EFO_0004833,0.2883879089566345,2.883955062975652,1,0.4,0.4,transcript,5265.0
VPS50,ENSG00000004766,growth differentiation factor 15 amount,OBA_2050135,0.2883545877780646,2.8835570397406864,1,0.4,0.4,transcript,35836.0
CFAP46,ENSG00000171811,urinary microalbumin measurement,EFO_0010967,0.2883448245884134,2.8834696061028624,1,0.5,0.5,transcript,23408.0
PHIP,ENSG00000146247,response to xenobiotic stimulus,GO_0009410,0.28832950416529474,2.8833030188063797,1,0.5,0.5,transcript,62679.0
IMPG2,ENSG00000081148,retinopathy,EFO_0003839,0.2882352157903734,2.8825676751451135,2,0.9,1.8,transcript,8352.0
IKZF3,ENSG00000161405,acute lymphoblastic leukemia,EFO_0000220,0.28816784258272155,2.8816861666639997,1,0.4,0.4,transcript,51674.0
TULP4,ENSG00000130338,neutrophil count,EFO_0004833,0.2881443651328821,2.881462576385596,1,0.4,0.4,transcript,21136.0
CCBE1,ENSG00000183287,open-angle glaucoma,EFO_0004190,0.28812384518168765,2.88125224206717,1,0.4,0.4,transcript,29006.0
MDGA2,ENSG00000139915,body mass index,EFO_0004340,0.2881164914013954,2.8811880047026337,1,0.4,0.4,transcript,17323.0
PAQR3,ENSG00000163291,breast adenocarcinoma,EFO_0000304,0.28809761284909213,2.880991180231279,1,0.4,0.4,transcript,26575.0
IPP,ENSG00000197429,neurodegenerative disease,EFO_0005772,0.28809508755413765,2.8810316509856415,1,0.5,0.5,transcript,6190.0
USP37,ENSG00000135913,neutrophil count,EFO_0004833,0.28806393400642777,2.88077896695021,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
MTCH2,ENSG00000109919,metabolic syndrome,EFO_0000195,0.28805727625923494,2.8806322156244537,1,0.4,0.4,transcript,6728.0
PICALM,ENSG00000073921,late-onset Alzheimers disease,EFO_1001870,0.28804447938930927,2.880458062211665,1,0.4,0.4,transcript,30147.0
ARL3,ENSG00000138175,uric acid measurement,EFO_0004761,0.28797236554338596,2.879827985115654,1,0.4,0.4,transcript,3834.0
TRPC6,ENSG00000137672,triglyceride measurement,EFO_0004530,0.28783959732696324,2.878424860393197,1,0.4,0.4,transcript,13847.0
FRMD4B,ENSG00000114541,sodium measurement,EFO_0009282,0.2878192337952885,2.878268434214656,2,0.8,1.6,transcript,21026.0
PLEKHA6,ENSG00000143850,body height,OBA_VT0001253,0.2877995163849898,2.878001978508228,1,0.4,0.4,transcript,58697.0
FYB1,ENSG00000082074,sleep quality,OBA_2040170,0.28778228088540453,2.8778424590800227,1,0.5,0.5,transcript,25445.0
DOK5,ENSG00000101134,type 2 diabetes mellitus,MONDO_0005148,0.28775195952125376,2.877607430082981,1,0.4,0.4,transcript,4554.0
SMU1,ENSG00000122692,hemoglobin measurement,EFO_0004509,0.28772957348572065,2.8778002191621392,3,1.2000000000000002,3.6000000000000005,transcript,7136.0
LIMA1,ENSG00000050405,lymphocyte count,EFO_0004587,0.2877244918154272,2.8772583225308006,1,0.4,0.4,transcript,29841.0
BCAS2,ENSG00000116752,Red cell distribution width,EFO_0009188,0.28771783183668076,2.87736299057364,1,0.4,0.4,transcript,2166.0
HTR1F,ENSG00000179097,intestinal disease,EFO_0009431,0.2877091262097502,2.8772093955883467,1,0.4,0.4,transcript,3386.0
RPS20,ENSG00000008988,Becker muscular dystrophy,MONDO_0010311,0.2877076507649658,2.877093717132083,1,0.4,0.4,transcript,23243.0
ANKRD30B,ENSG00000180777,arterial stiffness measurement,EFO_0004517,0.2877061165874039,2.8770857322770267,1,0.5,0.5,transcript,20353.0
CWH43,ENSG00000109182,hemoglobin A1 measurement,EFO_0007629,0.2876726485274716,2.876788558521147,1,0.5,0.5,transcript,8055.0
NDFIP2,ENSG00000102471,platelet volume,OBA_0003277,0.2876342663173117,2.8763571450391057,2,0.8,1.6,transcript,110483.0
RASEF,ENSG00000165105,serum creatinine amount,OBA_2050096,0.2876342663173117,2.8763970849418246,1,0.4,0.4,transcript,7350.0
GPAT3,ENSG00000138678,ovarian neoplasm,EFO_0003893,0.2876342663173117,2.8764897896098987,2,0.8,1.6,transcript,10875.0
COLEC10,ENSG00000184374,collectin-10 measurement,EFO_0801491,0.28756785444112387,2.8757837245321958,1,0.4,0.4,transcript,3803.0
KIAA0232,ENSG00000170871,amino acid measurement,EFO_0005134,0.28755300725270966,2.8755533608363653,1,0.4,0.4,transcript,17176.0
FIGLA,ENSG00000183733,arterial stiffness measurement,EFO_0004517,0.28755300725270966,2.87622259330272,1,0.5,0.5,transcript,722.0
KIAA0232,ENSG00000170871,n-methyl-2-pyridone-5-carboxamide measurement,EFO_0010994,0.28755300725270966,2.8755533608363653,1,0.4,0.4,transcript,17176.0
CCDC62,ENSG00000130783,Abruptio Placentae,EFO_1001754,0.28755300725270966,2.8755570085540327,1,0.4,0.4,transcript,14850.0
KIAA0232,ENSG00000170871,1-methylnicotinamide measurement,EFO_0021829,0.28755300725270966,2.8755533608363653,1,0.4,0.4,transcript,17176.0
AGPAT5,ENSG00000155189,ventral hernia,EFO_1001866,0.28754275357069836,2.875464908406227,1,0.4,0.4,transcript,10703.0
ARHGAP12,ENSG00000165322,arterial stiffness measurement,EFO_0004517,0.28749032173646033,2.874915279727017,1,0.4,0.4,transcript,33161.0
KCNJ15,ENSG00000157551,bilirubin measurement,EFO_0004570,0.28748652974110145,2.874875131461414,1,0.4,0.4,transcript,40675.0
RAD23B,ENSG00000119318,protozoa infectious disease,MONDO_0002428,0.28748652974110145,2.874905571273278,1,0.4,0.4,transcript,9932.0
RAD23B,ENSG00000119318,COVID-19,MONDO_0100096,0.28748652974110145,2.874905571273278,1,0.4,0.4,transcript,9932.0
TNPO3,ENSG00000064419,autoimmune disease,EFO_0005140,0.2874673040641552,2.8746997129983214,1,0.5,0.5,transcript,18746.0
CMTR2,ENSG00000180917,body mass index,EFO_0004340,0.2874526891798579,2.8746303110992057,2,0.8,1.6,transcript,15471.0
ARFIP1,ENSG00000164144,Sjogren syndrome,EFO_0000699,0.2874291774974784,2.874318827592125,1,0.4,0.4,transcript,14786.0
METTL8,ENSG00000123600,ulcerative colitis,EFO_0000729,0.2874291774974784,2.8743037960115987,1,0.4,0.4,transcript,33275.0
BACE2,ENSG00000182240,placenta praevia,EFO_0007442,0.2874291774974784,2.8744253309013286,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
MIOS,ENSG00000164654,nervous system disease,EFO_0000618,0.2874291774974784,2.8746531527274666,4,1.6,6.4,transcript,17710.0
FYB1,ENSG00000082074,urinary microalbumin measurement,EFO_0010967,0.2874291774974784,2.8743114252007618,1,0.5,0.5,transcript,25445.0
CD163L1,ENSG00000177675,high density lipoprotein cholesterol measurement,EFO_0004612,0.28738929416551223,2.8739228169258673,1,0.4,0.4,transcript,13389.0
ZNF257,ENSG00000197134,lipoma,EFO_0000759,0.28737341022104995,2.873761684612927,1,0.4,0.4,transcript,14502.0
USP37,ENSG00000135913,triglycerides to total lipids in very large HDL percentage ,EFO_0022339,0.2873530727629394,2.8736703545153266,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
SH3TC2,ENSG00000169247,vital capacity,EFO_0004312,0.287320691837716,2.873211341785839,1,0.4,0.4,transcript,90428.0
POU2F1,ENSG00000143190,adult onset asthma,EFO_1002011,0.28731966730617403,2.873211685118298,2,0.8,1.6,transcript,106581.0
SH3GL3,ENSG00000140600,arterial stiffness measurement,EFO_0004517,0.28725768022520054,2.8726284951959182,1,0.4,0.4,transcript,7738.0
KCNJ15,ENSG00000157551,erythrocyte volume,OBA_0003460,0.2872490039606124,2.8724998736565235,1,0.4,0.4,transcript,40675.0
AGA,ENSG00000038002,Hematemesis,HP_0002248,0.28724632895981744,2.872561271177638,1,0.5,0.5,transcript,5103.0
PPDPFL,ENSG00000168333,injury,EFO_0000546,0.28724632895981744,2.8727886912658582,2,0.8,1.6,transcript,4917.0
PAG1,ENSG00000076641,sialadenitis,EFO_1001179,0.28722283221343275,2.8723584140117158,2,0.8,1.6,transcript,12299.0
SP8,ENSG00000164651,heart rate,OBA_1001087,0.28722283221343275,2.8723032285013685,1,0.4,0.4,transcript,5340.0
CWH43,ENSG00000109182,type 2 diabetes mellitus,MONDO_0005148,0.2871140078834108,2.8712021520805386,1,0.5,0.5,transcript,8055.0
NDFIP2,ENSG00000102471,growth differentiation factor 15 amount,OBA_2050135,0.2871025426570138,2.8710399084361264,2,0.8,1.6,transcript,110483.0
PRTG,ENSG00000166450,trauma complication,EFO_0009888,0.28710130175414733,2.871231093625796,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
MAP4K3,ENSG00000011566,familial glucocorticoid deficiency,MONDO_0008733,0.28710130175414733,2.8710358251592174,1,0.4,0.4,transcript,17538.0
PRTG,ENSG00000166450,cataract,MONDO_0005129,0.28710130175414733,2.871231093625796,3,1.2000000000000002,3.6000000000000005,transcript,16508.0
PARP11,ENSG00000111224,hippocampus molecular layer volume,OBA_2050050,0.28708454591316923,2.8708634076195323,1,0.4,0.4,transcript,22286.0
PARP11,ENSG00000111224,hippocampal amigdala transition area volume,EFO_0009401,0.28708454591316923,2.8708634076195323,1,0.4,0.4,transcript,22286.0
PARP11,ENSG00000111224,hippocampal CA3 volume,EFO_0009395,0.28708454591316923,2.8708634076195323,1,0.4,0.4,transcript,22286.0
SP8,ENSG00000164651,hippocampal volume,EFO_0005035,0.287074034052834,2.870815246895381,1,0.4,0.4,transcript,5340.0
U2SURP,ENSG00000163714,hematocrit,EFO_0004348,0.2869772164479498,2.8698225724691646,2,0.8,1.6,transcript,31741.0
BHLHE41,ENSG00000123095,BMI-adjusted hip circumference,EFO_0008039,0.2869553925801433,2.8696422065341634,1,0.4,0.4,transcript,4531.0
TULP4,ENSG00000130338,educational attainment,EFO_0011015,0.2869280680588566,2.8692996056453413,1,0.4,0.4,transcript,21136.0
TMCC1,ENSG00000172765,body mass index,EFO_0004340,0.2869112829908279,2.8691230313874936,1,0.4,0.4,transcript,39210.0
ROCK2,ENSG00000134318,cardiovascular disease,EFO_0000319,0.28684114895320284,2.868422483133752,1,0.5,0.5,transcript,45481.0
PRRG4,ENSG00000135378,platelet crit,EFO_0007985,0.28683566037541747,2.868428766842755,1,0.4,0.4,transcript,5543.0
ABCB5,ENSG00000004846,body mass index,EFO_0004340,0.2868324669620215,2.8683515820874157,1,0.4,0.4,transcript,14863.0
TLR10,ENSG00000174123,seasonal allergic rhinitis,EFO_0003956,0.28680493695129344,2.868210811730074,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
PROK2,ENSG00000163421,smoking status measurement,EFO_0006527,0.28678259376496057,2.8683414015671316,2,0.8,1.6,transcript,3104.0
PRDM10,ENSG00000170325,neurodegenerative disease,EFO_0005772,0.28676282696942024,2.8676396722027544,1,0.4,0.4,transcript,35080.0
HNRNPA0,ENSG00000177733,heart rate variability measurement,EFO_0008003,0.28672157688699385,2.8672387230762966,1,0.4,0.4,transcript,17426.0
ATP12A,ENSG00000075673,metabolite measurement,EFO_0004725,0.28666212552712705,2.8666704073971,1,0.4,0.4,transcript,8138.0
WDR12,ENSG00000138442,hemolytic anemia,EFO_0005558,0.28666212552712705,2.866641194456755,1,0.4,0.4,transcript,20061.0
C2CD2,ENSG00000157617,chronic primary adrenal insufficiency,MONDO_0015129,0.28666212552712705,2.866635236396751,1,0.4,0.4,transcript,28610.0
TMEM17,ENSG00000186889,arterial stiffness measurement,EFO_0004517,0.28665549610588054,2.8666189610588053,1,0.4,0.4,transcript,6250.0
DENND3,ENSG00000105339,citrate measurement,EFO_0010114,0.28665364424620743,2.8665472591197267,1,0.5,0.5,transcript,46225.0
KLF10,ENSG00000155090,trauma complication,EFO_0009888,0.28665364424620743,2.866597288218083,1,0.4,0.4,transcript,6574.0
KLF10,ENSG00000155090,complication,EFO_0009518,0.28665364424620743,2.866597288218083,1,0.4,0.4,transcript,6574.0
DENND3,ENSG00000105339,isocitrate measurement,EFO_0010505,0.28665364424620743,2.8665472591197267,1,0.5,0.5,transcript,46225.0
KLF10,ENSG00000155090,medical procedure,EFO_0002571,0.28665364424620743,2.866597288218083,1,0.4,0.4,transcript,6574.0
TMEM17,ENSG00000186889,drug use measurement,EFO_0007010,0.2865897226511949,2.865961226511949,1,0.4,0.4,transcript,6250.0
TMEM17,ENSG00000186889,amyotrophic lateral sclerosis,MONDO_0004976,0.2865897226511949,2.865961226511949,1,0.4,0.4,transcript,6250.0
ANO6,ENSG00000177119,1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement,EFO_0800391,0.28653446583935155,2.865352079543794,1,0.4,0.4,transcript,53900.0
ABCB1,ENSG00000085563,acute myeloid leukemia,EFO_0000222,0.28653263437067444,2.8653503914174023,1,0.5,0.5,transcript,20792.0
RELCH,ENSG00000134444,bone tissue density,OBA_1000110,0.28651584714566913,2.8651721898187192,1,0.4,0.4,transcript,29158.0
ZNF716,ENSG00000182111,skin microbiome measurement,EFO_0801228,0.28649542763544183,2.8678333550492363,6,2.5,15.0,transcript,5210.0
LRPAP1,ENSG00000163956,platelet count,EFO_0004309,0.2864893574781943,2.865124210953383,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
MTR,ENSG00000116984,Intellectual disability,HP_0001249,0.28642438738064385,2.8642482862362533,1,0.4,0.4,transcript,90653.0
IKZF3,ENSG00000161405,breast carcinoma,EFO_0000305,0.28642069158209704,2.864214656657755,1,0.4,0.4,transcript,51674.0
SRSF7,ENSG00000115875,smoking initiation,EFO_0005670,0.2864016058225851,2.864038021766374,1,0.4,0.4,transcript,18212.0
PEX7,ENSG00000112357,eosinophil count,EFO_0004842,0.28630669086736593,2.863109452813204,1,0.4,0.4,transcript,9402.0
ST8SIA4,ENSG00000113532,aspartate aminotransferase measurement,EFO_0004736,0.28626614752688073,2.8627043523188664,1,0.4,0.4,transcript,9329.0
PRPF4B,ENSG00000112739,ovarian dysfunction,EFO_0009003,0.2862436961113879,2.862457745949263,1,0.5,0.5,transcript,24056.0
CDH19,ENSG00000071991,response to statin,GO_0036273,0.28621851368470114,2.8624596945041194,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
NXPH2,ENSG00000144227,color vision disorder,MONDO_0001703,0.28621851368470114,2.862332792808621,1,0.4,0.4,transcript,2709.0
RASEF,ENSG00000165105,chronotype measurement,EFO_0008328,0.28621851368470114,2.8622395586157188,1,0.4,0.4,transcript,7350.0
NAF1,ENSG00000145414,educational attainment,EFO_0011015,0.28621851368470114,2.862247087039057,1,0.5,0.5,transcript,8071.0
TXNL1,ENSG00000091164,educational attainment,EFO_0011015,0.28621851368470114,2.862267335665403,2,0.8,1.6,transcript,19465.0
CDH19,ENSG00000071991,drug-induced liver injury,EFO_0004228,0.28621851368470114,2.8624596945041194,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
DOK5,ENSG00000101134,poisoning,EFO_0008546,0.28621851368470114,2.862272971717455,1,0.4,0.4,transcript,4554.0
FAM98A,ENSG00000119812,interleukin 1 receptor antagonist measurement,EFO_0004754,0.28621851368470114,2.8621924900585265,1,0.4,0.4,transcript,54398.0
DOK5,ENSG00000101134,response to xenobiotic stimulus,GO_0009410,0.28621851368470114,2.862272971717455,1,0.4,0.4,transcript,4554.0
MAP3K7,ENSG00000135341,smoking initiation,EFO_0005670,0.28621851368470114,2.8622745235702896,4,1.6,6.4,transcript,71599.0
ZNF33B,ENSG00000196693,Abruptio Placentae,EFO_1001754,0.28620284733767787,2.8620595988747866,1,0.5,0.5,transcript,16064.0
TSPAN3,ENSG00000140391,level of serum globulin type protein,OBA_2045206,0.2861746129920517,2.86176804052525,1,0.4,0.4,transcript,18256.0
GKAP1,ENSG00000165113,neutrophil count,EFO_0004833,0.28616590081687554,2.861716134704031,1,0.4,0.4,transcript,7002.0
LMNTD1,ENSG00000152936,erythrocyte volume,OBA_0003460,0.2861633603153872,2.861788268904001,2,0.9,1.8,transcript,11638.0
MAN1A2,ENSG00000198162,glucose measurement,EFO_0004468,0.28608457577843954,2.8609732783072297,2,0.8,1.6,transcript,12547.0
SLC7A2,ENSG00000003989,C-reactive protein measurement,EFO_0004458,0.2860648444743635,2.8607694403647455,3,1.4,4.199999999999999,transcript,34712.0
OTULIN,ENSG00000154124,post term pregnancy,EFO_0009681,0.2860648444743635,2.8606676792118018,1,0.4,0.4,transcript,20796.0
ARFIP1,ENSG00000164144,lysophosphatidylethanolamine 18:0 measurement,EFO_0010367,0.2860605060359373,2.860632112976714,1,0.4,0.4,transcript,14786.0
IMPG2,ENSG00000081148,retinoschisis,MONDO_0004579,0.28605916903828016,2.860807207624181,2,0.9,1.8,transcript,8352.0
TRMT9B,ENSG00000250305,hypertrophic cardiomyopathy,EFO_0000538,0.28605916903828016,2.86073281704398,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
BTAF1,ENSG00000095564,metabolic syndrome,EFO_0000195,0.286020523662831,2.860241981070713,1,0.4,0.4,transcript,10886.0
NPFFR1,ENSG00000148734,body mass index,EFO_0004340,0.28595282893380236,2.8595715372567176,1,0.4,0.4,transcript,9249.0
APOBEC3H,ENSG00000100298,neurodegenerative disease,EFO_0005772,0.28591858287837446,2.8592624131222477,1,0.4,0.4,transcript,5223.0
EXOC6,ENSG00000138190,IGF-1 measurement,EFO_0004627,0.2858803579425678,2.8588261966962256,1,0.5,0.5,transcript,22107.0
TBXT,ENSG00000164458,arterial stiffness measurement,EFO_0004517,0.28587816571637065,2.859242132988726,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
LGSN,ENSG00000146166,obesity,EFO_0001073,0.28587816571637065,2.858812254578225,1,0.4,0.4,transcript,13073.0
IGFBPL1,ENSG00000137142,Splenomegaly,HP_0001744,0.28587816571637065,2.860576385150246,4,1.6,6.4,transcript,3566.0
PLCXD2,ENSG00000240891,frozen shoulder,EFO_1000941,0.2858674012605888,2.858705032380995,1,0.4,0.4,transcript,12895.0
TMEM154,ENSG00000170006,frozen shoulder,EFO_1000941,0.2858674012605888,2.858693097485892,1,0.4,0.4,transcript,20959.0
CEP85L,ENSG00000111860,hypertension,EFO_0000537,0.2857189024250872,2.857204427231349,1,0.4,0.4,transcript,25969.0
TOPAZ1,ENSG00000173769,insomnia measurement,EFO_0007876,0.2855694697622926,2.8557884359056405,1,0.5,0.5,transcript,5334.0
TOPAZ1,ENSG00000173769,"osteoarthritis, spine",EFO_1000787,0.2855694697622926,2.8557884359056405,1,0.5,0.5,transcript,5334.0
IL17A,ENSG00000112115,Behcet's syndrome,EFO_0003780,0.2855538760610802,2.855752550028226,1,0.4,0.4,transcript,1871.0
PLEKHA6,ENSG00000143850,electrocardiography,EFO_0004327,0.285539967462055,2.85540648927888,1,0.4,0.4,transcript,58697.0
ATG16L1,ENSG00000085978,common variable immunodeficiency,MONDO_0015517,0.285529704518334,2.855309036669385,1,0.4,0.4,transcript,33357.0
ZNF697,ENSG00000143067,appendicular lean mass,EFO_0004980,0.2854719606791796,2.855364883723146,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
FARSB,ENSG00000116120,balding measurement,EFO_0007825,0.28543146312793655,2.8543656516875284,1,0.4,0.4,transcript,7840.0
GBP6,ENSG00000183347,type 2 diabetes mellitus,MONDO_0005148,0.28541106158222934,2.8544948207315786,2,0.9,1.8,transcript,4685.0
HEG1,ENSG00000173706,cystatin B measurement,EFO_0010593,0.2853653800864553,2.853675667152204,1,0.4,0.4,transcript,18293.0
ITM2A,ENSG00000078596,adolescent idiopathic scoliosis,EFO_0005423,0.2852464649106184,2.8528646491061838,1,0.4,0.4,transcript,1000.0
FAM186A,ENSG00000185958,neurodegenerative disease,EFO_0005772,0.2852314352741432,2.8524252543716857,2,1.0,2.0,transcript,18034.0
GPATCH2L,ENSG00000089916,triglyceride measurement,EFO_0004530,0.28513539002081256,2.851496372548456,4,1.6,6.4,transcript,44921.0
ZNF716,ENSG00000182111,sialolithiasis,EFO_1001180,0.2851307510430162,2.8541865891249802,6,2.5,15.0,transcript,5210.0
USP37,ENSG00000135913,cholesterol to total lipids in very small VLDL percentage ,EFO_0022245,0.28512295106824526,2.851369137568385,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
USP37,ENSG00000135913,cholesteryl esters to total lipids in very small VLDL percentage ,EFO_0022259,0.28512295106824526,2.851369137568385,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
PARP11,ENSG00000111224,hippocampal CA1 volume,EFO_0009394,0.28510788305879237,2.8510967790757635,1,0.4,0.4,transcript,22286.0
SC5D,ENSG00000109929,serum creatinine amount,OBA_2050096,0.2851051238424855,2.8510740812093904,1,0.4,0.4,transcript,17511.0
CYSLTR1,ENSG00000173198,rheumatoid arthritis,EFO_0000685,0.28507952735387454,2.85098541019947,2,0.8,1.6,transcript,8415.0
CENPE,ENSG00000138778,mean corpuscular hemoglobin concentration,EFO_0004528,0.28503435171785374,2.850369210909267,1,0.5,0.5,transcript,19460.0
SH3GL3,ENSG00000140600,skin neoplasm,EFO_0004198,0.28503435171785374,2.8503952101224503,1,0.4,0.4,transcript,7738.0
TRIT1,ENSG00000043514,neutrophil count,EFO_0004833,0.28500757275891136,2.8500909303560173,1,0.4,0.4,transcript,26311.0
CERKL,ENSG00000188452,lysosomal storage disease,MONDO_0002561,0.2849922291770992,2.8499423656428404,1,0.5,0.5,transcript,24908.0
CERKL,ENSG00000188452,multiple sclerosis,MONDO_0005301,0.2849922291770992,2.8499423656428404,1,0.5,0.5,transcript,24908.0
CERKL,ENSG00000188452,Alzheimer disease,MONDO_0004975,0.2849922291770992,2.8499423656428404,1,0.5,0.5,transcript,24908.0
CERKL,ENSG00000188452,Parkinson disease,MONDO_0005180,0.2849922291770992,2.8499423656428404,1,0.5,0.5,transcript,24908.0
TLK1,ENSG00000198586,body height,OBA_VT0001253,0.28497279104170076,2.849741805578018,1,0.4,0.4,transcript,28787.0
CPPED1,ENSG00000103381,placenta praevia,EFO_0007442,0.28488337913046485,2.8488715200350767,1,0.4,0.4,transcript,10602.0
MTCH2,ENSG00000109919,total cholesterol measurement,EFO_0004574,0.28486470423516197,2.8487064953837242,1,0.4,0.4,transcript,6728.0
TRIM36,ENSG00000152503,smoking status measurement,EFO_0006527,0.2848454358694039,2.8484805195835095,1,0.4,0.4,transcript,15290.0
ZDHHC21,ENSG00000175893,central nervous system cancer,EFO_0000326,0.2848051620643309,2.848399201157076,4,1.6,6.4,transcript,18413.0
ZDHHC21,ENSG00000175893,Hypercholesterolemia,HP_0003124,0.2848051620643309,2.848399201157076,4,1.6,6.4,transcript,18413.0
TSPAN19,ENSG00000231738,strand of hair color,OBA_0002313,0.2847687374306568,2.8477365506035923,1,0.4,0.4,transcript,8134.0
SLC44A1,ENSG00000070214,waist-hip ratio,EFO_0004343,0.28476530773559344,2.8476626862730092,1,0.4,0.4,transcript,41628.0
SPOCK3,ENSG00000196104,urate measurement,EFO_0004531,0.28476530773559344,2.8477354421404133,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
SPOCK3,ENSG00000196104,osteitis deformans,EFO_0004261,0.28476530773559344,2.8477354421404133,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
PAQR3,ENSG00000163291,arterial stiffness measurement,EFO_0004517,0.28476530773559344,2.847668129096292,1,0.4,0.4,transcript,26575.0
MYO3A,ENSG00000095777,blood pyridoxal measurement,EFO_0022222,0.28476530773559344,2.8476767931459075,1,0.5,0.5,transcript,21083.0
MMADHC,ENSG00000168288,low density lipoprotein cholesterol measurement,EFO_0004611,0.28476530773559344,2.8477346434244497,1,0.4,0.4,transcript,4904.0
MMADHC,ENSG00000168288,response to selective serotonin reuptake inhibitor,EFO_0005658,0.28476530773559344,2.8477346434244497,1,0.4,0.4,transcript,4904.0
MDGA2,ENSG00000139915,cognitive function measurement,EFO_0008354,0.28476530773559344,2.847676168044614,1,0.4,0.4,transcript,17323.0
OTULINL,ENSG00000145569,citrate measurement,EFO_0010114,0.2847563648747637,2.8476136237601306,1,0.4,0.4,transcript,8004.0
CD69,ENSG00000110848,growth differentiation factor 15 amount,OBA_2050135,0.28472808149478385,2.8481252906691616,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
CCDC127,ENSG00000164366,mean corpuscular hemoglobin concentration,EFO_0004528,0.28472808149478385,2.847321387013971,1,0.4,0.4,transcript,9859.0
NLRP10,ENSG00000182261,glomerulonephritis,MONDO_0002462,0.28472808149478385,2.847327549379431,1,0.4,0.4,transcript,8559.0
PLIN3,ENSG00000105355,immune system disease,EFO_0000540,0.28472808149478385,2.847333854090726,1,0.5,0.5,transcript,9427.0
GID4,ENSG00000141034,phospholipids in small HDL measurement ,EFO_0022296,0.28472808149478385,2.8473379251705686,1,0.4,0.4,transcript,7004.0
ZNF436,ENSG00000125945,serum gamma-glutamyl transferase measurement,EFO_0004532,0.28472808149478385,2.847314456663566,1,0.4,0.4,transcript,11890.0
GID4,ENSG00000141034,lipid measurement,EFO_0004529,0.28472808149478385,2.8473379251705686,1,0.4,0.4,transcript,7004.0
GID4,ENSG00000141034,phospholipids:total lipids ratio,EFO_0020946,0.28472808149478385,2.8473379251705686,1,0.4,0.4,transcript,7004.0
AKAP10,ENSG00000108599,brain volume,OBA_2050009,0.2846448449701985,2.8464836300010172,1,0.4,0.4,transcript,11370.0
ABCB5,ENSG00000004846,mean corpuscular hemoglobin concentration,EFO_0004528,0.2846063019821912,2.8460899322891127,1,0.4,0.4,transcript,14863.0
TLR10,ENSG00000174123,eosinophil count,EFO_0004842,0.28459911385439124,2.846152580761052,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
LRRC7,ENSG00000033122,arterial stiffness measurement,EFO_0004517,0.28456488796527296,2.84571298335828,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
SPOCK3,ENSG00000196104,cytokine measurement,EFO_0004873,0.28456488796527296,2.8457312444372085,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
SPOCK3,ENSG00000196104,response to vaccine,EFO_0004645,0.28456488796527296,2.8457312444372085,3,1.2000000000000002,3.6000000000000005,transcript,43708.0
YBX3,ENSG00000060138,high density lipoprotein cholesterol measurement,EFO_0004612,0.2845372057907438,2.8453925119880275,1,0.4,0.4,transcript,19556.0
DTHD1,ENSG00000197057,Abruptio Placentae,EFO_1001754,0.2845323779516336,2.8453501800654672,1,0.5,0.5,transcript,18939.0
FAM98A,ENSG00000119812,liver disease,EFO_0001421,0.28449286917535455,2.8449360449650607,1,0.4,0.4,transcript,54398.0
IGFBPL1,ENSG00000137142,bone tissue density,OBA_1000110,0.28435681002592017,2.845362828245741,4,1.6,6.4,transcript,3566.0
NUP153,ENSG00000124789,clear cell renal carcinoma,EFO_0000349,0.284347820331751,2.8435061878700365,1,0.5,0.5,transcript,17867.0
MGA,ENSG00000174197,obesity,EFO_0001073,0.28431752243919706,2.843181146177033,1,0.5,0.5,transcript,84434.0
KPNA4,ENSG00000186432,hypertension,EFO_0000537,0.28420565829143174,2.8420655761244435,1,0.4,0.4,transcript,44478.0
ARPC5,ENSG00000162704,high density lipoprotein cholesterol measurement,EFO_0004612,0.28420057560144174,2.8420324850488314,1,0.4,0.4,transcript,14965.0
GASK1B,ENSG00000164125,medical procedure,EFO_0002571,0.284127883702619,2.8414517227775224,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
GASK1B,ENSG00000164125,trauma complication,EFO_0009888,0.284127883702619,2.8414517227775224,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
PARP11,ENSG00000111224,dentate gyrus volume,OBA_2045237,0.28412499480951503,2.8412678965829903,1,0.4,0.4,transcript,22286.0
SMARCC1,ENSG00000173473,aging,EFO_0022597,0.28410314545541526,2.841145601661237,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,aging,EFO_0022597,0.28410314545541526,2.841145601661237,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,aging,EFO_0022597,0.28410314545541526,2.841145601661237,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,aging,EFO_0022597,0.28410314545541526,2.841145601661237,2,0.8,1.6,transcript,14017.0
ATXN7L3B,ENSG00000253719,contracture,EFO_0003899,0.2840768686652207,2.8408213459465723,1,0.4,0.4,transcript,7596.0
RAD21L1,ENSG00000244588,systolic blood pressure,EFO_0006335,0.28407095126191895,2.840773730446058,1,0.5,0.5,transcript,7786.0
ZNF24,ENSG00000172466,alcohol consumption quality,OBA_1000840,0.284041144461623,2.840434317443311,1,0.5,0.5,transcript,21860.0
TMEM17,ENSG00000186889,red blood cell density,OBA_2045260,0.28402802455393245,2.8403442455393244,1,0.4,0.4,transcript,6250.0
FAM114A1,ENSG00000197712,mean corpuscular hemoglobin concentration,EFO_0004528,0.2839904920102387,2.8399535996691387,1,0.4,0.4,transcript,8217.0
MYO3A,ENSG00000095777,brain volume,OBA_2050009,0.28386842097682313,2.8387079255582046,1,0.5,0.5,transcript,21083.0
CD69,ENSG00000110848,platelet-to-lymphocyte ratio,EFO_0008446,0.2838424615482189,2.839269091203512,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
ROCK2,ENSG00000134318,cortical thickness,EFO_0004840,0.28382002893872615,2.838211282988985,1,0.5,0.5,transcript,45481.0
ROCK2,ENSG00000134318,neuroimaging measurement,EFO_0004346,0.28382002893872615,2.838211282988985,1,0.5,0.5,transcript,45481.0
MAP3K7,ENSG00000135341,biliary tract disease,EFO_0009534,0.2838198004851099,2.8382873915743776,4,1.6,6.4,transcript,71599.0
TFEC,ENSG00000105967,gastrointestinal disease,EFO_0010282,0.2838198004851099,2.838213702206095,1,0.4,0.4,transcript,25482.0
IMPG2,ENSG00000081148,alcohol consumption quality,OBA_1000840,0.2838198004851099,2.8384135220924787,2,0.9,1.8,transcript,8352.0
IMPG2,ENSG00000081148,placenta praevia,EFO_0007442,0.2838198004851099,2.8384135220924787,2,0.9,1.8,transcript,8352.0
RASEF,ENSG00000165105,endocrine system disease,EFO_0001379,0.2838198004851099,2.838252426619807,1,0.4,0.4,transcript,7350.0
DTHD1,ENSG00000197057,placental retention,EFO_0009578,0.2838198004851099,2.8382244054002306,1,0.5,0.5,transcript,18939.0
RASEF,ENSG00000165105,blood sodium bicarbonate amount,OBA_2050094,0.2838198004851099,2.838252426619807,1,0.4,0.4,transcript,7350.0
TLK1,ENSG00000198586,triglyceride measurement,EFO_0004530,0.283782385045698,2.8378377456179904,1,0.4,0.4,transcript,28787.0
SLC4A8,ENSG00000050438,heart rate,OBA_1001087,0.28377983997326056,2.8378299075800286,2,0.8,1.6,transcript,50781.0
SC5D,ENSG00000109929,lymphocyte count,EFO_0004587,0.283774644376844,2.837769286552976,1,0.4,0.4,transcript,17511.0
TBXT,ENSG00000164458,thyroiditis,MONDO_0004126,0.28372586736672994,2.837719149492319,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
RASGRP3,ENSG00000152689,diaphragmatic hernia,EFO_0008561,0.283702378137891,2.837034984291668,1,0.4,0.4,transcript,35705.0
BACE2,ENSG00000182240,body mass index,EFO_0004340,0.28368127940585125,2.8369463499850567,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
ATXN3,ENSG00000066427,bone tissue density,OBA_1000110,0.28362863197758253,2.836292042973376,1,0.4,0.4,transcript,69891.0
DTHD1,ENSG00000197057,placenta praevia,EFO_0007442,0.28361782090540055,2.836204609603137,1,0.5,0.5,transcript,18939.0
TXNL1,ENSG00000091164,balding measurement,EFO_0007825,0.28361782090540055,2.8362604078723974,2,0.8,1.6,transcript,19465.0
PSD3,ENSG00000156011,Hodgkins lymphoma,EFO_0000183,0.2835933708323257,2.8359431514168145,1,0.4,0.4,transcript,42359.0
TMEM68,ENSG00000167904,insomnia,EFO_0004698,0.28356479431241344,2.835666614645396,1,0.4,0.4,transcript,21423.0
GPR158,ENSG00000151025,allergic conjunctivitis,EFO_0007141,0.28355693099135443,2.83559498121816,1,0.5,0.5,transcript,19477.0
FSIP2,ENSG00000188738,body weight,EFO_0004338,0.2835355478806336,2.83563441883423,4,2.0,8.0,transcript,28680.0
IQGAP1,ENSG00000140575,endometrial cancer,MONDO_0011962,0.28352016612480824,2.835255759165313,2,0.8,1.6,transcript,29576.0
YWHAG,ENSG00000170027,breast adenocarcinoma,EFO_0000304,0.28351344078491975,2.835242370062423,1,0.4,0.4,transcript,3705.0
FZD3,ENSG00000104290,cortical thickness,EFO_0004840,0.2834698910052446,2.834713026869104,1,0.4,0.4,transcript,28335.0
LYPD6,ENSG00000187123,cerebral cortex area attribute,OBA_2045267,0.28346873010151524,2.83472005031923,1,0.4,0.4,transcript,12214.0
SLC35B4,ENSG00000205060,sodium measurement,EFO_0009282,0.283465649882523,2.834698418758158,1,0.4,0.4,transcript,9542.0
SLC35F5,ENSG00000115084,BMI-adjusted waist circumference,EFO_0007789,0.2834461530583424,2.83453228947251,2,0.8,1.6,transcript,22612.0
SLC4A8,ENSG00000050438,smoking status measurement,EFO_0006527,0.2834319105809247,2.83435061365667,2,0.8,1.6,transcript,50781.0
SLC4A8,ENSG00000050438,smoking cessation,EFO_0004319,0.2834319105809247,2.83435061365667,2,0.8,1.6,transcript,50781.0
BTAF1,ENSG00000095564,ovarian neoplasm,EFO_0003893,0.28343012197470135,2.8343379641894164,1,0.4,0.4,transcript,10886.0
VAT1L,ENSG00000171724,Abnormality of the genital system,HP_0000078,0.28343012197470135,2.834392005039796,1,0.4,0.4,transcript,4406.0
ZDHHC21,ENSG00000175893,liver disease,EFO_0001421,0.28343012197470135,2.834648800260781,4,1.6,6.4,transcript,18413.0
ARFIP1,ENSG00000164144,FEV/FVC ratio,EFO_0004713,0.2833823537177289,2.83385058979463,1,0.4,0.4,transcript,14786.0
ITPRID2,ENSG00000138434,Tietze syndrome,MONDO_0001858,0.28323933141929364,2.8324021017322054,1,0.4,0.4,transcript,45519.0
NAA30,ENSG00000139977,response to stimulus,GO_0050896,0.2832142301258596,2.832172056521558,1,0.4,0.4,transcript,13443.0
NAA30,ENSG00000139977,adverse effect,EFO_0009658,0.2832142301258596,2.832172056521558,1,0.4,0.4,transcript,13443.0
TMEM123,ENSG00000152558,high density lipoprotein cholesterol measurement,EFO_0004612,0.2832093297920512,2.8321330198668875,1,0.4,0.4,transcript,10070.0
NMRK1,ENSG00000106733,potassium measurement,EFO_0009283,0.28314180396263045,2.8314640113536917,1,0.4,0.4,transcript,8701.0
FYCO1,ENSG00000163820,osteoarthritis,MONDO_0005178,0.2831346223309321,2.8313708341503965,1,0.4,0.4,transcript,16253.0
FSIP2,ENSG00000188738,psoriasis,EFO_0000676,0.28303000661942107,2.830579006222105,4,2.0,8.0,transcript,28680.0
SLC9B1,ENSG00000164037,apolipoprotein A 1 measurement,EFO_0004614,0.283010162891916,2.8301466010364473,1,0.5,0.5,transcript,11118.0
IKZF3,ENSG00000161405,multiple myeloma,EFO_0001378,0.28291955765802373,2.8292033174170217,1,0.4,0.4,transcript,51674.0
SLC7A2,ENSG00000003989,kidney disease,EFO_0003086,0.2829145436647532,2.8292664322686427,3,1.4,4.199999999999999,transcript,34712.0
GNA13,ENSG00000120063,cortical thickness,EFO_0004840,0.28291097809957366,2.829161387240092,1,0.4,0.4,transcript,7751.0
ATF7IP2,ENSG00000166669,mean corpuscular hemoglobin concentration,EFO_0004528,0.2829089555720855,2.8291057647525273,1,0.5,0.5,transcript,30847.0
RCC1L,ENSG00000274523,growth differentiation factor 15 amount,OBA_2050135,0.2828839694434245,2.8288827561201098,1,0.4,0.4,transcript,9289.0
LIMA1,ENSG00000050405,nephrotic syndrome,EFO_0004255,0.2828839694434245,2.8288530988107734,1,0.4,0.4,transcript,29841.0
RUFY3,ENSG00000018189,CXCL1 measurement,EFO_0010777,0.2828839694434245,2.828860022736323,1,0.4,0.4,transcript,19677.0
IGDCC3,ENSG00000174498,spondylolisthesis,EFO_0007493,0.2828839694434245,2.828887427131142,1,0.4,0.4,transcript,8380.0
KIAA0232,ENSG00000170871,Paralytic ileus,HP_0002590,0.2828839694434245,2.828862982743513,1,0.4,0.4,transcript,17176.0
KIAA0232,ENSG00000170871,urinary microalbumin measurement,EFO_0010967,0.2828839694434245,2.828862982743513,1,0.4,0.4,transcript,17176.0
STXBP4,ENSG00000166263,breast cancer,MONDO_0007254,0.2826906714405618,2.8272984257926685,5,2.0,10.0,transcript,25529.0
NCS1,ENSG00000107130,neurodegenerative disease,EFO_0005772,0.28264885981792764,2.8265502504604108,1,0.4,0.4,transcript,6488.0
KLHL3,ENSG00000146021,red blood cell density,OBA_2045260,0.282645670253404,2.8265040132173835,2,0.8,1.6,transcript,33819.0
FAM210A,ENSG00000177150,upper extremity fracture,EFO_0009514,0.28259626935971593,2.8259848395389153,1,0.4,0.4,transcript,18062.0
SERPINB9,ENSG00000170542,heart function attribute,OBA_2045275,0.2825916969001184,2.8259646846161193,1,0.4,0.4,transcript,8383.0
CNMD,ENSG00000136110,sleep apnea,EFO_0003877,0.2825843370291184,2.8262841416410462,2,0.8,1.6,transcript,3630.0
TBXT,ENSG00000164458,heel bone mineral density,EFO_0009270,0.2825522973364999,2.825983449190018,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
ARL3,ENSG00000138175,pulse pressure measurement,EFO_0005763,0.28250158263679004,2.825120156049695,1,0.4,0.4,transcript,3834.0
ONECUT2,ENSG00000119547,pain,EFO_0003843,0.28247994740598886,2.8259612997860297,7,2.8000000000000003,19.6,transcript,16870.0
CPPED1,ENSG00000103381,arterial stiffness measurement,EFO_0004517,0.2824755328278705,2.8247930570091335,1,0.4,0.4,transcript,10602.0
SH3GL3,ENSG00000140600,glioblastoma multiforme,EFO_0000519,0.28246446716433227,2.8246963645872354,1,0.4,0.4,transcript,7738.0
CFHR4,ENSG00000134365,body weight,EFO_0004338,0.2824433561083448,2.8244740698738555,1,0.5,0.5,transcript,12343.0
ATXN7L3B,ENSG00000253719,neurofibrillary tangles measurement,EFO_0006797,0.282412473046476,2.8241773897591256,1,0.4,0.4,transcript,7596.0
ATXN7L3B,ENSG00000253719,adolescent idiopathic scoliosis,EFO_0005423,0.2824050740766898,2.8241034000612637,1,0.4,0.4,transcript,7596.0
MDGA2,ENSG00000139915,protein measurement,EFO_0004747,0.2824050740766898,2.824073831455578,1,0.4,0.4,transcript,17323.0
HTR1F,ENSG00000179097,Abnormal nasolacrimal system morphology,HP_0000614,0.2824050740766898,2.824168874257743,1,0.4,0.4,transcript,3386.0
MMADHC,ENSG00000168288,body mass index,EFO_0004340,0.2824050740766898,2.8241323068354136,1,0.4,0.4,transcript,4904.0
PTCHD4,ENSG00000244694,response to corticosteroid,GO_0031960,0.2824050740766898,2.8244645814382396,6,2.4000000000000004,14.400000000000002,transcript,34796.0
FAM98A,ENSG00000119812,mathematical ability,EFO_0004875,0.2824050740766898,2.8240580939784135,1,0.4,0.4,transcript,54398.0
STT3B,ENSG00000163527,amputation,EFO_0009632,0.2824050740766898,2.8240704636602465,1,0.4,0.4,transcript,20281.0
ARSJ,ENSG00000180801,retinal degeneration,MONDO_0004580,0.2824050740766898,2.824228974029681,2,0.8,1.6,transcript,8977.0
HS3ST3A1,ENSG00000153976,bone tissue density,OBA_1000110,0.2824050740766898,2.8241317780440456,1,0.4,0.4,transcript,4936.0
EDEM1,ENSG00000134109,serum metabolite measurement,EFO_0005653,0.2824050740766898,2.8241837194903026,2,0.8,1.6,transcript,12032.0
ATXN7L3B,ENSG00000253719,anxiety disorder measurement,EFO_0007795,0.28239249224291624,2.8239775817235278,1,0.4,0.4,transcript,7596.0
ATXN7L3B,ENSG00000253719,lifestyle measurement,EFO_0010724,0.28239249224291624,2.8239775817235278,1,0.4,0.4,transcript,7596.0
DAG1,ENSG00000173402,growth differentiation factor 15 amount,OBA_2050135,0.2823842095397003,2.8238482835158147,1,0.4,0.4,transcript,64640.0
WDR12,ENSG00000138442,diastolic blood pressure change measurement,EFO_0006945,0.2823738077081066,2.8237580162665505,1,0.4,0.4,transcript,20061.0
MFAP3,ENSG00000037749,grip strength measurement,EFO_0006941,0.28235229849698595,2.8235355746714834,1,0.4,0.4,transcript,31772.0
ALPK3,ENSG00000136383,hypothyroidism,EFO_0004705,0.2822968138194709,2.8230054342320052,1,0.4,0.4,transcript,10725.0
CD69,ENSG00000110848,eosinophil percentage of leukocytes,EFO_0007991,0.28228255143319014,2.8236699900532245,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
PLEKHA6,ENSG00000143850,uric acid measurement,EFO_0004761,0.2822642737880794,2.822649552539124,1,0.4,0.4,transcript,58697.0
AGO3,ENSG00000126070,endometrial cancer,MONDO_0011962,0.2822522100386782,2.822535266510346,1,0.4,0.4,transcript,30381.0
CCDC66,ENSG00000180376,diastolic blood pressure,EFO_0006336,0.2822394595481456,2.822409824990152,1,0.5,0.5,transcript,32831.0
USP37,ENSG00000135913,triglycerides:total lipids ratio,EFO_0020947,0.2821144673627418,2.8212843005133506,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
ANKRD36,ENSG00000135976,heart rate,OBA_1001087,0.282082522091854,2.82090060727361,2,1.0,2.0,transcript,26530.0
FANCF,ENSG00000183161,diastolic blood pressure,EFO_0006336,0.28206215672317775,2.8207431108355454,1,0.4,0.4,transcript,3291.0
FANCF,ENSG00000183161,hepatocellular carcinoma,EFO_0000182,0.2820422860917658,2.8205444045214256,1,0.4,0.4,transcript,3291.0
MUC16,ENSG00000181143,pancreatic adenocarcinoma,EFO_1000044,0.28193804013006923,2.819383221650077,1,0.5,0.5,transcript,177283.0
GUCA1C,ENSG00000138472,neurodegenerative disease,EFO_0005772,0.28192550869760213,2.819454290163272,1,0.5,0.5,transcript,2510.0
TNPO3,ENSG00000064419,"chromosome, telomeric region length",OBA_0003784,0.28190601301201523,2.819086802476922,1,0.5,0.5,transcript,18746.0
CENPQ,ENSG00000031691,polygenic risk score,EFO_0030082,0.28190488881817205,2.819278641197229,1,0.4,0.4,transcript,1741.0
CENPQ,ENSG00000031691,Alzheimer disease,MONDO_0004975,0.28190488881817205,2.819278641197229,1,0.4,0.4,transcript,1741.0
EDEM1,ENSG00000134109,pulse wave reflection index measurement,EFO_0009804,0.28180545897517956,2.8181875684752,2,0.8,1.6,transcript,12032.0
EDEM1,ENSG00000134109,hypertrophic cardiomyopathy,EFO_0000538,0.28180545897517956,2.8181875684752,2,0.8,1.6,transcript,12032.0
OTULIN,ENSG00000154124,vital capacity,EFO_0004312,0.28180545897517956,2.8180738242199626,1,0.4,0.4,transcript,20796.0
SENP6,ENSG00000112701,cutaneous lupus erythematosus,EFO_0003834,0.28180545897517956,2.8184836069124817,5,2.2,11.0,transcript,25640.0
FAM171B,ENSG00000144369,vital capacity,EFO_0004312,0.2817846593862952,2.817916389710099,1,0.4,0.4,transcript,5731.0
PROK2,ENSG00000163421,blood protein measurement,EFO_0007937,0.281780668599857,2.8183221499160958,2,0.8,1.6,transcript,3104.0
ATF7IP2,ENSG00000166669,platelet volume,OBA_0003277,0.2817524402583401,2.8175406116150734,1,0.5,0.5,transcript,30847.0
PARP11,ENSG00000111224,hypertrophic cardiomyopathy,EFO_0000538,0.2817524402583401,2.817542351071241,1,0.4,0.4,transcript,22286.0
SYT13,ENSG00000019505,cardiomyopathy,EFO_0000318,0.2817524402583401,2.817739687836361,2,0.8,1.6,transcript,7432.0
MMP12,ENSG00000262406,occlusion precerebral artery,EFO_0009677,0.2817327096359587,2.817546635327754,1,0.4,0.4,transcript,1822.0
TRAPPC8,ENSG00000153339,type 1 diabetes mellitus,MONDO_0005147,0.28171361862600186,2.817156595256304,1,0.5,0.5,transcript,24499.0
NAF1,ENSG00000145414,Abruptio Placentae,EFO_1001754,0.2817010813610255,2.8170727638023005,1,0.5,0.5,transcript,8071.0
TMEM68,ENSG00000167904,growth differentiation factor 15 amount,OBA_2050135,0.2817010813610255,2.817029485131517,1,0.4,0.4,transcript,21423.0
TBXT,ENSG00000164458,chloride measurement,EFO_0009284,0.28167591918441814,2.817219667669201,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
CASQ2,ENSG00000118729,QRS-T angle,EFO_0020097,0.2816641911690706,2.8166545627122757,1,0.4,0.4,transcript,31618.0
FANCF,ENSG00000183161,smoking initiation,EFO_0005670,0.2816635208857287,2.816756752461055,1,0.4,0.4,transcript,3291.0
TC2N,ENSG00000165929,lean body mass,EFO_0004995,0.2815641418904509,2.81566418368739,1,0.4,0.4,transcript,17571.0
GABPA,ENSG00000154727,adverse effect,EFO_0009658,0.28155487350490843,2.8155846868736396,1,0.4,0.4,transcript,11126.0
GABPA,ENSG00000154727,response to stimulus,GO_0050896,0.28155487350490843,2.8155846868736396,1,0.4,0.4,transcript,11126.0
PUS7L,ENSG00000129317,protein measurement,EFO_0004747,0.28150497058071794,2.8151866243786623,3,1.2000000000000002,3.6000000000000005,transcript,26293.0
GPM6A,ENSG00000150625,X-25790 measurement,EFO_0800933,0.2814564774907864,2.814582945988589,1,0.4,0.4,transcript,22013.0
FSIP2,ENSG00000188738,aneurysm,EFO_0009659,0.2814564774907864,2.814843714935758,4,2.0,8.0,transcript,28680.0
IQGAP1,ENSG00000140575,preeclampsia,EFO_0000668,0.2814476663478558,2.814530761395788,2,0.8,1.6,transcript,29576.0
NDFIP2,ENSG00000102471,lymphocyte count,EFO_0004587,0.2813981507629098,2.8139959894950866,2,0.8,1.6,transcript,110483.0
EPRS1,ENSG00000136628,reticulocyte measurement,EFO_0010700,0.28135108924945046,2.81355560721459,1,0.5,0.5,transcript,11182.0
TMEM17,ENSG00000186889,diabetic ketoacidosis,EFO_1000897,0.28129261618081,2.8129901618081,1,0.4,0.4,transcript,6250.0
TPRG1,ENSG00000188001,body mass index,EFO_0004340,0.2812832124368602,2.8129319808249464,2,0.8,1.6,transcript,16023.0
DIRAS2,ENSG00000165023,5-acetylamino-6-amino-3-methyluracil measurement,EFO_0800951,0.2812832124368602,2.8129083729389417,1,0.4,0.4,transcript,5246.0
MYO5A,ENSG00000197535,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.28113336243888926,2.811335664050105,1,0.4,0.4,transcript,196111.0
TRIT1,ENSG00000043514,breast cancer,MONDO_0007254,0.2811107675994303,2.8111228787612066,1,0.4,0.4,transcript,26311.0
IQGAP1,ENSG00000140575,basophil percentage of granulocytes,EFO_0007995,0.28110567347974624,2.811110832714693,2,0.8,1.6,transcript,29576.0
FITM2,ENSG00000197296,erythrocyte volume,OBA_0003460,0.2810545031930692,2.8106314623542006,1,0.4,0.4,transcript,4628.0
PEX13,ENSG00000162928,multiple sclerosis,MONDO_0005301,0.2810167803619265,2.8102136331334724,1,0.4,0.4,transcript,8728.0
YEATS2,ENSG00000163872,metabolite measurement,EFO_0004725,0.280903552857597,2.8090692690442873,1,0.5,0.5,transcript,14819.0
AKR1C1,ENSG00000187134,arterial stiffness measurement,EFO_0004517,0.280903552857597,2.809174719528558,2,0.8,1.6,transcript,11495.0
POU2F1,ENSG00000143190,neurodegenerative disease,EFO_0005772,0.28088151357408586,2.8088301477974165,2,0.8,1.6,transcript,106581.0
ATXN7L3B,ENSG00000253719,temporal measurement,EFO_0000719,0.2808111704896876,2.8081643641912417,1,0.4,0.4,transcript,7596.0
ATXN7L3B,ENSG00000253719,urinary microalbumin measurement,EFO_0010967,0.2808111704896876,2.8081643641912417,1,0.4,0.4,transcript,7596.0
ATXN7L3B,ENSG00000253719,esophageal ulcer,MONDO_0044782,0.2808111704896876,2.8081643641912417,1,0.4,0.4,transcript,7596.0
PLPP4,ENSG00000203805,ventricular fibrillation,EFO_0004287,0.2808111704896876,2.8081925946845407,1,0.4,0.4,transcript,4945.0
IQGAP1,ENSG00000140575,lung adenocarcinoma,EFO_0000571,0.28077641749767146,2.807818272893945,2,0.8,1.6,transcript,29576.0
TMEM170B,ENSG00000205269,hypertrophic cardiomyopathy,EFO_0000538,0.2807158700482036,2.8072036897970736,1,0.4,0.4,transcript,8891.0
ANO6,ENSG00000177119,1-palmitoyl-GPC (16:0) measurement,EFO_0800214,0.2807158700482036,2.807166121632314,1,0.4,0.4,transcript,53900.0
OTOGL,ENSG00000165899,skin disease,EFO_0000701,0.2807158700482036,2.807173558439958,1,0.5,0.5,transcript,33652.0
ZNF483,ENSG00000173258,testosterone measurement,EFO_0004908,0.2807130649879485,2.8072141310440473,2,0.8,1.6,transcript,19166.0
WBP2NL,ENSG00000183066,heart rate,OBA_1001087,0.28059434331660693,2.8059855881277085,1,0.5,0.5,transcript,11861.0
NUP43,ENSG00000120253,placenta praevia,EFO_0007442,0.28053552516963043,2.805557450609485,2,0.8,1.6,transcript,7913.0
SLC44A1,ENSG00000070214,serum creatinine amount,OBA_2050096,0.2804827821334825,2.8048374302519,1,0.4,0.4,transcript,41628.0
PLPP4,ENSG00000203805,Subdural hemorrhage,HP_0100309,0.28043584351389345,2.804439324926599,1,0.4,0.4,transcript,4945.0
FANCF,ENSG00000183161,head and neck squamous cell carcinoma,EFO_0000181,0.2803631206295228,2.8037527498989956,1,0.4,0.4,transcript,3291.0
AHCTF1,ENSG00000153207,arterial stiffness measurement,EFO_0004517,0.2802568084679716,2.8025813511500384,1,0.5,0.5,transcript,37689.0
CYTIP,ENSG00000115165,allantoin measurement,EFO_0010456,0.28015907850282223,2.8016185724544123,1,0.4,0.4,gene_variant,14395.0
GASK1B,ENSG00000164125,high density lipoprotein cholesterol measurement,EFO_0004612,0.28010763994482224,2.801249285199555,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
MAP4K3,ENSG00000011566,neurodegenerative disease,EFO_0005772,0.2800783901204561,2.800806708822305,1,0.4,0.4,transcript,17538.0
USP6,ENSG00000129204,melanoma,EFO_0000756,0.27996700603073615,2.799681356870382,1,0.4,0.4,transcript,35409.0
FANCF,ENSG00000183161,lung carcinoma,EFO_0001071,0.2799212457248307,2.7993340008520744,1,0.4,0.4,transcript,3291.0
DENND3,ENSG00000105339,urinary microalbumin measurement,EFO_0010967,0.2798720573842348,2.798731390500001,1,0.5,0.5,transcript,46225.0
PSD3,ENSG00000156011,retinal vasculature measurement,EFO_0010554,0.2798632351336417,2.798641794429974,1,0.4,0.4,transcript,42359.0
USP37,ENSG00000135913,growth differentiation factor 15 amount,OBA_2050135,0.2798468843114616,2.7986084700005485,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
CAV2,ENSG00000105971,platelet volume,OBA_0003277,0.2798196314651623,2.798220488217828,1,0.4,0.4,transcript,16547.0
SFRP1,ENSG00000104332,coronary artery disease,EFO_0001645,0.27981803301906394,2.7982283090799283,1,0.4,0.4,transcript,8337.0
DCLK1,ENSG00000133083,self reported educational attainment,EFO_0004784,0.27978857668646545,2.7979359645179143,2,0.8,1.6,transcript,31874.0
MYO3A,ENSG00000095777,serum creatinine amount,OBA_2050096,0.27978646221836395,2.7978883379736126,1,0.5,0.5,transcript,21083.0
NXPH2,ENSG00000144227,Low back pain,HP_0003419,0.2797850605328857,2.797998261290467,1,0.4,0.4,transcript,2709.0
KIF20B,ENSG00000138182,placental retention,EFO_0009578,0.2797850605328857,2.797877917286032,1,0.5,0.5,transcript,18307.0
KIF20B,ENSG00000138182,triglyceride measurement,EFO_0004530,0.2797850605328857,2.797877917286032,1,0.5,0.5,transcript,18307.0
DIRAS2,ENSG00000165023,secondary malignant neoplasm,EFO_0009812,0.2797850605328857,2.7979268538991966,1,0.4,0.4,transcript,5246.0
FAM98A,ENSG00000119812,optic cup area,OBA_2045265,0.2797850605328857,2.7978579585403724,1,0.4,0.4,transcript,54398.0
YTHDC2,ENSG00000047188,metabolite measurement,EFO_0004725,0.2797850605328857,2.7978708144937134,1,0.4,0.4,transcript,19793.0
ASMT,ENSG00000196433,Abnormality of prenatal development or birth,HP_0001197,0.2797850605328857,2.7979653368570814,1,0.5,0.5,transcript,4358.0
FAM98A,ENSG00000119812,spondylolisthesis,EFO_0007493,0.2797850605328857,2.7978579585403724,1,0.4,0.4,transcript,54398.0
NAF1,ENSG00000145414,health study participation,EFO_0010130,0.2797850605328857,2.797912555520903,1,0.5,0.5,transcript,8071.0
NXPH2,ENSG00000144227,Sciatica,HP_0011868,0.2797850605328857,2.797998261290467,1,0.4,0.4,transcript,2709.0
FAM98A,ENSG00000119812,musculoskeletal system disease,EFO_0009676,0.2797850605328857,2.7978579585403724,1,0.4,0.4,transcript,54398.0
TXNL1,ENSG00000091164,sinusitis,EFO_0007486,0.2797850605328857,2.797932804147249,2,0.8,1.6,transcript,19465.0
NDST3,ENSG00000164100,metabolite measurement,EFO_0004725,0.2797850605328857,2.79790066790708,1,0.4,0.4,transcript,7990.0
ST8SIA4,ENSG00000113532,Visual field defect,HP_0001123,0.2797850605328857,2.797893482378916,1,0.4,0.4,transcript,9329.0
NXPH2,ENSG00000144227,high density lipoprotein cholesterol measurement,EFO_0004612,0.2797850605328857,2.797998261290467,1,0.4,0.4,transcript,2709.0
ST8SIA4,ENSG00000113532,phosphatidylethanolamine measurement,EFO_0010228,0.2797850605328857,2.797893482378916,1,0.4,0.4,transcript,9329.0
TOPAZ1,ENSG00000173769,waist circumference,OBA_1001085,0.2797850605328857,2.797944343611572,1,0.5,0.5,transcript,5334.0
NXPH2,ENSG00000144227,body mass index,EFO_0004340,0.2797850605328857,2.797998261290467,1,0.4,0.4,transcript,2709.0
SI,ENSG00000090402,pituitary gland disease,EFO_0009607,0.2797850605328857,2.7979226514383675,1,0.5,0.5,transcript,6940.0
KYNU,ENSG00000115919,Splenomegaly,HP_0001744,0.2797850605328857,2.7980088540430863,3,1.2000000000000002,3.6000000000000005,transcript,22749.0
NXPH2,ENSG00000144227,executive function measurement,EFO_0009332,0.2797850605328857,2.797998261290467,1,0.4,0.4,transcript,2709.0
ST8SIA4,ENSG00000113532,erythrocyte volume,OBA_0003460,0.2797850605328857,2.797893482378916,1,0.4,0.4,transcript,9329.0
TRIM36,ENSG00000152503,breast neoplasm,EFO_0003869,0.2797850605328857,2.7978767662183275,1,0.4,0.4,transcript,15290.0
SLC25A16,ENSG00000122912,sexual dimorphism measurement,EFO_0021796,0.27974785007244307,2.797509537347646,1,0.4,0.4,transcript,12888.0
METTL14,ENSG00000145388,platelet volume,OBA_0003277,0.27973663198197596,2.797391906719267,1,0.4,0.4,transcript,15633.0
ZBTB34,ENSG00000177125,neurodegenerative disease,EFO_0005772,0.27970861084081566,2.797116436712046,1,0.4,0.4,transcript,13189.0
BHLHE41,ENSG00000123095,temporal measurement,EFO_0000719,0.27970638696171124,2.7971521503498424,1,0.4,0.4,transcript,4531.0
C15orf61,ENSG00000189227,insomnia measurement,EFO_0007876,0.2796472839677285,2.7980943736484214,5,2.0,10.0,transcript,6167.0
FANCF,ENSG00000183161,non-small cell lung carcinoma,EFO_0003060,0.27964685748161555,2.7965901184199233,1,0.4,0.4,transcript,3291.0
PKD2L2,ENSG00000078795,atrial fibrillation,EFO_0000275,0.2796113456626918,2.7961528329066474,1,0.5,0.5,transcript,12698.0
SMARCC1,ENSG00000173473,glucose measurement,EFO_0004468,0.2795795156303796,2.79590930341088,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,glucose measurement,EFO_0004468,0.2795795156303796,2.79590930341088,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,glucose measurement,EFO_0004468,0.2795795156303796,2.79590930341088,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,glucose measurement,EFO_0004468,0.2795795156303796,2.79590930341088,2,0.8,1.6,gene_variant,14017.0
IKZF3,ENSG00000161405,lung adenocarcinoma,EFO_0000571,0.2794389688133554,2.7943974289703384,1,0.4,0.4,transcript,51674.0
DOCK1,ENSG00000150760,alcohol consumption quality,OBA_1000840,0.27943692835078043,2.7943943713151302,1,0.4,0.4,transcript,15944.0
ATG16L1,ENSG00000085978,celiac disease,EFO_0001060,0.279423321369306,2.794245205179105,1,0.4,0.4,transcript,33357.0
IKZF3,ENSG00000161405,bladder transitional cell carcinoma,EFO_0006544,0.27940237014163455,2.79403144225313,1,0.4,0.4,transcript,51674.0
SFRP1,ENSG00000104332,reticulocyte count,EFO_0007986,0.27939322069113415,2.79398018580063,1,0.4,0.4,transcript,8337.0
SLF1,ENSG00000133302,platelet volume,OBA_0003277,0.27939322069113415,2.7939671200648717,1,0.4,0.4,transcript,11457.0
SFRP1,ENSG00000104332,reticulocyte measurement,EFO_0010700,0.27939322069113415,2.79398018580063,1,0.4,0.4,transcript,8337.0
IKZF3,ENSG00000161405,acute myeloid leukemia,EFO_0000222,0.2793632562736804,2.793640303573589,1,0.4,0.4,transcript,51674.0
IYD,ENSG00000009765,lymphocyte count,EFO_0004587,0.27933098144636037,2.7933272178746726,1,0.4,0.4,transcript,22984.0
GAGE1,ENSG00000205777,platelet volume,OBA_0003277,0.2793302167916569,2.793367506041365,1,0.4,0.4,transcript,6122.0
DNAH14,ENSG00000185842,bone tissue density,OBA_1000110,0.2793044289730711,2.7931022682142514,3,1.5,4.5,transcript,77615.0
ABCA13,ENSG00000179869,mean corpuscular hemoglobin concentration,EFO_0004528,0.2792723421305557,2.792733753164878,1,0.5,0.5,transcript,48394.0
KBTBD3,ENSG00000182359,body mass index,EFO_0004340,0.2792014622334031,2.7921339985930773,2,0.8,1.6,transcript,13403.0
FAM98A,ENSG00000119812,X-23678 measurement,EFO_0800861,0.27917569228777084,2.7917642760892236,1,0.4,0.4,transcript,54398.0
FAM98A,ENSG00000119812,ovarian neoplasm,EFO_0003893,0.27917569228777084,2.7917642760892236,1,0.4,0.4,transcript,54398.0
CNTLN,ENSG00000044459,anthropometric measurement,EFO_0004302,0.27917569228777084,2.7918783834409817,2,0.8,1.6,transcript,13173.0
CNTLN,ENSG00000044459,lymphocyte count,EFO_0004587,0.27917569228777084,2.7918783834409817,2,0.8,1.6,transcript,13173.0
SLC15A5,ENSG00000188991,alcohol consumption quality,OBA_1000840,0.2791571113949215,2.7928027253074084,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
SYCP1,ENSG00000198765,erythrocyte volume,OBA_0003460,0.2791310430046944,2.791331558295412,1,0.4,0.4,transcript,18932.0
COQ3,ENSG00000132423,lysosomal storage disease,MONDO_0002561,0.2791241619619824,2.791392165348089,1,0.4,0.4,transcript,2657.0
MMP12,ENSG00000262406,atherosclerosis,EFO_0003914,0.27910926432418043,2.791312182209971,1,0.4,0.4,transcript,1822.0
MAN1A2,ENSG00000198162,arterial stiffness measurement,EFO_0004517,0.27907887330969455,2.7909162536197796,2,0.8,1.6,transcript,12547.0
STAU2,ENSG00000040341,Splenomegaly,HP_0001744,0.27907887330969455,2.7908003012798153,1,0.5,0.5,transcript,43222.0
BTAF1,ENSG00000095564,placenta praevia,EFO_0007442,0.27907887330969455,2.7908254775393484,1,0.4,0.4,transcript,10886.0
ARHGAP29,ENSG00000137962,temporal measurement,EFO_0000719,0.27907887330969455,2.79080895881597,1,0.5,0.5,transcript,24721.0
CMTR2,ENSG00000180917,fat pad mass,OBA_0004528,0.2790780657896762,2.7908840771973886,2,0.8,1.6,transcript,15471.0
MR1,ENSG00000153029,eosinophil count,EFO_0004842,0.27905556624946426,2.7906887051052345,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
KCNJ15,ENSG00000157551,placenta praevia,EFO_0007442,0.2790316588079785,2.790326422130184,1,0.4,0.4,transcript,40675.0
ZNF236,ENSG00000130856,aspartate aminotransferase measurement,EFO_0004736,0.2790316588079785,2.790375556138753,2,0.9,1.8,transcript,30525.0
LONRF1,ENSG00000154359,bilirubin measurement,EFO_0004570,0.2789669061090749,2.7897043543779656,1,0.5,0.5,transcript,14167.0
PYHIN1,ENSG00000163564,asthma,MONDO_0004979,0.27893277389276044,2.789365496148673,1,0.4,0.4,transcript,10594.0
NEK7,ENSG00000151414,body mass index,EFO_0004340,0.2789201959303357,2.7892472235332995,1,0.4,0.4,transcript,8837.0
NDST3,ENSG00000164100,growth differentiation factor 15 amount,OBA_2050135,0.2789183737795279,2.7892338003735015,1,0.4,0.4,transcript,7990.0
MCL1,ENSG00000143384,Oral ulcer,HP_0000155,0.2789064017576947,2.789080786956061,1,0.4,0.4,transcript,23853.0
ZNF148,ENSG00000163848,urate measurement,EFO_0004531,0.27886044079444383,2.788616276324108,1,0.4,0.4,transcript,33703.0
FANCF,ENSG00000183161,urinary bladder carcinoma,MONDO_0004986,0.27885826646668205,2.7887042082705884,1,0.4,0.4,transcript,3291.0
RNF17,ENSG00000132972,arterial stiffness measurement,EFO_0004517,0.2788528254140997,2.7885646045590273,1,0.5,0.5,transcript,13755.0
DOK5,ENSG00000101134,interleukin-6 measurement,EFO_0004810,0.2788429829054177,2.7885176639246207,1,0.4,0.4,transcript,4554.0
MAP3K7,ENSG00000135341,placenta praevia,EFO_0007442,0.27880575781912775,2.7881469649145556,4,1.6,6.4,transcript,71599.0
GPATCH2L,ENSG00000089916,electrocardiography,EFO_0004327,0.27880575781912775,2.788200050531608,4,1.6,6.4,transcript,44921.0
MAP3K7,ENSG00000135341,metabolite measurement,EFO_0004725,0.27880575781912775,2.7881469649145556,4,1.6,6.4,transcript,71599.0
GPATCH2L,ENSG00000089916,pulse wave reflection index measurement,EFO_0009804,0.27880575781912775,2.788200050531608,4,1.6,6.4,transcript,44921.0
GPATCH2L,ENSG00000089916,DNA methylation,EFO_0022599,0.27880314447903487,2.7881739171306794,4,1.6,6.4,transcript,44921.0
ABCB1,ENSG00000085563,multiple myeloma,EFO_0001378,0.27877012834698495,2.7877253311805075,1,0.5,0.5,transcript,20792.0
WAPL,ENSG00000062650,sitting height measurement,EFO_0011011,0.2787424159451006,2.7875579163478457,2,0.8,1.6,transcript,11962.0
KLRD1,ENSG00000134539,eosinophil count,EFO_0004842,0.27871399017134174,2.7873043913118694,4,1.7000000000000002,6.800000000000001,transcript,41340.0
SMIM36,ENSG00000261873,hip circumference,OBA_1000032,0.2786459530467414,2.786641101052979,1,0.4,0.4,transcript,2203.0
PCDH10,ENSG00000138650,eugenol sulfate measurement,EFO_0800999,0.2785957548994933,2.7860714117902643,2,0.8,1.6,transcript,14052.0
PCDH10,ENSG00000138650,cervical carcinoma,EFO_0001061,0.2785957548994933,2.7860714117902643,2,0.8,1.6,transcript,14052.0
DIRAS2,ENSG00000165023,type 1 diabetes mellitus,MONDO_0005147,0.2785957548994933,2.7860337975652723,1,0.4,0.4,transcript,5246.0
TXNL1,ENSG00000091164,ovarian dysfunction,EFO_0009003,0.2785957548994933,2.7860397478133248,2,0.8,1.6,transcript,19465.0
PSD3,ENSG00000156011,osteoarthritis,MONDO_0005178,0.2785677168638194,2.7856866117317516,1,0.4,0.4,transcript,42359.0
PAG1,ENSG00000076641,placenta praevia,EFO_0007442,0.2785677168638194,2.7858072605155826,2,0.8,1.6,transcript,12299.0
FANCF,ENSG00000183161,squamous cell lung carcinoma,EFO_0000708,0.2784784205049228,2.7849057486529953,1,0.4,0.4,transcript,3291.0
CNR2,ENSG00000188822,wellbeing measurement,EFO_0007869,0.278435135180101,2.7844273252103164,1,0.4,0.4,transcript,5265.0
LIN54,ENSG00000189308,systolic blood pressure,EFO_0006335,0.2784056870628963,2.784069797206006,1,0.4,0.4,transcript,30944.0
TMEM170B,ENSG00000205269,ovarian neoplasm,EFO_0003893,0.2783719603788651,2.7837645931036885,1,0.4,0.4,transcript,8891.0
NBEAL1,ENSG00000144426,apolipoprotein B measurement,EFO_0004615,0.27835599380451786,2.783563791646851,1,0.4,0.4,transcript,103799.0
TNPO3,ENSG00000064419,platelet crit,EFO_0007985,0.27833490800238836,2.7833757523806533,1,0.5,0.5,transcript,18746.0
MARCKS,ENSG00000277443,celiac disease,EFO_0001060,0.2783335658090273,2.7834287679599194,1,0.4,0.4,transcript,4296.0
KIAA0319,ENSG00000137261,vascular disease,EFO_0004264,0.2783180998523762,2.783193385876275,1,0.4,0.4,transcript,32291.0
KIAA0319,ENSG00000137261,Vertigo,HP_0002321,0.2783180998523762,2.783193385876275,1,0.4,0.4,transcript,32291.0
C2CD6,ENSG00000155754,brain volume,OBA_2050009,0.2783180998523762,2.783221921751786,1,0.5,0.5,transcript,12218.0
PYHIN1,ENSG00000163564,blood phosphate measurement,EFO_0010972,0.2783180998523762,2.7832187557448305,1,0.4,0.4,transcript,10594.0
TRIT1,ENSG00000043514,2-hydroxystearate measurement,EFO_0021059,0.2783180998523762,2.7831962012906657,1,0.4,0.4,transcript,26311.0
NOL9,ENSG00000162408,placenta praevia,EFO_0007442,0.2783180998523762,2.7832237016304133,1,0.4,0.4,transcript,9367.0
NOL9,ENSG00000162408,preeclampsia,EFO_0000668,0.2783180998523762,2.7832237016304133,1,0.4,0.4,transcript,9367.0
MTCH2,ENSG00000109919,HbA1c measurement,EFO_0004541,0.2782937868242509,2.782997321274613,1,0.4,0.4,transcript,6728.0
DOCK1,ENSG00000150760,pancreatic adenocarcinoma,EFO_1000044,0.27826865881736773,2.782711675981003,1,0.4,0.4,transcript,15944.0
LGSN,ENSG00000146166,multiple sclerosis,MONDO_0005301,0.27823445995630547,2.782375196977573,1,0.4,0.4,transcript,13073.0
GPAT3,ENSG00000138678,alpha fetoprotein measurement,EFO_0010583,0.2782015642089465,2.782162768526246,2,0.8,1.6,transcript,10875.0
UBL3,ENSG00000122042,diastolic blood pressure change measurement,EFO_0006945,0.27818787085713764,2.7827126210105706,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
UBL3,ENSG00000122042,urinary microalbumin measurement,EFO_0010967,0.27818787085713764,2.7827126210105706,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
GLCE,ENSG00000138604,urate measurement,EFO_0004531,0.2781843502607522,2.7819738276054857,2,0.8,1.6,transcript,12277.0
SLC22A15,ENSG00000163393,N-acetylglutamate measurement,EFO_0800005,0.27815150419893364,2.78176406922669,2,0.8,1.6,transcript,6425.0
ZNF267,ENSG00000185947,body mass index,EFO_0004340,0.27812585327736994,2.7812960351175957,1,0.4,0.4,transcript,10666.0
PCNX4,ENSG00000126773,high density lipoprotein cholesterol measurement,EFO_0004612,0.27804604648932774,2.7804701289699714,1,0.5,0.5,transcript,51738.0
GPRIN2,ENSG00000204175,neurodegenerative disease,EFO_0005772,0.27801095599704523,2.781241452386773,7,3.0,21.0,transcript,18553.0
PTBP3,ENSG00000119314,neurodegenerative disease,EFO_0005772,0.27795658413230545,2.7797992789251835,5,2.0,10.0,transcript,42838.0
YWHAG,ENSG00000170027,endometrial cancer,MONDO_0011962,0.2779445829370449,2.779553791583674,1,0.4,0.4,transcript,3705.0
IQGAP1,ENSG00000140575,allergic disease,MONDO_0005271,0.27787942432203955,2.7788483411376257,2,0.8,1.6,transcript,29576.0
TMEM236,ENSG00000148483,vital capacity,EFO_0004312,0.2778752912159322,2.7790430300197024,2,0.8,1.6,transcript,5515.0
FANCF,ENSG00000183161,urinary microalbumin measurement,EFO_0010967,0.2778752912159322,2.7788744557630896,1,0.4,0.4,transcript,3291.0
CASQ2,ENSG00000118729,Wolff-Parkinson-White Syndrome,EFO_1001450,0.27786685516055115,2.7786812026270815,1,0.4,0.4,transcript,31618.0
MTCH2,ENSG00000109919,self reported educational attainment,EFO_0004784,0.27785575614878905,2.778617014519995,1,0.4,0.4,transcript,6728.0
SLCO1C1,ENSG00000139155,protein measurement,EFO_0004747,0.27785381391951747,2.7785690300885393,1,0.5,0.5,transcript,16186.0
FANCF,ENSG00000183161,lung adenocarcinoma,EFO_0000571,0.2778316557592245,2.7784381011960133,1,0.4,0.4,transcript,3291.0
NPFFR1,ENSG00000148734,appendicular lean mass,EFO_0004980,0.27782636395070803,2.778306887425774,1,0.4,0.4,transcript,9249.0
DNAJC10,ENSG00000077232,educational attainment,EFO_0011015,0.2777513787586041,2.7775330393165736,4,1.7000000000000002,6.800000000000001,transcript,353215.0
SYNC,ENSG00000162520,monocyte count,EFO_0005091,0.2777389801954708,2.7776379409125243,2,0.8,1.6,transcript,6448.0
MUC16,ENSG00000181143,glioblastoma multiforme,EFO_0000519,0.2775737999785053,2.7757408201344376,1,0.5,0.5,transcript,177283.0
RPRD2,ENSG00000163125,platelet volume,OBA_0003277,0.27754627415026517,2.7754812480262014,1,0.4,0.4,transcript,21614.0
LIN54,ENSG00000189308,QT interval,EFO_0004682,0.2775437568580451,2.775450495157494,1,0.4,0.4,transcript,30944.0
TRIM36,ENSG00000152503,body mass index,EFO_0004340,0.2775285881974231,2.775312042863701,1,0.4,0.4,transcript,15290.0
BACE2,ENSG00000182240,fibroblast growth factor receptor 1 amount,OBA_2050132,0.27746218805777295,2.774755436504274,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
IREB2,ENSG00000136381,lung cancer,MONDO_0008903,0.27744965116449966,2.7745963674088934,2,0.9,1.8,transcript,18026.0
CST9,ENSG00000173335,glomerular filtration rate,OBA_0003747,0.27741462290299074,2.7743911769784684,1,0.4,0.4,transcript,1633.0
LNPEP,ENSG00000113441,myeloid leukocyte count,OBA_2045223,0.2773931019213665,2.7739516814379535,1,0.4,0.4,transcript,19359.0
MAP1LC3B2,ENSG00000258102,aneurysm,EFO_0009659,0.2773867699667947,2.774033950707016,1,0.4,0.4,transcript,2406.0
KIF20B,ENSG00000138182,neuroimaging measurement,EFO_0004346,0.27730651482033486,2.7730924601605236,1,0.5,0.5,transcript,18307.0
KIF20B,ENSG00000138182,brain attribute,OBA_2045210,0.27730651482033486,2.7730924601605236,1,0.5,0.5,transcript,18307.0
GFRAL,ENSG00000187871,frozen shoulder,EFO_1000941,0.2772607589118647,2.7728169036136756,1,0.4,0.4,transcript,1911.0
BTLA,ENSG00000186265,monocyte count,EFO_0005091,0.2771989479134368,2.772169839855811,2,0.9,1.8,transcript,9980.0
MC2R,ENSG00000185231,rheumatoid arthritis,EFO_0000685,0.27718489101352634,2.771943517514639,1,0.4,0.4,transcript,4228.0
NEK7,ENSG00000151414,depressive disorder,MONDO_0002050,0.27705449669626603,2.7705902311926027,1,0.4,0.4,transcript,8837.0
ARHGAP28,ENSG00000088756,metabolite measurement,EFO_0004725,0.27704811422337805,2.7704934438698983,1,0.4,0.4,transcript,32516.0
TRMT9B,ENSG00000250305,vital capacity,EFO_0004312,0.27704811422337805,2.770622268894959,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
PSD3,ENSG00000156011,keratoconus,MONDO_0015486,0.27704811422337805,2.770490585327338,1,0.4,0.4,transcript,42359.0
TRMT9B,ENSG00000250305,concussion,EFO_0011023,0.27704811422337805,2.770622268894959,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
ZNF236,ENSG00000130856,cervical carcinoma,EFO_0001061,0.27704811422337805,2.7705401102927487,2,0.9,1.8,transcript,30525.0
LIN54,ENSG00000189308,JT interval,EFO_0007885,0.2770157247638563,2.7701701742156053,1,0.4,0.4,transcript,30944.0
FZD3,ENSG00000104290,cerebral cortex area attribute,OBA_2045267,0.2770135136038261,2.7701492528549188,1,0.4,0.4,transcript,28335.0
ZFP1,ENSG00000184517,prostate specific antigen amount,OBA_2050200,0.27696864392816134,2.769714791989297,1,0.4,0.4,transcript,14108.0
ELAPOR1,ENSG00000116299,platelet volume,OBA_0003277,0.27694338064462726,2.7694468997359616,1,0.4,0.4,transcript,30550.0
TRIT1,ENSG00000043514,breast neoplasm,EFO_0003869,0.27673191361837646,2.767334338950668,1,0.4,0.4,transcript,26311.0
SCAMP1,ENSG00000085365,platelet component distribution width,EFO_0007984,0.27670004875208093,2.767026834510666,1,0.4,0.4,transcript,15182.0
LGSN,ENSG00000146166,urate measurement,EFO_0004531,0.2766228570601284,2.7662591680158024,1,0.4,0.4,transcript,13073.0
CAV2,ENSG00000105971,pulse pressure measurement,EFO_0005763,0.27657817393318246,2.76580591289803,1,0.4,0.4,transcript,16547.0
KIF20B,ENSG00000138182,low density lipoprotein cholesterol measurement,EFO_0004611,0.27657597161671094,2.7657870281242842,1,0.5,0.5,transcript,18307.0
IPP,ENSG00000197429,lymphocyte count,EFO_0004587,0.27657336466217536,2.7658144220660184,1,0.5,0.5,transcript,6190.0
MYO3A,ENSG00000095777,Conotruncal defect,HP_0001710,0.27656044873941305,2.7656282031841037,1,0.5,0.5,transcript,21083.0
SFRP1,ENSG00000104332,metabolite measurement,EFO_0004725,0.27653587839730226,2.765406762862311,1,0.4,0.4,transcript,8337.0
METTL8,ENSG00000123600,liver disease,EFO_0001421,0.2764867301019582,2.7648793220563963,1,0.4,0.4,transcript,33275.0
TFEC,ENSG00000105967,bone tissue density,OBA_1000110,0.27635694795424937,2.7635851768974895,1,0.4,0.4,transcript,25482.0
TRMT9B,ENSG00000250305,hemoglobin measurement,EFO_0004509,0.2763496563486601,2.7636376901477795,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
CWH43,ENSG00000109182,body height,OBA_VT0001253,0.2763055995234629,2.76311806848106,1,0.5,0.5,transcript,8055.0
ATG16L1,ENSG00000085978,autoimmune disease,EFO_0005140,0.2762851264282145,2.76286325576819,1,0.4,0.4,transcript,33357.0
RSBN1L,ENSG00000187257,level of serum globulin type protein,OBA_2045206,0.2762786359375315,2.7629230764564054,2,0.8,1.6,transcript,11703.0
STX7,ENSG00000079950,pulse wave reflection index measurement,EFO_0009804,0.2762708645822748,2.762797160980969,2,0.8,1.6,transcript,18076.0
EXD1,ENSG00000178997,body height,OBA_VT0001253,0.27618741605726616,2.7619159447573476,1,0.4,0.4,transcript,9573.0
TRAM1,ENSG00000067167,urate measurement,EFO_0004531,0.2761691255970039,2.7618817548389516,2,0.8,1.6,transcript,8399.0
USP15,ENSG00000135655,pancreatic adenocarcinoma,EFO_1000044,0.27615769318653133,2.7616600497079435,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
NUP153,ENSG00000124789,Intrahepatic cholestasis of pregnancy,EFO_0009048,0.2761079642032883,2.76110762658541,1,0.5,0.5,transcript,17867.0
RTKN2,ENSG00000182010,eosinophil count,EFO_0004842,0.2760983843822922,2.761019101645751,1,0.4,0.4,transcript,11345.0
NHLH2,ENSG00000177551,level of lysophosphatidic acid phosphatase type 6 in blood serum,OBA_2040483,0.27606495675125753,2.760687328298,1,0.4,0.4,transcript,10593.0
WDR12,ENSG00000138442,poisoning,EFO_0008546,0.27602079298058485,2.760227868991333,1,0.4,0.4,transcript,20061.0
NOM1,ENSG00000146909,arterial stiffness measurement,EFO_0004517,0.27602079298058485,2.761089297688803,5,2.0,10.0,transcript,11346.0
GABPA,ENSG00000154727,lymphocyte count,EFO_0004587,0.27602079298058485,2.760243881630404,1,0.4,0.4,transcript,11126.0
PEX7,ENSG00000112357,arterial stiffness measurement,EFO_0004517,0.27602079298058485,2.7602504739453932,1,0.4,0.4,transcript,9402.0
TRDMT1,ENSG00000107614,hypertension,EFO_0000537,0.2759932225036964,2.759946016713687,1,0.4,0.4,transcript,29003.0
C2orf73,ENSG00000177994,hematocrit,EFO_0004348,0.2759759015774218,2.759807324952962,1,0.4,0.4,transcript,8280.0
C2orf73,ENSG00000177994,hemoglobin measurement,EFO_0004509,0.2759759015774218,2.759807324952962,1,0.4,0.4,transcript,8280.0
ZNF429,ENSG00000197013,pain,EFO_0003843,0.2758616724990432,2.758772533735198,2,0.8,1.6,transcript,10269.0
OTULIN,ENSG00000154124,body weights and measures,EFO_0004324,0.27581634230760005,2.7581826575441677,1,0.4,0.4,transcript,20796.0
TXNL1,ENSG00000091164,lean body mass,EFO_0004995,0.2757510947943762,2.757593146762154,2,0.8,1.6,transcript,19465.0
TECRL,ENSG00000205678,Vertigo,HP_0002321,0.2757510947943762,2.7579137226137105,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
TXNL1,ENSG00000091164,corneal resistance factor,EFO_0010067,0.2757510947943762,2.757593146762154,2,0.8,1.6,transcript,19465.0
PTCHD4,ENSG00000244694,glucose measurement,EFO_0004468,0.2757510947943762,2.7579247886151035,6,2.4000000000000004,14.400000000000002,transcript,34796.0
PCDH10,ENSG00000138650,lymphocyte count,EFO_0004587,0.2757510947943762,2.7576248107390935,2,0.8,1.6,transcript,14052.0
CDH19,ENSG00000071991,high density lipoprotein cholesterol measurement,EFO_0004612,0.2757510947943762,2.75778550560087,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
GPAT3,ENSG00000138678,dihomo-linoleate 20:2n6 measurement,EFO_0021064,0.2757510947943762,2.7576580743805437,2,0.8,1.6,transcript,10875.0
NXPH2,ENSG00000144227,arterial stiffness measurement,EFO_0004517,0.2757510947943762,2.7576586039053717,1,0.4,0.4,transcript,2709.0
NAF1,ENSG00000145414,ovarian neoplasm,EFO_0003893,0.2757510947943762,2.7575728981358076,1,0.5,0.5,transcript,8071.0
PPDPFL,ENSG00000168333,ileostomy,EFO_0010681,0.2757510947943762,2.7578363496114457,2,0.8,1.6,transcript,4917.0
ST8SIA4,ENSG00000113532,skin disease,EFO_0000701,0.2757510947943762,2.757553824993821,1,0.4,0.4,transcript,9329.0
YTHDC2,ENSG00000047188,erythrocyte volume,OBA_0003460,0.2757510947943762,2.7575311571086183,1,0.4,0.4,transcript,19793.0
PTCHD4,ENSG00000244694,injury,EFO_0000546,0.2757510947943762,2.7579247886151035,6,2.4000000000000004,14.400000000000002,transcript,34796.0
YTHDC2,ENSG00000047188,Abruptio Placentae,EFO_1001754,0.2757510947943762,2.7575311571086183,1,0.4,0.4,transcript,19793.0
ATXN7L3B,ENSG00000253719,basophil measurement,EFO_0803539,0.2757510947943762,2.7575636072381275,1,0.4,0.4,transcript,7596.0
YTHDC2,ENSG00000047188,platelet volume,OBA_0003277,0.2757510947943762,2.7575311571086183,1,0.4,0.4,transcript,19793.0
RASEF,ENSG00000165105,body weight,EFO_0004338,0.2757510947943762,2.7575653697124696,1,0.4,0.4,transcript,7350.0
NDST3,ENSG00000164100,preeclampsia,EFO_0000668,0.2757510947943762,2.757561010521985,1,0.4,0.4,transcript,7990.0
SI,ENSG00000090402,placenta praevia,EFO_0007442,0.2757510947943762,2.7575829940532723,1,0.5,0.5,transcript,6940.0
EDEM1,ENSG00000134109,arterial stiffness measurement,EFO_0004517,0.2757510947943762,2.7576439266671664,2,0.8,1.6,transcript,12032.0
RASEF,ENSG00000165105,hypersomnia,EFO_0005246,0.2757510947943762,2.7575653697124696,1,0.4,0.4,transcript,7350.0
DOK5,ENSG00000101134,body weight,EFO_0004338,0.2757510947943762,2.7575987828142057,1,0.4,0.4,transcript,4554.0
PCDH10,ENSG00000138650,growth differentiation factor 15 amount,OBA_2050135,0.2757510947943762,2.7576248107390935,2,0.8,1.6,transcript,14052.0
MDGA2,ENSG00000139915,urinary microalbumin measurement,EFO_0010967,0.2757510947943762,2.757534038632442,1,0.4,0.4,transcript,17323.0
ATXN7L3B,ENSG00000253719,duodenitis,MONDO_0004627,0.2757510947943762,2.7575636072381275,1,0.4,0.4,transcript,7596.0
PCDH10,ENSG00000138650,serum creatinine amount,OBA_2050096,0.2757510947943762,2.7576248107390935,2,0.8,1.6,transcript,14052.0
LRRC7,ENSG00000033122,device complication,EFO_0009519,0.2757510947943762,2.7575750516493125,3,1.2000000000000002,3.6000000000000005,transcript,56159.0
DOK5,ENSG00000101134,body fat percentage,EFO_0007800,0.2757510947943762,2.7575987828142057,1,0.4,0.4,transcript,4554.0
LRRIQ3,ENSG00000162620,post-traumatic stress disorder symptom measurement,EFO_0008535,0.2757233326696588,2.7572602228773304,1,0.5,0.5,transcript,18590.0
MORF4L2,ENSG00000123562,urate measurement,EFO_0004531,0.2757154833668203,2.7571856835833657,1,0.4,0.4,transcript,12966.0
ABCA10,ENSG00000154263,neutrophil count,EFO_0004833,0.27571017295289413,2.757201665680844,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
EDEM1,ENSG00000134109,smoking status measurement,EFO_0006527,0.2757062826571065,2.7571958052944696,2,0.8,1.6,transcript,12032.0
FAM98A,ENSG00000119812,smoking initiation,EFO_0005670,0.2757062826571065,2.7570701797825805,1,0.4,0.4,transcript,54398.0
GNA13,ENSG00000120063,HbA1c measurement,EFO_0004541,0.2756530857571357,2.756582463815713,1,0.4,0.4,transcript,7751.0
ZNF28,ENSG00000198538,growth differentiation factor 15 amount,OBA_2050135,0.27559759745282764,2.7562305714165363,3,1.2000000000000002,3.6000000000000005,transcript,14140.0
ZFP90,ENSG00000184939,phospholipids:total lipids ratio,EFO_0020946,0.27555238022860246,2.755537157432764,1,0.4,0.4,transcript,29951.0
LIN54,ENSG00000189308,granulocyte count,EFO_0007987,0.2755517518975848,2.7555304455528904,1,0.4,0.4,transcript,30944.0
ALDOB,ENSG00000136872,protein measurement,EFO_0004747,0.275498864828131,2.755030060435778,1,0.4,0.4,transcript,9659.0
OTUD7A,ENSG00000169918,sodium measurement,EFO_0009282,0.2754706755964119,2.7547244825318127,1,0.4,0.4,transcript,22565.0
RCOR3,ENSG00000117625,erythrocyte count,EFO_0004305,0.27546123171190673,2.7546766723599974,2,0.8,1.6,transcript,24862.0
STX7,ENSG00000079950,Raynaud disease,EFO_1001145,0.2754568676327184,2.754657191485405,2,0.8,1.6,transcript,18076.0
OXSR1,ENSG00000172939,drug use measurement,EFO_0007010,0.2754568676327184,2.7546092525089656,1,0.4,0.4,transcript,9858.0
IQCB1,ENSG00000173226,obesity,EFO_0001073,0.2754568676327184,2.7546102953054383,1,0.4,0.4,transcript,9611.0
OXSR1,ENSG00000172939,Loss of consciousness,HP_0007185,0.2754568676327184,2.7546092525089656,1,0.4,0.4,transcript,9858.0
ONECUT2,ENSG00000119547,alcohol consumption quality,OBA_1000840,0.2754151896714404,2.7553137224405453,7,2.8000000000000003,19.6,transcript,16870.0
PLEKHA6,ENSG00000143850,mean corpuscular hemoglobin concentration,EFO_0004528,0.2754072066009074,2.754078880667404,1,0.4,0.4,transcript,58697.0
C18orf54,ENSG00000166845,psoriasis,EFO_0000676,0.2752005098610041,2.7520905732614644,2,0.8,1.6,transcript,18719.0
TEX15,ENSG00000133863,"chromosome, telomeric region length",OBA_0003784,0.2751994502165009,2.752009425756222,1,0.5,0.5,transcript,33504.0
TRIT1,ENSG00000043514,high density lipoprotein cholesterol measurement,EFO_0004612,0.2751772117452112,2.7517873202190155,1,0.4,0.4,transcript,26311.0
DUSP22,ENSG00000112679,neutrophil count,EFO_0004833,0.2751614643803936,2.751638248194352,1,0.4,0.4,transcript,16946.0
TMEM17,ENSG00000186889,cystatin C measurement,EFO_0004617,0.2751614643803936,2.7516786438039356,1,0.4,0.4,transcript,6250.0
TMEM17,ENSG00000186889,serum creatinine amount,OBA_2050096,0.2751614643803936,2.7516786438039356,1,0.4,0.4,transcript,6250.0
GUCA1C,ENSG00000138472,urinary microalbumin measurement,EFO_0010967,0.2751369450677027,2.7515686538642776,1,0.5,0.5,transcript,2510.0
SARAF,ENSG00000133872,pathological myopia,EFO_0004207,0.2750815382803299,2.7508418360801983,1,0.4,0.4,transcript,15121.0
TOPAZ1,ENSG00000173769,esophageal ulcer,MONDO_0044782,0.2750474698121627,2.750568436404342,1,0.5,0.5,transcript,5334.0
TOPAZ1,ENSG00000173769,gastroesophageal reflux disease,EFO_0003948,0.2750474698121627,2.750568436404342,1,0.5,0.5,transcript,5334.0
TSPAN3,ENSG00000140391,vital capacity,EFO_0004312,0.27500991720007245,2.750121082605457,1,0.4,0.4,transcript,18256.0
THEM4,ENSG00000159445,"X12442--5,8-tetradecadienoate measurement",EFO_0021308,0.2749945809496222,2.7501001602583286,2,0.8,1.6,transcript,10366.0
PRRG4,ENSG00000135378,serum creatinine amount,OBA_2050096,0.27491550259649433,2.7492271890535234,1,0.4,0.4,transcript,5543.0
ATG16L1,ENSG00000085978,juvenile idiopathic arthritis,EFO_0002609,0.27480357318574716,2.7480477233435168,1,0.4,0.4,transcript,33357.0
ATG16L1,ENSG00000085978,autoimmune thyroid disease,EFO_0006812,0.27480357318574716,2.7480477233435168,1,0.4,0.4,transcript,33357.0
ATG16L1,ENSG00000085978,type 1 diabetes mellitus,MONDO_0005147,0.27480357318574716,2.7480477233435168,1,0.4,0.4,transcript,33357.0
ATG16L1,ENSG00000085978,systemic lupus erythematosus,MONDO_0007915,0.27480357318574716,2.7480477233435168,1,0.4,0.4,transcript,33357.0
CFHR4,ENSG00000134365,complement factor H-related protein 4 measurement,EFO_0600091,0.2747557148989375,2.7475976577797825,1,0.5,0.5,transcript,12343.0
SLC9B1,ENSG00000164037,serum creatinine amount,OBA_2050096,0.27471016634074763,2.747146635524764,1,0.5,0.5,transcript,11118.0
RASEF,ENSG00000165105,HbA1c measurement,EFO_0004541,0.2746827377039759,2.7468817988084666,1,0.4,0.4,transcript,7350.0
EPRS1,ENSG00000136628,reticulocyte count,EFO_0007986,0.27464047703848604,2.746449485104946,1,0.5,0.5,transcript,11182.0
SLC5A7,ENSG00000115665,muscular atrophy,MONDO_0004323,0.2746401811731184,2.746457375003861,1,0.4,0.4,transcript,7199.0
ARHGAP28,ENSG00000088756,urinary microalbumin measurement,EFO_0010967,0.2746401811731184,2.746414113367302,1,0.4,0.4,transcript,32516.0
PEX7,ENSG00000112357,erythrocyte volume,OBA_0003460,0.2746114033473739,2.7461565776132835,1,0.4,0.4,transcript,9402.0
TAF2,ENSG00000064313,systolic blood pressure,EFO_0006335,0.2745440229528834,2.7454430225128577,1,0.5,0.5,transcript,179020.0
SLC5A7,ENSG00000115665,platelet volume,OBA_0003277,0.274520435496742,2.7452599182400967,1,0.4,0.4,transcript,7199.0
YTHDC2,ENSG00000047188,heart rate,OBA_1001087,0.27449659650629366,2.744986174227793,1,0.4,0.4,transcript,19793.0
LSM6,ENSG00000164167,neuroinflammatory disorder,EFO_0020092,0.2744662892401309,2.7448283012713595,2,0.8,1.6,transcript,9673.0
CPD,ENSG00000108582,neuroinflammatory disorder,EFO_0020092,0.2744662892401309,2.744683110759578,1,0.4,0.4,transcript,19784.0
PARD6B,ENSG00000124171,skin neoplasm,EFO_0004198,0.27445290510768605,2.744607467073724,1,0.4,0.4,transcript,5101.0
ALPK3,ENSG00000136383,Left ventricular mass to end-diastolic volume ratio,EFO_0010556,0.2744016891948772,2.744054187986068,1,0.4,0.4,transcript,10725.0
KIAA1143,ENSG00000163807,high density lipoprotein cholesterol measurement,EFO_0004612,0.2743086834175346,2.7431584417657504,1,0.4,0.4,transcript,5586.0
PHF24,ENSG00000122733,cervical carcinoma,EFO_0001061,0.2743086834175346,2.743134345756294,1,0.4,0.4,transcript,8419.0
LONRF1,ENSG00000154359,goiter,EFO_0004283,0.2741607162718459,2.741642456005676,1,0.5,0.5,transcript,14167.0
EXOC6,ENSG00000138190,drug use measurement,EFO_0007010,0.2741301586123442,2.7413242033939897,1,0.5,0.5,transcript,22107.0
SEC63,ENSG00000025796,abscess,EFO_0003030,0.2741301586123442,2.741577110384884,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
SEC63,ENSG00000025796,cellulitis,EFO_0003035,0.2741301586123442,2.741577110384884,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
EXOC6,ENSG00000138190,Blindness,HP_0000618,0.2741301586123442,2.7413242033939897,1,0.5,0.5,transcript,22107.0
COG3,ENSG00000136152,arterial stiffness measurement,EFO_0004517,0.2741301586123442,2.741355424822699,1,0.5,0.5,transcript,9287.0
CD93,ENSG00000125810,thrombomodulin measurement,EFO_0007774,0.2741301586123442,2.7413279036443314,1,0.4,0.4,transcript,15199.0
SCRG1,ENSG00000164106,Abnormality of refraction,HP_0000539,0.2741301586123442,2.7415851735038035,2,0.8,1.6,transcript,5642.0
OR5AN1,ENSG00000176495,3-hydroxypropylmercapturic acid measurement,EFO_0007014,0.27412195553399193,2.7412487064593223,1,0.5,0.5,transcript,17152.0
ABCB5,ENSG00000004846,sum of eosinophil and basophil counts,EFO_0009389,0.27410968539708547,2.741123766438055,1,0.4,0.4,transcript,14863.0
TMCC1,ENSG00000172765,body weight,EFO_0004338,0.27405046152693224,2.7405148167485365,1,0.4,0.4,transcript,39210.0
IGFBPL1,ENSG00000137142,amyotrophic lateral sclerosis,MONDO_0004976,0.27404106532053973,2.7422053811919365,4,1.6,6.4,transcript,3566.0
IGFBPL1,ENSG00000137142,drug use measurement,EFO_0007010,0.27404106532053973,2.7422053811919365,4,1.6,6.4,transcript,3566.0
MMP12,ENSG00000262406,breast cancer,MONDO_0007254,0.27402389061223403,2.7404584450905074,1,0.4,0.4,transcript,1822.0
PROK2,ENSG00000163421,Alzheimer disease,MONDO_0004975,0.2739864692312663,2.740380156230189,2,0.8,1.6,transcript,3104.0
TOPAZ1,ENSG00000173769,visual perception quality,OBA_2045263,0.2739788789372424,2.7398825276551384,1,0.5,0.5,transcript,5334.0
ARHGAP28,ENSG00000088756,non-Hodgkins lymphoma,EFO_0005952,0.2739160315967734,2.739172617603852,1,0.4,0.4,transcript,32516.0
FAM98A,ENSG00000119812,sexual dimorphism measurement,EFO_0021796,0.27386011439842406,2.738608497195756,1,0.4,0.4,transcript,54398.0
ST8SIA4,ENSG00000113532,arterial stiffness measurement,EFO_0004517,0.27386011439842406,2.7386440210342995,1,0.4,0.4,transcript,9329.0
PCDH10,ENSG00000138650,insulin measurement,EFO_0004467,0.27386011439842406,2.738715006779572,2,0.8,1.6,transcript,14052.0
CCBE1,ENSG00000183287,heel bone mineral density,EFO_0009270,0.27382886323384187,2.738302422588712,1,0.4,0.4,transcript,29006.0
CCDC66,ENSG00000180376,HbA1c measurement,EFO_0004541,0.2737988883616559,2.738004113125255,1,0.5,0.5,transcript,32831.0
TECRL,ENSG00000205678,frozen shoulder,EFO_1000941,0.273772834830073,2.738131122970678,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
AMTN,ENSG00000187689,neurodegenerative disease,EFO_0005772,0.2737493570091214,2.737719558791779,1,0.4,0.4,transcript,1770.0
TRIM69,ENSG00000185880,coronary atherosclerosis,MONDO_0021661,0.273629200633805,2.7363075838752415,1,0.4,0.4,transcript,25678.0
PLEKHA6,ENSG00000143850,heart rate,OBA_1001087,0.2735881371118927,2.7358881857772572,1,0.4,0.4,transcript,58697.0
WDR12,ENSG00000138442,white matter integrity,EFO_0004641,0.27357215615662067,2.735741500751691,1,0.4,0.4,transcript,20061.0
MARCKS,ENSG00000277443,oral mucosa leukoplakia,MONDO_0004844,0.2735343575752002,2.7354366856216488,1,0.4,0.4,transcript,4296.0
TMEM17,ENSG00000186889,mean corpuscular hemoglobin concentration,EFO_0004528,0.2735343575752002,2.7354075757520024,1,0.4,0.4,transcript,6250.0
MARCKS,ENSG00000277443,growth differentiation factor 15 amount,OBA_2050135,0.2735343575752002,2.7354366856216488,1,0.4,0.4,transcript,4296.0
SNTG2,ENSG00000172554,poisoning,EFO_0008546,0.2735343575752002,2.735393465993471,1,0.5,0.5,transcript,10022.0
MARCKS,ENSG00000277443,X-11880 measurement,EFO_0800698,0.2735343575752002,2.7354366856216488,1,0.4,0.4,transcript,4296.0
SNTG2,ENSG00000172554,response to xenobiotic stimulus,GO_0009410,0.2735343575752002,2.735393465993471,1,0.5,0.5,transcript,10022.0
SNTG2,ENSG00000172554,response to antibiotic,GO_0046677,0.2735343575752002,2.735393465993471,1,0.5,0.5,transcript,10022.0
SRGN,ENSG00000122862,basophil percentage of leukocytes,EFO_0007992,0.2735313623727366,2.7354370043566076,1,0.4,0.4,transcript,3242.0
MGA,ENSG00000174197,appendicular lean mass,EFO_0004980,0.273518158191682,2.735187503701883,1,0.5,0.5,transcript,84434.0
ABCB5,ENSG00000004846,lymphatic system disease,EFO_0007352,0.27350405494480723,2.735067461915273,1,0.4,0.4,transcript,14863.0
ABCB5,ENSG00000004846,vein disorder,MONDO_0004634,0.27350405494480723,2.735067461915273,1,0.4,0.4,transcript,14863.0
GID4,ENSG00000141034,triglyceride measurement,EFO_0004530,0.27340768604697324,2.7341339706924623,1,0.4,0.4,transcript,7004.0
CCDC62,ENSG00000130783,mouth neoplasm,EFO_0003868,0.27340071924974924,2.7340341285244283,1,0.4,0.4,transcript,14850.0
DENND3,ENSG00000105339,myeloid leukocyte count,OBA_2045223,0.27337321528378045,2.733742969495457,1,0.5,0.5,transcript,46225.0
TRIM69,ENSG00000185880,serum creatinine amount,OBA_2050096,0.2732737348385319,2.7327529259225103,1,0.4,0.4,transcript,25678.0
DYNC1I2,ENSG00000077380,diet measurement,EFO_0008111,0.2732626889901338,2.7326380768349994,1,0.4,0.4,transcript,35756.0
ZNF697,ENSG00000143067,body height,OBA_VT0001253,0.27323491805822114,2.7329944575135614,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
TPRG1,ENSG00000188001,lymphocyte count,EFO_0004587,0.27319414085536003,2.7320412650099444,2,0.8,1.6,transcript,16023.0
TMEM17,ENSG00000186889,schizophrenia,MONDO_0005090,0.27316356691174926,2.731699669117493,1,0.4,0.4,transcript,6250.0
PDCD5,ENSG00000105185,body fat percentage,EFO_0007800,0.273106258653384,2.7311406962780302,1,0.4,0.4,transcript,5121.0
APOBEC3H,ENSG00000100298,metabolite measurement,EFO_0004725,0.2730791517573743,2.730868101912246,1,0.4,0.4,transcript,5223.0
DTHD1,ENSG00000197057,executive function measurement,EFO_0009332,0.27295406806544414,2.7295670812035726,1,0.5,0.5,transcript,18939.0
SFRP1,ENSG00000104332,HbA1c measurement,EFO_0004541,0.27295392700540555,2.729587248943344,1,0.4,0.4,transcript,8337.0
SLC35B4,ENSG00000205060,educational attainment,EFO_0011015,0.27289170563477344,2.7289589762806625,1,0.4,0.4,transcript,9542.0
SNTG2,ENSG00000172554,chloride measurement,EFO_0009284,0.27288528040166943,2.728902694258163,1,0.5,0.5,transcript,10022.0
MUC16,ENSG00000181143,protein measurement,EFO_0004747,0.2728543657385209,2.728546477734594,1,0.5,0.5,transcript,177283.0
TXNL1,ENSG00000091164,HbA1c measurement,EFO_0004541,0.27284906453279284,2.72857284414632,2,0.8,1.6,transcript,19465.0
DYNC1I2,ENSG00000077380,smoking status measurement,EFO_0006527,0.2728304215755273,2.7283154026889345,1,0.4,0.4,transcript,35756.0
IL1A,ENSG00000115008,colorectal cancer,MONDO_0005575,0.27282645477950573,2.728462862123268,1,0.4,0.4,transcript,2017.0
ARL3,ENSG00000138175,Red cell distribution width,EFO_0009188,0.2728238780544233,2.7283431102260276,1,0.4,0.4,transcript,3834.0
AKAP10,ENSG00000108599,hemoglobin measurement,EFO_0004509,0.2728174695649736,2.7282098759487687,1,0.4,0.4,transcript,11370.0
TRAM1,ENSG00000067167,BMI-adjusted waist circumference,EFO_0007789,0.27275740539271476,2.7277645527960606,2,0.8,1.6,transcript,8399.0
ZNF267,ENSG00000185947,4-acetamidobenzoate measurement,EFO_0801014,0.2727573987380635,2.727611489724531,1,0.4,0.4,transcript,10666.0
SCAMP1,ENSG00000085365,platelet crit,EFO_0007985,0.2727373301228004,2.7273996482178604,1,0.4,0.4,transcript,15182.0
IQGAP1,ENSG00000140575,androgenetic alopecia,EFO_0004191,0.27270870828435445,2.727141180760775,2,0.8,1.6,transcript,29576.0
ONECUT2,ENSG00000119547,ovarian dysfunction,EFO_0009003,0.27267489166098324,2.727910742335973,7,2.8000000000000003,19.6,transcript,16870.0
DLG1,ENSG00000075711,Abnormal erythrocyte morphology,HP_0001877,0.2726422250931406,2.7264376607029135,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
FAM98A,ENSG00000119812,Red cell distribution width,EFO_0009188,0.2726422250931406,2.7264296041429215,1,0.4,0.4,transcript,54398.0
PRPF4B,ENSG00000112739,neuroticism measurement,EFO_0007660,0.2726304917970015,2.726325702805399,1,0.5,0.5,transcript,24056.0
KIAA0232,ENSG00000170871,amyotrophic lateral sclerosis,MONDO_0004976,0.27259669100018696,2.725990198311138,1,0.4,0.4,transcript,17176.0
KIAA0232,ENSG00000170871,drug use measurement,EFO_0007010,0.27259669100018696,2.725990198311138,1,0.4,0.4,transcript,17176.0
KIAA0319,ENSG00000137261,arterial stiffness measurement,EFO_0004517,0.27259669100018696,2.7259792973543826,1,0.4,0.4,transcript,32291.0
ZNF236,ENSG00000130856,hemoglobin A1 measurement,EFO_0007629,0.27252191346752713,2.7252781027342396,2,0.9,1.8,transcript,30525.0
MUC16,ENSG00000181143,endometrial cancer,MONDO_0011962,0.2725191470360758,2.7251942907101427,1,0.5,0.5,transcript,177283.0
ITPRID2,ENSG00000138434,cardiovascular disease,EFO_0000319,0.27250920450267296,2.7251008325659987,1,0.4,0.4,transcript,45519.0
FRAS1,ENSG00000138759,strand of hair color,OBA_0002313,0.272451901808608,2.7245511546306873,2,0.9,1.8,transcript,56011.0
RASEF,ENSG00000165105,sphingomyelin measurement,EFO_0010118,0.27242536279781016,2.724308049746809,1,0.4,0.4,transcript,7350.0
SHC4,ENSG00000185634,Abruptio Placentae,EFO_1001754,0.2724189870954587,2.7242236461804588,1,0.4,0.4,transcript,11843.0
TMEM17,ENSG00000186889,total cholesterol measurement,EFO_0004574,0.2724054025004958,2.724118025004958,1,0.4,0.4,transcript,6250.0
NEMF,ENSG00000165525,arterial stiffness measurement,EFO_0004517,0.2724006824564756,2.724027007828793,1,0.5,0.5,transcript,24773.0
U2SURP,ENSG00000163714,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.27240062758861316,2.7240566838757982,2,0.8,1.6,transcript,31741.0
U2SURP,ENSG00000163714,serum alanine aminotransferase measurement,EFO_0004735,0.27240062758861316,2.7240566838757982,2,0.8,1.6,transcript,31741.0
UNC80,ENSG00000144406,Intellectual disability,HP_0001249,0.27238606741124066,2.7238653361170684,1,0.4,0.4,transcript,85800.0
RBM25,ENSG00000119707,eosinophil count,EFO_0004842,0.2723600796288257,2.723613486240987,1,0.4,0.4,transcript,31521.0
PLEKHA6,ENSG00000143850,hematocrit,EFO_0004348,0.2723584462471104,2.7235912771294344,1,0.4,0.4,transcript,58697.0
ABCA13,ENSG00000179869,nephrotic syndrome,EFO_0004255,0.27235748615858274,2.7235851934451487,1,0.5,0.5,transcript,48394.0
GPATCH2L,ENSG00000089916,adolescent idiopathic scoliosis,EFO_0005423,0.2723255775649594,2.7233982479899246,4,1.6,6.4,transcript,44921.0
TMEM144,ENSG00000164124,skin disease,EFO_0000701,0.2723197839997152,2.7232147497413917,1,0.4,0.4,transcript,23655.0
PICALM,ENSG00000073921,high density lipoprotein cholesterol measurement,EFO_0004612,0.2723117473965005,2.723130742283577,1,0.4,0.4,transcript,30147.0
PLEKHA6,ENSG00000143850,neutrophil count,EFO_0004833,0.2722568688929616,2.722575503587946,1,0.4,0.4,transcript,58697.0
CMTR2,ENSG00000180917,hip circumference,OBA_1000032,0.2722022963430931,2.7221263827315583,2,0.8,1.6,transcript,15471.0
TM9SF3,ENSG00000077147,lymphocyte count,EFO_0004587,0.2721914274521724,2.721939787980073,1,0.4,0.4,transcript,15678.0
TAF2,ENSG00000064313,myelodysplastic syndrome,EFO_0000198,0.27218734085398777,2.721876201523902,1,0.5,0.5,transcript,179020.0
TMEM144,ENSG00000164124,urinary microalbumin measurement,EFO_0010967,0.272161094208155,2.7216278518257897,1,0.4,0.4,transcript,23655.0
ARMC1,ENSG00000104442,adjustment disorder,MONDO_0003265,0.27212673603784904,2.7213119087691795,1,0.4,0.4,transcript,8979.0
ARMC1,ENSG00000104442,stress-related disorder,EFO_0010098,0.27212673603784904,2.7213119087691795,1,0.4,0.4,transcript,8979.0
TPRG1,ENSG00000188001,cholelithiasis,EFO_0004799,0.2721222527313818,2.721322383770162,2,0.8,1.6,transcript,16023.0
AOX1,ENSG00000138356,triglyceride measurement,EFO_0004530,0.27209338090724405,2.720961910800697,1,0.4,0.4,transcript,14234.0
CYSLTR1,ENSG00000173198,eosinophilic esophagitis,EFO_0004232,0.2720518374762388,2.720708511423113,2,0.8,1.6,transcript,8415.0
RBM44,ENSG00000177483,device complication,EFO_0009519,0.2719229447389557,2.7192576959771273,1,0.4,0.4,transcript,14160.0
ALPK3,ENSG00000136383,esophageal ulcer,MONDO_0044782,0.2719229447389557,2.7192667434268527,1,0.4,0.4,transcript,10725.0
YWHAG,ENSG00000170027,level of scavenger receptor cysteine-rich domain-containing group B protein in blood serum,OBA_2045013,0.2719229447389557,2.7193374096027823,1,0.4,0.4,transcript,3705.0
CAV2,ENSG00000105971,cardiac arrhythmia,EFO_0004269,0.27189732592640764,2.7189974328302817,1,0.4,0.4,transcript,16547.0
HS3ST3A1,ENSG00000153976,radiation-induced disorder,EFO_0009565,0.271884054866209,2.718921585939237,1,0.4,0.4,transcript,4936.0
HS3ST3A1,ENSG00000153976,skin disease,EFO_0000701,0.271884054866209,2.718921585939237,1,0.4,0.4,transcript,4936.0
TRIT1,ENSG00000043514,Red cell distribution width,EFO_0009188,0.27187453635968095,2.7187605663637133,1,0.4,0.4,transcript,26311.0
FZD6,ENSG00000164930,Non-immune hydrops fetalis,EFO_0009051,0.2718721806024338,2.7188016981699414,2,0.8,1.6,transcript,20027.0
RPRD2,ENSG00000163125,hemoglobin measurement,EFO_0004509,0.27183708544854673,2.718389361009017,1,0.4,0.4,transcript,21614.0
RNMT,ENSG00000101654,placenta praevia,EFO_0007442,0.27182341170363866,2.7182505387458864,1,0.4,0.4,transcript,24358.0
FBXO28,ENSG00000143756,Delayed puberty,HP_0000823,0.27182341170363866,2.7192831047632304,5,2.0,10.0,transcript,9533.0
ARL3,ENSG00000138175,kidney disease,EFO_0003086,0.2717872145502161,2.7179764751839555,1,0.4,0.4,transcript,3834.0
TBXT,ENSG00000164458,body height,OBA_VT0001253,0.27178182209646434,2.7182786967896626,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
PLEKHA6,ENSG00000143850,basophil measurement,EFO_0803539,0.2717793669438525,2.7178004840968555,1,0.4,0.4,transcript,58697.0
MAP4K3,ENSG00000011566,ulcerative colitis,EFO_0000729,0.271701931516986,2.7170421227876043,1,0.4,0.4,transcript,17538.0
STAU2,ENSG00000040341,Hernia,HP_0100790,0.2717004317124616,2.717015885307486,1,0.5,0.5,transcript,43222.0
ALPK3,ENSG00000136383,JT interval,EFO_0007885,0.27165575120923313,2.716594808129627,1,0.4,0.4,transcript,10725.0
EDEM1,ENSG00000134109,urinary microalbumin measurement,EFO_0010967,0.2716461948922265,2.7165949276456693,2,0.8,1.6,transcript,12032.0
ZPLD1,ENSG00000170044,high density lipoprotein cholesterol measurement,EFO_0004612,0.271622695302636,2.7163859355382836,2,0.8,1.6,transcript,10064.0
MMADHC,ENSG00000168288,cervical carcinoma,EFO_0001061,0.271622695302636,2.7163085190948753,1,0.4,0.4,transcript,4904.0
NAF1,ENSG00000145414,level of cathepsin O in blood serum,OBA_2041195,0.271622695302636,2.7162889032184054,1,0.5,0.5,transcript,8071.0
EDEM1,ENSG00000134109,5-methyluridine (ribothymidine) measurement,EFO_0020013,0.271622695302636,2.716359931749764,2,0.8,1.6,transcript,12032.0
NAF1,ENSG00000145414,lymphocyte count,EFO_0004587,0.271622695302636,2.7162889032184054,1,0.5,0.5,transcript,8071.0
ARMC1,ENSG00000104442,growth differentiation factor 15 amount,OBA_2050135,0.271622695302636,2.716271501417049,1,0.4,0.4,transcript,8979.0
HS3ST3A1,ENSG00000153976,response to antihypertensive drug,EFO_0005405,0.271622695302636,2.7163079903035072,1,0.4,0.4,transcript,4936.0
HS3ST3A1,ENSG00000153976,hip geometry,EFO_0004685,0.271622695302636,2.7163079903035072,1,0.4,0.4,transcript,4936.0
NDST3,ENSG00000164100,diabetes mellitus,EFO_0000400,0.271622695302636,2.716277015604583,1,0.4,0.4,transcript,7990.0
ZPLD1,ENSG00000170044,ulcerative colitis,EFO_0000729,0.271622695302636,2.7163859355382836,2,0.8,1.6,transcript,10064.0
NDST3,ENSG00000164100,serum creatinine amount,OBA_2050096,0.271622695302636,2.716277015604583,1,0.4,0.4,transcript,7990.0
XKR4,ENSG00000206579,cerebrospinal fluid composition attribute,OBA_2045291,0.271622695302636,2.7162459049831496,1,0.4,0.4,transcript,21106.0
PLPP4,ENSG00000203805,urinary microalbumin measurement,EFO_0010967,0.271622695302636,2.7163078428140244,1,0.4,0.4,transcript,4945.0
PLPP4,ENSG00000203805,body weight,EFO_0004338,0.271622695302636,2.7163078428140244,1,0.4,0.4,transcript,4945.0
TRIM36,ENSG00000152503,chronic obstructive pulmonary disease,EFO_0000341,0.271622695302636,2.71625311391583,1,0.4,0.4,transcript,15290.0
ATXN7L3B,ENSG00000253719,liver disease,EFO_0001421,0.271622695302636,2.7162796123207253,1,0.4,0.4,transcript,7596.0
AGA,ENSG00000038002,glucose measurement,EFO_0004468,0.271622695302636,2.716324934605823,1,0.5,0.5,transcript,5103.0
PPDPFL,ENSG00000168333,hyperpituitarism,EFO_1000973,0.271622695302636,2.7165523546940435,2,0.8,1.6,transcript,4917.0
EDEM1,ENSG00000134109,fructosamine measurement,EFO_0009303,0.271622695302636,2.716359931749764,2,0.8,1.6,transcript,12032.0
MED10,ENSG00000133398,liver disease,EFO_0001421,0.271622695302636,2.716376541657624,1,0.4,0.4,transcript,2674.0
PLPP4,ENSG00000203805,secondary malignant neoplasm,EFO_0009812,0.271622695302636,2.7163078428140244,1,0.4,0.4,transcript,4945.0
ARMC1,ENSG00000104442,liver disease,EFO_0001421,0.271622695302636,2.716271501417049,1,0.4,0.4,transcript,8979.0
HTR1F,ENSG00000179097,cataract,MONDO_0005129,0.271622695302636,2.7163450865172045,1,0.4,0.4,transcript,3386.0
HTR1F,ENSG00000179097,trauma complication,EFO_0009888,0.271622695302636,2.7163450865172045,1,0.4,0.4,transcript,3386.0
RASEF,ENSG00000165105,lymphocyte count,EFO_0004587,0.271622695302636,2.7162813747950674,1,0.4,0.4,transcript,7350.0
DIRAS2,ENSG00000165023,triglyceride measurement,EFO_0004530,0.271622695302636,2.7163032015966992,1,0.4,0.4,transcript,5246.0
PCDH10,ENSG00000138650,brain volume,OBA_2050009,0.271622695302636,2.7163408158216913,2,0.8,1.6,transcript,14052.0
ST8SIA4,ENSG00000113532,body mass index,EFO_0004340,0.271622695302636,2.7162698300764188,1,0.4,0.4,transcript,9329.0
EXOC6,ENSG00000138190,arterial stiffness measurement,EFO_0004517,0.271605012414818,2.716072741418728,1,0.5,0.5,transcript,22107.0
CCDC126,ENSG00000169193,high density lipoprotein cholesterol measurement,EFO_0004612,0.271605012414818,2.7160925869931902,1,0.4,0.4,transcript,9420.0
CD93,ENSG00000125810,bone tissue density,OBA_1000110,0.271605012414818,2.7160764416690695,1,0.4,0.4,transcript,15199.0
SPRY3,ENSG00000168939,eosinophil count,EFO_0004842,0.271560049101764,2.715618068026912,1,0.4,0.4,transcript,22757.0
PHIP,ENSG00000146247,atopic eczema,EFO_0000274,0.2715075006663932,2.7150829838173642,1,0.5,0.5,transcript,62679.0
LYPD6,ENSG00000187123,educational attainment,EFO_0011015,0.2715075006663932,2.7151077559680092,1,0.4,0.4,transcript,12214.0
SERPINB10,ENSG00000242550,urinary microalbumin measurement,EFO_0010967,0.2715075006663932,2.7153070252254166,1,0.5,0.5,transcript,2155.0
LGSN,ENSG00000146166,"fatty acid-binding protein, adipocyte measurement",EFO_0010914,0.2715075006663932,2.7151056040784503,1,0.4,0.4,transcript,13073.0
SI,ENSG00000090402,erythrocyte volume,OBA_0003460,0.2715075006663932,2.715147052773442,1,0.5,0.5,transcript,6940.0
LYPD6,ENSG00000187123,type 1 diabetes nephropathy,EFO_0004996,0.2715075006663932,2.7151077559680092,1,0.4,0.4,transcript,12214.0
CEP85L,ENSG00000111860,urinary microalbumin measurement,EFO_0010967,0.2715075006663932,2.7150904096444086,1,0.4,0.4,transcript,25969.0
USP37,ENSG00000135913,free cholesterol to total lipids in large LDL percentage ,EFO_0022280,0.27148741670175286,2.715013793903461,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
USP37,ENSG00000135913,cholesteryl esters:total lipids ratio,EFO_0020944,0.27148741670175286,2.715013793903461,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
USP37,ENSG00000135913,free cholesterol:total lipids ratio,EFO_0020945,0.27148741670175286,2.715013793903461,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
USP37,ENSG00000135913,triglycerides to total lipids in very small VLDL percentage ,EFO_0022341,0.27148741670175286,2.715013793903461,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
USP37,ENSG00000135913,triglycerides to total lipids in IDL percentage ,EFO_0022329,0.27148741670175286,2.715013793903461,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
SLC30A9,ENSG00000014824,autism spectrum disorder,EFO_0003756,0.27145207716179826,2.714872534944401,3,1.3,3.9000000000000004,transcript,11087.0
SLC30A9,ENSG00000014824,urinary microalbumin measurement,EFO_0010967,0.2714249141038383,2.714600904364801,3,1.3,3.9000000000000004,transcript,11087.0
EPRS1,ENSG00000136628,hyperpituitarism,EFO_1000973,0.2714249141038383,2.7142938557584686,1,0.5,0.5,transcript,11182.0
EPRS1,ENSG00000136628,tooth disease,EFO_1001216,0.2714249141038383,2.7142938557584686,1,0.5,0.5,transcript,11182.0
C2CD2,ENSG00000157617,mean corpuscular hemoglobin concentration,EFO_0004528,0.2714249141038383,2.7142631221638633,1,0.4,0.4,transcript,28610.0
SYNJ2,ENSG00000078269,gestational diabetes,EFO_0004593,0.2714249141038383,2.7143002886632153,2,0.8,1.6,transcript,31282.0
U2SURP,ENSG00000163714,growth differentiation factor 15 amount,OBA_2050135,0.2714249141038383,2.7142995490280493,2,0.8,1.6,transcript,31741.0
PLPP4,ENSG00000203805,mean corpuscular hemoglobin concentration,EFO_0004528,0.27138830860687435,2.713963975856408,1,0.4,0.4,transcript,4945.0
KIAA0586,ENSG00000100578,Jeune syndrome,MONDO_0018770,0.27133577650778723,2.713363416136316,1,0.5,0.5,transcript,88479.0
EXD1,ENSG00000178997,hypertension,EFO_0000537,0.27131986261422797,2.7132404103269656,1,0.4,0.4,transcript,9573.0
GPR158,ENSG00000151025,intraocular pressure measurement,EFO_0004695,0.2713164090837666,2.7131897621422816,1,0.5,0.5,transcript,19477.0
PPP1R3G,ENSG00000219607,alkaline phosphatase measurement,EFO_0004533,0.2712483443667391,2.71257989893626,1,0.4,0.4,transcript,4147.0
NHLH2,ENSG00000177551,primary thrombocytopenia,MONDO_0004680,0.2712483443667391,2.7125212044528153,1,0.4,0.4,transcript,10593.0
DYNC1I2,ENSG00000077380,phosphatidate measurement,EFO_0020047,0.2712483443667391,2.7124946306010527,1,0.4,0.4,transcript,35756.0
HEATR1,ENSG00000119285,musculoskeletal system disease,EFO_0009676,0.2712483443667391,2.712513034719057,1,0.5,0.5,transcript,16897.0
GPR158,ENSG00000151025,bone tissue density,OBA_1000110,0.2712483443667391,2.712509114972007,1,0.5,0.5,transcript,19477.0
CFAP46,ENSG00000171811,frozen shoulder,EFO_1000941,0.2712483443667391,2.7125048038861195,1,0.5,0.5,transcript,23408.0
PPP1R3G,ENSG00000219607,serum gamma-glutamyl transferase measurement,EFO_0004532,0.2712483443667391,2.71257989893626,1,0.4,0.4,transcript,4147.0
LHX9,ENSG00000143355,urinary tract obstruction,EFO_0009571,0.27121740004266964,2.712248267043852,2,0.8,1.6,transcript,21544.0
ABCA13,ENSG00000179869,schizophrenia,MONDO_0005090,0.27119180549956406,2.711928386854962,1,0.5,0.5,transcript,48394.0
ANKRD36,ENSG00000135976,brain attribute,OBA_2045210,0.27113334642595777,2.711408850614647,2,1.0,2.0,transcript,26530.0
SLC22A24,ENSG00000197658,free androgen index,EFO_0007005,0.27108583303812217,2.710943625502341,1,0.5,0.5,transcript,5862.0
MAN1A2,ENSG00000198162,high density lipoprotein cholesterol measurement,EFO_0004612,0.2710694451579947,2.710821972102781,2,0.8,1.6,transcript,12547.0
NOL9,ENSG00000162408,reticulocyte count,EFO_0007986,0.2710066799381578,2.7101095024882293,1,0.4,0.4,transcript,9367.0
FARSB,ENSG00000116120,neuroinflammatory disorder,EFO_0020092,0.27099432758329256,2.7099942962410886,1,0.4,0.4,transcript,7840.0
NEK1,ENSG00000137601,neuroinflammatory disorder,EFO_0020092,0.27099432758329256,2.7099575357012,2,0.8,1.6,transcript,112203.0
ABCA13,ENSG00000179869,neuroimaging measurement,EFO_0004346,0.27092295143787287,2.70923984623805,1,0.5,0.5,transcript,48394.0
VAT1L,ENSG00000171724,neuroimaging measurement,EFO_0004346,0.27090877818959824,2.709178567188765,1,0.4,0.4,transcript,4406.0
PAG1,ENSG00000076641,cardiac transplant,EFO_0010673,0.27090877818959824,2.7092178737733708,2,0.8,1.6,transcript,12299.0
VAT1L,ENSG00000171724,brain volume,OBA_2050009,0.27090877818959824,2.709178567188765,1,0.4,0.4,transcript,4406.0
DOCK1,ENSG00000150760,temporomandibular joint disorder,EFO_0005279,0.2709020334838864,2.7090454226461897,1,0.4,0.4,transcript,15944.0
PTPN4,ENSG00000088179,erythrocyte count,EFO_0004305,0.27088179085008024,2.709281515362184,5,2.0,10.0,transcript,21570.0
KLHL3,ENSG00000146021,educational attainment,EFO_0011015,0.2708814018210102,2.708861328893446,2,0.8,1.6,transcript,33819.0
SULT6B1,ENSG00000138068,neurodegenerative disease,EFO_0005772,0.27086774263745306,2.708790522959014,1,0.5,0.5,transcript,4421.0
AGO3,ENSG00000126070,head and neck squamous cell carcinoma,EFO_0000181,0.2708301707343644,2.708314873467208,1,0.4,0.4,transcript,30381.0
ZNF143,ENSG00000166478,body mass index,EFO_0004340,0.2708235174842993,2.708261454670597,1,0.5,0.5,transcript,19026.0
GPATCH2L,ENSG00000089916,arterial stiffness measurement,EFO_0004517,0.27082212943168094,2.70836376665714,4,1.6,6.4,transcript,44921.0
PDHX,ENSG00000110435,temporal measurement,EFO_0000719,0.27082212943168094,2.7082660620840167,1,0.4,0.4,transcript,8935.0
PDHX,ENSG00000110435,glomerulonephritis,MONDO_0002462,0.27082212943168094,2.7082660620840167,1,0.4,0.4,transcript,8935.0
FBXO28,ENSG00000143756,mean corpuscular hemoglobin,EFO_0004527,0.27080481669687395,2.7090971546955833,5,2.0,10.0,transcript,9533.0
OXSR1,ENSG00000172939,reticulocyte measurement,EFO_0010700,0.27075460370101,2.7075866131918813,1,0.4,0.4,transcript,9858.0
U2SURP,ENSG00000163714,platelet crit,EFO_0007985,0.2707495244837495,2.7075456528271613,2,0.8,1.6,transcript,31741.0
HNRNPA0,ENSG00000177733,systolic blood pressure,EFO_0006335,0.27072330804099065,2.707256034616265,1,0.4,0.4,transcript,17426.0
CCDC62,ENSG00000130783,BMI-adjusted waist-hip ratio,EFO_0007788,0.2707218799956478,2.707245735983414,1,0.4,0.4,transcript,14850.0
PDE12,ENSG00000174840,high density lipoprotein cholesterol measurement,EFO_0004612,0.2706744571011557,2.706763624981928,1,0.4,0.4,transcript,20993.0
MAP1LC3B2,ENSG00000258102,cervical carcinoma,EFO_0001061,0.2706410472825135,2.706576723864204,1,0.4,0.4,transcript,2406.0
TECRL,ENSG00000205678,bone tissue density,OBA_1000110,0.2706410472825135,2.706813247495083,3,1.2000000000000002,3.6000000000000005,transcript,8938.0
UBL3,ENSG00000122042,blood urea nitrogen measurement,EFO_0004741,0.2706410472825135,2.7072443852643286,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
MAP1LC3B2,ENSG00000258102,metabolic disease,EFO_0000589,0.2706410472825135,2.706576723864204,1,0.4,0.4,transcript,2406.0
TMED5,ENSG00000117500,cortical thickness,EFO_0004840,0.2706108089337483,2.7061400566030027,1,0.5,0.5,transcript,15641.0
TMEM68,ENSG00000167904,urinary microalbumin measurement,EFO_0010967,0.27056246481099505,2.7056433196312124,1,0.4,0.4,transcript,21423.0
DOK5,ENSG00000101134,ovarian dysfunction,EFO_0009003,0.2705560032062289,2.7056478669327326,1,0.4,0.4,transcript,4554.0
NEK7,ENSG00000151414,chitotriosidase-1 measurement,EFO_0008084,0.2705560032062289,2.7056052962922315,1,0.4,0.4,transcript,8837.0
TMTC3,ENSG00000139324,placenta praevia,EFO_0007442,0.2705445383368656,2.7054843925358103,1,0.4,0.4,transcript,10254.0
RASEF,ENSG00000165105,acute tonsillitis,MONDO_0020686,0.2705445383368656,2.7054998051373635,1,0.4,0.4,transcript,7350.0
CDH19,ENSG00000071991,liver disease,EFO_0001421,0.2705445383368656,2.705719941025764,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
YTHDC2,ENSG00000047188,serum creatinine amount,OBA_2050096,0.2705445383368656,2.7054655925335123,1,0.4,0.4,transcript,19793.0
IQCB1,ENSG00000173226,Bardet-Biedl syndrome,MONDO_0015229,0.27048050712740435,2.7048466902522974,1,0.4,0.4,transcript,9611.0
MFAP3,ENSG00000037749,chloride measurement,EFO_0009284,0.27046695234592416,2.7046821131608656,1,0.4,0.4,transcript,31772.0
VPS50,ENSG00000004766,Abnormal corpus callosum morphology,HP_0001273,0.27046059087967966,2.704617070756837,1,0.4,0.4,transcript,35836.0
AGO3,ENSG00000126070,lung adenocarcinoma,EFO_0000571,0.27046059087967966,2.704619074920361,1,0.4,0.4,transcript,30381.0
VPS50,ENSG00000004766,Failure to thrive,HP_0001508,0.27046059087967966,2.704617070756837,1,0.4,0.4,transcript,35836.0
VPS50,ENSG00000004766,Seizure,HP_0001250,0.27046059087967966,2.704617070756837,1,0.4,0.4,transcript,35836.0
VPS50,ENSG00000004766,Profound global developmental delay,HP_0012736,0.27046059087967966,2.704617070756837,1,0.4,0.4,transcript,35836.0
VPS50,ENSG00000004766,Secondary microcephaly,HP_0005484,0.27046059087967966,2.704617070756837,1,0.4,0.4,transcript,35836.0
MGA,ENSG00000174197,hemoglobin A1 measurement,EFO_0007629,0.2703269120088496,2.703275041873559,1,0.5,0.5,transcript,84434.0
SLC35F5,ENSG00000115084,placenta praevia,EFO_0007442,0.27029414151608266,2.703012174049912,2,0.8,1.6,transcript,22612.0
MAN1A2,ENSG00000198162,familial glucocorticoid deficiency,MONDO_0008733,0.2702242648795111,2.702370169317945,2,0.8,1.6,transcript,12547.0
MAN1A2,ENSG00000198162,chronic primary adrenal insufficiency,MONDO_0015129,0.2702242648795111,2.702370169317945,2,0.8,1.6,transcript,12547.0
STAM,ENSG00000136738,metabolite measurement,EFO_0004725,0.27022073034153626,2.7022732991256415,1,0.4,0.4,transcript,6061.0
PDP1,ENSG00000164951,neurodegenerative disease,EFO_0005772,0.27016093658654433,2.7016327330812393,1,0.4,0.4,transcript,17118.0
IREB2,ENSG00000136381,chronic bronchitis,EFO_0006505,0.2699871139324694,2.6999709950885906,2,0.9,1.8,transcript,18026.0
THEM4,ENSG00000159445,monocyte count,EFO_0005091,0.26995425087294533,2.69969685949156,2,0.8,1.6,transcript,10366.0
LAMA1,ENSG00000101680,tibia fracture,EFO_0003944,0.2698617520015221,2.6986334152339393,1,0.5,0.5,transcript,31456.0
GRSF1,ENSG00000132463,clear cell renal carcinoma,EFO_0000349,0.2698587711355415,2.6986788015916807,2,0.8,1.6,transcript,17565.0
NBEAL1,ENSG00000144426,cortical thickness,EFO_0004840,0.2698292655996837,2.698296509598509,1,0.4,0.4,transcript,103799.0
LDLRAP1,ENSG00000157978,total blood protein measurement,EFO_0004536,0.26981565439085753,2.698182457357655,1,0.4,0.4,transcript,15436.0
GASK1B,ENSG00000164125,brain aneurysm,EFO_0003870,0.2697756167818041,2.697929053569374,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
GASK1B,ENSG00000164125,Abnormality of the cardiovascular system,HP_0001626,0.2697756167818041,2.697929053569374,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
MED10,ENSG00000133398,alpha-hydroxyisocaproate measurement,EFO_0800009,0.2697341109707665,2.697490698338929,1,0.4,0.4,transcript,2674.0
ONECUT2,ENSG00000119547,arterial stiffness measurement,EFO_0004517,0.2697341109707665,2.698502935433806,7,2.8000000000000003,19.6,transcript,16870.0
SLC15A5,ENSG00000188991,serum alanine aminotransferase measurement,EFO_0004735,0.2697312192283801,2.6985438036419946,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
SLC15A5,ENSG00000188991,Red cell distribution width,EFO_0009188,0.2697312192283801,2.6985438036419946,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
SLC15A5,ENSG00000188991,cup-to-disc ratio measurement,EFO_0006939,0.2697312192283801,2.6985438036419946,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
SLC15A5,ENSG00000188991,Antidepressant use measurement,EFO_0009940,0.2697312192283801,2.6985438036419946,3,1.2000000000000002,3.6000000000000005,transcript,2923.0
SC5D,ENSG00000109929,protein measurement,EFO_0004747,0.2696183179569463,2.6962060223539983,1,0.4,0.4,transcript,17511.0
YWHAG,ENSG00000170027,esophageal cancer,MONDO_0007576,0.26957240886523487,2.695832050865574,1,0.4,0.4,transcript,3705.0
PF4V1,ENSG00000109272,level of serum globulin type protein,OBA_2045206,0.26956508419443215,2.696189199952397,1,0.4,0.4,transcript,743.0
FARSB,ENSG00000116120,liver disease,EFO_0001421,0.2695590870990623,2.695641891398786,1,0.4,0.4,transcript,7840.0
MYO1B,ENSG00000128641,lymphocyte count,EFO_0004587,0.26949621659674505,2.694975574387939,1,0.4,0.4,transcript,29832.0
GPM6A,ENSG00000150625,hemolytic anemia,EFO_0005558,0.26949621659674505,2.6949803370481757,1,0.4,0.4,transcript,22013.0
DOK5,ENSG00000101134,benign urinary system neoplasm,MONDO_0004180,0.26949621659674505,2.6950500008378944,1,0.4,0.4,transcript,4554.0
MYO1B,ENSG00000128641,Pathologic fracture,HP_0002756,0.26949621659674505,2.694975574387939,1,0.4,0.4,transcript,29832.0
OR5M1,ENSG00000255012,total cholesterol measurement,EFO_0004574,0.2694689145202443,2.695061065239635,2,0.8,1.6,transcript,4302.0
SOCS4,ENSG00000180008,platelet volume,OBA_0003277,0.2693804228190868,2.6938236024037905,1,0.4,0.4,transcript,20646.0
FRMD4B,ENSG00000114541,type 1 diabetes mellitus,MONDO_0005147,0.2693675369355558,2.6937514656173294,2,0.8,1.6,transcript,21026.0
CCDC34,ENSG00000109881,systolic blood pressure,EFO_0006335,0.26932501231612904,2.6933436466590694,1,0.4,0.4,transcript,4277.0
CCDC66,ENSG00000180376,respiratory system disease,EFO_0000684,0.2692998349713058,2.6930135792217538,1,0.5,0.5,transcript,32831.0
PSD3,ENSG00000156011,arterial stiffness measurement,EFO_0004517,0.269188354060297,2.6918929836965275,1,0.4,0.4,transcript,42359.0
IL17A,ENSG00000112115,osteoarthritis,MONDO_0005178,0.2691713767819736,2.69192755723716,1,0.4,0.4,transcript,1871.0
TLK1,ENSG00000198586,blood protein measurement,EFO_0007937,0.26915508773515034,2.6915647725125136,1,0.4,0.4,transcript,28787.0
TLK1,ENSG00000198586,level of serum globulin type protein,OBA_2045206,0.26915508773515034,2.6915647725125136,1,0.4,0.4,transcript,28787.0
SLC11A2,ENSG00000110911,ovarian neoplasm,EFO_0003893,0.2690597247533104,2.69062520880674,2,0.8,1.6,transcript,57222.0
SAXO1,ENSG00000155875,brain connectivity attribute,OBA_2045295,0.26905383228215934,2.690564998380113,1,0.4,0.4,transcript,14995.0
DGKH,ENSG00000102780,C-reactive protein measurement,EFO_0004458,0.2689811862952718,2.689839255991462,2,0.8,1.6,transcript,58409.0
NEMF,ENSG00000165525,type 1 diabetes mellitus,MONDO_0005147,0.26895593605996176,2.689579543863655,1,0.5,0.5,transcript,24773.0
RAB40B,ENSG00000141542,enteritis,MONDO_0043579,0.26895593605996176,2.6895877475132504,1,0.4,0.4,transcript,14091.0
THEM4,ENSG00000159445,pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) measurement,EFO_0800494,0.2689468345810859,2.689622696572966,2,0.8,1.6,transcript,10366.0
ZNF236,ENSG00000130856,white matter microstructure measurement,EFO_0005674,0.2689220841591707,2.689279809650675,2,0.9,1.8,transcript,30525.0
LRRIQ3,ENSG00000162620,health study participation,EFO_0010130,0.26891698951522364,2.6891967913329786,1,0.5,0.5,transcript,18590.0
RCN2,ENSG00000117906,liver disease,EFO_0001421,0.26889753147649015,2.689002629706174,1,0.4,0.4,transcript,14644.0
TLR10,ENSG00000174123,systolic blood pressure,EFO_0006335,0.2688735877427916,2.688897319645055,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
DGKH,ENSG00000102780,glomerular filtration rate,OBA_0003747,0.26884911568114195,2.6885185498501634,2,0.8,1.6,transcript,58409.0
ZBTB21,ENSG00000173276,Proptosis,HP_0000520,0.26879440954563155,2.6879583975158123,1,0.4,0.4,transcript,27968.0
CLDN16,ENSG00000113946,nephrocalcinosis,MONDO_0001567,0.26876490446159235,2.687749421027467,1,0.4,0.4,transcript,3985.0
PSD3,ENSG00000156011,serum gamma-glutamyl transferase measurement,EFO_0004532,0.2687609185310384,2.6876186284039414,1,0.4,0.4,transcript,42359.0
MARCKS,ENSG00000277443,salivary gland disease,EFO_0008581,0.2687609185310384,2.6877022951800305,1,0.4,0.4,transcript,4296.0
CLDN1,ENSG00000163347,heart rate,OBA_1001087,0.2686928948967933,2.6885792841922758,4,1.6,6.4,transcript,3878.0
PPP1R3G,ENSG00000219607,urinary microalbumin measurement,EFO_0010967,0.26867502197032567,2.6868466749721254,1,0.4,0.4,transcript,4147.0
FIGNL1,ENSG00000132436,waist circumference,OBA_1001085,0.2686539057702156,2.686555240241196,1,0.4,0.4,transcript,24718.0
TRPC6,ENSG00000137672,breast adenocarcinoma,EFO_0000304,0.2685939811892317,2.685968699015882,1,0.4,0.4,transcript,13847.0
CLDN16,ENSG00000113946,renal hypomagnesemia 5 with ocular involvement,MONDO_0009548,0.2685496577088183,2.685596953499726,1,0.4,0.4,transcript,3985.0
NAF1,ENSG00000145414,lean body mass,EFO_0004995,0.26851180374839817,2.6851799876760274,1,0.5,0.5,transcript,8071.0
ARMC1,ENSG00000104442,osteitis deformans,EFO_0004261,0.26851180374839817,2.685162585874671,1,0.4,0.4,transcript,8979.0
GAN,ENSG00000261609,peripheral neuropathy,EFO_0003100,0.2684997644284358,2.685008308391639,1,0.4,0.4,transcript,37509.0
FARSB,ENSG00000116120,muscular atrophy,MONDO_0004323,0.26849154230714073,2.6849664434795706,1,0.4,0.4,transcript,7840.0
FARSB,ENSG00000116120,cervical carcinoma,EFO_0001061,0.26849154230714073,2.6849664434795706,1,0.4,0.4,transcript,7840.0
FARSB,ENSG00000116120,placenta praevia,EFO_0007442,0.26849154230714073,2.6849664434795706,1,0.4,0.4,transcript,7840.0
MARCKS,ENSG00000277443,smoking initiation,EFO_0005670,0.2684807372983301,2.6849004828529477,1,0.4,0.4,transcript,4296.0
TMEM170B,ENSG00000205269,outer nuclear layer thickness measurement,EFO_0803371,0.2684764049977075,2.6848090392921127,1,0.4,0.4,transcript,8891.0
TMEM170B,ENSG00000205269,photoreceptor cell layer thickness measurement,EFO_0803370,0.2684764049977075,2.6848090392921127,1,0.4,0.4,transcript,8891.0
TMEM170B,ENSG00000205269,retinal layer thickness,OBA_2050110,0.2684764049977075,2.6848090392921127,1,0.4,0.4,transcript,8891.0
TOPAZ1,ENSG00000173769,colon adenocarcinoma,EFO_1001949,0.26845279909498093,2.684621729232524,1,0.5,0.5,transcript,5334.0
SAXO1,ENSG00000155875,polycystic ovary syndrome,EFO_0000660,0.2683760958818982,2.6837876343775013,1,0.4,0.4,transcript,14995.0
MYO5A,ENSG00000197535,Keloid,EFO_0004212,0.2683760958818982,2.6837629984801943,1,0.4,0.4,transcript,196111.0
UBL3,ENSG00000122042,eosinophil count,EFO_0004842,0.26836661366944287,2.684500049133623,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
YWHAG,ENSG00000170027,head and neck squamous cell carcinoma,EFO_0000181,0.26832131402027576,2.683321102415983,1,0.4,0.4,transcript,3705.0
GPM6A,ENSG00000150625,brain volume,OBA_2050009,0.26828663825504256,2.6828845536311507,1,0.4,0.4,transcript,22013.0
NXPH2,ENSG00000144227,age at initiation of smoking,EFO_0021784,0.26828663825504256,2.6830140385120353,1,0.4,0.4,transcript,2709.0
ATP8A1,ENSG00000124406,eye inflammation,EFO_0005752,0.26828663825504256,2.6830441455146232,4,1.6,6.4,transcript,36003.0
XKR4,ENSG00000206579,Abruptio Placentae,EFO_1001754,0.26828663825504256,2.6828853345072154,1,0.4,0.4,transcript,21106.0
PLPP4,ENSG00000203805,diabetes mellitus,EFO_0000400,0.26828663825504256,2.6829472723380903,1,0.4,0.4,transcript,4945.0
NXPH2,ENSG00000144227,muscular disease,EFO_0002970,0.26828663825504256,2.6830140385120353,1,0.4,0.4,transcript,2709.0
PTCHD4,ENSG00000244694,mean corpuscular hemoglobin concentration,EFO_0004528,0.26828663825504256,2.683280223221767,6,2.4000000000000004,14.400000000000002,transcript,34796.0
FSIP2,ENSG00000188738,arterial stiffness measurement,EFO_0004517,0.26828663825504256,2.6831453225783197,4,2.0,8.0,transcript,28680.0
HS3ST3A1,ENSG00000153976,abscess,EFO_0003030,0.26828663825504256,2.682947419827573,1,0.4,0.4,transcript,4936.0
XKR4,ENSG00000206579,chronic primary adrenal insufficiency,MONDO_0015129,0.26828663825504256,2.6828853345072154,1,0.4,0.4,transcript,21106.0
HTR1F,ENSG00000179097,Genu valgum,HP_0002857,0.26828663825504256,2.6829845160412704,1,0.4,0.4,transcript,3386.0
NPS,ENSG00000214285,systemic lupus erythematosus,MONDO_0007915,0.26828663825504256,2.6831913216243493,1,0.4,0.4,transcript,1231.0
XKR4,ENSG00000206579,male infertility,EFO_0004248,0.26828663825504256,2.6828853345072154,1,0.4,0.4,transcript,21106.0
PAQR3,ENSG00000163291,temporal measurement,EFO_0000719,0.26828663825504256,2.6828814342907834,1,0.4,0.4,transcript,26575.0
HS3ST3A1,ENSG00000153976,cellulitis,EFO_0003035,0.26828663825504256,2.682947419827573,1,0.4,0.4,transcript,4936.0
FSIP2,ENSG00000188738,ovarian dysfunction,EFO_0009003,0.26828663825504256,2.6831453225783197,4,2.0,8.0,transcript,28680.0
NXPH2,ENSG00000144227,educational attainment,EFO_0011015,0.26828663825504256,2.6830140385120353,1,0.4,0.4,transcript,2709.0
HTR1F,ENSG00000179097,Genu varum,HP_0002970,0.26828663825504256,2.6829845160412704,1,0.4,0.4,transcript,3386.0
HTR1F,ENSG00000179097,ovarian dysfunction,EFO_0009003,0.26828663825504256,2.6829845160412704,1,0.4,0.4,transcript,3386.0
MUC16,ENSG00000181143,head and neck squamous cell carcinoma,EFO_0000181,0.26827189985577365,2.682721818907121,1,0.5,0.5,transcript,177283.0
CAV2,ENSG00000105971,lymphocyte percentage of leukocytes,EFO_0007993,0.268212586947353,2.6821500430397354,1,0.4,0.4,transcript,16547.0
CYSLTR1,ENSG00000173198,potassium measurement,EFO_0009283,0.26815979108700505,2.6817880475307754,2,0.8,1.6,transcript,8415.0
SYNJ2,ENSG00000078269,glioblastoma multiforme,EFO_0000519,0.26811696001068513,2.681220747731684,2,0.8,1.6,transcript,31282.0
SLC4A8,ENSG00000050438,alcohol use disorder measurement,EFO_0009458,0.2680848292782745,2.680879800630168,2,0.8,1.6,transcript,50781.0
RCN2,ENSG00000117906,hematocrit,EFO_0004348,0.26799461553029424,2.679973470244215,1,0.4,0.4,transcript,14644.0
BMP10,ENSG00000163217,bone morphogenetic protein 10 measurement,EFO_0020185,0.2679751546301469,2.6798178153538212,1,0.4,0.4,transcript,6036.0
SENP6,ENSG00000112701,migraine disorder,MONDO_0005277,0.2678436825583821,2.678865842744507,5,2.2,11.0,transcript,25640.0
TOPAZ1,ENSG00000173769,educational attainment,EFO_0011015,0.26780865529527254,2.67818029123544,1,0.5,0.5,transcript,5334.0
LMNTD1,ENSG00000152936,ovarian neoplasm,EFO_0003893,0.26780865529527254,2.6782412187028544,2,0.9,1.8,transcript,11638.0
ITM2A,ENSG00000078596,vein disorder,MONDO_0004634,0.2677799590322584,2.678199590322584,1,0.4,0.4,transcript,1000.0
ITM2A,ENSG00000078596,Varicose veins,HP_0002619,0.2677799590322584,2.678199590322584,1,0.4,0.4,transcript,1000.0
ITM2A,ENSG00000078596,lymphatic system disease,EFO_0007352,0.2677799590322584,2.678199590322584,1,0.4,0.4,transcript,1000.0
DOK5,ENSG00000101134,arterial stiffness measurement,EFO_0004517,0.2677788412582812,2.6778762474532556,1,0.4,0.4,transcript,4554.0
KIF20B,ENSG00000138182,arterial stiffness measurement,EFO_0004517,0.2677788412582812,2.677815724539987,1,0.5,0.5,transcript,18307.0
DOK5,ENSG00000101134,complex regional pain syndrome,EFO_1001998,0.2677788412582812,2.6778762474532556,1,0.4,0.4,transcript,4554.0
TFEC,ENSG00000105967,erythrocyte volume,OBA_0003460,0.2677788412582812,2.677804109937808,1,0.4,0.4,transcript,25482.0
MCL1,ENSG00000143384,prostate carcinoma,EFO_0001663,0.2676862859847948,2.676879629227062,1,0.4,0.4,transcript,23853.0
PSD3,ENSG00000156011,Alzheimer disease,MONDO_0004975,0.2676800285328959,2.6768097284225165,1,0.4,0.4,transcript,42359.0
AGA,ENSG00000038002,platelet volume,OBA_0003277,0.2676439586172489,2.676537567751952,1,0.5,0.5,transcript,5103.0
LAMA1,ENSG00000101680,breast adenocarcinoma,EFO_0000304,0.2676288414672462,2.6763043098911803,1,0.5,0.5,transcript,31456.0
DMXL1,ENSG00000172869,bone tissue density,OBA_1000110,0.26758359830085454,2.6758466676253683,1,0.4,0.4,transcript,37437.0
GCNT1,ENSG00000187210,bilirubin measurement,EFO_0004570,0.2675330157017678,2.6753492546543454,1,0.4,0.4,transcript,20945.0
CD2AP,ENSG00000198087,body height,OBA_VT0001253,0.26750966314035984,2.675148701177095,1,0.4,0.4,transcript,7682.0
ANKRD36B,ENSG00000196912,Thyroid preparation use measurement,EFO_0009933,0.2674973276317751,2.67500281492471,1,0.5,0.5,transcript,16927.0
TRIM69,ENSG00000185880,glomerular filtration rate,OBA_0003747,0.26734480694423807,2.673463646979572,1,0.4,0.4,transcript,25678.0
RNF17,ENSG00000132972,blood urea nitrogen measurement,EFO_0004741,0.26731272885968443,2.673163639014874,1,0.5,0.5,transcript,13755.0
SMARCC1,ENSG00000173473,prostate specific antigen amount,OBA_2050200,0.26727008379346445,2.672814985041729,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,prostate specific antigen amount,OBA_2050200,0.26727008379346445,2.672814985041729,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,prostate specific antigen amount,OBA_2050200,0.26727008379346445,2.672814985041729,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,prostate specific antigen amount,OBA_2050200,0.26727008379346445,2.672814985041729,2,0.8,1.6,transcript,14017.0
GPR158,ENSG00000151025,reticulocyte measurement,EFO_0010700,0.267243601190696,2.672461683211576,1,0.5,0.5,transcript,19477.0
LHX9,ENSG00000143355,heel bone mineral density,EFO_0009270,0.2672418713687644,2.6724929803048,2,0.8,1.6,transcript,21544.0
ACADSB,ENSG00000196177,serum creatinine amount,OBA_2050096,0.2672356227189838,2.672403049149337,1,0.4,0.4,transcript,8543.0
SMARCC1,ENSG00000173473,Global developmental delay,HP_0001263,0.2672062349370394,2.672176496477478,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,Global developmental delay,HP_0001263,0.2672062349370394,2.672176496477478,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,Global developmental delay,HP_0001263,0.2672062349370394,2.672176496477478,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,Global developmental delay,HP_0001263,0.2672062349370394,2.672176496477478,2,0.8,1.6,gene_variant,14017.0
PRDM10,ENSG00000170325,hyperaldosteronism,EFO_0009452,0.26718876914892575,2.67189909399781,1,0.4,0.4,transcript,35080.0
TBXT,ENSG00000164458,high density lipoprotein cholesterol measurement,EFO_0004612,0.26708974211918884,2.671357897016908,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
CCDC34,ENSG00000109881,ovarian dysfunction,EFO_0009003,0.2670079144075791,2.6701726675735697,1,0.4,0.4,transcript,4277.0
KIF20B,ENSG00000138182,Red cell distribution width,EFO_0009188,0.2669390115397793,2.6694174273549676,1,0.5,0.5,transcript,18307.0
MGA,ENSG00000174197,neutrophil count,EFO_0004833,0.2669002357735429,2.6690082795204915,1,0.5,0.5,transcript,84434.0
IREB2,ENSG00000136381,drug use measurement,EFO_0007010,0.2668997637387175,2.669097493151072,2,0.9,1.8,transcript,18026.0
MYO1B,ENSG00000128641,hypothyroidism,EFO_0004705,0.2668838389880516,2.6688517983010045,1,0.4,0.4,transcript,29832.0
MYO1B,ENSG00000128641,hepatitis C virus infection,EFO_0003047,0.2668838389880516,2.6688517983010045,1,0.4,0.4,transcript,29832.0
MDGA2,ENSG00000139915,Intellectual disability,HP_0001249,0.2668366550823547,2.668389641512227,1,0.4,0.4,transcript,17323.0
DUSP22,ENSG00000112679,Crohn's disease,EFO_0000384,0.26683116589770445,2.668335263367461,1,0.4,0.4,transcript,16946.0
SKP2,ENSG00000145604,endometrial cancer,MONDO_0011962,0.2668148122800508,2.6681531456544936,1,0.4,0.4,transcript,79636.0
RAD18,ENSG00000070950,triglyceride measurement,EFO_0004530,0.2668015641207221,2.668049122415893,1,0.4,0.4,transcript,11947.0
ATF6,ENSG00000118217,adolescent idiopathic scoliosis,EFO_0005423,0.26675437646176847,2.667550117050667,1,0.4,0.4,transcript,62968.0
CCDC66,ENSG00000180376,BMI-adjusted hip circumference,EFO_0008039,0.2667307870018374,2.66732309952707,1,0.5,0.5,transcript,32831.0
SHOC1,ENSG00000165181,"osteoarthritis, hip",EFO_1000786,0.26667397677141613,2.666856140465034,3,1.3,3.9000000000000004,transcript,33513.0
EXD1,ENSG00000178997,platelet count,EFO_0004309,0.26665045183765534,2.6665463025612395,1,0.4,0.4,transcript,9573.0
OTUD7A,ENSG00000169918,Neurodevelopmental disorder,EFO_0010642,0.26660053461963945,2.6660230727640877,1,0.4,0.4,transcript,22565.0
MTCH2,ENSG00000109919,cognitive function measurement,EFO_0008354,0.26656170261221357,2.66567647915424,1,0.4,0.4,transcript,6728.0
NDST3,ENSG00000164100,keratoconus,MONDO_0015486,0.26652921867241086,2.6653422493023315,1,0.4,0.4,transcript,7990.0
FYB1,ENSG00000082074,erythrocyte count,EFO_0004305,0.2664719370055181,2.6647390202811585,1,0.5,0.5,transcript,25445.0
CERKL,ENSG00000188452,Macular dystrophy,HP_0007754,0.26646707522767,2.664690826148548,1,0.5,0.5,transcript,24908.0
TXK,ENSG00000074966,multiple sclerosis,MONDO_0005301,0.2664659555951222,2.664688948265132,1,0.4,0.4,transcript,13609.0
PEAK1,ENSG00000173517,hemoglobin A1 measurement,EFO_0007629,0.266457551373084,2.66458243618208,1,0.4,0.4,transcript,57783.0
TLK1,ENSG00000198586,whole body water mass,EFO_0009805,0.2664366440200972,2.664380335361982,1,0.4,0.4,transcript,28787.0
SKIL,ENSG00000136603,triglyceride measurement,EFO_0004530,0.2663759546690502,2.663776006512077,1,0.5,0.5,transcript,30377.0
PSD3,ENSG00000156011,polygenic risk score,EFO_0030082,0.26634543461320115,2.663463789225569,1,0.4,0.4,transcript,42359.0
SYCP1,ENSG00000198765,neurodegenerative disease,EFO_0005772,0.2662937887315718,2.662959015564186,1,0.4,0.4,transcript,18932.0
PFAS,ENSG00000178921,mean reticulocyte volume,EFO_0010701,0.2661557075706625,2.6615804020420573,1,0.4,0.4,transcript,17148.0
MTCH2,ENSG00000109919,alkaline phosphatase measurement,EFO_0004533,0.2661207149708281,2.661266602740386,1,0.4,0.4,transcript,6728.0
RCN2,ENSG00000117906,urate measurement,EFO_0004531,0.2661117466171223,2.6611447811124957,1,0.4,0.4,transcript,14644.0
PIGN,ENSG00000197563,Abnormal brain morphology,HP_0012443,0.26609749537298527,2.6609774935575254,1,0.4,0.4,transcript,157491.0
ANO6,ENSG00000177119,congenital hydrocephalus,MONDO_0016349,0.26609749537298527,2.660982374880131,1,0.4,0.4,transcript,53900.0
INF2,ENSG00000203485,hypertension,EFO_0000537,0.26609749537298527,2.6609780166107986,1,0.4,0.4,transcript,130596.0
KLHL3,ENSG00000146021,cerebral palsy,EFO_1000632,0.26609749537298527,2.6610222644131967,2,0.8,1.6,transcript,33819.0
INF2,ENSG00000203485,hypertensive disorder,MONDO_0005044,0.26609749537298527,2.6609780166107986,1,0.4,0.4,transcript,130596.0
CERKL,ENSG00000188452,Adult-onset night blindness,HP_0007830,0.26609749537298527,2.660995027601701,1,0.5,0.5,transcript,24908.0
ANO6,ENSG00000177119,Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies,Orphanet_352687,0.26609749537298527,2.660982374880131,1,0.4,0.4,transcript,53900.0
SLC44A1,ENSG00000070214,Neurodevelopmental disorder,EFO_0010642,0.26609749537298527,2.6609845626469277,1,0.4,0.4,transcript,41628.0
ATP5F1A,ENSG00000152234,lactic acidosis,EFO_1000036,0.26609749537298527,2.66098875444749,1,0.4,0.4,transcript,28984.0
SGCB,ENSG00000163069,sialidosis,MONDO_0017734,0.26609749537298527,2.6610475490111596,1,0.4,0.4,transcript,5510.0
UHMK1,ENSG00000152332,Rare genetic intellectual disability with developmental anomaly,Orphanet_183763,0.26609749537298527,2.6611015716251822,3,1.2000000000000002,3.6000000000000005,transcript,28432.0
SPATA22,ENSG00000141255,Abnormality of metabolism/homeostasis,HP_0001939,0.26609749537298527,2.661008626031018,1,0.5,0.5,transcript,14849.0
HECW2,ENSG00000138411,Abnormality of the nervous system,HP_0000707,0.26609749537298527,2.6609807698813053,1,0.4,0.4,transcript,68774.0
PEX7,ENSG00000112357,Abnormality of metabolism/homeostasis,HP_0001939,0.26609749537298527,2.6610174978693975,1,0.4,0.4,transcript,9402.0
SLC5A7,ENSG00000115665,Charcot-Marie-Tooth disease type 2,MONDO_0018993,0.26609749537298527,2.6610305170025295,1,0.4,0.4,transcript,7199.0
ANOS1,ENSG00000011201,Delayed puberty,HP_0000823,0.26609749537298527,2.6610264602969402,1,0.4,0.4,transcript,7766.0
FYCO1,ENSG00000163820,Abnormality of the eye,HP_0000478,0.26609749537298527,2.660999564570928,1,0.4,0.4,transcript,16253.0
SAMD9L,ENSG00000177409,Intellectual disability,HP_0001249,0.26609749537298527,2.6609834066365963,1,0.4,0.4,transcript,47321.0
UNC80,ENSG00000144406,Moderate global developmental delay,HP_0011343,0.26609749537298527,2.6609796157345147,1,0.4,0.4,transcript,85800.0
TRIT1,ENSG00000043514,Epileptic encephalopathy,HP_0200134,0.26609749537298527,2.6609901564967564,1,0.4,0.4,transcript,26311.0
TRIT1,ENSG00000043514,Macrocephaly,HP_0000256,0.26609749537298527,2.6609901564967564,1,0.4,0.4,transcript,26311.0
VWDE,ENSG00000146530,optic atrophy 12,MONDO_0033549,0.26609749537298527,2.661001576380404,1,0.5,0.5,transcript,18781.0
SLC25A16,ENSG00000122912,Rare genetic intellectual disability with developmental anomaly,Orphanet_183763,0.26609749537298527,2.6610059903530683,1,0.4,0.4,transcript,12888.0
NCKAP1,ENSG00000061676,immunodeficiency 72 with autoinflammation,MONDO_0033551,0.26609749537298527,2.6609847829472013,1,0.4,0.4,transcript,40695.0
CPPED1,ENSG00000103381,high density lipoprotein cholesterol measurement,EFO_0004612,0.2660668422215899,2.6607061509463272,1,0.4,0.4,transcript,10602.0
FGFR1OP2,ENSG00000111790,breast adenocarcinoma,EFO_0000304,0.26596950679462733,2.6597312016409433,1,0.4,0.4,transcript,11070.0
PSD3,ENSG00000156011,non-Hodgkins lymphoma,EFO_0005952,0.26591144838523856,2.659123926945943,1,0.4,0.4,transcript,42359.0
IL17A,ENSG00000112115,metabolite measurement,EFO_0004725,0.26581247901188915,2.6583385795363155,1,0.4,0.4,transcript,1871.0
CPB1,ENSG00000153002,arterial stiffness measurement,EFO_0004517,0.26581247901188915,2.6581703689703047,1,0.5,0.5,transcript,10970.0
CFAP46,ENSG00000171811,placenta praevia,EFO_0007442,0.26581247901188915,2.65814615033762,1,0.5,0.5,transcript,23408.0
HPF1,ENSG00000056050,serum creatinine amount,OBA_2050096,0.26578069580113056,2.658028884331767,1,0.5,0.5,transcript,2253.0
DUSP22,ENSG00000112679,dermatomycosis,MONDO_0002040,0.2657783797598926,2.6578074019893423,1,0.4,0.4,transcript,16946.0
SENP6,ENSG00000112701,age at menarche,EFO_0004703,0.26571488907020646,2.6575779078627506,5,2.2,11.0,transcript,25640.0
HFM1,ENSG00000162669,wellbeing measurement,EFO_0007869,0.26567039386765684,2.6568337750826965,2,1.0,2.0,transcript,15404.0
DOCK1,ENSG00000150760,endometrial cancer,MONDO_0011962,0.26565605276877857,2.6565856154951115,1,0.4,0.4,transcript,15944.0
SAXO1,ENSG00000155875,body height,OBA_VT0001253,0.26563831898936163,2.6564098654521358,1,0.4,0.4,transcript,14995.0
RBM25,ENSG00000119707,neuroticism measurement,EFO_0007660,0.26563360606704867,2.656348750623217,1,0.4,0.4,transcript,31521.0
SMC6,ENSG00000163029,"chromosome, telomeric region length",OBA_0003784,0.265578277431092,2.655799183894117,1,0.4,0.4,transcript,24376.0
SCARA3,ENSG00000168077,adolescent idiopathic scoliosis,EFO_0005423,0.2655289549401427,2.6553597617939144,1,0.4,0.4,transcript,5697.0
CCDC66,ENSG00000180376,sexual dimorphism measurement,EFO_0021796,0.2655033017401912,2.6550482469106083,1,0.5,0.5,transcript,32831.0
DUSP22,ENSG00000112679,free cholesterol:total lipids ratio,EFO_0020945,0.265493119945617,2.654954803846586,1,0.4,0.4,transcript,16946.0
DUSP22,ENSG00000112679,high density lipoprotein cholesterol measurement,EFO_0004612,0.265493119945617,2.654954803846586,1,0.4,0.4,transcript,16946.0
RAD23B,ENSG00000119318,response to paracetamol,GO_1901554,0.265493119945617,2.654971473318433,1,0.4,0.4,transcript,9932.0
ARHGAP20,ENSG00000137727,erythrocyte volume,OBA_0003460,0.2654835518138238,2.6548457627278146,1,0.4,0.4,transcript,39045.0
TMEM132B,ENSG00000139364,corneal degeneration,MONDO_0001515,0.26543750790775705,2.6544644423641537,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
RGS4,ENSG00000117152,monocyte count,EFO_0005091,0.2652861993390031,2.6529582629447845,2,0.8,1.6,transcript,16620.0
DOCK1,ENSG00000150760,breast adenocarcinoma,EFO_0000304,0.2652485389532065,2.6525104773393906,1,0.4,0.4,transcript,15944.0
RPAP3,ENSG00000005175,eosinophil count,EFO_0004842,0.2652239482109196,2.652387850061718,2,0.8,1.6,transcript,10784.0
SAXO1,ENSG00000155875,type 2 diabetes mellitus,MONDO_0005148,0.26513681844920156,2.651394860050535,1,0.4,0.4,transcript,14995.0
ZNF485,ENSG00000198298,myocardial infarction,EFO_0000612,0.2649734054760337,2.6498313878341158,1,0.5,0.5,transcript,5137.0
LIMA1,ENSG00000050405,glomerular filtration rate,OBA_0003747,0.2649444412237529,2.6494578166140577,1,0.4,0.4,transcript,29841.0
SENP6,ENSG00000112701,hip geometry,EFO_0004685,0.264937546344779,2.649804480608476,5,2.2,11.0,transcript,25640.0
SRGN,ENSG00000122862,basophil count,EFO_0005090,0.26493749913384407,2.649498371967682,1,0.4,0.4,transcript,3242.0
SI,ENSG00000090402,age of onset of alcohol dependence,OBA_2001016,0.2648955757860356,2.6490278039698665,1,0.5,0.5,transcript,6940.0
LRPAP1,ENSG00000163956,Cleft palate,HP_0000175,0.2648587981718497,2.648818617889937,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
SPART,ENSG00000133104,retinopathy,EFO_0003839,0.2648476315928479,2.6484905812637143,1,0.4,0.4,transcript,28040.0
SPART,ENSG00000133104,retinoschisis,MONDO_0004579,0.2648476315928479,2.6484905812637143,1,0.4,0.4,transcript,28040.0
CASQ2,ENSG00000118729,level of lysophosphatidic acid phosphatase type 6 in blood serum,OBA_2040483,0.26484579145843434,2.6484705656059133,1,0.4,0.4,transcript,31618.0
RAD23B,ENSG00000119318,mean corpuscular hemoglobin concentration,EFO_0004528,0.26484019132192,2.6484421870814634,1,0.4,0.4,transcript,9932.0
RPRD2,ENSG00000163125,bone tissue density,OBA_1000110,0.26476607178231715,2.6476792243467213,1,0.4,0.4,transcript,21614.0
RPAP3,ENSG00000005175,cup-to-disc ratio measurement,EFO_0006939,0.26469115057361764,2.6470598736886983,2,0.8,1.6,transcript,10784.0
NBEAL1,ENSG00000144426,coronary atherosclerosis,MONDO_0021661,0.26460844015284507,2.646088255130123,1,0.4,0.4,transcript,103799.0
PHC1,ENSG00000111752,breast adenocarcinoma,EFO_0000304,0.2645560149420902,2.645579299905409,1,0.5,0.5,transcript,26109.0
FAM8A1,ENSG00000137414,heart rate,OBA_1001087,0.26455183577903874,2.6455375996606976,1,0.4,0.4,transcript,20788.0
GMCL1,ENSG00000087338,platelet volume,OBA_0003277,0.26449272660065637,2.6451816784727744,2,0.8,1.6,transcript,6289.0
CASQ2,ENSG00000118729,QRS complex,EFO_0005054,0.2644923583637184,2.644936234658754,1,0.4,0.4,transcript,31618.0
SAMD11,ENSG00000187634,cystatin B measurement,EFO_0010593,0.2644898593676722,2.6449614225465883,2,0.8,1.6,transcript,25466.0
TLK1,ENSG00000198586,immature platelet measurement,EFO_0803541,0.2644192516669932,2.6442064118309423,1,0.4,0.4,transcript,28787.0
OTULIN,ENSG00000154124,deep vein thrombosis,EFO_0003907,0.264342932808124,2.643448562549407,1,0.4,0.4,transcript,20796.0
ZNF675,ENSG00000197372,brain attribute,OBA_2045210,0.264342932808124,2.6434721253079796,1,0.5,0.5,transcript,11683.0
ZNF675,ENSG00000197372,cerebral cortex area attribute,OBA_2045267,0.264342932808124,2.6434721253079796,1,0.5,0.5,transcript,11683.0
FARSB,ENSG00000116120,alcohol consumption quality,OBA_1000840,0.2643303140432792,2.643354160840955,1,0.4,0.4,transcript,7840.0
FAM102B,ENSG00000162636,platelet volume,OBA_0003277,0.2642262436663411,2.642288239785589,1,0.4,0.4,transcript,15502.0
RALGPS2,ENSG00000116191,body weight,EFO_0004338,0.26422537261737156,2.6423332608955925,2,0.8,1.6,transcript,20117.0
YTHDC2,ENSG00000047188,ovarian neoplasm,EFO_0003893,0.26419930990252455,2.642013308190102,1,0.4,0.4,transcript,19793.0
GPR158,ENSG00000151025,body weight,EFO_0004338,0.26415648857264257,2.6415905570310416,1,0.5,0.5,transcript,19477.0
NAF1,ENSG00000145414,rheumatoid arthritis,EFO_0000685,0.26415243879065514,2.641586338098597,1,0.5,0.5,transcript,8071.0
PCDH10,ENSG00000138650,Paroxysmal supraventricular tachycardia,HP_0004763,0.26415243879065514,2.6416382507018827,2,0.8,1.6,transcript,14052.0
PAG1,ENSG00000076641,spondylolisthesis,EFO_0007493,0.26409600206937306,2.641090112571119,2,0.8,1.6,transcript,12299.0
CPPED1,ENSG00000103381,cortisol measurement,EFO_0005843,0.26409600206937306,2.6409977494241588,1,0.4,0.4,transcript,10602.0
VPS50,ENSG00000004766,platelet count,EFO_0004309,0.26407316867933234,2.6407428487533635,1,0.4,0.4,transcript,35836.0
ARL3,ENSG00000138175,sialolithiasis,EFO_1001180,0.26405898371290404,2.640694166810835,1,0.4,0.4,transcript,3834.0
CCDC34,ENSG00000109881,blood sodium bicarbonate amount,OBA_2050094,0.26405056181838976,2.6405991416816765,1,0.4,0.4,transcript,4277.0
ATP12A,ENSG00000075673,X-17325 measurement,EFO_0800771,0.26401445523295497,2.640193704455379,1,0.4,0.4,transcript,8138.0
ZNF681,ENSG00000196172,wellbeing measurement,EFO_0007869,0.26397935959309193,2.6403425437808736,3,1.4000000000000001,4.2,transcript,7651.0
XKR4,ENSG00000206579,alcohol consumption quality,OBA_1000840,0.263962128355822,2.6396402355150097,1,0.4,0.4,transcript,21106.0
EXOC6,ENSG00000138190,ovarian neoplasm,EFO_0003893,0.2639374792626255,2.639397409896803,1,0.5,0.5,transcript,22107.0
ADAT2,ENSG00000189007,pulse pressure measurement,EFO_0005763,0.2639333609737126,2.639363418217639,1,0.4,0.4,transcript,13419.0
NAF1,ENSG00000145414,response to exercise,EFO_0007768,0.2639213829020055,2.6392757792121007,1,0.5,0.5,transcript,8071.0
ARHGAP20,ENSG00000137727,ovarian neoplasm,EFO_0003893,0.2639213829020055,2.6392240736096313,1,0.4,0.4,transcript,39045.0
ARHGAP20,ENSG00000137727,pulse pressure measurement,EFO_0005763,0.2639213829020055,2.6392240736096313,1,0.4,0.4,transcript,39045.0
PTCHD4,ENSG00000244694,placenta praevia,EFO_0007442,0.2639213829020055,2.6396276696913965,6,2.4000000000000004,14.400000000000002,transcript,34796.0
FSIP2,ENSG00000188738,erythrocyte count,EFO_0004305,0.2639213829020055,2.639492769047949,4,2.0,8.0,transcript,28680.0
HS3ST3A1,ENSG00000153976,succinate measurement,EFO_0011002,0.2639213829020055,2.6392948662972024,1,0.4,0.4,transcript,4936.0
MDGA2,ENSG00000139915,multinodular goiter,MONDO_0000334,0.2639213829020055,2.639236919708735,1,0.4,0.4,transcript,17323.0
CDH19,ENSG00000071991,cinnamoylglycine measurement,EFO_0800962,0.2639213829020055,2.6394883866771632,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
NAF1,ENSG00000145414,TPE interval measurement,EFO_0004644,0.2639213829020055,2.6392757792121007,1,0.5,0.5,transcript,8071.0
DOCK1,ENSG00000150760,lymphocyte count,EFO_0004587,0.2639213829020055,2.639238916827381,1,0.4,0.4,transcript,15944.0
ZNF33B,ENSG00000196693,4-acetamidobenzoate measurement,EFO_0801014,0.263906063142804,2.639091756926048,1,0.5,0.5,transcript,16064.0
DCK,ENSG00000156136,hypertrophic cardiomyopathy,EFO_0000538,0.2638703781717783,2.638740767385836,1,0.4,0.4,transcript,10815.0
METTL25,ENSG00000127720,serum creatinine amount,OBA_2050096,0.2638455615787744,2.6385075638396924,1,0.5,0.5,transcript,9625.0
CNTN1,ENSG00000018236,Crohn's disease,EFO_0000384,0.2638432811681531,2.638449338558364,1,0.4,0.4,transcript,24203.0
ORMDL1,ENSG00000128699,appendicular lean mass,EFO_0004980,0.2637616628273012,2.6377437031677777,2,0.8,1.6,transcript,12591.0
CCDC127,ENSG00000164366,hippocampal CA3 volume,EFO_0009395,0.2636701251316338,2.6367418233824704,1,0.4,0.4,transcript,9859.0
BTAF1,ENSG00000095564,glucose measurement,EFO_0004468,0.26359974968171895,2.6360342412595927,1,0.4,0.4,transcript,10886.0
SLF1,ENSG00000133302,diabetes mellitus,EFO_0000400,0.263531036458164,2.6353452777351705,1,0.4,0.4,transcript,11457.0
U2SURP,ENSG00000163714,neurodegenerative disease,EFO_0005772,0.26350447083330636,2.63509511632273,2,0.8,1.6,transcript,31741.0
TLR10,ENSG00000174123,mean corpuscular hemoglobin,EFO_0004527,0.26348814342284493,2.635042876445589,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
HNRNPA0,ENSG00000177733,chloride measurement,EFO_0009284,0.2634535735408243,2.6345586896146016,1,0.4,0.4,transcript,17426.0
CNOT6L,ENSG00000138767,acute myeloid leukemia,EFO_0000222,0.2633991984518021,2.6341218733908742,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
GASK1B,ENSG00000164125,Herpes Zoster,EFO_0006510,0.26332194211380533,2.633392306889386,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
GASK1B,ENSG00000164125,nervous system disease,EFO_0000618,0.26332194211380533,2.633392306889386,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
SARAF,ENSG00000133872,Dupuytren Contracture,EFO_0004229,0.26332194211380533,2.633245874414953,1,0.4,0.4,transcript,15121.0
ATPSCKMT,ENSG00000150756,cornea transplantation,EFO_0010676,0.26332194211380533,2.6332671310617175,1,0.4,0.4,transcript,8384.0
CDV3,ENSG00000091527,total iron binding capacity,EFO_0006334,0.2633115787321037,2.6331419106230225,1,0.4,0.4,transcript,15312.0
CDV3,ENSG00000091527,iron biomarker measurement,EFO_0004461,0.2633115787321037,2.6331419106230225,1,0.4,0.4,transcript,15312.0
SNIP1,ENSG00000163877,monocyte count,EFO_0005091,0.26318078738663336,2.631853369771702,1,0.4,0.4,transcript,8792.0
KERA,ENSG00000139330,protein measurement,EFO_0004747,0.2631784432870635,2.6325107152128955,2,0.8,1.6,transcript,2203.0
MGA,ENSG00000174197,overnutrition,MONDO_0003916,0.2631381155436108,2.6313870772211705,1,0.5,0.5,transcript,84434.0
FGFR1OP2,ENSG00000111790,endometrial cancer,MONDO_0011962,0.2630689937859857,2.630726071554527,1,0.4,0.4,transcript,11070.0
AGO3,ENSG00000126070,squamous cell lung carcinoma,EFO_0000708,0.2630689937859857,2.630703103983421,1,0.4,0.4,transcript,30381.0
PIAS2,ENSG00000078043,endometrial cancer,MONDO_0011962,0.2630689937859857,2.6307033278775984,1,0.4,0.4,transcript,29873.0
DLG1,ENSG00000075711,thyroid gland adenocarcinoma,MONDO_0024622,0.2630689937859857,2.630705347631364,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
PHC1,ENSG00000111752,ovarian cancer,MONDO_0008170,0.2630689937859857,2.630709088344364,1,0.5,0.5,transcript,26109.0
ANKRD36,ENSG00000135976,body weight,EFO_0004338,0.26295188339589864,2.629594220314056,2,1.0,2.0,transcript,26530.0
SLCO6A1,ENSG00000205359,Respiratory insufficiency,HP_0002093,0.26293614997478,2.6294027538732125,1,0.5,0.5,transcript,12120.0
CLSTN2,ENSG00000158258,pericarditis,EFO_0007427,0.26293614997478,2.6293855859764985,1,0.4,0.4,transcript,16607.0
CLSTN2,ENSG00000158258,inflammation of heart layer,MONDO_0024636,0.26293614997478,2.6293855859764985,1,0.4,0.4,transcript,16607.0
MYO3A,ENSG00000095777,glutamine measurement,EFO_0009768,0.26293614997478,2.629385215537773,1,0.5,0.5,transcript,21083.0
USP37,ENSG00000135913,free cholesterol to total lipids in medium LDL percentage ,EFO_0022283,0.2629054790777725,2.6291944176636575,3,1.2000000000000002,3.6000000000000005,transcript,25783.0
LMNTD1,ENSG00000152936,"1,5 anhydroglucitol measurement",EFO_0008009,0.2628780801509638,2.628935467259767,2,0.9,1.8,transcript,11638.0
STAM,ENSG00000136738,lung adenocarcinoma,EFO_0000571,0.2628547137756473,2.628613133466752,1,0.4,0.4,transcript,6061.0
DOCK1,ENSG00000150760,glioblastoma multiforme,EFO_0000519,0.2628395091776308,2.628420179583634,1,0.4,0.4,transcript,15944.0
SEC63,ENSG00000025796,Abruptio Placentae,EFO_1001754,0.26282815422827455,2.6285570665441873,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
NRK,ENSG00000123572,whole body water mass,EFO_0009805,0.2628265431220412,2.6282906487213573,1,0.4,0.4,transcript,15862.0
RBM25,ENSG00000119707,self reported educational attainment,EFO_0004784,0.2628250807135584,2.628263497088314,1,0.4,0.4,transcript,31521.0
LRRIQ3,ENSG00000162620,platelet count,EFO_0004309,0.26280379746263094,2.6280648708070515,1,0.5,0.5,transcript,18590.0
CPPED1,ENSG00000103381,tympanic membrane disease,EFO_0009570,0.26280210066194476,2.628058735349876,1,0.4,0.4,transcript,10602.0
GLCE,ENSG00000138604,immune system disease,EFO_0000540,0.26279886127798785,2.6281189377778422,2,0.8,1.6,transcript,12277.0
IL1A,ENSG00000115008,quality of life,OBA_2045261,0.2627689438017695,2.6278877523459054,1,0.4,0.4,transcript,2017.0
SLC7A2,ENSG00000003989,neurodegenerative disease,EFO_0005772,0.2627642132257844,2.627763127878955,3,1.4,4.199999999999999,transcript,34712.0
RIF1,ENSG00000080345,thyroid stimulating hormone amount,OBA_1000983,0.262762997420399,2.627691517521017,3,1.3,3.9000000000000004,transcript,63370.0
TLR10,ENSG00000174123,sialadenitis,EFO_1001179,0.26274503881691363,2.627611830386276,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
TRAM1,ENSG00000067167,bone quantitative ultrasound measurement,EFO_0004514,0.26273397700178447,2.6275302688867574,2,0.8,1.6,transcript,8399.0
METTL25,ENSG00000127720,body mass index,EFO_0004340,0.2627290887271565,2.627342835323513,1,0.5,0.5,transcript,9625.0
IL1A,ENSG00000115008,colorectal adenocarcinoma,EFO_0000365,0.262726272066897,2.6274610349971805,1,0.4,0.4,transcript,2017.0
LDLRAP1,ENSG00000157978,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.2627078175625525,2.627104089074605,1,0.4,0.4,transcript,15436.0
PEX13,ENSG00000162928,erythrocyte count,EFO_0004305,0.26264149160809525,2.6264607455951596,1,0.4,0.4,transcript,8728.0
SLAMF7,ENSG00000026751,neutrophil count,EFO_0004833,0.26261575168343765,2.626173713133522,1,0.4,0.4,transcript,24697.0
SLAMF7,ENSG00000026751,myeloid leukocyte count,OBA_2045223,0.26261575168343765,2.626173713133522,1,0.4,0.4,transcript,24697.0
METTL8,ENSG00000123600,hemiplegia,EFO_0009453,0.2626124943027983,2.6261369640647976,1,0.4,0.4,transcript,33275.0
KLHL31,ENSG00000124743,platelet component distribution width,EFO_0007984,0.2626105828637558,2.6261579051900905,1,0.4,0.4,transcript,7681.0
SLF1,ENSG00000133302,neuroticism measurement,EFO_0007660,0.26258408889397955,2.625875802093326,1,0.4,0.4,transcript,11457.0
OR4X1,ENSG00000176567,sex hormone-binding globulin measurement,EFO_0004696,0.2624658660761139,2.625203323070507,1,0.5,0.5,transcript,918.0
LHX9,ENSG00000143355,Phenotypic abnormality,HP_0000118,0.26244256007439914,2.624499867361147,2,0.8,1.6,transcript,21544.0
DCK,ENSG00000156136,Abruptio Placentae,EFO_1001754,0.26244256007439914,2.624462586412045,1,0.4,0.4,transcript,10815.0
CHFR,ENSG00000072609,neuroimaging measurement,EFO_0004346,0.262385891331614,2.6238670026220774,1,0.4,0.4,transcript,49448.0
LRRIQ3,ENSG00000162620,monocyte count,EFO_0005091,0.2623242243604428,2.6232691397851697,1,0.5,0.5,transcript,18590.0
COL19A1,ENSG00000082293,triglyceride measurement,EFO_0004530,0.2623055829657495,2.6231931687132892,2,0.8,1.6,transcript,11650.0
COL19A1,ENSG00000082293,mean corpuscular hemoglobin concentration,EFO_0004528,0.2623055829657495,2.6231931687132892,2,0.8,1.6,transcript,11650.0
DTHD1,ENSG00000197057,cardiac arrest,EFO_0009492,0.2623055829657495,2.6230822302066263,1,0.5,0.5,transcript,18939.0
COL19A1,ENSG00000082293,growth differentiation factor 15 amount,OBA_2050135,0.2623055829657495,2.6231931687132892,2,0.8,1.6,transcript,11650.0
ATF7IP2,ENSG00000166669,response to stimulus,GO_0050896,0.26226770218617995,2.622693230893472,1,0.5,0.5,transcript,30847.0
GNA13,ENSG00000120063,ovarian dysfunction,EFO_0009003,0.26226770218617995,2.622728628106155,1,0.4,0.4,transcript,7751.0
ATF7IP2,ENSG00000166669,adverse effect,EFO_0009658,0.26226770218617995,2.622693230893472,1,0.5,0.5,transcript,30847.0
ATF7IP2,ENSG00000166669,lean body mass,EFO_0004995,0.26226770218617995,2.622693230893472,1,0.5,0.5,transcript,30847.0
MAP4K3,ENSG00000011566,calcium measurement,EFO_0004838,0.26226323372650595,2.622655144882804,1,0.4,0.4,transcript,17538.0
LAMA1,ENSG00000101680,lung adenocarcinoma,EFO_0000571,0.26225189121672665,2.6225348073859847,1,0.5,0.5,transcript,31456.0
APIP,ENSG00000149089,FEV/FVC ratio,EFO_0004713,0.26216122837294475,2.621685053340858,1,0.5,0.5,transcript,6871.0
SEC63,ENSG00000025796,monocyte count,EFO_0005091,0.2620912497133478,2.62118802139492,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
U2SURP,ENSG00000163714,Hypercholesterolemia,HP_0003124,0.2620912497133478,2.6209629051231444,2,0.8,1.6,transcript,31741.0
SERPINB9,ENSG00000170542,mean corpuscular hemoglobin concentration,EFO_0004528,0.26209088482312826,2.6209565638462173,1,0.4,0.4,transcript,8383.0
PYHIN1,ENSG00000163564,platelet count,EFO_0004309,0.26209088482312826,2.620946605452351,1,0.4,0.4,transcript,10594.0
OTULINL,ENSG00000145569,multinodular goiter,MONDO_0000334,0.2620772686512123,2.6208226615246164,1,0.4,0.4,transcript,8004.0
SENP6,ENSG00000112701,cystatin C measurement,EFO_0004617,0.26202415347371605,2.6206705518978466,5,2.2,11.0,transcript,25640.0
ING1,ENSG00000153487,neurodegenerative disease,EFO_0005772,0.26198626423334653,2.619889125384313,1,0.4,0.4,transcript,15104.0
ADAT2,ENSG00000189007,aortic measurement,EFO_0020865,0.2619117846149527,2.6191476546300394,1,0.4,0.4,transcript,13419.0
WDR12,ENSG00000138442,low density lipoprotein cholesterol measurement,EFO_0004611,0.2618099459332169,2.618119398517653,1,0.4,0.4,transcript,20061.0
RALGPS2,ENSG00000116191,neurodegenerative disease,EFO_0005772,0.2618005695547607,2.618085230269484,2,0.8,1.6,transcript,20117.0
CNOT6L,ENSG00000138767,brain volume,OBA_2050009,0.2617897702145343,2.6180275910181963,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
LONRF1,ENSG00000154359,X-12063 measurement,EFO_0021283,0.2617826932531357,2.6178622258185738,1,0.5,0.5,transcript,14167.0
MTR,ENSG00000116984,epilepsy,EFO_0000474,0.26170873459860444,2.6170917584158593,1,0.4,0.4,transcript,90653.0
PLA2R1,ENSG00000153246,smoking initiation,EFO_0005670,0.26166778702701765,2.616757062509337,2,0.8,1.6,transcript,20204.0
GPRIN2,ENSG00000204175,growth differentiation factor 15 amount,OBA_2050135,0.2616306383467977,2.6174382758842976,7,3.0,21.0,transcript,18553.0
CCDC62,ENSG00000130783,Parkinson disease,MONDO_0005180,0.26158634907970996,2.6158904268240355,1,0.4,0.4,transcript,14850.0
RCOR3,ENSG00000117625,Polyarteritis Nodosa,EFO_0009012,0.26151893827806166,2.6152537380215466,2,0.8,1.6,transcript,24862.0
TXNL1,ENSG00000091164,"chromosome, telomeric region length",OBA_0003784,0.2614950005133637,2.615032203952029,2,0.8,1.6,transcript,19465.0
GASK1B,ENSG00000164125,bone remodeling disease,MONDO_0000833,0.2614950005133637,2.6151228908849697,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
NXPH2,ENSG00000144227,jaw disease,EFO_0009468,0.2614950005133637,2.6150976610952466,1,0.4,0.4,transcript,2709.0
TFEC,ENSG00000105967,systolic blood pressure,EFO_0006335,0.2614950005133637,2.614965702488633,1,0.4,0.4,transcript,25482.0
ST8SIA4,ENSG00000113532,sialolithiasis,EFO_1001180,0.2614950005133637,2.614992882183696,1,0.4,0.4,transcript,9329.0
MARCKS,ENSG00000277443,type 2 diabetes mellitus,MONDO_0005148,0.2614950005133637,2.6150431150032833,1,0.4,0.4,transcript,4296.0
ZPLD1,ENSG00000170044,orchitis,EFO_1001078,0.2614950005133637,2.6151089876455607,2,0.8,1.6,transcript,10064.0
TFEC,ENSG00000105967,ovarian dysfunction,EFO_0009003,0.2614950005133637,2.614965702488633,1,0.4,0.4,transcript,25482.0
FAM98A,ENSG00000119812,purulent endophthalmitis,MONDO_0004863,0.2614950005133637,2.614957358345152,1,0.4,0.4,transcript,54398.0
MED10,ENSG00000133398,growth differentiation factor 15 amount,OBA_2050135,0.2614950005133637,2.615099593764901,1,0.4,0.4,transcript,2674.0
ZPLD1,ENSG00000170044,Epididymitis,HP_0000031,0.2614950005133637,2.6151089876455607,2,0.8,1.6,transcript,10064.0
NAF1,ENSG00000145414,placenta praevia,EFO_0007442,0.2614950005133637,2.6150119553256825,1,0.5,0.5,transcript,8071.0
SLCO5A1,ENSG00000137571,placenta praevia,EFO_0007442,0.26148632962583374,2.61529384822596,5,2.0,10.0,transcript,23226.0
ANKRD30B,ENSG00000180777,urate measurement,EFO_0004531,0.26148632962583374,2.614887862661325,1,0.5,0.5,transcript,20353.0
SLC30A9,ENSG00000014824,attention deficit hyperactivity disorder,EFO_0003888,0.26148416311544653,2.6151933944808836,3,1.3,3.9000000000000004,transcript,11087.0
SLC30A9,ENSG00000014824,Tourette syndrome,EFO_0004895,0.26148416311544653,2.6151933944808836,3,1.3,3.9000000000000004,transcript,11087.0
SLC30A9,ENSG00000014824,anorexia nervosa,MONDO_0005351,0.26148416311544653,2.6151933944808836,3,1.3,3.9000000000000004,transcript,11087.0
SLC30A9,ENSG00000014824,obsessive-compulsive disorder,EFO_0004242,0.26148416311544653,2.6151933944808836,3,1.3,3.9000000000000004,transcript,11087.0
SLC30A9,ENSG00000014824,schizophrenia,MONDO_0005090,0.26148416311544653,2.6151933944808836,3,1.3,3.9000000000000004,transcript,11087.0
TLR10,ENSG00000174123,interleukin-6 measurement,EFO_0004810,0.2614083223538304,2.6142446657554435,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
ATG16L1,ENSG00000085978,type 2 diabetes mellitus,MONDO_0005148,0.26133735247350953,2.6133855162211406,1,0.4,0.4,transcript,33357.0
MGA,ENSG00000174197,morbid obesity,EFO_0001074,0.2612544372515047,2.6125502943001098,1,0.5,0.5,transcript,84434.0
TRIM44,ENSG00000166326,neurodegenerative disease,EFO_0005772,0.26121272642413124,2.6121566091169637,1,0.4,0.4,transcript,13631.0
PEAK1,ENSG00000173517,age at menarche,EFO_0004703,0.26116416381147545,2.6116485605659943,1,0.4,0.4,transcript,57783.0
GUF1,ENSG00000151806,C-reactive protein measurement,EFO_0004458,0.26099835901601187,2.6100255118504014,1,0.5,0.5,transcript,11927.0
NBEAL1,ENSG00000144426,von Willebrand factor quality,OBA_1000199,0.260995406345481,2.609957917056483,1,0.4,0.4,transcript,103799.0
NBEAL1,ENSG00000144426,factor XI measurement,EFO_0004694,0.260995406345481,2.609957917056483,1,0.4,0.4,transcript,103799.0
NBEAL1,ENSG00000144426,factor VIII measurement,EFO_0004630,0.260995406345481,2.609957917056483,1,0.4,0.4,transcript,103799.0
NBEAL1,ENSG00000144426,factor VII measurement,EFO_0004619,0.260995406345481,2.609957917056483,1,0.4,0.4,transcript,103799.0
LNPEP,ENSG00000113441,lymphocyte percentage of leukocytes,EFO_0007993,0.260958522267814,2.6096058849024284,1,0.4,0.4,transcript,19359.0
PLEKHA6,ENSG00000143850,diverticular disease,EFO_0009959,0.26094255320959087,2.6094323467542386,1,0.4,0.4,transcript,58697.0
MC2R,ENSG00000185231,nephrotic syndrome,EFO_0004255,0.26092337740739946,2.6093283814533703,1,0.4,0.4,transcript,4228.0
KERA,ENSG00000139330,cutaneous melanoma,EFO_0000389,0.2609075625707672,2.6098019080499326,2,0.8,1.6,transcript,2203.0
SPART,ENSG00000133104,Global developmental delay,HP_0001263,0.26084638160434015,2.6084780813786366,1,0.4,0.4,transcript,28040.0
MANSC4,ENSG00000205693,potassium measurement,EFO_0009283,0.26084428303160234,2.608742770328021,1,0.5,0.5,transcript,1667.0
TPRG1,ENSG00000188001,muscular disease,EFO_0002970,0.2607967454459408,2.608067310915752,2,0.8,1.6,transcript,16023.0
ZNF697,ENSG00000143067,growth differentiation factor 15 amount,OBA_2050135,0.26077877856293674,2.6084330625607173,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
CPO,ENSG00000144410,neuroimaging measurement,EFO_0004346,0.2607616305177792,2.6080179116034943,1,0.5,0.5,transcript,1245.0
CHL1,ENSG00000134121,contactin-4 measurement,EFO_0020287,0.26074137457568497,2.6074609461816536,2,0.8,1.6,transcript,33898.0
PPP1R2,ENSG00000184203,neuroinflammatory disorder,EFO_0020092,0.2606883002229053,2.6069294868310284,1,0.4,0.4,transcript,8605.0
TMEM236,ENSG00000148483,neurodegenerative disease,EFO_0005772,0.26068829862673143,2.607173104127695,2,0.8,1.6,transcript,5515.0
C15orf61,ENSG00000189227,neuroimaging measurement,EFO_0004346,0.2606251657821957,2.6078731917930935,5,2.0,10.0,transcript,6167.0
PDHX,ENSG00000110435,pyruvate dehydrogenase E1-alpha deficiency,MONDO_0010717,0.26055379755271474,2.605582743294355,1,0.4,0.4,transcript,8935.0
APIP,ENSG00000149089,CC16 measurement,EFO_0005080,0.2605459753587068,2.6055325231984785,1,0.5,0.5,transcript,6871.0
PHC1,ENSG00000111752,Primary microcephaly,HP_0011451,0.2605204327047224,2.605223477531731,1,0.5,0.5,transcript,26109.0
KLHL31,ENSG00000124743,systolic blood pressure,EFO_0006335,0.2604989031373519,2.605041107926051,1,0.4,0.4,transcript,7681.0
CLDN16,ENSG00000113946,nephrolithiasis,EFO_0004253,0.2604539051881933,2.6046394282934764,1,0.4,0.4,transcript,3985.0
ZNF85,ENSG00000105750,bone tissue density,OBA_1000110,0.2603356297528607,2.603469426810236,2,0.9,1.8,transcript,15911.0
KLHL3,ENSG00000146021,heart rate variability measurement,EFO_0008003,0.26026235672298775,2.6026708779132215,2,0.8,1.6,transcript,33819.0
GKAP1,ENSG00000165113,triglyceride measurement,EFO_0004530,0.2602567010407614,2.6026241369428895,1,0.4,0.4,transcript,7002.0
RNF150,ENSG00000170153,triglyceride measurement,EFO_0004530,0.2602265158262337,2.6025238172770075,4,1.6,6.4,transcript,24743.0
ORMDL1,ENSG00000128699,neuroimaging measurement,EFO_0004346,0.2602186319076687,2.602313393971453,2,0.8,1.6,transcript,12591.0
GKAP1,ENSG00000165113,Alzheimer disease,MONDO_0004975,0.2602168834441574,2.6022259609768494,1,0.4,0.4,transcript,7002.0
DENND3,ENSG00000105339,color vision disorder,MONDO_0001703,0.26019867145327485,2.6019975311904013,1,0.5,0.5,transcript,46225.0
NOM1,ENSG00000146909,neurodegenerative disease,EFO_0005772,0.2601218237110675,2.60209960499363,5,2.0,10.0,transcript,11346.0
RASSF2,ENSG00000101265,Vertigo,HP_0002321,0.2600344000310648,2.600444800411448,2,0.8,1.6,transcript,15873.0
RNF150,ENSG00000170153,platelet crit,EFO_0007985,0.25996412283953907,2.5998998874100616,4,1.6,6.4,transcript,24743.0
CYSLTR1,ENSG00000173198,ovarian cancer,MONDO_0008170,0.25993921639007433,2.5995823005614684,2,0.8,1.6,transcript,8415.0
ABCB1,ENSG00000085563,generalised epilepsy,EFO_0005917,0.25981463784334535,2.598170426144111,1,0.5,0.5,transcript,20792.0
FZD3,ENSG00000104290,Hydrocephalus,HP_0000238,0.25981463784334535,2.598160495250111,1,0.4,0.4,transcript,28335.0
WAPL,ENSG00000062650,hypertension,EFO_0000537,0.2598012595562671,2.5981463524595108,2,0.8,1.6,transcript,11962.0
DUSP22,ENSG00000112679,Takayasu arteritis,EFO_1001857,0.25979922921747367,2.598015896565153,1,0.4,0.4,transcript,16946.0
TMEM154,ENSG00000170006,protein measurement,EFO_0004747,0.2597418335994492,2.597437420874496,1,0.4,0.4,transcript,20959.0
PHC1,ENSG00000111752,Intellectual disability,HP_0001249,0.25972224287967416,2.5972415792812487,1,0.5,0.5,transcript,26109.0
MC2R,ENSG00000185231,focal segmental glomerulosclerosis,EFO_0004236,0.25962984791600296,2.5963930865394054,1,0.4,0.4,transcript,4228.0
SLC9B1,ENSG00000164037,hypertension,EFO_0000537,0.25955003003098026,2.59554527242709,1,0.5,0.5,transcript,11118.0
FARSB,ENSG00000116120,aging rate,OBA_0005494,0.25954823454880527,2.595533365896216,1,0.4,0.4,transcript,7840.0
RPRD2,ENSG00000163125,basophil count,EFO_0005090,0.25954321424206145,2.595450648944164,1,0.4,0.4,transcript,21614.0
ARHGAP29,ENSG00000137962,Hepatitis,HP_0012115,0.25954156470735146,2.5954358727925393,1,0.5,0.5,transcript,24721.0
HTR1F,ENSG00000179097,anxiety,EFO_0005230,0.2595161476374662,2.595279609865507,1,0.4,0.4,transcript,3386.0
HTR1F,ENSG00000179097,depressive disorder,MONDO_0002050,0.2594880729773031,2.5949988632638754,1,0.4,0.4,transcript,3386.0
ABCB1,ENSG00000085563,myeloproliferative disorder,EFO_0004251,0.25939372745328776,2.5939613222435356,1,0.5,0.5,transcript,20792.0
ATP10D,ENSG00000145246,phosphatidylcholine measurement,EFO_0010226,0.2593701993540408,2.593733816350999,1,0.5,0.5,transcript,15712.0
MGA,ENSG00000174197,multiple myeloma,EFO_0001378,0.2592602680613183,2.5926086023982458,1,0.5,0.5,transcript,84434.0
RAB40B,ENSG00000141542,skin disease,EFO_0000701,0.25923497988562827,2.5923781857699155,1,0.4,0.4,transcript,14091.0
GUF1,ENSG00000151806,body mass index,EFO_0004340,0.2592311788656872,2.5923537103471546,1,0.5,0.5,transcript,11927.0
FAM210A,ENSG00000177150,lymphocyte count,EFO_0004587,0.25916957834687687,2.5917179294105246,1,0.4,0.4,transcript,18062.0
IGFBPL1,ENSG00000137142,aseptic loosening,EFO_0010725,0.25910300584935253,2.592824786480065,4,1.6,6.4,transcript,3566.0
IGFBPL1,ENSG00000137142,revision of total joint arthroplasty,EFO_0020974,0.25910300584935253,2.592824786480065,4,1.6,6.4,transcript,3566.0
ATF7IP2,ENSG00000166669,Tietze syndrome,MONDO_0001858,0.25910300584935253,2.591046267525198,1,0.5,0.5,transcript,30847.0
AHCTF1,ENSG00000153207,premature birth,EFO_0003917,0.2590944337906595,2.590957604376918,1,0.5,0.5,transcript,37689.0
FZD6,ENSG00000164930,Abruptio Placentae,EFO_1001754,0.2590944337906595,2.5910242300521986,2,0.8,1.6,transcript,20027.0
SMC3,ENSG00000108055,autism spectrum disorder,EFO_0003756,0.25907547813397597,2.5907633938623675,1,0.4,0.4,transcript,46444.0
NOM1,ENSG00000146909,metabolite measurement,EFO_0004725,0.2590593920893922,2.5914752887768766,5,2.0,10.0,transcript,11346.0
SARAF,ENSG00000133872,serum creatinine amount,OBA_2050096,0.2590593920893922,2.590620374170822,1,0.4,0.4,transcript,15121.0
RIF1,ENSG00000080345,muscle measurement,EFO_0004515,0.2590134822171595,2.5901963654886218,3,1.3,3.9000000000000004,transcript,63370.0
GKAP1,ENSG00000165113,lysosomal storage disease,MONDO_0002561,0.2589869041993594,2.5899261685288693,1,0.4,0.4,transcript,7002.0
GKAP1,ENSG00000165113,Parkinson disease,MONDO_0005180,0.2589869041993594,2.5899261685288693,1,0.4,0.4,transcript,7002.0
CYTIP,ENSG00000115165,neurodegenerative disease,EFO_0005772,0.2589721188420382,2.5897489758465717,1,0.4,0.4,gene_variant,14395.0
CNR2,ENSG00000188822,level of serum globulin type protein,OBA_2045206,0.2589160580546351,2.5892365539556574,1,0.4,0.4,transcript,5265.0
TWSG1,ENSG00000128791,erythrocyte count,EFO_0004305,0.2589103074920677,2.589158785227084,1,0.4,0.4,transcript,7180.0
MDGA2,ENSG00000139915,body weight,EFO_0004338,0.25889893095736494,2.589012400262329,1,0.4,0.4,transcript,17323.0
NMRK1,ENSG00000106733,protein measurement,EFO_0004747,0.2588891451889312,2.5889374236166995,1,0.4,0.4,transcript,8701.0
SLAMF7,ENSG00000026751,monocyte count,EFO_0005091,0.2588403239421346,2.5884194357204917,1,0.4,0.4,transcript,24697.0
AKAP10,ENSG00000108599,systolic blood pressure,EFO_0006335,0.2588011517008383,2.588046697307415,1,0.4,0.4,transcript,11370.0
TMEM131,ENSG00000075568,hypothyroidism,EFO_0004705,0.2587215747811592,2.587237196682845,1,0.4,0.4,transcript,18649.0
RPS20,ENSG00000008988,qualitative or quantitative defects of dystrophin,MONDO_0016147,0.25870589827929125,2.5870761922753376,1,0.4,0.4,transcript,23243.0
GAN,ENSG00000261609,Hypotonia,HP_0001252,0.25870589827929125,2.5870696469001935,1,0.4,0.4,transcript,37509.0
LAMA1,ENSG00000101680,macular holes,EFO_1001028,0.25870589827929125,2.587074878011631,1,0.5,0.5,transcript,31456.0
KIAA0586,ENSG00000100578,Meckel syndrome,MONDO_0018921,0.25870589827929125,2.587064633851356,1,0.5,0.5,transcript,88479.0
SPART,ENSG00000133104,cerebellar ataxia,MONDO_0000437,0.25870589827929125,2.587073248128148,1,0.4,0.4,transcript,28040.0
FZD3,ENSG00000104290,multicystic dysplastic kidney,MONDO_0015988,0.25870589827929125,2.5870730996095705,1,0.4,0.4,transcript,28335.0
STX7,ENSG00000079950,Abnormality of neuronal migration,HP_0002269,0.25870589827929125,2.5871474979511335,2,0.8,1.6,transcript,18076.0
RP2,ENSG00000102218,Macular dystrophy,HP_0007754,0.25870589827929125,2.587167090901021,1,0.4,0.4,transcript,3700.0
SPART,ENSG00000133104,Failure to thrive,HP_0001508,0.25870589827929125,2.587073248128148,1,0.4,0.4,transcript,28040.0
SPART,ENSG00000133104,Strabismus,HP_0000486,0.25870589827929125,2.587073248128148,1,0.4,0.4,transcript,28040.0
SPART,ENSG00000133104,Dysarthria,HP_0001260,0.25870589827929125,2.587073248128148,1,0.4,0.4,transcript,28040.0
SPART,ENSG00000133104,Microcephaly,HP_0000252,0.25870589827929125,2.587073248128148,1,0.4,0.4,transcript,28040.0
FZD3,ENSG00000104290,Agenesis of corpus callosum,HP_0001274,0.25870589827929125,2.5870730996095705,1,0.4,0.4,transcript,28335.0
SPATA22,ENSG00000141255,autism,EFO_0003758,0.25870589827929125,2.587092655094078,1,0.5,0.5,transcript,14849.0
GAN,ENSG00000261609,Intellectual disability,HP_0001249,0.25870589827929125,2.5870696469001935,1,0.4,0.4,transcript,37509.0
ABCB1,ENSG00000085563,acute myeloblastic leukemia with maturation,EFO_0003028,0.25870589827929125,2.5870830305035706,1,0.5,0.5,transcript,20792.0
ATF6,ENSG00000118217,Macular dystrophy,HP_0007754,0.25870589827929125,2.5870653352258945,1,0.4,0.4,transcript,62968.0
SLFN11,ENSG00000172716,Moyamoya disease,MONDO_0016820,0.25870589827929125,2.5870768327639064,1,0.4,0.4,transcript,22409.0
CYSLTR1,ENSG00000173198,sinusitis,EFO_0007486,0.25870589827929125,2.5872491194536376,2,0.8,1.6,transcript,8415.0
CYSLTR1,ENSG00000173198,acne,EFO_0003894,0.25870589827929125,2.5872491194536376,2,0.8,1.6,transcript,8415.0
ABCB1,ENSG00000085563,plasma cell neoplasm,EFO_0000200,0.25870589827929125,2.5870830305035706,1,0.5,0.5,transcript,20792.0
DAG1,ENSG00000173402,isolated asymptomatic elevation of creatine phosphokinase,MONDO_0016103,0.25870589827929125,2.5870651709117247,1,0.4,0.4,transcript,64640.0
CYSLTR1,ENSG00000173198,diabetic nephropathy,EFO_0000401,0.25870589827929125,2.5872491194536376,2,0.8,1.6,transcript,8415.0
HTR1F,ENSG00000179097,Dementia,HP_0000726,0.25870589827929125,2.5871771162837573,1,0.4,0.4,transcript,3386.0
CYSLTR1,ENSG00000173198,pain,EFO_0003843,0.25870589827929125,2.5872491194536376,2,0.8,1.6,transcript,8415.0
ABCB1,ENSG00000085563,childhood acute myeloid leukemia,EFO_0000330,0.25870589827929125,2.5870830305035706,1,0.5,0.5,transcript,20792.0
FZD3,ENSG00000104290,isolated cerebellar hypoplasia/agenesis,MONDO_0008939,0.25870589827929125,2.5870730996095705,1,0.4,0.4,transcript,28335.0
BMP10,ENSG00000163217,colorectal neoplasm,EFO_0004142,0.25870589827929125,2.5871252518452654,1,0.4,0.4,transcript,6036.0
HTR1F,ENSG00000179097,migraine without aura,MONDO_0100431,0.25870589827929125,2.5871771162837573,1,0.4,0.4,transcript,3386.0
GBP1,ENSG00000117228,Neutrophil inclusion bodies,HP_0008264,0.25870589827929125,2.587162798001841,2,0.8,1.6,transcript,15412.0
MC2R,ENSG00000185231,kidney disease,EFO_0003086,0.25870589827929125,2.587153590172288,1,0.4,0.4,transcript,4228.0
MC2R,ENSG00000185231,relapsing-remitting multiple sclerosis,EFO_0003929,0.25870589827929125,2.587153590172288,1,0.4,0.4,transcript,4228.0
ABCB1,ENSG00000085563,acute basophilic leukemia,EFO_0003029,0.25870589827929125,2.5870830305035706,1,0.5,0.5,transcript,20792.0
CLHC1,ENSG00000162994,Waddling gait,HP_0002515,0.25870589827929125,2.5870842736376267,1,0.4,0.4,transcript,15816.0
HTR1F,ENSG00000179097,migraine with aura,MONDO_0005475,0.25870589827929125,2.5871771162837573,1,0.4,0.4,transcript,3386.0
MC2R,ENSG00000185231,developmental and epileptic encephalopathy,MONDO_0100062,0.25870589827929125,2.587153590172288,1,0.4,0.4,transcript,4228.0
RP2,ENSG00000102218,Abnormality of the eye,HP_0000478,0.25870589827929125,2.587167090901021,1,0.4,0.4,transcript,3700.0
FZD3,ENSG00000104290,arthrogryposis multiplex congenita,MONDO_0015168,0.25870589827929125,2.5870730996095705,1,0.4,0.4,transcript,28335.0
DAG1,ENSG00000173402,Elevated circulating creatine kinase concentration,HP_0003236,0.25870589827929125,2.5870651709117247,1,0.4,0.4,transcript,64640.0
ABCB1,ENSG00000085563,childhood acute myeloid leukemia with maturation,EFO_1001945,0.25870589827929125,2.5870830305035706,1,0.5,0.5,transcript,20792.0
AHCTF1,ENSG00000153207,brain volume,OBA_2050009,0.25869130669707974,2.58692633344112,1,0.5,0.5,transcript,37689.0
SMARCC1,ENSG00000173473,growth differentiation factor 15 amount,OBA_2050135,0.25869130669707974,2.5870272140778816,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,growth differentiation factor 15 amount,OBA_2050135,0.25869130669707974,2.5870272140778816,2,0.8,1.6,gene_variant,14017.0
LNPEP,ENSG00000113441,frozen shoulder,EFO_1000941,0.25869130669707974,2.586933729195086,1,0.4,0.4,transcript,19359.0
SMARCC1,ENSG00000173473,growth differentiation factor 15 amount,OBA_2050135,0.25869130669707974,2.5870272140778816,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,growth differentiation factor 15 amount,OBA_2050135,0.25869130669707974,2.5870272140778816,2,0.8,1.6,gene_variant,14017.0
COL19A1,ENSG00000082293,breast adenocarcinoma,EFO_0000304,0.2586288130487415,2.5864254695432094,2,0.8,1.6,transcript,11650.0
SCRG1,ENSG00000164106,refractive error,MONDO_0004892,0.258616275793657,2.5864463453169315,2,0.8,1.6,transcript,5642.0
MUC16,ENSG00000181143,breast adenocarcinoma,EFO_0000304,0.25855246697897794,2.5855274901391643,1,0.5,0.5,transcript,177283.0
RAB40B,ENSG00000141542,Abruptio Placentae,EFO_1001754,0.25854715071163176,2.58549989402995,1,0.4,0.4,transcript,14091.0
NEMF,ENSG00000165525,glomerulonephritis,MONDO_0002462,0.25854715071163176,2.585491690380355,1,0.5,0.5,transcript,24773.0
PCDH10,ENSG00000138650,type 1 diabetes nephropathy,EFO_0004996,0.25852396614707474,2.5853535242660786,2,0.8,1.6,transcript,14052.0
TSPAN3,ENSG00000140391,platelet count,EFO_0004309,0.25852293500874185,2.5852512606921514,1,0.4,0.4,transcript,18256.0
SLC44A1,ENSG00000070214,serum gamma-glutamyl transferase measurement,EFO_0004532,0.2584358374478166,2.584367983395241,1,0.4,0.4,transcript,41628.0
MED10,ENSG00000133398,neuroimaging measurement,EFO_0004346,0.2584358374478166,2.5845079631094303,1,0.4,0.4,transcript,2674.0
ELAPOR1,ENSG00000116299,Nephropathy,HP_0000112,0.2583948979460997,2.583962072750686,1,0.4,0.4,transcript,30550.0
ELAPOR1,ENSG00000116299,nephritis,EFO_1002050,0.2583948979460997,2.583962072750686,1,0.4,0.4,transcript,30550.0
ARPC5,ENSG00000162704,eosinophil count,EFO_0004842,0.2583888556628161,2.583915285662575,1,0.4,0.4,transcript,14965.0
LAMA1,ENSG00000101680,HbA1c measurement,EFO_0004541,0.2583776288168504,2.583792183387222,1,0.5,0.5,transcript,31456.0
LAMA1,ENSG00000101680,erythrocyte count,EFO_0004305,0.2583776288168504,2.583792183387222,1,0.5,0.5,transcript,31456.0
LAMA1,ENSG00000101680,arterial stiffness measurement,EFO_0004517,0.2583776288168504,2.583792183387222,1,0.5,0.5,transcript,31456.0
EXOC6,ENSG00000138190,neuroimaging measurement,EFO_0004346,0.258375426497008,2.583776882240628,1,0.5,0.5,transcript,22107.0
ARHGAP12,ENSG00000165322,bone tissue density,OBA_1000110,0.2583533199659864,2.583545262022278,1,0.4,0.4,transcript,33161.0
TTL,ENSG00000114999,eosinophil count,EFO_0004842,0.2583047809933201,2.5830675786393393,1,0.4,0.4,transcript,20234.0
BHLHE41,ENSG00000123095,hypertension,EFO_0000537,0.2583005128558337,2.5830934092910676,1,0.4,0.4,transcript,4531.0
WDR12,ENSG00000138442,body fat percentage,EFO_0007800,0.2582455092225579,2.5824750314110636,1,0.4,0.4,transcript,20061.0
GNA13,ENSG00000120063,electrocardiography,EFO_0004327,0.2582426410328959,2.5824780165733148,1,0.4,0.4,transcript,7751.0
GNA13,ENSG00000120063,pulse wave reflection index measurement,EFO_0009804,0.2582217925942565,2.5822695321869205,1,0.4,0.4,transcript,7751.0
SLAMF7,ENSG00000026751,serum amyloid P-component amount,OBA_2050090,0.2582103994930745,2.582120191229891,1,0.4,0.4,transcript,24697.0
CCDC50,ENSG00000152492,BMI-adjusted waist circumference,EFO_0007789,0.2581152942062492,2.5811893885317403,1,0.4,0.4,transcript,10975.0
EPRS1,ENSG00000136628,mathematical ability,EFO_0004875,0.25808087019073445,2.58085341662743,1,0.5,0.5,transcript,11182.0
ZNF236,ENSG00000130856,metabolite measurement,EFO_0004725,0.2580495597066463,2.580554565125431,2,0.9,1.8,transcript,30525.0
ZNF236,ENSG00000130856,wellbeing measurement,EFO_0007869,0.2580495597066463,2.580554565125431,2,0.9,1.8,transcript,30525.0
YWHAG,ENSG00000170027,gastric adenocarcinoma,EFO_0000503,0.25803780722141056,2.580486034427331,1,0.4,0.4,transcript,3705.0
NAF1,ENSG00000145414,chronotype measurement,EFO_0008328,0.2580292604053154,2.5803545542451993,1,0.5,0.5,transcript,8071.0
FSIP2,ENSG00000188738,neuroticism measurement,EFO_0007660,0.2580292604053154,2.5805715440810477,4,2.0,8.0,transcript,28680.0
NXPH2,ENSG00000144227,smoking initiation,EFO_0005670,0.2580292604053154,2.5804402600147633,1,0.4,0.4,transcript,2709.0
FRAS1,ENSG00000138759,congenital diaphragmatic hernia,EFO_0007216,0.25784354528502695,2.5784675893948767,2,0.9,1.8,transcript,56011.0
KLHL3,ENSG00000146021,age at menarche,EFO_0004703,0.25784181996883876,2.5784655103717316,2,0.8,1.6,transcript,33819.0
RAD18,ENSG00000070950,lysosomal storage disease,MONDO_0002561,0.25781815444420236,2.5782150256506955,1,0.4,0.4,transcript,11947.0
SECISBP2L,ENSG00000138593,cystatin C measurement,EFO_0004617,0.25779046923057014,2.577923776275167,1,0.4,0.4,transcript,20960.0
PDHX,ENSG00000110435,urinary microalbumin measurement,EFO_0010967,0.2577834344777396,2.5778791125446037,1,0.4,0.4,transcript,8935.0
NPFFR1,ENSG00000148734,neurodegenerative disease,EFO_0005772,0.25776585269765345,2.5777017748952282,1,0.4,0.4,transcript,9249.0
PLEKHA6,ENSG00000143850,hemoglobin measurement,EFO_0004509,0.2577551638342352,2.577558453000682,1,0.4,0.4,transcript,58697.0
GJA3,ENSG00000121743,platelet volume,OBA_0003277,0.25772494485635694,2.5773261650959824,1,0.4,0.4,transcript,5214.0
HTR1F,ENSG00000179097,multinodular goiter,MONDO_0000334,0.2576969680473982,2.577087813964827,1,0.4,0.4,transcript,3386.0
PCMTD1,ENSG00000168300,polycystic ovary syndrome,EFO_0000660,0.2575910848535476,2.57611569660649,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
DLG1,ENSG00000075711,brain aneurysm,EFO_0003870,0.2575910848535476,2.5759262583069833,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
DLG1,ENSG00000075711,metabolite measurement,EFO_0004725,0.2575910848535476,2.5759262583069833,3,1.2000000000000002,3.6000000000000005,transcript,233618.0
PLPP4,ENSG00000203805,placenta praevia,EFO_0007442,0.25753497256178925,2.575430615405557,1,0.4,0.4,transcript,4945.0
ANKRD30B,ENSG00000180777,Splenomegaly,HP_0001744,0.257512166236896,2.5751462287719473,1,0.5,0.5,transcript,20353.0
OR5A2,ENSG00000172324,pulse wave reflection index measurement,EFO_0009804,0.257462597836562,2.574643821170509,1,0.4,0.4,transcript,22418.0
CST9,ENSG00000173335,placenta praevia,EFO_0007442,0.257462597836562,2.5748709263141807,1,0.4,0.4,transcript,1633.0
SH3GL3,ENSG00000140600,chronic obstructive pulmonary disease,EFO_0000341,0.2574442048832781,2.574493741776694,1,0.4,0.4,transcript,7738.0
FAM114A1,ENSG00000197712,mean corpuscular hemoglobin,EFO_0004527,0.2573525536717866,2.573574216284618,1,0.4,0.4,transcript,8217.0
LIN54,ENSG00000189308,atrial fibrillation,EFO_0000275,0.25728652217631903,2.5728781483402328,1,0.4,0.4,transcript,30944.0
AKR1C1,ENSG00000187134,ovarian cancer,MONDO_0008170,0.25724492858150844,2.5725884767676725,2,0.8,1.6,transcript,11495.0
SLC22A24,ENSG00000197658,lipid measurement,EFO_0004529,0.2572343441005946,2.572428736127065,1,0.5,0.5,transcript,5862.0
TMEM131,ENSG00000075568,interleukin 1 receptor-like 2 measurement,EFO_0008169,0.25722373881878685,2.5722588370591217,1,0.4,0.4,transcript,18649.0
TMEM131,ENSG00000075568,primary thrombocytopenia,MONDO_0004680,0.25722373881878685,2.5722588370591217,1,0.4,0.4,transcript,18649.0
NHLH2,ENSG00000177551,serum gamma-glutamyl transferase measurement,EFO_0004532,0.2572111923634146,2.5721496844195704,1,0.4,0.4,transcript,10593.0
NHLH2,ENSG00000177551,pulse wave reflection index measurement,EFO_0009804,0.2572111923634146,2.5721496844195704,1,0.4,0.4,transcript,10593.0
GUF1,ENSG00000151806,body weight,EFO_0004338,0.25721069961478504,2.572148917838133,1,0.5,0.5,transcript,11927.0
IQCB1,ENSG00000173226,platelet count,EFO_0004309,0.25716446016664973,2.571686220644751,1,0.4,0.4,transcript,9611.0
TRMT9B,ENSG00000250305,heart rate,OBA_1001087,0.25715081812583157,2.571649307919494,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
SRGN,ENSG00000122862,neutrophil measurement,EFO_0803548,0.2571500006968932,2.5716233875981733,1,0.4,0.4,transcript,3242.0
TPRG1,ENSG00000188001,musculoskeletal system disease,EFO_0009676,0.25714618547158147,2.571561711172159,2,0.8,1.6,transcript,16023.0
GRSF1,ENSG00000132463,body height,OBA_VT0001253,0.2571133185298265,2.5712242755345303,2,0.8,1.6,transcript,17565.0
KLHL31,ENSG00000124743,serum albumin amount,OBA_2050068,0.25695973541499617,2.5696494307024937,1,0.4,0.4,transcript,7681.0
KLHL31,ENSG00000124743,triglyceride measurement,EFO_0004530,0.25695973541499617,2.5696494307024937,1,0.4,0.4,transcript,7681.0
KLHL31,ENSG00000124743,HbA1c measurement,EFO_0004541,0.25695973541499617,2.5696494307024937,1,0.4,0.4,transcript,7681.0
SUMF1,ENSG00000144455,neuroimaging measurement,EFO_0004346,0.2568493996511177,2.5685263458844076,1,0.4,0.4,transcript,12365.0
ATXN3,ENSG00000066427,erythrocyte count,EFO_0004305,0.2567011438910664,2.5670171621082147,1,0.4,0.4,transcript,69891.0
MTCH2,ENSG00000109919,fat pad mass,OBA_0004528,0.25659159085271266,2.5659753615592313,1,0.4,0.4,transcript,6728.0
SMC3,ENSG00000108055,breast adenocarcinoma,EFO_0000304,0.25657195760218554,2.5657281885444636,1,0.4,0.4,transcript,46444.0
PRDM10,ENSG00000170325,body mass index,EFO_0004340,0.2565435037786493,2.565446440295045,1,0.4,0.4,transcript,35080.0
SC5D,ENSG00000109929,monocyte count,EFO_0005091,0.25649172748000526,2.564940117584588,1,0.4,0.4,transcript,17511.0
METTL14,ENSG00000145388,platelet count,EFO_0004309,0.2564887544924971,2.564913131824478,1,0.4,0.4,transcript,15633.0
DENND3,ENSG00000105339,liver disease,EFO_0001421,0.2564887544924971,2.5648983615826233,1,0.5,0.5,transcript,46225.0
PIAS2,ENSG00000078043,breast adenocarcinoma,EFO_0000304,0.25648610119683257,2.564874401986067,1,0.4,0.4,transcript,29873.0
RASEF,ENSG00000165105,smoking initiation,EFO_0005670,0.2564835728752088,2.5648901505207955,1,0.4,0.4,transcript,7350.0
IQGAP1,ENSG00000140575,respiratory system disease,EFO_0000684,0.25648124013374135,2.5648664992546437,2,0.8,1.6,transcript,29576.0
ABCB5,ENSG00000004846,deep vein thrombosis,EFO_0003907,0.2564792879647274,2.5648197921144744,1,0.4,0.4,transcript,14863.0
FAM98A,ENSG00000119812,erythrocyte volume,OBA_0003460,0.2564792879647274,2.564800232858789,1,0.4,0.4,transcript,54398.0
PCMTD1,ENSG00000168300,serotonin measurement,EFO_0004846,0.2564792879647274,2.564997727718288,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
FAM98A,ENSG00000119812,ovarian dysfunction,EFO_0009003,0.2564792879647274,2.564800232858789,1,0.4,0.4,transcript,54398.0
GAN,ENSG00000261609,level of metalloproteinase inhibitor 4 in blood serum,OBA_2043856,0.2564759404152109,2.5647700682593895,1,0.4,0.4,transcript,37509.0
DENND3,ENSG00000105339,smoking initiation,EFO_0005670,0.25644782676927746,2.5644890843504276,1,0.5,0.5,transcript,46225.0
SERPINB9,ENSG00000170542,mean reticulocyte volume,EFO_0010701,0.256436401660865,2.5644117322235847,1,0.4,0.4,transcript,8383.0
KLHL31,ENSG00000124743,apolipoprotein B measurement,EFO_0004615,0.25641642994238995,2.5642163759764314,1,0.4,0.4,transcript,7681.0
DCK,ENSG00000156136,hyperpituitarism,EFO_1000973,0.256412603334424,2.5641630190122937,1,0.4,0.4,transcript,10815.0
KCNN3,ENSG00000143603,high density lipoprotein cholesterol measurement,EFO_0004612,0.2563746108954553,2.5638651447644927,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
KIAA0232,ENSG00000170871,platelet count,EFO_0004309,0.25637369011154926,2.563760189424761,1,0.4,0.4,transcript,17176.0
POU2F1,ENSG00000143190,myeloid leukocyte count,OBA_2045223,0.2563493628598222,2.5635086406547796,2,0.8,1.6,transcript,106581.0
GPR158,ENSG00000151025,diverticulitis,MONDO_0004235,0.25632249082124453,2.563250579517061,1,0.5,0.5,transcript,19477.0
LRPAP1,ENSG00000163956,Spinal cord injury,EFO_1001919,0.25628081492877475,2.563038785459187,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
ZNF716,ENSG00000182111,lymphocyte count,EFO_0004587,0.2561391136940229,2.564270215635047,6,2.5,15.0,transcript,5210.0
PLEKHA6,ENSG00000143850,glioblastoma multiforme,EFO_0000519,0.2561143893926276,2.561150708584606,1,0.4,0.4,transcript,58697.0
PEAK1,ENSG00000173517,type 2 diabetes nephropathy,EFO_0004997,0.2561136591068091,2.561143513519331,1,0.4,0.4,transcript,57783.0
FYCO1,ENSG00000163820,sum of eosinophil and basophil counts,EFO_0009389,0.25598137237191887,2.559838334560264,1,0.4,0.4,transcript,16253.0
PEX13,ENSG00000162928,Alzheimer disease,MONDO_0004975,0.2559539889481409,2.5595857189956166,1,0.4,0.4,transcript,8728.0
LRPAP1,ENSG00000163956,congenital anomaly of cardiovascular system,MONDO_0024239,0.25591123507409,2.55934298691234,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
PEX7,ENSG00000112357,monocyte count,EFO_0005091,0.255910754430738,2.5591500884469247,1,0.4,0.4,transcript,9402.0
FYCO1,ENSG00000163820,major depressive disorder,MONDO_0002009,0.25585559633704585,2.558580574211534,1,0.4,0.4,transcript,16253.0
PYHIN1,ENSG00000163564,eosinophil count,EFO_0004842,0.2558530618692068,2.5585683759131364,1,0.4,0.4,transcript,10594.0
SEC63,ENSG00000025796,17alpha-hydroxypregnanolone glucuronide measurement,EFO_0800363,0.255850979090869,2.558785315170132,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
PPP1R2,ENSG00000184203,body mass index,EFO_0004340,0.2558411129029535,2.5584576136315107,1,0.4,0.4,transcript,8605.0
SC5D,ENSG00000109929,blood urea nitrogen measurement,EFO_0004741,0.25582724400972495,2.558295282881785,1,0.4,0.4,transcript,17511.0
AGA,ENSG00000038002,liver disease,EFO_0001421,0.25579102678675214,2.558008249446985,1,0.5,0.5,transcript,5103.0
KLF10,ENSG00000155090,gout,EFO_0004274,0.2557723147078025,2.5577839928340333,1,0.4,0.4,transcript,6574.0
DUSP22,ENSG00000112679,sum of eosinophil and basophil counts,EFO_0009389,0.2557588387227064,2.55761199161748,1,0.4,0.4,transcript,16946.0
IL17A,ENSG00000112115,Abruptio Placentae,EFO_1001754,0.25574296214174885,2.5576434108349124,1,0.4,0.4,transcript,1871.0
CLEC6A,ENSG00000205846,N-acetylglutamate measurement,EFO_0800005,0.25566461388500994,2.556889152215834,1,0.4,0.4,transcript,1646.0
NMRK1,ENSG00000106733,high density lipoprotein cholesterol measurement,EFO_0004612,0.2556099163335686,2.5561451350630735,1,0.4,0.4,transcript,8701.0
GPR158,ENSG00000151025,bone remodeling disease,MONDO_0000833,0.25559401746435323,2.555965845948148,1,0.5,0.5,transcript,19477.0
BACH1,ENSG00000156273,hemorrhoid,EFO_0009552,0.25554625543095416,2.5558204160854308,4,1.6,6.4,transcript,17884.0
MYO5A,ENSG00000197535,pleural empyema,EFO_0009680,0.25553728044943197,2.555374844155532,1,0.4,0.4,transcript,196111.0
MYO5A,ENSG00000197535,pneumothorax,MONDO_0002076,0.25553728044943197,2.555374844155532,1,0.4,0.4,transcript,196111.0
GSTA5,ENSG00000182793,psoriatic arthritis,EFO_0003778,0.2555256819921639,2.5556069599776614,1,0.5,0.5,transcript,1428.0
SERPINB9,ENSG00000170542,ovarian dysfunction,EFO_0009003,0.2555256819921639,2.5553045355365738,1,0.4,0.4,transcript,8383.0
TMEM68,ENSG00000167904,thyroid stimulating hormone amount,OBA_1000983,0.25547532429294106,2.5547719144506726,1,0.4,0.4,transcript,21423.0
TMEM68,ENSG00000167904,self reported educational attainment,EFO_0004784,0.25547532429294106,2.5547719144506726,1,0.4,0.4,transcript,21423.0
TPRG1,ENSG00000188001,chronic kidney disease,EFO_0003884,0.25547532429294106,2.5548530993857548,2,0.8,1.6,transcript,16023.0
SLF1,ENSG00000133302,neuroendocrine neoplasm,EFO_1001901,0.25547532429294106,2.554788156082941,1,0.4,0.4,transcript,11457.0
BACH1,ENSG00000156273,ocular hypertension,EFO_1001069,0.25547532429294106,2.5551111047052997,4,1.6,6.4,transcript,17884.0
BACH1,ENSG00000156273,adolescent idiopathic scoliosis,EFO_0005423,0.25547532429294106,2.5551111047052997,4,1.6,6.4,transcript,17884.0
BACH1,ENSG00000156273,trait in response to triamcinolone acetonide,OBA_2040119,0.25547532429294106,2.5551111047052997,4,1.6,6.4,transcript,17884.0
SLF1,ENSG00000133302,keratoconus,MONDO_0015486,0.25547532429294106,2.554788156082941,1,0.4,0.4,transcript,11457.0
BACH1,ENSG00000156273,refractive error,MONDO_0004892,0.25547532429294106,2.5551111047052997,4,1.6,6.4,transcript,17884.0
BACH1,ENSG00000156273,age of onset of myopia,OBA_2001030,0.25547532429294106,2.5551111047052997,4,1.6,6.4,transcript,17884.0
MYO3A,ENSG00000095777,response to vaccine,EFO_0004645,0.25547532429294106,2.554776958719384,1,0.5,0.5,transcript,21083.0
TRMT9B,ENSG00000250305,nitric oxide exhalation measurement,EFO_0005536,0.25547532429294106,2.5548943695905892,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
SLF1,ENSG00000133302,educational attainment,EFO_0011015,0.25547532429294106,2.554788156082941,1,0.4,0.4,transcript,11457.0
PROK2,ENSG00000163421,polygenic risk score,EFO_0030082,0.25539078090144074,2.554423272931933,2,0.8,1.6,transcript,3104.0
PROK2,ENSG00000163421,apolipoprotein A 1 measurement,EFO_0004614,0.25539078090144074,2.554423272931933,2,0.8,1.6,transcript,3104.0
SLC35D3,ENSG00000182747,glucose tolerance test,EFO_0004307,0.25539078090144074,2.554078530311889,1,0.4,0.4,transcript,2343.0
ZNF77,ENSG00000175691,calcium measurement,EFO_0004838,0.2553299460864059,2.553453960670934,1,0.4,0.4,transcript,2589.0
XKR4,ENSG00000206579,self reported educational attainment,EFO_0004784,0.2552642271687367,2.5526612236441566,1,0.4,0.4,transcript,21106.0
ATP5F1A,ENSG00000152234,neutrophil count,EFO_0004833,0.2552630248663044,2.5526440493806812,1,0.4,0.4,transcript,28984.0
RSBN1L,ENSG00000187257,neurodegenerative disease,EFO_0005772,0.25525737676227456,2.552710484703836,2,0.8,1.6,transcript,11703.0
RPAP3,ENSG00000005175,cardiovascular disease,EFO_0000319,0.2551374899813967,2.551523267766489,2,0.8,1.6,transcript,10784.0
MCL1,ENSG00000143384,serum alanine aminotransferase measurement,EFO_0004735,0.25511020090681896,2.5511187784473033,1,0.4,0.4,transcript,23853.0
MCF2L2,ENSG00000053524,HbA1c measurement,EFO_0004541,0.2551013871917364,2.5510553216207397,2,0.8,1.6,transcript,38601.0
ANKRD36,ENSG00000135976,smoking status measurement,EFO_0006527,0.2549790425084655,2.5498658114397244,2,1.0,2.0,transcript,26530.0
NDST3,ENSG00000164100,kidney disease,EFO_0003086,0.2549523884998301,2.549573947576524,1,0.4,0.4,transcript,7990.0
DTHD1,ENSG00000197057,ceramide measurement,EFO_0010222,0.25493190938326565,2.5493454943817877,1,0.5,0.5,transcript,18939.0
SKA3,ENSG00000165480,erythrocyte volume,OBA_0003460,0.25492703210720186,2.54941668038413,2,0.8,1.6,transcript,10932.0
PHC1,ENSG00000111752,glioblastoma multiforme,EFO_0000519,0.2549165984753255,2.549185135237762,1,0.5,0.5,transcript,26109.0
DAG1,ENSG00000173402,breast adenocarcinoma,EFO_0000304,0.2547235582203883,2.547241770322695,1,0.4,0.4,transcript,64640.0
MARCKS,ENSG00000277443,platelet count,EFO_0004309,0.2546787504623594,2.54688061449324,1,0.4,0.4,transcript,4296.0
CDH19,ENSG00000071991,hypopituitarism,EFO_0001380,0.25458280864514543,2.5461026441085624,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
PTCHD4,ENSG00000244694,cervical carcinoma,EFO_0001061,0.25458280864514543,2.5462419271227956,6,2.4000000000000004,14.400000000000002,transcript,34796.0
DNAJC10,ENSG00000077232,pulmonary arterial hypertension,EFO_0001361,0.25454505450292086,2.545469796759741,4,1.7000000000000002,6.800000000000001,transcript,353215.0
TBXT,ENSG00000164458,respiratory tract infectious disorder,MONDO_0024355,0.25452430123167197,2.545703488141739,3,1.2000000000000002,3.6000000000000005,transcript,7818.0
DCK,ENSG00000156136,diabetes mellitus,EFO_0000400,0.25449894708984416,2.5450264565664953,1,0.4,0.4,transcript,10815.0
PFAS,ENSG00000178921,sitting height measurement,EFO_0011011,0.2544630347735401,2.5446536740708336,1,0.4,0.4,transcript,17148.0
MRPL32,ENSG00000106591,smoking initiation,EFO_0005670,0.25445918864697,2.544675029267455,1,0.4,0.4,transcript,4811.0
GASK1B,ENSG00000164125,reticulocyte measurement,EFO_0010700,0.2544251256930489,2.544424142681822,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
GASK1B,ENSG00000164125,reticulocyte count,EFO_0007986,0.2544251256930489,2.544424142681822,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
ZNF33B,ENSG00000196693,1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2) measurement,EFO_0800422,0.2544133646792508,2.544164772290516,1,0.5,0.5,transcript,16064.0
ZNF33B,ENSG00000196693,aconitate measurement,EFO_0010451,0.25439976779815254,2.544028803479533,1,0.5,0.5,transcript,16064.0
HHLA2,ENSG00000114455,age at first sexual intercourse measurement,EFO_0009749,0.2543946942935136,2.5439807472756133,1,0.5,0.5,transcript,14791.0
PSD3,ENSG00000156011,alkaline phosphatase measurement,EFO_0004533,0.25438692716368017,2.543878714730359,1,0.4,0.4,transcript,42359.0
TRDN,ENSG00000186439,breast adenocarcinoma,EFO_0000304,0.25400946754524956,2.5401138788937523,1,0.5,0.5,transcript,26037.0
SKIL,ENSG00000136603,high density lipoprotein cholesterol measurement,EFO_0004612,0.2539575284805031,2.5395917446266068,1,0.5,0.5,transcript,30377.0
FZD6,ENSG00000164930,endometrial cancer,MONDO_0011962,0.25392189238253926,2.539298815970996,2,0.8,1.6,transcript,20027.0
ZNF267,ENSG00000185947,neurodegenerative disease,EFO_0005772,0.25390900437521,2.539127546095997,1,0.4,0.4,transcript,10666.0
RCN2,ENSG00000117906,Red cell distribution width,EFO_0009188,0.25384851255694896,2.5385124405107624,1,0.4,0.4,transcript,14644.0
SECISBP2L,ENSG00000138593,diabetes mellitus,EFO_0000400,0.2537721925493549,2.5377410094630144,1,0.4,0.4,transcript,20960.0
SECISBP2L,ENSG00000138593,urinary microalbumin measurement,EFO_0010967,0.2537721925493549,2.5377410094630144,1,0.4,0.4,transcript,20960.0
CCDC66,ENSG00000180376,attention deficit hyperactivity disorder,EFO_0003888,0.25365437745730063,2.536559004081702,1,0.5,0.5,transcript,32831.0
CCDC66,ENSG00000180376,social inhibition quality,OBA_1000278,0.25365437745730063,2.536559004081702,1,0.5,0.5,transcript,32831.0
CCDC66,ENSG00000180376,substance abuse,MONDO_0002491,0.25365437745730063,2.536559004081702,1,0.5,0.5,transcript,32831.0
ARHGAP28,ENSG00000088756,ovarian neoplasm,EFO_0003893,0.25364355131513505,2.5364478147874685,1,0.4,0.4,transcript,32516.0
OR5A2,ENSG00000172324,total cortical area measurement,EFO_0008381,0.2535856205095082,2.5358740478999713,1,0.4,0.4,transcript,22418.0
SLC4A8,ENSG00000050438,cigarettes per day measurement,EFO_0006525,0.25357100263493365,2.5357415341967595,2,0.8,1.6,transcript,50781.0
ARHGAP28,ENSG00000088756,age-related hearing impairment,EFO_0005782,0.2533640205909729,2.5336525075458467,1,0.4,0.4,transcript,32516.0
DAG1,ENSG00000173402,glomerular filtration rate,OBA_0003747,0.25335332975947933,2.5335394857136055,1,0.4,0.4,transcript,64640.0
TAF2,ENSG00000064313,placenta praevia,EFO_0007442,0.25328722864204317,2.5328750794044557,1,0.5,0.5,transcript,179020.0
RFX7,ENSG00000181827,neuroimaging measurement,EFO_0004346,0.2532127688972542,2.5321372812986813,1,0.4,0.4,transcript,41700.0
GNA13,ENSG00000120063,perfluorooctanoate (PFOA) measurement,EFO_0801024,0.2532127688972542,2.5321792952168978,1,0.4,0.4,transcript,7751.0
CCDC34,ENSG00000109881,diastolic blood pressure change measurement,EFO_0006945,0.2531514980486059,2.531608503983838,1,0.4,0.4,transcript,4277.0
PSD3,ENSG00000156011,neuroimaging measurement,EFO_0004346,0.2530840291647735,2.5308497347412926,1,0.4,0.4,transcript,42359.0
TRDMT1,ENSG00000107614,low density lipoprotein cholesterol measurement,EFO_0004611,0.25293046503203936,2.5293184419971166,1,0.4,0.4,transcript,29003.0
MAP1LC3B2,ENSG00000258102,hair color,EFO_0003924,0.2529081360297127,2.529247611336196,1,0.4,0.4,transcript,2406.0
SYNJ2,ENSG00000078269,placenta growth factor measurement,EFO_0010626,0.2528647279622096,2.5286984272469284,2,0.8,1.6,transcript,31282.0
SYNJ2,ENSG00000078269,growth differentiation factor 15 amount,OBA_2050135,0.2528647279622096,2.5286984272469284,2,0.8,1.6,transcript,31282.0
PICALM,ENSG00000073921,post term pregnancy,EFO_0009681,0.2528647279622096,2.5286605479406683,1,0.4,0.4,transcript,30147.0
LRRIQ3,ENSG00000162620,Abnormality of the gastrointestinal tract,HP_0011024,0.25282433212077454,2.5282702173884877,1,0.5,0.5,transcript,18590.0
TFEC,ENSG00000105967,central nervous system cancer,EFO_0000326,0.25282433212077454,2.5282590185627414,1,0.4,0.4,transcript,25482.0
HS3ST3A1,ENSG00000153976,metabolite measurement,EFO_0004725,0.25282433212077454,2.528324358484893,1,0.4,0.4,transcript,4936.0
CNOT6L,ENSG00000138767,serum creatinine amount,OBA_2050096,0.2528133015314474,2.528262904187327,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
MTCH2,ENSG00000109919,serum alanine aminotransferase measurement,EFO_0004735,0.2527979087698243,2.528038540730347,1,0.4,0.4,transcript,6728.0
ATG16L1,ENSG00000085978,sclerosing cholangitis,EFO_0004268,0.25279110281728523,2.527923019658897,1,0.4,0.4,transcript,33357.0
DNAJC10,ENSG00000077232,hematologic disease,EFO_0005803,0.25269715522949737,2.5269908040255062,4,1.7000000000000002,6.800000000000001,transcript,353215.0
NEK7,ENSG00000151414,cervical carcinoma,EFO_0001061,0.25269715522949737,2.5270168165249163,1,0.4,0.4,transcript,8837.0
FAM174A,ENSG00000174132,myeloid leukocyte count,OBA_2045223,0.2526933934722169,2.5270343111337126,1,0.4,0.4,transcript,3985.0
DTHD1,ENSG00000197057,Inguinal hernia,HP_0000023,0.2526933934722169,2.5269603352713004,1,0.5,0.5,transcript,18939.0
ZNF398,ENSG00000197024,sum of eosinophil and basophil counts,EFO_0009389,0.2526899891092963,2.526925385038151,1,0.4,0.4,transcript,15690.0
HS3ST3A1,ENSG00000153976,lymphocyte count,EFO_0004587,0.25268451603523484,2.526926197629496,1,0.4,0.4,transcript,4936.0
DPY19L2,ENSG00000177990,neuroimaging measurement,EFO_0004346,0.25268451603523484,2.526985906305902,2,0.8,1.6,transcript,11368.0
TFEC,ENSG00000105967,heart rate,OBA_1001087,0.25268451603523484,2.5268608577073444,1,0.4,0.4,transcript,25482.0
TFEC,ENSG00000105967,atherosclerosis,EFO_0003914,0.25268451603523484,2.5268608577073444,1,0.4,0.4,transcript,25482.0
DPY19L2,ENSG00000177990,musculoskeletal system disease,EFO_0009676,0.25268451603523484,2.526985906305902,2,0.8,1.6,transcript,11368.0
DTHD1,ENSG00000197057,retinoschisis,MONDO_0004579,0.25268451603523484,2.52687156090148,1,0.5,0.5,transcript,18939.0
DTHD1,ENSG00000197057,retinopathy,EFO_0003839,0.25268451603523484,2.52687156090148,1,0.5,0.5,transcript,18939.0
TFEC,ENSG00000105967,diastolic blood pressure,EFO_0006336,0.25268451603523484,2.5268608577073444,1,0.4,0.4,transcript,25482.0
CDH19,ENSG00000071991,HbA1c measurement,EFO_0004541,0.25268451603523484,2.5271197180094567,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
SI,ENSG00000090402,neuropathy,EFO_0004149,0.25268451603523484,2.526917206461859,1,0.5,0.5,transcript,6940.0
DPY19L2,ENSG00000177990,pulse wave reflection index measurement,EFO_0009804,0.25268451603523484,2.526985906305902,2,0.8,1.6,transcript,11368.0
TLR10,ENSG00000174123,pulse pressure measurement,EFO_0005763,0.25260320426662103,2.52619348488335,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
IL1A,ENSG00000115008,breast adenocarcinoma,EFO_0000304,0.2525106796808069,2.5253051111362796,1,0.4,0.4,transcript,2017.0
UBE2J1,ENSG00000198833,high density lipoprotein cholesterol measurement,EFO_0004612,0.25249292688492214,2.5253615455062817,2,0.9,1.8,transcript,4164.0
GBP6,ENSG00000183347,platelet count,EFO_0004309,0.2524899647176059,2.525283852085344,2,0.9,1.8,transcript,4685.0
PLEKHA6,ENSG00000143850,aspartate aminotransferase measurement,EFO_0004736,0.2524899647176059,2.524906461834389,1,0.4,0.4,transcript,58697.0
NEU3,ENSG00000162139,nervous system benign neoplasm,MONDO_0000648,0.2524717663599116,2.5247499737768218,1,0.4,0.4,transcript,12380.0
SLAIN2,ENSG00000109171,educational attainment,EFO_0011015,0.252462119061839,2.524756933385846,2,0.8,1.6,transcript,11787.0
HTR1F,ENSG00000179097,ovarian cancer,MONDO_0008170,0.25244357296380043,2.524553863128849,1,0.4,0.4,transcript,3386.0
FZD6,ENSG00000164930,Iron deficiency anemia,HP_0001891,0.25235722021341056,2.523652094279709,2,0.8,1.6,transcript,20027.0
MYO5A,ENSG00000197535,chloride measurement,EFO_0009284,0.2523230550327907,2.523232589989119,1,0.4,0.4,transcript,196111.0
TMED5,ENSG00000117500,systolic blood pressure,EFO_0006335,0.2521859401683583,2.5218913689491034,1,0.5,0.5,transcript,15641.0
STAM,ENSG00000136738,breast adenocarcinoma,EFO_0000304,0.2521695631158744,2.521761626869023,1,0.4,0.4,transcript,6061.0
CD2AP,ENSG00000198087,urate measurement,EFO_0004531,0.2520720946433653,2.520773016207149,1,0.4,0.4,transcript,7682.0
NOM1,ENSG00000146909,glucose tolerance test,EFO_0004307,0.2520279241328122,2.5211606092110768,5,2.0,10.0,transcript,11346.0
ALPK3,ENSG00000136383,erythrocyte volume,OBA_0003460,0.2520058239372058,2.5200955354093537,1,0.4,0.4,transcript,10725.0
CD2AP,ENSG00000198087,erythrocyte volume,OBA_0003460,0.2519416849441254,2.5194689192147504,1,0.4,0.4,transcript,7682.0
DAG1,ENSG00000173402,self reported educational attainment,EFO_0004784,0.2518938878421073,2.518945066539885,1,0.4,0.4,transcript,64640.0
TMEM68,ENSG00000167904,pathological myopia,EFO_0004207,0.25187843154596834,2.5188029869809454,1,0.4,0.4,transcript,21423.0
PHF24,ENSG00000122733,eosinophil count,EFO_0004842,0.25186570516366,2.5187045632175478,1,0.4,0.4,transcript,8419.0
ABCB5,ENSG00000004846,Abnormal thrombosis,HP_0001977,0.25182852278091983,2.518312140276399,1,0.4,0.4,transcript,14863.0
NUP43,ENSG00000120253,neuroimaging measurement,EFO_0004346,0.25180699373776483,2.518272136290829,2,0.8,1.6,transcript,7913.0
IL1A,ENSG00000115008,Dysmenorrhea,HP_0100607,0.25173731230673246,2.5175714373955347,1,0.4,0.4,transcript,2017.0
CENPQ,ENSG00000031691,vitamin B12 measurement,EFO_0004620,0.2516887586828614,2.517117339844122,1,0.4,0.4,transcript,1741.0
SLC4A8,ENSG00000050438,self reported educational attainment,EFO_0004784,0.2516567446001661,2.5165989538490843,2,0.8,1.6,transcript,50781.0
TMEM154,ENSG00000170006,metabolite measurement,EFO_0004725,0.25163412960987275,2.5163603809787314,1,0.4,0.4,transcript,20959.0
CHL1,ENSG00000134121,response to xenobiotic stimulus,GO_0009410,0.2516291189550882,2.516338389975686,2,0.8,1.6,transcript,33898.0
ZNF697,ENSG00000143067,level of lysophosphatidic acid phosphatase type 6 in blood serum,OBA_2040483,0.2516187601911433,2.516832878842783,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
PHC1,ENSG00000111752,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.2515677347340067,2.5156964978245737,1,0.5,0.5,transcript,26109.0
MATN2,ENSG00000132561,high density lipoprotein cholesterol measurement,EFO_0004612,0.2515560645993044,2.515577601467967,1,0.5,0.5,transcript,29489.0
HLA-E,ENSG00000204592,thyroid gland adenocarcinoma,MONDO_0024622,0.2515196233270887,2.515291904163018,1,0.4,0.4,transcript,4181.0
SH3GL3,ENSG00000140600,pancreatic adenocarcinoma,EFO_1000044,0.2515196233270887,2.5152479262148,1,0.4,0.4,transcript,7738.0
MC2R,ENSG00000185231,ovarian cancer,MONDO_0008170,0.2515196233270887,2.5152908406502625,1,0.4,0.4,transcript,4228.0
SH3GL3,ENSG00000140600,lung adenocarcinoma,EFO_0000571,0.2515196233270887,2.5152479262148,1,0.4,0.4,transcript,7738.0
HEATR1,ENSG00000119285,hypertrophic cardiomyopathy,EFO_0000538,0.25151158700537035,2.5151454611053694,1,0.5,0.5,transcript,16897.0
LMNTD1,ENSG00000152936,urinary microalbumin measurement,EFO_0010967,0.2514627054098315,2.514781719848444,2,0.9,1.8,transcript,11638.0
DUSP22,ENSG00000112679,p-acetamidophenylglucuronide measurement,EFO_0021160,0.2514627054098315,2.5146506584887316,1,0.4,0.4,transcript,16946.0
SLCO1C1,ENSG00000139155,forced expiratory volume,EFO_0004314,0.25145976061315023,2.514628497024867,1,0.5,0.5,transcript,16186.0
CHL1,ENSG00000134121,1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4n6) measurement,EFO_0800390,0.25144256539011856,2.5144728543259895,2,0.8,1.6,transcript,33898.0
TRIM44,ENSG00000166326,gout,EFO_0004274,0.25141727709648604,2.5142021158405115,1,0.4,0.4,transcript,13631.0
POU2F1,ENSG00000143190,osteitis deformans,EFO_0004261,0.25141727709648604,2.514187783021418,2,0.8,1.6,transcript,106581.0
WDR59,ENSG00000103091,Non-Neoplastic Bile Duct Disorder,EFO_1000400,0.2512996680217252,2.5130703348690036,2,0.8,1.6,transcript,21723.0
PDE12,ENSG00000174840,reticulocyte count,EFO_0007986,0.2512870001173329,2.5128890551437,1,0.4,0.4,transcript,20993.0
C18orf54,ENSG00000166845,Fuchs' endothelial dystrophy,MONDO_0005321,0.2511998452642498,2.512083927293922,2,0.8,1.6,transcript,18719.0
C18orf54,ENSG00000166845,corneal disease,EFO_0009464,0.2511998452642498,2.512083927293922,2,0.8,1.6,transcript,18719.0
FAM186A,ENSG00000185958,sum of basophil and neutrophil counts,EFO_0009388,0.2511954731926947,2.5120656335572007,2,1.0,2.0,transcript,18034.0
FAM186A,ENSG00000185958,myeloid leukocyte count,OBA_2045223,0.2511954731926947,2.5120656335572007,2,1.0,2.0,transcript,18034.0
FAM186A,ENSG00000185958,sum of neutrophil and eosinophil counts,EFO_0009390,0.2511954731926947,2.5120656335572007,2,1.0,2.0,transcript,18034.0
FAM186A,ENSG00000185958,granulocyte count,EFO_0007987,0.2511954731926947,2.5120656335572007,2,1.0,2.0,transcript,18034.0
C2orf76,ENSG00000186132,glucose measurement,EFO_0004468,0.25116281713634636,2.5117174371523503,1,0.4,0.4,transcript,4481.0
CP,ENSG00000047457,Parkinson disease,MONDO_0005180,0.25109871265636685,2.511008184515151,1,0.5,0.5,transcript,23744.0
SLC7A2,ENSG00000003989,serum creatinine amount,OBA_2050096,0.2510856532394848,2.5109775280159585,3,1.4,4.199999999999999,transcript,34712.0
SLC35D3,ENSG00000182747,lymphocyte count,EFO_0004587,0.2510856532394848,2.5110272536923297,1,0.4,0.4,transcript,2343.0
KERA,ENSG00000139330,lung adenocarcinoma,EFO_0000571,0.2510243914280565,2.5109701966228255,2,0.8,1.6,transcript,2203.0
CPB1,ENSG00000153002,protein measurement,EFO_0004747,0.2510101508462874,2.5101470873142873,1,0.5,0.5,transcript,10970.0
ANO6,ENSG00000177119,type 2 diabetes mellitus,MONDO_0005148,0.25098821639758534,2.509889585126132,1,0.4,0.4,transcript,53900.0
RPRD2,ENSG00000163125,blood sodium bicarbonate amount,OBA_2050094,0.2509853600806536,2.5098721073300854,1,0.4,0.4,transcript,21614.0
PKD2L2,ENSG00000078795,blood sodium bicarbonate amount,OBA_2050094,0.2509824951258262,2.5098643275379913,1,0.5,0.5,transcript,12698.0
ALPK3,ENSG00000136383,magnetic resonance imaging of the heart,EFO_0022611,0.2507725896658972,2.507763192696268,1,0.4,0.4,transcript,10725.0
SCAMP1,ENSG00000085365,depressive disorder,MONDO_0002050,0.2507675333133775,2.507701680123631,1,0.4,0.4,transcript,15182.0
CNOT6L,ENSG00000138767,low grade glioma,MONDO_0021637,0.25073281569191014,2.507458045791955,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
SARAF,ENSG00000133872,BMI-adjusted waist circumference,EFO_0007789,0.2506913522063118,2.5069399753400177,1,0.4,0.4,transcript,15121.0
ZNF485,ENSG00000198298,low density lipoprotein cholesterol measurement,EFO_0004611,0.2506913522063118,2.5070108551368966,1,0.5,0.5,transcript,5137.0
CNOT6L,ENSG00000138767,glomerular filtration rate,OBA_0003747,0.2506404230528453,2.5065341194013064,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
FARSB,ENSG00000116120,5alpha-pregnan-diol disulfate measurement,EFO_0800286,0.2504915203307129,2.5049662237152925,1,0.4,0.4,transcript,7840.0
DYNC1I2,ENSG00000077380,body fat percentage,EFO_0007800,0.2504549859462347,2.504561046396009,1,0.4,0.4,transcript,35756.0
FIGNL1,ENSG00000132436,fat pad mass,OBA_0004528,0.25045116351211777,2.504527817660218,1,0.4,0.4,transcript,24718.0
KLHL3,ENSG00000146021,mean corpuscular hemoglobin concentration,EFO_0004528,0.25043794409822007,2.5044267516655445,2,0.8,1.6,transcript,33819.0
KLHL3,ENSG00000146021,heart rate,OBA_1001087,0.25043794409822007,2.5044267516655445,2,0.8,1.6,transcript,33819.0
MC2R,ENSG00000185231,glioblastoma multiforme,EFO_0000519,0.25042683935770965,2.504363000956472,1,0.4,0.4,transcript,4228.0
DTHD1,ENSG00000197057,neuroticism measurement,EFO_0007660,0.25041421129664254,2.5041685135155567,1,0.5,0.5,transcript,18939.0
PROK2,ENSG00000163421,breast adenocarcinoma,EFO_0000304,0.25040143706740137,2.5045298345915397,2,0.8,1.6,transcript,3104.0
ST8SIA4,ENSG00000113532,placental retention,EFO_0009578,0.2503267192878176,2.5033100699282347,1,0.4,0.4,transcript,9329.0
SLC5A7,ENSG00000115665,growth differentiation factor 15 amount,OBA_2050135,0.2502176716240096,2.5022322795127727,1,0.4,0.4,transcript,7199.0
DENND3,ENSG00000105339,trauma complication,EFO_0009888,0.250201631774779,2.5020271344054428,1,0.5,0.5,transcript,46225.0
HTR1F,ENSG00000179097,glioblastoma multiforme,EFO_0000519,0.25018267145051803,2.501944847996025,1,0.4,0.4,transcript,3386.0
DUSP22,ENSG00000112679,albumin:globulin ratio measurement,EFO_0005128,0.2501284363634838,2.5013079680252543,1,0.4,0.4,transcript,16946.0
SLC35F5,ENSG00000115084,lymphocyte count,EFO_0004587,0.25011918338247086,2.5012625927137937,2,0.8,1.6,transcript,22612.0
USP15,ENSG00000135655,glioblastoma multiforme,EFO_0000519,0.25010998416467883,2.5011829594894186,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
LONRF1,ENSG00000154359,serum creatinine amount,OBA_2050096,0.25007522727578413,2.5007875660450583,1,0.5,0.5,transcript,14167.0
RAD23B,ENSG00000119318,prostate specific antigen amount,OBA_2050200,0.2500039067642463,2.500079341504726,1,0.4,0.4,transcript,9932.0
TRIM44,ENSG00000166326,ovarian neoplasm,EFO_0003893,0.24999140423208246,2.499943387196476,1,0.4,0.4,transcript,13631.0
RAD18,ENSG00000070950,educational attainment,EFO_0011015,0.24997465908596933,2.499780072068365,1,0.4,0.4,transcript,11947.0
ARL3,ENSG00000138175,prostate specific antigen amount,OBA_2050200,0.2499364922980703,2.4994692526624975,1,0.4,0.4,transcript,3834.0
CMTR2,ENSG00000180917,overall survival,EFO_0000638,0.2499251035350229,2.499354454650856,2,0.8,1.6,transcript,15471.0
ZNF697,ENSG00000143067,neutrophil count,EFO_0004833,0.24987140326969368,2.4993593096282867,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
ZNF398,ENSG00000197024,eosinophil percentage of leukocytes,EFO_0007991,0.24986658707026357,2.4986913646478235,1,0.4,0.4,transcript,15690.0
KPNA4,ENSG00000186432,clear cell renal carcinoma,EFO_0000349,0.2498479018155938,2.498488011366064,1,0.4,0.4,transcript,44478.0
MUC16,ENSG00000181143,neuroimaging measurement,EFO_0004346,0.24984636835476887,2.4984665038970735,1,0.5,0.5,transcript,177283.0
DMXL1,ENSG00000172869,arterial stiffness measurement,EFO_0004517,0.24973854653222122,2.497396149939035,1,0.4,0.4,transcript,37437.0
FBXO42,ENSG00000037637,cerebral cortex area attribute,OBA_2045267,0.2497319561860738,2.4973551332257893,1,0.4,0.4,transcript,11245.0
GPM6A,ENSG00000150625,liver disease,EFO_0001421,0.24972251310130986,2.4972433020938234,1,0.4,0.4,transcript,22013.0
IPP,ENSG00000197429,placental retention,EFO_0009578,0.24964279969735145,2.4965087724177795,1,0.5,0.5,transcript,6190.0
FBXO42,ENSG00000037637,alcohol consumption quality,OBA_1000840,0.2496307152570853,2.4963427239359044,1,0.4,0.4,transcript,11245.0
TMEM132B,ENSG00000139364,nephrotic syndrome,EFO_0004255,0.24962182437739777,2.4963076070605608,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
GPATCH2L,ENSG00000089916,type 1 diabetes nephropathy,EFO_0004996,0.24962182437739777,2.4963607161143084,4,1.6,6.4,transcript,44921.0
SLC30A9,ENSG00000014824,growth differentiation factor 15 amount,OBA_2050135,0.24962182437739777,2.496570007100396,3,1.3,3.9000000000000004,transcript,11087.0
TMEM132B,ENSG00000139364,ovarian neoplasm,EFO_0003893,0.24962182437739777,2.4963076070605608,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
TRIM44,ENSG00000166326,placental retention,EFO_0009578,0.24962182437739777,2.496247588649629,1,0.4,0.4,transcript,13631.0
SLF1,ENSG00000133302,reaction time measurement,EFO_0008393,0.249569232094175,2.4957272340952805,1,0.4,0.4,transcript,11457.0
PCMTD1,ENSG00000168300,acute myeloid leukemia,EFO_0000222,0.24946693791793165,2.4948742272503304,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
KLHL3,ENSG00000146021,self reported educational attainment,EFO_0004784,0.24941903172001198,2.4942376278834635,2,0.8,1.6,transcript,33819.0
SPART,ENSG00000133104,mathematical ability,EFO_0004875,0.24941903172001198,2.494204582535355,1,0.4,0.4,transcript,28040.0
PTBP3,ENSG00000119314,beverage consumption measurement,EFO_0010088,0.24940217235403414,2.4942551611424704,5,2.0,10.0,transcript,42838.0
VPS50,ENSG00000004766,neutrophil count,EFO_0004833,0.2493226344438894,2.4932375063989345,1,0.4,0.4,transcript,35836.0
SLC4A8,ENSG00000050438,sodium measurement,EFO_0009282,0.2492455532558639,2.492487040406062,2,0.8,1.6,transcript,50781.0
TPRG1,ENSG00000188001,eosinophil count,EFO_0004842,0.2490865281245237,2.4909651377015813,2,0.8,1.6,transcript,16023.0
C13orf42,ENSG00000226792,threitol measurement,EFO_0021031,0.2490523157550328,2.4905852404309736,1,0.4,0.4,transcript,6443.0
EXOC6,ENSG00000138190,sensorineural hearing loss,EFO_1001176,0.24897979471111964,2.4898205643817444,1,0.5,0.5,transcript,22107.0
STX7,ENSG00000079950,waist-hip ratio,EFO_0004343,0.24892061191748938,2.4892946343331146,2,0.8,1.6,transcript,18076.0
CPPED1,ENSG00000103381,diabetic ketoacidosis,EFO_1000897,0.24880152660639643,2.488052994794393,1,0.4,0.4,transcript,10602.0
ZNF267,ENSG00000185947,serum creatinine amount,OBA_2050096,0.2487376027354549,2.4874135296984456,1,0.4,0.4,transcript,10666.0
CD93,ENSG00000125810,Varicose veins,HP_0002619,0.24873728606470386,2.4873991781679283,1,0.4,0.4,transcript,15199.0
DPP8,ENSG00000074603,serum creatinine amount,OBA_2050096,0.24872202221409934,2.4874019422352607,4,1.6,6.4,transcript,35219.0
CR2,ENSG00000117322,arterial stiffness measurement,EFO_0004517,0.2487121933609387,2.4871402595359915,1,0.4,0.4,transcript,21827.0
CD93,ENSG00000125810,neuroimaging measurement,EFO_0004346,0.2487121933609387,2.4871482511302765,1,0.4,0.4,transcript,15199.0
ONECUT2,ENSG00000119547,acute tonsillitis,MONDO_0020686,0.24863867983438193,2.48754862406996,7,2.8000000000000003,19.6,transcript,16870.0
SLC22A24,ENSG00000197658,X-24494 measurement,EFO_0800889,0.24852419029523817,2.4853271980735006,1,0.5,0.5,transcript,5862.0
FAM114A1,ENSG00000197712,bilirubin measurement,EFO_0004570,0.248439446309669,2.4844431426634417,1,0.4,0.4,transcript,8217.0
PEX13,ENSG00000162928,autoimmune disease,EFO_0005140,0.2484348262122538,2.4843940916367453,1,0.4,0.4,transcript,8728.0
CPO,ENSG00000144410,macular degeneration,EFO_0009606,0.2484026824696847,2.4844284311225495,1,0.5,0.5,transcript,1245.0
NBEAL1,ENSG00000144426,low density lipoprotein cholesterol measurement,EFO_0004611,0.24837660122853997,2.483769865887072,1,0.4,0.4,transcript,103799.0
SLCO6A1,ENSG00000205359,BMI-adjusted waist-hip ratio,EFO_0007788,0.24830711951757709,2.4831124493011836,1,0.5,0.5,transcript,12120.0
RFX7,ENSG00000181827,frozen shoulder,EFO_1000941,0.24815346878278258,2.481544280153965,1,0.4,0.4,transcript,41700.0
PLA2R1,ENSG00000153246,response to COVID-19 vaccine,EFO_0803362,0.2481531466814005,2.4816106590531657,2,0.8,1.6,transcript,20204.0
PLA2R1,ENSG00000153246,SARS-CoV-2 antibody measurement,EFO_0803360,0.2481531466814005,2.4816106590531657,2,0.8,1.6,transcript,20204.0
LRRIQ3,ENSG00000162620,neurodegenerative disease,EFO_0005772,0.2481454646089166,2.481481542269908,1,0.5,0.5,transcript,18590.0
DGKH,ENSG00000102780,breast adenocarcinoma,EFO_0000304,0.24814151045063168,2.4814424975450606,2,0.8,1.6,transcript,58409.0
GPM6A,ENSG00000150625,lymphocyte count,EFO_0004587,0.2481050404411194,2.481068575491919,1,0.4,0.4,transcript,22013.0
LRRIQ3,ENSG00000162620,EDTA measurement,EFO_0800946,0.24801152729431136,2.4801421691238557,1,0.5,0.5,transcript,18590.0
CAVIN2,ENSG00000168497,muscular dystrophy,MONDO_0020121,0.24799780458006354,2.480109021570118,1,0.4,0.4,transcript,3054.0
SH3GL3,ENSG00000140600,response to antihypertensive drug,EFO_0005405,0.24796461133130818,2.4796978062569948,1,0.4,0.4,transcript,7738.0
GKAP1,ENSG00000165113,eosinophil percentage of leukocytes,EFO_0007991,0.24795244429544272,2.479581569489703,1,0.4,0.4,transcript,7002.0
HS3ST3A1,ENSG00000153976,brain connectivity attribute,OBA_2045295,0.24795170669882102,2.4795981042653574,1,0.4,0.4,transcript,4936.0
NCKAP1,ENSG00000061676,breast adenocarcinoma,EFO_0000304,0.24794713086111278,2.4794811378284765,1,0.4,0.4,transcript,40695.0
MED10,ENSG00000133398,N-acetylglutamate measurement,EFO_0800005,0.2478543254924203,2.4786928435554674,1,0.4,0.4,transcript,2674.0
CMTR2,ENSG00000180917,heart rate,OBA_1001087,0.24780706917584547,2.4781741110590816,2,0.8,1.6,transcript,15471.0
CHFR,ENSG00000072609,mitotic checkpoint serine/threonine-protein kinase BUB1 measurement,EFO_0801806,0.24773668910052332,2.4773749803111706,1,0.4,0.4,transcript,49448.0
SLC35D3,ENSG00000182747,protein measurement,EFO_0004747,0.2476282228137679,2.476452949435161,1,0.4,0.4,transcript,2343.0
AKR1C1,ENSG00000187134,interleukin-2 receptor subunit alpha measurement,EFO_0010587,0.2476282228137679,2.476421419090267,2,0.8,1.6,transcript,11495.0
CAPN7,ENSG00000131375,protozoa infectious disease,MONDO_0002428,0.2476282228137679,2.476320875480674,1,0.4,0.4,transcript,10350.0
ANKRD10,ENSG00000088448,brain aneurysm,EFO_0003870,0.2476282228137679,2.4764603225277058,2,0.8,1.6,transcript,8984.0
RCOR3,ENSG00000117625,skin disease,EFO_0000701,0.2476282228137679,2.476346583378609,2,0.8,1.6,transcript,24862.0
TRAPPC8,ENSG00000153339,vertebral disorder,MONDO_0045002,0.2476282228137679,2.4763026371339643,1,0.5,0.5,transcript,24499.0
ANKRD34B,ENSG00000189127,X-linked dystonia-parkinsonism,MONDO_0010747,0.2476282228137679,2.4763758610964803,1,0.4,0.4,transcript,4272.0
ZNF398,ENSG00000197024,hippocampal volume,EFO_0005035,0.24758543337311345,2.475879827676322,1,0.4,0.4,transcript,15690.0
ATPSCKMT,ENSG00000150756,ovarian dysfunction,EFO_0009003,0.24732566762729866,2.473304386196651,1,0.4,0.4,transcript,8384.0
SLC11A2,ENSG00000110911,mean corpuscular hemoglobin concentration,EFO_0004528,0.24731359593853772,2.473163920659013,2,0.8,1.6,transcript,57222.0
GMCL2,ENSG00000244234,platelet crit,EFO_0007985,0.24730106441303756,2.4731501627909966,1,0.4,0.4,transcript,2867.0
SHOC1,ENSG00000165181,HbA1c measurement,EFO_0004541,0.247274334049401,2.4728597132448824,3,1.3,3.9000000000000004,transcript,33513.0
SHOC1,ENSG00000165181,triglyceride measurement,EFO_0004530,0.247274334049401,2.4728597132448824,3,1.3,3.9000000000000004,transcript,33513.0
LSM6,ENSG00000164167,glucose measurement,EFO_0004468,0.24725721007768706,2.472737509646921,2,0.8,1.6,transcript,9673.0
MCL1,ENSG00000143384,urate measurement,EFO_0004531,0.2472220166497279,2.472236935876393,1,0.4,0.4,transcript,23853.0
HEPHL1,ENSG00000181333,level of tubulointerstitial nephritis antigen-like in blood serum,OBA_2043857,0.24721015967438514,2.4721704554114363,1,0.4,0.4,transcript,5809.0
GCNT1,ENSG00000187210,platelet count,EFO_0004309,0.24710629624960231,2.471082060132691,1,0.4,0.4,transcript,20945.0
TAF1B,ENSG00000115750,endometrial cancer,MONDO_0011962,0.2470372012954733,2.4704264139992334,1,0.5,0.5,transcript,9191.0
SLC25A16,ENSG00000122912,drug dependence,EFO_0003890,0.2469861126119705,2.4698921627429207,1,0.4,0.4,transcript,12888.0
PTBP3,ENSG00000119314,male infertility,EFO_0004248,0.24698048381170293,2.4700382757191583,5,2.0,10.0,transcript,42838.0
SYNJ2,ENSG00000078269,nervous system cancer,EFO_0007392,0.24698048381170293,2.469855985741862,2,0.8,1.6,transcript,31282.0
CD2AP,ENSG00000198087,Peyronie disease,MONDO_0008231,0.24698048381170293,2.469856907890526,1,0.4,0.4,transcript,7682.0
TMCC1,ENSG00000172765,serum creatinine amount,OBA_2050096,0.24698048381170293,2.4698150395962437,1,0.4,0.4,transcript,39210.0
EPRS1,ENSG00000136628,frozen shoulder,EFO_1000941,0.24698048381170293,2.469849552837115,1,0.5,0.5,transcript,11182.0
STXBP4,ENSG00000166263,breast neoplasm,EFO_0003869,0.2469715196737906,2.470106908124956,5,2.0,10.0,transcript,25529.0
RALGPS2,ENSG00000116191,cerebral cortex area attribute,OBA_2045267,0.24693101796064545,2.4693897143283317,2,0.8,1.6,transcript,20117.0
TMEM154,ENSG00000170006,chronic kidney disease,EFO_0003884,0.24692062732620332,2.469225358142037,1,0.4,0.4,transcript,20959.0
TAF2,ENSG00000064313,diabetic ketoacidosis,EFO_1000897,0.24692062732620332,2.4692090662460573,1,0.5,0.5,transcript,179020.0
OTOGL,ENSG00000165899,arterial stiffness measurement,EFO_0004517,0.2469062817352628,2.46907767531055,1,0.5,0.5,transcript,33652.0
METTL14,ENSG00000145388,arterial stiffness measurement,EFO_0004517,0.2469062817352628,2.4690884042521355,1,0.4,0.4,transcript,15633.0
ARHGAP28,ENSG00000088756,lymphocyte count,EFO_0004587,0.2469062817352628,2.4690751189887457,1,0.4,0.4,transcript,32516.0
DPP8,ENSG00000074603,neutrophil count,EFO_0004833,0.2469009807904123,2.4691915279983903,4,1.6,6.4,transcript,35219.0
CDH19,ENSG00000071991,neutrophil count,EFO_0004833,0.24686998335825447,2.468974391239653,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
FRAS1,ENSG00000138759,CXCL1 measurement,EFO_0010777,0.24683702456771547,2.468402382221762,2,0.9,1.8,transcript,56011.0
NRK,ENSG00000123572,squamous cell lung carcinoma,EFO_0000708,0.24683170112776967,2.4683422287786425,1,0.4,0.4,transcript,15862.0
ITPRID2,ENSG00000138434,body mass index,EFO_0004340,0.2468257935432201,2.46826672297147,1,0.4,0.4,transcript,45519.0
CD93,ENSG00000125810,deep vein thrombosis,EFO_0003907,0.2468220345815101,2.4682466633359907,1,0.4,0.4,transcript,15199.0
CMTR2,ENSG00000180917,tyrosine measurement,EFO_0005058,0.24676332457808436,2.4677366650814707,2,0.8,1.6,transcript,15471.0
CNOT6L,ENSG00000138767,breast adenocarcinoma,EFO_0000304,0.24655122705879753,2.465642159460829,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
OR4X1,ENSG00000176567,Agents acting on the renin-angiotensin system use measurement,EFO_0009931,0.24648769837542964,2.465421646063665,1,0.5,0.5,transcript,918.0
UBE2J1,ENSG00000198833,cystatin B measurement,EFO_0010593,0.24644077059640057,2.4648399826210663,2,0.9,1.8,transcript,4164.0
SMC3,ENSG00000108055,endometrial cancer,MONDO_0011962,0.24643852655088389,2.464393878031447,1,0.4,0.4,transcript,46444.0
SERPINB9,ENSG00000170542,reticulocyte count,EFO_0007986,0.24634864578706867,2.4635341734856215,1,0.4,0.4,transcript,8383.0
QSOX1,ENSG00000116260,breast adenocarcinoma,EFO_0000304,0.24625138823652015,2.4625429457961396,1,0.4,0.4,transcript,13763.0
METTL14,ENSG00000145388,Red cell distribution width,EFO_0009188,0.24622452876111103,2.462270874510618,1,0.4,0.4,transcript,15633.0
MMP12,ENSG00000262406,emphysema pattern measurement,EFO_0005850,0.24621845203727455,2.4624040593409124,1,0.4,0.4,transcript,1822.0
CDH19,ENSG00000071991,lung disease,EFO_0003818,0.24618873357131205,2.4621618933702285,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
HS3ST3A1,ENSG00000153976,epilepsy,EFO_0000474,0.24618873357131205,2.4619683729902677,1,0.4,0.4,transcript,4936.0
ATXN3,ENSG00000066427,glucose measurement,EFO_0004468,0.2461792026980576,2.4617977501781265,1,0.4,0.4,transcript,69891.0
TAF2,ENSG00000064313,breast adenocarcinoma,EFO_0000304,0.24616998170328566,2.461702610016881,1,0.5,0.5,transcript,179020.0
APIP,ENSG00000149089,urate measurement,EFO_0004531,0.2461639595811742,2.4617123654231525,1,0.5,0.5,transcript,6871.0
NRCAM,ENSG00000091129,diastolic blood pressure,EFO_0006336,0.24614748667813768,2.461486520095288,1,0.4,0.4,transcript,34325.0
SEPTIN7,ENSG00000122545,response to stimulus,GO_0050896,0.2461389042522309,2.4613987188491753,1,0.4,0.4,transcript,41338.0
SEPTIN7,ENSG00000122545,adverse effect,EFO_0009658,0.2461389042522309,2.4613987188491753,1,0.4,0.4,transcript,41338.0
AHCTF1,ENSG00000153207,insulin measurement,EFO_0004467,0.2461063335445006,2.4610766019153285,1,0.5,0.5,transcript,37689.0
SLC35D3,ENSG00000182747,sialate O-acetylesterase measurement,EFO_0803073,0.2460906842843445,2.461077564140927,1,0.4,0.4,transcript,2343.0
MTMR6,ENSG00000139505,hematocrit,EFO_0004348,0.2459632910584226,2.459686535637851,1,0.5,0.5,transcript,9324.0
CLDN16,ENSG00000113946,breast adenocarcinoma,EFO_0000304,0.2459201928390305,2.4593023048018483,1,0.4,0.4,transcript,3985.0
PARD6B,ENSG00000124171,breast adenocarcinoma,EFO_0000304,0.2459201928390305,2.4592803443871682,1,0.4,0.4,transcript,5101.0
NCS1,ENSG00000107130,hemoglobin measurement,EFO_0004509,0.24591626100526992,2.4592242623338336,1,0.4,0.4,transcript,6488.0
LDLRAP1,ENSG00000157978,lung adenocarcinoma,EFO_0000571,0.24590653846043733,2.4590912980534534,1,0.4,0.4,transcript,15436.0
ARHGAP12,ENSG00000165322,pulse wave reflection index measurement,EFO_0009804,0.2458989231083966,2.45900129344638,1,0.4,0.4,transcript,33161.0
CNTN1,ENSG00000018236,platelet count,EFO_0004309,0.24589209863789052,2.4589375132557385,1,0.4,0.4,transcript,24203.0
PFAS,ENSG00000178921,reticulocyte measurement,EFO_0010700,0.2458823374866011,2.4588467012014434,1,0.4,0.4,transcript,17148.0
KLRD1,ENSG00000134539,erythrocyte volume,OBA_0003460,0.24583650916422367,2.4585295812406884,4,1.7000000000000002,6.800000000000001,transcript,41340.0
SYNJ2,ENSG00000078269,breast adenocarcinoma,EFO_0000304,0.24578988278621924,2.4579499754870247,2,0.8,1.6,transcript,31282.0
MTMR6,ENSG00000139505,breast adenocarcinoma,EFO_0000304,0.24578988278621924,2.4579524529158174,1,0.5,0.5,transcript,9324.0
TRMT9B,ENSG00000250305,biliary tract disease,EFO_0009534,0.24578766924643458,2.4580178191255246,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
PEX7,ENSG00000112357,total blood protein measurement,EFO_0004536,0.24570463915446755,2.45708893568422,1,0.4,0.4,transcript,9402.0
DZIP3,ENSG00000198919,autoimmune disease,EFO_0005140,0.24567407723160556,2.4567629072283457,1,0.4,0.4,transcript,18071.0
MAP1LC3B2,ENSG00000258102,ovarian neoplasm,EFO_0003893,0.24564699751255584,2.4566362261646275,1,0.4,0.4,transcript,2406.0
MTCH2,ENSG00000109919,neuroticism measurement,EFO_0007660,0.24558395777557687,2.455899030787873,1,0.4,0.4,transcript,6728.0
GSTA5,ENSG00000182793,erythrocyte volume,OBA_0003460,0.24554487545174875,2.4557988945735096,1,0.5,0.5,transcript,1428.0
IL1A,ENSG00000115008,glioblastoma multiforme,EFO_0000519,0.24553298512321825,2.4555281655603927,1,0.4,0.4,transcript,2017.0
ZNF236,ENSG00000130856,Abruptio Placentae,EFO_1001754,0.24549773518547766,2.4550363199137446,2,0.9,1.8,transcript,30525.0
ZNF33B,ENSG00000196693,aging,EFO_0022597,0.24549773518547766,2.4550084773527843,1,0.5,0.5,transcript,16064.0
CLEC1A,ENSG00000150048,neurodegenerative disease,EFO_0005772,0.24547333522946224,2.454808416098856,1,0.5,0.5,transcript,6661.0
CPB1,ENSG00000153002,growth differentiation factor 15 amount,OBA_2050135,0.2454105685571878,2.454151264423291,1,0.5,0.5,transcript,10970.0
NUP43,ENSG00000120253,breast adenocarcinoma,EFO_0000304,0.24540527363655962,2.454254935278777,2,0.8,1.6,transcript,7913.0
NUP153,ENSG00000124789,breast adenocarcinoma,EFO_0000304,0.24540527363655962,2.454080720918123,1,0.5,0.5,transcript,17867.0
MAP1LC3B2,ENSG00000258102,P-selectin glycoprotein ligand 1 measurement,EFO_0010922,0.24538154497491949,2.453981700788264,1,0.4,0.4,transcript,2406.0
TMCC1,ENSG00000172765,drug use measurement,EFO_0007010,0.24533493341743956,2.4533595356536098,1,0.4,0.4,transcript,39210.0
TMCC1,ENSG00000172765,Loss of consciousness,HP_0007185,0.24533493341743956,2.4533595356536098,1,0.4,0.4,transcript,39210.0
TMCC1,ENSG00000172765,inherited retinal dystrophy,MONDO_0019118,0.24533493341743956,2.4533595356536098,1,0.4,0.4,transcript,39210.0
DMXL1,ENSG00000172869,nephrotic syndrome,EFO_0004255,0.24533493341743956,2.4533600187912183,1,0.4,0.4,transcript,37437.0
SRGN,ENSG00000122862,breast adenocarcinoma,EFO_0000304,0.24532743859980843,2.453397766627326,1,0.4,0.4,transcript,3242.0
NEK1,ENSG00000137601,high density lipoprotein cholesterol measurement,EFO_0004612,0.24519566693718892,2.4519709292401637,2,0.8,1.6,transcript,112203.0
PROK2,ENSG00000163421,lymphocyte count,EFO_0004587,0.24507042308116642,2.4512196947291898,2,0.8,1.6,transcript,3104.0
TAF2,ENSG00000064313,glioblastoma multiforme,EFO_0000519,0.24502493919328688,2.450252184916893,1,0.5,0.5,transcript,179020.0
SLC35F5,ENSG00000115084,arterial stiffness measurement,EFO_0004517,0.24500792222975754,2.450149981186661,2,0.8,1.6,transcript,22612.0
TEX15,ENSG00000133863,triglyceride measurement,EFO_0004530,0.24490582692066987,2.4490731927979117,1,0.5,0.5,transcript,33504.0
LHX9,ENSG00000143355,heart rate,OBA_1001087,0.2448826812270647,2.4489010788878023,2,0.8,1.6,transcript,21544.0
LIMA1,ENSG00000050405,neuroimaging measurement,EFO_0004346,0.24480691105374458,2.4480825149139744,1,0.4,0.4,transcript,29841.0
PDP1,ENSG00000164951,bone tissue density,OBA_1000110,0.2447995170681865,2.4480185378976613,1,0.4,0.4,transcript,17118.0
HNRNPA0,ENSG00000177733,Allergy,HP_0012393,0.2447995170681865,2.4480181248882236,1,0.4,0.4,transcript,17426.0
CD93,ENSG00000125810,ovarian neoplasm,EFO_0003893,0.2447995170681865,2.448021488202755,1,0.4,0.4,transcript,15199.0
CD93,ENSG00000125810,frozen shoulder,EFO_1000941,0.2447995170681865,2.448021488202755,1,0.4,0.4,transcript,15199.0
RSBN1L,ENSG00000187257,serum creatinine amount,OBA_2050096,0.24472468780361478,2.447383595117238,2,0.8,1.6,transcript,11703.0
MTCH2,ENSG00000109919,omega-6 polyunsaturated fatty acid measurement,EFO_0005680,0.24470163416132304,2.4470757946453348,1,0.4,0.4,transcript,6728.0
KIAA0586,ENSG00000100578,wellbeing measurement,EFO_0007869,0.2446718573144346,2.4467242242027893,1,0.5,0.5,transcript,88479.0
CCDC7,ENSG00000216937,eosinophil count,EFO_0004842,0.24463824546648733,2.4464010517042243,1,0.5,0.5,transcript,26886.0
EXD1,ENSG00000178997,cystatin C measurement,EFO_0004617,0.24456862017631306,2.4457279859478165,1,0.4,0.4,transcript,9573.0
MCL1,ENSG00000143384,lymphocyte count,EFO_0004587,0.24451069370024817,2.4451237063815956,1,0.4,0.4,transcript,23853.0
SH3GL3,ENSG00000140600,body mass index,EFO_0004340,0.24442366965955067,2.4442883895394196,1,0.4,0.4,transcript,7738.0
APIP,ENSG00000149089,cystic fibrosis,MONDO_0009061,0.2444018737509666,2.4440915071210765,1,0.5,0.5,transcript,6871.0
HEPHL1,ENSG00000181333,bilirubin measurement,EFO_0004570,0.2443119016820379,2.443187875487964,1,0.4,0.4,transcript,5809.0
POU2F1,ENSG00000143190,arterial stiffness measurement,EFO_0004517,0.2443119016820379,2.443134028876937,2,0.8,1.6,transcript,106581.0
SERPINB9,ENSG00000170542,HbA1c measurement,EFO_0004541,0.24425099147728865,2.4425576303878214,1,0.4,0.4,transcript,8383.0
LGSN,ENSG00000146166,lean body mass,EFO_0004995,0.2442381286085456,2.4424118834999744,1,0.4,0.4,transcript,13073.0
KLF10,ENSG00000155090,systemic lupus erythematosus,MONDO_0007915,0.2442381286085456,2.4424421318414646,1,0.4,0.4,transcript,6574.0
SLC35D3,ENSG00000182747,pain,EFO_0003843,0.2442381286085456,2.442552007382938,1,0.4,0.4,transcript,2343.0
MAP1LC3B2,ENSG00000258102,pulse wave reflection index measurement,EFO_0009804,0.2442381286085456,2.442547537124525,1,0.4,0.4,transcript,2406.0
SLC35D3,ENSG00000182747,phosphate measurement,EFO_0010968,0.2442381286085456,2.442552007382938,1,0.4,0.4,transcript,2343.0
KLF10,ENSG00000155090,uric acid measurement,EFO_0004761,0.24415889187818374,2.4416497645378463,1,0.4,0.4,transcript,6574.0
GSTA5,ENSG00000182793,saturated fatty acids measurement ,EFO_0022304,0.244098750277347,2.4413376428294926,1,0.5,0.5,transcript,1428.0
CCDC50,ENSG00000152492,placenta praevia,EFO_0007442,0.24388325918752513,2.4388690383444995,1,0.4,0.4,transcript,10975.0
PDCD4,ENSG00000150593,lymphocyte percentage of leukocytes,EFO_0007993,0.24384076160063273,2.43844262756014,1,0.5,0.5,transcript,14281.0
PKHD1L1,ENSG00000205038,erythrocyte volume,OBA_0003460,0.24382268671375,2.4382429133505936,1,0.4,0.4,transcript,24928.0
WBP2NL,ENSG00000183066,testosterone measurement,EFO_0004908,0.24377121024275014,2.4377542573891406,1,0.5,0.5,transcript,11861.0
UBE2U,ENSG00000177414,brain attribute,OBA_2045210,0.24375212476325106,2.4375884632265286,1,0.4,0.4,transcript,5951.0
B4GALT6,ENSG00000118276,chloride measurement,EFO_0009284,0.24369069717926814,2.4369382095904166,1,0.4,0.4,transcript,12805.0
APIP,ENSG00000149089,chronic obstructive pulmonary disease,EFO_0000341,0.24366090199826593,2.43668178959407,1,0.5,0.5,transcript,6871.0
PEX7,ENSG00000112357,platelet volume,OBA_0003277,0.2436435928269527,2.4364784724090716,1,0.4,0.4,transcript,9402.0
AHNAK2,ENSG00000185567,systemic scleroderma,EFO_0000717,0.24358041520223864,2.435851981748561,2,1.0,2.0,transcript,41815.0
FIGNL1,ENSG00000132436,metabolite measurement,EFO_0004725,0.2435287852917747,2.4353040354567876,1,0.4,0.4,transcript,24718.0
DENND3,ENSG00000105339,Oculomotor palsy,Orphanet_98685,0.243517276907369,2.4351835857313424,1,0.5,0.5,transcript,46225.0
CFHR4,ENSG00000134365,phosphopantothenoylcysteine decarboxylase measurement,EFO_0802867,0.24324892835858694,2.4325297923762768,1,0.5,0.5,transcript,12343.0
MYO3A,ENSG00000095777,Hypercholesterolemia,HP_0003124,0.24322631758057853,2.4322868915957585,1,0.5,0.5,transcript,21083.0
CPPED1,ENSG00000103381,intelligence,EFO_0004337,0.2432162863967948,2.432200592698376,1,0.4,0.4,transcript,10602.0
SLC35B4,ENSG00000205060,self reported educational attainment,EFO_0004784,0.2431967598467158,2.432009518400086,1,0.4,0.4,transcript,9542.0
FRRS1L,ENSG00000260230,BMI-adjusted waist-hip ratio,EFO_0007788,0.24318875899532064,2.431973495993475,2,0.8,1.6,transcript,18625.0
CENPQ,ENSG00000031691,megaloblastic anemia,MONDO_0001700,0.24308099736698544,2.4310397266853627,1,0.4,0.4,transcript,1741.0
SHC4,ENSG00000185634,Keloid,EFO_0004212,0.24299339207757345,2.429967696001606,1,0.4,0.4,transcript,11843.0
ADAT2,ENSG00000189007,liver disease,EFO_0001421,0.24290171769514415,2.4290469854319543,1,0.4,0.4,transcript,13419.0
CR2,ENSG00000117322,temporal measurement,EFO_0000719,0.24285969944954905,2.4286153204220953,1,0.4,0.4,transcript,21827.0
BACH1,ENSG00000156273,urinary microalbumin measurement,EFO_0010967,0.24285673772589383,2.4289252390348275,4,1.6,6.4,transcript,17884.0
TPRG1,ENSG00000188001,cartilage disease,EFO_0005802,0.24285673772589383,2.4286672337152826,2,0.8,1.6,transcript,16023.0
MYO3A,ENSG00000095777,peritonitis,EFO_0008588,0.24285673772589383,2.4285910930489116,1,0.5,0.5,transcript,21083.0
BACH1,ENSG00000156273,hypoxanthine measurement,EFO_0010500,0.24285673772589383,2.4289252390348275,4,1.6,6.4,transcript,17884.0
MYO3A,ENSG00000095777,arterial stiffness measurement,EFO_0004517,0.24285673772589383,2.4285910930489116,1,0.5,0.5,transcript,21083.0
TPRG1,ENSG00000188001,urinary microalbumin measurement,EFO_0010967,0.24285673772589383,2.4286672337152826,2,0.8,1.6,transcript,16023.0
SAXO1,ENSG00000155875,drug use measurement,EFO_0007010,0.24285673772589383,2.428594052817458,1,0.4,0.4,transcript,14995.0
TPRG1,ENSG00000188001,high density lipoprotein cholesterol measurement,EFO_0004612,0.24285673772589383,2.4286672337152826,2,0.8,1.6,transcript,16023.0
SAXO1,ENSG00000155875,response to antihypertensive drug,EFO_0005405,0.24285673772589383,2.428594052817458,1,0.4,0.4,transcript,14995.0
TMEM68,ENSG00000167904,lean body mass,EFO_0004995,0.24285673772589383,2.4285860487802005,1,0.4,0.4,transcript,21423.0
TMEM68,ENSG00000167904,trauma complication,EFO_0009888,0.24285673772589383,2.4285860487802005,1,0.4,0.4,transcript,21423.0
TMEM68,ENSG00000167904,high density lipoprotein cholesterol measurement,EFO_0004612,0.24285673772589383,2.4285860487802005,1,0.4,0.4,transcript,21423.0
TMEM68,ENSG00000167904,bilirubin measurement,EFO_0004570,0.24285673772589383,2.4285860487802005,1,0.4,0.4,transcript,21423.0
TMEM68,ENSG00000167904,cataract,MONDO_0005129,0.24285673772589383,2.4285860487802005,1,0.4,0.4,transcript,21423.0
MYO3A,ENSG00000095777,protozoa infectious disease,MONDO_0002428,0.24285673772589383,2.4285910930489116,1,0.5,0.5,transcript,21083.0
TMEM68,ENSG00000167904,metabolite measurement,EFO_0004725,0.24285673772589383,2.4285860487802005,1,0.4,0.4,transcript,21423.0
TMEM68,ENSG00000167904,liver disease,EFO_0001421,0.24285673772589383,2.4285860487802005,1,0.4,0.4,transcript,21423.0
SLF1,ENSG00000133302,blood urea nitrogen measurement,EFO_0004741,0.24285673772589383,2.428602290412469,1,0.4,0.4,transcript,11457.0
SLF1,ENSG00000133302,diabetic ketoacidosis,EFO_1000897,0.24285673772589383,2.428602290412469,1,0.4,0.4,transcript,11457.0
SLF1,ENSG00000133302,body fat percentage,EFO_0007800,0.24285673772589383,2.428602290412469,1,0.4,0.4,transcript,11457.0
SAXO1,ENSG00000155875,kidney disease,EFO_0003086,0.24285673772589383,2.428594052817458,1,0.4,0.4,transcript,14995.0
GPAT3,ENSG00000138678,benign chondrogenic neoplasm,MONDO_0024470,0.24283104158574437,2.4284575422942254,2,0.8,1.6,transcript,10875.0
ALPK3,ENSG00000136383,taste liking measurement,EFO_0010155,0.2427860223117379,2.427897519154675,1,0.4,0.4,transcript,10725.0
ZNF148,ENSG00000163848,high density lipoprotein cholesterol measurement,EFO_0004612,0.24275628010573586,2.427574669437028,1,0.4,0.4,transcript,33703.0
TBC1D9B,ENSG00000197226,appendicular lean mass,EFO_0004980,0.24275590624679394,2.4275712773273157,1,0.4,0.4,transcript,32747.0
ABCB5,ENSG00000004846,eosinophil percentage of granulocytes,EFO_0007996,0.24270815107149993,2.4271084231822,1,0.4,0.4,transcript,14863.0
SIX4,ENSG00000100625,HbA1c measurement,EFO_0004541,0.242686667577783,2.4269064095614796,1,0.4,0.4,transcript,10067.0
CD2AP,ENSG00000198087,glioblastoma multiforme,EFO_0000519,0.242654810135306,2.426600171126556,1,0.4,0.4,transcript,7682.0
SRSF7,ENSG00000115875,pulse wave reflection index measurement,EFO_0009804,0.24260372576264425,2.426059221166965,1,0.4,0.4,transcript,18212.0
ZNF697,ENSG00000143067,urate measurement,EFO_0004531,0.2425903750033771,2.426549026965121,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
SLC25A16,ENSG00000122912,appendicular lean mass,EFO_0004980,0.24250762833417128,2.425107319964928,1,0.4,0.4,transcript,12888.0
SLC22A15,ENSG00000163393,arterial stiffness measurement,EFO_0004517,0.24246423721515162,2.42489139938887,2,0.8,1.6,transcript,6425.0
RBM23,ENSG00000100461,eosinophil count,EFO_0004842,0.24236047667479604,2.423614625521036,1,0.4,0.4,transcript,40573.0
ONECUT2,ENSG00000119547,headache disorder,EFO_0009550,0.24229733483958987,2.4241351741220396,7,2.8000000000000003,19.6,transcript,16870.0
CCDC14,ENSG00000175455,self reported educational attainment,EFO_0004784,0.24225459533472696,2.4225546188585345,1,0.4,0.4,transcript,46160.0
TRDMT1,ENSG00000107614,high density lipoprotein cholesterol measurement,EFO_0004612,0.24220581644041086,2.4220719560808317,1,0.4,0.4,transcript,29003.0
MTMR6,ENSG00000139505,urinary microalbumin measurement,EFO_0010967,0.24208835514798047,2.42093717653343,1,0.5,0.5,transcript,9324.0
MTMR6,ENSG00000139505,C-reactive protein measurement,EFO_0004458,0.24208835514798047,2.42093717653343,1,0.5,0.5,transcript,9324.0
USP15,ENSG00000135655,serum creatinine amount,OBA_2050096,0.24198838202356338,2.419966938078264,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
FRAS1,ENSG00000138759,blood urea nitrogen measurement,EFO_0004741,0.2419787657067844,2.4198197936124513,2,0.9,1.8,transcript,56011.0
RPAP3,ENSG00000005175,nutritional deficiency disease,EFO_1001067,0.24197496544388208,2.419898022391343,2,0.8,1.6,transcript,10784.0
PTPN4,ENSG00000088179,Palmar Fibromatosis,EFO_1000438,0.24197091345740512,2.4201727414354326,5,2.0,10.0,transcript,21570.0
MTMR6,ENSG00000139505,head and neck malignant neoplasia,EFO_0006859,0.241903465886994,2.419088283923565,1,0.5,0.5,transcript,9324.0
ZBTB34,ENSG00000177125,skin disease,EFO_0000701,0.24190001856196378,2.4190305139235275,1,0.4,0.4,transcript,13189.0
AHCTF1,ENSG00000153207,platelet volume,OBA_0003277,0.2417964672185781,2.4179779386561036,1,0.5,0.5,transcript,37689.0
NOM1,ENSG00000146909,glomerular filtration rate,OBA_0003747,0.24157152989992967,2.416596666882251,5,2.0,10.0,transcript,11346.0
CAV2,ENSG00000105971,neutrophil percentage of leukocytes,EFO_0007990,0.24153881660551155,2.4154123396213207,1,0.4,0.4,transcript,16547.0
LNPEP,ENSG00000113441,birdshot chorioretinopathy,MONDO_0011599,0.2414943722319485,2.4149643845437736,1,0.4,0.4,transcript,19359.0
LMNTD1,ENSG00000152936,Hypocalcemia,HP_0002901,0.2414583066767432,2.414737732517561,2,0.9,1.8,transcript,11638.0
GPR85,ENSG00000164604,body fat percentage,EFO_0007800,0.24141067030186278,2.4141302504372417,1,0.4,0.4,transcript,16987.0
ZNF77,ENSG00000175691,neurodegenerative disease,EFO_0005772,0.24132586988964064,2.4134131987032816,1,0.4,0.4,transcript,2589.0
SLAMF7,ENSG00000026751,phospholipid measurement,EFO_0004639,0.24130487779444665,2.4130649742436123,1,0.4,0.4,transcript,24697.0
CPD,ENSG00000108582,platelet volume,OBA_0003277,0.24124403275255854,2.412460545883855,1,0.4,0.4,transcript,19784.0
SH3GL3,ENSG00000140600,FEV/FVC ratio,EFO_0004713,0.24122615433923467,2.4123132363362596,1,0.4,0.4,transcript,7738.0
REG1A,ENSG00000115386,lithostathine-1-alpha measurement,EFO_0801083,0.24115539695878288,2.4116951626693677,1,0.4,0.4,transcript,2833.0
GLCE,ENSG00000138604,appendicular lean mass,EFO_0004980,0.2409812501066459,2.4099428260644227,2,0.8,1.6,transcript,12277.0
GSTA5,ENSG00000182793,fatty acid measurement,EFO_0005110,0.2407447538547535,2.4077976786035573,1,0.5,0.5,transcript,1428.0
KPNA4,ENSG00000186432,pit and fissure surface dental caries,EFO_0006338,0.2407369871694909,2.4073788649050356,1,0.4,0.4,transcript,44478.0
SERPINB9,ENSG00000170542,high density lipoprotein cholesterol measurement,EFO_0004612,0.24073453732336622,2.407393088848597,1,0.4,0.4,transcript,8383.0
FAM114A1,ENSG00000197712,response to darapladib,EFO_0008395,0.24072390804856672,2.407287760052419,1,0.4,0.4,transcript,8217.0
FAM114A1,ENSG00000197712,Diarrhea,HP_0002014,0.24072390804856672,2.407287760052419,1,0.4,0.4,transcript,8217.0
WDR59,ENSG00000103091,hemolytic anemia,EFO_0005558,0.24072390804856672,2.4073127351374186,2,0.8,1.6,transcript,21723.0
SLC22A24,ENSG00000197658,progesterone measurement,EFO_0007004,0.24069025894677573,2.4069878845888764,1,0.5,0.5,transcript,5862.0
SLC22A24,ENSG00000197658,hormone measurement,EFO_0004730,0.24069025894677573,2.4069878845888764,1,0.5,0.5,transcript,5862.0
RPRD2,ENSG00000163125,glucose measurement,EFO_0004468,0.24068569552318242,2.406875461755374,1,0.4,0.4,transcript,21614.0
DBR1,ENSG00000138231,glucose measurement,EFO_0004468,0.2405706761578706,2.4057251930596752,1,0.4,0.4,transcript,21702.0
ZNF697,ENSG00000143067,connective tissue disease,EFO_1001986,0.24042327625355145,2.4048780394668645,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
ZNF675,ENSG00000197372,carnosine measurement,EFO_0010470,0.24035873220289458,2.4036301192556855,1,0.5,0.5,transcript,11683.0
HPSE,ENSG00000173083,blood protein measurement,EFO_0007937,0.24033236276748793,2.4034114754054796,2,0.9,1.8,transcript,20490.0
ADAT2,ENSG00000189007,aortic atherosclerosis,MONDO_0000980,0.24028570854287984,2.402886893909311,1,0.4,0.4,transcript,13419.0
TLR10,ENSG00000174123,hypertension,EFO_0000537,0.24027938837973353,2.402955326014475,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
CPPED1,ENSG00000103381,schizophrenia,MONDO_0005090,0.24026919245802655,2.402729653310694,1,0.4,0.4,transcript,10602.0
RNMT,ENSG00000101654,glomerular filtration rate,OBA_0003747,0.24015319782577915,2.4015483999672913,1,0.4,0.4,transcript,24358.0
AKAP10,ENSG00000108599,pain measurement,EFO_0010639,0.240135767778295,2.4013928580819828,1,0.4,0.4,transcript,11370.0
AGO3,ENSG00000126070,gastric adenocarcinoma,EFO_0000503,0.24011041066072372,2.4011172727308017,1,0.4,0.4,transcript,30381.0
SLC22A15,ENSG00000163393,monocyte count,EFO_0005091,0.24010911335514226,2.4013401607887763,2,0.8,1.6,transcript,6425.0
F13B,ENSG00000143278,serum albumin amount,OBA_2050068,0.23998705470324766,2.3999784451766284,1,0.5,0.5,transcript,4634.0
FBXO42,ENSG00000037637,smoking initiation,EFO_0005670,0.23995500142746548,2.399585585639706,1,0.4,0.4,transcript,11245.0
LSM6,ENSG00000164167,tooth disease,EFO_1001216,0.23995062708895518,2.3996716797596025,2,0.8,1.6,transcript,9673.0
TPRG1,ENSG00000188001,asthma,MONDO_0004979,0.23992601911838388,2.399360047640183,2,0.8,1.6,transcript,16023.0
FIGNL1,ENSG00000132436,metabolic rate measurement,EFO_0005115,0.23983111057887258,2.398327288327766,1,0.4,0.4,transcript,24718.0
FIGNL1,ENSG00000132436,whole body water mass,EFO_0009805,0.23983111057887258,2.398327288327766,1,0.4,0.4,transcript,24718.0
USP15,ENSG00000135655,ovarian cancer,MONDO_0008170,0.23980455300998835,2.3981286479425137,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
TRDN,ENSG00000186439,heart rate,OBA_1001087,0.2397529686041327,2.3975488894825836,1,0.5,0.5,transcript,26037.0
TMED5,ENSG00000117500,intermediate density lipoprotein measurement,EFO_0008595,0.23970245518820207,2.3970565191475406,1,0.5,0.5,transcript,15641.0
TMED5,ENSG00000117500,free cholesterol:total lipids ratio,EFO_0020945,0.23970245518820207,2.3970565191475406,1,0.5,0.5,transcript,15641.0
KCNN3,ENSG00000143603,apolipoprotein A 1 measurement,EFO_0004614,0.23969571746627139,2.3970762104726537,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
LSM11,ENSG00000155858,systolic blood pressure,EFO_0006335,0.23968539040213224,2.396914814634997,1,0.4,0.4,transcript,6567.0
DOCK1,ENSG00000150760,triglyceride measurement,EFO_0004530,0.2396567503554026,2.396592591361352,1,0.4,0.4,transcript,15944.0
ADAT2,ENSG00000189007,systemic lupus erythematosus,MONDO_0007915,0.23958593609952433,2.395889169475756,1,0.4,0.4,transcript,13419.0
ADAT2,ENSG00000189007,alkaline phosphatase measurement,EFO_0004533,0.23958593609952433,2.395889169475756,1,0.4,0.4,transcript,13419.0
POU2F1,ENSG00000143190,gestational diabetes,EFO_0004593,0.2395687858260918,2.395702870317476,2,0.8,1.6,transcript,106581.0
SLC35F5,ENSG00000115084,serum alanine aminotransferase measurement,EFO_0004735,0.2393963722209247,2.3940344810983323,2,0.8,1.6,transcript,22612.0
NXPH2,ENSG00000144227,mental or behavioural disorder,EFO_0000677,0.23939331173110545,2.3940807732726643,1,0.4,0.4,transcript,2709.0
HNRNPA0,ENSG00000177733,glomerular filtration rate,OBA_0003747,0.23933644944580842,2.3933874486644426,1,0.4,0.4,transcript,17426.0
TAF2,ENSG00000064313,reticulocyte count,EFO_0007986,0.2393061694094138,2.393064487078162,1,0.5,0.5,transcript,179020.0
FIGLA,ENSG00000183733,pernicious anemia,EFO_0005576,0.23930270733794282,2.3937195941550518,1,0.5,0.5,transcript,722.0
ATPSCKMT,ENSG00000150756,Genu valgum,HP_0002857,0.23918929428492147,2.391940652772879,1,0.4,0.4,transcript,8384.0
ATPSCKMT,ENSG00000150756,Genu varum,HP_0002970,0.23918929428492147,2.391940652772879,1,0.4,0.4,transcript,8384.0
ZNF485,ENSG00000198298,angina pectoris,EFO_0003913,0.23912650514197284,2.391362384493507,1,0.5,0.5,transcript,5137.0
TAF1B,ENSG00000115750,erythrocyte volume,OBA_0003460,0.23910413858490306,2.3910957868935308,1,0.5,0.5,transcript,9191.0
BACE2,ENSG00000182240,educational attainment,EFO_0011015,0.23910259355884722,2.3911594915150167,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
ZNF148,ENSG00000163848,eosinophil count,EFO_0004842,0.23909702738607574,2.3909821422404267,1,0.4,0.4,transcript,33703.0
SHOC1,ENSG00000165181,erythrocyte volume,OBA_0003460,0.2390428970361487,2.3905453431123598,3,1.3,3.9000000000000004,transcript,33513.0
PEX13,ENSG00000162928,HbA1c measurement,EFO_0004541,0.23904083335780513,2.3904541630922584,1,0.4,0.4,transcript,8728.0
ZFP1,ENSG00000184517,cardiovascular disease,EFO_0000319,0.23902154905642561,2.3902438432719397,1,0.4,0.4,transcript,14108.0
MTCH2,ENSG00000109919,linoleic acid measurement,EFO_0006807,0.2390188541002726,2.3902479940348305,1,0.4,0.4,transcript,6728.0
GALNT3,ENSG00000115339,lung adenocarcinoma,EFO_0000571,0.23892727146710677,2.389301622671357,1,0.4,0.4,transcript,13837.0
ANOS1,ENSG00000011201,lung adenocarcinoma,EFO_0000571,0.23874289356609435,2.3874804422280307,1,0.4,0.4,transcript,7766.0
NBEAL1,ENSG00000144426,mean reticulocyte volume,EFO_0010701,0.23873478335541926,2.387351687155865,1,0.4,0.4,transcript,103799.0
DUSP22,ENSG00000112679,monocyte percentage of leukocytes,EFO_0007989,0.23871765924264898,2.3872001968169063,1,0.4,0.4,transcript,16946.0
RASSF2,ENSG00000101265,Red cell distribution width,EFO_0009188,0.2387094712256502,2.387195512357302,2,0.8,1.6,transcript,15873.0
TRMT9B,ENSG00000250305,self reported educational attainment,EFO_0004784,0.23866759061746393,2.386817032835818,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
TLR10,ENSG00000174123,atopic asthma,EFO_0010638,0.23864578227347297,2.3866192649518694,3,1.2000000000000002,3.6000000000000005,transcript,22299.0
FYCO1,ENSG00000163820,body mass index,EFO_0004340,0.2386451843454106,2.386476454295181,1,0.4,0.4,transcript,16253.0
MDGA2,ENSG00000139915,body fat percentage,EFO_0007800,0.23841065218396987,2.3841296125283784,1,0.4,0.4,transcript,17323.0
SKP2,ENSG00000145604,ovarian cancer,MONDO_0008170,0.23839541564509467,2.383959179304932,1,0.4,0.4,transcript,79636.0
CLASP2,ENSG00000163539,sitting height measurement,EFO_0011011,0.238356625049499,2.3835723698842752,1,0.4,0.4,transcript,65366.0
SNTG2,ENSG00000172554,aspartate aminotransferase measurement,EFO_0004736,0.23825033575294208,2.3825532477708897,1,0.5,0.5,transcript,10022.0
PLA2R1,ENSG00000153246,platelet crit,EFO_0007985,0.23809306516874615,2.381009843926622,2,0.8,1.6,transcript,20204.0
MRPL32,ENSG00000106591,BMI-adjusted waist-hip ratio,EFO_0007788,0.2380792679037586,2.380875821835341,1,0.4,0.4,transcript,4811.0
PDHX,ENSG00000110435,erythrocyte volume,OBA_0003460,0.23804899598643448,2.3805347276315523,1,0.4,0.4,transcript,8935.0
MTCH2,ENSG00000109919,diabetic eye disease,EFO_0009486,0.23803203850031524,2.3803798380352568,1,0.4,0.4,transcript,6728.0
MTCH2,ENSG00000109919,grip strength measurement,EFO_0006941,0.23803203850031524,2.3803798380352568,1,0.4,0.4,transcript,6728.0
DYNC1I2,ENSG00000077380,breast adenocarcinoma,EFO_0000304,0.23796748992931294,2.379686086226791,1,0.4,0.4,transcript,35756.0
SEC63,ENSG00000025796,connective tissue disease,EFO_1001986,0.23795795309947643,2.3798550552562063,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
PDP1,ENSG00000164951,multinodular goiter,MONDO_0000334,0.23795795309947643,2.3796028982105604,1,0.4,0.4,transcript,17118.0
RALGPS2,ENSG00000116191,aneurysm,EFO_0009659,0.23795795309947643,2.379659065716641,2,0.8,1.6,transcript,20117.0
ING1,ENSG00000153487,P-Selectin measurement,EFO_0008254,0.23795795309947643,2.3796060140456117,1,0.4,0.4,transcript,15104.0
ARPC5,ENSG00000162704,triglyceride measurement,EFO_0004530,0.23770104016073443,2.377037130641758,1,0.4,0.4,transcript,14965.0
UHMK1,ENSG00000152332,neurodegenerative disease,EFO_0005772,0.23764940326358966,2.376620650531226,3,1.2000000000000002,3.6000000000000005,transcript,28432.0
MC2R,ENSG00000185231,hemoglobin measurement,EFO_0004509,0.2376341948115424,2.3764365554947995,1,0.4,0.4,transcript,4228.0
PROK2,ENSG00000163421,serum metabolite measurement,EFO_0005653,0.23760192263673605,2.376534690284886,2,0.8,1.6,transcript,3104.0
TMED5,ENSG00000117500,C-reactive protein measurement,EFO_0004458,0.23752266835716587,2.375258650837179,1,0.5,0.5,transcript,15641.0
KIAA0319,ENSG00000137261,glioblastoma multiforme,EFO_0000519,0.23750315153875262,2.3750439027400394,1,0.4,0.4,transcript,32291.0
MTCH2,ENSG00000109919,visceral adipose tissue quantity,OBA_2045224,0.23750168749082423,2.375076327940347,1,0.4,0.4,transcript,6728.0
DOCK1,ENSG00000150760,educational attainment,EFO_0011015,0.23722984502093394,2.372323538016665,1,0.4,0.4,transcript,15944.0
PDCD5,ENSG00000105185,lysosomal storage disease,MONDO_0002561,0.23720897103859714,2.3721678201301617,1,0.4,0.4,transcript,5121.0
MTCH2,ENSG00000109919,glomerular filtration rate,OBA_0003747,0.23706982974158924,2.370757750447997,1,0.4,0.4,transcript,6728.0
ARPC5,ENSG00000162704,systolic blood pressure,EFO_0006335,0.2370116800435977,2.3701435294703908,1,0.4,0.4,transcript,14965.0
GSTA5,ENSG00000182793,phenylalanine measurement,EFO_0005001,0.23698956079211272,2.3702457479771497,1,0.5,0.5,transcript,1428.0
FIGLA,ENSG00000183733,premature menopause,EFO_0009005,0.23684935631752096,2.369186083950833,1,0.5,0.5,transcript,722.0
METTL2B,ENSG00000165055,X-25265 measurement,EFO_0800917,0.2367681846627729,2.3677844699360477,2,0.8,1.6,transcript,15591.0
FBXO28,ENSG00000143756,osteitis deformans,EFO_0004261,0.23661611076066724,2.3672100953335162,5,2.0,10.0,transcript,9533.0
FBXO28,ENSG00000143756,Subdural hemorrhage,HP_0100309,0.23661611076066724,2.3672100953335162,5,2.0,10.0,transcript,9533.0
SKP2,ENSG00000145604,breast adenocarcinoma,EFO_0000304,0.2365931149178777,2.3659361720327627,1,0.4,0.4,transcript,79636.0
DCK,ENSG00000156136,trauma complication,EFO_0009888,0.2365405990209486,2.3654429758775395,1,0.4,0.4,transcript,10815.0
DCK,ENSG00000156136,medical procedure,EFO_0002571,0.2365405990209486,2.3654429758775395,1,0.4,0.4,transcript,10815.0
DCK,ENSG00000156136,complication,EFO_0009518,0.2365405990209486,2.3654429758775395,1,0.4,0.4,transcript,10815.0
LIN9,ENSG00000183814,ovarian cancer,MONDO_0008170,0.23653110699820917,2.3654159055213397,2,0.8,1.6,transcript,15262.0
PEX7,ENSG00000112357,high density lipoprotein cholesterol measurement,EFO_0004612,0.23647785906239693,2.364821134763514,1,0.4,0.4,transcript,9402.0
SC5D,ENSG00000109929,HbA1c measurement,EFO_0004541,0.23644144410652715,2.364437283849807,1,0.4,0.4,transcript,17511.0
FYB1,ENSG00000082074,hemoglobin measurement,EFO_0004509,0.23637530007062066,2.363772650932184,1,0.5,0.5,transcript,25445.0
NOL9,ENSG00000162408,reticulocyte measurement,EFO_0010700,0.23624243346805154,2.362467037787167,1,0.4,0.4,transcript,9367.0
SMARCC1,ENSG00000173473,breast adenocarcinoma,EFO_0000304,0.23622879675978775,2.362402114704962,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,breast adenocarcinoma,EFO_0000304,0.23622879675978775,2.362402114704962,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,breast adenocarcinoma,EFO_0000304,0.23622879675978775,2.362402114704962,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,breast adenocarcinoma,EFO_0000304,0.23622879675978775,2.362402114704962,2,0.8,1.6,gene_variant,14017.0
ALAD,ENSG00000148218,neurodegenerative disease,EFO_0005772,0.23613105899685707,2.3613478999210007,1,0.4,0.4,transcript,10721.0
CPPED1,ENSG00000103381,lymphocyte count,EFO_0004587,0.23612360918507388,2.361273820581167,1,0.4,0.4,transcript,10602.0
GASK1B,ENSG00000164125,bone tissue density,OBA_1000110,0.23611395713726127,2.3613124571239457,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
ZNF716,ENSG00000182111,level of inactive C-alpha-formylglycine-generating enzyme 2 in blood serum,OBA_2043733,0.23611395713726127,2.3640186500674307,6,2.5,15.0,transcript,5210.0
ZNF716,ENSG00000182111,bone tissue density,OBA_1000110,0.23611395713726127,2.3640186500674307,6,2.5,15.0,transcript,5210.0
GASK1B,ENSG00000164125,growth differentiation factor 15 amount,OBA_2050135,0.23611395713726127,2.3613124571239457,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
IL1A,ENSG00000115008,head and neck squamous cell carcinoma,EFO_0000181,0.2360537206483493,2.3607355208117036,1,0.4,0.4,transcript,2017.0
MDGA2,ENSG00000139915,social inhibition quality,OBA_1000278,0.236035755754709,2.3603806482357697,1,0.4,0.4,transcript,17323.0
MDGA2,ENSG00000139915,substance abuse,MONDO_0002491,0.236035755754709,2.3603806482357697,1,0.4,0.4,transcript,17323.0
MDGA2,ENSG00000139915,attention deficit hyperactivity disorder,EFO_0003888,0.236035755754709,2.3603806482357697,1,0.4,0.4,transcript,17323.0
OTULINL,ENSG00000145569,anaphylaxis,MONDO_0100053,0.23602060758421908,2.3602560508546846,1,0.4,0.4,transcript,8004.0
ATF6,ENSG00000118217,serum alanine aminotransferase measurement,EFO_0004735,0.23599305909669613,2.3599369433999433,1,0.4,0.4,transcript,62968.0
DOCK1,ENSG00000150760,diet measurement,EFO_0008111,0.23591686930673747,2.3591937808747003,1,0.4,0.4,transcript,15944.0
RASSF2,ENSG00000101265,Abnormality of refraction,HP_0000539,0.23586273760713536,2.3587281761721535,2,0.8,1.6,transcript,15873.0
RBM44,ENSG00000177483,high density lipoprotein cholesterol measurement,EFO_0004612,0.23584864438700934,2.3585146924576637,1,0.4,0.4,transcript,14160.0
ARAP1,ENSG00000186635,cognitive function measurement,EFO_0008354,0.23584260151103958,2.3584350247281627,1,0.4,0.4,transcript,44397.0
CPPED1,ENSG00000103381,kidney disease,EFO_0003086,0.23583128411237064,2.3583505698541347,1,0.4,0.4,transcript,10602.0
CFAP46,ENSG00000171811,pulse wave reflection index measurement,EFO_0009804,0.23582514807229235,2.358272840941652,1,0.5,0.5,transcript,23408.0
CPPED1,ENSG00000103381,IGF-1 measurement,EFO_0004627,0.23580268700047405,2.3580645987351687,1,0.4,0.4,transcript,10602.0
CPPED1,ENSG00000103381,Abruptio Placentae,EFO_1001754,0.23580268700047405,2.3580645987351687,1,0.4,0.4,transcript,10602.0
SLC22A24,ENSG00000197658,X-11444 measurement,EFO_0021237,0.2356818830380105,2.3569041255012237,1,0.5,0.5,transcript,5862.0
CR1L,ENSG00000197721,Alzheimer disease,MONDO_0004975,0.23552075575407652,2.3553008411228546,1,0.5,0.5,transcript,5360.0
GPM6A,ENSG00000150625,body mass index,EFO_0004340,0.23550901631525603,2.3551083342332855,1,0.4,0.4,transcript,22013.0
EXOC6,ENSG00000138190,disorder of ear,MONDO_0021205,0.23549642881205243,2.354986905391072,1,0.5,0.5,transcript,22107.0
ZNF716,ENSG00000182111,X-11847 measurement,EFO_0021268,0.23537680273292527,2.3566471060240706,6,2.5,15.0,transcript,5210.0
AKR1C1,ENSG00000187134,lung adenocarcinoma,EFO_0000571,0.23536617225601544,2.353800913512743,2,0.8,1.6,transcript,11495.0
EXD1,ENSG00000178997,cardiovascular disease,EFO_0000319,0.2352916097657957,2.352957881842643,1,0.4,0.4,transcript,9573.0
FAM210A,ENSG00000177150,glomerular filtration rate,OBA_0003747,0.23522620387937196,2.3522841847354754,1,0.4,0.4,transcript,18062.0
ZNF24,ENSG00000172466,serum creatinine amount,OBA_2050096,0.23518102367982335,2.3518331096253147,1,0.5,0.5,transcript,21860.0
EXD1,ENSG00000178997,body fat percentage,EFO_0007800,0.23515463296340444,2.3515881138187305,1,0.4,0.4,transcript,9573.0
TMEM68,ENSG00000167904,frozen shoulder,EFO_1000941,0.23497689029654195,2.3497875744866814,1,0.4,0.4,transcript,21423.0
TMEM68,ENSG00000167904,taxonomic microbiome measurement,EFO_0007883,0.23497689029654195,2.3497875744866814,1,0.4,0.4,transcript,21423.0
TMEM68,ENSG00000167904,gut microbiome measurement,EFO_0007874,0.23497689029654195,2.3497875744866814,1,0.4,0.4,transcript,21423.0
LSM6,ENSG00000164167,injury,EFO_0000546,0.23497689029654195,2.34993431183547,2,0.8,1.6,transcript,9673.0
TMEM68,ENSG00000167904,mannonate measurement,EFO_0800971,0.23497689029654195,2.3497875744866814,1,0.4,0.4,transcript,21423.0
ABCB5,ENSG00000004846,atopic asthma,EFO_0010638,0.23497689029654195,2.34979581543262,1,0.4,0.4,transcript,14863.0
KIAA0319,ENSG00000137261,alkaline phosphatase measurement,EFO_0004533,0.2349518576113746,2.349530963466259,1,0.4,0.4,transcript,32291.0
CAV2,ENSG00000105971,Hernia,HP_0100790,0.23494039306017844,2.34942810416799,1,0.4,0.4,transcript,16547.0
EXOC6,ENSG00000138190,erythrocyte volume,OBA_0003460,0.2347349558296447,2.347372175566995,1,0.5,0.5,transcript,22107.0
SLF1,ENSG00000133302,high density lipoprotein cholesterol measurement,EFO_0004612,0.23472709767804292,2.34730588993396,1,0.4,0.4,transcript,11457.0
RGS4,ENSG00000117152,serum amyloid P-component amount,OBA_2050090,0.23469351609746847,2.3470314305294377,2,0.8,1.6,transcript,16620.0
IGFBPL1,ENSG00000137142,post term pregnancy,EFO_0009681,0.2346748861289792,2.348543589276331,4,1.6,6.4,transcript,3566.0
AKR1C1,ENSG00000187134,Lung Abscess,EFO_1001362,0.2346748861289792,2.34688805224238,2,0.8,1.6,transcript,11495.0
RALGPS2,ENSG00000116191,obesity,EFO_0001073,0.2346748861289792,2.3468283960116687,2,0.8,1.6,transcript,20117.0
HNRNPA0,ENSG00000177733,lymphocyte count,EFO_0004587,0.2346748861289792,2.34677181549615,1,0.4,0.4,transcript,17426.0
CDV3,ENSG00000091527,biliary tract disease,EFO_0009534,0.2346748861289792,2.3467749845917774,1,0.4,0.4,transcript,15312.0
AKR1C1,ENSG00000187134,bronchopneumonia,EFO_0007184,0.2346748861289792,2.34688805224238,2,0.8,1.6,transcript,11495.0
CPPED1,ENSG00000103381,self reported educational attainment,EFO_0004784,0.2346221364894929,2.346259093625357,1,0.4,0.4,transcript,10602.0
RPS20,ENSG00000008988,"osteoarthritis, knee",EFO_0004616,0.23460668138079827,2.3460840232904077,1,0.4,0.4,transcript,23243.0
PPP1R9A,ENSG00000158528,lymphocyte count,EFO_0004587,0.23458678389382795,2.345946847082196,3,1.3,3.9000000000000004,transcript,49362.0
TRIT1,ENSG00000043514,apolipoprotein A 1 measurement,EFO_0004614,0.23452736145824843,2.3452888173493878,1,0.4,0.4,transcript,26311.0
SC5D,ENSG00000109929,vertebral column disorder,MONDO_0000812,0.234522086853899,2.3452437113235254,1,0.4,0.4,transcript,17511.0
GLCE,ENSG00000138604,N-acetylmethionine measurement,EFO_0021427,0.234522086853899,2.3453511935369535,2,0.8,1.6,transcript,12277.0
ZNF485,ENSG00000198298,coronary atherosclerosis,MONDO_0021661,0.23440128935331275,2.3441102266069063,1,0.5,0.5,transcript,5137.0
TMED5,ENSG00000117500,platelet crit,EFO_0007985,0.2343239399264611,2.3432713665301312,1,0.5,0.5,transcript,15641.0
ADAT2,ENSG00000189007,carotid artery thickness,OBA_2050108,0.23418960340705275,2.3419258425510403,1,0.4,0.4,transcript,13419.0
ITGA8,ENSG00000077943,breast adenocarcinoma,EFO_0000304,0.2341355134355312,2.3418198903584106,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
KCNN3,ENSG00000143603,pulse wave reflection index measurement,EFO_0009804,0.23412989031136341,2.341417938923574,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
CHFR,ENSG00000072609,lymphocyte count,EFO_0004587,0.23412879304609743,2.341296019766912,1,0.4,0.4,transcript,49448.0
PYGO1,ENSG00000171016,appendicular lean mass,EFO_0004980,0.23397704864343094,2.3400983216970896,4,1.6,6.4,transcript,19522.0
KLRD1,ENSG00000134539,mean corpuscular hemoglobin concentration,EFO_0004528,0.23392463245014816,2.3394108140999337,4,1.7000000000000002,6.800000000000001,transcript,41340.0
ANKRD36B,ENSG00000196912,reticulocyte measurement,EFO_0010700,0.23391682761873,2.339197814794259,1,0.5,0.5,transcript,16927.0
FBXO22,ENSG00000167196,preeclampsia,EFO_0000668,0.2338975234229177,2.3389964330208457,1,0.4,0.4,transcript,18869.0
NRK,ENSG00000123572,anthropometric measurement,EFO_0004302,0.23381643281833897,2.3381895456843353,1,0.4,0.4,transcript,15862.0
THAP1,ENSG00000131931,mean reticulocyte volume,EFO_0010701,0.23378351022540583,2.337914467333423,1,0.4,0.4,transcript,5040.0
ARPC5,ENSG00000162704,diastolic blood pressure,EFO_0006336,0.2336305151911472,2.336331880945886,1,0.4,0.4,transcript,14965.0
ATP12A,ENSG00000075673,ovarian neoplasm,EFO_0003893,0.2335977393981332,2.336026546107161,1,0.4,0.4,transcript,8138.0
ARAP1,ENSG00000186635,self reported educational attainment,EFO_0004784,0.23348421815242595,2.3348511911420267,1,0.4,0.4,transcript,44397.0
ZNF148,ENSG00000163848,low density lipoprotein cholesterol measurement,EFO_0004611,0.2333156328667995,2.333168197047664,1,0.4,0.4,transcript,33703.0
CLDN1,ENSG00000163347,endometrial cancer,MONDO_0011962,0.2331875899156262,2.3335262343806047,4,1.6,6.4,transcript,3878.0
SLCO5A1,ENSG00000137571,platelet count,EFO_0004309,0.23317462525670113,2.3321768045346336,5,2.0,10.0,transcript,23226.0
ARHGAP29,ENSG00000137962,digestive system neoplasm,EFO_0008549,0.23316529727408933,2.3316731984599177,1,0.5,0.5,transcript,24721.0
CPD,ENSG00000108582,alkaline phosphatase measurement,EFO_0004533,0.23315212566613072,2.3315414750195766,1,0.4,0.4,transcript,19784.0
BACH1,ENSG00000156273,cartilage disease,EFO_0005802,0.2331509455734541,2.33186731751043,4,1.6,6.4,transcript,17884.0
CCDC34,ENSG00000109881,hematocrit,EFO_0004348,0.2330988611146646,2.331082134644425,1,0.4,0.4,transcript,4277.0
HNRNPA0,ENSG00000177733,hip circumference,OBA_1000032,0.23308883890769186,2.330911343283277,1,0.4,0.4,transcript,17426.0
SMC6,ENSG00000163029,pancreatic adenocarcinoma,EFO_1000044,0.2330831659119927,2.3308480687031237,1,0.4,0.4,transcript,24376.0
ZNF716,ENSG00000182111,phosphatidylcholine measurement,EFO_0010226,0.23308033026940664,2.333682381388884,6,2.5,15.0,transcript,5210.0
AKR1B10,ENSG00000198074,lung adenocarcinoma,EFO_0000571,0.2330577105869006,2.3307092411755597,1,0.5,0.5,transcript,3784.0
CST9,ENSG00000173335,cystatin B measurement,EFO_0010593,0.2329960171475346,2.3302051194239066,1,0.4,0.4,transcript,1633.0
RAPGEF4,ENSG00000091428,atopic eczema,EFO_0000274,0.23287056316708382,2.3287188177595146,1,0.4,0.4,transcript,30335.0
FIGLA,ENSG00000183733,Premature ovarian insufficiency,HP_0008209,0.23283530845136213,2.3290456052892448,1,0.5,0.5,transcript,722.0
SMC3,ENSG00000108055,ovarian cancer,MONDO_0008170,0.23283530845136213,2.3283616970362293,1,0.4,0.4,transcript,46444.0
PIAS2,ENSG00000078043,ovarian cancer,MONDO_0008170,0.23283530845136213,2.328366474531363,1,0.4,0.4,transcript,29873.0
SMC5,ENSG00000198887,ovarian cancer,MONDO_0008170,0.23283530845136213,2.3284174345779713,1,0.5,0.5,transcript,7770.0
SMC5,ENSG00000198887,endometrial cancer,MONDO_0011962,0.23283530845136213,2.3284174345779713,1,0.5,0.5,transcript,7770.0
TRIM44,ENSG00000166326,lymphocyte count,EFO_0004587,0.23273569663662758,2.327386311241927,1,0.4,0.4,transcript,13631.0
FZD3,ENSG00000104290,Abruptio Placentae,EFO_1001754,0.23273569663662758,2.3273710831829337,1,0.4,0.4,transcript,28335.0
EDEM1,ENSG00000134109,brain volume,OBA_2050009,0.2326576526794995,2.3267095055183993,2,0.8,1.6,transcript,12032.0
ALPK3,ENSG00000136383,creatine kinase measurement,EFO_0004534,0.23264025319746556,2.3264398280119516,1,0.4,0.4,transcript,10725.0
OR4X1,ENSG00000176567,serum creatinine amount,OBA_2050096,0.23246423115235643,2.3251869738329325,1,0.5,0.5,transcript,918.0
SRSF7,ENSG00000115875,chronic lymphocytic leukemia,EFO_0000095,0.2324395949819725,2.324417913360248,1,0.4,0.4,transcript,18212.0
KLRD1,ENSG00000134539,serum alanine aminotransferase measurement,EFO_0004735,0.2324265636699678,2.3244301262981297,4,1.7000000000000002,6.800000000000001,transcript,41340.0
ZNF483,ENSG00000173258,iminodiacetate (IDA) measurement,EFO_0800945,0.23227496778146242,2.3228331589791864,2,0.8,1.6,transcript,19166.0
DOCK1,ENSG00000150760,lung adenocarcinoma,EFO_0000571,0.23223474118749948,2.3223724996823205,1,0.4,0.4,transcript,15944.0
TMED5,ENSG00000117500,sex hormone-binding globulin measurement,EFO_0004696,0.23223299465190647,2.322361913784585,1,0.5,0.5,transcript,15641.0
ZFP90,ENSG00000184939,lymphatic system disease,EFO_0007352,0.2321595619475227,2.3216089746219666,1,0.4,0.4,transcript,29951.0
ZFP90,ENSG00000184939,vein disorder,MONDO_0004634,0.2321595619475227,2.3216089746219666,1,0.4,0.4,transcript,29951.0
ZNF697,ENSG00000143067,platelet count,EFO_0004309,0.23211770950739943,2.3218223720053444,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
RELCH,ENSG00000134444,serum albumin amount,OBA_2050068,0.231963327278169,2.319646991143718,1,0.4,0.4,transcript,29158.0
COQ3,ENSG00000132423,platelet volume,OBA_0003277,0.23191995323351222,2.319350078063387,1,0.4,0.4,transcript,2657.0
SMC6,ENSG00000163029,endometrial cancer,MONDO_0011962,0.23191135881465036,2.3191299977297004,1,0.4,0.4,transcript,24376.0
MUC16,ENSG00000181143,acute myeloid leukemia,EFO_0000222,0.231895093175593,2.318953752105315,1,0.5,0.5,transcript,177283.0
SMARCC1,ENSG00000173473,cognitive function measurement,EFO_0008354,0.23183014501333682,2.3184155972404525,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,cognitive function measurement,EFO_0008354,0.23183014501333682,2.3184155972404525,2,0.8,1.6,transcript,14017.0
SMARCC1,ENSG00000173473,cognitive function measurement,EFO_0008354,0.23183014501333682,2.3184155972404525,2,0.8,1.6,gene_variant,14017.0
SMARCC1,ENSG00000173473,cognitive function measurement,EFO_0008354,0.23183014501333682,2.3184155972404525,2,0.8,1.6,transcript,14017.0
XKR4,ENSG00000206579,cataract,MONDO_0005129,0.23182071348822506,2.31822608683904,1,0.4,0.4,transcript,21106.0
XKR4,ENSG00000206579,trauma complication,EFO_0009888,0.23182071348822506,2.31822608683904,1,0.4,0.4,transcript,21106.0
GPM6A,ENSG00000150625,alopecia areata,EFO_0004192,0.23174804561422627,2.317498627222988,1,0.4,0.4,transcript,22013.0
FAM186A,ENSG00000185958,diastolic blood pressure,EFO_0006336,0.2317352988550318,2.317463890180572,2,1.0,2.0,transcript,18034.0
ZNF283,ENSG00000167637,high density lipoprotein cholesterol measurement,EFO_0004612,0.2317101571487797,2.317131657533889,1,0.5,0.5,transcript,16619.0
NPS,ENSG00000214285,protein measurement,EFO_0004747,0.23163063656968216,2.316631304770745,1,0.4,0.4,transcript,1231.0
SLF1,ENSG00000133302,Antihypertensive use measurement,EFO_0009927,0.23163063656968216,2.316341278850352,1,0.4,0.4,transcript,11457.0
SLF1,ENSG00000133302,attention deficit hyperactivity disorder,EFO_0003888,0.23163063656968216,2.316341278850352,1,0.4,0.4,transcript,11457.0
CCDC66,ENSG00000180376,Abnormality of refraction,HP_0000539,0.2316299433532675,2.316314663041371,1,0.5,0.5,transcript,32831.0
TAF2,ENSG00000064313,ovarian cancer,MONDO_0008170,0.23154177895996567,2.315420582583681,1,0.5,0.5,transcript,179020.0
KLHDC10,ENSG00000128607,"osteoarthritis, hip",EFO_1000786,0.23137888162070594,2.3138385488938678,1,0.4,0.4,transcript,8043.0
SOGA1,ENSG00000149639,brain volume,OBA_2050009,0.23137888162070594,2.313810367002284,1,0.5,0.5,transcript,23201.0
STAM,ENSG00000136738,ovarian cancer,MONDO_0008170,0.23135698903262333,2.3136358860365123,1,0.4,0.4,transcript,6061.0
RPAP3,ENSG00000005175,mean corpuscular hemoglobin concentration,EFO_0004528,0.2312725224992869,2.312873592945391,2,0.8,1.6,transcript,10784.0
ITGA8,ENSG00000077943,lung adenocarcinoma,EFO_0000571,0.23126186021265016,2.3130833581296,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
ZNF236,ENSG00000130856,frozen shoulder,EFO_1000941,0.23121884176002927,2.312247385659261,2,0.9,1.8,transcript,30525.0
PROK2,ENSG00000163421,bone tissue density,OBA_1000110,0.2312031553491535,2.3125470174090608,2,0.8,1.6,transcript,3104.0
FDCSP,ENSG00000181617,growth differentiation factor 15 amount,OBA_2050135,0.23109041548191026,2.3116838819146195,1,0.4,0.4,transcript,513.0
DYNC1I2,ENSG00000077380,ovarian cancer,MONDO_0008170,0.2309874091779386,2.3098852787130477,1,0.4,0.4,transcript,35756.0
DYNC1I2,ENSG00000077380,low grade glioma,MONDO_0021637,0.2309874091779386,2.3098852787130477,1,0.4,0.4,transcript,35756.0
ANOS1,ENSG00000011201,cutaneous melanoma,EFO_0000389,0.2309874091779386,2.3099255983464735,1,0.4,0.4,transcript,7766.0
SKP2,ENSG00000145604,low grade glioma,MONDO_0021637,0.2309874091779386,2.3098791146333717,1,0.4,0.4,transcript,79636.0
CNOT6L,ENSG00000138767,squamous cell lung carcinoma,EFO_0000708,0.2309874091779386,2.3100039806522394,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
POU2F1,ENSG00000143190,thyroid gland adenocarcinoma,MONDO_0024622,0.2309874091779386,2.309889103835944,2,0.8,1.6,transcript,106581.0
CNOT6L,ENSG00000138767,lung adenocarcinoma,EFO_0000571,0.2309874091779386,2.3100039806522394,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
PYGO1,ENSG00000171016,endometrial cancer,MONDO_0011962,0.2309874091779386,2.3102019270421663,4,1.6,6.4,transcript,19522.0
NUP153,ENSG00000124789,endometrial cancer,MONDO_0011962,0.2309874091779386,2.309902076331913,1,0.5,0.5,transcript,17867.0
NUP153,ENSG00000124789,ovarian cancer,MONDO_0008170,0.2309874091779386,2.309902076331913,1,0.5,0.5,transcript,17867.0
OTUD7A,ENSG00000169918,glioblastoma multiforme,EFO_0000519,0.2309874091779386,2.3098918183470794,1,0.4,0.4,transcript,22565.0
F13B,ENSG00000143278,lung adenocarcinoma,EFO_0000571,0.2309874091779386,2.309981989923538,1,0.5,0.5,transcript,4634.0
LDLRAP1,ENSG00000157978,cutaneous melanoma,EFO_0000389,0.2309874091779386,2.309900005228466,1,0.4,0.4,transcript,15436.0
RIF1,ENSG00000080345,low grade glioma,MONDO_0021637,0.2309874091779386,2.309935635096413,3,1.3,3.9000000000000004,transcript,63370.0
FZD3,ENSG00000104290,endometrial cancer,MONDO_0011962,0.2309874091779386,2.309888208596044,1,0.4,0.4,transcript,28335.0
CNOT6L,ENSG00000138767,urinary bladder cancer,MONDO_0001187,0.2309874091779386,2.3100039806522394,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
PLPP4,ENSG00000203805,endometrial cancer,MONDO_0011962,0.2309874091779386,2.3099549815670506,1,0.4,0.4,transcript,4945.0
DSC2,ENSG00000134755,glioblastoma multiforme,EFO_0000519,0.2309874091779386,2.3098865338460133,2,0.8,1.6,transcript,128596.0
CLDN16,ENSG00000113946,endometrial cancer,MONDO_0011962,0.2309874091779386,2.3099744681909296,1,0.4,0.4,transcript,3985.0
CNOT6L,ENSG00000138767,head and neck squamous cell carcinoma,EFO_0000181,0.2309874091779386,2.3100039806522394,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
PARD6B,ENSG00000124171,endometrial cancer,MONDO_0011962,0.2309874091779386,2.3099525077762495,1,0.4,0.4,transcript,5101.0
MYO5A,ENSG00000197535,endometrial cancer,MONDO_0011962,0.2309874091779386,2.3098761314405984,1,0.4,0.4,transcript,196111.0
TTL,ENSG00000114999,protein measurement,EFO_0004747,0.23097026848029792,2.3097224535091176,1,0.4,0.4,transcript,20234.0
IQGAP1,ENSG00000140575,lymphocyte percentage of leukocytes,EFO_0007993,0.2309650946416187,2.3097050443334175,2,0.8,1.6,transcript,29576.0
F13B,ENSG00000143278,glioblastoma multiforme,EFO_0000519,0.23095775680518174,2.3096854661959694,1,0.5,0.5,transcript,4634.0
PPDPFL,ENSG00000168333,erythrocyte volume,OBA_0003460,0.23067006093794457,2.3070260110471295,2,0.8,1.6,transcript,4917.0
GUF1,ENSG00000151806,systolic blood pressure,EFO_0006335,0.23056169426907686,2.3056588643810514,1,0.5,0.5,transcript,11927.0
AGPAT5,ENSG00000155189,alcohol consumption quality,OBA_1000840,0.2304489955904695,2.3045273286039385,1,0.4,0.4,transcript,10703.0
NBEAL1,ENSG00000144426,neuroticism measurement,EFO_0007660,0.23036274068299592,2.3036312604316316,1,0.4,0.4,transcript,103799.0
ZNF143,ENSG00000166478,spondin-1 measurement,EFO_0008290,0.23024358037010542,2.3024620835286584,1,0.5,0.5,transcript,19026.0
IL1A,ENSG00000115008,Ovarian Endometriosis,EFO_1000418,0.23019678720769657,2.302166186405176,1,0.4,0.4,transcript,2017.0
FAM91A1,ENSG00000176853,eustachian tube disease,EFO_0009667,0.2301835066665596,2.3018654396457925,1,0.5,0.5,transcript,16462.0
CCDC34,ENSG00000109881,triglyceride measurement,EFO_0004530,0.23002839563830244,2.300377479880803,1,0.4,0.4,transcript,4277.0
EXOC6,ENSG00000138190,blood protein measurement,EFO_0007937,0.23000957134596972,2.3001183307302453,1,0.5,0.5,transcript,22107.0
TTL,ENSG00000114999,metabolite measurement,EFO_0004725,0.22991492943332775,2.299169063039416,1,0.4,0.4,transcript,20234.0
CD2AP,ENSG00000198087,platelet component distribution width,EFO_0007984,0.22988337188220317,2.2988857885955283,1,0.4,0.4,transcript,7682.0
IQCB1,ENSG00000173226,coronary atherosclerosis,MONDO_0021661,0.2298351914952369,2.298393533930623,1,0.4,0.4,transcript,9611.0
SLC25A16,ENSG00000122912,optic cup area,OBA_2045265,0.2298309873921004,2.298340910544219,1,0.4,0.4,transcript,12888.0
SEC63,ENSG00000025796,donor genotype effect measurement,EFO_0007892,0.22973690491595564,2.2976445734209983,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
SEC63,ENSG00000025796,renal transplant outcome measurement,EFO_0005199,0.22973690491595564,2.2976445734209983,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
SEC63,ENSG00000025796,APOL1 risk genotype carrier status,EFO_0009324,0.22973690491595564,2.2976445734209983,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
RAD23B,ENSG00000119318,Stuttering,HP_0025268,0.22968730090332382,2.2969132828955017,1,0.4,0.4,transcript,9932.0
RAD23B,ENSG00000119318,Tics,HP_0100033,0.22968730090332382,2.2969132828955017,1,0.4,0.4,transcript,9932.0
CCDC34,ENSG00000109881,cystatin B measurement,EFO_0010593,0.22967427992547315,2.2968363227525104,1,0.4,0.4,transcript,4277.0
CCDC34,ENSG00000109881,body height,OBA_VT0001253,0.22967427992547315,2.2968363227525104,1,0.4,0.4,transcript,4277.0
CCDC62,ENSG00000130783,body mass index,EFO_0004340,0.2296633518766568,2.296660454793504,1,0.4,0.4,transcript,14850.0
RTF1,ENSG00000137815,hematocrit,EFO_0004348,0.22943778395956102,2.294429559274948,1,0.4,0.4,transcript,7734.0
GAN,ENSG00000261609,bilirubin measurement,EFO_0004570,0.22943362911664875,2.294346955273768,1,0.4,0.4,transcript,37509.0
RALGPS2,ENSG00000116191,neuroimaging measurement,EFO_0004346,0.2294307279510272,2.294386814232149,2,0.8,1.6,transcript,20117.0
SELENOI,ENSG00000138018,high density lipoprotein cholesterol measurement,EFO_0004612,0.22940477582664331,2.29408934695431,1,0.4,0.4,transcript,9618.0
OR5A2,ENSG00000172324,smoking initiation,EFO_0005670,0.22940236337885783,2.2940414765934674,1,0.4,0.4,transcript,22418.0
TMEM144,ENSG00000164124,mean corpuscular hemoglobin concentration,EFO_0004528,0.22937603483306238,2.2937772580748637,1,0.4,0.4,transcript,23655.0
CP,ENSG00000047457,ovarian dysfunction,EFO_0009003,0.2293006905694952,2.2930279636464346,1,0.5,0.5,transcript,23744.0
RALGPS2,ENSG00000116191,cholesterol esters in large HDL measurement,EFO_0022159,0.22928972834693692,2.292976818191246,2,0.8,1.6,transcript,20117.0
BACE2,ENSG00000182240,retinoschisis,MONDO_0004579,0.22924390438917985,2.292572599818343,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
BACE2,ENSG00000182240,retinopathy,EFO_0003839,0.22924390438917985,2.292572599818343,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
NAF1,ENSG00000145414,lysosomal storage disease,MONDO_0002561,0.22915957625562208,2.2916577127482665,1,0.5,0.5,transcript,8071.0
KLHL3,ENSG00000146021,glucose measurement,EFO_0004468,0.2290582944367457,2.2906302550508006,2,0.8,1.6,transcript,33819.0
SPART,ENSG00000133104,self reported educational attainment,EFO_0004784,0.2290582944367457,2.290597209702692,1,0.4,0.4,transcript,28040.0
NCKAP1,ENSG00000061676,smoking initiation,EFO_0005670,0.2290582944367457,2.2905927735848053,1,0.4,0.4,transcript,40695.0
PKD2L2,ENSG00000078795,glomerular filtration rate,OBA_0003747,0.2290582944367457,2.290622320647186,1,0.5,0.5,transcript,12698.0
LYPD6,ENSG00000187123,platelet count,EFO_0004309,0.2290582944367457,2.2906156936715343,1,0.4,0.4,transcript,12214.0
PROK2,ENSG00000163421,triglyceride measurement,EFO_0004530,0.2290582944367457,2.2910984082849826,2,0.8,1.6,transcript,3104.0
TRMT6,ENSG00000089195,forced expiratory volume,EFO_0004314,0.2290582944367457,2.2906164255761285,1,0.4,0.4,transcript,11947.0
ASPM,ENSG00000066279,wet macular degeneration,EFO_0004683,0.2290582944367457,2.290617942714757,2,0.9,1.8,transcript,51431.0
TMED5,ENSG00000117500,neutrophil count,EFO_0004833,0.2290000773554717,2.2900327408202372,1,0.5,0.5,transcript,15641.0
PARP14,ENSG00000173193,smoking initiation,EFO_0005670,0.22899053499849675,2.289919337955313,1,0.4,0.4,transcript,28596.0
ATF6,ENSG00000118217,monocyte count,EFO_0005091,0.2289758137560014,2.289764489992996,1,0.4,0.4,transcript,62968.0
SNTG2,ENSG00000172554,body fat percentage,EFO_0007800,0.22893068825230972,2.289356772764566,1,0.5,0.5,transcript,10022.0
ANKRD10,ENSG00000088448,pulse wave reflection index measurement,EFO_0009804,0.22893068825230972,2.289484976913124,2,0.8,1.6,transcript,8984.0
ARHGAP28,ENSG00000088756,placenta praevia,EFO_0007442,0.22893068825230972,2.289319184159215,1,0.4,0.4,transcript,32516.0
ARHGAP28,ENSG00000088756,head and neck malignant neoplasia,EFO_0006859,0.22893068825230972,2.289319184159215,1,0.4,0.4,transcript,32516.0
TRMT9B,ENSG00000250305,arterial stiffness measurement,EFO_0004517,0.22893068825230972,2.2894480091842757,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
PSD3,ENSG00000156011,white matter microstructure measurement,EFO_0005674,0.22893068825230972,2.2893163256166544,1,0.4,0.4,transcript,42359.0
PSD3,ENSG00000156011,mean fractional anisotropy measurement,EFO_0008399,0.22893068825230972,2.2893163256166544,1,0.4,0.4,transcript,42359.0
CD69,ENSG00000110848,drug use measurement,EFO_0007010,0.22890473981189718,2.2898918738402947,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
DCLK1,ENSG00000133083,cognitive function measurement,EFO_0008354,0.22883501254223373,2.288400323075597,2,0.8,1.6,transcript,31874.0
SLC6A5,ENSG00000165970,placenta praevia,EFO_0007442,0.2288250643802775,2.288289279946888,1,0.4,0.4,transcript,10353.0
NBEAL1,ENSG00000144426,angina pectoris,EFO_0003913,0.2287588664947084,2.2875925185487564,1,0.4,0.4,transcript,103799.0
GPATCH2L,ENSG00000089916,heart rate,OBA_1001087,0.22863227707089664,2.2864652430492973,4,1.6,6.4,transcript,44921.0
TWSG1,ENSG00000128791,gut microbiome measurement,EFO_0007874,0.22862662999635933,2.28632201027,1,0.4,0.4,transcript,7180.0
DCAF4L1,ENSG00000182308,insomnia,EFO_0004698,0.22861356297730995,2.2862205554631205,1,0.4,0.4,transcript,4710.0
GBP6,ENSG00000183347,educational attainment,EFO_0011015,0.22856885516002104,2.2860727565094954,2,0.9,1.8,transcript,4685.0
ZFP90,ENSG00000184939,kit ligand amount,OBA_2050260,0.22856343094167283,2.285647664563468,1,0.4,0.4,transcript,29951.0
MAP1LC3B2,ENSG00000258102,gut microbiome measurement,EFO_0007874,0.22845381505788054,2.2847044016178746,1,0.4,0.4,transcript,2406.0
C15orf61,ENSG00000189227,eosinophil count,EFO_0004842,0.22843453555829002,2.285966889554037,5,2.0,10.0,transcript,6167.0
CCDC66,ENSG00000180376,Hernia,HP_0100790,0.22839481554328747,2.2839633849415706,1,0.5,0.5,transcript,32831.0
KIAA0232,ENSG00000170871,lymphocyte count,EFO_0004587,0.22838577055156248,2.2838809938248934,1,0.4,0.4,transcript,17176.0
GPM6A,ENSG00000150625,pulse wave reflection index measurement,EFO_0009804,0.22832012216092107,2.2832193926899356,1,0.4,0.4,transcript,22013.0
FIGNL1,ENSG00000132436,3-methoxytyrosine measurement,EFO_0021009,0.22809371372630158,2.280953319802056,1,0.4,0.4,transcript,24718.0
CMTR2,ENSG00000180917,body height,OBA_VT0001253,0.22802899501732174,2.280393369473844,2,0.8,1.6,transcript,15471.0
CD69,ENSG00000110848,Thyroid preparation use measurement,EFO_0009933,0.22799761414381176,2.2808206171594407,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
RIF1,ENSG00000080345,breast adenocarcinoma,EFO_0000304,0.22798472924565047,2.2799088357735315,3,1.3,3.9000000000000004,transcript,63370.0
GSTA5,ENSG00000182793,triglyceride measurement,EFO_0004530,0.22792017896751088,2.2795519297311313,1,0.5,0.5,transcript,1428.0
RUFY3,ENSG00000018189,optic disc area,OBA_2045264,0.22791830801649676,2.2792034084670463,1,0.4,0.4,transcript,19677.0
IL1A,ENSG00000115008,EDTA measurement,EFO_0800946,0.22791830801649676,2.279381394493178,1,0.4,0.4,transcript,2017.0
OR10A6,ENSG00000279000,dermatomycosis,MONDO_0002040,0.22782742545245796,2.2783071600856197,1,0.4,0.4,transcript,12156.0
ANKRD30B,ENSG00000180777,erythrocyte volume,OBA_0003460,0.22781858452175027,2.27821041162049,1,0.5,0.5,transcript,20353.0
METTL14,ENSG00000145388,liver disease,EFO_0001421,0.2277481169869601,2.2775067567691085,1,0.4,0.4,transcript,15633.0
FAM171B,ENSG00000144369,tissue factor pathway inhibitor amount,OBA_2050208,0.22770367812008532,2.2771065770480003,1,0.4,0.4,transcript,5731.0
MUC16,ENSG00000181143,gastric adenocarcinoma,EFO_0000503,0.227701364577064,2.2770164661200245,1,0.5,0.5,transcript,177283.0
FIGNL1,ENSG00000132436,body weight,EFO_0004338,0.2276671036396721,2.2766872189357614,1,0.4,0.4,transcript,24718.0
SCARA3,ENSG00000168077,waist circumference,OBA_1001085,0.2276377439304148,2.276447651696635,1,0.4,0.4,transcript,5697.0
NBEAL1,ENSG00000144426,serum creatinine amount,OBA_2050096,0.22755416166844175,2.2755454702860898,1,0.4,0.4,transcript,103799.0
TMEM144,ENSG00000164124,spondylolisthesis,EFO_0007493,0.2275196423563179,2.275213333307419,1,0.4,0.4,transcript,23655.0
CD93,ENSG00000125810,response to antihypertensive drug,EFO_0005405,0.22741596730026767,2.2741859905235664,1,0.4,0.4,transcript,15199.0
CPPED1,ENSG00000103381,parental genotype effect measurement,EFO_0005939,0.2273781046421305,2.2738187751517334,1,0.4,0.4,transcript,10602.0
CPPED1,ENSG00000103381,fatty acid measurement,EFO_0005110,0.2273781046421305,2.2738187751517334,1,0.4,0.4,transcript,10602.0
CAV2,ENSG00000105971,drug use measurement,EFO_0007010,0.2273034618278912,2.2730587918451173,1,0.4,0.4,transcript,16547.0
SMC3,ENSG00000108055,head and neck squamous cell carcinoma,EFO_0000181,0.22723076769892403,2.2723162895118483,1,0.4,0.4,transcript,46444.0
SYCP1,ENSG00000198765,head and neck squamous cell carcinoma,EFO_0000181,0.22723076769892403,2.2723288052377084,1,0.4,0.4,transcript,18932.0
TTL,ENSG00000114999,alkaline phosphatase measurement,EFO_0004533,0.22713348373027442,2.2713546060088823,1,0.4,0.4,transcript,20234.0
ING1,ENSG00000153487,HbA1c measurement,EFO_0004541,0.22705602315098095,2.2705867145606566,1,0.4,0.4,transcript,15104.0
CD2AP,ENSG00000198087,inherited focal segmental glomerulosclerosis,MONDO_0005363,0.2268809663481086,2.268861733254582,1,0.4,0.4,transcript,7682.0
KCNN3,ENSG00000143603,endometriosis,EFO_0001065,0.22687677047600335,2.268886740569973,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
GUF1,ENSG00000151806,high density lipoprotein cholesterol measurement,EFO_0004612,0.2267887973877517,2.2679298955678,1,0.5,0.5,transcript,11927.0
PAG1,ENSG00000076641,breast adenocarcinoma,EFO_0000304,0.22669508414693498,2.267080933346738,2,0.8,1.6,transcript,12299.0
TAF2,ENSG00000064313,BMI-adjusted hip circumference,EFO_0008039,0.2264737495783934,2.264740288767958,1,0.5,0.5,transcript,179020.0
MTCH2,ENSG00000109919,calcium measurement,EFO_0004838,0.2264619731214709,2.2646791842468135,1,0.4,0.4,transcript,6728.0
LIN9,ENSG00000183814,breast adenocarcinoma,EFO_0000304,0.22643649335465815,2.2644697690858293,2,0.8,1.6,transcript,15262.0
GNA13,ENSG00000120063,breast adenocarcinoma,EFO_0000304,0.22640826974679004,2.264134303712256,1,0.4,0.4,transcript,7751.0
HS3ST3A1,ENSG00000153976,lobe attachment,EFO_0007667,0.22640471634521783,2.2641282007293255,1,0.4,0.4,transcript,4936.0
CNR2,ENSG00000188822,monocyte count,EFO_0005091,0.22639576274396406,2.2640336008489474,1,0.4,0.4,transcript,5265.0
GALNT3,ENSG00000115339,breast adenocarcinoma,EFO_0000304,0.22638911312188917,2.263920039219181,1,0.4,0.4,transcript,13837.0
CFHR4,ENSG00000134365,serum creatinine amount,OBA_2050096,0.22634549282738278,2.2634954370642353,1,0.5,0.5,transcript,12343.0
IQGAP1,ENSG00000140575,age of onset of allergic disease,OBA_2001017,0.2263361370095567,2.2634154680127976,2,0.8,1.6,transcript,29576.0
CFAP54,ENSG00000188596,response to antihypertensive drug,EFO_0005405,0.22624587872860633,2.26252741911064,2,1.0,2.0,transcript,29141.0
CCDC7,ENSG00000216937,arterial stiffness measurement,EFO_0004517,0.22624587872860633,2.2624773843254142,1,0.5,0.5,transcript,26886.0
IKBIP,ENSG00000166130,BMI-adjusted hip circumference,EFO_0008039,0.22620651865071098,2.262335685239147,2,0.8,1.6,transcript,5915.0
ZNF483,ENSG00000173258,protein measurement,EFO_0004747,0.22619029814112412,2.2619864625758033,2,0.8,1.6,transcript,19166.0
KIAA0319,ENSG00000137261,ulcerative colitis,EFO_0000729,0.22608356453718437,2.2608480327243567,1,0.4,0.4,transcript,32291.0
UBE2G2,ENSG00000184787,serum gamma-glutamyl transferase measurement,EFO_0004532,0.22602993693077578,2.26032542454486,1,0.4,0.4,transcript,15352.0
RSBN1L,ENSG00000187257,serum albumin amount,OBA_2050068,0.22600820093899887,2.2602187264710794,2,0.8,1.6,transcript,11703.0
ARL3,ENSG00000138175,body weight,EFO_0004338,0.2259823348358142,2.259927678039937,1,0.4,0.4,transcript,3834.0
OTUD7A,ENSG00000169918,breast adenocarcinoma,EFO_0000304,0.22594633730141253,2.2594810995818184,1,0.4,0.4,transcript,22565.0
USP15,ENSG00000135655,smoking status measurement,EFO_0006527,0.22594579741793022,2.2595410920219328,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
KCNN3,ENSG00000143603,cervical carcinoma,EFO_0001061,0.22591099519243418,2.2592289877342813,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
GKAP1,ENSG00000165113,neuroinflammatory disorder,EFO_0020092,0.22590953866089308,2.2591525131442065,1,0.4,0.4,transcript,7002.0
ANOS1,ENSG00000011201,breast adenocarcinoma,EFO_0000304,0.22588490096291688,2.258900516196256,1,0.4,0.4,transcript,7766.0
USP15,ENSG00000135655,breast adenocarcinoma,EFO_0000304,0.22577509987159514,2.257834116558582,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
RASEF,ENSG00000165105,Abruptio Placentae,EFO_1001754,0.2256848217442689,2.2569026392113964,1,0.4,0.4,transcript,7350.0
CLEC1B,ENSG00000165682,breast adenocarcinoma,EFO_0000304,0.22567042613398264,2.2570688921511297,2,1.0,2.0,transcript,5485.0
RAD23B,ENSG00000119318,breast adenocarcinoma,EFO_0000304,0.22566971454347087,2.256737419296972,1,0.4,0.4,transcript,9932.0
SH3GL3,ENSG00000140600,breast adenocarcinoma,EFO_0000304,0.2256485197779391,2.2565368907233037,1,0.4,0.4,transcript,7738.0
RALGPS2,ENSG00000116191,total cholesterol change measurement,EFO_0007806,0.22552112214911468,2.2552907562130238,2,0.8,1.6,transcript,20117.0
IPP,ENSG00000197429,heart rate,OBA_1001087,0.22549689287324612,2.255049704176726,1,0.5,0.5,transcript,6190.0
TEX15,ENSG00000133863,head and neck squamous cell carcinoma,EFO_0000181,0.225468736338707,2.2547022869782833,1,0.5,0.5,transcript,33504.0
RPS20,ENSG00000008988,monocyte count,EFO_0005091,0.2254540483798159,2.2545576932805838,1,0.4,0.4,transcript,23243.0
UBL3,ENSG00000122042,hemangioma of subcutaneous tissue,EFO_1000707,0.22540195220667208,2.254853434505915,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
UBL3,ENSG00000122042,Ascites,HP_0001541,0.22540195220667208,2.254853434505915,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
ATF7IP2,ENSG00000166669,color vision disorder,MONDO_0001703,0.22540195220667208,2.2540357310983934,1,0.5,0.5,transcript,30847.0
UBL3,ENSG00000122042,arterial stiffness measurement,EFO_0004517,0.22540195220667208,2.254853434505915,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
UBL3,ENSG00000122042,heart rate,OBA_1001087,0.22540195220667208,2.254853434505915,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
ATF7IP2,ENSG00000166669,eye disease,EFO_0003966,0.22540195220667208,2.2540357310983934,1,0.5,0.5,transcript,30847.0
METTL14,ENSG00000145388,generalized dystonia,MONDO_0000476,0.22540195220667208,2.2540451089662286,1,0.4,0.4,transcript,15633.0
ATF7IP2,ENSG00000166669,chronic primary adrenal insufficiency,MONDO_0015129,0.22540195220667208,2.2540357310983934,1,0.5,0.5,transcript,30847.0
SMC6,ENSG00000163029,breast adenocarcinoma,EFO_0000304,0.22531300432707335,2.25314645285393,1,0.4,0.4,transcript,24376.0
SMC5,ENSG00000198887,breast adenocarcinoma,EFO_0000304,0.22531300432707335,2.2531943933350833,1,0.5,0.5,transcript,7770.0
ZPLD1,ENSG00000170044,HbA1c measurement,EFO_0004541,0.2252626108006518,2.2527850905184414,2,0.8,1.6,transcript,10064.0
TXK,ENSG00000074966,blood sodium bicarbonate amount,OBA_2050094,0.2252153666279604,2.252183058593514,1,0.4,0.4,transcript,13609.0
EXOC6,ENSG00000138190,metabolite measurement,EFO_0004725,0.22520863472289232,2.252108964499471,1,0.5,0.5,transcript,22107.0
SMIM36,ENSG00000261873,growth differentiation factor 15 amount,OBA_2050135,0.22520863472289232,2.252267917814488,1,0.4,0.4,transcript,2203.0
ZNF398,ENSG00000197024,neutrophil percentage of granulocytes,EFO_0007994,0.22516393843149848,2.2516648782601725,1,0.4,0.4,transcript,15690.0
XKR4,ENSG00000206579,thyroid stimulating hormone amount,OBA_1000983,0.22502701459446928,2.2502890979014825,1,0.4,0.4,transcript,21106.0
SGCB,ENSG00000163069,appendicular lean mass,EFO_0004980,0.22500711693946063,2.250143764675913,1,0.4,0.4,transcript,5510.0
AKAP10,ENSG00000108599,heart rate,OBA_1001087,0.22499729108009925,2.250008091100025,1,0.4,0.4,transcript,11370.0
KLHL31,ENSG00000124743,sleep duration trait,OBA_2040171,0.22498498033058095,2.2499018798583417,1,0.4,0.4,transcript,7681.0
PCNX4,ENSG00000126773,calcium measurement,EFO_0004838,0.22496736287256575,2.2496832928023514,1,0.5,0.5,transcript,51738.0
SYCP1,ENSG00000198765,breast adenocarcinoma,EFO_0000304,0.22494270063459576,2.2494481345944255,1,0.4,0.4,transcript,18932.0
ZNF33B,ENSG00000196693,high density lipoprotein cholesterol measurement,EFO_0004612,0.2249335764985378,2.249366890483386,1,0.5,0.5,transcript,16064.0
ZNF33B,ENSG00000196693,sex interaction measurement,EFO_0008343,0.2249335764985378,2.249366890483386,1,0.5,0.5,transcript,16064.0
ZNF33B,ENSG00000196693,atopy,EFO_0002686,0.2249335764985378,2.249366890483386,1,0.5,0.5,transcript,16064.0
ARL3,ENSG00000138175,cigarettes per day measurement,EFO_0006525,0.2249173625835272,2.2492779555170666,1,0.4,0.4,transcript,3834.0
CNTN1,ENSG00000018236,breast adenocarcinoma,EFO_0000304,0.2248586212127199,2.248602739004032,1,0.4,0.4,transcript,24203.0
CCDC7,ENSG00000216937,erythrocyte volume,OBA_0003460,0.22484362084561066,2.2484548054954576,1,0.5,0.5,transcript,26886.0
ZDHHC21,ENSG00000175893,dodecenedioate (C12:1-DC) measurement,EFO_0800561,0.22483420175944702,2.2486895981082373,4,1.6,6.4,transcript,18413.0
DSC2,ENSG00000134755,breast adenocarcinoma,EFO_0000304,0.22462656111204043,2.2462780531870314,2,0.8,1.6,transcript,128596.0
NRCAM,ENSG00000091129,breast adenocarcinoma,EFO_0000304,0.2245158686239538,2.2451703395534492,1,0.4,0.4,transcript,34325.0
MTCH2,ENSG00000109919,creatine kinase measurement,EFO_0004534,0.22447105222483169,2.2447699752804215,1,0.4,0.4,transcript,6728.0
BACE2,ENSG00000182240,high density lipoprotein cholesterol measurement,EFO_0004612,0.22444175080372422,2.2445510639637867,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
TEX15,ENSG00000133863,breast adenocarcinoma,EFO_0000304,0.2243457918926964,2.243472842518177,1,0.5,0.5,transcript,33504.0
ARAP1,ENSG00000186635,serum albumin amount,OBA_2050068,0.22430076947848632,2.24301670440263,1,0.4,0.4,transcript,44397.0
ZNF502,ENSG00000196653,depressive symptom measurement,EFO_0007006,0.22427757353580485,2.242824803071493,1,0.5,0.5,transcript,10190.0
TMED5,ENSG00000117500,total cholesterol measurement,EFO_0004574,0.22427682666967347,2.242800233962255,1,0.5,0.5,transcript,15641.0
ABCA10,ENSG00000154263,serum albumin amount,OBA_2050068,0.22425903306902534,2.242690266842156,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
MORF4L2,ENSG00000123562,breast adenocarcinoma,EFO_0000304,0.22420492860786884,2.2420801359938514,1,0.4,0.4,transcript,12966.0
YEATS2,ENSG00000163872,breast adenocarcinoma,EFO_0000304,0.22420492860786884,2.242083026547006,1,0.5,0.5,transcript,14819.0
CAPN7,ENSG00000131375,breast adenocarcinoma,EFO_0000304,0.22417258391962272,2.2417644865392226,1,0.4,0.4,transcript,10350.0
CFHR4,ENSG00000134365,complement factor H-related protein 2 measurement,EFO_0600055,0.2240107836441196,2.2401483452316033,1,0.5,0.5,transcript,12343.0
RGS4,ENSG00000117152,trauma complication,EFO_0009888,0.22395709644844944,2.239667234039248,2,0.8,1.6,transcript,16620.0
SMIM36,ENSG00000261873,Spinal cord injury,EFO_1001919,0.22395709644844944,2.2397525350700596,1,0.4,0.4,transcript,2203.0
SMIM36,ENSG00000261873,high density lipoprotein cholesterol measurement,EFO_0004612,0.22395709644844944,2.2397525350700596,1,0.4,0.4,transcript,2203.0
RGS4,ENSG00000117152,cataract,MONDO_0005129,0.22395709644844944,2.239667234039248,2,0.8,1.6,transcript,16620.0
ZNF267,ENSG00000185947,monocyte count,EFO_0005091,0.22391567413517416,2.2391942436956382,1,0.4,0.4,transcript,10666.0
MUC16,ENSG00000181143,thyroid gland adenocarcinoma,MONDO_0024622,0.223908897063277,2.2390917909821546,1,0.5,0.5,transcript,177283.0
TXK,ENSG00000074966,body fat percentage,EFO_0007800,0.22390337913011085,2.2390631836150185,1,0.4,0.4,transcript,13609.0
SEC22A,ENSG00000121542,platelet volume,OBA_0003277,0.22381761190635185,2.2382981539960176,2,0.8,1.6,transcript,13111.0
KLRD1,ENSG00000134539,neutrophil count,EFO_0004833,0.22378993681387532,2.238063857737205,4,1.7000000000000002,6.800000000000001,transcript,41340.0
DPY19L2,ENSG00000177990,neurodegenerative disease,EFO_0005772,0.22372608927175963,2.23740163867115,2,0.8,1.6,transcript,11368.0
LRRIQ3,ENSG00000162620,response to paracetamol,GO_1901554,0.22372410794387598,2.2372679756195017,1,0.5,0.5,transcript,18590.0
ZNF230,ENSG00000159882,low density lipoprotein cholesterol measurement,EFO_0004611,0.22371521529494973,2.2371879888212045,1,0.4,0.4,transcript,11162.0
ANKRD36,ENSG00000135976,smoking initiation,EFO_0005670,0.22366816128629924,2.236756999218062,2,1.0,2.0,transcript,26530.0
CPO,ENSG00000144410,trigeminal nerve disease,EFO_0009569,0.2235747889105533,2.2361494955312358,1,0.5,0.5,transcript,1245.0
GABPA,ENSG00000154727,temporal measurement,EFO_0000719,0.2235747889105533,2.2357838409300883,1,0.4,0.4,transcript,11126.0
GABPA,ENSG00000154727,urinary microalbumin measurement,EFO_0010967,0.2235747889105533,2.2357838409300883,1,0.4,0.4,transcript,11126.0
DOCK1,ENSG00000150760,longitudinal BMI measurement,EFO_0005937,0.22354954268062435,2.2355205146135693,1,0.4,0.4,transcript,15944.0
DOCK1,ENSG00000150760,protein measurement,EFO_0004747,0.22354954268062435,2.2355205146135693,1,0.4,0.4,transcript,15944.0
GPAT3,ENSG00000138678,frozen shoulder,EFO_1000941,0.22354630146808857,2.235610141117667,2,0.8,1.6,transcript,10875.0
C13orf42,ENSG00000226792,brain aneurysm,EFO_0003870,0.22351026346753833,2.235164717556029,1,0.4,0.4,transcript,6443.0
SYCP1,ENSG00000198765,mean corpuscular hemoglobin concentration,EFO_0004528,0.2233048344037555,2.233069472286023,1,0.4,0.4,transcript,18932.0
PTPN4,ENSG00000088179,neuroimaging measurement,EFO_0004346,0.22330212751613515,2.233484882022733,5,2.0,10.0,transcript,21570.0
ARL3,ENSG00000138175,HbA1c measurement,EFO_0004541,0.22326118412105866,2.2327161708923815,1,0.4,0.4,transcript,3834.0
LDLRAP1,ENSG00000157978,androgenetic alopecia,EFO_0004191,0.2232109452012234,2.2321353654613136,1,0.4,0.4,transcript,15436.0
CPD,ENSG00000108582,sodium measurement,EFO_0009282,0.2232109452012234,2.232129670370503,1,0.4,0.4,transcript,19784.0
CAPN7,ENSG00000131375,growth differentiation factor 15 amount,OBA_2050135,0.22318821445644374,2.2319207919074326,1,0.4,0.4,transcript,10350.0
HPSE,ENSG00000173083,Hypercholesterolemia,HP_0003124,0.22318821445644374,2.2319699922950376,2,0.9,1.8,transcript,20490.0
ZNF396,ENSG00000186496,Eosinophilia,HP_0001880,0.22318821445644374,2.2319167107586995,1,0.4,0.4,transcript,11572.0
UHMK1,ENSG00000152332,low affinity immunoglobulin gamma Fc region receptor II-b measurement,EFO_0021970,0.22318821445644374,2.232008762459767,3,1.2000000000000002,3.6000000000000005,transcript,28432.0
GRSF1,ENSG00000132463,insulin-like growth factor-binding protein 7 amount,OBA_2050142,0.22318821445644374,2.231973234800703,2,0.8,1.6,transcript,17565.0
ADGRA1,ENSG00000197177,bilirubin measurement,EFO_0004570,0.22318821445644374,2.231934079126889,1,0.4,0.4,transcript,7702.0
ADGRA1,ENSG00000197177,aspartate aminotransferase measurement,EFO_0004736,0.22318821445644374,2.231934079126889,1,0.4,0.4,transcript,7702.0
RAD23B,ENSG00000119318,bone tissue density,OBA_1000110,0.22307305330649066,2.23077080692717,1,0.4,0.4,transcript,9932.0
ZNF143,ENSG00000166478,body weights and measures,EFO_0004324,0.22307254604666635,2.230751740294268,1,0.5,0.5,transcript,19026.0
CAV2,ENSG00000105971,Abnormality of refraction,HP_0000539,0.2230601585987583,2.230625759553788,1,0.4,0.4,transcript,16547.0
ATPSCKMT,ENSG00000150756,urate measurement,EFO_0004531,0.2230262875736164,2.230310585659828,1,0.4,0.4,transcript,8384.0
FIGLA,ENSG00000183733,influenza A (H1N1),EFO_1001488,0.2229765902019377,2.2304584227950004,1,0.5,0.5,transcript,722.0
PF4V1,ENSG00000109272,vitamin D-binding protein measurement,EFO_0005675,0.2229765902019377,2.2303042600274523,1,0.4,0.4,transcript,743.0
RUFY3,ENSG00000018189,lymphocyte count,EFO_0004587,0.2229765902019377,2.2297862303214555,1,0.4,0.4,transcript,19677.0
ITGA8,ENSG00000077943,erythrocyte volume,OBA_0003460,0.22283449974311187,2.2288097534342173,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
MTCH2,ENSG00000109919,cardiac arrhythmia,EFO_0004269,0.22274110730227867,2.227470526054891,1,0.4,0.4,transcript,6728.0
PDCD5,ENSG00000105185,asthma,MONDO_0004979,0.2226951033731254,2.2270291434754443,1,0.4,0.4,transcript,5121.0
PYHIN1,ENSG00000163564,basophil measurement,EFO_0803539,0.22267368755447503,2.2267746327658187,1,0.4,0.4,transcript,10594.0
ZNF716,ENSG00000182111,type 2 diabetes mellitus,MONDO_0005148,0.22257001372475071,2.228579215942325,6,2.5,15.0,transcript,5210.0
NCKAP1,ENSG00000061676,muscular disease,EFO_0002970,0.22254364646877875,2.225446293905136,1,0.4,0.4,transcript,40695.0
SLC35B4,ENSG00000205060,health study participation,EFO_0010130,0.2223250082497897,2.223292002430825,1,0.4,0.4,transcript,9542.0
ZNF398,ENSG00000197024,eosinophil percentage of granulocytes,EFO_0007996,0.22211273190133832,2.221152812958571,1,0.4,0.4,transcript,15690.0
SLC9B1,ENSG00000164037,neurodegenerative disease,EFO_0005772,0.22207366133355202,2.2207815854528077,1,0.5,0.5,transcript,11118.0
GJA3,ENSG00000121743,aging,EFO_0022597,0.22207147805085056,2.2207914970409184,1,0.4,0.4,transcript,5214.0
HACD4,ENSG00000188921,erythrocyte volume,OBA_0003460,0.2219087883224053,2.2191304228390694,1,0.4,0.4,transcript,9403.0
SRGN,ENSG00000122862,mean corpuscular hemoglobin concentration,EFO_0004528,0.22184476650231866,2.218571045652428,1,0.4,0.4,transcript,3242.0
TENT4B,ENSG00000121274,metabolite measurement,EFO_0004725,0.22183892981834274,2.2186387136160075,4,1.6,6.4,transcript,25660.0
GABPA,ENSG00000154727,Alzheimer disease,MONDO_0004975,0.22182840666252662,2.2183200184498215,1,0.4,0.4,transcript,11126.0
RNMT,ENSG00000101654,serum albumin amount,OBA_2050068,0.22152550899302278,2.2152715116397275,1,0.4,0.4,transcript,24358.0
RBM23,ENSG00000100461,prostate specific antigen amount,OBA_2050200,0.22135414147354698,2.2135512735085454,1,0.4,0.4,transcript,40573.0
TNFRSF19,ENSG00000127863,Parkinson disease,MONDO_0005180,0.22127610283169027,2.2127940294389408,1,0.5,0.5,transcript,15151.0
AHCTF1,ENSG00000153207,metabolite measurement,EFO_0004725,0.2211914357797249,2.2119276242675716,1,0.5,0.5,transcript,37689.0
SLC9B1,ENSG00000164037,HbA1c measurement,EFO_0004541,0.22118698028408657,2.2119147749581534,1,0.5,0.5,transcript,11118.0
ORMDL1,ENSG00000128699,ferritin measurement,EFO_0004459,0.2210567652096836,2.2106947269916017,2,0.8,1.6,transcript,12591.0
OXSR1,ENSG00000172939,mean corpuscular hemoglobin,EFO_0004527,0.22095158137960497,2.209556389977831,1,0.4,0.4,transcript,9858.0
C18orf54,ENSG00000166845,cortical thickness,EFO_0004840,0.22093426417910197,2.2094281164424436,2,0.8,1.6,transcript,18719.0
WDR12,ENSG00000138442,retinal vasculature measurement,EFO_0010554,0.2209016603217592,2.2090365424030765,1,0.4,0.4,transcript,20061.0
G3BP2,ENSG00000138757,HbA1c measurement,EFO_0004541,0.22083673424593833,2.2083690956995907,1,0.4,0.4,transcript,228149.0
SULT6B1,ENSG00000138068,neutrophil count,EFO_0004833,0.22061367631853934,2.2062498597698768,1,0.5,0.5,transcript,4421.0
METTL2B,ENSG00000165055,metabolite measurement,EFO_0004725,0.22059324769431526,2.2060351002514715,2,0.8,1.6,transcript,15591.0
MED10,ENSG00000133398,retinal degeneration,MONDO_0004580,0.22056502612568518,2.205799849888116,1,0.4,0.4,transcript,2674.0
EDEM1,ENSG00000134109,social inhibition quality,OBA_1000278,0.22056502612568518,2.2057832399802564,2,0.8,1.6,transcript,12032.0
TFEC,ENSG00000105967,heel bone mineral density,EFO_0009270,0.22056502612568518,2.205665958611848,1,0.4,0.4,transcript,25482.0
NDST3,ENSG00000164100,self reported educational attainment,EFO_0004784,0.22056502612568518,2.205700323835075,1,0.4,0.4,transcript,7990.0
CDH19,ENSG00000071991,S-6-hydroxywarfarin measurement,EFO_0803326,0.22056502612568518,2.20592481891396,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
CDH19,ENSG00000071991,roseburia seropositivity,EFO_0803646,0.22056502612568518,2.20592481891396,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
PRPF4B,ENSG00000112739,placenta praevia,EFO_0007442,0.22046683370720166,2.2046891219074003,1,0.5,0.5,transcript,24056.0
MAP1LC3B2,ENSG00000258102,strand of hair color,OBA_0002313,0.22046683370720166,2.2048345881110856,1,0.4,0.4,transcript,2406.0
PRPF4B,ENSG00000112739,N-acetylalliin measurement,EFO_0800987,0.22046683370720166,2.2046891219074003,1,0.5,0.5,transcript,24056.0
PRPF4B,ENSG00000112739,growth differentiation factor 15 amount,OBA_2050135,0.22046683370720166,2.2046891219074003,1,0.5,0.5,transcript,24056.0
PRPF4B,ENSG00000112739,palmitoylcholine measurement,EFO_0800473,0.22046683370720166,2.2046891219074003,1,0.5,0.5,transcript,24056.0
CLHC1,ENSG00000162994,pulse wave reflection index measurement,EFO_0009804,0.22035778290842598,2.2036031199289736,1,0.4,0.4,transcript,15816.0
CDKL2,ENSG00000138769,high density lipoprotein cholesterol measurement,EFO_0004612,0.2203053136013756,2.2032172385778583,2,0.8,1.6,transcript,9750.0
KPNA4,ENSG00000186432,N-acetylmethionine measurement,EFO_0021427,0.22013473881895684,2.201356381399695,1,0.4,0.4,transcript,44478.0
DSC2,ENSG00000134755,educational attainment,EFO_0011015,0.22011923608359082,2.2012048029025353,2,0.8,1.6,transcript,128596.0
TRAM1,ENSG00000067167,serum creatinine amount,OBA_2050096,0.22011923608359082,2.201382859704821,2,0.8,1.6,transcript,8399.0
SLC6A5,ENSG00000165970,self reported educational attainment,EFO_0004784,0.22011923608359082,2.201230996980021,1,0.4,0.4,transcript,10353.0
PRPF4B,ENSG00000112739,gut microbiome measurement,EFO_0007874,0.22011923608359082,2.201213145671292,1,0.5,0.5,transcript,24056.0
STXBP4,ENSG00000166263,prostate specific antigen amount,OBA_2050200,0.22011923608359082,2.2015840722229583,5,2.0,10.0,transcript,25529.0
ZNF485,ENSG00000198298,total cholesterol measurement,EFO_0004574,0.22011923608359082,2.2012896939096867,1,0.5,0.5,transcript,5137.0
RIF1,ENSG00000080345,vital capacity,EFO_0004312,0.2200448194719993,2.20050973803702,3,1.3,3.9000000000000004,transcript,63370.0
BACE2,ENSG00000182240,mathematical ability,EFO_0004875,0.2199921835718884,2.2000553916454284,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
ZNF697,ENSG00000143067,secondary malignant neoplasm,EFO_0009812,0.21998369267512263,2.200482203682576,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
NBEAL1,ENSG00000144426,Chronic pain,HP_0012532,0.21997921684507177,2.19979602205239,1,0.4,0.4,transcript,103799.0
SGTB,ENSG00000197860,white matter integrity,EFO_0004641,0.21995978565687702,2.1996609978473813,1,0.4,0.4,transcript,6335.0
ZNF148,ENSG00000163848,mean reticulocyte volume,EFO_0010701,0.21969802245017708,2.19699209288144,1,0.4,0.4,transcript,33703.0
OR4X1,ENSG00000176567,thyroid gland adenocarcinoma,MONDO_0024622,0.21967323822174428,2.1972770445268113,1,0.5,0.5,transcript,918.0
OR5AS1,ENSG00000181785,thyroid gland adenocarcinoma,MONDO_0024622,0.21967323822174428,2.196783272802685,1,0.4,0.4,transcript,7860.0
OR10G4,ENSG00000254737,thyroid gland adenocarcinoma,MONDO_0024622,0.21967323822174428,2.196790152292544,1,0.4,0.4,transcript,6924.0
DGKH,ENSG00000102780,thyroid gland adenocarcinoma,MONDO_0024622,0.21967323822174428,2.196759775256187,2,0.8,1.6,transcript,58409.0
DGKH,ENSG00000102780,lean body mass,EFO_0004995,0.21950674653429603,2.1950948583817045,2,0.8,1.6,transcript,58409.0
CFHR4,ENSG00000134365,tachykinin-4 measurement,EFO_0803137,0.2193870235483162,2.1939107442735697,1,0.5,0.5,transcript,12343.0
CFHR4,ENSG00000134365,growth factor receptor-bound protein 7 measurement,EFO_0801659,0.2193870235483162,2.1939107442735697,1,0.5,0.5,transcript,12343.0
CFHR4,ENSG00000134365,E3 ubiquitin-protein ligase RNF128 measurement,EFO_0801555,0.2193870235483162,2.1939107442735697,1,0.5,0.5,transcript,12343.0
CFHR4,ENSG00000134365,sorting nexin-7 measurement,EFO_0803094,0.2193870235483162,2.1939107442735697,1,0.5,0.5,transcript,12343.0
CFHR4,ENSG00000134365,dipeptidyl peptidase 1 measurement,EFO_0020325,0.2193870235483162,2.1939107442735697,1,0.5,0.5,transcript,12343.0
CFHR4,ENSG00000134365,probable E3 ubiquitin-protein ligase HERC4 measurement,EFO_0802903,0.2193870235483162,2.1939107442735697,1,0.5,0.5,transcript,12343.0
GMCL1,ENSG00000087338,atrial flutter,EFO_0003911,0.21934074164935907,2.1936618289598018,2,0.8,1.6,transcript,6289.0
KCNN3,ENSG00000143603,Paralytic ileus,HP_0002590,0.2193005017708678,2.1931240535186176,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
KCNN3,ENSG00000143603,arterial stiffness measurement,EFO_0004517,0.2193005017708678,2.1931240535186176,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
PHC1,ENSG00000111752,intermediate density lipoprotein measurement,EFO_0008595,0.2192889981284851,2.192909131769358,1,0.5,0.5,transcript,26109.0
MMP12,ENSG00000262406,peripheral arterial disease,EFO_0004265,0.21922068098093606,2.1924263487775275,1,0.4,0.4,transcript,1822.0
ZFP90,ENSG00000184939,mean corpuscular hemoglobin,EFO_0004527,0.21917529695606064,2.191766324707346,1,0.4,0.4,transcript,29951.0
FAM171B,ENSG00000144369,sitting height measurement,EFO_0011011,0.21916255938465928,2.19169538969374,1,0.4,0.4,transcript,5731.0
PLCXD2,ENSG00000240891,diastolic blood pressure,EFO_0006336,0.2189364846414551,2.189395866189658,1,0.4,0.4,transcript,12895.0
SERPINB9,ENSG00000170542,platelet component distribution width,EFO_0007984,0.21873714918652998,2.1874192074802346,1,0.4,0.4,transcript,8383.0
ZNF230,ENSG00000159882,free cholesterol:total lipids ratio,EFO_0020945,0.2186646354935568,2.1866821908072755,1,0.4,0.4,transcript,11162.0
REG1A,ENSG00000115386,protein measurement,EFO_0004747,0.2185771192390045,2.185912385471584,1,0.4,0.4,transcript,2833.0
INIP,ENSG00000148153,neurodegenerative disease,EFO_0005772,0.21852615084993224,2.185311785020187,1,0.4,0.4,transcript,7956.0
ZNF594,ENSG00000180626,platelet count,EFO_0004309,0.21848061865950036,2.184844347251367,1,0.4,0.4,transcript,10482.0
TMEM144,ENSG00000164124,sialolithiasis,EFO_1001180,0.2183638093923607,2.183655003667847,1,0.4,0.4,transcript,23655.0
MAP1LC3B2,ENSG00000258102,pericarditis,EFO_0007427,0.2183638093923607,2.183804344962676,1,0.4,0.4,transcript,2406.0
ZNF716,ENSG00000182111,urinary microalbumin measurement,EFO_0010967,0.21830822432133554,2.1859613219081733,6,2.5,15.0,transcript,5210.0
SNTG2,ENSG00000172554,cystatin C measurement,EFO_0004617,0.21830822432133554,2.183132133454824,1,0.5,0.5,transcript,10022.0
ANKRD30B,ENSG00000180777,pulse wave reflection index measurement,EFO_0009804,0.21830822432133554,2.183106809616343,1,0.5,0.5,transcript,20353.0
SLCO5A1,ENSG00000137571,placental retention,EFO_0009578,0.21830822432133554,2.183512795180978,5,2.0,10.0,transcript,23226.0
SLCO5A1,ENSG00000137571,Abruptio Placentae,EFO_1001754,0.21830822432133554,2.183512795180978,5,2.0,10.0,transcript,23226.0
ZNF236,ENSG00000130856,systemic lupus erythematosus,MONDO_0007915,0.21830822432133554,2.1831412112723236,2,0.9,1.8,transcript,30525.0
DTHD1,ENSG00000197057,alcohol drinking,EFO_0004329,0.21829315104492952,2.1829579109984265,1,0.5,0.5,transcript,18939.0
BTLA,ENSG00000186265,eosinophil count,EFO_0004842,0.21819371442717647,2.1821175049932076,2,0.9,1.8,transcript,9980.0
GCNT1,ENSG00000187210,preeclampsia,EFO_0000668,0.21794029023824815,2.1794220000191493,1,0.4,0.4,transcript,20945.0
GCNT1,ENSG00000187210,growth differentiation factor 15 amount,OBA_2050135,0.21794029023824815,2.1794220000191493,1,0.4,0.4,transcript,20945.0
TMEM68,ENSG00000167904,spondylolisthesis,EFO_0007493,0.21794029023824815,2.1794215739037437,1,0.4,0.4,transcript,21423.0
GCNT1,ENSG00000187210,ovarian neoplasm,EFO_0003893,0.21794029023824815,2.1794220000191493,1,0.4,0.4,transcript,20945.0
TPRG1,ENSG00000188001,glycerophospholipid measurement,EFO_0007630,0.21794029023824815,2.179502758838826,2,0.8,1.6,transcript,16023.0
ZDHHC21,ENSG00000175893,social inhibition quality,OBA_1000278,0.2178612944127852,2.1789605246416195,4,1.6,6.4,transcript,18413.0
ZDHHC21,ENSG00000175893,mathematical ability,EFO_0004875,0.2178612944127852,2.1789605246416195,4,1.6,6.4,transcript,18413.0
ZDHHC21,ENSG00000175893,substance abuse,MONDO_0002491,0.2178612944127852,2.1789605246416195,4,1.6,6.4,transcript,18413.0
ZDHHC21,ENSG00000175893,attention deficit hyperactivity disorder,EFO_0003888,0.2178612944127852,2.1789605246416195,4,1.6,6.4,transcript,18413.0
PPP1R9A,ENSG00000158528,body height,OBA_VT0001253,0.2176650477176635,2.1767294853205517,3,1.3,3.9000000000000004,transcript,49362.0
ASPM,ENSG00000066279,hepatocellular carcinoma,EFO_0000182,0.21766423604860718,2.176677358833372,2,0.9,1.8,transcript,51431.0
GPAT3,ENSG00000138678,neuroimaging measurement,EFO_0004346,0.21759743540675397,2.1761214805043214,2,0.8,1.6,transcript,10875.0
OR6N1,ENSG00000197403,neutrophil count,EFO_0004833,0.21759406837698542,2.1781468195850904,4,1.6,6.4,transcript,2901.0
FAM114A1,ENSG00000197712,high density lipoprotein cholesterol measurement,EFO_0004612,0.21757583168929467,2.1758069964596984,1,0.4,0.4,transcript,8217.0
PCNX4,ENSG00000126773,glomerular filtration rate,OBA_0003747,0.21754625377408648,2.1754722018175587,1,0.5,0.5,transcript,51738.0
TRIT1,ENSG00000043514,1-linoleoyl-GPC (18:2) measurement,EFO_0800223,0.21752854877592803,2.175300690526184,1,0.4,0.4,transcript,26311.0
OR5AN1,ENSG00000176495,hypertrophic cardiomyopathy,EFO_0000538,0.2173533531283647,2.17356268240305,1,0.5,0.5,transcript,17152.0
ZNF283,ENSG00000167637,bone tissue density,OBA_1000110,0.2173281794382063,2.173311880428155,1,0.5,0.5,transcript,16619.0
GAGE1,ENSG00000205777,Vitiligo,EFO_0004208,0.2172242652828284,2.17230799095308,1,0.4,0.4,transcript,6122.0
CCDC62,ENSG00000130783,erythrocyte count,EFO_0004305,0.21721530278767318,2.172179963903668,1,0.4,0.4,transcript,14850.0
HHLA2,ENSG00000114455,social interaction measurement,EFO_0009592,0.21715486925730249,2.1715824969135022,1,0.5,0.5,transcript,14791.0
ZFP90,ENSG00000184939,preeclampsia,EFO_0000668,0.21711542698286126,2.1711676249753524,1,0.4,0.4,transcript,29951.0
WDR12,ENSG00000138442,total cholesterol measurement,EFO_0004574,0.21700586333372104,2.1700785725226948,1,0.4,0.4,transcript,20061.0
SARAF,ENSG00000133872,protein measurement,EFO_0004747,0.2169328557981817,2.1693550112587165,1,0.4,0.4,transcript,15121.0
MC2R,ENSG00000185231,bilirubin measurement,EFO_0004570,0.2169328557981817,2.1694231653611924,1,0.4,0.4,transcript,4228.0
RPAP3,ENSG00000005175,spermatocele,EFO_1001189,0.2169328557981817,2.169476925934339,2,0.8,1.6,transcript,10784.0
ING1,ENSG00000153487,bilirubin measurement,EFO_0004570,0.2169328557981817,2.1693550410326643,1,0.4,0.4,transcript,15104.0
ING1,ENSG00000153487,autoimmune thyroid disease,EFO_0006812,0.2169328557981817,2.1693550410326643,1,0.4,0.4,transcript,15104.0
PRPF4B,ENSG00000112739,renal osteodystrophy,EFO_1001152,0.2169328557981817,2.169349342817201,1,0.5,0.5,transcript,24056.0
SCRG1,ENSG00000164106,chin morphology trait,OBA_2050101,0.2169328557981817,2.1696121453621786,2,0.8,1.6,transcript,5642.0
GBP1,ENSG00000117228,protein measurement,EFO_0004747,0.21690344320033997,2.1691382472123277,2,0.8,1.6,transcript,15412.0
CD93,ENSG00000125810,body height,OBA_VT0001253,0.2166756193060082,2.1667825105809717,1,0.4,0.4,transcript,15199.0
RAPGEF4,ENSG00000091428,breast adenocarcinoma,EFO_0000304,0.216671713963441,2.1667303257230865,1,0.4,0.4,transcript,30335.0
SC5D,ENSG00000109929,neurodegenerative disease,EFO_0005772,0.21653653166464598,2.165388159430995,1,0.4,0.4,transcript,17511.0
LSM6,ENSG00000164167,prostate carcinoma,EFO_0001663,0.2164000208963697,2.164165617833748,2,0.8,1.6,transcript,9673.0
DSC2,ENSG00000134755,metabolite measurement,EFO_0004725,0.21637702392856395,2.163782681352267,2,0.8,1.6,transcript,128596.0
GSTA5,ENSG00000182793,free androgen index,EFO_0007005,0.21628840713370484,2.1632342113930707,1,0.5,0.5,transcript,1428.0
OXSR1,ENSG00000172939,serum creatinine amount,OBA_2050096,0.21617086284493928,2.161749204631174,1,0.4,0.4,transcript,9858.0
OXSR1,ENSG00000172939,urinary metabolite measurement,EFO_0005116,0.21617086284493928,2.161749204631174,1,0.4,0.4,transcript,9858.0
STX7,ENSG00000079950,BMI-adjusted waist circumference,EFO_0007789,0.21617086284493928,2.1617971436076138,2,0.8,1.6,transcript,18076.0
AMTN,ENSG00000187689,insulin-like growth factor-binding protein 7 amount,OBA_2050142,0.21611683842829002,2.161394372983465,1,0.4,0.4,transcript,1770.0
RALGPS2,ENSG00000116191,cortical thickness,EFO_0004840,0.21607507696985476,2.1608303044204247,2,0.8,1.6,transcript,20117.0
PEX13,ENSG00000162928,type 2 diabetes mellitus,MONDO_0005148,0.21605689235255396,2.160614753039747,1,0.4,0.4,transcript,8728.0
DZIP3,ENSG00000198919,lymphocyte count,EFO_0004587,0.21598731528475856,2.1598952877598756,1,0.4,0.4,transcript,18071.0
DCK,ENSG00000156136,mean reticulocyte volume,EFO_0010701,0.21593948376332822,2.1594318233013357,1,0.4,0.4,transcript,10815.0
ANKRD36,ENSG00000135976,body mass index,EFO_0004340,0.2158406964815735,2.1584823511708047,2,1.0,2.0,transcript,26530.0
SLC22A24,ENSG00000197658,urinary metabolite measurement,EFO_0005116,0.21578630746849545,2.1579483698060735,1,0.5,0.5,transcript,5862.0
KLRD1,ENSG00000134539,mean corpuscular hemoglobin,EFO_0004527,0.21570376443516934,2.157202133950145,4,1.7000000000000002,6.800000000000001,transcript,41340.0
MTR,ENSG00000116984,head and neck squamous cell carcinoma,EFO_0000181,0.2155999701749914,2.156004114179729,1,0.4,0.4,transcript,90653.0
OR5M1,ENSG00000255012,lipid measurement,EFO_0004529,0.21557513161619543,2.1561232361991465,2,0.8,1.6,transcript,4302.0
OR6C75,ENSG00000187857,lymphocyte count,EFO_0004587,0.21557513161619543,2.155798827742902,1,0.4,0.4,transcript,8419.0
CENPQ,ENSG00000031691,HbA1c measurement,EFO_0004541,0.2154772676809402,2.15500242982491,1,0.4,0.4,transcript,1741.0
EXD1,ENSG00000178997,lean body mass,EFO_0004995,0.21537139404413724,2.1537557246260586,1,0.4,0.4,transcript,9573.0
FBXO28,ENSG00000143756,secondary malignant neoplasm,EFO_0009812,0.21528901016574561,2.1539390893843,5,2.0,10.0,transcript,9533.0
CAV2,ENSG00000105971,retinal vasculature measurement,EFO_0010554,0.21519414994186287,2.1519656729848338,1,0.4,0.4,transcript,16547.0
UNC80,ENSG00000144406,protein measurement,EFO_0004747,0.21516398522726154,2.1516445142772773,1,0.4,0.4,transcript,85800.0
POF1B,ENSG00000124429,Premature ovarian insufficiency,HP_0008209,0.21509547542649643,2.1510404440678776,1,0.5,0.5,transcript,5835.0
SLCO1C1,ENSG00000139155,cutaneous melanoma,EFO_0000389,0.21508178632773003,2.150848754170665,1,0.5,0.5,transcript,16186.0
SGCB,ENSG00000163069,neurodegenerative disease,EFO_0005772,0.21502028233392795,2.1502754186205864,1,0.4,0.4,transcript,5510.0
RPRD2,ENSG00000163125,Red cell distribution width,EFO_0009188,0.2150015500259056,2.150034006782606,1,0.4,0.4,transcript,21614.0
KLRD1,ENSG00000134539,monocyte percentage of leukocytes,EFO_0007989,0.21486254212747607,2.1487899108732127,4,1.7000000000000002,6.800000000000001,transcript,41340.0
DOCK1,ENSG00000150760,beverage consumption measurement,EFO_0010088,0.21470804764414142,2.14710556424874,1,0.4,0.4,transcript,15944.0
MAP1LC3B2,ENSG00000258102,glucose measurement,EFO_0004468,0.2146932909355543,2.147099160394612,1,0.4,0.4,transcript,2406.0
UBL3,ENSG00000122042,adolescent idiopathic scoliosis,EFO_0005423,0.2146932909355543,2.147766821794737,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
UBE2J1,ENSG00000198833,preeclampsia,EFO_0000668,0.21465616543884727,2.1469939310455333,2,0.9,1.8,transcript,4164.0
ASMT,ENSG00000196433,lung adenocarcinoma,EFO_0000571,0.21465225214914138,2.146637253019638,1,0.5,0.5,transcript,4358.0
XKR4,ENSG00000206579,ocular hypotension,MONDO_0004390,0.2146095698551168,2.1461146505079576,1,0.4,0.4,transcript,21106.0
MUC16,ENSG00000181143,neoplasm,EFO_0000616,0.21458757375591117,2.1458785579084965,1,0.5,0.5,transcript,177283.0
CNR2,ENSG00000188822,neurodegenerative disease,EFO_0005772,0.21452393851774268,2.1453153585867337,1,0.4,0.4,transcript,5265.0
GLCE,ENSG00000138604,systolic blood pressure,EFO_0006335,0.2143825355269006,2.1439556802669695,2,0.8,1.6,transcript,12277.0
DTHD1,ENSG00000197057,body mass index,EFO_0004340,0.2142911660346884,2.1429380608960154,1,0.5,0.5,transcript,18939.0
ZNF283,ENSG00000167637,heel bone mineral density,EFO_0009270,0.2141529269678289,2.1415593557243806,1,0.5,0.5,transcript,16619.0
ZNF436,ENSG00000125945,eosinophil percentage of leukocytes,EFO_0007991,0.21410330284137644,2.141066670129492,1,0.4,0.4,transcript,11890.0
HECW2,ENSG00000138411,mental or behavioural disorder,EFO_0000677,0.21408950487966127,2.140900864948065,1,0.4,0.4,transcript,68774.0
ABCB5,ENSG00000004846,metabolite measurement,EFO_0004725,0.21406102808333713,2.140637193300572,1,0.4,0.4,transcript,14863.0
BTLA,ENSG00000186265,cognitive decline measurement,EFO_0007710,0.21404379447989558,2.1406183055203987,2,0.9,1.8,transcript,9980.0
ARL3,ENSG00000138175,smoking behavior trait,OBA_2050116,0.21390924476714768,2.139196777353271,1,0.4,0.4,transcript,3834.0
KCNN3,ENSG00000143603,basophil measurement,EFO_0803539,0.21383260321894815,2.138445067999421,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
TMED5,ENSG00000117500,erythrocyte volume,OBA_0003460,0.21380624918828883,2.1380944591484083,1,0.5,0.5,transcript,15641.0
EXD1,ENSG00000178997,potassium measurement,EFO_0009283,0.21375132476307002,2.137555031815386,1,0.4,0.4,transcript,9573.0
EXD1,ENSG00000178997,COVID-19,MONDO_0100096,0.21359581603947936,2.1359999445794795,1,0.4,0.4,transcript,9573.0
THAP1,ENSG00000131931,Alzheimer disease,MONDO_0004975,0.2133860653631926,2.1339400187112907,1,0.4,0.4,transcript,5040.0
LY75-CD302,ENSG00000248672,lymphocyte percentage of leukocytes,EFO_0007993,0.2133641778113727,2.1336866936724768,1,0.5,0.5,transcript,11132.0
OR2M7,ENSG00000177186,neuroblastoma,EFO_0000621,0.21332291738535597,2.133761655216712,1,0.5,0.5,transcript,939.0
OR2T6,ENSG00000198104,neuroblastoma,EFO_0000621,0.21332291738535597,2.1333148269584847,1,0.4,0.4,transcript,4670.0
OR5M1,ENSG00000255012,neuroblastoma,EFO_0000621,0.21332291738535597,2.1336010938907517,2,0.8,1.6,transcript,4302.0
ZNF502,ENSG00000196653,neurodegenerative disease,EFO_0005772,0.21331091296348875,2.133158197348332,1,0.5,0.5,transcript,10190.0
ITPRID2,ENSG00000138434,ovarian neoplasm,EFO_0003893,0.2133085825119422,2.133094612658691,1,0.4,0.4,transcript,45519.0
ZDHHC21,ENSG00000175893,protein measurement,EFO_0004747,0.21323695589275848,2.132717139441352,4,1.6,6.4,transcript,18413.0
POU2F1,ENSG00000143190,viral load,EFO_0010125,0.2132250036248981,2.132265048305539,2,0.8,1.6,transcript,106581.0
TWSG1,ENSG00000128791,mean corpuscular hemoglobin,EFO_0004527,0.21322483926910407,2.1323041029974474,1,0.4,0.4,transcript,7180.0
ARPC5,ENSG00000162704,alcohol consumption quality,OBA_1000840,0.21301525274025068,2.1301792564369206,1,0.4,0.4,transcript,14965.0
ARFIP1,ENSG00000164144,HbA1c measurement,EFO_0004541,0.21290946349854759,2.129121687602817,1,0.4,0.4,transcript,14786.0
ZNF793,ENSG00000188227,platelet count,EFO_0004309,0.21282572159783378,2.1282715405736683,1,0.4,0.4,transcript,27924.0
PDCD5,ENSG00000105185,viral load,EFO_0010125,0.21280689128372873,2.128147022581478,1,0.4,0.4,transcript,5121.0
KIAA0232,ENSG00000170871,JT interval,EFO_0007885,0.21278317772594638,2.1278550655687325,1,0.4,0.4,transcript,17176.0
MUC16,ENSG00000181143,growth differentiation factor 15 amount,OBA_2050135,0.2127143074282522,2.127145894631907,1,0.5,0.5,transcript,177283.0
TENT4B,ENSG00000121274,birth weight,EFO_0004344,0.21263277240730205,2.1265771395056006,4,1.6,6.4,transcript,25660.0
MUC16,ENSG00000181143,multiple myeloma,EFO_0001378,0.21257517663505876,2.1257545866999723,1,0.5,0.5,transcript,177283.0
SLC25A16,ENSG00000122912,hematocrit,EFO_0004348,0.21256330365065468,2.1256640731297622,1,0.4,0.4,transcript,12888.0
THAP1,ENSG00000131931,polygenic risk score,EFO_0030082,0.21246211572648085,2.1247005223441735,1,0.4,0.4,transcript,5040.0
GBP6,ENSG00000183347,blood sodium bicarbonate amount,OBA_2050094,0.21246211572648085,2.1250053621740936,2,0.9,1.8,transcript,4685.0
DOCK1,ENSG00000150760,low grade glioma,MONDO_0021637,0.21240372606924196,2.1240623484997454,1,0.4,0.4,transcript,15944.0
ITPRID2,ENSG00000138434,hypertension,EFO_0000537,0.212321005306997,2.123218840609239,1,0.4,0.4,transcript,45519.0
SLC25A36,ENSG00000114120,level of calsyntenin-2 in blood serum,OBA_2041057,0.21223766791700951,2.12239034597343,1,0.4,0.4,transcript,29268.0
TMEM215,ENSG00000188133,liver disease,EFO_0001421,0.21223278759467548,2.1226273892376573,2,0.8,1.6,transcript,5342.0
SH3GL3,ENSG00000140600,smoking status measurement,EFO_0006527,0.2121176840969764,2.121228533913677,1,0.4,0.4,transcript,7738.0
NOL9,ENSG00000162408,hemoglobin A1 measurement,EFO_0007629,0.21203605163752037,2.120403219481855,1,0.4,0.4,transcript,9367.0
ASPM,ENSG00000066279,lung adenocarcinoma,EFO_0000571,0.2118263018665209,2.1182980170125094,2,0.9,1.8,transcript,51431.0
SMC3,ENSG00000108055,glioblastoma multiforme,EFO_0000519,0.21174552664626076,2.1174638789852156,1,0.4,0.4,transcript,46444.0
LRPAP1,ENSG00000163956,blood dibutyl sulfosuccinate measurement,EFO_0022212,0.21163338780676458,2.1165645142390854,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
KIAA0319,ENSG00000137261,nervous system disease,EFO_0000618,0.21152439592560396,2.1152563466085526,1,0.4,0.4,transcript,32291.0
F13B,ENSG00000143278,breast adenocarcinoma,EFO_0000304,0.21150014645746948,2.1151093627188464,1,0.5,0.5,transcript,4634.0
TSPAN3,ENSG00000140391,body weight,EFO_0004338,0.21148128797489288,2.1148347903536617,1,0.4,0.4,transcript,18256.0
HEG1,ENSG00000173706,type 2 diabetes mellitus,MONDO_0005148,0.21144734821848704,2.1144953484725217,1,0.4,0.4,transcript,18293.0
MMP12,ENSG00000262406,level of stromelysin-1 in blood serum,OBA_2042390,0.21144359555894848,2.1146554945576517,1,0.4,0.4,transcript,1822.0
TMEM132B,ENSG00000139364,high density lipoprotein cholesterol measurement,EFO_0004612,0.2112864976797659,2.112954340084242,3,1.2000000000000002,3.6000000000000005,transcript,40285.0
PHF24,ENSG00000122733,self reported educational attainment,EFO_0004784,0.211285120946911,2.1128987210500574,1,0.4,0.4,transcript,8419.0
MUC16,ENSG00000181143,hepatocellular carcinoma,EFO_0000182,0.21124629282157364,2.1124657485651213,1,0.5,0.5,transcript,177283.0
TRMT9B,ENSG00000250305,emphysema imaging measurement,EFO_0007626,0.21104901254995373,2.110631252160716,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
RPAP3,ENSG00000005175,liver disease,EFO_0001421,0.21100596563020377,2.1102080242545598,2,0.8,1.6,transcript,10784.0
RPAP3,ENSG00000005175,cardiomyopathy,EFO_0000318,0.21100596563020377,2.1102080242545598,2,0.8,1.6,transcript,10784.0
RPAP3,ENSG00000005175,ceramide measurement,EFO_0010222,0.21100596563020377,2.1102080242545598,2,0.8,1.6,transcript,10784.0
ZNF143,ENSG00000166478,whole body water mass,EFO_0009805,0.21097435308787474,2.109769810706352,1,0.5,0.5,transcript,19026.0
KIAA0319,ENSG00000137261,complication,EFO_0009518,0.21097002614357693,2.1097126487882822,1,0.4,0.4,transcript,32291.0
KIAA0319,ENSG00000137261,Herpes Zoster,EFO_0006510,0.21097002614357693,2.1097126487882822,1,0.4,0.4,transcript,32291.0
PF4V1,ENSG00000109272,total blood protein measurement,EFO_0004536,0.21096762600859317,2.110214618094007,1,0.4,0.4,transcript,743.0
PDP1,ENSG00000164951,spondylolisthesis,EFO_0007493,0.21086736964734693,2.1086970636892652,1,0.4,0.4,transcript,17118.0
DCK,ENSG00000156136,"chromosome, telomeric region length",OBA_0003784,0.21079268736878506,2.107963859355904,1,0.4,0.4,transcript,10815.0
WAPL,ENSG00000062650,total cholesterol measurement,EFO_0004574,0.21075256236616077,2.1076593805584474,2,0.8,1.6,transcript,11962.0
IL17A,ENSG00000112115,head and neck squamous cell carcinoma,EFO_0000181,0.21075228708868468,2.107736660304271,1,0.4,0.4,transcript,1871.0
FYCO1,ENSG00000163820,monocyte count,EFO_0005091,0.21068362224388149,2.10686083327989,1,0.4,0.4,transcript,16253.0
NOL9,ENSG00000162408,platelet crit,EFO_0007985,0.21066578970989647,2.106700600205616,1,0.4,0.4,transcript,9367.0
CDKL2,ENSG00000138769,Testicular Germ Cell Tumor,EFO_1000566,0.2106292224107193,2.1064563266712955,2,0.8,1.6,transcript,9750.0
ATPSCKMT,ENSG00000150756,viral load,EFO_0010125,0.2106181520489166,2.10622923041283,1,0.4,0.4,transcript,8384.0
ZNF429,ENSG00000197013,triglyceride measurement,EFO_0004530,0.2106181520489166,2.1063373292339316,2,0.8,1.6,transcript,10269.0
ZNF429,ENSG00000197013,sleep quality,OBA_2040170,0.2106181520489166,2.1063373292339316,2,0.8,1.6,transcript,10269.0
ATF6,ENSG00000118217,metabolite measurement,EFO_0004725,0.21059974017568112,2.106003754189793,1,0.4,0.4,transcript,62968.0
TPRG1,ENSG00000188001,allergic rhinitis,EFO_0005854,0.21048139513936157,2.1049138078499596,2,0.8,1.6,transcript,16023.0
CMTR2,ENSG00000180917,adolescent idiopathic scoliosis,EFO_0005423,0.21037012124179716,2.1038046317185986,2,0.8,1.6,transcript,15471.0
KCNN3,ENSG00000143603,Red cell distribution width,EFO_0009188,0.21035881943801701,2.1037072301901096,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
LRRIQ3,ENSG00000162620,food allergy,EFO_1001890,0.21024303797010474,2.1024572758817897,1,0.5,0.5,transcript,18590.0
LRRIQ3,ENSG00000162620,"osteoarthritis, hand",EFO_1000789,0.21024303797010474,2.1024572758817897,1,0.5,0.5,transcript,18590.0
MUC16,ENSG00000181143,pancreatic neoplasm,EFO_0003860,0.2101741646823908,2.1017444671732926,1,0.5,0.5,transcript,177283.0
GPATCH2L,ENSG00000089916,ectonucleoside triphosphate diphosphohydrolase 5 measurement,EFO_0008115,0.21002752313084355,2.100417703648766,4,1.6,6.4,transcript,44921.0
ZNF697,ENSG00000143067,glomerular filtration rate,OBA_0003747,0.20976271826087273,2.0982724595400772,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
SMC3,ENSG00000108055,acute myeloid leukemia,EFO_0000222,0.20969696646959474,2.0969782772185552,1,0.4,0.4,transcript,46444.0
CNTN1,ENSG00000018236,head and neck squamous cell carcinoma,EFO_0000181,0.20966637790967813,2.0966803059736145,1,0.4,0.4,transcript,24203.0
CNTN1,ENSG00000018236,platelet volume,OBA_0003277,0.2096656083138732,2.0966726100155655,1,0.4,0.4,transcript,24203.0
B4GALT6,ENSG00000118276,pancreatic adenocarcinoma,EFO_1000044,0.20962403968786056,2.0962716346763406,1,0.4,0.4,transcript,12805.0
SEC22A,ENSG00000121542,pancreatic adenocarcinoma,EFO_1000044,0.20962403968786056,2.0963624318111047,2,0.8,1.6,transcript,13111.0
PPFIBP2,ENSG00000166387,pituitary gland disease,EFO_0009607,0.20958870470455485,2.0959007299309955,1,0.5,0.5,transcript,36542.0
FBXO42,ENSG00000037637,cortical thickness,EFO_0004840,0.2095241487312906,2.0952770586779574,1,0.4,0.4,transcript,11245.0
ATRNL1,ENSG00000107518,erythrocyte volume,OBA_0003460,0.20947469721604262,2.094763831302296,1,0.4,0.4,transcript,23726.0
ATG2B,ENSG00000066739,neurodegenerative disease,EFO_0005772,0.2094493563348759,2.0945221985930176,1,0.5,0.5,transcript,17461.0
NCS1,ENSG00000107130,erythrocyte count,EFO_0004305,0.20942022760692927,2.0942639283504274,1,0.4,0.4,transcript,6488.0
SELENOI,ENSG00000138018,erythrocyte count,EFO_0004305,0.20940366339230954,2.0940782226109724,1,0.4,0.4,transcript,9618.0
METTL2B,ENSG00000165055,heart rate,OBA_1001087,0.20927251864409702,2.0928278097492887,2,0.8,1.6,transcript,15591.0
ANKRD36B,ENSG00000196912,diastolic blood pressure,EFO_0006336,0.20908445029676292,2.090874041574588,1,0.5,0.5,transcript,16927.0
BMP10,ENSG00000163217,lung adenocarcinoma,EFO_0000571,0.20907658701307222,2.090832139183075,1,0.4,0.4,transcript,6036.0
ANKRD36,ENSG00000135976,bitter alcoholic beverage consumption measurement,EFO_0010092,0.20903563317597115,2.090431718114781,2,1.0,2.0,transcript,26530.0
OR9Q2,ENSG00000186513,medulloblastoma,EFO_0002939,0.20899391290688807,2.0900451174101633,1,0.4,0.4,transcript,3774.0
OR6C75,ENSG00000187857,medulloblastoma,EFO_0002939,0.20899391290688807,2.0899866406498284,1,0.4,0.4,transcript,8419.0
LYPD6,ENSG00000187123,transverse temporal cortex volume,OBA_2045252,0.208972728058895,2.0897600298930277,1,0.4,0.4,transcript,12214.0
ARAP1,ENSG00000186635,lung adenocarcinoma,EFO_0000571,0.20875974744542244,2.0876064840719915,1,0.4,0.4,transcript,44397.0
SGTB,ENSG00000197860,age at assessment,EFO_0008007,0.20870225025378425,2.0870856438164536,1,0.4,0.4,transcript,6335.0
GALNT3,ENSG00000115339,retinal perforation,MONDO_0001539,0.2086995800925503,2.087024708925792,1,0.4,0.4,transcript,13837.0
GALNT3,ENSG00000115339,retinal detachment,EFO_0005773,0.2086995800925503,2.087024708925792,1,0.4,0.4,transcript,13837.0
TMED5,ENSG00000117500,serum alanine aminotransferase measurement,EFO_0004735,0.20858383748179563,2.085870342083476,1,0.5,0.5,transcript,15641.0
ARHGAP12,ENSG00000165322,glomerular filtration rate,OBA_0003747,0.2084788890344559,2.084800952706973,1,0.4,0.4,transcript,33161.0
ARMC1,ENSG00000104442,cystatin C measurement,EFO_0004617,0.20840346437405524,2.0840791921312416,1,0.4,0.4,transcript,8979.0
LMNTD1,ENSG00000152936,"osteoarthritis, knee",EFO_0004616,0.2083888804557553,2.084043470307682,2,0.9,1.8,transcript,11638.0
LMNTD1,ENSG00000152936,diglyceride measurement,EFO_0010223,0.2083888804557553,2.084043470307682,2,0.9,1.8,transcript,11638.0
ZNF675,ENSG00000197372,cellulitis,EFO_0003035,0.20838541193450238,2.0838969165717636,1,0.5,0.5,transcript,11683.0
GABPA,ENSG00000154727,pulse wave reflection index measurement,EFO_0009804,0.20838541193450238,2.083890071169579,1,0.4,0.4,transcript,11126.0
ZNF675,ENSG00000197372,abscess,EFO_0003030,0.20838541193450238,2.0838969165717636,1,0.5,0.5,transcript,11683.0
GPAT3,ENSG00000138678,high density lipoprotein cholesterol measurement,EFO_0004612,0.2083536592223362,2.0836837186601436,2,0.8,1.6,transcript,10875.0
ASPM,ENSG00000066279,glioma,EFO_0005543,0.2083473684476634,2.0835086828239344,2,0.9,1.8,transcript,51431.0
PEX7,ENSG00000112357,reticulocyte measurement,EFO_0010700,0.2083315832818758,2.0833583769583024,1,0.4,0.4,transcript,9402.0
MR1,ENSG00000153029,pallidum volume,OBA_2050027,0.20821612038006773,2.0822942464112693,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
RNMT,ENSG00000101654,heel bone mineral density,EFO_0009270,0.20820269281410483,2.082043349850548,1,0.4,0.4,transcript,24358.0
PKD2L2,ENSG00000078795,Alzheimer disease,MONDO_0004975,0.2081864797880042,2.0819041741597712,1,0.5,0.5,transcript,12698.0
MUC16,ENSG00000181143,non-small cell lung carcinoma,EFO_0003060,0.2079857230689185,2.0798600510385694,1,0.5,0.5,transcript,177283.0
FRRS1L,ENSG00000260230,BMI-adjusted waist circumference,EFO_0007789,0.207979581250823,2.0798817185484983,2,0.8,1.6,transcript,18625.0
STX7,ENSG00000079950,body height,OBA_VT0001253,0.2079407799178903,2.079496314337124,2,0.8,1.6,transcript,18076.0
ZNF429,ENSG00000197013,prostate adenocarcinoma,EFO_0000673,0.20788866826014474,2.079042491346213,2,0.8,1.6,transcript,10269.0
FSIP2,ENSG00000188738,intelligence,EFO_0004337,0.20775692361701406,2.0778481761980347,4,2.0,8.0,transcript,28680.0
TSPAN3,ENSG00000140391,type 2 diabetes mellitus,MONDO_0005148,0.20763870744766932,2.076408985081426,1,0.4,0.4,transcript,18256.0
INF2,ENSG00000203485,peak expiratory flow,EFO_0009718,0.2075147639588537,2.075150702469483,1,0.4,0.4,transcript,130596.0
RPRD2,ENSG00000163125,heart rate,OBA_1001087,0.20744402309216511,2.074458737445201,1,0.4,0.4,transcript,21614.0
TSPAN3,ENSG00000140391,blood protein measurement,EFO_0007937,0.20730834096109932,2.073105320215726,1,0.4,0.4,transcript,18256.0
OTULINL,ENSG00000145569,platelet volume,OBA_0003277,0.207211793072941,2.0721679057419036,1,0.4,0.4,transcript,8004.0
PPP1R9A,ENSG00000158528,mycoplasma pneumoniae seropositivity,EFO_0803636,0.2072068765369653,2.0721477735135694,3,1.3,3.9000000000000004,transcript,49362.0
METTL14,ENSG00000145388,brain connectivity attribute,OBA_2045295,0.2072068765369653,2.0720943522691604,1,0.4,0.4,transcript,15633.0
MATN2,ENSG00000132561,body height,OBA_VT0001253,0.20717106135451932,2.071727569020116,1,0.5,0.5,transcript,29489.0
TMEM144,ENSG00000164124,metabolite measurement,EFO_0004725,0.20706660892555723,2.0706829989998123,1,0.4,0.4,transcript,23655.0
TMCC1,ENSG00000172765,erythrocyte volume,OBA_0003460,0.20703056447309137,2.070315846210128,1,0.4,0.4,transcript,39210.0
NCKAP1,ENSG00000061676,phosphatidylethanolamine measurement,EFO_0010228,0.20698497281774805,2.069859557394829,1,0.4,0.4,transcript,40695.0
AGPAT5,ENSG00000155189,alcohol drinking,EFO_0004329,0.20696911389290823,2.0697285116283255,1,0.4,0.4,transcript,10703.0
YTHDC2,ENSG00000047188,Inguinal hernia,HP_0000023,0.20693167497020226,2.069336958866879,1,0.4,0.4,transcript,19793.0
SERPINB10,ENSG00000242550,monocyte count,EFO_0005091,0.20691956370842285,2.0694276556457134,1,0.5,0.5,transcript,2155.0
SKP2,ENSG00000145604,head and neck squamous cell carcinoma,EFO_0000181,0.20665134749848485,2.066518497838834,1,0.4,0.4,transcript,79636.0
ARHGAP20,ENSG00000137727,FEV/FVC ratio,EFO_0004713,0.2066466609119505,2.0664768537090814,1,0.4,0.4,transcript,39045.0
CMTR2,ENSG00000180917,blood urea nitrogen measurement,EFO_0004741,0.20661966094102102,2.066300028710837,2,0.8,1.6,transcript,15471.0
GMCL2,ENSG00000244234,erythrocyte count,EFO_0004305,0.20661966094102102,2.066336128070831,1,0.4,0.4,transcript,2867.0
GPAT3,ENSG00000138678,2'-deoxyuridine measurement,EFO_0800643,0.20654944267525222,2.065641553189304,2,0.8,1.6,transcript,10875.0
NXPH2,ENSG00000144227,lymphocyte count,EFO_0004587,0.20654944267525222,2.065642082714132,1,0.4,0.4,transcript,2709.0
AGA,ENSG00000038002,secondary malignant neoplasm,EFO_0009812,0.20654944267525222,2.0655924083319857,1,0.5,0.5,transcript,5103.0
ZPLD1,ENSG00000170044,ovarian neoplasm,EFO_0003893,0.20654944267525222,2.065653409264446,2,0.8,1.6,transcript,10064.0
ZPLD1,ENSG00000170044,rheumatoid arthritis,EFO_0000685,0.20654944267525222,2.065653409264446,2,0.8,1.6,transcript,10064.0
TXNL1,ENSG00000091164,urinary microalbumin measurement,EFO_0010967,0.20654944267525222,2.0655766255709143,2,0.8,1.6,transcript,19465.0
ST8SIA4,ENSG00000113532,acute tonsillitis,MONDO_0020686,0.20654944267525222,2.0655373038025813,1,0.4,0.4,transcript,9329.0
LRRIQ3,ENSG00000162620,arterial stiffness measurement,EFO_0004517,0.20654944267525222,2.0655213229332645,1,0.5,0.5,transcript,18590.0
SI,ENSG00000090402,Cerebral degeneration,HP_0007313,0.20654944267525222,2.0655664728620327,1,0.5,0.5,transcript,6940.0
CDH19,ENSG00000071991,type 1 diabetes nephropathy,EFO_0004996,0.20654944267525222,2.0657689844096305,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
TXNL1,ENSG00000091164,cataract,MONDO_0005129,0.20654944267525222,2.0655766255709143,2,0.8,1.6,transcript,19465.0
PTCHD4,ENSG00000244694,trigeminal nerve disease,EFO_0009569,0.20654944267525222,2.065908267423864,6,2.4000000000000004,14.400000000000002,transcript,34796.0
SI,ENSG00000090402,alopecia areata,EFO_0004192,0.20654944267525222,2.0655664728620327,1,0.5,0.5,transcript,6940.0
ST8SIA4,ENSG00000113532,cervical carcinoma,EFO_0001061,0.20654944267525222,2.0655373038025813,1,0.4,0.4,transcript,9329.0
LRRIQ3,ENSG00000162620,type 1 diabetes mellitus,MONDO_0005147,0.20654944267525222,2.0655213229332645,1,0.5,0.5,transcript,18590.0
NDST3,ENSG00000164100,arterial stiffness measurement,EFO_0004517,0.20654944267525222,2.0655444893307453,1,0.4,0.4,transcript,7990.0
PTCHD4,ENSG00000244694,diabetes mellitus,EFO_0000400,0.20654944267525222,2.065908267423864,6,2.4000000000000004,14.400000000000002,transcript,34796.0
CDH19,ENSG00000071991,lymphocyte count,EFO_0004587,0.20654944267525222,2.0657689844096305,3,1.2000000000000002,3.6000000000000005,transcript,13112.0
PCDH10,ENSG00000138650,body mass index,EFO_0004340,0.20654944267525222,2.065608289547854,2,0.8,1.6,transcript,14052.0
TXNL1,ENSG00000091164,cornea transplantation,EFO_0010676,0.20654944267525222,2.0655766255709143,2,0.8,1.6,transcript,19465.0
MED10,ENSG00000133398,preeclampsia,EFO_0000668,0.20654944267525222,2.0656440153837865,1,0.4,0.4,transcript,2674.0
MMADHC,ENSG00000168288,brain aneurysm,EFO_0003870,0.20654944267525222,2.0655759928210378,1,0.4,0.4,transcript,4904.0
KLHL3,ENSG00000146021,autosomal dominant pseudohypoaldosteronism type 1,MONDO_0008329,0.20653194388582596,2.0653667495416035,2,0.8,1.6,transcript,33819.0
CHFR,ENSG00000072609,Lung Abscess,EFO_1001362,0.2065224857717365,2.065232947023303,1,0.4,0.4,transcript,49448.0
CHFR,ENSG00000072609,bronchopneumonia,EFO_0007184,0.2065224857717365,2.065232947023303,1,0.4,0.4,transcript,49448.0
ANKRD30B,ENSG00000180777,lymphocyte count,EFO_0004587,0.2064284995279403,2.06430956168239,1,0.5,0.5,transcript,20353.0
NMRK1,ENSG00000106733,low density lipoprotein cholesterol measurement,EFO_0004611,0.20620223002747723,2.06206827200216,1,0.4,0.4,transcript,8701.0
MRPL35,ENSG00000132313,reticulocyte measurement,EFO_0010700,0.20617920794582448,2.061855895667562,1,0.4,0.4,transcript,6268.0
CR1L,ENSG00000197721,pyruvate measurement,EFO_0010117,0.2060937022374333,2.0610303059564226,1,0.5,0.5,transcript,5360.0
CD69,ENSG00000110848,chronic lymphocytic leukemia,EFO_0000095,0.20576893313299677,2.058533807051291,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
KCNN3,ENSG00000143603,eosinophil count,EFO_0004842,0.2057586321924175,2.0577053577341147,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
CLSTN2,ENSG00000158258,platelet volume,OBA_0003277,0.20555628592952616,2.0555869455239604,1,0.4,0.4,transcript,16607.0
SH3GL3,ENSG00000140600,BMI-adjusted hip circumference,EFO_0008039,0.2052128477194806,2.052180170138719,1,0.4,0.4,transcript,7738.0
RPRD2,ENSG00000163125,squamous cell carcinoma,EFO_0000707,0.20513206905522566,2.0513391970758064,1,0.4,0.4,transcript,21614.0
FAM171B,ENSG00000144369,handedness,EFO_0009902,0.2050093765288696,2.050163561135843,1,0.4,0.4,transcript,5731.0
TWSG1,ENSG00000128791,glomerulonephritis,MONDO_0002462,0.20497984683803436,2.04985417868675,1,0.4,0.4,transcript,7180.0
MRPL32,ENSG00000106591,heel bone mineral density,EFO_0009270,0.20488146182823813,2.0488977610801364,1,0.4,0.4,transcript,4811.0
RGS4,ENSG00000117152,schizophrenia,MONDO_0005090,0.20486165623962926,2.048712831951046,2,0.8,1.6,transcript,16620.0
BACE2,ENSG00000182240,frozen shoulder,EFO_1000941,0.20479893317589487,2.048122887685493,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
UBE2U,ENSG00000177414,tyrosine-protein kinase transmembrane receptor ROR1 measurement,EFO_0020831,0.20477645822455356,2.0478317978395535,1,0.4,0.4,transcript,5951.0
HNRNPA0,ENSG00000177733,waist circumference,OBA_1001085,0.2047635411384755,2.0476583655911136,1,0.4,0.4,transcript,17426.0
PUS7L,ENSG00000129317,bone tissue density,OBA_1000110,0.20471243145857665,2.0472612331572493,3,1.2000000000000002,3.6000000000000005,transcript,26293.0
ZDHHC21,ENSG00000175893,osteoarthritis,MONDO_0005178,0.2043739606295742,2.0440871868095094,4,1.6,6.4,transcript,18413.0
ZDHHC21,ENSG00000175893,hypertrophic cardiomyopathy,EFO_0000538,0.2043739606295742,2.0440871868095094,4,1.6,6.4,transcript,18413.0
ZDHHC21,ENSG00000175893,placental retention,EFO_0009578,0.2043739606295742,2.0440871868095094,4,1.6,6.4,transcript,18413.0
MUC16,ENSG00000181143,diffuse large B-cell lymphoma,EFO_0000403,0.2043318421876782,2.0433212422261664,1,0.5,0.5,transcript,177283.0
SLC4A8,ENSG00000050438,stomatitis,EFO_0009688,0.20430521215566888,2.0430836294041117,2,0.8,1.6,transcript,50781.0
SLC4A8,ENSG00000050438,mucositis,EFO_1001898,0.20430521215566888,2.0430836294041117,2,0.8,1.6,transcript,50781.0
CNTN1,ENSG00000018236,metabolite measurement,EFO_0004725,0.2042823560500227,2.0428400873770602,1,0.4,0.4,transcript,24203.0
GPR158,ENSG00000151025,metabolite measurement,EFO_0004725,0.204056291885536,2.040588590159976,1,0.5,0.5,transcript,19477.0
TMED5,ENSG00000117500,mathematical ability,EFO_0004875,0.20398862114983185,2.0399181787638385,1,0.5,0.5,transcript,15641.0
ZDHHC21,ENSG00000175893,waist circumference,OBA_1001085,0.20378256676527085,2.038173248166476,4,1.6,6.4,transcript,18413.0
ZDHHC21,ENSG00000175893,ocular hypotension,MONDO_0004390,0.20378256676527085,2.038173248166476,4,1.6,6.4,transcript,18413.0
YIPF4,ENSG00000119820,sitting height measurement,EFO_0011011,0.20377880237854407,2.037906200903396,2,0.8,1.6,transcript,13539.0
TEX15,ENSG00000133863,erythrocyte volume,OBA_0003460,0.2037445006578408,2.037459930169621,1,0.5,0.5,transcript,33504.0
RALGPS2,ENSG00000116191,brain attribute,OBA_2045210,0.20372723585809194,2.0373518933027963,2,0.8,1.6,transcript,20117.0
RNF14,ENSG00000013561,serum gamma-glutamyl transferase measurement,EFO_0004532,0.20370683484346247,2.037128179412113,2,0.8,1.6,transcript,26742.0
GPR85,ENSG00000164604,body mass index,EFO_0004340,0.2036060408253625,2.0360839556722388,1,0.4,0.4,transcript,16987.0
BACH1,ENSG00000156273,Abnormality of refraction,HP_0000539,0.20343567875662802,2.034714649342169,4,1.6,6.4,transcript,17884.0
TMTC3,ENSG00000139324,sunburn,EFO_0003958,0.20326685782071388,2.032707587374293,1,0.4,0.4,transcript,10254.0
HEATR1,ENSG00000119285,total cholesterol measurement,EFO_0004574,0.20314799642072062,2.031509555258872,1,0.5,0.5,transcript,16897.0
KCNN3,ENSG00000143603,response to paracetamol,GO_1901554,0.20300846039568776,2.0302036397668175,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
FRRS1L,ENSG00000260230,injury,EFO_0000546,0.20294205236525567,2.0295064296928254,2,0.8,1.6,transcript,18625.0
LNPEP,ENSG00000113441,endoplasmic reticulum aminopeptidase 2 measurement,EFO_0801566,0.20289217166761997,2.028942378900488,1,0.4,0.4,transcript,19359.0
NUP43,ENSG00000120253,brain attribute,OBA_2045210,0.2025583524677047,2.0257857235902277,2,0.8,1.6,transcript,7913.0
INIP,ENSG00000148153,sorting nexin-4 measurement,EFO_0020747,0.20249181871833982,2.024968463704263,1,0.4,0.4,transcript,7956.0
FBXO22,ENSG00000167196,erythrocyte count,EFO_0004305,0.2024176666854025,2.024197865645694,1,0.4,0.4,transcript,18869.0
HECW2,ENSG00000138411,mood disorder,EFO_0004247,0.20241395723103608,2.0241453884618132,1,0.4,0.4,transcript,68774.0
TXNL1,ENSG00000091164,smoking initiation,EFO_0005670,0.20241186898374194,2.024200888655811,2,0.8,1.6,transcript,19465.0
EPRS1,ENSG00000136628,calcium measurement,EFO_0004838,0.20236261796990887,2.0236708944191744,1,0.5,0.5,transcript,11182.0
RIF1,ENSG00000080345,ovarian cancer,MONDO_0008170,0.2021963853591588,2.022025396908615,3,1.3,3.9000000000000004,transcript,63370.0
GFRAL,ENSG00000187871,daytime rest measurement,EFO_0007828,0.20217994259121772,2.022008740407206,1,0.4,0.4,transcript,1911.0
ZNF502,ENSG00000196653,bone tissue density,OBA_1000110,0.20212532159609328,2.0213022836743773,1,0.5,0.5,transcript,10190.0
SEC22A,ENSG00000121542,hemoglobin A1 measurement,EFO_0007629,0.2021091906945257,2.021213941877756,2,0.8,1.6,transcript,13111.0
RBM23,ENSG00000100461,Red cell distribution width,EFO_0009188,0.20197423613694426,2.0197522201425184,1,0.4,0.4,transcript,40573.0
PDCD5,ENSG00000105185,reticulocyte count,EFO_0007986,0.20181377213465732,2.0182158310907634,1,0.4,0.4,transcript,5121.0
PDCD5,ENSG00000105185,reticulocyte measurement,EFO_0010700,0.20181377213465732,2.0182158310907634,1,0.4,0.4,transcript,5121.0
PDCD5,ENSG00000105185,red blood cell density,OBA_2045260,0.20181377213465732,2.0182158310907634,1,0.4,0.4,transcript,5121.0
CR1L,ENSG00000197721,platelet component distribution width,EFO_0007984,0.20170308171152357,2.017124100697325,1,0.5,0.5,transcript,5360.0
SARAF,ENSG00000133872,Hirsutism,HP_0001007,0.20157174408845038,2.0157438941614036,1,0.4,0.4,transcript,15121.0
MAP1LC3B2,ENSG00000258102,basophil measurement,EFO_0803539,0.20157174408845038,2.015883691923573,1,0.4,0.4,transcript,2406.0
ATPSCKMT,ENSG00000150756,gastrointestinal disease,EFO_0010282,0.20157174408845038,2.015765150808168,1,0.4,0.4,transcript,8384.0
RPAP3,ENSG00000005175,metabolite measurement,EFO_0004725,0.20157174408845038,2.015865808837026,2,0.8,1.6,transcript,10784.0
AMTN,ENSG00000187689,amelogenesis imperfecta,MONDO_0019507,0.2015258491631795,2.01548448033236,1,0.4,0.4,transcript,1770.0
GBP1,ENSG00000117228,acute myeloid leukemia,EFO_0000222,0.20141401101034112,2.014243925312339,2,0.8,1.6,transcript,15412.0
ZNF697,ENSG00000143067,temporal measurement,EFO_0000719,0.20129500815291462,2.013595358460496,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
ANKRD36,ENSG00000135976,colorectal cancer,MONDO_0005575,0.20127079579409762,2.0127833442960457,2,1.0,2.0,transcript,26530.0
TRMT6,ENSG00000089195,"osteoarthritis, hip",EFO_1000786,0.20126152074366332,2.012648688645305,1,0.4,0.4,transcript,11947.0
KIAA0319,ENSG00000137261,dyslexia,EFO_0005424,0.2011784776270082,2.011797163622595,1,0.4,0.4,transcript,32291.0
KLRD1,ENSG00000134539,mean reticulocyte volume,EFO_0010701,0.20114212243529203,2.011585713951372,4,1.7000000000000002,6.800000000000001,transcript,41340.0
ZNF793,ENSG00000188227,prostate carcinoma,EFO_0001663,0.2008799847690347,2.0088141722856774,1,0.4,0.4,transcript,27924.0
GUF1,ENSG00000151806,pituitary gland disease,EFO_0009607,0.20085356367704718,2.0085775584607544,1,0.5,0.5,transcript,11927.0
ZNF675,ENSG00000197372,alkaline phosphatase measurement,EFO_0004533,0.20078019906582636,2.0078447878850034,1,0.5,0.5,transcript,11683.0
ZNF675,ENSG00000197372,bilirubin measurement,EFO_0004570,0.20078019906582636,2.0078447878850034,1,0.5,0.5,transcript,11683.0
SYCP1,ENSG00000198765,vital capacity,EFO_0004312,0.20072451257030402,2.0072662539515083,1,0.4,0.4,transcript,18932.0
RAD23B,ENSG00000119318,body weight,EFO_0004338,0.20061524403564518,2.0061927142187153,1,0.4,0.4,transcript,9932.0
WDR12,ENSG00000138442,serum creatinine amount,OBA_2050096,0.2006146469835053,2.0061664090205378,1,0.4,0.4,transcript,20061.0
EXD1,ENSG00000178997,cystatin B measurement,EFO_0010593,0.20059525857731808,2.005994369957867,1,0.4,0.4,transcript,9573.0
RAB40B,ENSG00000141542,appendicular lean mass,EFO_0004980,0.20057278634058426,2.0057562503194752,1,0.4,0.4,transcript,14091.0
RGS7BP,ENSG00000186479,central nervous system cancer,EFO_0000326,0.2005094784941546,2.0051829061963926,1,0.5,0.5,transcript,5674.0
IL1A,ENSG00000115008,metabolite measurement,EFO_0004725,0.20041794410511984,2.0043777553794087,1,0.4,0.4,transcript,2017.0
PARP14,ENSG00000173193,metabolite measurement,EFO_0004725,0.20041794410511984,2.004193429021544,1,0.4,0.4,transcript,28596.0
CD69,ENSG00000110848,alcohol consumption quality,OBA_1000840,0.20041794410511984,2.0050239167725215,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
C18orf54,ENSG00000166845,hemoglobin measurement,EFO_0004509,0.20039938745929212,2.004079349244345,2,0.8,1.6,transcript,18719.0
MUC16,ENSG00000181143,gastrointestinal stromal tumor,MONDO_0011719,0.20038337088791394,2.0038365292285243,1,0.5,0.5,transcript,177283.0
GFRAL,ENSG00000187871,vital capacity,EFO_0004312,0.20034323260388834,2.003641640533912,1,0.4,0.4,transcript,1911.0
SLC22A15,ENSG00000163393,neurodegenerative disease,EFO_0005772,0.20033587775217013,2.003607804759055,2,0.8,1.6,transcript,6425.0
SLCO1C1,ENSG00000139155,sex hormone-binding globulin measurement,EFO_0004696,0.20024461214122152,2.00247701230558,1,0.5,0.5,transcript,16186.0
RBM25,ENSG00000119707,eicosanoids measurement,EFO_0020044,0.20008288555131704,2.0008415454659003,1,0.4,0.4,transcript,31521.0
LMNTD1,ENSG00000152936,electrocardiography,EFO_0004327,0.20003234579226523,2.000478123672781,2,0.9,1.8,transcript,11638.0
TMEM144,ENSG00000164124,arterial stiffness measurement,EFO_0004517,0.19989187173302658,1.998935627074506,1,0.4,0.4,transcript,23655.0
SLC35F5,ENSG00000115084,aspartate aminotransferase measurement,EFO_0004736,0.19989187173302658,1.9989894762193512,2,0.8,1.6,transcript,22612.0
ATP12A,ENSG00000075673,neurofibrillary tangles measurement,EFO_0006797,0.19989187173302658,1.9989678694560953,1,0.4,0.4,transcript,8138.0
ASPM,ENSG00000066279,breast carcinoma,EFO_0000305,0.1996556326910267,1.9965913252575673,2,0.9,1.8,transcript,51431.0
ASPM,ENSG00000066279,bladder transitional cell carcinoma,EFO_0006544,0.19961418595803723,1.9961768579276726,2,0.9,1.8,transcript,51431.0
CNTN1,ENSG00000018236,glioblastoma multiforme,EFO_0000519,0.1996005339448254,1.9960218663250877,1,0.4,0.4,transcript,24203.0
WAPL,ENSG00000062650,brain aneurysm,EFO_0003870,0.19958893224145396,1.9960230793113796,2,0.8,1.6,transcript,11962.0
ZNF143,ENSG00000166478,age at menopause,EFO_0004704,0.1994714116711992,1.9947403965395962,1,0.5,0.5,transcript,19026.0
P3H4,ENSG00000141696,pulse pressure measurement,EFO_0005763,0.19941041360291667,1.9941441120435581,1,0.4,0.4,transcript,10006.0
TBC1D9B,ENSG00000197226,sign or symptom,EFO_0003765,0.199375377831854,1.9937659931779164,1,0.4,0.4,transcript,32747.0
SLFN11,ENSG00000172716,brain cancer,MONDO_0001657,0.19932210409935758,1.9932388909645695,1,0.4,0.4,transcript,22409.0
RAD23B,ENSG00000119318,breast cancer,MONDO_0007254,0.19927118111890813,1.9927520850513445,1,0.4,0.4,transcript,9932.0
GASK1B,ENSG00000164125,mean corpuscular hemoglobin concentration,EFO_0004528,0.1992459428699342,1.9926323144506746,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
SMC5,ENSG00000198887,glioblastoma multiforme,EFO_0000519,0.19921887012382994,1.9922530513026495,1,0.5,0.5,transcript,7770.0
NUP153,ENSG00000124789,glioblastoma multiforme,EFO_0000519,0.19921887012382994,1.9922166857908266,1,0.5,0.5,transcript,17867.0
PHC1,ENSG00000111752,esophageal cancer,MONDO_0007576,0.19914527788481887,1.991471929332696,1,0.5,0.5,transcript,26109.0
KLRD1,ENSG00000134539,neutrophil percentage of leukocytes,EFO_0007990,0.19899350498954063,1.990099539493858,4,1.7000000000000002,6.800000000000001,transcript,41340.0
LAIR1,ENSG00000167613,complication,EFO_0009518,0.19899163595985697,1.9899320115002757,1,0.4,0.4,transcript,25556.0
LAIR1,ENSG00000167613,Herpes Zoster,EFO_0006510,0.19899163595985697,1.9899320115002757,1,0.4,0.4,transcript,25556.0
LAIR1,ENSG00000167613,nervous system disease,EFO_0000618,0.19899163595985697,1.9899320115002757,1,0.4,0.4,transcript,25556.0
OR5AN1,ENSG00000176495,vitamin B deficiency,MONDO_0042976,0.19898573091241475,1.9898864602435506,1,0.5,0.5,transcript,17152.0
GASK1B,ENSG00000164125,pericarditis,EFO_0007427,0.19889478107871,1.9891206965384327,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
STT3B,ENSG00000163527,arterial stiffness measurement,EFO_0004517,0.19888319235645566,1.9888516464579051,1,0.4,0.4,transcript,20281.0
IQCB1,ENSG00000173226,asthma,MONDO_0004979,0.19884005029690563,1.9884421219473105,1,0.4,0.4,transcript,9611.0
LIN9,ENSG00000183814,platelet count,EFO_0004309,0.19877033720730675,1.9878082076123154,2,0.8,1.6,transcript,15262.0
SC5D,ENSG00000109929,myeloid leukocyte count,OBA_2045223,0.198603586862542,1.9860587114099555,1,0.4,0.4,transcript,17511.0
RPAP3,ENSG00000005175,platelet crit,EFO_0007985,0.19852866614411666,1.9854350293936889,2,0.8,1.6,transcript,10784.0
QSOX1,ENSG00000116260,monocyte count,EFO_0005091,0.1985046557832289,1.985075621263227,1,0.4,0.4,transcript,13763.0
CDKL2,ENSG00000138769,glucose measurement,EFO_0004468,0.19850110856855271,1.9851751882496298,2,0.8,1.6,transcript,9750.0
ANKRD36,ENSG00000135976,cerebral cortex area attribute,OBA_2045267,0.19849506067216413,1.9850259930767111,2,1.0,2.0,transcript,26530.0
CD93,ENSG00000125810,amino acid measurement,EFO_0005134,0.19842312903104256,1.984257607831315,1,0.4,0.4,transcript,15199.0
SCRG1,ENSG00000164106,multinodular goiter,MONDO_0000334,0.19842312903104256,1.984514877690787,2,0.8,1.6,transcript,5642.0
CPO,ENSG00000144410,growth differentiation factor 15 amount,OBA_2050135,0.19842312903104256,1.9846328967361284,1,0.5,0.5,transcript,1245.0
RIF1,ENSG00000080345,BMI-adjusted waist circumference,EFO_0007789,0.19837800506128808,1.9838415939299079,3,1.3,3.9000000000000004,transcript,63370.0
KCNN3,ENSG00000143603,response to xenobiotic stimulus,GO_0009410,0.19820683032312314,1.9821873390411708,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
FIGLA,ENSG00000183733,Parkinson disease,MONDO_0005180,0.1979784131441839,1.9804766522174624,1,0.5,0.5,transcript,722.0
RPRD2,ENSG00000163125,aortic measurement,EFO_0020865,0.19793521748228157,1.9793706813463654,1,0.4,0.4,transcript,21614.0
FSIP2,ENSG00000188738,smoking cessation,EFO_0004319,0.1979069251776014,1.9793481918039078,4,2.0,8.0,transcript,28680.0
CCDC34,ENSG00000109881,lymphocyte count,EFO_0004587,0.19787143762001316,1.9788078996979104,1,0.4,0.4,transcript,4277.0
PUS7L,ENSG00000129317,t-tau measurement,EFO_0004760,0.19787143762001316,1.9788512947716146,3,1.2000000000000002,3.6000000000000005,transcript,26293.0
NOL9,ENSG00000162408,erythrocyte volume,OBA_0003460,0.19771497655417894,1.9771924686484403,1,0.4,0.4,transcript,9367.0
ARHGAP12,ENSG00000165322,glaucoma,MONDO_0005041,0.19767779202638472,1.9767899826262607,1,0.4,0.4,transcript,33161.0
CLHC1,ENSG00000162994,mean corpuscular hemoglobin concentration,EFO_0004528,0.19763939637065453,1.9764192545512596,1,0.4,0.4,transcript,15816.0
TRDN,ENSG00000186439,ptosis,MONDO_0000728,0.19751660195865717,1.9751852230278284,1,0.5,0.5,transcript,26037.0
YTHDC2,ENSG00000047188,smoking status measurement,EFO_0006527,0.19751660195865717,1.975186228751428,1,0.4,0.4,transcript,19793.0
ZNF436,ENSG00000125945,bone tissue density,OBA_1000110,0.19749763293124148,1.9750099710281421,1,0.4,0.4,transcript,11890.0
CD93,ENSG00000125810,Thromboembolism,HP_0001907,0.19745762766520808,1.9746025941729701,1,0.4,0.4,transcript,15199.0
FAM114A1,ENSG00000197712,red blood cell density,OBA_2045260,0.1974095671731531,1.9741443512982828,1,0.4,0.4,transcript,8217.0
SNIP1,ENSG00000163877,open-angle glaucoma,EFO_0004190,0.1972798191243955,1.9728436871493236,1,0.4,0.4,transcript,8792.0
ASPM,ENSG00000066279,non-small cell lung carcinoma,EFO_0003060,0.19710437600599495,1.9710787584072498,2,0.9,1.8,transcript,51431.0
OR5A2,ENSG00000172324,tea consumption measurement,EFO_0010091,0.1970196943499095,1.970214786303984,1,0.4,0.4,transcript,22418.0
SENP6,ENSG00000112701,sexual dimorphism measurement,EFO_0021796,0.19699220550932062,1.9703510722538926,5,2.2,11.0,transcript,25640.0
ZNF398,ENSG00000197024,Fasciitis,HP_0100537,0.19684857925112983,1.9685112864564864,1,0.4,0.4,transcript,15690.0
TRMT9B,ENSG00000250305,temporomandibular joint disorder,EFO_0005279,0.19683936247878558,1.9685347514490343,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
ZNF267,ENSG00000185947,body height,OBA_VT0001253,0.19673561859430275,1.967393688286924,1,0.4,0.4,transcript,10666.0
KRT20,ENSG00000171431,pancreatic adenocarcinoma,EFO_1000044,0.19665006030719864,1.9666900867290211,1,0.4,0.4,transcript,2111.0
APOBEC3H,ENSG00000100298,vertebral column disorder,MONDO_0000812,0.19661896236442153,1.9662662079827182,1,0.4,0.4,transcript,5223.0
ZNF573,ENSG00000189144,triglyceride measurement,EFO_0004530,0.196404411479104,1.964071731471515,1,0.5,0.5,transcript,18105.0
OR5A1,ENSG00000172320,smoking status measurement,EFO_0006527,0.1963092726839719,1.963139173658112,1,0.4,0.4,transcript,8612.0
C18orf54,ENSG00000166845,systolic blood pressure,EFO_0006335,0.19630155384495881,1.9631010131010118,2,0.8,1.6,transcript,18719.0
RBM25,ENSG00000119707,mean corpuscular hemoglobin concentration,EFO_0004528,0.196239958864765,1.96241227860038,1,0.4,0.4,transcript,31521.0
BHLHE41,ENSG00000123095,strand of hair color,OBA_0002313,0.1961274055201377,1.9613623359341068,1,0.4,0.4,transcript,4531.0
ANKRD36B,ENSG00000196912,cystatin C measurement,EFO_0004617,0.19608642214072755,1.9608937600142349,1,0.5,0.5,transcript,16927.0
RPAP3,ENSG00000005175,hematocrit,EFO_0004348,0.1959109842444108,1.9592582103966303,2,0.8,1.6,transcript,10784.0
UBE2G2,ENSG00000184787,serum alanine aminotransferase measurement,EFO_0004735,0.19589717498583978,1.9589978050955006,1,0.4,0.4,transcript,15352.0
MC2R,ENSG00000185231,head and neck squamous cell carcinoma,EFO_0000181,0.19589271032900094,1.9590217106693848,1,0.4,0.4,transcript,4228.0
SELENOI,ENSG00000138018,body height,OBA_VT0001253,0.19567053156861292,1.956746904374006,1,0.4,0.4,transcript,9618.0
PDHX,ENSG00000110435,QRS duration,OBA_1001086,0.1956241104143282,1.9562858719104894,1,0.4,0.4,transcript,8935.0
SAMD9L,ENSG00000177409,genetic disorder,EFO_0000508,0.19555252368027276,1.9555336897094708,1,0.4,0.4,transcript,47321.0
RCN2,ENSG00000117906,HbA1c measurement,EFO_0004541,0.19551422485490663,1.9551695634903392,1,0.4,0.4,transcript,14644.0
DNAH14,ENSG00000185842,lean body mass,EFO_0004995,0.19550248995570826,1.9550828780406233,3,1.5,4.5,transcript,77615.0
WAPL,ENSG00000062650,neutrophil count,EFO_0004833,0.19539576868235697,1.9540914437204098,2,0.8,1.6,transcript,11962.0
WAPL,ENSG00000062650,myeloid leukocyte count,OBA_2045223,0.19539576868235697,1.9540914437204098,2,0.8,1.6,transcript,11962.0
PDHX,ENSG00000110435,body height,OBA_VT0001253,0.19536311547124566,1.953675922479664,1,0.4,0.4,transcript,8935.0
MRPL35,ENSG00000132313,FEV/FVC ratio,EFO_0004713,0.19530302066550492,1.9530940228643663,1,0.4,0.4,transcript,6268.0
IYD,ENSG00000009765,level of low-density lipoprotein receptor-related protein 11 in blood serum,OBA_2042229,0.19522795539068394,1.9522969573179079,1,0.4,0.4,transcript,22984.0
ASPM,ENSG00000066279,lung carcinoma,EFO_0001071,0.1949966228599763,1.9500012269470632,2,0.9,1.8,transcript,51431.0
RNMT,ENSG00000101654,interleukin 1 receptor antagonist measurement,EFO_0004754,0.19499463009961146,1.9499627227056147,1,0.4,0.4,transcript,24358.0
RNMT,ENSG00000101654,trait in response to apixaban,OBA_2050328,0.19499463009961146,1.9499627227056147,1,0.4,0.4,transcript,24358.0
SAMD11,ENSG00000187634,urinary microalbumin measurement,EFO_0010967,0.19490396040189764,1.949102432888842,2,0.8,1.6,transcript,25466.0
CR1L,ENSG00000197721,gastroesophageal reflux disease,EFO_0003948,0.19488333908036665,1.9489266743857558,1,0.5,0.5,transcript,5360.0
CR1L,ENSG00000197721,peptic ulcer disease,MONDO_0004247,0.19488333908036665,1.9489266743857558,1,0.5,0.5,transcript,5360.0
CR1L,ENSG00000197721,Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement,EFO_0009923,0.19488333908036665,1.9489266743857558,1,0.5,0.5,transcript,5360.0
ASPM,ENSG00000066279,squamous cell lung carcinoma,EFO_0000708,0.19487056855865473,1.9487406839338475,2,0.9,1.8,transcript,51431.0
STAM,ENSG00000136738,head and neck squamous cell carcinoma,EFO_0000181,0.19463694147023128,1.9464354104125916,1,0.4,0.4,transcript,6061.0
OR4X1,ENSG00000176567,body mass index,EFO_0004340,0.19452641191213937,1.9458087814307619,1,0.5,0.5,transcript,918.0
WDR12,ENSG00000138442,glomerular filtration rate,OBA_0003747,0.1944935414512577,1.944955353698061,1,0.4,0.4,transcript,20061.0
SLAMF7,ENSG00000026751,lipid measurement,EFO_0004529,0.19445640069785458,1.9445802032776915,1,0.4,0.4,transcript,24697.0
SLAMF7,ENSG00000026751,free cholesterol measurement,EFO_0008591,0.19445640069785458,1.9445802032776915,1,0.4,0.4,transcript,24697.0
KPNA4,ENSG00000186432,DNA repair protein XRCC4 measurement,EFO_0801532,0.1944335341653774,1.9443443348639002,1,0.4,0.4,transcript,44478.0
GANC,ENSG00000214013,metabolite measurement,EFO_0004725,0.1943440899659331,1.943470173664015,1,0.5,0.5,transcript,17080.0
NRCAM,ENSG00000091129,glioblastoma multiforme,EFO_0000519,0.19433459247463117,1.9433575780602228,1,0.4,0.4,transcript,34325.0
CDKL2,ENSG00000138769,low density lipoprotein cholesterol measurement,EFO_0004611,0.19404966312044114,1.940660733768514,2,0.8,1.6,transcript,9750.0
UNC80,ENSG00000144406,genetic disorder,EFO_0000508,0.19399953886023227,1.9400000506069848,1,0.4,0.4,transcript,85800.0
ARHGAP29,ENSG00000137962,food allergy,EFO_1001890,0.19391253492888905,1.9391455750079147,1,0.5,0.5,transcript,24721.0
TAF1B,ENSG00000115750,tyramine O-sulfate measurement,EFO_0800076,0.19391253492888905,1.9391797503333905,1,0.5,0.5,transcript,9191.0
C18orf54,ENSG00000166845,lipid measurement,EFO_0004529,0.19391253492888905,1.939210823940314,2,0.8,1.6,transcript,18719.0
TAF1B,ENSG00000115750,placenta praevia,EFO_0007442,0.19391253492888905,1.9391797503333905,1,0.5,0.5,transcript,9191.0
HPF1,ENSG00000056050,lymphocyte count,EFO_0004587,0.19391253492888905,1.9393472756093522,1,0.5,0.5,transcript,2253.0
SC5D,ENSG00000109929,body mass index,EFO_0004340,0.19387837107388187,1.938806553523354,1,0.4,0.4,transcript,17511.0
SC5D,ENSG00000109929,peak expiratory flow,EFO_0009718,0.19387837107388187,1.938806553523354,1,0.4,0.4,transcript,17511.0
HECW2,ENSG00000138411,depressive disorder,MONDO_0002050,0.19385808170577792,1.9385866332092319,1,0.4,0.4,transcript,68774.0
GUF1,ENSG00000151806,serum creatinine amount,OBA_2050096,0.19372059777424144,1.937247899432697,1,0.5,0.5,transcript,11927.0
RCN2,ENSG00000117906,vitamin B deficiency,MONDO_0042976,0.193689549062511,1.936922805566383,1,0.4,0.4,transcript,14644.0
C6,ENSG00000039537,genetic disorder,EFO_0000508,0.19365398718508903,1.936569434908893,1,0.5,0.5,transcript,16913.0
ANO6,ENSG00000177119,genetic disorder,EFO_0000508,0.19361131159283868,1.936120537078665,1,0.4,0.4,transcript,53900.0
MMP12,ENSG00000262406,matrix metalloproteinase 7 measurement,EFO_0010591,0.19360674341519243,1.9362869731200913,1,0.4,0.4,transcript,1822.0
OR5A2,ENSG00000172324,urinary microalbumin measurement,EFO_0010967,0.19360674341519243,1.9360852769568133,1,0.4,0.4,transcript,22418.0
NRCAM,ENSG00000091129,genetic disorder,EFO_0000508,0.19352495997172936,1.9352612530312048,1,0.4,0.4,transcript,34325.0
ITGA8,ENSG00000077943,genetic disorder,EFO_0000508,0.19351618937762285,1.9356266497793269,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
SMC5,ENSG00000198887,genetic disorder,EFO_0000508,0.1934883209240639,1.934947559304989,1,0.5,0.5,transcript,7770.0
PEX13,ENSG00000162928,hypertension,EFO_0000537,0.19344408671122804,1.9344866966264875,1,0.4,0.4,transcript,8728.0
NEK1,ENSG00000137601,genetic disorder,EFO_0000508,0.193424132992578,1.9342555897940543,2,0.8,1.6,transcript,112203.0
ARHGAP29,ENSG00000137962,genetic disorder,EFO_0000508,0.19323401538045723,1.9323603795235966,1,0.5,0.5,transcript,24721.0
POU2F1,ENSG00000143190,head and neck squamous cell carcinoma,EFO_0000181,0.19315254103100774,1.9315404223666353,2,0.8,1.6,transcript,106581.0
CR2,ENSG00000117322,genetic disorder,EFO_0000508,0.19314788161010218,1.9314971420276266,1,0.4,0.4,transcript,21827.0
CNTN1,ENSG00000018236,genetic disorder,EFO_0000508,0.19313346700529352,1.9313511969297688,1,0.4,0.4,transcript,24203.0
YBX3,ENSG00000060138,systolic blood pressure,EFO_0006335,0.19301002248313295,1.9301206789119185,1,0.4,0.4,transcript,19556.0
ZDHHC21,ENSG00000175893,pulse pressure measurement,EFO_0005763,0.1927280357472692,1.9276279379864594,4,1.6,6.4,transcript,18413.0
CERKL,ENSG00000188452,genetic disorder,EFO_0000508,0.19271059310724376,1.9271260049442858,1,0.5,0.5,transcript,24908.0
FARSB,ENSG00000116120,genetic disorder,EFO_0000508,0.19270772139504372,1.9271282343586003,1,0.4,0.4,transcript,7840.0
PTBP3,ENSG00000119314,erythrocyte volume,OBA_0003460,0.1926222210245115,1.9264556478472437,5,2.0,10.0,transcript,42838.0
ATF6,ENSG00000118217,genetic disorder,EFO_0000508,0.19251957712682186,1.9252021237012005,1,0.4,0.4,transcript,62968.0
TAF2,ENSG00000064313,genetic disorder,EFO_0000508,0.1924866181623731,1.9248689746077552,1,0.5,0.5,transcript,179020.0
SLFN11,ENSG00000172716,C-C motif chemokine 15 measurement,EFO_0008043,0.19245518749940488,1.9245697249650426,1,0.4,0.4,transcript,22409.0
SLFN11,ENSG00000172716,C-C motif chemokine 16 measurement,EFO_0008044,0.19245518749940488,1.9245697249650426,1,0.4,0.4,transcript,22409.0
PCMTD1,ENSG00000168300,erythrocyte volume,OBA_0003460,0.192428139958152,1.924486247652534,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
DPY19L2,ENSG00000177990,genetic disorder,EFO_0000508,0.19241501397102237,1.9242908856637775,2,0.8,1.6,transcript,11368.0
SLC5A7,ENSG00000115665,genetic disorder,EFO_0000508,0.19241482032093596,1.9242037664820364,1,0.4,0.4,transcript,7199.0
CIAO2A,ENSG00000166797,urate measurement,EFO_0004531,0.19239317708740594,1.9241523996661167,2,0.8,1.6,transcript,7252.0
RIF1,ENSG00000080345,fat pad mass,OBA_0004528,0.19238118946029067,1.9238734379199338,3,1.3,3.9000000000000004,transcript,63370.0
TMTC3,ENSG00000139324,genetic disorder,EFO_0000508,0.19237616415915373,1.9238006507586916,1,0.4,0.4,transcript,10254.0
KIAA0586,ENSG00000100578,pericarditis,EFO_0007427,0.19237545403882933,1.9237601914467366,1,0.5,0.5,transcript,88479.0
EXD1,ENSG00000178997,hemoglobin measurement,EFO_0004509,0.19234154959789143,1.9234572801636003,1,0.4,0.4,transcript,9573.0
POU2F1,ENSG00000143190,glioblastoma multiforme,EFO_0000519,0.19231498382801437,1.9231648503367016,2,0.8,1.6,transcript,106581.0
IL17A,ENSG00000112115,lupus nephritis,EFO_0005761,0.19231369998620146,1.9233507892794384,1,0.4,0.4,transcript,1871.0
KPNA4,ENSG00000186432,chloride measurement,EFO_0009284,0.19228972451825788,1.9229062383927051,1,0.4,0.4,transcript,44478.0
FZD6,ENSG00000164930,genetic disorder,EFO_0000508,0.19215287266870087,1.921608618832612,2,0.8,1.6,transcript,20027.0
ATP9A,ENSG00000054793,genetic disorder,EFO_0000508,0.1921499160298634,1.9215245265235055,1,0.4,0.4,transcript,15769.0
FAM171B,ENSG00000144369,blood protein measurement,EFO_0007937,0.19209178486673958,1.920987644514543,1,0.4,0.4,transcript,5731.0
FAM171B,ENSG00000144369,protein FAM171B measurement,EFO_0801947,0.19209178486673958,1.920987644514543,1,0.4,0.4,transcript,5731.0
BHLHE41,ENSG00000123095,chronic obstructive pulmonary disease,EFO_0000341,0.1920405514826757,1.9204937955594872,1,0.4,0.4,transcript,4531.0
DBR1,ENSG00000138231,genetic disorder,EFO_0000508,0.19194339275371766,1.919452359018146,1,0.4,0.4,transcript,21702.0
RNMT,ENSG00000101654,bone fracture,EFO_0003931,0.1919260369514041,1.919276791223541,1,0.4,0.4,transcript,24358.0
GJA3,ENSG00000121743,genetic disorder,EFO_0000508,0.19192063491451666,1.9192830656775792,1,0.4,0.4,transcript,5214.0
SPATA22,ENSG00000141255,Non-epidermolytic palmoplantar keratoderma,Orphanet_2337,0.19191210630025302,1.9191547353036953,1,0.5,0.5,transcript,14849.0
F13B,ENSG00000143278,genetic disorder,EFO_0000508,0.1916935936216298,1.91704383436045,1,0.5,0.5,transcript,4634.0
PEX13,ENSG00000162928,genetic disorder,EFO_0000508,0.1916935936216298,1.916981765730505,1,0.4,0.4,transcript,8728.0
TEX15,ENSG00000133863,mean corpuscular hemoglobin concentration,EFO_0004528,0.19167948846368313,1.9168098082280443,1,0.5,0.5,transcript,33504.0
CNR2,ENSG00000188822,Splenomegaly,HP_0001744,0.19167302981037654,1.9168062715130723,1,0.4,0.4,transcript,5265.0
SEC63,ENSG00000025796,genetic disorder,EFO_0000508,0.19158851658546017,1.9161606901160435,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
PEX13,ENSG00000162928,atopic eczema,EFO_0000274,0.19158456689679823,1.9158914984821895,1,0.4,0.4,transcript,8728.0
BHLHE41,ENSG00000123095,atrial fibrillation,EFO_0000275,0.19156999702036168,1.9157882509363469,1,0.4,0.4,transcript,4531.0
PDP1,ENSG00000164951,genetic disorder,EFO_0000508,0.19154714952417728,1.9154948624575692,1,0.4,0.4,transcript,17118.0
SCRG1,ENSG00000164106,Constipation,HP_0002019,0.1915448005114759,1.9157315924951206,2,0.8,1.6,transcript,5642.0
PIGB,ENSG00000069943,genetic disorder,EFO_0000508,0.19131908590145616,1.9132310099822,1,0.5,0.5,transcript,12453.0
SGCB,ENSG00000163069,Uterine leiomyoma,HP_0000131,0.19126245701513325,1.9126971654326392,1,0.4,0.4,transcript,5510.0
PKD2L2,ENSG00000078795,chloride measurement,EFO_0009284,0.19122065039564093,1.9122458802361384,1,0.5,0.5,transcript,12698.0
RPS20,ENSG00000008988,pulse pressure measurement,EFO_0005763,0.19112808414489202,1.911298050931345,1,0.4,0.4,transcript,23243.0
FAM210A,ENSG00000177150,interleukin 1 receptor antagonist measurement,EFO_0004754,0.1910537346884518,1.9105594928262741,1,0.4,0.4,transcript,18062.0
FAM210A,ENSG00000177150,trait in response to apixaban,OBA_2050328,0.1910537346884518,1.9105594928262741,1,0.4,0.4,transcript,18062.0
TRDMT1,ENSG00000107614,diastolic blood pressure,EFO_0006336,0.19100877796984608,1.9101015713751839,1,0.4,0.4,transcript,29003.0
F13B,ENSG00000143278,squamous cell lung carcinoma,EFO_0000708,0.1909797535723379,1.909905433867531,1,0.5,0.5,transcript,4634.0
NMRK1,ENSG00000106733,adolescent idiopathic scoliosis,EFO_0005423,0.190968286799558,1.9097288397229677,1,0.4,0.4,transcript,8701.0
ING1,ENSG00000153487,colorectal adenocarcinoma,EFO_0000365,0.1908779246049625,1.9088057291004725,1,0.4,0.4,transcript,15104.0
ARPC5,ENSG00000162704,apolipoprotein A 1 measurement,EFO_0004614,0.19085877115931774,1.908614440627591,1,0.4,0.4,transcript,14965.0
SPART,ENSG00000133104,hereditary spastic paraplegia,MONDO_0019064,0.19084773165376012,1.9084915818728365,1,0.4,0.4,transcript,28040.0
IPP,ENSG00000197429,mean corpuscular hemoglobin,EFO_0004527,0.19079905441620695,1.9080713196063344,1,0.5,0.5,transcript,6190.0
OR5A2,ENSG00000172324,vitamin B deficiency,MONDO_0042976,0.19075313149755818,1.9075491577804706,1,0.4,0.4,transcript,22418.0
NUP43,ENSG00000120253,brain volume,OBA_2050009,0.19074215432571884,1.9076237421703692,2,0.8,1.6,transcript,7913.0
KIAA0586,ENSG00000100578,eosinophil count,EFO_0004842,0.1906809988654637,1.90681563971308,1,0.5,0.5,transcript,88479.0
RNMT,ENSG00000101654,bone quantitative ultrasound measurement,EFO_0004514,0.19066998206618,1.9067162423713,1,0.4,0.4,transcript,24358.0
TRAM1,ENSG00000067167,eye measurement,EFO_0004731,0.19064009251350453,1.9065914240039583,2,0.8,1.6,transcript,8399.0
SC5D,ENSG00000109929,high density lipoprotein cholesterol measurement,EFO_0004612,0.1904583189334254,1.9046060321187896,1,0.4,0.4,transcript,17511.0
SCAMP1,ENSG00000085365,body weight,EFO_0004338,0.1904481258715377,1.9045076057052335,1,0.4,0.4,transcript,15182.0
ZNF573,ENSG00000189144,platelet count,EFO_0004309,0.1904434366514533,1.904461983195008,1,0.5,0.5,transcript,18105.0
SLC11A2,ENSG00000110911,genetic disorder,EFO_0000508,0.19039858395345013,1.9040138008081373,2,0.8,1.6,transcript,57222.0
SNIP1,ENSG00000163877,FEV/FVC ratio,EFO_0004713,0.19038889366010145,1.9039344325063832,1,0.4,0.4,transcript,8792.0
METTL25,ENSG00000127720,body weight,EFO_0004338,0.19037744213659458,1.9038263694178938,1,0.5,0.5,transcript,9625.0
ZNF485,ENSG00000198298,Myocardial Ischemia,EFO_1001375,0.19037744213659458,1.9038717544397243,1,0.5,0.5,transcript,5137.0
BHLHE41,ENSG00000123095,cardiac arrhythmia,EFO_0004269,0.19037744213659458,1.9038627020986758,1,0.4,0.4,transcript,4531.0
ZNF485,ENSG00000198298,intermediate coronary syndrome,EFO_1000985,0.19037744213659458,1.9038717544397243,1,0.5,0.5,transcript,5137.0
ZNF485,ENSG00000198298,cardiovascular disease,EFO_0000319,0.19037744213659458,1.9038717544397243,1,0.5,0.5,transcript,5137.0
ZNF485,ENSG00000198298,percutaneous transluminal coronary angioplasty,EFO_0003951,0.19037744213659458,1.9038717544397243,1,0.5,0.5,transcript,5137.0
RPAP3,ENSG00000005175,body weight,EFO_0004338,0.19037744213659458,1.903922789318468,2,0.8,1.6,transcript,10784.0
ZNF485,ENSG00000198298,coronary artery bypass,EFO_0003776,0.19037744213659458,1.9038717544397243,1,0.5,0.5,transcript,5137.0
GUF1,ENSG00000151806,body height,OBA_VT0001253,0.19037744213659458,1.9038163430562283,1,0.5,0.5,transcript,11927.0
CNR2,ENSG00000188822,erythrocyte volume,OBA_0003460,0.19035669506313624,1.9036429240406691,1,0.4,0.4,transcript,5265.0
RP2,ENSG00000102218,genetic disorder,EFO_0000508,0.19028228126206786,1.9029309207287868,1,0.4,0.4,transcript,3700.0
LRPAP1,ENSG00000163956,level of spondin-2 in blood serum,OBA_2043641,0.19019366187896927,1.9021672549611321,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
ATXN3,ENSG00000066427,genetic disorder,EFO_0000508,0.1901668174446072,1.9016738976436225,1,0.4,0.4,transcript,69891.0
ATXN3,ENSG00000066427,Parkinson disease,MONDO_0005180,0.19016460224958925,1.9016517456934432,1,0.4,0.4,transcript,69891.0
TMED5,ENSG00000117500,eosinophil percentage of granulocytes,EFO_0007996,0.19013769308430503,1.9014088981085704,1,0.5,0.5,transcript,15641.0
SKP2,ENSG00000145604,neuroinflammatory disorder,EFO_0020092,0.1901077476725674,1.9010824995796598,1,0.4,0.4,transcript,79636.0
LRPAP1,ENSG00000163956,low density lipoprotein cholesterol measurement,EFO_0004611,0.19008861038929825,1.901116740064422,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
LSM11,ENSG00000155858,HbA1c measurement,EFO_0004541,0.1900882403428299,1.9009433140419734,1,0.4,0.4,transcript,6567.0
IKBIP,ENSG00000166130,smoking initiation,EFO_0005670,0.1900882403428299,1.9011529021603362,2,0.8,1.6,transcript,5915.0
PARD6B,ENSG00000124171,heart rate,OBA_1001087,0.19006185930600566,1.9006970090569202,1,0.4,0.4,transcript,5101.0
ADGRA1,ENSG00000197177,gastroesophageal reflux disease,EFO_0003948,0.190052722566836,1.9005791602308113,1,0.4,0.4,transcript,7702.0
SLFN11,ENSG00000172716,thyroid disease,EFO_1000627,0.19001143114587704,1.9001321614297642,1,0.4,0.4,transcript,22409.0
MR1,ENSG00000153029,amygdala volume,OBA_2050034,0.1899536863604063,1.8996699062146547,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
LRRIQ3,ENSG00000162620,taste liking measurement,EFO_0010155,0.18990749693648784,1.8991018655456207,1,0.5,0.5,transcript,18590.0
OR5A2,ENSG00000172324,Tietze syndrome,MONDO_0001858,0.1898480814295006,1.898498657099895,1,0.4,0.4,transcript,22418.0
CRYGD,ENSG00000118231,bone tissue density,OBA_1000110,0.1898480814295006,1.8991038672545075,1,0.4,0.4,transcript,642.0
GAN,ENSG00000261609,wellbeing measurement,EFO_0007869,0.1897261321300333,1.897271985407614,1,0.4,0.4,transcript,37509.0
UNC80,ENSG00000144406,neurodegenerative disease,EFO_0005772,0.18963322341464975,1.8963368961511595,1,0.4,0.4,transcript,85800.0
SYCP1,ENSG00000198765,tiglylcarnitine (C5:1-DC) measurement,EFO_0800032,0.18955293507222776,1.8955504789707458,1,0.4,0.4,transcript,18932.0
CLDN16,ENSG00000113946,genetic disorder,EFO_0000508,0.18946278908660816,1.894728267277625,1,0.4,0.4,transcript,3985.0
CNR2,ENSG00000188822,eosinophil count,EFO_0004842,0.18945876241047152,1.894663597514022,1,0.4,0.4,transcript,5265.0
RAD23B,ENSG00000119318,breast neoplasm,EFO_0003869,0.1893983054761611,1.8940233286238743,1,0.4,0.4,transcript,9932.0
RTF1,ENSG00000137815,serum creatinine amount,OBA_2050096,0.1893707258041861,1.893758977721199,1,0.4,0.4,transcript,7734.0
DCK,ENSG00000156136,low density lipoprotein cholesterol measurement,EFO_0004611,0.18930184160517977,1.893055401719851,1,0.4,0.4,transcript,10815.0
SLC30A9,ENSG00000014824,genetic disorder,EFO_0000508,0.18929762846505555,1.8933280479769738,3,1.3,3.9000000000000004,transcript,11087.0
SECISBP2L,ENSG00000138593,platelet volume,OBA_0003277,0.18911379007699883,1.8911569847394538,1,0.4,0.4,transcript,20960.0
PFAS,ENSG00000178921,body height,OBA_VT0001253,0.18903174695134276,1.8903407958488603,1,0.4,0.4,transcript,17148.0
MMADHC,ENSG00000168288,disorders of vitamin D metabolism,MONDO_0017322,0.18892342355094,1.8893158015779155,1,0.4,0.4,transcript,4904.0
HNRNPA0,ENSG00000177733,body mass index,EFO_0004340,0.18891781320373457,1.889201086243704,1,0.4,0.4,transcript,17426.0
FIGLA,ENSG00000183733,genetic disorder,EFO_0000508,0.18878789050744216,1.8885714258500448,1,0.5,0.5,transcript,722.0
AGA,ENSG00000038002,hemangioma of subcutaneous tissue,EFO_1000707,0.18867681700261948,1.886866151605658,1,0.5,0.5,transcript,5103.0
TXNL1,ENSG00000091164,vein disorder,MONDO_0004634,0.18867681700261948,1.8868503688445868,2,0.8,1.6,transcript,19465.0
MED10,ENSG00000133398,5-methylthioadenosine (MTA) measurement,EFO_0800130,0.18867681700261948,1.886917758657459,1,0.4,0.4,transcript,2674.0
PTCHD4,ENSG00000244694,temporomandibular joint disorder,EFO_0005279,0.18867681700261948,1.8871820106975363,6,2.4000000000000004,14.400000000000002,transcript,34796.0
TXNL1,ENSG00000091164,lymphatic system disease,EFO_0007352,0.18867681700261948,1.8868503688445868,2,0.8,1.6,transcript,19465.0
ZNF33B,ENSG00000196693,systemic lupus erythematosus,MONDO_0007915,0.18867681700261948,1.8867992955242028,1,0.5,0.5,transcript,16064.0
CPXCR1,ENSG00000147183,rheumatoid arthritis,EFO_0000685,0.18867681700261948,1.8868534942582769,1,0.4,0.4,transcript,4688.0
LRRIQ3,ENSG00000162620,metabolite measurement,EFO_0004725,0.18867681700261948,1.8867950662069373,1,0.5,0.5,transcript,18590.0
TXNL1,ENSG00000091164,Varicose veins,HP_0002619,0.18867681700261948,1.8868503688445868,2,0.8,1.6,transcript,19465.0
POM121L2,ENSG00000158553,erythrocyte volume,OBA_0003460,0.18859723662703343,1.8860641304364274,1,0.4,0.4,transcript,4359.0
INIP,ENSG00000148153,systolic blood pressure,EFO_0006335,0.18854136345075,1.8854639110283649,1,0.4,0.4,transcript,7956.0
SMC5,ENSG00000198887,neurodegenerative disease,EFO_0005772,0.18831714161923688,1.8832357662567187,1,0.5,0.5,transcript,7770.0
IPP,ENSG00000197429,red blood cell density,OBA_2045260,0.18831132939435333,1.8831940693877982,1,0.5,0.5,transcript,6190.0
POF1B,ENSG00000124429,premature menopause,EFO_0009005,0.1883007613958994,1.8830933037619073,1,0.5,0.5,transcript,5835.0
RAD23B,ENSG00000119318,prostate cancer,MONDO_0008315,0.1882023031979971,1.8820633058422345,1,0.4,0.4,transcript,9932.0
ALAD,ENSG00000148218,genetic disorder,EFO_0000508,0.18818681455214126,1.8819054554738424,1,0.4,0.4,transcript,10721.0
CLDN1,ENSG00000163347,genetic disorder,EFO_0000508,0.18816833555940704,1.8833336908184128,4,1.6,6.4,transcript,3878.0
SGCB,ENSG00000163069,type 2 diabetes mellitus,MONDO_0005148,0.18809062240977417,1.8809788193790484,1,0.4,0.4,transcript,5510.0
INF2,ENSG00000203485,adenylosuccinate synthetase isozyme 1 measurement,EFO_0802256,0.18807944514650668,1.8807975143460125,1,0.4,0.4,transcript,130596.0
HECW2,ENSG00000138411,clear cell renal carcinoma,EFO_0000349,0.18798309728682672,1.8798367890197198,1,0.4,0.4,transcript,68774.0
WAPL,ENSG00000062650,body weight,EFO_0004338,0.18795444419186547,1.8796781988154947,2,0.8,1.6,transcript,11962.0
ATP9A,ENSG00000054793,Neurodevelopmental disorder,EFO_0010642,0.18791339041979035,1.879159270422775,1,0.4,0.4,transcript,15769.0
HACD1,ENSG00000165996,genetic disorder,EFO_0000508,0.18783559453061485,1.8784206388206237,1,0.4,0.4,transcript,6183.0
CNR2,ENSG00000188822,lymphocyte percentage of leukocytes,EFO_0007993,0.1877900818542265,1.8779767919515717,1,0.4,0.4,transcript,5265.0
MMADHC,ENSG00000168288,genetic disorder,EFO_0000508,0.187782843080768,1.8779099968761954,1,0.4,0.4,transcript,4904.0
MTMR6,ENSG00000139505,head and neck squamous cell carcinoma,EFO_0000181,0.18768573112465958,1.876910936300221,1,0.5,0.5,transcript,9324.0
CAV2,ENSG00000105971,PR interval,EFO_0004462,0.18765562649187345,1.8765804384849398,1,0.4,0.4,transcript,16547.0
SUMF1,ENSG00000144455,retinal vasculature measurement,EFO_0010554,0.18761628624570445,1.8761952118302754,1,0.4,0.4,transcript,12365.0
RTF1,ENSG00000137815,eosinophil percentage of leukocytes,EFO_0007991,0.18751553535534746,1.8752070732328125,1,0.4,0.4,transcript,7734.0
LRRIQ3,ENSG00000162620,insomnia,EFO_0004698,0.1874872108762333,1.8748990049430754,1,0.5,0.5,transcript,18590.0
C15orf61,ENSG00000189227,fat pad mass,OBA_0004528,0.18741094113646553,1.875730945335792,5,2.0,10.0,transcript,6167.0
KRT20,ENSG00000171431,glioblastoma multiforme,EFO_0000519,0.18738606536854208,1.8740501373424554,1,0.4,0.4,transcript,2111.0
CNTN1,ENSG00000018236,serum gamma-glutamyl transferase measurement,EFO_0004532,0.18732475262146012,1.8732640530914346,1,0.4,0.4,transcript,24203.0
ZFP3,ENSG00000180787,alopecia areata,EFO_0004192,0.1873076117921139,1.8731563264633486,1,0.4,0.4,transcript,4987.0
BACE2,ENSG00000182240,primary thrombocytopenia,MONDO_0004680,0.1872566262508131,1.8726998184346753,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
ZNF697,ENSG00000143067,cystatin C measurement,EFO_0004617,0.18718506043482658,1.8724958812796155,3,1.2000000000000002,3.6000000000000005,transcript,5579.0
ATP9A,ENSG00000054793,Neurodevelopmental delay,HP_0012758,0.18714599891596587,1.87148535538453,1,0.4,0.4,transcript,15769.0
SECISBP2L,ENSG00000138593,diet measurement,EFO_0008111,0.18714122714585227,1.8714313554279882,1,0.4,0.4,transcript,20960.0
ANKRD36B,ENSG00000196912,reticulocyte count,EFO_0007986,0.187133462094984,1.8713641595567994,1,0.5,0.5,transcript,16927.0
PFAS,ENSG00000178921,neurodegenerative disease,EFO_0005772,0.18710680854689485,1.8710914118043813,1,0.4,0.4,transcript,17148.0
F13B,ENSG00000143278,BMI-adjusted waist-hip ratio,EFO_0007788,0.1870955682663617,1.8710635808077691,1,0.5,0.5,transcript,4634.0
FIGNL1,ENSG00000132436,eosinophil count,EFO_0004842,0.18701404847662423,1.8701566673052827,1,0.4,0.4,transcript,24718.0
SC5D,ENSG00000109929,genetic disorder,EFO_0000508,0.186988908351859,1.8699119263031254,1,0.4,0.4,transcript,17511.0
POU2F1,ENSG00000143190,ovarian cancer,MONDO_0008170,0.1869445778951627,1.8694607910081849,2,0.8,1.6,transcript,106581.0
ZNF398,ENSG00000197024,eosinophil measurement,EFO_0803540,0.18683999793316863,1.8684254732768744,1,0.4,0.4,transcript,15690.0
KIAA0232,ENSG00000170871,mean corpuscular hemoglobin concentration,EFO_0004528,0.18680766332873847,1.8680999215966534,1,0.4,0.4,transcript,17176.0
FZD3,ENSG00000104290,ovarian cancer,MONDO_0008170,0.18677128600774387,1.8677269768940965,1,0.4,0.4,transcript,28335.0
C6,ENSG00000039537,lung adenocarcinoma,EFO_0000571,0.1867355735047426,1.8673852981054286,1,0.5,0.5,transcript,16913.0
GUF1,ENSG00000151806,1-(1-enyl-palmitoyl)-2-oleoyl-GPE (P-16:0/18:1) measurement,EFO_0800419,0.18660298051819738,1.8660717268722562,1,0.5,0.5,transcript,11927.0
SYNJ2,ENSG00000078269,head and neck squamous cell carcinoma,EFO_0000181,0.18657699156060548,1.865821063230887,2,0.8,1.6,transcript,31282.0
SCAMP1,ENSG00000085365,body weights and measures,EFO_0004324,0.18656754043518664,1.865701751341723,1,0.4,0.4,transcript,15182.0
RAPGEF4,ENSG00000091428,thyroid cancer,MONDO_0002108,0.18655224219991665,1.865535608087843,1,0.4,0.4,transcript,30335.0
ATRNL1,ENSG00000107518,high density lipoprotein cholesterol measurement,EFO_0004612,0.18651450095931377,1.8651618687350073,1,0.4,0.4,transcript,23726.0
SLCO1C1,ENSG00000139155,metabolite measurement,EFO_0004725,0.1865114840363107,1.8651457312564717,1,0.5,0.5,transcript,16186.0
PAQR3,ENSG00000163291,lung adenocarcinoma,EFO_0000571,0.18646330279550663,1.8646480796954237,1,0.4,0.4,transcript,26575.0
ARL3,ENSG00000138175,genetic disorder,EFO_0000508,0.1863860202116849,1.8639645317986435,1,0.4,0.4,transcript,3834.0
WAPL,ENSG00000062650,glomerular filtration rate,OBA_0003747,0.18636054228671325,1.8637391797639726,2,0.8,1.6,transcript,11962.0
WAPL,ENSG00000062650,blood urea nitrogen measurement,EFO_0004741,0.18636054228671325,1.8637391797639726,2,0.8,1.6,transcript,11962.0
TEX15,ENSG00000133863,lung adenocarcinoma,EFO_0000571,0.18617585179741852,1.8617734415653984,1,0.5,0.5,transcript,33504.0
APIP,ENSG00000149089,glucose measurement,EFO_0004468,0.18615935988510113,1.8616663684624215,1,0.5,0.5,transcript,6871.0
EHD1,ENSG00000110047,ovarian cancer,MONDO_0008170,0.18610142252112785,1.861032572151926,1,0.4,0.4,transcript,21802.0
SI,ENSG00000090402,lung adenocarcinoma,EFO_0000571,0.18608345683374733,1.8609066144469832,1,0.5,0.5,transcript,6940.0
REG1A,ENSG00000115386,lymphocyte count,EFO_0004587,0.18592072136964208,1.8593484067779598,1,0.4,0.4,transcript,2833.0
FYCO1,ENSG00000163820,alkaline phosphatase measurement,EFO_0004533,0.18590393392709884,1.8590639501120638,1,0.4,0.4,transcript,16253.0
RTF1,ENSG00000137815,asthma,MONDO_0004979,0.18584933082329222,1.8585450279122602,1,0.4,0.4,transcript,7734.0
APIP,ENSG00000149089,hemoglobin A1 measurement,EFO_0007629,0.18583403604747037,1.858413130086114,1,0.5,0.5,transcript,6871.0
ZNF429,ENSG00000197013,lung adenocarcinoma,EFO_0000571,0.1858062719427338,1.8582185281721038,2,0.8,1.6,transcript,10269.0
GANC,ENSG00000214013,urinary microalbumin measurement,EFO_0010967,0.18578960467649042,1.857925320769588,1,0.5,0.5,transcript,17080.0
ADAT2,ENSG00000189007,systolic blood pressure,EFO_0006335,0.18578068573878914,1.8578366658684042,1,0.4,0.4,transcript,13419.0
DSC2,ENSG00000134755,ovarian cancer,MONDO_0008170,0.18571387697906264,1.8571512118572535,2,0.8,1.6,transcript,128596.0
NCKAP1,ENSG00000061676,endometrial cancer,MONDO_0011962,0.18571387697906264,1.8571485990079748,1,0.4,0.4,transcript,40695.0
ZNF429,ENSG00000197013,colorectal adenocarcinoma,EFO_0000365,0.18571387697906264,1.857294578535392,2,0.8,1.6,transcript,10269.0
SLC44A1,ENSG00000070214,glioblastoma multiforme,EFO_0000519,0.18571387697906264,1.8571483787077014,1,0.4,0.4,transcript,41628.0
COL19A1,ENSG00000082293,lung adenocarcinoma,EFO_0000571,0.18571387697906264,1.8572761088464202,2,0.8,1.6,transcript,11650.0
POU2F1,ENSG00000143190,endometrial cancer,MONDO_0011962,0.18566767949722704,1.8566918070288283,2,0.8,1.6,transcript,106581.0
ZNF429,ENSG00000197013,oral squamous cell carcinoma,EFO_0000199,0.18543705465224286,1.8545263552671942,2,0.8,1.6,transcript,10269.0
DSC2,ENSG00000134755,head and neck squamous cell carcinoma,EFO_0000181,0.18534429712437792,1.8534554133104064,2,0.8,1.6,transcript,128596.0
MCF2L2,ENSG00000053524,type 2 diabetes mellitus,MONDO_0005148,0.18534429712437792,1.8534844209471548,2,0.8,1.6,transcript,38601.0
SERPINB9,ENSG00000170542,ghrelin measurement,EFO_0600001,0.1853306972009953,1.8533546876248879,1,0.4,0.4,transcript,8383.0
CRYGD,ENSG00000118231,gamma-crystallin D measurement,EFO_0802560,0.1853306972009953,1.8539300249694544,1,0.4,0.4,transcript,642.0
CMTR2,ENSG00000180917,glycoprotein measurement,EFO_0004555,0.1853306972009953,1.85341039131058,2,0.8,1.6,transcript,15471.0
SERPINB9,ENSG00000170542,complement factor D measurement,EFO_0020283,0.1853306972009953,1.8533546876248879,1,0.4,0.4,transcript,8383.0
PRDM10,ENSG00000170325,lipoma,EFO_0000759,0.18529568058113294,1.8529682083198813,1,0.4,0.4,transcript,35080.0
ZNF485,ENSG00000198298,metabolite measurement,EFO_0004725,0.18526492360170407,1.8527465690908194,1,0.5,0.5,transcript,5137.0
SOGA1,ENSG00000149639,strand of hair color,OBA_0002313,0.18526054689567026,1.852627019751927,1,0.5,0.5,transcript,23201.0
CDCA4,ENSG00000170779,biliary tract disease,EFO_0009534,0.1852139159481827,1.8522395610882527,1,0.4,0.4,transcript,3984.0
CENPQ,ENSG00000031691,mean reticulocyte volume,EFO_0010701,0.18519767722259425,1.852206525241451,1,0.4,0.4,transcript,1741.0
ZNF429,ENSG00000197013,non-small cell lung carcinoma,EFO_0003060,0.18515950719703558,1.8517508807151215,2,0.8,1.6,transcript,10269.0
LNPEP,ENSG00000113441,clear cell renal carcinoma,EFO_0000349,0.18515950719703558,1.8516157341946442,1,0.4,0.4,transcript,19359.0
ZNF429,ENSG00000197013,urinary bladder carcinoma,MONDO_0004986,0.18515950719703558,1.8517508807151215,2,0.8,1.6,transcript,10269.0
GNA13,ENSG00000120063,urinary bladder cancer,MONDO_0001187,0.18513630660041433,1.851414672248499,1,0.4,0.4,transcript,7751.0
EXD1,ENSG00000178997,atopic asthma,EFO_0010638,0.18498903486145835,1.8499321327992695,1,0.4,0.4,transcript,9573.0
DMXL1,ENSG00000172869,hypertension,EFO_0000537,0.18496689470884004,1.8496796317052233,1,0.4,0.4,transcript,37437.0
RPRD2,ENSG00000163125,monocyte percentage of leukocytes,EFO_0007989,0.18494126875874503,1.849431194111,1,0.4,0.4,transcript,21614.0
CENPQ,ENSG00000031691,Ischemic stroke,HP_0002140,0.18484651188606355,1.848694871876144,1,0.4,0.4,transcript,1741.0
OR6C75,ENSG00000187857,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8479467850044569,1,0.4,0.4,transcript,8419.0
OR5A2,ENSG00000172324,prostate adenocarcinoma,EFO_0000673,0.1847899273423509,1.8479171162283978,1,0.4,0.4,transcript,22418.0
OR5A2,ENSG00000172324,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.8479171162283978,1,0.4,0.4,transcript,22418.0
OR5AS1,ENSG00000181785,hepatocellular carcinoma,EFO_0000182,0.1847899273423509,1.8479501640087506,1,0.4,0.4,transcript,7860.0
PAQR3,ENSG00000163291,cutaneous melanoma,EFO_0000389,0.1847899273423509,1.8479143251638663,1,0.4,0.4,transcript,26575.0
AKR1B10,ENSG00000198074,cutaneous melanoma,EFO_0000389,0.1847899273423509,1.8480314087300629,1,0.5,0.5,transcript,3784.0
GAN,ENSG00000261609,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.84790993753079,1,0.4,0.4,transcript,37509.0
OR5AS1,ENSG00000181785,prostate adenocarcinoma,EFO_0000673,0.1847899273423509,1.8479501640087506,1,0.4,0.4,transcript,7860.0
OR5AS1,ENSG00000181785,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8479501640087506,1,0.4,0.4,transcript,7860.0
OR5AS1,ENSG00000181785,low grade glioma,MONDO_0021637,0.1847899273423509,1.8479501640087506,1,0.4,0.4,transcript,7860.0
OR6C75,ENSG00000187857,prostate adenocarcinoma,EFO_0000673,0.1847899273423509,1.8479467850044569,1,0.4,0.4,transcript,8419.0
SI,ENSG00000090402,endometrial cancer,MONDO_0011962,0.1847899273423509,1.847971319533019,1,0.5,0.5,transcript,6940.0
OR5M1,ENSG00000255012,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.848271193460701,2,0.8,1.6,transcript,4302.0
ATP9A,ENSG00000054793,Functional abnormality of the gastrointestinal tract,HP_0012719,0.1847899273423509,1.8479246396483804,1,0.4,0.4,transcript,15769.0
OR6N1,ENSG00000197403,pancreatic adenocarcinoma,EFO_1000044,0.1847899273423509,1.850105409238745,4,1.6,6.4,transcript,2901.0
OR6N1,ENSG00000197403,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.850105409238745,4,1.6,6.4,transcript,2901.0
OR6N1,ENSG00000197403,ovarian cancer,MONDO_0008170,0.1847899273423509,1.850105409238745,4,1.6,6.4,transcript,2901.0
DBR1,ENSG00000138231,ichthyosis,MONDO_0019269,0.1847899273423509,1.8479177049044784,1,0.4,0.4,transcript,21702.0
OR8H2,ENSG00000181767,prostate adenocarcinoma,EFO_0000673,0.1847899273423509,1.8479546904365318,1,0.4,0.4,transcript,7218.0
OR8H2,ENSG00000181767,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8479546904365318,1,0.4,0.4,transcript,7218.0
OR9Q2,ENSG00000186513,prostate adenocarcinoma,EFO_0000673,0.1847899273423509,1.8480052617647913,1,0.4,0.4,transcript,3774.0
OR9Q2,ENSG00000186513,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8480052617647913,1,0.4,0.4,transcript,3774.0
OR2M7,ENSG00000177186,low grade glioma,MONDO_0021637,0.1847899273423509,1.848431754786661,1,0.5,0.5,transcript,939.0
OR6C75,ENSG00000187857,hepatocellular carcinoma,EFO_0000182,0.1847899273423509,1.8479467850044569,1,0.4,0.4,transcript,8419.0
SI,ENSG00000090402,cutaneous melanoma,EFO_0000389,0.1847899273423509,1.847971319533019,1,0.5,0.5,transcript,6940.0
OR5M1,ENSG00000255012,hepatocellular carcinoma,EFO_0000182,0.1847899273423509,1.848271193460701,2,0.8,1.6,transcript,4302.0
ARAP1,ENSG00000186635,endometrial cancer,MONDO_0011962,0.1847899273423509,1.8479082830412759,1,0.4,0.4,transcript,44397.0
CNTN1,ENSG00000018236,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8479158003003424,1,0.4,0.4,transcript,24203.0
OR5M1,ENSG00000255012,ovarian cancer,MONDO_0008170,0.1847899273423509,1.848271193460701,2,0.8,1.6,transcript,4302.0
RNF14,ENSG00000013561,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.8479591044009975,2,0.8,1.6,transcript,26742.0
STAM,ENSG00000136738,endometrial cancer,MONDO_0011962,0.1847899273423509,1.8479652691337878,1,0.4,0.4,transcript,6061.0
DZIP3,ENSG00000198919,pancreatic adenocarcinoma,EFO_1000044,0.1847899273423509,1.8479214083357993,1,0.4,0.4,transcript,18071.0
UBE2J1,ENSG00000198833,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.8483315500805695,2,0.9,1.8,transcript,4164.0
OR5M1,ENSG00000255012,prostate adenocarcinoma,EFO_0000673,0.1847899273423509,1.848271193460701,2,0.8,1.6,transcript,4302.0
C6,ENSG00000039537,cutaneous melanoma,EFO_0000389,0.1847899273423509,1.8479288364815116,1,0.5,0.5,transcript,16913.0
DGKH,ENSG00000102780,glioblastoma multiforme,EFO_0000519,0.1847899273423509,1.847926666462253,2,0.8,1.6,transcript,58409.0
SI,ENSG00000090402,head and neck squamous cell carcinoma,EFO_0000181,0.1847899273423509,1.847971319533019,1,0.5,0.5,transcript,6940.0
OR10A6,ENSG00000279000,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8479321789845486,1,0.4,0.4,transcript,12156.0
ZNF429,ENSG00000197013,lymphoid neoplasm,EFO_0001642,0.1847899273423509,1.8480550821682746,2,0.8,1.6,transcript,10269.0
OR10A6,ENSG00000279000,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.8479321789845486,1,0.4,0.4,transcript,12156.0
OR10G4,ENSG00000254737,ovarian cancer,MONDO_0008170,0.1847899273423509,1.84795704349861,1,0.4,0.4,transcript,6924.0
OR10G4,ENSG00000254737,chronic lymphocytic leukemia,EFO_0000095,0.1847899273423509,1.84795704349861,1,0.4,0.4,transcript,6924.0
OR10G4,ENSG00000254737,low grade glioma,MONDO_0021637,0.1847899273423509,1.84795704349861,1,0.4,0.4,transcript,6924.0
OR10G4,ENSG00000254737,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.84795704349861,1,0.4,0.4,transcript,6924.0
OR2T6,ENSG00000198104,ovarian cancer,MONDO_0008170,0.1847899273423509,1.847984926528434,1,0.4,0.4,transcript,4670.0
ZNF143,ENSG00000166478,methylmalonic aciduria and homocystinuria,MONDO_0016826,0.1847899273423509,1.8479255532511132,1,0.5,0.5,transcript,19026.0
OR5A1,ENSG00000172320,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8479457202419018,1,0.4,0.4,transcript,8612.0
OR5A1,ENSG00000172320,low grade glioma,MONDO_0021637,0.1847899273423509,1.8479457202419018,1,0.4,0.4,transcript,8612.0
TRIM69,ENSG00000185880,CINCA syndrome,MONDO_0011776,0.1847899273423509,1.8479148509607002,1,0.4,0.4,transcript,25678.0
SI,ENSG00000090402,ovarian cancer,MONDO_0008170,0.1847899273423509,1.847971319533019,1,0.5,0.5,transcript,6940.0
OR2M7,ENSG00000177186,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.848431754786661,1,0.5,0.5,transcript,939.0
ZNF429,ENSG00000197013,prostate carcinoma,EFO_0001663,0.1847899273423509,1.8480550821682746,2,0.8,1.6,transcript,10269.0
OR2T12,ENSG00000177201,hepatocellular carcinoma,EFO_0000182,0.1847899273423509,1.8504220484760667,6,2.4000000000000004,14.400000000000002,transcript,5708.0
DSC2,ENSG00000134755,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.847911715490136,2,0.8,1.6,transcript,128596.0
OR5AN1,ENSG00000176495,ovarian cancer,MONDO_0008170,0.1847899273423509,1.847928424542912,1,0.5,0.5,transcript,17152.0
OR5AN1,ENSG00000176495,low grade glioma,MONDO_0021637,0.1847899273423509,1.847928424542912,1,0.5,0.5,transcript,17152.0
IQCB1,ENSG00000173226,Leber congenital amaurosis 10,MONDO_0012723,0.1847899273423509,1.847940892401763,1,0.4,0.4,transcript,9611.0
SMC5,ENSG00000198887,developmental disorder of mental health,EFO_0005548,0.1847899273423509,1.847963623487859,1,0.5,0.5,transcript,7770.0
SH3GL3,ENSG00000140600,endometrial cancer,MONDO_0011962,0.1847899273423509,1.847950966367422,1,0.4,0.4,transcript,7738.0
ZNF429,ENSG00000197013,pancreatic ductal adenocarcinoma,MONDO_0005184,0.1847899273423509,1.8480550821682746,2,0.8,1.6,transcript,10269.0
OR4X1,ENSG00000176567,pancreatic adenocarcinoma,EFO_1000044,0.1847899273423509,1.848443935732877,1,0.5,0.5,transcript,918.0
OR2T12,ENSG00000177201,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8504220484760667,6,2.4000000000000004,14.400000000000002,transcript,5708.0
OR4X1,ENSG00000176567,low grade glioma,MONDO_0021637,0.1847899273423509,1.848443935732877,1,0.5,0.5,transcript,918.0
OR4X1,ENSG00000176567,chronic lymphocytic leukemia,EFO_0000095,0.1847899273423509,1.848443935732877,1,0.5,0.5,transcript,918.0
OR2T12,ENSG00000177201,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.8504220484760667,6,2.4000000000000004,14.400000000000002,transcript,5708.0
ZNF429,ENSG00000197013,ovarian mucinous adenocarcinoma,EFO_0006462,0.1847899273423509,1.8480550821682746,2,0.8,1.6,transcript,10269.0
OR4X1,ENSG00000176567,ovarian cancer,MONDO_0008170,0.1847899273423509,1.848443935732877,1,0.5,0.5,transcript,918.0
KRT74,ENSG00000170484,glioblastoma multiforme,EFO_0000519,0.1847899273423509,1.8479632939100645,1,0.4,0.4,transcript,6248.0
KRT74,ENSG00000170484,head and neck squamous cell carcinoma,EFO_0000181,0.1847899273423509,1.8479632939100645,1,0.4,0.4,transcript,6248.0
ZNF429,ENSG00000197013,head and neck squamous cell carcinoma,EFO_0000181,0.1847899273423509,1.8480550821682746,2,0.8,1.6,transcript,10269.0
NCKAP1,ENSG00000061676,glioblastoma multiforme,EFO_0000519,0.1847899273423509,1.8479091026408574,1,0.4,0.4,transcript,40695.0
ZNF429,ENSG00000197013,pancreatic carcinoma,EFO_0002618,0.1847899273423509,1.8480550821682746,2,0.8,1.6,transcript,10269.0
TAF2,ENSG00000064313,head and neck squamous cell carcinoma,EFO_0000181,0.1847899273423509,1.847902066407533,1,0.5,0.5,transcript,179020.0
TAF2,ENSG00000064313,lung adenocarcinoma,EFO_0000571,0.1847899273423509,1.847902066407533,1,0.5,0.5,transcript,179020.0
ZNF429,ENSG00000197013,skin carcinoma,EFO_0009259,0.1847899273423509,1.8480550821682746,2,0.8,1.6,transcript,10269.0
TAF2,ENSG00000064313,endometrial cancer,MONDO_0011962,0.1847899273423509,1.847902066407533,1,0.5,0.5,transcript,179020.0
KIAA0319,ENSG00000137261,lung adenocarcinoma,EFO_0000571,0.1847899273423509,1.847911660776022,1,0.4,0.4,transcript,32291.0
OR6C1,ENSG00000205330,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.8480595812144676,1,0.5,0.5,transcript,3119.0
CNTN1,ENSG00000018236,endometrial cancer,MONDO_0011962,0.1847899273423509,1.8479158003003424,1,0.4,0.4,transcript,24203.0
OR6N1,ENSG00000197403,prostate adenocarcinoma,EFO_0000673,0.1847899273423509,1.850105409238745,4,1.6,6.4,transcript,2901.0
GRK7,ENSG00000114124,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8479403074817773,1,0.4,0.4,transcript,9748.0
OTUD7A,ENSG00000169918,lung adenocarcinoma,EFO_0000571,0.1847899273423509,1.8479169999912022,1,0.4,0.4,transcript,22565.0
KRTAP19-1,ENSG00000184351,head and neck squamous cell carcinoma,EFO_0000181,0.1847899273423509,1.8485035030307597,1,0.4,0.4,transcript,662.0
KRT74,ENSG00000170484,clear cell renal carcinoma,EFO_0000349,0.1847899273423509,1.8479632939100645,1,0.4,0.4,transcript,6248.0
AKR1C1,ENSG00000187134,cutaneous melanoma,EFO_0000389,0.1847899273423509,1.848038464376097,2,0.8,1.6,transcript,11495.0
CR2,ENSG00000117322,pancreatic adenocarcinoma,EFO_1000044,0.1847899273423509,1.8479175993501136,1,0.4,0.4,transcript,21827.0
MTR,ENSG00000116984,Seizure,HP_0001250,0.1847899273423509,1.8479036858533238,1,0.4,0.4,transcript,90653.0
AKAP10,ENSG00000108599,ovarian cancer,MONDO_0008170,0.1847899273423509,1.8479344537225415,1,0.4,0.4,transcript,11370.0
KRTAP19-1,ENSG00000184351,glioblastoma multiforme,EFO_0000519,0.1847899273423509,1.8485035030307597,1,0.4,0.4,transcript,662.0
MTR,ENSG00000116984,pancreatic adenocarcinoma,EFO_1000044,0.1847899273423509,1.8479036858533238,1,0.4,0.4,transcript,90653.0
MTR,ENSG00000116984,thyroid gland adenocarcinoma,MONDO_0024622,0.1847899273423509,1.8479036858533238,1,0.4,0.4,transcript,90653.0
OTUD7A,ENSG00000169918,head and neck squamous cell carcinoma,EFO_0000181,0.1847899273423509,1.8479169999912022,1,0.4,0.4,transcript,22565.0
ZNF429,ENSG00000197013,papillary renal cell carcinoma,EFO_0000640,0.1847899273423509,1.8480550821682746,2,0.8,1.6,transcript,10269.0
CPB1,ENSG00000153002,endometrial cancer,MONDO_0011962,0.1847899273423509,1.8479448522749218,1,0.5,0.5,transcript,10970.0
OTUD7A,ENSG00000169918,esophageal cancer,MONDO_0007576,0.1847899273423509,1.8479169999912022,1,0.4,0.4,transcript,22565.0
OTUD7A,ENSG00000169918,endometrial cancer,MONDO_0011962,0.1847899273423509,1.8479169999912022,1,0.4,0.4,transcript,22565.0
OTUD7A,ENSG00000169918,squamous cell lung carcinoma,EFO_0000708,0.1847899273423509,1.8479169999912022,1,0.4,0.4,transcript,22565.0
OTUD7A,ENSG00000169918,gastric adenocarcinoma,EFO_0000503,0.1847899273423509,1.8479169999912022,1,0.4,0.4,transcript,22565.0
OR5A2,ENSG00000172324,smoking status measurement,EFO_0006527,0.18473179877752072,1.8473358305800962,1,0.4,0.4,transcript,22418.0
CD69,ENSG00000110848,depressive symptom measurement,EFO_0007006,0.1846453343668276,1.847297819389599,3,1.2000000000000002,3.6000000000000005,transcript,4263.0
TM9SF3,ENSG00000077147,monocyte percentage of leukocytes,EFO_0007989,0.18447499919269686,1.8447755053853179,1,0.4,0.4,transcript,15678.0
MRPL35,ENSG00000132313,platelet count,EFO_0004309,0.18443742865456628,1.8444381027549799,1,0.4,0.4,transcript,6268.0
OR10A6,ENSG00000279000,lymphocyte count,EFO_0004587,0.18439643029271366,1.8439972084881764,1,0.4,0.4,transcript,12156.0
PFAS,ENSG00000178921,low density lipoprotein cholesterol measurement,EFO_0004611,0.1843752160214956,1.8437754865503886,1,0.4,0.4,transcript,17148.0
CCDC14,ENSG00000175455,platelet volume,OBA_0003277,0.18429052434149307,1.8429139089261959,1,0.4,0.4,transcript,46160.0
TMEM131,ENSG00000075568,erythrocyte volume,OBA_0003460,0.1842146094476982,1.8421675433482352,1,0.4,0.4,transcript,18649.0
ZNF485,ENSG00000198298,acute myeloid leukemia,EFO_0000222,0.18415992432045847,1.8416965762783633,1,0.5,0.5,transcript,5137.0
TLK1,ENSG00000198586,neuroinflammatory disorder,EFO_0020092,0.1841237442603869,1.8412513377648794,1,0.4,0.4,transcript,28787.0
TRAM1,ENSG00000067167,Myopia,HP_0000545,0.18409661581458614,1.8411566570147744,2,0.8,1.6,transcript,8399.0
RCOR3,ENSG00000117625,neurodegenerative disease,EFO_0005772,0.18405850266543142,1.840649381895244,2,0.8,1.6,transcript,24862.0
KLRD1,ENSG00000134539,platelet count,EFO_0004309,0.18399769062355156,1.8401413958339674,4,1.7000000000000002,6.800000000000001,transcript,41340.0
PEX13,ENSG00000162928,mathematical ability,EFO_0004875,0.18394781925379447,1.8395240220521518,1,0.4,0.4,transcript,8728.0
AGO3,ENSG00000126070,urinary bladder cancer,MONDO_0001187,0.18392153185058444,1.8392284846294085,1,0.4,0.4,transcript,30381.0
NRCAM,ENSG00000091129,bone tissue density,OBA_1000110,0.18378399282109972,1.8378515815249084,1,0.4,0.4,transcript,34325.0
RPS20,ENSG00000008988,hereditary nonpolyposis colon cancer,MONDO_0018630,0.18365371837614716,1.8365543932438966,1,0.4,0.4,transcript,23243.0
CNR2,ENSG00000188822,reticulocyte measurement,EFO_0010700,0.18353167311295862,1.835392704538893,1,0.4,0.4,transcript,5265.0
THAP1,ENSG00000131931,genetic disorder,EFO_0000508,0.18339655663612206,1.8340449314405858,1,0.4,0.4,transcript,5040.0
IGDCC3,ENSG00000174498,threitol measurement,EFO_0021031,0.1833902260477812,1.8339499931747094,1,0.4,0.4,transcript,8380.0
ARPC5,ENSG00000162704,genetic disorder,EFO_0000508,0.18328413852146244,1.832868114249038,1,0.4,0.4,transcript,14965.0
CNOT6L,ENSG00000138767,pancreatic adenocarcinoma,EFO_1000044,0.18327189988431794,1.8328488877160325,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
SPART,ENSG00000133104,metabolite measurement,EFO_0004725,0.18324663554939655,1.8324806208292008,1,0.4,0.4,transcript,28040.0
SC5D,ENSG00000109929,serum urea amount,OBA_2050065,0.18324663554939655,1.832489198278501,1,0.4,0.4,transcript,17511.0
KLF10,ENSG00000155090,Iron deficiency anemia,HP_0001891,0.18324663554939655,1.832527201249974,1,0.4,0.4,transcript,6574.0
TNFRSF19,ENSG00000127863,open-angle glaucoma,EFO_0004190,0.18324663554939655,1.8324993566160037,1,0.5,0.5,transcript,15151.0
SPART,ENSG00000133104,benign chondrogenic neoplasm,MONDO_0024470,0.18324663554939655,1.8324806208292008,1,0.4,0.4,transcript,28040.0
C18orf54,ENSG00000166845,cardiomyopathy,EFO_0000318,0.18324663554939655,1.8325518301453891,2,0.8,1.6,transcript,18719.0
SERPINB10,ENSG00000242550,ovarian dysfunction,EFO_0009003,0.18324663554939655,1.8326983740554506,1,0.5,0.5,transcript,2155.0
LHX9,ENSG00000143355,wet macular degeneration,EFO_0004683,0.18324663554939655,1.8325406221111211,2,0.8,1.6,transcript,21544.0
SC5D,ENSG00000109929,FEV/FVC ratio,EFO_0004713,0.18324663554939655,1.832489198278501,1,0.4,0.4,transcript,17511.0
SC5D,ENSG00000109929,IGA glomerulonephritis,EFO_0004194,0.18324663554939655,1.832489198278501,1,0.4,0.4,transcript,17511.0
COL19A1,ENSG00000082293,diet measurement,EFO_0008111,0.18324663554939655,1.8326036945497595,2,0.8,1.6,transcript,11650.0
SC5D,ENSG00000109929,viral human hepatitis infection,EFO_0004196,0.18324663554939655,1.832489198278501,1,0.4,0.4,transcript,17511.0
SCRG1,ENSG00000164106,brain cancer,MONDO_0001657,0.18324663554939655,1.832749942874327,2,0.8,1.6,transcript,5642.0
NCKAP1,ENSG00000061676,attention deficit hyperactivity disorder,EFO_0003888,0.18324663554939655,1.832476184711314,1,0.4,0.4,transcript,40695.0
SC5D,ENSG00000109929,Hallucinations,HP_0000738,0.18324663554939655,1.832489198278501,1,0.4,0.4,transcript,17511.0
NCKAP1,ENSG00000061676,substance abuse,MONDO_0002491,0.18324663554939655,1.832476184711314,1,0.4,0.4,transcript,40695.0
SC5D,ENSG00000109929,alcohol use disorder measurement,EFO_0009458,0.18324663554939655,1.832489198278501,1,0.4,0.4,transcript,17511.0
STXBP4,ENSG00000166263,X-12189 measurement,EFO_0021291,0.18324663554939655,1.8328580668810155,5,2.0,10.0,transcript,25529.0
SC5D,ENSG00000109929,Microscopic hematuria,HP_0002907,0.18324663554939655,1.832489198278501,1,0.4,0.4,transcript,17511.0
NCKAP1,ENSG00000061676,social inhibition quality,OBA_1000278,0.18324663554939655,1.832476184711314,1,0.4,0.4,transcript,40695.0
NCKAP1,ENSG00000061676,metabolite measurement,EFO_0004725,0.18324663554939655,1.832476184711314,1,0.4,0.4,transcript,40695.0
NEK7,ENSG00000151414,wet macular degeneration,EFO_0004683,0.18324663554939655,1.8325116197239077,1,0.4,0.4,transcript,8837.0
SC5D,ENSG00000109929,immune system disease,EFO_0000540,0.18324663554939655,1.832489198278501,1,0.4,0.4,transcript,17511.0
FZD6,ENSG00000164930,nervous system benign neoplasm,MONDO_0000648,0.18324663554939655,1.8325462476395689,2,0.8,1.6,transcript,20027.0
AOX1,ENSG00000138356,ulcerative proctosigmoiditis,EFO_1001223,0.18324663554939655,1.8324944572222217,1,0.4,0.4,transcript,14234.0
FZD6,ENSG00000164930,glucose measurement,EFO_0004468,0.18324663554939655,1.8325462476395689,2,0.8,1.6,transcript,20027.0
TRDN,ENSG00000186439,pulse wave reflection index measurement,EFO_0009804,0.18324663554939655,1.8324855589352222,1,0.5,0.5,transcript,26037.0
FAM171B,ENSG00000144369,body weight,EFO_0004338,0.18324663554939655,1.8325361513411127,1,0.4,0.4,transcript,5731.0
TRDN,ENSG00000186439,aortic measurement,EFO_0020865,0.18324663554939655,1.8324855589352222,1,0.5,0.5,transcript,26037.0
PNLIPRP3,ENSG00000203837,serum alanine aminotransferase measurement,EFO_0004735,0.18324663554939655,1.8326348474905956,1,0.4,0.4,transcript,2374.0
PNLIPRP3,ENSG00000203837,bone tissue density,OBA_1000110,0.18324663554939655,1.8326348474905956,1,0.4,0.4,transcript,2374.0
PNLIPRP3,ENSG00000203837,neurofibrillary tangles measurement,EFO_0006797,0.18324663554939655,1.8326348474905956,1,0.4,0.4,transcript,2374.0
PDCD4,ENSG00000150593,sign or symptom,EFO_0003765,0.18324663554939655,1.8325013670477783,1,0.5,0.5,transcript,14281.0
SPART,ENSG00000133104,hypopituitarism,EFO_0001380,0.18324663554939655,1.8324806208292008,1,0.4,0.4,transcript,28040.0
HNRNPA0,ENSG00000177733,smoking initiation,EFO_0005670,0.18324663554939655,1.8324893097003239,1,0.4,0.4,transcript,17426.0
SLCO5A1,ENSG00000137571,Benign Thyroid Gland Neoplasm,EFO_1000122,0.18324663554939655,1.832896907461588,5,2.0,10.0,transcript,23226.0
HNRNPA0,ENSG00000177733,mathematical ability,EFO_0004875,0.18324663554939655,1.8324893097003239,1,0.4,0.4,transcript,17426.0
TRMT6,ENSG00000089195,body mass index,EFO_0004340,0.18324663554939655,1.832499836702637,1,0.4,0.4,transcript,11947.0
PEX13,ENSG00000162928,sleep apnea,EFO_0003877,0.18324663554939655,1.8325121850081727,1,0.4,0.4,transcript,8728.0
YTHDC2,ENSG00000047188,tooth disease,EFO_1001216,0.18324663554939655,1.8324865646588218,1,0.4,0.4,transcript,19793.0
TRDN,ENSG00000186439,liver disease,EFO_0001421,0.18324663554939655,1.8324855589352222,1,0.5,0.5,transcript,26037.0
SPART,ENSG00000133104,cognitive function measurement,EFO_0008354,0.18324663554939655,1.8324806208292008,1,0.4,0.4,transcript,28040.0
PNLIPRP3,ENSG00000203837,metabolite measurement,EFO_0004725,0.18324663554939655,1.8326348474905956,1,0.4,0.4,transcript,2374.0
DBR1,ENSG00000138231,muscular disease,EFO_0002970,0.18324663554939655,1.832484786974935,1,0.4,0.4,transcript,21702.0
PNLIPRP3,ENSG00000203837,lymphocyte count,EFO_0004587,0.18324663554939655,1.8326348474905956,1,0.4,0.4,transcript,2374.0
SPART,ENSG00000133104,urinary microalbumin measurement,EFO_0010967,0.18324663554939655,1.8324806208292008,1,0.4,0.4,transcript,28040.0
SPART,ENSG00000133104,educational attainment,EFO_0011015,0.18324663554939655,1.8324806208292008,1,0.4,0.4,transcript,28040.0
TRMT6,ENSG00000089195,body height,OBA_VT0001253,0.18324663554939655,1.832499836702637,1,0.4,0.4,transcript,11947.0
FAM174A,ENSG00000174132,placental retention,EFO_0009578,0.18324663554939655,1.8325667319055088,1,0.4,0.4,transcript,3985.0
MRPL32,ENSG00000106591,tongue cancer,MONDO_0004631,0.18324663554939655,1.8325494982917208,1,0.4,0.4,transcript,4811.0
YTHDC2,ENSG00000047188,frozen shoulder,EFO_1000941,0.18324663554939655,1.8324865646588218,1,0.4,0.4,transcript,19793.0
FZD6,ENSG00000164930,restless legs syndrome,EFO_0004270,0.18324663554939655,1.8325462476395689,2,0.8,1.6,transcript,20027.0
WAPL,ENSG00000062650,heart rate,OBA_1001087,0.1831466570020946,1.8316003269177858,2,0.8,1.6,transcript,11962.0
BACE2,ENSG00000182240,osteitis deformans,EFO_0004261,0.1831466570020946,1.83160012594749,3,1.2000000000000002,3.6000000000000005,transcript,26955.0
ADAT2,ENSG00000189007,thoracic aortic aneurysm,EFO_0004282,0.18314488248573355,1.8314786333378483,1,0.4,0.4,transcript,13419.0
PCMTD1,ENSG00000168300,high density lipoprotein cholesterol measurement,EFO_0004612,0.18311627003574768,1.8313675484284908,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
RBM25,ENSG00000119707,occupational attainment,EFO_0020977,0.1830988012130473,1.831000702083203,1,0.4,0.4,transcript,31521.0
TAF1B,ENSG00000115750,sexually transmitted disease,MONDO_0021681,0.1830677340261821,1.830731741306321,1,0.5,0.5,transcript,9191.0
DSC2,ENSG00000134755,dilated cardiomyopathy,EFO_0000407,0.18306604264238824,1.8306728684905096,2,0.8,1.6,transcript,128596.0
MANSC4,ENSG00000205693,hemoglobin A1 measurement,EFO_0007629,0.18306437115560747,1.8309436515680724,1,0.5,0.5,transcript,1667.0
KRT20,ENSG00000171431,breast adenocarcinoma,EFO_0000304,0.18304303383343845,1.8306198219914191,1,0.4,0.4,transcript,2111.0
FAM186A,ENSG00000185958,HbA1c measurement,EFO_0004541,0.183013360414732,1.8302445057775742,2,1.0,2.0,transcript,18034.0
SLC6A5,ENSG00000165970,cutaneous melanoma,EFO_0000389,0.18299403139931378,1.8299789501372508,1,0.4,0.4,transcript,10353.0
RNF150,ENSG00000170153,erythrocyte volume,OBA_0003460,0.1829234897325809,1.82949355634048,4,1.6,6.4,transcript,24743.0
TAF1B,ENSG00000115750,bone tissue density,OBA_1000110,0.1828030863231897,1.8280852642763972,1,0.5,0.5,transcript,9191.0
TAF1B,ENSG00000115750,glucose measurement,EFO_0004468,0.1828030863231897,1.8280852642763972,1,0.5,0.5,transcript,9191.0
TRAM1,ENSG00000067167,Abnormality of refraction,HP_0000539,0.1828030863231897,1.82822136210081,2,0.8,1.6,transcript,8399.0
TAF1B,ENSG00000115750,deficiency anemia,MONDO_0001639,0.1828030863231897,1.8280852642763972,1,0.5,0.5,transcript,9191.0
TAF1B,ENSG00000115750,urate measurement,EFO_0004531,0.1828030863231897,1.8280852642763972,1,0.5,0.5,transcript,9191.0
TRAM1,ENSG00000067167,age of onset of myopia,OBA_2001030,0.1828030863231897,1.82822136210081,2,0.8,1.6,transcript,8399.0
TRAM1,ENSG00000067167,refractive error,MONDO_0004892,0.1828030863231897,1.82822136210081,2,0.8,1.6,transcript,8399.0
SARAF,ENSG00000133872,Spinal cord injury,EFO_1001919,0.1828030863231897,1.8280573165087968,1,0.4,0.4,transcript,15121.0
SARAF,ENSG00000133872,strand of hair color,OBA_0002313,0.1828030863231897,1.8280573165087968,1,0.4,0.4,transcript,15121.0
ING1,ENSG00000153487,urethritis,EFO_0003878,0.1828030863231897,1.8280573462827445,1,0.4,0.4,transcript,15104.0
ING1,ENSG00000153487,cystitis,EFO_1000025,0.1828030863231897,1.8280573462827445,1,0.4,0.4,transcript,15104.0
C18orf54,ENSG00000166845,neuroimaging measurement,EFO_0004346,0.1828030863231897,1.8281163378833207,2,0.8,1.6,transcript,18719.0
MAP1LC3B2,ENSG00000258102,body mass index,EFO_0004340,0.1828030863231897,1.828197114270966,1,0.4,0.4,transcript,2406.0
SERPINB9,ENSG00000170542,metabolite measurement,EFO_0004725,0.18278809401726892,1.8279286557876242,1,0.4,0.4,transcript,8383.0
C15orf61,ENSG00000189227,cerebellar volume measurement,EFO_0020864,0.18277770336971091,1.8293985676682458,5,2.0,10.0,transcript,6167.0
GPR85,ENSG00000164604,high density lipoprotein cholesterol measurement,EFO_0004612,0.18276828666032793,1.8277064140218937,1,0.4,0.4,transcript,16987.0
SUMF1,ENSG00000144455,calcium measurement,EFO_0004838,0.18274717953388545,1.8275041447120852,1,0.4,0.4,transcript,12365.0
WAPL,ENSG00000062650,acute myeloid leukemia,EFO_0000222,0.18269152441570324,1.8270490010538725,2,0.8,1.6,transcript,11962.0
TSPAN3,ENSG00000140391,Drugs used in diabetes use measurement,EFO_0009924,0.18269003037972606,1.8269222144019934,1,0.4,0.4,transcript,18256.0
ZNF436,ENSG00000125945,monocyte count,EFO_0005091,0.18245263203016732,1.8245599620174007,1,0.4,0.4,transcript,11890.0
RPRD2,ENSG00000163125,smoking initiation,EFO_0005670,0.18238933652923878,1.8239118718159375,1,0.4,0.4,transcript,21614.0
ADAT2,ENSG00000189007,neurodegenerative disease,EFO_0005772,0.18238257423327042,1.823855550813217,1,0.4,0.4,transcript,13419.0
GPATCH2L,ENSG00000089916,diet measurement,EFO_0008111,0.18235210654520637,1.8236635377923944,4,1.6,6.4,transcript,44921.0
SPATA22,ENSG00000141255,Olmsted syndrome 1,MONDO_0100296,0.18228781707206795,1.8229118430218447,1,0.5,0.5,transcript,14849.0
ZNF793,ENSG00000188227,C-reactive protein measurement,EFO_0004458,0.18217835619440848,1.8217978865394149,1,0.4,0.4,transcript,27924.0
SHOC1,ENSG00000165181,genetic disorder,EFO_0000508,0.18217539895740834,1.8218703623249561,3,1.3,3.9000000000000004,transcript,33513.0
INF2,ENSG00000203485,Charcot-Marie-Tooth disease,MONDO_0015626,0.1821699236318497,1.8217022991994427,1,0.4,0.4,transcript,130596.0
NUP43,ENSG00000120253,hippocampal volume,EFO_0005035,0.18216520147293008,1.8218542136424816,2,0.8,1.6,transcript,7913.0
DZIP3,ENSG00000198919,phosphatidylethanolamine measurement,EFO_0010228,0.18215776816461002,1.8215998165583906,1,0.4,0.4,transcript,18071.0
PF4V1,ENSG00000109272,CXCL1 measurement,EFO_0010777,0.18191978312156867,1.819736189223762,1,0.4,0.4,transcript,743.0
SH3GL3,ENSG00000140600,serum creatinine amount,OBA_2050096,0.1818831438907457,1.81888313185137,1,0.4,0.4,transcript,7738.0
OR5AN1,ENSG00000176495,metabolite measurement,EFO_0004725,0.1818145607684582,1.8181747588039852,1,0.5,0.5,transcript,17152.0
KLRD1,ENSG00000134539,level of serum globulin type protein,OBA_2045206,0.18179920710603256,1.8181565606587775,4,1.7000000000000002,6.800000000000001,transcript,41340.0
ZNF143,ENSG00000166478,metabolite measurement,EFO_0004725,0.18167348540505154,1.8167611338781198,1,0.5,0.5,transcript,19026.0
NHLH2,ENSG00000177551,body mass index,EFO_0004340,0.18166222502141888,1.816660010999613,1,0.4,0.4,transcript,10593.0
FZD6,ENSG00000164930,breast adenocarcinoma,EFO_0000304,0.18166174343628383,1.8166973265084416,2,0.8,1.6,transcript,20027.0
KPNA4,ENSG00000186432,aging,EFO_0022597,0.18164115511387838,1.81642054434891,1,0.4,0.4,transcript,44478.0
ITPRID2,ENSG00000138434,glomerular filtration rate,OBA_0003747,0.18160951587400492,1.8161039462793187,1,0.4,0.4,transcript,45519.0
SENP6,ENSG00000112701,BMI-adjusted waist circumference,EFO_0007789,0.18152866814498722,1.8157156986105587,5,2.2,11.0,transcript,25640.0
LRRIQ3,ENSG00000162620,schizophrenia,MONDO_0005090,0.1812450798311439,1.8124776944921814,1,0.5,0.5,transcript,18590.0
RNMT,ENSG00000101654,alkaline phosphatase measurement,EFO_0004533,0.18121196969386197,1.8121361186481197,1,0.4,0.4,transcript,24358.0
OTULIN,ENSG00000154124,chondrocalcinosis,MONDO_0001314,0.18116628260911788,1.8116820605593456,1,0.4,0.4,transcript,20796.0
OTULIN,ENSG00000154124,"craniometadiaphyseal dysplasia, wormian bone type",MONDO_0010014,0.18116628260911788,1.8116820605593456,1,0.4,0.4,transcript,20796.0
SLC4A8,ENSG00000050438,serine measurement,EFO_0009774,0.1811581932090418,1.8116134399378414,2,0.8,1.6,transcript,50781.0
ATG16L1,ENSG00000085978,eosinophil count,EFO_0004842,0.18114837000474893,1.811495691533534,1,0.4,0.4,transcript,33357.0
POU2F1,ENSG00000143190,breast adenocarcinoma,EFO_0000304,0.18109182716009212,1.810933283657479,2,0.8,1.6,transcript,106581.0
TRMT9B,ENSG00000250305,bronchus cancer,MONDO_0001672,0.18103642324287952,1.8105053590899736,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
EHD1,ENSG00000110047,breast adenocarcinoma,EFO_0000304,0.18103370082214404,1.8103553551620881,1,0.4,0.4,transcript,21802.0
GASK1B,ENSG00000164125,blood protein measurement,EFO_0007937,0.1809493549519636,1.8096664352709686,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
CERKL,ENSG00000188452,MODY,Orphanet_552,0.1807326687098614,1.8073467609704623,1,0.5,0.5,transcript,24908.0
CERKL,ENSG00000188452,maturity-onset diabetes of the young,MONDO_0018911,0.1807326687098614,1.8073467609704623,1,0.5,0.5,transcript,24908.0
MRPL32,ENSG00000106591,BMI-adjusted waist circumference,EFO_0007789,0.1806966683796519,1.8070498265942743,1,0.4,0.4,transcript,4811.0
RNMT,ENSG00000101654,serum creatinine amount,OBA_2050096,0.1806342709046708,1.806359130756208,1,0.4,0.4,transcript,24358.0
RNMT,ENSG00000101654,Abnormality of the cardiovascular system,HP_0001626,0.1806342709046708,1.806359130756208,1,0.4,0.4,transcript,24358.0
RNMT,ENSG00000101654,response to antihypertensive drug,EFO_0005405,0.1806342709046708,1.806359130756208,1,0.4,0.4,transcript,24358.0
STAM,ENSG00000136738,platelet count,EFO_0004309,0.1805063274306388,1.8051292700166668,1,0.4,0.4,transcript,6061.0
LGSN,ENSG00000146166,body mass index,EFO_0004340,0.18046655115584018,1.8046961089729203,1,0.4,0.4,transcript,13073.0
DPP8,ENSG00000074603,platelet volume,OBA_0003277,0.18037718698699468,1.803953589964214,4,1.6,6.4,transcript,35219.0
ATG16L1,ENSG00000085978,breast adenocarcinoma,EFO_0000304,0.18027596477209237,1.8027716392069686,1,0.4,0.4,transcript,33357.0
SYNJ2,ENSG00000078269,Meniere disease,EFO_0006862,0.18025271865967168,1.802578334221549,2,0.8,1.6,transcript,31282.0
NRCAM,ENSG00000091129,endometrial cancer,MONDO_0011962,0.18024808673023537,1.802492520616265,1,0.4,0.4,transcript,34325.0
AGPAT5,ENSG00000155189,breast adenocarcinoma,EFO_0000304,0.180237069518078,1.8024080678800232,1,0.4,0.4,transcript,10703.0
SLC44A1,ENSG00000070214,breast adenocarcinoma,EFO_0000304,0.180237069518078,1.802380304097855,1,0.4,0.4,transcript,41628.0
OR6N1,ENSG00000197403,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8043196081736843,4,1.6,6.4,transcript,2901.0
OR10A6,ENSG00000279000,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.802146377919488,1,0.4,0.4,transcript,12156.0
OR5AN1,ENSG00000176495,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8021426234778513,1,0.5,0.5,transcript,17152.0
OR4X1,ENSG00000176567,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8026581346678163,1,0.5,0.5,transcript,918.0
OR8H2,ENSG00000181767,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8021688893714711,1,0.4,0.4,transcript,7218.0
OR5M1,ENSG00000255012,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8024853923956403,2,0.8,1.6,transcript,4302.0
OR9Q2,ENSG00000186513,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8022194606997306,1,0.4,0.4,transcript,3774.0
OR10G4,ENSG00000254737,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8021712424335492,1,0.4,0.4,transcript,6924.0
OR2T6,ENSG00000198104,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8021991254633734,1,0.4,0.4,transcript,4670.0
OR5A2,ENSG00000172324,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8021313151633371,1,0.4,0.4,transcript,22418.0
OR2M7,ENSG00000177186,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8026459537216004,1,0.5,0.5,transcript,939.0
OR5AS1,ENSG00000181785,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8021643629436899,1,0.4,0.4,transcript,7860.0
OR2T12,ENSG00000177201,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.804636247411006,6,2.4000000000000004,14.400000000000002,transcript,5708.0
OR5A1,ENSG00000172320,breast adenocarcinoma,EFO_0000304,0.1802113472358448,1.8021599191768412,1,0.4,0.4,transcript,8612.0
PFAS,ENSG00000178921,hemoglobin measurement,EFO_0004509,0.18014625312473495,1.8014858575827823,1,0.4,0.4,transcript,17148.0
CMTR2,ENSG00000180917,glomerulonephritis,MONDO_0002462,0.1801091432866701,1.8011948521673282,2,0.8,1.6,transcript,15471.0
KLRD1,ENSG00000134539,erythrocyte count,EFO_0004305,0.1799182541258202,1.7993470308566537,4,1.7000000000000002,6.800000000000001,transcript,41340.0
IYD,ENSG00000009765,congenital hypothyroidism,MONDO_0018612,0.17981051249920185,1.798122528403087,1,0.4,0.4,transcript,22984.0
OTUD7A,ENSG00000169918,urinary bladder cancer,MONDO_0001187,0.17977449378198254,1.7977626643875186,1,0.4,0.4,transcript,22565.0
KRT74,ENSG00000170484,breast adenocarcinoma,EFO_0000304,0.17976301262311176,1.7976941467176732,1,0.4,0.4,transcript,6248.0
CR1L,ENSG00000197721,protein measurement,EFO_0004747,0.1797390895600283,1.7974841791823724,1,0.5,0.5,transcript,5360.0
HEG1,ENSG00000173706,platelet volume,OBA_0003277,0.1797390895600283,1.7974127618879339,1,0.4,0.4,transcript,18293.0
RAD18,ENSG00000070950,breast adenocarcinoma,EFO_0000304,0.1796388415757017,1.7964218969656887,1,0.4,0.4,transcript,11947.0
RPS20,ENSG00000008988,monocyte percentage of leukocytes,EFO_0007989,0.1796368840199141,1.7963860496815658,1,0.4,0.4,transcript,23243.0
SH3GL3,ENSG00000140600,inflammatory bowel disease,EFO_0003767,0.17957657362742496,1.7958174292181628,1,0.4,0.4,transcript,7738.0
ATF6,ENSG00000118217,neutrophil count,EFO_0004833,0.17957594566830445,1.7957658091160265,1,0.4,0.4,transcript,62968.0
TAF2,ENSG00000064313,lysosomal storage disease,MONDO_0002561,0.17952359486312794,1.7952387416153035,1,0.5,0.5,transcript,179020.0
SAMD11,ENSG00000187634,mitochondrial DNA measurement,EFO_0006312,0.17938687825989671,1.7939316114688328,2,0.8,1.6,transcript,25466.0
SELENOI,ENSG00000138018,fatty acid measurement,EFO_0005110,0.1793219315258417,1.7932609039462937,1,0.4,0.4,transcript,9618.0
PLIN3,ENSG00000105355,lymphocyte count,EFO_0004587,0.17923208029532867,1.7923738420961741,1,0.5,0.5,transcript,9427.0
PHF24,ENSG00000122733,erythrocyte volume,OBA_0003460,0.17920478140752663,1.7920953256562142,1,0.4,0.4,transcript,8419.0
MAN1A2,ENSG00000198162,monocyte count,EFO_0005091,0.1790800741150408,1.790928261673242,2,0.8,1.6,transcript,12547.0
CCDC80,ENSG00000091986,high density lipoprotein cholesterol measurement,EFO_0004612,0.1790800741150408,1.7908799490712,2,0.8,1.6,transcript,20200.0
LRPAP1,ENSG00000163956,eosinophil count,EFO_0004842,0.1790800741150408,1.7910313773218474,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
GPR158,ENSG00000151025,ovarian dysfunction,EFO_0009003,0.1790800741150408,1.7908264124550235,1,0.5,0.5,transcript,19477.0
CR1L,ENSG00000197721,pulse pressure measurement,EFO_0005763,0.17904367890719358,1.7905300726540254,1,0.5,0.5,transcript,5360.0
WBP2NL,ENSG00000183066,urate measurement,EFO_0004531,0.1789205957320127,1.7892481122817658,1,0.5,0.5,transcript,11861.0
NRK,ENSG00000123572,base metabolic rate measurement,EFO_0007777,0.1789130132197852,1.7891553496987975,1,0.4,0.4,transcript,15862.0
NSUN7,ENSG00000179299,neurodegenerative disease,EFO_0005772,0.17889953119194948,1.7890343408789828,1,0.5,0.5,transcript,12811.0
SLC9B1,ENSG00000164037,genetic disorder,EFO_0000508,0.17879351515133057,1.787980123630593,1,0.5,0.5,transcript,11118.0
BMP10,ENSG00000163217,breast adenocarcinoma,EFO_0000304,0.17874566556021598,1.7875229246545123,1,0.4,0.4,transcript,6036.0
APOBEC3H,ENSG00000100298,level of neuronal pentraxin receptor in blood serum,OBA_2042624,0.1786545099682581,1.786621684021084,1,0.4,0.4,transcript,5223.0
TRHDE,ENSG00000072657,adolescent idiopathic scoliosis,EFO_0005423,0.1785543622972503,1.785643193574283,2,0.8,1.6,transcript,16069.0
YTHDC2,ENSG00000047188,educational attainment,EFO_0011015,0.17806523938643823,1.7806726030292386,1,0.4,0.4,transcript,19793.0
KCNN3,ENSG00000143603,poisoning,EFO_0008546,0.17793288741780183,1.7794479099879579,3,1.2000000000000002,3.6000000000000005,transcript,30243.0
UTP20,ENSG00000120800,eosinophil count,EFO_0004842,0.1779049174899346,1.7790918552237163,1,0.5,0.5,transcript,11715.0
CCDC50,ENSG00000152492,systolic blood pressure,EFO_0006335,0.17769177583634288,1.7769542048326772,1,0.4,0.4,transcript,10975.0
SGCB,ENSG00000163069,Spinal cord injury,EFO_1001919,0.1775685752320742,1.7757583476020486,1,0.4,0.4,transcript,5510.0
PRDM10,ENSG00000170325,benign lipomatous neoplasm,MONDO_0044983,0.17754800030304269,1.7754914055389788,1,0.4,0.4,transcript,35080.0
LRRIQ3,ENSG00000162620,attention deficit hyperactivity disorder,EFO_0003888,0.17726860590849733,1.7727129552657157,1,0.5,0.5,transcript,18590.0
OR5AN1,ENSG00000176495,drug use measurement,EFO_0007010,0.17725091661207024,1.7725383172401055,1,0.5,0.5,transcript,17152.0
OR5AN1,ENSG00000176495,amyotrophic lateral sclerosis,MONDO_0004976,0.17725091661207024,1.7725383172401055,1,0.5,0.5,transcript,17152.0
OR5A2,ENSG00000172324,smoking behavior,EFO_0004318,0.17711641044812565,1.7711819472861454,1,0.4,0.4,transcript,22418.0
CCDC62,ENSG00000130783,type 2 diabetes mellitus,MONDO_0005148,0.17708152607768554,1.7708421968037915,1,0.4,0.4,transcript,14850.0
FZD3,ENSG00000104290,glioblastoma multiforme,EFO_0000519,0.17703375830054097,1.7703516998220676,1,0.4,0.4,transcript,28335.0
OTOGL,ENSG00000165899,Hearing impairment,HP_0000365,0.1769240361018115,1.7692552189760373,1,0.5,0.5,transcript,33652.0
FAM210A,ENSG00000177150,Abnormality of the cardiovascular system,HP_0001626,0.17668987676368073,1.7669209135785635,1,0.4,0.4,transcript,18062.0
FAM210A,ENSG00000177150,serum creatinine amount,OBA_2050096,0.17668987676368073,1.7669209135785635,1,0.4,0.4,transcript,18062.0
FAM210A,ENSG00000177150,response to antihypertensive drug,EFO_0005405,0.17668987676368073,1.7669209135785635,1,0.4,0.4,transcript,18062.0
SLC25A16,ENSG00000122912,hemoglobin A1 measurement,EFO_0007629,0.1766841231393567,1.7668722680167823,1,0.4,0.4,transcript,12888.0
TM9SF3,ENSG00000077147,monocyte count,EFO_0005091,0.17667922295458016,1.766817743004151,1,0.4,0.4,transcript,15678.0
UNC80,ENSG00000144406,cerebral cortex area attribute,OBA_2045267,0.17649264450246663,1.7649311070293283,1,0.4,0.4,transcript,85800.0
ORMDL1,ENSG00000128699,serum creatinine amount,OBA_2050096,0.17627918127987965,1.7629188876935626,2,0.8,1.6,transcript,12591.0
SLC5A7,ENSG00000115665,cutaneous melanoma,EFO_0000389,0.17624659358833394,1.7625214991560163,1,0.4,0.4,transcript,7199.0
SLC22A25,ENSG00000196600,eicosanoids measurement,EFO_0020044,0.17616259527464756,1.7616525467229398,1,0.4,0.4,transcript,15041.0
SNIP1,ENSG00000163877,lower respiratory tract disease,EFO_0009433,0.17615005154340257,1.7615460113393944,1,0.4,0.4,transcript,8792.0
TMTC3,ENSG00000139324,lymphocyte count,EFO_0004587,0.17609538886687268,1.760992897835881,1,0.4,0.4,transcript,10254.0
SERPINB10,ENSG00000242550,cystatin C measurement,EFO_0004617,0.17609538886687268,1.7611859072302118,1,0.5,0.5,transcript,2155.0
SCAMP1,ENSG00000085365,cardiac transplant,EFO_0010673,0.17609538886687268,1.7609802356585833,1,0.4,0.4,transcript,15182.0
SERPINB10,ENSG00000242550,skin disease,EFO_0000701,0.17609538886687268,1.7611859072302118,1,0.5,0.5,transcript,2155.0
ZNF485,ENSG00000198298,lymphocyte count,EFO_0004587,0.17609538886687268,1.7610512217425054,1,0.5,0.5,transcript,5137.0
ZPLD1,ENSG00000170044,lymphocyte count,EFO_0004587,0.17609538886687268,1.7611128711806505,2,0.8,1.6,transcript,10064.0
ZNF485,ENSG00000198298,platelet volume,OBA_0003277,0.17609538886687268,1.7610512217425054,1,0.5,0.5,transcript,5137.0
PCMTD1,ENSG00000168300,frozen shoulder,EFO_1000941,0.17609538886687268,1.7611587367397408,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
GUF1,ENSG00000151806,narcolepsy,MONDO_0021107,0.17609538886687268,1.7609958103590093,1,0.5,0.5,transcript,11927.0
GUF1,ENSG00000151806,insulin-like growth factor-binding protein 7 amount,OBA_2050142,0.17609538886687268,1.7609958103590093,1,0.5,0.5,transcript,11927.0
SERPINB10,ENSG00000242550,brain volume,OBA_2050009,0.17609538886687268,1.7611859072302118,1,0.5,0.5,transcript,2155.0
GUF1,ENSG00000151806,complication,EFO_0009518,0.17609538886687268,1.7609958103590093,1,0.5,0.5,transcript,11927.0
GUF1,ENSG00000151806,gut microbiome measurement,EFO_0007874,0.17609538886687268,1.7609958103590093,1,0.5,0.5,transcript,11927.0
SLC6A5,ENSG00000165970,spondin-1 measurement,EFO_0008290,0.17609538886687268,1.7609925248128397,1,0.4,0.4,transcript,10353.0
GUF1,ENSG00000151806,trauma complication,EFO_0009888,0.17609538886687268,1.7609958103590093,1,0.5,0.5,transcript,11927.0
MRPL32,ENSG00000106591,DNA methylation,EFO_0022599,0.17609538886687268,1.761037031466482,1,0.4,0.4,transcript,4811.0
NDST3,ENSG00000164100,pulse wave reflection index measurement,EFO_0009804,0.17609538886687268,1.7610039512469495,1,0.4,0.4,transcript,7990.0
SLC6A5,ENSG00000165970,injury,EFO_0000546,0.17609538886687268,1.7609925248128397,1,0.4,0.4,transcript,10353.0
USP15,ENSG00000135655,Abnormality of the integument,HP_0001574,0.17609538886687268,1.761037006511357,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
CCDC126,ENSG00000169193,1-palmitoyl-GPC (16:0) measurement,EFO_0800214,0.17609538886687268,1.7609963515137375,1,0.4,0.4,transcript,9420.0
GUF1,ENSG00000151806,medical procedure,EFO_0002571,0.17609538886687268,1.7609958103590093,1,0.5,0.5,transcript,11927.0
SLC6A5,ENSG00000165970,vital capacity,EFO_0004312,0.17609538886687268,1.7609925248128397,1,0.4,0.4,transcript,10353.0
ARSJ,ENSG00000180801,adolescent idiopathic scoliosis,EFO_0005423,0.17609538886687268,1.7611321219315095,2,0.8,1.6,transcript,8977.0
ARSJ,ENSG00000180801,ovarian neoplasm,EFO_0003893,0.17609538886687268,1.7611321219315095,2,0.8,1.6,transcript,8977.0
SLC6A5,ENSG00000165970,protein kinase C-binding protein NELL1 measurement,EFO_0801950,0.17609538886687268,1.7609925248128397,1,0.4,0.4,transcript,10353.0
ZNF485,ENSG00000198298,drug use measurement,EFO_0007010,0.17609538886687268,1.7610512217425054,1,0.5,0.5,transcript,5137.0
BHLHE41,ENSG00000123095,erythrocyte volume,OBA_0003460,0.17609538886687268,1.7610421694014569,1,0.4,0.4,transcript,4531.0
SLC6A5,ENSG00000165970,blood protein measurement,EFO_0007937,0.17609538886687268,1.7609925248128397,1,0.4,0.4,transcript,10353.0
SLC6A5,ENSG00000165970,educational attainment,EFO_0011015,0.17609538886687268,1.7609925248128397,1,0.4,0.4,transcript,10353.0
REG1A,ENSG00000115386,X-12544 measurement,EFO_0021315,0.17609538886687268,1.7610950817502657,1,0.4,0.4,transcript,2833.0
FAM91A1,ENSG00000176853,lymphocyte count,EFO_0004587,0.17609538886687268,1.7609842616489237,1,0.5,0.5,transcript,16462.0
DSC2,ENSG00000134755,spermatocele,EFO_1001189,0.17609538886687268,1.760966330735354,2,0.8,1.6,transcript,128596.0
U2SURP,ENSG00000163714,protein measurement,EFO_0004747,0.17609538886687268,1.7610042966583932,2,0.8,1.6,transcript,31741.0
ARSJ,ENSG00000180801,urinary microalbumin measurement,EFO_0010967,0.17609538886687268,1.7611321219315095,2,0.8,1.6,transcript,8977.0
TMEM144,ENSG00000164124,Abnormality of the cardiovascular system,HP_0001626,0.17609538886687268,1.760970798412967,1,0.4,0.4,transcript,23655.0
CLASP2,ENSG00000163539,aspartate aminotransferase measurement,EFO_0004736,0.17609538886687268,1.7609600080580117,1,0.4,0.4,transcript,65366.0
TMEM144,ENSG00000164124,brain aneurysm,EFO_0003870,0.17609538886687268,1.760970798412967,1,0.4,0.4,transcript,23655.0
DSC2,ENSG00000134755,supraventricular ectopy,EFO_0009277,0.17609538886687268,1.760966330735354,2,0.8,1.6,transcript,128596.0
DSC2,ENSG00000134755,urinary microalbumin measurement,EFO_0010967,0.17609538886687268,1.760966330735354,2,0.8,1.6,transcript,128596.0
ARHGAP12,ENSG00000165322,metabolite measurement,EFO_0004725,0.17609538886687268,1.7609659510311404,1,0.4,0.4,transcript,33161.0
CLASP2,ENSG00000163539,monocyte count,EFO_0005091,0.17609538886687268,1.7609600080580117,1,0.4,0.4,transcript,65366.0
TRAM1,ENSG00000067167,glomerular filtration rate,OBA_0003747,0.17609538886687268,1.7611443875376398,2,0.8,1.6,transcript,8399.0
CCDC126,ENSG00000169193,"Sphingomyelin (d18:2/24:1, d18:1/24:2) measurement",EFO_0022117,0.17609538886687268,1.7609963515137375,1,0.4,0.4,transcript,9420.0
BACH1,ENSG00000156273,hemolytic anemia,EFO_0005558,0.17609538886687268,1.7613117504446159,4,1.6,6.4,transcript,17884.0
CLASP2,ENSG00000163539,body mass index,EFO_0004340,0.17609538886687268,1.7609600080580117,1,0.4,0.4,transcript,65366.0
CCDC126,ENSG00000169193,palmitoyl sphingomyelin (d18:1/16:0) measurement,EFO_0800300,0.17609538886687268,1.7609963515137375,1,0.4,0.4,transcript,9420.0
ATPSCKMT,ENSG00000150756,urinary microalbumin measurement,EFO_0010967,0.17609538886687268,1.761001598592391,1,0.4,0.4,transcript,8384.0
REG1A,ENSG00000115386,placenta praevia,EFO_0007442,0.17609538886687268,1.7610950817502657,1,0.4,0.4,transcript,2833.0
SGCB,ENSG00000163069,insulin-like growth factor-binding protein 7 amount,OBA_2050142,0.17609538886687268,1.7610264839500336,1,0.4,0.4,transcript,5510.0
DMXL1,ENSG00000172869,metabolite measurement,EFO_0004725,0.17609538886687268,1.7609645732855497,1,0.4,0.4,transcript,37437.0
NCKAP1,ENSG00000061676,age at menarche,EFO_0004703,0.17609538886687268,1.7609637178860753,1,0.4,0.4,transcript,40695.0
STT3B,ENSG00000163527,breast benign neoplasm,MONDO_0000620,0.17609538886687268,1.7609736115620753,1,0.4,0.4,transcript,20281.0
ZNF485,ENSG00000198298,circulating fibrinogen levels,OBA_0000061,0.17609538886687268,1.7610512217425054,1,0.5,0.5,transcript,5137.0
LSM11,ENSG00000155858,diastolic blood pressure,EFO_0006336,0.17609538886687268,1.7610147992824012,1,0.4,0.4,transcript,6567.0
CCDC14,ENSG00000175455,cervical carcinoma,EFO_0001061,0.17609538886687268,1.760962554179992,1,0.4,0.4,transcript,46160.0
TMEM144,ENSG00000164124,blood protein measurement,EFO_0007937,0.17609538886687268,1.760970798412967,1,0.4,0.4,transcript,23655.0
LSM11,ENSG00000155858,glucose measurement,EFO_0004468,0.17609538886687268,1.7610147992824012,1,0.4,0.4,transcript,6567.0
TMEM144,ENSG00000164124,bone remodeling disease,MONDO_0000833,0.17609538886687268,1.760970798412967,1,0.4,0.4,transcript,23655.0
TMEM144,ENSG00000164124,pericarditis,EFO_0007427,0.17609538886687268,1.760970798412967,1,0.4,0.4,transcript,23655.0
SLC6A5,ENSG00000165970,Hypercholesterolemia,HP_0003124,0.17609538886687268,1.7609925248128397,1,0.4,0.4,transcript,10353.0
SLC6A5,ENSG00000165970,type 2 diabetes mellitus,MONDO_0005148,0.17609538886687268,1.7609925248128397,1,0.4,0.4,transcript,10353.0
U2SURP,ENSG00000163714,platelet component distribution width,EFO_0007984,0.17608886925526715,1.7609391005423378,2,0.8,1.6,transcript,31741.0
GUF1,ENSG00000151806,response to stimulus,GO_0050896,0.17600343347501712,1.7600762564404537,1,0.5,0.5,transcript,11927.0
GUF1,ENSG00000151806,neutrophil measurement,EFO_0803548,0.17600343347501712,1.7600762564404537,1,0.5,0.5,transcript,11927.0
CLSTN2,ENSG00000158258,alkaline phosphatase measurement,EFO_0004533,0.17599480828704733,1.7599721690991719,1,0.4,0.4,transcript,16607.0
NCS1,ENSG00000107130,eosinophil count,EFO_0004842,0.1759672632219227,1.7597342845003612,1,0.4,0.4,transcript,6488.0
NUP43,ENSG00000120253,erythrocyte volume,OBA_0003460,0.17595077999376935,1.7597099988508744,2,0.8,1.6,transcript,7913.0
HEPHL1,ENSG00000181333,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.17582073367780277,1.7582761954456125,1,0.4,0.4,transcript,5809.0
RBM25,ENSG00000119707,serum gamma-glutamyl transferase measurement,EFO_0004532,0.17582024388481562,1.7582151288008863,1,0.4,0.4,transcript,31521.0
ZNF436,ENSG00000125945,sex hormone-binding globulin measurement,EFO_0004696,0.1757240659239968,1.7572743009556955,1,0.4,0.4,transcript,11890.0
FIGNL1,ENSG00000132436,indoleacetate measurement,EFO_0021015,0.17570660367666688,1.7570822193057092,1,0.4,0.4,transcript,24718.0
ATP5F1A,ENSG00000152234,platelet count,EFO_0004309,0.17569086525631586,1.7569224532807959,1,0.4,0.4,transcript,28984.0
SAXO1,ENSG00000155875,thyroid cancer,MONDO_0002108,0.1756866794240244,1.7568934697987635,1,0.4,0.4,transcript,14995.0
GUF1,ENSG00000151806,type 2 diabetes mellitus,MONDO_0005148,0.17556882286860545,1.755730150376337,1,0.5,0.5,transcript,11927.0
PAGE2,ENSG00000234068,mean corpuscular hemoglobin,EFO_0004527,0.175519619867699,1.755578461673932,1,0.5,0.5,transcript,1308.0
PAGE2,ENSG00000234068,erythrocyte volume,OBA_0003460,0.175519619867699,1.755578461673932,1,0.5,0.5,transcript,1308.0
ADAT2,ENSG00000189007,ascending aorta diameter,OBA_2050001,0.1754702519908738,1.7547323283892506,1,0.4,0.4,transcript,13419.0
SAMD11,ENSG00000187634,Retinal dystrophy,HP_0000556,0.17546473998880302,1.7547102287578957,2,0.8,1.6,transcript,25466.0
LRRIQ3,ENSG00000162620,body mass index,EFO_0004340,0.17542514248838637,1.754278321064606,1,0.5,0.5,transcript,18590.0
GPATCH2L,ENSG00000089916,smoking initiation,EFO_0005670,0.17541938127529505,1.7543362850932813,4,1.6,6.4,transcript,44921.0
SNIP1,ENSG00000163877,neutrophil count,EFO_0004833,0.17540054176508837,1.7540509135562523,1,0.4,0.4,transcript,8792.0
GSTA5,ENSG00000182793,vitamin C measurement,EFO_0600003,0.1753295285310706,1.7536454253667282,1,0.5,0.5,transcript,1428.0
GKAP1,ENSG00000165113,daytime rest measurement,EFO_0007828,0.17522049318813535,1.752262058416629,1,0.4,0.4,transcript,7002.0
RAD21L1,ENSG00000244588,erythrocyte volume,OBA_0003460,0.17521552814857005,1.7522194993125695,1,0.5,0.5,transcript,7786.0
RTF1,ENSG00000137815,cystatin C measurement,EFO_0004617,0.17508926822498752,1.750944401929213,1,0.4,0.4,transcript,7734.0
GID4,ENSG00000141034,schizophrenia,MONDO_0005090,0.17474551310342504,1.7475122412569801,1,0.4,0.4,transcript,7004.0
SAXO1,ENSG00000155875,glucose measurement,EFO_0004468,0.17469486581631283,1.7469753337216476,1,0.4,0.4,transcript,14995.0
ARHGAP12,ENSG00000165322,Hallux valgus,HP_0001822,0.17453585981584835,1.7453706605208972,1,0.4,0.4,transcript,33161.0
DPP8,ENSG00000074603,glomerular filtration rate,OBA_0003747,0.17443530706597754,1.7445347907540427,4,1.6,6.4,transcript,35219.0
OXSR1,ENSG00000172939,hemoglobin A1 measurement,EFO_0007629,0.1743842397765183,1.7438829739469641,1,0.4,0.4,transcript,9858.0
PAGE2,ENSG00000234068,androgenetic alopecia,EFO_0004191,0.1743270070844393,1.7436523338413348,1,0.5,0.5,transcript,1308.0
PAGE2,ENSG00000234068,balding measurement,EFO_0007825,0.1743270070844393,1.7436523338413348,1,0.5,0.5,transcript,1308.0
TRIT1,ENSG00000043514,cerebellar volume measurement,EFO_0020864,0.17430658160882423,1.743081018855146,1,0.4,0.4,transcript,26311.0
MAP4K3,ENSG00000011566,total blood protein measurement,EFO_0004536,0.17430006708206464,1.743023478438391,1,0.4,0.4,transcript,17538.0
GNA13,ENSG00000120063,neoplasm,EFO_0000616,0.17429421585858768,1.7429937648302323,1,0.4,0.4,transcript,7751.0
RGS7BP,ENSG00000186479,triglyceride measurement,EFO_0004530,0.17409239281450048,1.7410120493998515,1,0.5,0.5,transcript,5674.0
CLEC6A,ENSG00000205846,squamous cell lung carcinoma,EFO_0000708,0.17397729847438242,1.7400159981095593,1,0.4,0.4,transcript,1646.0
KERA,ENSG00000139330,blood urea nitrogen measurement,EFO_0004741,0.1739051701388689,1.7397779837309493,2,0.8,1.6,transcript,2203.0
LSM11,ENSG00000155858,major depressive disorder,MONDO_0002009,0.17371234311301867,1.737184341743861,1,0.4,0.4,transcript,6567.0
LSM11,ENSG00000155858,dysthymic disorder,EFO_0008623,0.17371234311301867,1.737184341743861,1,0.4,0.4,transcript,6567.0
ACADSB,ENSG00000196177,urinary microalbumin measurement,EFO_0010967,0.173541438109621,1.7354612030557088,1,0.4,0.4,transcript,8543.0
SLC4A8,ENSG00000050438,spontaneous preterm birth,EFO_0006917,0.17319797843417886,1.732011292189212,2,0.8,1.6,transcript,50781.0
GMCL2,ENSG00000244234,erythrocyte volume,OBA_0003460,0.1731134070239864,1.7312735889004847,1,0.4,0.4,transcript,2867.0
PEX13,ENSG00000162928,peroxisome biogenesis disorder 1A (Zellweger),MONDO_0008953,0.173094778162995,1.7309936111441573,1,0.4,0.4,transcript,8728.0
OTULIN,ENSG00000154124,genetic disorder,EFO_0000508,0.173094778162995,1.730967016098117,1,0.4,0.4,transcript,20796.0
SLCO1C1,ENSG00000139155,IGF-1 measurement,EFO_0004627,0.17283027696763048,1.7283336605696693,1,0.5,0.5,transcript,16186.0
ARPC5,ENSG00000162704,type 1 diabetes mellitus,MONDO_0005147,0.17282068940376072,1.7282336230720208,1,0.4,0.4,transcript,14965.0
ATP5F1A,ENSG00000152234,glomerular filtration rate,OBA_0003747,0.1727911393987246,1.7279251947048833,1,0.4,0.4,transcript,28984.0
CPD,ENSG00000108582,IGF-1 measurement,EFO_0004627,0.1726959810588288,1.7269800289465573,1,0.4,0.4,transcript,19784.0
SLC22A25,ENSG00000196600,pregnanediol-3-glucuronide measurement,EFO_0800341,0.17265158739873215,1.726542467963786,1,0.4,0.4,transcript,15041.0
STAM,ENSG00000136738,clear cell renal carcinoma,EFO_0000349,0.1726292098268522,1.726358093978801,1,0.4,0.4,transcript,6061.0
CCDC62,ENSG00000130783,apolipoprotein A 1 measurement,EFO_0004614,0.17259757680663182,1.7260027040932542,1,0.4,0.4,transcript,14850.0
WDR12,ENSG00000138442,white matter microstructure measurement,EFO_0005674,0.17252797981268458,1.7252997373123302,1,0.4,0.4,transcript,20061.0
RAD18,ENSG00000070950,chronic laryngitis,MONDO_0001369,0.17249574021299896,1.7249908833386611,1,0.4,0.4,transcript,11947.0
RALGPS2,ENSG00000116191,total lipids in large HDL,EFO_0022189,0.17238572920204334,1.7239368267423103,2,0.8,1.6,transcript,20117.0
CMTR2,ENSG00000180917,total cholesterol measurement,EFO_0004574,0.1723208384139473,1.7233118034401,2,0.8,1.6,transcript,15471.0
RPRD2,ENSG00000163125,brain connectivity attribute,OBA_2045295,0.17208998506216383,1.7209183571451878,1,0.4,0.4,transcript,21614.0
C6,ENSG00000039537,head and neck squamous cell carcinoma,EFO_0000181,0.1720879449936897,1.7209090129948998,1,0.5,0.5,transcript,16913.0
ZNF793,ENSG00000188227,hematocrit,EFO_0004348,0.1719581064399616,1.719595388994946,1,0.4,0.4,transcript,27924.0
ALAD,ENSG00000148218,blood lead amount,OBA_2050087,0.17186186500370557,1.7186559599894855,1,0.4,0.4,transcript,10721.0
OR5AN1,ENSG00000176495,prostate carcinoma,EFO_0001663,0.1718306922146043,1.7183360732654462,1,0.5,0.5,transcript,17152.0
IL1A,ENSG00000115008,platelet volume,OBA_0003277,0.1716006217569156,1.7162045318973662,1,0.4,0.4,transcript,2017.0
CNR2,ENSG00000188822,reticulocyte count,EFO_0007986,0.17157080844080594,1.7157840578173662,1,0.4,0.4,transcript,5265.0
FYCO1,ENSG00000163820,triglyceride measurement,EFO_0004530,0.17141615303295565,1.714186141170632,1,0.4,0.4,transcript,16253.0
CAV2,ENSG00000105971,red blood cell density,OBA_2045260,0.17139826569373812,1.7140068305035865,1,0.4,0.4,transcript,16547.0
MCF2L2,ENSG00000053524,urinary microalbumin measurement,EFO_0010967,0.17139079426943044,1.7139493923976798,2,0.8,1.6,transcript,38601.0
TRHDE,ENSG00000072657,small intestine carcinoma,EFO_0005588,0.17127275384354712,1.712827109037251,2,0.8,1.6,transcript,16069.0
RTF1,ENSG00000137815,glomerular filtration rate,OBA_0003747,0.17121542254772204,1.7122059451565583,1,0.4,0.4,transcript,7734.0
CNR2,ENSG00000188822,eosinophil percentage of leukocytes,EFO_0007991,0.17115575032858746,1.7116334766951813,1,0.4,0.4,transcript,5265.0
FIGNL1,ENSG00000132436,psoriasis,EFO_0000676,0.17110847647232616,1.711100947262302,1,0.4,0.4,transcript,24718.0
BCAS2,ENSG00000116752,platelet component distribution width,EFO_0007984,0.17109573627437424,1.7111420349505753,1,0.4,0.4,transcript,2166.0
RASSF2,ENSG00000101265,inflammatory bowel disease,EFO_0003767,0.1710860588612316,1.710961388713116,2,0.8,1.6,transcript,15873.0
ADAT2,ENSG00000189007,Hernia,HP_0100790,0.17101654438708852,1.7101952523513981,1,0.4,0.4,transcript,13419.0
OR5A1,ENSG00000172320,tea consumption measurement,EFO_0010091,0.1709709249919107,1.7097556967374998,1,0.4,0.4,transcript,8612.0
TRIT1,ENSG00000043514,myeloid leukocyte count,OBA_2045223,0.17085045052997902,1.7085197080666938,1,0.4,0.4,transcript,26311.0
ANKRD36B,ENSG00000196912,neuroimaging measurement,EFO_0004346,0.170744283269396,1.7074723713009192,1,0.5,0.5,transcript,16927.0
ZNF436,ENSG00000125945,risk-taking behaviour,EFO_0008579,0.17072870933807544,1.7073207350964816,1,0.4,0.4,transcript,11890.0
CRYGD,ENSG00000118231,pulse wave reflection index measurement,EFO_0009804,0.1706676677712657,1.7072997306721587,1,0.4,0.4,transcript,642.0
CRYGD,ENSG00000118231,response to vaccine,EFO_0004645,0.1706676677712657,1.7072997306721587,1,0.4,0.4,transcript,642.0
CRYGD,ENSG00000118231,lymphocyte count,EFO_0004587,0.1706676677712657,1.7072997306721587,1,0.4,0.4,transcript,642.0
KIAA0232,ENSG00000170871,urinary tract obstruction,EFO_0009571,0.1706676677712657,1.706699966021926,1,0.4,0.4,transcript,17176.0
RPRD2,ENSG00000163125,erythrocyte count,EFO_0004305,0.1706167138994727,1.7061856455182767,1,0.4,0.4,transcript,21614.0
PDHX,ENSG00000110435,cystic fibrosis,MONDO_0009061,0.17049707502930844,1.705015518060292,1,0.4,0.4,transcript,8935.0
ELAPOR1,ENSG00000116299,monocyte count,EFO_0005091,0.17048875709303207,1.7049006642200097,1,0.4,0.4,transcript,30550.0
RTF1,ENSG00000137815,eosinophil percentage of granulocytes,EFO_0007996,0.17044111742015797,1.7044628938809177,1,0.4,0.4,transcript,7734.0
RTF1,ENSG00000137815,erythrocyte count,EFO_0004305,0.17044111742015797,1.7044628938809177,1,0.4,0.4,transcript,7734.0
GMCL1,ENSG00000087338,reticulocyte count,EFO_0007986,0.17036951161728647,1.7039495286390758,2,0.8,1.6,transcript,6289.0
TRHDE,ENSG00000072657,serum alanine aminotransferase measurement,EFO_0004735,0.17034904290196806,1.7035899996214605,2,0.8,1.6,transcript,16069.0
GPR85,ENSG00000164604,fat pad mass,OBA_0004528,0.17033281449229046,1.7033516923415188,1,0.4,0.4,transcript,16987.0
OR2T12,ENSG00000177201,platelet component distribution width,EFO_0007984,0.17012751944505133,1.7037979695030712,6,2.4000000000000004,14.400000000000002,transcript,5708.0
FAM91A1,ENSG00000176853,auditory system disease,EFO_1001455,0.1698909237737343,1.6989396107175398,1,0.5,0.5,transcript,16462.0
FAM171B,ENSG00000144369,inflammatory bowel disease,EFO_0003767,0.1698202646694198,1.6982724425413451,1,0.4,0.4,transcript,5731.0
RNMT,ENSG00000101654,clear cell renal carcinoma,EFO_0000349,0.1697444337388966,1.697460759098466,1,0.4,0.4,transcript,24358.0
TAF2,ENSG00000064313,clear cell renal carcinoma,EFO_0000349,0.1697444337388966,1.69744713037299,1,0.5,0.5,transcript,179020.0
IPP,ENSG00000197429,neuroimaging measurement,EFO_0004346,0.16967417299796414,1.6968225054239063,1,0.5,0.5,transcript,6190.0
OR2M7,ENSG00000177186,systolic blood pressure,EFO_0006335,0.16961036413691977,1.6966361227323499,1,0.5,0.5,transcript,939.0
MC2R,ENSG00000185231,breast adenocarcinoma,EFO_0000304,0.169585121374993,1.6959458211293055,1,0.4,0.4,transcript,4228.0
KLRD1,ENSG00000134539,blood protein measurement,EFO_0007937,0.16957823350876708,1.6959468246861227,4,1.7000000000000002,6.800000000000001,transcript,41340.0
PCMTD1,ENSG00000168300,monocyte count,EFO_0005091,0.16957776566929642,1.695982504763978,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
SLC7A2,ENSG00000003989,glycine measurement,EFO_0009767,0.16955038825588029,1.6956248781799137,3,1.4,4.199999999999999,transcript,34712.0
RAD18,ENSG00000070950,high density lipoprotein cholesterol measurement,EFO_0004612,0.16945020732251212,1.6945355544337928,1,0.4,0.4,transcript,11947.0
SLC22A25,ENSG00000196600,epiandrosterone sulfate measurement,EFO_0021120,0.1694126312407871,1.6941529063843352,1,0.4,0.4,transcript,15041.0
IQCB1,ENSG00000173226,systemic lupus erythematosus,MONDO_0007915,0.16938424109258915,1.6938840299041458,1,0.4,0.4,transcript,9611.0
SAXO1,ENSG00000155875,thyroid neoplasm,EFO_0003841,0.1693716379690023,1.6937430552485422,1,0.4,0.4,transcript,14995.0
SAXO1,ENSG00000155875,papillary thyroid carcinoma,EFO_0000641,0.1693716379690023,1.6937430552485422,1,0.4,0.4,transcript,14995.0
APIP,ENSG00000149089,pyruvate dehydrogenase E3-binding protein deficiency,MONDO_0009503,0.16935774250846952,1.6936501946961056,1,0.5,0.5,transcript,6871.0
CNOT6L,ENSG00000138767,blood urea nitrogen measurement,EFO_0004741,0.1691901421761962,1.6920313106348153,3,1.2000000000000002,3.6000000000000005,transcript,27716.0
AGPAT5,ENSG00000155189,Hypercalcemia,HP_0003072,0.1690230524066981,1.6902678967662244,1,0.4,0.4,transcript,10703.0
IPP,ENSG00000197429,brain attribute,OBA_2045210,0.16886996049213238,1.6887803803655888,1,0.5,0.5,transcript,6190.0
ANKRD36,ENSG00000135976,diastolic blood pressure,EFO_0006336,0.16883468046394356,1.6884221909945054,2,1.0,2.0,transcript,26530.0
SULT6B1,ENSG00000138068,protein measurement,EFO_0004747,0.16878856664778127,1.687998763062296,1,0.5,0.5,transcript,4421.0
ATP5F1A,ENSG00000152234,serum creatinine amount,OBA_2050096,0.16862520134641412,1.6862658141817786,1,0.4,0.4,transcript,28984.0
TMPRSS4,ENSG00000137648,triglyceride measurement,EFO_0004530,0.1685387357807829,1.6853976894536602,1,0.4,0.4,transcript,38716.0
FAM186A,ENSG00000185958,platelet count,EFO_0004309,0.16850072816318332,1.6851181832620872,2,1.0,2.0,transcript,18034.0
FAM186A,ENSG00000185958,platelet crit,EFO_0007985,0.16850072816318332,1.6851181832620872,2,1.0,2.0,transcript,18034.0
FBXO22,ENSG00000167196,cystatin B measurement,EFO_0010593,0.1684562198839319,1.6845833976309879,1,0.4,0.4,transcript,18869.0
LNPEP,ENSG00000113441,lymphocyte count,EFO_0004587,0.16842999305009038,1.684320592725192,1,0.4,0.4,transcript,19359.0
PIAS2,ENSG00000078043,glomerular filtration rate,OBA_0003747,0.1683521620850885,1.6835350108686267,1,0.4,0.4,transcript,29873.0
CLASP2,ENSG00000163539,body height,OBA_VT0001253,0.168292764310366,1.6829337624929448,1,0.4,0.4,transcript,65366.0
FBXO42,ENSG00000037637,muscular disease,EFO_0002970,0.1682683067107283,1.6827186384723338,1,0.4,0.4,transcript,11245.0
PCMTD1,ENSG00000168300,cortical thickness,EFO_0004840,0.1680684065082595,1.6808889131536089,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
SLFN11,ENSG00000172716,body mass index,EFO_0004340,0.16803565512412974,1.6803744012122912,1,0.4,0.4,transcript,22409.0
RBM23,ENSG00000100461,self reported educational attainment,EFO_0004784,0.16785384129355255,1.678548271708601,1,0.4,0.4,transcript,40573.0
LIMA1,ENSG00000050405,Red cell distribution width,EFO_0009188,0.1677652799914104,1.677666204290633,1,0.4,0.4,transcript,29841.0
UNC80,ENSG00000144406,brain connectivity attribute,OBA_2045295,0.16773248665109858,1.6773295285156478,1,0.4,0.4,transcript,85800.0
CAVIN2,ENSG00000168497,cervical carcinoma,EFO_0001061,0.16773248665109858,1.6774558422804684,1,0.4,0.4,transcript,3054.0
LYPD6,ENSG00000187123,bone tissue density,OBA_1000110,0.16773248665109858,1.677357615815063,1,0.4,0.4,transcript,12214.0
RGS7BP,ENSG00000186479,preeclampsia,EFO_0000668,0.16773248665109858,1.6774129877658324,1,0.5,0.5,transcript,5674.0
FBXO42,ENSG00000037637,brain attribute,OBA_2045210,0.1676193189850325,1.676228761215376,1,0.4,0.4,transcript,11245.0
SH3GL3,ENSG00000140600,head and neck squamous cell carcinoma,EFO_0000181,0.167546372252885,1.675515415472763,1,0.4,0.4,transcript,7738.0
RCN2,ENSG00000117906,isobutyrylcarnitine measurement,EFO_0021023,0.16747581257681657,1.6747854407094385,1,0.4,0.4,transcript,14644.0
UNC80,ENSG00000144406,arterial stiffness measurement,EFO_0004517,0.16745181286957916,1.6745227907004538,1,0.4,0.4,transcript,85800.0
RGS7BP,ENSG00000186479,fungal infectious disease,MONDO_0002041,0.16745181286957916,1.6746062499506384,1,0.5,0.5,transcript,5674.0
CAVIN2,ENSG00000168497,risk-taking behaviour,EFO_0008579,0.16745181286957916,1.6746491044652745,1,0.4,0.4,transcript,3054.0
DBR1,ENSG00000138231,brain volume,OBA_2050009,0.16744016581638219,1.6744200896447914,1,0.4,0.4,transcript,21702.0
BTAF1,ENSG00000095564,monocyte count,EFO_0005091,0.1673988690616497,1.6740254350589,1,0.4,0.4,transcript,10886.0
PEX13,ENSG00000162928,dermatitis,MONDO_0002406,0.16736970487684266,1.6737428782826338,1,0.4,0.4,transcript,8728.0
PEX13,ENSG00000162928,Eczematoid dermatitis,HP_0000964,0.16736970487684266,1.6737428782826338,1,0.4,0.4,transcript,8728.0
ITPRID2,ENSG00000138434,muscular dystrophy,MONDO_0020121,0.1673456109392027,1.6734648969312962,1,0.4,0.4,transcript,45519.0
UBE2U,ENSG00000177414,duodenitis,MONDO_0004627,0.16721678545502075,1.6722350701442252,1,0.4,0.4,transcript,5951.0
TRIT1,ENSG00000043514,body mass index,EFO_0004340,0.16716462578249994,1.671661460591903,1,0.4,0.4,transcript,26311.0
GUF1,ENSG00000151806,obesity,EFO_0001073,0.16706164306443919,1.6706583523346743,1,0.5,0.5,transcript,11927.0
OTULIN,ENSG00000154124,type 2 diabetes mellitus,MONDO_0005148,0.16697522929037006,1.6697715273718676,1,0.4,0.4,transcript,20796.0
MANSC4,ENSG00000205693,diastolic blood pressure change measurement,EFO_0006945,0.16693571156375003,1.6696570556494978,1,0.5,0.5,transcript,1667.0
SRGN,ENSG00000122862,connective tissue disease,EFO_1001986,0.16688933110242699,1.669016691653511,1,0.4,0.4,transcript,3242.0
IKBIP,ENSG00000166130,cervical carcinoma,EFO_0001061,0.16688648774158535,1.6691353761478906,2,0.8,1.6,transcript,5915.0
AKR1B10,ENSG00000198074,head and neck squamous cell carcinoma,EFO_0000181,0.16685827936679642,1.6687149289745182,1,0.5,0.5,transcript,3784.0
RNF150,ENSG00000170153,urinary microalbumin measurement,EFO_0010967,0.16683667335434826,1.6686253925581536,4,1.6,6.4,transcript,24743.0
PFAS,ENSG00000178921,high density lipoprotein cholesterol measurement,EFO_0004612,0.16674464221402807,1.6674697484757135,1,0.4,0.4,transcript,17148.0
CD163L1,ENSG00000177675,brain aneurysm,EFO_0003870,0.16673652150721224,1.6673950903428671,1,0.4,0.4,transcript,13389.0
PKHD1L1,ENSG00000205038,tooth disease,EFO_1001216,0.16665358238666364,1.6665518700797302,1,0.4,0.4,transcript,24928.0
RPS20,ENSG00000008988,blood urea nitrogen measurement,EFO_0004741,0.16657877015686937,1.6658049110511186,1,0.4,0.4,transcript,23243.0
RBM23,ENSG00000100461,educational attainment,EFO_0011015,0.16656007535633877,1.6656106123364633,1,0.4,0.4,transcript,40573.0
DCLK1,ENSG00000133083,balding measurement,EFO_0007825,0.16655603155804313,1.665610513233691,2,0.8,1.6,transcript,31874.0
SLC4A8,ENSG00000050438,erythrocyte volume,OBA_0003460,0.1665030462392119,1.6650619702395422,2,0.8,1.6,transcript,50781.0
DPP8,ENSG00000074603,red blood cell density,OBA_2045260,0.16642874318756767,1.6644691519699442,4,1.6,6.4,transcript,35219.0
OR5AN1,ENSG00000176495,lymphocyte count,EFO_0004587,0.16618771978298644,1.6619063489492674,1,0.5,0.5,transcript,17152.0
ITPRID2,ENSG00000138434,neuromuscular disease,EFO_1001902,0.16607663161466946,1.660775103685964,1,0.4,0.4,transcript,45519.0
GSTA5,ENSG00000182793,cystatin C measurement,EFO_0004617,0.1660089971345046,1.6604401114010683,1,0.5,0.5,transcript,1428.0
TMEM225,ENSG00000204300,Jaundice,HP_0000952,0.1657954897018408,1.65817711924063,1,0.4,0.4,transcript,1800.0
RPAP3,ENSG00000005175,HbA1c measurement,EFO_0004541,0.16576874737923714,1.6578358417448935,2,0.8,1.6,transcript,10784.0
RPRD2,ENSG00000163125,platelet count,EFO_0004309,0.16572804915122563,1.657298998035806,1,0.4,0.4,transcript,21614.0
WBP2NL,ENSG00000183066,metoprolol measurement,EFO_0801179,0.16571335025158526,1.6571756574774916,1,0.5,0.5,transcript,11861.0
PKHD1L1,ENSG00000205038,grip strength measurement,EFO_0006941,0.16563670382840176,1.6563830844971115,1,0.4,0.4,transcript,24928.0
TMTC3,ENSG00000139324,high density lipoprotein cholesterol measurement,EFO_0004612,0.16559988839476408,1.656037893114795,1,0.4,0.4,transcript,10254.0
TMEM144,ENSG00000164124,complication,EFO_0009518,0.1654264801142941,1.654281710887181,1,0.4,0.4,transcript,23655.0
ZNF501,ENSG00000186446,diastolic blood pressure change measurement,EFO_0006945,0.1654014561826212,1.654081460407962,1,0.5,0.5,transcript,7474.0
LIMA1,ENSG00000050405,Abnormality of the skeletal system,HP_0000924,0.16539954961768216,1.6540089005533505,1,0.4,0.4,transcript,29841.0
YBX3,ENSG00000060138,age at menopause,EFO_0004704,0.16531232154405834,1.6531436695211725,1,0.4,0.4,transcript,19556.0
RBM23,ENSG00000100461,blood sodium bicarbonate amount,OBA_2050094,0.16517732394850704,1.651783098258146,1,0.4,0.4,transcript,40573.0
HECW2,ENSG00000138411,heel bone mineral density,EFO_0009270,0.16515341218087118,1.6515399379601645,1,0.4,0.4,transcript,68774.0
PEX13,ENSG00000162928,gastrointestinal disease,EFO_0010282,0.1651350466787641,1.6513962963018483,1,0.4,0.4,transcript,8728.0
FBXO22,ENSG00000167196,hemoglobin measurement,EFO_0004509,0.16492898554902127,1.6493110542818816,1,0.4,0.4,transcript,18869.0
CCDC80,ENSG00000091986,cervical carcinoma,EFO_0001061,0.16479607889786124,1.6480399968994046,2,0.8,1.6,transcript,20200.0
MYLK3,ENSG00000140795,high density lipoprotein cholesterol measurement,EFO_0004612,0.1647453032823855,1.6474799634102688,1,0.4,0.4,transcript,14853.0
HEG1,ENSG00000173706,visceral adipose tissue quantity,OBA_2045224,0.1647181354176335,1.647203220463986,1,0.4,0.4,transcript,18293.0
GUF1,ENSG00000151806,erythrocyte volume,OBA_0003460,0.1646841838638118,1.6468837603284006,1,0.5,0.5,transcript,11927.0
RBM23,ENSG00000100461,mathematical ability,EFO_0004875,0.16466730673016808,1.6466829260747564,1,0.4,0.4,transcript,40573.0
FAM114A1,ENSG00000197712,lymphocyte percentage of leukocytes,EFO_0007993,0.1644778689017212,1.6448273685839638,1,0.4,0.4,transcript,8217.0
DPP8,ENSG00000074603,monocyte percentage of leukocytes,EFO_0007989,0.16447584082871178,1.6449401283813851,4,1.6,6.4,transcript,35219.0
LINS1,ENSG00000140471,chronotype measurement,EFO_0008328,0.16439447766725462,1.6439720647803888,1,0.5,0.5,transcript,18323.0
GNA13,ENSG00000120063,oral cavity carcinoma,MONDO_0044925,0.16438911936375533,1.643942799881909,1,0.4,0.4,transcript,7751.0
SKIL,ENSG00000136603,purine measurement,EFO_0010526,0.16434272023873864,1.6434436622089619,1,0.5,0.5,transcript,30377.0
PF4V1,ENSG00000109272,head and neck squamous cell carcinoma,EFO_0000181,0.16428148016718433,1.6433531596799187,1,0.4,0.4,transcript,743.0
CAV2,ENSG00000105971,Paroxysmal supraventricular tachycardia,HP_0004763,0.16427812872640088,1.6428054608302143,1,0.4,0.4,transcript,16547.0
SELENOI,ENSG00000138018,total cholesterol measurement,EFO_0004574,0.1641908541813929,1.6419501305018058,1,0.4,0.4,transcript,9618.0
BACH1,ENSG00000156273,heart failure,EFO_0003144,0.16417591156110856,1.6421169773869746,4,1.6,6.4,transcript,17884.0
OTOGL,ENSG00000165899,Churg-Strauss syndrome,EFO_0007208,0.1640986602981463,1.641001460939385,1,0.5,0.5,transcript,33652.0
TRMT6,ENSG00000089195,age at menopause,EFO_0004704,0.16402030451841706,1.6402365263928422,1,0.4,0.4,transcript,11947.0
OTULINL,ENSG00000145569,deep vein thrombosis,EFO_0003907,0.16398022687130898,1.6398522437255836,1,0.4,0.4,transcript,8004.0
CCDC77,ENSG00000120647,type 2 diabetes mellitus,MONDO_0005148,0.16380336369265375,1.6380620016974918,1,0.4,0.4,transcript,14102.0
CNR2,ENSG00000188822,thyroid gland adenocarcinoma,MONDO_0024622,0.16362667648479184,1.636342738257225,1,0.4,0.4,transcript,5265.0
TRMT9B,ENSG00000250305,lung cancer,MONDO_0008903,0.1635750501124777,1.6358916277859554,3,1.2000000000000002,3.6000000000000005,transcript,25509.0
BCAS2,ENSG00000116752,platelet count,EFO_0004309,0.16354067193081936,1.6355913915150264,1,0.4,0.4,transcript,2166.0
RNMT,ENSG00000101654,erythrocyte count,EFO_0004305,0.1635287025192625,1.6353034469021248,1,0.4,0.4,transcript,24358.0
SLFN11,ENSG00000172716,ovarian neoplasm,EFO_0003893,0.1633933696045253,1.6339515460162468,1,0.4,0.4,transcript,22409.0
NAA30,ENSG00000139977,basophil percentage of leukocytes,EFO_0007992,0.1633880690664708,1.6339104459276703,1,0.4,0.4,transcript,13443.0
STT3B,ENSG00000163527,adolescent idiopathic scoliosis,EFO_0005423,0.16338688316372124,1.633888554530561,1,0.4,0.4,transcript,20281.0
STT3B,ENSG00000163527,facial pain,EFO_0009625,0.16338688316372124,1.633888554530561,1,0.4,0.4,transcript,20281.0
OTUD7A,ENSG00000169918,diastolic blood pressure change measurement,EFO_0006945,0.16338300849005669,1.6338478114682602,1,0.4,0.4,transcript,22565.0
FIGLA,ENSG00000183733,diabetes mellitus,EFO_0000400,0.16337436432728358,1.634436164048459,1,0.5,0.5,transcript,722.0
CENPQ,ENSG00000031691,homocysteine measurement,EFO_0004578,0.16333979830019352,1.6336277360174436,1,0.4,0.4,transcript,1741.0
PLCXD2,ENSG00000240891,peak expiratory flow,EFO_0009718,0.16326937042951797,1.6327247240702862,1,0.4,0.4,transcript,12895.0
GAN,ENSG00000261609,Charcot-Marie-Tooth disease,MONDO_0015626,0.16296931675534163,1.6297038316606973,1,0.4,0.4,transcript,37509.0
MRPL32,ENSG00000106591,Iron deficiency anemia,HP_0001891,0.1626656603631678,1.626739746429433,1,0.4,0.4,transcript,4811.0
ZPLD1,ENSG00000170044,metabolite measurement,EFO_0004725,0.1626656603631678,1.6268155861436016,2,0.8,1.6,transcript,10064.0
MRPL32,ENSG00000106591,waist-hip ratio,EFO_0004343,0.1626656603631678,1.626739746429433,1,0.4,0.4,transcript,4811.0
MRPL32,ENSG00000106591,arterial stiffness measurement,EFO_0004517,0.1626656603631678,1.626739746429433,1,0.4,0.4,transcript,4811.0
ATPSCKMT,ENSG00000150756,metabolite measurement,EFO_0004725,0.1626477786053137,1.6265254959768014,1,0.4,0.4,transcript,8384.0
IYD,ENSG00000009765,cutaneous melanoma,EFO_0000389,0.1625573879279684,1.6255912826907524,1,0.4,0.4,transcript,22984.0
OR2M7,ENSG00000177186,multiple myeloma,EFO_0001378,0.16249225293935654,1.6254550107567176,1,0.5,0.5,transcript,939.0
OR5AN1,ENSG00000176495,multiple myeloma,EFO_0001378,0.16249225293935654,1.6249516805129685,1,0.5,0.5,transcript,17152.0
TLK1,ENSG00000198586,sitting height measurement,EFO_0011011,0.16244245665835957,1.624438461744606,1,0.4,0.4,transcript,28787.0
C15orf61,ENSG00000189227,lymphocyte count,EFO_0004587,0.16236835144499273,1.625305048421064,5,2.0,10.0,transcript,6167.0
ZNF436,ENSG00000125945,high density lipoprotein cholesterol measurement,EFO_0004612,0.16234470890381686,1.6234807307538959,1,0.4,0.4,transcript,11890.0
OTOGL,ENSG00000165899,Meniere disease,EFO_0006862,0.1622763545278078,1.6227784032360004,1,0.5,0.5,transcript,33652.0
RALGPS2,ENSG00000116191,phospholipids in large HDL measurement,EFO_0022190,0.16217679315756395,1.6218474662975164,2,0.8,1.6,transcript,20117.0
RBM25,ENSG00000119707,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.16210821457260732,1.6210948356788033,1,0.4,0.4,transcript,31521.0
SLC36A4,ENSG00000180773,intestinal disaccharide deficiency and disaccharide malabsorption,EFO_1000060,0.16203715562315787,1.620482091637451,2,0.8,1.6,transcript,14475.0
ATG16L1,ENSG00000085978,reticulocyte measurement,EFO_0010700,0.16136240073252708,1.6136359988113156,1,0.4,0.4,transcript,33357.0
TRIT1,ENSG00000043514,hemoglobin measurement,EFO_0004509,0.1612708807343582,1.6127240101104854,1,0.4,0.4,transcript,26311.0
PDCD4,ENSG00000150593,lymphocyte measurement,EFO_0803546,0.16126145428464486,1.6126495544002615,1,0.5,0.5,transcript,14281.0
RALGPS2,ENSG00000116191,breast disease,EFO_0009483,0.1611968562684409,1.612048097406286,2,0.8,1.6,transcript,20117.0
METTL8,ENSG00000123600,genetic disorder,EFO_0000508,0.1609725589293368,1.6097376103301824,1,0.4,0.4,transcript,33275.0
WDR59,ENSG00000103091,adolescent idiopathic scoliosis,EFO_0005423,0.16096266741398568,1.6097003287916085,2,0.8,1.6,transcript,21723.0
HNRNPA0,ENSG00000177733,hematocrit,EFO_0004348,0.16083144846366176,1.6083374388429759,1,0.4,0.4,transcript,17426.0
GABPA,ENSG00000154727,open-angle glaucoma,EFO_0004190,0.16074563388059263,1.6074922906304814,1,0.4,0.4,transcript,11126.0
RBM23,ENSG00000100461,glomerular filtration rate,OBA_0003747,0.1606556456162691,1.6065663149357667,1,0.4,0.4,transcript,40573.0
DPP8,ENSG00000074603,monocyte count,EFO_0005091,0.16060098195422123,1.6061915396364796,4,1.6,6.4,transcript,35219.0
LIN9,ENSG00000183814,endometrial cancer,MONDO_0011962,0.1605400958456407,1.6055057939956547,2,0.8,1.6,transcript,15262.0
TMEM144,ENSG00000164124,medical procedure,EFO_0002571,0.16037864158402987,1.6038033255845388,1,0.4,0.4,transcript,23655.0
SAXO1,ENSG00000155875,pulse wave reflection index measurement,EFO_0009804,0.16037864158402987,1.603813091398818,1,0.4,0.4,transcript,14995.0
TMEM144,ENSG00000164124,trauma complication,EFO_0009888,0.16037864158402987,1.6038033255845388,1,0.4,0.4,transcript,23655.0
SAXO1,ENSG00000155875,mouth neoplasm,EFO_0003868,0.16037864158402987,1.603813091398818,1,0.4,0.4,transcript,14995.0
OR2M7,ENSG00000177186,sensory perception of smell,GO_0007608,0.1603701894432455,1.604234375795607,1,0.5,0.5,transcript,939.0
LIMA1,ENSG00000050405,mean corpuscular hemoglobin concentration,EFO_0004528,0.16018377887114196,1.6018511930879487,1,0.4,0.4,transcript,29841.0
TC2N,ENSG00000165929,protein measurement,EFO_0004747,0.16008168952875065,1.6008396600703876,1,0.4,0.4,transcript,17571.0
NUP43,ENSG00000120253,ventral diencephalon volume,OBA_2045253,0.15994551673294088,1.5996573662425897,2,0.8,1.6,transcript,7913.0
AGA,ENSG00000038002,phospholipids:total lipids ratio,EFO_0020946,0.15977480054759377,1.5978459870554007,1,0.5,0.5,transcript,5103.0
SELENOI,ENSG00000138018,total cholesterol in medium VLDL,EFO_0022162,0.15958990495655287,1.5959406382534056,1,0.4,0.4,transcript,9618.0
SELENOI,ENSG00000138018,phospholipids in VLDL measurement ,EFO_0022301,0.15958990495655287,1.5959406382534056,1,0.4,0.4,transcript,9618.0
FBXO45,ENSG00000174013,prostate specific antigen amount,OBA_2050200,0.15953216545723475,1.5954880439234291,2,0.8,1.6,transcript,9616.0
MRPL32,ENSG00000106591,bone tissue density,OBA_1000110,0.15947073805749198,1.5947905233726751,1,0.4,0.4,transcript,4811.0
SLFN11,ENSG00000172716,nervous system cancer,EFO_0007392,0.15945768327948606,1.5945946827658544,1,0.4,0.4,transcript,22409.0
SYNJ2,ENSG00000078269,ocular hypotension,MONDO_0004390,0.1594377176245858,1.5944283238706902,2,0.8,1.6,transcript,31282.0
AP1S2,ENSG00000182287,ovarian carcinoma,EFO_0001075,0.15935174594440285,1.5935382689331554,1,0.4,0.4,transcript,19222.0
SGCB,ENSG00000163069,HbA1c measurement,EFO_0004541,0.15934849606722878,1.5935575559535946,1,0.4,0.4,transcript,5510.0
LY75-CD302,ENSG00000248672,neutrophil percentage of leukocytes,EFO_0007990,0.15912524922349644,1.591297407793714,1,0.5,0.5,transcript,11132.0
OR5AN1,ENSG00000176495,erythrocyte volume,OBA_0003460,0.15901679359134507,1.590197087032854,1,0.5,0.5,transcript,17152.0
CPB1,ENSG00000153002,pancreatic adenocarcinoma,EFO_1000044,0.15893841462854563,1.5894297251368692,1,0.5,0.5,transcript,10970.0
DYNLT5,ENSG00000152760,bone tissue density,OBA_1000110,0.15885604390084643,1.5886306021377399,1,0.4,0.4,transcript,5701.0
SAXO1,ENSG00000155875,gestational diabetes,EFO_0004593,0.1587343609448815,1.5873702850073343,1,0.4,0.4,transcript,14995.0
UNC80,ENSG00000144406,breast adenocarcinoma,EFO_0000304,0.15873037672685125,1.5873084292731747,1,0.4,0.4,transcript,85800.0
ANO6,ENSG00000177119,breast adenocarcinoma,EFO_0000304,0.15873037672685125,1.587311188418791,1,0.4,0.4,transcript,53900.0
C15orf61,ENSG00000189227,body fat percentage,EFO_0007800,0.15854917672942595,1.5871133012653962,5,2.0,10.0,transcript,6167.0
UNC80,ENSG00000144406,anxiety,EFO_0005230,0.15852683939834553,1.5852730559881174,1,0.4,0.4,transcript,85800.0
GUF1,ENSG00000151806,body fat percentage,EFO_0007800,0.15850153143231208,1.5850572360134032,1,0.5,0.5,transcript,11927.0
PARD6B,ENSG00000124171,glioblastoma multiforme,EFO_0000519,0.1584675098715918,1.5847535147127814,1,0.4,0.4,transcript,5101.0
ASMT,ENSG00000196433,cutaneous melanoma,EFO_0000389,0.15844850449850498,1.5845997765132738,1,0.5,0.5,transcript,4358.0
ATP5F1A,ENSG00000152234,urate measurement,EFO_0004531,0.15842648448506938,1.584278645568331,1,0.4,0.4,transcript,28984.0
FSIP2,ENSG00000188738,protein measurement,EFO_0004747,0.1583255401420811,1.583534341448705,4,2.0,8.0,transcript,28680.0
DPP8,ENSG00000074603,mean corpuscular hemoglobin,EFO_0004527,0.15825520976461688,1.582733817740436,4,1.6,6.4,transcript,35219.0
LNPEP,ENSG00000113441,juvenile idiopathic arthritis,EFO_0002609,0.15820339762211003,1.5820546384453886,1,0.4,0.4,transcript,19359.0
HACD4,ENSG00000188921,erythrocyte count,EFO_0004305,0.1581429569739623,1.5814721093546396,1,0.4,0.4,transcript,9403.0
ARHGAP20,ENSG00000137727,N-acetylalanine measurement,EFO_0800118,0.1580723373699124,1.5807336182887004,1,0.4,0.4,transcript,39045.0
METTL2B,ENSG00000165055,2-hydroxydecanoate measurement,EFO_0800347,0.15801627938055998,1.5802654171139188,2,0.8,1.6,transcript,15591.0
OXSR1,ENSG00000172939,mean reticulocyte volume,EFO_0010701,0.15799904417885,1.5800310179702812,1,0.4,0.4,transcript,9858.0
SPRY3,ENSG00000168939,erythrocyte count,EFO_0004305,0.15793916454018622,1.579409222411134,1,0.4,0.4,transcript,22757.0
SPRY3,ENSG00000168939,hematocrit,EFO_0004348,0.15793916454018622,1.579409222411134,1,0.4,0.4,transcript,22757.0
SPRY3,ENSG00000168939,erythrocyte volume,OBA_0003460,0.15793916454018622,1.579409222411134,1,0.4,0.4,transcript,22757.0
SPRY3,ENSG00000168939,hemoglobin measurement,EFO_0004509,0.15793916454018622,1.579409222411134,1,0.4,0.4,transcript,22757.0
SPRY3,ENSG00000168939,mean corpuscular hemoglobin,EFO_0004527,0.15793916454018622,1.579409222411134,1,0.4,0.4,transcript,22757.0
MTR,ENSG00000116984,glioblastoma multiforme,EFO_0000519,0.15793189411042946,1.5793233535341096,1,0.4,0.4,transcript,90653.0
PFAS,ENSG00000178921,cervical carcinoma,EFO_0001061,0.15764829000491995,1.5765062263846323,1,0.4,0.4,transcript,17148.0
SUMF1,ENSG00000144455,erythrocyte count,EFO_0004305,0.1576432435036058,1.576464784409289,1,0.4,0.4,transcript,12365.0
GSTA5,ENSG00000182793,cystatin B measurement,EFO_0010593,0.15733550515404743,1.5737051915964968,1,0.5,0.5,transcript,1428.0
IKBIP,ENSG00000166130,alcohol consumption quality,OBA_1000840,0.15716857100405693,1.5719562087726064,2,0.8,1.6,transcript,5915.0
SELENOI,ENSG00000138018,HbA1c measurement,EFO_0004541,0.15716821083432073,1.5717236970310842,1,0.4,0.4,transcript,9618.0
ZNF347,ENSG00000197937,urinary microalbumin measurement,EFO_0010967,0.15712212412356838,1.5712489851042888,1,0.5,0.5,transcript,18022.0
NUP153,ENSG00000124789,aspartate aminotransferase measurement,EFO_0004736,0.1571011686704376,1.571039671256903,1,0.5,0.5,transcript,17867.0
GPR85,ENSG00000164604,eosinophil count,EFO_0004842,0.15699592469351603,1.5699827943537745,1,0.4,0.4,transcript,16987.0
RBM25,ENSG00000119707,reticulocyte count,EFO_0007986,0.15698675596625175,1.5698802496152475,1,0.4,0.4,transcript,31521.0
ZNF398,ENSG00000197024,brain volume,OBA_2050009,0.1568339311250432,1.56836480519562,1,0.4,0.4,transcript,15690.0
PKD2L2,ENSG00000078795,hematocrit,EFO_0004348,0.15674010978604933,1.5674404741402224,1,0.5,0.5,transcript,12698.0
TC2N,ENSG00000165929,phosphate measurement,EFO_0010968,0.15672037035902375,1.5672264683731185,1,0.4,0.4,transcript,17571.0
NPS,ENSG00000214285,benign chondrogenic neoplasm,MONDO_0024470,0.156703598265296,1.5673609217268838,1,0.4,0.4,transcript,1231.0
NPS,ENSG00000214285,erythrocyte volume,OBA_0003460,0.156703598265296,1.5673609217268838,1,0.4,0.4,transcript,1231.0
HIPK3,ENSG00000110422,neuroinflammatory disorder,EFO_0020092,0.1566724275708985,1.5667391092030145,1,0.4,0.4,transcript,26966.0
NUP43,ENSG00000120253,subiculum volume,OBA_2050024,0.15662286663454353,1.566430865258616,2,0.8,1.6,transcript,7913.0
STT3B,ENSG00000163527,protein measurement,EFO_0004747,0.15661501501198424,1.566169873013191,1,0.4,0.4,transcript,20281.0
NSUN7,ENSG00000179299,neuroimaging measurement,EFO_0004346,0.15655686926428672,1.5656077216023552,1,0.5,0.5,transcript,12811.0
MCF2L2,ENSG00000053524,body mass index,EFO_0004340,0.15654324507056358,1.5654739004090115,2,0.8,1.6,transcript,38601.0
FAM210A,ENSG00000177150,fat pad mass,OBA_0004528,0.15630577439312116,1.5630798898729676,1,0.4,0.4,transcript,18062.0
GNA13,ENSG00000120063,corpus callosum volume,OBA_2045249,0.15630186759319126,1.5630702821762683,1,0.4,0.4,transcript,7751.0
GNA13,ENSG00000120063,brain volume,OBA_2050009,0.15630186759319126,1.5630702821762683,1,0.4,0.4,transcript,7751.0
GNA13,ENSG00000120063,corpus callosum central volume,OBA_2045248,0.15630186759319126,1.5630702821762683,1,0.4,0.4,transcript,7751.0
CYTIP,ENSG00000115165,inflammatory bowel disease,EFO_0003767,0.15627510297791788,1.5627788172053685,1,0.4,0.4,gene_variant,14395.0
DCAF4L1,ENSG00000182308,diet measurement,EFO_0008111,0.15617738638720208,1.561858789562042,1,0.4,0.4,transcript,4710.0
MTMR6,ENSG00000139505,melanoma,EFO_0000756,0.15614748860428648,1.56152851109649,1,0.5,0.5,transcript,9324.0
CLEC6A,ENSG00000205846,breast adenocarcinoma,EFO_0000304,0.15614406495401892,1.5616836629059243,1,0.4,0.4,transcript,1646.0
IKBIP,ENSG00000166130,high density lipoprotein cholesterol measurement,EFO_0004612,0.15607514092367006,1.5610219079687377,2,0.8,1.6,transcript,5915.0
GUF1,ENSG00000151806,fat pad mass,OBA_0004528,0.1560751219283324,1.5607931409736064,1,0.5,0.5,transcript,11927.0
LAIR1,ENSG00000167613,inflammatory bowel disease,EFO_0003767,0.15592574069147566,1.5592730588164627,1,0.4,0.4,transcript,25556.0
GANC,ENSG00000214013,histidine measurement,EFO_0009769,0.155904295107303,1.5590722250777138,1,0.5,0.5,transcript,17080.0
AKR1C1,ENSG00000187134,testosterone measurement,EFO_0004908,0.15589723884799728,1.559111579432561,2,0.8,1.6,transcript,11495.0
GUF1,ENSG00000151806,lean body mass,EFO_0004995,0.15556985305465534,1.5557404522368359,1,0.5,0.5,transcript,11927.0
AGA,ENSG00000038002,pulse wave reflection index measurement,EFO_0009804,0.15550557462333814,1.5551537278128444,1,0.5,0.5,transcript,5103.0
IQCB1,ENSG00000173226,monocyte count,EFO_0005091,0.1554490804491817,1.5545324234700713,1,0.4,0.4,transcript,9611.0
LRPAP1,ENSG00000163956,triglycerides in LDL measurement ,EFO_0022320,0.15540013155764212,1.5542319517478607,3,1.2000000000000002,3.6000000000000005,transcript,15609.0
RBM44,ENSG00000177483,Self-injurious behavior,HP_0100716,0.15532863532790936,1.5533146018666641,1,0.4,0.4,transcript,14160.0
RBM44,ENSG00000177483,cesarean section,EFO_0009636,0.15532863532790936,1.5533146018666641,1,0.4,0.4,transcript,14160.0
GSTA5,ENSG00000182793,glioblastoma multiforme,EFO_0000519,0.15530890375287554,1.5534391775847778,1,0.5,0.5,transcript,1428.0
SMC3,ENSG00000108055,esophageal cancer,MONDO_0007576,0.15513383179249055,1.5513469304475134,1,0.4,0.4,transcript,46444.0
OR5AS1,ENSG00000181785,growth differentiation factor 15 amount,OBA_2050135,0.15512255009754727,1.5512763915607144,1,0.4,0.4,transcript,7860.0
TBC1D9B,ENSG00000197226,serum albumin amount,OBA_2050068,0.15504695866652776,1.550481801524654,1,0.4,0.4,transcript,32747.0
DNAJC10,ENSG00000077232,self reported educational attainment,EFO_0004784,0.15492335165382565,1.5492527682687889,4,1.7000000000000002,6.800000000000001,transcript,353215.0
OR2T12,ENSG00000177201,erythrocyte count,EFO_0004305,0.15475147135697606,1.5500374886223185,6,2.4000000000000004,14.400000000000002,transcript,5708.0
GCNT1,ENSG00000187210,low density lipoprotein cholesterol measurement,EFO_0004611,0.15464203542252358,1.5464394518619031,1,0.4,0.4,transcript,20945.0
SPART,ENSG00000133104,Red cell distribution width,EFO_0009188,0.15455669092666452,1.5455811746018804,1,0.4,0.4,transcript,28040.0
SLCO1C1,ENSG00000139155,glycochenodeoxycholate 3-sulfate measurement,EFO_0800384,0.1545556045320912,1.5455869362142765,1,0.5,0.5,transcript,16186.0
RPRD2,ENSG00000163125,monocyte count,EFO_0005091,0.15434611709231152,1.5434796774466648,1,0.4,0.4,transcript,21614.0
ATG16L1,ENSG00000085978,Drugs used in diabetes use measurement,EFO_0009924,0.1540966132407767,1.5409781238938118,1,0.4,0.4,transcript,33357.0
GMCL2,ENSG00000244234,heterogeneous nuclear ribonucleoprotein A/B amount,OBA_2050273,0.1540874791343628,1.5410143100042488,1,0.4,0.4,transcript,2867.0
PIAS2,ENSG00000078043,head and neck squamous cell carcinoma,EFO_0000181,0.15402390198615482,1.5402524098792898,1,0.4,0.4,transcript,29873.0
OXSR1,ENSG00000172939,taxonomic microbiome measurement,EFO_0007883,0.1539882379449698,1.539922955631479,1,0.4,0.4,transcript,9858.0
OXSR1,ENSG00000172939,gut microbiome measurement,EFO_0007874,0.1539882379449698,1.539922955631479,1,0.4,0.4,transcript,9858.0
PCMTD1,ENSG00000168300,mean corpuscular hemoglobin concentration,EFO_0004528,0.15394251196652164,1.5396299677362304,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
PCMTD1,ENSG00000168300,Sjogren syndrome,EFO_0000699,0.15394251196652164,1.5396299677362304,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
TBC1D9B,ENSG00000197226,high density lipoprotein cholesterol measurement,EFO_0004612,0.15371877619728563,1.5371999768322326,1,0.4,0.4,transcript,32747.0
UBL3,ENSG00000122042,high density lipoprotein cholesterol measurement,EFO_0004612,0.15369305318276436,1.5377644442668374,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
MRPL35,ENSG00000132313,pulse pressure measurement,EFO_0005763,0.15352540238121512,1.5353178400214684,1,0.4,0.4,transcript,6268.0
FAM174A,ENSG00000174132,type 2 diabetes mellitus,MONDO_0005148,0.15352212215610886,1.5353215979726318,1,0.4,0.4,transcript,3985.0
FITM2,ENSG00000197296,HbA1c measurement,EFO_0004541,0.1534682091843792,1.534768522267301,1,0.4,0.4,transcript,4628.0
CLSTN2,ENSG00000158258,Phenotypic abnormality,HP_0000118,0.15340071897111626,1.5340312759398613,1,0.4,0.4,transcript,16607.0
PARD6B,ENSG00000124171,gastric carcinoma,EFO_0000178,0.15337563969415124,1.5338348129383759,1,0.4,0.4,transcript,5101.0
UBE2G2,ENSG00000184787,esophageal squamous cell carcinoma,EFO_0005922,0.15337563969415124,1.5337824521786152,1,0.4,0.4,transcript,15352.0
KLHDC10,ENSG00000128607,brain attribute,OBA_2045210,0.15333753812984222,1.5334251139852304,1,0.4,0.4,transcript,8043.0
ARHGAP12,ENSG00000165322,diastolic blood pressure,EFO_0006336,0.15331317745012144,1.5331438368636279,1,0.4,0.4,transcript,33161.0
DPP8,ENSG00000074603,basophil count,EFO_0005090,0.15310856301204304,1.5312673502146976,4,1.6,6.4,transcript,35219.0
CRYGD,ENSG00000118231,HbA1c measurement,EFO_0004541,0.15285486276910842,1.5291716806505857,1,0.4,0.4,transcript,642.0
DPP8,ENSG00000074603,polycythemia vera,EFO_0002429,0.15276358304622017,1.527817550556469,4,1.6,6.4,transcript,35219.0
RCN2,ENSG00000117906,platelet count,EFO_0004309,0.15275728118615592,1.527600126802832,1,0.4,0.4,transcript,14644.0
ZNF594,ENSG00000180626,gastrointestinal disease,EFO_0010282,0.15270219633971432,1.5270601240535067,1,0.4,0.4,transcript,10482.0
GPR85,ENSG00000164604,body weight,EFO_0004338,0.15267325034505197,1.526756050869134,1,0.4,0.4,transcript,16987.0
NRCAM,ENSG00000091129,Raynaud disease,EFO_1001145,0.15241852456201802,1.5241968989340913,1,0.4,0.4,transcript,34325.0
TLK1,ENSG00000198586,high density lipoprotein cholesterol measurement,EFO_0004612,0.15238568695590066,1.5238707647200167,1,0.4,0.4,transcript,28787.0
SMC5,ENSG00000198887,acute myeloid leukemia,EFO_0000222,0.15217422789053237,1.5218066289696737,1,0.5,0.5,transcript,7770.0
OR5M1,ENSG00000255012,triglyceride measurement,EFO_0004530,0.15214193923058683,1.5217913123430604,2,0.8,1.6,transcript,4302.0
GABPA,ENSG00000154727,strand of hair color,OBA_0002313,0.15207059227426392,1.5207418745671943,1,0.4,0.4,transcript,11126.0
CCDC50,ENSG00000152492,metabolite measurement,EFO_0004725,0.15207059227426392,1.5207423692118875,1,0.4,0.4,transcript,10975.0
CCDC126,ENSG00000169193,IGF-1 measurement,EFO_0004627,0.15207059227426392,1.5207483855876498,1,0.4,0.4,transcript,9420.0
GABPA,ENSG00000154727,aspartate aminotransferase to alanine aminotransferase ratio,EFO_0010934,0.15207059227426392,1.5207418745671943,1,0.4,0.4,transcript,11126.0
KERA,ENSG00000139330,cystatin C measurement,EFO_0004617,0.15207059227426392,1.5214322050848996,2,0.8,1.6,transcript,2203.0
TSPAN19,ENSG00000231738,urinary microalbumin measurement,EFO_0010967,0.15207059227426392,1.520755099039664,1,0.4,0.4,transcript,8134.0
PRPF4B,ENSG00000112739,brain aneurysm,EFO_0003870,0.15207059227426392,1.5207267075780233,1,0.5,0.5,transcript,24056.0
LSM11,ENSG00000155858,Abruptio Placentae,EFO_1001754,0.15207059227426392,1.5207668333563136,1,0.4,0.4,transcript,6567.0
AGA,ENSG00000038002,platelet count,EFO_0004309,0.15207059227426392,1.5208039043221022,1,0.5,0.5,transcript,5103.0
KERA,ENSG00000139330,serum creatinine amount,OBA_2050096,0.15207059227426392,1.5214322050848996,2,0.8,1.6,transcript,2203.0
GABPA,ENSG00000154727,bone tissue density,OBA_1000110,0.15207059227426392,1.5207418745671943,1,0.4,0.4,transcript,11126.0
WDR12,ENSG00000138442,cystatin C measurement,EFO_0004617,0.15206416820418867,1.520661621227371,1,0.4,0.4,transcript,20061.0
AGO3,ENSG00000126070,multiple myeloma,EFO_0001378,0.15201413920323817,1.5201545581559457,1,0.4,0.4,transcript,30381.0
STT3B,ENSG00000163527,executive function measurement,EFO_0009332,0.15201201983580445,1.520139921251393,1,0.4,0.4,transcript,20281.0
BTLA,ENSG00000186265,coronary artery disease,EFO_0001645,0.1519342782608809,1.5195231433302518,2,0.9,1.8,transcript,9980.0
RPAP3,ENSG00000005175,temporal measurement,EFO_0000719,0.15178193098426931,1.5179676777952154,2,0.8,1.6,transcript,10784.0
AKR1B10,ENSG00000198074,breast adenocarcinoma,EFO_0000304,0.15174763430735524,1.5176084783801065,1,0.5,0.5,transcript,3784.0
RBM23,ENSG00000100461,cup-to-disc ratio measurement,EFO_0006939,0.15170343850656057,1.5170442438386813,1,0.4,0.4,transcript,40573.0
CENPQ,ENSG00000031691,Spinal cord injury,EFO_1001919,0.15153108277032076,1.5155405807187161,1,0.4,0.4,transcript,1741.0
PDCD4,ENSG00000150593,QRS-T angle,EFO_0020097,0.15149806021094747,1.5150156136632875,1,0.5,0.5,transcript,14281.0
SMC6,ENSG00000163029,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.15126569946205495,1.512673404203746,1,0.4,0.4,transcript,24376.0
SH3GL3,ENSG00000140600,BMI-adjusted waist circumference,EFO_0007789,0.15126472870459623,1.5126989799898756,1,0.4,0.4,transcript,7738.0
CNTN1,ENSG00000018236,lung adenocarcinoma,EFO_0000571,0.15110042869729615,1.511020813849795,1,0.4,0.4,transcript,24203.0
AGBL3,ENSG00000146856,COVID-19,MONDO_0100096,0.15109271109694458,1.510963064086581,1,0.5,0.5,transcript,13907.0
CHFR,ENSG00000072609,Red cell distribution width,EFO_0009188,0.15098231370045093,1.5098312263104468,1,0.4,0.4,transcript,49448.0
SAMD9L,ENSG00000177409,Microcephaly,HP_0000252,0.15091177399625322,1.5091261928692754,1,0.4,0.4,transcript,47321.0
ONECUT2,ENSG00000119547,Isolated polycystic liver disease,Orphanet_2924,0.15091177399625322,1.5102795656886732,7,2.8000000000000003,19.6,transcript,16870.0
ANOS1,ENSG00000011201,amenorrhea,MONDO_0001836,0.15091177399625322,1.5091692465296196,1,0.4,0.4,transcript,7766.0
ONECUT2,ENSG00000119547,autosomal dominant polycystic liver disease,MONDO_0000447,0.15091177399625322,1.5102795656886732,7,2.8000000000000003,19.6,transcript,16870.0
ATP5F1A,ENSG00000152234,monocyte count,EFO_0005091,0.15090902132701167,1.509104013987754,1,0.4,0.4,transcript,28984.0
SCAMP1,ENSG00000085365,diastolic blood pressure change measurement,EFO_0006945,0.1509013021318874,1.5090393683087306,1,0.4,0.4,transcript,15182.0
SCAMP1,ENSG00000085365,thrombocytopenia 4,MONDO_0012775,0.15089338434343938,1.5089601904242502,1,0.4,0.4,transcript,15182.0
FIGNL1,ENSG00000132436,platelet volume,OBA_0003277,0.1508875252639396,1.5088914351784362,1,0.4,0.4,transcript,24718.0
NEK1,ENSG00000137601,Jeune syndrome,MONDO_0018770,0.15076034891690326,1.507617749037307,2,0.8,1.6,transcript,112203.0
C15orf61,ENSG00000189227,neurotic disorder,EFO_0004257,0.15075512776993988,1.5091728116705356,5,2.0,10.0,transcript,6167.0
C15orf61,ENSG00000189227,neuroticism measurement,EFO_0007660,0.15075512776993988,1.5091728116705356,5,2.0,10.0,transcript,6167.0
TMEM192,ENSG00000170088,mathematical ability,EFO_0004875,0.15068020966879417,1.5069254868321538,2,0.8,1.6,transcript,12967.0
GPR85,ENSG00000164604,glucuronate measurement,EFO_0010486,0.15052515562890967,1.505275103707711,1,0.4,0.4,transcript,16987.0
ZNF485,ENSG00000198298,blood sodium bicarbonate amount,OBA_2050094,0.15052515562890967,1.5053488893628753,1,0.5,0.5,transcript,5137.0
GPR85,ENSG00000164604,atrial fibrillation,EFO_0000275,0.15052515562890967,1.505275103707711,1,0.4,0.4,transcript,16987.0
GPR85,ENSG00000164604,serum creatinine amount,OBA_2050096,0.15052515562890967,1.505275103707711,1,0.4,0.4,transcript,16987.0
METTL25,ENSG00000127720,platelet volume,OBA_0003277,0.15052515562890967,1.5053035043410448,1,0.5,0.5,transcript,9625.0
ZNF485,ENSG00000198298,brain attribute,OBA_2045210,0.15052515562890967,1.5053488893628753,1,0.5,0.5,transcript,5137.0
ZNF485,ENSG00000198298,arterial stiffness measurement,EFO_0004517,0.15052515562890967,1.5053488893628753,1,0.5,0.5,transcript,5137.0
TAF2,ENSG00000064313,esophageal cancer,MONDO_0007576,0.15041752897343302,1.5041780827183544,1,0.5,0.5,transcript,179020.0
CFAP54,ENSG00000188596,body mass index,EFO_0004340,0.15038182624924065,1.5038868943169836,2,1.0,2.0,transcript,29141.0
TMEM236,ENSG00000148483,platelet count,EFO_0004309,0.15034823547300333,1.503772472590414,2,0.8,1.6,transcript,5515.0
C18orf54,ENSG00000166845,diastolic blood pressure,EFO_0006336,0.15014092511319943,1.501494725783418,2,0.8,1.6,transcript,18719.0
RGS4,ENSG00000117152,glioblastoma multiforme,EFO_0000519,0.15013814176787815,1.501477687233535,2,0.8,1.6,transcript,16620.0
DPP8,ENSG00000074603,hemoglobin measurement,EFO_0004509,0.15013305794704482,1.5015122995647154,4,1.6,6.4,transcript,35219.0
DCLK1,ENSG00000133083,multiple sclerosis,MONDO_0005301,0.1501031333756912,1.5010815314101718,2,0.8,1.6,transcript,31874.0
TMEM131,ENSG00000075568,Hashimoto's thyroiditis,EFO_0003779,0.15007937271093555,1.5008151759806085,1,0.4,0.4,transcript,18649.0
RBM23,ENSG00000100461,intelligence,EFO_0004337,0.14991925160786135,1.4992023748516892,1,0.4,0.4,transcript,40573.0
UBE2U,ENSG00000177414,protein measurement,EFO_0004747,0.14983028649222074,1.4983700805162252,1,0.4,0.4,transcript,5951.0
NOM1,ENSG00000146909,gestational diabetes,EFO_0004593,0.14971489227878654,1.4980302906708198,5,2.0,10.0,transcript,11346.0
RNMT,ENSG00000101654,thyroid stimulating hormone amount,OBA_1000983,0.14962727237328655,1.4962891454423655,1,0.4,0.4,transcript,24358.0
RNMT,ENSG00000101654,HbA1c measurement,EFO_0004541,0.14962727237328655,1.4962891454423655,1,0.4,0.4,transcript,24358.0
RNMT,ENSG00000101654,hemoglobin measurement,EFO_0004509,0.14962727237328655,1.4962891454423655,1,0.4,0.4,transcript,24358.0
RNMT,ENSG00000101654,lean body mass,EFO_0004995,0.14962727237328655,1.4962891454423655,1,0.4,0.4,transcript,24358.0
SOCS4,ENSG00000180008,osteoarthritis,MONDO_0005178,0.14960818545178486,1.4961012287307713,1,0.4,0.4,transcript,20646.0
ABCA10,ENSG00000154263,sex hormone-binding globulin measurement,EFO_0004696,0.1495357449985199,1.495457386137102,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
BTAF1,ENSG00000095564,coronary atherosclerosis,MONDO_0021661,0.1494481967264347,1.49451871170675,1,0.4,0.4,transcript,10886.0
LDLRAP1,ENSG00000157978,"hypercholesterolemia, familial, 1",MONDO_0007750,0.14941086914195037,1.4941346048685837,1,0.4,0.4,transcript,15436.0
CR2,ENSG00000117322,Venous thrombosis,HP_0004936,0.1492124263178298,1.4921425891049027,1,0.4,0.4,transcript,21827.0
CR2,ENSG00000117322,hemorrhoid,EFO_0009552,0.1492124263178298,1.4921425891049027,1,0.4,0.4,transcript,21827.0
ITGA8,ENSG00000077943,Genu varum,HP_0002970,0.14919484845811828,1.4924132405842812,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
SNTG2,ENSG00000172554,lymphocyte count,EFO_0004587,0.14919484845811828,1.4919983748226515,1,0.5,0.5,transcript,10022.0
ITGA8,ENSG00000077943,Genu valgum,HP_0002857,0.14919484845811828,1.4924132405842812,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
DCLK1,ENSG00000133083,Alzheimer disease,MONDO_0004975,0.14915153366011585,1.4915655342544183,2,0.8,1.6,transcript,31874.0
PFAS,ENSG00000178921,genetic disorder,EFO_0000508,0.1491152052582026,1.4911753789174587,1,0.4,0.4,transcript,17148.0
RCN2,ENSG00000117906,exfoliation syndrome,EFO_0004235,0.14908783292440297,1.4909056441853026,1,0.4,0.4,transcript,14644.0
MANSC4,ENSG00000205693,diabetic neuropathy,EFO_1000783,0.14906228243783273,1.490922764390325,1,0.5,0.5,transcript,1667.0
CKAP2,ENSG00000136108,Alzheimer disease,MONDO_0004975,0.14901885583304716,1.4902160989528899,1,0.4,0.4,transcript,14524.0
ATP8A1,ENSG00000124406,glioblastoma multiforme,EFO_0000519,0.14900518325360207,1.4902295955002183,4,1.6,6.4,transcript,36003.0
EHD1,ENSG00000110047,ocular hypotension,MONDO_0004390,0.1489792014238872,1.4898103611795197,1,0.4,0.4,transcript,21802.0
SYNJ2,ENSG00000078269,platelet count,EFO_0004309,0.14897184899310764,1.4897696375559086,2,0.8,1.6,transcript,31282.0
FBXO42,ENSG00000037637,brain volume,OBA_2050009,0.1488833819809963,1.488869391175014,1,0.4,0.4,transcript,11245.0
SGCB,ENSG00000163069,body fat percentage,EFO_0007800,0.14876971485346605,1.4877697438159672,1,0.4,0.4,transcript,5510.0
FRAS1,ENSG00000138759,pulse wave reflection index measurement,EFO_0009804,0.14869980030385163,1.4870301395831236,2,0.9,1.8,transcript,56011.0
DCLK1,ENSG00000133083,Parkinson disease,MONDO_0005180,0.14868163685961014,1.486866566249361,2,0.8,1.6,transcript,31874.0
CLEC6A,ENSG00000205846,endometrial cancer,MONDO_0011962,0.14850774904581904,1.4853205038239257,1,0.4,0.4,transcript,1646.0
STAU2,ENSG00000040341,body height,OBA_VT0001253,0.14849735568706304,1.4849851250535002,1,0.5,0.5,transcript,43222.0
PKHD1L1,ENSG00000205038,educational attainment,EFO_0011015,0.14847364417199302,1.484752487933024,1,0.4,0.4,transcript,24928.0
FYB1,ENSG00000082074,glomerular filtration rate,OBA_0003747,0.14815020102908577,1.4815216605168353,1,0.5,0.5,transcript,25445.0
FYB1,ENSG00000082074,serum creatinine amount,OBA_2050096,0.14815020102908577,1.4815216605168353,1,0.5,0.5,transcript,25445.0
IPP,ENSG00000197429,platelet count,EFO_0004309,0.14813372716324785,1.4814180470767435,1,0.5,0.5,transcript,6190.0
FAM171B,ENSG00000144369,phosphate measurement,EFO_0010968,0.14806924321190054,1.4807622279661525,1,0.4,0.4,transcript,5731.0
TRMT6,ENSG00000089195,hypertension,EFO_0000537,0.148068684890482,1.4807203301134915,1,0.4,0.4,transcript,11947.0
GABPA,ENSG00000154727,Phenotypic abnormality,HP_0000118,0.14803791600274377,1.4804151118519928,1,0.4,0.4,transcript,11126.0
GPR85,ENSG00000164604,cigarettes per day measurement,EFO_0006525,0.14803791600274377,1.480402707446052,1,0.4,0.4,transcript,16987.0
SMC6,ENSG00000163029,platelet count,EFO_0004309,0.14803791600274377,1.4803955696106341,1,0.4,0.4,transcript,24376.0
TSPAN19,ENSG00000231738,X-11299 measurement,EFO_0021222,0.14803791600274377,1.4804283363244626,1,0.4,0.4,transcript,8134.0
SLC35F5,ENSG00000115084,Polyarteritis Nodosa,EFO_0009012,0.14803791600274377,1.480449918916523,2,0.8,1.6,transcript,22612.0
ITPRID2,ENSG00000138434,potassium measurement,EFO_0009283,0.14803791600274377,1.480387947566707,1,0.4,0.4,transcript,45519.0
SLCO1C1,ENSG00000139155,glycochenodeoxycholate glucuronide (1) measurement,EFO_0800474,0.1480312180258128,1.4803430711514924,1,0.5,0.5,transcript,16186.0
PEX7,ENSG00000112357,Peroxisome biogenesis disorder-Zellweger syndrome spectrum,Orphanet_79189,0.1478319418738807,1.478361962878352,1,0.4,0.4,transcript,9402.0
DNAH14,ENSG00000185842,"Intellectual disability, severe",HP_0010864,0.1478319418738807,1.4783773972223477,3,1.5,4.5,transcript,77615.0
DNAH14,ENSG00000185842,Microcephaly,HP_0000252,0.1478319418738807,1.4783773972223477,3,1.5,4.5,transcript,77615.0
DNAH14,ENSG00000185842,Seizure,HP_0001250,0.1478319418738807,1.4783773972223477,3,1.5,4.5,transcript,77615.0
ACER3,ENSG00000078124,neuromuscular disease,EFO_1001902,0.1478319418738807,1.478719418738807,1,0.4,0.4,transcript,1000.0
TMTC3,ENSG00000139324,"Meckel syndrome, type 4",MONDO_0012626,0.1478319418738807,1.4783584279059614,1,0.4,0.4,transcript,10254.0
TMTC3,ENSG00000139324,Senior-Loken syndrome 6,MONDO_0012433,0.1478319418738807,1.4783584279059614,1,0.4,0.4,transcript,10254.0
TMTC3,ENSG00000139324,Bardet-Biedl syndrome 14,MONDO_0014442,0.1478319418738807,1.4783584279059614,1,0.4,0.4,transcript,10254.0
TMTC3,ENSG00000139324,Joubert syndrome 5,MONDO_0012432,0.1478319418738807,1.4783584279059614,1,0.4,0.4,transcript,10254.0
TMTC3,ENSG00000139324,Leber congenital amaurosis 10,MONDO_0012723,0.1478319418738807,1.4783584279059614,1,0.4,0.4,transcript,10254.0
SMC6,ENSG00000163029,Inherited cancer-predisposing syndrome,Orphanet_140162,0.1478319418738807,1.4783358283220036,1,0.4,0.4,transcript,24376.0
SMC6,ENSG00000163029,hereditary neoplastic syndrome,MONDO_0015356,0.1478319418738807,1.4783358283220036,1,0.4,0.4,transcript,24376.0
SMC5,ENSG00000198887,age at first sexual intercourse measurement,EFO_0009749,0.147742821272683,1.4774925627911801,1,0.5,0.5,transcript,7770.0
CCDC80,ENSG00000091986,preeclampsia,EFO_0000668,0.1475309057160624,1.475388265081416,2,0.8,1.6,transcript,20200.0
FIGNL1,ENSG00000132436,protein measurement,EFO_0004747,0.14735764062373585,1.4735925887763988,1,0.4,0.4,transcript,24718.0
ITGA8,ENSG00000077943,placenta praevia,EFO_0007442,0.14696077261332224,1.4700724821363207,3,1.2000000000000002,3.6000000000000005,transcript,7746.0
PIAS2,ENSG00000078043,metabolite measurement,EFO_0004725,0.14686448834887691,1.4686582735065108,1,0.4,0.4,transcript,29873.0
ATP12A,ENSG00000075673,glioblastoma multiforme,EFO_0000519,0.14683173913622474,1.4683665434880768,1,0.4,0.4,transcript,8138.0
GCNT1,ENSG00000187210,mean corpuscular hemoglobin concentration,EFO_0004528,0.1468152802984479,1.4681719006211464,1,0.4,0.4,transcript,20945.0
CLDN16,ENSG00000113946,head and neck squamous cell carcinoma,EFO_0000181,0.14679481139243325,1.4680484903358757,1,0.4,0.4,transcript,3985.0
WDR12,ENSG00000138442,hematocrit,EFO_0004348,0.14675002302327533,1.4675201694182376,1,0.4,0.4,transcript,20061.0
WDR12,ENSG00000138442,hemoglobin measurement,EFO_0004509,0.14675002302327533,1.4675201694182376,1,0.4,0.4,transcript,20061.0
ZNF675,ENSG00000197372,insulin measurement,EFO_0004467,0.14674475866785022,1.4674903839052418,1,0.5,0.5,transcript,11683.0
SEC22A,ENSG00000121542,brain aneurysm,EFO_0003870,0.1465884758729506,1.4660067936620054,2,0.8,1.6,transcript,13111.0
SLC30A9,ENSG00000014824,alcohol drinking,EFO_0004329,0.14658829801104759,1.466234743436894,3,1.3,3.9000000000000004,transcript,11087.0
RPRD2,ENSG00000163125,"osteoarthritis, hip",EFO_1000786,0.14646067988402023,1.464625305363752,1,0.4,0.4,transcript,21614.0
OR4X1,ENSG00000176567,high density lipoprotein cholesterol measurement,EFO_0004612,0.14640212883027218,1.4645659506120898,1,0.5,0.5,transcript,918.0
WDR12,ENSG00000138442,insomnia,EFO_0004698,0.14636364996191883,1.4636564388046727,1,0.4,0.4,transcript,20061.0
CAVIN2,ENSG00000168497,renal osteodystrophy,EFO_1001152,0.14634096157521131,1.463540591521596,1,0.4,0.4,transcript,3054.0
UBE2U,ENSG00000177414,wellbeing measurement,EFO_0007869,0.14634096157521131,1.463476831346131,1,0.4,0.4,transcript,5951.0
RGS7BP,ENSG00000186479,endocrine neoplasm,EFO_0003769,0.14634096157521131,1.46349773700696,1,0.5,0.5,transcript,5674.0
UBE2U,ENSG00000177414,triglyceride measurement,EFO_0004530,0.14634096157521131,1.463476831346131,1,0.4,0.4,transcript,5951.0
LYPD6,ENSG00000187123,cervical carcinoma,EFO_0001061,0.14634096157521131,1.4634423650561905,1,0.4,0.4,transcript,12214.0
HECW2,ENSG00000138411,brain connectivity attribute,OBA_2045295,0.14633879178606474,1.4633937340121002,1,0.4,0.4,transcript,68774.0
COL19A1,ENSG00000082293,protein measurement,EFO_0004747,0.14633879178606474,1.4635252569164414,2,0.8,1.6,transcript,11650.0
ATP5F1A,ENSG00000152234,cystatin C measurement,EFO_0004617,0.1463382418020949,1.4633962187385863,1,0.4,0.4,transcript,28984.0
MCF2L2,ENSG00000053524,body weight,EFO_0004338,0.1463382418020949,1.4634238677243245,2,0.8,1.6,transcript,38601.0
ATRNL1,ENSG00000107518,polycystic ovary syndrome,EFO_0000660,0.14628472953750984,1.462864154516968,1,0.4,0.4,transcript,23726.0
PEX7,ENSG00000112357,neutrophil percentage of leukocytes,EFO_0007990,0.14627821319134335,1.4628246760529784,1,0.4,0.4,transcript,9402.0
PARD6B,ENSG00000124171,head and neck squamous cell carcinoma,EFO_0000181,0.1462404416104062,1.4624828321009253,1,0.4,0.4,transcript,5101.0
CHFR,ENSG00000072609,body mass index,EFO_0004340,0.1462058951902488,1.4620670412084253,1,0.4,0.4,transcript,49448.0
KIAA0319,ENSG00000137261,lymphocyte count,EFO_0004587,0.14611844089601791,1.4611967963126922,1,0.4,0.4,transcript,32291.0
DGKH,ENSG00000102780,systolic blood pressure,EFO_0006335,0.1459355199746586,1.45938259278533,2,0.8,1.6,transcript,58409.0
ST8SIA4,ENSG00000113532,neutrophil count,EFO_0004833,0.1459232903637927,1.459275780687986,1,0.4,0.4,transcript,9329.0
IKBIP,ENSG00000166130,body height,OBA_VT0001253,0.14574510491741102,1.4577215479061474,2,0.8,1.6,transcript,5915.0
FGFR1OP2,ENSG00000111790,neutrophil measurement,EFO_0803548,0.1454033290082904,1.4540694237775742,1,0.4,0.4,transcript,11070.0
SLCO1C1,ENSG00000139155,cardiovascular disease,EFO_0000319,0.1452808875446266,1.4528397663396304,1,0.5,0.5,transcript,16186.0
TRHDE,ENSG00000072657,nephritis,EFO_1002050,0.1452292017825042,1.452391588426822,2,0.8,1.6,transcript,16069.0
TRHDE,ENSG00000072657,Nephropathy,HP_0000112,0.1452292017825042,1.452391588426822,2,0.8,1.6,transcript,16069.0
DCUN1D1,ENSG00000043093,body weight,EFO_0004338,0.14494535897201058,1.4494778674574207,1,0.4,0.4,transcript,16476.0
SARAF,ENSG00000133872,breast carcinoma,EFO_0000305,0.14494535897201058,1.4494800429970054,1,0.4,0.4,transcript,15121.0
KPNA4,ENSG00000186432,body mass index,EFO_0004340,0.14488903852192672,1.4488993784293935,1,0.4,0.4,transcript,44478.0
G3BP2,ENSG00000138757,Testicular Germ Cell Tumor,EFO_1000566,0.1447467276888552,1.447469030128759,1,0.4,0.4,transcript,228149.0
MCF2L2,ENSG00000053524,balding measurement,EFO_0007825,0.14469819099642459,1.4470233596676214,2,0.8,1.6,transcript,38601.0
ABCA10,ENSG00000154263,lipid measurement,EFO_0004529,0.14464085836710994,1.4465085198230023,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
ZNF594,ENSG00000180626,Myasthenia gravis,EFO_0004991,0.14458576694449102,1.4458958301012734,1,0.4,0.4,transcript,10482.0
RBM23,ENSG00000100461,Abruptio Placentae,EFO_1001754,0.14458576694449102,1.4458675282179858,1,0.4,0.4,transcript,40573.0
OR5M1,ENSG00000255012,blood coagulation disease,EFO_0009314,0.14451265220096468,1.4454984420468389,2,0.8,1.6,transcript,4302.0
ATP9A,ENSG00000054793,glioblastoma multiforme,EFO_0000519,0.14450209128348515,1.445046279059723,1,0.4,0.4,transcript,15769.0
RUFY3,ENSG00000018189,triglyceride measurement,EFO_0004530,0.14449506685517388,1.4449709968538174,1,0.4,0.4,transcript,19677.0
OR8H2,ENSG00000181767,total cholesterol measurement,EFO_0004574,0.14447225667243996,1.4447779837374224,1,0.4,0.4,transcript,7218.0
GASK1B,ENSG00000164125,protozoa infectious disease,MONDO_0002428,0.1444315984540074,1.4444888702914067,3,1.2000000000000002,3.6000000000000005,transcript,20823.0
MED10,ENSG00000133398,protozoa infectious disease,MONDO_0002428,0.1444315984540074,1.4444655731713383,1,0.4,0.4,transcript,2674.0
MED10,ENSG00000133398,brain volume,OBA_2050009,0.1444315984540074,1.4444655731713383,1,0.4,0.4,transcript,2674.0
WBP2NL,ENSG00000183066,eosinophil count,EFO_0004842,0.14437848675129764,1.4438270224746153,1,0.5,0.5,transcript,11861.0
CPB1,ENSG00000153002,vital capacity,EFO_0004312,0.14428867895133593,1.4429323683647721,1,0.5,0.5,transcript,10970.0
CPB1,ENSG00000153002,Abnormality of the integument,HP_0001574,0.14428867895133593,1.4429323683647721,1,0.5,0.5,transcript,10970.0
SMC5,ENSG00000198887,esophageal cancer,MONDO_0007576,0.1442085737569608,1.4421500876339581,1,0.5,0.5,transcript,7770.0
RNF150,ENSG00000170153,systolic blood pressure,EFO_0006335,0.144207333338472,1.442331992399391,4,1.6,6.4,transcript,24743.0
DGKH,ENSG00000102780,appendicular lean mass,EFO_0004980,0.14419713092520356,1.4419987022907796,2,0.8,1.6,transcript,58409.0
C15orf61,ENSG00000189227,hypertension,EFO_0000537,0.14413746134951602,1.442996147466297,5,2.0,10.0,transcript,6167.0
SLC11A2,ENSG00000110911,brain physiology trait,OBA_VT0015058,0.14411603060843314,1.4411882673579675,2,0.8,1.6,transcript,57222.0
SGCB,ENSG00000163069,platelet count,EFO_0004309,0.14390138495156082,1.439086444796915,1,0.4,0.4,transcript,5510.0
SLC35B4,ENSG00000205060,mathematical ability,EFO_0004875,0.14370617770964594,1.4371036970293876,1,0.4,0.4,transcript,9542.0
RCC1L,ENSG00000274523,sleep apnea,EFO_0003877,0.1436854672609021,1.4368977342948859,1,0.4,0.4,transcript,9289.0
ANKRD30B,ENSG00000180777,level of Phosphatidylcholine (16:1_18:1) in blood serum,OBA_2045082,0.14367418699809426,1.4367664363839296,1,0.5,0.5,transcript,20353.0
DIRAS2,ENSG00000165023,growth differentiation factor 15 amount,OBA_2050135,0.14367418699809426,1.4368181185512818,1,0.4,0.4,transcript,5246.0
ANKRD30B,ENSG00000180777,magnetic resonance imaging of the heart,EFO_0022611,0.14367418699809426,1.4367664363839296,1,0.5,0.5,transcript,20353.0
ZPLD1,ENSG00000170044,optic cup area,OBA_2045265,0.14367418699809426,1.4369008524928661,2,0.8,1.6,transcript,10064.0
HEG1,ENSG00000173706,diabetes mellitus,EFO_0000400,0.14338188441400881,1.433840710427739,1,0.4,0.4,transcript,18293.0
SLC44A1,ENSG00000070214,cutaneous melanoma,EFO_0000389,0.1433049722831965,1.43305933174904,1,0.4,0.4,transcript,41628.0
GMCL1,ENSG00000087338,protein measurement,EFO_0004747,0.14326938376804876,1.4329482501466986,2,0.8,1.6,transcript,6289.0
ZNF28,ENSG00000198538,skin disease,EFO_0000701,0.14321942175361907,1.4324488144244512,3,1.2000000000000002,3.6000000000000005,transcript,14140.0
USP15,ENSG00000135655,body mass index,EFO_0004340,0.14305740500802613,1.4306571679228914,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
NUP43,ENSG00000120253,hypertrophic cardiomyopathy,EFO_0000538,0.1429346470369256,1.4295486692824368,2,0.8,1.6,transcript,7913.0
IQCB1,ENSG00000173226,pulse wave reflection index measurement,EFO_0009804,0.1428192231835198,1.4282338508134522,1,0.4,0.4,transcript,9611.0
ZNF257,ENSG00000197134,diastolic blood pressure,EFO_0006336,0.14275031332175325,1.4275307156199597,1,0.4,0.4,transcript,14502.0
ZNF230,ENSG00000159882,phospholipids in small LDL measurement ,EFO_0022297,0.1426472338624382,1.4265081744960895,1,0.4,0.4,transcript,11162.0
RBM25,ENSG00000119707,erythrocyte count,EFO_0004305,0.14264597126711445,1.4264724026238744,1,0.4,0.4,transcript,31521.0
LY75-CD302,ENSG00000248672,mean corpuscular hemoglobin,EFO_0004527,0.1426172712330963,1.4262176278897127,1,0.5,0.5,transcript,11132.0
SPRY3,ENSG00000168939,eosinophil percentage of leukocytes,EFO_0007991,0.14251636150072725,1.4251811920165443,1,0.4,0.4,transcript,22757.0
CCDC62,ENSG00000130783,BMI-adjusted waist circumference,EFO_0007789,0.1424784933843103,1.424811869870039,1,0.4,0.4,transcript,14850.0
PARP14,ENSG00000173193,nicotinamide measurement,EFO_0800178,0.14227678356258916,1.422781823596237,1,0.4,0.4,transcript,28596.0
ARFIP1,ENSG00000164144,appendicular lean mass,EFO_0004980,0.14195172711801252,1.4195443237974659,1,0.4,0.4,transcript,14786.0
TC2N,ENSG00000165929,casein kinase II 2-alpha:2-beta heterotetramer measurement,EFO_0020236,0.1419044360259901,1.419067125042782,1,0.4,0.4,transcript,17571.0
RPRD2,ENSG00000163125,insomnia,EFO_0004698,0.14179149808432093,1.4179334873667588,1,0.4,0.4,transcript,21614.0
MR1,ENSG00000153029,eosinophil percentage of leukocytes,EFO_0007991,0.14177787330794936,1.4179117756900852,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
CFAP54,ENSG00000188596,high density lipoprotein cholesterol measurement,EFO_0004612,0.14167821118479398,1.4168507436725168,2,1.0,2.0,transcript,29141.0
SLCO6A1,ENSG00000205359,glucose measurement,EFO_0004468,0.14164934133171223,1.4165346674425348,1,0.5,0.5,transcript,12120.0
SEC22A,ENSG00000121542,lymphocyte count,EFO_0004587,0.14163148028871045,1.416436837819604,2,0.8,1.6,transcript,13111.0
SELENOI,ENSG00000138018,glucose measurement,EFO_0004468,0.14161831401708397,1.4162247288587164,1,0.4,0.4,transcript,9618.0
GLCE,ENSG00000138604,D-glucuronyl C5-epimerase measurement,EFO_0801519,0.14154817104353853,1.415612035433349,2,0.8,1.6,transcript,12277.0
MTMR6,ENSG00000139505,neuroinflammatory disorder,EFO_0020092,0.14150922918228695,1.4151459168764946,1,0.5,0.5,transcript,9324.0
ANO6,ENSG00000177119,"Sphingomyelin (d18:2/24:1, d18:1/24:2) measurement",EFO_0022117,0.14123655947986247,1.412373015948903,1,0.4,0.4,transcript,53900.0
SAMD11,ENSG00000187634,"chromosome, telomeric region length",OBA_0003784,0.14120351730023273,1.412098001872193,2,0.8,1.6,transcript,25466.0
RGS7BP,ENSG00000186479,brain aneurysm,EFO_0003870,0.14119411560197329,1.4120292772745795,1,0.5,0.5,transcript,5674.0
LYPD6,ENSG00000187123,aspartate aminotransferase measurement,EFO_0004736,0.14119411560197329,1.41197390532381,1,0.4,0.4,transcript,12214.0
UBE2U,ENSG00000177414,respiratory system disease,EFO_0000684,0.14119411560197329,1.4120083716137506,1,0.4,0.4,transcript,5951.0
UBE2U,ENSG00000177414,benign neoplasm,EFO_0002422,0.14119411560197329,1.4120083716137506,1,0.4,0.4,transcript,5951.0
CNTN1,ENSG00000018236,inflammatory bowel disease,EFO_0003767,0.14119411560197329,1.4119576828965663,1,0.4,0.4,transcript,24203.0
CNTN1,ENSG00000018236,cervical carcinoma,EFO_0001061,0.14119411560197329,1.4119576828965663,1,0.4,0.4,transcript,24203.0
SKA3,ENSG00000165480,lysosomal storage disease,MONDO_0002561,0.14111832945400057,1.411329653852117,2,0.8,1.6,transcript,10932.0
CKAP2,ENSG00000136108,polygenic risk score,EFO_0030082,0.14107288895732606,1.4107564301956788,1,0.4,0.4,transcript,14524.0
NPS,ENSG00000214285,blood sodium bicarbonate amount,OBA_2050094,0.14107157948131824,1.411040733887106,1,0.4,0.4,transcript,1231.0
SGTB,ENSG00000197860,brain stem volume,OBA_2050021,0.14103471134442228,1.4104102547228337,1,0.4,0.4,transcript,6335.0
ELAPOR1,ENSG00000116299,low density lipoprotein cholesterol measurement,EFO_0004611,0.14102835194738694,1.4102966127635586,1,0.4,0.4,transcript,30550.0
CFAP54,ENSG00000188596,educational attainment,EFO_0011015,0.14098405100238268,1.4099091418484038,2,1.0,2.0,transcript,29141.0
CPD,ENSG00000108582,body mass index,EFO_0004340,0.1408301645449882,1.4083218638081514,1,0.4,0.4,transcript,19784.0
METTL25,ENSG00000127720,X-25790 measurement,EFO_0800933,0.14074608323363363,1.4075127803882843,1,0.5,0.5,transcript,9625.0
METTL25,ENSG00000127720,adverse effect,EFO_0009658,0.14074608323363363,1.4075127803882843,1,0.5,0.5,transcript,9625.0
METTL25,ENSG00000127720,response to stimulus,GO_0050896,0.14074608323363363,1.4075127803882843,1,0.5,0.5,transcript,9625.0
FIGNL1,ENSG00000132436,basophil measurement,EFO_0803539,0.14047915251392717,1.404807707678312,1,0.4,0.4,transcript,24718.0
GPR85,ENSG00000164604,lean body mass,EFO_0004995,0.14045737828385224,1.4045973302571368,1,0.4,0.4,transcript,16987.0
GPR85,ENSG00000164604,waist circumference,OBA_1001085,0.14045737828385224,1.4045973302571368,1,0.4,0.4,transcript,16987.0
RCN2,ENSG00000117906,vital capacity,EFO_0004312,0.14033534212185883,1.4033807361598611,1,0.4,0.4,transcript,14644.0
SMC6,ENSG00000163029,benign prostatic hyperplasia,EFO_0000284,0.14025752453275062,1.4025916549107027,1,0.4,0.4,transcript,24376.0
NRCAM,ENSG00000091129,lung adenocarcinoma,EFO_0000571,0.14014895455459292,1.4015011988598403,1,0.4,0.4,transcript,34325.0
APOBEC3H,ENSG00000100298,cutaneous melanoma,EFO_0000389,0.14003299886493786,1.4004065729878814,1,0.4,0.4,transcript,5223.0
OR5M1,ENSG00000255012,acute myeloid leukemia,EFO_0000222,0.1400293980764648,1.4006659008018403,2,0.8,1.6,transcript,4302.0
OR5AS1,ENSG00000181785,acute myeloid leukemia,EFO_0000222,0.1400293980764648,1.4003448713498898,1,0.4,0.4,transcript,7860.0
SELENOI,ENSG00000138018,severe acute respiratory syndrome,EFO_0000694,0.13997707373974325,1.3998123260853093,1,0.4,0.4,transcript,9618.0
SELENOI,ENSG00000138018,COVID-19,MONDO_0100096,0.13997707373974325,1.3998123260853093,1,0.4,0.4,transcript,9618.0
ZNF436,ENSG00000125945,waist-hip ratio,EFO_0004343,0.13996132959380717,1.399646937653799,1,0.4,0.4,transcript,11890.0
KRTAP19-1,ENSG00000184351,esophageal cancer,MONDO_0007576,0.13962042299634259,1.3968084595706767,1,0.4,0.4,transcript,662.0
GPAT3,ENSG00000138678,forced expiratory volume,EFO_0004314,0.13960308786009226,1.3961780050377042,2,0.8,1.6,transcript,10875.0
BTBD8,ENSG00000189195,aspartate aminotransferase measurement,EFO_0004736,0.13956388189965552,1.3956553010640658,1,0.5,0.5,transcript,30336.0
KLRD1,ENSG00000134539,total blood protein measurement,EFO_0004536,0.13935850824507232,1.393749572049175,4,1.7000000000000002,6.800000000000001,transcript,41340.0
NSUN7,ENSG00000179299,growth differentiation factor 15 amount,OBA_2050135,0.13925452707773858,1.3925842997368738,1,0.5,0.5,transcript,12811.0
FYCO1,ENSG00000163820,eosinophil count,EFO_0004842,0.1391510404360698,1.3915350152017736,1,0.4,0.4,transcript,16253.0
WAPL,ENSG00000062650,endometrial cancer,MONDO_0011962,0.13906005635650734,1.3907343204619134,2,0.8,1.6,transcript,11962.0
UBL3,ENSG00000122042,platelet volume,OBA_0003277,0.13890689746924728,1.3899028871316668,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
UBL3,ENSG00000122042,arterial embolism,EFO_0010671,0.13890689746924728,1.3899028871316668,3,1.2000000000000002,3.6000000000000005,transcript,4317.0
SECISBP2L,ENSG00000138593,diastolic blood pressure change measurement,EFO_0006945,0.13871221924259494,1.387141276395415,1,0.4,0.4,transcript,20960.0
COL19A1,ENSG00000082293,endometrial cancer,MONDO_0011962,0.13871065917358638,1.3872439307916578,2,0.8,1.6,transcript,11650.0
ATP5F1A,ENSG00000152234,erythrocyte count,EFO_0004305,0.1387001221473052,1.3870150221906894,1,0.4,0.4,transcript,28984.0
ABCA10,ENSG00000154263,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.13866298362501198,1.3867297724020227,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
NPS,ENSG00000214285,bone tissue density,OBA_1000110,0.13833847007102032,1.3837096397841269,1,0.4,0.4,transcript,1231.0
NPS,ENSG00000214285,gut microbiome measurement,EFO_0007874,0.13833847007102032,1.3837096397841269,1,0.4,0.4,transcript,1231.0
SGCB,ENSG00000163069,arterial stiffness measurement,EFO_0004517,0.1383059369462434,1.3831319647437408,1,0.4,0.4,transcript,5510.0
YBX3,ENSG00000060138,menopause,GO_0042697,0.13822855947329385,1.3823060488135275,1,0.4,0.4,transcript,19556.0
OR2M7,ENSG00000177186,reticulocyte measurement,EFO_0010700,0.13821892238269928,1.382721705190145,1,0.5,0.5,transcript,939.0
SLC35B4,ENSG00000205060,vitamin D measurement,EFO_0004631,0.13813798777374325,1.3814217976703604,1,0.4,0.4,transcript,9542.0
RNF150,ENSG00000170153,BMI-adjusted hip circumference,EFO_0008039,0.13804614700758194,1.3807201290904905,4,1.6,6.4,transcript,24743.0
MATN2,ENSG00000132561,ethylmalonate measurement,EFO_0020009,0.1379422474121501,1.3794394295964238,1,0.5,0.5,transcript,29489.0
NPS,ENSG00000214285,bone remodeling disease,MONDO_0000833,0.13793965792332197,1.3797215183071434,1,0.4,0.4,transcript,1231.0
GSTA5,ENSG00000182793,"1,3,7-trimethylurate measurement",EFO_0021172,0.13774052334946388,1.3777553735506611,1,0.5,0.5,transcript,1428.0
GCNT1,ENSG00000187210,lymphocyte count,EFO_0004587,0.13753221970686016,1.375341294705269,1,0.4,0.4,transcript,20945.0
GCNT1,ENSG00000187210,high density lipoprotein cholesterol measurement,EFO_0004612,0.13753221970686016,1.375341294705269,1,0.4,0.4,transcript,20945.0
GCNT1,ENSG00000187210,erythrocyte volume,OBA_0003460,0.13753221970686016,1.375341294705269,1,0.4,0.4,transcript,20945.0
NSUN7,ENSG00000179299,Ovarian Endometriosis,EFO_1000418,0.13753221970686016,1.3753612260280896,1,0.5,0.5,transcript,12811.0
CCDC77,ENSG00000120647,serum alanine aminotransferase measurement,EFO_0004735,0.13723763362022012,1.3724047009731557,1,0.4,0.4,transcript,14102.0
CFAP46,ENSG00000171811,metabolite measurement,EFO_0004725,0.13722352157979703,1.372256576016699,1,0.5,0.5,transcript,23408.0
RTF1,ENSG00000137815,basophil measurement,EFO_0803539,0.13717357059343582,1.3717874256136962,1,0.4,0.4,transcript,7734.0
FYB1,ENSG00000082074,red blood cell density,OBA_2045260,0.13711785092868228,1.3711981595128004,1,0.5,0.5,transcript,25445.0
TMEM236,ENSG00000148483,high density lipoprotein cholesterol measurement,EFO_0004612,0.1370301141188697,1.3705912590490776,2,0.8,1.6,transcript,5515.0
MMP12,ENSG00000262406,chronic obstructive pulmonary disease,EFO_0000341,0.13697019374080513,1.3699214763762182,1,0.4,0.4,transcript,1822.0
PDCD4,ENSG00000150593,neutrophil count,EFO_0004833,0.13696227548668172,1.36965776642063,1,0.5,0.5,transcript,14281.0
ARHGAP20,ENSG00000137727,neuroimaging measurement,EFO_0004346,0.13674229646342143,1.3674332092237904,1,0.4,0.4,transcript,39045.0
ARHGAP20,ENSG00000137727,brain volume,OBA_2050009,0.13674229646342143,1.3674332092237904,1,0.4,0.4,transcript,39045.0
PIAS2,ENSG00000078043,serum creatinine amount,OBA_2050096,0.1366700953311506,1.3667143433292477,1,0.4,0.4,transcript,29873.0
GCNT1,ENSG00000187210,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.1366359201614346,1.3663782992510136,1,0.4,0.4,transcript,20945.0
EXD1,ENSG00000178997,pneumonia,EFO_0003106,0.13662059212718744,1.3662477054565605,1,0.4,0.4,transcript,9573.0
EXD1,ENSG00000178997,asthma,MONDO_0004979,0.13662059212718744,1.3662477054565605,1,0.4,0.4,transcript,9573.0
RELCH,ENSG00000134444,cervical carcinoma,EFO_0001061,0.13661175938390185,1.366131312201046,1,0.4,0.4,transcript,29158.0
IKBIP,ENSG00000166130,bipolar disorder,MONDO_0004985,0.13659931115597218,1.3662636102917591,2,0.8,1.6,transcript,5915.0
B4GALT6,ENSG00000118276,glioblastoma multiforme,EFO_0000519,0.13659921668164166,1.3660234046141517,1,0.4,0.4,transcript,12805.0
PEX7,ENSG00000112357,lymphocyte percentage of leukocytes,EFO_0007993,0.13654998936156648,1.3655424377552097,1,0.4,0.4,transcript,9402.0
GABPA,ENSG00000154727,lymphatic system disease,EFO_0007352,0.13626709007064938,1.362706852531049,1,0.4,0.4,transcript,11126.0
GABPA,ENSG00000154727,vein disorder,MONDO_0004634,0.13626709007064938,1.362706852531049,1,0.4,0.4,transcript,11126.0
ZFP3,ENSG00000180787,ovarian dysfunction,EFO_0009003,0.13617344865125988,1.3618146950548087,1,0.4,0.4,transcript,4987.0
GABPA,ENSG00000154727,diabetic ketoacidosis,EFO_1000897,0.13608130457530204,1.3608489975775755,1,0.4,0.4,transcript,11126.0
RGS7BP,ENSG00000186479,phosphatidylcholine measurement,EFO_0010226,0.13603662433769226,1.3604543646317693,1,0.5,0.5,transcript,5674.0
KLRD1,ENSG00000134539,granulocyte percentage of myeloid white cells,EFO_0007997,0.13597387092994562,1.359903198897908,4,1.7000000000000002,6.800000000000001,transcript,41340.0
KIAA0319,ENSG00000137261,celiac disease,EFO_0001060,0.1359198363010462,1.3592107503629751,1,0.4,0.4,transcript,32291.0
MAP4K3,ENSG00000011566,body height,OBA_VT0001253,0.13583949430827166,1.3584177507004611,1,0.4,0.4,transcript,17538.0
BMP10,ENSG00000163217,endometrial cancer,MONDO_0011962,0.1357316186996816,1.3573824560491683,1,0.4,0.4,transcript,6036.0
HHLA2,ENSG00000114455,metabolite measurement,EFO_0004725,0.13555616343610444,1.3555954387015217,1,0.5,0.5,transcript,14791.0
CPD,ENSG00000108582,breast cancer,MONDO_0007254,0.13549215773923287,1.354941795750598,1,0.4,0.4,transcript,19784.0
CDKL2,ENSG00000138769,neurodegenerative disease,EFO_0005772,0.13548030429971364,1.354967145561239,2,0.8,1.6,transcript,9750.0
OR4X1,ENSG00000176567,systolic blood pressure,EFO_0006335,0.1354554446995661,1.3550991093050293,1,0.5,0.5,transcript,918.0
DPP8,ENSG00000074603,intelligence,EFO_0004337,0.13540165550599229,1.3541982751541901,4,1.6,6.4,transcript,35219.0
TRIT1,ENSG00000043514,platelet count,EFO_0004309,0.13531462041250977,1.3531614068920013,1,0.4,0.4,transcript,26311.0
STAM,ENSG00000136738,high density lipoprotein cholesterol measurement,EFO_0004612,0.13531281025264502,1.3531940982367292,1,0.4,0.4,transcript,6061.0
EXD1,ENSG00000178997,pulse pressure measurement,EFO_0005763,0.135280482107914,1.352846605263826,1,0.4,0.4,transcript,9573.0
GSTA5,ENSG00000182793,hematocrit,EFO_0004348,0.13516877566616137,1.352037896717636,1,0.5,0.5,transcript,1428.0
SKIL,ENSG00000136603,body mass index,EFO_0004340,0.13512753220622759,1.3512917818838512,1,0.5,0.5,transcript,30377.0
MCF2L2,ENSG00000053524,androgenetic alopecia,EFO_0004191,0.13506167137158526,1.3506581634192283,2,0.8,1.6,transcript,38601.0
GCNT1,ENSG00000187210,apolipoprotein B measurement,EFO_0004615,0.13506167137158526,1.35063581135252,1,0.4,0.4,transcript,20945.0
RALGPS2,ENSG00000116191,apolipoprotein A 1 measurement,EFO_0004614,0.13499815455277384,1.3500610802496154,2,0.8,1.6,transcript,20117.0
SLC22A24,ENSG00000197658,serum metabolite measurement,EFO_0005653,0.13498235682217685,1.3499088633428875,1,0.5,0.5,transcript,5862.0
SLCO1C1,ENSG00000139155,tyrosine measurement,EFO_0005058,0.1349622181089092,1.3496530719824567,1,0.5,0.5,transcript,16186.0
CP,ENSG00000047457,platelet crit,EFO_0007985,0.13491850739134362,1.3492061318649187,1,0.5,0.5,transcript,23744.0
RCN2,ENSG00000117906,FEV/FVC ratio,EFO_0004713,0.1348623105612805,1.348650420554078,1,0.4,0.4,transcript,14644.0
MANSC4,ENSG00000205693,chloride measurement,EFO_0009284,0.13485610735142342,1.3488610135262318,1,0.5,0.5,transcript,1667.0
CNR2,ENSG00000188822,eosinophil percentage of granulocytes,EFO_0007996,0.13484743524923962,1.3485503259017029,1,0.4,0.4,transcript,5265.0
CFAP54,ENSG00000188596,self reported educational attainment,EFO_0004784,0.13479450729983905,1.3480137048229677,2,1.0,2.0,transcript,29141.0
DCUN1D1,ENSG00000043093,balding measurement,EFO_0007825,0.13479450729983905,1.3479693507357056,1,0.4,0.4,transcript,16476.0
PIAS2,ENSG00000078043,self reported educational attainment,EFO_0004784,0.13478778573242758,1.3478912473420175,1,0.4,0.4,transcript,29873.0
GUCA1C,ENSG00000138472,smoking status measurement,EFO_0006527,0.13471194962952773,1.3473186994825284,1,0.5,0.5,transcript,2510.0
NEU3,ENSG00000162139,type 2 diabetes mellitus,MONDO_0005148,0.13455738846236906,1.3456061948013966,1,0.4,0.4,transcript,12380.0
ARFIP1,ENSG00000164144,arfaptin-1 measurement,EFO_0801392,0.1343305622266891,1.3433326748842316,1,0.4,0.4,transcript,14786.0
VWDE,ENSG00000146530,vein disorder,MONDO_0004634,0.1342331866868437,1.342358489518988,1,0.5,0.5,transcript,18781.0
VWDE,ENSG00000146530,lymphatic system disease,EFO_0007352,0.1342331866868437,1.342358489518988,1,0.5,0.5,transcript,18781.0
GCNT1,ENSG00000187210,lymphangioma,MONDO_0002013,0.13423299399095276,1.342349037546195,1,0.4,0.4,transcript,20945.0
GCNT1,ENSG00000187210,hemangioma,EFO_1000635,0.13423299399095276,1.342349037546195,1,0.4,0.4,transcript,20945.0
KIAA0319,ENSG00000137261,HbA1c measurement,EFO_0004541,0.13418695117931664,1.3418818991456796,1,0.4,0.4,transcript,32291.0
BCAS2,ENSG00000116752,cystatin C measurement,EFO_0004617,0.1340063674837418,1.340248347044251,1,0.4,0.4,transcript,2166.0
GLCE,ENSG00000138604,smoking initiation,EFO_0005670,0.13400481926028823,1.340178517600846,2,0.8,1.6,transcript,12277.0
AMTN,ENSG00000187689,"amelogenesis imperfecta, type 3A",MONDO_0007538,0.13397824102102468,1.3400083989108116,1,0.4,0.4,transcript,1770.0
FYCO1,ENSG00000163820,lens disease,EFO_0009674,0.1339660470639662,1.3396850814807375,1,0.4,0.4,transcript,16253.0
LINS1,ENSG00000140471,vital capacity,EFO_0004312,0.13396316093448343,1.339658897452677,1,0.5,0.5,transcript,18323.0
CPB1,ENSG00000153002,cutaneous melanoma,EFO_0000389,0.13376532390926002,1.337698817944013,1,0.5,0.5,transcript,10970.0
ARHGAP12,ENSG00000165322,cortical thickness,EFO_0004840,0.1336322151483518,1.3363342138459315,1,0.4,0.4,transcript,33161.0
CLHC1,ENSG00000162994,body height,OBA_VT0001253,0.13348800733942007,1.3349053642389148,1,0.4,0.4,transcript,15816.0
MR1,ENSG00000153029,monocyte percentage of leukocytes,EFO_0007989,0.1334513444180616,1.3346464867912078,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
SKA3,ENSG00000165480,type 2 diabetes mellitus,MONDO_0005148,0.13342162056591494,1.3343625649712605,2,0.8,1.6,transcript,10932.0
RALGPS2,ENSG00000116191,coronary artery disease,EFO_0001645,0.1333259325775062,1.333338860496939,2,0.8,1.6,transcript,20117.0
GCNT1,ENSG00000187210,glioblastoma multiforme,EFO_0000519,0.13327728010096368,1.332791898646304,1,0.4,0.4,transcript,20945.0
ABCA13,ENSG00000179869,placenta praevia,EFO_0007442,0.1331825489509386,1.3318358213687074,1,0.5,0.5,transcript,48394.0
PEX7,ENSG00000112357,myeloid leukocyte count,OBA_2045223,0.1331774700079001,1.3318172442185456,1,0.4,0.4,transcript,9402.0
CPD,ENSG00000108582,breast neoplasm,EFO_0003869,0.13288677375531185,1.328887955911388,1,0.4,0.4,transcript,19784.0
OTULINL,ENSG00000145569,placental retention,EFO_0009578,0.1328610419951471,1.3286603949639646,1,0.4,0.4,transcript,8004.0
COG3,ENSG00000136152,type 1 diabetes mellitus,MONDO_0005147,0.13262926025969915,1.3263464412962485,1,0.5,0.5,transcript,9287.0
C15orf61,ENSG00000189227,pulse pressure measurement,EFO_0005763,0.1324771731767875,1.3263932657390118,5,2.0,10.0,transcript,6167.0
CLASP2,ENSG00000163539,body weight,EFO_0004338,0.1322745366925207,1.3227514863144918,1,0.4,0.4,transcript,65366.0
FBXO28,ENSG00000143756,mean reticulocyte volume,EFO_0010701,0.13222906502959386,1.3233396380227822,5,2.0,10.0,transcript,9533.0
RCN2,ENSG00000117906,eosinophil count,EFO_0004842,0.13209463685871656,1.3209736835284385,1,0.4,0.4,transcript,14644.0
GKAP1,ENSG00000165113,self reported educational attainment,EFO_0004784,0.1320589574459889,1.3206467009951646,1,0.4,0.4,transcript,7002.0
GLCE,ENSG00000138604,body height,OBA_VT0001253,0.1317680444142205,1.3178107691401686,2,0.8,1.6,transcript,12277.0
OR5M1,ENSG00000255012,systolic blood pressure,EFO_0006335,0.13161635318912868,1.3165354519284789,2,0.8,1.6,transcript,4302.0
CCDC62,ENSG00000130783,Red cell distribution width,EFO_0009188,0.13137629347329496,1.3137898707598856,1,0.4,0.4,transcript,14850.0
POU2F1,ENSG00000143190,"Hepatitis, Alcoholic",EFO_1001345,0.13133825233198387,1.3133975353763967,2,0.8,1.6,transcript,106581.0
SUMF1,ENSG00000144455,serum gamma-glutamyl transferase measurement,EFO_0004532,0.1313248311001905,1.3132806603751357,1,0.4,0.4,transcript,12365.0
GKAP1,ENSG00000165113,linoleic acid measurement,EFO_0006807,0.13129367208983878,1.3129938474336633,1,0.4,0.4,transcript,7002.0
UBE2U,ENSG00000177414,high density lipoprotein cholesterol measurement,EFO_0004612,0.13115569081372097,1.3116241237312276,1,0.4,0.4,transcript,5951.0
SEC22A,ENSG00000121542,metabolite measurement,EFO_0004725,0.13110621410505713,1.311184175983071,2,0.8,1.6,transcript,13111.0
SLC6A5,ENSG00000165970,trait in response to apixaban,OBA_2050328,0.13103629384730028,1.3104015746171158,1,0.4,0.4,transcript,10353.0
ATRNL1,ENSG00000107518,urinary microalbumin measurement,EFO_0010967,0.13095711071570212,1.309587966298891,1,0.4,0.4,transcript,23726.0
AGBL3,ENSG00000146856,Umbilical hernia,HP_0001537,0.1309134165770057,1.3091701188871923,1,0.5,0.5,transcript,13907.0
ZNF471,ENSG00000196263,alkaline phosphatase measurement,EFO_0004533,0.13084554663529685,1.3084857052401775,1,0.4,0.4,transcript,13228.0
IL1A,ENSG00000115008,metastatic colorectal cancer,EFO_1001480,0.13082613550484715,1.3084596693766817,1,0.4,0.4,transcript,2017.0
OR4X1,ENSG00000176567,pulse pressure measurement,EFO_0005763,0.13078509447067427,1.308395607016111,1,0.5,0.5,transcript,918.0
ATP5F1A,ENSG00000152234,mean corpuscular hemoglobin,EFO_0004527,0.13071860169432523,1.3071998176608897,1,0.4,0.4,transcript,28984.0
IKBIP,ENSG00000166130,schizophrenia,MONDO_0005090,0.1306022682271734,1.3062931810037715,2,0.8,1.6,transcript,5915.0
C15orf61,ENSG00000189227,educational attainment,EFO_0011015,0.1305996659267017,1.3076181932381536,5,2.0,10.0,transcript,6167.0
TSPAN19,ENSG00000231738,glomerular filtration rate,OBA_0003747,0.1304625678658361,1.304674854955386,1,0.4,0.4,transcript,8134.0
BTAF1,ENSG00000095564,body height,OBA_VT0001253,0.13044921415386687,1.3045288859810718,1,0.4,0.4,transcript,10886.0
GABPA,ENSG00000154727,gut microbiome measurement,EFO_0007874,0.13030334071477723,1.3030693589723275,1,0.4,0.4,transcript,11126.0
GBP1,ENSG00000117228,inflammatory bowel disease,EFO_0003767,0.1302869189970945,1.3029730051798731,2,0.8,1.6,transcript,15412.0
RBM23,ENSG00000100461,periodontal measurement,EFO_0007780,0.13023811263183294,1.302390985091405,1,0.4,0.4,transcript,40573.0
CLASP2,ENSG00000163539,cutaneous melanoma,EFO_0000389,0.1300525704009924,1.300531823399209,1,0.4,0.4,transcript,65366.0
TMEM131,ENSG00000075568,monocyte percentage of leukocytes,EFO_0007989,0.12989812660177782,1.2990027148890313,1,0.4,0.4,transcript,18649.0
SUMF1,ENSG00000144455,uterine fibroid,EFO_0000731,0.12986354687096205,1.2986678180828513,1,0.4,0.4,transcript,12365.0
C15orf61,ENSG00000189227,hemoglobin measurement,EFO_0004509,0.12985707008572425,1.3001922348283792,5,2.0,10.0,transcript,6167.0
UTP20,ENSG00000120800,P-selectin glycoprotein ligand 1 measurement,EFO_0010922,0.1298533451511618,1.2985761318359883,1,0.5,0.5,transcript,11715.0
EDDM3A,ENSG00000181562,fumarate measurement,EFO_0010480,0.12980916729111983,1.2985208574605545,1,0.4,0.4,transcript,932.0
SELENOI,ENSG00000138018,total lipids in small VLDL,EFO_0022148,0.12971531303513315,1.2971947190392084,1,0.4,0.4,transcript,9618.0
SELENOI,ENSG00000138018,free cholesterol in medium VLDL measurement ,EFO_0022269,0.12971531303513315,1.2971947190392084,1,0.4,0.4,transcript,9618.0
EDDM3A,ENSG00000181562,arterial stiffness measurement,EFO_0004517,0.1294877965737999,1.2953071502873554,1,0.4,0.4,transcript,932.0
OTULIN,ENSG00000154124,eosinophil count,EFO_0004842,0.12948471544479134,1.2948663889160803,1,0.4,0.4,transcript,20796.0
DPP8,ENSG00000074603,chloride measurement,EFO_0009284,0.12936214641702334,1.2938031842645008,4,1.6,6.4,transcript,35219.0
GKAP1,ENSG00000165113,eosinophil percentage of granulocytes,EFO_0007996,0.12925339054343757,1.2925910319696512,1,0.4,0.4,transcript,7002.0
IPP,ENSG00000197429,aspartate aminotransferase measurement,EFO_0004736,0.12918982882357238,1.2919790636799888,1,0.5,0.5,transcript,6190.0
KLRD1,ENSG00000134539,lymphocyte measurement,EFO_0803546,0.12914342056391084,1.2915986952375602,4,1.7000000000000002,6.800000000000001,transcript,41340.0
KLRD1,ENSG00000134539,neutrophil measurement,EFO_0803548,0.12914342056391084,1.2915986952375602,4,1.7000000000000002,6.800000000000001,transcript,41340.0
PYGO1,ENSG00000171016,hepatocellular carcinoma,EFO_0000182,0.12913948281343324,1.2917226633971128,4,1.6,6.4,transcript,19522.0
REG1A,ENSG00000115386,educational attainment,EFO_0011015,0.1290898713059909,1.291039906141448,1,0.4,0.4,transcript,2833.0
CHFR,ENSG00000072609,lymphocyte percentage of leukocytes,EFO_0007993,0.12906198471193778,1.2906279364253153,1,0.4,0.4,transcript,49448.0
ABCA10,ENSG00000154263,cutaneous melanoma,EFO_0000389,0.1290071471478893,1.290171407630796,3,1.2000000000000002,3.6000000000000005,transcript,36023.0
ZPLD1,ENSG00000170044,C-reactive protein measurement,EFO_0004458,0.1289725241256731,1.2898842237686545,2,0.8,1.6,transcript,10064.0
GPR85,ENSG00000164604,aspartate aminotransferase measurement,EFO_0004736,0.1289725241256731,1.2897487886753451,1,0.4,0.4,transcript,16987.0
GPR85,ENSG00000164604,sex hormone-binding globulin measurement,EFO_0004696,0.1289725241256731,1.2897487886753451,1,0.4,0.4,transcript,16987.0
GPR85,ENSG00000164604,hip circumference,OBA_1000032,0.1289725241256731,1.2897487886753451,1,0.4,0.4,transcript,16987.0
GPR85,ENSG00000164604,serum alanine aminotransferase measurement,EFO_0004735,0.1289725241256731,1.2897487886753451,1,0.4,0.4,transcript,16987.0
GPR85,ENSG00000164604,low density lipoprotein triglyceride measurement,EFO_0009946,0.1289725241256731,1.2897487886753451,1,0.4,0.4,transcript,16987.0
GUCA1C,ENSG00000138472,smoking initiation,EFO_0005670,0.12882921563234304,1.2884913595106815,1,0.5,0.5,transcript,2510.0
KPNA4,ENSG00000186432,pulse pressure measurement,EFO_0005763,0.12875061781677538,1.2875151713778803,1,0.4,0.4,transcript,44478.0
OR2M7,ENSG00000177186,reticulocyte count,EFO_0007986,0.12871107989035033,1.2876432802666555,1,0.5,0.5,transcript,939.0
RBM23,ENSG00000100461,Alzheimer disease,MONDO_0004975,0.12866921630276562,1.286702021800732,1,0.4,0.4,transcript,40573.0
SLC9B1,ENSG00000164037,erythrocyte count,EFO_0004305,0.12862996930933368,1.286344665210624,1,0.5,0.5,transcript,11118.0
QSOX1,ENSG00000116260,high density lipoprotein cholesterol measurement,EFO_0004612,0.12837239986606533,1.2837530620915913,1,0.4,0.4,transcript,13763.0
TMEM225,ENSG00000204300,erythrocyte volume,OBA_0003460,0.1283061585201748,1.28328380742397,1,0.4,0.4,transcript,1800.0
CHFR,ENSG00000072609,mean corpuscular hemoglobin concentration,EFO_0004528,0.1281367987118162,1.2813760764240998,1,0.4,0.4,transcript,49448.0
HACD4,ENSG00000188921,metabolite measurement,EFO_0004725,0.12803836348263362,1.2804261744413528,1,0.4,0.4,transcript,9403.0
RPS20,ENSG00000008988,platelet count,EFO_0004309,0.12800232252925067,1.2800404347749317,1,0.4,0.4,transcript,23243.0
TMEM131,ENSG00000075568,body weight,EFO_0004338,0.12797435451217068,1.2797649939929598,1,0.4,0.4,transcript,18649.0
RBM23,ENSG00000100461,diastolic blood pressure change measurement,EFO_0006945,0.12794910718515048,1.2795009306245806,1,0.4,0.4,transcript,40573.0
KIAA0319,ENSG00000137261,mean corpuscular hemoglobin concentration,EFO_0004528,0.12777269088503485,1.2777392962028615,1,0.4,0.4,transcript,32291.0
SUMF1,ENSG00000144455,triglyceride measurement,EFO_0004530,0.1277461928405226,1.2774942777784568,1,0.4,0.4,transcript,12365.0
NUP43,ENSG00000120253,body mass index,EFO_0004340,0.12773607132471318,1.2775629121603127,2,0.8,1.6,transcript,7913.0
ZNF283,ENSG00000167637,low density lipoprotein cholesterol measurement,EFO_0004611,0.12770639397403244,1.277094025786416,1,0.5,0.5,transcript,16619.0
PAQR3,ENSG00000163291,forced expiratory volume,EFO_0004314,0.12768017065451415,1.2768167582854988,1,0.4,0.4,transcript,26575.0
HHLA2,ENSG00000114455,smoking cessation,EFO_0004319,0.127565787456294,1.2756916789034172,1,0.5,0.5,transcript,14791.0
ZFP90,ENSG00000184939,cutaneous melanoma,EFO_0000389,0.1275052214163286,1.2750655693100257,1,0.4,0.4,transcript,29951.0
OR4X1,ENSG00000176567,free cholesterol in very large HDL measurement ,EFO_0022273,0.12733953686836885,1.2739400309930566,1,0.5,0.5,transcript,918.0
LHX9,ENSG00000143355,pituitary stalk interruption syndrome,MONDO_0019828,0.12733689103234058,1.2734431769405614,2,0.8,1.6,transcript,21544.0
PTPN4,ENSG00000088179,calcium measurement,EFO_0004838,0.1272162630154619,1.2726262370160004,5,2.0,10.0,transcript,21570.0
CR2,ENSG00000117322,serum albumin amount,OBA_2050068,0.1271995587535759,1.2720139134623636,1,0.4,0.4,transcript,21827.0
YEATS2,ENSG00000163872,neuroimaging measurement,EFO_0004346,0.12717744736457004,1.2718082141140181,1,0.5,0.5,transcript,14819.0
MRPL35,ENSG00000132313,triglyceride measurement,EFO_0004530,0.12706449860302238,1.270708802239541,1,0.4,0.4,transcript,6268.0
ANKRD30B,ENSG00000180777,optic cup area,OBA_2045265,0.12700382196116858,1.270062786014673,1,0.5,0.5,transcript,20353.0
PKD2L2,ENSG00000078795,heart rate,OBA_1001087,0.12695957863781118,1.2696351626578408,1,0.5,0.5,transcript,12698.0
CNR2,ENSG00000188822,platelet count,EFO_0004309,0.12671311787047423,1.267207152114049,1,0.4,0.4,transcript,5265.0
FIGNL1,ENSG00000132436,monocyte percentage of leukocytes,EFO_0007989,0.126708297836318,1.2670991609022204,1,0.4,0.4,transcript,24718.0
FITM2,ENSG00000197296,bronchial disease,EFO_1002018,0.1266533954772533,1.266620385196042,1,0.4,0.4,transcript,4628.0
SARAF,ENSG00000133872,mammographic density percentage,EFO_0006502,0.12651215577511735,1.265148011028073,1,0.4,0.4,transcript,15121.0
DCUN1D1,ENSG00000043093,Parkinson disease,MONDO_0005180,0.1264795728666722,1.264820006404037,1,0.4,0.4,transcript,16476.0
SUMF1,ENSG00000144455,C-reactive protein measurement,EFO_0004458,0.12643939341313576,1.2644262835045885,1,0.4,0.4,transcript,12365.0
AKR1B10,ENSG00000198074,glioblastoma multiforme,EFO_0000519,0.12641709131217072,1.2643030484282611,1,0.5,0.5,transcript,3784.0
COL19A1,ENSG00000082293,platelet volume,OBA_0003277,0.12634751759471585,1.2636125150029525,2,0.8,1.6,transcript,11650.0
CNR2,ENSG00000188822,mean corpuscular hemoglobin,EFO_0004527,0.12613478116784163,1.261423785087723,1,0.4,0.4,transcript,5265.0
AKR1B10,ENSG00000198074,esophageal cancer,MONDO_0007576,0.12605356427747927,1.2606677780813467,1,0.5,0.5,transcript,3784.0
RAPGEF4,ENSG00000091428,Abruptio Placentae,EFO_1001754,0.12604701045356423,1.2604832906243189,1,0.4,0.4,transcript,30335.0
GABPA,ENSG00000154727,neurodegenerative disease,EFO_0005772,0.12591461242780477,1.259182076102603,1,0.4,0.4,transcript,11126.0
NUP43,ENSG00000120253,5-methylthioadenosine (MTA) measurement,EFO_0800130,0.12589683701806098,1.2591705690937907,2,0.8,1.6,transcript,7913.0
TLK1,ENSG00000198586,3-methyladipate measurement,EFO_0800263,0.12589025232054313,1.2589164183664416,1,0.4,0.4,transcript,28787.0
IKBIP,ENSG00000166130,phosphatidylcholine measurement,EFO_0010226,0.12576056140900632,1.2578761128221003,2,0.8,1.6,transcript,5915.0
CCDC50,ENSG00000152492,serum alanine aminotransferase measurement,EFO_0004735,0.12569769710694376,1.257013417538686,1,0.4,0.4,transcript,10975.0
LDLRAP1,ENSG00000157978,upper respiratory tract disorder,MONDO_0004867,0.1254735219520689,1.254761132969769,1,0.4,0.4,transcript,15436.0
CCDC62,ENSG00000130783,free cholesterol in HDL measurement ,EFO_0022264,0.12532652477981532,1.2532921838250892,1,0.4,0.4,transcript,14850.0
ZFP1,ENSG00000184517,chronic laryngitis,MONDO_0001369,0.12526502276197715,1.2526785803274552,1,0.4,0.4,transcript,14108.0
MRPL35,ENSG00000132313,reticulocyte count,EFO_0007986,0.1251920881522462,1.251984697731779,1,0.4,0.4,transcript,6268.0
TENT4B,ENSG00000121274,uterine fibroid,EFO_0000731,0.12509921171648544,1.2512415325974342,4,1.6,6.4,transcript,25660.0
BMP10,ENSG00000163217,atrial fibrillation,EFO_0000275,0.1250526124393354,1.2505923934457066,1,0.4,0.4,transcript,6036.0
FAM210A,ENSG00000177150,femoral neck bone mineral density,EFO_0007785,0.1250446195144969,1.2504683410867254,1,0.4,0.4,transcript,18062.0
FAM210A,ENSG00000177150,hip bone mineral density,EFO_0007702,0.1250446195144969,1.2504683410867254,1,0.4,0.4,transcript,18062.0
MAGOHB,ENSG00000111196,metabolite measurement,EFO_0004725,0.12499443029059361,1.2499745143862986,1,0.4,0.4,transcript,13240.0
FAM186A,ENSG00000185958,erythrocyte volume,OBA_0003460,0.12497976426733991,1.249908544303653,2,1.0,2.0,transcript,18034.0
SOCS4,ENSG00000180008,phenylalanine measurement,EFO_0005001,0.12492347565605912,1.2492541307735139,1,0.4,0.4,transcript,20646.0
MAGOHB,ENSG00000111196,Abruptio Placentae,EFO_1001754,0.1249153251648025,1.2491834631283876,1,0.4,0.4,transcript,13240.0
TBC1D9B,ENSG00000197226,viral load,EFO_0010125,0.12473084581904147,1.247320673049791,1,0.4,0.4,transcript,32747.0
CPD,ENSG00000108582,body weight,EFO_0004338,0.1246902694895418,1.2469229132536874,1,0.4,0.4,transcript,19784.0
SCAMP1,ENSG00000085365,rostrum of corpus callosum volume,OBA_2045228,0.12467922191336808,1.2468185661235374,1,0.4,0.4,transcript,15182.0
RNMT,ENSG00000101654,upper extremity fracture,EFO_0009514,0.12467531513708917,1.2467695730803916,1,0.4,0.4,transcript,24358.0
C6,ENSG00000039537,squamous cell lung carcinoma,EFO_0000708,0.12453789570849559,1.2454085201429586,1,0.5,0.5,transcript,16913.0
FAM91A1,ENSG00000176853,Otitis media,EFO_0004992,0.12452155324686352,1.245245905448832,1,0.5,0.5,transcript,16462.0
SEC22A,ENSG00000121542,circulating fibrinogen levels,OBA_0000061,0.12450717458584422,1.2451937807909417,2,0.8,1.6,transcript,13111.0
CFAP54,ENSG00000188596,food allergy,EFO_1001890,0.12445446289514335,1.2446132607760105,2,1.0,2.0,transcript,29141.0
NUP153,ENSG00000124789,esophageal disease,EFO_0009544,0.12412659003282137,1.2412938848807407,1,0.5,0.5,transcript,17867.0
CCDC127,ENSG00000164366,atrial flutter,EFO_0003911,0.12402174328660039,1.2402580049321363,1,0.4,0.4,transcript,9859.0
CCDC127,ENSG00000164366,atrial fibrillation,EFO_0000275,0.12402174328660039,1.2402580049321363,1,0.4,0.4,transcript,9859.0
TMEM144,ENSG00000164124,monocyte count,EFO_0005091,0.12399719170660876,1.2399888268103278,1,0.4,0.4,transcript,23655.0
ZNF573,ENSG00000189144,cystatin C measurement,EFO_0004617,0.1238850843113544,1.2388784597940188,1,0.5,0.5,transcript,18105.0
DCUN1D1,ENSG00000043093,androgenetic alopecia,EFO_0004191,0.12379087405087259,1.2379330182460409,1,0.4,0.4,transcript,16476.0
SCRG1,ENSG00000164106,heel bone mineral density,EFO_0009270,0.12379087405087259,1.2381923278890874,2,0.8,1.6,transcript,5642.0
SCRG1,ENSG00000164106,gestational age,EFO_0005112,0.12379087405087259,1.2381923278890874,2,0.8,1.6,transcript,5642.0
CFAP54,ENSG00000188596,mathematical ability,EFO_0004875,0.12379087405087259,1.237977372333303,2,1.0,2.0,transcript,29141.0
CCDC126,ENSG00000169193,chronotype measurement,EFO_0008328,0.12379087405087259,1.2379512033537365,1,0.4,0.4,transcript,9420.0
CFAP54,ENSG00000188596,body fat percentage,EFO_0007800,0.12379087405087259,1.237977372333303,2,1.0,2.0,transcript,29141.0
KPNA4,ENSG00000186432,blood sodium bicarbonate amount,OBA_2050094,0.123741398587013,1.2374229790802564,1,0.4,0.4,transcript,44478.0
EDDM3A,ENSG00000181562,diabetes mellitus,EFO_0000400,0.12369928539905645,1.2374220385399206,1,0.4,0.4,transcript,932.0
AGBL3,ENSG00000146856,Abnormality of the skeletal system,HP_0000924,0.12359396607173706,1.235975613834506,1,0.5,0.5,transcript,13907.0
IKBIP,ENSG00000166130,drug use measurement,EFO_0007010,0.12351840025660796,1.2354545012981168,2,0.8,1.6,transcript,5915.0
SAXO1,ENSG00000155875,cartilage disease,EFO_0005802,0.1234427491678444,1.2344541672369633,1,0.4,0.4,transcript,14995.0
ALDOB,ENSG00000136872,hepatocellular carcinoma,EFO_0000182,0.1233612862556475,1.2336542747109425,1,0.4,0.4,transcript,9659.0
USP15,ENSG00000135655,diffuse large B-cell lymphoma,EFO_0000403,0.123353422071532,1.2336173385579503,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
SUMF1,ENSG00000144455,breast carcinoma,EFO_0000305,0.12333330399940276,1.2333653893672585,1,0.4,0.4,transcript,12365.0
OR5M1,ENSG00000255012,hypertension,EFO_0000537,0.12333016045505094,1.2336735245877015,2,0.8,1.6,transcript,4302.0
NMRK1,ENSG00000106733,phospholipids:total lipids ratio,EFO_0020946,0.12331208166311675,1.2331667883585553,1,0.4,0.4,transcript,8701.0
YWHAG,ENSG00000170027,cortical thickness,EFO_0004840,0.12327499406367336,1.2328579028499589,1,0.4,0.4,transcript,3705.0
GANC,ENSG00000214013,serum albumin amount,OBA_2050068,0.12304286718767246,1.2304579458814084,1,0.5,0.5,transcript,17080.0
SGCB,ENSG00000163069,fat pad mass,OBA_0004528,0.1229486624155578,1.2295592194368847,1,0.4,0.4,transcript,5510.0
ZNF471,ENSG00000196263,body height,OBA_VT0001253,0.12292741009734426,1.2293043398606516,1,0.4,0.4,transcript,13228.0
CCDC50,ENSG00000152492,multinodular goiter,MONDO_0000334,0.12285863231064059,1.2286227695756544,1,0.4,0.4,transcript,10975.0
DZIP3,ENSG00000198919,Thyroid preparation use measurement,EFO_0009933,0.12284755463037694,1.2284976812160597,1,0.4,0.4,transcript,18071.0
LINS1,ENSG00000140471,glomerular filtration rate,OBA_0003747,0.12277999544608496,1.2278272425686922,1,0.5,0.5,transcript,18323.0
TRIT1,ENSG00000043514,2-stearoyl-GPE (18:0) measurement,EFO_0800343,0.1223060719270247,1.2230759220371505,1,0.4,0.4,transcript,26311.0
SAMD9L,ENSG00000177409,liver disease,EFO_0001421,0.12230279620352244,1.2230364149419677,1,0.4,0.4,transcript,47321.0
SLAIN2,ENSG00000109171,platelet count,EFO_0004309,0.12227447347846367,1.2228804775520925,2,0.8,1.6,transcript,11787.0
C15orf61,ENSG00000189227,body mass index,EFO_0004340,0.12225850671478027,1.2242066011189394,5,2.0,10.0,transcript,6167.0
LIMA1,ENSG00000050405,monocyte count,EFO_0005091,0.1221799958179484,1.221813362556013,1,0.4,0.4,transcript,29841.0
PF4V1,ENSG00000109272,gastric adenocarcinoma,EFO_0000503,0.12212476011263966,1.221785959134472,1,0.4,0.4,transcript,743.0
NRCAM,ENSG00000091129,gastric adenocarcinoma,EFO_0000503,0.12209032423320486,1.2209148956459597,1,0.4,0.4,transcript,34325.0
CCDC50,ENSG00000152492,nonsyndromic genetic hearing loss,MONDO_0019497,0.12185869097520585,1.218623356221307,1,0.4,0.4,transcript,10975.0
ELMOD1,ENSG00000110675,lean body mass,EFO_0004995,0.12180622407993039,1.2181026040687286,1,0.4,0.4,transcript,9910.0
ZNF283,ENSG00000167637,monocyte percentage of leukocytes,EFO_0007989,0.12179563940928649,1.2179864801389566,1,0.5,0.5,transcript,16619.0
ZNF283,ENSG00000167637,monocyte count,EFO_0005091,0.12179563940928649,1.2179864801389566,1,0.5,0.5,transcript,16619.0
CLEC1B,ENSG00000165682,hepatocellular carcinoma,EFO_0000182,0.12151179265928647,1.215482557404168,2,1.0,2.0,transcript,5485.0
LIMA1,ENSG00000050405,erythrocyte volume,OBA_0003460,0.12131567101279589,1.2131701145044878,1,0.4,0.4,transcript,29841.0
IKBIP,ENSG00000166130,spondylolisthesis,EFO_0007493,0.12125831805865489,1.212853679318586,2,0.8,1.6,transcript,5915.0
IKBIP,ENSG00000166130,musculoskeletal system disease,EFO_0009676,0.12125831805865489,1.212853679318586,2,0.8,1.6,transcript,5915.0
OR5M1,ENSG00000255012,platelet count,EFO_0004309,0.12120172828691887,1.2123892029063807,2,0.8,1.6,transcript,4302.0
SLC35B4,ENSG00000205060,cutaneous melanoma,EFO_0000389,0.12116743594151655,1.2117162793480936,1,0.4,0.4,transcript,9542.0
METTL25,ENSG00000127720,arterial stiffness measurement,EFO_0004517,0.12114800613851591,1.2115320094371071,1,0.5,0.5,transcript,9625.0
SLC4A8,ENSG00000050438,total cholesterol measurement,EFO_0004574,0.12112271909789395,1.2112586988263627,2,0.8,1.6,transcript,50781.0
ZBTB34,ENSG00000177125,hypertension,EFO_0000537,0.12108838173602801,1.2109141456641697,1,0.4,0.4,transcript,13189.0
SLC5A7,ENSG00000115665,squamous cell lung carcinoma,EFO_0000708,0.121055704950912,1.2106126127817969,1,0.4,0.4,transcript,7199.0
AKR1B10,ENSG00000198074,hepatocellular carcinoma,EFO_0000182,0.12105559104985399,1.210688045805094,1,0.5,0.5,transcript,3784.0
NUP43,ENSG00000120253,retinal layer thickness,OBA_2050110,0.12102557804045928,1.2104579793177737,2,0.8,1.6,transcript,7913.0
QSOX1,ENSG00000116260,body mass index,EFO_0004340,0.1209424075693186,1.209453139124124,1,0.4,0.4,transcript,13763.0
GABPA,ENSG00000154727,Dementia,HP_0000726,0.1209395893914582,1.209431845739137,1,0.4,0.4,transcript,11126.0
CCDC127,ENSG00000164366,mitochondrial disease,MONDO_0044970,0.12093474133849409,1.2093879854510734,1,0.4,0.4,transcript,9859.0
CCDC127,ENSG00000164366,"mitochondrial complex II deficiency, nuclear type 1",MONDO_0100294,0.12093474133849409,1.2093879854510734,1,0.4,0.4,transcript,9859.0
CCDC127,ENSG00000164366,Leigh syndrome,MONDO_0009723,0.12093474133849409,1.2093879854510734,1,0.4,0.4,transcript,9859.0
CCDC127,ENSG00000164366,pheochromocytoma,MONDO_0008233,0.12093474133849409,1.2093879854510734,1,0.4,0.4,transcript,9859.0
ZNF24,ENSG00000172466,mathematical ability,EFO_0004875,0.12084449134208801,1.2084677862479616,1,0.5,0.5,transcript,21860.0
ZNF483,ENSG00000173258,nervous system disease,EFO_0000618,0.12068915687472782,1.2069750499118406,2,0.8,1.6,transcript,19166.0
CRYGD,ENSG00000118231,hereditary hyperferritinemia with congenital cataracts,MONDO_0010952,0.12065113857303712,1.2071344386898728,1,0.4,0.4,transcript,642.0
CDKL2,ENSG00000138769,total cholesterol measurement,EFO_0004574,0.1205879356312366,1.2060434588764686,2,0.8,1.6,transcript,9750.0
ORMDL1,ENSG00000128699,brain volume,OBA_2050009,0.12054265147654704,1.2055535896602365,2,0.8,1.6,transcript,12591.0
LIMA1,ENSG00000050405,brain attribute,OBA_2045210,0.1204827714872829,1.204841119249358,1,0.4,0.4,transcript,29841.0
GABPA,ENSG00000154727,neoplasm,EFO_0000616,0.12044976128097062,1.2045335646342614,1,0.4,0.4,transcript,11126.0
GABPA,ENSG00000154727,cancer,MONDO_0004992,0.12034375147593299,1.203473466583885,1,0.4,0.4,transcript,11126.0
ZDHHC21,ENSG00000175893,serum gamma-glutamyl transferase measurement,EFO_0004532,0.12032341965445612,1.2035817770583286,4,1.6,6.4,transcript,18413.0
GANC,ENSG00000214013,citrate measurement,EFO_0010114,0.12029308547980304,1.2029601288027143,1,0.5,0.5,transcript,17080.0
CRYGD,ENSG00000118231,Rheumatoid arthritis,HP_0001370,0.12027417852077533,1.2033648381672548,1,0.4,0.4,transcript,642.0
AKR1B10,ENSG00000198074,level of aldo-keto reductase family 1 member B1 in blood serum,OBA_2040547,0.1202676496753406,1.2028086320599598,1,0.5,0.5,transcript,3784.0
ZNF148,ENSG00000163848,autism spectrum disorder,EFO_0003756,0.12011345277252809,1.2011463961049504,1,0.4,0.4,transcript,33703.0
RBM23,ENSG00000100461,schizophrenia,MONDO_0005090,0.12009774017316291,1.2009872605047047,1,0.4,0.4,transcript,40573.0
TMEM131,ENSG00000075568,total blood protein measurement,EFO_0004536,0.12009165821808043,1.2009380310520574,1,0.4,0.4,transcript,18649.0
ZBTB34,ENSG00000177125,low tension glaucoma,EFO_1001022,0.12000726386655754,1.200102966969465,1,0.4,0.4,transcript,13189.0
DPP8,ENSG00000074603,mean reticulocyte volume,EFO_0010701,0.11998916763925584,1.2000733964868258,4,1.6,6.4,transcript,35219.0
LINS1,ENSG00000140471,serum creatinine amount,OBA_2050096,0.1199637022923057,1.1996643110308998,1,0.5,0.5,transcript,18323.0
MAN1A2,ENSG00000198162,mathematical ability,EFO_0004875,0.1198990394908765,1.1991179154315992,2,0.8,1.6,transcript,12547.0
SUMF1,ENSG00000144455,urinary microalbumin measurement,EFO_0010967,0.11983744367290008,1.1984067861022316,1,0.4,0.4,transcript,12365.0
ZBTB34,ENSG00000177125,level of kynurenine--oxoglutarate transaminase 1 in blood serum,OBA_2040924,0.11982689952665332,1.198299323570423,1,0.4,0.4,transcript,13189.0
MANSC4,ENSG00000205693,adverse effect,EFO_0009658,0.11962113696875264,1.196511309699524,1,0.5,0.5,transcript,1667.0
SLC35B4,ENSG00000205060,cognitive function measurement,EFO_0008354,0.11950401906885365,1.1950821106214644,1,0.4,0.4,transcript,9542.0
CGAS,ENSG00000164430,neoplasm,EFO_0000616,0.11935642741603174,1.193801929296309,2,0.9,1.8,transcript,7574.0
KLRD1,ENSG00000134539,platelet crit,EFO_0007985,0.1193104282429388,1.1932687720278399,4,1.7000000000000002,6.800000000000001,transcript,41340.0
GABPA,ENSG00000154727,hepatocellular carcinoma,EFO_0000182,0.11923881145044378,1.192424066328993,1,0.4,0.4,transcript,11126.0
SLC35B4,ENSG00000205060,level of carboxypeptidase A1 in blood serum,OBA_2041112,0.11920425372288185,1.1920844571617466,1,0.4,0.4,transcript,9542.0
RAPGEF4,ENSG00000091428,arterial stiffness measurement,EFO_0004517,0.11919212388932171,1.1919344249818935,1,0.4,0.4,transcript,30335.0
SKA3,ENSG00000165480,hypertension,EFO_0000537,0.11916983022503207,1.1918446615624319,2,0.8,1.6,transcript,10932.0
HECW2,ENSG00000138411,eosinophil percentage of leukocytes,EFO_0007991,0.11914810125836117,1.1914868287350644,1,0.4,0.4,transcript,68774.0
YEATS2,ENSG00000163872,acute myeloid leukemia,EFO_0000222,0.1191019177175699,1.1910529176440166,1,0.5,0.5,transcript,14819.0
KRT20,ENSG00000171431,neoplasm,EFO_0000616,0.11907884997526488,1.1909779834096834,1,0.4,0.4,transcript,2111.0
FAM174A,ENSG00000174132,HbA1c measurement,EFO_0004541,0.11907321785680841,1.1908325549796273,1,0.4,0.4,transcript,3985.0
SUMF1,ENSG00000144455,hemoglobin measurement,EFO_0004509,0.11906394782858064,1.1906718276590371,1,0.4,0.4,transcript,12365.0
RNF14,ENSG00000013561,erythrocyte count,EFO_0004305,0.11899088760458136,1.1899687070233023,2,0.8,1.6,transcript,26742.0
CLEC6A,ENSG00000205846,head and neck squamous cell carcinoma,EFO_0000181,0.11896912598575116,1.1899342732232467,1,0.4,0.4,transcript,1646.0
NMRK1,ENSG00000106733,hematocrit,EFO_0004348,0.11894572322614383,1.189503203988826,1,0.4,0.4,transcript,8701.0
DZIP3,ENSG00000198919,hypothyroidism,EFO_0004705,0.1189035265540441,1.1890574004527315,1,0.4,0.4,transcript,18071.0
PRDM10,ENSG00000170325,metabolite measurement,EFO_0004725,0.11887366528128888,1.1887480553214407,1,0.4,0.4,transcript,35080.0
ATP5F1A,ENSG00000152234,mitochondrial disease,MONDO_0044970,0.11881992328113164,1.1882130335289538,1,0.4,0.4,transcript,28984.0
HFE,ENSG00000010704,neoplasm,EFO_0000616,0.11877781017228842,1.1877863868986334,1,0.4,0.4,transcript,48279.0
CLDN1,ENSG00000163347,bone tissue density,OBA_1000110,0.1187769514563355,1.1894198497876975,4,1.6,6.4,transcript,3878.0
PIGN,ENSG00000197563,Neurodevelopmental delay,HP_0012758,0.11863513335378928,1.1863538733655654,1,0.4,0.4,transcript,157491.0
SYCP1,ENSG00000198765,brain aneurysm,EFO_0003870,0.11863513335378928,1.186372461786361,1,0.4,0.4,transcript,18932.0
GSTA5,ENSG00000182793,IGF-1 measurement,EFO_0004627,0.1185792290666281,1.1861424307223034,1,0.5,0.5,transcript,1428.0
FRRS1L,ENSG00000260230,body weight,EFO_0004338,0.11852902645332933,1.1853761705735617,2,0.8,1.6,transcript,18625.0
GABPA,ENSG00000154727,late-onset Alzheimers disease,EFO_1001870,0.11851192331884018,1.185155185012957,1,0.4,0.4,transcript,11126.0
WAPL,ENSG00000062650,Abnormal pinna morphology,HP_0000377,0.11826555349910459,1.182789291887886,2,0.8,1.6,transcript,11962.0
WAPL,ENSG00000062650,clubfoot,MONDO_0007342,0.11826555349910459,1.182789291887886,2,0.8,1.6,transcript,11962.0
WAPL,ENSG00000062650,ventricular septal defect,MONDO_0002070,0.11826555349910459,1.182789291887886,2,0.8,1.6,transcript,11962.0
INF2,ENSG00000203485,glomerulonephritis,MONDO_0002462,0.11826555349910459,1.1826585978719917,1,0.4,0.4,transcript,130596.0
INF2,ENSG00000203485,oligohydramnios,EFO_0007401,0.11826555349910459,1.1826585978719917,1,0.4,0.4,transcript,130596.0
LHX9,ENSG00000143355,genetic disorder,EFO_0000508,0.11826555349910459,1.1827298016082015,2,0.8,1.6,transcript,21544.0
NEMF,ENSG00000165525,Hereditary breast and ovarian cancer syndrome,Orphanet_145,0.11826555349910459,1.1826757182550833,1,0.5,0.5,transcript,24773.0
INF2,ENSG00000203485,motor peripheral neuropathy,MONDO_0002316,0.11826555349910459,1.1826585978719917,1,0.4,0.4,transcript,130596.0
SMC3,ENSG00000108055,neuromuscular disease,EFO_1001902,0.11826555349910459,1.182664147513654,1,0.4,0.4,transcript,46444.0
FZD6,ENSG00000164930,Primary amenorrhea,HP_0000786,0.11826555349910459,1.1827354271366493,2,0.8,1.6,transcript,20027.0
SMC3,ENSG00000108055,Neurodevelopmental disorder,EFO_0010642,0.11826555349910459,1.182664147513654,1,0.4,0.4,transcript,46444.0
ZNF483,ENSG00000173258,primary ovarian insufficiency,EFO_0004266,0.11826555349910459,1.1827390161556082,2,0.8,1.6,transcript,19166.0
ZBTB34,ENSG00000177125,Neurodevelopmental disorder,EFO_0010642,0.11826555349910459,1.1826858632949355,1,0.4,0.4,transcript,13189.0
XG,ENSG00000124343,primary ovarian insufficiency,EFO_0004266,0.11826555349910459,1.182868329245601,2,0.8,1.6,transcript,7519.0
VAT1L,ENSG00000171724,undetermined early-onset epileptic encephalopathy,MONDO_0018614,0.11826555349910459,1.1827463202838284,1,0.4,0.4,transcript,4406.0
VAT1L,ENSG00000171724,developmental and epileptic encephalopathy,MONDO_0100062,0.11826555349910459,1.1827463202838284,1,0.4,0.4,transcript,4406.0
WAPL,ENSG00000062650,Polyhydramnios,HP_0001561,0.11826555349910459,1.182789291887886,2,0.8,1.6,transcript,11962.0
INF2,ENSG00000203485,premature birth,EFO_0003917,0.11826555349910459,1.1826585978719917,1,0.4,0.4,transcript,130596.0
AHNAK2,ENSG00000185567,Familial paroxysmal ataxia,Orphanet_97,0.11826555349910459,1.1827033647172207,2,1.0,2.0,transcript,41815.0
ARHGAP29,ENSG00000137962,isolated cleft palate,MONDO_0007336,0.11826555349910459,1.1826757607100702,1,0.5,0.5,transcript,24721.0
NEMF,ENSG00000165525,hereditary breast ovarian cancer syndrome,MONDO_0003582,0.11826555349910459,1.1826757182550833,1,0.5,0.5,transcript,24773.0
PIGB,ENSG00000069943,hyperphosphatasia-intellectual disability syndrome,MONDO_0016596,0.11826555349910459,1.1826956859586844,1,0.5,0.5,transcript,12453.0
ADAT2,ENSG00000189007,peroxisome biogenesis disorder 1A (Zellweger),MONDO_0008953,0.11826555349910459,1.1826853434715587,1,0.4,0.4,transcript,13419.0
TAF1B,ENSG00000115750,orofacial cleft 1,MONDO_0007335,0.11826555349910459,1.182709936035546,1,0.5,0.5,transcript,9191.0
HECW2,ENSG00000138411,developmental disorder of mental health,EFO_0005548,0.11826555349910459,1.1826613511424986,1,0.4,0.4,transcript,68774.0
PUS7L,ENSG00000129317,immunodeficiency 67,MONDO_0011888,0.11826555349910459,1.182792453562529,3,1.2000000000000002,3.6000000000000005,transcript,26293.0
PUS7L,ENSG00000129317,Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency,Orphanet_70592,0.11826555349910459,1.182792453562529,3,1.2000000000000002,3.6000000000000005,transcript,26293.0
AHNAK2,ENSG00000185567,hereditary episodic ataxia,MONDO_0016227,0.11826555349910459,1.1827033647172207,2,1.0,2.0,transcript,41815.0
VAT1L,ENSG00000171724,"developmental and epileptic encephalopathy, 28",MONDO_0014533,0.11826555349910459,1.1827463202838284,1,0.4,0.4,transcript,4406.0
AHNAK2,ENSG00000185567,migraine disorder,MONDO_0005277,0.11826555349910459,1.1827033647172207,2,1.0,2.0,transcript,41815.0
WAPL,ENSG00000062650,Talipes equinovarus,HP_0001762,0.11826555349910459,1.182789291887886,2,0.8,1.6,transcript,11962.0
NEU3,ENSG00000162139,marfanoid habitus and intellectual disability,EFO_0022914,0.11826555349910459,1.182687845168752,1,0.4,0.4,transcript,12380.0
REG1A,ENSG00000115386,focal segmental glomerulosclerosis,EFO_0004236,0.11826555349910459,1.1827967280725848,1,0.4,0.4,transcript,2833.0
WAPL,ENSG00000062650,Large for gestational age,HP_0001520,0.11826555349910459,1.182789291887886,2,0.8,1.6,transcript,11962.0
INF2,ENSG00000203485,Small for gestational age,HP_0001518,0.11826555349910459,1.1826585978719917,1,0.4,0.4,transcript,130596.0
INF2,ENSG00000203485,glomerulopathy with fibronectin deposits 2,MONDO_0011165,0.11826555349910459,1.1826585978719917,1,0.4,0.4,transcript,130596.0
CMYA5,ENSG00000164309,urinary tract obstruction,EFO_0009571,0.11821395268140093,1.1821671434944843,1,0.5,0.5,transcript,18105.0
IL1A,ENSG00000115008,systemic scleroderma,EFO_0000717,0.11819405880111439,1.182138902339354,1,0.4,0.4,transcript,2017.0
CCDC126,ENSG00000169193,insomnia,EFO_0004698,0.1181556943989641,1.1815994068346516,1,0.4,0.4,transcript,9420.0
CGAS,ENSG00000164430,body height,OBA_VT0001253,0.1181556943989641,1.1817945991256325,2,0.9,1.8,transcript,7574.0
SMC6,ENSG00000163029,pneumothorax,MONDO_0002076,0.1181556943989641,1.1815733535728374,1,0.4,0.4,transcript,24376.0
ARMCX4,ENSG00000196440,"osteoarthritis, hip",EFO_1000786,0.1181556943989641,1.181573567988045,1,0.5,0.5,transcript,30077.0
THAP1,ENSG00000131931,color vision disorder,MONDO_0001703,0.1181556943989641,1.181636309069006,1,0.4,0.4,transcript,5040.0
SMC6,ENSG00000163029,pleural empyema,EFO_0009680,0.1181556943989641,1.1815733535728374,1,0.4,0.4,transcript,24376.0
ABCA13,ENSG00000179869,urinary microalbumin measurement,EFO_0010967,0.11813430687565218,1.1813534006158433,1,0.5,0.5,transcript,48394.0
GABPA,ENSG00000154727,non-small cell lung carcinoma,EFO_0003060,0.11809496367262945,1.1809855885508496,1,0.4,0.4,transcript,11126.0
CLASP2,ENSG00000163539,appendicular lean mass,EFO_0004980,0.11809098013252582,1.180915920714543,1,0.4,0.4,transcript,65366.0
SLC9B1,ENSG00000164037,Agents acting on the renin-angiotensin system use measurement,EFO_0009931,0.11806160589548644,1.1806610310721517,1,0.5,0.5,transcript,11118.0
HPSE,ENSG00000173083,neoplasm,EFO_0000616,0.11800768660765229,1.1801647138071232,2,0.9,1.8,transcript,20490.0
RCN2,ENSG00000117906,irritable bowel syndrome,EFO_0000555,0.11792927986478413,1.1793201135891143,1,0.4,0.4,transcript,14644.0
RCN2,ENSG00000117906,heart rate,OBA_1001087,0.11792927986478413,1.1793201135891143,1,0.4,0.4,transcript,14644.0
GABPA,ENSG00000154727,breast cancer,MONDO_0007254,0.11786576830140198,1.178693634838575,1,0.4,0.4,transcript,11126.0
CP,ENSG00000047457,neoplasm,EFO_0000616,0.11781030908855628,1.1781241488370453,1,0.5,0.5,transcript,23744.0
METTL14,ENSG00000145388,serum creatinine amount,OBA_2050096,0.1177514091776658,1.1775396786761654,1,0.4,0.4,transcript,15633.0
YEATS2,ENSG00000163872,body mass index,EFO_0004340,0.11773105534169366,1.1773442938852543,1,0.5,0.5,transcript,14819.0
CRYGD,ENSG00000118231,cataract 38,MONDO_0013859,0.11771543872990463,1.1777774402585477,1,0.4,0.4,transcript,642.0
CRYGD,ENSG00000118231,cataract 13 with adult I phenotype,MONDO_0007289,0.11771543872990463,1.1777774402585477,1,0.4,0.4,transcript,642.0
CFAP54,ENSG00000188596,Polyarteritis Nodosa,EFO_0009012,0.11762475702649677,1.1763162020895448,2,1.0,2.0,transcript,29141.0
GABPA,ENSG00000154727,cataract,MONDO_0005129,0.11758962204875399,1.175932172312095,1,0.4,0.4,transcript,11126.0
SUMF1,ENSG00000144455,hematocrit,EFO_0004348,0.11754894918844737,1.1755218412577044,1,0.4,0.4,transcript,12365.0
TENT4B,ENSG00000121274,adolescent idiopathic scoliosis,EFO_0005423,0.11747009849901703,1.1749504004227502,4,1.6,6.4,transcript,25660.0
NRCAM,ENSG00000091129,serum creatinine amount,OBA_2050096,0.11746829443112067,1.174694597625118,1,0.4,0.4,transcript,34325.0
HHLA2,ENSG00000114455,neoplasm,EFO_0000616,0.11745222401399907,1.174556044480468,1,0.5,0.5,transcript,14791.0
LSM11,ENSG00000155858,Red cell distribution width,EFO_0009188,0.11739177068773049,1.1739786174909794,1,0.4,0.4,transcript,6567.0
NEU3,ENSG00000162139,diabetic eye disease,EFO_0009486,0.11738139748218981,1.173846284999604,1,0.4,0.4,transcript,12380.0
NSUN7,ENSG00000179299,sinusitis,EFO_0007486,0.11736607786861702,1.1736998076456582,1,0.5,0.5,transcript,12811.0
ZFP3,ENSG00000180787,platelet count,EFO_0004309,0.11732181245503508,1.1732983330925606,1,0.4,0.4,transcript,4987.0
KRTAP19-1,ENSG00000184351,urinary microalbumin measurement,EFO_0010967,0.11732181245503508,1.1738223541576016,1,0.4,0.4,transcript,662.0
CRYGD,ENSG00000118231,isolated ectopia lentis,MONDO_0015998,0.11719903661672298,1.1726134191267314,1,0.4,0.4,transcript,642.0
ALDOB,ENSG00000136872,endometrial cancer,MONDO_0011962,0.11719195699650248,1.1719609821194923,1,0.4,0.4,transcript,9659.0
USP15,ENSG00000135655,metabolite measurement,EFO_0004725,0.11713035517352183,1.1713866695778485,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
C6,ENSG00000039537,Central Nervous System Neoplasm,EFO_1000158,0.11708034860437495,1.1708330491017522,1,0.5,0.5,transcript,16913.0
C6,ENSG00000039537,Benign Brain Neoplasm,EFO_1000107,0.11708034860437495,1.1708330491017522,1,0.5,0.5,transcript,16913.0
TXK,ENSG00000074966,tyrosine-protein kinase TEC measurement,EFO_0020830,0.11705679059193741,1.170597298233284,1,0.4,0.4,transcript,13609.0
CCDC14,ENSG00000175455,diastolic blood pressure change measurement,EFO_0006945,0.11701124713934744,1.1701211369047395,1,0.4,0.4,transcript,46160.0
SGCB,ENSG00000163069,body mass index,EFO_0004340,0.11700381102116351,1.1701107054929418,1,0.4,0.4,transcript,5510.0
CRYGD,ENSG00000118231,Posterior polar cataract,Orphanet_98993,0.11696481340848976,1.1702711870443991,1,0.4,0.4,transcript,642.0
SLC30A9,ENSG00000014824,serum creatinine amount,OBA_2050096,0.11692875502359934,1.1696393135624117,3,1.3,3.9000000000000004,transcript,11087.0
NOM1,ENSG00000146909,hippocampal volume,EFO_0005035,0.11689475271681432,1.1698288950510976,5,2.0,10.0,transcript,11346.0
PDCD4,ENSG00000150593,Mitral valve prolapse,HP_0001634,0.11685384109008991,1.168573422454712,1,0.5,0.5,transcript,14281.0
ANKRD29,ENSG00000154065,reticulocyte count,EFO_0007986,0.11681538884840799,1.168187499105036,1,0.4,0.4,transcript,11901.0
PAG1,ENSG00000076641,breast cancer,MONDO_0007254,0.11669138882095523,1.1670439800869405,2,0.8,1.6,transcript,12299.0
CP,ENSG00000047457,Alzheimer disease,MONDO_0004975,0.11667116619620152,1.1667327199134978,1,0.5,0.5,transcript,23744.0
PAQR3,ENSG00000163291,hemoglobin measurement,EFO_0004509,0.11659910541997329,1.1660061059400904,1,0.4,0.4,transcript,26575.0
SEC22A,ENSG00000121542,placenta praevia,EFO_0007442,0.11655643111955477,1.1656863461280473,2,0.8,1.6,transcript,13111.0
RBM23,ENSG00000100461,cerebral cortex area attribute,OBA_2045267,0.1165206901103256,1.1652167598763317,1,0.4,0.4,transcript,40573.0
SGCB,ENSG00000163069,platelet crit,EFO_0007985,0.11648118999890454,1.164884495270352,1,0.4,0.4,transcript,5510.0
SLC9B1,ENSG00000164037,head and neck squamous cell carcinoma,EFO_0000181,0.11634152109611706,1.1634601830784579,1,0.5,0.5,transcript,11118.0
ANO6,ENSG00000177119,head and neck squamous cell carcinoma,EFO_0000181,0.11634152109611706,1.163422632111449,1,0.4,0.4,transcript,53900.0
SMU1,ENSG00000122692,aspartate aminotransferase measurement,EFO_0004736,0.11627571197426212,1.1632616040475539,3,1.2000000000000002,3.6000000000000005,transcript,7136.0
RCC1L,ENSG00000274523,Sleep Disorder,EFO_0008568,0.11620989747249527,1.1621420364108177,1,0.4,0.4,transcript,9289.0
METTL14,ENSG00000145388,colorectal carcinoma,EFO_1001951,0.11616116482704703,1.1616372351699777,1,0.4,0.4,transcript,15633.0
VWDE,ENSG00000146530,body mass index,EFO_0004340,0.11608769777673036,1.1609036004178546,1,0.5,0.5,transcript,18781.0
LIN9,ENSG00000183814,sex hormone-binding globulin measurement,EFO_0004696,0.11598467195132642,1.1599515550525121,2,0.8,1.6,transcript,15262.0
TEX15,ENSG00000133863,ovarian cancer,MONDO_0008170,0.11582731518606149,1.1582880754518279,1,0.5,0.5,transcript,33504.0
CD93,ENSG00000125810,neoplasm,EFO_0000616,0.11582192562845352,1.1582455738054247,1,0.4,0.4,transcript,15199.0
RELCH,ENSG00000134444,upper respiratory tract disorder,MONDO_0004867,0.11581352246228666,1.1581489429848943,1,0.4,0.4,transcript,29158.0
UBE2U,ENSG00000177414,musculoskeletal system disease,EFO_0009676,0.11573411174761494,1.1574083330701672,1,0.4,0.4,transcript,5951.0
CCDC62,ENSG00000130783,reticulocyte measurement,EFO_0010700,0.11570429883433192,1.1570699243702554,1,0.4,0.4,transcript,14850.0
C15orf61,ENSG00000189227,erythrocyte count,EFO_0004305,0.11567756374005836,1.1583971713717203,5,2.0,10.0,transcript,6167.0
LIMA1,ENSG00000050405,bone tissue density,OBA_1000110,0.11561558026478298,1.1561692070243588,1,0.4,0.4,transcript,29841.0
OR8H2,ENSG00000181767,lipid measurement,EFO_0004529,0.11557780533795196,1.1558334703925426,1,0.4,0.4,transcript,7218.0
ALDOB,ENSG00000136872,systolic blood pressure,EFO_0006335,0.1154937045889693,1.1549784580441604,1,0.4,0.4,transcript,9659.0
POM121L2,ENSG00000158553,Red cell distribution width,EFO_0009188,0.1154937045889693,1.1550288100557862,1,0.4,0.4,transcript,4359.0
MAGOHB,ENSG00000111196,cardiomyopathy,EFO_0000318,0.1154937045889693,1.1549672573700556,1,0.4,0.4,transcript,13240.0
CDCA4,ENSG00000170779,body height,OBA_VT0001253,0.1154937045889693,1.1550374474961187,1,0.4,0.4,transcript,3984.0
RTF1,ENSG00000137815,body fat percentage,EFO_0007800,0.11543855077612122,1.15443722744055,1,0.4,0.4,transcript,7734.0
RBM23,ENSG00000100461,blood phosphate measurement,EFO_0010972,0.11542241103660833,1.154233969139159,1,0.4,0.4,transcript,40573.0
CLSTN2,ENSG00000158258,mean corpuscular hemoglobin concentration,EFO_0004528,0.11538870719390674,1.1539111581677661,1,0.4,0.4,transcript,16607.0
ADAT2,ENSG00000189007,diastolic blood pressure,EFO_0006336,0.11538128211192283,1.1538426295997413,1,0.4,0.4,transcript,13419.0
NOM1,ENSG00000146909,glucose measurement,EFO_0004468,0.11523892737542918,1.1532706416372462,5,2.0,10.0,transcript,11346.0
ATP8A1,ENSG00000124406,Abruptio Placentae,EFO_1001754,0.11523105411990031,1.1524883041632006,4,1.6,6.4,transcript,36003.0
GANC,ENSG00000214013,circulating fibrinogen levels,OBA_0000061,0.1150449779294227,1.1504790532989109,1,0.5,0.5,transcript,17080.0
ATP5F1A,ENSG00000152234,serum urea amount,OBA_2050065,0.11500810838234346,1.150094884541072,1,0.4,0.4,transcript,28984.0
SNIP1,ENSG00000163877,mean corpuscular hemoglobin concentration,EFO_0004528,0.11497906349251412,1.1498361308305098,1,0.4,0.4,transcript,8792.0
CGAS,ENSG00000164430,cancer,MONDO_0004992,0.11497500892460333,1.1499877443820248,2,0.9,1.8,transcript,7574.0
FAM210A,ENSG00000177150,triglyceride measurement,EFO_0004530,0.11495261001958094,1.1495482461375657,1,0.4,0.4,transcript,18062.0
G3BP2,ENSG00000138757,glucose measurement,EFO_0004468,0.1149406868979213,1.14940862221942,1,0.4,0.4,transcript,228149.0
SEC22A,ENSG00000121542,pulse wave reflection index measurement,EFO_0009804,0.11490654169212518,1.1491874518537513,2,0.8,1.6,transcript,13111.0
RBM25,ENSG00000119707,uric acid measurement,EFO_0004761,0.11479369817155631,1.147949671668293,1,0.4,0.4,transcript,31521.0
CRYGD,ENSG00000118231,Partial congenital cataract,Orphanet_98992,0.11469422973688705,1.147565350328372,1,0.4,0.4,transcript,642.0
RTF1,ENSG00000137815,granulocyte count,EFO_0007987,0.11460066327561431,1.146058352435481,1,0.4,0.4,transcript,7734.0
RTF1,ENSG00000137815,sum of neutrophil and eosinophil counts,EFO_0009390,0.11460066327561431,1.146058352435481,1,0.4,0.4,transcript,7734.0
BMP10,ENSG00000163217,head and neck squamous cell carcinoma,EFO_0000181,0.1144811074430765,1.1448773434831176,1,0.4,0.4,transcript,6036.0
PARP14,ENSG00000173193,platelet volume,OBA_0003277,0.11440687405671549,1.1440827285375004,1,0.4,0.4,transcript,28596.0
CCDC62,ENSG00000130783,azoospermia,EFO_0000279,0.11439775185420253,1.1440044545689614,1,0.4,0.4,transcript,14850.0
CENPQ,ENSG00000031691,Abnormal pupillary function,HP_0007686,0.11438009843667796,1.144030737382288,1,0.4,0.4,transcript,1741.0
ZNF148,ENSG00000163848,non-high density lipoprotein cholesterol measurement,EFO_0005689,0.11428984374866165,1.142910305866286,1,0.4,0.4,transcript,33703.0
NRCAM,ENSG00000091129,glomerular filtration rate,OBA_0003747,0.11421298773960405,1.1421415307099516,1,0.4,0.4,transcript,34325.0
NCS1,ENSG00000107130,benign chondrogenic neoplasm,MONDO_0024470,0.11419502227324294,1.1420118750135637,1,0.4,0.4,transcript,6488.0
RBM25,ENSG00000119707,"chromosome, telomeric region length",OBA_0003784,0.1141860253052567,1.141872943005297,1,0.4,0.4,transcript,31521.0
MC2R,ENSG00000185231,neuroblastoma,EFO_0000621,0.11413196017202028,1.1414142090995782,1,0.4,0.4,transcript,4228.0
OTULIN,ENSG00000154124,phosphate measurement,EFO_0010968,0.11408834078460846,1.1409026423142514,1,0.4,0.4,transcript,20796.0
METTL14,ENSG00000145388,neoplasm,EFO_0000616,0.11401889604028576,1.1402145473023648,1,0.4,0.4,transcript,15633.0
IKBIP,ENSG00000166130,body mass index,EFO_0004340,0.11398190064167979,1.1400895051488351,2,0.8,1.6,transcript,5915.0
FRRS1L,ENSG00000260230,educational attainment,EFO_0011015,0.113869112089882,1.1387770269390884,2,0.8,1.6,transcript,18625.0
GBP1,ENSG00000117228,neoplasm,EFO_0000616,0.11385852451583482,1.1386890603672764,2,0.8,1.6,transcript,15412.0
SUMF1,ENSG00000144455,alkaline phosphatase measurement,EFO_0004533,0.1138367501190332,1.1383998505635629,1,0.4,0.4,transcript,12365.0
RCN2,ENSG00000117906,diverticular disease,EFO_0009959,0.1138367501190332,1.1383948161316049,1,0.4,0.4,transcript,14644.0
SGCB,ENSG00000163069,body weight,EFO_0004338,0.113733107221571,1.1374036674970167,1,0.4,0.4,transcript,5510.0
FBXO28,ENSG00000143756,phosphatidylcholine 36:0 measurement,EFO_0021473,0.11360670453811819,1.1371160331080254,5,2.0,10.0,transcript,9533.0
SLC5A7,ENSG00000115665,distal hereditary motor neuropathy,MONDO_0018894,0.11359447478017291,1.136000311074406,1,0.4,0.4,transcript,7199.0
SEC22A,ENSG00000121542,temporomandibular joint disorder,EFO_0005279,0.11350596139327797,1.1351816488652793,2,0.8,1.6,transcript,13111.0
IPP,ENSG00000197429,body mass index,EFO_0004340,0.1134239638984672,1.134320414428937,1,0.5,0.5,transcript,6190.0
HLA-E,ENSG00000204592,neoplasm,EFO_0000616,0.11335668637734572,1.1336625346655884,1,0.4,0.4,transcript,4181.0
KPNA4,ENSG00000186432,glomerular filtration rate,OBA_0003747,0.11324842980055586,1.1324932912156849,1,0.4,0.4,transcript,44478.0
OR4X1,ENSG00000176567,cholesterol:total lipids ratio,EFO_0020943,0.1130514133409247,1.1310587957186151,1,0.5,0.5,transcript,918.0
CR1L,ENSG00000197721,X-21444 measurement,EFO_0020016,0.1130376846219471,1.1304701298015605,1,0.5,0.5,transcript,5360.0
REG1A,ENSG00000115386,neoplasm,EFO_0000616,0.11294128880555218,1.1295540811370608,1,0.4,0.4,transcript,2833.0
SRGN,ENSG00000122862,breast cancer,MONDO_0007254,0.11290441232203494,1.1291675038495905,1,0.4,0.4,transcript,3242.0
SCAMP1,ENSG00000085365,dysthymic disorder,EFO_0008623,0.11289798327077863,1.1290061796976427,1,0.4,0.4,transcript,15182.0
TAF1B,ENSG00000115750,breast adenocarcinoma,EFO_0000304,0.11289706481555352,1.1290250492000353,1,0.5,0.5,transcript,9191.0
IKBIP,ENSG00000166130,amyotrophic lateral sclerosis,MONDO_0004976,0.11288666473212267,1.129137146053264,2,0.8,1.6,transcript,5915.0
AKR1B10,ENSG00000198074,neoplasm,EFO_0000616,0.1127547783992486,1.12767991929904,1,0.5,0.5,transcript,3784.0
NUP43,ENSG00000120253,presubiculum volume,OBA_2050049,0.1126994534318688,1.1271967332318689,2,0.8,1.6,transcript,7913.0
STAU2,ENSG00000040341,peak expiratory flow,EFO_0009718,0.11269468936416764,1.1269584618245463,1,0.5,0.5,transcript,43222.0
METTL14,ENSG00000145388,breast cancer,MONDO_0007254,0.11248003382620474,1.1248259251615547,1,0.4,0.4,transcript,15633.0
TXK,ENSG00000074966,rheumatoid arthritis,EFO_0000685,0.11247934341557496,1.1248228264696594,1,0.4,0.4,transcript,13609.0
TMTC3,ENSG00000139324,protozoa infectious disease,MONDO_0002428,0.11247117425825164,1.1247507517496707,1,0.4,0.4,transcript,10254.0
SLC5A7,ENSG00000115665,head and neck squamous cell carcinoma,EFO_0000181,0.11242148969798582,1.124270460252535,1,0.4,0.4,transcript,7199.0
PNLIPRP3,ENSG00000203837,lung adenocarcinoma,EFO_0000571,0.11241559305873541,1.1243244225839841,1,0.4,0.4,transcript,2374.0
NRCAM,ENSG00000091129,urinary microalbumin measurement,EFO_0010967,0.11234362270310659,1.123447880344977,1,0.4,0.4,transcript,34325.0
SEC22A,ENSG00000121542,body weight,EFO_0004338,0.11232833714224864,1.1234054063549859,2,0.8,1.6,transcript,13111.0
KBTBD3,ENSG00000182359,food allergy,EFO_1001890,0.11231669802721916,1.1232863565312383,2,0.8,1.6,transcript,13403.0
KRT20,ENSG00000171431,chronic lymphocytic leukemia,EFO_0000095,0.11226277023293887,1.1228171859864233,1,0.4,0.4,transcript,2111.0
MR1,ENSG00000153029,menopause,GO_0042697,0.11222977286839518,1.1224307712945434,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
SLC30A9,ENSG00000014824,lysosomal storage disease,MONDO_0002561,0.11210697044045168,1.121421467730935,3,1.3,3.9000000000000004,transcript,11087.0
NMRK1,ENSG00000106733,loneliness measurement,EFO_0007865,0.11209854479756186,1.1210314197030062,1,0.4,0.4,transcript,8701.0
USP15,ENSG00000135655,neoplasm,EFO_0000616,0.1120466113775066,1.1205492316176962,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
ZNF117,ENSG00000152926,calcium measurement,EFO_0004838,0.11200932601937087,1.122220384171053,13,5.2,67.60000000000001,transcript,31780.0
METTL14,ENSG00000145388,hepatocellular carcinoma,EFO_0000182,0.11190121192238126,1.1190377061233199,1,0.4,0.4,transcript,15633.0
MTR,ENSG00000116984,squamous cell lung carcinoma,EFO_0000708,0.11188125002296599,1.1188169126594747,1,0.4,0.4,transcript,90653.0
CHFR,ENSG00000072609,gastric cancer,MONDO_0001056,0.11185327255398009,1.1185408148457383,1,0.4,0.4,transcript,49448.0
SLC5A7,ENSG00000115665,prostate cancer,MONDO_0008315,0.11179790604212228,1.1180346236938996,1,0.4,0.4,transcript,7199.0
PCNX4,ENSG00000126773,erythrocyte volume,OBA_0003460,0.11175593277937576,1.1175689918704517,1,0.5,0.5,transcript,51738.0
CLSTN2,ENSG00000158258,blood vessel replacement,EFO_0010672,0.11171718201308596,1.1171959063595582,1,0.4,0.4,transcript,16607.0
AGBL3,ENSG00000146856,FEV/FVC ratio,EFO_0004713,0.11171269360815415,1.1171628891986767,1,0.5,0.5,transcript,13907.0
ZNF623,ENSG00000183309,pyruvate measurement,EFO_0010117,0.11165877471136194,1.116617482468957,1,0.4,0.4,transcript,13452.0
CPD,ENSG00000108582,body height,OBA_VT0001253,0.11161781440964365,1.1161983624547058,1,0.4,0.4,transcript,19784.0
KRT20,ENSG00000171431,acute lymphoblastic leukemia,EFO_0000220,0.1115578866303058,1.1157683499600926,1,0.4,0.4,transcript,2111.0
ARHGAP20,ENSG00000137727,prostate cancer,MONDO_0008315,0.11152072115110875,1.1152174561006638,1,0.4,0.4,transcript,39045.0
BTLA,ENSG00000186265,neoplasm,EFO_0000616,0.11150009785133536,1.1151813392347965,2,0.9,1.8,transcript,9980.0
HFE,ENSG00000010704,cancer,MONDO_0004992,0.11147765007680935,1.1147847859438427,1,0.4,0.4,transcript,48279.0
YIPF4,ENSG00000119820,gout,EFO_0004274,0.11143819336587328,1.1145001107766883,2,0.8,1.6,transcript,13539.0
NEMF,ENSG00000165525,prostate cancer,MONDO_0008315,0.11142832618743759,1.1143034451384133,1,0.5,0.5,transcript,24773.0
MR1,ENSG00000153029,brain attribute,OBA_2045210,0.11142444733966277,1.1143775160072193,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
FBXO42,ENSG00000037637,body mass index,EFO_0004340,0.11141566086693189,1.11419218003437,1,0.4,0.4,transcript,11245.0
GUCA1C,ENSG00000138472,breast adenocarcinoma,EFO_0000304,0.11140518950759473,1.1142510982631983,1,0.5,0.5,transcript,2510.0
GRK7,ENSG00000114124,breast adenocarcinoma,EFO_0000304,0.11140518950759473,1.1140929291342156,1,0.4,0.4,transcript,9748.0
LIMA1,ENSG00000050405,serum alanine aminotransferase measurement,EFO_0004735,0.11134062608864136,1.1134196652629424,1,0.4,0.4,transcript,29841.0
PDCD4,ENSG00000150593,hepatocellular carcinoma,EFO_0000182,0.11132370740084062,1.113272085562219,1,0.5,0.5,transcript,14281.0
NRCAM,ENSG00000091129,cutaneous melanoma,EFO_0000389,0.11128337927540771,1.1128454460679884,1,0.4,0.4,transcript,34325.0
ZNF283,ENSG00000167637,alkaline phosphatase measurement,EFO_0004533,0.11126019373385636,1.1126320233846554,1,0.5,0.5,transcript,16619.0
PNLIPRP3,ENSG00000203837,cutaneous melanoma,EFO_0000389,0.11125239331226199,1.1126924251192498,1,0.4,0.4,transcript,2374.0
PYHIN1,ENSG00000163564,prostate cancer,MONDO_0008315,0.11124353626009523,1.1124731198220208,1,0.4,0.4,transcript,10594.0
SEC63,ENSG00000025796,autosomal dominant medullary cystic kidney disease with or without hyperuricemia,MONDO_0008264,0.11124353626009523,1.112710886862394,3,1.2000000000000002,3.6000000000000005,transcript,13066.0
LINS1,ENSG00000140471,Microcephaly,HP_0000252,0.11124353626009523,1.112462650708795,1,0.5,0.5,transcript,18323.0
ZNF230,ENSG00000159882,Alzheimer disease,MONDO_0004975,0.11119255588769682,1.1119613947486757,1,0.4,0.4,transcript,11162.0
ZNF230,ENSG00000159882,polygenic risk score,EFO_0030082,0.11119255588769682,1.1119613947486757,1,0.4,0.4,transcript,11162.0
CLDN1,ENSG00000163347,colorectal carcinoma,EFO_1001951,0.11111762610583242,1.1128265962826667,4,1.6,6.4,transcript,3878.0
WBP2NL,ENSG00000183066,response to selective serotonin reuptake inhibitor,EFO_0005658,0.11099921411109925,1.1100342960726315,1,0.5,0.5,transcript,11861.0
AGBL3,ENSG00000146856,diaphragmatic hernia,EFO_0008561,0.11093996472234428,1.109435600340578,1,0.5,0.5,transcript,13907.0
CLDN1,ENSG00000163347,neoplasm,EFO_0000616,0.11089323813932034,1.110582716617546,4,1.6,6.4,transcript,3878.0
SKA3,ENSG00000165480,hepatocellular carcinoma,EFO_0000182,0.11087960719016551,1.1089424312137663,2,0.8,1.6,transcript,10932.0
PHF24,ENSG00000122733,breast ductal adenocarcinoma,EFO_0006318,0.11087395640541053,1.1087870756350533,1,0.4,0.4,transcript,8419.0
SNTG2,ENSG00000172554,pathological myopia,EFO_0004207,0.11087395640541053,1.108789454295574,1,0.5,0.5,transcript,10022.0
SPATA22,ENSG00000141255,Fraser syndrome,MONDO_0009046,0.11087395640541053,1.1087732363552705,1,0.5,0.5,transcript,14849.0
SPATA22,ENSG00000141255,Intellectual disability,HP_0001249,0.11087395640541053,1.1087732363552705,1,0.5,0.5,transcript,14849.0
PYHIN1,ENSG00000163564,Familial prostate cancer,Orphanet_1331,0.11087395640541053,1.108777321275174,1,0.4,0.4,transcript,10594.0
SNTG2,ENSG00000172554,Myopia,HP_0000545,0.11087395640541053,1.108789454295574,1,0.5,0.5,transcript,10022.0
FRAS1,ENSG00000138759,Microcephaly,HP_0000252,0.11087395640541053,1.1087717005987126,2,0.9,1.8,transcript,56011.0
SLC7A2,ENSG00000003989,myoepithelial tumor,MONDO_0002380,0.11087395640541053,1.1088605596752161,3,1.4,4.199999999999999,transcript,34712.0
SLC5A7,ENSG00000115665,Charcot-Marie-Tooth disease,MONDO_0015626,0.11087395640541053,1.1087951273267822,1,0.4,0.4,transcript,7199.0
SKIL,ENSG00000136603,Familial prostate cancer,Orphanet_1331,0.11087395640541053,1.1087560238756808,1,0.5,0.5,transcript,30377.0
SMC6,ENSG00000163029,"laterality defects, autosomal dominant",MONDO_0010991,0.11087395640541053,1.1087559736373018,1,0.4,0.4,transcript,24376.0
RBM28,ENSG00000106344,Microcephaly,HP_0000252,0.11087395640541053,1.1088117988170851,2,0.8,1.6,transcript,22150.0
NEMF,ENSG00000165525,prostate carcinoma,EFO_0001663,0.11087395640541053,1.1087597473181428,1,0.5,0.5,transcript,24773.0
FRAS1,ENSG00000138759,myoepithelial tumor,MONDO_0002380,0.11087395640541053,1.1087717005987126,2,0.9,1.8,transcript,56011.0
YEATS2,ENSG00000163872,breast ductal adenocarcinoma,EFO_0006318,0.11087395640541053,1.108773304522423,1,0.5,0.5,transcript,14819.0
SLC5A7,ENSG00000115665,Familial prostate cancer,Orphanet_1331,0.11087395640541053,1.1087951273267822,1,0.4,0.4,transcript,7199.0
SLC5A7,ENSG00000115665,prostate carcinoma,EFO_0001663,0.11087395640541053,1.1087951273267822,1,0.4,0.4,transcript,7199.0
C2CD6,ENSG00000155754,prostate cancer,MONDO_0008315,0.11087395640541053,1.1087804872821296,1,0.5,0.5,transcript,12218.0
PIGN,ENSG00000197563,schizophrenia,MONDO_0005090,0.11087395640541053,1.108742103881778,1,0.4,0.4,transcript,157491.0
C2CD6,ENSG00000155754,prostate carcinoma,EFO_0001663,0.11087395640541053,1.1087804872821296,1,0.5,0.5,transcript,12218.0
NEMF,ENSG00000165525,Familial prostate cancer,Orphanet_1331,0.11087395640541053,1.1087597473181428,1,0.5,0.5,transcript,24773.0
CFAP46,ENSG00000171811,Heterotaxy,HP_0030853,0.11087395640541053,1.108760924272834,1,0.5,0.5,transcript,23408.0
PYHIN1,ENSG00000163564,prostate carcinoma,EFO_0001663,0.11087395640541053,1.108777321275174,1,0.4,0.4,transcript,10594.0
ARHGAP20,ENSG00000137727,Familial prostate cancer,Orphanet_1331,0.11087395640541053,1.1087498086436816,1,0.4,0.4,transcript,39045.0
ZNF534,ENSG00000198633,Familial prostate cancer,Orphanet_1331,0.11087395640541053,1.1087856257768138,1,0.5,0.5,transcript,10855.0
ARHGAP20,ENSG00000137727,prostate carcinoma,EFO_0001663,0.11087395640541053,1.1087498086436816,1,0.4,0.4,transcript,39045.0
OR6C1,ENSG00000205330,essential tremor,EFO_0003108,0.11087395640541053,1.108899871845064,1,0.5,0.5,transcript,3119.0
HEPHL1,ENSG00000181333,lichen planopilaris,EFO_0009856,0.11087395640541053,1.1088084227216901,1,0.4,0.4,transcript,5809.0
AHCTF1,ENSG00000153207,Strabismus,HP_0000486,0.11087395640541053,1.1087528305244283,1,0.5,0.5,transcript,37689.0
AHCTF1,ENSG00000153207,Intellectual disability,HP_0001249,0.11087395640541053,1.1087528305244283,1,0.5,0.5,transcript,37689.0
FZD6,ENSG00000164930,Nephroblastoma,Orphanet_654,0.11087395640541053,1.1088194561997087,2,0.8,1.6,transcript,20027.0
AHNAK2,ENSG00000185567,Enhancement of the C-reflex,HP_0001340,0.11087395640541053,1.1087873937802801,2,1.0,2.0,transcript,41815.0
SAMD11,ENSG00000187634,optic atrophy,MONDO_0003608,0.11087395640541053,1.108802392923971,2,0.8,1.6,transcript,25466.0
ANKRD30B,ENSG00000180777,tooth agenesis,EFO_0005410,0.11087395640541053,1.1087641304570925,1,0.5,0.5,transcript,20353.0
ZNF534,ENSG00000198633,prostate cancer,MONDO_0008315,0.11087395640541053,1.1087856257768138,1,0.5,0.5,transcript,10855.0
ZNF534,ENSG00000198633,prostate carcinoma,EFO_0001663,0.11087395640541053,1.1087856257768138,1,0.5,0.5,transcript,10855.0
C2CD6,ENSG00000155754,Familial prostate cancer,Orphanet_1331,0.11087395640541053,1.1087804872821296,1,0.5,0.5,transcript,12218.0
SAMD11,ENSG00000187634,Neutrophil inclusion bodies,HP_0008264,0.11087395640541053,1.108802392923971,2,0.8,1.6,transcript,25466.0
NRCAM,ENSG00000091129,pathological myopia,EFO_0004207,0.11087395640541053,1.1087512173680165,1,0.4,0.4,transcript,34325.0
MAP4K3,ENSG00000011566,ependymoma,EFO_1000028,0.11087395640541053,1.1087623716718498,1,0.4,0.4,transcript,17538.0
ONECUT2,ENSG00000119547,Autosomal dominant polycystic kidney disease,EFO_1001496,0.11087395640541053,1.1099013897802463,7,2.8000000000000003,19.6,transcript,16870.0
SLAMF7,ENSG00000026751,autism,EFO_0003758,0.11087395640541053,1.108755760353251,1,0.4,0.4,transcript,24697.0
AHNAK2,ENSG00000185567,Dysmetria,HP_0001310,0.11087395640541053,1.1087873937802801,2,1.0,2.0,transcript,41815.0
AHCTF1,ENSG00000153207,Delayed speech and language development,HP_0000750,0.11087395640541053,1.1087528305244283,1,0.5,0.5,transcript,37689.0
NRCAM,ENSG00000091129,Myopia,HP_0000545,0.11087395640541053,1.1087512173680165,1,0.4,0.4,transcript,34325.0
TEX15,ENSG00000133863,myoepithelial tumor,MONDO_0002380,0.11087395640541053,1.1087544876453184,1,0.5,0.5,transcript,33504.0
SLC35A5,ENSG00000138459,monoclonal B-cell lymphocytosis,EFO_0006889,0.11087395640541053,1.1087768600914014,1,0.4,0.4,transcript,10725.0
ACADSB,ENSG00000196177,Microcephaly,HP_0000252,0.11087395640541053,1.1087863860136042,1,0.4,0.4,transcript,8543.0
MTR,ENSG00000116984,gastrointestinal stromal tumor,MONDO_0011719,0.11087395640541053,1.1087439764839202,1,0.4,0.4,transcript,90653.0
NRK,ENSG00000123572,autism,EFO_0003758,0.11087395640541053,1.108764781555051,1,0.4,0.4,transcript,15862.0
CCDC7,ENSG00000216937,ovarian neoplasm,EFO_0003893,0.11085665280450517,1.108585125084403,1,0.5,0.5,transcript,26886.0
CNR2,ENSG00000188822,neoplasm,EFO_0000616,0.11079322133626235,1.1080081867719302,1,0.4,0.4,transcript,5265.0
RBM23,ENSG00000100461,brain attribute,OBA_2045210,0.11075405882448729,1.1075504470179485,1,0.4,0.4,transcript,40573.0
METTL25,ENSG00000127720,COVID-19,MONDO_0100096,0.11074442780188713,1.1074962260708194,1,0.5,0.5,transcript,9625.0
HEG1,ENSG00000173706,serum alanine aminotransferase measurement,EFO_0004735,0.11069753090935636,1.1069971753812144,1,0.4,0.4,transcript,18293.0
COQ3,ENSG00000132423,serum alanine aminotransferase measurement,EFO_0004735,0.11065941056782302,1.1067446514064951,1,0.4,0.4,transcript,2657.0
TM9SF3,ENSG00000077147,lymphocyte:monocyte ratio,EFO_0600088,0.11065660372099138,1.106591550668263,1,0.4,0.4,transcript,15678.0
MANSC4,ENSG00000205693,heart rate,OBA_1001087,0.11065039187927873,1.106803858804785,1,0.5,0.5,transcript,1667.0
FAM171B,ENSG00000144369,Ascher syndrome,MONDO_0007198,0.11063859550507248,1.1064557508978718,1,0.4,0.4,transcript,5731.0
LSM11,ENSG00000155858,Hallux valgus,HP_0001822,0.11063859550507248,1.106446865664399,1,0.4,0.4,transcript,6567.0
OR5M1,ENSG00000255012,coagulation protein disease,MONDO_0002242,0.11063621941137429,1.106734114150935,2,0.8,1.6,transcript,4302.0
FAM171B,ENSG00000144369,lymphocyte count,EFO_0004587,0.11062035945872745,1.1062733904344215,1,0.4,0.4,transcript,5731.0
PDCD4,ENSG00000150593,neoplasm,EFO_0000616,0.11061790568952463,1.1062140684490591,1,0.5,0.5,transcript,14281.0
CCDC50,ENSG00000152492,triacylglycerol 60:12 measurement,EFO_0010444,0.11060156417789624,1.1060520882482108,1,0.4,0.4,transcript,10975.0
ORMDL1,ENSG00000128699,pulse pressure measurement,EFO_0005763,0.11059592896856424,1.1060863645804087,2,0.8,1.6,transcript,12591.0
KRT20,ENSG00000171431,low grade glioma,MONDO_0021637,0.11056513773801344,1.105840861037169,1,0.4,0.4,transcript,2111.0
ANOS1,ENSG00000011201,low grade glioma,MONDO_0021637,0.11056513773801344,1.1057028839472218,1,0.4,0.4,transcript,7766.0
NUP43,ENSG00000120253,amygdala volume,OBA_2050034,0.11056464618450508,1.1058486607582316,2,0.8,1.6,transcript,7913.0
IFNA13,ENSG00000233816,systemic lupus erythematosus,MONDO_0007915,0.11054256018367158,1.105728632139746,1,0.4,0.4,transcript,1320.0
ATRNL1,ENSG00000107518,neutrophil count,EFO_0004833,0.11043112934576393,1.104328152599509,1,0.4,0.4,transcript,23726.0
PDP1,ENSG00000164951,neoplasm,EFO_0000616,0.1103853653423355,1.1038770206391513,1,0.4,0.4,transcript,17118.0
OR5AS1,ENSG00000181785,hypertrophic cardiomyopathy,EFO_0000538,0.11026342133506502,1.1026851039358918,1,0.4,0.4,transcript,7860.0
GBP1,ENSG00000117228,glioblastoma multiforme,EFO_0000519,0.11010638626947997,1.1011676779037278,2,0.8,1.6,transcript,15412.0
TRIT1,ENSG00000043514,hematocrit,EFO_0004348,0.10997928569396995,1.0998080597066031,1,0.4,0.4,transcript,26311.0
NUP153,ENSG00000124789,medulloblastoma,EFO_0002939,0.1099465831184312,1.099493815736839,1,0.5,0.5,transcript,17867.0
NUP43,ENSG00000120253,metabolite ratio,EFO_0022223,0.10991464809485109,1.0993486798616918,2,0.8,1.6,transcript,7913.0
UBE2G2,ENSG00000184787,protein measurement,EFO_0004747,0.10988272053657418,1.0988532606028445,1,0.4,0.4,transcript,15352.0
ZBTB34,ENSG00000177125,lean body mass,EFO_0004995,0.10985194964555753,1.098549824759465,1,0.4,0.4,transcript,13189.0
GID4,ENSG00000141034,platelet crit,EFO_0007985,0.10978642170439006,1.0979213272666304,1,0.4,0.4,transcript,7004.0
SLC11A2,ENSG00000110911,hepcidin measurement,EFO_0020440,0.10969151496019845,1.0969431108756205,2,0.8,1.6,transcript,57222.0
MAN1A2,ENSG00000198162,educational attainment,EFO_0011015,0.10967826558600127,1.0969101763828468,2,0.8,1.6,transcript,12547.0
ITPRID2,ENSG00000138434,lean body mass,EFO_0004995,0.10966443476518338,1.096653135191103,1,0.4,0.4,transcript,45519.0
SGCB,ENSG00000163069,neoplasm,EFO_0000616,0.1096221342265092,1.0962939375463987,1,0.4,0.4,transcript,5510.0
PAG1,ENSG00000076641,neoplasm,EFO_0000616,0.10960401938755546,1.096170285752943,2,0.8,1.6,transcript,12299.0
CGAS,ENSG00000164430,hepatocellular carcinoma,EFO_0000182,0.10952299147131629,1.0954675698491545,2,0.9,1.8,transcript,7574.0
DPP8,ENSG00000074603,immature reticulocyte measurement,EFO_0803545,0.10950350750981527,1.09521679519242,4,1.6,6.4,transcript,35219.0
SLC4A8,ENSG00000050438,cutaneous melanoma,EFO_0000389,0.10949524695612665,1.0949839774086898,2,0.8,1.6,transcript,50781.0
SCAMP1,ENSG00000085365,neuroimaging measurement,EFO_0004346,0.10946492429613691,1.0946755899512257,1,0.4,0.4,transcript,15182.0
PAQR3,ENSG00000163291,blood protein measurement,EFO_0007937,0.10944621053471942,1.0944771570875516,1,0.4,0.4,transcript,26575.0
PAQR3,ENSG00000163291,level of serum globulin type protein,OBA_2045206,0.10944621053471942,1.0944771570875516,1,0.4,0.4,transcript,26575.0
LAIR1,ENSG00000167613,neoplasm,EFO_0000616,0.109441821622813,1.094433868129836,1,0.4,0.4,transcript,25556.0
METTL14,ENSG00000145388,gastric cancer,MONDO_0001056,0.10942038214130324,1.09422940831254,1,0.4,0.4,transcript,15633.0
RPS20,ENSG00000008988,body weight,EFO_0004338,0.1093490838348777,1.0935080478312018,1,0.4,0.4,transcript,23243.0
HFE,ENSG00000010704,Mobius syndrome,MONDO_0008006,0.10932920418330838,1.093300327008833,1,0.4,0.4,transcript,48279.0
GSTA5,ENSG00000182793,phosphate measurement,EFO_0010968,0.10924821527084545,1.092832292764477,1,0.5,0.5,transcript,1428.0
ZNF189,ENSG00000136870,total cholesterol measurement,EFO_0004574,0.10915776130615967,1.091611635346193,1,0.4,0.4,transcript,11757.0
BTLA,ENSG00000186265,chronic lymphocytic leukemia,EFO_0000095,0.10909220504448772,1.09110241116632,2,0.9,1.8,transcript,9980.0
ATRNL1,ENSG00000107518,cardiovascular disease,EFO_0000319,0.1089920324476277,1.0899371836181466,1,0.4,0.4,transcript,23726.0
PDP1,ENSG00000164951,Diarrhea,HP_0002014,0.10898940144426736,1.08991738165847,1,0.4,0.4,transcript,17118.0
MANSC4,ENSG00000205693,response to stimulus,GO_0050896,0.10898940144426736,1.0901939544546713,1,0.5,0.5,transcript,1667.0
GANC,ENSG00000214013,basophil count,EFO_0005090,0.10894024291695198,1.0894317031742036,1,0.5,0.5,transcript,17080.0
AGBL3,ENSG00000146856,Rheumatoid arthritis,HP_0001370,0.10891845700388932,1.0892205231560284,1,0.5,0.5,transcript,13907.0
OR4X1,ENSG00000176567,testosterone measurement,EFO_0004908,0.10891424580112362,1.0896871203206042,1,0.5,0.5,transcript,918.0
SLC30A9,ENSG00000014824,insomnia,EFO_0004698,0.10885096966035766,1.0888614599299948,3,1.3,3.9000000000000004,transcript,11087.0
SLC35B4,ENSG00000205060,executive function measurement,EFO_0009332,0.10880700185262746,1.0881119384592026,1,0.4,0.4,transcript,9542.0
RNF150,ENSG00000170153,ulcer of lower limb,EFO_0007068,0.10880197107849078,1.0882783697995788,4,1.6,6.4,transcript,24743.0
CP,ENSG00000047457,infection,EFO_0000544,0.10875339008993964,1.087554958850879,1,0.5,0.5,transcript,23744.0
PDCD4,ENSG00000150593,breast cancer,MONDO_0007254,0.10872266756335049,1.0872616871873177,1,0.5,0.5,transcript,14281.0
ONECUT2,ENSG00000119547,neoplasm,EFO_0000616,0.10871207979638292,1.0882826236899703,7,2.8000000000000003,19.6,transcript,16870.0
PARP14,ENSG00000173193,serum albumin amount,OBA_2050068,0.10871107283571883,1.087124716327534,1,0.4,0.4,transcript,28596.0
RELCH,ENSG00000134444,serum urea amount,OBA_2050065,0.10867701522554951,1.0867838706175228,1,0.4,0.4,transcript,29158.0
CENPQ,ENSG00000031691,high density lipoprotein cholesterol measurement,EFO_0004612,0.10866991337932967,1.0869288868088052,1,0.4,0.4,transcript,1741.0
PHF24,ENSG00000122733,obesity,EFO_0001073,0.1086488024438952,1.0865355360199,1,0.4,0.4,transcript,8419.0
HPSE,ENSG00000173083,breast cancer,MONDO_0007254,0.10860481810165813,1.0861360287471817,2,0.9,1.8,transcript,20490.0
DPP8,ENSG00000074603,HbA1c measurement,EFO_0004541,0.10851256970208817,1.0853074171151489,4,1.6,6.4,transcript,35219.0
HHLA2,ENSG00000114455,hepatocellular carcinoma,EFO_0000182,0.10850907707075551,1.0851245750480323,1,0.5,0.5,transcript,14791.0
NSUN7,ENSG00000179299,total cholesterol measurement,EFO_0004574,0.10850846571085491,1.085123686068037,1,0.5,0.5,transcript,12811.0
KIAA0319,ENSG00000137261,platelet count,EFO_0004309,0.10840948869281425,1.0841072742806555,1,0.4,0.4,transcript,32291.0
NXPH2,ENSG00000144227,smoking status measurement,EFO_0006527,0.10839613409070556,1.084108996868665,1,0.4,0.4,transcript,2709.0
RNF150,ENSG00000170153,retinal vascular disorder,MONDO_0002311,0.10836890991690717,1.0839477581837427,4,1.6,6.4,transcript,24743.0
SHOC1,ENSG00000165181,monocyte percentage of leukocytes,EFO_0007989,0.1083632380001145,1.083748752752018,3,1.3,3.9000000000000004,transcript,33513.0
KRT20,ENSG00000171431,diffuse large B-cell lymphoma,EFO_0000403,0.1082912024199464,1.0831015078564987,1,0.4,0.4,transcript,2111.0
GRK7,ENSG00000114124,X-14632 measurement,EFO_0021375,0.10827779669737883,1.0828190010320566,1,0.4,0.4,transcript,9748.0
IL1A,ENSG00000115008,infection,EFO_0000544,0.10825781302067027,1.0827764445349128,1,0.4,0.4,transcript,2017.0
SERPINB10,ENSG00000242550,X-21807 measurement,EFO_0800827,0.10815864764153704,1.0818184949768554,1,0.5,0.5,transcript,2155.0
FBXO22,ENSG00000167196,neoplasm,EFO_0000616,0.1081513736808588,1.0815349356002568,1,0.4,0.4,transcript,18869.0
DZIP3,ENSG00000198919,myxedema,EFO_1001055,0.10813098672219962,1.0813320021342865,1,0.4,0.4,transcript,18071.0
PTBP3,ENSG00000119314,neoplasm,EFO_0000616,0.10809025498998273,1.0811359875019562,5,2.0,10.0,transcript,42838.0
ATP5F1A,ENSG00000152234,uric acid measurement,EFO_0004761,0.1080493370972682,1.0805071716903194,1,0.4,0.4,transcript,28984.0
NUP43,ENSG00000120253,hippocampus molecular layer volume,OBA_2050050,0.108035963784049,1.080561836753671,2,0.8,1.6,transcript,7913.0
POU2F1,ENSG00000143190,gastric cancer,MONDO_0001056,0.10802562336322508,1.0802712456888086,2,0.8,1.6,transcript,106581.0
TMEM131,ENSG00000075568,diastolic blood pressure,EFO_0006336,0.10799226137005603,1.0799440625718135,1,0.4,0.4,transcript,18649.0
PDCD4,ENSG00000150593,gastric cancer,MONDO_0001056,0.10798150252394809,1.0798500367932937,1,0.5,0.5,transcript,14281.0
RAD18,ENSG00000070950,generalized dystonia,MONDO_0000476,0.10797962528463621,1.0798297340550336,1,0.4,0.4,transcript,11947.0
SRGN,ENSG00000122862,neoplasm,EFO_0000616,0.10796255951071508,1.0797489757363918,1,0.4,0.4,transcript,3242.0
IPP,ENSG00000197429,type 2 diabetes mellitus,MONDO_0005148,0.1079349561763771,1.079430337208036,1,0.5,0.5,transcript,6190.0
AHNAK2,ENSG00000185567,lung adenocarcinoma,EFO_0000571,0.10789536992643757,1.0790015289905506,2,1.0,2.0,transcript,41815.0
AGBL3,ENSG00000146856,red blood cell density,OBA_2045260,0.10777394400931309,1.077775393210266,1,0.5,0.5,transcript,13907.0
NEMF,ENSG00000165525,triacylglycerol 60:12 measurement,EFO_0010444,0.10766154659254833,1.0766356491895206,1,0.5,0.5,transcript,24773.0
BCAS2,ENSG00000116752,platelet volume,OBA_0003277,0.10764541762412118,1.0766388484480447,1,0.4,0.4,transcript,2166.0
RBM18,ENSG00000119446,lifestyle measurement,EFO_0010724,0.10758452794539464,1.075907007849008,1,0.4,0.4,transcript,6480.0
SPART,ENSG00000133104,cerebral cortex area attribute,OBA_2045267,0.10758452794539464,1.0758595447891817,1,0.4,0.4,transcript,28040.0
HNRNPA0,ENSG00000177733,platelet count,EFO_0004309,0.10758452794539464,1.0758682336603047,1,0.4,0.4,transcript,17426.0
POU2F1,ENSG00000143190,hepatocellular carcinoma,EFO_0000182,0.10755513122347872,1.0755663242913451,2,0.8,1.6,transcript,106581.0
ZNF257,ENSG00000197134,multinodular goiter,MONDO_0000334,0.10751656191347414,1.0751932015371686,1,0.4,0.4,transcript,14502.0
CYTIP,ENSG00000115165,diastolic blood pressure,EFO_0006336,0.10750789681617952,1.0751067555879847,1,0.4,0.4,gene_variant,14395.0
TSPAN19,ENSG00000231738,Cerebral degeneration,HP_0007313,0.10750789681617952,1.07512814445882,1,0.4,0.4,transcript,8134.0
DYNLT5,ENSG00000152760,pulse wave reflection index measurement,EFO_0009804,0.10750789681617952,1.0751491312910708,1,0.4,0.4,transcript,5701.0
DYNLT5,ENSG00000152760,gallbladder disease,EFO_0003832,0.10750789681617952,1.0751491312910708,1,0.4,0.4,transcript,5701.0
COL19A1,ENSG00000082293,head and neck squamous cell carcinoma,EFO_0000181,0.10747977270765152,1.0749350661323092,2,0.8,1.6,transcript,11650.0
C18orf54,ENSG00000166845,Eczematoid dermatitis,HP_0000964,0.10746592396335414,1.074744714284965,2,0.8,1.6,transcript,18719.0
C18orf54,ENSG00000166845,allergic rhinitis,EFO_0005854,0.10746592396335414,1.074744714284965,2,0.8,1.6,transcript,18719.0
APOBEC3H,ENSG00000100298,multiple myeloma,EFO_0001378,0.1074498875012235,1.074575459350738,1,0.4,0.4,transcript,5223.0
ZNF143,ENSG00000166478,diastolic blood pressure,EFO_0006336,0.10744884122195882,1.0745146920471924,1,0.5,0.5,transcript,19026.0
YIPF4,ENSG00000119820,alkaline phosphatase measurement,EFO_0004533,0.10733674988391333,1.0734856759570888,2,0.8,1.6,transcript,13539.0
GSTA5,ENSG00000182793,omega-6 polyunsaturated fatty acid measurement,EFO_0005680,0.107310489271951,1.0734550327755323,1,0.5,0.5,transcript,1428.0
FAM186A,ENSG00000185958,serum alanine aminotransferase measurement,EFO_0004735,0.10730837548595216,1.0731946564897756,2,1.0,2.0,transcript,18034.0
KERA,ENSG00000139330,breast adenocarcinoma,EFO_0000304,0.10729466951229555,1.073672977465216,2,0.8,1.6,transcript,2203.0
METTL14,ENSG00000145388,nonpapillary renal cell carcinoma,MONDO_0007763,0.10729210841587314,1.0729466710582387,1,0.4,0.4,transcript,15633.0
FAM102B,ENSG00000162636,growth differentiation factor 15 amount,OBA_2050135,0.10728602384423516,1.0728860415645294,1,0.4,0.4,transcript,15502.0
SERPINB9,ENSG00000170542,neoplasm,EFO_0000616,0.10725243544932765,1.0725720701082115,1,0.4,0.4,transcript,8383.0
SEC22A,ENSG00000121542,cardiac arrest,EFO_0009492,0.10710268598641551,1.0711488947966545,2,0.8,1.6,transcript,13111.0
DYNLT5,ENSG00000152760,heel bone mineral density,EFO_0009270,0.1070956274427003,1.0710264375562788,1,0.4,0.4,transcript,5701.0
PAQR3,ENSG00000163291,blood urea nitrogen measurement,EFO_0004741,0.10709316100953917,1.070946661835749,1,0.4,0.4,transcript,26575.0
ING1,ENSG00000153487,monocyte count,EFO_0005091,0.10707267829153097,1.0707532659661572,1,0.4,0.4,transcript,15104.0
C2CD2,ENSG00000157617,alcohol consumption quality,OBA_1000840,0.10705016809669753,1.0705156620924559,1,0.4,0.4,transcript,28610.0
HNRNPA0,ENSG00000177733,educational attainment,EFO_0011015,0.10696946378087906,1.069717592015149,1,0.4,0.4,transcript,17426.0
ITM2A,ENSG00000078596,autoimmune disease,EFO_0005140,0.1069490870505585,1.069890870505585,1,0.4,0.4,transcript,1000.0
GNA13,ENSG00000120063,medulloblastoma,EFO_0002939,0.10694826406730283,1.0695342469173839,1,0.4,0.4,transcript,7751.0
SLFN11,ENSG00000172716,cancer,MONDO_0004992,0.10692876049141586,1.0693054548851524,1,0.4,0.4,transcript,22409.0
CLEC6A,ENSG00000205846,gastric adenocarcinoma,EFO_0000503,0.106873538215303,1.0689783955187653,1,0.4,0.4,transcript,1646.0
ZNF675,ENSG00000197372,Testicular Germ Cell Tumor,EFO_1000566,0.10685452766150387,1.0685880738417783,1,0.5,0.5,transcript,11683.0
TMEM131,ENSG00000075568,sum of eosinophil and basophil counts,EFO_0009389,0.10684903196317791,1.068511768503032,1,0.4,0.4,transcript,18649.0
TMPRSS4,ENSG00000137648,hyperaldosteronism,EFO_0009452,0.10676675281270202,1.0676778597728513,1,0.4,0.4,transcript,38716.0
ALDOB,ENSG00000136872,neoplasm,EFO_0000616,0.10671904837772753,1.0672318959317426,1,0.4,0.4,transcript,9659.0
KRT20,ENSG00000171431,non-Hodgkins lymphoma,EFO_0005952,0.10665323095223285,1.066721793179363,1,0.4,0.4,transcript,2111.0
AKR1B10,ENSG00000198074,breast cancer,MONDO_0007254,0.1065682823060999,1.065814958367553,1,0.5,0.5,transcript,3784.0
AMTN,ENSG00000187689,Hypomaturation amelogenesis imperfecta,Orphanet_100033,0.10655476040676369,1.0657735927682017,1,0.4,0.4,transcript,1770.0
SLFN11,ENSG00000172716,neoplasm,EFO_0000616,0.10631564265527542,1.063174276523748,1,0.4,0.4,transcript,22409.0
FAM186A,ENSG00000185958,bone tissue density,OBA_1000110,0.10628953714636832,1.0630062730939374,2,1.0,2.0,transcript,18034.0
TMPRSS4,ENSG00000137648,neoplasm,EFO_0000616,0.10624621047922603,1.0624724364380913,1,0.4,0.4,transcript,38716.0
VWDE,ENSG00000146530,Hypomaturation amelogenesis imperfecta,Orphanet_100033,0.10617642578357568,1.0617908804863079,1,0.5,0.5,transcript,18781.0
CYTIP,ENSG00000115165,growth differentiation factor 15 amount,OBA_2050135,0.10617419135830938,1.0617697010092835,1,0.4,0.4,gene_variant,14395.0
KRT20,ENSG00000171431,infection,EFO_0000544,0.10617295806805206,1.0619190643375553,1,0.4,0.4,transcript,2111.0
LIMA1,ENSG00000050405,myeloid leukocyte count,OBA_2045223,0.10614460524439656,1.0614594568204947,1,0.4,0.4,transcript,29841.0
CP,ENSG00000047457,Wilson disease,MONDO_0010200,0.10608222187322183,1.0608432766837008,1,0.5,0.5,transcript,23744.0
ELAPOR1,ENSG00000116299,azoospermia,EFO_0000279,0.10600571222894864,1.0600702155791755,1,0.4,0.4,transcript,30550.0
SGCB,ENSG00000163069,sex hormone-binding globulin measurement,EFO_0004696,0.10597148107374062,1.059787406018713,1,0.4,0.4,transcript,5510.0
TRAM1,ENSG00000067167,endometrial cancer,MONDO_0011962,0.1059504911727391,1.059695410596304,2,0.8,1.6,transcript,8399.0
SLAMF7,ENSG00000026751,Miyoshi myopathy,MONDO_0009685,0.1057987061523369,1.0580032578225147,1,0.4,0.4,transcript,24697.0
TRIT1,ENSG00000043514,lymphocyte count,EFO_0004587,0.10575635227160686,1.0575787254829723,1,0.4,0.4,transcript,26311.0
RTF1,ENSG00000137815,JT interval,EFO_0007885,0.10570489170701432,1.057100636749481,1,0.4,0.4,transcript,7734.0
NMRK1,ENSG00000106733,placental retention,EFO_0009578,0.10568832884140172,1.0569292601414049,1,0.4,0.4,transcript,8701.0
IKBIP,ENSG00000166130,growth differentiation factor 15 amount,OBA_2050135,0.10568832884140172,1.0571537871460543,2,0.8,1.6,transcript,5915.0
KBTBD3,ENSG00000182359,matrix metalloproteinase 7 measurement,EFO_0010591,0.10568832884140172,1.0570026646730637,2,0.8,1.6,transcript,13403.0
NMRK1,ENSG00000106733,cerebellar volume measurement,EFO_0020864,0.10568832884140172,1.0569292601414049,1,0.4,0.4,transcript,8701.0
KBTBD3,ENSG00000182359,preeclampsia,EFO_0000668,0.10568832884140172,1.0570026646730637,2,0.8,1.6,transcript,13403.0
ZNF143,ENSG00000166478,lung adenocarcinoma,EFO_0000571,0.10566547887356637,1.056681068563268,1,0.5,0.5,transcript,19026.0
TMEM236,ENSG00000148483,erythrocyte volume,OBA_0003460,0.10542451278404577,1.0545352457008383,2,0.8,1.6,transcript,5515.0
ZNF225,ENSG00000256294,lymphocyte count,EFO_0004587,0.10535395018826067,1.053570926189308,1,0.4,0.4,transcript,12729.0
SMC5,ENSG00000198887,carotid artery disease,EFO_0003781,0.1053062912578338,1.053127262642688,1,0.5,0.5,transcript,7770.0
SLAMF7,ENSG00000026751,eosinophil percentage of leukocytes,EFO_0007991,0.10529930468507964,1.053009243149942,1,0.4,0.4,transcript,24697.0
SLAMF7,ENSG00000026751,red blood cell density,OBA_2045260,0.10529930468507964,1.053009243149942,1,0.4,0.4,transcript,24697.0
NRCAM,ENSG00000091129,head and neck squamous cell carcinoma,EFO_0000181,0.10526137792523131,1.0526254325662243,1,0.4,0.4,transcript,34325.0
CCDC62,ENSG00000130783,male infertility with teratozoospermia due to single gene mutation,MONDO_0018394,0.10517091001959364,1.0517360362228725,1,0.4,0.4,transcript,14850.0
EHD1,ENSG00000110047,non-small cell lung carcinoma,EFO_0003060,0.10515661270805983,1.0515844740212459,1,0.4,0.4,transcript,21802.0
HPSE,ENSG00000173083,gastric cancer,MONDO_0001056,0.1051407663767008,1.0514955114976083,2,0.9,1.8,transcript,20490.0
SLC6A5,ENSG00000165970,spondylolisthesis,EFO_0007493,0.10513190040444964,1.0513576401886093,1,0.4,0.4,transcript,10353.0
MAP4K3,ENSG00000011566,hepatocellular carcinoma,EFO_0000182,0.10512512454855868,1.0512740531033313,1,0.4,0.4,transcript,17538.0
GPR85,ENSG00000164604,eosinophil percentage of leukocytes,EFO_0007991,0.10510040747239162,1.0510276221425305,1,0.4,0.4,transcript,16987.0
KRT20,ENSG00000171431,colorectal carcinoma,EFO_1001951,0.10507500048347186,1.0509394884917533,1,0.4,0.4,transcript,2111.0
PDE12,ENSG00000174840,platelet count,EFO_0004309,0.10500063531550063,1.0500254071253774,1,0.4,0.4,transcript,20993.0
TRAM1,ENSG00000067167,neoplasm,EFO_0000616,0.10495120065546543,1.0497025054235671,2,0.8,1.6,transcript,8399.0
SKA3,ENSG00000165480,lung adenocarcinoma,EFO_0000571,0.10493393879932647,1.0494857473053758,2,0.8,1.6,transcript,10932.0
RALGPS2,ENSG00000116191,vital capacity,EFO_0004312,0.10492660180858446,1.0493455528077216,2,0.8,1.6,transcript,20117.0
CR1L,ENSG00000197721,monocyte count,EFO_0005091,0.10490641086637369,1.0491573922458264,1,0.5,0.5,transcript,5360.0
GLCE,ENSG00000138604,calcium measurement,EFO_0004838,0.10480666917995124,1.048197016797476,2,0.8,1.6,transcript,12277.0
PPP1R9A,ENSG00000158528,glucose measurement,EFO_0004468,0.10471227826288752,1.0472017907727915,3,1.3,3.9000000000000004,transcript,49362.0
ATP12A,ENSG00000075673,breast adenocarcinoma,EFO_0000304,0.10462164825762994,1.0462656347021289,1,0.4,0.4,transcript,8138.0
ATP9A,ENSG00000054793,breast adenocarcinoma,EFO_0000304,0.10462164825762994,1.0462418488011709,1,0.4,0.4,transcript,15769.0
ATP8A1,ENSG00000124406,breast adenocarcinoma,EFO_0000304,0.10462164825762994,1.0463942455404969,4,1.6,6.4,transcript,36003.0
PDCD4,ENSG00000150593,glioma,EFO_0005543,0.10459349603923028,1.0459699719461155,1,0.5,0.5,transcript,14281.0
GSTA5,ENSG00000182793,red blood cell density,OBA_2045260,0.10451295652210138,1.0454797052770362,1,0.5,0.5,transcript,1428.0
TWSG1,ENSG00000128791,cancer,MONDO_0004992,0.10449205458578543,1.044976256164261,1,0.4,0.4,transcript,7180.0
OR5AS1,ENSG00000181785,IGF-1 measurement,EFO_0004627,0.1044676497417879,1.0447273880031207,1,0.4,0.4,transcript,7860.0
C15orf61,ENSG00000189227,triglyceride measurement,EFO_0004530,0.10445600030846056,1.0461815370557423,5,2.0,10.0,transcript,6167.0
CPD,ENSG00000108582,total cholesterol measurement,EFO_0004574,0.10443920956015663,1.0444123139598358,1,0.4,0.4,transcript,19784.0
KERA,ENSG00000139330,liver disease,EFO_0001421,0.10441391396484237,1.044865421990684,2,0.8,1.6,transcript,2203.0
IPP,ENSG00000197429,erythrocyte volume,OBA_0003460,0.10424026957925021,1.042483471236767,1,0.5,0.5,transcript,6190.0
HHLA2,ENSG00000114455,cancer,MONDO_0004992,0.10420505782254207,1.0420843825658979,1,0.5,0.5,transcript,14791.0
AHNAK2,ENSG00000185567,neoplasm,EFO_0000616,0.10417982465094772,1.041846076235652,2,1.0,2.0,transcript,41815.0
RCN2,ENSG00000117906,mean corpuscular hemoglobin concentration,EFO_0004528,0.10413736507873488,1.0414009657286216,1,0.4,0.4,transcript,14644.0
TRIM44,ENSG00000166326,Miyoshi myopathy,MONDO_0009685,0.10410764275214213,1.0411057723970722,1,0.4,0.4,transcript,13631.0
CAVIN2,ENSG00000168497,lung adenocarcinoma,EFO_0000571,0.10397258066547381,1.0398567824242209,1,0.4,0.4,transcript,3054.0
PYGO1,ENSG00000171016,head and neck squamous cell carcinoma,EFO_0000181,0.10389709936328738,1.0392988288956542,4,1.6,6.4,transcript,19522.0
NXPH2,ENSG00000144227,Abdominal pain,HP_0002027,0.10381184823969117,1.038266138358521,1,0.4,0.4,transcript,2709.0
CENPQ,ENSG00000031691,N1-methyladenosine measurement,EFO_0021122,0.10381184823969117,1.03834823541242,1,0.4,0.4,transcript,1741.0
PCMTD1,ENSG00000168300,facial pain,EFO_0009625,0.10381184823969117,1.0383233304679256,3,1.2000000000000002,3.6000000000000005,transcript,17574.0
CENPQ,ENSG00000031691,systolic blood pressure,EFO_0006335,0.10381184823969117,1.03834823541242,1,0.4,0.4,transcript,1741.0
TMPRSS4,ENSG00000137648,non-small cell lung carcinoma,EFO_0003060,0.10379939369591118,1.0380042686049429,1,0.4,0.4,transcript,38716.0
GMCL1,ENSG00000087338,body mass index,EFO_0004340,0.10379905352991968,1.0382449477654077,2,0.8,1.6,transcript,6289.0
COG3,ENSG00000136152,breast adenocarcinoma,EFO_0000304,0.10377896917189317,1.0378435304181886,1,0.5,0.5,transcript,9287.0
SEC22A,ENSG00000121542,breast adenocarcinoma,EFO_0000304,0.10377896917189317,1.037911726651431,2,0.8,1.6,transcript,13111.0
SMIM36,ENSG00000261873,BMI-adjusted waist-hip ratio,EFO_0007788,0.10374122313911832,1.0375938019767486,1,0.4,0.4,transcript,2203.0
MR1,ENSG00000153029,cancer,MONDO_0004992,0.10371525772949565,1.0372856199055482,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
MR1,ENSG00000153029,neoplasm,EFO_0000616,0.10366492855010784,1.0367823281116701,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
KRT20,ENSG00000171431,melanoma,EFO_0000756,0.1036604347528008,1.0367938311850426,1,0.4,0.4,transcript,2111.0
RBM23,ENSG00000100461,adolescent idiopathic scoliosis,EFO_0005423,0.10350380602516043,1.03504791902468,1,0.4,0.4,transcript,40573.0
PTBP3,ENSG00000119314,gastric cancer,MONDO_0001056,0.10347561257484608,1.0349895633505897,5,2.0,10.0,transcript,42838.0
SMC6,ENSG00000163029,heart rate,OBA_1001087,0.103443056934455,1.0344469789277466,1,0.4,0.4,transcript,24376.0
RAB40B,ENSG00000141542,breast cancer,MONDO_0007254,0.10340348531694542,1.034063240083087,1,0.4,0.4,transcript,14091.0
C2CD6,ENSG00000155754,azoospermia,EFO_0000279,0.10337862637558719,1.0338271869838962,1,0.5,0.5,transcript,12218.0
CLDN1,ENSG00000163347,breast cancer,MONDO_0007254,0.10330706107244346,1.034720945948777,4,1.6,6.4,transcript,3878.0
CLASP2,ENSG00000163539,adult-onset Still's disease,EFO_0007135,0.10328531614094857,1.0328592807987707,1,0.4,0.4,transcript,65366.0
DYNLT5,ENSG00000152760,Chest pain,HP_0100749,0.10327315468025329,1.0328017099318085,1,0.4,0.4,transcript,5701.0
GPAT3,ENSG00000138678,neoplasm,EFO_0000616,0.10324112266159637,1.0325583530527453,2,0.8,1.6,transcript,10875.0
CDV3,ENSG00000091527,bone tissue density,OBA_1000110,0.10323880613087681,1.0324141846107535,1,0.4,0.4,transcript,15312.0
C6,ENSG00000039537,cardiomyopathy,EFO_0000318,0.10309608051032751,1.0309903681612778,1,0.5,0.5,transcript,16913.0
GBP6,ENSG00000183347,soluble triggering receptor expressed on myeloid cells 2 measurement,EFO_0010151,0.10308529427999007,1.0312371477091857,2,0.9,1.8,transcript,4685.0
GANC,ENSG00000214013,hemoglobin measurement,EFO_0004509,0.102988910667324,1.029918380677924,1,0.5,0.5,transcript,17080.0
METTL14,ENSG00000145388,non-small cell lung carcinoma,EFO_0003060,0.10294998077138467,1.0295253946133542,1,0.4,0.4,transcript,15633.0
GLCE,ENSG00000138604,diastolic blood pressure,EFO_0006336,0.10294553012219103,1.029585626219874,2,0.8,1.6,transcript,12277.0
LAIR1,ENSG00000167613,hepatocellular carcinoma,EFO_0000182,0.10272369931288083,1.0272526450305144,1,0.4,0.4,transcript,25556.0
CPB1,ENSG00000153002,squamous cell lung carcinoma,EFO_0000708,0.1026624375278724,1.0266699541301367,1,0.5,0.5,transcript,10970.0
USP15,ENSG00000135655,esophageal cancer,MONDO_0007576,0.1026353838510522,1.0264369563531521,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
SMC3,ENSG00000108055,squamous cell lung carcinoma,EFO_0000708,0.10259050567589015,1.0259136692815094,1,0.4,0.4,transcript,46444.0
SYCP1,ENSG00000198765,squamous cell lung carcinoma,EFO_0000708,0.10259050567589015,1.0259261850073695,1,0.4,0.4,transcript,18932.0
CENPQ,ENSG00000031691,sialolithiasis,EFO_1001180,0.10247198235052869,1.0249495765207954,1,0.4,0.4,transcript,1741.0
SRGN,ENSG00000122862,eosinophil count,EFO_0004842,0.10239113091449091,1.0240346897741501,1,0.4,0.4,transcript,3242.0
RAD18,ENSG00000070950,renal osteodystrophy,EFO_1001152,0.10236131666356467,1.0236466478443182,1,0.4,0.4,transcript,11947.0
PAG1,ENSG00000076641,acute myeloid leukemia,EFO_0000222,0.10233535178900503,1.0234836097674387,2,0.8,1.6,transcript,12299.0
C2orf73,ENSG00000177994,HbA1c measurement,EFO_0004541,0.10229178471904471,1.0229661563691912,1,0.4,0.4,transcript,8280.0
OR5M1,ENSG00000255012,high density lipoprotein cholesterol measurement,EFO_0004612,0.10227698095656351,1.0231417296028273,2,0.8,1.6,transcript,4302.0
BTBD8,ENSG00000189195,body mass index,EFO_0004340,0.10222090168787729,1.0222254989462833,1,0.5,0.5,transcript,30336.0
METTL14,ENSG00000145388,nasopharyngeal carcinoma,MONDO_0015459,0.10206868741866852,1.0207124610861926,1,0.4,0.4,transcript,15633.0
MR1,ENSG00000153029,infection,EFO_0000544,0.10205161230808599,1.0206491656914516,3,1.2000000000000002,3.6000000000000005,transcript,27059.0
SLAMF7,ENSG00000026751,acute myeloid leukemia,EFO_0000222,0.10203312546850872,1.0203474509842327,1,0.4,0.4,transcript,24697.0
PAG1,ENSG00000076641,Alzheimer disease,MONDO_0004975,0.10199274323082287,1.0200575241856171,2,0.8,1.6,transcript,12299.0
VWDE,ENSG00000146530,Hypoplastic amelogenesis imperfecta,Orphanet_100031,0.10175790997586474,1.0176057224091983,1,0.5,0.5,transcript,18781.0
SLC9B1,ENSG00000164037,cardiovascular disease,EFO_0000319,0.10172390695424612,1.0172840416597484,1,0.5,0.5,transcript,11118.0
CNR2,ENSG00000188822,Alzheimer disease,MONDO_0004975,0.1016856008604019,1.0169319820133258,1,0.4,0.4,transcript,5265.0
AKR1B10,ENSG00000198074,nasopharyngeal carcinoma,MONDO_0015459,0.10167459845549888,1.0168781198615429,1,0.5,0.5,transcript,3784.0
SLC7A2,ENSG00000003989,neoplasm,EFO_0000616,0.10167244588139916,1.0168454544351024,3,1.4,4.199999999999999,transcript,34712.0
HPSE,ENSG00000173083,alkaline phosphatase measurement,EFO_0004533,0.10163061362361742,1.0163939839667744,2,0.9,1.8,transcript,20490.0
KRT20,ENSG00000171431,myeloid sarcoma,EFO_1001052,0.10150933865361911,1.0152828701932257,1,0.4,0.4,transcript,2111.0
ATP5F1A,ENSG00000152234,gout,EFO_0004274,0.1014891338745869,1.0149051394635062,1,0.4,0.4,transcript,28984.0
ATP5F1A,ENSG00000152234,smoking behavior,EFO_0004318,0.1014891338745869,1.0149051394635062,1,0.4,0.4,transcript,28984.0
ATP5F1A,ENSG00000152234,body weights and measures,EFO_0004324,0.1014891338745869,1.0149051394635062,1,0.4,0.4,transcript,28984.0
ATP5F1A,ENSG00000152234,social inhibition quality,OBA_1000278,0.1014891338745869,1.0149051394635062,1,0.4,0.4,transcript,28984.0
SLC35B4,ENSG00000205060,smoking initiation,EFO_0005670,0.1014891338745869,1.014933258678797,1,0.4,0.4,transcript,9542.0
SLC35B4,ENSG00000205060,anorexia nervosa,MONDO_0005351,0.1014891338745869,1.014933258678797,1,0.4,0.4,transcript,9542.0
SGCB,ENSG00000163069,breast cancer,MONDO_0007254,0.10148875876185091,1.0149601828998158,1,0.4,0.4,transcript,5510.0
USP15,ENSG00000135655,hepatocellular carcinoma,EFO_0000182,0.1014831295887055,1.0149144137296853,3,1.2000000000000002,3.6000000000000005,transcript,43312.0
PNLIPRP3,ENSG00000203837,esophageal cancer,MONDO_0007576,0.10147708056172203,1.0149392976138503,1,0.4,0.4,transcript,2374.0
FITM2,ENSG00000197296,esophageal cancer,MONDO_0007576,0.10147708056172203,1.0148572360407293,1,0.4,0.4,transcript,4628.0
G3BP2,ENSG00000138757,type 2 diabetes mellitus,MONDO_0005148,0.10133125821679746,1.0133143354081817,1,0.4,0.4,transcript,228149.0
METTL14,ENSG00000145388,cancer,MONDO_0004992,0.10125146412896671,1.0125402281891744,1,0.4,0.4,transcript,15633.0
GBP1,ENSG00000117228,breast cancer,MONDO_0007254,0.10123870669336796,1.0124908821426077,2,0.8,1.6,transcript,15412.0
SRGN,ENSG00000122862,eosinophil percentage of leukocytes,EFO_0007991,0.10120772256101951,1.0122006062394362,1,0.4,0.4,transcript,3242.0
HHLA2,ENSG00000114455,nonpapillary renal cell carcinoma,MONDO_0007763,0.10119639374175855,1.0119977417580628,1,0.5,0.5,transcript,14791.0
PDCD4,ENSG00000150593,oral squamous cell carcinoma,EFO_0000199,0.10116770102753853,1.011712021829198,1,0.5,0.5,transcript,14281.0
CLDN1,ENSG00000163347,triple-negative breast cancer,EFO_0005537,0.10115662047150781,1.0132165399394204,4,1.6,6.4,transcript,3878.0
TNFRSF19,ENSG00000127863,glioma,EFO_0005543,0.10113126516490234,1.0113456527710616,1,0.5,0.5,transcript,15151.0
TRMT6,ENSG00000089195,hepatocellular carcinoma,EFO_0000182,0.10109206724538101,1.0109541536624818,1,0.4,0.4,transcript,11947.0
CDCA4,ENSG00000170779,neoplasm,EFO_0000616,0.10105491376765863,1.010649539283012,1,0.4,0.4,transcript,3984.0
PTCHD4,ENSG00000244694,Abruptio Placentae,EFO_1001754,0.10098833817941316,1.0102972224654732,6,2.4000000000000004,14.400000000000002,transcript,34796.0
FGFR1OP2,ENSG00000111790,atrial fibrillation,EFO_0000275,0.1009261155952023,1.0092972896466934,1,0.4,0.4,transcript,11070.0
LIMA1,ENSG00000050405,neoplasm,EFO_0000616,0.10086695427223488,1.0086829470988778,1,0.4,0.4,transcript,29841.0
HLA-E,ENSG00000204592,Miyoshi myopathy,MONDO_0009685,0.10082538935927539,1.008349564484885,1,0.4,0.4,transcript,4181.0
GMCL1,ENSG00000087338,platelet count,EFO_0004309,0.1008211584371978,1.008465996838189,2,0.8,1.6,transcript,6289.0
C2CD2,ENSG00000157617,serum creatinine amount,OBA_2050096,0.10079940543323895,1.0080080354578702,1,0.4,0.4,transcript,28610.0
OXSR1,ENSG00000172939,diastolic blood pressure change measurement,EFO_0006945,0.10079296434114976,1.007970219593279,1,0.4,0.4,transcript,9858.0
CD93,ENSG00000125810,cancer,MONDO_0004992,0.10077486988859238,1.0077750164068133,1,0.4,0.4,transcript,15199.0
APIP,ENSG00000149089,ovarian dysfunction,EFO_0009003,0.10067961928653019,1.0068689624767122,1,0.5,0.5,transcript,6871.0
APIP,ENSG00000149089,vascular disease,EFO_0004264,0.10067961928653019,1.0068689624767122,1,0.5,0.5,transcript,6871.0
STT3B,ENSG00000163527,drug use measurement,EFO_0007010,0.10064967358109243,1.0065164587042728,1,0.4,0.4,transcript,20281.0
STT3B,ENSG00000163527,dementia,MONDO_0001627,0.10064967358109243,1.0065164587042728,1,0.4,0.4,transcript,20281.0
GMCL1,ENSG00000087338,azoospermia,EFO_0000279,0.10060826609306707,1.0063370733968817,2,0.8,1.6,transcript,6289.0
GMCL2,ENSG00000244234,azoospermia,EFO_0000279,0.10060826609306707,1.0062221795912916,1,0.4,0.4,transcript,2867.0
CNR2,ENSG00000188822,Alopecia-intellectual disability syndrome,Orphanet_2850,0.10060784933083548,1.0061544667176616,1,0.4,0.4,transcript,5265.0
GRSF1,ENSG00000132463,mean corpuscular hemoglobin concentration,EFO_0004528,0.10058773352866697,1.0059684255229349,2,0.8,1.6,transcript,17565.0
GUCA1C,ENSG00000138472,social inhibition quality,OBA_1000278,0.10053732069494913,1.0055724101367423,1,0.5,0.5,transcript,2510.0
GUCA1C,ENSG00000138472,attention deficit hyperactivity disorder,EFO_0003888,0.10053732069494913,1.0055724101367423,1,0.5,0.5,transcript,2510.0
GUCA1C,ENSG00000138472,substance abuse,MONDO_0002491,0.10053732069494913,1.0055724101367423,1,0.5,0.5,transcript,2510.0
C18orf54,ENSG00000166845,balding measurement,EFO_0007825,0.10053732069494913,1.0054586816009148,2,0.8,1.6,transcript,18719.0
CNR2,ENSG00000188822,breast adenocarcinoma,EFO_0000304,0.10052041763894748,1.0052801497987816,1,0.4,0.4,transcript,5265.0
KRT20,ENSG00000171431,cancer,MONDO_0004992,0.10043024666589383,1.0044919503159728,1,0.4,0.4,transcript,2111.0
YEATS2,ENSG00000163872,white matter integrity,EFO_0004641,0.10042793001745025,1.0043130406428202,1,0.5,0.5,transcript,14819.0
TXK,ENSG00000074966,lung adenocarcinoma,EFO_0000571,0.10037123085474112,1.003741700861321,1,0.4,0.4,transcript,13609.0
WBP2NL,ENSG00000183066,cognitive function measurement,EFO_0008354,0.10035754553997178,1.0036176103613568,1,0.5,0.5,transcript,11861.0
HECW2,ENSG00000138411,generalized dystonia,MONDO_0000476,0.10035016896558639,1.0035075058073166,1,0.4,0.4,transcript,68774.0
TRDMT1,ENSG00000107614,neutrophil measurement,EFO_0803548,0.10030048540844556,1.0030186457611787,1,0.4,0.4,transcript,29003.0
C18orf54,ENSG00000166845,high density lipoprotein cholesterol measurement,EFO_0004612,0.10028956695924443,1.0029811442438679,2,0.8,1.6,transcript,18719.0
EHD1,ENSG00000110047,neoplasm,EFO_0000616,0.10022205062169814,1.0022388531576292,1,0.4,0.4,transcript,21802.0
PKHD1L1,ENSG00000205038,lung adenocarcinoma,EFO_0000571,0.10020512415058407,1.0020672877189345,1,0.4,0.4,transcript,24928.0
AGO3,ENSG00000126070,Abnormal central motor function,HP_0011442,0.10016648735817187,1.0016780397052827,1,0.4,0.4,transcript,30381.0
PAQR3,ENSG00000163291,neoplasm,EFO_0000616,0.10011458912656589,1.0011609430060162,1,0.4,0.4,transcript,26575.0
CMTR2,ENSG00000180917,cystatin C measurement,EFO_0004617,0.10010994269869496,1.0012028462875766,2,0.8,1.6,transcript,15471.0
ITPRID2,ENSG00000138434,Miyoshi myopathy,MONDO_0009685,0.10007500696637338,1.000758857203003,1,0.4,0.4,transcript,45519.0
